-- MySQL dump 10.13  Distrib 8.0.42, for Win64 (x86_64)
--
-- Host: localhost    Database: veritext
-- ------------------------------------------------------
-- Server version	9.3.0

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!50503 SET NAMES utf8 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `analyses`
--

DROP TABLE IF EXISTS `analyses`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `analyses` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `user_id` bigint unsigned DEFAULT NULL,
  `text` text COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `score` double NOT NULL,
  `top_words` text COLLATE utf8mb4_unicode_520_ci,
  `created_at` datetime(6) NOT NULL DEFAULT CURRENT_TIMESTAMP(6),
  PRIMARY KEY (`id`),
  KEY `ix_analyses_user` (`user_id`),
  KEY `ix_analyses_created` (`created_at`),
  KEY `ix_analyses_user_created` (`user_id`,`created_at` DESC),
  CONSTRAINT `fk_analyses_user` FOREIGN KEY (`user_id`) REFERENCES `users` (`id`) ON DELETE SET NULL ON UPDATE CASCADE
) ENGINE=InnoDB AUTO_INCREMENT=105 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `analyses`
--

LOCK TABLES `analyses` WRITE;
/*!40000 ALTER TABLE `analyses` DISABLE KEYS */;
INSERT INTO `analyses` VALUES (1,3,'En las últimas décadas, la evolución de las tecnologías digitales ha transformado profundamente la manera en que las personas interactúan, aprenden y resuelven problemas cotidianos. La inteligencia artificial, en particular, ha dejado de ser una herramienta experimental para convertirse en un componente esencial de múltiples servicios, desde aplicaciones móviles hasta sistemas de análisis de datos a gran escala. Uno de los avances más relevantes es la capacidad de los modelos de lenguaje para comprender y generar texto con un nivel de coherencia similar —e incluso superior— al humano. Estos modelos pueden analizar documentos extensos, resumir contenido complejo y ofrecer recomendaciones personalizadas en cuestión de segundos. Su funcionamiento se basa en redes neuronales entrenadas con millones de ejemplos, lo que les permite identificar patrones lingüísticos, inferencias lógicas y estructuras semánticas que antes solo podían ser tratadas mediante métodos manuales. Asimismo, el uso de IA en educación, salud y productividad ha mostrado beneficios significativos. En el ámbito educativo, los asistentes inteligentes pueden adaptar el contenido al ritmo de cada estudiante, detectando vacíos de conocimiento y proporcionando retroalimentación inmediata. En salud, los sistemas conversacionales pueden guiar a los usuarios en temas preventivos, apoyar en la gestión emocional y ofrecer orientación preliminar basada en evidencia científica. En productividad, los modelos automatizan tareas repetitivas, redactan informes y ayudan a planificar actividades de forma eficiente. A pesar de estas ventajas, es importante mantener una perspectiva crítica sobre su uso. La precisión del modelo depende de la calidad de los datos con los que fue entrenado, y aún existen riesgos de sesgos, errores o malinterpretaciones. Por ello, la supervisión humana sigue siendo una pieza fundamental para garantizar que la tecnología se aplique de manera ética y responsable. En resumen, la inteligencia artificial se ha consolidado como una herramienta poderosa que amplifica las capacidades humanas. Su desarrollo continuo sugiere un futuro en el que la colaboración entre personas y sistemas inteligentes será cada vez más natural, fluida y accesible para todos.',1,'[\"a\", \"accesible\", \"actividades\", \"adaptar\", \"al\"]','2025-11-28 22:55:08.285957'),(2,3,'Conceptos básicos:  •   Música.   La música es, según la definición tradicional del término, el  arte de crear y organizar sonidos y silencios respetando los principios  fundamentales de la melodía, la armonía y el ritmo.  •   Nota musical.   En música, u na nota es un símbolo que denota un  sonido musical. En el lenguaje, una nota es también el sonido en sí.  •   Escala musical.   Una escala musical es un grupo de notas que se tocan  en secuencia de forma ascendente o descendente en su tono (suelen  sonar agradable s al oído).  •   Melodía.   La melodía es una secuencia organizada de notas musicales  que se escuchan una tras otra de manera sucesiva. Es la parte de una  composición que se percibe como la línea principal.  •   Tonalidad.   La tonalidad hace alusión al tono de una ob ra. El tono es  un conjunto de sonidos que se sostienen en una misma nota principal  llamada tónica. La sucesión de esas notas compone las escalas.  •   Acorde.   Entendemos por acorde a un conjunto de tres o más notas  musicales diferentes, que suenan simultáneame nte.  •   Armonía musical.   Relación y orden de notas musicales que hace  referencia a la combinación de diferentes sonidos o notas que se  emiten al mismo tiempo, aunque el término también se utiliza para  referirse a la sucesión de estos sonidos emitidos a la ve z  •   Ritmo.   El ritmo puede definirse como la combinación armoniosa de  sonidos, voces o palabras, que incluyen las pausas, los silencios y los  cortes necesarios para que resulte grato a los sentidos.',1,'[\"(suelen\", \"a\", \"acorde\", \"acorde.\", \"agradable\"]','2025-11-28 22:57:01.617452'),(3,3,'Hola soy una persona intelige nte que me g usta jugar futb ol con mis amigos.',0.077,'[\"amigos.\", \"con\", \"futb\", \"g\", \"hola\"]','2025-11-28 22:58:23.421752'),(4,3,'En las últimas décadas, la evolución de las tecnologías digitales ha transformado profundamente la manera en que las personas interactúan, aprenden y resuelven problemas cotidianos.',0.181,'[\"aprenden\", \"cotidianos.\", \"de\", \"digitales\", \"d\\u00e9cadas,\"]','2025-11-28 23:01:14.865588'),(5,3,'Uno de los avances más relevantes es la capacidad de los modelos de lenguaje para comprender y generar texto con un nivel de coherencia similar —e incluso superior— al humano. Estos modelos pueden analizar documentos extensos, resumir contenido complejo y ofrecer recomendaciones personalizadas en cuestión de segundos. Su funcionamiento se basa en redes neuronales entrenadas con millones de ejemplos, lo que les permite identificar patrones lingüísticos, inferencias lógicas y estructuras semánticas que antes solo podían ser tratadas mediante métodos manuales.\n\nAsimismo, el uso de IA en educación, salud y productividad ha mostrado beneficios significativos. En el ámbito educativo, los asistentes inteligentes pueden adaptar el contenido al ritmo de cada estudiante, detectando vacíos de conocimiento y proporcionando retroalimentación inmediata. En salud, los sistemas conversacionales pueden guiar a los usuarios en temas preventivos, apoyar en la gestión emocional y ofrecer orientación preliminar basada en evidencia científica. En productividad, los modelos automatizan tareas repetitivas, redactan informes y ayudan a planificar actividades de forma eficiente.',1,'[\"a\", \"actividades\", \"adaptar\", \"al\", \"analizar\"]','2025-11-28 23:02:47.734354'),(6,3,'Asegúrate de que el archivo pdfjs-dist.d.ts esté en una ruta incluida por tu tsconfig.json (por ejemplo en la raíz del proyecto o en una carpeta types/ incluida en \"include\").\n\nSi tenías el comentario // @ts-ignore encima de los import(\"pdfjs-dist/build/pdf\"), ya lo puedes quitar si quieres, debería compilar bien.\n\nReinicia el servidor de Metro / bundler de Expo después de cambiar el .d.ts para que recoja los nuevos tipos.',0.426,'[\"\\\"include\\\").\", \"(por\", \".d.ts\", \"/\", \"//\"]','2025-11-28 23:05:24.041343'),(7,NULL,'Este es un texto de prueba para ver si el modelo está funcionando',0.15892863575744673,'[\"de\", \"el\", \"es\", \"este\", \"est\\u00e1\"]','2025-11-28 23:44:28.083714'),(8,NULL,'Este es un texto de prueba para ver si el modelo está funcionando',0.15892863575744673,'[\"de\", \"el\", \"es\", \"este\", \"est\\u00e1\"]','2025-11-28 23:45:38.491732'),(9,3,'En la presente investigación, el modelo de detección de texto generado por inteligencia artificial se entrena de forma offline, mientras que la aplicación móvil realiza únicamente el proceso de inferencia en tiempo real. Este enfoque separa la fase de entrenamiento del uso del modelo, permitiendo que el sistema funcione de manera eficiente, estable y sin necesidad de recalcular los parámetros cada vez que un usuario realiza un análisis.\n\nPara el entrenamiento se utilizó un pipeline desarrollado con la biblioteca scikit-learn. El pipeline combina dos componentes principales:\n\nTF-IDF (Term Frequency–Inverse Document Frequency)\nEste vectorizador convierte el texto en una representación numérica basada en la relevancia de cada término dentro del documento y su importancia relativa en el conjunto total. Se utilizaron ngramas de 1 a 2 palabras y un máximo de 5 000 características para capturar patrones léxicos propios de texto humano e IA.\n\nRegresión Logística\nSe empleó como clasificador binario para estimar la probabilidad de que un texto haya sido generado por IA (clase 1) o por un humano (clase 0). Este modelo es adecuado para problemas de clasificación lineal y ofrece probabilidades interpretables para el usuario.\n\nEl pipeline completo (TF-IDF + Regresión Logística) se entrena una sola vez utilizando un conjunto de datos previamente procesado. Al finalizar, el modelo es serializado mediante joblib y almacenado como un archivo binario llamado model.joblib.\n\nDurante la ejecución de la aplicación, el backend desarrollado en FastAPI no vuelve a entrenar el modelo. En su lugar, realiza un cargado perezoso (lazy load): al recibir la primera llamada al endpoint /analyze/text, el servidor lee el archivo model.joblib, inicializa el pipeline y lo mantiene en memoria durante todo el ciclo de vida del proceso. Las llamadas siguientes simplemente ejecutan el método predict_proba() del modelo para obtener la probabilidad de generación por IA, lo cual garantiza un rendimiento alto y tiempos de respuesta cortos.\n\nFinalmente, cada análisis es registrado en la base de datos, asociando al usuario autenticado con el texto evaluado, la probabilidad estimada y la fecha y hora del procesamiento. Esto permite mantener un historial consultable directamente desde la aplicación móvil.\n\nEn conjunto, esta arquitectura configura un sistema robusto y escalable, capaz de realizar detección de IA con un modelo entrenado profesionalmente sin necesidad de reentrenamientos constantes, optimizando tanto el desempeño como la experiencia del usuario.',0.15538847902656744,'[\"(clase\", \"(lazy\", \"(term\", \"(tf-idf\", \"+\"]','2025-11-28 23:48:19.426996'),(10,3,'Blocked aria-hidden on an element because its descendant retained focus. The focus must not be hidden from assistive technology users. Avoid using aria-hidden on a focused element or its ancestor. Consider using the inert attribute instead, which will also prevent focus. For more details, see the aria-hidden section of the WAI-ARIA specification at https://w3c.github.io/aria/#aria-hidden.\nElement with focus: <div.css-view-g5y9jx r-cursor-1loqt21 r-touchAction-1otgn73 r-alignItems-1awozwy r-backgroundColor-16kgrik r-borderRadius-6ncur5 r-height-ff8gi r-justifyContent-1777fci r-width-5flfrz>\nAncestor with aria-hidden: <div.css-view-g5y9jx r-flex-13awgt0 r-bottom-1p0dtai r-left-1d2f490 r-position-u8s1d r-right-zchlnj r-top-ipm5af> <div class=​\"css-view-g5y9jx r-flex-13awgt0 r-bottom-1p0dtai r-left-1d2f490 r-position-u8s1d r-right-zchlnj r-top-ipm5af\" style=​\"background-color:​ rgb(242, 242, 242)​;​ display:​ flex;​\" aria-hidden=​\"true\">​…​</div>​Comprende esta advertencia',0.17065967691594394,'[\"242)\\u200b;\\u200b\", \"242,\", \"<div\", \"<div.css-view-g5y9jx\", \"a\"]','2025-11-28 23:51:03.879071'),(11,3,'Estudiante de décimo ciclo de Ingeniería  de Sistemas Computacionales en la  Universidad Privada del Norte. Con  experiencia en desarrollo web (Frontend y  Backend), administración de hosting y  bases de datos, busco realizar prácticas  preprofesionales para aplicar mis  conocimientos y aportar soluciones  tecnológicas en instituciones educativas y  empresariales como CEPTRO Trujillo.',0.1688341926021005,'[\"(frontend\", \"administraci\\u00f3n\", \"aplicar\", \"aportar\", \"backend),\"]','2025-11-29 00:06:30.279489'),(12,3,'Conceptos básicos:  •   Música.   La música es, según la definición tradicional del término, el  arte de crear y organizar sonidos y silencios respetando los principios  fundamentales de la melodía, la armonía y el ritmo.  •   Nota musical.   En música, u na nota es un símbolo que denota un  sonido musical. En el lenguaje, una nota es también el sonido en sí.  •   Escala musical.   Una escala musical es un grupo de notas que se tocan  en secuencia de forma ascendente o descendente en su tono (suelen  sonar agradable s al oído).  •   Melodía.   La melodía es una secuencia organizada de notas musicales  que se escuchan una tras otra de manera sucesiva. Es la parte de una  composición que se percibe como la línea principal.  •   Tonalidad.   La tonalidad hace alusión al tono de una ob ra. El tono es  un conjunto de sonidos que se sostienen en una misma nota principal  llamada tónica. La sucesión de esas notas compone las escalas.  •   Acorde.   Entendemos por acorde a un conjunto de tres o más notas  musicales diferentes, que suenan simultáneame nte.  •   Armonía musical.   Relación y orden de notas musicales que hace  referencia a la combinación de diferentes sonidos o notas que se  emiten al mismo tiempo, aunque el término también se utiliza para  referirse a la sucesión de estos sonidos emitidos a la ve z  •   Ritmo.   El ritmo puede definirse como la combinación armoniosa de  sonidos, voces o palabras, que incluyen las pausas, los silencios y los  cortes necesarios para que resulte grato a los sentidos.',0.15791296272708558,'[\"(suelen\", \"a\", \"acorde\", \"acorde.\", \"agradable\"]','2025-11-29 00:07:14.953823'),(13,3,'Facultad   de   Ingeniería  Ingeniería   de   Sistemas  Computacionales  “Actividades Desarrolladas en el Año 2025  como Practicante Preprofesional de Ingeniería  de Sistemas Computacionales en el Área de  Desarrollo e Integración de Sistemas para la  Automatización   de Búsquedas Científicas en  LACCEI”  Empresa:   Latin American and  Caribbean Consortium of  Engineering Institutions (LACCEI)  Cargo:   Asistente de desarrollo de  sistemas e integración de datos  científicos  Apellidos   y   nombres:  Walter Ángel Nizama Zapata  Código:   N00309169  NRC:   1 6271  Modalidad:   Pasantía  Docente:   Miguel   Ángel   Chávez   Herrera  Sede:   Breña   –   Lima  Junio - 2025\nTabla   de   contenido  I.   Introducción   ................................ ................................ ................................ ....   3  II.   ASPECTOS   GENERALES   DE   LA   ORGANIZACIÓN   O   LOCALIDAD   ............   4  RUC   ................................ ................................ ................................ ...............................   4  Razón   Social   ................................ ................................ ................................ .................   4  MISIÓN   ................................ ................................ ................................ ..........................   4  VISIÓN ................................ ................................ ................................ ...........................   5  FODA ................................ ................................ ................................ .............................   5  ORGANIGRAMA   ................................ ................................ ................................ ...........   6  III.   ACTIVIDADES   REALIZADAS   DURANTE   LA   PRACTICA   ..........................   6  3.1.   Funciones   realizadas   ................................ ................................ ........................   6  3.2.   Relación   académica   –   laboral   ................................ ................................ ..........   7  IV.   IDENTIFICACION   DE   PROBLEMAS   Y   PROPUESTAS   DE   MEJORA   ........   7  4.1.   Identificación   de   problema(s)   o   retos   en   la   actividad   desempeñada   .............   7  4.2.   Descripción   de   las   estrategias   y   actividades   realizadas   ............................... 10  V.   CONCLUSIONES ................................ ................................ ...........................   11  VI.   RECOMENDACIONES   ................................ ................................ ...............   11  VII.   REFERENCIAS   BIBLIOGRAFICAS   ................................ ...........................   12  VIII.   ANEXOS ................................ ................................ ................................ .....   12\nI.   Introducción  En el presente   informe se describe la experiencia profesional desarrollada  durante mis prácticas preprofesionales en el   Latin American and Caribbean  Consortium of Engineering Institutions (LACCEI) , organización dedicada al  fortalecimiento   de   la   educación   y   la   investigaci ón   en   ingeniería   a   nivel  internacional.   Durante   este   proceso,   me   desempeñé   como   asistente   de  desarrollo   de   sistemas   e   integración   de   datos   científicos ,   participando  activamente en el proyecto   “Búsquedas Científicas Automáticas” , centrado en  el diseño e imp lementación de una plataforma web interactiva para la exploración,  análisis   y   visualización   de   información   científica   proveniente   de   la   API   de  OpenAlex.  Las   funciones   realizadas   se   alinearon   directamente   con   mi   formación  profesional   como   estudiante   de   Ing eniería   de   Sistemas   Computacionales ,  permitiéndome aplicar conocimientos en programación Python, consumo de APIs  REST, visualización de datos con Plotly y Matplotlib, diseño de interfaces web con  Streamlit, así como integración de autenticación y manejo de   usuarios mediante  conexión   a   bases   de   datos   MySQL.   Esta   experiencia   no   solo   reforzó   mis  competencias técnicas, sino que también impulsó habilidades transversales como  el trabajo colaborativo, la solución de problemas complejos y la adaptación ágil a  un en torno tecnológico real.  La   relevancia   de   las   actividades ejecutadas   radica en   su   aporte a   la  transformación digital de los procesos de búsqueda y análisis académico ,  automatizando   tareas   que   tradicionalmente   requerían   esfuerzo   manual   e  interpretativo. El   desarrollo del sistema permitió reducir significativamente el tiempo  de obtención de artículos científicos relevantes, implementar filtros avanzados de  consulta,   y   generar   perfiles   institucionales   dinámicos   basados   en   producción  científica, todo ello artic ulado desde una arquitectura modular orientada a usuarios  académicos y administrativos.\nLas   prácticas preprofesionales (PPP)   constituyen un componente clave  en la formación de un ingeniero de sistemas, al permitir la aplicación concreta de  los conocimientos teóricos adquiridos en la universidad dentro de un entorno  organizacional real. A través de ellas, se fortalece la capacid ad para enfrentar  desafíos tecnológicos, tomar decisiones fundamentadas y contribuir activamente al  desarrollo de soluciones digitales con impacto social y académico. Este informe  tiene como objetivo documentar de manera detallada las actividades realizada s,  reflexionar sobre su valor formativo y resaltar la importancia estratégica de las PPP  en la consolidación del perfil profesional del estudiante.\nII.   ASPECTOS   GENERALES   DE   LA   ORGANIZACIÓN   O  LOCALIDAD  RUC:   EIN 33 - 1044734  R AZÓN SOCIAL :   The Latin   American and Caribbean Consortium of Engineering Institutions, LACCEI  MISIÓN - VISIÓN - VALORES :\nFODA :\nORGANIGRAMA\nIII.   ACTIVIDADES   REALIZADAS   DURANTE   LA  PRACTICA  3.1.   Funciones   realizadas  Durante   el   periodo   de   prácticas   preprofesionales   en   la   organización  LACCEI ,   me   desempeñé   como   asistente   de   desarrollo   de   sistemas   e  integración   de   datos   científicos ,   en   el   marco   del   proyecto   “Búsquedas  Científicas Automáticas” . Mis funciones se   desarrollaron bajo la supervisión directa  del Dr. Fernando Zorto, quien asignó tareas técnicas orientadas a la construcción  de una plataforma digital para la recolección, análisis y visualización de artículos  académicos mediante la API de OpenAlex.  Entre   l as   funciones   realizadas   destacan:   la   implementación   de   filtros  avanzados de búsqueda científica, desarrollo de algoritmos de clustering (UMAP +  HDBSCAN), generación de visualizaciones interactivas con Plotly, Matplotlib y  NetworkX, automatización de report es en PDF, así como el diseño de módulos  funcionales para perfiles institucionales. Durante las semanas finales, colaboré en  la integración de estos módulos dentro de una nueva interfaz de usuario con  Streamlit   para   el   FRONTEND   y   que   también   se   usó   para   el   BACKEND ,  desarrollando funcionalidades de login y conexión con base de datos MySQL.  Estas   actividades   se   realizaron   conforme   a   los   objetivos   del   área   de  transformación digital aplicada a la investigación académica y bajo estándares de  calidad y seguridad   en el manejo de datos.\n3.2.   Relación   académica   –   laboral  Durante el   desarrollo de   mis   prácticas, apliqué   de   manera directa   los  conocimientos adquiridos en los siguientes cursos universitarios:     Programación Orientada a Objetos (POO):   Me permitió estructurar el código en  Python de forma eficiente, modularizando funciones y mejorando la mantenibilidad de  los scripts utilizados para análisis temático y clustering.     Bases de Datos:   Fue fundamental para implementar la conexión entre la apli cación y  la   base   de   datos   MySQL.   Comprendí   cómo   diseñar   y   consultar   estructuras  relacionales para autenticar usuarios y almacenar registros de acceso.     Inteligencia Artificial y Ciencia de Datos:   Los conceptos de minería de datos,  reducción   de   dimensionalid ad   y   agrupamiento   no   supervisado   me   ayudaron   a  implementar algoritmos como UMAP y HDBSCAN, optimizando el agrupamiento  temático de publicaciones científicas.     Desarrollo   de   Aplicaciones   Web:   Me   brindó   las   bases   para   colaborar   en   la  construcción   de   la   interf az   en   Streamlit,   donde   pude   integrar   componentes  interactivos, filtros dinámicos y visualizaciones embebidas orientadas al usuario final.  Estas asignaturas no solo reforzaron mis habilidades técnicas durante la  práctica, sino que también validaron el valor   de una formación académica integral  al enfrentar desafíos reales en el desarrollo de soluciones tecnológicas.\nIV.   IDENTIFICACION   DE   PROBLEMAS   Y   PROPUESTAS  DE MEJORA  Durante el desarrollo de mis prácticas preprofesionales en LACCEI, se  identificaron   diversos retos técnicos que influyeron directamente en la operatividad  y escalabilidad del proyecto “Búsquedas Científicas Automáticas”. La resolución de  dichos problemas implicó aplicar conocimientos teóricos adquiridos durante la  carrera   y el uso de herr amientas específicas en el entorno   de desarrollo. A  continuación, se detallan dos de los principales problemas enfrentados, junto con  las estrategias implementadas y su respectivo sustento teórico.\n4.1.   Identificación   de   problema(s)   o   retos   en   la  actividad   desempeñada  Problema 1:   Ausencia de un sistema de autenticación y segmentación de  usuarios  Al iniciar la integración del backend con el sistema general, se evidenció que el  proyecto no contaba con un mecanismo para gestionar usuarios, roles, ni p ermisos  de   acceso   diferenciados.   Esto   imposibilitaba   aplicar   criterios   de   seguridad,  personalización de interfaz y trazabilidad de sesiones. El desarrollo e integración  del   sistema   de   autenticación   fue   una   necesidad   técnica   no   contemplada  inicialmente.  Her ramientas utilizadas:  o   Python   (auth.py,   Frontend.py,   app.py, Perfil_por_Universidad.py)  o   MySQL   (tablas usuarios, roles)  o   Streamlit   (backend   y   frontend   de   aplicación,   control   de   sesiones   y  visualización condicional)  Ver Anexo A.1   –   creación de   Base de datos en   MYSQL   de roles   y usuarios  Ver Anexo A.3   –   Fragmento de código de login y validación de credenciales  Problema 2:   Falta de control visual de contenido por tipo de usuario en la  interfaz  En etapas posteriores del desarrollo   del backend , se identificó que la   plataforma  mostraba contenido indistinto a todos los perfiles, generando riesgos de acceso a  información no autorizada. No existía una lógica que adaptara el contenido de la  interfaz   según   el   tipo   de   usuario   autenticado.  Herramientas utilizadas:  o   Validacio nes por rol en st.session_state de   Streamlit  o   Scripts app.py y Perfil_por_Universidad.py con condicionales por tipo de usuario  dentro del Script Frontend.py.  Ver   Anexo   A.2   –   Diagrama   de   flujo   de   navegación   de   usuarios  Ver Anexo A.4   –   Captura de interfaz co n contenido restringido por rol\n4.2.   Descripción de las estrategias y actividades  realizadas  Problema   1   –   Solución   implementada:   Sistema   completo   de  autenticación y control de roles  Estrategia   y   mejora   aplicada:  Se desarrolló desde cero un sistema de autenticación, usando MySQL como  base   para   almacenar   usuarios,   contraseñas   encriptadas,   y   roles  diferenciados. El módulo auth.py valida credenciales e inicializa la sesión,  mientras que   la   lógica   condicional   se   conect a a   la base   de   datos   para  determinar el acceso permitido. Se implementaron roles como   estudiante ,  profesor   y   webmaster .  Logro   o   aporte:  Se   dotó   al   sistema   de   una   capa   fundamental   de   seguridad,   escalabilidad   y  personalización de uso. El proyecto ahora permi te diferenciar accesos, registrar  sesiones y gestionar usuarios desde un backend propio.  Sustento   teórico:  La implementación se basa en el modelo de   Control de Acceso Basado en  Roles (RBAC) , el cual permite asignar privilegios en función de un perfil defin ido.  Este modelo es recomendado por la norma   ISO/IEC 29146:2016 , la cual establece  directrices para la gestión de accesos en entornos digitales. Asimismo, según la  OWASP   Foundation ,   un   sistema   seguro   debe   incluir   mecanismos   de  autenticación robusta y difer enciación de privilegios para evitar escalamiento no  autorizado.\nProblema 2   –   Solución implementada: Visualización condicional según  tipo de usuario  Estrategia   y   mejora   aplicada:  Se   codificó   una   lógica   basada   en   el   estado   de   sesión   del   usuario  (st.session_state[\'usuario\'][\'rol\']) que permite activar o bloquear vistas según el tipo  de rol. Esto permitió crear una navegación controlada: los estudiantes solo pueden  acceder a su universidad, mientras que los roles superiores acceden a múltiples  vis tas analíticas.  Logro   o   aporte:  La   plataforma   ahora   cuenta   con   una   experiencia   personalizada,   donde   cada  usuario accede únicamente a lo necesario. Esta segmentación también optimiza la  seguridad y facilita futuras expansiones del sistema.  Sustento   teórico:  Esta mejora se basa en el   Principio del Menor Privilegio , recomendado por la  guía   NIST SP 800 - 53 Rev. 5 , que establece que los sistemas deben limitar el  acceso de cada usuario a los mínimos recursos necesarios. Además, se sustenta  en   la   ISO   9241 - 210:2019 ,   que   promueve   el   diseño   centrado   en   el   usuario,  garantizando que la interfaz se adapte a los perfiles y roles dentro del sistema.\nV.   CONCLUSIONES  Durante el desarrollo de las prácticas preprofesionales realizadas en LACCEI, se  alcanzaron   resultad os   significativos que aportaron   valor tanto al proyecto  institucional como a mi formación como futuro ingeniero de sistemas. La  ejecución técnica del sistema de automatización de búsquedas científicas  permitió integrar soluciones innovadoras orientadas a l a transformación digital  del acceso a la información académica. A continuación, se presentan los  principales resultados y nuevos conocimientos generados:  1.   El desarrollo de un sistema de búsqueda automatizada con filtros temáticos,  geográficos y por   institución académica permite reducir considerablemente el  tiempo   invertido   en   procesos   de   recolección   y   clasificación   de   literatura  científica , facilitando la toma de decisiones estratégicas en entornos académicos.  Esta solución   responde al objetivo centr al del   proyecto,   convirtiéndose en una  herramienta de impacto regional.  2.   La implementación desde cero de un sistema de autenticación y control de  roles aporta escalabilidad, seguridad y personalización al sistema, permitiendo  adaptar   el   acceso   según   el   perf il   del   usuario   (estudiante,   administrador,  investigador) . Este componente, no previsto en el planteamiento inicial, representa  un aporte técnico sustancial basado en principios de arquitectura de software y  ciberseguridad.  3.   La experiencia de trabajar con   tecnologías como Streamlit, OpenAlex, MySQL,  UMAP y HDBSCAN consolidó conocimientos en integración de APIs, ciencia  de   datos   y   visualización   interactiva ,   reforzando   competencias   profesionales  aplicadas en contextos reales. Esta integración tecnológica fome nta el dominio  práctico de soluciones modernas dentro de la ingeniería de sistemas.  4.   El proyecto genera un aporte social e institucional,   al democratizar el acceso a  datos científicos y ofrecer a universidades latinoamericanas una herramienta gratuita  para   analizar   su producción   académica,   identificar   clústeres   de   investigación   y  promover colaboraciones interuniversitarias.\nIdeas resumen / Nuevo conocimiento adquirido:  1.   La automatización de procesos puede optimizar tareas complejas como la búsqueda cient ífica.  2.   Diseñar   sistemas   desde   cero   permite   comprender   mejor   la   arquitectura   y   seguridad   de   las  aplicaciones.  3.   El control de acceso por roles es fundamental en plataformas académicas multiusuario.  4.   La   ingeniería   de   sistemas   tiene   un   rol   estratégico   en   la   mejora de procesos   institucionales  mediante soluciones digitales.  VI.   RECOMENDACIONES  1.   Implementar un sistema de retroalimentación entre usuarios y administradores  dentro   de   la   plataforma ,   que   permita   identificar   necesidades   específicas   de   las  universidades   usuarias   y   ajustar   los   filtros,   visualizaciones   o   funcionalidades   del  sistema. Esto contribuiría a una mejora continua y centrada en el usuario.  2.   Fomentar espacios de capacitación interna sobre el uso de herramientas de  acceso   abierto   como   OpenAlex ,   promov iendo   una   cultura   de   investigación  responsable, accesible y alineada con principios de responsabilidad social universitaria.  3.   Diseñar   un   módulo   complementario   de   trazabilidad   de   búsquedas   y  estadísticas de uso , para que los administradores puedan monitorea r el impacto real  de   la   herramienta, tomar   decisiones basadas en datos   y fortalecer   la gestión del  conocimiento dentro de LACCEI.  4.   Mantener y fortalecer la cultura de trabajo colaborativo virtual , asegurando una  comunicación fluida, objetivos compartidos y   claridad en los roles asignados, lo cual  contribuye a un clima laboral sano, participativo y orientado a resultados.\nVII.   REFERENCIAS BIBLIOGRÁFICAS     International Organization for Standardization. (2016).   ISO/IEC 29146:2016   –  Information   technology   –   Security   techniques   –   A   framework   for   access  management .   https://www.iso.org/standard/45138.html     International   Organization   for   Standardization.   (2019).   ISO   9241 - 210:2019   –  Ergonomics of hu man - system interaction   –   Part 210: Human - centred design for  interactive systems .   https://www.iso.org/standard/77520.html     National Institute of Standards and Technology. (2020).   Security and   privacy  controls   for   information   systems   and   organizations   (SP   800 - 53   Rev.   5) .  https://doi.org/10.6028/NIST.SP.800 - 53r5     OWASP Foundation. (2023).   Authentication cheat sheet .   https://owasp.org/www -  project - cheat - sheets/cheatsheets/Authentication_Cheat_Sheet.html     OpenAlex. (2024).   OpenAlex API documentation .   https://docs.openalex.org/     Streamlit Inc. (2024).   Streamlit documentation .   https://docs.streamlit.io/     MySQL.   (2024).   MySQL   8.0   reference   manual .   Oracle   Corporation.  https://dev.mysql.com/doc/refman/8.0/en/     LACCEI. (2024).   Organization chart . Latin American and Caribbean Consortium  of Engineering Institutions.   https://laccei.org/organization - chart/\nVIII.   ANEXOS  Anexo A:  Relacionado al Problema 1: Ausencia de autenticación y roles  A.1 -   Creación de   Base de datos en MYSQL  A.3 -   Fragmento de códigos de autenticación\nA.6 -   Evidencia del backend y frontend en ejecución   dentro de la plataforma streamlit\nCódigo backend de perfil por Universidades: El estudiante solo visualiza su universidad .  Código   backend   de   la   búsqueda   avanzada:   El   web   master   maneja   la   activación   e  inhabilitación de dicha herramienta para el estudiante , aquí se visualizan ambos códigos del  backend.\n\nEl profesor tiene acceso a todas las universidades previstas:  Ingresando como   web máster (usuario superior) que gestiona a los usuarios y tiene acceso  a los códigos del backend , y puede activar o desactivar la opción de búsqueda avanzada  para los estudiantes.\nRelacionado al Problema 2: Visualización condicional por rol  A.2   –   Flujograma de navegación del sistema según rol\nA.4   –   Captura del frontend diferenciado por usuario  A.5   –   Fragmento del código de control de acceso visual (st.session_state)\nAdicionales  A.7 -   Carpeta del proyecto y estructura de archivos\nA.8 -   Repositorio en GitHub\nAnexo B:  -   Documentos presentados en el Examen Parcial.  1.   Acuerdo de pasantía\n\n2.   Carta de presentación\n-   Certificado o Constancias de PPP o trabajo en donde se acredite el cumplimiento  de las horas de prácticas exigidas en   su carrera.  Por medio del presente, informo respetuosamente que el   certificado oficial de  cumplimiento de prácticas preprofesionales   será entregado entre el  miércoles 7 de julio y el viernes 9 de julio del presente año , ya que la  pasantía que vengo desarrollando con   LACCEI (Latin American and Caribbean  Consortium of Engineering Institutions)   finaliza en ese tramo de tiempo,  conforme al cronograma acordado con la organización.  Solicito su comprensión ante esta situación , asegurando que he cumplido con  responsabilidad y compromiso las actividades asignadas, tal como se refleja en  los informes periódicos presentados. Agradezco de antemano que esta condición  pueda ser considerada sin afectar la calificación final ni el prom edio acumulado,  ya que el cumplimiento efectivo de las horas y entregables está garantizado.\n-   Reportes de Actividades Periódicas (4 RAPS).  1.   RAP 1 :\n\n2.   RAP 2 :\n\n3.   RAP 3:\n\n4.   RAP 4:\n\n-   Evaluación de Desempeño (reporte del empleador).',0.1685894018734534,'[\"(2016).\", \"(2019).\", \"(2020).\", \"(2023).\", \"(2024).\"]','2025-11-29 00:08:00.447329'),(14,3,'ENCUESTA SOBRE EL CONSUMO DE  ÑUÑA  1.   ¿Conoces la ñuña como producto tradicional?  o   Sí  o   No  2.   Has consumido ñuña alguna vez?  o   Sí, frecuentemente  o   Sí, pocas veces  o   Nunca  3.   ¿Cómo conociste la ñuña?  o   Familiares  o   Mercado local  o   Amigos  o   Otros  4.   ¿Con qué frecuencia consumes ñuña?  o   Semanalmente  o   Mensualmente  o   Muy rara vez  o   Nunca  5.   ¿Dónde sueles comprar ñuña?  o   Mercado local  o   Productores de la zona  o   Fiestas o ferias  o   No la compro  6.   ¿Qué presentación prefieres?  o   Natural (grano crudo)  o   Tostada/lista para   consumir  o   Otros derivados (harina, snacks, etc.)  o   No consumo  7.   ¿Cuánto estarías dispuesto a pagar por una porción  (bolsita) de ñuña?  o   S/ 1.00   –   S/ 2.00  o   Más de S/ 4.00  o   No pagaría  8.   ¿Qué factor consideras más importante al comprar  ñuña?  o   Precio  o   Calidad  o   Tradici ón/Cultura  o   Presentación  9.   ¿Conoces sus beneficios nutricionales?  o   Sí, claramente  o   Algo  o   No  10.   ¿Con quién consumes normalmente ñuña?  o   En familia  o   Con amigos  o   Solo/a  o   No consumo  11.   ¿En qué ocasiones consumes ñuña?  o   A diario  o   Como snack  o   En festividades  o   No consumo  12.   ¿Consideras que la ñuña es un alimento  saludable?  o   Sí  o   No  o   No sé  13.   ¿Te gustaría encontrar más derivados de  la ñuña en el mercado?  o   Sí  o   No  o   Me es indiferente  14.   ¿Crees que la ñuña   debería promoverse  como   producto   representativo   de  Huancaspata?  o   Sí, definitivamente  o   b)   Tal vez  o   c)   No  15.   ¿Te   atrae   comprar   productos   con   buen  empaque o presentación?  o   Sí  o   No  o   Depende del precio  16.   ¿Qué edad tienes?  o   18   –   25 años  o   26   –   40 años  o   41   –   60 años  o   Más de 60 a ños  17.   Sexo:  o   Masculino  o   Femenino  o   Prefiero no decirlo  18.   ¿Tu nivel de ingresos influye al comprar  la ñuña?  o   Sí  o   No  o   A veces  19.   ¿Recomendarías la ñuña a otras personas?  o   Sí  o   No  o   No sé  20.   ¿Te gustaría que se realicen campañas  para incentivar el consumo de la ñuña?  o   Sí  o   No  o   Tal vez  ENCUESTA SOBRE EL CONSUMO DE  ÑUÑA  6.   1   ¿Conoces la ñuña como producto tradicional?  o   Sí  o   No  7.   2   Has consumido ñuña alguna vez?  o   Sí, frecuentemente  o   Sí, pocas veces  o   Nunca  8.   3   ¿Cómo conociste la ñuña?  o   Familiares  o   Mercado local  o   Amigos  o   Otros  9.   4   ¿Con qué frecuencia consumes ñuña?  o   Semanalmente  o   Mensualmente  o   Muy rara vez  o   Nunca  10.   5   ¿Dónde sueles comprar ñuña?  o   Mercado local  o   Productores de la zona  o   Fiestas o ferias  o   No la compro  6.   6   ¿Qué presentación prefieres?  o   Natural (grano crudo)  o   Tostada/lista para consumir  o   Otros derivados (harina, snacks, etc.)  o   No consumo  7.   7   ¿Cuánto estarías dispuesto a pagar por una porción  (bol (bol sita) de ñuña?  o   S/ 1.00   –   S/ 2.00  o   Más de S/ 4.00  o   No   pagaría  8.   8   ¿Qué factor consideras más importante al comprar  ñuñ ñ uña ?  o   Precio  o   Calidad  o   Tradición/Cultura  o   Presentación  21.   9   ¿Conoces sus beneficios nutricionales?  o   Sí, claramente  o   Algo  o   No  22.   10 ¿Con quién consumes normalmente ñuña?  o   En familia  o   Con amigos  o   Solo/a  o   No   consumo  11 ¿En qué ocasiones consumes ñuña?  o   A diario  o   Como snack  o   En festividades  o   No consumo  12 ¿Consideras que la ñuña es un alimento  saludable?  o   Sí  o   No  o   No sé  13   ¿Te gustaría encontrar más derivados de  la ñuña en el mercado?  o   Sí  o   No  o   Me es indiferente  14   ¿Crees que la ñ uña debería promoverse  como   producto   representativo   de  Huancaspata?  o   Sí, definitivamente  o   b)   Tal vez  o   c)   No  15   ¿Te   atrae   comprar   productos   con   buen  empaque o presentación?  o   Sí  o   No  o   Depende del precio  16   ¿Qué edad tienes?  o   18   –   25 años  o   26   –   40 años  o   41   –   60 años  o   Más de   60 años  17   Sexo:  o   Masculino  o   Femenino  o   Prefiero no decirlo  18   ¿Tu nivel de ingresos influye al comprar  la ñuña?  o   Sí  o   No  o   A veces  19   ¿Recomendarías la ñuña a otras personas?  o   Sí  o   No  o   No sé  20   ¿Te gustaría que se realicen campañas para  incentivar el consumo de la ñuña?  o   Sí  o   No  o   Tal vez',0.14688633825304123,'[\"(bol\", \"(bolsita)\", \"(grano\", \"(harina,\", \"1\"]','2025-11-29 00:08:14.656146'),(15,3,'@licstart The following is the entire license notice for the\n   * JavaScript code in this page\n   *\n   * Copyright 2023 Mozilla Foundation\n   *\n   * Licensed under the Apache License, Version 2.0 (the \"License\");\n   * you may not use this file except in compliance with the License.\n   * You may obtain a copy of the License at\n   *\n   *     http://www.apache.org/licenses/LICENSE-2.0\n   *\n   * Unless required by applicable law or agreed to in writing, software\n   * distributed under the License is distributed on an \"AS IS\" BASIS,\n   * WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n   * See the License for the specific language governing permissions and\n   * limitations under the License.\n   *\n   * @licend The above is the entire license notice for the\n   * JavaScript code in this page',0.42686698555235053,'[\"\\\"as\", \"\\\"license\\\");\", \"(the\", \"*\", \"2.0\"]','2025-11-29 00:08:30.769777'),(16,3,'En las últimas décadas, la evolución de las tecnologías digitales ha transformado profundamente la manera en que las personas interactúan, aprenden y resuelven problemas cotidianos. La inteligencia artificial, en particular, ha dejado de ser una herramienta experimental para convertirse en un componente esencial de múltiples servicios, desde aplicaciones móviles hasta sistemas de análisis de datos a gran escala. Uno de los avances más relevantes es la capacidad de los modelos de lenguaje para comprender y generar texto con un nivel de coherencia similar —e incluso superior— al humano. Estos modelos pueden analizar documentos extensos, resumir contenido complejo y ofrecer recomendaciones personalizadas en cuestión de segundos. Su funcionamiento se basa en redes neuronales entrenadas con millones de ejemplos, lo que les permite identificar patrones lingüísticos, inferencias lógicas y estructuras semánticas que antes solo podían ser tratadas mediante métodos manuales. Asimismo, el uso de IA en educación, salud y productividad ha mostrado beneficios significativos. En el ámbito educativo, los asistentes inteligentes pueden adaptar el contenido al ritmo de cada estudiante, detectando vacíos de conocimiento y proporcionando retroalimentación inmediata. En salud, los sistemas conversacionales pueden guiar a los usuarios en temas preventivos, apoyar en la gestión emocional y ofrecer orientación preliminar basada en evidencia científica. En productividad, los modelos automatizan tareas repetitivas, redactan informes y ayudan a planificar actividades de forma eficiente. A pesar de estas ventajas, es importante mantener una perspectiva crítica sobre su uso. La precisión del modelo depende de la calidad de los datos con los que fue entrenado, y aún existen riesgos de sesgos, errores o malinterpretaciones. Por ello, la supervisión humana sigue siendo una pieza fundamental para garantizar que la tecnología se aplique de manera ética y responsable. En resumen, la inteligencia artificial se ha consolidado como una herramienta poderosa que amplifica las capacidades humanas. Su desarrollo continuo sugiere un futuro en el que la colaboración entre personas y sistemas inteligentes será cada vez más natural, fluida y accesible para todos.',0.1542971735305855,'[\"a\", \"accesible\", \"actividades\", \"adaptar\", \"al\"]','2025-11-29 00:11:29.604920'),(17,3,'Hola soy una persona inteligente que me gusta jugar futbol con mis amigos',0.29255490841323745,'[\"amigos\", \"con\", \"futbol\", \"gusta\", \"hola\"]','2025-11-29 00:13:54.611595'),(18,2,'FACULTAD DE INGENIERÍA  CARRERA DE INGENIERÍA DE SISTEMAS  COMPUTACIONALES  PROYECTO FINAL  CURSO:   REDES 2  DOCENTE:   Jorge Luis Alvarado Ramos  INTEGRANTES:  •   Calderón Nolorbe Manuel N00213978  •   Chávez Juárez Sergio Gerardo N00305458  •   Marino Ñique Luis Enrique N00325094  •   Romer Ramírez Williams Anthony N00324335  •   Vázquez Ulloa Renzo Sair  •   Yarleque Flores Yarkoff Roberth N00300401  Trujillo   -   Perú 2025\nIntroducción   General:  La presente propuesta tiene como finalidad diseñar el plano integral de comunicaciones  correspondiente a los ambientes del 5to y 6to piso destinados a la Sede Administrativa  de la Municipalidad Distrital de Lince, ubicada en el distrito de Lince, provincia   de Lima,  departamento de Lima.  Dicho diseño forma parte del proceso de implementación de infraestructura tecnológica  para asegurar que las nuevas áreas administrativas cuenten con un sistema de  comunicaciones moderno, seguro y escalable.  El proyecto considera la elaboración del diseño lógico y físico de la red, el plano de  comunicaciones, así como un inventario   detallado   de los componentes de red  necesarios para garantizar el funcionamiento adecuado de los servicios institucionales.  Dichos   servicios, identificados a partir de las Gerencias y Subgerencias que se  establecerán en el quinto piso, son los siguientes 4 ejes clave:  Ejes Clave de Servicios Institucionales  1.   Gerencia de Desarrollo Urbano (GDU):  •   Planificación Territorial y ordenamiento urbano.  •   Trámite y otorgamiento de Licencias y Permisos de construcción.  •   Regulación y aplicación de Zonificación.  2.   Sub Gerencia de Infraestructura Urbana:  •   Supervisión y Ejecución de Obras públicas.  •   Mantenimiento de la infraestructura urbana.  •   Revisión y aprobación de Expedientes Técnicos (Comisión Técnica).  3.   Sub Gerencia de Fiscalización  •   Inspecciones de cumplimiento de licencias y normativas.  •   Aplicación de Sanciones Correctivas por infracciones.  •   Control de Condiciones de Seguridad en ambientes públicos y privados.  4.   Sub Gerencia de Desarrollo Económico Local:  •   Emisión de Licencias de Funcionamiento comercial.  •   Implementación de Programas de Apoyo a PYMEs locales.  •   Regulación de Ferias y comercio ambulatorio.  Ejes Clave de Servicios Institucionales (Proyección   -   Sexto Piso)  La red del sexto piso ha sido modelada como parte del alcance didáctico del proyecto,  proyectando la expansión de la Municipalidad para incorporar servicios de soporte y  gestión financiera. Es importante destacar que, al momento de este informe, la  informa ción de esta planta no se encuentra consolidada en los planos arquitectónicos  o de telecomunicaciones del edificio.\nLos servicios clave proyectados para esta planta, y que sustentan el diseño de la red  lógica, son:  5.   Recursos Humanos y Logística (RRHH_LOGISTICA):  •   Gestión   de   Talento   Humano:   Administración   de   personal,   planillas,   y  capacitación.  •   Gestión de Suministros: Adquisición, almacenamiento y distribución de bienes y  servicios.  •   Control de Activos: Inventario y seguimiento del patrimonio municipal.  6.   Rentas y Caja (RENTAS_CAJA):  •   Recaudación de Tributos: Administración y cobranza de impuestos y tasas  municipales (Rentas).  •   Tesorería   y   Movimiento   de   Fondos:   Manejo   de   ingresos   y   egresos   de   la  Municipalidad (Caja).  •   Control Presupuestal: Seguimiento a la ejecución del presupuesto municipal.  Los planos proporcionados de los pisos 5 y 6 sirven como base para la distribución  estratégica del cableado, los puntos de red, los equipos activos y las zonas de cobertura  inalámbrica.\nI. Diseño Lógico de la Red  ✔   Topología lógica clara :  El diseño lógico de la red de la Municipalidad Distrital de Lince se implementó en  Packet Tracer, representando de forma precisa la distribución de equipos del 5to y 6to  piso.  La topología incluye la conexión de computadoras, switches, puntos de acceso y  enlaces troncales que conectan ambos pisos.  Cada área administrativa está organizada dentro de su respectiva VLAN.  Piso 5:  Switches del piso 5:  •   Switch_Piso5_A (INFRA)   –   Switch principal del piso Transporta VLAN 10, 40, 50 y  VLAN 99 (nativa).  •   Switch_Piso5_B (FIZCA)   –   Switch secundario Conecta todas las estaciones de  Fiscalización (VLAN 20). Troncales en VLAN 99 hacia A.  •   Switch_Piso5_C (DESARROLLO)   –   Switch dedicado Conecta el área de  Desarrollo Económico (VLAN 30).  Access Points del Piso 5 (VLAN 50):  •   AccessPoint1   –   Zona Infra Urbana / Comisión Técnica  •   AccessPoint2   –   Zona Sub Gerencia / Fiscalización\n•   AccessPoint3   –   Zona Desarrollo Económico  Áreas conectadas (todas del piso 5):  •   Infra Urbana   –   VLAN 10:   PC9, PC13, PC15, PC14, PC46, PC47, PC17  •   Comisión Técnica   –   VLAN 10 : PC8, PC6, PC5, PC2, PC7, PC0  •   Sub Gerencia (Zona 1)   –   VLAN 10 : PC10, PC11_Secretaría  •   Gerencia GDU   –   VLAN 40:   PC19, PC20  •   GDU Secretaría   –   VLAN 40 : PC18, PC21, PC22  •   Fiscalización y Control Urbano   –   VLAN 20 : PC24, PC26, PC28, PC30, PC32,  PC34, PC35, PC33, PC31, PC29, PC27, PC25  •   Sub Gerencia (Zona 2)   –   VLAN 20 : PC36, PC7_Secretaría  •   Sub Gerencia (Zona 3)   –   VLAN 30 : PC43, PC44  •   Desarrollo Económico   –   VLAN 30 : PC38, PC39, PC40, PC41, PC42  Enlaces principales :  •   EtherChannel entre Switch_Piso5_A y Switch_Piso5_B (VLAN 99 nativa para  administración)  •   Enlace troncal Switch_Piso5_A   ↔   Switch_Piso5_C Transporta VLAN 30 y VLAN  99.  •   Enlaces de acceso Desde Switch_Piso5_A hacia los APs 1 y 2 Desde  Switch_Piso5_C hacia AP3  Piso 6:  Switches del piso 6:  •   Switch_Piso6_A   –   Switch principal del piso Conecta RRHH (VLAN 60) y parte de  Rentas (VLAN 70).  •   Switch_Piso6_B   –   Switch secundario Conecta Rentas/Caja (VLAN 70) y parte de  RRHH (VLAN 60).  Access Points del Piso 6 (VLAN 50):  •   AccessPoint3   –   Zona RRHH/Logística  •   AccessPoint4   –   Zona Rentas/Caja  •   Conexión de dispositivos móviles: Smartphone1, Smartphone2\nÁreas conectadas (todas del piso   6 ):  •   RRHH / Logística   –   VLAN 60:   PC5 2 , PC5 3 , PC54. PC5 5 , PC5 6 , PC57, PC58  •   Sub Gerencia   –   VLAN 60 :   PC57_Secretaría , PC 58  •   Rentas / Caja   –   VLAN 70 : PC 44 , PC 45, PC46, PC47, PC48, PC49  •   Sub Gerencia   –   VLAN 70 : PC 50 , PC 51  Enlaces principales:  •   Troncal   Switch_Piso6_A   ↔   Switch_Piso6_B VLAN 50, 60, 70, 99  •   Troncal Piso 6   ↔   Piso 5 Mediante interfaz Gig0/2 VLAN 50, 60, 70, 99  • Interconexión de switches, routers, APs y servidores.  - Enlaces troncales 802.1Q  Transportan las VLAN entre pisos y entre switches del mismo nivel.  - VLAN nativa 99   –   MANAGEMENT  •   Administración de switches  •   Gestión remota  •   Base del EtherChannel  •   Soporte para los troncales entre pisos  -   Router Cisco 1941 (Capa 3)  •   Subinterfaces configuradas por VLAN  •   DHCP para cada segmento  •   Routing inter - VLAN  •   Gateway por VLAN  - APs conectados a VLAN 50  •   Wi - Fi invitados  •   Soporte para smartphones y laptops dentro del edificio  • Direccionamiento IP:\nVLA  N ID  Nombre de  VLAN  Departamento/Á  rea  Dirección  de red  Máscara/CI  DR  Gateway  10   INFRA_URB   Infraestructura  Urbana, Sub  Gerencia Zona 1  192.168.10.  0  255.255.0.0/  16  192.168.10.  1  20   FISCALIZACION   Fiscalización y  Control Urbano,  Sub Gerencia  Zona 2  192.168.20.  0  255.255.0.0/  16  192.168.20.  1  30   DES_ECONOMI  CO  Desarrollo  Económico, Sub  Gerencia Zona 3  192.168.30.  0  255.255.0.0/  16  192.168.30.  1  40   GERENCIA_GD  U  Gerencia GDU y  GDU Secretaría  192.168.40.  0  255.255.0.0/  16  192.168.40.  1  50   WIFI_INVITADO  S  -   192.168.50.  0  255.255.0.0/  16  192.168.50.  1  60   RRHH_LOGISTI  CA  Recursos  Humanos y  Logística   –   Piso  6  192.168.60.  0  255.255.0.0/  16  192.168.60.  1  70   RENTAS_CAJA   Rentas / Caja   –  Piso 6  192.168.70.  0  255.255.0.0/  16  192.168.70.  1  100   SERVIDORES   Administración  de switches /  VLAN nativa  192.168.10  0.0  255.255.0.0/  16  192.168.10  0.1  o VLAN asignadas  Switch_piso5_A(infra)  Switch_piso5_B (tiene port security) (FIZCA)\nswitch_piso5_c(desarrollo)  switch_piso6_A  switch_piso6_B\no Puertas de enlace  ✔   Componentes requeridos  • Switches layer 2 o layer 3  • Routers  • Access points  • Servidores (DHCP, DNS, archivos, web)  ✔   Servicios configurados  Debe considerarse incluir al menos:  • VLAN  • Rutas dinámicas   ( OSPF )  • DHCP o DHCP relay  • Seguridad del switch (port security)  • WLAN (SSID, seguridad WPA2/WPA3)\nII. Diseño Físico de la Red  ✔   Plano físico del edificio o instalación  ARQUITECTURA   –   DISTRIBUCION   -   QUINTO PISO\n\nEste plano de arquitectura, que corresponde al quinto piso de oficinas, es la   base física  que determinó el   diseño lógico y la distribución del cableado   en nuestro modelo de  red. La distribución de los ambientes confirmó la necesidad de una   segmentación  estricta   de   la   red.   Cada   ambiente   principal   — como   GERENCIA   GDU ,  INFRAESTRUCTURA URBANA ,   FISCALIZACIÓN Y CONTROL URBANO   y   DESARROLLO  ECONÓMICO LOCAL —   fue tratado como un grupo funcional aislado. Esta separación  física de los usuarios justificó la creación de una   VLAN específica   para cada una de  estas oficinas clave en el diseño de Packet Tracer.  Además, la densidad de puestos de trabajo mostrada en cada área (escritorios y sillas)  sirvió para calcular la   cantidad de puertos de red   necesarios en los Switches de Acceso  del Piso 5 (A, B y C), asegurando que se proveyera la conectividad necesaria sin  sobredimensionar el equipo. La ubicación central del   Pasillo   y el acceso al   Rack  Principal   (aunque no   se muestre aquí,   se asume su   ubicación   en   la   Sala   de  Comunicaciones) es vital para el   tendido de la canalización horizontal   hacia los  switches   de cada áre a.  Plano de data y computo:  Parte de la   Leyenda 1  Parte de la Leyenda 2\n✔   Plano de comunicaciones  DATA Y COMPUTO 5TO PISO\n\nEl plano de telecomunicaciones para el quinto piso de oficinas ilustra la   canalización  horizontal   y la estrategia de agrupamiento de cables de red hacia el Gabinete de  Comunicaciones (Rack Principal).  1. Estrategia de Agrupamiento y Nomenclatura  El diseño sigue una estrategia clara de   agrupamiento por zonas   utilizando la  nomenclatura   PAQx   (Paquete).  •   Puntos de Red:   Se observa la ubicación de los puntos de red de cómputo  (indicados por círculos con un símbolo interno), que se distribuyen  estratégicamente en las áreas de trabajo, proveyendo conectividad a cada  puesto.  •   Agrupamiento (PAQx):   Los cables de red se agrupan en   16 paquetes  identificados de   PAQ1   a   PAQ16 . Cada PAQ representa el conjunto de cables  provenientes de   3 o 4 tomas de red   cercanas. Por ejemplo,   PAQ1   agrupa las  tomas de la zona cercana a la Secretaría de GDU, y   PAQ10   agrupa tomas en el  área de Fiscalización.  2. Diseño de Canalización  El diseño se enfoca en una canalización oculta y un punto de concentración  centralizado.  •   Tendido Oculto:   El cableado se dirige desde las rosetas de pared hacia un  sistema de canalización que, según la lógica del diseño de oficinas, se realiza  empotrado en el piso/muro   y luego   por el techo falso (plenum) ,  aprovechando los espacios no visibles para mantener la estética de la oficina.  •   Transición al Rack:   La flecha asociada a cada etiqueta   PAQx   marca la  trayectoria final   de ese haz de cables. Indica que el grupo de cables abandona  su canalización de acceso (tubería de $25   \\ text{ mm}$ en piso) y se dirige,  presumiblemente por una   bandeja de cables o conducto principal en el techo  falso , hacia el Rack Principal.  3. Justificación del Diseño  Este diseño garantiza el   orden   y la   trazabilidad   de la red.  •   Organización:   Al dividir la totalidad de los cables en 16 paquetes identificados,  se facilita enormemente la   instalación y la gestión   futura.  •   Mantenimiento:   Si surge un problema en una zona específica (p. ej.,  Infraestructura Urbana), el personal de soporte puede identificar rápidamente  qué grupo de cables (PAQ7, PAQ8, etc.) y qué   puertos del   patch panel   en el\nRack están afectados, en lugar de tener que rastrear cada cable  individualmente.  Este diseño es consistente con las   buenas prácticas de cableado estructurado   que  buscan simplificar la administración de la red horizontal.  III. Plano de Comunicaciones Completo  El esquema físico modelado en Packet Tracer se utilizó para validar la distribución real  de los puntos de red del quinto piso, tal como se define en los planos arquitectónicos, y  para integrar la proyección funcional del sexto piso. Aunque el plano de fond o  corresponde solo al quinto piso, los dispositivos ubicados fuera de sus límites físicos  (PC53 a PC58 y PC45 a PC51) representan los puestos de trabajo proyectados para los  departamentos del sexto piso (RRHH_LOGISTICA y RENTAS_CAJA). Este enfoque,  aunque   no respeta la geografía arquitectónica completa, es funcional y permitió simular  la topología de acceso del proyecto en su totalidad (ambos pisos). Dada la escala del  proyecto y la centralización de los equipos en un único Main Wiring Closet (Rack  Principa l), el diseño físico resulta ser eficiente y de baja complejidad, facilitando la  administración y el mantenimiento del cableado horizontal.\n\nIV. Relación de Componentes de Red  Componente   Modelo   Función   Cantidad   Ubicación  Switch   Cisco 2960   Segmentación de VLAN   5   Piso 5 - 6  Router   Cisco 1941   Salida a internet   1   Hall piso 5  Conectores  RJ - 45  Panduit /  Cat6  Terminación del  cableado estructurado  60 (aprox)   En cada punto  de datos del  piso 5 – 6  Rack   22U / Mural  o de piso  Alojar equipos de red  (switches, patch panel,  router)  1   Hall   piso 5  UPS   APC  1500VA  Respaldo eléctrico para  equipos de red  1   Hall   piso 5  Multilayer  Switch  3560 24PS   Permitir comunicación  de los switches.  1   Hall piso 5  V. Resumen Técnico del Proyecto  ✔   Justificación del diseño  El diseño de la red lógica de la Municipalidad de Lince se basa en una Topología de  Estrella Jerárquica (Core/Distribución Colapsada y Acceso). Esta topología fue elegida  por su escalabilidad, facilidad de gestión y alta disponibilidad.  Elemento Clave   Justificación de la Elección  Switch Multicapa  (Core/Distribución  Colapsada)  Se eligió para centralizar el tráfico y realizar el  Enrutamiento Inter - VLAN   de alto rendimiento, eliminando  la necesidad de múltiples   routers   y proporcionando una  solución eficiente de   Capa 3   para la comunicación entre  departamentos.  VLANs (Redes  Virtuales)  Implementadas para segmentar la red por   función  municipal   (p. ej.,   FISCALIZACION ,   RRHH_LOGISTICA ).  Esto aísla el tráfico sensible, reduce el dominio de  broadcast   (mejorando el rendimiento) y facilita la  aplicación de políticas de seguridad por grupo.\nSwitches de  Acceso (por Piso)  Se utilizan para la conectividad directa de los usuarios. Su  distribución por piso ( Switch_Piso5_A ,   Switch_Piso6_B ,  etc.) facilita el diagnóstico de fallos y el manejo del  cableado horizontal.  Servidor  Centralizado  Aloja el servicio   DHCP   para automatizar la asignación de  direcciones IP, reduciendo los errores de configuración  manual y agilizando la incorporación de nuevos  dispositivos.  Router Único  (Borde)  Se utiliza exclusivamente como   puerta de enlace   para la  salida a Internet, simplificando la configuración de la red  perimetral y el NAT.  ✔   Problemas resueltos  Problema  Resuelto  Tecnología  Implementada   Cómo se Garantiza  Redundancia y  Ancho de Banda  EtherChannel  (Agregación  de Enlaces)  Se agrupan múltiples enlaces físicos  entre el Switch Multicapa (Core) y los  Switches de Acceso. Esto proporciona  mayor ancho de banda   (suma de los  enlaces) y   redundancia automática : si  un cable o puerto falla, el tráfico se  redirige instantáneamente por el enlace  restante.  Seguridad de  Acceso a Puertos   Port Security  Implementado en los   Switches   de Acceso  (especialmente en el área de  FISCALIZACION ). Se limita el número de  direcciones MAC   que un puerto puede  aprender, impidiendo que dispositivos no  autorizados (como la   Laptop Intrusa ) se  conecten a la red corporativa.  Seguridad de  Gestión y Control  VLANs y ACLs  (Implícito)  La red está segregada. La VLAN  MANAGEMENT (99)   aísla la  administración de los dispositivos, y la  arquitectura permite aplicar   Listas de\nControl de Acceso (ACLs)   en el Switch  Multicapa para controlar qué  departamentos pueden acceder a qué  recursos (p. ej., prohibir el acceso de  WIFI_INVITADOS   a servidores internos).  Cobertura Wi - Fi   Access Points  (AP)  Se dispuso un Access Point por cada área  funcional en el piso 5 y 6 (conectados a la  VLAN   WIFI_INVITADOS ). Esto garantiza  una cobertura completa y uniforme,  manteniendo el tráfico inalámbrico de  invitados totalmente   segregado   de la red  interna de la Municipalidad.  Enrutamiento  Dinámico  (Didáctico)  OSPF  Aunque la topología es sencilla, la  implementación de OSPF enseña a los  routers   a   descubrir y compartir rutas  eficientemente. En una futura expansión  con múltiples salidas a Internet o  sucursales, OSPF garantizaría la  convergencia rápida y la selección del  mejor camino.  ✔   Buenas prácticas aplicadas  Eje de Buenas  Prácticas   Descripción de la Aplicación en el Diseño  Segmentación  Lógica:   Uso riguroso de   VLANs   para separar la red  corporativa ( INFRA_URB ,   GERENCIA_GDU , etc.) de los  servicios ( MANAGEMENT ) y del público  ( WIFI_INVITADOS ).  Seguridad  Acceso Físico:   Implementación de   Port Security   para  control de acceso a nivel de puerto.   Acceso Lógico:  Segregación de VLANs y arquitectura lista para la  aplicación de   ACLs .  Administración   Direccionamiento:   Uso de   DHCP   para simplificar la  gestión de direcciones IP.   Gestión de Red:\nImplementación de una VLAN de   MANAGEMENT (99)   para  centralizar el acceso seguro a los equipos.  Ubicación  Piso 5 - 6: Rack Principal / Sala de Comunicaciones:   Se  establece como el   punto central de la red (CORE)   donde  reside el Switch Multicapa y el Router.  Ubicación  Oficinas y Salas (Pisos 5 y 6):   Los Switches de Acceso y  los Access Points están distribuidos estratégicamente  para minimizar la longitud del cableado horizontal y  garantizar la cobertura.  VI. Conclusiones  El diseño de la red para la Municipalidad de Lince, desarrollado en Packet Tracer,  establece una infraestructura de red troncal robusta y jerárquica basada en un Switch  Multicapa (Core), implementando VLANs segmentadas por función departamental y  separando   rigurosamente el tráfico corporativo del tráfico de invitados y de gestión. La  inclusión estratégica de tecnologías como EtherChannel y Port Security garantiza tanto  la alta disponibilidad y el alto rendimiento de la interconexión entre pisos como la  segu ridad   estricta   en   los   puntos   de   acceso,   resolviendo   así   los   requisitos   de  escalabilidad, eficiencia y control necesarios para soportar los servicios institucionales  clave (GDU, Fiscalización, Infraestructura y Desarrollo Económico) de manera segura y  admin istrable.\nVII. ANEXOS  Prueba de   simulación :  Mensajes enviados correctamente:  Prueba de seguridad con port segurity:  Prueba de funcionamiento del   E therchannel:',0.1494710853467651,'[\"$25\", \"(\", \"(99)\", \"(a,\", \"(acls)\"]','2025-11-29 00:34:49.587838'),(19,3,'Planes de Servicio SaaS  POS • E-commerce • Multitienda • Profesional  PLAN SOLO POS (S/ 70 – 99)  • POS completo para ventas presenciales.  • Caja / Corte de Caja con historial y auditoría.  • Gestión de productos, categorías y stock mínimo.  • Gestión de clientes POS con historial de compras.  • Dashboard profesional con ventas del día y mes.  • Exportación de reportes a PDF y Excel.  • Impresión de tickets y boletas en PDF.  • Usuarios y permisos por rol (admin, cajero, supervisor).  PLAN SOLO E-COMMERCE (S/ 70 – 99)  • Tienda virtual completa con catálogo y buscador.  • Carrito de compras y proceso de Checkout.  • Pasarelas de pago: Yape, Plin, Culqi, Izipay, Stripe.  • Gestión de pedidos online con estados.  • Integración con WhatsApp para confirmar pedidos.  • SEO básico (títulos, descripciones, URLs amigables).  • Libro de reclamaciones online.  • Marketing básico: banners, ofertas y descuentos.  PLAN NEGOCIO (S/ 120 – 150)  • Incluye todo el módulo de POS.  • Incluye todo el módulo de E-commerce.  • Integración total de ventas físicas y online.  • Dashboard avanzado con KPIs y gráficas.  • Reportes consolidados y exportación avanzada.  • Gestión de clientes, proveedores, contactos y reclamos.  • Configuración avanzada de tienda, pagos y envíos.  PLAN EMPRESARIAL (S/ 200 – 350)  • Multitienda con subdominios independientes.  • Facturación electrónica integrada con SUNAT.  • Inventario avanzado con Kardex y movimientos.  • Módulo de delivery con zonas y estados de envío.  • Marketing avanzado, fidelización y cupones.  • Promociones configurables por producto o categoría.  • App móvil para monitoreo (opcional).',0.17448199774051812,'[\"(admin,\", \"(opcional).\", \"(s/\", \"(t\\u00edtulos,\", \"/\"]','2025-11-29 00:48:13.095020'),(20,3,'Su solicitud de pago se ha registrado satisfactoriamente.  Detalles del pago  TIENDA   IZI*DigitalTecc Dirección URL   https://digitaltecc.com Identificador de la tienda   84896980 Referencia pedido   ORD-20251121204522-861  Visa: 3,00 PEN  Fecha / Hora   21-11-2025 / 15:45:13 (GMT-5) Número de tarjeta   455788XXXXXX5547 Número de autorización   941228 Número de afiliación   5888879 Número de transacción Procesos   564974 Modo de pago   Sin cuotas 1  1/',0.1522597109610854,'[\"(gmt-5)\", \"/\", \"1\", \"1/\", \"15:45:13\"]','2025-11-29 00:53:20.196130'),(21,3,'FACULTAD DE INGENIERÍA  CARRERA DE INGENIERÍA DE SISTEMAS  COMPUTACIONALES  PROYECTO FINAL  CURSO:   REDES 2  DOCENTE:   Jorge Luis Alvarado Ramos  INTEGRANTES:  •   Calderón Nolorbe Manuel N00213978  •   Chávez Juárez Sergio Gerardo N00305458  •   Marino Ñique Luis Enrique N00325094  •   Romer Ramírez Williams Anthony N00324335  •   Vázquez Ulloa Renzo Sair  •   Yarleque Flores Yarkoff Roberth N00300401  Trujillo   -   Perú 2025\nIntroducción   General:  La presente propuesta tiene como finalidad diseñar el plano integral de comunicaciones  correspondiente a los ambientes del 5to y 6to piso destinados a la Sede Administrativa  de la Municipalidad Distrital de Lince, ubicada en el distrito de Lince, provincia   de Lima,  departamento de Lima.  Dicho diseño forma parte del proceso de implementación de infraestructura tecnológica  para asegurar que las nuevas áreas administrativas cuenten con un sistema de  comunicaciones moderno, seguro y escalable.  El proyecto considera la elaboración del diseño lógico y físico de la red, el plano de  comunicaciones, así como un inventario   detallado   de los componentes de red  necesarios para garantizar el funcionamiento adecuado de los servicios institucionales.  Dichos   servicios, identificados a partir de las Gerencias y Subgerencias que se  establecerán en el quinto piso, son los siguientes 4 ejes clave:  Ejes Clave de Servicios Institucionales  1.   Gerencia de Desarrollo Urbano (GDU):  •   Planificación Territorial y ordenamiento urbano.  •   Trámite y otorgamiento de Licencias y Permisos de construcción.  •   Regulación y aplicación de Zonificación.  2.   Sub Gerencia de Infraestructura Urbana:  •   Supervisión y Ejecución de Obras públicas.  •   Mantenimiento de la infraestructura urbana.  •   Revisión y aprobación de Expedientes Técnicos (Comisión Técnica).  3.   Sub Gerencia de Fiscalización  •   Inspecciones de cumplimiento de licencias y normativas.  •   Aplicación de Sanciones Correctivas por infracciones.  •   Control de Condiciones de Seguridad en ambientes públicos y privados.  4.   Sub Gerencia de Desarrollo Económico Local:  •   Emisión de Licencias de Funcionamiento comercial.  •   Implementación de Programas de Apoyo a PYMEs locales.  •   Regulación de Ferias y comercio ambulatorio.  Ejes Clave de Servicios Institucionales (Proyección   -   Sexto Piso)  La red del sexto piso ha sido modelada como parte del alcance didáctico del proyecto,  proyectando la expansión de la Municipalidad para incorporar servicios de soporte y  gestión financiera. Es importante destacar que, al momento de este informe, la  informa ción de esta planta no se encuentra consolidada en los planos arquitectónicos  o de telecomunicaciones del edificio.\nLos servicios clave proyectados para esta planta, y que sustentan el diseño de la red  lógica, son:  5.   Recursos Humanos y Logística (RRHH_LOGISTICA):  •   Gestión   de   Talento   Humano:   Administración   de   personal,   planillas,   y  capacitación.  •   Gestión de Suministros: Adquisición, almacenamiento y distribución de bienes y  servicios.  •   Control de Activos: Inventario y seguimiento del patrimonio municipal.  6.   Rentas y Caja (RENTAS_CAJA):  •   Recaudación de Tributos: Administración y cobranza de impuestos y tasas  municipales (Rentas).  •   Tesorería   y   Movimiento   de   Fondos:   Manejo   de   ingresos   y   egresos   de   la  Municipalidad (Caja).  •   Control Presupuestal: Seguimiento a la ejecución del presupuesto municipal.  Los planos proporcionados de los pisos 5 y 6 sirven como base para la distribución  estratégica del cableado, los puntos de red, los equipos activos y las zonas de cobertura  inalámbrica.\nI. Diseño Lógico de la Red  ✔   Topología lógica clara :  El diseño lógico de la red de la Municipalidad Distrital de Lince se implementó en  Packet Tracer, representando de forma precisa la distribución de equipos del 5to y 6to  piso.  La topología incluye la conexión de computadoras, switches, puntos de acceso y  enlaces troncales que conectan ambos pisos.  Cada área administrativa está organizada dentro de su respectiva VLAN.  Piso 5:  Switches del piso 5:  •   Switch_Piso5_A (INFRA)   –   Switch principal del piso Transporta VLAN 10, 40, 50 y  VLAN 99 (nativa).  •   Switch_Piso5_B (FIZCA)   –   Switch secundario Conecta todas las estaciones de  Fiscalización (VLAN 20). Troncales en VLAN 99 hacia A.  •   Switch_Piso5_C (DESARROLLO)   –   Switch dedicado Conecta el área de  Desarrollo Económico (VLAN 30).  Access Points del Piso 5 (VLAN 50):  •   AccessPoint1   –   Zona Infra Urbana / Comisión Técnica  •   AccessPoint2   –   Zona Sub Gerencia / Fiscalización\n•   AccessPoint3   –   Zona Desarrollo Económico  Áreas conectadas (todas del piso 5):  •   Infra Urbana   –   VLAN 10:   PC9, PC13, PC15, PC14, PC46, PC47, PC17  •   Comisión Técnica   –   VLAN 10 : PC8, PC6, PC5, PC2, PC7, PC0  •   Sub Gerencia (Zona 1)   –   VLAN 10 : PC10, PC11_Secretaría  •   Gerencia GDU   –   VLAN 40:   PC19, PC20  •   GDU Secretaría   –   VLAN 40 : PC18, PC21, PC22  •   Fiscalización y Control Urbano   –   VLAN 20 : PC24, PC26, PC28, PC30, PC32,  PC34, PC35, PC33, PC31, PC29, PC27, PC25  •   Sub Gerencia (Zona 2)   –   VLAN 20 : PC36, PC7_Secretaría  •   Sub Gerencia (Zona 3)   –   VLAN 30 : PC43, PC44  •   Desarrollo Económico   –   VLAN 30 : PC38, PC39, PC40, PC41, PC42  Enlaces principales :  •   EtherChannel entre Switch_Piso5_A y Switch_Piso5_B (VLAN 99 nativa para  administración)  •   Enlace troncal Switch_Piso5_A   ↔   Switch_Piso5_C Transporta VLAN 30 y VLAN  99.  •   Enlaces de acceso Desde Switch_Piso5_A hacia los APs 1 y 2 Desde  Switch_Piso5_C hacia AP3  Piso 6:  Switches del piso 6:  •   Switch_Piso6_A   –   Switch principal del piso Conecta RRHH (VLAN 60) y parte de  Rentas (VLAN 70).  •   Switch_Piso6_B   –   Switch secundario Conecta Rentas/Caja (VLAN 70) y parte de  RRHH (VLAN 60).  Access Points del Piso 6 (VLAN 50):  •   AccessPoint3   –   Zona RRHH/Logística  •   AccessPoint4   –   Zona Rentas/Caja  •   Conexión de dispositivos móviles: Smartphone1, Smartphone2\nÁreas conectadas (todas del piso   6 ):  •   RRHH / Logística   –   VLAN 60:   PC5 2 , PC5 3 , PC54. PC5 5 , PC5 6 , PC57, PC58  •   Sub Gerencia   –   VLAN 60 :   PC57_Secretaría , PC 58  •   Rentas / Caja   –   VLAN 70 : PC 44 , PC 45, PC46, PC47, PC48, PC49  •   Sub Gerencia   –   VLAN 70 : PC 50 , PC 51  Enlaces principales:  •   Troncal   Switch_Piso6_A   ↔   Switch_Piso6_B VLAN 50, 60, 70, 99  •   Troncal Piso 6   ↔   Piso 5 Mediante interfaz Gig0/2 VLAN 50, 60, 70, 99  • Interconexión de switches, routers, APs y servidores.  - Enlaces troncales 802.1Q  Transportan las VLAN entre pisos y entre switches del mismo nivel.  - VLAN nativa 99   –   MANAGEMENT  •   Administración de switches  •   Gestión remota  •   Base del EtherChannel  •   Soporte para los troncales entre pisos  -   Router Cisco 1941 (Capa 3)  •   Subinterfaces configuradas por VLAN  •   DHCP para cada segmento  •   Routing inter - VLAN  •   Gateway por VLAN  - APs conectados a VLAN 50  •   Wi - Fi invitados  •   Soporte para smartphones y laptops dentro del edificio  • Direccionamiento IP:\nVLA  N ID  Nombre de  VLAN  Departamento/Á  rea  Dirección  de red  Máscara/CI  DR  Gateway  10   INFRA_URB   Infraestructura  Urbana, Sub  Gerencia Zona 1  192.168.10.  0  255.255.0.0/  16  192.168.10.  1  20   FISCALIZACION   Fiscalización y  Control Urbano,  Sub Gerencia  Zona 2  192.168.20.  0  255.255.0.0/  16  192.168.20.  1  30   DES_ECONOMI  CO  Desarrollo  Económico, Sub  Gerencia Zona 3  192.168.30.  0  255.255.0.0/  16  192.168.30.  1  40   GERENCIA_GD  U  Gerencia GDU y  GDU Secretaría  192.168.40.  0  255.255.0.0/  16  192.168.40.  1  50   WIFI_INVITADO  S  -   192.168.50.  0  255.255.0.0/  16  192.168.50.  1  60   RRHH_LOGISTI  CA  Recursos  Humanos y  Logística   –   Piso  6  192.168.60.  0  255.255.0.0/  16  192.168.60.  1  70   RENTAS_CAJA   Rentas / Caja   –  Piso 6  192.168.70.  0  255.255.0.0/  16  192.168.70.  1  100   SERVIDORES   Administración  de switches /  VLAN nativa  192.168.10  0.0  255.255.0.0/  16  192.168.10  0.1  o VLAN asignadas  Switch_piso5_A(infra)  Switch_piso5_B (tiene port security) (FIZCA)\nswitch_piso5_c(desarrollo)  switch_piso6_A  switch_piso6_B\no Puertas de enlace  ✔   Componentes requeridos  • Switches layer 2 o layer 3  • Routers  • Access points  • Servidores (DHCP, DNS, archivos, web)  ✔   Servicios configurados  Debe considerarse incluir al menos:  • VLAN  • Rutas dinámicas   ( OSPF )  • DHCP o DHCP relay  • Seguridad del switch (port security)  • WLAN (SSID, seguridad WPA2/WPA3)\nII. Diseño Físico de la Red  ✔   Plano físico del edificio o instalación  ARQUITECTURA   –   DISTRIBUCION   -   QUINTO PISO\n\nEste plano de arquitectura, que corresponde al quinto piso de oficinas, es la   base física  que determinó el   diseño lógico y la distribución del cableado   en nuestro modelo de  red. La distribución de los ambientes confirmó la necesidad de una   segmentación  estricta   de   la   red.   Cada   ambiente   principal   — como   GERENCIA   GDU ,  INFRAESTRUCTURA URBANA ,   FISCALIZACIÓN Y CONTROL URBANO   y   DESARROLLO  ECONÓMICO LOCAL —   fue tratado como un grupo funcional aislado. Esta separación  física de los usuarios justificó la creación de una   VLAN específica   para cada una de  estas oficinas clave en el diseño de Packet Tracer.  Además, la densidad de puestos de trabajo mostrada en cada área (escritorios y sillas)  sirvió para calcular la   cantidad de puertos de red   necesarios en los Switches de Acceso  del Piso 5 (A, B y C), asegurando que se proveyera la conectividad necesaria sin  sobredimensionar el equipo. La ubicación central del   Pasillo   y el acceso al   Rack  Principal   (aunque no   se muestre aquí,   se asume su   ubicación   en   la   Sala   de  Comunicaciones) es vital para el   tendido de la canalización horizontal   hacia los  switches   de cada áre a.  Plano de data y computo:  Parte de la   Leyenda 1  Parte de la Leyenda 2\n✔   Plano de comunicaciones  DATA Y COMPUTO 5TO PISO\n\nEl plano de telecomunicaciones para el quinto piso de oficinas ilustra la   canalización  horizontal   y la estrategia de agrupamiento de cables de red hacia el Gabinete de  Comunicaciones (Rack Principal).  1. Estrategia de Agrupamiento y Nomenclatura  El diseño sigue una estrategia clara de   agrupamiento por zonas   utilizando la  nomenclatura   PAQx   (Paquete).  •   Puntos de Red:   Se observa la ubicación de los puntos de red de cómputo  (indicados por círculos con un símbolo interno), que se distribuyen  estratégicamente en las áreas de trabajo, proveyendo conectividad a cada  puesto.  •   Agrupamiento (PAQx):   Los cables de red se agrupan en   16 paquetes  identificados de   PAQ1   a   PAQ16 . Cada PAQ representa el conjunto de cables  provenientes de   3 o 4 tomas de red   cercanas. Por ejemplo,   PAQ1   agrupa las  tomas de la zona cercana a la Secretaría de GDU, y   PAQ10   agrupa tomas en el  área de Fiscalización.  2. Diseño de Canalización  El diseño se enfoca en una canalización oculta y un punto de concentración  centralizado.  •   Tendido Oculto:   El cableado se dirige desde las rosetas de pared hacia un  sistema de canalización que, según la lógica del diseño de oficinas, se realiza  empotrado en el piso/muro   y luego   por el techo falso (plenum) ,  aprovechando los espacios no visibles para mantener la estética de la oficina.  •   Transición al Rack:   La flecha asociada a cada etiqueta   PAQx   marca la  trayectoria final   de ese haz de cables. Indica que el grupo de cables abandona  su canalización de acceso (tubería de $25   \\ text{ mm}$ en piso) y se dirige,  presumiblemente por una   bandeja de cables o conducto principal en el techo  falso , hacia el Rack Principal.  3. Justificación del Diseño  Este diseño garantiza el   orden   y la   trazabilidad   de la red.  •   Organización:   Al dividir la totalidad de los cables en 16 paquetes identificados,  se facilita enormemente la   instalación y la gestión   futura.  •   Mantenimiento:   Si surge un problema en una zona específica (p. ej.,  Infraestructura Urbana), el personal de soporte puede identificar rápidamente  qué grupo de cables (PAQ7, PAQ8, etc.) y qué   puertos del   patch panel   en el\nRack están afectados, en lugar de tener que rastrear cada cable  individualmente.  Este diseño es consistente con las   buenas prácticas de cableado estructurado   que  buscan simplificar la administración de la red horizontal.  III. Plano de Comunicaciones Completo  El esquema físico modelado en Packet Tracer se utilizó para validar la distribución real  de los puntos de red del quinto piso, tal como se define en los planos arquitectónicos, y  para integrar la proyección funcional del sexto piso. Aunque el plano de fond o  corresponde solo al quinto piso, los dispositivos ubicados fuera de sus límites físicos  (PC53 a PC58 y PC45 a PC51) representan los puestos de trabajo proyectados para los  departamentos del sexto piso (RRHH_LOGISTICA y RENTAS_CAJA). Este enfoque,  aunque   no respeta la geografía arquitectónica completa, es funcional y permitió simular  la topología de acceso del proyecto en su totalidad (ambos pisos). Dada la escala del  proyecto y la centralización de los equipos en un único Main Wiring Closet (Rack  Principa l), el diseño físico resulta ser eficiente y de baja complejidad, facilitando la  administración y el mantenimiento del cableado horizontal.\n\nIV. Relación de Componentes de Red  Componente   Modelo   Función   Cantidad   Ubicación  Switch   Cisco 2960   Segmentación de VLAN   5   Piso 5 - 6  Router   Cisco 1941   Salida a internet   1   Hall piso 5  Conectores  RJ - 45  Panduit /  Cat6  Terminación del  cableado estructurado  60 (aprox)   En cada punto  de datos del  piso 5 – 6  Rack   22U / Mural  o de piso  Alojar equipos de red  (switches, patch panel,  router)  1   Hall   piso 5  UPS   APC  1500VA  Respaldo eléctrico para  equipos de red  1   Hall   piso 5  Multilayer  Switch  3560 24PS   Permitir comunicación  de los switches.  1   Hall piso 5  V. Resumen Técnico del Proyecto  ✔   Justificación del diseño  El diseño de la red lógica de la Municipalidad de Lince se basa en una Topología de  Estrella Jerárquica (Core/Distribución Colapsada y Acceso). Esta topología fue elegida  por su escalabilidad, facilidad de gestión y alta disponibilidad.  Elemento Clave   Justificación de la Elección  Switch Multicapa  (Core/Distribución  Colapsada)  Se eligió para centralizar el tráfico y realizar el  Enrutamiento Inter - VLAN   de alto rendimiento, eliminando  la necesidad de múltiples   routers   y proporcionando una  solución eficiente de   Capa 3   para la comunicación entre  departamentos.  VLANs (Redes  Virtuales)  Implementadas para segmentar la red por   función  municipal   (p. ej.,   FISCALIZACION ,   RRHH_LOGISTICA ).  Esto aísla el tráfico sensible, reduce el dominio de  broadcast   (mejorando el rendimiento) y facilita la  aplicación de políticas de seguridad por grupo.\nSwitches de  Acceso (por Piso)  Se utilizan para la conectividad directa de los usuarios. Su  distribución por piso ( Switch_Piso5_A ,   Switch_Piso6_B ,  etc.) facilita el diagnóstico de fallos y el manejo del  cableado horizontal.  Servidor  Centralizado  Aloja el servicio   DHCP   para automatizar la asignación de  direcciones IP, reduciendo los errores de configuración  manual y agilizando la incorporación de nuevos  dispositivos.  Router Único  (Borde)  Se utiliza exclusivamente como   puerta de enlace   para la  salida a Internet, simplificando la configuración de la red  perimetral y el NAT.  ✔   Problemas resueltos  Problema  Resuelto  Tecnología  Implementada   Cómo se Garantiza  Redundancia y  Ancho de Banda  EtherChannel  (Agregación  de Enlaces)  Se agrupan múltiples enlaces físicos  entre el Switch Multicapa (Core) y los  Switches de Acceso. Esto proporciona  mayor ancho de banda   (suma de los  enlaces) y   redundancia automática : si  un cable o puerto falla, el tráfico se  redirige instantáneamente por el enlace  restante.  Seguridad de  Acceso a Puertos   Port Security  Implementado en los   Switches   de Acceso  (especialmente en el área de  FISCALIZACION ). Se limita el número de  direcciones MAC   que un puerto puede  aprender, impidiendo que dispositivos no  autorizados (como la   Laptop Intrusa ) se  conecten a la red corporativa.  Seguridad de  Gestión y Control  VLANs y ACLs  (Implícito)  La red está segregada. La VLAN  MANAGEMENT (99)   aísla la  administración de los dispositivos, y la  arquitectura permite aplicar   Listas de\nControl de Acceso (ACLs)   en el Switch  Multicapa para controlar qué  departamentos pueden acceder a qué  recursos (p. ej., prohibir el acceso de  WIFI_INVITADOS   a servidores internos).  Cobertura Wi - Fi   Access Points  (AP)  Se dispuso un Access Point por cada área  funcional en el piso 5 y 6 (conectados a la  VLAN   WIFI_INVITADOS ). Esto garantiza  una cobertura completa y uniforme,  manteniendo el tráfico inalámbrico de  invitados totalmente   segregado   de la red  interna de la Municipalidad.  Enrutamiento  Dinámico  (Didáctico)  OSPF  Aunque la topología es sencilla, la  implementación de OSPF enseña a los  routers   a   descubrir y compartir rutas  eficientemente. En una futura expansión  con múltiples salidas a Internet o  sucursales, OSPF garantizaría la  convergencia rápida y la selección del  mejor camino.  ✔   Buenas prácticas aplicadas  Eje de Buenas  Prácticas   Descripción de la Aplicación en el Diseño  Segmentación  Lógica:   Uso riguroso de   VLANs   para separar la red  corporativa ( INFRA_URB ,   GERENCIA_GDU , etc.) de los  servicios ( MANAGEMENT ) y del público  ( WIFI_INVITADOS ).  Seguridad  Acceso Físico:   Implementación de   Port Security   para  control de acceso a nivel de puerto.   Acceso Lógico:  Segregación de VLANs y arquitectura lista para la  aplicación de   ACLs .  Administración   Direccionamiento:   Uso de   DHCP   para simplificar la  gestión de direcciones IP.   Gestión de Red:\nImplementación de una VLAN de   MANAGEMENT (99)   para  centralizar el acceso seguro a los equipos.  Ubicación  Piso 5 - 6: Rack Principal / Sala de Comunicaciones:   Se  establece como el   punto central de la red (CORE)   donde  reside el Switch Multicapa y el Router.  Ubicación  Oficinas y Salas (Pisos 5 y 6):   Los Switches de Acceso y  los Access Points están distribuidos estratégicamente  para minimizar la longitud del cableado horizontal y  garantizar la cobertura.  VI. Conclusiones  El diseño de la red para la Municipalidad de Lince, desarrollado en Packet Tracer,  establece una infraestructura de red troncal robusta y jerárquica basada en un Switch  Multicapa (Core), implementando VLANs segmentadas por función departamental y  separando   rigurosamente el tráfico corporativo del tráfico de invitados y de gestión. La  inclusión estratégica de tecnologías como EtherChannel y Port Security garantiza tanto  la alta disponibilidad y el alto rendimiento de la interconexión entre pisos como la  segu ridad   estricta   en   los   puntos   de   acceso,   resolviendo   así   los   requisitos   de  escalabilidad, eficiencia y control necesarios para soportar los servicios institucionales  clave (GDU, Fiscalización, Infraestructura y Desarrollo Económico) de manera segura y  admin istrable.\nVII. ANEXOS  Prueba de   simulación :  Mensajes enviados correctamente:  Prueba de seguridad con port segurity:  Prueba de funcionamiento del   E therchannel:',0.1494710853467651,'[\"$25\", \"(\", \"(99)\", \"(a,\", \"(acls)\"]','2025-11-29 00:53:33.952663'),(22,3,'FACULTAD DE INGENIERÍA  CARRERA DE INGENIERÍA DE SISTEMAS  COMPUTACIONALES  PROYECTO FINAL  CURSO:   REDES 2  DOCENTE:   Jorge Luis Alvarado Ramos  INTEGRANTES:  •   Calderón Nolorbe Manuel N00213978  •   Chávez Juárez Sergio Gerardo N00305458  •   Marino Ñique Luis Enrique N00325094  •   Romer Ramírez Williams Anthony N00324335  •   Vázquez Ulloa Renzo Sair  •   Yarleque Flores Yarkoff Roberth N00300401  Trujillo   -   Perú 2025\nIntroducción   General:  La presente propuesta tiene como finalidad diseñar el plano integral de comunicaciones  correspondiente a los ambientes del 5to y 6to piso destinados a la Sede Administrativa  de la Municipalidad Distrital de Lince, ubicada en el distrito de Lince, provincia   de Lima,  departamento de Lima.  Dicho diseño forma parte del proceso de implementación de infraestructura tecnológica  para asegurar que las nuevas áreas administrativas cuenten con un sistema de  comunicaciones moderno, seguro y escalable.  El proyecto considera la elaboración del diseño lógico y físico de la red, el plano de  comunicaciones, así como un inventario   detallado   de los componentes de red  necesarios para garantizar el funcionamiento adecuado de los servicios institucionales.  Dichos   servicios, identificados a partir de las Gerencias y Subgerencias que se  establecerán en el quinto piso, son los siguientes 4 ejes clave:  Ejes Clave de Servicios Institucionales  1.   Gerencia de Desarrollo Urbano (GDU):  •   Planificación Territorial y ordenamiento urbano.  •   Trámite y otorgamiento de Licencias y Permisos de construcción.  •   Regulación y aplicación de Zonificación.  2.   Sub Gerencia de Infraestructura Urbana:  •   Supervisión y Ejecución de Obras públicas.  •   Mantenimiento de la infraestructura urbana.  •   Revisión y aprobación de Expedientes Técnicos (Comisión Técnica).  3.   Sub Gerencia de Fiscalización  •   Inspecciones de cumplimiento de licencias y normativas.  •   Aplicación de Sanciones Correctivas por infracciones.  •   Control de Condiciones de Seguridad en ambientes públicos y privados.  4.   Sub Gerencia de Desarrollo Económico Local:  •   Emisión de Licencias de Funcionamiento comercial.  •   Implementación de Programas de Apoyo a PYMEs locales.  •   Regulación de Ferias y comercio ambulatorio.  Ejes Clave de Servicios Institucionales (Proyección   -   Sexto Piso)  La red del sexto piso ha sido modelada como parte del alcance didáctico del proyecto,  proyectando la expansión de la Municipalidad para incorporar servicios de soporte y  gestión financiera. Es importante destacar que, al momento de este informe, la  informa ción de esta planta no se encuentra consolidada en los planos arquitectónicos  o de telecomunicaciones del edificio.\nLos servicios clave proyectados para esta planta, y que sustentan el diseño de la red  lógica, son:  5.   Recursos Humanos y Logística (RRHH_LOGISTICA):  •   Gestión   de   Talento   Humano:   Administración   de   personal,   planillas,   y  capacitación.  •   Gestión de Suministros: Adquisición, almacenamiento y distribución de bienes y  servicios.  •   Control de Activos: Inventario y seguimiento del patrimonio municipal.  6.   Rentas y Caja (RENTAS_CAJA):  •   Recaudación de Tributos: Administración y cobranza de impuestos y tasas  municipales (Rentas).  •   Tesorería   y   Movimiento   de   Fondos:   Manejo   de   ingresos   y   egresos   de   la  Municipalidad (Caja).  •   Control Presupuestal: Seguimiento a la ejecución del presupuesto municipal.  Los planos proporcionados de los pisos 5 y 6 sirven como base para la distribución  estratégica del cableado, los puntos de red, los equipos activos y las zonas de cobertura  inalámbrica.\nI. Diseño Lógico de la Red  ✔   Topología lógica clara :  El diseño lógico de la red de la Municipalidad Distrital de Lince se implementó en  Packet Tracer, representando de forma precisa la distribución de equipos del 5to y 6to  piso.  La topología incluye la conexión de computadoras, switches, puntos de acceso y  enlaces troncales que conectan ambos pisos.  Cada área administrativa está organizada dentro de su respectiva VLAN.  Piso 5:  Switches del piso 5:  •   Switch_Piso5_A (INFRA)   –   Switch principal del piso Transporta VLAN 10, 40, 50 y  VLAN 99 (nativa).  •   Switch_Piso5_B (FIZCA)   –   Switch secundario Conecta todas las estaciones de  Fiscalización (VLAN 20). Troncales en VLAN 99 hacia A.  •   Switch_Piso5_C (DESARROLLO)   –   Switch dedicado Conecta el área de  Desarrollo Económico (VLAN 30).  Access Points del Piso 5 (VLAN 50):  •   AccessPoint1   –   Zona Infra Urbana / Comisión Técnica  •   AccessPoint2   –   Zona Sub Gerencia / Fiscalización\n•   AccessPoint3   –   Zona Desarrollo Económico  Áreas conectadas (todas del piso 5):  •   Infra Urbana   –   VLAN 10:   PC9, PC13, PC15, PC14, PC46, PC47, PC17  •   Comisión Técnica   –   VLAN 10 : PC8, PC6, PC5, PC2, PC7, PC0  •   Sub Gerencia (Zona 1)   –   VLAN 10 : PC10, PC11_Secretaría  •   Gerencia GDU   –   VLAN 40:   PC19, PC20  •   GDU Secretaría   –   VLAN 40 : PC18, PC21, PC22  •   Fiscalización y Control Urbano   –   VLAN 20 : PC24, PC26, PC28, PC30, PC32,  PC34, PC35, PC33, PC31, PC29, PC27, PC25  •   Sub Gerencia (Zona 2)   –   VLAN 20 : PC36, PC7_Secretaría  •   Sub Gerencia (Zona 3)   –   VLAN 30 : PC43, PC44  •   Desarrollo Económico   –   VLAN 30 : PC38, PC39, PC40, PC41, PC42  Enlaces principales :  •   EtherChannel entre Switch_Piso5_A y Switch_Piso5_B (VLAN 99 nativa para  administración)  •   Enlace troncal Switch_Piso5_A   ↔   Switch_Piso5_C Transporta VLAN 30 y VLAN  99.  •   Enlaces de acceso Desde Switch_Piso5_A hacia los APs 1 y 2 Desde  Switch_Piso5_C hacia AP3  Piso 6:  Switches del piso 6:  •   Switch_Piso6_A   –   Switch principal del piso Conecta RRHH (VLAN 60) y parte de  Rentas (VLAN 70).  •   Switch_Piso6_B   –   Switch secundario Conecta Rentas/Caja (VLAN 70) y parte de  RRHH (VLAN 60).  Access Points del Piso 6 (VLAN 50):  •   AccessPoint3   –   Zona RRHH/Logística  •   AccessPoint4   –   Zona Rentas/Caja  •   Conexión de dispositivos móviles: Smartphone1, Smartphone2\nÁreas conectadas (todas del piso   6 ):  •   RRHH / Logística   –   VLAN 60:   PC5 2 , PC5 3 , PC54. PC5 5 , PC5 6 , PC57, PC58  •   Sub Gerencia   –   VLAN 60 :   PC57_Secretaría , PC 58  •   Rentas / Caja   –   VLAN 70 : PC 44 , PC 45, PC46, PC47, PC48, PC49  •   Sub Gerencia   –   VLAN 70 : PC 50 , PC 51  Enlaces principales:  •   Troncal   Switch_Piso6_A   ↔   Switch_Piso6_B VLAN 50, 60, 70, 99  •   Troncal Piso 6   ↔   Piso 5 Mediante interfaz Gig0/2 VLAN 50, 60, 70, 99  • Interconexión de switches, routers, APs y servidores.  - Enlaces troncales 802.1Q  Transportan las VLAN entre pisos y entre switches del mismo nivel.  - VLAN nativa 99   –   MANAGEMENT  •   Administración de switches  •   Gestión remota  •   Base del EtherChannel  •   Soporte para los troncales entre pisos  -   Router Cisco 1941 (Capa 3)  •   Subinterfaces configuradas por VLAN  •   DHCP para cada segmento  •   Routing inter - VLAN  •   Gateway por VLAN  - APs conectados a VLAN 50  •   Wi - Fi invitados  •   Soporte para smartphones y laptops dentro del edificio  • Direccionamiento IP:\nVLA  N ID  Nombre de  VLAN  Departamento/Á  rea  Dirección  de red  Máscara/CI  DR  Gateway  10   INFRA_URB   Infraestructura  Urbana, Sub  Gerencia Zona 1  192.168.10.  0  255.255.0.0/  16  192.168.10.  1  20   FISCALIZACION   Fiscalización y  Control Urbano,  Sub Gerencia  Zona 2  192.168.20.  0  255.255.0.0/  16  192.168.20.  1  30   DES_ECONOMI  CO  Desarrollo  Económico, Sub  Gerencia Zona 3  192.168.30.  0  255.255.0.0/  16  192.168.30.  1  40   GERENCIA_GD  U  Gerencia GDU y  GDU Secretaría  192.168.40.  0  255.255.0.0/  16  192.168.40.  1  50   WIFI_INVITADO  S  -   192.168.50.  0  255.255.0.0/  16  192.168.50.  1  60   RRHH_LOGISTI  CA  Recursos  Humanos y  Logística   –   Piso  6  192.168.60.  0  255.255.0.0/  16  192.168.60.  1  70   RENTAS_CAJA   Rentas / Caja   –  Piso 6  192.168.70.  0  255.255.0.0/  16  192.168.70.  1  100   SERVIDORES   Administración  de switches /  VLAN nativa  192.168.10  0.0  255.255.0.0/  16  192.168.10  0.1  o VLAN asignadas  Switch_piso5_A(infra)  Switch_piso5_B (tiene port security) (FIZCA)\nswitch_piso5_c(desarrollo)  switch_piso6_A  switch_piso6_B\no Puertas de enlace  ✔   Componentes requeridos  • Switches layer 2 o layer 3  • Routers  • Access points  • Servidores (DHCP, DNS, archivos, web)  ✔   Servicios configurados  Debe considerarse incluir al menos:  • VLAN  • Rutas dinámicas   ( OSPF )  • DHCP o DHCP relay  • Seguridad del switch (port security)  • WLAN (SSID, seguridad WPA2/WPA3)\nII. Diseño Físico de la Red  ✔   Plano físico del edificio o instalación  ARQUITECTURA   –   DISTRIBUCION   -   QUINTO PISO\n\nEste plano de arquitectura, que corresponde al quinto piso de oficinas, es la   base física  que determinó el   diseño lógico y la distribución del cableado   en nuestro modelo de  red. La distribución de los ambientes confirmó la necesidad de una   segmentación  estricta   de   la   red.   Cada   ambiente   principal   — como   GERENCIA   GDU ,  INFRAESTRUCTURA URBANA ,   FISCALIZACIÓN Y CONTROL URBANO   y   DESARROLLO  ECONÓMICO LOCAL —   fue tratado como un grupo funcional aislado. Esta separación  física de los usuarios justificó la creación de una   VLAN específica   para cada una de  estas oficinas clave en el diseño de Packet Tracer.  Además, la densidad de puestos de trabajo mostrada en cada área (escritorios y sillas)  sirvió para calcular la   cantidad de puertos de red   necesarios en los Switches de Acceso  del Piso 5 (A, B y C), asegurando que se proveyera la conectividad necesaria sin  sobredimensionar el equipo. La ubicación central del   Pasillo   y el acceso al   Rack  Principal   (aunque no   se muestre aquí,   se asume su   ubicación   en   la   Sala   de  Comunicaciones) es vital para el   tendido de la canalización horizontal   hacia los  switches   de cada áre a.  Plano de data y computo:  Parte de la   Leyenda 1  Parte de la Leyenda 2\n✔   Plano de comunicaciones  DATA Y COMPUTO 5TO PISO\n\nEl plano de telecomunicaciones para el quinto piso de oficinas ilustra la   canalización  horizontal   y la estrategia de agrupamiento de cables de red hacia el Gabinete de  Comunicaciones (Rack Principal).  1. Estrategia de Agrupamiento y Nomenclatura  El diseño sigue una estrategia clara de   agrupamiento por zonas   utilizando la  nomenclatura   PAQx   (Paquete).  •   Puntos de Red:   Se observa la ubicación de los puntos de red de cómputo  (indicados por círculos con un símbolo interno), que se distribuyen  estratégicamente en las áreas de trabajo, proveyendo conectividad a cada  puesto.  •   Agrupamiento (PAQx):   Los cables de red se agrupan en   16 paquetes  identificados de   PAQ1   a   PAQ16 . Cada PAQ representa el conjunto de cables  provenientes de   3 o 4 tomas de red   cercanas. Por ejemplo,   PAQ1   agrupa las  tomas de la zona cercana a la Secretaría de GDU, y   PAQ10   agrupa tomas en el  área de Fiscalización.  2. Diseño de Canalización  El diseño se enfoca en una canalización oculta y un punto de concentración  centralizado.  •   Tendido Oculto:   El cableado se dirige desde las rosetas de pared hacia un  sistema de canalización que, según la lógica del diseño de oficinas, se realiza  empotrado en el piso/muro   y luego   por el techo falso (plenum) ,  aprovechando los espacios no visibles para mantener la estética de la oficina.  •   Transición al Rack:   La flecha asociada a cada etiqueta   PAQx   marca la  trayectoria final   de ese haz de cables. Indica que el grupo de cables abandona  su canalización de acceso (tubería de $25   \\ text{ mm}$ en piso) y se dirige,  presumiblemente por una   bandeja de cables o conducto principal en el techo  falso , hacia el Rack Principal.  3. Justificación del Diseño  Este diseño garantiza el   orden   y la   trazabilidad   de la red.  •   Organización:   Al dividir la totalidad de los cables en 16 paquetes identificados,  se facilita enormemente la   instalación y la gestión   futura.  •   Mantenimiento:   Si surge un problema en una zona específica (p. ej.,  Infraestructura Urbana), el personal de soporte puede identificar rápidamente  qué grupo de cables (PAQ7, PAQ8, etc.) y qué   puertos del   patch panel   en el\nRack están afectados, en lugar de tener que rastrear cada cable  individualmente.  Este diseño es consistente con las   buenas prácticas de cableado estructurado   que  buscan simplificar la administración de la red horizontal.  III. Plano de Comunicaciones Completo  El esquema físico modelado en Packet Tracer se utilizó para validar la distribución real  de los puntos de red del quinto piso, tal como se define en los planos arquitectónicos, y  para integrar la proyección funcional del sexto piso. Aunque el plano de fond o  corresponde solo al quinto piso, los dispositivos ubicados fuera de sus límites físicos  (PC53 a PC58 y PC45 a PC51) representan los puestos de trabajo proyectados para los  departamentos del sexto piso (RRHH_LOGISTICA y RENTAS_CAJA). Este enfoque,  aunque   no respeta la geografía arquitectónica completa, es funcional y permitió simular  la topología de acceso del proyecto en su totalidad (ambos pisos). Dada la escala del  proyecto y la centralización de los equipos en un único Main Wiring Closet (Rack  Principa l), el diseño físico resulta ser eficiente y de baja complejidad, facilitando la  administración y el mantenimiento del cableado horizontal.\n\nIV. Relación de Componentes de Red  Componente   Modelo   Función   Cantidad   Ubicación  Switch   Cisco 2960   Segmentación de VLAN   5   Piso 5 - 6  Router   Cisco 1941   Salida a internet   1   Hall piso 5  Conectores  RJ - 45  Panduit /  Cat6  Terminación del  cableado estructurado  60 (aprox)   En cada punto  de datos del  piso 5 – 6  Rack   22U / Mural  o de piso  Alojar equipos de red  (switches, patch panel,  router)  1   Hall   piso 5  UPS   APC  1500VA  Respaldo eléctrico para  equipos de red  1   Hall   piso 5  Multilayer  Switch  3560 24PS   Permitir comunicación  de los switches.  1   Hall piso 5  V. Resumen Técnico del Proyecto  ✔   Justificación del diseño  El diseño de la red lógica de la Municipalidad de Lince se basa en una Topología de  Estrella Jerárquica (Core/Distribución Colapsada y Acceso). Esta topología fue elegida  por su escalabilidad, facilidad de gestión y alta disponibilidad.  Elemento Clave   Justificación de la Elección  Switch Multicapa  (Core/Distribución  Colapsada)  Se eligió para centralizar el tráfico y realizar el  Enrutamiento Inter - VLAN   de alto rendimiento, eliminando  la necesidad de múltiples   routers   y proporcionando una  solución eficiente de   Capa 3   para la comunicación entre  departamentos.  VLANs (Redes  Virtuales)  Implementadas para segmentar la red por   función  municipal   (p. ej.,   FISCALIZACION ,   RRHH_LOGISTICA ).  Esto aísla el tráfico sensible, reduce el dominio de  broadcast   (mejorando el rendimiento) y facilita la  aplicación de políticas de seguridad por grupo.\nSwitches de  Acceso (por Piso)  Se utilizan para la conectividad directa de los usuarios. Su  distribución por piso ( Switch_Piso5_A ,   Switch_Piso6_B ,  etc.) facilita el diagnóstico de fallos y el manejo del  cableado horizontal.  Servidor  Centralizado  Aloja el servicio   DHCP   para automatizar la asignación de  direcciones IP, reduciendo los errores de configuración  manual y agilizando la incorporación de nuevos  dispositivos.  Router Único  (Borde)  Se utiliza exclusivamente como   puerta de enlace   para la  salida a Internet, simplificando la configuración de la red  perimetral y el NAT.  ✔   Problemas resueltos  Problema  Resuelto  Tecnología  Implementada   Cómo se Garantiza  Redundancia y  Ancho de Banda  EtherChannel  (Agregación  de Enlaces)  Se agrupan múltiples enlaces físicos  entre el Switch Multicapa (Core) y los  Switches de Acceso. Esto proporciona  mayor ancho de banda   (suma de los  enlaces) y   redundancia automática : si  un cable o puerto falla, el tráfico se  redirige instantáneamente por el enlace  restante.  Seguridad de  Acceso a Puertos   Port Security  Implementado en los   Switches   de Acceso  (especialmente en el área de  FISCALIZACION ). Se limita el número de  direcciones MAC   que un puerto puede  aprender, impidiendo que dispositivos no  autorizados (como la   Laptop Intrusa ) se  conecten a la red corporativa.  Seguridad de  Gestión y Control  VLANs y ACLs  (Implícito)  La red está segregada. La VLAN  MANAGEMENT (99)   aísla la  administración de los dispositivos, y la  arquitectura permite aplicar   Listas de\nControl de Acceso (ACLs)   en el Switch  Multicapa para controlar qué  departamentos pueden acceder a qué  recursos (p. ej., prohibir el acceso de  WIFI_INVITADOS   a servidores internos).  Cobertura Wi - Fi   Access Points  (AP)  Se dispuso un Access Point por cada área  funcional en el piso 5 y 6 (conectados a la  VLAN   WIFI_INVITADOS ). Esto garantiza  una cobertura completa y uniforme,  manteniendo el tráfico inalámbrico de  invitados totalmente   segregado   de la red  interna de la Municipalidad.  Enrutamiento  Dinámico  (Didáctico)  OSPF  Aunque la topología es sencilla, la  implementación de OSPF enseña a los  routers   a   descubrir y compartir rutas  eficientemente. En una futura expansión  con múltiples salidas a Internet o  sucursales, OSPF garantizaría la  convergencia rápida y la selección del  mejor camino.  ✔   Buenas prácticas aplicadas  Eje de Buenas  Prácticas   Descripción de la Aplicación en el Diseño  Segmentación  Lógica:   Uso riguroso de   VLANs   para separar la red  corporativa ( INFRA_URB ,   GERENCIA_GDU , etc.) de los  servicios ( MANAGEMENT ) y del público  ( WIFI_INVITADOS ).  Seguridad  Acceso Físico:   Implementación de   Port Security   para  control de acceso a nivel de puerto.   Acceso Lógico:  Segregación de VLANs y arquitectura lista para la  aplicación de   ACLs .  Administración   Direccionamiento:   Uso de   DHCP   para simplificar la  gestión de direcciones IP.   Gestión de Red:\nImplementación de una VLAN de   MANAGEMENT (99)   para  centralizar el acceso seguro a los equipos.  Ubicación  Piso 5 - 6: Rack Principal / Sala de Comunicaciones:   Se  establece como el   punto central de la red (CORE)   donde  reside el Switch Multicapa y el Router.  Ubicación  Oficinas y Salas (Pisos 5 y 6):   Los Switches de Acceso y  los Access Points están distribuidos estratégicamente  para minimizar la longitud del cableado horizontal y  garantizar la cobertura.  VI. Conclusiones  El diseño de la red para la Municipalidad de Lince, desarrollado en Packet Tracer,  establece una infraestructura de red troncal robusta y jerárquica basada en un Switch  Multicapa (Core), implementando VLANs segmentadas por función departamental y  separando   rigurosamente el tráfico corporativo del tráfico de invitados y de gestión. La  inclusión estratégica de tecnologías como EtherChannel y Port Security garantiza tanto  la alta disponibilidad y el alto rendimiento de la interconexión entre pisos como la  segu ridad   estricta   en   los   puntos   de   acceso,   resolviendo   así   los   requisitos   de  escalabilidad, eficiencia y control necesarios para soportar los servicios institucionales  clave (GDU, Fiscalización, Infraestructura y Desarrollo Económico) de manera segura y  admin istrable.\nVII. ANEXOS  Prueba de   simulación :  Mensajes enviados correctamente:  Prueba de seguridad con port segurity:  Prueba de funcionamiento del   E therchannel:',0.1494710853467651,'[\"$25\", \"(\", \"(99)\", \"(a,\", \"(acls)\"]','2025-11-29 00:53:40.351976'),(23,3,'Conceptos básicos:  •   Música.   La música es, según la definición tradicional del término, el  arte de crear y organizar sonidos y silencios respetando los principios  fundamentales de la melodía, la armonía y el ritmo.  •   Nota musical.   En música, u na nota es un símbolo que denota un  sonido musical. En el lenguaje, una nota es también el sonido en sí.  •   Escala musical.   Una escala musical es un grupo de notas que se tocan  en secuencia de forma ascendente o descendente en su tono (suelen  sonar agradable s al oído).  •   Melodía.   La melodía es una secuencia organizada de notas musicales  que se escuchan una tras otra de manera sucesiva. Es la parte de una  composición que se percibe como la línea principal.  •   Tonalidad.   La tonalidad hace alusión al tono de una ob ra. El tono es  un conjunto de sonidos que se sostienen en una misma nota principal  llamada tónica. La sucesión de esas notas compone las escalas.  •   Acorde.   Entendemos por acorde a un conjunto de tres o más notas  musicales diferentes, que suenan simultáneame nte.  •   Armonía musical.   Relación y orden de notas musicales que hace  referencia a la combinación de diferentes sonidos o notas que se  emiten al mismo tiempo, aunque el término también se utiliza para  referirse a la sucesión de estos sonidos emitidos a la ve z  •   Ritmo.   El ritmo puede definirse como la combinación armoniosa de  sonidos, voces o palabras, que incluyen las pausas, los silencios y los  cortes necesarios para que resulte grato a los sentidos.',0.15791296272708558,'[\"(suelen\", \"a\", \"acorde\", \"acorde.\", \"agradable\"]','2025-11-29 00:53:54.247334'),(24,3,'Estudiante de décimo ciclo de Ingeniería  de Sistemas Computacionales en la  Universidad Privada del Norte. Con  experiencia en desarrollo web (Frontend y  Backend), administración de hosting y  bases de datos, busco realizar prácticas  preprofesionales para aplicar mis  conocimientos y aportar soluciones  tecnológicas en instituciones educativas y  empresariales como CEPTRO Trujillo.',0.1688341926021005,'[\"(frontend\", \"administraci\\u00f3n\", \"aplicar\", \"aportar\", \"backend),\"]','2025-11-29 01:17:37.427324'),(25,3,'Conceptos básicos:  •   Música.   La música es, según la definición tradicional del término, el  arte de crear y organizar sonidos y silencios respetando los principios  fundamentales de la melodía, la armonía y el ritmo.  •   Nota musical.   En música, u na nota es un símbolo que denota un  sonido musical. En el lenguaje, una nota es también el sonido en sí.  •   Escala musical.   Una escala musical es un grupo de notas que se tocan  en secuencia de forma ascendente o descendente en su tono (suelen  sonar agradable s al oído).  •   Melodía.   La melodía es una secuencia organizada de notas musicales  que se escuchan una tras otra de manera sucesiva. Es la parte de una  composición que se percibe como la línea principal.  •   Tonalidad.   La tonalidad hace alusión al tono de una ob ra. El tono es  un conjunto de sonidos que se sostienen en una misma nota principal  llamada tónica. La sucesión de esas notas compone las escalas.  •   Acorde.   Entendemos por acorde a un conjunto de tres o más notas  musicales diferentes, que suenan simultáneame nte.  •   Armonía musical.   Relación y orden de notas musicales que hace  referencia a la combinación de diferentes sonidos o notas que se  emiten al mismo tiempo, aunque el término también se utiliza para  referirse a la sucesión de estos sonidos emitidos a la ve z  •   Ritmo.   El ritmo puede definirse como la combinación armoniosa de  sonidos, voces o palabras, que incluyen las pausas, los silencios y los  cortes necesarios para que resulte grato a los sentidos.',0.15791296272708558,'[\"(suelen\", \"a\", \"acorde\", \"acorde.\", \"agradable\"]','2025-11-29 16:49:21.379953'),(26,3,'Estudiante de décimo ciclo de Ingeniería  de Sistemas Computacionales en la  Universidad Privada del Norte. Con  experiencia en desarrollo web (Frontend y  Backend), administración de hosting y  bases de datos, busco realizar prácticas  preprofesionales para aplicar mis  conocimientos y aportar soluciones  tecnológicas en instituciones educativas y  empresariales como CEPTRO Trujillo. HISTORIAL   LABORAL  Marzo   2024   -   Actual  Desarrollo   Tecnológico   DigitalTecc   |   Trujillo  .   Administración   de   Hosting.  9   Trujillo,   13003,   Trujillo,   El   Porvenir   .   Implementación   de   soluciones   Web   en   Frontend   y   Backend.  .   Gestión   de   base   de   datos   realacionales   Oracle,   MySQL,   y  A   Microsoft   SQL   Server.  ARCO ci   .   Desarrollo Frontend en Worpress.  .   Maquetación   y   diseño   Web   con   Figma.  .   Implementación   de   procesos   y   procedimientos. NA   AE   .   Preparación y   presentación de   informes y   estadísticas. IGV LATO  Mayo   2023   -   Febrero   2024  Técnico   en   soporte   informático   Iglesia   Movimiento  Misionero   Mundial   |   Trujillo  RESUMEN   PROFESIONAL  .   Realización   de   pruebas   técnicas   para   verificar   el  funcionamiento   y   correcto   desarrollo   de   procesos.  .   Configuración   y   operación   de   equipos   de   prueba   y   medición.  +.   Uso   de   herramientas   de   reparación,   mantenimiento   y  desmontaje   de   equipos.  .   Instalación   de   sistemas   y   componentes   electrónicos.  FORMACIÓN  2025  Facultad   de   Ingeniería  Universidad   Privada   del   Norte,   Trujillo  +   Estudiante   del   décimo   ciclo   de   la   carrera   de   Ingeniería   de  Sistemas   Computacionales.  A  2015  SS   Computación   e   informática  .   Trabajo   en   equipo   SENCICO,   Trujillo  STAN   A Ele  AUTO LU E [Tool   lle fte  oie telteTa  +   Estudios   en   la   carrera   de   Computación   e   Informática.  DIPLOMAS  .   Certificación   en   Redes   por   CISCO  »   Certificación   en   lenguaje   Python   por   CISCO  *   Licencia   para   conducir   vehículos   A-|   y   B-llc',0.16653950575261176,'[\"(frontend\", \"*\", \"+\", \"+.\", \"-\"]','2025-11-29 16:50:11.409643'),(27,3,'GUITARRA  manuelcn33btrujillo@gmail.com   1\nGUITARRA  manuelcn33btrujillo@gmail.com   2  CONTENIDO  INTRODUCCIÓN   ................................ ................................ ................................ ................................ ...............   4  CAPÍTULO N°1   ................................ ................................ ................................ ................................ ...................   8  1. La partitura   ................................ ................................ ................................ ................................ ................   8  1.1. Elementos del lenguaje musical   ................................ ................................ ................................ ....   9  1.1.1. El pentagrama   ................................ ................................ ................................ ............................   9  1.1.2. Las claves   ................................ ................................ ................................ ................................ ...   9  1.1.3. Las notas musicales   ................................ ................................ ................................ ...............   10  1.1.4. Alteraciones de las notas naturales   ................................ ................................ ....................   12  1.1.5. Octavas   ................................ ................................ ................................ ................................ .....   12  1.1.6. Figuras musicales   ................................ ................................ ................................ ...................   13  1.1.7. Métrica musical   ................................ ................................ ................................ .......................   14  1.1.8. El compás   ................................ ................................ ................................ ................................ .   14  1.1.9. El metrónomo ................................ ................................ ................................ ...........................   16  1.1.10. El ritmo   ................................ ................................ ................................ ................................ ....   16  1.1.11. Solfeo   ................................ ................................ ................................ ................................ ......   17  Examen teórico/práctico N°1   ................................ ................................ ................................ ...................   18  CAPÍTULO N°2   ................................ ................................ ................................ ................................ .................   19  2. Escalas musicales   ................................ ................................ ................................ ................................ .   19  2.1. Escalas mayores   ................................ ................................ ................................ .............................   19  2.1.1. Interpretación (M)   ................................ ................................ ................................ ....................   21  2.2. Escalas menores   ................................ ................................ ................................ ............................   25  2.2.1. Interpretación (m)   ................................ ................................ ................................ ...................   26  2.3. Las armaduras de clave   ................................ ................................ ................................ .................   30  2.4. Intervalos musicales   ................................ ................................ ................................ ......................   31  3. La tablatura   ................................ ................................ ................................ ................................ .............   33  3.1. Partes de la tablatura   ................................ ................................ ................................ .....................   33  3.2. Símbolos en la tablatura   ................................ ................................ ................................ ...............   34  3.3. Interpretación   ................................ ................................ ................................ ................................ .   34  CAPÍTULO N°3   ................................ ................................ ................................ ................................ .................   39  4. Acordes (Rasgueo, plaqué y arpegio)   ................................ ................................ ................................ .   39  4.1. Acordes mayores   ................................ ................................ ................................ ............................   39  4.3. Acordes de séptimas   ................................ ................................ ................................ .....................   41  4.5. Interpretación   ................................ ................................ ................................ ................................ .   44  5. Arpegios   ................................ ................................ ................................ ................................ ...................   47\nGUITARRA  manuelcn33btrujillo@gmail.com   3  5.1. Interpretación   ................................ ................................ ................................ ................................ .   47  Examen teórico/práctico N°2   ................................ ................................ ................................ ...................   49\nGUITARRA  manuelcn33btrujillo@gmail.com   4  INTRODUCCIÓN  La guitarra acústica  La guitarra acústica es un tipo de guitarra en la que el sonido se produce por la vibración de  las cuerdas y se propaga a intensidades audibles a través la resonancia de la caja armónica,  sin necesidad de amplificación eléctrica. El término \"guitarra acúst ica\" es un retrónimo  después del advenimiento de la guitarra eléctrica que, en cambio, utiliza amplificación  electrónica para hacer que el sonido sea audible.  El requinto  El término requinto es el nombre genérico de una serie de instrumentos cordófonos similares  a la guitarra, aunque de menor tamaño, cuyas características varían de acuerdo con la  región. La afinación es una cuarta justa arriba que la de la guitarra, es deci r, 2 ½ tonos o 5  semitonos más altos a la guitarra.\nGUITARRA  manuelcn33btrujillo@gmail.com   5  Partes de la guitarra acústica  Afinación de las cuerdas en la guitarra  En el caso de afinar una guitarra acústica u otro tipo de guitarra, como una guitarra eléctrica o  una guitarra española, debemos tener en cuenta que existen afinaciones alternativas, aunque  la más   común (afinación estándar para guitarra de 6 cuerdas) es EADGBE: mi - la - re - sol - si - mi. Y  a frecuencia 440 Hz  440 Hz.\nGUITARRA  manuelcn33btrujillo@gmail.com   6  Posición de la guitarra y el ejecutante  Lo más importante con respecto a la postura del instrumento y del   ejecutante es que éste  último tenga buena visión sobre el diapasón y que su brazo derecho se coloque en el vértice  que forman el aro y la caja armónica. Es muy importante que el brazo no quede ni  “encaramado” ni “colgado” sobre el aro. Teniendo correctamen te colocado el brazo  derecho, la mano nos debe llegar exactamente a la boca de la guitarra.  La “cintura” en el aro de la guitarra le sirve para apoyar perfectamente el instrumento en la  pierna izquierda (posición clásica) o bien en la pierna derecha (aunque en esta posición el  diapasón quedará más lejano).  Las siguientes imágenes muestran las formas más usuales de sujetar el instrumento.  Con   apoyapié   o   escabel   en   pierna  izquierda   Con   apoyapié   o   escabel   en   pierna  derecha  Con escabel   Gitano   En   posición   de  Carrizo\nGUITARRA  manuelcn33btrujillo@gmail.com   7  Conceptos básicos:  •   Música.   La música es, según la definición tradicional del término, el arte de crear y  organizar sonidos y silencios respetando los principios fundamentales de la melodía, la  armonía y el ritmo.  •   Nota musical.   En música, una nota es un símbolo que denota un   sonido musical. En el  lenguaje, una nota es también el sonido en sí.  •   Escala musical.   Una escala musical es un grupo de notas que se tocan en secuencia de  forma ascendente o descendente en su tono (suelen sonar agradables al oído).  •   Melodía.   La melodía es una secuencia organizada de notas musicales que se escuchan  una tras otra de manera sucesiva. Es la parte de una composición que se percibe como  la línea principal.  •   Tonalidad.   La tonalidad hace alusión al tono de una obra. El tono es un conjunto de  sonidos que se sostienen en una misma nota principal llamada tónica. La sucesión de  esas notas compone las escalas.  •   Acorde.   Entendemos por acorde a un conjunto de tres o más notas musicales  diferentes, que suenan simultáneamente.  •   Armonía musical.   Relación y orden de notas musicales que hace referencia a la  combinación de diferentes sonidos o notas que se emiten al mismo tiempo, aunque el  término también se utiliza para referirse a la sucesión de estos sonidos emitidos a la vez  •   Ritmo.   El ritmo puede definirse como la combinación armoniosa de sonidos, voces o  palabras, que incluyen las pausas, los silencios y los cortes necesarios para que resulte  grato a los sentidos.  •   Partitura.   Una partitura es un documento manuscrito o impreso que representa e indica  cómo debe interpretarse una composición musical, mediante un lenguaje propio  formado por signos musicales y el llamado sistema de notación.\nGUITARRA  manuelcn33btrujillo@gmail.com   8  CAPÍTULO N°1  1. La partitura  La partitura es el lenguaje escrito de la música y, aunque la notación musical puede ser  compleja, es increíble lo que nos puede decir una partitura. En la partitura se puede plasmar  gráficamente todo lo que podemos expresar y decir con este lenguaje unive rsal que es: La  Música. Gracias a las partituras podemos interpretar todos los elementos de la música como  son: el ritmo, la melodía y la armonía.  Para hacer música y aprender a tocar un instrumento, conviene aprender el Lenguaje Musical;  en resumen, todo lo que está contenido y dibujado en una partitura.  La partitura es un gran invento que ha permitido a todos los compositores transmitir su música  a lo largo del tiempo y compartirla con todos.  En una partitura tenemos representados: la altura de los sonidos, la duración de éstos, a qué  velocidad se ejecutan, cuantos se tocan a la vez, con que instrumento, con que ritmo... En la  partitura vemos los matices musicales, la complejidad sonora y much os más elementos que  componen la música.\nGUITARRA  manuelcn33btrujillo@gmail.com   9  1.1. Elementos del lenguaje musical  En la partitura podemos encontrar una variedad de elementos las cuales debemos ser  capaces de reconocer su función y la información que nos entregan cada una de ellas.  1.1. 1 . El pentagrama  El pentagrama o pauta musical es un conjunto de   5   líneas horizontales paralelas  equidistantes y   4   espacios entre sí, sobre el cual se escriben las notas musicales y  demás signos de notación.  1.1. 2 . Las claves  Las claves musicales son símbolos que se   colocan al inicio de cada pentagrama e  indican donde se sitúa la nota que nos servirá de referencia para colocar las demás  notas.\nGUITARRA  manuelcn33btrujillo@gmail.com   10  1. 1 . 3 . Las notas musicales  Las notas musicales son el material básico para definir la altura de un sonido  determinado. La organización de las notas musicales está dada por los nombres de Do,  Re, Mi, Fa, Sol, La y Si. Añadiendo a estas 5 alteraciones, haciendo un total de 12 notas  un iversales.  Las notas musicales ubicadas en el pentagrama van en orden sucesivo entre líneas y  espacios. Si se necesita colocar una nota alterada (#/b) se modifica la armadura de clave  o simplemente se coloca la nota juntamente con la alteración a la izquierda.  Notas de la   guitarra   en clave de Sol  Notas en clave de Sol  Ubicación de las notas en la guitarra\nGUITARRA  manuelcn33btrujillo@gmail.com   11\nGUITARRA  manuelcn33btrujillo@gmail.com   12  1.1.4. Alteraciones de las notas naturales  1.1.5. Octavas  Las octavas son un tipo de intervalo musical formado por dos notas iguales a distancia  de seis tonos. Se interpretan con los dedos 1 y 5 como   norma general. Esto permite la  máxima apertura de la mano a la hora de abarcar el intervalo.  Four Elise  Octavas en la guitarra\nGUITARRA  manuelcn33btrujillo@gmail.com   13  1.1.6. Figuras musicales  En música, una figura es un signo que representa gráficamente la duración de un  determinado sonido o   de un silencio en una pieza musical.  1.1.6.1. Equivalencias de figuras musicales  Las equivalencias son relaciones entre dos figuras, cada una perteneciente a un compás  distinto, que van a tener la misma duración y por eso van unidas por el símbolo   =.\nGUITARRA  manuelcn33btrujillo@gmail.com   14  1.1.6.2. El puntillo, la ligadura y el calderón  En el plano musical, el puntillo se señala a la derecha de la nota que se pretende  modificar, incrementando su valor y su duración en la mitad. La ligadura nos permite  lograr el mismo efecto. Una ligadura añade a la primera nota el valor de la segunda. El  calderón, corona o fermata, es un signo de prolongación en el sonido, en notación  musical es un signo que indica un punto de reposo, alargando la duración de las figuras  musicales a las que afecta.  1.1. 7 . Métrica musical  La métrica musical es un aspecto fundamental de la música determina la estructura  rítmica de una pieza musical, dividiéndola en unidades regulares de tiempo. Estas  unidades de tiempo se llaman compases, y cada compás contiene un número  específico de pulsos   o tiempos fuertes y débiles que se repiten de manera regular.  1.1.8. El compás  Podemos decir que el compás divide el tiempo en partes iguales y que permite dar a la  pieza musical la contraposición de unas partes   acentuadas frente a otras sin acento o  átonas.  Práctica N°1\nGUITARRA  manuelcn33btrujillo@gmail.com   15  1.1.8.1. Líneas divisorias de compás  Es la línea vertical que atraviesa el pentagrama desde la primera línea hasta la quinta y  que lo divide en compases. La función de las líneas es indicar un acento agógico, es  decir, el primer tiempo de cada compás, que siempre, por regla, es el más fuerte.   Para  comprenderlo mejor podemos decir que sirven para ordenar los tiempos musicales,  indicándonos   el   final   de   un   compás   y   el   inicio   de   otro.  Existen varias líneas divisorias:\nGUITARRA  manuelcn33btrujillo@gmail.com   16  1.1.9. El metrónomo  Un metrónomo es un artefacto que reproduce una pulsación constante, que ayuda a los  músicos a tocar en armonía con los tiempos. La pulsación se mide en PPM (pulsaciones  por minuto), y también se   usa comúnmente BPM por sus siglas en inglés (beats - per -  minute). Un tempo de 60 PPM equivale a una pulsación por segundo, mientras que el de  120 PPM equivaldría a dos pulsaciones por segundo.  Se suele usar el metrónomo como una herramienta de práctica para mantener un buen  tempo o compás mientras se practican algunos pasajes difíciles. También se puede usar  en presentaciones en vivo y en estudios de grabación para garantizar un compás  perfecto   durante toda la presentación.  1.1.10. El ritmo  El ritmo musical puede entenderse como una sucesión regular de sonidos (notas)  fuertes y débiles de modo recurrente, regular, medida y controlada que resulta en la  ordenación de los sonidos o notas musicales.  Es precisamente el ritmo una de las características fundamentales de las artes en  general y la música en particular y hace que los sonidos, con sus notas y silencios,  resulten agradables al oído del oyente organizando así las notas acentuadas, pulsos y  com pás dando estructura y coherencia a la obra o pieza musical.  En conclusión, el ritmo es la proporción y el orden en el tiempo y el espacio.  Práctica N°2\nGUITARRA  manuelcn33btrujillo@gmail.com   17  1.1. 11 . Solfeo  El solfeo es una técnica de entrenamiento para adquirir rapidez en la lectura de una  partitura. Requiere además de entrenamiento   auditivo, concentración y constancia en  la práctica.  ✓   Solfeo Rítmico  Hay dos tipos de solfeo rítmico.  -   El primero se realiza percutiendo con las manos.\nGUITARRA  manuelcn33btrujillo@gmail.com   18  -   Un segundo tipo de solfeo es el solfeo hablado. En este tipo de solfeo  diremos los   nombres de las notas en voz alta sin entonación.  ✓   Solfeo Melódico  El solfeo melódico es similar al solfeo rítmico, pero realizando la entonación  de cada nota.  Examen teórico/práctico N°1\nGUITARRA  manuelcn33btrujillo@gmail.com   19  CAPÍTULO   N° 2  2.   Escalas musicales  La escala es en principio uno de los conceptos más importantes en la teoría musical. Es el  fundamento de la música y conocerlo te permite aprender nueva música más fácilmente,  educar tu voz para cantar e incluso componer tus propias creaciones. Se puede definir  también como un grupo de notas que se tocan en secuencia de forma ascendente o  descen dente en su tono (suelen sonar agradables al oído).  2. 1 .   Escalas mayores  Las escalas mayores contienen siete notas (antes de que la escala comience de nuevo una  octava más alta) y consisten en una estructura particular de semitonos (dos notas  adyacentes) y tonos (notas que están separadas por dos semitonos). Esta escala se  caracteriza por dar la sensación de alegría.  Tenemos como ejemplo la escala de C en   la guitarra\nGUITARRA  manuelcn33btrujillo@gmail.com   20  Escalas en el pentagrama\nGUITARRA  manuelcn33btrujillo@gmail.com   21  Patr ones   de escalas mayores en guitarra  2. 1.1 . Interpretación (M)\nGUITARRA  manuelcn33btrujillo@gmail.com   22\nGUITARRA  manuelcn33btrujillo@gmail.com   23\nGUITARRA  manuelcn33btrujillo@gmail.com   24\nGUITARRA  manuelcn33btrujillo@gmail.com   25  2.2. Escalas m enor es  La escala menor natural es equivalente al modo eólico de la escala mayor. La escala menor  natural de la (que coincide con las teclas blancas del piano al   igual que su relativo mayor,  do mayor) está formada por las notas: la, si, do, re, mi, fa, sol y la. Esta escala es notable  por dar la sensación de tristeza.  Tenemos como ejemplo la escala de Am en   la guitarra\nGUITARRA  manuelcn33btrujillo@gmail.com   26  Patrones de e scalas menores en   la guitarra  2. 2.1 . Interpretación (m)\nGUITARRA  manuelcn33btrujillo@gmail.com   27\nGUITARRA  manuelcn33btrujillo@gmail.com   28\nGUITARRA  manuelcn33btrujillo@gmail.com   29\nGUITARRA  manuelcn33btrujillo@gmail.com   30  2. 3 . Las armaduras de clave  La armadura de tonalidad (también llamada armadura de clave o simplemente  armadura), es el conjunto de alteraciones propias de la escala (sostenidos o bemoles)  que, escritas después de la clave y al principio del pentagrama, sitúan una frase musical  en una   tonalidad específica. Su función es determinar qué notas deben ser interpretadas  de manera sistemática un semitono por encima o por debajo de sus notas naturales  equivalentes,   a   menos   que   tal   modificación   se   realice   mediante   alteraciones  accidentales.  b En clave de G  # En clave de G  Si no se   encuentran armaduras de clave, esto  hace referencia que está en escala de C/Am.\nGUITARRA  manuelcn33btrujillo@gmail.com   31  2. 4 . Intervalos musicales  Así como en la vida cotidiana usamos, por ejemplo, metros para medir distancias entre un  objeto y   otro, en música utilizamos intervalos para determinar la diferencia entre dos notas.  Llamamos intervalo musical a la diferencia de altura   — frecuencia —   entre dos notas  musicales,   medida   cuantitativamente   (número)   en   grados   o   notas   naturales   y  cualitativamen te (especie) en tonos y semitonos. U = unísono (dos notas iguales) m2 = de segunda menor (1st) M2 = de segunda mayor (1T) m3 = de tercera menor (1T 1st) M3 = de tercera mayor (2T) P4 = de cuarta justa o perfecta (2T 1st) TT = de cuarta aumentada o tritono (2T 2st) P5 = de quinta justa o perfecta (3T 1st) m6 = de sexta menor (3T 2st) M6 = de sexta mayor (4T 1st) m7 = de séptima menor (4T 2st) M7 = de séptima mayor (5T 1st) P8 = de octava justa o perfecta (5T 2st)\nGUITARRA  manuelcn33btrujillo@gmail.com   32  La hoja Random  La hoja Random es una herramienta diseñada para mostrar notas de forma aleatoria, sin  secuencia ni patrón, como es lógico muchas de las progresiones o secuencias de escalas  que hagamos para practicar con ella no sonaran muy musicales, prepararnos para lo  i mpredecible es la función de esta herramienta.\nGUITARRA  manuelcn33btrujillo@gmail.com   33  3.   La tablatura  Una tablatura es un sistema gráfico de escritura musical simplificada para guitarra. Nos ayuda  a   conocer las posiciones y colocaciones de los dedos en el mástil del instrumento.  3.1. Partes de la tablatura  La tablatura consta de seis líneas (cada una representando un orden del laúd o de la  vihuela) en donde la inferior representa el primer   orden y la superior el sexto. Sobre cada  línea se anotan números que indican en qué traste se debe pisar la cuerda.\nGUITARRA  manuelcn33btrujillo@gmail.com   34  3.2. Símbolos en la tablatura  3.3. Interpretación\nGUITARRA  manuelcn33btrujillo@gmail.com   35\nGUITARRA  manuelcn33btrujillo@gmail.com   36\nGUITARRA  manuelcn33btrujillo@gmail.com   37\nGUITARRA  manuelcn33btrujillo@gmail.com   38\nGUITARRA  manuelcn33btrujillo@gmail.com   39  CAPÍTULO   N° 3  4.   Acordes   (Rasgueo, plaqué y arpegio)  Entendemos por acorde a un conjunto de tres o más notas musicales diferentes, que suenan  simultáneamente.  4.1. Acordes mayores  A nivel técnico, un acorde mayor es un conjunto de tres notas compuesto por un  intervalo de   Tercera Mayor y Quinta Justa; es decir, desde la Nota Fundamental (la que  da nombre al acorde) a la segunda nota habrá 4 semitonos de distancia y desde la  segunda nota a la tercera habrá 3 semitonos\nGUITARRA  manuelcn33btrujillo@gmail.com   40  4.2. Acordes menores  Los acordes   menores en su triada básica están formados por una primera, una tercera  menor y una quinta justa; es decir, desde la Nota Fundamental (la que da nombre al  acorde) a la segunda nota habrá 3 semitonos de distancia y desde la segunda nota a  la tercera habrá 4   semitonos .\nGUITARRA  manuelcn33btrujillo@gmail.com   41  4.3. Acordes de séptimas  Un acorde de séptima se puede interpretar como formado mediante una tríada a la que se  agrega una nota que forma un intervalo musical de una séptima con respecto a la raíz del  acorde.   La teoría clásica de la música considera disonantes a todos los acordes de  séptima, ya que el intervalo de séptima que contienen es considerado también un intervalo  disonante.  Mayores   7\nGUITARRA  manuelcn33btrujillo@gmail.com   42  M enores   7\nGUITARRA  manuelcn33btrujillo@gmail.com   43\nGUITARRA  manuelcn33btrujillo@gmail.com   44  4. 5 .   Interpretación  Perú campeón\nGUITARRA  manuelcn33btrujillo@gmail.com   45  Feliz navidad\nGUITARRA  manuelcn33btrujillo@gmail.com   46  Mi querido viejo\nGUITARRA  manuelcn33btrujillo@gmail.com   47  5.   Arpegios  El arpegio es una manera de ejecutar los tonos de un acorde: en vez de tocarlos de manera  simultánea, se hacen oír en sucesión rápida, generalmente del más   grave al más agudo.  5.1. Interpretación\nGUITARRA  manuelcn33btrujillo@gmail.com   48\nGUITARRA  manuelcn33btrujillo@gmail.com   49  Examen teórico/práctico N°2\nGUITARRA  manuelcn33btrujillo@gmail.com   50',0.15899324839265708,'[\"\\\"guitarra\", \"#\", \"(#/b)\", \"(1st)\", \"(1t\"]','2025-11-29 16:51:56.331971'),(28,3,'En un mundo que cambia cada día, avanzar con propósito se ha convertido en una necesidad. No se trata únicamente de caminar hacia adelante, sino de elegir con claridad aquello que realmente aporta valor a nuestra vida. Cada meta, por pequeña que parezca, representa un paso firme hacia un futuro mejor.\n\nTomarse un momento para reflexionar, organizar ideas y decidir el siguiente movimiento permite que nuestras acciones tengan sentido. La disciplina transforma las intenciones en resultados, y la constancia convierte esos resultados en hábitos duraderos. Así, poco a poco, construimos el camino hacia nuestras propias metas.\n\nAvanzar con propósito no es correr sin dirección, sino mantener un ritmo consciente, equilibrado y motivador. Significa reconocer los desafíos, aprender de ellos y continuar fortalecidos. La clave está en recordar que cada día ofrece una nueva oportunidad para crecer, mejorar y reinventarnos.',0.1722702209185498,'[\"a\", \"acciones\", \"adelante,\", \"aporta\", \"aprender\"]','2025-11-29 16:52:28.144982'),(29,3,'En un mundo que cambia cada día, avanzar con propósito se ha convertido en una necesidad. No se trata únicamente de caminar hacia adelante, sino de elegir con claridad aquello que realmente aporta valor a nuestra vida. Cada meta, por pequeña que parezca, representa un paso firme hacia un futuro mejor.',0.15996400330741628,'[\"a\", \"adelante,\", \"aporta\", \"aquello\", \"avanzar\"]','2025-11-29 16:52:38.780966'),(30,3,'Avanzar con propósito no es correr sin dirección, sino mantener un ritmo consciente, equilibrado y motivador. Significa reconocer los desafíos, aprender de ellos y continuar fortalecidos. La clave está en recordar que cada día ofrece una nueva oportunidad para crecer, mejorar y reinventarnos.',0.15541937116718926,'[\"aprender\", \"avanzar\", \"cada\", \"clave\", \"con\"]','2025-11-29 16:52:51.831952'),(31,3,'mpre podemos empezar de nuevo, con más equilibrio y determinación.',0.1598422219873836,'[\"con\", \"de\", \"determinaci\\u00f3n.\", \"empezar\", \"equilibrio\"]','2025-11-29 16:53:28.828727'),(32,3,'Estudiante de décimo ciclo de Ingeniería  de Sistemas Computacionales en la  Universidad Privada del Norte. Con  experiencia en desarrollo web (Frontend y  Backend), administración de hosting y  bases de datos, busco realizar prácticas  preprofesionales para aplicar mis  conocimientos y aportar soluciones  tecnológicas en instituciones educativas y  empresariales como CEPTRO Trujillo.',0.1688341926021005,'[\"(frontend\", \"administraci\\u00f3n\", \"aplicar\", \"aportar\", \"backend),\"]','2025-11-29 16:54:04.791487'),(33,3,'parte de nuestro día, todo parece ordenarse con más facilidad.',0.1598422219873836,'[\"con\", \"de\", \"d\\u00eda,\", \"facilidad.\", \"m\\u00e1s\"]','2025-11-29 16:54:29.729285'),(34,3,'hola',0.16651815288878052,'[\"hola\"]','2025-11-29 16:54:55.297264'),(35,3,'hola erijoihjño   gf gr rb r',0.1660529294906714,'[\"erijoihj\\u00f1o\", \"gf\", \"gr\", \"hola\", \"r\"]','2025-11-29 16:55:03.473260'),(36,3,'Conceptos básicos:  •   Música.   La música es, según la definición tradicional del término, el  arte de crear y organizar sonidos y silencios respetando los principios  fundamentales de la melodía, la armonía y el ritmo.  •   Nota musical.   En música, u na nota es un símbolo que denota un  sonido musical. En el lenguaje, una nota es también el sonido en sí.  •   Escala musical.   Una escala musical es un grupo de notas que se tocan  en secuencia de forma ascendente o descendente en su tono (suelen  sonar agradable s al oído).  •   Melodía.   La melodía es una secuencia organizada de notas musicales  que se escuchan una tras otra de manera sucesiva. Es la parte de una  composición que se percibe como la línea principal.  •   Tonalidad.   La tonalidad hace alusión al tono de una ob ra. El tono es  un conjunto de sonidos que se sostienen en una misma nota principal  llamada tónica. La sucesión de esas notas compone las escalas.  •   Acorde.   Entendemos por acorde a un conjunto de tres o más notas  musicales diferentes, que suenan simultáneame nte.  •   Armonía musical.   Relación y orden de notas musicales que hace  referencia a la combinación de diferentes sonidos o notas que se  emiten al mismo tiempo, aunque el término también se utiliza para  referirse a la sucesión de estos sonidos emitidos a la ve z  •   Ritmo.   El ritmo puede definirse como la combinación armoniosa de  sonidos, voces o palabras, que incluyen las pausas, los silencios y los  cortes necesarios para que resulte grato a los sentidos.',0.15791296272708558,'[\"(suelen\", \"a\", \"acorde\", \"acorde.\", \"agradable\"]','2025-11-29 16:55:21.613892'),(37,3,'Estudiante de décimo ciclo de Ingeniería  de Sistemas Computacionales en la  Universidad Privada del Norte. Con  experiencia en desarrollo web (Frontend y  Backend), administración de hosting y  bases de datos, busco realizar prácticas  preprofesionales para aplicar mis  conocimientos y aportar soluciones  tecnológicas en instituciones educativas y  empresariales como CEPTRO Trujillo.',0.1688341926021005,'[\"(frontend\", \"administraci\\u00f3n\", \"aplicar\", \"aportar\", \"backend),\"]','2025-11-29 16:55:52.307308'),(38,3,'En medio del ritmo acelerado de la vida,',0.15928089046400798,'[\"acelerado\", \"de\", \"del\", \"en\", \"la\"]','2025-11-29 16:56:06.550741'),(39,3,'En medio del ritmo acelerado de la vida,',0.15928089046400798,'[\"acelerado\", \"de\", \"del\", \"en\", \"la\"]','2025-11-29 16:56:12.203824'),(40,3,'Manuel Calderón Nolorbe  Básico   -   Intermedio\nã   3 3   œ   œ   œ   œ 1   œ   œ   œ   œ  ã   œ   Œ   œ   Œ 2   œ   Œ   œ   Œ  ã   œ   œ   Ó 3   œ   œ   Ó  ã   œ   œ   ˙ 4   œ   œ   ˙  ã   œ   ˙   œ 5   ˙   œ   œ  ã   ˙   œ   œ 6   ˙   œ   œ  ã   ˙   œ   Œ 7   Ó   ˙  ã   Ó   ˙ 8   œ   Ó   Œ  N e g r a s   y   b l a n c a s  manuelcn33btrujillo@gmail.com 2\nã   œ   Œ   ˙ 9   œ   Œ   œ   œ  ã   œ   œ   Ó 1 0   œ   Œ   ˙  ã   œ   Œ   œ   œ 1 1   œ   Œ   Ó  ã   œ   ˙   Œ 1 2   ˙   Œ   œ  ã   Œ   œ   Ó 1 3   Œ   œ   Ó  ã   Œ   ˙   œ 1 4   Œ   ˙   œ  ã   Ó   œ   Œ 1 5   ˙   Œ   œ  ã   Œ   Ó   œ 1 6  N e g r a s   y   b l a n c a s  manuelcn33btrujillo@gmail.com 3\nã   3 3   œ   œ   œ   œ   œ 1   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ 2   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ 3   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ 4   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ 5   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ 6   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ 7   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ 8   œ   œ   œ   œ   œ   œ   œ   œ  N e g r a s   y   c o r c h e a s  manuelcn33btrujillo@gmail.com 4\nã   œ   Œ   œ   œ   œ 9   œ   Œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ 1 0   Œ   œ   œ   œ   œ   œ  ã   Œ   œ   œ   œ   œ 1 1   Œ   œ   œ   œ   œ  ã   Œ   œ   œ   Œ   œ   œ 1 2   Œ   œ   œ   Œ   œ   œ  ã   œ   œ   œ   Œ   œ   œ 1 3   œ   œ   œ   Œ   œ   œ  ã   ι  œ   ‰   œ   œ   œ   œ   œ 1 4   Œ   œ   ι  œ   ‰   ι  œ   ‰  ã   ι  œ   ‰   œ   ι  œ   ‰   œ 1 5   ι  œ   ‰   œ   ι  œ   ‰   œ  ã   Œ   ι  œ   œ   ‰   œ   œ 1 6  N e g r a s   y   c o r c h e a s  manuelcn33btrujillo@gmail.com 5\nã   3 3   œ   œ   œ   œ   œ   œ   œ 1   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 2   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 3   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 4   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 5   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 6   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 7   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 8   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  N e g r a s   y   s e m i c o r c h e a s  manuelcn33btrujillo@gmail.com 6\nã   œ   Œ   œ   œ   œ   œ   œ 9   œ   Œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   Œ   œ   œ   œ   œ 1 0   œ   œ   œ   œ   œ   Œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   Œ   œ 1 1   œ   œ   œ   œ   œ   Œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   Œ 1 2   œ   œ   œ   œ   œ   œ   œ   œ   œ   Œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   Œ 1 3   œ   œ   œ   œ   œ   œ   œ   œ   Œ   œ   œ   œ   œ  ã   Œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 1 4   Œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   Œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 1 5   œ   œ   œ   œ   œ   Œ   Œ  ã   Œ   œ   œ   ≈   ≈   œ   œ   œ   ≈   ≈ 1 6  N e g r a s   y   s e m i c o r c h e a s  manuelcn33btrujillo@gmail.com 7\nã   3 3   œ   œ   ˙ 1   œ   œ   œ   ˙  ã   œ   œ   œ   œ   œ 2   œ   œ   œ   œ   œ  ã   œ   œ   œ   ˙ 3   œ   œ   œ   ˙  ã   œ   œ   œ   œ   œ   œ 4   ˙   œ   œ   œ  ã   œ   œ   œ   ˙ 5   œ   œ   œ   ˙  ã   œ   œ   œ   œ   œ   œ   œ 6   ˙   œ   œ   œ   œ  ã   ˙   œ   œ   œ   œ 7   ˙   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ 8   œ   œ   œ   ˙  B l a n c a s ,   n e g r a s   y   c o r c h e a s  manuelcn33btrujillo@gmail.com 8\nã   œ   œ   Ó 9   œ   œ   œ   œ   Œ  ã   œ   Œ   ˙ 1 0   Œ   œ   œ   ˙  ã   œ   œ   œ   œ   Œ 1 1   Ó   œ   œ   œ  ã   Œ   œ   œ   Ó 1 2   Œ   œ   œ   ˙  ã   ˙   œ   œ   œ   œ 1 3   Œ   ˙   œ   œ  ã   œ   œ   Ó   Œ 1 4   œ   ˙   ι  œ   ‰  ã   Œ   ι  œ   ‰   Ó 1 5   ι  œ   ‰   œ   ι  œ   ‰   Œ  ã   Ó   Œ   œ   œ 1 6  B l a n c a s ,   n e g r a s   y   c o r c h e a s  manuelcn33btrujillo@gmail.com 9\nã   3 3   œ   œ   œ   œ   œ 1   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ 2   œ   œ   œ   œ   œ   œ   œ  ã   ˙   œ   œ   œ   œ   œ 3   ˙   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ 4   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   ˙ 5   œ   œ   œ   œ   œ   œ   ˙  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ 6   œ   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 7   ˙   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 8   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  B l a n c a s ,   n e g r a s ,   c o r c h e a s   y   s e m i c o r c h e a s  manuelcn33btrujillo@gmail.com 10\nã   œ   œ   œ   œ   œ   Ó 9   œ   œ   œ   œ   œ   Ó  ã   œ   œ   Œ   ˙ 1 0   œ   œ   œ   œ   ˙  ã   œ   œ   œ   œ   œ   œ   œ   Œ 1 1   œ   œ   œ   œ   œ   œ   œ   Œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 1 2   Ó   Œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ 1 3   Œ   ˙   œ   œ   œ   œ  ã   œ   œ   œ   œ   Œ   Ó 1 4   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   ι  œ   ‰   œ   œ   œ   œ 1 5   œ   œ   œ   œ   œ   œ   œ   Œ  ã   œ   œ   Œ   œ   œ   œ   œ   œ   œ   œ   œ 1 6  B l a n c a s ,   n e g r a s ,   c o r c h e a s   y   s e m i c o r c h e a s  manuelcn33btrujillo@gmail.com 11\nã   3 3   œ   − ˙ 1   œ   − ˙  ã   − ˙   œ 2   − ˙   œ  ã   ˙   œ   œ 3   ˙   œ   œ  ã   œ   œ   œ   œ 4   œ   œ   œ   œ  ã   œ   − œ   − œ 5   œ   − œ   − œ  ã   − ˙   œ 6   − ˙   œ  ã   œ   œ   œ   œ 7   œ   œ   œ   œ  ã   œ   œ   œ   œ 8   œ   œ   œ   œ  P u n t i l l o   y   l i g a d u r a  manuelcn33btrujillo@gmail.com 12\nã   ˙   œ   Œ 9   ˙   œ   Œ  ã   − ˙   œ 1 0   Œ   œ   œ   ˙  ã   − ˙   œ   œ 1 1   − ˙   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ 1 2   œ   œ   œ   œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ 1 3   − œ   ι  œ   Œ   œ   œ  ã   ˙   œ   œ   œ 1 4   ˙   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ   œ   œ   œ 1 5   œ   œ   œ   œ   Œ   œ   œ   œ   œ  ã   œ   œ   œ   œ   œ   œ 1 6  P u n t i l l o   y   l i g a d u r a  manuelcn33btrujillo@gmail.com 13\n%   3 0 2  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 1 1 1  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  2 2 2  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  3 3 3 3  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  4 4 4  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  5 5 5  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  6  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 7  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   > 8  S o l f e o   h a b l a d o  manuelcn33btrujillo@gmail.com 14\n>   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 9  >  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 0  >  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 1  >  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 2 1 2 1 2  >  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 3 1 3 1 3  >  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 4  >   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 5  >   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  % 1 6  S o l f e o   h a b l a d o  manuelcn33btrujillo@gmail.com 15\n%   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 1 7  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 1 8  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 1 9  %   œ   œ  œ   œ   œ   œ  œ  œ   œ   œ   œ   œ   œ  2 0  %   œ   œ   œ   œ   œ  œ   œ   œ   œ   œ  œ   œ   œ 2 1  %   œ   œ   œ   œ   œ  œ   œ   œ   œ   œ   œ   œ  œ  2 2  %  œ  œ   œ   œ  œ   œ  œ  œ  œ  œ  œ   œ  œ  2 3  %   œ   œ  œ  œ  œ  œ  œ  œ  œ  œ  œ  œ   œ  2 4  S o l f e o   h a b l a d o  manuelcn33btrujillo@gmail.com 16\n%   3 0 1  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 1 1 1  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ 2 2 2  %   œ   œ   ˙   œ   œ   ˙   œ   œ   ˙ 3 3 3 3 3  %   œ   œ   œ   ˙   œ   œ   œ   ˙   œ   œ  4 4 4 4 4  %   ˙   œ   œ   ˙   œ   œ   ˙   œ   œ  5 5 5 5 5  %   œ   ˙   œ   ˙   œ   ˙   œ   ˙ 6  %   œ   œ   − ˙   œ   œ   − ˙   œ   œ  7  %   3  3  œ   œ   − ˙   œ   œ   − ˙   œ   œ  8  S o l f e o   m e l ó d i c o  manuelcn33btrujillo@gmail.com 17\n%   3 3   œ   œ   œ   œ 9  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  %   œ   œ   œ   œ   œ 1 0  œ   œ   œ   œ   œ   ˙   œ   œ   œ   ˙   œ   œ   œ  %   œ   œ   œ   œ   œ 1 1  œ   œ   œ   œ   œ   œ   œ   œ   ˙   œ   œ   œ   ˙  %   œ   œ   œ   œ   œ   œ   œ  1 2  œ   œ   œ   œ   œ   œ   œ   Œ   œ   œ   œ   œ   œ   œ   Œ   œ   œ   œ   œ   œ   œ  %   œ   œ   œ   œ   œ   œ   œ 1 3  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   Ó   Œ   œ   œ   œ   œ   œ   œ  %   œ   œ   œ   œ   œ   œ  1 4  œ   œ   œ   Œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   Œ   œ   œ  %   œ   œ   œ   œ   œ   œ   œ   œ 1 5   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   Ó   œ   œ   œ   œ   œ   œ   œ   œ  %   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ  1 6  œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ   œ œ   œ   œ   œ   œ œ   œ   œ  S o l f e o   m e l ó d i c o  manuelcn33btrujillo@gmail.com 18\nTalentos  Redondas, blancas y negras  Birritmia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            = 60  4  3  5  6  8  7  2  1  manuelcn33btrujillo@gmail.com 19\nBirritmia  Claves: sol y fa   Talentos                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              = 60  4  6  2  3  1  5              manuelcn33btrujillo@gmail.com 20\n33  41  37  39                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         5  6  1  3  2  4  Octavas              manuelcn33btrujillo@gmail.com 21\n54  44  56  47  52  50                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     10  11  8  12  9  7              manuelcn33btrujillo@gmail.com 22',0.18544000032399102,'[\"%\", \",\", \"-\", \"0\", \"1\"]','2025-11-29 16:56:32.542875'),(41,3,'ã   3 3   œ   œ   œ   œ 1   œ   œ   œ   œ  ã   œ   Œ   œ   Œ 2   œ   Œ   œ   Œ  ã   œ   œ   Ó 3   œ   œ   Ó  ã   œ   œ   ˙ 4   œ   œ   ˙  ã   œ   ˙   œ 5   ˙   œ   œ  ã   ˙   œ   œ 6   ˙   œ   œ  ã   ˙   œ   Œ 7   Ó   ˙  ã   Ó   ˙ 8   œ   Ó   Œ  M . C . N .  N e g r a s   y   b l a n c a s\nã   œ   Œ   ˙ 9   œ   Œ   œ   œ  ã   œ   œ   Ó 1 0   œ   Œ   ˙  ã   œ   Œ   œ   œ 1 1   œ   Œ   Ó  ã   œ   ˙   Œ 1 2   ˙   Œ   œ  ã   Œ   œ   Ó 1 3   Œ   œ   Ó  ã   Œ   ˙   œ 1 4   Œ   ˙   œ  ã   Ó   œ   Œ 1 5   ˙   Œ   œ  ã   Œ   Ó   œ 1 6  N e g r a s   y   b l a n c a s  M . C . N .',0.16651815288878052,'[\".\", \"0\", \"1\", \"2\", \"3\"]','2025-11-29 16:57:04.870081'),(42,3,'.................',0.16651815288878052,'[\".................\"]','2025-11-29 16:58:01.380767'),(43,3,'1. Gestión avanzada de tiendas (Operaciones)\r\n\r\nDentro de Tiendas, podrías sumar:\r\n\r\nVer / entrar como la tienda\r\nBotón “Ingresar como admin” → te loguea temporalmente como ese cliente para ayudarlo sin pedirle su contraseña (impersonación).\r\n\r\nHistorial de la tienda\r\n\r\nFecha de alta, últimos accesos.\r\n\r\nCambios de plan.\r\n\r\nSuspensiones / reactivaciones y quién las hizo.\r\n\r\nLímites por plan\r\n\r\nLímite de productos, usuarios, cajas, etc.\r\n\r\nDesde el master definir esos límites por plan y mostrar un pequeño resumen en la fila de la tienda: 45/100 productos, 2/3 cajas abiertas, etc.\r\n\r\nNotas internas\r\nCampo tipo “Notas” solo visibles para ti (ej: “Cliente moroso, negociar renovación en diciembre”).\r\n\r\n2. Gestión de usuarios del panel master\r\n\r\nUn módulo tipo “Equipo / Usuarios”:\r\n\r\nCrear usuarios internos: SuperAdmin, Soporte, Comercial, Finanzas.\r\n\r\nPermisos por rol:\r\n\r\nSoporte: ver tiendas, impersonar, ver métricas, pero no tocar facturación.\r\n\r\nFinanzas: ver/editar facturación, ver pagos, descargar reportes.\r\n\r\netc.\r\n\r\nRegistro de actividad por usuario (ver punto de auditoría).\r\n\r\nEsto da sensación de empresa organizada, no panel “solo para el programador”.\r\n\r\n3. Soporte al cliente\r\n\r\nUn módulo “Soporte” o “Tickets”:\r\n\r\nLista de tickets / solicitudes:\r\n\r\nTienda\r\n\r\nAsunto\r\n\r\nEstado (Abierto, En proceso, Resuelto)\r\n\r\nPrioridad (Alta, Media, Baja)\r\n\r\nIntegración con:\r\n\r\nFormulario de contacto de cada tienda.\r\n\r\nCorreo de soporte del SaaS.\r\n\r\nDesde el ticket:\r\n\r\nVer datos de la tienda.\r\n\r\nBotón “Entrar como tienda”.\r\n\r\nAgregar notas internas y respuesta enviada al cliente.\r\n\r\n4. Auditoría y seguridad\r\n\r\nMuy importante para un SaaS pro:\r\n\r\nLog de actividad:\r\n\r\nQuién hizo qué y cuándo:\r\n\r\n“Usuario X cambió plan de Tienda Y de Básico → Full”\r\n\r\n“Usuario Soporte suspendió la tienda Z”\r\n\r\nFiltros por usuario, tienda, acción, fecha.\r\n\r\nRegistro de accesos:\r\n\r\nÚltimos logins de administradores master (IP, navegador, fecha).\r\n\r\nIntentos fallidos de acceso.\r\n\r\nOpcional: 2FA para el panel master (Google Authenticator o por email).\r\n\r\n5. Configuración global del SaaS\r\n\r\nUna página “Configuración general”:\r\n\r\nPlanes y precios\r\n\r\nCrear/editar/eliminar planes.\r\n\r\nDefinir qué incluye cada plan (límite de tiendas, POS, ecommerce, reportes, etc.).\r\n\r\nParámetros de negocio\r\n\r\nMoneda principal.\r\n\r\nPorcentaje de mora / recargo.\r\n\r\nDías de gracia antes de suspender una tienda.\r\n\r\nIntegraciones globales\r\n\r\nAPI keys de pasarelas de pago si las gestionas centralizadas.\r\n\r\nServicios de correo (SMTP global del SaaS).\r\n\r\nPlantillas de correo\r\n\r\nEmail de bienvenida a nueva tienda.\r\n\r\nAviso de factura emitida.\r\n\r\nAviso de deuda / suspensión.\r\n\r\nAviso de reactivación.\r\n\r\n6. Automatizaciones de facturación\r\n\r\nTu módulo de Facturación ya está chévere; para nivel PRO:\r\n\r\nReglas automáticas:\r\n\r\nGenerar factura cada mes según plan.\r\n\r\nEnviar email automático con la factura.\r\n\r\nRecordatorios de pago (7 días antes, día de vencimiento, 3 días después).\r\n\r\nCambio automático de estado:\r\n\r\n“Pendiente” → “Vencida” → “Suspendida la tienda” según días de atraso.\r\n\r\nReportes financieros:\r\n\r\nMRR (Monthly Recurring Revenue).\r\n\r\nIngresos por plan.\r\n\r\nChurn (tiendas que cancelaron).\r\n\r\nNuevas altas vs bajas por mes.\r\n\r\n7. Métricas más profundas (nivel negocio SaaS)\r\n\r\nEn tu sección Métricas, además de lo que ya tienes:\r\n\r\nFunel de conversión:\r\n\r\nPruebas gratuitas → Activadas → De baja.\r\n\r\nUso de funcionalidades:\r\n\r\nCuántas tiendas usan POS.\r\n\r\nCuántas usan Ecommerce.\r\n\r\nCuántas usan Reclamos, Caja, etc. (te ayuda a decidir qué mejorar).\r\n\r\nAlertas:\r\n\r\nLista de tiendas “en riesgo”:\r\n\r\nPoco uso en últimos 30 días.\r\n\r\nMuchos tickets de soporte.\r\n\r\nVarias facturas vencidas.\r\n\r\n8. Detallitos visuales/UX que dan sensación de “producto grande”\r\n\r\nAlgunos toques que suman mucho:\r\n\r\nSkeleton loaders cuando cargan tablas y gráficas.\r\n\r\nEstados vacíos bonitos (“Aún no hay facturas este mes”, con icono y botón de acción).\r\n\r\nFiltros guardados o persistentes por usuario (que recuerde lo que filtraste).\r\n\r\nBadges/colores consistentes para estados (Activo, Suspendida, Pendiente, Pagada, etc.).\r\n\r\nBotones de acciones rápidas:\r\n\r\nEn la lista de tiendas: menú con Ver, Entrar como tienda, Ver facturas, Enviar recordatorio de pago.\r\n\r\nResponsive 100% para tablet/móvil (aunque solo lo uses tú, se siente profesional).\r\n\r\n9. Exportación y backups\r\n\r\nExportar Tiendas, Facturación y Métricas a Excel / PDF.\r\n\r\nBotón para exportar datos de una tienda (por si te pide baja con backup).\r\n\r\nPanel simple de backups:\r\n\r\n“Último backup general: 2025-11-16 03:20”.\r\n\r\nOpción para forzar un backup manual (aunque sea solo registro de que se hizo).',0.17011142344985106,'[\"(7\", \"(abierto,\", \"(activo,\", \"(alta,\", \"(aunque\"]','2025-11-29 16:58:09.389886'),(44,3,'FACULTAD DE   INGENIERIA  Carrera de   Ingeniería de Sistemas Computacionales  “ ANÁLISIS DE LAS TECNOLOGÍAS EMERGENTES EN LA MEDICINA: UNA  REVISIÓN DE LA LITERATURA ”  Trabajo de investigación para optar el grado de:  Bachiller en   Ingeniería de Sistemas Computacion ale s  Autores:  Manuel Calderón Nolorbe  Jean Terrones Guarniz  Asesor:  Dr. Mg. Lic.   Fernando Alex Sierra Liñan  Trujillo   –   Perú  2025\nTítulo de la revisión sistemática  Pág.   2  Calderon Norlobe M; Terrones Guarniz J  R esumen  El presente estudio tiene como objetivo analizar el uso de las tecnologías emergentes  en la medicina en los últimos años. Se empleó la metodología PRISMA para el desarrollo del  trabajo de revisión. Se analizaron 394 artículos, de los cuales se seleccionaro n 53 por su  relevancia. Estos fueron publicados e indexados en bases de datos como Dialnet, Redalyc,  Scopus, PubMed y ProQuest. Las principales áreas de impacto identificadas fueron: mejoras  en diagnósticos y tratamientos, optimización de la atención médic a y avances en la educación  médica. Las tecnologías emergentes más mencionadas incluyen:   Inteligencia Artificial,  Tecnología de Diagnóstico, Telemedicina, Impresión 3 D,   Dispositivos   Portátiles y   Blockchain.  En cuanto a las áreas médicas de aplicación más f recuentes, se destacan: diagnóstico por  imágenes,   oncología,   cirugía,   cuidados intensivos y   urgencias,   rehabilitación y   fisioterapia y  medicina preventiva y   genómica.   China lidera la producción científica sobre el uso de  tecnologías emergentes en medicina,   con 11   de los artículos revisados, seguido por Estados  Unidos con 7, España   con 6,   India,   Italia, Francia (ambos con 3). Los resultados evidencian un  crecimiento significativo en la producción científica sobre el uso de tecnologías emergentes en  medicina,   reflejando el considerable esfuerzo científico desarrollado en los últimos años .  Palabras claves:   tecnologías emergentes, médicas, artificial, inteligencia.\nTítulo de la revisión sistemática  Pág.   3  Calderon Norlobe M; Terrones Guarniz J  A bstract  This study aims to analyze the use of emerging technologies   in medicine in recent years.  The PRISMA methodology was used for the review. A total of 394 articles were analyzed, of  which 53 were selected for their relevance. These were published and indexed in databases  such as Dialnet, Redalyc, Scopus, PubMed, and   ProQuest. The main areas of impact identified  were: improvements in diagnosis and treatment, optimization of medical care, and advances in  medical education. The most frequently mentioned emerging technologies include artificial  intelligence,   diagnostic   te chnology,   telemedicine,   3D   printing,   wearable   devices,   and  blockchain. The most frequent areas of medical application include: diagnostic imaging,  oncology, surgery, intensive care and emergencies, rehabilitation and physical therapy, and  preventive medici ne and genomics. China leads the scientific output on the use of emerging  technologies in medicine, with 11 of the articles reviewed, followed by the United States with  7, Spain with 6, and India, Italy, and France (both with 3). The results show significa nt growth  in scientific output on the use of emerging technologies in medicine, reflecting the considerable  scientific effort developed in recent years.  Keywords:   Separar las palabras clave   traducidas al inglés   con   comas   (,) . Verificar que  se utilice el té rmino en inglés utilizado para cada variable.\nTítulo de la revisión sistemática  Pág.   4  Calderon Norlobe M; Terrones Guarniz J  Capítulo 1.   Introducción  En salud, se entiende por cobertura sanitaria universal que todas las personas tengan  acceso al conjunto de servicios de salud de calidad que necesiten en el momento y el lugar  adecuados y sin sufrir dificultades económicas   [1] . El porcentaje de la población que no está  cubierta p or los servicios de salud esenciales se redujo aproximadamente en un 15% entre 2000  y 2021, pero desde 2015 se cosecharon muy pocos avances. Ello implica que, en 2021, unos  4500 millones de personas no estaban plenamente cubiertas por los servicios de salu d  esenciales   [1] .  Desde la fundación de la Organización Mundial de la Salud (OMS) en 1948, el mundo ha  experimentado innumerables problemas de salud pública que amenazan nuestra salud y  bienestar   [2] . La labor de la OMS sigue firmemente anclada en los principios básicos del  derecho a la salud y al bienestar de todas las personas   [3] . También el Banco Mundial se ha  comprometido a ayudar a los países en desarrollo a lograr la cobertura sanitaria universal (C SU)  a través de sistemas de salud más sólidos y más resilientes y proporcionar servicios sanitarios  de calidad y asequibles para todos, especialmente los más vulnerables   [4]  La pandemia de COVID - 19 ha demostrado que la salud debe ocupar un lugar destacado en la  agenda de la ONU: las enfermedades cruzan fronteras y af ectan a ciudadanos de todo el mundo,  y la ausencia de salud tiene un impacto en muchos de los objetivos de la ONU, como el  desarrollo económico o la reducción de las desigualdades   [5] .  Sin embargo, en los últimos años se han logrado grandes avances en la mejora de la salud de  las personas. 146 de 200 países o zonas ya han alcanzado o están en vías de alcanzar la meta  de los ODS sobre la mortalidad de menores de 5 años. El tratamiento efi caz del VIH ha  reducido las muertes relacionadas con el sida en un 52 % a nivel mundial desde 2010, y al  menos una enfermedad tropical desatendida se ha eliminado en 47 países   [6] .\nTítulo de la revisión sistemática  Pág.   5  Calderon Norlobe M; Terrones Guarniz J  La OMS ha estado evaluando tecnologías innovadoras durante los últimos 10 años, y algunos  de los productos seleccionados están permitiendo solventar ahora problemas sanitarios  prioritarios en entornos   de bajos recursos   [7] .  La Industria 4.0 en el sector sanitario ha evolucionado drásticamente durante el último siglo.  De hecho, evoluciona a diario, con nuevas herramientas y estrategias desarrolladas por médicos  e investigadores   [8] . Los métodos y procedimie ntos que involucran robots médicos en el  continuo de atención, que abarca desde la prevención de enfermedades, la detección, el  diagnóstico, el tratamiento y la atención domiciliaria, se han implementado ampliamente y  también presentan increíbles oportunid ades de desarrollo futuro   [9] .  En el mundo actual, las tecnologías emergentes están revolucionando la gestión sanitaria. La  telemedicina es una de las áreas clave que está experimentando un rápido   crecimiento, pero  también hay muchas otras tecnologías innovadoras que están mejorando la atención médica y  el bienestar de los pacientes   [10] . La telemedicina es una de las tecnologías más importantes  en la gestión sanitaria actual, ya que permite a los pacientes acceder a atención médica de  calidad desde la comodidad de sus hogares.  Entre las ventajas de la telemedicina se encuentran la reduc ción de costos, la mejora del acceso  a especialistas y la posibilidad de monitorear a pacientes crónicos de manera más eficiente   [10] .  La integración de la inteligencia artificial, la realidad virtual y la robótica en el campo de l a  salud está transformando la atención médica de maneras sin precedentes. Estas tecnologías  emergentes no solo están mejorando la precisión y eficiencia de los tratamientos, sino que  también están haciendo que la atención médica sea más personalizada y acc esible   [11] .  El objetivo de esta investigación fue analizar los diferentes artículos donde   se pueden destacar  los alcances relacionados con el uso de las tecnologías emergentes en la medicina.\nTítulo de la revisión sistemática  Pág.   7  Calderon Norlobe M; Terrones Guarniz J  Capítulo 2.   Método  2.1 Tipo de Estudio  Este estudio se basó en una revisión sistemática de la literatura, aplicando el modelo PRISMA  [12]   para la selección, depuración e inclusión final de los artículos.  2.2 Preguntas de Investigación  RQ1: ¿CUAL ES EL IMPACTO DE LAS T ECNOLOGÍAS EMERGENTES EN LA  MEDICINA?  RQ2: ¿CUALES SON LAS PRINCIPALES TECNOLOGÍAS EMERGENTES EN LA  MEDICINA?  RQ3: ¿EN QUÉ ÁREAS DE LA MEDICINA MODERNA SE UTILIZA CON MAYOR  FRECUENCIA LA TECNOLOGÍA EMERGENTE?  2.3 Estrategia de Búsqueda  Para responder a l as preguntas se recopiló información de artículos de las principales  bases de datos Dialnet, Redalyc, Scopus,   Pubmed,   Proquest. Esto permitió identificar 394  artículos científicos. Al buscar toda la   información relacionada   con el tema de investigación se  c onsideraron las siguientes palabras clave: emerging AND medical AND technologies AND  artificial AND intelligence.  Figura 1. Cuadro de inclusión de artículos\nTítulo de la revisión sistemática  Pág.   8  Calderon Norlobe M; Terrones Guarniz J  2.4 Criterios de inclusión y exclusión  Se aplicaron los siguientes criterios de   inclusión y exclusión para el estudio de revisión  sistemática de la literatura  Criterio de Inclusión  I01   Artículos relacionado con las tecnologías  emergentes en la medicina  I02   Artículos   escritos   en   idioma   inglés   y  español  I03   Artículos   publicados entre los años 2020 y  2025  I04   Articulos Disponibles en texto completo  I05   Artículos relacionado con la medicina  Criterio de Exclusión  E01   Artículos   no   relacionados   sobre  tecnologías   emergentes   basadas   en  medicina  E02   Artículos que no   responden las preguntas  de investigación  E03   Artículos que no presenten texto completo  E04   Artículos publicados antes del 2020  E05   Artículos no relacionados a la medicina  Tabla 01: Inclusión y Exclusión\nTítulo de la revisión sistemática  Pág.   9  Calderon Norlobe M; Terrones Guarniz J  Capítulo 3.   Resultados  Se encontraron un total de 394 artículos en las bases de datos relacionadas con el tema  de investigación, desde qué artículos eran duplicados, no cumplían los criterios de inclusión o  no   contribuyen.   Se   descartaron   los   artículos   de   la   investigación.   Tras   r evisarlos,   se  seleccionaron 53 artículos para la revisión sistemática. La Figura 2 muestra la automatización  realizada con base en el método PRISMA   [12] , y muestra la importancia de este método de  forma detallada .  Figura 2. Prisma diagrama\nTítulo de la revisión sistemática  Pág.   10  Calderon Norlobe M; Terrones Guarniz J  Figura 3: Artículos base de datos  Figura 4: Países cantidad de Artículos\nTítulo de la revisión sistemática  Pág.   11  Calderon Norlobe M; Terrones Guarniz J  La bibliometría es un campo estudiado por varios autores debido a la importancia que tiene en  el contexto científico; actualmente se han realizado investigaciones de este tipo en diferentes  campos de estu dio   [13] . La bibliometría facilita evaluar la producción científica y su impacto,  lo que contribuye a reconocer y expandir el conocimiento en un área específica de investigación  [14] .VOSviewer es una herramienta utilizada para construir y visualizar redes bibliométricas,  permitiendo analizar relaciones de cocitación, acoplamiento bibliográfico y vínculos entre  revistas, autores o publ icaciones   [15] . Para llevar a cabo este estudio bibliométrico, se empleó  VOSviewer, el cual facilitó el examen de la coocurrencia de términos clave y la aplicación del  método de reconocimiento integral. A partir de el lo, se generaron representaciones visuales,  mostradas en la Figura 5 .\nTítulo de la revisión sistemática  Pág.   12  Calderon Norlobe M; Terrones Guarniz J  Figura 5: Visualización en red de documentos disponibles basada en análisis bibliométrico.  Grupo 1 (Red): Relacionado con la incorporación de tecnologías   emergentes que constituyen  el   componente   principal   de   nuestra   investigación:   inteligencia   artificial,   aprendizaje  automático y medicina personalizada.  Grupo 2 (Green): Relacionado con los procedimientos médicos, tecnologías educativas y  simulación médica.   Agrupa elementos como procedimientos,   cirugía,   imágenes diagnósticas y  realidad virtual.  Grupo 3 (Blue): Relacionado con la impresión 3D incluye elementos como impresión  tridimensional, estudios controlados y regeneración ósea.  Figure 6 Se muestran en la n ube de palabras obtenidas a partir de análisis de palabras clave de  los artículos sistematizados, utilizando la herramienta R studio para este análisis bibliométrico.  Destacan las siguientes palabras: artificial intelligence, deep learning , human.  La Fig ura 7 presenta el mapa de relaciones con las proporciones de los términos más frecuentes,  según el análisis bibliométrico realizado.  Figura 6: Visualización superpuesta de documentos disponibles en la base de datos Scopus:  nube de palabras\nTítulo de la revisión sistemática  Pág.   13  Calderon Norlobe M; Terrones Guarniz J  Figura 7: Visualización de los documentos basada en análisis bibliométrico.\nTítulo de la revisión sistemática  Pág.   14  Calderon Norlobe M; Terrones Guarniz J  Capítulo   4 .   Discusión  Con   esta   revisión   sistemática   de   la   literatura   se   pretende   responder   las   preguntas   de  investigación propuestas.  4.1 RQ1. ¿Cuál es el impacto de las tecnologías emergentes en la medicina?  Entre los artículos analizados, se identifican impactos como   mejoras en diagnósticos y  tratamientos mediante el uso de inteligencia artificial y análisis de imágenes 3D; optimización  de la atención médica gracias a la reducción de tiempos de respuesta y la facilitación en la toma  de decisiones; y avances en la educa ción médica a través de realidad aumentada, laboratorios  virtuales y simuladores.  Figura 8. Distribución de impactos según tecnologías emergentes en medicina.\nTítulo de la revisión sistemática  Pág.   15  Calderon Norlobe M; Terrones Guarniz J  Según la Tabla 2, se observa que la tecnología más utilizada es la   inteligencia artificial,  destacando por su aporte en la mejora de diagnósticos, tratamientos y optimización de la  atención médica.  Tabla 2. Clasificación de artículos según impactos en tecnologías emergentes  Impacto   Cantidad   Referencias  Mejoras en   diagnósticos y  tratamientos  22   [16] ,   [19] ,   [20] ,   [21] ,   [22] ,   [23] ,   [24] ,   [25] ,  [26] ,   [27] ,   [28] ,   [29] ,   [30] ,   [31] ,   [32] ,   [33] ,  [34] ,   [35] ,   [36] ,   [37] ,   [41] , [44]  Optimización   de   la  atención médica  6   [17] ,   [31] ,   [39] ,   [40] ,   [41] ,   [42]  Avances en la educación  médica  4   [16] ,   [43] ,   [44] ,   [45]  4.2 RQ2. ¿Cuáles son las principales tecnologías emergentes en la medicina?  La Figura 3 muestra los artículos según su aplicación en medicina utilizando tecnologías  emergentes,   destacando:   inteligencia   artificial,   tecnología   de   diagnóstico,   telemedicina ,  impresión 3D, dispositivos portátiles y blockchain.\nTítulo de la revisión sistemática  Pág.   16  Calderon Norlobe M; Terrones Guarniz J  Figura 9. Distribución de los artículos de investigación según tecnologías emergentes aplicadas  en la medicina.  En la Tabla 3 se muestran los artículos que evidencian el uso de   tecnologías emergentes en la  medicina, destacando que la tecnología más utilizada fue la inteligencia artificial.  Tecnologías Emergentes   Cantidad   Referencia  Inteligencia Artificial   11   [23] ,   [24] ,   [25] ,   [28] ,   [40] ,   [44] ,  [46] ,   [47] ,   [51] ,   [59] ,   [68]  Tecnología de Diagnóstico   5   [20] ,   [23] ,   [27] ,   [47] ,   [48]  Telemedicina   3   [19] ,   [43] ,   [45]  Impresión 3D   16   [17] ,   [19] ,   [21] ,   [22] ,   [24] ,   [28] , [  29] ,   [31] ,   [34] ,   [35] ,   [38] ,   [39] ,  [42] ,   [44] ,   [52] ,   [57]\nTítulo de la revisión sistemática  Pág.   17  Calderon Norlobe M; Terrones Guarniz J  Dispositivos Portátiles   4   [26] ,   [38] ,   [53] ,   [54]  Blockchain   5   [18] ,   [65] ,   [66] ,   [67] ,   [68]  4.3 RQ3. ¿En qué áreas de la medicina moderna se utiliza con mayor frecuencia la tecnología  emergente?  La Figura 10 muestra los artículos según su aplicación en diferentes áreas de la medicina  utilizando tecnologías emergentes, destacando:   diagnóstico por imágenes, oncología, cirugía,  cuidados intensivos y urgencias, rehabilitación y fisioterapia, y medicina preventiva y  genómica.  Figura 4. Distribución de los artículos de investigación según áreas de aplicación de las  tecnologías emergentes en la medicina.\nTítulo de la revisión sistemática  Pág.   18  Calderon Norlobe M; Terrones Guarniz J  En la Tabla 4 se muestran los artículos que evidencian el uso de tecnologías emergentes en  diferentes áreas de la medicina, destacando que las más frecuentes son diagnóstico por  imágenes, oncología y cirugía.  Áreas   Cantidad   Referencias  Diagnóstico   por  imágenes  4   [32] ,   [37] ,   [42] ,   [49]  Oncología   9   [30] ,   [36] ,   [46] ,   [55] ,   [56] ,   [57] ,   [58] ,   [59] ,   [62]  Cirugía   6   [20] ,   [34] ,   [35] ,   [58] ,   [60] ,   [61]  Cuidados  intensivos   y  urgencias  2   [57] ,   [64]  Rehabilitación   y  fisioterapia  3   [29] ,   [59] ,   [62]  Medicina  preventiva   y  genómica  7   [30] ,   [31] ,   [50] ,   [37] ,   [55] ,   [63] ,   [64]\nTítulo de la revisión sistemática  Pág.   19  Calderon Norlobe M; Terrones Guarniz J  Capítulo   5. Conclusión  Los estudios revisados coinciden en que las tecnologías emergentes están transformando de  manera significativa la atención médica entre los años 2020 y 2025. Este impacto se refleja en  mejoras en la eficiencia del diagnóstico, el monitoreo remoto de pa cientes, la automatización  de procesos clínicos y la personalización de tratamientos. Además, han fortalecido la capacidad  de respuesta frente a emergencias sanitarias, como la pandemia de COVID - 19, mediante el  desarrollo acelerado de soluciones.  La revisi ón identificó como más relevantes: la inteligencia artificial, el internet de las cosas  médicas, el análisis de big data, la robótica médica y las plataformas digitales de salud. Estas  tecnologías   fueron   consistentemente   mencionadas   en   los   estudios   por   su   potencial   de  transformar procesos médicos, mejorar diagnósticos y permitir una atención continua a  distancia.  Se observó una aplicación destacada en las áreas de diagnóstico por imágenes, cuidados  intensivos, atención remota, gestión de datos clínicos y ap oyo a la toma de decisiones médicas.  Tecnologías como la IA, los dispositivos portátiles y los sistemas de ayuda clínica fueron las  más utilizadas en estos ámbitos.  Los países con mayor producción científica y adopción de estas tecnologías fueron Estados  U nidos, China y España lo que demuestra un interés global en el fortalecimiento de la salud  digital. Los resultados de esta revisión sistemática proporcionan una base sólida para futuras  investigaciones que busquen desarrollar e implementar tecnologías emer gentes en contextos  médicos diversos, promoviendo sistemas de salud más inteligentes, sostenibles y equitativos.  .\nTítulo de la revisión sistemática  Pág.   20  Calderon Norlobe M; Terrones Guarniz J  Referencias  [1]   «Cobertura sanitaria universal (CSU)». Accedido: 11 de mayo de 2025. [En línea].  Disponible   en:   https://www.who.int/es/news - room/fact - sheets/detail/universal - health -  coverage - (u hc)  [2]   U. Nations, «Salud | Naciones Unidas», United Nations. Accedido: 11 de mayo de 2025.  [En línea]. Disponible en: https://www.un.org/es/global - issues/health  [3]   «Acerca de la OMS». Accedido: 11 de mayo de 2025. [En línea]. Disponible en:  https://ww w.who.int/es/about  [4]   «Salud», World Bank. Accedido: 11 de mayo de 2025. [En línea]. Disponible en:  https://www.bancomundial.org/es/topic/health/overview  [5]   «Salud | ONU GINEBRA». Accedido: 11 de mayo de 2025. [En línea]. Disponible en:  https://www.ung eneva.org/es/about/topics/health  [6]   M. Moran, «Salud», Desarrollo Sostenible. Accedido: 11 de mayo de 2025. [En línea].  Disponible en: https://www.un.org/sustainabledevelopment/es/health/  [7]   «La OMS publica un nuevo compendio de tecnologías sanitarias   innovadoras para la  COVID - 19 y otras enfermedades prioritarias». Accedido: 11 de mayo de 2025. [En línea].  Disponible   en:   https://www.who.int/es/news/item/31 - 08 - 2021 - who - releases - new -  compendium - of - innovative - health - technologies - for - covid - 19 - and - other - prior ity -  diseases  [8]   M. M. Ahsan y Z. Siddique, «Industry 4.0 in Healthcare: A systematic review»,  International Journal of Information Management Data Insights , vol. 2, n. o   1, p. 100079,  abr. 2022, doi: 10.1016/j.jjimei.2022.100079.  [9]   A. D. Lallo, R. R. M urphy, A. Krieger, J. Zhu, R. H. Taylor, y H. Su, «Medical Robots  for Infectious Diseases: Lessons and Challenges from the COVID - 19 Pandemic», 14 de  diciembre de 2020,   arXiv : arXiv:2012.07756. doi: 10.48550/arXiv.2012.07756.  [10]   «Tecnologías emergentes e n la gestión sanitaria: telemedicina y más allá | CESTE».  Accedido: 11 de mayo de 2025. [En línea]. Disponible en: https://www.ceste.es/areas - de -  negocio/tecnologia/tecnologias - emergentes - en - la - gestion - sanitaria - telemedicina - y - mas -  alla/  [11]   E. Altamirano,   «Tecnologías Emergentes en la Salud: IA, RV, Robótica», Altamiratec.  Accedido:   11   de   mayo   de   2025.   [En   línea].   Disponible   en:  https://www.blog.altamiratec.com/tecnologias - emergentes - en - la - salud - ia - rv - robotica/\nTítulo de la revisión sistemática  Pág.   21  Calderon Norlobe M; Terrones Guarniz J  [12]   «Declaración PRISMA 2020 una guía actualizada para la publicación de revisiones  sistemáticasThe PRISMA 2020 statement an updated guideline for reporting systematic  reviews.pdf».  [13]   R. J. Borges, «ANÁLISIS BIBLIOMÉTRICO APLICADO A ESTUDIOS SOBRE  CIENCIA , TECNOLOGÍA Y SOCIEDAD», 2020.  [14]   G. K. Muñoz - Estrada, H. E. Chumpitaz Caycho, J. Barja - Ore, N. Valverde - Espinoza, L.  Verde - Vargas, y F. Mayta - Tovalino, «Análisis bibliométrico de la producción científica  mundial sobre el aula invertida en la educación   médica»,   Educación Médica , vol. 23, n. o  5, p. 100758, sep. 2022, doi: 10.1016/j.edumed.2022.100758.  [15]   U. A. Bukar, M. S. Sayeed, S. F. A. Razak, S. Yogarayan, O. A. Amodu, y R. A. R.  Mahmood, «A method for analyzing text using VOSviewer»,   MethodsX , vo l. 11, p.  102339, dic. 2023, doi: 10.1016/j.mex.2023.102339.  [ 16 ] M. Ruiz - Aquino, A. L. Osorio - Llancachagua, J. O. Botiquín - Encarnación, A. V. Diaz -  Lazo, S. Á. Cortez - Orellana, y R. C. Duran - Aquino, «Uso de las tecnologías al servicio  de la investigación por estudiantes de medicina de una universidad privada de Huancay o»,  Rev Cient Sist Inform, vol. 5, n.º 1, p. e864, ene. 2025, doi: 10.51252/rcsi.v5i1.864.  [ 17 ] M. Bernal - García, M. Quemba - Mesa, S. Silva - Ortiz, y B. Pacheco - Olmos, «Laboratorios  Tradicionales versus Nuevas Tecnologías para el Estudio de Anatomía Humana e n  Estudiantes de Medicina: Revisión Sistemática y Meta Análisis», Int. J. Morphol., vol. 40,  n.º 1, pp. 30 - 36, feb. 2022, doi: 10.4067/S0717 - 95022022000100030.  [ 18 ] Universidad Ricardo Palma y C. J. Tinoco Plasencia, «Blockchain technology applied in  medic ine:   a   systematic   review»,   RFMH,   vol.   24,   n.º   1,   may   2024,   doi:  10.25176/RFMH.v24i1.5900.  [ 19 ] A. Zugasti Murillo, «Applicability of innovation in clinical nutrition», Nutr Hosp, 2021,  doi: 10.20960/nh.03559.  [ 20 ] S. Fuentes, M. Berlioz, F. Damián, J. M.   Pradillos, T. Lorenzo, y E. Ardela, «Satisfacción  de pacientes y profesionales con las nuevas tecnologías de imagen tridimensional aplicadas  a   la   medicina»,   Radiología,   vol.   62,   n.º   1,   pp.   46 - 50,   ene.   2020,   doi:  10.1016/j.rx.2019.06.001.  [2 1 ] Y. Zhu y X. Z heng, «Application of a Computerized Decision Support System to Develop  Care Strategies for Elderly Hemodialysis Patients», Journal of Healthcare Engineering, vol.  2021, pp. 1 - 10, jun. 2021, doi: 10.1155/2021/5060484.  [ 22 ] C. M. Andrews, A. B. Henry, I. M.   Soriano, M. K. Southworth, y J. R. Silva, «Registration  Techniques for Clinical Applications of Three - Dimensional Augmented Reality Devices»,  IEEE   J.   Transl.   Eng.   Health   Med.,   vol.   9,   pp.   1 - 14,   2021,   doi:  10.1109/JTEHM.2020.3045642.\nTítulo de la revisión sistemática  Pág.   22  Calderon Norlobe M; Terrones Guarniz J  [ 23 ] M. J. Cervantes   López, J. Cruz Casados, y L. N. Cruz Casados, «Inteligencia artificial en  la gestión de la medicina: avances y desafíos», RVG, vol. 29, n.º 108, pp. 1817 - 1835, sep.  2024, doi: 10.52080/rvgluz.29.108.21.  [ 24 ] P. Jiang, «APPLICATION OF 3D ANALYSIS TECHNOLOG Y OF VISION SYSTEM  IMAGE IN SPORTS MEDICINE», Rev Bras Med Esporte, vol. 27, n.º 4, pp. 381 - 385, ago.  2021, doi: 10.1590/1517 - 8692202127042021_0123.  [ 25 ] J. F. Avila - Tomás, M. A. Mayer - Pujadas, y V. J. Quesada - Varela, «La inteligencia  artificial y sus apli caciones en medicina I: introducción antecedentes a la IA y robótica»,  Atención   Primaria,   vol.   52,   n.º   10,   pp.   778 - 784,   dic.   2020,   doi:  10.1016/j.aprim.2020.04.013.  [ 26 ] V. Pérez Cantó et   al., «Development and Evaluation of a Software Designed by a Nursing  and Technology Team to Assess the Health Status of Adults over 65 Years of Age», Educ.  Enferm., vol. 42, n.º 2, 2024, doi: 10.17533/udea.iee.v42n2e07.  [2 7 ] I. L. D. O. M. Cunha, «Tecnologías asistivas   para pacientes ancianos con demencia:  perspectivas desde la bioética de los cuidados en salud», SCOL, vol. 19, p. e4488, oct. 2023,  doi: 10.18294/sc.2023.4488.  [ 28 ] E. Fornetti et   al., «A novel extrusion - based 3D bioprinting system for skeletal muscle  tis sue engineering», Biofabrication, vol. 15, n.º 2, p. 025009, abr. 2023, doi: 10.1088/1758 -  5090/acb573.  [ 29 ] B. Chen et   al., «Enhancement of critical - sized bone defect regeneration by magnesium  oxide - reinforced 3D scaffold with improved osteogenic and angio genic properties», Journal  of   Materials   Science   &   Technology,   vol.   135,   pp.   186 - 198,   feb.   2023,   doi:  10.1016/j.jmst.2022.06.036.  [ 30 ] K. Dhillon et   al., «Directional control of neurite outgrowth: emerging technologies for  Parkinson’s disease using magnetic   nanoparticles and magnetic field gradients», J. R. Soc.  Interface., vol. 19, n.º 196, p. 20220576, nov. 2022, doi: 10.1098/rsif.2022.0576.  [ 31 ] E. Weaver, S. Uddin, y D. A. Lamprou, «Emerging technologies for combating  pandemics», Expert Review of   Medical Devices, vol. 19, n.º 7, pp. 533 - 538, jul. 2022, doi:  10.1080/17434440.2022.2115355.  [ 32 ] «Retracted: Conservative Treatment and Rehabilitation Training for Rectus Femoris Tear  in Basketball Training Based on Computer Vision», Applied Bionics and   Biomechanics,  vol. 2023, pp. 1 - 1, nov. 2023, doi: 10.1155/2023/9897613.  [ 33 ] C. C. Huttin, «Biotech value chain and technologies for COVID - 19 research areas for  collaboration on cost quality tradeoff with tool companies», THC, vol. 30, n.º 2, pp. 513 -  516,   mar. 2022, doi: 10.3233/THC - 213297.  [ 34 ] X. - R. Li et   al., «3D cryo - printed hierarchical porous scaffolds provide immobilization of  surface - functionalized sleep - inspired small extracellular vesicles: synergistic therapeutic  strategies for vascularized bone   regeneration based on macrophage phenotype modulation  and angiogenesis - osteogenesis coupling», J Nanobiotechnol, vol. 22, n.º 1, p. 764, dic. 2024,  doi: 10.1186/s12951 - 024 - 02977 - 5.\nTítulo de la revisión sistemática  Pág.   23  Calderon Norlobe M; Terrones Guarniz J  [ 35 ] M. Maintz et   al., «Patient - specific implants made of 3D printed bior esorbable polymers at  the point - of - care: material, technology, and scope of surgical application», 3D Print Med,  vol. 10, n.º 1, p. 13, abr. 2024, doi: 10.1186/s41205 - 024 - 00207 - 0.  [ 36 ] C. Thyagarajan, S. Vijay Bhanu, y S. Suthir, «A secure network path of   implantable  medical devices for detecting the vulnerabilities using hybrid DBNF network», Biomedical  Signal   Processing   and   Control,   vol.   92,   p.   105968,   jun.   2024,   doi:  10.1016/j.bspc.2024.105968.  [ 37 ] T. He, J. Chen, X. Xu, G. Fortino, y W. Wang, «Early De tection of Parkinson’s Disease  Using Deep NeuroEnhanceNet With Smartphone Walking Recordings», IEEE Trans.  Neural   Syst.   Rehabil.   Eng.,   vol.   32,   pp.   3603 - 3614,   2024,   doi:  10.1109/TNSRE.2024.3462392.  [ 38 ] A. Angelucci, S. Canali, y A. Aliverti, «Digital tech nologies for step counting: between  promises of reliability and risks of reductionism», Front. Digit. Health, vol. 5, p. 1330189,  dic. 2023, doi: 10.3389/fdgth.2023.1330189.  [ 39 ] M. Byakodi et   al., «Emerging 0D, 1D, 2D, and 3D nanostructures for efficient   point - of -  care biosensing», Biosensors and Bioelectronics: X, vol. 12, p. 100284, dic. 2022, doi:  10.1016/j.biosx.2022.100284.  [ 40 ] G. Alhussain, A. Kelly, E. I. O’Flaherty, D. P. Quinn, y G. T. Flaherty, «Emerging role of  artificial intelligence in global   health care», Health Policy and Technology, vol. 11, n.º 3, p.  100661, sep. 2022, doi: 10.1016/j.hlpt.2022.100661.  [ 41 ] T. M. Klompstra, K. - J. Yoon, y B. - K. Koo, «Evolution of organoid genetics», European  Journal   of   Cell   Biology,   vol.   104,   n.º   2,   p.   151481 ,   jun.   2025,   doi:  10.1016/j.ejcb.2025.151481.  [ 4 2]   X.   Rodríguez - Maciñeiras   et   al.,   «Advancing   medication   compounding:   Use   of   a  pharmaceutical 3D printer to auto - fill minoxidil capsules for dispensing to patients in a  community pharmacy», International Jour nal of Pharmaceutics, vol. 671, p. 125251, feb.  2025, doi: 10.1016/j.ijpharm.2025.125251.  [ 4 3] Z. Fu, Y. Wu, L. Xu, F. Cai, R. Liu, y Z. Jiang, «Optimizing cost - effectiveness in remote  objective structured clinical examinations through targeted double scor ing methodologies»,  Medical   Education   Online,   vol.   30,   n.º   1,   p.   2467477,   dic.   2025,   doi:  10.1080/10872981.2025.2467477.  [4 4 ] L. Dipietro et   al., «Integrating Big Data, Artificial Intelligence, and motion analysis for  emerging precision medicine applicatio ns in Parkinson’s Disease», J Big Data, vol. 11, n.º  1, p. 155, oct. 2024, doi: 10.1186/s40537 - 024 - 01023 - 3.  [ 4 5] A. R. Latorre - Rodríguez, R. H. Shah, S. Munir, y S. K. Mittal, «Adoption of telemedicine  for obesity treatment during the COVID - 19 pandemic ac hieved comparable outcomes to in -  person   visits»,   Obesity   Pillars,   vol.   12,   p.   100131,   dic.   2024,   doi:  10.1016/j.obpill.2024.100131.\nTítulo de la revisión sistemática  Pág.   24  Calderon Norlobe M; Terrones Guarniz J  [ 4 6] T. Preijers, A. E. Muller, A. Abdulla, B. C. M. De Winter, B. C. P. Koch, y S. D. T. Sassen,  «Dose Individualisation o f Antimicrobials from a Pharmacometric Standpoint: The Current  Landscape», Drugs, vol. 84, n.º 10, pp. 1167 - 1178, oct. 2024, doi: 10.1007/s40265 - 024 -  02084 - 7.  [ 4 7] S. Freeman et   al., «Health consumers’ ethical concerns towards artificial intelligence in  Aus tralian emergency departments», Emerg Medicine Australasia, vol. 36, n.º 5, pp. 768 -  776, oct. 2024, doi: 10.1111/1742 - 6723.14449.  [ 4 8] M. Lippmann, M. Hitzemann, J. Winkelholz, D. Bailey, y S. Zimmermann, «A modular,  isolated high - voltage switch for applic ation in ion mobility spectrometry», HardwareX, vol.  19, p. e00574, sep. 2024, doi: 10.1016/j.ohx.2024.e00574.  [ 4 9] S. Leng et   al., «Standardizing technical parameters and terms for abdominopelvic photon -  counting CT: laying the groundwork for innovation an d evidence sharing», Abdom Radiol,  vol. 49, n.º 9, pp. 3261 - 3273, may 2024, doi: 10.1007/s00261 - 024 - 04342 - 4.  [ 5 0] D. Kleftogiannis et   al., «Automated cell type annotation and exploration of single - cell  signaling dynamics using mass cytometry»,   iScience, vol. 27, n.º 7, p. 110261, jul. 2024,  doi: 10.1016/j.isci.2024.110261.  [ 5 1] C. A. Sparks et   al., «ChatGPT Is Moderately Accurate in Providing a General Overview  of   Orthopaedic   Conditions»,   JBJS   Open   Access,   vol.   9,   n.º   2,   abr.   2024,   doi:  10.2106/ JBJS.OA.23.00129.  [ 5 2] Dr. I. Prusty, «Exploring New Avenues In Drug Discovery And Development: Insight Into  Pharmacokinetics And Pharmacodynamics», JAB, jun. 2024, doi: 10.53555/jab.v10.006.  [ 5 3] S. Qian, T. Zhang, y S. Hu, «Research on intelligent routin g with VAE - GAN in the internet  of   body»,   PLoS   ONE,   vol.   20,   n.º   2,   p.   e0317698,   feb.   2025,   doi:  10.1371/journal.pone.0317698.  [ 5 4] X. Sun, J. Zhu, M. Lu, Z. Zhang, C. Li, y R. Zhan, «Robot - assisted puncture versus  conservative treatment for severe   brainstem hemorrhage: clinical outcomes comparison  with experience of 138 cases in a single medical center», World J Emerg Surg, vol. 20, n.º  1, p. 15, feb. 2025, doi: 10.1186/s13017 - 025 - 00592 - 9.  [ 5 5] T. Alsahfi, A. Badshah, O. I. Aboulola, y A. Daud, «Opt imizing healthcare big data  performance through regional computing», Sci Rep, vol. 15, n.º 1, p. 3129, ene. 2025, doi:  10.1038/s41598 - 025 - 87515 - 5.  [ 56 ] J. Xue, Z. Li, y S. Zhang, «Multi - resource constrained elective surgical scheduling with  Nash equilibriu m toward smart hospitals», Sci Rep, vol. 15, n.º 1, p. 3946, ene. 2025, doi:  10.1038/s41598 - 025 - 87867 - y.  [ 57 ] Á. García - Granero et   al., «3D - reconstruction printed models and virtual reality improve  teaching in oncological colorectal surgery», Tech Coloproc tol, vol. 29, n.º 1, p. 24, dic.  2025, doi: 10.1007/s10151 - 024 - 03074 - 3.  [ 58 ] D. I. Szabó, A. Vereczkei, y A. Papp, «From gaming to surgery: the influence of digital  natives on robotic skills development», J Robotic Surg, vol. 19, n.º 1, p. 12, nov. 2024,   doi:\nTítulo de la revisión sistemática  Pág.   25  Calderon Norlobe M; Terrones Guarniz J  10.1007/s11701 - 024 - 02178 - 0.  [ 59 ] B. B. Ozmen y P. Mathur, «Evidence - based artificial intelligence: Implementing retrieval -  augmented generation models to enhance clinical decision support in plastic surgery»,  Journal of Plastic, Reconstructive & Aesth etic Surgery, vol. 104, pp. 414 - 416, may 2025,  doi: 10.1016/j.bjps.2025.03.053.  [ 60 ] T. Fan, L. Shi, X. Peng, M. Wu, L. Yu, y B. Zhu, «High Simulation Training System for  Spinal Full‐Endoscopic Surgery, Based on the Combination of VR / AR and Magneto‐  Optic al Navigation Technology», Orthopaedic Surgery, vol. 17, n.º 4, pp. 1243 - 1254, abr.  2025, doi: 10.1111/os.70008.  [6 1 ] S. S. Kim et   al., «The Society of Thoracic Surgeons Expert Consensus Statements on a  Framework   for   a   Standardized   National   Robotic   Curricu lum   for   Thoracic   Surgery  Trainees», The Annals of Thoracic Surgery, vol. 119, n.º 4, pp. 719 - 732, abr. 2025, doi:  10.1016/j.athoracsur.2024.12.003.  [ 62 ] Y. J. Wang, W. C. Choo, K. Y. Ng, R. Bi, y P. W. Wang, «Evolution of AI enabled  healthcare systems usin g textual data with a pretrained BERT deep learning model», Sci  Rep, vol. 15, n.º 1, p. 7540, mar. 2025, doi: 10.1038/s41598 - 025 - 91622 - 8.  [ 63 ] U. Khalid, L. Chen, A. A. Khan, B. Chen, F. Mehmood, y M. Yasir, «A smart facial acne  disease monitoring for auto mate severity assessment using AI - enabled cloud - based internet  of things», Discov Computing, vol. 28, n.º 1, p. 12, feb. 2025, doi: 10.1007/s10791 - 025 -  09503 - 7.  [ 64 ] M. Pulcinelli, I. Condò, V. Lavorgna, C. Massaroni, E. Schena, y D. Lo Presti,  «Combining f iber Bragg grating sensors and artificial intelligence in medicine», APL  Photonics, vol. 10, n.º 3, p. 030901, mar. 2025, doi: 10.1063/5.0251132.  [ 65 ] R. Pava, J. N. Perez Castillo, y L. F. Niño Vasquez, «Perspectiva para el uso del modelo  P6 de atención e n salud bajo un escenario soportado en IoT y blockchain», Tecnura, vol. 25,  n.º 67, pp. 112 - 130, ene. 2021, doi: 10.14483/22487638.16159.  [ 66 ] C. R. Araujo - Inastrilla y A. A. Vitón - Castillo, «Blockchain in health sciences: Research  trends in Scopus», Ibero american Journal of Science Measurement and Communication,  vol. 3, n.º 2, ago. 2023, doi: 10.47909/ijsmc.56.  [ 67 ] «El Futuro de la Gestión de Archivos Médicos: Tendencias y PerspectivasThe Future of  Medical Records Management: Trends and Perspectives».  [ 68 ] H. E. D. Villarruel, «Impacto de la inteligencia artificial en la monitorización de pacientes  en enfermería Impact of artificial intelligence on patient monitoring in nursing Impact of  artificial intelligence on patient monitoring in nursing», vol. 8, n. º 9, 2023.',0.14494766567443623,'[\"%\", \"&\", \"(,)\", \"(ambos\", \"(blue):\"]','2025-11-29 16:58:25.957288'),(45,3,'Rev.   C ient.   S ist.   I nform.   5 ( 1 ), e 864 , doi:   10.51252/rcsi.v 5 i 1 . 864  Original article  Artículo original  Jan - Jun , 202 5 https://revistas.unsm.edu.pe/index.php/r csi  e - ISSN:   2709 - 992X  ©   The authors. This is an open - access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distr ibution,  and reproduction in any medium,   provided the original work is properly cited.  Use of technology in research among medical students at a  private university in Huancayo  Uso de las tecnologías al servicio de la investigacion por estudiantes de medicina  de una universidad privada de Huancayo  Mely Ruiz - Aquino 1* ,   Andrés   Leonardo Osorio - Llancachagua 2 ,   Julio Oswaldo Botiquín -  Encarnación 2 ,   Aníbal Valentín Diaz - Lazo 2 ,   Santiago Ángel Cortez - Orellana 2 ,   Rivaldo Carlos  Duran - Aquino 3  1 Universidad de Huanuco .   Huanuco, Peru  2 Universidad Peruana Los Andes .   Huancayo, Peru  3 Universidad Nacional Mayor de San Marcos .   Lima, Peru  Received :   29   Sept .   202 4   |   Ac c ept ed :   23   Nov .   202 4   |   Publi shed :   2 0   Jan.   202 5  Corresponding author *:   melyruizaquino@udh.edu.pe  How to cite this article :   Ruiz - Aquino, M., Osorio - Llancachagua, A. L., Botiquín - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A   .,  & Duran - Aquino, R. C .   (202 5 ).   Use of technology in research among medical students at a private university in Huancayo .   Revista  C ientífica de   S istemas e   I nformática ,   5 ( 1 ), e 7 63 .   https://doi.org/10.51252/rcsi.v5i1.864  ABSTRACT  This study mainly assessed the level of technology use in research among medical students during the infodemic  period at a private university in Huancayo. A quantitative, descriptive study was conducted with a randomly  selected sample of 109 students from   a total population of 764. A validated technology usage scale for research  was applied, followed by a descriptive data analysis. The results indicated that 44.95% of students had a basic  level of technological proficiency, 45.87% had an intermediate level,   and only 8.26% had an advanced level. The  most frequently used tools were PubMed and SciELO for literature searches, whereas the use of reference  managers and academic integrity tools was notably limited. The findings suggest that despite having access to  digital devices and internet services, students require further training in advanced technological tools to enhance  the quality of their research .  Keywords :   competencies; education; infodemic;   research; technology  RESUMEN  El objetivo de este estudio fue identificar el nivel de uso de las tecnologías al servicio de la investigacion por parte  de estudiantes de medicina en tiempos de infodemia en una universidad privada de Huancayo. Se   realizo un  estudio cuantitativo, descriptivo simple, con una muestra de 109 estudiantes seleccionados aleatoriamente de  una poblacion de 764. Se aplico una escala de uso de tecnologías para la investigacion y se realizo un analisis  descriptivo de los datos . Los resultados indicaron que el 44,95% de los estudiantes tenía un nivel basico, el  45,87% un nivel intermedio y solo el 8,26% un nivel avanzado en el uso de tecnologías. Las herramientas mas  utilizadas fueron PubMed y Scielo para la busqueda de informac ion, mientras que el uso de gestores de  referencias y herramientas de integridad academica fue limitado. Se concluye que, aunque los estudiantes  cuentan con acceso a dispositivos y servicios de internet, existe una necesidad de fortalecer sus habilidades e n  el uso de tecnologías avanzadas para mejorar la calidad de sus investigaciones .  Palabras clave :   competencias; educacion; infodemia; investigacion; tecnología.\nRuiz - Aquino   et al.  2   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  1.   INTRODUC TION  In recent years, the COVID - 19 pandemic has fueled   the rise of an infodemic, characterized by the  rapid spread of all types of information, including rumors and unreliable data. This has been  facilitated by the widespread use of mobile phones, social networks, the internet, and other  communication technolo gies (Arroyo et al., 2020). However, technology use is not inherently  detrimental. We are experiencing a technological revolution marked by the global expansion of  computers and digital communication systems (Grande et al., 2016), which have proven invalua ble  across various fields, including scientific research. Information and Communication Technologies  (ICTs) exemplify this transformation, significantly impacting research by enabling more efficient  problem - solving and data management (Grande et al., 2016) . Medical students increasingly rely  on ICTs to streamline research tasks that would otherwise be time - consuming and resource -  intensive (Arbelaez, 2014).  A 2019 study in Spain by Garcí a   &   Canton (2019) reported that nearly all students (98%) used  search engines such as Google or Safari, and 96% utilized instant messaging applications like  WhatsApp or Telegram. In Mexico, Gomez (2019) found that only 18% of university students had  internet a ccess at home, with financial constraints being the primary barrier. Social media use was  also widespread, with 95% of students on Facebook, 79% on Twitter, and 65% on Instagram.  Similarly, Campos et al. (2018) reported th at 72.4% of students at a Mexican research center were  familiar with ICTs, with an average competence rating of 3.54 on a scale of 1 to 5. A 2017 study in  Chile by Cerda et al. (2017) found that 97% of surveyed students owned a laptop and 87% had a  smartph one, with extensive internet coverage at home.  In Peru, Morales (2020) examined ICT integration in video surveillance in Santiago de Surco,  noting a lack of system interoperability. Mendoza (2018) found that 70.4% of educators  incorporated ICT into their teaching, mainly through images (69.1%), videos   (64.2%), and audio  (44.4%), with PowerPoint being the most frequently used tool (93.8%). However, 38.3% of  teachers reported insufficient training and requested instruction on virtual classroom design.  Licona   &   Veitya (2019) further emphasized the necessit y of technological training for researchers,  highlighting its role in accessing and managing scientific information.  Given the transition to virtual learning environments, evaluating the extent of technology use in  research among medical students during the infodemic is crucial (Al - Hail et al., 2023; Almufarreh  & Arshad, 2023). ICTs have become essential in both in - perso n and remote education (Licona &  Veitya, 2019), enhancing research quality by facilitating access to databases, data processing  software, academic writing tools, presentation applications, plagiarism detection programs, and  reference management systems. Re cent studies have demonstrated a direct link between students\'  technological competencies and the effectiveness of their academic research (Martínez & Flores,  2021; Reyes et al., 2020).  Furthermore, Navarrete Enrí quez et al. (2024) and Salguero Alcala et al.   (2024) underscored the  importance of digital competencies for academic performance, particularly in information - dense  environments like the infodemic. These studies highlight the necessity of integrating educational  strategies to strengthen students\' techn ological skills, enabling them to efficiently manage  information and enhance research quality.\nRuiz - Aquino   et al.  3   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Thus, the objective of this study is to identify the level of technology use in research among medical  students at a private university in Huancayo during the infodemic period.  2.   MATERIALS   AND   M ETHODS  2.1.   Type and area study  A quantitative, descriptive, cross - sectional study was conducted among medical students. The area  where the study was   conducted was the Peruvian University of Los Andes. It was carried out from  September 2021 to January 2022.  2.2.   Population and sample  The study population consisted of 764 students of the Faculty of Human Medicine of the  Universidad Peruana Los   Andes, and the sample consisted of 109 students to whom a scale of use  of technologies in the service of research was applied, performing a descriptive analysis. The  inclusion criteria considered students who were doing research work, those between the fif th and  twelfth year of studies, and all students who expressed their willingness to participate. Students  who were between the first and fourth cycle of studies were excluded from the study, as well as  those who did not adequately complete the questionnair e (Table 1).  Table 1.   neral characteristics of the sample of medical students  General characteristics   n=109  fi   %  Demographic characteristics  Age group (years)  Teenagers (15 - 19)   87   79,82  Youth (20 - 25)   20   18,5  Adults (>25)   2   1,83  Sex  Male   48   44  Female   61   56  Academic characteristics  Cycle of studies  Fifth cycle   15   13,8  Sixth cycle   22   20,2  Seventh cycle   23   21,1  Eighth cycle   9   8,3  Ninth cycle   22   20,2  Tenth cycle   8   7,3  Eleventh cycle   9   8,3  Twelfth cycle   1   0,9  Characteristics of the   research  Type of study  According to the researcher\'s intervention  Observational   106   97,2  Experimental   3   2,8  According to the source of information  Retrospective   73   67  Prospective   36   33  According to the number of measurements  Transversal   104   95,41  Longitudinal   5   4,59  According to the number of variables  Descriptive   95   87,16  Analytical   14   12,84\nRuiz - Aquino   et al.  4   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Project phase  Planning   95   87,2  Execution   11   10,1  Final report   3   2,8  Publication   0   0  Informative data  Previous scientific   publication  Yes   2   1,8  No   107   98,2  Type of study  Original article   -   -  Letter to the editor   -   -  Editorial   -   -  Review article   2   1,8  Symposium   -   -  Case report   -   -  Essays   -   -  2.3.   Data collection techniques and instruments.  The online survey   technique was used, using the \"Scale of the use of technologies in the service of  research\" as an instrument. This instrument was composed of 49 items distributed in 7  dimensions:   technology   for   information   search,   database   technology,   technology   for   data  processing, technology for writing, technology for the presentation of research results, technology  for academic integrity, and technology for reference managers. In addition, a survey guide was  applied to collect the general characteristics of the sample,   which consisted of 13 items organized  into   4   dimensions:   demographic   characteristics,   academic   characteristics,   research  characteristics, and informational data (Table 2) .  Tabl e   2.   Characteristics of the use of technologies by medical students  Equipment and/or devices  N=109  Yes   No  fi   %   fi   %  Desktop computer   93   85.32   16   14.68  Laptop   61   55.96   48   44.04  Cell phone   95   87.16   14   12.84  Tablet   49   44.95   60   55.05  Printer   82   75.23   27   24.77  External memory   28   25.69   81   74.31  USB   81   74.31   28   25.69  MP4   44   40.37   65   59.63  Other   -   -   -   -  Internet service  Home Internet (Router)   100   91.74   9   8.26  Mobile Internet   65   59.63   44   40.37  Wireless Internet (Modem)   87   79.82   22   20.18  Other   -   -   -   -  The \"Scale of the use of technologies in the   service of research\" was validated by a panel of 5  experts, who evaluated the pertinence, relevance, clarity, and organization of the items, ensuring  that they were representative of the variable to be measured. The survey was conducted using the  Google Fo rms platform.\nRuiz - Aquino   et al.  5   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  2.4.   Data collection procedures  For data collection, the online survey was sent through the WhatsApp messaging application to  different groups of students, previously organized by academic cycles (from 5th to 12th). The  survey was designed to be answered in an average time of 20 minutes,   to ensure the participation  and adequate dedication of the respondents.  The process of constructing the instrument began with the development of a matrix in Microsoft  Word, in which the items and dimensions of the survey were clearly defined. Subsequently, this  matrix was transferred to the Google Forms platform, where the que stionnaire was developed in  its final format. This digital transition allowed for greater organization and accuracy in data  collection, as well as a more accessible experience for participants. In addition, the use of Google  Forms facilitated the collectio n and secure storage of responses, allowing for efficient management  of the data collected and minimizing the risk of data entry errors.  The distribution of the survey via WhatsApp was strategically planned to maximize the response  rate, taking advantage of the popularity and reach of this application among university students.  2.5.   Data analysis  Data collection was carried out through an online survey distributed via institutional email and  academic platforms. The survey responses were recorded and analyzed using descriptive  statistics, including frequency distributions, means, and standard deviat ions. The collected data  were processed using SPSS version 26.  2.6.   Ethical aspects  Before initiating the study, permission was obtained from the Universidad Peruana Los Andes,  ensuring institutional conformity with the research. Prior to the application of the survey,  participants were asked to   provide informed consent virtually, in which the purpose of the study,  the intended use of the information collected and their rights as participants were explained  clearly and in detail, including their freedom to withdraw their participation at any time   without  negative consequences.  At all times, the protection of the confidentiality of respondents\' personal data was guaranteed. To  this end, specific measures were implemented, such as the use of anonymous identifiers and  encryption of information, minimizing the risk of unauthorized d isclosure. In addition, a strict  commitment was maintained with the regulations and guidelines established in the Code of Ethics  for Scientific Research of the Universidad Peruana Los Andes, which ensured respect for the  integrity of the participants and t ransparency in all phases of the study.  Compliance with these ethical principles was essential to preserve the confidence of the  participants and ensure the validity and reliability of the data obtained. Likewise, specific  protocols were established for the management of any ethical situation th at might arise during the  development of the research, ensuring a safe and respectful environment for all those involved .  3.   RESULTS  The results of this study show that the majority of medical students at a private university in  Huancayo are in the planning phase of their research, being mostly adolescents and with a slightly  higher   female   representation.   The   nature   of   the   studies   they   conduct   is   predominantly\nRuiz - Aquino   et al.  6   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  observational, retrospective, cross - sectional and descriptive, indicating a basic approach to  information collection and analysis. In addition, it is observed that, although the students have  access to appropriate technological devices and Internet service s, their level of mastery in the use  of specific technologies for research is mostly basic or intermediate   (Table 3) .  The study found that 44.95% of students had a basic level of technological proficiency, 45.87%  demonstrated an intermediate level, and only 8.26% possessed an advanced level   (Table 4) .  Information search, database, and presentation technologies were the most used, with tools such  as PubMed and Scielo standing out. However, limited use of advanced tools for academic integrity  and reference management was observed, indicating areas for i mprovement in the management  of essential technologies for research .  Table 3.   Dimensions of the use of technologies in the service of research by medical students  Dimensions  N=109  Usage   Leve lof use  Yes   No   Basic   Intermedia  te   Advanced  fi   %   fi   %   fi   %   fi   %   fi   %  Information search  technology   109   100   -   -   47   43.12   54   49.54   8   7.34  Database technology   107   98.17   2   1.83   48   44.04   52   47.70   9   8.26  Data processing  technologies   109   100   -   -   43   39.45   50   45.87   16   14.68  Writing technologies   106   97.25   3   2.75   51   46.79   50   45.87   8   7.34  Presentation  technologies   109   100   -   -   40   36.7   52   47.71   17   15.6  Academic integrity  technologies   92   84.4   17   15.6   52   47.71   50   45.87   7   6.42  Reference manager  technology   91   83.49   18   16.51   55   50.46   45   41.28   10   9.17  Table 4.   Use of technologies in the service of research by medical students  Level of technology use   N=109  fi   %  I do not use   1   0.92  Basic   49   44.95  Intermediate   50   45.87  Moving forward   9   8.26  These results coincide with the findings of Salguero Alcala et al. (2024), who found that 27% of  the students evaluated had a low level of digital competencies, similar to the finding of 44.95% at  the basic level. However, unlike studies such as those of N avarrete Enrí quez et al. (2024), which  identified 73% of students with high digital competencies, the present study reveals a significant  gap in the advanced use of technologies, which underlines the need for specific training  interventions.  Likewise, Alamo   &   Montenegro (2022) reported that nursing professionals possess basic  knowledge and skills in ICT, aligning with the finding of a high percentage of students with basic  and intermediate levels in the use of technologies. This limited level of competence cou ld be  associated with the lack of specific training in the management of advanced tools, such as reference  managers and academic integrity tools, crucial for the quality of scientific research (Licona &  Veitya, 2019).\nRuiz - Aquino   et al.  7   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  On the other hand, Llanos de Tarazona (2019) demonstrated that an effective integration of ICTs  in   university   education   improves   students\'   research   competencies,   which   highlights   the  importance of strengthening these skills in the context of the present re search. In addition, Gomez  (2019) found that access to technologies does not necessarily translate into effective use for  academic purposes, corroborating that, despite the high availability of devices and internet among  participants, the use of advanced t ools is still deficient.  In line with the studies of Mendoza   &   Placencia (2018), who pointed out that the use of ICT in  teaching requires adequate teacher training, the results suggest that current pedagogical  strategies may not be sufficiently focused on the development of advanced technological  competencies among st udents. This is especially relevant in times of infodemic, where the ability  to manage and critically evaluate information is fundamental for academic research (Reyes et al.,  2020).  In addition, Martinez   &   Flores (2021) highlighted that during the pandemic, virtual training has  exacerbated inequalities in access to and use of technologies, which may be reflected in the varied  technological competence observed in the sample. The lack of advanced skills in res earch  technologies may limit the effectiveness and quality of research projects developed by medical  students.  Cerda et al. (2017) found that the use of digital technologies is positively related to academic  achievement in student teachers, suggesting that greater technological competence could improve  academic performance in health careers such as medicine. Howeve r, Martínez Perez et al. (2023)  observed that excessive use of social networks, such as Facebook, can negatively affect academic  performance, underscoring the need to balance the use of technologies for recreational and  academic purposes.  Aleman   &   Ynojosa (2024) warn about the threats and disadvantages of ICT use in academic  training, suggesting that ICTs have not been adequately exploited due to a lack of technological  skills or insufficient methodological information. Mendoza (2024) also points o ut that 67% of  students experienced problems related to the management and mastery of virtual platforms,  which could be linked to a lack of training in these areas.  In this context, the results reveal the need to strengthen the technological training of students,  integrating a progressive approach that allows them to develop advanced competencies in the use  of technologies applied to research. Comparison with previous   studies suggests that the level of  technological competence of students varies considerably according to the institutional context  and the pedagogical strategies implemented, which highlights the importance of a timely  educational intervention to close th is gap.  Finally, the integration of advanced digital competencies would not only improve the quality of  academic research, but also prepare future medical professionals to deal more effectively with the  challenges of the infodemic, characterized by the overabundan ce and variable quality of available  information (Arroyo et al., 2020).  Among the limitations of this study is the fact that the sample consisted of students from a single  private university in Huancayo, which may limit the generalizability of the findings to other  institutions or regions of the country. In addition, the scale   used to measure the use of technologies  may not have exhaustively captured all relevant dimensions in the context of academic research.\nRuiz - Aquino   et al.  8   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  The quantitative approach, on the other hand, may have restricted the exploration of qualitative  aspects that could provide a deeper understanding of students\' experiences with technologies.  Another important limitation is the use of virtual surveys, as un equal access to the internet and  the possible unfamiliarity of some students with digital platforms could have affected the accuracy  and completeness of responses, introducing bias in data collection.  It is recommended that the scope of the study be broadened to include samples of students from  different universities, both public and private, and in different regions of the country, in order to  obtain a more representative view of the use of technologie s in the service of research. In addition,  the   development   of   more   detailed   and   specific   measurement   instruments   that   can  comprehensively evaluate the use of technologies in academic contexts is suggested. It would also  be valuable to incorporate qualitati ve approaches to explore perceptions, motivations and barriers  faced by students when using technological tools in their research. Finally, it is recommended to  design and implement continuous training programs aimed at improving students\' technological  co mpetencies, especially in the use of reference managers and academic integrity tools  CONCLUSIONS  Most medical students at a private university in Huancayo reach basic or intermediate levels in  using technological tools for research. Despite having access to internet devices and services, there  is limited use of advanced and specific tools such as refe rence managers and academic integrity.  These findings underline the need to implement training strategies focused on improving the  mastery of critical technologies for academic research, which will allow us to face more effectively  the information overload   in the infodemic era .  FINANCI NG  The authors did not receive sponsorship to carry out this study - article .  CONFLICT OF INTEREST  The authors declare that they have no conflicts of interest related to the development of the  study .  AVAILABILITY OF DEPOSITED DATA  The datasets collected during this study and supporting the findings of the study are available at:  https://data.mendeley.com/datasets/w9znxg38bw/1  AUTHORSHIP CONTRIBUTION  Conceptualization;   Data   Curation;   Formal   Analysis;   Research;   Methodology;   Visualization;  Validation; Writing   -   original draft; Writing   -   revision and editing:   Ruiz - Aquino, M., Osorio -  Llancachagua, A. L., Botiquí n - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A., and Duran -  Aquino, R. C.\nRuiz - Aquino   et al.  9   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  REFERENC ES  Alamo , E., & Montenegro, R. (2022). Competencias en la tecnologí a de informacion y  comunicacion del profesional de enfermerí a en instituciones del primer nivel de atencion  Chiclayo, 2020.   ACC CIETNA:   Revista De La Escuela De Enfermería , 9(1), 18 – 28.  https://doi.org/10.35383/cietna.v9i1.592  Aleman , O., & Ynojosa, Y. (2024). Desafí os frente al uso de las tics en pandemia en el programa de  enfermerí a de la UNEFM.   Aula Virtual , 5(11), 151 – 169.  https://doi.org/10.5281/zenodo.10465778  Al - Hail, M., Zguir, M. F., & Koç, M. (2023).   University students’ and educators’ perceptions on the  use of digital and social media platforms: A sentiment analysis and a multi - country review.  IScience , 26(8), 107322.   https://doi.org/10.1016/j.isci.2023.107322  Almufarreh , A., & Arshad, M. (2023). Promising Emerging Technologies for Teaching and  Learning: Recent Developments and Future Challenges.   Sustainability , 15(8), 6917.  https://doi.org/10.3390/su15086917  Arbelaez, M. (2014). Las tecnologí as de la informacion y la comunicacion (TIC) un instrumento  para la investigacion.   Investigaciones Andinas , 16(29), 997 – 1000.  https://revia.areandina.edu.co/index.php/IA/article/view/52  Arroyo, A., Cabrejo, J., & Cruzado, M. (2020). Infodemia, la otra pandemia durante la enfermedad  por coronavirus 2019.   Anales de la Facultad de Medicina , 81(2), 230 – 233.  http://dx.doi.org/10.15381/anales.v81i2.17793  Campos Cruz, H., & Ramí rez Sanchez, M. Y. (2018). Las TIC en los procesos educativos de un  centro publico de investigacion.   Apertura,   10(1), 56 – 70.  https://doi.org/10.32870/ap.v10n1.1160  Cerda, C., Huete - Nahuel, J., Molina - Sandoval, D., Ruminot - Martel, E., & Saiz, J. (2017). Uso de  Tecnologí as Digitales y Logro Academico en Estudiantes de Pedagogí a Chilenos.   Estudios  pedagógicos (Valdivia) , 43(3), 119 – 133.   http://dx.doi.org/10.4067/S0718 -  07052017000300007  Garcí a, S., & Canton, I. (2019). Uso de tecnologí as y rendimiento academico en estudiantes  adolescentes.   Comunicar,   59, 73 - 81 .   https://doi.org/10.3916/C59 - 2019 - 07  Gomez, D. (2019). Uso de las tecnologí as de la informacion y la comunicacion por universitarios  mayas en un contexto de brecha digital en Mexico . Región y Sociedad , 31, 1 – 25.  https://doi.org/10.22198/rys2019/31/1130  Grande, M., Canon, R., & Canton, I. (2016). Tecnologias de la informacion y la comunicacion:  Evolucion del concepto y caracterí sticas.   IJERI: International Journal of Educational Research  and Innovation , (6), 218 – 230.  https://www.upo.es/revistas/index.php/IJERI/article/view/1703  Licona, K., & Veitya, M. (2019). La Formacion en y para la investigacion y el uso de las Tecnologí as  de la Informacion y Comunicacion.   Atenas , 2(46), 64 – 78.  https://atenas.umcc.cu/index.php/atenas/article/view/343  Llanos de Tarazona, M. I. (2019). Aprendizaje de la investigacion mediante las tecnologí as de\nRuiz - Aquino   et al.  10   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  comunicacion e informacion en universitarios de Huanuco.   Revista de Salud UDH , 1(4), e48.  https://doi.org/10.37711/rpcs.2019.1.4.48  Martínez   Perez , E., Martínez   Sandoval , M., & Hernandez   Nava, N.   (2023). El uso de Facebook en  alumnos auxiliares de enfermerí a de una institucion publica de Queretaro.   LATAM Revista  Latinoamericana De Ciencias Sociales y Humanidades , 4(1), 2829 – 2840.  https://doi.org/10.56712/latam.v4i1.457  Martínez, N., & Flores, S. (2021). Uso de nuevas tecnologí as en tiempos de pandemia en la  formacion de los estudiantes de enfermerí a de la universidad tecnica de Ambato.   Enfermería  Investiga , 6(4), 19 – 29.  https://revistas.uta.edu.ec/erevista/index.php/enfi/article/view/1200  Mendoza, H., & Placencia, M. (2018). Uso docente de las tecnologí as de la informacion y  comunicacion como material didactico en Medicina Humana.   Investigación en Educación  Médica , 7(26), 54 – 62.   https://doi.org/10.1016/j.riem.2017.04.005  Navarrete Enrí quez, R. M., Remache Cachimuel, J. T., & Reyes, V. M. (2024). Uso de herramientas  digitales y rendimiento academico en estudiantes de enfermerí a: un estudio de caso en un  Instituto Tecnologico.   Prohominum , 6(2), 227 – 242.  https://doi.org/10.47606/ACVEN/PH0245  Reyes, M. C., Garcí a, E. J., Díaz, O. M., & Sanchez, I. (2020). Preparacion cientí fica en enfermeras de  la atencion primaria de salud.   Edumecentro , 12(3), 149 – 162.  https://pensamientoeducativo.uc.cl/index.php/RHE/article/view/58323  Salguero Alcala, G. K., Benites Zuniga, J. L., Salguero Alcala, A. G., Orosco Leon, O. E., Orosco  Toribio, E. G., & Vega Vilca, C. S. (2024). Competencias digitales y rendimiento academico en  los estudiantes universitarios. Horizontes . Revista De Investigación En Ciencias De La  Educación , 8(32), 164.   https://doi.org/10.33996/revistahorizontes.v8i32.713',0.14138832787671654,'[\"\\\"scale\", \"%\", \"&\", \"(\", \"(15\"]','2025-11-29 16:58:49.068835'),(46,3,'Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ARTÍCULO / ARTICLE SALUD COLECTIVA  Tecnologías asistivas para pacientes ancianos con  demencia: perspectivas desde la bioética de los  cuidados en salud  Assistive technologies for elderly patients with dementia:  perspectives from the bioethics of health care  Isis Laynne de Oliveira Machado Cunha 1  1 Doctora en Bioética. Posdoctoranda, Pontifícia Universidade Católica do Paraná, Brasil.   *  RESUMEN   La demencia es actualmente una de las enfermedades más comunes que afecta a las personas mayores,  siendo la séptima causa principal de muerte. Provoca pérdida de memoria, dificultad para razonar y, por consi -  guiente, dificultades para tomar y ejecutar decisiones, por lo que las tecnologías de asistencia y estimulación cog -  nitiva son valiosos recursos en el proceso de cuidado. Desde una investigación teórica basada en la bioética de los  cuidados en salud y en las investigaciones de Aline Albuquerque y Victor Montori, este artículo aborda, en primer  lugar, el concepto de bioética en el cuidado de la salud, la atención centrada en el paciente y la idea de empatía clínica;  en segundo lugar, se centra en el empleo de tecnologías asistivas para el cuidado de adultos mayores con demencia y,  por último, plantea la discusión sobre si el proceso de atención podría ser considerado como una tecnología sanitaria.  PALABRAS CLAVES   Anciano; Demencia; Dispositivos de Autoayuda; Bioética; Empatía.  ABSTRACT   Dementia is currently one of the most common diseases affecting elderly people, ranking seventh among  leading causes of death. As it causes memory loss, difficulties in reasoning, and resulting difficulties in making and ex -  ecuting decisions, assistive technologies and cognitive stimulation are valuable resources in the care process. Based on  a theoretical inquiry into the bioethics of health care, and drawing on the work of Aline Albuquerque and Victor Mon -  tori, this article focuses on three main issues: first, the concept of bioethics in health care, patient-centered care, and  the idea of clinical empathy. Second, it looks at the use of assistive technologies in caring for elderly patients with de -  mentia. Lastly, we offer a discussion of whether the care process could be considered a health technology.  KEYWORDS   Aged; Dementia; Self-Help Devices; Bioethics; Empathy.\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  2  INTRODUCCIÓN  El envejecimiento de la población ha despertado preo -  cupación en relación con la aparición de enfermedades  crónicas cada vez más limitantes. A pesar de no ser una  consecuencia inevitable del proceso de envejecimiento,  la demencia es actualmente una de las enfermedades  más comunes que afecta a las personas mayores, siendo  la séptima causa principal de muerte (1) .  En 2017, la Organización Mundial de la Salud (OMS)  estimó que alrededor de 50 millones de personas en todo  el mundo vivían con demencia, y se esperaba que ese  número se triplicara para 2050 (2) , debido a una serie de  factores poblacionales y demográficos que contribuyen  al aumento de dicho número. Esto genera una enorme  preocupación con relación a los cuidados en salud y la  preservación de los derechos de estas personas, y a la  necesidad de mantener una vida digna (3) , especialmente  en la vejez, ya que en esta etapa el cuidado del cuerpo y  de la salud se hacen más necesarios y costosos (4) .  La demencia, cuando está en su etapa más avan -  zada, afecta las habilidades mentales para la toma de  decisiones, lo que repercute en el ejercicio de la autono -  mía personal y el desarrollo de actividades cotidianas,  requiriendo un alto nivel de cuidado (5) . Cabe destacar que  uno de los predictores de la calidad de vida se refiere a  la posibilidad de realizar personalmente las actividades  del día a día, y al respeto por la autonomía en la toma de  decisiones, especialmente en lo que se refiere al cuidado  en salud (6,7) . En este sentido, los avances tecnológicos  pueden contribuir a mantener la vida autónoma durante  el mayor tiempo posible.  Las   definiciones   de   tecnología   varían   y   el   tér -  mino se puede utilizar como sinónimo de herramienta  o máquina, así como referirse a la aplicación del co -  nocimiento organizado a tareas prácticas por sistemas  ordenados por personas y máquinas (8) . La tecnología  asistencial puede ser descrita como todo dispositivo  técnico que ayuda y facilita la realización de actividades  diarias, reduce el trabajo de las personas cuidadoras y  proporciona mayor autonomía a las personas mayores.  Ejemplos de tecnologías asistivas incluyen dispositivos  GPS para facilitar la ubicación de personas con demen -  cia, robots que contribuyen a la estimulación cognitiva y  social, así como juegos que permiten a las personas con  demencia participar en el ámbito virtual (9) . Sin embargo,  el uso de estas tecnologías también plantea discusiones  éticas sobre el impacto individual y social, para la adap -  tación de pacientes mayores que viven con demencia (8) .  Teniendo en cuenta que la demencia conlleva la  pérdida de memoria, dificultad para razonar y, por con -  siguiente, dificultades para tomar y ejecutar decisiones,  las tecnologías de estimulación cognitiva son valiosos  recursos en el proceso de cuidado, ya que pueden au -  mentar la plasticidad neuronal, prolongar el manteni -  miento de las funciones mentales, motoras y sociales,  así como la capacidad de pensar con claridad y tomar  decisiones (10) .  A pesar del gran número de personas mayores que  viven con demencia en Brasil (4) , existen pocos estudios  que aborden el uso de tecnologías asistivas dirigidas a  este grupo, lo que subraya la necesidad de desarrollar  más investigaciones y discutir aspectos éticos relacio -  nados con el uso de tales mecanismos (9) .  La discusión es importante desde el punto de vista  bioético, ya que se trata de un área multidisciplinaria  que analiza éticamente aspectos de la vida humana en  sus campos más amplios, desde perspectivas que invo -  lucren conceptos ambientales, biológicos, sanitarios,  sociales y valores éticos adoptados en un determinado  contexto (11) . El tema es aún más relevante en lo que res -  pecta al campo de la bioética de los cuidados de salud, ya  que se orienta por el cuidado centrado en el paciente, en  su deseos y preferencias; reconoce la existencia de asi -  metrías de poder en la relación entre el profesional de la  salud y el paciente; y se basa en los derechos humanos  aplicados al contexto del cuidado de la salud, lo que con -  lleva prescripciones éticas y jurídicas para las personas  implicadas en el cuidado (12) .  El uso de tecnologías asistivas dirigidas a pacien -  tes mayores con demencia puede contribuir a la promo -  ción de la autonomía y una mejor calidad de vida o, en  determinados casos, puede aumentar la vulnerabilidad,  especialmente cuando se intenta reemplazar el cuidado  humano por el uso de estas tecnologías (9) .  Ante este escenario, desde una investigación teó -  rica basada en la bioética de los cuidados en salud, este  artículo propone analizar el uso adecuado de tecnolo -  gías asistivas en el campo de los cuidados de salud, con  el objetivo de señalar un camino ético, jurídico y social  apropiado para mejorar la calidad de vida y salud de pa -  cientes mayores con demencia (12,13,14,15) , y cómo el uso  adecuado de tecnologías puede contribuir a la promo -  ción de la autonomía, al aumento de los cuidados de sa -  lud y a la mejora de la calidad de vida de este grupo.  METODOLOGÍA  Este trabajo se sustenta en una investigación teórica, la  cual se distingue de la revisión bibliográfica al ser es -  tructurada sobre una teoría preexistente en un determi -  nado campo de investigación. La esencia de este tipo de  investigación es adoptar una línea teórica que permita  sustentar el análisis y el debate sobre un tema concreto.  El marco teórico no solo guía las direcciones de la inves -  tigación, sino que también proporciona los fundamen -  tos para avalar su solidez. De esta manera, actúa como  pilar sobre el que se erige el estudio (16) .  Para este artículo en particular, se adoptó como  marco teórico la bioética centrada en el cuidado de la\nTECNOLOGÍAS ASISTIVAS PARA PACIENTES ANCIANOS CON DEMENCIA: PERSPECTIVAS DESDE LA BIOÉTICA DE LOS CUIDADOS EN SALUD 3  Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488  salud, tomando como referencia investigaciones lleva -  das a cabo por Aline Albuquerque, complementadas con  los estudios de Victor Montori con relación a la atención  enfocada en el paciente.  La elección de este marco teórico para el análisis del  empleo de tecnologías asistivas en el ámbito de la salud  de adultos mayores con demencia se fundamenta en las  recientes contribuciones bioéticas orientadas al cuidado  de la salud, que destacan que el proceso de atención debe  responder a las necesidades concretas del paciente.  El desarrollo del artículo se divide en tres secciones.  La primera, aborda el concepto de bioética en el cuidado  de la salud, detallando su contribución teórica y sus fun -  damentos, para luego transitar por la atención centrada  en el paciente y la idea de empatía clínica. La segunda  sección se centra en el empleo de tecnologías asistivas  para el cuidado de adultos mayores con demencia. Por  último, la tercera sección plantea la discusión sobre si  el proceso de atención podría ser considerado, también,  una tecnología sanitaria.  EL PARADIGMA DE LA BIOÉTICA DE  LOS CUIDADOS EN SALUD  En primer lugar, es importante destacar que la llamada  “bioética de los cuidados en salud” se refiere a una co -  rriente de la bioética que, en contraposición a otras, en -  fatiza la relación humana entre el profesional de la salud  y el paciente, valorando la relación entre ambos, así  como la centralidad del paciente en el cuidado. Utiliza la  experiencia del paciente, junto con el papel del profe -  sional de la salud, como fuente de sus aportes teóricos,  buscando el bienestar y la calidad de vida del paciente (12) .  También hay que considerar que el término “pa -  ciente” se refiere a la persona que está bajo el cuidado de  salud, que puede estar enferma o sana, pero que busca  una mejor atención para su salud y calidad de vida (17) . En  este sentido, la palabra paciente no debe ser asimilada  a la condición de pasividad, sino a su doble condición  frente al proceso terapéutico, es decir, su vulnerabilidad  y su centralidad (17) .  La bioética de los cuidados en salud se basa en el en -  foque del   cuidado centrado en el paciente , en su participa -  ción y empoderamiento, así como en la empatía clínica  y en la aplicación de los derechos humanos al contexto  de los cuidados de salud. Pueden ser citados como ejes  teóricos la comunicación empática, la relación de ca -  maradería entre profesional y paciente y la centralidad  y empoderamiento de este último (12) .  El cuidado centrado en el paciente denota una rup -  tura con el paradigma actualmente predominante, en el  que el profesional de la salud, permeado por una serie de  factores estructurales y económicos, muchas veces des -  atendidos en su práctica profesional diaria, se aleja del  contacto cercano con el paciente y lo comprende como  objeto de cuidado, otorgando mayor atención a la en -  fermedad y al conocimiento profesional, en detrimento  de los conocimientos y experiencias personales del pa -  ciente (15,17) . Propone un cambio de conducta y desafía las  prácticas y comportamientos profundamente arraiga -  dos, en el sentido de implementar la camaradería en el  trabajo entre el profesional de la salud y el paciente (14) .  En este sentido, el cuidado centrado en el paciente  puede ser comprendido como una mirada más atenta al  proceso de cuidar (17) , que debe ser amable y enfocado en  las necesidades específicas del paciente, no solo en el  intento de sanar enfermedades o de cumplir protocolos  médicos, sino de adentrarse en su biografía, a través de  la escucha atenta y la valoración individual (15) . Propone  que las decisiones inherentes al cuidado de la salud de -  ben ser guiadas por las necesidades, la voluntad y las  preferencias del paciente, promoviendo su autonomía a  través de su compromiso y la oferta de apoyos necesa -  rios para la toma de decisiones relevantes que impacta -  rán en su salud y calidad de vida (18) .  La empatía clínica constituye uno de los pilares  fundamentales de la bioética orientada al cuidado de la  salud. Esta capacidad inherente al ser humano se des -  pliega en, al menos, dos dimensiones: una cognitiva en  la que el profesional de la salud comprende la perspec -  tiva del paciente, y otra emocional en la que el profe -  sional sintoniza con las “emociones del paciente” (15) . En  resumen, la empatía implica conectarse con los senti -  mientos de la otra persona sin asumirlos como propios,  sino comprenderlos y compartirlos. Su aspecto cog -  nitivo requiere el uso de la capacidad imaginativa para  acercarse a la perspectiva del otro. La empatía clínica  no lleva a la fatiga empática o al agotamiento del pro -  fesional de la salud, ya que reconoce las necesidades del  otro al mismo tiempo que es consciente de su propia di -  ferencia con relación a la otra persona (19) . Es decir, hay  una separación del sentimiento del otro con relación a  la propia emoción.  La empatía clínica implica tres componentes cla -  ves: la comprensión, la comunicación y la acción. La  comprensión se refiere a entender lo que la enfermedad  significa para el paciente, que requiere un diagnóstico  preciso, un pronóstico y un proceso de toma de decisio -  nes compartido. La comunicación tiene como objetivo  aliviar la ansiedad del paciente y responder sus dudas,  y es necesaria para que el profesional de la salud pueda  comprender la situación real del paciente y verificar si la  información proporcionada fue comprendida por el pa -  ciente. La acción está dirigida a maximizar los benefi -  cios terapéuticos (19) .  La empatía clínica es un concepto relacional, en el  sentido de que es una experiencia orientada a la cone -  xión con el otro (20)   y una habilidad humana que puede  ser aprendida, aumentada o disminuida, dependiendo  del entorno y la estructura organizacional en la que el  profesional de la salud se encuentre (21) . Tiene un pa -  pel relevante en la bioética de los cuidados de salud, ya  que implica tanto la noción de cuidar como la de curar,\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  4  y puede complementar la medicina basada en la eviden -  cia. Además, la función moral de la empatía clínica es  promover la autonomía del paciente, un elemento fun -  damental en el proceso de toma de decisiones de perso -  nas mayores que viven con demencia.  La aplicación de los derechos humanos en el con -  texto   de   los   cuidados   de   salud   tiene   como   objetivo  proteger la dignidad humana inherente al paciente, es -  pecialmente debido a su condición de vulnerabilidad.  Los derechos humanos de los pacientes se refieren a un  conjunto de derechos que los pacientes tienen cuando  están bajo cuidados de salud (17) . Estos derechos incluyen  el derecho a la vida, a la privacidad, a no ser sometido a  tortura o a tratos inhumanos o degradantes, a la infor -  mación, a la salud y el derecho a no ser discriminado (22) .  En el contexto de los pacientes mayores (23) , este  grupo se encuentra en una situación de vulnerabilidad  aumentada (24) , debido a los prejuicios relacionados con  la edad avanzada y el imaginario social de que la persona  pierde la autonomía para gestionar su vida a medida que  envejece, incluyendo las decisiones sobre cuidados de  salud (25) .  Además, los derechos humanos extraídos de nor -  mativas internacionales se aplican al campo de los cui -  dados de la salud (12,26) . Los derechos humanos de los  pacientes definen un concepto que se deriva de la digni -  dad humana inherente a cada persona y aplican de forma  neutral los principios de los derechos humanos univer -  sales y legalmente reconocidos, protegiendo tanto a pa -  cientes como a profesionales de la salud y admitiendo  limitaciones que puedan justificarse por normas de de -  rechos humanos (26) .  A partir de la tipología obligacional presente en las  concepciones inherentes a los derechos humanos, se  establecen las obligaciones del Estado de respetar, pro -  teger y garantizar dichos derechos, que se dividen en fa -  cilitar y proveer dichos derechos (27) . El incumplimiento  de alguna de estas obligaciones resulta en una violación  de los derechos humanos (17) . Este entendimiento es apli -  cable tanto al Estado como a la sociedad y, por consi -  guiente, a los profesionales que trabajan en el contexto  de los cuidados de salud (17) .   La concepción de los dere -  chos humanos de los pacientes ofrece un medio para  evaluar cuestiones sistémicas de obligaciones y respon -  sabilidades, siendo un instrumento importante para la  bioética de los cuidados de salud (12) .  En síntesis, la bioética de los cuidados en salud es  un nuevo enfoque seriamente comprometido con el es -  tablecimiento de una relación de colaboración entre el  profesional de la salud y el paciente, con el objetivo de  empoderarlo para que desempeñe un papel activo en el  proceso de toma de decisiones sobre sus cuidados en  salud (12) .  Este enfoque puede aplicarse a los cuidados en sa -  lud de pacientes mayores que viven con demencia, ya  que a medida que la enfermedad progresa, mayores son  las necesidades de cuidados más atentos, sin que tales  acciones restrinjan la autonomía personal y dignidad de  tales personas. Por lo tanto, el cuidado debe estar atento  a reconocer que al comprometerse las habilidades rela -  cionadas a la toma de decisiones no implica la pérdida  de derechos, sino que la voluntad y las preferencias de  la persona deben ser respetadas en los diversos ámbitos  de su vida, incluyendo sus cuidados en salud (4) . La bioé -  tica de los cuidados en salud, en estos casos, puede en -  tenderse más allá del entorno hospitalario, aplicándose  también a la relación establecida entre el cuidador y la  persona mayor, ya que con el aumento de la edad, otras  enfermedades y limitaciones acompañan los casos de  demencia, lo que requiere acciones continuas dirigidas  a sus cuidados en salud.  Con la evolución tecnológica se pueden incorporar  nuevos mecanismos en los cuidados de salud para fa -  cilitar la autonomía de los pacientes mayores que viven  con demencia, ya sea para la toma de decisiones o para la  realización de actividades diarias, reduciendo la carga de  las personas responsables de su cuidado. Sin embargo,  el uso de estas herramientas puede enfrentar desafíos  económicos y sociales, y se necesitan discusiones que  aborden aspectos bioéticos. Por lo tanto, la bioética de  los cuidados de salud puede utilizarse como una herra -  mienta tecnológica para mejorar o guiar el uso de otras  tecnologías, prácticas e instrumentos que impliquen el  cuidado de la salud de personas mayores con demencia.  Tecnologías asistivas y el cuidado de  personas mayores con demencia  En la vejez, el estímulo cognitivo es imprescindible para  posibilitar nuevas experiencias, nuevos desafíos y apren -  dizajes, que aumentan la plasticidad neural, incrementan  la transmisión de información en el cerebro que compone  la esencia del ser humano y distingue su personalidad y  forma de actuar (28) . La cognición es un proceso multi -  dimensional que admite que el cerebro continúe siendo  ejercitado incluso en la vejez, a través de actividades que  entrenan la memoria, la atención y demás funciones ce -  rebrales, y minimizan los efectos de la debilidad cognitiva  causada por el proceso demencial. Los estímulos pueden  ser realizados de manera individual o en grupo, de forma  presencial o a través de tecnologías de comunicación (29) .  Las tecnologías se están desarrollando para apo -  yar la toma de decisiones de personas con demencia.  Algunos ejemplos pueden ser:  a.   Sistemas de recordatorio, utilizados para recordar a  las personas con demencia sus compromisos, tareas  y medicamentos.  b.   Aplicaciones de teléfonos móviles y tabletas, que ayu -  dan a las personas con demencia a mejorar la cogni -  ción y la memoria, así como a recordar compromisos,  tareas y medicamentos.  c.   Dispositivos de monitoreo, utilizados para seguir la  salud y el bienestar de una persona con demencia;\nTECNOLOGÍAS ASISTIVAS PARA PACIENTES ANCIANOS CON DEMENCIA: PERSPECTIVAS DESDE LA BIOÉTICA DE LOS CUIDADOS EN SALUD 5  Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488  pueden incluir monitores de actividad, monitores de  frecuencia cardíaca y otros dispositivos.  d.   Sistemas de navegación, utilizados para ayudar a las  personas con demencia a orientarse en nuevos lugares.  e.   Sistemas de comunicación, utilizados para ayudar a  las personas con demencia a comunicarse con cuida -  dores y otros miembros de la familia.  f.   Tecnologías cognitivas, que son sistemas, dispositivos  y aplicaciones diseñados para mejorar el rendimiento  cognitivo humano, incluyendo funciones como aten -  ción, memoria, razonamiento, percepción y toma de  decisiones; tecnologías que pueden ayudar a las per -  sonas mayores a mantener su independencia (30) .  Además, las tecnologías cognitivas pueden incluir jue -  gos y aplicaciones de entrenamiento, tecnologías de  asistencia e interfaces cerebro-máquina, que permiten  la comunicación directa entre el cerebro y una computa -  dora u otro dispositivo, y sirven para ayudar a personas  con discapacidades motoras o de comunicación a inte -  ractuar con el mundo digital y sistemas de inteligencia  artificial, que están diseñados para imitar las funcio -  nes cognitivas humanas, como el aprendizaje, la toma  de decisiones y el reconocimiento de patrones. Se uti -  lizan en una variedad de aplicaciones, desde asisten -  tes virtuales hasta diagnóstico médico. En resumen, las  tecnologías cognitivas tienen como objetivo mejorar la  cognición humana y, por lo tanto, tienen el potencial de  mejorar la calidad de vida de muchas personas (31) .  También, la inteligencia artificial puede ayudar en  el   diagnóstico   temprano,   identificando   los   primeros  signos de demencia; en el monitoreo de pacientes, aler -  tando a cuidadores o profesionales de la salud cuando  ocurren cambios significativos en el comportamiento o  la salud de los pacientes; en el apoyo a la toma de deci -  siones sobre el cuidado de pacientes con demencia; en  el uso de terapias personalizadas adaptadas a las nece -  sidades y preferencias individuales del paciente; en la  asistencia a tareas cotidianas y el recordatorio de com -  promisos; y en el monitoreo remoto, siguiendo el pro -  greso del paciente (32) .  Algunos dispositivos electrónicos, como celulares y  computadoras, combinados con información, comuni -  cación y prácticas de cuidado, pueden ser importantes  tecnologías de mantenimiento de la salud, estimulación  cognitiva, administración de demencia y aislamiento  social. Su uso puede permitir la participación de las per -  sonas mayores con demencia en grupos de integración,  junto con sus familiares, cuidadores y profesionales de  la salud, para compartir miedos, angustias, prácticas de  cuidado e intercambiar experiencias. En este sentido,  dichos dispositivos se convierten en fuentes de apoyo (33) .  Sin embargo, a través de dispositivos electróni -  cos, la comunicación y la multiplicación de la presen -  cia y las experiencias subjetivas no siempre son bien  comprendidas por aquellos que experimentan el pro -  ceso demencial. Existe una dificultad para comprender  el funcionamiento de las pantallas y cómo las personas  pueden comunicarse sin estar físicamente presentes.  Además, está la falta de contacto físico, así como la difi -  cultad de concentración y enfoque del paciente anciano  con demencia en lo que las demás personas están com -  partiendo a través de los dispositivos electrónicos (33) .  Por esta razón, es necesario que el cuidador esté pre -  sente para ayudar a la persona en el uso de equipos elec -  trónicos que permitan la interacción con otras personas,  lo que no necesariamente tiene que ocurrir cuando la in -  teracción es presencial (29) .  En esta línea, el cuidador emerge como una figura  clave para la implementación de tecnologías asisti -  vas y cognitivas en adultos mayores que conviven con  demencia. Desempeñará el rol de mediador en la utili -  zación de ciertas tecnologías, promoviendo así la auto -  nomía e independencia del adulto mayor. Es esencial que  el cuidador esté atento a las necesidades particulares del  paciente, proporcionando una atención centrada en él,  honrando sus deseos y preferencias e incentivando el  empleo de tecnologías que potencien la autonomía. Por  ende, el cuidado ofrecido debe estar en consonancia con  el marco de la bioética orientada al cuidado de la salud.  Las personas mayores que viven con demencia pue -  den enfrentar varias dificultades en el uso de tecnolo -  gías asistivas y cognitivas, como la dificultad de acceso a  las tecnologías, la complejidad en su uso que puede cau -  sar que se frustren o desistan, la falta de adaptación, ya  que cada persona tiene especificidades que a menudo no  son abarcadas por dichas tecnologías, los costos eleva -  dos, la necesidad de capacitación para el uso de nuevos  dispositivos que no existían en la juventud de estas per -  sonas, y las limitaciones de memoria para seguir utili -  zando dispositivos electrónicos (34) .  El continuo cuidado de las personas mayores con  demencia contribuye al cuidado humanizado, en el que  se valora la calidad de vida del individuo. Las interven -  ciones de profesionales de la salud y cuidadores estimu -  lan y mantienen las capacidades mentales, fortalecen las  relaciones sociales, brindan mayor seguridad y aumen -  tan la autonomía del paciente, estimulando su identi -  dad, autoestima y desempeño cognitivo y funcional (10) .  Las tecnologías asistivas y cognitivas pueden mejo -  rar la calidad de vida de los pacientes mayores que viven  con demencia, ya que les ayudan a mantener su inde -  pendencia durante el mayor tiempo posible. Sin em -  bargo, su uso debe estar vinculado a una buena práctica  de atención, con la formación de una red de apoyo para  que el individuo se sienta acogido y valorado.  El proceso de cuidado como una tecnología  de la salud  La actividad humana es un acto productivo, ya que mo -  difica   algo   y   produce   algo   nuevo.   Muchas   activida -  des están organizadas de forma interdependiente. En el  campo de la salud, el “trabajo vivo en acto”, es decir, el\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  6  trabajo humano en el momento exacto en que se ejecuta,  determina cómo se llevará a cabo el proceso y la produc -  ción del cuidado (35) . La forma de organización de esta ac -  tividad se considera una tecnología blanda que integra  maletín del saber técnico estructurado, la utilización de  instrumentos propios de la actividad y las relaciones en -  tre las personas implicadas en el cuidado.  En la producción del cuidado, estos saberes se uti -  lizan de diferentes maneras, según la relación esta -  blecida entre el profesional de la salud, el cuidador y el  paciente (35) . De esta manera, dependiendo de los actores  implicados, el proceso de cuidado puede ser una tecno -  logía blanda centrada en las relaciones y en la compren -  sión de las necesidades del paciente o, por el contrario,  centrada en el uso de instrumentos o en el saber técnico  en detrimento del paciente.  El proceso de cuidado es complejo e integra fac -  tores clínicos, ambientales y sociales que se acumu -  lan y se articulan, haciendo que el acto de cuidar vaya  más allá de los aspectos inherentes solo a la enferme -  dad. Los pacientes existen en la intersección de circuns -  tancias sociales, personales y clínicas y, por lo tanto,  pueden enfrentar múltiples factores complicadores. En  general, estos factores se analizan de manera aislada  y a través de su forma (clínica, socioeconómica o cul -  tural) en lugar de sus funciones en la complejidad del  cuidado. Pocas investigaciones examinan de manera in -  tegral cómo las combinaciones de factores interactúan  para impactar a los pacientes (36) .  Los individuos se adaptan o sucumben a la com -  plejidad de factores que los rodean con el tiempo, lo que  omite la acumulación de factores complicadores y la po -  sibilidad de resiliencia del paciente. Como ejemplos, se  pueden citar: la carga de trabajo del paciente, referida a  las tareas y responsabilidades con las que las personas  lidian en su día a día, que incluyen el trabajo, la fami -  lia, el autocuidado y otras prioridades (37,38) ; o la capaci -  dad del paciente, vinculada a las habilidades, recursos o  disposición para manejar las demandas, que incluyen el  funcionamiento físico y mental, los recursos socioeco -  nómicos, el apoyo social, la alfabetización y las actitu -  des y creencias (39) . Por lo tanto, una capacidad excesiva o  baja puede desafiar por sí sola a los pacientes, causando  dificultades de acceso, falta de adherencia, baja calidad  de vida, entre otros problemas. Un desequilibrio entre la  carga de trabajo que excede la capacidad puede conside -  rarse uno de los principales factores de interrupción en  la atención, el autocuidado y los resultados (36) .  La adopción de un modelo tecnológico de cuidado  debe considerar necesariamente aspectos externos a la  enfermedad, con el fin de alcanzar la experiencia, los  impactos de las actividades desarrolladas por el pa -  ciente, sus creencias y la red de apoyo, de modo que el  proceso de cuidado tenga un impacto positivo en su sa -  lud y calidad de vida.  Las tecnologías leves pueden ser representadas por  actos de acogida, formación de vínculo y búsqueda de la  promoción de la autonomía de los pacientes, a través de  un diálogo abierto y una escucha activa y calificada (40) .  Además del conocimiento técnico, de los instrumentos de  trabajo y de las tecnologías más estructuradas, es nece -  sario prestar mayor atención al papel de la relación, como  tecnología leve presente en el acto de cuidar (41) . Este com -  ponente es fundamental para comprender que el cuidado  en salud siempre es relacional y que desvalorizar este as -  pecto trae perjuicios para todo el proceso terapéutico.  La realización del trabajo de cuidado en salud basado  en tecnologías leves, relacionales y empáticas, de acuerdo  con la bioética de los cuidados en salud, contribuye a la  formación de una línea de cuidado que, si se integra a  todo el espectro de servicios de salud, tiene el poder de  satisfacer diversas necesidades de los pacientes (41) .  Los factores mencionados muestran la urgente ne -  cesidad de abandonar el paradigma de cuidado centrado  en la enfermedad, adoptando un cuidado centrado en el  paciente, tanto en la relación entre profesionales de la  salud y pacientes, como en los modelos organizativos de  gestión y políticas públicas. Esto contribuirá al uso ade -  cuado de tecnologías asistivas, para que estas sirvan a  las necesidades reales de cada paciente anciano que vive  con demencia.  El uso de tecnologías de asistencia difícilmente al -  canzará su objetivo final si no se conecta con el para -  digma de la bioética de los cuidados en salud. Así, este  paradigma se convierte en un importante instrumento  y referente para la implementación de tecnologías asis -  tivas y tecnologías ligeras en el cuidado de personas  mayores que viven con demencia, ya que enfatiza la ne -  cesidad de respetar los derechos, aplicar la empatía clí -  nica y establecer una relación respetuosa que apunte al  cuidado centrado en el paciente.  CONCLUSIONES  El mundo está en constante cambio, exigiendo el de -  sarrollo de nuevas tecnologías y formas de relación. En  los cuidados en salud, las tecnologías han sido impor -  tantes herramientas para mejorar la calidad de vida. Sin  embargo, el uso de dichas herramientas y acciones rea -  lizadas por los cuidadores, precisan adaptarse a las ne -  cesidades sanitarias, económicas, sociales y también  individuales de cada paciente.  El cuidado de pacientes mayores que viven con de -  mencia ha planteado desafíos para familiares, cuida -  dores, profesionales de la salud y para la sociedad en  general. Las tecnologías asistenciales y cognitivas han  tenido un papel relevante para mantener la autonomía y  mejorar la calidad de vida del paciente y demás actores  implicados en su cuidado. Sin embargo, no pueden des -  vincularse de la empatía clínica, de la atención centrada  en el paciente, del respeto a sus derechos humanos y la  promoción de la autonomía.\nTECNOLOGÍAS ASISTIVAS PARA PACIENTES ANCIANOS CON DEMENCIA: PERSPECTIVAS DESDE LA BIOÉTICA DE LOS CUIDADOS EN SALUD 7  Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488  En este sentido, los aportes traídos por la bioética  de los cuidados en salud pueden ser considerados como  tecnologías de cuidado, relevantes y necesarias que,  asociados a tecnologías asistenciales y cognitivas, re -  presentan un camino ético, jurídico y social adecuado  para mejorar la calidad de vida y salud de pacientes ma -  yores con demencia.  FINANCIAMIENTO  Coordenação de Aperfeiçoamento de Pessoal de Nível Superior  (CAPES/MEC) a través de la beca de posdoctorado concedida  para el año 2023 al Programa de Pós-Graduação em Bioética de  la Pontifícia Universidade Católica do Paraná, Brasil.  CONFLICTO DE INTERÉS  La autora declara no tener vínculos o compromisos que con -  dicionen lo expresado en el texto y que puedan ser entendidos  como conflicto de intereses.  REFERENCIAS BIBLIOGRÁFICAS  1.   World Health Organization. Global Health Estimates: Life  expectancy and leading causes of death and disability [Inter -  net]. 2019 [cited 3 abr 2023]. Disponible en:   https://tinyurl.  com/2a9kkbx8 .  2.   World Health Organization.   Demência [Internet]. 2021 [cited  3 mar 2022]. Disponible en:   https://tinyurl.com/4emj333u .  3.   Machado ILO, Garrafa V. Bioética, o envelhecimento no Bra -  sil e o dever do Estado em garantir o respeito aos direitos  fundamentais das pessoas idosas. Revista de Direitos e Ga -  rantias   Fundamentais.   2020;21(1):79–106.   doi:   10.18759/  rdgf.v21i1.1804 .  4.   Machado ILO. Curatela e tomada de decisão apoiada (TDA)  com relação a pessoas idosas no Brasil: uma análise bioé -  tica. [Tesis de doctorado]. Brasilia: Universidade de Brasí -  lia; 2022.  5.   Ash EL. What is Dementia?   In: Foster C, Herring J, Doron I, eds.  The law and ethics of dementia. London: Hart; 2014. p. 3–14.  6.   Donnelly M. Healthcare decision-making and the law. Cam -  bridge: Cambridge University Press; 2010.  7.   Donnelly M. Deciding in dementia: The possibilities and  limits of supported decision-making. International Jour -  nal of Law and Psychiatry. 2019;66:101466. doi:   10.1016/j.  ijlp.2019.101466 .  8.   Baldwin C. Technology, dementia, and ethics: Rethinking the  issues. Disability Studies Quarterly. 2005;25(3). doi:   10.18061/  dsq.v25i3.583 .  9.   Carmo EG, Zazzetta MS, Fuzaro Junior G, Micali PN, Moraes  PF, Costa JLR.   A utilização de tecnologias assistivas por ido -  sos com Doença de Alzheimer. Kair ó s. 2015;4(18):311-336.  doi:   10.23925/2176-901X.2015v18i4p311-336 .  10.   Nunes C, Melo FC, Bonini JS. Prospecção tecnológica de es -  timulação cognitiva para idosos com doença de Alzheimer.  Cadernos de Prospecção. 2023;16(1):278-294. doi:   10.9771/  cp.v16i1.49634 .  11.   Andorno R. Bioética y dignidad de la persona. 2a ed. Madrid:  Tecnos; 2012.  12.   Albuquerque A. Empatia nos cuidados em saúde: comunica -  ção e ética na prática clínica.   Santana de Parnaíba: Manole;  2023.  13.   Albuquerque A, Tanure C. The necessity of new bioeth -  ics to clinical practice. Nursing & Care Open Access Journal.  2023;9(2):38-39. doi:   10.15406/ncoaj.2023.09.00257 .  14.   Richards T, Montori VM, Godlee F, Lapsley P, Paul D. Let the  patient revolution begin. BMJ. 2013;346:f2614. doi:   10.1136/  bmj.f2614 .  15.   Montori V. Why we revolt: a patient revolution for careful  and kind care. 2nd ed. Rochester: Mayo Clinic Press; 2020.  16.   Adom D, Hussein EK, Adu-Agyem J. Theoretical and concep -  tual framework: mandatory ingredients of a quality research  citations see profile theoretical and conceptual framework:  mandatory ingredients of a quality research.   International  Journal of Scientific Research. 2018;7(1):438-441.  17.   Albuquerque A. Direitos humanos dos pacientes. Curitiba:  Juruá; 2016.  18.   Albuquerque A. Manual de direito do paciente.   Belo Hori -  zonte: CEI; 2020.  19.   Howick J, Bizzari V, Dambha-Miller H. Therapeutic empathy:  what it is and what it isn’t. Journal of the Royal Society of Med -  icine. 2018;111(7):233-236. doi:   10.1177/0141076818781403 .  20.   van Dijke J, van Nistelrooij I, Bos P, Duyndam J. Towards a  relational conceptualization of empathy. Nursing Philoso -  phy. 2020;21(3):e12297. doi:   10.1111/nup.12297 .  21.   Hardman D, Howick J. The friendly relationship between  therapeutic empathy and person-centred care.   European  Journal for Person Centered Healthcare. 2019;7(2):351-357.  22.   Paranhos DGAM, Albuquerque A. Direitos humanos dos pa -  cientes como instrumentos bioéticos de proteção das pes -  soas idosas. Cadernos Ibero-Americanos de Direito Sanitário.  2019;8(1):53–64. doi:   10.17566/ciads.v8i1.507 .  23.   Albuquerque A, Paranhos DG de AM. Direitos humanos dos  pacientes e vulnerabilidade: o paciente idoso à luz da juris -  prudência da corte europeia de direitos humanos. Revista  Quaestio Iuris. 2017;10(4):2844-2462. doi:   10.37767/2591-  3476(2022)03 .  24.   Paranhos DGAM, Albuquerque A, Garrafa V. Vulnerabilidade  do paciente idoso à luz do princípio do cuidado centrado no  paciente. Sa ú de e Sociedade. 2017;26(4):932-942.  25.   Machado I, Garrafa V. Capacidades jurídica e decisional e os  importantes aportes bioéticos para promoção da autonomia  de pessoas idosas.   Redbioética. 2021;2(24):95-102.  26.   Cohen J, Ezer T. Human rights in patient care: a Theoreti -  cal and practical framework. Health and Human Rights.  2013;15(2):7-19.  27.   Albuquerque A, Barroso A. Curso de direitos humanos. Rio de  Janeiro: Lumen Juris; 2018.  28.   Ferreira EV, Medeiros de Mello J, Leiny de Lima L, De Mello  D, Sant’ana G. Plasticidade neural em indivíduos da terceira  idade. Arquivos do Mudi. 2019;23:120-129. doi:   10.4025/arq -  mudi.v23i3.51518 .  29.   Dos Santos CS, de Bessa TA, Xavier AJ.   Factors associated with  dementia   in   elderly.   Ci ê ncia   &   Sa ú de   Coletiva.   2020;25(2):603-  611. doi:   10.1590/1413-81232020252.02042018 .  30.   Palmdorf S, Stark AL, Nadolny S, Eliaß G, Karlheim C, Krei -  sel SH, et al. Technology-assisted home care for people with  dementia and their relatives: Scoping review. JMIR Aging.  2021;4(1):e25307. doi:   10.2196/25307 .\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  8  31.   Lee-Cheong S, Amanullah S, Jardine M. New assistive tech -  nologies in dementia and mild cognitive impairment care.  Asian Journal of Psychiatry. 2022;73:103135. doi:   10.1016/j.  ajp.2022.103135 .  32.   Battineni G, Chintalapudi N, Hossain MA, Losco G, Ruocco C,  Sagaro GG, et al. Artificial intelligence models in the diagno -  sis of adult-onset dementia disorders: A review. Bioenginee -  ring. 2022;9(8):370. doi:   10.3390/bioengineering9080370 .  33.   Costa BR. A memória em tela: os grupos de estimulação cog -  nitiva online para pessoas com a Doença de Alzheimer. Anais  da ReACT. 2021;1(1):2293-2309.  34.   Bernardo LD. Revisão integrativa sobre o engajamento em  ocupações de idosos com Alzheimer. Revista Interinstitu -  cional Brasileira de Terapia Ocupacional. 2017;1(3):386-407.  35.   Franco TB, Merhy EE. Produção imaginária da demanda e o  processo de trabalho em saúde. In: Pinheiro R, Mattos RA,  orgs. Construção social da demanda: direito à saúde, tra -  balho em equipe, participação e espaços públicos. Rio de Ja -  neiro: IMS/UERJ; 2005. p. 181-193.  36.   Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cu -  mulative complexity: A functional, patient-centered mo -  del of patient complexity can improve research and practice.  Journal of Clinical Epidemiology. 2012;65(10):1041-1051. doi:  10.1016/j.jclinepi.2012.05.005 .  37.   Ahmed SM, Drph M, Lemkau JP, Nealeigh N, Mann B. Barriers  to healthcare access in a non-elderly urban poor American  population. Health & Social Care in the Community. 2001  Nov;9(6):445-453. doi:   10.1046/j.1365-2524.2001.00318.x .  38.   Joseph AE, Hallman BC. Over the hill and far away: distance  as a barrier to the provision of assistance to elderly relatives.  Social Science & Medicine. 1998;46(6):631–639. doi:   10.1016/  s0277-9536(97)00181-0 .  39.   Mackenzie   CS,   Gekoski   WL,   Knox   VJ.   Age,   gender,   and  the   underutilization   of   mental   health   services:   The   in -  fluence of help-seeking attitudes. Aging & Mental Health.  2006;10(6):574-582. doi:   10.1080/13607860600641200 .  40.   Santos Koerich M, Stein Backes D, De Moura Scortegagna H,  Loewen Wall M, Veronese AM, Zeferino MT, et al. Tecnologias  de cuidado em saúde e enfermagem e suas perspecti-vas fi -  losóficas. Texto & Contexto-Enfermagem. 2006;15:178-185.  41.   Merhy EE, Franco TB. Por uma composição técnica do tra -  balho em saúde centrada no campo relacional e nas tec -  nologias   leves:   Apontando   mudanças   para   os   modelos  tecno-assistenciais. Saúde em Debate. 2003;27(65):316-323.  Recibido: 30 abr 2023 | Versión final: 30 ago 2023 | Aprobado: 1 sep 2023 | Publicado en línea: 3 oct 2023  FORMA DE CITAR  Cunha ILOM. Tecnologías asistivas para pacientes ancianos con demencia: perspectivas desde la bioética de los cuidados en salud. Salud Colectiva.  2023;19:e4488. doi: 10.18294/sc.2023.4488.  Esta obra está bajo una licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0).   http://creativecommons.org/licenses/  by-nc-nd/4.0 .   Atribución — Se debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado  cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la  licenciante. Sin restricciones adicionales — No se pueden aplicar términos legales ni medidas tecnológicas que restrinjan legalmente  a otras personas a hacer cualquier uso permitido por la licencia.',0.1545557267524401,'[\"&\", \"(1)\", \"(10)\", \"(11)\", \"(12)\"]','2025-11-29 16:59:00.411565'),(47,3,'Revista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  12   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  Revista Científica y Tecnológica UPSE  Tratamiento de lesiones de rodilla mediante prototipo robot  controlado por aplicaciones móviles  Treatment of knee injuries using a robot prototype controlled by  mobile applications  (1) Mercy Dalila Rea Yánez *   https://orcid.org/ 0000 - 0002 - 5005 - 9057 ,   (2) José E. Guerra Salazar   https://orcid.org/0000 - 0003 - 2535 - 7682 ,  (2) Sandra G. Barrazueta R   https://orcid.o rg/ 0000 - 0003 - 2837 - 8390 ,   (2) Jose L. Morales Gordon   https://orcid.org/ 0000 -   0002 - 1323 - 2164 .  (1)   Investigador Independiente.  (2)   Escuela Superior Politécnica de Chimborazo   (ESPOCH) , Ecuador .  Resumen  Palabras clave:  Robótica,  equipo de  rehabilitación,  rehabilitación  pasiva,  transmisión de  datos,  c omunicación  inalámbrica  Los   prototipos   electrónicos   desarrollados   en   los   últimos   tiempos   se   están   utilizando   en   el   campo  de   la   medicina   y   la   rehabilitación   física,   bajo   esta   premisa   se   desarrolló   un   tratamiento   para  lesiones   de   rodilla   mediante   un   prototipo   robot   controlado   por   aplicaciones   móviles,   el   diseño  y   construcción   se   realizó   en   tres   etapas:   diseño   mecánico,   electrónico   y   software.   La   estructura  mecánica   se   realizó   a   través   de   un   sistema   de   transmisión   por   medio   de   un   tornillo   de   potencia,  garantizando   la   transformación   del   movimiento   giratorio   generado   por   un   motor   a   un  movimiento   lineal   asegurando   un   desplazamiento   de   120°   en   flexión   a   0°   en   extensión   necesaria  para   la   rehabilitación.   En   la   segunda   etapa   se   alimentó   desde   una   fuente   de   12V,   controlado  mediante   un   Arduino   MEGA   2560   el   cual   recibió   los   datos   enviados   por   Bluetooth,   desde  un   encoder   rotatorio   y   dos   finales   de   carrera.   La   tercera   etapa   con s tó   de   dos   modo s   de   operación,  una   manual   que   permite   variar   la   velocidad   y   el   segundo   que   ejecuta   rutinas   preestablecidas  controladas   de   forma   inalámbrica   a   distancias   de   hasta   7.5m   por   medio   de   una   aplicación   móvil  que   dispone   de   una   base   de   datos   local   que   almacena   lo s   datos   del   paciente.   Se   comprobó   que  el   prototipo   en   operación   con   y   sin   paciente   presenta   un   ángulo   error   de   2°,   que   según   expertos  no   incide   en   los   resultados   de   la   rehabilitación   de   los   pacientes,   lo   que   le   hace   un   equipo   fiable  en   procesos   de   terapia .  Abstract  Keywords:  Robotics,  rehabilitation  equipment,  passive  rehabilitation,  data  transmission,  wireless  communication  The electronic prototypes developed in recent times are being used in the field of medicine and  physical   rehabilitation under this premise, a treatment for knee injuries was developed by means  of a robot prototype controlled by mobile applications, the design and construction was carried  out in three stages: mechanical, electronic and software design. The mec hanical structure was  made through a transmission system by means of a power screw, ensuring the transformation  of the rotary motion generated by a motor to a linear motion ensuring a displacement of 120° in  flexion to 0° in extension necessary for rehabil itation. The second stage was powered from a  12V source, controlled by an Arduino MEGA 2560 which received the data sent by Bluetooth,  from a rotary encoder and two limit switches. The third stage consisted of two modes of  operation, a manual one that allo ws to vary the speed and the second one that executes pre - set  routines controlled wirelessly at distances of up to 7.5m by means of a mobile application that  has a local database that stores the patient\'s data .   It was verified that the prototype in operati on  with and without patient presents an error angle of 2°, which according to experts does not affect  the rehabilitation results of the patients, making it a reliable equipment in therapy processes.  Recibido :   mayo   6 /202 1   Aceptado :   noviembre   5 /2021   Publicado:   diciembre   2 8 /2021  Forma de citar:   Rea Yánez ,   M .;   Guerra Salazar ,   J;   Barrazueta, S ; Morales Gordon, J .   (2021).   Tratamiento de lesiones  de rodilla mediante prototipo robot controlado por aplicaciones móviles .   Revista Científica y Tecnológica UPSE, 8 ( 2 ) pág.  12 - 2 6 .   DOI:   10.26423/rctu.v8i2. 576 .  *   Autor para correspondencia :   mercysmc.2695@hotmail.com\nRevista Científica y Tecnológica UPSE Vol. 8, Nº   2 , Edici ón   Diciembre   2021,   pág.   12 - 2 6  Tratamiento de lesiones de rodilla mediante   prototipo robot controlado por aplicaciones móviles   13  1.   Introducción  Las personas durante su vida cotidiana viven expuestas  a sufrir lesiones en las diferentes articulaciones del  cuerpo humano, tanto en las extremidades superiores  como en las extremidades inferiores. Este problema  ocurre debido al desgaste natural del cuerp o, accidentes  o lesiones al practicar actividades deportivas, las más  comunes   son   fracturas,   dislocaciones,   desgarres,  luxaciones, esguinces, atrofias o incapacidad de mover  la articulación afectada (Brad Walker, 2010).  La rodilla es la articulación más i mportante del cuerpo  humano, pues permite acciones como caminar y correr,  lo cual la hace sensible a sufrir impactos directos de alta  energía, generando traumatismos que causan lesiones  muy   complejas,   que   ameritan   rehabilitación   o  intervención quirúrgica.   Cuando se ha realizado una  operación inmediatamente se requiere de rehabilitación,  ya sea activa o pasiva (Paolo, 2012).  Las afectaciones de rodilla más frecuentes, según la  edad y sexo son: en niños y adolescentes padecen de  osteocondrosis   y   osteocondriti s   de   preferencia   en  hombres, menisco lateral discoide y luxación de la  rótula sobre todo en mujeres. Los jóvenes sufren de  lesión en meniscos o ligamentos, con más frecuencia en  varones   y   condropatía,   en   mujeres.   Los   adultos   y  ancianos soportan lesiones me niscales degenerativas,  enfermedades inflamatorias o metabólicas como artritis  reumatoide, condrocalcinosis y gota (Martínez, 2015).  A   nivel   mundial   las   lesiones   deportivas   son  consideradas un serio problema, pues solo en Estados  Unidos   durante   el   año   201 4   se   registró   lesiones  deportivas de mucho riesgo, donde el 55% son de  rodilla (Walker, 2018). En España, mediante un estudio  de casos se pudo determinar que el 69,3% de lesiones se  produce en el miembro inferior (García González et al.,  2015). En un estud io de las lesiones deportivas en  atletas de alto rendimiento de la provincia Las Tunas se  encontró un porcentaje elevado de lesiones en los  miembros   inferiores   con   un   47,7%   producido   por  practicar deportes como el futbol, hockey y taekwondo  (Barceló, 2014) .  En el Ecuador, según el registro de egresos hospitalarios  del   2014,   el   diagnóstico   de   luxación,   esguince   y  torcedura de la rodilla tuvo un total de 2973 salidas  hospitalarias, de las cuales el 72,8% son hombres y el  27,2% son mujeres. Del total de result ados, el 73% está  entre las edades de 25 a 64 años y el resto se reparte  entre las demás edades (INEC, 2014).  En   la   actualidad,   existen   diferentes   técnicas   de  rehabilitación, una de estas es el movimiento pasivo  continuo o MPC, el cual   consiste en proporci onar  desplazamientos regulares mediante una máquina y,  según estudios realizados, este proceso mejora en un  rango de 2 a 5% la amplitud de movimiento flexión -  extensión en comparación a personas que no recibieron  este tratamiento (Harvey, Brosseau y Herbert , 2014).  Aunque en el mercado sí existen dispositivos para la  rehabilitación postoperatoria de rodillas, sin embargo,  estos   tienen   un   alto   costo   de   adquisición   y  mantenimiento.  Después de realizar una indagación sobre estos equipos  se encontró que, en la   Universidad Tecnológica de  North   Bangkok   se   desarrolló   el   trabajo   siguiente  “ Design   and   Development   of   a   Smart   Continuous  Passive Motion Device for Knee Rehabilitation ”. Este  permite controlar todo el dispositivo   mediante una  pantalla LCD táctil de siete p ulgadas y opera de cuatro  modos: manual, auto run, intermitente y progresivo  (Umchid y Taraphongphan, 2016). En la Universidad de  Cuenca, los autores Pablo Loja y Andrés Ordoñez,  diseñaron y construyeron un exoesqueleto de rodilla  robótica   para   asistir   a   p acientes   en   etapas   de  rehabilitación con discapacidad moderada o inferior,  este equipo   es controlado mediante una aplicación  móvil,   se   comunica   mediante   Bluetooth   además  contiene una base de datos, que permite inspeccionar las  rutinas de rehabilitación por   medio de caminata asistida  (Loja Duchi y Ordóñez Torres, 2016). Por último, en la  Escuela Superior Politécnica del Ejercito se desarrolló  el   tema “Diseño y construcción   de un sistema de  rehabilitación pasivo para la rodilla”, este se controla  mediante una   pantalla táctil que posibilita un modo  manual y otro automático para ejecutar las rutinas de  rehabilitación (Urgilés, 2015).  En base a las investigaciones analizadas se propone el  desarrollo de un prototipo de robot para rehabilitación  de pacientes con   lesiones en rodilla controlado mediante  dispositivos móviles, y que permita enviar datos por  medio de Bluetooth al microcontrolador para producir  el movimiento flexión - extensión.  El objetivo del presente trabajo está encaminado a  diseñar e implementar un p rototipo de robot el cual  proporcione un rango de movimiento de 0° a 120°,  soporte un peso máximo de 150kg, sea ajustable y de  fácil operación para la rehabilitación de pacientes con  lesiones en rodilla, controlado mediante dispositivos  móviles .  2.   Noción   int egral   del   prototipo   de  rehabilitación  En la figura 1 se aprecia la consolidación general del  prototipo   de rehabilitación   que con una aplicación  móvil que permite ingresar al modo manual en donde se  elige la velocidad que se requiera para la rehabilitación,  y al modo automático donde se hace el registro de los  datos   del   paciente   y   sus   respectivas   rutinas,   la  aplicación   móvil   se   encarga   de   enviar   los   datos  necesarios mediante Bluetooth a la tarjeta controladora,  en la cual se procesa dicha información para in iciar con  el proceso de rehabilitación mediante la transmisión de  movimiento rotatorio del motor a un desplazamiento a  movimiento lineal por medio del tornillo de potencia,\nRevista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  14   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  para ello se realiza la lectura de la señal de un encoder  rotativo, de dos finales   de carrera y en caso de algún  siniestro se podrá pulsar los paros de emergencia que  están ubicados estratégicamente.  Figura   1 . -   Consolidación general del prototipo de rehabilitación .  El   desarrollo del prototipo de rehabilitación se realizó  en tres etapas:  2.1 .   Diseño   mecánico   del   prototipo   de  rehabilitación  En la primera etapa se utilizó el   software   Solidworks  2018. En la figura 2 se pueden observar las barras que  soportan el miembro inferior. Consta de dos barras  paralelas para soportar el muslo, estas barras se unen  por medio de tornillos a las dos barras paralelas para  soportar la pierna y al final se une co n la tuerca que es  accionada por el tornillo de potencia para producir el  movimiento   flexión - extensión.   También,   se une   un  posapié   el cual permite variar su longitud   de acuerdo  con   la   medida   antropométrica   del   paciente.  Adicionalmente,   se tiene   dos barras,   las   cuales   se  acoplan a la estructura base para darle robustez al  dispositivo y evitar que se produzca un movimiento en  sentido contrario .  Para los cálculos del tornillo de potencia se utilizó un  paso de 0.2in = 0.00508m, y aplicando fórmulas se  tienen lo s siguientes parámetros:  ?   =   ?  2   =   5 , 08  0 , 2   =   25 , 4 ??   =   1 ??  ?   =   ℎ   =   0 , 5   ∗   ?   =   0 , 5   ∗   5 , 08   =   2 , 54 ??   =   0 , 1 ??  ?   =   ?   −   2ℎ   =   25 , 4   −   2   ∗   2 , 54   =   20 , 32 ??   =   0 , 8 ??  Donde:  D = diámetro exterior del tornillo  p = paso del tornillo  e = espesor del filete, en el tornillo  h = altura del   filete, en el tornillo  d = diámetro interno del tornillo o diámetro de fondo  Los parámetros de la tuerca son:  ? ′   =   ?   +   0 . 125 ?   =   20 , 32   +   0 , 125   ∗   5 , 08  =   20 , 955 ??   =   0 , 825 ??  ? ′   =   ?   +   0 , 05   =   2 , 54   +   0 , 05   =   2 , 59 ??   =   0 , 1 ??  Donde:  D\'= diámetro a tornear de la tuerca  e\'= espes or del vano de la tuerca  Figura 2:   Barras de soporte y estructura base .  Además, para elevar la masa de un miembro inferior se  necesita calcular el par torsional para hacer girar el  tornillo tanto en elevación como en descenso. En la  figura 3 se puede observar un tornillo de potencia con  rosca cuadrada simple, la tuerca, la fue rza ejercida y de  reacción   (BUDYNAS y KEITH NISBETT, 2014) .\nRevista Científica y Tecnológica UPSE Vol. 8, Nº   2 , Edici ón   Diciembre   2021,   pág.   12 - 2 6  Tratamiento de lesiones de rodilla mediante   prototipo robot controlado por aplicaciones móviles   15  Figura 3:   Ro sca cuadrada simple .  Donde:  ψ   = ángulo de hélice  λ = ángulo de avance  d m   = diámetro medio o diámetro primitivo  F = suma de todas las fuerzas axiales que actúan sobre  el tornillo  En la figura 4 se puede observar el diagrama de cuerpo  libre cuando el tornillo se enrolla y desenrolla en una  vuelta   (Budynas   y   Keith Nisbett, 2014) ,   en donde:  P R   = para elevar la carga, fuerza que actúa a la derecha  (figura 4 a)  P L   = para bajar la carga, fuerza que actúa a la izquierda  (figura 4 b)  f r   = fuerza de fricción = fN  Figura 4:   DCL a) al subir la carga b) al bajar la carga .  El sistema está equilibrado bajo la acción de estas  fuerzas, para elevar la carga, se tiene:  ∑   ? ?  =   ? ?   −   ?????   −   ??????  =   0  Ecuación 1  ∑   ? ?  =   ?   −   ??????   −   ?????  =   0  Ecuación 2  Para bajar la carga se tiene:  ∑   ? ?  =   − ? ?   −   ????   +   ??????  =   0  Ecuación 3  ∑   ? ?  =   ?   −   ??????   −   ?????  =   0  Ecuación 4  Primero se despeja las ecuaciones 1, 2, 3 y 4, luego se  divide el numerador y el denominador de las ecuaciones  obtenidas, entre coseno   ?   y se emplea la relación   ?   =  ? / ? ? ?   el   cual   se   obtiene   al   aplicar   la   razón  trigonométrica tan   ? , entonces se tiene:  ? ?   =   ? ( ? / ? ? ?   +   ?   )  ?   −   ? ( ? / ? ? ? )  Ecuación 5  ? ?   =   ? ( ?   −   ? / ? ? ?   )  1   +   ? ( ? / ? ? ? )  Ecuación 6  Por   último,   el   par   de torsión   es igual   a   ? ? / 2   y  reemplazando en las ecuaciones 5 y 6 se obtiene:  ? ?   =   ? ? ?  2   (   ?   +   ?? ? ?  ? ? ?   −   ?? )   Ecuación 7  Donde:  f = coeficiente de fricción  ? ?   =   ? ? ?  2   ( ?? ? ?   −   ?  ? ? ?   +   ?? )   Ecuación 8  En donde :  ? ?   = Par de torsión de subida  ? ?   = Par de torsión de bajada  El tornillo de potencia es de rosca con diámetro medio  de   ? ?   =   0 , 9 ?? , con un coeficiente de fricción de 0,18   y  soporta un peso máximo de 24Kg debido a que el  porcentaje del total de la   pierna es de 16% del cuerpo  humano. Y reemplazando estos datos en las ecuaciones  7 y 8 se obtiene valores de torque de torsión de subida  y bajada respectivamente:  ? ?   =  0,68275Nm  ? ?   =  0,29001Nm  Para hacer girar el tornillo de potencia se necesita  utiliza r cojinetes, para ello se requiere calcular el par de  torsión necesario de la siguiente forma:  ? ?   =   ? ? ?   ? ?  2  Ecuación 9\nRevista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  16   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  Donde:  ? ?   =   Par de torsión del cojinete  F =   Fuerza aplicada  ? ?   =   Coeficiente de fricción del   cojinete  ? ?   = Diámetro medio del cojinete  De su aplicación se obtiene que el par de torsión del  cojinete es   0 , 40350 ?? .  La velocidad lineal máxima de la tuerca del tornillo de  potencia es de 2cm/s y mediante este dato se calcula las  RPM a las que gira el motor, pa ra ello se realiza una  analogía pues en una revolución la tuerca se desplaza la  distancia de paso de la rosca, entonces se tiene:  ?   =   2 ??  ?   ∗   1 ???  0 , 508 ??   ∗   60 ?  1 ???   =   236 , 22 ???  Para calcular la potencia mecánica que se necesita, se  debe sumar el va lor de las ecuaciones 5 y 6:  ? ?   =   ? ?   +   ? ?   Ecuación 10  Aplicando la   ecuación   se determina que el valor del  torque es   0 , 9727 ??  Después se procede a aplicar la fórmula:  ?   =   ? ?   ∗   ?   =   ? ?   ∗   ?  63025  Ecuación 11  Donde:  ?   = potencia requerida  ? ?   = torque total  ?   = velocidad angular  ?   = número de revoluciones por minuto  De la   ecuación   se obtiene que la potencia requerida es  0.0323HP.  Para calcular el torque del motor primero se   determinó  la eficiencia es 0,1954, la cual fue calculada mediante  la   ecuación   12.  ?   =   ?   ∗   ?  2 ? ? ?  Ecuación 12  Al sumar el torque de subida más el torque del cojinete  y esta respuesta se divide para la eficiencia, y se obtiene  aplicando   la   ecuación   13   un   torque   de   motor   de  7,45Nm.  ? ?????   =   ? ?   +   ? ?  ?  Ecuación 13  También se usó una caja de reducción con engra najes  helicoidales para   disminuir la velocidad de entrada, para  aumentar el torque de salida y dos chumaceras a los  extremos para dar apoyo al tornillo de potencia.  El material seleccionado para la estructura es acero  suave pues se puede conseguir fácilme nte en el mercado  a un precio aceptable. En la figura 5 se aprecia el diseño  del   prototipo   terminado,   consta   de   la   base   de   la  estructura, de las barras tanto para el muslo y pierna, un  tornillo de potencia, el cual está unido a la caja de  reducción y media nte un acople flexible al eje del  motor, además en sus extremos están las chumaceras,  por último, se tiene una caja de control la cual contiene  al motor.  Figura 5:   Diseño mecánico en Solidworks del prototipo  2.2   Diseño   electrónico   del   prototipo   de  rehabilitación  La segunda etapa es el diseño electrónico, para lo cual  se empleó un Arduino MEGA 2560 para controlar los  datos y señales recibidas, un módulo Bluetooth para la  comunicación inalámbrica el cual permite el enlace con  un   dispositivo   móvil   a   tr avés   de   una   aplicación  desarrollada en el   software   Android   Studio 3.5, un  encoder rotatorio incremental MCT38A como sensor  generador de pulsos con el fin de conocer con exactitud  la posición y el sentido de giro del tornillo de potencia.  Un   motor   AMP   Flow   A28 - 400   para   producir   el  movimiento giratorio, un Driver BTS7960   que soporta  altas   corrientes   y   se   puede   dar   órdenes   al   motor  controlando así su velocidad y dirección, un contactor  MC - 22b para evitar el consumo eléctrico innecesario  por parte del motor cua ndo no se está realizando la  terapia de rehabilitación, dos finales de carrera y tres  paros   de   emergencia   ubicados   estratégicamente.  Finalmente, todo el prototipo se alimenta con una fuente  de 12V a 20A.  Las conexiones del prototipo constan de dos partes:   la  parte eléctrica y la parte electrónica. En la figura 6 se  puede apreciar la parte eléctrica.   Consiste en   un fusible  de protección, un   switch,   el cual enciende todo el  dispositivo, además energiza al relé que activa la bobina  del contactor cuando el micr ocontrolador le manda una  señal en alto, para alimentar al motor, el cual está siendo  controlado mediante un puente H.  Figura 6:   Diagrama de conexión eléctrica\nRevista Científica y Tecnológica UPSE Vol. 8, Nº   2 , Edici ón   Diciembre   2021,   pág.   12 - 2 6  Tratamiento de lesiones de rodilla mediante   prototipo robot controlado por aplicaciones móviles   17  Figura   7 : a) Regulación de   voltaje b) Procesamiento de datos c) Indicadores d) I/O del sistema.  En la figura   7   se puede apreciar el diagrama de conexión  electrónico,   este se realizó por   medio de   software  (Proteus 8.8).  Este esquema consta de varias etapas. La primera etapa  constituye la protección de la placa electrónica tanto  para corto circuitos como para la inv ersión de polaridad  y la regulación de voltaje para los elementos que  necesitan 5V de alimentación .  La segunda etapa se encarga de la energización del  Arduino mega con 12V, GND y la conexión con las  entradas y salidas según se indica a   continuación:  •   El   encoder   rotativo se alimenta con 5V y GND,  para el funcionamiento se conecta la fase A, B, Z  a los terminales 2, 3, 4, respectivamente, a las  entradas digitales del Arduino.  •   Los finales de carrera se energizan con 5V y están  conectados a l os terminales 5 y 6 del Arduino.  •   El control del motor, el cual es ejercido por el  driver necesita de cuatro terminales, uno para la  alimentación   con   5V,   otro   para   GND   y   los  terminales que controlan la dirección y velocidad.  Estos terminales son RPWM conec tado al terminal  8 y LPWM conectado al terminal 9 del Arduino.  •   Los leds indicadores se conectan a los terminales  10 y 11 de la tarjeta controladora y a GND.\nRevista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  18   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  •   Los paros de emergencia se conectan en paralelo  al terminal 7 del microcontrolador y se energizan  c on 5V.  •   El módulo Bluetooth se alimenta mediante el  regulador de 5V del Arduino y GND, se conectan  los terminales Rx y Tx a los terminales 18 y 19,  respectivamente.   Estos   son   los   terminales   de  comunicación serial .  •   El switch el cual permite cambiar la mane ra de  utilizar el prototipo, de modo manual a modo  inalámbrico,   se   conecta   al   terminal   16   del  Arduino.  •   El potenciómetro que funciona al activarse el  switch del terminal 16, es decir en modo manual,  se conecta a 5V, GND y a la entrada analógica A0  del Ardui no.  •   El circuito que activa al relé se conecta al terminal  12 del Arduino.  En la figura   8   se puede apreciar el gabinete de control,  se muestra la conexión de cada elemento seleccionado.  Figura   8 : Caja de control  2.3   Diseño   del   software   del   prototipo   de  rehabilitación  El   software   del prototipo de rehabilitación consta de dos  partes:   el   progra ma   para   el   controlador   y   para   la  aplicación móvil.  El controlador se programó por medio del   software   libre  Arduino   1.8.1.   Se   declara   y   asigna   valores   a   las  variables globales, se configura las entradas y salidas,  se inicializa la comunicación serial tanto   de la consola  de Arduino y el puerto serial para la comunicación del  módulo Bluetooth   con el dispositivo, se realiza la  lectura de los sensores para comprobar su correcto  funcionamiento, después se definen las funciones:  void setup ():   Define si las   variables declaradas son  entradas o salidas.  void loop ():   se encarga de llamar a todas las funciones  según se necesite, esto se realiza de forma lineal.  void   potenciómetro   ():   habilita   el   funcionamiento  manual mediante la manipulación de un potenciómetro.  void FinCarrera2 ():   regresa a la posición inicial para  indicar al encoder que se encuentra a cero grados.  void ModoAuto ():   recopila la lectura de datos enviados  por Bluetooth, los cuales son el ángulo inicial, ángulo  final, velocidad y las repeticiones. Estos datos los  procesa y controla la rutina de rehabilitación mediante  los datos obtenidos del encoder y finales de carrera.  void encoder ():   cuenta los pulsos que genera el encoder  y los transforma en grados para controlar los ángulos.  En la Figura 9 se observa el diagrama de flujo de la  programación   del microcontrolador Arduino.  En la Figura 10 se muestra el diagrama de flujo   de la  función del potenciómetro .  En la Figura 11 se presenta el diagrama de flujo para la  programación del modo automático.  La programación de la aplicación móvil se realizó  mediante el   software   Android Studio 3.5. Consta de dos  modos de operación; el pr imero realiza el movimiento  flexión - extensión   por   medio   de   botones   y   la  manipulación de una barra deslizadora para variar la  velocidad y el segundo, permite registrar los datos del  paciente y las rutinas de rehabilitación en una base de  datos local para in iciar con el proceso de rehabilitación.  Las librerías y funciones utilizadas en el desarrollo de  la aplicación móvil se detallan a continuación (Cancela  y Ostos, 2010):  1.   android.util : contiene las clases de bajo nivel,  estos   son:   contenedores   especializados ,  formateadores de cadenas y de análisis XML de  servicios público.  2.   android.os : paquete de sistema operativo, permite  el acceso a los servicios básicos.  3.   android.text : herramientas de procesamiento de  texto para mostrarlo y analizarlo.  4.   android.database : prop orciona las clases de bajo  nivel necesario para la manipulación de cursores  cuando se trabaja con bases de datos.  5.   android.content : contenido de la API ( Aplication  Programming   Interfaces )   se   utiliza   para  admi n istrar el acceso a los datos y a la   publicación,  proporcionando los servicios para hacer frente a  los recursos, los proveedores de contenido y los  paquetes.  6.   android.widget : construido sobre el paquete de  Vista, elementos de la interfaz de usuario para su  uso en las aplicaciones . Se incluyen   listas, botones  y diseños.  7.   android.app : incluye la actividad de servicios y las  API que forman la base de todas sus aplicaciones.  8.   android.bluetooth :   proporciona   el   acceso   a   la  plataforma hardware, incluyendo Bluetooth.\nRevista Científica y Tecnológica UPSE Vol. 8, Nº   2 , Edici ón   Diciembre   2021,   pág.   12 - 2 6  Tratamiento de lesiones de rodilla mediante   prototipo robot controlado por aplicaciones móviles   19  Figura   9 : Diagrama de flujo de la programación de Arduino.  Figura 10 : Diagrama de flujo de la función potenciómetro\nRevista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  20   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  Figura 11 : Diagrama de flujo de la función en modo automático  Para guardar los datos se usó SQLite, es un motor de  base de datos ligero, no necesita de un servidor ya que  guarda los datos en un único fichero y además Android  incluye un soporte a SQLite, el cual se implementa  como una librería C, en lugar de ejecutars e en un  proceso propio. Esto reduce dependencias externas,  minimiza la latencia, y simplifica procesos como la  sincronización   (Ciencia de la Computacion e IA, 2012) .  En la figura 12 se observa la estructura de la base de  datos, consta de tres tablas con la finalidad   de almacenar  la información de paciente, su historia clínica y su  respectiva rutina de terapia.\nRevista Científica y Tecnológica UPSE Vol. 8, Nº   2 , Edici ón   Diciembre   2021,   pág.   12 - 2 6  Tratamiento de lesiones de rodilla mediante   prototipo robot controlado por aplicaciones móviles   21  Figura 12 : Estructura de la base de datos para el prototipo  Las pantallas de la aplicación móvil se   pueden observar  en las figuras: 13, 14   y 15.  En la figura 13 a, se elige entre: el modo manual para  realizar el movimiento flexión, extensión y detenerse  mediante los botones como se muestra en la figura 13 b.  En   la   opción   de   registrarse   se   ingresa   toda   la  información del paciente y luego se procede al inicio de  sesión como se observa en la figura 13 c.  Figura 13 : a) Pantalla de inicio, b) Modo Manual, c) Inicio de sesión  En la pantalla perfil de paciente hay un calendario,  como se observa en la figura 14 a, el cual permite  programar las rutinas de rehabilitación como se aprecia  en la figura 14b, por último, en la pantalla modo  automático como se muestra en la figura 14 c,   se tiene  botones para realizar el envío de cada uno de los  parámetros y los botones inicio y detener para controlar  la rehabilitación.  Figura 14 : a) Perfil de usuario, b) Programar rutina o evento c) Modo automático .\nRevista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  22   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  En   la   figura   15   se   observa   las   opciones   que   se  despliegan mediante el botón flotante de la pantalla  perfil de usuario, estas son: editar información y llenar  la historia clínica del paciente.  Figura 15 :   a) Editar información, b) Historia Clínica  3.   Validación del encoder en modo manual  Con   el   propósito   de   determinar   los   ángulos   de  desplazamiento se realiza una captura de datos enviados  por el encoder, el cual permite apreciar la pos ición  actual y el recorrido que debe realizar para obtener  dichos ángulos. En la tabla 1 se puede observar la  medición de los ángulos sin la presencia de un paciente,  estos datos se obtuvieron estando en el modo manual de  la aplicación móvil. Para el ángul o deseado se usa la  consola serial de Arduino como muestra la figura 1 6   a,  y el ángulo real se lo midió manualmente por medio de  un graduador como se observa en la figura 1 6   b.  Figura 1 6 : a) Medición del encoder, b)   Medición con un graduador .  Esta prueba consiste en comparar el valor de ángulo  apreciado por la consola de Arduino con el valor que se  obtiene tras la medición, para ello se utilizó una muestra  de 20 valores y se los tomó cuando se   ejecutó el modo  manual   desde   el   dispositivo   móvil,   al   50%   de   la  velocidad máxima. En la tabla 1 se aprecia un error  absoluto en seis valores, se observa que el error máximo  es de dos grados.  Tabla 1   Mediciones de ángulos sin paciente  N°  Ángulo del  rehabilitador  MPC (°)  Ángulo de  referencia  (°)  Error  Absoluto  (°)  1   5   5   0  2   10   10   0  3   15   15   0  4   20   21   1  5   25   25   0  6   30   31   1  7   35   35   0  8   40   40   0  9   45   46   1  10   50   50   0  11   55   55   0  12   60   60   0  13   65   65   0  14   70   72   2  15   75   76   1  16   80   80   0  17   85   85   0  18   90   90   0  19   95   95   0  20   100   101   1  Realizado por: Rea, Mercy; 2019\nRevista Científica y Tecnológica UPSE Vol. 8, Nº   2 , Edici ón   Diciembre   2021,   pág.   12 - 2 6  Tratamiento de lesiones de rodilla mediante   prototipo robot controlado por aplicaciones móviles   23  En la tabla 2 se puede apreciar la medición de los  ángulos con la presencia de un paciente. Se observa un  error absoluto en siete valores y el error máximo de dos  grados. Se   determina que el prototipo funciona con la  misma exactitud tanto con pacientes como sin paciente,  además según la evaluación de expertos no afecta en el  proceso de rehabilitación lo que le hace fiable para la  terapia.  Tabla 2 : Mediciones de ángulo con un p aciente  N°   Ángulo del  rehabilitador  MPC (°)  Ángulo de  referencia  (°)  Error  Absoluto  (°)  1   5   5   0  2   10   11   1  3   15   15   0  4   20   20   0  5   25   27   2  6   30   30   0  7   35   35   0  8   40   41   1  9   45   45   0  10   50   50   0  11   55   56   1  12   60   60   0  13   65   65   0  14   70   70   0  15   75   76   1  16   80   82   2  17   85   85   0  18   90   91   1  19   95   95   0  20   100   100   0  3.1 Validación del encoder en modo automático  En la tabla 3 se puede apreciar la medición de los  ángulos sin la presencia de un paciente, estando en  modo automático la aplicación móvil, los parámetros  fueron:   ángulo   inicial   de   15,   ángulo   final   de   90,  velocidad de 1cm/s y ocho repeticiones. Estos datos  presentan un coeficiente de variación de 3,963% para el  ángulo inicial y 0,783% para el ángulo final.  En la tabla 4 se puede apreciar la medición de los  ángulos con la presencia de un paciente, estando en  modo automático la aplicación móvil con los sigui entes  datos:   ángulo   inicial   de   40,   ángulo   final   de   100,  velocidad de 1,4cm/s y ocho repeticiones. Estos datos  presentan un coeficiente de variación de 1,186% para el  ángulo inicial y 0,701% para el ángulo final.  De acuerdo a los valores obtenidos en la ta bla 3 y 4, se  concluye que el   coeficiente de variación   tanto del  ángulo inicial y ángulo final, con y sin la presencia de  un paciente, se encuentra entre los límites permitidos  pues es menor al 10%   (Romero, 2012) .  Tabla   3:   Mediciones   realizadas   sin   presencia   de  paciente .  Hora   Número de  muestras  Ángulo  inicial  Ángulo  final  11:20:18   1   15   90  11:21:20   2   15   90  11:22:22   3   15   91  11:23:27   4   16   90  11:24:32   5   16   91  11:25:40   6   15   90  11:26:43   7   15   89  11:27:47   8   14   91  Media   ( ? ̅   )   15,125   90,250  Desviación Estándar   0,599   0,661  Coeficiente de  Variación (%)  3,963   0,783  Tabla   4:   Mediciones   realizadas   con   presencia   de  paciente  Hora   Número de  muestras  Ángulo  inicial  Ángulo  final  11:35:22   1   40   100  11:36:25   2   41   101  11:37:24   3   40   99  11:38:27   4   40   101  11:39:31   5   41   101  11:40:39   6   40   100  11:41:44   7   40   100  11:42:46   8   40   100  Media   ( ? ̅ )   40,500   100,250  Desviación Estándar   0,755   0,707  Coeficiente de  Variación (%)  1,866   0,701  3.2 Evaluación del envió de datos  Esta prueba consiste en enviar los datos cuando se está  trabajando en modo automático de forma inalámbrica a  diferente hora, en la tabla 5 se puede observar que hay  cinco valores para cada parámetro.  Se   determina que de todos los parámetros enviados se  obtuvo un solo error en el ángulo final el cual representa  un error absoluto de 0,05% mismo que se encuentra  dentro en rango de la tasa admisible pues es de 0,1%  (Core, 2001).\nRevista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  24   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  Tabla 5 : Resumen de datos en viados  Parámetro   N°   Valor  enviado  Valor  recibido  Dato  correcto  Ángulo  inicial  1   78   78   Si  2   63   63   Si  3   5   5   Si  4   28   28   Si  5   40   40   Si  Ángulo final  6   95   95   Si  7   120   12   No  8   85   85   Si  9   101   101   Si  10   99   99   Si  Velocidad  11   5   5   Si  12   4   4   Si  13   8   8   Si  14   6   6   Si  15   9   9   Si  Repeticiones  16   7   7   Si  17   2   2   Si  18   6   6   Si  19   1   1   Si  20   10   10   Si  Error   0,05  3.3.   Evaluación de la conexión a Bluetooth  La conexión Bluetooth permite realizar el envío de  datos para el   funcionamiento del prototipo. En la tabla  6 se puede apreciar las distancias a las cuales se realizó  la conexión, esta prueba se la hizo con barreras pues el  módulo Bluetooth se encuentra dentro de la caja de  control.  Tabla 6 : Conexión entre dispositivos  N °   Distancia (cm)   Conexión  1   5   Si  2   50   Si  3   100   Si  4   150   Si  5   200   Si  6   250   Si  7   300   Si  8   350   Si  9   400   Si  10   450   Si  11   500   Si  12   550   Si  13   600   Si  14   650   Si  15   700   Si  16   750   Si  17   800   No  18   850   No  19   900   No  20   950   No  La   conexión   entre   dispositivo   móvil   y   el   módulo  Bluetooth se realiza hasta 7,5m, lo cual es suficiente ya  que la terapia se realiza en un lugar cerrado de 3*3m  según expertos en terapia de rehabilitación.  3.4.   Grado de aceptación del prototipo  Después de concluir las pruebas de funcionamiento del  prototipo, se realizó sesiones de fisioterapia con el fin  de medir el nivel de aceptación en los fisioterapeutas y  pacientes del Centro de rehabilitación, fisioterapia y  kinesiología “CENREFK” de la ciu dad de Riobamba  como se observa en la figura 1 7 .  Figura 1 7 :   Interacción del prototipo con el paciente .  Luego de ser aplicada la terapia de rehabilitación al  paciente, se realizó una entrevista tanto al paciente  como a los   fisioterapeutas. Para esta prueba se aplicó la  escala de Likert, con el fin de conocer el grado de  satisfacción, obteniendo los resultados de la tabla 7:  Tabla 7 : Evaluación del grado de aceptación prototipo  de rehabilitación  N°   Preguntas   1   2   3   4  1   ¿El   prototipo cumplió con la  terapia de rehabilitación?   X  2  ¿Está de acuerdo con el  movimiento que realiza el  prototipo de rehabilitación?  X  3   ¿Está de acuerdo con el  prototipo de rehabilitación?   X  4  ¿Está de acuerdo con el  tamaño del   prototipo de  rehabilitación?  X  5  ¿Está de acuerdo con el peso  del prototipo de  rehabilitación?  X  6  ¿Está de acuerdo con el  control y manipulación de la  aplicación móvil?  X  7  ¿Qué tan satisfecho esta con  la transmisión de datos que  se   realiza entre el dispositivo  móvil y el prototipo?  X  Donde:  1 = muy satisfecho  2 = satisfecho  3 = poco satisfecho  4 = nada satisfecho\nRevista Científica y Tecnológica UPSE Vol. 8, Nº   2 , Edici ón   Diciembre   2021,   pág.   12 - 2 6  Tratamiento de lesiones de rodilla mediante   prototipo robot controlado por aplicaciones móviles   25  Después de analizar los resultados obtenidos de la  entrevista,   se   determinó   que   el   prototipo   de  rehabilitación presenta un alto grado de aceptación por  parte del paciente y de los fisioterapeutas, pues este  dispositivo ayudó a realizar la terapia de rehabilitación,  además permitió guardar los datos del paciente y su  rutina   de   rehabilitación   en   la   bas e   de   datos   del  dispositivo móvil .  4.   Conclusiones  Se   desarrolló   un   prototipo   electrónico   para   la  rehabilitación de rodilla, el cual es controlado por medio  de una aplicación móvil. Esta contiene una base de  datos en la que se almacena la información del paci ente  y la terapia que debe cumplir, su funcionamiento está  basado en desplazarse desde 0° en extensión a 120° en  flexión a una velocidad elegida por el paciente y el  número de repeticiones que se desee.  El resultado de la evaluación del encoder en modo  man ual muestra un error máximo de 2° con y sin la  presencia de un paciente, lo cual, según expertos, no  afecta el proceso de rehabilitación lo que le hace fiable  para la terapia.  Al evaluar el prototipo en modo automático se obtuvo  un coeficiente de variació n tanto del ángulo inicial y  ángulo final, con y sin la presencia de un paciente, entre  los límites permitidos pues el valor máximo que se  obtuvo fue de 3,963% lo cual es menor al 10%.  Las pruebas de transmisión de datos determinaron que  el dispositivo móv il puede controlar al prototipo a una  distancia máxima de 7,5m siendo suficiente pues las  terapias se las realiza en un lugar cerrado de 3*3m de  dimensiones.  La aplicación móvil permite la transmisión de datos  mediante Bluetooth con un margen de error de   0,05% el  cual se   encuentra dentro en rango de la tasa admisible  pues el valor permitido es de 0,1%.  Se concluye que el prototipo consume poca energía en  comparación a otros electrodomésticos utilizados en el  hogar.  Al hacer una comparación con equipos co merciales de  similares características se establece que el prototipo  implementado resulta ser más económico en un 27,83%  y que además cumple con los objetivos planteados al  inicio de la investigación.  Se observó que el prototipo tiene un alto grado de  acep tación ya que para el fisioterapeuta es un gran  apoyo tener este tipo de herramientas, ya que le permite  tener un mayor control de la rutina a realizarse y del  progreso que tiene el paciente.  5.   Referencias   b ibliográficas  Barceló, R . Estudio de las lesiones deportivas en atletas  de alto rendimiento de la provincia Las Tunas  en   el   año   2012.   (2014).Disponible   en:  https://www.efdeportes.com/efd193/lesiones -  deportivas - en - alto - rendimi ento.htm.  Budynas, R. Y Keith, J.   Diseño en Ingeniería Mecánica  de   Shigley (2014).   Octava   edición. ISBN  9780874216561.  https://termoaplicadaunefm.files.wordpress.com/2  015/03/disec3b1o - en - ingenierc3ada - mecc3a1nica -  de - shigley - 8 - edicic3b3n - budynas.pdf.  Brad Walker. (2010). The anatomy of sports injuries.  Cancela, L. Y Ostos, S.   Librerías Básicas   -   Software de  Comunicaciones.   (2010).   https://sites.google.  com/site/swcuc3m/home/android/api.  Ciencia De La Computacion e   IA. Persistencia en  Android: ficheros y SQLite.   [en línea] (2012).  https://panoramadeportivo.cl/cuida - tus -  rodillas/cintilla - iliotibial/.  Core . Specification of the Bluetooth System.   [en línea]  2001.   Disponible   en:   https://inf.ethz.ch/  personal/hvogt/proj /btmp3/Datasheets/Blueto  oth_11_Specifications_Book.pdf.  García ,   C.   et   al.   Deporte   de   ocio   en   España:  epidemiología   de   las   lesiones   y   sus  consecuencias.   Biotech (2015).:   https://www.  redalyc.org/pdf/5516/551656902002.pdf  Harvey ,   L.A.,   et   al.   Continuous   pa ssive   motion  following total knee arthroplasty in people  with   arthritis.   (2014).   ISSN   1469493X.  https://www.cochranelibrary.com/cdsr/doi/10.100  2/14651858.CD004260.pub3/epdf/full.  INEC. Anuario de Estadísticas Hospitalarias: Egresos  y   Camas.   (2014).   ISBN   8460562263.  https://www.ecuadorencifras.gob.ec//documentos/web -  inec/Estadisticas_Sociales/Camas_Egresos_Hospitalario  s/Publicaciones - Cam_Egre_Host/  Anuario_Camas_Egresos_Hospitalario s_2014.pdf.  Loja Duchi, J.P. Y Ordóñez Torres,   A.S. Diseño y  construcción de un exoesqueleto de rodilla  robótica para asistir a pacientes en etapas de  rehablitación(2010). (Ingenieria)   Universidad  De Cuenca . Cuenca - Ecuador. Disponible en:  http://dspace.uc uenca.edu.ec/jspui/handle/123456  789/25819 .  Martínez , F. Traumatología y Ortopedia para el grado  de medicina. (2015). Madrid - España ISBN  978 - 84 - 9022 - 941 - 5.  Paolo , D. Diseño de un rehabilitador de rodilla. (Tesis).  (Ingeniería).   Universidad   de   Carabobo.  Nag uanagua - Venezuela. 2012. pp. 113.\nRevista Científica y Tecnológica UPSE Vol. 8, Nº 2 , Edición   Diciembre 2021,   pág.   1 2 - 2 6  26   Rea Yánez , M.;   Guerra Salazar , J;   Barrazueta, S; Morales Gordon, J .   (2021) .  Romero , M. Diseño y Construcción de una Órtesis de  Rodilla,   Destinada   a   la   Rehabilitación  Automatizada   de   la   extremidad   inferior  (Tesis). (Ingeniería). Universidad Politécnica  Salesiana   Sede   Cuenca.   Cuenca - Ecuador.:  http s://dspace.ups.edu.ec/bitstream/1234567  89/2814/1/UPS - CT002463.pdf.  Umchid,   S.   Y   Taraphongphan,   P.   Design   and  development of a smart continuous passive  motion   device   for   knee   rehabilitation.  BMEiCON   2016   -   9th   Biomedical  Engineering International Conference, pp. 5.  DOI 10.1109/BMEiCON.2016.7859616.  Urgilés, F. Diseño Y Construcción De Un Sistema De  Rehabilitación   Pasivo   Para   La   Rodilla ”.  (2015) S.l.: Escuela Superior Politecnica del  Ejercito.   Latacunga - Ecuador 2015.  Walker , K. Las lesiones deportivas con más peligros   –  GPC   Biotech   (2018).   https://   www.gpc -  biotech.com/las - lesiones - deportivas - con -  mas - peligros/',0.14633245237869602,'[\"(\", \"(%)\", \"():\", \"(1)\", \"(2)\"]','2025-11-29 16:59:33.042624'),(48,3,'ARCHIVOS DE MEDICINA ISSN 1698-9465  2024  Vol.20.3:1635 1 Mini Review  Zhiyun Zhang*  Institute of Dentistry, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK  *Correspondencia:  Zhiyun Zhang     zhiyunzhang@foxmail.com  El Futuro de la Gestión de Archivos Médicos: Tendencias y Perspectivas The Future of Medical Records Management: Trends and Perspectives Fecha de recibido:   02-July-2024, Manuscript No. IPADM-24-15098;   Fecha del Editor asignado : 05- July -2024, PreQC No. IPADM-24-15098 (PQ);   Fecha de Revisados:   17- July -2024, QC No. IPADM-24-15098;   Fecha de Revisado : 23- July -2024, Manuscript No. IPADM-24-15098(R); Fecha de Publicación: 30- July -2024, DOI: 10.36648/1698-9465-20-1635  Introducción  La gestión de archivos médicos está en un punto de inflexión significativo, impulsado por avances tecnológicos que prometen redefinir el futuro del cuidado de la salud. A medida que la digitalización se convierte en la norma y las innovaciones emergen, es esencial explorar las tendencias actuales y las perspectivas futuras que moldearán la manera en que se gestionan los datos médicos. Este artículo ofrece una visión integral de las tendencias emergentes y las perspectivas que delinearán el futuro de la gestión de archivos médicos [1, 2].  Avances en Historia Clínica Electrónica (HCE) Historial Clínico Electrónico Avanzado  Las   HCE   continúan   evolucionando   con   la   integración de   características   avanzadas   que   permiten   una   mayor personalización   y   eficiencia.   Los   sistemas   de   HCE   están incorporando herramientas de inteligencia artificial (IA) para mejorar la calidad de los datos, automatizar tareas rutinarias y proporcionar soporte en la toma de decisiones clínicas.  Interoperabilidad y Estándares  La interoperabilidad sigue siendo un desafío clave, pero los esfuerzos hacia la estandarización y la creación de interfaces más abiertas están ganando terreno. La implementación de estándares   globales   permitirá   una   mejor   integración   entre sistemas de diferentes proveedores y una transferencia más fluida de datos entre plataformas [3, 4].  Inteligencia Artificial y Big Data Análisis Predictivo y Diagnóstico Asistido por IA  La IA y el análisis de Big Data están revolucionando el diagnóstico y el tratamiento. Los algoritmos de aprendizaje automático pueden analizar grandes volúmenes de datos para identificar patrones y prever resultados, asistiendo a los médicos en la detección temprana de enfermedades y la personalización de tratamientos.  Automatización y Optimización de Flujos de Trabajo  La automatización de procesos administrativos y clínicos mediante IA está reduciendo la carga de trabajo manual, mejorando la eficiencia en la gestión de archivos médicos y permitiendo a los profesionales concentrarse en la atención al paciente [5, 6].  Blockchain para Seguridad y Transparencia Garantía de Integridad de los Datos  La tecnología blockchain ofrece un enfoque prometedor para asegurar la integridad y la trazabilidad de los registros médicos. Mediante el uso de registros descentralizados y encriptados, blockchain puede prevenir manipulaciones y garantizar que la información médica se mantenga precisa y accesible solo para usuarios autorizados.  Consentimiento y Privacidad  Blockchain también facilita la gestión del consentimiento del paciente, proporcionando un marco transparente y auditable para las autorizaciones de acceso y el intercambio de datos médicos, lo que mejora la confianza y el control del paciente sobre su información personal [7].  Telemedicina y Acceso Móvil Expansión de la Telemedicina  La telemedicina ha demostrado ser una herramienta invaluable, especialmente   durante   situaciones   de   emergencia   como   la pandemia de COVID-19. La integración de archivos médicos digitales con plataformas de telemedicina permite un acceso remoto a la información del paciente y facilita la continuidad de la atención desde cualquier ubicación.  Aplicaciones Móviles y Portales del Paciente  Las   aplicaciones   móviles   y   los   portales   del   paciente   están ofreciendo a los usuarios un acceso más conveniente y directo a sus registros médicos. Estas herramientas permiten a los pacientes gestionar sus citas, revisar resultados de pruebas y comunicarse con sus proveedores de salud de manera más eficaz [8].\nARCHIVOS DE MEDICINA ISSN 1698-9465  2024  Vol.20.3:1635 2  Realidad Aumentada (RA) y Realidad Virtual (RV) Entrenamiento y Educación Médica  La RA y la RV están comenzando a jugar un papel importante en la formación y la educación médica. Estas tecnologías permiten a los estudiantes y profesionales practicar procedimientos en entornos virtuales, mejorando sus habilidades y comprensión de la gestión de datos clínicos en contextos simulados.  Visualización de Datos Médicos  La RA y la RV también están facilitando la visualización avanzada de datos médicos, permitiendo a los profesionales de la salud interactuar   con   modelos   tridimensionales   de   anatomía   y resultados de pruebas, lo que puede mejorar la precisión en la planificación de tratamientos.  Desafíos y Consideraciones Futuras Seguridad y Protección de Datos  A medida que se adoptan nuevas tecnologías, la seguridad y la protección de los datos médicos siguen siendo preocupaciones primordiales. Los sistemas deberán estar diseñados para resistir ataques   cibernéticos   y   garantizar   el   cumplimiento   con   las normativas de privacidad de datos.  Adaptación y Capacitación  La transición a nuevas tecnologías requiere una capacitación adecuada del personal médico y administrativo. La resistencia al cambio y la necesidad de actualización continua en habilidades digitales son desafíos importantes que deben abordarse para una integración exitosa.  Costos y Accesibilidad  Los costos asociados con la implementación de tecnologías avanzadas   pueden   ser   significativos,   especialmente   para pequeñas   prácticas   y   organizaciones   en   regiones   menos desarrolladas. Las estrategias para hacer que estas tecnologías sean accesibles y sostenibles serán cruciales para su adopción generalizada.  Conclusión  El futuro de la gestión de archivos médicos está siendo modelado por   una   serie   de   tendencias   emergentes   que   prometen transformar la atención sanitaria. La evolución continua de las HCE, la integración de IA y Big Data, la adopción de blockchain, y el crecimiento de la telemedicina y las tecnologías inmersivas están configurando un panorama emocionante y dinámico. A medida que estas tecnologías avanzan, es esencial que los profesionales de la salud, los responsables de políticas y las instituciones trabajen juntos para abordar los desafíos y aprovechar al máximo las oportunidades que presentan. El objetivo final es lograr una gestión de archivos médicos que no solo sea eficiente y segura, sino que también mejore la calidad de la atención y el bienestar de los pacientes en un entorno cada vez más digitalizado.  Referencias  1.   Clarke   SE.   In   vitro   assessment   of   human   cytochrome   P450. Xenobiotica. 1998;28(12):1167-202. 2.   Koley AP, Buters JT, Robinson RC, et al. co binding kinetics of human cytochrome p450 3a4: specific interaction of substrates with   kinetically   distinguishable   conformers   .   J   Bio   Chem. 1995;270(10):5014-8. 3.   Kumar S, Davydov DR, Halpert JR. Role of cytochrome B5 in modulating peroxide-supported cyp3a4 activity: evidence for a conformational transition and cytochrome P450 heterogeneity. Drug Metabol Dispos. 2005;33(8):1131-6. 4.   Tokuriki N, Tawfik DS. Protein dynamism and evolvability. Sci. 2009;324(5924):203-7. 5.   Buda K, Miton CM, Fan XC, et al. Molecular determinants of protein evolvability. Trends Biochem Sci. 2023. 6.   Doran A, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E, Chen C, Chen X, Choo E, Cianfrogna J, Cox LM. The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab Dispos 33(1):165–174. 7.   Kalliokoski   A,   Niemi   M.   Impact   of   OATP   transporters   on pharmacokinetics. Br J Pharmacol. 2009:158(3):693–705. 8.   Somogyi A, Stockley C, Keal J, et al. Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol 23(5):545–551. 9.   Bachmakov I, Glaeser H, Fromm MF, et al. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1. Diabetes. 2008;57(6):1463-9. 10.   Dresser   MJ,   Xiao   G,   Leabman   MK,   et   al.   Interactions   of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2). Pharm Res 19(8):1244– 1247',0.14490322610735365,'[\"(hce)\", \"(hoct2).\", \"(ia)\", \"(pq);\", \"(ra)\"]','2025-11-29 16:59:41.233200'),(49,3,'ARCHIVOS DE MEDICINA ISSN 1698-9465  2024  Vol.20.3:1635 1 Mini Review  Zhiyun Zhang*  Institute of Dentistry, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK  *Correspondencia:  Zhiyun Zhang     zhiyunzhang@foxmail.com  El Futuro de la Gestión de Archivos Médicos: Tendencias y Perspectivas The Future of Medical Records Management: Trends and Perspectives Fecha de recibido:   02-July-2024, Manuscript No. IPADM-24-15098;   Fecha del Editor asignado : 05- July -2024, PreQC No. IPADM-24-15098 (PQ);   Fecha de Revisados:   17- July -2024, QC No. IPADM-24-15098;   Fecha de Revisado : 23- July -2024, Manuscript No. IPADM-24-15098(R); Fecha de Publicación: 30- July -2024, DOI: 10.36648/1698-9465-20-1635  Introducción  La gestión de archivos médicos está en un punto de inflexión significativo, impulsado por avances tecnológicos que prometen redefinir el futuro del cuidado de la salud. A medida que la digitalización se convierte en la norma y las innovaciones emergen, es esencial explorar las tendencias actuales y las perspectivas futuras que moldearán la manera en que se gestionan los datos médicos. Este artículo ofrece una visión integral de las tendencias emergentes y las perspectivas que delinearán el futuro de la gestión de archivos médicos [1, 2].  Avances en Historia Clínica Electrónica (HCE) Historial Clínico Electrónico Avanzado  Las   HCE   continúan   evolucionando   con   la   integración de   características   avanzadas   que   permiten   una   mayor personalización   y   eficiencia.   Los   sistemas   de   HCE   están incorporando herramientas de inteligencia artificial (IA) para mejorar la calidad de los datos, automatizar tareas rutinarias y proporcionar soporte en la toma de decisiones clínicas.  Interoperabilidad y Estándares  La interoperabilidad sigue siendo un desafío clave, pero los esfuerzos hacia la estandarización y la creación de interfaces más abiertas están ganando terreno. La implementación de estándares   globales   permitirá   una   mejor   integración   entre sistemas de diferentes proveedores y una transferencia más fluida de datos entre plataformas [3, 4].  Inteligencia Artificial y Big Data Análisis Predictivo y Diagnóstico Asistido por IA  La IA y el análisis de Big Data están revolucionando el diagnóstico y el tratamiento. Los algoritmos de aprendizaje automático pueden analizar grandes volúmenes de datos para identificar patrones y prever resultados, asistiendo a los médicos en la detección temprana de enfermedades y la personalización de tratamientos.  Automatización y Optimización de Flujos de Trabajo  La automatización de procesos administrativos y clínicos mediante IA está reduciendo la carga de trabajo manual, mejorando la eficiencia en la gestión de archivos médicos y permitiendo a los profesionales concentrarse en la atención al paciente [5, 6].  Blockchain para Seguridad y Transparencia Garantía de Integridad de los Datos  La tecnología blockchain ofrece un enfoque prometedor para asegurar la integridad y la trazabilidad de los registros médicos. Mediante el uso de registros descentralizados y encriptados, blockchain puede prevenir manipulaciones y garantizar que la información médica se mantenga precisa y accesible solo para usuarios autorizados.  Consentimiento y Privacidad  Blockchain también facilita la gestión del consentimiento del paciente, proporcionando un marco transparente y auditable para las autorizaciones de acceso y el intercambio de datos médicos, lo que mejora la confianza y el control del paciente sobre su información personal [7].  Telemedicina y Acceso Móvil Expansión de la Telemedicina  La telemedicina ha demostrado ser una herramienta invaluable, especialmente   durante   situaciones   de   emergencia   como   la pandemia de COVID-19. La integración de archivos médicos digitales con plataformas de telemedicina permite un acceso remoto a la información del paciente y facilita la continuidad de la atención desde cualquier ubicación.  Aplicaciones Móviles y Portales del Paciente  Las   aplicaciones   móviles   y   los   portales   del   paciente   están ofreciendo a los usuarios un acceso más conveniente y directo a sus registros médicos. Estas herramientas permiten a los pacientes gestionar sus citas, revisar resultados de pruebas y comunicarse con sus proveedores de salud de manera más eficaz [8].\nARCHIVOS DE MEDICINA ISSN 1698-9465  2024  Vol.20.3:1635 2  Realidad Aumentada (RA) y Realidad Virtual (RV) Entrenamiento y Educación Médica  La RA y la RV están comenzando a jugar un papel importante en la formación y la educación médica. Estas tecnologías permiten a los estudiantes y profesionales practicar procedimientos en entornos virtuales, mejorando sus habilidades y comprensión de la gestión de datos clínicos en contextos simulados.  Visualización de Datos Médicos  La RA y la RV también están facilitando la visualización avanzada de datos médicos, permitiendo a los profesionales de la salud interactuar   con   modelos   tridimensionales   de   anatomía   y resultados de pruebas, lo que puede mejorar la precisión en la planificación de tratamientos.  Desafíos y Consideraciones Futuras Seguridad y Protección de Datos  A medida que se adoptan nuevas tecnologías, la seguridad y la protección de los datos médicos siguen siendo preocupaciones primordiales. Los sistemas deberán estar diseñados para resistir ataques   cibernéticos   y   garantizar   el   cumplimiento   con   las normativas de privacidad de datos.  Adaptación y Capacitación  La transición a nuevas tecnologías requiere una capacitación adecuada del personal médico y administrativo. La resistencia al cambio y la necesidad de actualización continua en habilidades digitales son desafíos importantes que deben abordarse para una integración exitosa.  Costos y Accesibilidad  Los costos asociados con la implementación de tecnologías avanzadas   pueden   ser   significativos,   especialmente   para pequeñas   prácticas   y   organizaciones   en   regiones   menos desarrolladas. Las estrategias para hacer que estas tecnologías sean accesibles y sostenibles serán cruciales para su adopción generalizada.  Conclusión  El futuro de la gestión de archivos médicos está siendo modelado por   una   serie   de   tendencias   emergentes   que   prometen transformar la atención sanitaria. La evolución continua de las HCE, la integración de IA y Big Data, la adopción de blockchain, y el crecimiento de la telemedicina y las tecnologías inmersivas están configurando un panorama emocionante y dinámico. A medida que estas tecnologías avanzan, es esencial que los profesionales de la salud, los responsables de políticas y las instituciones trabajen juntos para abordar los desafíos y aprovechar al máximo las oportunidades que presentan. El objetivo final es lograr una gestión de archivos médicos que no solo sea eficiente y segura, sino que también mejore la calidad de la atención y el bienestar de los pacientes en un entorno cada vez más digitalizado.  Referencias  1.   Clarke   SE.   In   vitro   assessment   of   human   cytochrome   P450. Xenobiotica. 1998;28(12):1167-202. 2.   Koley AP, Buters JT, Robinson RC, et al. co binding kinetics of human cytochrome p450 3a4: specific interaction of substrates with   kinetically   distinguishable   conformers   .   J   Bio   Chem. 1995;270(10):5014-8. 3.   Kumar S, Davydov DR, Halpert JR. Role of cytochrome B5 in modulating peroxide-supported cyp3a4 activity: evidence for a conformational transition and cytochrome P450 heterogeneity. Drug Metabol Dispos. 2005;33(8):1131-6. 4.   Tokuriki N, Tawfik DS. Protein dynamism and evolvability. Sci. 2009;324(5924):203-7. 5.   Buda K, Miton CM, Fan XC, et al. Molecular determinants of protein evolvability. Trends Biochem Sci. 2023. 6.   Doran A, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E, Chen C, Chen X, Choo E, Cianfrogna J, Cox LM. The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab Dispos 33(1):165–174. 7.   Kalliokoski   A,   Niemi   M.   Impact   of   OATP   transporters   on pharmacokinetics. Br J Pharmacol. 2009:158(3):693–705. 8.   Somogyi A, Stockley C, Keal J, et al. Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol 23(5):545–551. 9.   Bachmakov I, Glaeser H, Fromm MF, et al. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1. Diabetes. 2008;57(6):1463-9. 10.   Dresser   MJ,   Xiao   G,   Leabman   MK,   et   al.   Interactions   of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2). Pharm Res 19(8):1244– 1247',0.14490322610735365,'[\"(hce)\", \"(hoct2).\", \"(ia)\", \"(pq);\", \"(ra)\"]','2025-11-29 16:59:51.978585'),(50,3,'FACULTAD DE   INGENIERIA  Carrera de   Ingeniería de Sistemas Computacionales  “ ANÁLISIS DE LAS TECNOLOGÍAS EMERGENTES EN LA MEDICINA: UNA  REVISIÓN DE LA LITERATURA ”  Trabajo de investigación para optar el grado de:  Bachiller en   Ingeniería de Sistemas Computacion ale s  Autores:  Manuel Calderón Nolorbe  Jean Terrones Guarniz  Asesor:  Dr. Mg. Lic.   Fernando Alex Sierra Liñan  Trujillo   –   Perú  2025\nTítulo de la revisión sistemática  Pág.   2  Calderon Norlobe M; Terrones Guarniz J  R esumen  El presente estudio tiene como objetivo analizar el uso de las tecnologías emergentes  en la medicina en los últimos años. Se empleó la metodología PRISMA para el desarrollo del  trabajo de revisión. Se analizaron 394 artículos, de los cuales se seleccionaro n 53 por su  relevancia. Estos fueron publicados e indexados en bases de datos como Dialnet, Redalyc,  Scopus, PubMed y ProQuest. Las principales áreas de impacto identificadas fueron: mejoras  en diagnósticos y tratamientos, optimización de la atención médic a y avances en la educación  médica. Las tecnologías emergentes más mencionadas incluyen:   Inteligencia Artificial,  Tecnología de Diagnóstico, Telemedicina, Impresión 3 D,   Dispositivos   Portátiles y   Blockchain.  En cuanto a las áreas médicas de aplicación más f recuentes, se destacan: diagnóstico por  imágenes,   oncología,   cirugía,   cuidados intensivos y   urgencias,   rehabilitación y   fisioterapia y  medicina preventiva y   genómica.   China lidera la producción científica sobre el uso de  tecnologías emergentes en medicina,   con 11   de los artículos revisados, seguido por Estados  Unidos con 7, España   con 6,   India,   Italia, Francia (ambos con 3). Los resultados evidencian un  crecimiento significativo en la producción científica sobre el uso de tecnologías emergentes en  medicina,   reflejando el considerable esfuerzo científico desarrollado en los últimos años .  Palabras claves:   tecnologías emergentes, médicas, artificial, inteligencia.\nTítulo de la revisión sistemática  Pág.   3  Calderon Norlobe M; Terrones Guarniz J  A bstract  This study aims to analyze the use of emerging technologies   in medicine in recent years.  The PRISMA methodology was used for the review. A total of 394 articles were analyzed, of  which 53 were selected for their relevance. These were published and indexed in databases  such as Dialnet, Redalyc, Scopus, PubMed, and   ProQuest. The main areas of impact identified  were: improvements in diagnosis and treatment, optimization of medical care, and advances in  medical education. The most frequently mentioned emerging technologies include artificial  intelligence,   diagnostic   te chnology,   telemedicine,   3D   printing,   wearable   devices,   and  blockchain. The most frequent areas of medical application include: diagnostic imaging,  oncology, surgery, intensive care and emergencies, rehabilitation and physical therapy, and  preventive medici ne and genomics. China leads the scientific output on the use of emerging  technologies in medicine, with 11 of the articles reviewed, followed by the United States with  7, Spain with 6, and India, Italy, and France (both with 3). The results show significa nt growth  in scientific output on the use of emerging technologies in medicine, reflecting the considerable  scientific effort developed in recent years.  Keywords:   Separar las palabras clave   traducidas al inglés   con   comas   (,) . Verificar que  se utilice el té rmino en inglés utilizado para cada variable.\nTítulo de la revisión sistemática  Pág.   4  Calderon Norlobe M; Terrones Guarniz J  Capítulo 1.   Introducción  En salud, se entiende por cobertura sanitaria universal que todas las personas tengan  acceso al conjunto de servicios de salud de calidad que necesiten en el momento y el lugar  adecuados y sin sufrir dificultades económicas   [1] . El porcentaje de la población que no está  cubierta p or los servicios de salud esenciales se redujo aproximadamente en un 15% entre 2000  y 2021, pero desde 2015 se cosecharon muy pocos avances. Ello implica que, en 2021, unos  4500 millones de personas no estaban plenamente cubiertas por los servicios de salu d  esenciales   [1] .  Desde la fundación de la Organización Mundial de la Salud (OMS) en 1948, el mundo ha  experimentado innumerables problemas de salud pública que amenazan nuestra salud y  bienestar   [2] . La labor de la OMS sigue firmemente anclada en los principios básicos del  derecho a la salud y al bienestar de todas las personas   [3] . También el Banco Mundial se ha  comprometido a ayudar a los países en desarrollo a lograr la cobertura sanitaria universal (C SU)  a través de sistemas de salud más sólidos y más resilientes y proporcionar servicios sanitarios  de calidad y asequibles para todos, especialmente los más vulnerables   [4]  La pandemia de COVID - 19 ha demostrado que la salud debe ocupar un lugar destacado en la  agenda de la ONU: las enfermedades cruzan fronteras y af ectan a ciudadanos de todo el mundo,  y la ausencia de salud tiene un impacto en muchos de los objetivos de la ONU, como el  desarrollo económico o la reducción de las desigualdades   [5] .  Sin embargo, en los últimos años se han logrado grandes avances en la mejora de la salud de  las personas. 146 de 200 países o zonas ya han alcanzado o están en vías de alcanzar la meta  de los ODS sobre la mortalidad de menores de 5 años. El tratamiento efi caz del VIH ha  reducido las muertes relacionadas con el sida en un 52 % a nivel mundial desde 2010, y al  menos una enfermedad tropical desatendida se ha eliminado en 47 países   [6] .\nTítulo de la revisión sistemática  Pág.   5  Calderon Norlobe M; Terrones Guarniz J  La OMS ha estado evaluando tecnologías innovadoras durante los últimos 10 años, y algunos  de los productos seleccionados están permitiendo solventar ahora problemas sanitarios  prioritarios en entornos   de bajos recursos   [7] .  La Industria 4.0 en el sector sanitario ha evolucionado drásticamente durante el último siglo.  De hecho, evoluciona a diario, con nuevas herramientas y estrategias desarrolladas por médicos  e investigadores   [8] . Los métodos y procedimie ntos que involucran robots médicos en el  continuo de atención, que abarca desde la prevención de enfermedades, la detección, el  diagnóstico, el tratamiento y la atención domiciliaria, se han implementado ampliamente y  también presentan increíbles oportunid ades de desarrollo futuro   [9] .  En el mundo actual, las tecnologías emergentes están revolucionando la gestión sanitaria. La  telemedicina es una de las áreas clave que está experimentando un rápido   crecimiento, pero  también hay muchas otras tecnologías innovadoras que están mejorando la atención médica y  el bienestar de los pacientes   [10] . La telemedicina es una de las tecnologías más importantes  en la gestión sanitaria actual, ya que permite a los pacientes acceder a atención médica de  calidad desde la comodidad de sus hogares.  Entre las ventajas de la telemedicina se encuentran la reduc ción de costos, la mejora del acceso  a especialistas y la posibilidad de monitorear a pacientes crónicos de manera más eficiente   [10] .  La integración de la inteligencia artificial, la realidad virtual y la robótica en el campo de l a  salud está transformando la atención médica de maneras sin precedentes. Estas tecnologías  emergentes no solo están mejorando la precisión y eficiencia de los tratamientos, sino que  también están haciendo que la atención médica sea más personalizada y acc esible   [11] .  El objetivo de esta investigación fue analizar los diferentes artículos donde   se pueden destacar  los alcances relacionados con el uso de las tecnologías emergentes en la medicina.\nTítulo de la revisión sistemática  Pág.   7  Calderon Norlobe M; Terrones Guarniz J  Capítulo 2.   Método  2.1 Tipo de Estudio  Este estudio se basó en una revisión sistemática de la literatura, aplicando el modelo PRISMA  [12]   para la selección, depuración e inclusión final de los artículos.  2.2 Preguntas de Investigación  RQ1: ¿CUAL ES EL IMPACTO DE LAS T ECNOLOGÍAS EMERGENTES EN LA  MEDICINA?  RQ2: ¿CUALES SON LAS PRINCIPALES TECNOLOGÍAS EMERGENTES EN LA  MEDICINA?  RQ3: ¿EN QUÉ ÁREAS DE LA MEDICINA MODERNA SE UTILIZA CON MAYOR  FRECUENCIA LA TECNOLOGÍA EMERGENTE?  2.3 Estrategia de Búsqueda  Para responder a l as preguntas se recopiló información de artículos de las principales  bases de datos Dialnet, Redalyc, Scopus,   Pubmed,   Proquest. Esto permitió identificar 394  artículos científicos. Al buscar toda la   información relacionada   con el tema de investigación se  c onsideraron las siguientes palabras clave: emerging AND medical AND technologies AND  artificial AND intelligence.  Figura 1. Cuadro de inclusión de artículos\nTítulo de la revisión sistemática  Pág.   8  Calderon Norlobe M; Terrones Guarniz J  2.4 Criterios de inclusión y exclusión  Se aplicaron los siguientes criterios de   inclusión y exclusión para el estudio de revisión  sistemática de la literatura  Criterio de Inclusión  I01   Artículos relacionado con las tecnologías  emergentes en la medicina  I02   Artículos   escritos   en   idioma   inglés   y  español  I03   Artículos   publicados entre los años 2020 y  2025  I04   Articulos Disponibles en texto completo  I05   Artículos relacionado con la medicina  Criterio de Exclusión  E01   Artículos   no   relacionados   sobre  tecnologías   emergentes   basadas   en  medicina  E02   Artículos que no   responden las preguntas  de investigación  E03   Artículos que no presenten texto completo  E04   Artículos publicados antes del 2020  E05   Artículos no relacionados a la medicina  Tabla 01: Inclusión y Exclusión\nTítulo de la revisión sistemática  Pág.   9  Calderon Norlobe M; Terrones Guarniz J  Capítulo 3.   Resultados  Se encontraron un total de 394 artículos en las bases de datos relacionadas con el tema  de investigación, desde qué artículos eran duplicados, no cumplían los criterios de inclusión o  no   contribuyen.   Se   descartaron   los   artículos   de   la   investigación.   Tras   r evisarlos,   se  seleccionaron 53 artículos para la revisión sistemática. La Figura 2 muestra la automatización  realizada con base en el método PRISMA   [12] , y muestra la importancia de este método de  forma detallada .  Figura 2. Prisma diagrama\nTítulo de la revisión sistemática  Pág.   10  Calderon Norlobe M; Terrones Guarniz J  Figura 3: Artículos base de datos  Figura 4: Países cantidad de Artículos\nTítulo de la revisión sistemática  Pág.   11  Calderon Norlobe M; Terrones Guarniz J  La bibliometría es un campo estudiado por varios autores debido a la importancia que tiene en  el contexto científico; actualmente se han realizado investigaciones de este tipo en diferentes  campos de estu dio   [13] . La bibliometría facilita evaluar la producción científica y su impacto,  lo que contribuye a reconocer y expandir el conocimiento en un área específica de investigación  [14] .VOSviewer es una herramienta utilizada para construir y visualizar redes bibliométricas,  permitiendo analizar relaciones de cocitación, acoplamiento bibliográfico y vínculos entre  revistas, autores o publ icaciones   [15] . Para llevar a cabo este estudio bibliométrico, se empleó  VOSviewer, el cual facilitó el examen de la coocurrencia de términos clave y la aplicación del  método de reconocimiento integral. A partir de el lo, se generaron representaciones visuales,  mostradas en la Figura 5 .\nTítulo de la revisión sistemática  Pág.   12  Calderon Norlobe M; Terrones Guarniz J  Figura 5: Visualización en red de documentos disponibles basada en análisis bibliométrico.  Grupo 1 (Red): Relacionado con la incorporación de tecnologías   emergentes que constituyen  el   componente   principal   de   nuestra   investigación:   inteligencia   artificial,   aprendizaje  automático y medicina personalizada.  Grupo 2 (Green): Relacionado con los procedimientos médicos, tecnologías educativas y  simulación médica.   Agrupa elementos como procedimientos,   cirugía,   imágenes diagnósticas y  realidad virtual.  Grupo 3 (Blue): Relacionado con la impresión 3D incluye elementos como impresión  tridimensional, estudios controlados y regeneración ósea.  Figure 6 Se muestran en la n ube de palabras obtenidas a partir de análisis de palabras clave de  los artículos sistematizados, utilizando la herramienta R studio para este análisis bibliométrico.  Destacan las siguientes palabras: artificial intelligence, deep learning , human.  La Fig ura 7 presenta el mapa de relaciones con las proporciones de los términos más frecuentes,  según el análisis bibliométrico realizado.  Figura 6: Visualización superpuesta de documentos disponibles en la base de datos Scopus:  nube de palabras\nTítulo de la revisión sistemática  Pág.   13  Calderon Norlobe M; Terrones Guarniz J  Figura 7: Visualización de los documentos basada en análisis bibliométrico.\nTítulo de la revisión sistemática  Pág.   14  Calderon Norlobe M; Terrones Guarniz J  Capítulo   4 .   Discusión  Con   esta   revisión   sistemática   de   la   literatura   se   pretende   responder   las   preguntas   de  investigación propuestas.  4.1 RQ1. ¿Cuál es el impacto de las tecnologías emergentes en la medicina?  Entre los artículos analizados, se identifican impactos como   mejoras en diagnósticos y  tratamientos mediante el uso de inteligencia artificial y análisis de imágenes 3D; optimización  de la atención médica gracias a la reducción de tiempos de respuesta y la facilitación en la toma  de decisiones; y avances en la educa ción médica a través de realidad aumentada, laboratorios  virtuales y simuladores.  Figura 8. Distribución de impactos según tecnologías emergentes en medicina.\nTítulo de la revisión sistemática  Pág.   15  Calderon Norlobe M; Terrones Guarniz J  Según la Tabla 2, se observa que la tecnología más utilizada es la   inteligencia artificial,  destacando por su aporte en la mejora de diagnósticos, tratamientos y optimización de la  atención médica.  Tabla 2. Clasificación de artículos según impactos en tecnologías emergentes  Impacto   Cantidad   Referencias  Mejoras en   diagnósticos y  tratamientos  22   [16] ,   [19] ,   [20] ,   [21] ,   [22] ,   [23] ,   [24] ,   [25] ,  [26] ,   [27] ,   [28] ,   [29] ,   [30] ,   [31] ,   [32] ,   [33] ,  [34] ,   [35] ,   [36] ,   [37] ,   [41] , [44]  Optimización   de   la  atención médica  6   [17] ,   [31] ,   [39] ,   [40] ,   [41] ,   [42]  Avances en la educación  médica  4   [16] ,   [43] ,   [44] ,   [45]  4.2 RQ2. ¿Cuáles son las principales tecnologías emergentes en la medicina?  La Figura 3 muestra los artículos según su aplicación en medicina utilizando tecnologías  emergentes,   destacando:   inteligencia   artificial,   tecnología   de   diagnóstico,   telemedicina ,  impresión 3D, dispositivos portátiles y blockchain.\nTítulo de la revisión sistemática  Pág.   16  Calderon Norlobe M; Terrones Guarniz J  Figura 9. Distribución de los artículos de investigación según tecnologías emergentes aplicadas  en la medicina.  En la Tabla 3 se muestran los artículos que evidencian el uso de   tecnologías emergentes en la  medicina, destacando que la tecnología más utilizada fue la inteligencia artificial.  Tecnologías Emergentes   Cantidad   Referencia  Inteligencia Artificial   11   [23] ,   [24] ,   [25] ,   [28] ,   [40] ,   [44] ,  [46] ,   [47] ,   [51] ,   [59] ,   [68]  Tecnología de Diagnóstico   5   [20] ,   [23] ,   [27] ,   [47] ,   [48]  Telemedicina   3   [19] ,   [43] ,   [45]  Impresión 3D   16   [17] ,   [19] ,   [21] ,   [22] ,   [24] ,   [28] , [  29] ,   [31] ,   [34] ,   [35] ,   [38] ,   [39] ,  [42] ,   [44] ,   [52] ,   [57]\nTítulo de la revisión sistemática  Pág.   17  Calderon Norlobe M; Terrones Guarniz J  Dispositivos Portátiles   4   [26] ,   [38] ,   [53] ,   [54]  Blockchain   5   [18] ,   [65] ,   [66] ,   [67] ,   [68]  4.3 RQ3. ¿En qué áreas de la medicina moderna se utiliza con mayor frecuencia la tecnología  emergente?  La Figura 10 muestra los artículos según su aplicación en diferentes áreas de la medicina  utilizando tecnologías emergentes, destacando:   diagnóstico por imágenes, oncología, cirugía,  cuidados intensivos y urgencias, rehabilitación y fisioterapia, y medicina preventiva y  genómica.  Figura 4. Distribución de los artículos de investigación según áreas de aplicación de las  tecnologías emergentes en la medicina.\nTítulo de la revisión sistemática  Pág.   18  Calderon Norlobe M; Terrones Guarniz J  En la Tabla 4 se muestran los artículos que evidencian el uso de tecnologías emergentes en  diferentes áreas de la medicina, destacando que las más frecuentes son diagnóstico por  imágenes, oncología y cirugía.  Áreas   Cantidad   Referencias  Diagnóstico   por  imágenes  4   [32] ,   [37] ,   [42] ,   [49]  Oncología   9   [30] ,   [36] ,   [46] ,   [55] ,   [56] ,   [57] ,   [58] ,   [59] ,   [62]  Cirugía   6   [20] ,   [34] ,   [35] ,   [58] ,   [60] ,   [61]  Cuidados  intensivos   y  urgencias  2   [57] ,   [64]  Rehabilitación   y  fisioterapia  3   [29] ,   [59] ,   [62]  Medicina  preventiva   y  genómica  7   [30] ,   [31] ,   [50] ,   [37] ,   [55] ,   [63] ,   [64]\nTítulo de la revisión sistemática  Pág.   19  Calderon Norlobe M; Terrones Guarniz J  Capítulo   5. Conclusión  Los estudios revisados coinciden en que las tecnologías emergentes están transformando de  manera significativa la atención médica entre los años 2020 y 2025. Este impacto se refleja en  mejoras en la eficiencia del diagnóstico, el monitoreo remoto de pa cientes, la automatización  de procesos clínicos y la personalización de tratamientos. Además, han fortalecido la capacidad  de respuesta frente a emergencias sanitarias, como la pandemia de COVID - 19, mediante el  desarrollo acelerado de soluciones.  La revisi ón identificó como más relevantes: la inteligencia artificial, el internet de las cosas  médicas, el análisis de big data, la robótica médica y las plataformas digitales de salud. Estas  tecnologías   fueron   consistentemente   mencionadas   en   los   estudios   por   su   potencial   de  transformar procesos médicos, mejorar diagnósticos y permitir una atención continua a  distancia.  Se observó una aplicación destacada en las áreas de diagnóstico por imágenes, cuidados  intensivos, atención remota, gestión de datos clínicos y ap oyo a la toma de decisiones médicas.  Tecnologías como la IA, los dispositivos portátiles y los sistemas de ayuda clínica fueron las  más utilizadas en estos ámbitos.  Los países con mayor producción científica y adopción de estas tecnologías fueron Estados  U nidos, China y España lo que demuestra un interés global en el fortalecimiento de la salud  digital. Los resultados de esta revisión sistemática proporcionan una base sólida para futuras  investigaciones que busquen desarrollar e implementar tecnologías emer gentes en contextos  médicos diversos, promoviendo sistemas de salud más inteligentes, sostenibles y equitativos.  .\nTítulo de la revisión sistemática  Pág.   20  Calderon Norlobe M; Terrones Guarniz J  Referencias  [1]   «Cobertura sanitaria universal (CSU)». Accedido: 11 de mayo de 2025. [En línea].  Disponible   en:   https://www.who.int/es/news - room/fact - sheets/detail/universal - health -  coverage - (u hc)  [2]   U. Nations, «Salud | Naciones Unidas», United Nations. Accedido: 11 de mayo de 2025.  [En línea]. Disponible en: https://www.un.org/es/global - issues/health  [3]   «Acerca de la OMS». Accedido: 11 de mayo de 2025. [En línea]. Disponible en:  https://ww w.who.int/es/about  [4]   «Salud», World Bank. Accedido: 11 de mayo de 2025. [En línea]. Disponible en:  https://www.bancomundial.org/es/topic/health/overview  [5]   «Salud | ONU GINEBRA». Accedido: 11 de mayo de 2025. [En línea]. Disponible en:  https://www.ung eneva.org/es/about/topics/health  [6]   M. Moran, «Salud», Desarrollo Sostenible. Accedido: 11 de mayo de 2025. [En línea].  Disponible en: https://www.un.org/sustainabledevelopment/es/health/  [7]   «La OMS publica un nuevo compendio de tecnologías sanitarias   innovadoras para la  COVID - 19 y otras enfermedades prioritarias». Accedido: 11 de mayo de 2025. [En línea].  Disponible   en:   https://www.who.int/es/news/item/31 - 08 - 2021 - who - releases - new -  compendium - of - innovative - health - technologies - for - covid - 19 - and - other - prior ity -  diseases  [8]   M. M. Ahsan y Z. Siddique, «Industry 4.0 in Healthcare: A systematic review»,  International Journal of Information Management Data Insights , vol. 2, n. o   1, p. 100079,  abr. 2022, doi: 10.1016/j.jjimei.2022.100079.  [9]   A. D. Lallo, R. R. M urphy, A. Krieger, J. Zhu, R. H. Taylor, y H. Su, «Medical Robots  for Infectious Diseases: Lessons and Challenges from the COVID - 19 Pandemic», 14 de  diciembre de 2020,   arXiv : arXiv:2012.07756. doi: 10.48550/arXiv.2012.07756.  [10]   «Tecnologías emergentes e n la gestión sanitaria: telemedicina y más allá | CESTE».  Accedido: 11 de mayo de 2025. [En línea]. Disponible en: https://www.ceste.es/areas - de -  negocio/tecnologia/tecnologias - emergentes - en - la - gestion - sanitaria - telemedicina - y - mas -  alla/  [11]   E. Altamirano,   «Tecnologías Emergentes en la Salud: IA, RV, Robótica», Altamiratec.  Accedido:   11   de   mayo   de   2025.   [En   línea].   Disponible   en:  https://www.blog.altamiratec.com/tecnologias - emergentes - en - la - salud - ia - rv - robotica/\nTítulo de la revisión sistemática  Pág.   21  Calderon Norlobe M; Terrones Guarniz J  [12]   «Declaración PRISMA 2020 una guía actualizada para la publicación de revisiones  sistemáticasThe PRISMA 2020 statement an updated guideline for reporting systematic  reviews.pdf».  [13]   R. J. Borges, «ANÁLISIS BIBLIOMÉTRICO APLICADO A ESTUDIOS SOBRE  CIENCIA , TECNOLOGÍA Y SOCIEDAD», 2020.  [14]   G. K. Muñoz - Estrada, H. E. Chumpitaz Caycho, J. Barja - Ore, N. Valverde - Espinoza, L.  Verde - Vargas, y F. Mayta - Tovalino, «Análisis bibliométrico de la producción científica  mundial sobre el aula invertida en la educación   médica»,   Educación Médica , vol. 23, n. o  5, p. 100758, sep. 2022, doi: 10.1016/j.edumed.2022.100758.  [15]   U. A. Bukar, M. S. Sayeed, S. F. A. Razak, S. Yogarayan, O. A. Amodu, y R. A. R.  Mahmood, «A method for analyzing text using VOSviewer»,   MethodsX , vo l. 11, p.  102339, dic. 2023, doi: 10.1016/j.mex.2023.102339.  [ 16 ] M. Ruiz - Aquino, A. L. Osorio - Llancachagua, J. O. Botiquín - Encarnación, A. V. Diaz -  Lazo, S. Á. Cortez - Orellana, y R. C. Duran - Aquino, «Uso de las tecnologías al servicio  de la investigación por estudiantes de medicina de una universidad privada de Huancay o»,  Rev Cient Sist Inform, vol. 5, n.º 1, p. e864, ene. 2025, doi: 10.51252/rcsi.v5i1.864.  [ 17 ] M. Bernal - García, M. Quemba - Mesa, S. Silva - Ortiz, y B. Pacheco - Olmos, «Laboratorios  Tradicionales versus Nuevas Tecnologías para el Estudio de Anatomía Humana e n  Estudiantes de Medicina: Revisión Sistemática y Meta Análisis», Int. J. Morphol., vol. 40,  n.º 1, pp. 30 - 36, feb. 2022, doi: 10.4067/S0717 - 95022022000100030.  [ 18 ] Universidad Ricardo Palma y C. J. Tinoco Plasencia, «Blockchain technology applied in  medic ine:   a   systematic   review»,   RFMH,   vol.   24,   n.º   1,   may   2024,   doi:  10.25176/RFMH.v24i1.5900.  [ 19 ] A. Zugasti Murillo, «Applicability of innovation in clinical nutrition», Nutr Hosp, 2021,  doi: 10.20960/nh.03559.  [ 20 ] S. Fuentes, M. Berlioz, F. Damián, J. M.   Pradillos, T. Lorenzo, y E. Ardela, «Satisfacción  de pacientes y profesionales con las nuevas tecnologías de imagen tridimensional aplicadas  a   la   medicina»,   Radiología,   vol.   62,   n.º   1,   pp.   46 - 50,   ene.   2020,   doi:  10.1016/j.rx.2019.06.001.  [2 1 ] Y. Zhu y X. Z heng, «Application of a Computerized Decision Support System to Develop  Care Strategies for Elderly Hemodialysis Patients», Journal of Healthcare Engineering, vol.  2021, pp. 1 - 10, jun. 2021, doi: 10.1155/2021/5060484.  [ 22 ] C. M. Andrews, A. B. Henry, I. M.   Soriano, M. K. Southworth, y J. R. Silva, «Registration  Techniques for Clinical Applications of Three - Dimensional Augmented Reality Devices»,  IEEE   J.   Transl.   Eng.   Health   Med.,   vol.   9,   pp.   1 - 14,   2021,   doi:  10.1109/JTEHM.2020.3045642.\nTítulo de la revisión sistemática  Pág.   22  Calderon Norlobe M; Terrones Guarniz J  [ 23 ] M. J. Cervantes   López, J. Cruz Casados, y L. N. Cruz Casados, «Inteligencia artificial en  la gestión de la medicina: avances y desafíos», RVG, vol. 29, n.º 108, pp. 1817 - 1835, sep.  2024, doi: 10.52080/rvgluz.29.108.21.  [ 24 ] P. Jiang, «APPLICATION OF 3D ANALYSIS TECHNOLOG Y OF VISION SYSTEM  IMAGE IN SPORTS MEDICINE», Rev Bras Med Esporte, vol. 27, n.º 4, pp. 381 - 385, ago.  2021, doi: 10.1590/1517 - 8692202127042021_0123.  [ 25 ] J. F. Avila - Tomás, M. A. Mayer - Pujadas, y V. J. Quesada - Varela, «La inteligencia  artificial y sus apli caciones en medicina I: introducción antecedentes a la IA y robótica»,  Atención   Primaria,   vol.   52,   n.º   10,   pp.   778 - 784,   dic.   2020,   doi:  10.1016/j.aprim.2020.04.013.  [ 26 ] V. Pérez Cantó et   al., «Development and Evaluation of a Software Designed by a Nursing  and Technology Team to Assess the Health Status of Adults over 65 Years of Age», Educ.  Enferm., vol. 42, n.º 2, 2024, doi: 10.17533/udea.iee.v42n2e07.  [2 7 ] I. L. D. O. M. Cunha, «Tecnologías asistivas   para pacientes ancianos con demencia:  perspectivas desde la bioética de los cuidados en salud», SCOL, vol. 19, p. e4488, oct. 2023,  doi: 10.18294/sc.2023.4488.  [ 28 ] E. Fornetti et   al., «A novel extrusion - based 3D bioprinting system for skeletal muscle  tis sue engineering», Biofabrication, vol. 15, n.º 2, p. 025009, abr. 2023, doi: 10.1088/1758 -  5090/acb573.  [ 29 ] B. Chen et   al., «Enhancement of critical - sized bone defect regeneration by magnesium  oxide - reinforced 3D scaffold with improved osteogenic and angio genic properties», Journal  of   Materials   Science   &   Technology,   vol.   135,   pp.   186 - 198,   feb.   2023,   doi:  10.1016/j.jmst.2022.06.036.  [ 30 ] K. Dhillon et   al., «Directional control of neurite outgrowth: emerging technologies for  Parkinson’s disease using magnetic   nanoparticles and magnetic field gradients», J. R. Soc.  Interface., vol. 19, n.º 196, p. 20220576, nov. 2022, doi: 10.1098/rsif.2022.0576.  [ 31 ] E. Weaver, S. Uddin, y D. A. Lamprou, «Emerging technologies for combating  pandemics», Expert Review of   Medical Devices, vol. 19, n.º 7, pp. 533 - 538, jul. 2022, doi:  10.1080/17434440.2022.2115355.  [ 32 ] «Retracted: Conservative Treatment and Rehabilitation Training for Rectus Femoris Tear  in Basketball Training Based on Computer Vision», Applied Bionics and   Biomechanics,  vol. 2023, pp. 1 - 1, nov. 2023, doi: 10.1155/2023/9897613.  [ 33 ] C. C. Huttin, «Biotech value chain and technologies for COVID - 19 research areas for  collaboration on cost quality tradeoff with tool companies», THC, vol. 30, n.º 2, pp. 513 -  516,   mar. 2022, doi: 10.3233/THC - 213297.  [ 34 ] X. - R. Li et   al., «3D cryo - printed hierarchical porous scaffolds provide immobilization of  surface - functionalized sleep - inspired small extracellular vesicles: synergistic therapeutic  strategies for vascularized bone   regeneration based on macrophage phenotype modulation  and angiogenesis - osteogenesis coupling», J Nanobiotechnol, vol. 22, n.º 1, p. 764, dic. 2024,  doi: 10.1186/s12951 - 024 - 02977 - 5.\nTítulo de la revisión sistemática  Pág.   23  Calderon Norlobe M; Terrones Guarniz J  [ 35 ] M. Maintz et   al., «Patient - specific implants made of 3D printed bior esorbable polymers at  the point - of - care: material, technology, and scope of surgical application», 3D Print Med,  vol. 10, n.º 1, p. 13, abr. 2024, doi: 10.1186/s41205 - 024 - 00207 - 0.  [ 36 ] C. Thyagarajan, S. Vijay Bhanu, y S. Suthir, «A secure network path of   implantable  medical devices for detecting the vulnerabilities using hybrid DBNF network», Biomedical  Signal   Processing   and   Control,   vol.   92,   p.   105968,   jun.   2024,   doi:  10.1016/j.bspc.2024.105968.  [ 37 ] T. He, J. Chen, X. Xu, G. Fortino, y W. Wang, «Early De tection of Parkinson’s Disease  Using Deep NeuroEnhanceNet With Smartphone Walking Recordings», IEEE Trans.  Neural   Syst.   Rehabil.   Eng.,   vol.   32,   pp.   3603 - 3614,   2024,   doi:  10.1109/TNSRE.2024.3462392.  [ 38 ] A. Angelucci, S. Canali, y A. Aliverti, «Digital tech nologies for step counting: between  promises of reliability and risks of reductionism», Front. Digit. Health, vol. 5, p. 1330189,  dic. 2023, doi: 10.3389/fdgth.2023.1330189.  [ 39 ] M. Byakodi et   al., «Emerging 0D, 1D, 2D, and 3D nanostructures for efficient   point - of -  care biosensing», Biosensors and Bioelectronics: X, vol. 12, p. 100284, dic. 2022, doi:  10.1016/j.biosx.2022.100284.  [ 40 ] G. Alhussain, A. Kelly, E. I. O’Flaherty, D. P. Quinn, y G. T. Flaherty, «Emerging role of  artificial intelligence in global   health care», Health Policy and Technology, vol. 11, n.º 3, p.  100661, sep. 2022, doi: 10.1016/j.hlpt.2022.100661.  [ 41 ] T. M. Klompstra, K. - J. Yoon, y B. - K. Koo, «Evolution of organoid genetics», European  Journal   of   Cell   Biology,   vol.   104,   n.º   2,   p.   151481 ,   jun.   2025,   doi:  10.1016/j.ejcb.2025.151481.  [ 4 2]   X.   Rodríguez - Maciñeiras   et   al.,   «Advancing   medication   compounding:   Use   of   a  pharmaceutical 3D printer to auto - fill minoxidil capsules for dispensing to patients in a  community pharmacy», International Jour nal of Pharmaceutics, vol. 671, p. 125251, feb.  2025, doi: 10.1016/j.ijpharm.2025.125251.  [ 4 3] Z. Fu, Y. Wu, L. Xu, F. Cai, R. Liu, y Z. Jiang, «Optimizing cost - effectiveness in remote  objective structured clinical examinations through targeted double scor ing methodologies»,  Medical   Education   Online,   vol.   30,   n.º   1,   p.   2467477,   dic.   2025,   doi:  10.1080/10872981.2025.2467477.  [4 4 ] L. Dipietro et   al., «Integrating Big Data, Artificial Intelligence, and motion analysis for  emerging precision medicine applicatio ns in Parkinson’s Disease», J Big Data, vol. 11, n.º  1, p. 155, oct. 2024, doi: 10.1186/s40537 - 024 - 01023 - 3.  [ 4 5] A. R. Latorre - Rodríguez, R. H. Shah, S. Munir, y S. K. Mittal, «Adoption of telemedicine  for obesity treatment during the COVID - 19 pandemic ac hieved comparable outcomes to in -  person   visits»,   Obesity   Pillars,   vol.   12,   p.   100131,   dic.   2024,   doi:  10.1016/j.obpill.2024.100131.\nTítulo de la revisión sistemática  Pág.   24  Calderon Norlobe M; Terrones Guarniz J  [ 4 6] T. Preijers, A. E. Muller, A. Abdulla, B. C. M. De Winter, B. C. P. Koch, y S. D. T. Sassen,  «Dose Individualisation o f Antimicrobials from a Pharmacometric Standpoint: The Current  Landscape», Drugs, vol. 84, n.º 10, pp. 1167 - 1178, oct. 2024, doi: 10.1007/s40265 - 024 -  02084 - 7.  [ 4 7] S. Freeman et   al., «Health consumers’ ethical concerns towards artificial intelligence in  Aus tralian emergency departments», Emerg Medicine Australasia, vol. 36, n.º 5, pp. 768 -  776, oct. 2024, doi: 10.1111/1742 - 6723.14449.  [ 4 8] M. Lippmann, M. Hitzemann, J. Winkelholz, D. Bailey, y S. Zimmermann, «A modular,  isolated high - voltage switch for applic ation in ion mobility spectrometry», HardwareX, vol.  19, p. e00574, sep. 2024, doi: 10.1016/j.ohx.2024.e00574.  [ 4 9] S. Leng et   al., «Standardizing technical parameters and terms for abdominopelvic photon -  counting CT: laying the groundwork for innovation an d evidence sharing», Abdom Radiol,  vol. 49, n.º 9, pp. 3261 - 3273, may 2024, doi: 10.1007/s00261 - 024 - 04342 - 4.  [ 5 0] D. Kleftogiannis et   al., «Automated cell type annotation and exploration of single - cell  signaling dynamics using mass cytometry»,   iScience, vol. 27, n.º 7, p. 110261, jul. 2024,  doi: 10.1016/j.isci.2024.110261.  [ 5 1] C. A. Sparks et   al., «ChatGPT Is Moderately Accurate in Providing a General Overview  of   Orthopaedic   Conditions»,   JBJS   Open   Access,   vol.   9,   n.º   2,   abr.   2024,   doi:  10.2106/ JBJS.OA.23.00129.  [ 5 2] Dr. I. Prusty, «Exploring New Avenues In Drug Discovery And Development: Insight Into  Pharmacokinetics And Pharmacodynamics», JAB, jun. 2024, doi: 10.53555/jab.v10.006.  [ 5 3] S. Qian, T. Zhang, y S. Hu, «Research on intelligent routin g with VAE - GAN in the internet  of   body»,   PLoS   ONE,   vol.   20,   n.º   2,   p.   e0317698,   feb.   2025,   doi:  10.1371/journal.pone.0317698.  [ 5 4] X. Sun, J. Zhu, M. Lu, Z. Zhang, C. Li, y R. Zhan, «Robot - assisted puncture versus  conservative treatment for severe   brainstem hemorrhage: clinical outcomes comparison  with experience of 138 cases in a single medical center», World J Emerg Surg, vol. 20, n.º  1, p. 15, feb. 2025, doi: 10.1186/s13017 - 025 - 00592 - 9.  [ 5 5] T. Alsahfi, A. Badshah, O. I. Aboulola, y A. Daud, «Opt imizing healthcare big data  performance through regional computing», Sci Rep, vol. 15, n.º 1, p. 3129, ene. 2025, doi:  10.1038/s41598 - 025 - 87515 - 5.  [ 56 ] J. Xue, Z. Li, y S. Zhang, «Multi - resource constrained elective surgical scheduling with  Nash equilibriu m toward smart hospitals», Sci Rep, vol. 15, n.º 1, p. 3946, ene. 2025, doi:  10.1038/s41598 - 025 - 87867 - y.  [ 57 ] Á. García - Granero et   al., «3D - reconstruction printed models and virtual reality improve  teaching in oncological colorectal surgery», Tech Coloproc tol, vol. 29, n.º 1, p. 24, dic.  2025, doi: 10.1007/s10151 - 024 - 03074 - 3.  [ 58 ] D. I. Szabó, A. Vereczkei, y A. Papp, «From gaming to surgery: the influence of digital  natives on robotic skills development», J Robotic Surg, vol. 19, n.º 1, p. 12, nov. 2024,   doi:\nTítulo de la revisión sistemática  Pág.   25  Calderon Norlobe M; Terrones Guarniz J  10.1007/s11701 - 024 - 02178 - 0.  [ 59 ] B. B. Ozmen y P. Mathur, «Evidence - based artificial intelligence: Implementing retrieval -  augmented generation models to enhance clinical decision support in plastic surgery»,  Journal of Plastic, Reconstructive & Aesth etic Surgery, vol. 104, pp. 414 - 416, may 2025,  doi: 10.1016/j.bjps.2025.03.053.  [ 60 ] T. Fan, L. Shi, X. Peng, M. Wu, L. Yu, y B. Zhu, «High Simulation Training System for  Spinal Full‐Endoscopic Surgery, Based on the Combination of VR / AR and Magneto‐  Optic al Navigation Technology», Orthopaedic Surgery, vol. 17, n.º 4, pp. 1243 - 1254, abr.  2025, doi: 10.1111/os.70008.  [6 1 ] S. S. Kim et   al., «The Society of Thoracic Surgeons Expert Consensus Statements on a  Framework   for   a   Standardized   National   Robotic   Curricu lum   for   Thoracic   Surgery  Trainees», The Annals of Thoracic Surgery, vol. 119, n.º 4, pp. 719 - 732, abr. 2025, doi:  10.1016/j.athoracsur.2024.12.003.  [ 62 ] Y. J. Wang, W. C. Choo, K. Y. Ng, R. Bi, y P. W. Wang, «Evolution of AI enabled  healthcare systems usin g textual data with a pretrained BERT deep learning model», Sci  Rep, vol. 15, n.º 1, p. 7540, mar. 2025, doi: 10.1038/s41598 - 025 - 91622 - 8.  [ 63 ] U. Khalid, L. Chen, A. A. Khan, B. Chen, F. Mehmood, y M. Yasir, «A smart facial acne  disease monitoring for auto mate severity assessment using AI - enabled cloud - based internet  of things», Discov Computing, vol. 28, n.º 1, p. 12, feb. 2025, doi: 10.1007/s10791 - 025 -  09503 - 7.  [ 64 ] M. Pulcinelli, I. Condò, V. Lavorgna, C. Massaroni, E. Schena, y D. Lo Presti,  «Combining f iber Bragg grating sensors and artificial intelligence in medicine», APL  Photonics, vol. 10, n.º 3, p. 030901, mar. 2025, doi: 10.1063/5.0251132.  [ 65 ] R. Pava, J. N. Perez Castillo, y L. F. Niño Vasquez, «Perspectiva para el uso del modelo  P6 de atención e n salud bajo un escenario soportado en IoT y blockchain», Tecnura, vol. 25,  n.º 67, pp. 112 - 130, ene. 2021, doi: 10.14483/22487638.16159.  [ 66 ] C. R. Araujo - Inastrilla y A. A. Vitón - Castillo, «Blockchain in health sciences: Research  trends in Scopus», Ibero american Journal of Science Measurement and Communication,  vol. 3, n.º 2, ago. 2023, doi: 10.47909/ijsmc.56.  [ 67 ] «El Futuro de la Gestión de Archivos Médicos: Tendencias y PerspectivasThe Future of  Medical Records Management: Trends and Perspectives».  [ 68 ] H. E. D. Villarruel, «Impacto de la inteligencia artificial en la monitorización de pacientes  en enfermería Impact of artificial intelligence on patient monitoring in nursing Impact of  artificial intelligence on patient monitoring in nursing», vol. 8, n. º 9, 2023.',0.14494766567443623,'[\"%\", \"&\", \"(,)\", \"(ambos\", \"(blue):\"]','2025-11-29 17:00:13.952145'),(51,3,'Correspondence and Communications  Evidence - based artificial intelligence: Implementing retrieval - augmented generation models to enhance clinical decision support in plastic surgery  Berk B. Ozmen   a , ⁎ , Piyush Mathur   b , c  a   Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA  b   Department of General Anesthesiology, Cleveland Clinic, Cleveland, OH, USA  c   BrainXAI ReSearch, BrainX LLC, Cleveland, OH, USA  Received 18 March 2025; Accepted 26 March 2025  KEYWORDS  Artificial intelligence; Retrieval - augmented generation models; Large language models; Clinical decision support  Summary   The rapid advancement of large language models   ( LLMs )   has generated significant en -  thusiasm within healthcare, especially in supporting clinical decision - making and patient manage -  ment.   However,   inherent   limitations   including   hallucinations,   outdated   clinical   context,   and unreliable references pose serious concerns for their clinical utility. Retrieval - Augmented Generation  ( RAG )   models address these limitations by integrating validated, curated medical literature directly into AI workflows, significantly enhancing the accuracy, relevance, and transparency of generated outputs. This viewpoint discusses how RAG frameworks can specifically benefit plastic and re -  constructive surgery by providing contextually accurate, evidence - based, and clinically grounded support for decision - making. Potential clinical applications include clinical decision support, efficient evidence synthesis, customizable patient education, informed consent materials, multilingual cap -  abilities, and structured surgical documentation. By querying specialized databases that incorporate contemporary guidelines and literature, RAG models can markedly reduce inaccuracies and increase the reliability of AI - generated responses. However, the implementation of RAG technology demands rigorous database curation, regular updating with guidelines from surgical societies, and ongoing validation to maintain clinical relevance. Addressing challenges related to data privacy, governance, ethical considerations, and user training remains critical for successful clinical adoption. In conclu -  sion, RAG models represent a significant advancement in overcoming traditional LLM limitations, promoting transparency and clinical accuracy with great potential for plastic surgery. Plastic surgeons and researchers are encouraged to explore and integrate these innovative generative AI frameworks to enhance patient care, surgical outcomes, communication, documentation quality, and education.  Journal of Plastic, Reconstructive & Aesthetic Surgery 104   ( 2025 )   414–416  https://doi.org/10.1016/j.bjps.2025.03.053  1748 - 6815/© 2025 The Author ( s ) . Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons. This is an open access article under the CC BY - NC - ND license   ( http://creativecommons.org/licenses/by - nc - nd/4.0/ ) .  ]] ]] ]]]]]]  ⁎   Correspondence   to:   9500   Euclid   Avenue,   A60,   Cleveland, OH, USA.  E - mail address:   ozmenb@ccf.org   ( B.B. Ozmen ) .\n© 2025 The Author ( s ) . Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons. This is an open access article under the CC BY - NC - ND license  ( http://creativecommons.org/licenses/by - nc - nd/4.0/ ) .  The rapid advancement and widespread adoption of large language models   ( LLMs ) , such as ChatGPT   ( OpenAI, CA, USA ) ,   has   triggered   considerable   enthusiasm   within healthcare.   These   models   demonstrate   remarkable   cap -  abilities in language comprehension and generation, of -  fering   potential   to   support   clinical   decision - making, streamline documentation, and contribute significantly to patient management. However, inherent limitations, such as their tendency toward hallucinations, lack of updated clinical context, and inability to reliably provide traceable references, raise substantial safety and accuracy concerns restricting their clinical utility.  Retrieval - Augmented Generation   ( RAG )   frameworks ad -  dress these limitations by integrating external, validated medical   literature   directly   into   model   workflows.   This viewpoint   highlights   the   potential   RAG   frameworks   to overcome critical limitations of standard LLMs. We aim to inform of emergent RAG methodologies, emphasizing their potential   to   deliver   contextually   accurate,   clinically grounded, and evidence - based outputs for integration into surgical decision - making workflows.  Limitations of current LLM approaches in clinical environments  While   powerful   in   natural   language   processing,   con -  temporary LLMs synthesized primarily from publicly avail -  able   and   often   outdated   internet   data   display   limited ability to reference and leverage specialized, continuously updated medical literature. Hallucinations   ( the synthesis of plausible yet inaccurate or nonexistent data )   and difficulty maintaining consistent, verifiable accuracy are particularly concerning for medical and surgical practice, which man -  dates   precision   and   traceability   in   clinical   decision -  making. 1   For example, an LLM may incorrectly describe microsurgical anastomosis techniques due to hallucinations, potentially causing surgical errors.  In plastic and reconstructive surgery, clinical decisions often rely on accurate interpretation of nuanced information, in -  corporating published evidence, best - practice guidelines, and patient - specific clinical contexts. Trust in technology by clin -  icians critically depends on their ability to verify information sources and contexts reliably. Without direct grounding in cu -  rated medical literature and evidence bases, typical LLMs may provide unsatisfactory support in clinical practice.  Retrieval - augmented generation   ( RAG )   models: A potential solution  RAG models integrate retrieval mechanisms that query a curated database. This methodology represents a promising direction in enhancing clinical utility of LLM - driven AI by integrating   reliable   external   knowledge sources   directly into   their   generation   pipeline.   A   retrieval   mechanism queries a curated database of validated medical literature, clinical guidelines, institutional protocols, and guidelines specific to clinical contexts. Relevant excerpts or docu -  ments retrieved from this curated corpus serve as author -  itative context input for an LLM, enabling production of responses grounded firmly in validated clinical evidence.  Recent developments in AI research demonstrate that RAG models improve response accuracy, decrease halluci -  nations, and provide transparent reasoning paths through explicit citations of accurate sources. 2   Given the need for rigorous documentable evidence in patient care decisions, integrating RAG models into clinical workflows offers a critical advantage over traditional LLMs. It enables im -  proved clinical robustness and compliance, adds transpar -  ency   to   the   generated   medical   advice,   and   facilitates efficient clinical communication and education.  Potential clinical applications in plastic and reconstructive surgery  RAG - based models hold significant potential for effective clinical applications within plastic surgery. One area of certain benefit could include evidence synthesis and lit -  erature summarization. Plastic surgeons routinely require quick access to recently updated guidelines and new sur -  gical procedures. 3   RAG models can efficiently identify and succinctly synthesize updated surgical guidelines or sum -  marize   contemporary   literature   to   facilitate   evidence -  based clinical decisions.  In the area of patient education and informed consent, well - grounded information generation supports clear com -  munication   and   informed   decision - making. 4   RAG   models offer particular advantages for customizing information ac -  cessibility. Utilizing RAG models to produce patient - specific educational materials derived from validated guidelines and recent evidence can enhance patient comprehension, sa -  tisfaction, and informed consent processes. These systems can be configured to adjust readability levels based on health literacy assessments, ensuring information is both evidence -  based and comprehensible to diverse patient populations. By incorporating readability metrics such as Flesch - Kincaid or The   Simple   Measure   of   Gobbledygook   ( SMOG )   indices   as parameters during generation, clinicians could specify ap -  propriate complexity levels tailored to individual patient needs without sacrificing clinical accuracy.  RAG frameworks are well - positioned to support multi -  lingual   output   by   integrating   retrieval   components   that access multilingual medical corpora alongside generation components leveraging multilingual LLMs. This capability would enable plastic surgeons to provide evidence - based  Journal of Plastic, Reconstructive & Aesthetic Surgery 104   ( 2025 )   414–416  415\npatient information across language barriers while main -  taining consistency with source clinical evidence, particu -  larly valuable in diverse practice settings or international surgical missions. These capabilities represent important directions for future implementation research as RAG sys -  tems become more integrated into clinical workflows.  Additionally, surgical documentation and administrative support is another domain where these systems could be of benefit.   Hospitals   systems   require   accurate,   traceable documentation for patient records. 5   RAG models can gen -  erate   structured,   context - specific   summaries   linked   ex -  plicitly   to   standardized   clinical   references,   improving documentation quality, accuracy, and compliance.  Challenges and implementation considerations  Despite promising advantages, adopting RAG technologies into clinical practice requires careful consideration. Rigorous data -  base curation, regular updating with guidelines, surgical litera -  ture, and surgical society recommendations   ( e.g., ASPS, EURAPS, BAPRAS ) , and continuous validation for clinically meaningful use cases are essential. Transparent and verifiable traceability to knowledge corpus sources must be consistently ensured to instill trust and clinical acceptability. Additionally, data privacy, gov -  ernance oversight, ethical considerations, and user training re -  main essential aspects in clinical implementation.  Conclusion  While conventional LLMs encounter fundamental limitations regarding clinical   accuracy, relevance, and transparency   in clinical practice, RAG models emerge as promising enhance -  ments addressing these critical concerns. By anchoring gen -  erative   capabilities   in   curated   domain - specific   medical literature, clinical guidelines, and authoritative evidence bases, RAG   model   approaches   foster   transparency,   accuracy,   effi -  ciency, and increased integration potential in clinical workflows. Academic plastic surgeons and researchers are therefore en -  couraged to actively explore, evaluate, and implement these innovative generative AI frameworks, realizing their consider -  able potential to enhance patient care, education, commu -  nication, and clinical documentation in our specialty.  Ethical approval  Not required.  Disclosure/Conflicts of interest  The authors have no conflicts of interests to declare in re -  lation to this article\'s content.  Funding  None.  References  1.   Rao A, Pang M, Kim J, et al. Assessing the utility of ChatGPT throughout the entire clinical workflow: Development and us -  ability study.   J Med Internet Res   2023; 25 :e48659 . https://doi. org/10.2196/48659 .  2.   Woo JJ, Yang AJ, Olsen RJ, et al. Custom large language models improve accuracy: Comparing retrieval augmented generation and artificial intelligence agents to noncustom models for evi -  dence - based   medicine.   Arthroscopy   2025; 41 :565 – 573.e6 . https://doi.org/10.1016/j.arthro.2024.10.042 .  3.   Bartlett EK, O ’ Donoghue C, Boland G, et al. Society of Surgical Oncology Consensus Statement: Assessing the evidence for and utility of gene expression profiling of primary cutaneous mela -  noma.   Ann Surg Oncol   2025; 32 ( 3 ) :1429 – 42 . https://doi.org/10. 1245/s10434 - 024 - 16379 - 2 .  4.   Langbroek GB, Ronde EM, Lapid O, et al. Healthcare profes -  sionals ’   views on shared decision - making in plastic surgery in the Netherlands.   J   Plast   Reconstr   Aesthetic   Surg   JPRAS  2023; 85 :463 – 72 . https://doi.org/10.1016/j.bjps.2023.07.041 .  5.   Chen AJ, Baxter SL, Gali HE, et al. Evaluation of electronic health   record   implementation   in   an   academic   oculoplastics practice.   Ophthal   Plast   Reconstr   Surg   2020; 36 ( 3 ) :277 – 83 . https://doi.org/10.1097/IOP.0000000000001531 .  B.B. Ozmen and P. Mathur  416',0.21563139109538018,'[\"&\", \"(\", \")\", \",\", \"-\"]','2025-11-29 17:00:29.532804'),(52,3,'Vol.:(0123456789) Journal of Robotic Surgery   (2025) 19:12 https://doi.org/10.1007/s11701-024-02178-0  RESEARCH  From gaming to surgery: the influence of digital natives on robotic skills development  Dominik Imre Szabó 1   · András Vereczkei 1   · András Papp 1  Received: 4 October 2024 / Accepted: 23 November 2024 © The Author(s) 2024  Abstract  Our study investigates the potential correlation between generational differences, like age and previous experience with digital innovations, such as video games and smartphones, and the performance on the Da Vinci Skills Simulator, the cornerstone of robotic surgery training. Thirty participants were involved from three age groups: Generation Alpha, Generation Z, and Generation X. None had prior robotic surgical experience. Participants performed the Wrist Articulation 1 task on the Da Vinci Skills Simulator after two practice rounds. Analysis of performance metrics and statistical tests were conducted to assess the differences between groups. Additionally, participants had completed a survey on their habits related to video gaming, smartphone, and computer usage. A trend was observed where performance declined with age, meaning that Gen- eration Alpha performed the most successfully compared to the other generations, although the difference was not statisti- cally significant ( p   =   0.51). However, significant differences were found in Glass Movement (GM) by Generation Z showing superior precision, making less errors ( p   =   0.019). The study found no correlation between simulator performance and early or frequent exposure to smartphones or video games. Interestingly, frequent two-thumb typing on smartphones correlated with better performance in the GM metric ( p   =   0.006). Generation Z demonstrated greater precision in handling the simula- tor, reflecting that robotic surgery training might be best to be started at the beginning of residency programs. Young doctors using two-thumb typing develop robotic surgery skills faster. Further studies are needed to determine whether this quicker learning would also lead to better skills later on.  Keywords   Da Vinci Surgical System · Robotic surgery · Training · Video game usage · Age  Introduction  The last decades have seen a significant ascent in minimally invasive surgery with the spread of laparoscopic surgery (LS) and more recently robot-assisted surgery (RAS) [1]. Robotic surgical systems provide features like 10x mag- nification, tremor filter, a three-dimensional view, and a more ergonomic stance for the operating surgeon, allow- ing a more precise dissection, a decrease in blood loss, and faster recovery [2–4]. The Da Vinci Skills Simulator is a computer-based virtual-reality system that grants to prac- tice both basic maneuvers and more advanced techniques for robotic surgeon aspirants. Even simulated surgeries are available to be performed. It was found to be the most cited simulator when looking at published robotic surgery cur- ricula [5]. Compared to other virtual-reality robotic simula- tors, the Da Vinci Skills Simulator was found to have the highest score in face and content validity [6]. Furthermore, relationship has been investigated between simulator and clinical robotic performance, meaning that skills seem to be transferable [7, 8]. Several studies aimed to find non-surgical factors associ- ated with a more successful result on the simulator. Widely researched determinants are video gaming history, IQ, and dexterity [9]. Prior laparoscopic experience has been sug- gested to have the strongest impact [10]. With the under- standing of these variants, the training of robotic surgeons may undergo a revision, as studies have suggested that simu- lators are essential in training protocols. Additionally, distin- guishing between surgeon aspirants, the revealing of innate abilities may become more straightforward [11]. A study with limited participants previously proposed that age may be such a factor, as the younger generations are born into an  *   Dominik Imre Szabó  szabodomi02@gmail.com 1   Department of Surgery, Clinical Centre, Medical School, University of Pécs, Pécs, Hungary\nJournal of Robotic Surgery   (2025) 19:12 12   Page 2 of 7  environment where digital innovations are used in everyday life [12]. Hand–eye coordination, dexterity, and conversion of two-dimensional screen image into three-dimensional perception are requirements for both video gaming, smart- phone use, and also performing minimally invasive surgery. Therefore, acquiring these skills at a young age may lead to a quicker and more precise use of the surgical system. Our goal was to determine whether the age of naïve individuals, and video gaming or smartphone experience would influence the adaption to the controls of the Da Vinci Surgical System.  Methods  Participants  Thirty individuals were evenly divided into three groups by age, such as Children (age: 13–15 years), Young adults (age: 23–27 years), and Adults (age: 45–68 years). The selected age groups represented Generation Alpha, Generation Z, and Generation X.  Simulator testing  After instructing the participant on finger positioning, the use of the clutch switch, and other controls, all subjects were asked to perform on the Da Vinci Skills Simulator. The selected exercise is considered as one of the simplest, since all of the subjects were unprofessional in the field of robotic surgery and children were also included, the task was appointed accordingly. Namely, Wrist Articulation 1 only requires basic hand–eye coordination, depth perception, and dexterity. The exercise expects the controller to move the instruments through a hole on a glass ball to reach the target inside. This must be completed ten times, involving both the left hand and right hand, with the hole positioned in various locations. The participants had two rounds of practice, before the results of the third attempt were docu- mented. The scoring system had been briefly explained and a tutorial of the required task had been demonstrated. The Da Vinci Skills Simulator provides a detailed summary fol- lowing each attempt, containing: Overall Score (OS), Total Time (TT), Economy of Motion (EM), Penalty (P), Glass Movement (GM), Instrument Collision (IC), Success Rate (SR), and Number of Times Instrument out of View (TOV) (Table 1). These variables were the basis of the statistical analysis; however, the latter three metrics were excluded, since all individuals performed the best score.  Questionnaire  In addition to completing an exercise on the Da Vinci Skills Simulator, a survey was conducted including 18 questions. First, data were collected about age, occupation, education, and hand dominance. Then, multiple questions meant to explore the subjects’ habits regarding video gaming experi- ence, computer, and smartphone usage. Age at first meeting these IT devices and current frequency of utilization were in focus.  Data analysis  The purpose was to statistically prove a significant differ- ence between the age groups’ results, and also between the performances of other groups based on the answers given on the survey. Consequently, ANOVA was carried out, since we had three or more groups to compare. Therefore, assumption checks had had to be made. For inspecting the normality of the variables, Shapiro–Wilk test had been used and Levene’s test had been used for variance analysis. When normality examinations failed, Kruskal–Wallis non-parametric test was applied. Welch’s test was used in case the variances were not homogenous. Data analysis was done using Jamovi  Table   1   Descriptions of performance metrics provided by Skills Simulator after completing Wrist Articulation 1 Metric   Description Overall Score (OS)   A value given from 0 to 100 based on Total Time, Economy of Motion, and the penalties calculated by the algorithm of Intuitive Total Time (TT) (s)   The time spent completing the task, the lower is better Economy of Motion (EM) (cm)   The distance that the instruments traveled during the task. The lower is better, meaning no unnecessary movement was made Penalty (P)   A summed and rounded value of the penalty metrics: Glass Movement, Instrument Collision, Success Rate, Number of Times Instrument is out of View Glass Movement (GM) (cm)   While reaching for the target, the movement of the outer glass sphere. The lower is better Instrument Collision (IC) (ct.)   Number of times the instruments were collided during the task. The lower score is better Success rate (SR) (%)   Representing how many of the ten positions were successfully completed. The higher is better Number of Times Instruments are out of View (TOV) (ct.) Representing how many times the instruments were moved out of view. The lower is better\nJournal of Robotic Surgery   (2025) 19:12   Page 3 of 7   12  (Sydney, Australia) for Windows, version 2.5.6. Statistical significance was set at   p   values <0.05.  Results  Demographics  Overall, 30 participants were enrolled in the study, 10 chil- dren, 10 young adults, and 10 adults. All of them completed both the questionnaire and the task on the simulator. One subject was excluded due to lack of sufficient cooperation, leaving the Generation Alpha group with nine participants. The Children group included males only; all of the sub- jects were aged 13, 90.0% was right-handed. Mean age of the young adult participants was 24 ± 1.3; the majority were female (70.0–30.0%). In contrast to the youngsters, all of them were right-handed. In the Adult group, 50.5 ± 7.1 was the mean age, only right-handed participants were included and a female dominance was seen among the subjects (60.0%) (Table 2). All 30 participants came from the middle class, as the participants were mostly university graduates or currently studying in higher education institutes or members of a white-collar family.  Outcomes of questionnaire and simulator performance  Analysis of the survey revealed that younger generations got in contact with technical innovations, video games, and smartphones, at a much younger age. From the Generation Alpha group, eight out of nine (88.8%) children first used smartphones and first played video games before the age of 10. When asked about current usage, six out of nine (66.6%) responded that they play video games very often/often. In addition, seven (77.7%) children replied that they had expe- rienced virtual reality a few times or several times. Com- pared to this, responses on the same questions from Gen- eration Z revealed that only five out of ten people (50.0%) first played video games before the age of 10. These par- ticipants acquired smartphones only between the age of 10 and 15. Presently, three out of ten (30%) young adults play video games often. Looking at Generation X, nine out of ten (90.0%) said that they first used smartphones after the age of 20; furthermore, six out of those nine people answered that they were even older than 30. None of the participants in this group played video games before the age of 10. Four out of ten (40.0%) subjects said that they tried video games between the age of 10 and 15; equivalent number said that they first played those only after the age of 20, making the curve bimodal. When asked about typing with two thumbs on smart- phones, 15 of the 29 (51.7%) participants said that it was the method they use exclusively. Results on the Da Vinci Skills Simulator revealed a trend. Overall Scores (OS) gradually declined as the age increased; means of the groups were 91.7 ± 9.9, 89.8 ± 7.6, and 87.7 ± 9.8. The difference is conspicuous, however, not statistically significant ( p   = 0.51). Total time (TT) followed a similar tendency, children’s mean was 69.7 ± 12.1, young adults’ 76.6 ± 16.1, and the mean of adults’ was 81.6 ± 21.9. Glass Movement (GM) showed interesting results, Generation Z performed a surprisingly low mean (1.47 ± 1.5) compared to the others (Children: 4.05 ± 3.8, Adults: 5.2 ± 3.6), mak- ing this difference significant ( p   = 0.019) (Table 3, Fig. 1). Regarding genders, there was no difference between the results of males and females; both completed the task with the same outcome (OS   p   = 0.76). A link was not established between a successful score and how early smartphones ( p  = 0.57) and video games ( p   = 0.33) were first used and played. Our study was not able to confirm the association between performance on the Da Vinci Skills Simulator and the frequency of playing video games ( p   = 0.175). However, our results suggest that Glass Movement (GM) depends on how often and quickly both of the thumbs are used for typ- ing on smartphones, those who never or very rarely do it performed significantly poorer in this metric ( p   = 0.006) (Table 4 Fig. 2).  Table   2   Demographics of participants   Age group Children (Generation Alpha)   Young adults (Generation Z)   Adults (Generation X) N   9   10   10 Sex Female   0 (0.0%)   7 (70.0%)   6 (60.0%) Male   9 (100.0%)   3 (30.0%)   4 (40.0%) Mean of age   13   ±   0.0   24   ±   1.3   50.5   ±   7.1 Handedness   8 (88.9%) right-handed   10 (100.0%) right-handed   10 (100.0%) right-handed\nJournal of Robotic Surgery   (2025) 19:12 12   Page 4 of 7  Discussion  Twenty-three years after the transatlantic robot-assisted telesurgery executed by Jacques Marescaux, the Da Vinci Surgical System has spread all over the globe with more than 9000 units installed [13]. Between 2012 and 2018, an increase of 13.3% was documented in the use of robotic surgery [1]. In 2023, the Da Vinci Surgical System was used in more than 2.2 million procedures, making the total count over 14 million [14]. Along with the benefits provided to the surgeon while operating, such as tremor filter, three-dimensional view, and more degrees of free- dom, patient advantages have been circumscribed as well. Studies were published from various fields of surgery with the conclusion that compared to laparoscopic surgery, the risk for open conversion is lower besides a shorter length of hospitalization. Additional improvements were noticed  Table   3   Comparison of results achieved by age groups Overall Score, Total Time (s), and Economy of Motion (cm) were similar among Children, Young adults, and Adults. Glass Movement (cm) was significantly less in case of Young adults (* p   =   0,019) Age group   Overall score (OS)   Total time (TT)   Economy of motion (EM) Glass movement (GM) N   Adults   10   10   10   10 Young adults   10   10   10   10 Children   9   9   9   9 Mean   Adults   87.700   81.660   162.360   5.210 Young adults   89.800   76.630   177.120   1.470 * Children   91.778   69.700   173.178   4.056 Standard deviation Adults   9.787   21.904   39.456   3.661 Young adults   7.671   16.186   22.431   1.506 Children   9.909   12.107   24.509   3.804  a   b  c   d *  Fig.   1   Comparison of results achieved by age groups. Overall Score   a , Total Time (s)   b , and Economy of Motion (cm)   c   were similar among Children, Young adults, and Adults. Glass Movement (cm)   d   was significantly less in case of Young adults (* p   =   0,019)\nJournal of Robotic Surgery   (2025) 19:12   Page 5 of 7   12  in the rate of intraoperative complications and blood loss with the downside of longer operation time and higher costs [15–18]. These findings propose that robot-assisted surgery has a place among gold standard procedures in the future. Many publications and reviews have concluded that robot-assisted surgery should be regarded as an alter- native to laparoscopic surgery [19, 20]. Even when stud- ies did not find significant advantages from the aspect of the patients and stated that the outcome is equivalent, improvements in demands from the surgeon were still pre- sent [3, 4]. In spite of the prominent conquest of robotic surgery, many unknowns are still present; a worldwide elaborate evidence-based training protocol is lacking. A previous study found that 60% of general surgery resi- dents participate in their first robotic case without prior education or training; however, programs had been intro- duced with the hopes of standardization [21, 22]. A review examining 39 robotic surgery curricula revealed severe heterogeneity and deficiencies. It suggested the use of educational frameworks to address these issues [23]. In 2024, a protocol was developed to achieve a pan-European consensus on the essential components of a common train- ing program for GI robotic surgery [24]. One of its pillars is simulation education. The same year’s European Society of Coloproctology guideline on training in robotic colorec- tal surgery states that simulation should be used as part of training curriculum as strong recommendation [25]. Many publications delve into various factors playing a role in performing with the Da Vinci Skills Simulator, most importantly, devoted to establishing a link with video game experience [26, 27]. While other studies have discovered sur- prising determinants like playing sports or playing a musical instrument [28]. Our study was designed to explore the topic with a more holistic approach primarily, and looking at exact factors secondly. We investigated how different generations with total lack of experience in robotic systems and laparo- scopic practice can adjust to controlling the simulator rely- ing purely on the skillset gathered from other origins. Since the simulator operates with a computer-based virtual-reality interface, and with the assumption that youngsters nowadays grow up in an IT rich environment, we hoped to conclude that their performance will be more successful compared to the older generations. In our study, those among the children were selected, who already presented adequate commitment to the task and were able to control the simulator responsi- bly. The questionnaire served as a proof, that today’s chil- dren, Generation Alpha, get in contact with smartphones, video games at a much younger age along with a greater frequency in usage. Our study included children from the middle class mainly; however, we feel confident that our observations are true for the whole generation, alike habits are maintained by the whole society. Following two practice rounds on the designated task, the results of the third were the basis of statistical analysis.  Table   4   Statistical results of groups, based on their response in the following question, representing a difference in their performance in one of the penalty metrics How often do you type with your two thumbs only on your smartphone? Glass movement N   All the time without any effort   15 Occasionally, often   8 Very rarely or never   6 Mean   All the time without any effort   1.947 Occasionally, often   3.575 Very rarely or never   7.583 Standard deviation All the time without any effort   2.119 Occasionally, often   3.839 Very rarely or never   2.352  Fig.   2   Those who never or very rarely type on their smartphones using their two thumbs performed poorer in Glass Movement (cm) metric (* p   =   0.006)\nJournal of Robotic Surgery   (2025) 19:12 12   Page 6 of 7  The difference among the generations did not prove to be statistically significant; however, the means displayed the trend we had hoped for. Generation Alpha had the best result in Overall Score and Total Time. Additionally, we witnessed during the practice rounds that youngsters immediately achieved near excellent scores, and fine cor- rections were only needed for a perfect result. On the other hand, adults had a much harder time getting comfortable with the controls and performed poorly on the first tries. Thus, investigating learning curves could be a promising extension of the study, seeing that previous studies with limited participants suggested that the learning curve is not affected by the mentioned factors only the starting point varies [12]. The key finding was that young adults, participants from Generation Z, are more careful, precise when performing on the simulator, considering that how few penalty points from Glass Movement metric were gathered by them (Table 3 Fig. 1). The missing haptic feedback from current robotic surgical systems was handled the most successfully by them. People in their 20s present adequate vigilance and commit- ment to the task, and were born into an environment stacked with technology and electronic devices in contrast to the others, who may lack some of the above stated. The new Da Vinci 5 platform equipped with haptic feedback may level the difference reported between age groups [29]. Furthermore, a surprising finding was that typing on smartphones with two fingers fluently rather than using only one may be a skill that enables a more successful simulator experience (Table 4 Fig. 2). Limitations of this study have to be noted. Only 30 partic- ipants were included with one exclusion, leaving a need for more and making it hard to identify significant differences in the results. Besides quantity, the young adult group mainly consisted of medical students, making the group less diverse. Overall ratio of genders was balanced; however, within the groups, major disproportions were witnessed, only male children were involved, and female dominance was present in the young adult group. In addition, only one task was required and no data were registered during the practice rounds. Perhaps, applying more exercises, even harder ones, would result in more significant differences in the outcome. This study is unique, as we investigated performance on the Da Vinci Skills Simulator with a novel approach. To our knowledge, this is the first study that was conducted with participants aged between 13 and 15, naïve to robotic surgical systems. We demonstrated how generations differ, especially in the aspect of errors made. The results exhibit a need for a more comprehensive study welcoming a larger number of participants preferably necessitating more than one exercise. It also suggests that a possible extension to the topic may be the investigation of learning curves in a similar setup.  Conclusion  Our study suggests that Generation Alpha may have a head start in controlling the robotic systems, considering they achieved the best score in both Overall Score and Total Time metrics. Moreover, it showed that today’s young adults in their 20s are performing with fewer mistakes on the Da Vinci Skills Simulator. We also revealed a surprising con- nection; typing on smartphones may contribute to a better result on the simulator. However, meeting the IT innova- tions of video games, smartphones earlier in life, and the frequency of their utilization was not found to be a deter- minant of simulator performance. More research is neces- sary to identify the factors playing a role in the ability of controlling robotic systems, thus promoting robotic surgery.  Author contributions   DISZ contributed to the conception, material preparation, data collection and interpretation, creating figures, tables, and writing the first draft of the manuscript. AV contributed to the professional and linguistic revision. AP contributed to the conception, data collection, and interpretation and to the professional and linguistic revision. All authors read and approved the final manuscript.  Funding   Open access funding provided by University of Pécs. The authors declare that no funds, grants, or other supports were received during the preparation of this manuscript.  Data availability   No datasets were generated or analyzed during the current study.  Declarations  Conflict of interest   The authors declare no competing interests.  Consent to participate   Informed consent was obtained from all partici- pants included in the study; in case of children, it was obtained from the legal guardian.  Open Access   This article is licensed under a Creative Commons Attri- bution 4.0 International License, which permits use, sharing, adapta- tion, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.  References  1.   Sheetz K, Claflin J, Dimick J (2020) Trends in the adoption of robotic surgery for common surgical procedures. JAMA Netw Open 25:e1918911. https:// doi. org/ 10. 1001/ jaman etwor kopen.  2019. 18911\nJournal of Robotic Surgery   (2025) 19:12   Page 7 of 7   12  2.   Yeung T, Larkins K, Warrier S, Heriot A (2024) The rise of robotic colorectal surgery: better for patients and better for surgeons. J Robot Surg 18:69. https://   doi.   org/   10.   1007/  s11701- 024- 01822-z  3.   Shugaba A, Subar D, Slade K et al (2023) Surgical stress: the mus- cle and cognitive demands of robotic and laparoscopic surgery. Ann Surg Open 4:e284. https:// doi. org/ 10. 1097/ as9. 00000 00000  000284  4.   Shugaba A, Lambert J, Bampouras T, Nuttall H, Gaffney C, Subar D (2022) Should all minimal access surgery be robot-assisted? a systematic review into the musculoskeletal and cognitive demands of laparoscopic and robot-assisted laparoscopic sur- gery. J Gastrointest Surg 26:1520–1530. https:// doi. org/ 10. 1007/  s11605- 022- 05319-8  5.   Chen R, Rodrigues Armijo P, Krause C, Siu K, Oleynikov D (2020) A comprehensive review of robotic surgery curriculum and training for residents, fellows, and postgraduate surgical education. Surg Endosc 34:361–367. https:// doi.   org/   10.   1007/  s00464- 019- 06775-1  6.   Hertz A, George E, Vaccaro C, Brand T (2018) Head-to-head comparison of three virtual-reality robotic surgery simulators. JSLS 22:e201700081. https:// doi. org/ 10. 4293/ JSLS. 2017. 00081  7.   Aghazadeh M, Mercado M, Pan M, Miles B, Goh A (2016) Per- formance of robotic simulated skills tasks is positively associated with clinical robotic surgical performance. BJU Int 118:475–481. https:// doi. org/ 10. 1111/ bju. 13511  8.   Schmidt M, Köppinger K, Fan C et al (2021) Virtual reality sim- ulation in robot-assisted surgery: meta-analysis of skill transfer and predictability of skill. BJS Open 5:zraa066. https:// doi. org/  10. 1093/ bjsop en/ zraa0 66  9.   Hagen M, Wagner O, Inan I, Morel P (2009) Impact of IQ, com- puter-gaming skills, general dexterity, and laparoscopic experi- ence on performance with the da Vinci ® surgical system. Int J Med Robot Comput Assist Surg 5:327–331. https:// doi. org/ 10.  1002/ rcs. 264  10.   Davila D, Helm M, Frelich M, Gould J, Goldblatt M (2018) Robotic skills can be aided by laparoscopic training. Surg Endosc 32:2683–2688. https:// doi. org/ 10. 1007/ s00464- 017- 5963-5  11.   Moglia A, Ferrari V, Morelli L et al (2014) Distribution of innate ability for surgery amongst medical students assessed by an advanced virtual reality surgical simulator. Surg Endosc 28:1830– 1837. https:// doi. org/ 10. 1007/ s00464- 013- 3393-6  12.   Meier M, Horton K, John H (2016) Da Vinci© Skills Simulator™: is an early selection of talented console surgeons possible? J Robot Surg 10:289–296. https:// doi. org/ 10. 1007/ s11701- 016- 0616-6  13.   Marescaux J, Leroy J, Gagner M et al (2001) Transatlantic robot- assisted telesurgery. Nature 413:379–380. https:// doi. org/ 10. 1038/  35096 636  14.   “Intuitive Surgical, Annual Report 2023.” https:// isrg. intui tive.  com/   static-   files/   e9ed7   c14-   f042-   4923-   b7cc-   a1458   e11e6   7b. Accessed 21 Sep 2024  15.   Choi J, Diab A, Tsay K et al (2024) The evidence behind robot- assisted abdominopelvic surgery: a meta-analysis of randomized controlled trials. Surg Endosc 38:2371–2382. https:// doi. org/ 10.  1007/ s00464- 024- 10773-3  16.   Safiejko K, Tarkowski R, Koselak M et al (2021) Robotic-assisted vs. standard laparoscopic surgery for rectal cancer resection: a systematic review and meta-analysis of 19,731 patients. Cancers (Basel) 14:180. https:// doi. org/ 10. 3390/ cance rs140 10180  17.   Guerrini G, Esposito G, Magistri P et al (2020) Robotic versus laparoscopic gastrectomy for gastric cancer: The largest meta- analysis. Int J Surg 82:210–228. https:// doi. org/ 10. 1016/j. ijsu.  2020. 07. 053  18.   Wang L, Zeng W, Wu Y, Gong Z (2024) Comparison of clini- cal efficacy and safety between robotic-assisted and laparoscopic adrenalectomy for pheochromocytoma: a systematic review and meta-analysis. J Robot Surg 18:115. https://   doi.   org/   10.   1007/  s11701- 024- 01846-5  19.   Ataya K, Bsat A, Aljaafreh A, Bourji H, Al Ayoubi A, Hassan N (2023) Robot-assisted heller myotomy versus laparoscopic heller myotomy: a systematic review and meta-analysis. Cureus 15:e48495. https:// doi. org/ 10. 7759/ cureus. 48495  20.   Ziogas I, Giannis D, Esagian S, Economopoulos K, Tohme S, Geller D (2021) Laparoscopic versus robotic major hepatectomy: a systematic review and meta-analysis. Surg Endosc 35:524–535. https:// doi. org/ 10. 1007/ s00464- 020- 08008-2  21.   Tom C, Maciel J, Korn A et al (2019) A survey of robotic surgery training curricula in general surgery residency programs: how close are we to a standardized curriculum? Am J Surg 217:256– 260. https:// doi. org/ 10. 1016/j. amjsu rg. 2018. 11. 006  22.   Moit H, Dwyer A, De Sutter M, Heinzel S, Crawford D (2019) A standardized robotic training curriculum in a general surgery program. JSLS 23:e2019 00045. https:// doi. org/ 10. 4293/ JSLS.  2019. 00045  23.   Rahimi A, Ho K, Chang M et al (2023) A systematic review of robotic surgery curricula using a contemporary educational framework. Surg Endosc 37:2833–2841. https:// doi. org/ 10. 1007/  s00464- 022- 09788-5  24.   Fadel M, Walshaw J, Pecchini F et al (2024) European Robotic Surgery Consensus (ERSC): Protocol for the development of a consensus in robotic training for gastrointestinal surgery trainees. PLoS ONE 19:e0302648. https:// doi. org/ 10. 1371/ journ al. pone.  03026 48  25.   Tou S, Au S, Clancy C et al (2024) European Society of Coloproc- tology guideline on training in robotic colorectal surgery (2024). Colorectal Dis 26:776–801. https:// doi. org/ 10. 1111/ codi. 16904  26.   Harbin A, Nadhan K, Mooney J et al (2017) Prior video game utilization is associated with improved performance on a robotic skills simulator. J Robot Surg 11:317–324. https://   doi.   org/   10.  1007/ s11701- 016- 0657-x  27.   Kılınçarslan Ö, Türk Y, Vargör A, Özdemir M, Hassoy H, Makay Ö (2023) Video gaming improves robotic surgery simulator suc- cess: a multi-clinic study on robotic skills. J Robot Surg 17:1435– 1442. https:// doi. org/ 10. 1007/ s11701- 023- 01540-y  28.   Harper J, Kaiser S, Ebrahimi K et al (2007) Prior video game exposure does not enhance robotic surgical performance. J Endourol 21:1207–1210. https:// doi. org/ 10. 1089/ end. 2007. 9905  29.   “Intuitive Surgical, Da Vinci 5. https:// www. intui tive. com/ en- us/  produ cts- and- servi ces/ da- vinci/5. Accessed 21 Sep 2024  Publisher\'s Note   Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.',0.10829185566646424,'[\"(\", \"(%)\", \"(*\", \"(0.0%)\", \"(1.47\"]','2025-11-29 17:01:29.288735'),(53,3,'Biofabrication  PAPER • OPEN ACCESS  A novel extrusion-based 3D bioprinting system for skeletal muscle tissue engineering  To cite this article: E Fornetti et al 2023 Biofabrication 15 025009  View the article online for updates and enhancements.  You may also like  Pillar electrodes embedded in the skeletal muscle tissue for selective stimulation of biohybrid actuators with increased contractile distance Tingyu Li, Minghao Nie, Yuya Morimoto et al. - Skyrmion based majority logic gate by voltage controlled magnetic anisotropy in a nanomagnetic device Bibekananda Paikaray, Mahathi Kuchibhotla, Arabinda Haldar et al. - Engineering strategies for the construction of oriented and functional skeletal muscle tissues Tingting Fan, Minxuan Jia, Heng Liu et al. -  This content was downloaded from IP address 38.255.109.85 on 12/04/2025 at 23:54\nBiofabrication   15   (2023) 025009   https://doi.org/10.1088/1758-5090/acb573  Biofabrication  OPEN ACCESS  RECEIVED  27 June 2022  REVISED  16 December 2022  ACCEPTED FOR PUBLICATION  23 January 2023  PUBLISHED  3 February 2023 Original content from this work may be used under the terms of the Creative Commons Attribution 4.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.  PAPER  A novel extrusion-based 3D bioprinting system for skeletal muscle tissue engineering  E Fornetti 1  , F De Paolis 1,2 , C Fuoco 1 , S Bernardini 1 , S M Giannitelli 3 , A Rainer 3,4  , D Seliktar 5 , F Magdinier 6 , J Baldi 7 , R Biagini 7 , S Cannata 1 , S Testa 6, ∗   and C Gargioli 1, ∗  1   Department of Biology, University of Rome ‘Tor Vergata’, Rome, Italy  2   PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome ‘Tor Vergata’, Rome, Italy  3   Department of Engineering, Universit ` a Campus Bio-Medico, Rome, Italy  4   Institute of Nanotechnology (NANOTEC), National Research Council, Lecce, Italy  5   Department of Biomedical Engineering, Techion Institute, Haifa, Israel  6   Aix-Marseille University, INSERM, MMG, Marseille Medical Genetics, Marseille, France  7   IRCCS Regina Elena National Cancer Institute, Rome, Italy  ∗   Authors to whom any correspondence should be addressed.  E-mail: stefano.testa@univ-amu.fr   and   cesare.gargioli@uniroma2.it Keywords:   3D bioprinting, skeletal muscle tissue engineering, muscle reconstruction, VML, PEG-fibrinogen Supplementary material for this article is available online  Abstract  Three-dimensional (3D) bioprinting is an emerging technology, which turned out to be an optimal tool for tissue engineering approaches. To date, different printing systems have been developed. Among them, the extrusion-based approach demonstrated to be the most suitable for skeletal muscle tissue engineering, due to its ability to produce and deposit printing fibers in a parallel pattern that well mimic the native skeletal muscle tissue architecture. In tissue bioengineering, a key role is played by biomaterials, which must possess the key requisite of ‘printability’. Nevertheless, this feature is not often well correlated with cell requirements, such as motives for cellular adhesion and/or absorbability. To overcome this hurdle, several efforts have been made to obtain an effective bioink by combining two different biomaterials in order to reach a good printability besides a suitable biological activity. However, despite being efficient, this strategy reveals several outcomes limitations. We report here the development and characterization of a novel extrusion-based 3D bioprinting system, and its application for correction of volumetric muscle loss (VML) injury in a mouse model. The developed bioprinting system is based on the use of PEG-Fibrinogen, a unique biomaterial with excellent biocompatibility, well-suited for skeletal muscle tissue engineering. With this approach, we obtained highly organized 3D constructs, in which murine muscle progenitors were able to differentiate into muscle fibers arranged in aligned bundles and capable of spontaneously contracting when cultured   in vitro . Furthermore, to evaluate the potential of the developed system in future regenerative medicine applications, bioprinted constructs laden with either murine or human muscle progenitors were transplanted to regenerate the   Tibialis Anterior   muscle of a VML murine model, one month after grafting.  1. Introduction  In the last two decades, three-dimensional (3D) bioprinting has been widely employed in tissue engin- eering strategies. The possibility to build constructs with a spatially designed distribution of matrix and cells and the high reproducibility of these structures makes 3D bioprinting an excellent tool to produce and study artificial tissues. The extrusion-based 3D bioprinting systems proved to be particularly effective in obtaining artificial skeletal muscle tissues [1]. The continuous and controllable deposition of printing fibers loaded with muscle progenitors and the pos- sibility to arrange densely and evenly aligned fibers allows to reproduce the typical architecture of nat- ive skeletal muscle tissue, which is essential for the  © 2023 The Author(s). Published by IOP Publishing Ltd\nBiofabrication   15   (2023) 025009   E Fornetti   et al  tissue functionality [2]. Moreover, muscle progen- itor cells within the printing fiber are forced to fuse and elongate along the printing direction by both the shear stress occurring in the printing nozzle and the confinement of cells in a limited space [3, 4]. As a result, this method allows generating highly organ- ized artificial muscle constructs even in absence of external stimuli, such as mechanical stretching or electric stimulation. A key role is played by bioma- terials in this process, in particular hydrogels, and their capability of transitioning from liquid to gel in a cell-safe manner. This quality, so called ‘print- ability’, is mainly dependent on the hydrogel viscos- ity and crosslinking time [5, 6]. Several biomaterials share these features and are employed in extrusion- based bioprinting. Widely employed hydrogels in tis- sue engineering are among others alginate [7], able to instantly polymerize upon bivalent ions expos- ure; chitosan [8], providing many biological pro- prieties including the ability to interact with cell membrane and controllable degradation; and colla- gen type I, known to improve cellular attachment and growth [9]. However, mentioned biomaterials own some limitations: while alginate is biologically inert and has a limited biodegradability, chitosan has a poor post-printing shape fidelity and colla- gen type I polymerizes at high temperatures and its complete gelation can take more than 30 min [10]. To overcome these hindrances, most of the current extrusion-based printing system are based on a com- bination of two biomaterials, one having appropri- ate printability (commonly alginate), which is cru- cial during the printing process, and the other with desirable biocompatibility (commonly fibrin-based hydrogels or gelatin), fundamental in sustaining the biological processes required for cell proliferation and differentiation [11, 12]. While demonstrating great efficiency in producing highly organized structures  in vitro , this approach often requires removal of the printable material with chelating agents or specific enzymes to allow cellular physiological processes and  in vivo   integration [13]. PEG-Fibrinogen   (PF)   is   a   hybrid   hydrogel obtained by the combination of PolyEthylene Glycol (PEG) with denatured fibrinogen molecules that already demonstrated to be an excellent biomimetic matrix for skeletal muscle tissue engineering both  in vitro   and   in vivo   [14–16]. In fact, this hydrogel is characterized by a high biocompatibility, being enriched with cell adhesion domains and proteolytic enzymes targets, which ensure its integration, remod- eling and absorption   in vivo   [17]. However, the poly- merization process for this photocurable hydrogel is hardly compatible with the concept of printability, occurring relatively long time of UV exposure for the transition from liquid to gel state [18]. Here we report an innovative extrusion-based 3D bioprinting system exploiting PF, which properties demonstrated to be highly suitable for skeletal muscle differentiation. In particular, we developed a print- ing system able to drastically reduce the UV expos- ure time, allowing to use PF as bioink single com- ponent matrix. Moreover, this system presents a high resolution of the printing fibers (around 100   μ m), a high efficiency in skeletal muscle differentiation and organization   in vitro,   and remarkable biocompatibil- ity   in vivo . All the bioprinter components were stud- ied and optimized to obtain a 3D architecture closer as possible to the native organization of the skeletal muscle tissue, with bundles of fibers evenly orient- ated toward printing direction. The general morpho- logy of the construct was maintained throughout the experimental time thanks to the special stainless- steel supports, specifically designed for the presented biotechnology. The set-up for the printing system was conduc- ted using a murine source of muscle progenitors, the mesoangioblast (Mabs), which possess high myo- genic capabilities both   in vitro   and   in vivo   [14, 15]. Once demonstrated the validity of this system, a human source of muscle progenitors, the muscle- derived human mesenchymal stem cells (hMSCs) [19, 20] was tested in   in vivo   experiments, demon- strating that the described 3D bioprinting system could be a valuable tool for regenerative medicine approaches.  2. Materials and methods  2.1. Cell culture and bioink formulation  Mouse   mesoangioblasts   (Mabs)   were   transduced with   third-generation   lentiviral   vectors   encoding the reporter gene nuclear   β -galactosidase (nLacZ) as previously described [14]. Cells were cultured on Petri dishes (Falcon) at 37   ◦ C with 5% CO 2  in DMEM GlutaMAX (Gibco) supplemented with heat-inactivated   10%   fetal   bovine   serum   (Euro- clone), penicillin (100 IU ml − 1 , Gibco), streptomy- cin (100 mg ml − 1 , Gibco). hMSCs were isolated from skeletal muscle biopsies following a protocol that involves mechanical mincing, enzymatic digestion with type II collagenase, filtration, and selection of the colonies on plastic surface at low confluence, as pre- viously described [19]. Human progenitors were cul- tured on Petri dishes (Falcon) at 37   ◦ C with 5% CO 2  in Cyto-Grow medium (Resnova) supplemented with penicillin (100 IU ml − 1 , Gibco) and streptomycin (100 mg ml − 1 , Gibco). Skeletal muscle biopsies were obtained from healthy donors following informed consent in line with the guidelines of the Helsinki declaration on Human rights. For bioink formulation, muscular progenitors (Mabs or hMSCs) were resuspended to a final con- centration of 2   ×   10 7   cells ml − 1   in a solution of PF, (8 mg ml − 1 ) in phosphate buffered saline (PBS) and 0.1% w v − 1   Irgacure 2959 was added to the bioink 2\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 1.   Schematic representation of the 3D bioprinting and bulk polymerization processes. Muscle progenitors of either murine or human origin are combined with photocurable PEG-fibrinogen (PF) at a concentration of 2   ×   10 7   cells ml − 1 . In the 3D bioprinting system, a custom-made syringe pump system (1) pushes the bioink loaded into a syringe through a transparent PTFE microtube in a controllable manner (2). The passage of the microtube inside a low penetrance UV lamp allows the bioink to be exposed to the UV rays for a total of about 8 s (3), which are sufficient to promote bioink polymerization. The cellularized printing fiber extruded through the microtube is finally wrapped around a rotating C-shaped stainless-steel support (4) in order to obtain a bundle of fibers replicating the skeletal muscle native architecture (5). In bulk polymerization, the solution of PF and cells is poured into the Teflon mold in which the C-shaped support is wedged (1). After 5 min UV rays exposure (2), a cellularized bulk construct with the same dimension of the 3D bioprinted construct is obtained (3, 4). Scale bar: 1 cm.  as radical photoinitiator. Irgacure2959 was chosen as photoinitiator of the polymerization reaction due to its low cell toxicity, good performance in photocross- linking hydrogels, and the ability to be solubilized in the aqueous hydrogel precursor solution [21, 22].  2.2. Bioprinting system and 3D constructs culture  For this work, a custom-made 3D bioprinter was designed and manufactured. This novel extrusion- based printing system allows to employ PF as only biomaterial of the bioink, and to obtain printing fibers with a high resolution (105   ±   9   μ m) form- ing muscle bundles-like constructs of considerable dimension (4   ×   0.2   ×   0.2 cm 3 , figure 1). The core of the system is composed by the printing head that has been optimized to allow the quick polymerization of the bioink (8 s of UV exposure), which occurs during the liquid flow in the inner circuit (a low-attachment PTFE microtube, Ø 300   μ m). Liquid bioink is pushed in the circuit by a custom-made syringe pump system at a flow rate of 100   μ l min − 1 . With these parameters, the extrusion printer has a yield of 60 cm min − 1   of printed fiber. The diameter of the extruded printing fiber (300   μ m, corresponding to the diameter of the inner circuit) is further reduced by the tensile force generated by the rotation of a stainless-steel support (video S1). The C-shape of the support (figure 1) was studied to allow the deposition of parallel, dense and evenly aligned printing fibers with an architec- ture that closely resembles the native striated muscle bundles. Moreover, an oscillatory ‘forward-reverse’ movement ensures the uniform layer-by-layer distri- bution of the fibers on the support. The actuation of the printer is provided by stepper motors controlled by an Arduino Uno [www.arduino.cc] microcontrol- ler board. Bulk constructs as experimental control were obtained using a Teflon mold with the same dimen- sions of the printing constructs (4   ×   0.2   ×   0.2 cm 3 ). In   particular,   the   C-shaped   support   was   placed in the   mold and   the liquid bioink was   poured in the cavity and polymerized for 5 min, accord- ing   to   the   time   frame   defined   during   previous optimization [11, 13, 14] under a UV radiation of 365 nm (figure 1). In both bulk and 3D bioprin- ted constructs production, the time of exposure to 3\nBiofabrication   15   (2023) 025009   E Fornetti   et al  UV rays needed for PF polymerization demonstrated not to affect cell viability, as attested through the Live/Dead Cell Viability Assay Kit (Sigma-Aldrich, figure S1). This analysis also allowed to clarify that the printing process itself does not compromise the sur- vival of the cells included in the bioink. Bulk and 3D bioprinted constructs were kept in culture in the presence of growth medium and no spe- cific differentiation factors were added as both Mabs and hMSCs are able to spontaneously form myotubes upon reaching 80% confluence. For   in vitro   analysis, constructs were cultured up to 30 d in order to achieve an adequate muscle differentiation. Alternatively, for  in vivo   analysis, constructs were implanted in mice models 48 h after polymerization.  2.3. Volumetric muscle loss (VML) model, implants, and sample preparation  The VML murine model was established as previ- ously described [11]. Briefly, two-month-old male SCID/Beige mice were anesthetized with an intra- muscular injection of a physiologic saline solution (10 ml kg − 1 ) containing ketamine (5 mg ml − 1 ) and xylazine (1 mg ml − 1 ). After anesthesia, a limited incision was performed on the medial side of the leg to reach the   Tibialis Anterior   (TA). Approximately 90% for mouse-on-mouse implants and 50% for human- on-mouse implants of the total TA muscle volume was removed leaving tendons intact, by using a caut- ery to avoid bleeding and to create a venue for the implant accommodation (figure S2). The pre-shaped 3D bioprinted construct containing either Mabs or hMSCs was placed (without being sutured) to fill the volume of the surgically ablation that created an ana- tomic niche and the skin was subsequently sutured. In the control mice, the contralateral TA was surgically ablated, but no construct was implanted. Analgesic treatment (Rimadyl, Pfizer, USA) was administered after the surgery to reduce pain and dis- comfort. Mice were sacrificed 30 d after implanta- tion for immuno-histological analyses. Experiments on animals were conducted according to the rules of good animal experimentation I.A.C.U.C. N o   432 of 12 March 2006, and under Italian Health Ministry Approval No. 271/2021-PR.  2.4. Sample sectioning and immunofluorescence analysis  At the given time point, 3D constructs were fixed with 4% PFA in PBS for 30 min at 4   ◦ C and subsequently analyzed through immunofluorescence either in whole-mount or after sectioning. The con- structs to be processed for sectioning were incubated in solutions with increasing sucrose concentrations (10%, 20% and 30%, 6 h for each concentration), in order to remove most of the water volume and avoid damage during inclusion. Eight micrometers sections were obtained using a Leica cryostat from either fixed constructs or fresh surgical explants through embedding in OCT resin and quick freezing in liquid nitrogen-cooled isopentane.   In vitro   and   in vivo  resulting samples were accordingly processed for immunofluorescence analysis as previously described [23, 24]. Briefly, samples were permeabilized with 0.3% Triton X-100 in PBS for 1 h at room temper- ature (RT) and blocked with a blocking solution con- sisting of 10% goat serum, 1% glycine, 0.1% Triton X-100 in PBS for 1 h at RT. Subsequently, samples were incubated with primary antibodies in blocking solution for 2 h at RT and then rinsed with a washing solution consisting of 1% BSA and 0,2% Triton X-100 in PBS. Primary antibodies were diluted as follows: mouse monoclonal anti-myosin heavy chain (MyHC) (MF20 clone supernatant, DSHB) 1:2, rabbit poly- clonal anti-desmin (Abcam) 1:100, rabbit polyclonal anti-laminin (Sigma-Aldrich) 1:200, mouse mono- clonal anti-Pax7 (supernatant, DSHB) 1:20, rab- bit polyclonal anti-pNF (BioLegend) 1:400, mouse monoclonal anti-SMA (Sigma-Aldrich) 1:100, rabbit polyclonal anti-vWF (Abcam) 1:100, mouse mono- clonal anti-Lamin A/C (Thermo Fisher Scientific) 1:200. After washing, cells were incubated with Alexa Fluor 555-conjugated goat anti-mouse IgG (H   +   L; Thermo Fisher Scientific, diluted 1:400) and 488- conjugated goat anti-rabbit IgG (H   +   L; Thermo Fisher Scientific, diluted 1:400) for 1 h. Finally, nuc- lei were stained with 300 nM DAPI (Thermo Fisher Scientific) in PBS for 30 min. When fluorescent- BTX staining was needed,   α -BTX Alexa Fluor 488- conjugated was added to the DAPI solution at a con- centration of 1:400. Samples were observed using a Nikon TE 2000 epifluorescence microscope equipped with a Photometrics Cool SNAP MYO CCD camera and images were acquired through MetaMorph® soft- ware (Molecular Devices, Inc.). Alternatively, images were acquired through a Nikon A1R laser scanning confocal microscope with the NIS software.  2.5. Image analyses  Image analyses were performed by using the Image- J/FIJI program. Briefly,   in vitro   characterization of spontaneous twitching at day 10 in the bulk and 3D bioprinted constructs was obtained by analyzing the single frames of the live-imaging videos. After prop- erly calibrating images, radial displacement during twitching with respect to a reference point of the image was measured using the Straight Line function [25]. Myofibers size (width and length) was calcu- lated on whole-mount immunofluorescence images using the Straight Line function after image calib- ration, while coherency was calculated by using the Orientation J plugin, as previously described [11]. To describe fibers density and orientation in the con- struct cross sections, magnified region of interest (ROI)s were converted in highly contrasted eight-bit images and threshold was applied to generate binary images. After setting the measurements of interest, nuclei area and fibers cross sectional circularity and 4\nBiofabrication   15   (2023) 025009   E Fornetti   et al  area were calculated through the   Analyze Particles  function.  2.6. Statistical analysis  All experiments were performed in biological and technical   triplicates.   Data   were   analyzed   using GraphPad Prism 5, and values were expressed as means   ±   standard error. Statistical significance was tested using a t-test, as only two conditions were com- pared. A probability of less than 5% ( p   <   0.05) was considered to be statistically significant.  3. Results  3.1.   In vitro   analysis of myofibers maturation, organization and homogeneity in bioprinted and bulk constructs  The effectiveness of the printing system in sustaining biological processes such as cellular adhesion, pro- liferation and differentiation was assessed by using murine mesoangioblasts (Mabs). Mabs were added to the bioink composed by PF, a photocurable hydro- gel combining natural and synthetic benefit [17]. The obtained bioprinted constructs were maintained in culture up to 30 d, in order to obtain fully differen- tiated muscle fibers (figure 2(A)). As a parallel exper- imental control, bulk constructs were polymerized using a Teflon mold with the same dimension of the printing construct (refer to Materials and Methods section, figure 1). In both cases, constructs were kept attached to the C-shaped supports throughout the duration of the experiment in order to have the same passive tension. Interestingly, the effect of shear stress caused by the printing process can be noted by the flat appearance of cells at Day 0 compared to the round shape of cells within the bulk construct (figure 2(A)). Starting from day 10, spontaneous twitching events were recorded in both conditions (video S2). Video frames were analyzed in order to identify any differ- ences in contractile properties in the two conditions. Radial displacement, which indicates the shift occur- ring during the contraction phase of a single twitch, was significantly higher (2.5-fold) in the bioprin- ted condition (figure 2(B) and S3). Moreover, a dif- ferent twitching directionality was observed, being parallel to the printing axis in the bioprinted con- struct while randomly oriented in the bulk con- struct (figure 2(B)). At later time points, because of massive spontaneous twitching and the movement of whole constructs, it was not possible to perform video frames quantitative analysis (video S3). At day 30, upon muscle differentiation, whole- mount   immunofluorescence   analysis   against   the muscular differentiation markers MyHC and desmin were performed on both bulk and bioprinted con- structs (figure 3(A)). Image analysis confirmed that PF provides a favorable microenvironment for the maintenance of Mabs, able to proliferate and fuse for producing large multinucleated muscle fibers in both conditions (figure 3(B)). The evidence of a better organization and a greater homogeneity in myofibers size in the bioprinted construct, was assessed by com- paring myofibers width, length and coherency in both conditions. Myofibers average width resulted slightly higher in the bioprinted constructs even if not in a statistically significant way (figure 3(C), left). However, the width distribution in the bioprinted construct appeared shifted towards larger dimen- sions and more peaked as compared to bulk curve (figure 3(C), right). Interestingly, a greater width of fibers could be an indication of a better maturation [26]. Moreover, myofibers average length was signi- ficantly higher (two-fold) in bioprinted constructs compared to bulk myofibers, as also confirmed by the shifted length distribution (figure 3(D)). Coher- ency, a parameter ranging from 0 to 1 and describing the orientation and isotropic properties of analyzed region [27], was found to be significantly higher (3.5- fold) in the bioprinted constructs, with a distribution showing a very pronounced single peak as compared to the flat bulk curve (figure 3(E)).  3.2. Analysis of differentiation and fiber alignment on constructs sections  Both bulk and bioprinted constructs were snap frozen for OCT casting to obtain cryo-sections. Immun- ofluorescence analysis confirmed the presence of desmin-positive and MyHC-positive myofibers in both conditions (figure 4(A), left). Interestingly, cells were able to produce their own extracellular matrix (ECM), as evidenced by the presence of laminin sur- rounding the fibers and indicating proper matura- tion (figure 4(A), right). Laminin production is espe- cially visible around centrally nucleated regenerating fibers in bioprinted construct sections (figure 4(A), enlargement). Moreover, significant differences were highlighted by the quantitative analysis of different parameters related to constructs architectural organ- ization. Cellular density, a measurement indicating the presence and the cells localization within the section, is significantly higher in the bioprinted con- struct reflecting a better distribution of myofibers, whereas in the bulk construct cells localized mainly in the outermost layer (figure 4(B)). Moreover, the cir- cularity and the cross-sectional area measured on the constructs sections resulted respectively higher and lower in the bioprinting condition, indicating the bet- ter alignment of myofibers along the construct longit- udinal axis (figure 4(C)). On the other hand, the bulk constructs showed a larger cross-sectional area but a lower circularity, as expected for myofibers not ori- ented in a single direction. (figure 4(D)).  3.3. TA volume recovery after murine bioprinted construct implantation  To assess the potentiality of the printing system in   regenerative   medicine   applications,   a   murine model   of   VML   was   employed   [11].   The   VML 5\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 2.   Bright field imaging of muscle differentiation time-course in cellularized constructs. (A) Timeline showing the different experimental stages with representative bright field images from the production of bioprinted constructs and bulk control (Day 0), to the end of the experiment (30 d), a sufficient time to obtain differentiated muscle fibers capable of contracting. From day 10, differentiated muscle fibers start to spontaneously twitch. Scale bar   =   100   μ m. (B) Time-lapse representative images obtained from spontaneous twitching video recordings showing the shift of a reference segment during contraction in fibers within either bulk or bioprinted constructs. Black arrows indicate the direction of the constructs longitudinal axis and highlight how twitching directionality is parallel to the printing axis in the bioprinted construct while randomly oriented in the bulk construct.  model was obtained by massively ablating (90%) the TA of the mouse hind legs, in order to pre- vent   the   natural   healing   process   of   the   muscle [14]. 3D bioprinted constructs, obtained from nuc- lear LacZ Mabs (nLacZ-Mabs) [15], were placed in the anatomical space created by TA removal and the implant was allowed to integrate within the host muscle for 30 d. In the control mice, the TA muscle tissue was ablated without being replaced with the artificial construct. After sacrifice, 6\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 3.   Immunofluorescence analysis on bulk and 3D bioprinted constructs. (A) Confocal large-scale images showing the reconstruction of constructs large areas. Scale bar: 400   μ m. (B) Magnified images of differentiated muscle fibers expressing the muscle differentiation markers MyHC and Desmin. Scale bar: 100   μ m. (C) Myofibers width analysis, although not statistically significant in the two conditions, showing a distribution shifted towards larger dimensions and more peaked for the bioprinted constructs. ( n   =   9 analyzed fields from 3 independent experiments per condition, a minimum of 50 myofibers per field were analyzed). (D) Myofibers length analysis, displaying a significant increased length in the bioprinted structures, as confirmed by the shifted distribution ( n   =   9 analyzed fields from three independent experiments per condition, a minimum of 15 myofibers per field were analyzed). (E) Coherence analysis, describing the degree of myofibers alignment, being significantly higher in the bioprinted construct, as also shown in the very pronounced single peak distribution.   ∗∗∗ p   <   0.0008.   ∗∗ p   <   0.0019. Statistical significance was tested using a Student’s   t -test.  ablated and implanted TAs were collected and ana- lyzed through immunofluorescence analysis against laminin and MyHC, while LacZ-positive nuclei were identified by means of X-Gal labeling. The obtained cross sections images revealed the complete recov- ery of the tissue area in the implanted TA as com- pared to control, which conversely displayed a poor and   deficient   tissue   restoration   (figure   5(A)).   A large number of LacZ-positive nuclei were labeled within the centrally nucleated muscle fibers in the reconstructive   tissue,   which   demonstrated   to   be well organized (figure 5(B) and S4). Reconstruc- ted tissue deriving from the implanted constructs demonstrated to be properly vascularized, as high- lighted by the area enriched in LacZ-positive nuclei showing positive signal for smooth muscle actin (SMA) and von Willebrand factor (vWF), labeling vessel   muscle   wall   and   endothelium   respectively (figure 6(A)). Moreover, the reconstructed myofibers presenting LacZ-positive nuclei have been shown to be innervated, as demonstrated by the positive labeling of neural pre- and post-synaptic structures by immunostaining with phospho-neurofilament (pNF) and alpha-bungarotoxin (BTX), demonstrating the development of neuromuscular junctions within the regenerating TA muscle, after implantation of 3D constructs (figure 6(B)). Pax7-positive satellite cells were observed in the TA area reconstructed by nLacZ- Mabs, indicating the reestablishment of the stem cell niche required for muscle regeneration (figure 6(C)). 7\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 4.   Analysis of the constructs cross sections. (A) Cross sections of bulk and bioprinted constructs confirming the expression of the muscle differentiation markers MyHC and desmin (left) and the production of laminin-positive extracellular matrix (right), which is particularly noticeable around centrally nucleated transverse fibers in the bioprinted construct (enlargements). Left scale bar: 200   μ m, right scale bar: 100   μ m. Cellular density (B), which is expressed through nuclei percentage area, and alignment (C), which is expressed through circularity, resulted significantly higher in the bioprinted condition. Moreover, myofibers cross sectional area (D) resulted significantly higher in the control, as a result of a greater myofibers inclination.  ∗∗ p   <   0.0041.   ∗∗∗ p   <   0.0001.   ∗ p   <   0.0296. Statistical significance was tested using Student’s   t -test.  8\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 5.   Immunofluorescence analysis on ablated and implanted murine TAs. (A) Cross sections images analyzed through immunofluorescence analysis against laminin and MyHC revealed a complete area recovery of the TA implanted with the nLacZ-Mabs-laden bioprinted construct as compared to the ablated control. Scale bar: 400   μ m. (B) Magnified images of the area dashed in A showing LacZ-positive nuclei, labeled by X-Gal assay. Scale bar: 100   μ m.  Figure 6.   Higher magnifications analysis of the area regenerated by nLacZ-Mabs in 3D bioprinted constructs. (A) Immunofluorescence analysis against vessels-specific markers SMA and vWF indicate proper vascularization of the regenerating area. (B) Labeling by means of immunofluorescence for the pre- and post-synaptic neural markers pNF and BTX, targeting neurons cytoskeleton and muscular acetylcholine receptors, respectively. White arrowheads highlight developing fibers with central LacZ-positive nuclei showing host nerve terminals. (C) Pax7-positive satellite cells indicated by white arrowheads detected in LacZ-positive nuclei-rich area. Scale bar: 50   μ m.  9\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 7.   Immunofluorescence analysis on cross sections from murine TA implanted with hMSCs-laden bioprinted construct. (A) Immunostaining for laminin, MyHC and Lamin A/C on adjacent sections revealing a large reconstructed area derived from the xenograft. Dotted lines indicate interface between host native muscle and human-derived area. Scale bar: 400   μ m. (B) Magnified images of the dashed region in A showing MyHC-positive areas co-localizing with Lamin A/C-positive human nuclei. Scale bar: 100   μ m.  3.4. TA volume recovery after human bioprinted construct implantation  In order to evaluate the possibility to translate the proposed approach in human studies, pilot exper- iments   have   been   performed   exploiting   muscle- derived hMSCs-laden bioprinted constructs. For this purpose, constructs with human cells were implanted in the mouse hind limb upon 50% TA muscle abla- tion, similarly to the above-described experiment. After 30 d, tissues were collected and analyzed by means of immunofluorescence. Cross sections of the explanted TA show two distinct areas, one being the host native muscle and the other one resulting from the human-derived bioprinted implant (figure 7(A)). Although the tissue developed from the xenograft seems   overall   less   organized   compared   with   the murine-derived implants (figure 5), the large MyHC- positive area co-localizing with numerous human Lamin A/C (Lam A/C)-positive nuclei indicate that the reconstructed muscular tissue is from human ori- gin and that hMSCs were able to generate myofibers integrating with host ablated TA (figure 7(B)). Inter- estingly, a deeper analysis of the reconstructed TA tissue showed more organized areas with transverse small muscle fibers that in the contiguous section proved to be centrally nucleated and Lamin A/C- positive (figure 8(A)). Tissue reconstituted from the human-derived implant has shown also to be prop- erly vascularized and innervated, as highlighted by the positive signal revealed by vessels- (SMA and vWF) and neural-specific (pNF and BTX) markers (figures 8(B) and (C)). Moreover, the presence of 10\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 8.   Higher magnification analyses of the reconstructed TA area derived from human cells. (A) Transverse MyHC-positive myofibers that in the contiguous section proved to be centrally nucleated and Lamin A/C-positive, as indicated by white symbols. Vascularization (B), innervation (C) and stem cell niche (D) in the reconstructed muscular tissue derived from human bioprinted constructs are highlighted by the positivity for specific markers. The correspondence of the specific markers with the human Lamin A/C-positive nuclei is highlighted by white asterisks in two continuous sections. Scale bar: 30   μ m.  Pax7-positive satellite cells was observed in the peri- phery of some fibers, thereby suggesting the regener- ative potential of the reconstructed TA (figure 8(D)).  4. Discussion  To date, 3D bioprinting approach is gaining more and more interest for its ability to produce cellularized 3D constructs with a well-defined architecture closely replicating tissue organization in a quick and highly reproducible manner [28–31]. However, regardless of the printing system, this target often proves chal- lenging. Indeed, the technical requirements of 3D printing combined with the necessity for a biocom- patible cellular scaffold force researchers to find a compromise in formulating bioink between what is convenient for the machine and what is suitable for cell survival, proliferation and differentiation. Several research groups have faced these hurdles, investig- ating different strategies based on multi-component bioinks and/or multi-step polymerization processes. In particular, good outcomes have been obtained with PEG-Chitosan, Gelatin and porcine decellular- ized ECM [28, 30, 31]. However, existing approaches often require a difficult set-up involving considerable changes of temperature during the extrusion process and the combination of chemical/physical polymeriz- ation of the bioink, while at the same time not provid- ing a resolution of less than 300   μ m. Our team also focused its efforts on this direc- tion, basing the bioink formulation on the combin- ation of alginate and PF, in order to exploit alginate printability together with PF biological compatibility. With this approach, the bioink was transiently retic- ulated during the printing process by exposing the alginate to a covalent ions solution, while irreversible polymerization was achieved in a second step by UV exposure that acts on PF molecules. Subsequently, the alginate was removed from the scaffold with a calcium chelating agent or an alginase enzyme solu- tion. This technique demonstrated optimal outcomes  in vitro , allowing differentiation of muscle progenitor cells and production of highly organized muscle con- structs. However, in VML regeneration experiments, alginate residues remained in the constructs affected the quality of the resulting muscle [11, 13]. In an attempt to overcome these limitations, this work further described a novel and versatile alginate- free and extrusion-based 3D bioprinting system. The development of the proposed printing system is based on the characteristics of PF, a hydrogel able to sus- tain growth and differentiation of skeletal muscle cells both   in vivo   and   in vitro   [15, 16]. In this way, instead of formulating the right biomaterial according to the printing system features, priority was given to the cell physiological requirements. Initially, PF physical properties did not seem compatible with a printing system based on the use of this hydrogel only, as the polymerization time is relatively long (5 min of UV rays exposure). For this reason, the printer features have been customized in order to drastically reduce the PF polymerization time to 8 s, allowing a rapid and cell-friendly printing process. Another strength of the presented bioprinter is the C-shaped stainless- steel support, specifically designed to allow the pro- duction of 3D constructs composed by fibers bundles 11\nBiofabrication   15   (2023) 025009   E Fornetti   et al  similar to the skeletal muscle tissue architecture. The use of a linear support allows to collect the printing fibers in highly aligned lines between the two pins and to produce an elongated bundle, representing an improvement over the circular constructs obtained with cylindrical supports [11]. Notably, rotation of the C-shaped support pulls the printing fibers and leads to an increase of the printing resolution to 100   μ m (1/3 of the extruder microtube diameter). Moreover, a translational ‘forward-reverse’ move- ment allows the layer-by-layer deposition of print- ing fibers on the support, so as to recapitulate muscle organization. The potential of the PF-based bioprinting sys- tem in supporting the biological processes needed for muscle differentiation has been evaluated using murine mesoangioblasts (Mabs) as the source of muscle progenitors [15]. Our results confirmed PF as an ideal scaffold for the growth, differentiation and maturation of muscle fibers, which have been shown to be able to twitch spontaneously both in bioprinted and bulk condition. A difference in the myofibers overall organization between the two conditions emerged from the first brightfield ana- lyses, and the formation of differentiated and aligned myofibers in the bioprinted constructs demonstrated to be necessary to the coherent muscle bundles con- traction. Moreover, with the aim of identifying differ- ences in the contracting behavior of myofibers within bulk and bioprinted constructs, we recorded and described a greater radial displacement during the contraction phase of the bioprinted myofibers. Tak- ing into account the relationship between myofibers size and their ability to generate force [32], we specu- late this result might indicate an ability to produce a greater amount of force as compared to the twitch- ing myofibers of the bulk construct. Shear stress and geometric confinement induced by 3D bioprint- ing confirmed to have an influence on the elonga- tion and alignment of homogeneous muscle fibers. Moreover, cross sections showed how bioprinting promotes a more homogeneous myofibers distribu- tion within the construct as compared to the bulk condition, in which muscle fibers are arranged only in the most external layer. We speculate that this phe- nomenon could be the result of an improved oxygen and medium perfusion through the space between the printing fibers. Relying   on   the   encouraging   results   obtained  in vitro , we proceeded investigating the capability of the constructs obtained with the proposed bioprint- ing system in restoring a VML in a murine model. VML, resulting from severe trauma or sarcomas sur- gical ablation, is a pathological condition that pre- vents the regeneration of skeletal muscle, as it owns considerable ability to repair tissue damage but only when limited in size [33]. Unfortunately, currently adopted surgical therapies do not yet provide sat- isfactory results. To date, one of the most widely employed clinical strategy for the treatment of VML trauma is the implantation of acellularized scaf- folds composed by ECM often derived from nat- ural sources (e.g. porcine urinary bladder-derived ECM). However, the functional recovery is limited, making this reconstructive therapy inadequate [24]. For this reason, an increasing attention is being paid to skeletal muscle tissue engineering as a promising approach. In our experiments, 3D bioprinted Mabs-laden constructs lead to a full restoration of the lost muscle volume 30 d after grafting. The acellular PF bioprin- ted construct was not employed as experimental con- trol for implantation experiments, as it has already well demonstrated to be completely reabsorbed by the host organism in previous papers [11, 14]. The wide implantation of Mabs in the regenerating tissue (figure S4) indicates an active role of the implant not only in the regeneration of muscle fibers, but also in driving the recruitment of all the biological elements required for implant survival and for proper develop- ment of a functional muscle tissue. Functional recov- ery rate will be the focus of future studies. Finally, as a proof-of-concept to evaluate the translational potential of the proposed approach, hMSCs [19] were employed to obtain 3D bioprinted constructs. A less extensive VML (50% TA volume ablation) was chosen for these experiments, based on our previous experiences with human-on-mouse grafts where the host did not fully accept the human cells (data not shown). Similarly to murine exper- iments, 30 d after implantation the human cell- derived bioprinted constructs were able to restore the host muscle volume even if the reconstructed tissue was not fully organized as for Mabs-derived implant (mouse-on-mouse). However, a large num- ber of human cells survived in the host and were able to drive the formation of new muscle fibers, to recruit blood vessels and nerves, and to stimulate the forma- tion of a pool of satellite cells. Altogether, the presen- ted data make us confident that the proposed recon- structive strategy has the potential to be suitable for future translational medicine application in human.  5. Conclusion  In this work, the proposed alginate-free extrusion- based 3D bioprinting system, established on the use of PF as only hydrogel composing the cellular scaffold, demonstrated to be a novel and competitive tool for skeletal muscle tissue engineering. The bioprinter was developed by exploiting our expertise, acquired over the years, on skeletal muscle tissue engineering and on the use of the most suitable hydrogels for myogenesis. This background granted us to realize a simple yet effective strategy to overcome limitations of previous systems that depend on the combination of PF with other less biocompatible hydrogels (such as alginate). The presented results highlighted the potential of this 12\nBiofabrication   15   (2023) 025009   E Fornetti   et al  innovative printing approach in two main aspects: on one hand, the possibility to obtain   in vitro   biological substitutes showing properly organized muscle fibers capable of spontaneously contracting, which could represent a biological platform for drug screening and myopathies studies. On the other hand, the efficacy of the printed construct in restoring a VML damage in a mouse model, both with murine and human-derived myogenic progenitors, suggesting that the proposed approach could represent a remarkable and effective tool for regenerative medicine. Finally, the ease-of-use the presented approach could lend itself to the use of other photo-curable biomaterials (such as gelatin and other PEG-based hydrogels) and different types of mesodermal stem cells   (Bone   Mesenchymal   Stem   Cells   [34,   35], Adipose-derived Stem Cells [36], Tendon-derived Stem Cells [37]) to print a wide range of mesodermal- derived   tissues   as   3D   models   or   transplantable substitute.  Data availability statement  All data that support the findings of this study are included within the article (and any supplementary files).  Acknowledgments  We thank Massimo Testa for the support in designing and manufacturing the 3D bioprinter system and Dr Franca Abbruzzese (Universit ` a Campus Bio-Medico di Roma) for her technical support on confocal microscopy acquisition. The research has been carried out thanks to PRIN 2017: 201742SBXA_004 foun- ded by Italian Ministry of University and Research to Cesare Gargioli.  Conflict of interest  The authors declare no conflict of interest.  ORCID iDs  E Fornetti      https://orcid.org/0000-0002-6246-5351 A Rainer      https://orcid.org/0000-0001-8971-551X  References  [1] Fan T, Wang S, Jiang Z, Ji S, Cao W, Liu W, Ji Y, Li Y, Shyh-Chang N and Gu Q 2022 Controllable assembly of skeletal muscle-like bundles through 3D bioprinting  Biofabrication   14   015009 [2] Kim J H, Seol Y J, Ko I K, Kang H W, Lee Y K, Yoo J J, Atala A and Lee S J 2018 3D bioprinted human skeletal muscle constructs for muscle function restoration   Sci. Rep.   8   12307 [3] Aubin H, Nichol J W, Hutson C B, Bae H, Sieminski A L, Cropek D M, Akhyari P and Khademhosseini A 2010 Directed 3D cell alignment and elongation in microengineered hydrogels   Biomaterials   31   6941–51 [4] Kim W J and Kim G H 2020 3D bioprinting of functional cell-laden bioinks and its application for cell-alignment and maturation   Appl. Mater. Today   19   100588 [5] Naghieh S and Chen X 2021 Printability–a key issue in extrusion-based bioprinting   J. Pharm. Anal.   11   564–79 [6] Fu Z, Naghieh S, Xu C, Wang C, Sun W and Chen X 2021 Printability in extrusion bioprinting   Biofabrication  13   033001 [7] Hospodiuk M, Dey M, Sosnoski D and Ozbolat I T 2017 The bioink: a comprehensive review on bioprintable materials  Biotechnol. Adv.   35   217–39 [8] Croisier F and Jér ˆ ome C 2013 Chitosan-based biomaterials for tissue engineering   Eur. Polym. J.  49   780–92 [9] Ferreira A M, Gentile P, Chiono V and Ciardelli G 2012 Collagen for bone tissue regeneration   Acta Biomater.  8   3191–200 [10] Willson K, Atala A and Yoo J J 2021 Bioprinting au natural: the biologics of bioinks   Biomolecules   11   1593 [11] Costantini M   et al   2021 Biofabricating murine and human myo-substitutes for rapid volumetric muscle loss restoration  EMBO Mol. Med.   13   1–17 [12] Wang X, Li X, Dai X, Zhang X, Zhang J, Xu T and Lan Q 2018 Coaxial extrusion bioprinted shell-core hydrogel microfibers mimic glioma microenvironment and enhance the drug resistance of cancer cells   Colloids Surf.   B  171   291–9 [13] Costantini M   et al   2017 Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden hydrogels leads to functionally organized myofibers   in vitro   and   in vivo Biomaterials   131   98–110 [14] Fuoco C   et al   2015   In vivo   generation of a mature and functional artificial skeletal muscle   EMBO Mol. Med.  7   411–22 [15] Fuoco C   et al   2012 Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration   Skelet. Muscle   2   24 [16] Fuoco C   et al   2014 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering   Front. Physiol.   5   203 [17] Almany L and Seliktar D 2005 Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures   Biomaterials   26   2467–77 [18] Buonvino S, Ciocci M, Seliktar D and Melino S 2021 Photo-polymerization damage protection by hydrogen sulfide donors for 3D-cell culture systems optimization   Int. J. Mol. Sci.   22   6095 [19] Testa S   et al   2020 Skeletal muscle-derived human mesenchymal stem cells: influence of different culture conditions on proliferative and myogenic capabilities   Front. Physiol.   11   553198 [20] Schaefer B, Beier J P and Ruhl T 2020 Mesenchymal stem cells and the generation of neomuscle tissue   Surg. Technol. Int.   36   41–47 [21] Bryant S J, Nuttelman C R and Anseth K S 2000 Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts   in vitro J. Biomater. Sci. Polym. Ed.   11   439–57 [22] Mironi-Harpaz I, Wang D Y, Venkatraman S and Seliktar D 2012 Photopolymerization of cell-encapsulating hydrogels: crosslinking efficiency versus cytotoxicity   Acta Biomater.  8   1838–48 [23] Testa S, D’Addabbo P, Fornetti E, Belli R, Fuoco C, Bernardini S, Cannata S, Frezza D and Gargioli C 2018 Myoblast myogenic differentiation but not fusion process is inhibited via MyoD tetraplex interaction   Oxid. Med. Cell. Longev.   2018   7640272 [24] Testa S, Fornetti E, Fuoco C, Sanchez-Riera C, Rizzo F, Ciccotti M, Cannata S, Sciarra T and Gargioli C 2021 The war after war: volumetric muscle loss incidence, implication, current therapies and emerging reconstructive strategies, a comprehensive review   Biomedicines   9   564  13\nBiofabrication   15   (2023) 025009   E Fornetti   et al  [25] Chandel I, Baker R, Nakamura N and Panin V 2020 Live imaging and analysis of muscle contractions in Drosophila embryon   J. Vis. Exp.   9  [26] Bakooshli M A   et al   2019 A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction   Elife   8   1–29 [27] Clemons T D, Bradshaw M, Toshniwal P, Chaudhari N, Stevenson A W, Lynch J, Fear M W, Wood F M and Iyer K S 2018 Coherency image analysis to quantify collagen architecture: implications in scar assessment   RSC Adv.  8   9661–9 [28] Hu T, Cui X, Zhu M, Wu M, Tian Y, Yao B, Song W, Niu Z, Huang S and Fu X 2020 3D-printable supramolecular hydrogels with shear-thinning property: fabricating strength tunable bioink via dual crosslinking   Bioact. Mater.  5   808–18 [29] Ostrovidov S   et al   2019 Three dimensional bioprinting in skeletal muscle tissue engineering   Small   15   1805530 [30] Kim W, Lee H, Lee J, Atala A, Yoo J J, Lee S J and Kim G H 2020 Efficient myotube formation in 3D bioprinted tissue construct by biochemical and topographical cues  Biomaterials   230   119632 [31] Hwangbo H, Lee H, Jin E J, Lee J Y, Jo Y, Ryu D and Kim G H 2022 Bio-printing of aligned GelMa-based cell-laden structure for muscle tissue regeneration   Bioact. Mater.  8   57–70 [32] Cooper A N, McDermott William J, James C Martin, Dulaney Shea O and Carrier D R 2021 Great power comes at a high (locomotor) cost: the role of muscle fascicle length in the power versus economy performance trade-off   Exp. Biol.  224  [33] Corona B T, Garg K, Ward C L, McDaniel J S, Walters T J and Rathbone C R 2013 Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of skeletal muscle   Am. J. Physiol. Cell Physiol.   305   761–75 [34] Bae S W, Lee K W, Park J H, Lee J H, Jung C R, Yu J J, Kim H Y and Kim D H 2018 3D bioprinted artificial trachea with epithelial cells and chondrogenic-differentiated bone marrow-derived mesenchymal stem cells   Int. J. Mol. Sci.  19   1–14 [35] Luo C, Xie R, Zhang J, Liu Y, Li Z, Zhang Y, Zhang X, Yuan T, Chen Y and Fan W 2020 Lowerature three-dimensional printing of tissue cartilage engineered with gelatin methacrylamide   Tissue Eng.   C   26   306–16 [36] Stanco D, Boffito M, Bogni A, Puricelli L, Barrero J, Soldati G and Ciardelli G 2020 3D bioprinting of human adipose-derived stem cells and their tenogenic differentiation in clinical-grade medium   Int. J. Mol. Sci.   21   1–23 [37] Lui P P Y and Chan K M 2011 Tendon-derived stem cells (TDSCs): from basic science to potential roles in tendon pathology and tissue engineering applications   Stem Cell Rev. Rep.   7   883–97  14',0.04032283923962292,'[\"(\", \"(1\", \"(1)\", \"(1).\", \"(1/3\"]','2025-11-29 17:02:02.382820'),(54,3,'Health Policy and Technology 11 (2022) 100661  Available online 13 August 2022 2211-8837/©   2022   Fellowship   of   Postgraduate   Medicine.   Published   by   Elsevier   Ltd.   This   is   an   open   access   article   under   the   CC   BY   license (http://creativecommons.org/licenses/by/4.0/). Emerging role of artificial intelligence in global health care  Ghadeer Alhussain   a , Alexandra Kelly   a , Ellerose I. O ’ Flaherty   a , Darragh P. Quinn   a , Gerard T. Flaherty   a , b , *  a   School of Medicine, University of Galway, Galway, Ireland  b   School of Medicine, International Medical University, Kuala Lumpur, Malaysia  A R T I C L E   I N F O  Keywords:  Machine learning Algorithm Medical ethics Health technology Global health Sustainable development goals Health systems  Introduction  The Covid-19 pandemic has accelerated the greater integration of digital technology into education and healthcare. Artificial Intelligence (AI), which may be defined as intelligence displayed by machines to simulate human cognitive functions such as the ability to learn, recog -  nise patterns, plan, and make decisions, has emerged as a promising development in health technology. While concerns have been expressed about the impact of AI on doctor-patient communication and mainte -  nance of clinical oversight [1], significant enthusiasm surrounds its potential for improving workflow efficiency and reducing harm result -  ing from human error. This commentary will explore the current status and future prospects of AI in addressing the major challenges in global health as portrayed in the United Nations Sustainable Development Goals (UN SDGs), first published in 2012 [2]. It will first consider some of the established applications of AI in healthcare before considering how AI may influence the reform of health systems and stimulate progress towards the advancement of global health priorities.  AI and the Covid-19 pandemic  The increasing influence of AI in society gained traction during the Covid-19 pandemic. The Covid-19 pandemic has witnessed a greater focus on the communication of health-related information to the public but it has also resulted in a simultaneous ‘misinfodemic ’ , which has undermined attempts at global vaccination. AI has a role to play in countering pseudoscientific misinformation. Machine learning tech -  niques can be utilised to highlight trends and harness the power of sentiment analysis on social media platforms [3]. This can aid in high -  lighting the origins of misinformation and curtailing the propagation of unfounded rumours. Instagram, for example, is programmed to remove posts that contain claims that violate their Covid-19 and vaccine pol -  icies. For posts that have not been discredited by health experts, Insta -  gram automatically applies informational labels about vaccines and Covid-19. These labels direct users to more credible sources of infor -  mation from health care professional agencies such as the WHO and the CDC, providing factual information which debunks common vaccine myths.  Applications of AI in clinical practice  Burnout   of   overstretched   health   care   professionals   (HCPs)   is   a pressing global health concern. AI can help in reducing the burden imposed on HCPs by maintaining patient records, pattern recognition processes, which can highlight trends and determine appropriate treat -  ments, calculating mortality risks, and training practitioners. Medical chatbots have the ability to rapidly share up-to-date information, sup -  port HCPs with clinical interviews and diagnosis, and encourage be -  haviours such as hand-washing and social distancing. Chatbots with the ability to offer emotionally supportive responses may be successful in  * Corresponding author at: School of Medicine, University of Galway, Galway, Ireland.  E-mail address:   gerard.flaherty@nuigalway.ie (G.T. Flaherty).  Contents lists available at ScienceDirect  Health Policy and Technology  journal homepage: www.elsevier.com/locate/hlpt  https://doi.org/10.1016/j.hlpt.2022.100661\nHealth Policy and Technology 11 (2022) 100661  2 reducing the long-term psychological impact of social isolation. Global health system challenges include the rising burden of chronic illness,   age-related   multi-morbidity,   polypharmacy   and   disability, increased demands on public health services, heightened public expec -  tations, and economic austerity policies that limit healthcare expendi -  ture. Machine learning may act as a catalyst to achieving fundamental global health system reforms by improving access, equity and efficiency of public health service provision. Table 1 summarises key applications of AI in the area of health systems management.  AI and the sustainable development goals  Almost all of the 17 Global Goals and 169 targets set out in the UN SDGs have at least an indirect relationship to human health. SDG 3 is specifically devoted to health. It undertakes to   “ ensure healthy lives and promote well-being for all at all ages ”   by 2030 [2]. This goal is under -  pinned by 13 focused targets, which relate to a diverse array of deliv -  erable   global   health   outcomes,   including   maternal   and   childhood mortality, epidemics of communicable disease, tobacco control, mental health, and road traffic accidents [3]. Vinuesa and colleagues have previously tabulated evidence from AI studies that address each of the SDGs. We will consider some salient global health-related examples in this article. SDG 3.1 pledges to reduce the global maternal mortality ratio by the year 2030 to below 70 per 100,000 live births [4]. An AI algorithm has been used to improve the detection of early and late pre-eclampsia and gestational hypertension with a low false positive rate. The authors es -  timate that 1 in 5 of pregnancies screened positive by this model would develop pregnancy-related hypertension. This method of detection is superior to a sole reliance on maternal history [5]. Communicable dis -  eases, including HIV-AIDS, tuberculosis and malaria, are the subject of SDG 3.3. Genotyping to determine resistance to combination antiretro -  viral therapy for patients with HIV is unavailable in poorer countries. Computational models that accurately predict response to antiretroviral therapy have been developed and tested on cases of the disease from India and Southern Africa [6]. Machine learning has also been applied to the automated digital detection and quantification of malarial parasites, which could have a significant impact on the ability of laboratories in resource poor settings to diagnose and treat malaria [7]. There is considerable scope for computational intelligence in the prevention and management of chronic illness. AI-based digital tech -  nology has already empowered patients to self-monitor various personal health parameters such as heart rate, blood pressure, physical activity and sleep, using data derived from wearable sensors. Promotion of adherence to long-term medications, motivational goal-setting, and early identification of drug-drug interactions continue to benefit from the use of AI innovations. AI is also showing promise in the areas of mental health (SDG 3.4) and substance abuse (SDG 3.5). Machine learning has been applied to the prediction of non-fatal suicide attempt risk, using Danish national suicide registry data. Individuals ranking in the top 5% of AI-predicted risk accounted for over 40% of all suicide attempts [8]. Although some safety concerns exist surrounding the use of autonomous vehicles based on AI technology, it is likely that these will be resolved over time and that AI will yield additional applications in the reduction of injury and death from road traffic collisions globally (SDG 3.6). The global disease burden attributable to environmental pollution   (SDG   3.9)   has   also   prompted   innovation   in   developing AI-based solutions. A recent study from China points to the use of ma -  chine learning techniques to analyse anthropogenic air pollution, for example [9].  Concerns about AI and health inequities  The reliance of AI on data could pose a major barrier to its imple -  mentation in low and middle-income countries (LMIC), with significant investment being required to compile sufficient data, requiring re -  sources not abundant in the developing world. Data are particularly lacking on the most marginalised in society, leading to datasets being inaccurately skewed towards those who have more access to healthcare. Concerns about a lack of investment in translation to diverse languages and scripts in the developing world are justified when many AI tech -  nologies are designed by and for high-income populations. The case of a skin cancer-detecting AI technology which proved ineffective for people of colour as the machine-learning was based on predominantly white populations in high-income countries acts as a warning against perpet -  uating racial disparities in healthcare through AI [10]. If AI technology is to be a tool for tackling global inequality, it must be responsibly implemented.  Ethical considerations  Although the emerging use of artificial intelligence in health care has allowed progress to be achieved in terms of diagnosis and prognosis, there are ethical considerations surrounding its use. As AI is interposed within the doctor-patient relationship, the integrity of informed consent may be jeopardised. This can be seen in everyday life with people downloading   mobile   health   apps,   such   as   those   that   help   track menstruation,   improve   medication   adherence,   and   provide   dietary guidance. The use of these applications requires merely the signing of a user agreement, as well as the acceptance of regular updates, and changing terms of service, which compromise transparency for the user. While a human would be able to ensure understanding and compliance of their patients, in the case of these mobile apps the user is the only advocate for their own consent and medical knowledge. The so-called black box algorithm, whereby humans, even those who design AI models, cannot completely understand how they combine variables to make predictions, undermines the time-honoured scientific method, which lies at the heart of medical practice. It remains to be seen how the medical community will respond and adapt to these unique challenges.  Conclusion  Artificial intelligence offers exciting potential in the area of accurate health information access and delivery, improvement in the efficiency of health system workflows and in lessening the burden on HCPs. Most of the health-related UN SDGs and targets would benefit from the appli -  cation of AI and machine learning. However, considerations regarding how AI could inadvertently introduce further inequality into healthcare in LMIC as well as the ethical conundrum of preserving the integrity of consent should not be ignored as this technology becomes more estab -  lished in mainstream clinical practice.  Table 1  Potential AI solutions to global health system challenges.  Global Health System Challenge Potential AI Solution  Increasing demand for health services Health administrator workload Lack of workflow efficiency Chronic illness management Hospital readmissions Remote patient monitoring Prediction of sepsis Electronic health record analysis Analysis of unstructured clinical notes Extraction of codes from death certificates Robotic process automation Identification of skin lesions and abnormalities in radiographic images, biopsies and cytologic smears Robotic surgery Patient self-monitoring from wearable devices Drug adherence reminders Drug-drug interaction alerts Use of chatbots for mental patient communication Prediction of readmission from discharge notes  G. Alhussain et al.\nHealth Policy and Technology 11 (2022) 100661  3 Funding  None  Ethical approval  Not required  Patient consent  Not required  CRediT authorship contribution statement  GTF was responsible for study conception. GA, AK, EO and DQ contributed equally to the preparation of the first draft of the manu -  script, which was edited for significant intellectual content by GTF. All authors read and approved the final version of the manuscript.  Declaration of Competing Interest  None declared  References  [1]   Lim B, Flaherty G. Artificial intelligence in dermatology: are we there yet? Br J Dermatol 2019;181(1):190 – 1. [2]   World Health Organization. 2012. Sustainable Development Goals (SDGs). Available at: https://www.who.int/health-topics/su stainable-development-goals#tab = tab_2 (accessed 14 April 2022). [3]   Arora N, Banerjee A, Narasu M. The role of artificial intelligence in tackling COVID-19. Future Virol 2020;15(11):717 – 24. [4]   Vinuesa R, Azizpour H, Leite I, et al. The role of artificial intelligence in achieving the Sustainable Development Goals. Nat Commun 2020;11(1):233. https://doi. org/10.1038/s41467-019-14108-y. [5]   Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53(5): 812 – 8. https://doi.org/10.1161/HYPERTENSIONAHA.108.127977. [6]   Revell AD, Wang D, Wood R, et al. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. J Antimicrob Chemother 2013;68(6):1406 – 14. https:// doi.org/10.1093/jac/dkt041. [7]   Das D, Vongpromek R, Assawariyathipat T, et al. Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning. Malar J 2022;21(1):122. https://doi.org/10.1186/s12936-022- 04146-1. [8]   Gradus JL, Rosellini AJ, Horv ´ ath-Puh ´ o E, et al. Predicting sex-specific nonfatal suicide attempt risk using machine learning and data from Danish national registries. Am J Epidemiol 2021;190(12):2517 – 27. https://doi.org/10.1093/aje/ kwab112. [9]   Liu H, Yue F, Xie Z. Quantify the role of anthropogenic emission and meteorology on air pollution using machine learning approach: a case study of PM2.5 during the COVID-19 outbreak in Hubei Province. China. Environ Pollut. 2022;300:118932. https://doi.org/10.1016/j.envpol.2022.118932. [10]   World Health Organization. 2021. Ethics and governance of artificial intelligence for health: WHO guidance. Available at https://www.who.int/publications-detail- redirect/9789240029200 (last accessed 4 November 2021).  G. Alhussain et al.',0.23865950359128857,'[\"(2022)\", \"(accessed\", \"(ai),\", \"(g.t.\", \"(hcps)\"]','2025-11-29 17:02:32.176025'),(55,3,'Vol. 42 No 2, May - August 2024 ISSNp: 0120-5307 • ISSNe: 2216-0280 Check for updates  Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age  Víctor Pérez Cantó 1,9 https://orcid.org/0000-0003-1669-6359 Víctor M. González Chorda 2 https://orcid.org/0000-0001-7426-6686 Francisco Miguel Escandell Rico 3,9 https://orcid.org/0000-0001-7888-8538 Manuel Platero Horcajadas 4,9 https://orcid.org/0000-0001-9211-7027 Francisco Javier Ferrández Pastor 5,9 https://orcid.org/0000-0002-3763-4790 Ana Castillo López   6 https://orcid.org/0000-0002-7117-1144 María Jesús Valero Chillerón 7 https://orcid.org/0000-0001-8943-5243 Loreto Maciá Soler 8,9 https://orcid.org/0000-0002-1801-7607  1   Nurse, Ph.D. Professor. Hospital VITHAS Perpetuo Socorro, Alicante; Spain. Email: victor.pc@ua.es 2   Nurse, Ph.D. Professor, Universitat Jaume I,   Castelló de la Plana; Spain. Email: vchorda@uji.es 3   Nurse, Ph.D. Professor. Email: francisco.escandell@ua.es 4   Computer Engineer, PhD candidate. Email: manuel.platero@ua.es 5   Industrial Engineer, Ph.D. Professor. E-mail Fjferran@ua.es 6   Nurse, Masters. Professor, Universidad Cardenal Herrera, Elche; Spain. E-mail:   anacl90.ac@gmail.com 7   Nurse, PhD. Professor, Universitat Jaume I, Castellón; Spain. Email: chillero@uji.es 8   Nurse PhD. Professor. Email: loreto.macia@ua.es. Corresponding author. 9   Universidad de Alicante; Spain  Conflicts of interest:   None.  Received:   April 13, 2024.  Approved:   May 23, 2024.  How to cite this article:   Pérez V, González VM, Escandell FM, Platero M, Ferrández FJ, Castillo A, Valero MJ, Maciá L. Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age. Invest. Educ. Enferm. 2024; 42(2):e07.  DOI:   https://doi.org/10.17533/udea.iee.v42n2e07 https://creativecommons.org/licenses/by-nc-sa/4.0  Original article\nDevelopment and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age Invest Educ Enferm. 2024; 42(2): e07 Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age  Abstract Objective.   This work sought to develop the   Actuasalud   platform   as a useful tool for nursing that permits assessing health, in term of frailty, in population over 65 years of age.   Methods.   For the design and development of   Actuasalud , two working  groups were formed: one from nursing with different profiles, to identify the scientific  content and a computer science group responsible for the software programming and  development. Both teams adapted the scientific content to the technology so that  the tool would allow for population screening with detection of health problems and frailty states.   Results.   The software was developed in three large blocks that include all the dimensions of frailty: a) sociodemographic variables, b) comorbidities, and c) assessment tools of autonomy-related needs that evaluate the dimensions of frailty. At the end of the evaluation, a detailed report is displayed through bar diagram with the diagnosis of each of the dimensions assessed. The assessment in the participating elderly showed that 44.7% ( n   = 38) of the population was considered not frail, and 55.3%;   (n   = 47) as frail. Regarding associated pathologies, high blood pressure (67.1%;   n   = 57), osteoarthritis and/or arthritis (55.3%;   n   = 47), diabetes (48.2%;   n   = 41) and falls during the last year (35.3%;   n   = 30) were highlighted.  Conclusion.   Actuasalud   is an application that allows nursing professionals to evaluate frailty and issue a quick diagnosis with ordered sequence,   which helps to provide individualized care to elderly individuals according to the problems detected during the evaluation.  Descriptors:   aged;   frailty;   software;   information   systems;   health   management; needs assessment.  Desarrollo y evaluación de un software diseñado por un equipo de enfermería y tecnología para la valoración del estado de salud de los adultos mayores de 65 años  Resumen Objetivo.   Desarrollar la plataforma   Actuasalud   como una herramienta útil para enfermería que permita evaluar la salud, en términos de fragilidad, en población mayor   de   65   años.   Métodos.   Para   el   diseño   y   desarrollo   de   Actuasalud ,   se  constituyeron dos grupos de trabajo: uno de enfermería con diferentes perfiles para identificar el contenido científico y uno informático que se responsabilizó de  la programación y desarrollo del software. Ambos equipos adaptaron el contenido  científico   a la tecnología de manera que la herramienta permitiese hacer un  cribado poblacional con detección de problemas de salud y estados de fragilidad.  Resultados.   Se desarrolló el software en tres grandes bloques que incluyen todas  las dimensiones de fragilidad: a) variables sociodemográficas, b) comorbilidades y  c) herramientas de evaluación de necesidades relacionadas con la autonomía que  evalúan las dimensiones de fragilidad. Al finalizar la evaluación, se visualiza un\nVíctor Pérez Cantó • Víctor M. González Chorda • Francisco Miguel Escandell Rico • Manuel Platero Horcajadas Francisco Javier Ferrández Pastor • Ana Castillo López • María Jesús Valero Chillerón • Loreto Maciá Soler Invest Educ Enferm. 2024; 42(2): e07 informe detallado mediante diagrama de barras con el diagnóstico de cada una de las dimensiones evaluadas. La evaluación en los mayores participantes mostró que el 44.7% ( n   = 38) de la población se consideró como no frágil, y un 55.3%;   (n   = 47) como frágiles. En cuanto a las patologías asociadas, destacaron hipertensión arterial (67,1 %;   n   = 57), artrosis y/o artritis (55.3%;   n   = 47), diabetes (48.2 %;   n   = 41) y caídas en el último año (35,3 %;   n   = 30).   Conclusión.   Actuasalud  es una aplicación que permite a los profesionales de enfermería evaluar fragilidad y emitir un diagnóstico de forma ágil con secuencia ordenada que ayuda a brindar cuidados individualizados a personas mayores de acuerdo los problemas detectados en la evaluación.  Descriptores:   adulto   mayor;   fragilidad,   programas   informáticos;   sistemas   de información; gestión en salud; evaluación de necesidades.  Desenvolvimento e avaliação de um software desenvolvido por uma equipe de enfermagem e tecnologia para avaliação do estado de saúde de adultos com mais de 65 anos  Resumo Objetivo.   Desenvolver a plataforma Actuasalud como uma ferramenta útil para a enfermagem que permite avaliar a saúde, em termos de fragilidade, numa população com mais de 65 anos.   Métodos.   Para a concepção e desenvolvimento do Actuasalud  foram formados dois grupos de trabalho: um grupo de enfermagem com perfis diferentes, para identificar o conteúdo científico, e um grupo de informática que foi  responsável pela programação e desenvolvimento do software. Ambas as equipas  adaptaram o conteúdo científico à tecnologia para que a ferramenta permitisse o  rastreio da população para detectar problemas de saúde e estados de fragilidade.  Resultados.   O software foi desenvolvido em três grandes blocos que incluem todas  as dimensões da fragilidade: a) variáveis   sociodemográficas, b) comorbidades ec) instrumentos de avaliação de necessidades relacionadas à autonomia que avaliam as dimensões da fragilidade. Ao final da avaliação é apresentado um relatório  detalhado através de um diagrama de barras com o diagnóstico de cada uma das dimensões avaliadas. A avaliação nos idosos mostrou que 44.7% ( n =38) da população foi considerada não frágil e 55.3%; ( n =47) como frágil. Quanto às  patologias associadas, destacaram-se a hipertensão arterial (67.1%;   n =57), a osteoartrite e/ou artrite (55.3%;   n =47), a diabetes (48.2%;   n =41) e as quedas no último ano (35.3%;   n =30).   Conclusão.   Actuasalud é um aplicativo que permite ao  profissional de enfermagem avaliar a fragilidade e emitir um diagnóstico de forma  ágil e com sequência ordenada que auxilia no atendimento individualizado ao idoso de acordo com os problemas detectados na avaliação.  Descriptores:   idoso ;   fragilidade; software; sistemas de informação; gestão em saúde  avaliação das necessidades.\nInvest Educ Enferm. 2024; 42(2): e07 Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age Introduction H ealth systems face an epidemiological outbreak of people with  an elderly profile, multimorbidity and complex care needs, which  represent a clinical and social challenge. Factors, like demographic change, increased life expectancy, lifestyles or sustainability of health systems, make the importance of prevention and health promotion  acquire   significant   dimensions   to   guarantee   accessible,   universal,   and  equitable health care.   (1)   In the 21   st   century, digital resources provide the opportunity for communication to progressively reach all social levels, which means receiving immediate feedback for people. Nursing is not immune to this technological impact, but must seek a balance between the comprehensive care of individuals and the use of technologies that facilitate this task. Information and communication technologies (ICTs) offer an opportunity for application in different areas from which the health sector is not exempt (e-health). (2)   E-health programs contribute to enhance people-centered systems, improve public health capacity towards universal coverage, and enable quality care using technology and internet connectivity to improve health services. (2)   Digital technologies and, especially mobile and wireless technologies, are  appropriate in the health field given their ease of use, dissemination, and acceptance. Specifically, the elderly, by increasing technological usability, are an ideal group to benefit from advances in the use of ICTs that can help  prevent frailty. (3)   A survey conducted in 2022 by the Statistics National Institute (INE, for the term in Spanish) in Spain, related with technological usability, showed increased use of ICTs up to 85% in the elderly with 22% of the population over 75 years of age included in the survey data using the internet.   (4)   This may be the reason why many commercial companies and researchers have taken advantage of ICTs to design applications aimed at promoting healthy habits that can also serve as social support for the elderly. (5)   Most applications focusing on the elderly address health problems such as multiple medications, monitoring of vital signs or falls, among other aspects, but in a single-dimensional manner.   (6)   Furthermore, the number of mobile applications that allow evaluating complex or frail situations and guaranteeing a comprehensive approach to nursing care is limited. (7)  To use the term frailty, we must go back to the 1980s when frailty was defined  as a syndrome with a multiplicity of clinical-biological manifestations but no symptoms.   (8)   Frailty is dynamic, potentially reversible, process, predictor and risk factor for disability and of serious adverse events where, once a state of disability is reached, it is no longer reversible and evolves towards dependency. (8)   Lack of consensus exists on the definition and screening methods for frailty, although by the late 1990s the World Health Organization defined as  risk factors for frailty that of being over 80 years of age; having a disabling chronic illness; being institutionalized; suffering from comorbidities, disability,\nInvest Educ Enferm. 2024; 42(2): e07 Víctor Pérez Cantó • Víctor M. González Chorda • Francisco Miguel Escandell Rico • Manuel Platero Horcajadas Francisco Javier Ferrández Pastor • Ana Castillo López • María Jesús Valero Chillerón • Loreto Maciá Soler dependence,   cognitive   alterations,   depression, frequent falls, loneliness, and risk of poverty. (1) Given the lack of comprehensive approaches to understanding the health status of the elderly, the scarcity of tools to support decision making, and the need to increase prevention and health promotion actions in this group, it seems pertinent to develop comprehensive assessment tools, as is the case of the   Actuasalud   digital platform, a software created for the purpose of standardizing and improving the assessment of health conditions and   frailty   screening   in   the   elderly   population living in the community. It is a software aimed at nurses that allows assessing the state of health and frailty in people over 65 years of age from any mobile device.   (9)   The aim of this study was to introduce the development of the   Actuasalud  platform   from its conception as research (R), its technological development (D), and innovation (I) as a useful tool for nursing that permits assessing health in population over 65 years of age and showing the results obtained from the assessment  of the first sample of elderly evaluated.  Methods  To create   Actuasalud , a scientific team called  Tecnosalud   was   organized   at   Universidad   de Alicante   in   Spain,   made   up   of   two   computer  engineers   and   five   nursing   professionals   with different profiles, two nurses with academic profile  and > 5-year experience in public universities, two care nurses from the public primary health care system, and one nurse with private hospital  management   profile.   To   carry   out   the   work, the   scientific   team   was   separated   into   two  groups, a health group and a technology group. The coordination was performed by the senior academic nurse as head of the Tecnosalud team. Both groups established the conceptual bases for the construction of the   Actuasalud   platform: basic  definition aspects of the application, development  objectives, and contributions or results expected, as well as the objectives of each R+D+I phase. The   research   and   development   process   was conducted between 2019 and 2020 The   work   of   the   health   group   consisted   in conducting   an   exhaustive   literature   review   to decide the content of the software with the best evidence on the environment in the assessment of the needs and syndromes that affect older adults prior to the development of the application. The   study   followed   recommendations   for   the detection of alterations in human needs and frailty in primary care and in the community setting. (10,11)   A selection of validated questionnaires and diagnostic tests was also made to assess health and   provide   a   diagnosis   related   with   frailty. (3) Additionally, a selection of complementary tests  was conducted to allow specific health problems  to be diagnosed independently. This would permit implementing adequate strategies in care, health promotion, and disease prevention to each group of   elderly   individuals   with   similar   problems. Upon constructing the   Actuasalud   contents, for its validation with individuals, the study had four healthcare   nurses   from   a   primary   care   center and who had not participated in the construction  of the platform. During the first 85 evaluations, every   time   five   health   diagnoses   were   made,  a consensus group compared the results of the evaluation   with   the   observation   by   the   nurse evaluator,   which   allowed   correcting   possible diagnostic errors. The software engineering used an agile application development   method   known   as   eXtreme Programming (XP).E. (12)   The method followed was based on continuous feedback between nurses and the development team. Thus, dynamic and short development cycles were proposed. Through several meetings by both teams, the requirements and functionalities were agreed; these meetings were   held   periodically   at   the   start   of   the development of each prototype. General phases in software development were followed to create the application’s prototypes;   (12)   hence, in each cycle,  a complete process of defining requirements and  needs, design and development, and evaluation was carried out (Figure 1).\nInvest Educ Enferm. 2024; 42(2): e07 Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age Figure 1. Phases of the development cycle of the   Actuasalud   s oftware to assess health in the elderly  Design and development de la Actuasalud platform  Upon   establishing   the   system’s   minimum requirements   through   meetings   between   the nursing and technology groups, it was decided on the construction of a digital platform aimed at nursing professionals to expedite the evaluation of non-institutionalized individuals > 65 years of age without cognitive impairment. The evaluation had   to   determine   the   health   status   of   the individuals by obtaining information related with their autonomy and possible state of frailty, in this order (Frailty; cognitive, functional, and nutritional states;   health-related   quality   of   life;   socio- family situation; affective state; mobility; vision; hearing;   security;   sleep;   and   pain);   (9)   besides collecting socio-demographic data, comorbidities and pharmacological treatment. This permitted viewing a health diagnosis and formulating an individualized   nursing   care   prescription.   The order of the items and nursing assessment scales was determined; once the informed consent from each person is obtained, the evaluation begins with the socio-demographic data to continue with the   comorbidities;   prosthesis   and   drugs   taken at the time of the evaluation to continue with the evaluation scales that the software should contain, as well as the scores that establish the differences among health states. The software was developed with two principal elements: (i) Element 1. Application programed with   WEB   technology   using   the   IONIC   cross- platform   mobile   programming   framework;   (ii) Element 2. Administration panel and an application programming interface (API) that permit managing the information shown in the application. This part was developed via PHP   through the Symfony development framework, which is connected to a MYSQL database   through the ORM   Doctrine. The application’s research and development was carried out between March and September 2019 and   innovation   with   knowledge   transfer   took place in November 2020. As of the moment of the knowledge transfer, the necessary steps to commercialize the platform were undertaken. (9)  Tool validation  To validate the tool, 85 individuals > 65 years of   age   without   cognitive   impairment   and   not institutionalized were evaluated. These subjects were   contacted   through   nurses   from   primary care centers who decided to collaborate in the project.   The   assessment   was   performed   by practicing   clinical   nurses   who   collaborated   in the   project   through   cooperation   agreements with the university. To contrast the results of the assessments,   six   consensus   groups   organized made up of the nurse who had carried out the assessment,   the   person   responsible   for   the software, an observer nurse, and the coordinator of the Tecnosalud team. The coordinator is an  academic/research nurse with over five years of  experience; the observer and evaluating nurses\nInvest Educ Enferm. 2024; 42(2): e07 Víctor Pérez Cantó • Víctor M. González Chorda • Francisco Miguel Escandell Rico • Manuel Platero Horcajadas Francisco Javier Ferrández Pastor • Ana Castillo López • María Jesús Valero Chillerón • Loreto Maciá Soler had over five years of clinical experience; and  the person responsible for the software was a  computer engineer with five years of experience.  This group met once per week to validate that the result, of the assessments issued by   Actuasalud , corresponded to the evaluator’s perception. (13 )   In case of disagreement between the score obtained in any dimension and the opinion of the evaluating nurse, its origin was analyzed to assess and even discard the evaluation with diagnostic purposes.  Statistical analysis  A descriptive statistical analysis was conducted using the chi-square test for the prevalence of frailty and care needs, comparing socio-demographic and clinical variables in function of two levels of frailty (Not frail and Frail). Thereafter, multivariate logistic models   were   adjusted   to   estimate   the magnitude   of   the   associations,   estimating   the Odds Ratios (OR). Analyses were performed via SPSS v.26 and R v.4.0.0 packages.  Ethical considerations  For the process of elaboration of   Actuasalud   and its validation, ethical and legal aspects have been followed according to the Declaration of Helsinki   (14) and Organic Legislation 3/2018, of December 5, on the Protection of Personal Data and guarantee of digital rights, (15)   as well as Regulation (EU) 2016/679 by the European Parliament and by the Council of 27 April 2016, on the Protection of Individuals. Prior to each assessment, informed consent was requested from each participant. Data stored in   Actuasalud   is encrypted through  a private key certificate, which encrypts all open  response evaluation data, such as the observation  fields   and   prevents   data   from   an   assessment  from being associated with a patient. The server and database where the data is stored has an access control system where all access attempts are   recorded.   Lastly,   access   to   data   from   an assessment from the application is recorded and  monitored through files that keep the registry of  user actions in the application. Thus, it allows to   verify   which   person   has   accessed   certain data. For data protection,   Actuasalud   includes a   module   online   management   of   informed  consents to ensure rights of access, rectification,  cancellation,   and   opposition.   Furthermore,   the system is designed to generate, without trace, the assignment of a random number that will be used  as identification of the user’s assessment.  Results  This study resulted in the development of the  Actuasalud   software, registered by Universidad de Alicante, (9)   transferred for its commercialization after having gone through all the technological maturity phases,   using   the   Technology   Readiness   levels (TRL) scale from TRL1 (basic principles observed) to   TRL9,   real   system   tested   in   an   operational environment   (competitive   manufacturing   in the   case   of   key   enabling   technologies).   It   can be assured that   Actuasalud   is able to evaluate autonomy, needs of daily life, and frailty states in population over 65 years of age without cognitive impair, with diagnostic report and data dump for subsequent analysis.  Software-related aspects  The   Actuasalud   platform   comprises three large blocks: (i) Sociodemographic variables: age, sex, educational   level,   marital   and   socioeconomic status among others; (ii) Comorbidities; and (iii) Validated needs assessment scales that evaluate cognitive state, frailty, functional status, nutritional status,   quality   of   life,   socio-family   situation, affective state, mobility, vision, hearing, safety (risk of falls and pressure ulcers), sleep, and pain. (3)   The forgoing are summarized in Table 1.\nInvest Educ Enferm. 2024; 42(2): e07 Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age Table 1. Scales used to assess needs and number of items that compose them  Need assessed   Scale used   Nº of items  Frailty   Frail   18 Cognitive state   PFEIFFER’S test   11 Nutritional assessment   Nutrition Screening Initiative (NSI)   10 Health-related quality of life   EQ-5D questionnaire   6 Functional state. Autonomy for basic daily living activities   BARTHEL’S index   10 Functional state. Instrumental daily living activities   LAWTON-BRODY index   8 Social risk   GIJON scale   5 Affective state   YESAVAGE scale   15 Assessment of visual ability   VF-14 scale   14 Hearing evaluation   ADDA scale   12 Risk and prediction of falls   STRATIFY scale   7 Risk of developing pressure ulcers   Braden’s index   6 Quality of sleep   Athens scale   8 Pain assessment   Pain numerical scale   1 Total   -   131 The three large blocks of   Actuasalud   make up 214 items and the mean time used by nurses to   conduct   the   assessment   is   35   minutes. Construction of the application’s functionalities had three iterations that served in the development of successive prototypes.   For 3 months, a first version   (first   iteration)   was   developed,   where  the proof of concept was carried out, followed by a second iteration with intervention by the  scientific team and the nurses who conducted  the   evaluations;   this   iteration   lasted   another  three   months   and   testing   began   on   the   final  version. During this period (third iteration), the  first 85 individuals were assessed by nurses from  primary care centers and through the meetings of the consensus groups, the result obtained by the platform was evaluated, with respect to the observation by the evaluating nurse regarding the elderly person evaluated.  Results of the first assessment performed on elderly individuals with   Actuasalud  The   study   included   85   participants   who  fulfilled the inclusion criteria with a mean age  of   74.28   (±6.43)   years,   the   minimum   age was 65 years and the most advanced was 91 years.   The   sociodemographic   characteristics revealed prevalence of the female sex (61.2%), no educational level (50.6%), not living alone (55.3%), and 77.6% were retired with income under 900 € (72.9%), and 71.8% did not receive  social benefits.\nInvest Educ Enferm. 2024; 42(2): e07 Víctor Pérez Cantó • Víctor M. González Chorda • Francisco Miguel Escandell Rico • Manuel Platero Horcajadas Francisco Javier Ferrández Pastor • Ana Castillo López • María Jesús Valero Chillerón • Loreto Maciá Soler Table 2. Sociodemographic variables of the 85 older adults participating in the study  Variables   Categories   n   %  Sex   Female   52   61.2 Male   33   38.8 Educational level   None   43   50.6 Primary studies   32   37.6 High school   5   5.9 University   5   5.9 Living conditions   Lives alone   38   44.7 Lives with partner   42   49.4 Lives with children   8   9.4 Lives with a relative   3   3.5 Lives with a caregiver   1   1.2 Usual occupation   Housekeeper   17   20.0 Employed   0   0.0 Unemployed   2   2.4 Retired   66   77.6 Marital status   With a partner   43   50.6 Without a partner   16   18.8 Widowed   26   30.6 Monthly income   Without income   7   8.3 < 900 €   55   64.7 Between 900 € and 1200 €   10   11.9 > 1200 €   13   15.5  Social benefits   Yes   24   28.2 No   61   71.8 Comorbidities   showed   a   series   of   associated pathologies among which were highlighted arterial hypertension (67.1%;   n   = 57), osteoarthritis and/ or arthritis (55.3%;   n   = 47), diabetes (48.2%;  n   =4 1), and falls within the last year (35.3%;  n   = 30). Regarding the analysis of care needs based on frailty, it was found that 44.7% ( n   = 38) of the population was considered Not frail, and 55.3%;   n   = 47 as frail. The cut-off point to differentiate the groups is three or more points according with the frailty scale. The results of the sociodemographic and clinical variables showed  statistically   significant   differences   in   function of   frailty;   specifically,   a   significant   association  was observed, with lower percentages in non- frail   individuals   against   those   who   are   frail,  between being frail and receiving social benefits  (25% Vs. 75%;   p =   0.001),   having circulatory problems (18.8% Vs. 81.2%;   p =   0.041), and taking analgesics regularly (24.2% Vs. 75.8%;  p   = 0.005).\nInvest Educ Enferm. 2024; 42(2): e07 Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age Regarding the results of the analysis of the battery of   instruments   to   measure   frailty-based   care  needs,   those   with   statistical   significance   were  included; it was noted that frail participants with respect to those not frail had greater care needs in relation to their cognitive state (50% Vs. 50%;  p   = 0.004), basic needs of daily life (75.9% Vs. 24.1%;   p   = 0.012), instrumental activities (45.5% Vs. 54.5%;   p   = 0.002). The quality of life results were broken down into three levels: very good; good, and fair-poor for correlation with frailty and observing very good 26.3% Vs. 73.7%; good 62.9% Vs. 37.1%, and fair-poor 64.5% Vs. 35.5; ( p   = 0.016). Among the responses to the  EQ-5D questionnaire, statistical significance was  found in the following items, mobility (39% Vs. 61%;   p   = 0.037), hearing (69.4% Vs. 30.6%;   p  = 0.043), falls (42.1% Vs. 57.9%;   p   = 0.048), risk of pressure ulcers (77.8% Vs. 22.2%;   p   = 0.009), and pain (35% Vs. 65;   p =0.001). According with the results of the logistic regression, any status other than retired was considered a risk factor for developing frailty (OR = 4.1, 95% CI = 1.1-15.7);   p   = 0.0355), while not being diabetic (OR = 0.3; 95% CI = 0.1-0.9;   p   = 0.0446) and not having hearing problems (OR = 0.2; 95% CI = 0.1-0.8;   p   = 0.0202) were considered protective factors (Table 3).  Table 3. Multivariate analysis of frailty with the total scores of the questionnaires, and with the sociodemographic variables and comorbidities  Variables   Categories   OR (95% CI OR)   p- value  Age in years   65-74   1   0.0544 >= 75 years   2.6 (0.9-7.2) Sex   Female   1   0.3105 Male   0.5 (0.2-1.6) Usual occupation   Retired   1   0.0355 Other   4.1 (1.1-15.7) Diabetes   Yes   1   0.0446 No   0.4(0.1-0.9) Final hearing score   Requires exploration   1   0.0202 Does not require exploration   0.2 (0.1-0.8)  Discussion  Evaluating   the   health   status   of   the   elderly population and seeking to identify intervention programs that improve the lives of the elderly is a socio-health need of interest. In this regard,  Actuasalud   has been developed, composed of 14 scales, which assesses 12 dimensions, like cognitive   state,   frailty,   basic   and   instrumental activities of daily living, feeding, mobility, affective state, social, risk of falls, and pressure ulcers among others to allow autonomous decision making by nurses about the health of the elderly population. Most   mobile   applications   aimed   at   assessing health problems lack a comprehensive evaluation system of health problems in the elderly, with their  use limited to specific purposes. (16)   Nevertheless, mobile   applications   exist   that   bear   similarities with   Actuasalud , given that they use similar tools to assess different dimensions with repercussion\nInvest Educ Enferm. 2024; 42(2): e07 Víctor Pérez Cantó • Víctor M. González Chorda • Francisco Miguel Escandell Rico • Manuel Platero Horcajadas Francisco Javier Ferrández Pastor • Ana Castillo López • María Jesús Valero Chillerón • Loreto Maciá Soler on frailty and the elderly. A number of applications  were identified with a frailty approach, each with  different recipients for their use, different clinical criteria, scales and areas, on the one hand, some of these applications are commercialized, which is   the   case   of   Dependence   Indicators   (17)   that include validated scales and permit calculating functional values, with an approach for social work professionals. Other applications have use on development based on comprehensive geriatric assessment, allowing to calculate scale scores and explore clinical recommendations.   (18) For   example,   there   is   PowerFrail   that   mainly evaluates   muscle   strength   (19)   or   GeriatriAPP ,   (18) which   although   designed   to   carry   out   a comprehensive geriatric assessment, has a clinical approach that includes the prediction of mortality through the Charlson Index, evaluation of risk medications, and a frailty approach focused on the Study of Osteoporotic Fractures, which provides data for non-nursing decision making. According to a Cochrane systematic review published in 2022, (20)   the comprehensive geriatric assessment was designed to elaborate a comprehensive care plan with inconclusive results.  Actuasalud   was constructed with a preventive disease approach to promote active aging and identify prevention programs relevant to the older population, as recommended in frailty consensus documents,   like   the   updated   proposal   by   the Spanish Ministry of Health for 2022 that includes recent situations, such as the COVID-19 pandemic. (21)   One of the key points in the   Actuasalud   design focuses on the evaluation of needs, early detection of problems, and care continuity, aspects of caring that   are   the   responsibility   of   nurses   and   that assessment   instruments,   such   as   Actuasalud ,  contribute   to   decision   making   by   nursing   to maintain health in the elderly. According with the digital recommendations by the WHO, digital monitoring of the population is a priority to gather information on health status and its management and electronic health records allow the availability of information and facilitate the search, analysis, and way of sharing information and streamline different phases of care processes. Screening for frailty and assessment of human needs in primary care is useful;   (18,22)   however, in actuality in the daily clinical practice screening is not yet carried out homogeneously and, in fact, in Spain, health indicators related with frailty since 2022 seek to gather reliable frailty monitoring information   that   permits   intervening   with prevention as of younger ages. (21)   The challenge  is to move towards a standardized definition of  frailty, as well as the use of electronic problem detection systems that can be easily implemented in clinical practice.   (18,22)   Nevertheless, efforts in implementing   tools   that   support   surveillance, awareness,   and   support   systems   in   decision making   are   currently   the   least   implemented, behind services such as telephone services and telemedicine. The   need   to   use   ICTs   requires   material   and human resources that, in turn, increase the cost of care in the short term; nevertheless, in the mid- and long term ICTs diminish care costs.   (23) Not only should we ponder about the search for new tools that include user participation, these must also be cost-effective and in addition to robotics   (23)   and technological innovation, be able to produce changes in the process of caring for the elderly.   Along these lines, the presence of mobile technologies is evident, associated with monitoring daily activities and risk situations,   (24) which are complementary to the contributions made by   Actuasalud . Herein, we highlight three points of improvement that can be obtained with the study of frailty: fall   prevention,   frailty   prevention   or   detection, and improved autonomy to carry out activities of daily life. (8)   Prevention is the key to improve the quality of life of the elderly and sensory-based fall prevention systems are advanced; the majority of fall prevention devices use wireless motion and pressure sensors to determine the risk of falls by comparing data with normal behavioral\nInvest Educ Enferm. 2024; 42(2): e07 Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age patterns.   (25)   Sensorization   of   daily   activities   to report on habits, such as pressure in bed, time away from home, or home activities has also been used. (25)   However, all prevention systems require prior evaluation and screening that starts with the health assessment, so that the results of   said   assessment   permit   guiding   prevention  actions efficiently. This is the principal function by  Actuasalud   that as usability increases, it will allow progress towards automatic care prescription and frailty prediction. This study concludes that the   Actuasalud   digital platform has been constructed with knowledge from nursing and technology and is accessible to be used by nursing aimed at increasing the use of frailty assessment tools. Its use by clinical nurses contributes in decision making and to support the use and treatment of the assessment data.  In the field of nursing education, it can be used  in students learning about the use of information technology and computing to evaluate care needs. With the selection of the dimensions   to assess in  Actuasalud ,   the dynamics of the interview between professional and user were favored, along with achieving   reduced   assessment   time,   improved visualization of patient data, the possibility of the tool to assist the interviewer (through notes in the questions), and, in short, speeding up the interview and data collection process.   Actuasalud  is a preventive tool for use by nurses that allows population screening to detect health problems and frailty states. It consists of a computer system accessible from any mobile device, which permits easily   assessing   and   detecting   altered   human needs, health and frailty states in population over 65 years of age, with an ordered sequence and with featured functionalities, like management of informed consents, data storage and evaluations, export to databases for subsequent processing, and issuance of graphic reports of the assessments.  Actuasalud   has   completed   the   R+D+I   cycle successfully. This research has a limitation in the recruitment of subjects and their subsequent follow-up, given  its difficulty to compete with evaluation systems  established in health systems. As future lines of research and development, the implementation of a meta tool is planned to simplify data collection while   maintaining   the   effectiveness   of   the evaluation that is already being worked on. It is also planned, within the same tool, to advance in the prescription of care and monitoring of individuals assessed to observe possible improvements in their condition or delay in frailty, and even for the system to allow their reference healthcare team to be informed of these warning signs to prevent complications.  Funding.   Conducted within the framework of a business innovation project, funded by Agencia Valenciana de Innovación (AVI) and Universidad de Alicante with a group of experts from the areas   of   engineering   and   health.   Management Center:   Department   of   Information   Technology and Computing. Code:2019/01135/003. Internal reference:AVI1-21.\nInvest Educ Enferm. 2024; 42(2): e07 Víctor Pérez Cantó • Víctor M. González Chorda • Francisco Miguel Escandell Rico • Manuel Platero Horcajadas Francisco Javier Ferrández Pastor • Ana Castillo López • María Jesús Valero Chillerón • Loreto Maciá Soler References  1.   World Health Organization/Regional Office for Europe. Health 2020: the European policy for health and well-being  [Internet]. 1 st   ed. Denmark: World Health Organization/Regional Office for Europe; 2012. 180 p. Available from: http://www.euro.who.int/__data/assets/pdf_file/0011/199532/Health2020-Long.pdf  2.   González Oñate C, Fanjul Peyró C. Aplicaciones móviles para personas mayores: un estudio sobre su estrategia actual. Revista Aula Abierta. 2018; 47(1):107–12 3.   Pérez Cantó V. Desarrollo de un sistema informático para la identificación de necesidades humanas alteradas,  fragilidad y estados de salud en adultos mayores de 65 años que viven en la comunidad. 2021; Available from: http://hdl.handle.net/10803/672239. 4.   Instituto nacional de estadística. España; 2022. Available from: https://www.ine.es/jaxi/Datos.htm?tpx=60815#_  tabs-grafico  5.   Zhang Q, Guo X, Vogel D. Addressing elderly loneliness with ICT Use: the role of ICT self-efficacy and health  consciousness. Psychology, Health & Medicine. 2022; 27(5):1063-71. 6.   Solidaridad intergeneracional. Agenda 2030 [Internet]. Available from: https://solidaridadintergeneracional.es/wp/ applications-moviles-para-personas-mayores/ 7.   Koivunen M, Saranto K. Nursing professionals’ experiences of the facilitators and barriers to the use of telehealth applications: a systematic review of qualitative studies. ScandinavianJournal of Caring Sciences. 2018; 32(1):24- 44. 8.   Menéndez-González L, Izaguirre-Risk A, Tranche-Iparraguirre S, Montero-Rodríguez Á, Orts-Cortés MI. Prevalencia y factores asociados de fragilidad en adultos mayores de 70 años en la comunidad [Prevalence and associated factors of frailty in adults over 70 years in the community]. Revista Atención Primaria. 2021 Dec;53(10):102128. Spanish. doi: 10.1016/j.aprim.2021.102128. Epub 2021 Sep 21. PMID: 34560377; PMCID: PMC8473464. 9.   García-Chamizo JM, Molina-Carmona R, Ferrandez-Pastor F-J, Maciá Soler L, Pérez Cantó V, Ors Montenegro A,   et al .   Actuasalud . RUA_. Universidad de Alicante; 2019. p. 39. Available from: https:// Actuasalud .net 10.   Veronese N, Custodero C, Cella A, Demurtas J, Zora S, Maggi S, Barbagallo M, Sabbà C, Ferrucci L, Pilotto A.  Prevalence of multidimensional frailty and pre-frailty in older people in different settings: A systematic review and meta-analysis. Ageing Research Reviews. 2021; 72:101498. 11.   Early J, Gonzalez C, Gordon-Dseagu V, Robles-Calderon L. Use of Mobile Health (mHealth) Technologies and Interventions Among Community Health Workers Globally: A Scoping Review. Health Promotion Practice. 2019; 20(6):805-17. 12.   Herrera   M.   Ingeniería   del   Software:   Metodologías   y   ciclos   de   vida.   Laboratorio   Nacional   de   Calidad   del Software   [Internet].   Available   from:   https://www.academia.edu/9795641/INGENIERÍA_DEL_SOFTWARE_ METODOLOGÍAS_Y_CICLOS_DE_VIDA_Laboratorio_Nacional_de_Calidad_del_Software 13.   Puigdomenech E, Poses-Ferrer E, Espallarges M. Evaluación de tecnología basada en mSalud para aplicaciones móviles. Informe de evaluación de tecnologías sanitarias [Internet]. 2021. Agència de Qualitat i avaluació  sanitàries de Cataluña. Available from: [https://scientiasalut.gencat.cat/bitstream/handle/11351/6758/evaluacion_  tecnologia_basada_mSalud_para_applications_moviles_2021] 14.   Asociación Médica Mundial (AMM). Declaración de Helsinki. Principios éticos para las investigaciones con seres humanos. 59 a   Asamblea General, Seúl, Corea 2008. 15.   Ley Orgánica 3/2018, de Protección de Datos Personales y garantía de los derechos digitales [Internet]. 5 de diciembre 2018 (España). Available from: https://www.boe.es/buscar/doc.php?id=BOE-A-2018-16673 16.   Silva S, Felgueiras R, Oliveira I. Geriatric Helper: An mHealth Application to Support Comprehensive Geriatric Assessment. Sensors [Internet]. 2018; 18(4):1285. 17.   Indicators of dependence - Apps on Google Play [Internet]. Available from: https://play.google.com/store/apps/ details?id=gr.trevenque.indicadoresdependencia&hl=en_US 18.   Heider A. Bautista, David Perafán, Catalina Torres, Jorge H. López GeriatriApp. Revista Atención primaria. 2020; 52(6): 436-438\nInvest Educ Enferm. 2024; 42(2): e07 Development and Evaluation of a Software Designed by a Nursing and Technology Team to Assess the Health Status of Adults over 65 Years of Age 19.   PowerFrail.   Available   from:   https://www.ciberisciii.es/noticias/powerfrail-una-app-para-evaluar-y-mejorar-la- fragilidad-y-la-potencia-muscular-en-personas-mayores 20.   Briggs R, McDonough A, Ellis G, Bennett K, O’Neill D, Robinson D. Comprehensive Geriatric Assessment for community-dwelling,   high-risk,   frail,   older   people.   Cochrane   Database   of   Systematic   Reviews.   2022;   (5): CD012705. 21.   Ministerio de Sanidad. Actualización del documento de consenso sobre prevención de la fragilidad en la persona mayor. Madrid; 2022. Available from: https://www.sanidad.gob.es/areas/promocionPrevencion/envejecimientoSaludable/ frailtyCaidas/docs/ActualizacionDoc_FrailtyyCaidas_personamayor.pdf]. 22.   Ludlow K, Todd O, Reid N, Yaman H. Frailty in primary care: challenges, innovations, and future directions. BMC Primary Care. 2023; 24(1):129. 23.   Feng Q, Yuan W, Li T, Tang B, Jia B, Zhou Y,   et al . Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. The Lancet Gastroenterology & Hepatology. 2022; 7(11):991-1004. 24.   Stavropoulos TG, Papastergiou A, Mpaltadoros L, Nikolopoulos S, Kompatsiaris I. IoT Wearable Sensors and Devices in Elderly Care: A Literature Review. Sensors (Basel). 2020; 20(10):2826. 25.   Usmani S, Saboor A, Haris M, Khan MA, Park H. Latest Research Trends in Fall Detection and Prevention Using Machine Learning: A Systematic Review. Sensors (Basel). 2021; 21(15):5134.',0.14292798311499208,'[\"%\", \"%;\", \"&\", \"(\", \"(0.1-0.8)\"]','2025-11-29 17:02:58.905926'),(56,3,'Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ARTÍCULO / ARTICLE SALUD COLECTIVA  Tecnologías asistivas para pacientes ancianos con  demencia: perspectivas desde la bioética de los  cuidados en salud  Assistive technologies for elderly patients with dementia:  perspectives from the bioethics of health care  Isis Laynne de Oliveira Machado Cunha 1  1 Doctora en Bioética. Posdoctoranda, Pontifícia Universidade Católica do Paraná, Brasil.   *  RESUMEN   La demencia es actualmente una de las enfermedades más comunes que afecta a las personas mayores,  siendo la séptima causa principal de muerte. Provoca pérdida de memoria, dificultad para razonar y, por consi -  guiente, dificultades para tomar y ejecutar decisiones, por lo que las tecnologías de asistencia y estimulación cog -  nitiva son valiosos recursos en el proceso de cuidado. Desde una investigación teórica basada en la bioética de los  cuidados en salud y en las investigaciones de Aline Albuquerque y Victor Montori, este artículo aborda, en primer  lugar, el concepto de bioética en el cuidado de la salud, la atención centrada en el paciente y la idea de empatía clínica;  en segundo lugar, se centra en el empleo de tecnologías asistivas para el cuidado de adultos mayores con demencia y,  por último, plantea la discusión sobre si el proceso de atención podría ser considerado como una tecnología sanitaria.  PALABRAS CLAVES   Anciano; Demencia; Dispositivos de Autoayuda; Bioética; Empatía.  ABSTRACT   Dementia is currently one of the most common diseases affecting elderly people, ranking seventh among  leading causes of death. As it causes memory loss, difficulties in reasoning, and resulting difficulties in making and ex -  ecuting decisions, assistive technologies and cognitive stimulation are valuable resources in the care process. Based on  a theoretical inquiry into the bioethics of health care, and drawing on the work of Aline Albuquerque and Victor Mon -  tori, this article focuses on three main issues: first, the concept of bioethics in health care, patient-centered care, and  the idea of clinical empathy. Second, it looks at the use of assistive technologies in caring for elderly patients with de -  mentia. Lastly, we offer a discussion of whether the care process could be considered a health technology.  KEYWORDS   Aged; Dementia; Self-Help Devices; Bioethics; Empathy.\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  2  INTRODUCCIÓN  El envejecimiento de la población ha despertado preo -  cupación en relación con la aparición de enfermedades  crónicas cada vez más limitantes. A pesar de no ser una  consecuencia inevitable del proceso de envejecimiento,  la demencia es actualmente una de las enfermedades  más comunes que afecta a las personas mayores, siendo  la séptima causa principal de muerte (1) .  En 2017, la Organización Mundial de la Salud (OMS)  estimó que alrededor de 50 millones de personas en todo  el mundo vivían con demencia, y se esperaba que ese  número se triplicara para 2050 (2) , debido a una serie de  factores poblacionales y demográficos que contribuyen  al aumento de dicho número. Esto genera una enorme  preocupación con relación a los cuidados en salud y la  preservación de los derechos de estas personas, y a la  necesidad de mantener una vida digna (3) , especialmente  en la vejez, ya que en esta etapa el cuidado del cuerpo y  de la salud se hacen más necesarios y costosos (4) .  La demencia, cuando está en su etapa más avan -  zada, afecta las habilidades mentales para la toma de  decisiones, lo que repercute en el ejercicio de la autono -  mía personal y el desarrollo de actividades cotidianas,  requiriendo un alto nivel de cuidado (5) . Cabe destacar que  uno de los predictores de la calidad de vida se refiere a  la posibilidad de realizar personalmente las actividades  del día a día, y al respeto por la autonomía en la toma de  decisiones, especialmente en lo que se refiere al cuidado  en salud (6,7) . En este sentido, los avances tecnológicos  pueden contribuir a mantener la vida autónoma durante  el mayor tiempo posible.  Las   definiciones   de   tecnología   varían   y   el   tér -  mino se puede utilizar como sinónimo de herramienta  o máquina, así como referirse a la aplicación del co -  nocimiento organizado a tareas prácticas por sistemas  ordenados por personas y máquinas (8) . La tecnología  asistencial puede ser descrita como todo dispositivo  técnico que ayuda y facilita la realización de actividades  diarias, reduce el trabajo de las personas cuidadoras y  proporciona mayor autonomía a las personas mayores.  Ejemplos de tecnologías asistivas incluyen dispositivos  GPS para facilitar la ubicación de personas con demen -  cia, robots que contribuyen a la estimulación cognitiva y  social, así como juegos que permiten a las personas con  demencia participar en el ámbito virtual (9) . Sin embargo,  el uso de estas tecnologías también plantea discusiones  éticas sobre el impacto individual y social, para la adap -  tación de pacientes mayores que viven con demencia (8) .  Teniendo en cuenta que la demencia conlleva la  pérdida de memoria, dificultad para razonar y, por con -  siguiente, dificultades para tomar y ejecutar decisiones,  las tecnologías de estimulación cognitiva son valiosos  recursos en el proceso de cuidado, ya que pueden au -  mentar la plasticidad neuronal, prolongar el manteni -  miento de las funciones mentales, motoras y sociales,  así como la capacidad de pensar con claridad y tomar  decisiones (10) .  A pesar del gran número de personas mayores que  viven con demencia en Brasil (4) , existen pocos estudios  que aborden el uso de tecnologías asistivas dirigidas a  este grupo, lo que subraya la necesidad de desarrollar  más investigaciones y discutir aspectos éticos relacio -  nados con el uso de tales mecanismos (9) .  La discusión es importante desde el punto de vista  bioético, ya que se trata de un área multidisciplinaria  que analiza éticamente aspectos de la vida humana en  sus campos más amplios, desde perspectivas que invo -  lucren conceptos ambientales, biológicos, sanitarios,  sociales y valores éticos adoptados en un determinado  contexto (11) . El tema es aún más relevante en lo que res -  pecta al campo de la bioética de los cuidados de salud, ya  que se orienta por el cuidado centrado en el paciente, en  su deseos y preferencias; reconoce la existencia de asi -  metrías de poder en la relación entre el profesional de la  salud y el paciente; y se basa en los derechos humanos  aplicados al contexto del cuidado de la salud, lo que con -  lleva prescripciones éticas y jurídicas para las personas  implicadas en el cuidado (12) .  El uso de tecnologías asistivas dirigidas a pacien -  tes mayores con demencia puede contribuir a la promo -  ción de la autonomía y una mejor calidad de vida o, en  determinados casos, puede aumentar la vulnerabilidad,  especialmente cuando se intenta reemplazar el cuidado  humano por el uso de estas tecnologías (9) .  Ante este escenario, desde una investigación teó -  rica basada en la bioética de los cuidados en salud, este  artículo propone analizar el uso adecuado de tecnolo -  gías asistivas en el campo de los cuidados de salud, con  el objetivo de señalar un camino ético, jurídico y social  apropiado para mejorar la calidad de vida y salud de pa -  cientes mayores con demencia (12,13,14,15) , y cómo el uso  adecuado de tecnologías puede contribuir a la promo -  ción de la autonomía, al aumento de los cuidados de sa -  lud y a la mejora de la calidad de vida de este grupo.  METODOLOGÍA  Este trabajo se sustenta en una investigación teórica, la  cual se distingue de la revisión bibliográfica al ser es -  tructurada sobre una teoría preexistente en un determi -  nado campo de investigación. La esencia de este tipo de  investigación es adoptar una línea teórica que permita  sustentar el análisis y el debate sobre un tema concreto.  El marco teórico no solo guía las direcciones de la inves -  tigación, sino que también proporciona los fundamen -  tos para avalar su solidez. De esta manera, actúa como  pilar sobre el que se erige el estudio (16) .  Para este artículo en particular, se adoptó como  marco teórico la bioética centrada en el cuidado de la\nTECNOLOGÍAS ASISTIVAS PARA PACIENTES ANCIANOS CON DEMENCIA: PERSPECTIVAS DESDE LA BIOÉTICA DE LOS CUIDADOS EN SALUD 3  Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488  salud, tomando como referencia investigaciones lleva -  das a cabo por Aline Albuquerque, complementadas con  los estudios de Victor Montori con relación a la atención  enfocada en el paciente.  La elección de este marco teórico para el análisis del  empleo de tecnologías asistivas en el ámbito de la salud  de adultos mayores con demencia se fundamenta en las  recientes contribuciones bioéticas orientadas al cuidado  de la salud, que destacan que el proceso de atención debe  responder a las necesidades concretas del paciente.  El desarrollo del artículo se divide en tres secciones.  La primera, aborda el concepto de bioética en el cuidado  de la salud, detallando su contribución teórica y sus fun -  damentos, para luego transitar por la atención centrada  en el paciente y la idea de empatía clínica. La segunda  sección se centra en el empleo de tecnologías asistivas  para el cuidado de adultos mayores con demencia. Por  último, la tercera sección plantea la discusión sobre si  el proceso de atención podría ser considerado, también,  una tecnología sanitaria.  EL PARADIGMA DE LA BIOÉTICA DE  LOS CUIDADOS EN SALUD  En primer lugar, es importante destacar que la llamada  “bioética de los cuidados en salud” se refiere a una co -  rriente de la bioética que, en contraposición a otras, en -  fatiza la relación humana entre el profesional de la salud  y el paciente, valorando la relación entre ambos, así  como la centralidad del paciente en el cuidado. Utiliza la  experiencia del paciente, junto con el papel del profe -  sional de la salud, como fuente de sus aportes teóricos,  buscando el bienestar y la calidad de vida del paciente (12) .  También hay que considerar que el término “pa -  ciente” se refiere a la persona que está bajo el cuidado de  salud, que puede estar enferma o sana, pero que busca  una mejor atención para su salud y calidad de vida (17) . En  este sentido, la palabra paciente no debe ser asimilada  a la condición de pasividad, sino a su doble condición  frente al proceso terapéutico, es decir, su vulnerabilidad  y su centralidad (17) .  La bioética de los cuidados en salud se basa en el en -  foque del   cuidado centrado en el paciente , en su participa -  ción y empoderamiento, así como en la empatía clínica  y en la aplicación de los derechos humanos al contexto  de los cuidados de salud. Pueden ser citados como ejes  teóricos la comunicación empática, la relación de ca -  maradería entre profesional y paciente y la centralidad  y empoderamiento de este último (12) .  El cuidado centrado en el paciente denota una rup -  tura con el paradigma actualmente predominante, en el  que el profesional de la salud, permeado por una serie de  factores estructurales y económicos, muchas veces des -  atendidos en su práctica profesional diaria, se aleja del  contacto cercano con el paciente y lo comprende como  objeto de cuidado, otorgando mayor atención a la en -  fermedad y al conocimiento profesional, en detrimento  de los conocimientos y experiencias personales del pa -  ciente (15,17) . Propone un cambio de conducta y desafía las  prácticas y comportamientos profundamente arraiga -  dos, en el sentido de implementar la camaradería en el  trabajo entre el profesional de la salud y el paciente (14) .  En este sentido, el cuidado centrado en el paciente  puede ser comprendido como una mirada más atenta al  proceso de cuidar (17) , que debe ser amable y enfocado en  las necesidades específicas del paciente, no solo en el  intento de sanar enfermedades o de cumplir protocolos  médicos, sino de adentrarse en su biografía, a través de  la escucha atenta y la valoración individual (15) . Propone  que las decisiones inherentes al cuidado de la salud de -  ben ser guiadas por las necesidades, la voluntad y las  preferencias del paciente, promoviendo su autonomía a  través de su compromiso y la oferta de apoyos necesa -  rios para la toma de decisiones relevantes que impacta -  rán en su salud y calidad de vida (18) .  La empatía clínica constituye uno de los pilares  fundamentales de la bioética orientada al cuidado de la  salud. Esta capacidad inherente al ser humano se des -  pliega en, al menos, dos dimensiones: una cognitiva en  la que el profesional de la salud comprende la perspec -  tiva del paciente, y otra emocional en la que el profe -  sional sintoniza con las “emociones del paciente” (15) . En  resumen, la empatía implica conectarse con los senti -  mientos de la otra persona sin asumirlos como propios,  sino comprenderlos y compartirlos. Su aspecto cog -  nitivo requiere el uso de la capacidad imaginativa para  acercarse a la perspectiva del otro. La empatía clínica  no lleva a la fatiga empática o al agotamiento del pro -  fesional de la salud, ya que reconoce las necesidades del  otro al mismo tiempo que es consciente de su propia di -  ferencia con relación a la otra persona (19) . Es decir, hay  una separación del sentimiento del otro con relación a  la propia emoción.  La empatía clínica implica tres componentes cla -  ves: la comprensión, la comunicación y la acción. La  comprensión se refiere a entender lo que la enfermedad  significa para el paciente, que requiere un diagnóstico  preciso, un pronóstico y un proceso de toma de decisio -  nes compartido. La comunicación tiene como objetivo  aliviar la ansiedad del paciente y responder sus dudas,  y es necesaria para que el profesional de la salud pueda  comprender la situación real del paciente y verificar si la  información proporcionada fue comprendida por el pa -  ciente. La acción está dirigida a maximizar los benefi -  cios terapéuticos (19) .  La empatía clínica es un concepto relacional, en el  sentido de que es una experiencia orientada a la cone -  xión con el otro (20)   y una habilidad humana que puede  ser aprendida, aumentada o disminuida, dependiendo  del entorno y la estructura organizacional en la que el  profesional de la salud se encuentre (21) . Tiene un pa -  pel relevante en la bioética de los cuidados de salud, ya  que implica tanto la noción de cuidar como la de curar,\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  4  y puede complementar la medicina basada en la eviden -  cia. Además, la función moral de la empatía clínica es  promover la autonomía del paciente, un elemento fun -  damental en el proceso de toma de decisiones de perso -  nas mayores que viven con demencia.  La aplicación de los derechos humanos en el con -  texto   de   los   cuidados   de   salud   tiene   como   objetivo  proteger la dignidad humana inherente al paciente, es -  pecialmente debido a su condición de vulnerabilidad.  Los derechos humanos de los pacientes se refieren a un  conjunto de derechos que los pacientes tienen cuando  están bajo cuidados de salud (17) . Estos derechos incluyen  el derecho a la vida, a la privacidad, a no ser sometido a  tortura o a tratos inhumanos o degradantes, a la infor -  mación, a la salud y el derecho a no ser discriminado (22) .  En el contexto de los pacientes mayores (23) , este  grupo se encuentra en una situación de vulnerabilidad  aumentada (24) , debido a los prejuicios relacionados con  la edad avanzada y el imaginario social de que la persona  pierde la autonomía para gestionar su vida a medida que  envejece, incluyendo las decisiones sobre cuidados de  salud (25) .  Además, los derechos humanos extraídos de nor -  mativas internacionales se aplican al campo de los cui -  dados de la salud (12,26) . Los derechos humanos de los  pacientes definen un concepto que se deriva de la digni -  dad humana inherente a cada persona y aplican de forma  neutral los principios de los derechos humanos univer -  sales y legalmente reconocidos, protegiendo tanto a pa -  cientes como a profesionales de la salud y admitiendo  limitaciones que puedan justificarse por normas de de -  rechos humanos (26) .  A partir de la tipología obligacional presente en las  concepciones inherentes a los derechos humanos, se  establecen las obligaciones del Estado de respetar, pro -  teger y garantizar dichos derechos, que se dividen en fa -  cilitar y proveer dichos derechos (27) . El incumplimiento  de alguna de estas obligaciones resulta en una violación  de los derechos humanos (17) . Este entendimiento es apli -  cable tanto al Estado como a la sociedad y, por consi -  guiente, a los profesionales que trabajan en el contexto  de los cuidados de salud (17) .   La concepción de los dere -  chos humanos de los pacientes ofrece un medio para  evaluar cuestiones sistémicas de obligaciones y respon -  sabilidades, siendo un instrumento importante para la  bioética de los cuidados de salud (12) .  En síntesis, la bioética de los cuidados en salud es  un nuevo enfoque seriamente comprometido con el es -  tablecimiento de una relación de colaboración entre el  profesional de la salud y el paciente, con el objetivo de  empoderarlo para que desempeñe un papel activo en el  proceso de toma de decisiones sobre sus cuidados en  salud (12) .  Este enfoque puede aplicarse a los cuidados en sa -  lud de pacientes mayores que viven con demencia, ya  que a medida que la enfermedad progresa, mayores son  las necesidades de cuidados más atentos, sin que tales  acciones restrinjan la autonomía personal y dignidad de  tales personas. Por lo tanto, el cuidado debe estar atento  a reconocer que al comprometerse las habilidades rela -  cionadas a la toma de decisiones no implica la pérdida  de derechos, sino que la voluntad y las preferencias de  la persona deben ser respetadas en los diversos ámbitos  de su vida, incluyendo sus cuidados en salud (4) . La bioé -  tica de los cuidados en salud, en estos casos, puede en -  tenderse más allá del entorno hospitalario, aplicándose  también a la relación establecida entre el cuidador y la  persona mayor, ya que con el aumento de la edad, otras  enfermedades y limitaciones acompañan los casos de  demencia, lo que requiere acciones continuas dirigidas  a sus cuidados en salud.  Con la evolución tecnológica se pueden incorporar  nuevos mecanismos en los cuidados de salud para fa -  cilitar la autonomía de los pacientes mayores que viven  con demencia, ya sea para la toma de decisiones o para la  realización de actividades diarias, reduciendo la carga de  las personas responsables de su cuidado. Sin embargo,  el uso de estas herramientas puede enfrentar desafíos  económicos y sociales, y se necesitan discusiones que  aborden aspectos bioéticos. Por lo tanto, la bioética de  los cuidados de salud puede utilizarse como una herra -  mienta tecnológica para mejorar o guiar el uso de otras  tecnologías, prácticas e instrumentos que impliquen el  cuidado de la salud de personas mayores con demencia.  Tecnologías asistivas y el cuidado de  personas mayores con demencia  En la vejez, el estímulo cognitivo es imprescindible para  posibilitar nuevas experiencias, nuevos desafíos y apren -  dizajes, que aumentan la plasticidad neural, incrementan  la transmisión de información en el cerebro que compone  la esencia del ser humano y distingue su personalidad y  forma de actuar (28) . La cognición es un proceso multi -  dimensional que admite que el cerebro continúe siendo  ejercitado incluso en la vejez, a través de actividades que  entrenan la memoria, la atención y demás funciones ce -  rebrales, y minimizan los efectos de la debilidad cognitiva  causada por el proceso demencial. Los estímulos pueden  ser realizados de manera individual o en grupo, de forma  presencial o a través de tecnologías de comunicación (29) .  Las tecnologías se están desarrollando para apo -  yar la toma de decisiones de personas con demencia.  Algunos ejemplos pueden ser:  a.   Sistemas de recordatorio, utilizados para recordar a  las personas con demencia sus compromisos, tareas  y medicamentos.  b.   Aplicaciones de teléfonos móviles y tabletas, que ayu -  dan a las personas con demencia a mejorar la cogni -  ción y la memoria, así como a recordar compromisos,  tareas y medicamentos.  c.   Dispositivos de monitoreo, utilizados para seguir la  salud y el bienestar de una persona con demencia;\nTECNOLOGÍAS ASISTIVAS PARA PACIENTES ANCIANOS CON DEMENCIA: PERSPECTIVAS DESDE LA BIOÉTICA DE LOS CUIDADOS EN SALUD 5  Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488  pueden incluir monitores de actividad, monitores de  frecuencia cardíaca y otros dispositivos.  d.   Sistemas de navegación, utilizados para ayudar a las  personas con demencia a orientarse en nuevos lugares.  e.   Sistemas de comunicación, utilizados para ayudar a  las personas con demencia a comunicarse con cuida -  dores y otros miembros de la familia.  f.   Tecnologías cognitivas, que son sistemas, dispositivos  y aplicaciones diseñados para mejorar el rendimiento  cognitivo humano, incluyendo funciones como aten -  ción, memoria, razonamiento, percepción y toma de  decisiones; tecnologías que pueden ayudar a las per -  sonas mayores a mantener su independencia (30) .  Además, las tecnologías cognitivas pueden incluir jue -  gos y aplicaciones de entrenamiento, tecnologías de  asistencia e interfaces cerebro-máquina, que permiten  la comunicación directa entre el cerebro y una computa -  dora u otro dispositivo, y sirven para ayudar a personas  con discapacidades motoras o de comunicación a inte -  ractuar con el mundo digital y sistemas de inteligencia  artificial, que están diseñados para imitar las funcio -  nes cognitivas humanas, como el aprendizaje, la toma  de decisiones y el reconocimiento de patrones. Se uti -  lizan en una variedad de aplicaciones, desde asisten -  tes virtuales hasta diagnóstico médico. En resumen, las  tecnologías cognitivas tienen como objetivo mejorar la  cognición humana y, por lo tanto, tienen el potencial de  mejorar la calidad de vida de muchas personas (31) .  También, la inteligencia artificial puede ayudar en  el   diagnóstico   temprano,   identificando   los   primeros  signos de demencia; en el monitoreo de pacientes, aler -  tando a cuidadores o profesionales de la salud cuando  ocurren cambios significativos en el comportamiento o  la salud de los pacientes; en el apoyo a la toma de deci -  siones sobre el cuidado de pacientes con demencia; en  el uso de terapias personalizadas adaptadas a las nece -  sidades y preferencias individuales del paciente; en la  asistencia a tareas cotidianas y el recordatorio de com -  promisos; y en el monitoreo remoto, siguiendo el pro -  greso del paciente (32) .  Algunos dispositivos electrónicos, como celulares y  computadoras, combinados con información, comuni -  cación y prácticas de cuidado, pueden ser importantes  tecnologías de mantenimiento de la salud, estimulación  cognitiva, administración de demencia y aislamiento  social. Su uso puede permitir la participación de las per -  sonas mayores con demencia en grupos de integración,  junto con sus familiares, cuidadores y profesionales de  la salud, para compartir miedos, angustias, prácticas de  cuidado e intercambiar experiencias. En este sentido,  dichos dispositivos se convierten en fuentes de apoyo (33) .  Sin embargo, a través de dispositivos electróni -  cos, la comunicación y la multiplicación de la presen -  cia y las experiencias subjetivas no siempre son bien  comprendidas por aquellos que experimentan el pro -  ceso demencial. Existe una dificultad para comprender  el funcionamiento de las pantallas y cómo las personas  pueden comunicarse sin estar físicamente presentes.  Además, está la falta de contacto físico, así como la difi -  cultad de concentración y enfoque del paciente anciano  con demencia en lo que las demás personas están com -  partiendo a través de los dispositivos electrónicos (33) .  Por esta razón, es necesario que el cuidador esté pre -  sente para ayudar a la persona en el uso de equipos elec -  trónicos que permitan la interacción con otras personas,  lo que no necesariamente tiene que ocurrir cuando la in -  teracción es presencial (29) .  En esta línea, el cuidador emerge como una figura  clave para la implementación de tecnologías asisti -  vas y cognitivas en adultos mayores que conviven con  demencia. Desempeñará el rol de mediador en la utili -  zación de ciertas tecnologías, promoviendo así la auto -  nomía e independencia del adulto mayor. Es esencial que  el cuidador esté atento a las necesidades particulares del  paciente, proporcionando una atención centrada en él,  honrando sus deseos y preferencias e incentivando el  empleo de tecnologías que potencien la autonomía. Por  ende, el cuidado ofrecido debe estar en consonancia con  el marco de la bioética orientada al cuidado de la salud.  Las personas mayores que viven con demencia pue -  den enfrentar varias dificultades en el uso de tecnolo -  gías asistivas y cognitivas, como la dificultad de acceso a  las tecnologías, la complejidad en su uso que puede cau -  sar que se frustren o desistan, la falta de adaptación, ya  que cada persona tiene especificidades que a menudo no  son abarcadas por dichas tecnologías, los costos eleva -  dos, la necesidad de capacitación para el uso de nuevos  dispositivos que no existían en la juventud de estas per -  sonas, y las limitaciones de memoria para seguir utili -  zando dispositivos electrónicos (34) .  El continuo cuidado de las personas mayores con  demencia contribuye al cuidado humanizado, en el que  se valora la calidad de vida del individuo. Las interven -  ciones de profesionales de la salud y cuidadores estimu -  lan y mantienen las capacidades mentales, fortalecen las  relaciones sociales, brindan mayor seguridad y aumen -  tan la autonomía del paciente, estimulando su identi -  dad, autoestima y desempeño cognitivo y funcional (10) .  Las tecnologías asistivas y cognitivas pueden mejo -  rar la calidad de vida de los pacientes mayores que viven  con demencia, ya que les ayudan a mantener su inde -  pendencia durante el mayor tiempo posible. Sin em -  bargo, su uso debe estar vinculado a una buena práctica  de atención, con la formación de una red de apoyo para  que el individuo se sienta acogido y valorado.  El proceso de cuidado como una tecnología  de la salud  La actividad humana es un acto productivo, ya que mo -  difica   algo   y   produce   algo   nuevo.   Muchas   activida -  des están organizadas de forma interdependiente. En el  campo de la salud, el “trabajo vivo en acto”, es decir, el\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  6  trabajo humano en el momento exacto en que se ejecuta,  determina cómo se llevará a cabo el proceso y la produc -  ción del cuidado (35) . La forma de organización de esta ac -  tividad se considera una tecnología blanda que integra  maletín del saber técnico estructurado, la utilización de  instrumentos propios de la actividad y las relaciones en -  tre las personas implicadas en el cuidado.  En la producción del cuidado, estos saberes se uti -  lizan de diferentes maneras, según la relación esta -  blecida entre el profesional de la salud, el cuidador y el  paciente (35) . De esta manera, dependiendo de los actores  implicados, el proceso de cuidado puede ser una tecno -  logía blanda centrada en las relaciones y en la compren -  sión de las necesidades del paciente o, por el contrario,  centrada en el uso de instrumentos o en el saber técnico  en detrimento del paciente.  El proceso de cuidado es complejo e integra fac -  tores clínicos, ambientales y sociales que se acumu -  lan y se articulan, haciendo que el acto de cuidar vaya  más allá de los aspectos inherentes solo a la enferme -  dad. Los pacientes existen en la intersección de circuns -  tancias sociales, personales y clínicas y, por lo tanto,  pueden enfrentar múltiples factores complicadores. En  general, estos factores se analizan de manera aislada  y a través de su forma (clínica, socioeconómica o cul -  tural) en lugar de sus funciones en la complejidad del  cuidado. Pocas investigaciones examinan de manera in -  tegral cómo las combinaciones de factores interactúan  para impactar a los pacientes (36) .  Los individuos se adaptan o sucumben a la com -  plejidad de factores que los rodean con el tiempo, lo que  omite la acumulación de factores complicadores y la po -  sibilidad de resiliencia del paciente. Como ejemplos, se  pueden citar: la carga de trabajo del paciente, referida a  las tareas y responsabilidades con las que las personas  lidian en su día a día, que incluyen el trabajo, la fami -  lia, el autocuidado y otras prioridades (37,38) ; o la capaci -  dad del paciente, vinculada a las habilidades, recursos o  disposición para manejar las demandas, que incluyen el  funcionamiento físico y mental, los recursos socioeco -  nómicos, el apoyo social, la alfabetización y las actitu -  des y creencias (39) . Por lo tanto, una capacidad excesiva o  baja puede desafiar por sí sola a los pacientes, causando  dificultades de acceso, falta de adherencia, baja calidad  de vida, entre otros problemas. Un desequilibrio entre la  carga de trabajo que excede la capacidad puede conside -  rarse uno de los principales factores de interrupción en  la atención, el autocuidado y los resultados (36) .  La adopción de un modelo tecnológico de cuidado  debe considerar necesariamente aspectos externos a la  enfermedad, con el fin de alcanzar la experiencia, los  impactos de las actividades desarrolladas por el pa -  ciente, sus creencias y la red de apoyo, de modo que el  proceso de cuidado tenga un impacto positivo en su sa -  lud y calidad de vida.  Las tecnologías leves pueden ser representadas por  actos de acogida, formación de vínculo y búsqueda de la  promoción de la autonomía de los pacientes, a través de  un diálogo abierto y una escucha activa y calificada (40) .  Además del conocimiento técnico, de los instrumentos de  trabajo y de las tecnologías más estructuradas, es nece -  sario prestar mayor atención al papel de la relación, como  tecnología leve presente en el acto de cuidar (41) . Este com -  ponente es fundamental para comprender que el cuidado  en salud siempre es relacional y que desvalorizar este as -  pecto trae perjuicios para todo el proceso terapéutico.  La realización del trabajo de cuidado en salud basado  en tecnologías leves, relacionales y empáticas, de acuerdo  con la bioética de los cuidados en salud, contribuye a la  formación de una línea de cuidado que, si se integra a  todo el espectro de servicios de salud, tiene el poder de  satisfacer diversas necesidades de los pacientes (41) .  Los factores mencionados muestran la urgente ne -  cesidad de abandonar el paradigma de cuidado centrado  en la enfermedad, adoptando un cuidado centrado en el  paciente, tanto en la relación entre profesionales de la  salud y pacientes, como en los modelos organizativos de  gestión y políticas públicas. Esto contribuirá al uso ade -  cuado de tecnologías asistivas, para que estas sirvan a  las necesidades reales de cada paciente anciano que vive  con demencia.  El uso de tecnologías de asistencia difícilmente al -  canzará su objetivo final si no se conecta con el para -  digma de la bioética de los cuidados en salud. Así, este  paradigma se convierte en un importante instrumento  y referente para la implementación de tecnologías asis -  tivas y tecnologías ligeras en el cuidado de personas  mayores que viven con demencia, ya que enfatiza la ne -  cesidad de respetar los derechos, aplicar la empatía clí -  nica y establecer una relación respetuosa que apunte al  cuidado centrado en el paciente.  CONCLUSIONES  El mundo está en constante cambio, exigiendo el de -  sarrollo de nuevas tecnologías y formas de relación. En  los cuidados en salud, las tecnologías han sido impor -  tantes herramientas para mejorar la calidad de vida. Sin  embargo, el uso de dichas herramientas y acciones rea -  lizadas por los cuidadores, precisan adaptarse a las ne -  cesidades sanitarias, económicas, sociales y también  individuales de cada paciente.  El cuidado de pacientes mayores que viven con de -  mencia ha planteado desafíos para familiares, cuida -  dores, profesionales de la salud y para la sociedad en  general. Las tecnologías asistenciales y cognitivas han  tenido un papel relevante para mantener la autonomía y  mejorar la calidad de vida del paciente y demás actores  implicados en su cuidado. Sin embargo, no pueden des -  vincularse de la empatía clínica, de la atención centrada  en el paciente, del respeto a sus derechos humanos y la  promoción de la autonomía.\nTECNOLOGÍAS ASISTIVAS PARA PACIENTES ANCIANOS CON DEMENCIA: PERSPECTIVAS DESDE LA BIOÉTICA DE LOS CUIDADOS EN SALUD 7  Salud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488  En este sentido, los aportes traídos por la bioética  de los cuidados en salud pueden ser considerados como  tecnologías de cuidado, relevantes y necesarias que,  asociados a tecnologías asistenciales y cognitivas, re -  presentan un camino ético, jurídico y social adecuado  para mejorar la calidad de vida y salud de pacientes ma -  yores con demencia.  FINANCIAMIENTO  Coordenação de Aperfeiçoamento de Pessoal de Nível Superior  (CAPES/MEC) a través de la beca de posdoctorado concedida  para el año 2023 al Programa de Pós-Graduação em Bioética de  la Pontifícia Universidade Católica do Paraná, Brasil.  CONFLICTO DE INTERÉS  La autora declara no tener vínculos o compromisos que con -  dicionen lo expresado en el texto y que puedan ser entendidos  como conflicto de intereses.  REFERENCIAS BIBLIOGRÁFICAS  1.   World Health Organization. Global Health Estimates: Life  expectancy and leading causes of death and disability [Inter -  net]. 2019 [cited 3 abr 2023]. Disponible en:   https://tinyurl.  com/2a9kkbx8 .  2.   World Health Organization.   Demência [Internet]. 2021 [cited  3 mar 2022]. Disponible en:   https://tinyurl.com/4emj333u .  3.   Machado ILO, Garrafa V. Bioética, o envelhecimento no Bra -  sil e o dever do Estado em garantir o respeito aos direitos  fundamentais das pessoas idosas. Revista de Direitos e Ga -  rantias   Fundamentais.   2020;21(1):79–106.   doi:   10.18759/  rdgf.v21i1.1804 .  4.   Machado ILO. Curatela e tomada de decisão apoiada (TDA)  com relação a pessoas idosas no Brasil: uma análise bioé -  tica. [Tesis de doctorado]. Brasilia: Universidade de Brasí -  lia; 2022.  5.   Ash EL. What is Dementia?   In: Foster C, Herring J, Doron I, eds.  The law and ethics of dementia. London: Hart; 2014. p. 3–14.  6.   Donnelly M. Healthcare decision-making and the law. Cam -  bridge: Cambridge University Press; 2010.  7.   Donnelly M. Deciding in dementia: The possibilities and  limits of supported decision-making. International Jour -  nal of Law and Psychiatry. 2019;66:101466. doi:   10.1016/j.  ijlp.2019.101466 .  8.   Baldwin C. Technology, dementia, and ethics: Rethinking the  issues. Disability Studies Quarterly. 2005;25(3). doi:   10.18061/  dsq.v25i3.583 .  9.   Carmo EG, Zazzetta MS, Fuzaro Junior G, Micali PN, Moraes  PF, Costa JLR.   A utilização de tecnologias assistivas por ido -  sos com Doença de Alzheimer. Kair ó s. 2015;4(18):311-336.  doi:   10.23925/2176-901X.2015v18i4p311-336 .  10.   Nunes C, Melo FC, Bonini JS. Prospecção tecnológica de es -  timulação cognitiva para idosos com doença de Alzheimer.  Cadernos de Prospecção. 2023;16(1):278-294. doi:   10.9771/  cp.v16i1.49634 .  11.   Andorno R. Bioética y dignidad de la persona. 2a ed. Madrid:  Tecnos; 2012.  12.   Albuquerque A. Empatia nos cuidados em saúde: comunica -  ção e ética na prática clínica.   Santana de Parnaíba: Manole;  2023.  13.   Albuquerque A, Tanure C. The necessity of new bioeth -  ics to clinical practice. Nursing & Care Open Access Journal.  2023;9(2):38-39. doi:   10.15406/ncoaj.2023.09.00257 .  14.   Richards T, Montori VM, Godlee F, Lapsley P, Paul D. Let the  patient revolution begin. BMJ. 2013;346:f2614. doi:   10.1136/  bmj.f2614 .  15.   Montori V. Why we revolt: a patient revolution for careful  and kind care. 2nd ed. Rochester: Mayo Clinic Press; 2020.  16.   Adom D, Hussein EK, Adu-Agyem J. Theoretical and concep -  tual framework: mandatory ingredients of a quality research  citations see profile theoretical and conceptual framework:  mandatory ingredients of a quality research.   International  Journal of Scientific Research. 2018;7(1):438-441.  17.   Albuquerque A. Direitos humanos dos pacientes. Curitiba:  Juruá; 2016.  18.   Albuquerque A. Manual de direito do paciente.   Belo Hori -  zonte: CEI; 2020.  19.   Howick J, Bizzari V, Dambha-Miller H. Therapeutic empathy:  what it is and what it isn’t. Journal of the Royal Society of Med -  icine. 2018;111(7):233-236. doi:   10.1177/0141076818781403 .  20.   van Dijke J, van Nistelrooij I, Bos P, Duyndam J. Towards a  relational conceptualization of empathy. Nursing Philoso -  phy. 2020;21(3):e12297. doi:   10.1111/nup.12297 .  21.   Hardman D, Howick J. The friendly relationship between  therapeutic empathy and person-centred care.   European  Journal for Person Centered Healthcare. 2019;7(2):351-357.  22.   Paranhos DGAM, Albuquerque A. Direitos humanos dos pa -  cientes como instrumentos bioéticos de proteção das pes -  soas idosas. Cadernos Ibero-Americanos de Direito Sanitário.  2019;8(1):53–64. doi:   10.17566/ciads.v8i1.507 .  23.   Albuquerque A, Paranhos DG de AM. Direitos humanos dos  pacientes e vulnerabilidade: o paciente idoso à luz da juris -  prudência da corte europeia de direitos humanos. Revista  Quaestio Iuris. 2017;10(4):2844-2462. doi:   10.37767/2591-  3476(2022)03 .  24.   Paranhos DGAM, Albuquerque A, Garrafa V. Vulnerabilidade  do paciente idoso à luz do princípio do cuidado centrado no  paciente. Sa ú de e Sociedade. 2017;26(4):932-942.  25.   Machado I, Garrafa V. Capacidades jurídica e decisional e os  importantes aportes bioéticos para promoção da autonomia  de pessoas idosas.   Redbioética. 2021;2(24):95-102.  26.   Cohen J, Ezer T. Human rights in patient care: a Theoreti -  cal and practical framework. Health and Human Rights.  2013;15(2):7-19.  27.   Albuquerque A, Barroso A. Curso de direitos humanos. Rio de  Janeiro: Lumen Juris; 2018.  28.   Ferreira EV, Medeiros de Mello J, Leiny de Lima L, De Mello  D, Sant’ana G. Plasticidade neural em indivíduos da terceira  idade. Arquivos do Mudi. 2019;23:120-129. doi:   10.4025/arq -  mudi.v23i3.51518 .  29.   Dos Santos CS, de Bessa TA, Xavier AJ.   Factors associated with  dementia   in   elderly.   Ci ê ncia   &   Sa ú de   Coletiva.   2020;25(2):603-  611. doi:   10.1590/1413-81232020252.02042018 .  30.   Palmdorf S, Stark AL, Nadolny S, Eliaß G, Karlheim C, Krei -  sel SH, et al. Technology-assisted home care for people with  dementia and their relatives: Scoping review. JMIR Aging.  2021;4(1):e25307. doi:   10.2196/25307 .\nSalud Colectiva | ISSN 1851-8265 |   http://revistas.unla.edu.ar/saludcolectiva   | Salud Colectiva. 2023;19:e4488 |   https://doi.org/10.18294/sc.2023.4488 ISIS LAYNNE DE OLIVEIRA MACHADO CUNHA  8  31.   Lee-Cheong S, Amanullah S, Jardine M. New assistive tech -  nologies in dementia and mild cognitive impairment care.  Asian Journal of Psychiatry. 2022;73:103135. doi:   10.1016/j.  ajp.2022.103135 .  32.   Battineni G, Chintalapudi N, Hossain MA, Losco G, Ruocco C,  Sagaro GG, et al. Artificial intelligence models in the diagno -  sis of adult-onset dementia disorders: A review. Bioenginee -  ring. 2022;9(8):370. doi:   10.3390/bioengineering9080370 .  33.   Costa BR. A memória em tela: os grupos de estimulação cog -  nitiva online para pessoas com a Doença de Alzheimer. Anais  da ReACT. 2021;1(1):2293-2309.  34.   Bernardo LD. Revisão integrativa sobre o engajamento em  ocupações de idosos com Alzheimer. Revista Interinstitu -  cional Brasileira de Terapia Ocupacional. 2017;1(3):386-407.  35.   Franco TB, Merhy EE. Produção imaginária da demanda e o  processo de trabalho em saúde. In: Pinheiro R, Mattos RA,  orgs. Construção social da demanda: direito à saúde, tra -  balho em equipe, participação e espaços públicos. Rio de Ja -  neiro: IMS/UERJ; 2005. p. 181-193.  36.   Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cu -  mulative complexity: A functional, patient-centered mo -  del of patient complexity can improve research and practice.  Journal of Clinical Epidemiology. 2012;65(10):1041-1051. doi:  10.1016/j.jclinepi.2012.05.005 .  37.   Ahmed SM, Drph M, Lemkau JP, Nealeigh N, Mann B. Barriers  to healthcare access in a non-elderly urban poor American  population. Health & Social Care in the Community. 2001  Nov;9(6):445-453. doi:   10.1046/j.1365-2524.2001.00318.x .  38.   Joseph AE, Hallman BC. Over the hill and far away: distance  as a barrier to the provision of assistance to elderly relatives.  Social Science & Medicine. 1998;46(6):631–639. doi:   10.1016/  s0277-9536(97)00181-0 .  39.   Mackenzie   CS,   Gekoski   WL,   Knox   VJ.   Age,   gender,   and  the   underutilization   of   mental   health   services:   The   in -  fluence of help-seeking attitudes. Aging & Mental Health.  2006;10(6):574-582. doi:   10.1080/13607860600641200 .  40.   Santos Koerich M, Stein Backes D, De Moura Scortegagna H,  Loewen Wall M, Veronese AM, Zeferino MT, et al. Tecnologias  de cuidado em saúde e enfermagem e suas perspecti-vas fi -  losóficas. Texto & Contexto-Enfermagem. 2006;15:178-185.  41.   Merhy EE, Franco TB. Por uma composição técnica do tra -  balho em saúde centrada no campo relacional e nas tec -  nologias   leves:   Apontando   mudanças   para   os   modelos  tecno-assistenciais. Saúde em Debate. 2003;27(65):316-323.  Recibido: 30 abr 2023 | Versión final: 30 ago 2023 | Aprobado: 1 sep 2023 | Publicado en línea: 3 oct 2023  FORMA DE CITAR  Cunha ILOM. Tecnologías asistivas para pacientes ancianos con demencia: perspectivas desde la bioética de los cuidados en salud. Salud Colectiva.  2023;19:e4488. doi: 10.18294/sc.2023.4488.  Esta obra está bajo una licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0).   http://creativecommons.org/licenses/  by-nc-nd/4.0 .   Atribución — Se debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado  cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la  licenciante. Sin restricciones adicionales — No se pueden aplicar términos legales ni medidas tecnológicas que restrinjan legalmente  a otras personas a hacer cualquier uso permitido por la licencia.',0.1545557267524401,'[\"&\", \"(1)\", \"(10)\", \"(11)\", \"(12)\"]','2025-11-29 17:03:04.553050'),(57,3,'Biofabrication  PAPER • OPEN ACCESS  A novel extrusion-based 3D bioprinting system for skeletal muscle tissue engineering  To cite this article: E Fornetti et al 2023 Biofabrication 15 025009  View the article online for updates and enhancements.  You may also like  Pillar electrodes embedded in the skeletal muscle tissue for selective stimulation of biohybrid actuators with increased contractile distance Tingyu Li, Minghao Nie, Yuya Morimoto et al. - Skyrmion based majority logic gate by voltage controlled magnetic anisotropy in a nanomagnetic device Bibekananda Paikaray, Mahathi Kuchibhotla, Arabinda Haldar et al. - Engineering strategies for the construction of oriented and functional skeletal muscle tissues Tingting Fan, Minxuan Jia, Heng Liu et al. -  This content was downloaded from IP address 38.255.109.85 on 12/04/2025 at 23:54\nBiofabrication   15   (2023) 025009   https://doi.org/10.1088/1758-5090/acb573  Biofabrication  OPEN ACCESS  RECEIVED  27 June 2022  REVISED  16 December 2022  ACCEPTED FOR PUBLICATION  23 January 2023  PUBLISHED  3 February 2023 Original content from this work may be used under the terms of the Creative Commons Attribution 4.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.  PAPER  A novel extrusion-based 3D bioprinting system for skeletal muscle tissue engineering  E Fornetti 1  , F De Paolis 1,2 , C Fuoco 1 , S Bernardini 1 , S M Giannitelli 3 , A Rainer 3,4  , D Seliktar 5 , F Magdinier 6 , J Baldi 7 , R Biagini 7 , S Cannata 1 , S Testa 6, ∗   and C Gargioli 1, ∗  1   Department of Biology, University of Rome ‘Tor Vergata’, Rome, Italy  2   PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome ‘Tor Vergata’, Rome, Italy  3   Department of Engineering, Universit ` a Campus Bio-Medico, Rome, Italy  4   Institute of Nanotechnology (NANOTEC), National Research Council, Lecce, Italy  5   Department of Biomedical Engineering, Techion Institute, Haifa, Israel  6   Aix-Marseille University, INSERM, MMG, Marseille Medical Genetics, Marseille, France  7   IRCCS Regina Elena National Cancer Institute, Rome, Italy  ∗   Authors to whom any correspondence should be addressed.  E-mail: stefano.testa@univ-amu.fr   and   cesare.gargioli@uniroma2.it Keywords:   3D bioprinting, skeletal muscle tissue engineering, muscle reconstruction, VML, PEG-fibrinogen Supplementary material for this article is available online  Abstract  Three-dimensional (3D) bioprinting is an emerging technology, which turned out to be an optimal tool for tissue engineering approaches. To date, different printing systems have been developed. Among them, the extrusion-based approach demonstrated to be the most suitable for skeletal muscle tissue engineering, due to its ability to produce and deposit printing fibers in a parallel pattern that well mimic the native skeletal muscle tissue architecture. In tissue bioengineering, a key role is played by biomaterials, which must possess the key requisite of ‘printability’. Nevertheless, this feature is not often well correlated with cell requirements, such as motives for cellular adhesion and/or absorbability. To overcome this hurdle, several efforts have been made to obtain an effective bioink by combining two different biomaterials in order to reach a good printability besides a suitable biological activity. However, despite being efficient, this strategy reveals several outcomes limitations. We report here the development and characterization of a novel extrusion-based 3D bioprinting system, and its application for correction of volumetric muscle loss (VML) injury in a mouse model. The developed bioprinting system is based on the use of PEG-Fibrinogen, a unique biomaterial with excellent biocompatibility, well-suited for skeletal muscle tissue engineering. With this approach, we obtained highly organized 3D constructs, in which murine muscle progenitors were able to differentiate into muscle fibers arranged in aligned bundles and capable of spontaneously contracting when cultured   in vitro . Furthermore, to evaluate the potential of the developed system in future regenerative medicine applications, bioprinted constructs laden with either murine or human muscle progenitors were transplanted to regenerate the   Tibialis Anterior   muscle of a VML murine model, one month after grafting.  1. Introduction  In the last two decades, three-dimensional (3D) bioprinting has been widely employed in tissue engin- eering strategies. The possibility to build constructs with a spatially designed distribution of matrix and cells and the high reproducibility of these structures makes 3D bioprinting an excellent tool to produce and study artificial tissues. The extrusion-based 3D bioprinting systems proved to be particularly effective in obtaining artificial skeletal muscle tissues [1]. The continuous and controllable deposition of printing fibers loaded with muscle progenitors and the pos- sibility to arrange densely and evenly aligned fibers allows to reproduce the typical architecture of nat- ive skeletal muscle tissue, which is essential for the  © 2023 The Author(s). Published by IOP Publishing Ltd\nBiofabrication   15   (2023) 025009   E Fornetti   et al  tissue functionality [2]. Moreover, muscle progen- itor cells within the printing fiber are forced to fuse and elongate along the printing direction by both the shear stress occurring in the printing nozzle and the confinement of cells in a limited space [3, 4]. As a result, this method allows generating highly organ- ized artificial muscle constructs even in absence of external stimuli, such as mechanical stretching or electric stimulation. A key role is played by bioma- terials in this process, in particular hydrogels, and their capability of transitioning from liquid to gel in a cell-safe manner. This quality, so called ‘print- ability’, is mainly dependent on the hydrogel viscos- ity and crosslinking time [5, 6]. Several biomaterials share these features and are employed in extrusion- based bioprinting. Widely employed hydrogels in tis- sue engineering are among others alginate [7], able to instantly polymerize upon bivalent ions expos- ure; chitosan [8], providing many biological pro- prieties including the ability to interact with cell membrane and controllable degradation; and colla- gen type I, known to improve cellular attachment and growth [9]. However, mentioned biomaterials own some limitations: while alginate is biologically inert and has a limited biodegradability, chitosan has a poor post-printing shape fidelity and colla- gen type I polymerizes at high temperatures and its complete gelation can take more than 30 min [10]. To overcome these hindrances, most of the current extrusion-based printing system are based on a com- bination of two biomaterials, one having appropri- ate printability (commonly alginate), which is cru- cial during the printing process, and the other with desirable biocompatibility (commonly fibrin-based hydrogels or gelatin), fundamental in sustaining the biological processes required for cell proliferation and differentiation [11, 12]. While demonstrating great efficiency in producing highly organized structures  in vitro , this approach often requires removal of the printable material with chelating agents or specific enzymes to allow cellular physiological processes and  in vivo   integration [13]. PEG-Fibrinogen   (PF)   is   a   hybrid   hydrogel obtained by the combination of PolyEthylene Glycol (PEG) with denatured fibrinogen molecules that already demonstrated to be an excellent biomimetic matrix for skeletal muscle tissue engineering both  in vitro   and   in vivo   [14–16]. In fact, this hydrogel is characterized by a high biocompatibility, being enriched with cell adhesion domains and proteolytic enzymes targets, which ensure its integration, remod- eling and absorption   in vivo   [17]. However, the poly- merization process for this photocurable hydrogel is hardly compatible with the concept of printability, occurring relatively long time of UV exposure for the transition from liquid to gel state [18]. Here we report an innovative extrusion-based 3D bioprinting system exploiting PF, which properties demonstrated to be highly suitable for skeletal muscle differentiation. In particular, we developed a print- ing system able to drastically reduce the UV expos- ure time, allowing to use PF as bioink single com- ponent matrix. Moreover, this system presents a high resolution of the printing fibers (around 100   μ m), a high efficiency in skeletal muscle differentiation and organization   in vitro,   and remarkable biocompatibil- ity   in vivo . All the bioprinter components were stud- ied and optimized to obtain a 3D architecture closer as possible to the native organization of the skeletal muscle tissue, with bundles of fibers evenly orient- ated toward printing direction. The general morpho- logy of the construct was maintained throughout the experimental time thanks to the special stainless- steel supports, specifically designed for the presented biotechnology. The set-up for the printing system was conduc- ted using a murine source of muscle progenitors, the mesoangioblast (Mabs), which possess high myo- genic capabilities both   in vitro   and   in vivo   [14, 15]. Once demonstrated the validity of this system, a human source of muscle progenitors, the muscle- derived human mesenchymal stem cells (hMSCs) [19, 20] was tested in   in vivo   experiments, demon- strating that the described 3D bioprinting system could be a valuable tool for regenerative medicine approaches.  2. Materials and methods  2.1. Cell culture and bioink formulation  Mouse   mesoangioblasts   (Mabs)   were   transduced with   third-generation   lentiviral   vectors   encoding the reporter gene nuclear   β -galactosidase (nLacZ) as previously described [14]. Cells were cultured on Petri dishes (Falcon) at 37   ◦ C with 5% CO 2  in DMEM GlutaMAX (Gibco) supplemented with heat-inactivated   10%   fetal   bovine   serum   (Euro- clone), penicillin (100 IU ml − 1 , Gibco), streptomy- cin (100 mg ml − 1 , Gibco). hMSCs were isolated from skeletal muscle biopsies following a protocol that involves mechanical mincing, enzymatic digestion with type II collagenase, filtration, and selection of the colonies on plastic surface at low confluence, as pre- viously described [19]. Human progenitors were cul- tured on Petri dishes (Falcon) at 37   ◦ C with 5% CO 2  in Cyto-Grow medium (Resnova) supplemented with penicillin (100 IU ml − 1 , Gibco) and streptomycin (100 mg ml − 1 , Gibco). Skeletal muscle biopsies were obtained from healthy donors following informed consent in line with the guidelines of the Helsinki declaration on Human rights. For bioink formulation, muscular progenitors (Mabs or hMSCs) were resuspended to a final con- centration of 2   ×   10 7   cells ml − 1   in a solution of PF, (8 mg ml − 1 ) in phosphate buffered saline (PBS) and 0.1% w v − 1   Irgacure 2959 was added to the bioink 2\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 1.   Schematic representation of the 3D bioprinting and bulk polymerization processes. Muscle progenitors of either murine or human origin are combined with photocurable PEG-fibrinogen (PF) at a concentration of 2   ×   10 7   cells ml − 1 . In the 3D bioprinting system, a custom-made syringe pump system (1) pushes the bioink loaded into a syringe through a transparent PTFE microtube in a controllable manner (2). The passage of the microtube inside a low penetrance UV lamp allows the bioink to be exposed to the UV rays for a total of about 8 s (3), which are sufficient to promote bioink polymerization. The cellularized printing fiber extruded through the microtube is finally wrapped around a rotating C-shaped stainless-steel support (4) in order to obtain a bundle of fibers replicating the skeletal muscle native architecture (5). In bulk polymerization, the solution of PF and cells is poured into the Teflon mold in which the C-shaped support is wedged (1). After 5 min UV rays exposure (2), a cellularized bulk construct with the same dimension of the 3D bioprinted construct is obtained (3, 4). Scale bar: 1 cm.  as radical photoinitiator. Irgacure2959 was chosen as photoinitiator of the polymerization reaction due to its low cell toxicity, good performance in photocross- linking hydrogels, and the ability to be solubilized in the aqueous hydrogel precursor solution [21, 22].  2.2. Bioprinting system and 3D constructs culture  For this work, a custom-made 3D bioprinter was designed and manufactured. This novel extrusion- based printing system allows to employ PF as only biomaterial of the bioink, and to obtain printing fibers with a high resolution (105   ±   9   μ m) form- ing muscle bundles-like constructs of considerable dimension (4   ×   0.2   ×   0.2 cm 3 , figure 1). The core of the system is composed by the printing head that has been optimized to allow the quick polymerization of the bioink (8 s of UV exposure), which occurs during the liquid flow in the inner circuit (a low-attachment PTFE microtube, Ø 300   μ m). Liquid bioink is pushed in the circuit by a custom-made syringe pump system at a flow rate of 100   μ l min − 1 . With these parameters, the extrusion printer has a yield of 60 cm min − 1   of printed fiber. The diameter of the extruded printing fiber (300   μ m, corresponding to the diameter of the inner circuit) is further reduced by the tensile force generated by the rotation of a stainless-steel support (video S1). The C-shape of the support (figure 1) was studied to allow the deposition of parallel, dense and evenly aligned printing fibers with an architec- ture that closely resembles the native striated muscle bundles. Moreover, an oscillatory ‘forward-reverse’ movement ensures the uniform layer-by-layer distri- bution of the fibers on the support. The actuation of the printer is provided by stepper motors controlled by an Arduino Uno [www.arduino.cc] microcontrol- ler board. Bulk constructs as experimental control were obtained using a Teflon mold with the same dimen- sions of the printing constructs (4   ×   0.2   ×   0.2 cm 3 ). In   particular,   the   C-shaped   support   was   placed in the   mold and   the liquid bioink was   poured in the cavity and polymerized for 5 min, accord- ing   to   the   time   frame   defined   during   previous optimization [11, 13, 14] under a UV radiation of 365 nm (figure 1). In both bulk and 3D bioprin- ted constructs production, the time of exposure to 3\nBiofabrication   15   (2023) 025009   E Fornetti   et al  UV rays needed for PF polymerization demonstrated not to affect cell viability, as attested through the Live/Dead Cell Viability Assay Kit (Sigma-Aldrich, figure S1). This analysis also allowed to clarify that the printing process itself does not compromise the sur- vival of the cells included in the bioink. Bulk and 3D bioprinted constructs were kept in culture in the presence of growth medium and no spe- cific differentiation factors were added as both Mabs and hMSCs are able to spontaneously form myotubes upon reaching 80% confluence. For   in vitro   analysis, constructs were cultured up to 30 d in order to achieve an adequate muscle differentiation. Alternatively, for  in vivo   analysis, constructs were implanted in mice models 48 h after polymerization.  2.3. Volumetric muscle loss (VML) model, implants, and sample preparation  The VML murine model was established as previ- ously described [11]. Briefly, two-month-old male SCID/Beige mice were anesthetized with an intra- muscular injection of a physiologic saline solution (10 ml kg − 1 ) containing ketamine (5 mg ml − 1 ) and xylazine (1 mg ml − 1 ). After anesthesia, a limited incision was performed on the medial side of the leg to reach the   Tibialis Anterior   (TA). Approximately 90% for mouse-on-mouse implants and 50% for human- on-mouse implants of the total TA muscle volume was removed leaving tendons intact, by using a caut- ery to avoid bleeding and to create a venue for the implant accommodation (figure S2). The pre-shaped 3D bioprinted construct containing either Mabs or hMSCs was placed (without being sutured) to fill the volume of the surgically ablation that created an ana- tomic niche and the skin was subsequently sutured. In the control mice, the contralateral TA was surgically ablated, but no construct was implanted. Analgesic treatment (Rimadyl, Pfizer, USA) was administered after the surgery to reduce pain and dis- comfort. Mice were sacrificed 30 d after implanta- tion for immuno-histological analyses. Experiments on animals were conducted according to the rules of good animal experimentation I.A.C.U.C. N o   432 of 12 March 2006, and under Italian Health Ministry Approval No. 271/2021-PR.  2.4. Sample sectioning and immunofluorescence analysis  At the given time point, 3D constructs were fixed with 4% PFA in PBS for 30 min at 4   ◦ C and subsequently analyzed through immunofluorescence either in whole-mount or after sectioning. The con- structs to be processed for sectioning were incubated in solutions with increasing sucrose concentrations (10%, 20% and 30%, 6 h for each concentration), in order to remove most of the water volume and avoid damage during inclusion. Eight micrometers sections were obtained using a Leica cryostat from either fixed constructs or fresh surgical explants through embedding in OCT resin and quick freezing in liquid nitrogen-cooled isopentane.   In vitro   and   in vivo  resulting samples were accordingly processed for immunofluorescence analysis as previously described [23, 24]. Briefly, samples were permeabilized with 0.3% Triton X-100 in PBS for 1 h at room temper- ature (RT) and blocked with a blocking solution con- sisting of 10% goat serum, 1% glycine, 0.1% Triton X-100 in PBS for 1 h at RT. Subsequently, samples were incubated with primary antibodies in blocking solution for 2 h at RT and then rinsed with a washing solution consisting of 1% BSA and 0,2% Triton X-100 in PBS. Primary antibodies were diluted as follows: mouse monoclonal anti-myosin heavy chain (MyHC) (MF20 clone supernatant, DSHB) 1:2, rabbit poly- clonal anti-desmin (Abcam) 1:100, rabbit polyclonal anti-laminin (Sigma-Aldrich) 1:200, mouse mono- clonal anti-Pax7 (supernatant, DSHB) 1:20, rab- bit polyclonal anti-pNF (BioLegend) 1:400, mouse monoclonal anti-SMA (Sigma-Aldrich) 1:100, rabbit polyclonal anti-vWF (Abcam) 1:100, mouse mono- clonal anti-Lamin A/C (Thermo Fisher Scientific) 1:200. After washing, cells were incubated with Alexa Fluor 555-conjugated goat anti-mouse IgG (H   +   L; Thermo Fisher Scientific, diluted 1:400) and 488- conjugated goat anti-rabbit IgG (H   +   L; Thermo Fisher Scientific, diluted 1:400) for 1 h. Finally, nuc- lei were stained with 300 nM DAPI (Thermo Fisher Scientific) in PBS for 30 min. When fluorescent- BTX staining was needed,   α -BTX Alexa Fluor 488- conjugated was added to the DAPI solution at a con- centration of 1:400. Samples were observed using a Nikon TE 2000 epifluorescence microscope equipped with a Photometrics Cool SNAP MYO CCD camera and images were acquired through MetaMorph® soft- ware (Molecular Devices, Inc.). Alternatively, images were acquired through a Nikon A1R laser scanning confocal microscope with the NIS software.  2.5. Image analyses  Image analyses were performed by using the Image- J/FIJI program. Briefly,   in vitro   characterization of spontaneous twitching at day 10 in the bulk and 3D bioprinted constructs was obtained by analyzing the single frames of the live-imaging videos. After prop- erly calibrating images, radial displacement during twitching with respect to a reference point of the image was measured using the Straight Line function [25]. Myofibers size (width and length) was calcu- lated on whole-mount immunofluorescence images using the Straight Line function after image calib- ration, while coherency was calculated by using the Orientation J plugin, as previously described [11]. To describe fibers density and orientation in the con- struct cross sections, magnified region of interest (ROI)s were converted in highly contrasted eight-bit images and threshold was applied to generate binary images. After setting the measurements of interest, nuclei area and fibers cross sectional circularity and 4\nBiofabrication   15   (2023) 025009   E Fornetti   et al  area were calculated through the   Analyze Particles  function.  2.6. Statistical analysis  All experiments were performed in biological and technical   triplicates.   Data   were   analyzed   using GraphPad Prism 5, and values were expressed as means   ±   standard error. Statistical significance was tested using a t-test, as only two conditions were com- pared. A probability of less than 5% ( p   <   0.05) was considered to be statistically significant.  3. Results  3.1.   In vitro   analysis of myofibers maturation, organization and homogeneity in bioprinted and bulk constructs  The effectiveness of the printing system in sustaining biological processes such as cellular adhesion, pro- liferation and differentiation was assessed by using murine mesoangioblasts (Mabs). Mabs were added to the bioink composed by PF, a photocurable hydro- gel combining natural and synthetic benefit [17]. The obtained bioprinted constructs were maintained in culture up to 30 d, in order to obtain fully differen- tiated muscle fibers (figure 2(A)). As a parallel exper- imental control, bulk constructs were polymerized using a Teflon mold with the same dimension of the printing construct (refer to Materials and Methods section, figure 1). In both cases, constructs were kept attached to the C-shaped supports throughout the duration of the experiment in order to have the same passive tension. Interestingly, the effect of shear stress caused by the printing process can be noted by the flat appearance of cells at Day 0 compared to the round shape of cells within the bulk construct (figure 2(A)). Starting from day 10, spontaneous twitching events were recorded in both conditions (video S2). Video frames were analyzed in order to identify any differ- ences in contractile properties in the two conditions. Radial displacement, which indicates the shift occur- ring during the contraction phase of a single twitch, was significantly higher (2.5-fold) in the bioprin- ted condition (figure 2(B) and S3). Moreover, a dif- ferent twitching directionality was observed, being parallel to the printing axis in the bioprinted con- struct while randomly oriented in the bulk con- struct (figure 2(B)). At later time points, because of massive spontaneous twitching and the movement of whole constructs, it was not possible to perform video frames quantitative analysis (video S3). At day 30, upon muscle differentiation, whole- mount   immunofluorescence   analysis   against   the muscular differentiation markers MyHC and desmin were performed on both bulk and bioprinted con- structs (figure 3(A)). Image analysis confirmed that PF provides a favorable microenvironment for the maintenance of Mabs, able to proliferate and fuse for producing large multinucleated muscle fibers in both conditions (figure 3(B)). The evidence of a better organization and a greater homogeneity in myofibers size in the bioprinted construct, was assessed by com- paring myofibers width, length and coherency in both conditions. Myofibers average width resulted slightly higher in the bioprinted constructs even if not in a statistically significant way (figure 3(C), left). However, the width distribution in the bioprinted construct appeared shifted towards larger dimen- sions and more peaked as compared to bulk curve (figure 3(C), right). Interestingly, a greater width of fibers could be an indication of a better maturation [26]. Moreover, myofibers average length was signi- ficantly higher (two-fold) in bioprinted constructs compared to bulk myofibers, as also confirmed by the shifted length distribution (figure 3(D)). Coher- ency, a parameter ranging from 0 to 1 and describing the orientation and isotropic properties of analyzed region [27], was found to be significantly higher (3.5- fold) in the bioprinted constructs, with a distribution showing a very pronounced single peak as compared to the flat bulk curve (figure 3(E)).  3.2. Analysis of differentiation and fiber alignment on constructs sections  Both bulk and bioprinted constructs were snap frozen for OCT casting to obtain cryo-sections. Immun- ofluorescence analysis confirmed the presence of desmin-positive and MyHC-positive myofibers in both conditions (figure 4(A), left). Interestingly, cells were able to produce their own extracellular matrix (ECM), as evidenced by the presence of laminin sur- rounding the fibers and indicating proper matura- tion (figure 4(A), right). Laminin production is espe- cially visible around centrally nucleated regenerating fibers in bioprinted construct sections (figure 4(A), enlargement). Moreover, significant differences were highlighted by the quantitative analysis of different parameters related to constructs architectural organ- ization. Cellular density, a measurement indicating the presence and the cells localization within the section, is significantly higher in the bioprinted con- struct reflecting a better distribution of myofibers, whereas in the bulk construct cells localized mainly in the outermost layer (figure 4(B)). Moreover, the cir- cularity and the cross-sectional area measured on the constructs sections resulted respectively higher and lower in the bioprinting condition, indicating the bet- ter alignment of myofibers along the construct longit- udinal axis (figure 4(C)). On the other hand, the bulk constructs showed a larger cross-sectional area but a lower circularity, as expected for myofibers not ori- ented in a single direction. (figure 4(D)).  3.3. TA volume recovery after murine bioprinted construct implantation  To assess the potentiality of the printing system in   regenerative   medicine   applications,   a   murine model   of   VML   was   employed   [11].   The   VML 5\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 2.   Bright field imaging of muscle differentiation time-course in cellularized constructs. (A) Timeline showing the different experimental stages with representative bright field images from the production of bioprinted constructs and bulk control (Day 0), to the end of the experiment (30 d), a sufficient time to obtain differentiated muscle fibers capable of contracting. From day 10, differentiated muscle fibers start to spontaneously twitch. Scale bar   =   100   μ m. (B) Time-lapse representative images obtained from spontaneous twitching video recordings showing the shift of a reference segment during contraction in fibers within either bulk or bioprinted constructs. Black arrows indicate the direction of the constructs longitudinal axis and highlight how twitching directionality is parallel to the printing axis in the bioprinted construct while randomly oriented in the bulk construct.  model was obtained by massively ablating (90%) the TA of the mouse hind legs, in order to pre- vent   the   natural   healing   process   of   the   muscle [14]. 3D bioprinted constructs, obtained from nuc- lear LacZ Mabs (nLacZ-Mabs) [15], were placed in the anatomical space created by TA removal and the implant was allowed to integrate within the host muscle for 30 d. In the control mice, the TA muscle tissue was ablated without being replaced with the artificial construct. After sacrifice, 6\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 3.   Immunofluorescence analysis on bulk and 3D bioprinted constructs. (A) Confocal large-scale images showing the reconstruction of constructs large areas. Scale bar: 400   μ m. (B) Magnified images of differentiated muscle fibers expressing the muscle differentiation markers MyHC and Desmin. Scale bar: 100   μ m. (C) Myofibers width analysis, although not statistically significant in the two conditions, showing a distribution shifted towards larger dimensions and more peaked for the bioprinted constructs. ( n   =   9 analyzed fields from 3 independent experiments per condition, a minimum of 50 myofibers per field were analyzed). (D) Myofibers length analysis, displaying a significant increased length in the bioprinted structures, as confirmed by the shifted distribution ( n   =   9 analyzed fields from three independent experiments per condition, a minimum of 15 myofibers per field were analyzed). (E) Coherence analysis, describing the degree of myofibers alignment, being significantly higher in the bioprinted construct, as also shown in the very pronounced single peak distribution.   ∗∗∗ p   <   0.0008.   ∗∗ p   <   0.0019. Statistical significance was tested using a Student’s   t -test.  ablated and implanted TAs were collected and ana- lyzed through immunofluorescence analysis against laminin and MyHC, while LacZ-positive nuclei were identified by means of X-Gal labeling. The obtained cross sections images revealed the complete recov- ery of the tissue area in the implanted TA as com- pared to control, which conversely displayed a poor and   deficient   tissue   restoration   (figure   5(A)).   A large number of LacZ-positive nuclei were labeled within the centrally nucleated muscle fibers in the reconstructive   tissue,   which   demonstrated   to   be well organized (figure 5(B) and S4). Reconstruc- ted tissue deriving from the implanted constructs demonstrated to be properly vascularized, as high- lighted by the area enriched in LacZ-positive nuclei showing positive signal for smooth muscle actin (SMA) and von Willebrand factor (vWF), labeling vessel   muscle   wall   and   endothelium   respectively (figure 6(A)). Moreover, the reconstructed myofibers presenting LacZ-positive nuclei have been shown to be innervated, as demonstrated by the positive labeling of neural pre- and post-synaptic structures by immunostaining with phospho-neurofilament (pNF) and alpha-bungarotoxin (BTX), demonstrating the development of neuromuscular junctions within the regenerating TA muscle, after implantation of 3D constructs (figure 6(B)). Pax7-positive satellite cells were observed in the TA area reconstructed by nLacZ- Mabs, indicating the reestablishment of the stem cell niche required for muscle regeneration (figure 6(C)). 7\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 4.   Analysis of the constructs cross sections. (A) Cross sections of bulk and bioprinted constructs confirming the expression of the muscle differentiation markers MyHC and desmin (left) and the production of laminin-positive extracellular matrix (right), which is particularly noticeable around centrally nucleated transverse fibers in the bioprinted construct (enlargements). Left scale bar: 200   μ m, right scale bar: 100   μ m. Cellular density (B), which is expressed through nuclei percentage area, and alignment (C), which is expressed through circularity, resulted significantly higher in the bioprinted condition. Moreover, myofibers cross sectional area (D) resulted significantly higher in the control, as a result of a greater myofibers inclination.  ∗∗ p   <   0.0041.   ∗∗∗ p   <   0.0001.   ∗ p   <   0.0296. Statistical significance was tested using Student’s   t -test.  8\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 5.   Immunofluorescence analysis on ablated and implanted murine TAs. (A) Cross sections images analyzed through immunofluorescence analysis against laminin and MyHC revealed a complete area recovery of the TA implanted with the nLacZ-Mabs-laden bioprinted construct as compared to the ablated control. Scale bar: 400   μ m. (B) Magnified images of the area dashed in A showing LacZ-positive nuclei, labeled by X-Gal assay. Scale bar: 100   μ m.  Figure 6.   Higher magnifications analysis of the area regenerated by nLacZ-Mabs in 3D bioprinted constructs. (A) Immunofluorescence analysis against vessels-specific markers SMA and vWF indicate proper vascularization of the regenerating area. (B) Labeling by means of immunofluorescence for the pre- and post-synaptic neural markers pNF and BTX, targeting neurons cytoskeleton and muscular acetylcholine receptors, respectively. White arrowheads highlight developing fibers with central LacZ-positive nuclei showing host nerve terminals. (C) Pax7-positive satellite cells indicated by white arrowheads detected in LacZ-positive nuclei-rich area. Scale bar: 50   μ m.  9\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 7.   Immunofluorescence analysis on cross sections from murine TA implanted with hMSCs-laden bioprinted construct. (A) Immunostaining for laminin, MyHC and Lamin A/C on adjacent sections revealing a large reconstructed area derived from the xenograft. Dotted lines indicate interface between host native muscle and human-derived area. Scale bar: 400   μ m. (B) Magnified images of the dashed region in A showing MyHC-positive areas co-localizing with Lamin A/C-positive human nuclei. Scale bar: 100   μ m.  3.4. TA volume recovery after human bioprinted construct implantation  In order to evaluate the possibility to translate the proposed approach in human studies, pilot exper- iments   have   been   performed   exploiting   muscle- derived hMSCs-laden bioprinted constructs. For this purpose, constructs with human cells were implanted in the mouse hind limb upon 50% TA muscle abla- tion, similarly to the above-described experiment. After 30 d, tissues were collected and analyzed by means of immunofluorescence. Cross sections of the explanted TA show two distinct areas, one being the host native muscle and the other one resulting from the human-derived bioprinted implant (figure 7(A)). Although the tissue developed from the xenograft seems   overall   less   organized   compared   with   the murine-derived implants (figure 5), the large MyHC- positive area co-localizing with numerous human Lamin A/C (Lam A/C)-positive nuclei indicate that the reconstructed muscular tissue is from human ori- gin and that hMSCs were able to generate myofibers integrating with host ablated TA (figure 7(B)). Inter- estingly, a deeper analysis of the reconstructed TA tissue showed more organized areas with transverse small muscle fibers that in the contiguous section proved to be centrally nucleated and Lamin A/C- positive (figure 8(A)). Tissue reconstituted from the human-derived implant has shown also to be prop- erly vascularized and innervated, as highlighted by the positive signal revealed by vessels- (SMA and vWF) and neural-specific (pNF and BTX) markers (figures 8(B) and (C)). Moreover, the presence of 10\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 8.   Higher magnification analyses of the reconstructed TA area derived from human cells. (A) Transverse MyHC-positive myofibers that in the contiguous section proved to be centrally nucleated and Lamin A/C-positive, as indicated by white symbols. Vascularization (B), innervation (C) and stem cell niche (D) in the reconstructed muscular tissue derived from human bioprinted constructs are highlighted by the positivity for specific markers. The correspondence of the specific markers with the human Lamin A/C-positive nuclei is highlighted by white asterisks in two continuous sections. Scale bar: 30   μ m.  Pax7-positive satellite cells was observed in the peri- phery of some fibers, thereby suggesting the regener- ative potential of the reconstructed TA (figure 8(D)).  4. Discussion  To date, 3D bioprinting approach is gaining more and more interest for its ability to produce cellularized 3D constructs with a well-defined architecture closely replicating tissue organization in a quick and highly reproducible manner [28–31]. However, regardless of the printing system, this target often proves chal- lenging. Indeed, the technical requirements of 3D printing combined with the necessity for a biocom- patible cellular scaffold force researchers to find a compromise in formulating bioink between what is convenient for the machine and what is suitable for cell survival, proliferation and differentiation. Several research groups have faced these hurdles, investig- ating different strategies based on multi-component bioinks and/or multi-step polymerization processes. In particular, good outcomes have been obtained with PEG-Chitosan, Gelatin and porcine decellular- ized ECM [28, 30, 31]. However, existing approaches often require a difficult set-up involving considerable changes of temperature during the extrusion process and the combination of chemical/physical polymeriz- ation of the bioink, while at the same time not provid- ing a resolution of less than 300   μ m. Our team also focused its efforts on this direc- tion, basing the bioink formulation on the combin- ation of alginate and PF, in order to exploit alginate printability together with PF biological compatibility. With this approach, the bioink was transiently retic- ulated during the printing process by exposing the alginate to a covalent ions solution, while irreversible polymerization was achieved in a second step by UV exposure that acts on PF molecules. Subsequently, the alginate was removed from the scaffold with a calcium chelating agent or an alginase enzyme solu- tion. This technique demonstrated optimal outcomes  in vitro , allowing differentiation of muscle progenitor cells and production of highly organized muscle con- structs. However, in VML regeneration experiments, alginate residues remained in the constructs affected the quality of the resulting muscle [11, 13]. In an attempt to overcome these limitations, this work further described a novel and versatile alginate- free and extrusion-based 3D bioprinting system. The development of the proposed printing system is based on the characteristics of PF, a hydrogel able to sus- tain growth and differentiation of skeletal muscle cells both   in vivo   and   in vitro   [15, 16]. In this way, instead of formulating the right biomaterial according to the printing system features, priority was given to the cell physiological requirements. Initially, PF physical properties did not seem compatible with a printing system based on the use of this hydrogel only, as the polymerization time is relatively long (5 min of UV rays exposure). For this reason, the printer features have been customized in order to drastically reduce the PF polymerization time to 8 s, allowing a rapid and cell-friendly printing process. Another strength of the presented bioprinter is the C-shaped stainless- steel support, specifically designed to allow the pro- duction of 3D constructs composed by fibers bundles 11\nBiofabrication   15   (2023) 025009   E Fornetti   et al  similar to the skeletal muscle tissue architecture. The use of a linear support allows to collect the printing fibers in highly aligned lines between the two pins and to produce an elongated bundle, representing an improvement over the circular constructs obtained with cylindrical supports [11]. Notably, rotation of the C-shaped support pulls the printing fibers and leads to an increase of the printing resolution to 100   μ m (1/3 of the extruder microtube diameter). Moreover, a translational ‘forward-reverse’ move- ment allows the layer-by-layer deposition of print- ing fibers on the support, so as to recapitulate muscle organization. The potential of the PF-based bioprinting sys- tem in supporting the biological processes needed for muscle differentiation has been evaluated using murine mesoangioblasts (Mabs) as the source of muscle progenitors [15]. Our results confirmed PF as an ideal scaffold for the growth, differentiation and maturation of muscle fibers, which have been shown to be able to twitch spontaneously both in bioprinted and bulk condition. A difference in the myofibers overall organization between the two conditions emerged from the first brightfield ana- lyses, and the formation of differentiated and aligned myofibers in the bioprinted constructs demonstrated to be necessary to the coherent muscle bundles con- traction. Moreover, with the aim of identifying differ- ences in the contracting behavior of myofibers within bulk and bioprinted constructs, we recorded and described a greater radial displacement during the contraction phase of the bioprinted myofibers. Tak- ing into account the relationship between myofibers size and their ability to generate force [32], we specu- late this result might indicate an ability to produce a greater amount of force as compared to the twitch- ing myofibers of the bulk construct. Shear stress and geometric confinement induced by 3D bioprint- ing confirmed to have an influence on the elonga- tion and alignment of homogeneous muscle fibers. Moreover, cross sections showed how bioprinting promotes a more homogeneous myofibers distribu- tion within the construct as compared to the bulk condition, in which muscle fibers are arranged only in the most external layer. We speculate that this phe- nomenon could be the result of an improved oxygen and medium perfusion through the space between the printing fibers. Relying   on   the   encouraging   results   obtained  in vitro , we proceeded investigating the capability of the constructs obtained with the proposed bioprint- ing system in restoring a VML in a murine model. VML, resulting from severe trauma or sarcomas sur- gical ablation, is a pathological condition that pre- vents the regeneration of skeletal muscle, as it owns considerable ability to repair tissue damage but only when limited in size [33]. Unfortunately, currently adopted surgical therapies do not yet provide sat- isfactory results. To date, one of the most widely employed clinical strategy for the treatment of VML trauma is the implantation of acellularized scaf- folds composed by ECM often derived from nat- ural sources (e.g. porcine urinary bladder-derived ECM). However, the functional recovery is limited, making this reconstructive therapy inadequate [24]. For this reason, an increasing attention is being paid to skeletal muscle tissue engineering as a promising approach. In our experiments, 3D bioprinted Mabs-laden constructs lead to a full restoration of the lost muscle volume 30 d after grafting. The acellular PF bioprin- ted construct was not employed as experimental con- trol for implantation experiments, as it has already well demonstrated to be completely reabsorbed by the host organism in previous papers [11, 14]. The wide implantation of Mabs in the regenerating tissue (figure S4) indicates an active role of the implant not only in the regeneration of muscle fibers, but also in driving the recruitment of all the biological elements required for implant survival and for proper develop- ment of a functional muscle tissue. Functional recov- ery rate will be the focus of future studies. Finally, as a proof-of-concept to evaluate the translational potential of the proposed approach, hMSCs [19] were employed to obtain 3D bioprinted constructs. A less extensive VML (50% TA volume ablation) was chosen for these experiments, based on our previous experiences with human-on-mouse grafts where the host did not fully accept the human cells (data not shown). Similarly to murine exper- iments, 30 d after implantation the human cell- derived bioprinted constructs were able to restore the host muscle volume even if the reconstructed tissue was not fully organized as for Mabs-derived implant (mouse-on-mouse). However, a large num- ber of human cells survived in the host and were able to drive the formation of new muscle fibers, to recruit blood vessels and nerves, and to stimulate the forma- tion of a pool of satellite cells. Altogether, the presen- ted data make us confident that the proposed recon- structive strategy has the potential to be suitable for future translational medicine application in human.  5. Conclusion  In this work, the proposed alginate-free extrusion- based 3D bioprinting system, established on the use of PF as only hydrogel composing the cellular scaffold, demonstrated to be a novel and competitive tool for skeletal muscle tissue engineering. The bioprinter was developed by exploiting our expertise, acquired over the years, on skeletal muscle tissue engineering and on the use of the most suitable hydrogels for myogenesis. This background granted us to realize a simple yet effective strategy to overcome limitations of previous systems that depend on the combination of PF with other less biocompatible hydrogels (such as alginate). The presented results highlighted the potential of this 12\nBiofabrication   15   (2023) 025009   E Fornetti   et al  innovative printing approach in two main aspects: on one hand, the possibility to obtain   in vitro   biological substitutes showing properly organized muscle fibers capable of spontaneously contracting, which could represent a biological platform for drug screening and myopathies studies. On the other hand, the efficacy of the printed construct in restoring a VML damage in a mouse model, both with murine and human-derived myogenic progenitors, suggesting that the proposed approach could represent a remarkable and effective tool for regenerative medicine. Finally, the ease-of-use the presented approach could lend itself to the use of other photo-curable biomaterials (such as gelatin and other PEG-based hydrogels) and different types of mesodermal stem cells   (Bone   Mesenchymal   Stem   Cells   [34,   35], Adipose-derived Stem Cells [36], Tendon-derived Stem Cells [37]) to print a wide range of mesodermal- derived   tissues   as   3D   models   or   transplantable substitute.  Data availability statement  All data that support the findings of this study are included within the article (and any supplementary files).  Acknowledgments  We thank Massimo Testa for the support in designing and manufacturing the 3D bioprinter system and Dr Franca Abbruzzese (Universit ` a Campus Bio-Medico di Roma) for her technical support on confocal microscopy acquisition. The research has been carried out thanks to PRIN 2017: 201742SBXA_004 foun- ded by Italian Ministry of University and Research to Cesare Gargioli.  Conflict of interest  The authors declare no conflict of interest.  ORCID iDs  E Fornetti      https://orcid.org/0000-0002-6246-5351 A Rainer      https://orcid.org/0000-0001-8971-551X  References  [1] Fan T, Wang S, Jiang Z, Ji S, Cao W, Liu W, Ji Y, Li Y, Shyh-Chang N and Gu Q 2022 Controllable assembly of skeletal muscle-like bundles through 3D bioprinting  Biofabrication   14   015009 [2] Kim J H, Seol Y J, Ko I K, Kang H W, Lee Y K, Yoo J J, Atala A and Lee S J 2018 3D bioprinted human skeletal muscle constructs for muscle function restoration   Sci. Rep.   8   12307 [3] Aubin H, Nichol J W, Hutson C B, Bae H, Sieminski A L, Cropek D M, Akhyari P and Khademhosseini A 2010 Directed 3D cell alignment and elongation in microengineered hydrogels   Biomaterials   31   6941–51 [4] Kim W J and Kim G H 2020 3D bioprinting of functional cell-laden bioinks and its application for cell-alignment and maturation   Appl. Mater. Today   19   100588 [5] Naghieh S and Chen X 2021 Printability–a key issue in extrusion-based bioprinting   J. Pharm. Anal.   11   564–79 [6] Fu Z, Naghieh S, Xu C, Wang C, Sun W and Chen X 2021 Printability in extrusion bioprinting   Biofabrication  13   033001 [7] Hospodiuk M, Dey M, Sosnoski D and Ozbolat I T 2017 The bioink: a comprehensive review on bioprintable materials  Biotechnol. Adv.   35   217–39 [8] Croisier F and Jér ˆ ome C 2013 Chitosan-based biomaterials for tissue engineering   Eur. Polym. J.  49   780–92 [9] Ferreira A M, Gentile P, Chiono V and Ciardelli G 2012 Collagen for bone tissue regeneration   Acta Biomater.  8   3191–200 [10] Willson K, Atala A and Yoo J J 2021 Bioprinting au natural: the biologics of bioinks   Biomolecules   11   1593 [11] Costantini M   et al   2021 Biofabricating murine and human myo-substitutes for rapid volumetric muscle loss restoration  EMBO Mol. Med.   13   1–17 [12] Wang X, Li X, Dai X, Zhang X, Zhang J, Xu T and Lan Q 2018 Coaxial extrusion bioprinted shell-core hydrogel microfibers mimic glioma microenvironment and enhance the drug resistance of cancer cells   Colloids Surf.   B  171   291–9 [13] Costantini M   et al   2017 Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden hydrogels leads to functionally organized myofibers   in vitro   and   in vivo Biomaterials   131   98–110 [14] Fuoco C   et al   2015   In vivo   generation of a mature and functional artificial skeletal muscle   EMBO Mol. Med.  7   411–22 [15] Fuoco C   et al   2012 Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration   Skelet. Muscle   2   24 [16] Fuoco C   et al   2014 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering   Front. Physiol.   5   203 [17] Almany L and Seliktar D 2005 Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures   Biomaterials   26   2467–77 [18] Buonvino S, Ciocci M, Seliktar D and Melino S 2021 Photo-polymerization damage protection by hydrogen sulfide donors for 3D-cell culture systems optimization   Int. J. Mol. Sci.   22   6095 [19] Testa S   et al   2020 Skeletal muscle-derived human mesenchymal stem cells: influence of different culture conditions on proliferative and myogenic capabilities   Front. Physiol.   11   553198 [20] Schaefer B, Beier J P and Ruhl T 2020 Mesenchymal stem cells and the generation of neomuscle tissue   Surg. Technol. Int.   36   41–47 [21] Bryant S J, Nuttelman C R and Anseth K S 2000 Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts   in vitro J. Biomater. Sci. Polym. Ed.   11   439–57 [22] Mironi-Harpaz I, Wang D Y, Venkatraman S and Seliktar D 2012 Photopolymerization of cell-encapsulating hydrogels: crosslinking efficiency versus cytotoxicity   Acta Biomater.  8   1838–48 [23] Testa S, D’Addabbo P, Fornetti E, Belli R, Fuoco C, Bernardini S, Cannata S, Frezza D and Gargioli C 2018 Myoblast myogenic differentiation but not fusion process is inhibited via MyoD tetraplex interaction   Oxid. Med. Cell. Longev.   2018   7640272 [24] Testa S, Fornetti E, Fuoco C, Sanchez-Riera C, Rizzo F, Ciccotti M, Cannata S, Sciarra T and Gargioli C 2021 The war after war: volumetric muscle loss incidence, implication, current therapies and emerging reconstructive strategies, a comprehensive review   Biomedicines   9   564  13\nBiofabrication   15   (2023) 025009   E Fornetti   et al  [25] Chandel I, Baker R, Nakamura N and Panin V 2020 Live imaging and analysis of muscle contractions in Drosophila embryon   J. Vis. Exp.   9  [26] Bakooshli M A   et al   2019 A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction   Elife   8   1–29 [27] Clemons T D, Bradshaw M, Toshniwal P, Chaudhari N, Stevenson A W, Lynch J, Fear M W, Wood F M and Iyer K S 2018 Coherency image analysis to quantify collagen architecture: implications in scar assessment   RSC Adv.  8   9661–9 [28] Hu T, Cui X, Zhu M, Wu M, Tian Y, Yao B, Song W, Niu Z, Huang S and Fu X 2020 3D-printable supramolecular hydrogels with shear-thinning property: fabricating strength tunable bioink via dual crosslinking   Bioact. Mater.  5   808–18 [29] Ostrovidov S   et al   2019 Three dimensional bioprinting in skeletal muscle tissue engineering   Small   15   1805530 [30] Kim W, Lee H, Lee J, Atala A, Yoo J J, Lee S J and Kim G H 2020 Efficient myotube formation in 3D bioprinted tissue construct by biochemical and topographical cues  Biomaterials   230   119632 [31] Hwangbo H, Lee H, Jin E J, Lee J Y, Jo Y, Ryu D and Kim G H 2022 Bio-printing of aligned GelMa-based cell-laden structure for muscle tissue regeneration   Bioact. Mater.  8   57–70 [32] Cooper A N, McDermott William J, James C Martin, Dulaney Shea O and Carrier D R 2021 Great power comes at a high (locomotor) cost: the role of muscle fascicle length in the power versus economy performance trade-off   Exp. Biol.  224  [33] Corona B T, Garg K, Ward C L, McDaniel J S, Walters T J and Rathbone C R 2013 Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of skeletal muscle   Am. J. Physiol. Cell Physiol.   305   761–75 [34] Bae S W, Lee K W, Park J H, Lee J H, Jung C R, Yu J J, Kim H Y and Kim D H 2018 3D bioprinted artificial trachea with epithelial cells and chondrogenic-differentiated bone marrow-derived mesenchymal stem cells   Int. J. Mol. Sci.  19   1–14 [35] Luo C, Xie R, Zhang J, Liu Y, Li Z, Zhang Y, Zhang X, Yuan T, Chen Y and Fan W 2020 Lowerature three-dimensional printing of tissue cartilage engineered with gelatin methacrylamide   Tissue Eng.   C   26   306–16 [36] Stanco D, Boffito M, Bogni A, Puricelli L, Barrero J, Soldati G and Ciardelli G 2020 3D bioprinting of human adipose-derived stem cells and their tenogenic differentiation in clinical-grade medium   Int. J. Mol. Sci.   21   1–23 [37] Lui P P Y and Chan K M 2011 Tendon-derived stem cells (TDSCs): from basic science to potential roles in tendon pathology and tissue engineering applications   Stem Cell Rev. Rep.   7   883–97  14',0.04032283923962292,'[\"(\", \"(1\", \"(1)\", \"(1).\", \"(1/3\"]','2025-11-29 17:03:09.915929'),(58,3,'royalsocietypublishing.org/journal/rsif  Research  Cite this article:   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients.   J. R. Soc. Interface   19 : 20220576. https://doi.org/10.1098/rsif.2022.0576 Received: 8 August 2022 Accepted: 19 October 2022  Subject Category:  Life sciences – engineering interface  Subject Areas:  biomedical engineering  Keywords:  magnetic nanoparticles, regenerative medicine, tissue engineering, neurite outgrowth  Author for correspondence:  A. J. El Haj e-mail: a.elhaj@bham.ac.uk Electronic supplementary material is available online at https://doi.org/10.6084/m9.figshare. c.6266161.  Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients K. Dhillon   1   , K. Aizel   2 , T. J. Broomhall   1 , E. Secret 3   , T. Goodman   4 , M. Rotherham   1 , N. Telling   4   , J. M. Siaugue   3 , C. Ménager   3   , J. Fresnais   3 , M. Coppey   2 , A. J. El Haj   1   and M. A. Gates   4,5  1 Healthcare Technologies Institute, Department of Chemical Engineering, University of Birmingham, Birmingham, UK  2 Institut Curie, PSL Research University, CNRS, Sorbonne Université, Physico Chimie, Paris, France  3 Sorbonne Université, CNRS, Laboratoire Physicochimie des Électrolytes et Nanosystèmes Interfaciaux, PHENIX, 75005 Paris, France  4 School of Pharmacy and Bioengineering, Guy Hilton Research Centre, and   5 School of Medicine, Keele University, Staffordshire, UK  KD, 0000-0003-1335-8442; TJB, 0000-0002-7528-0831; ES, 0000-0003-2200-7265; MR, 0000-0002-9297-7681; NT, 0000-0002-2683-5546; JMS, 0000-0003-1217-9493; CM, 0000-0002-4080-3508; JF, 0000-0002-2037-0637; MC, 0000-0001-8924-3233; AJE, 0000-0003-3544-5678; MAG, 0000-0002-2901-1083  A challenge in current stem cell therapies for Parkinson ’ s disease (PD) is controlling   neuronal   outgrowth   from   the   substantia   nigra   towards the targeted area where connectivity is required in the striatum. Here we present progress towards controlling directional neurite extensions through the application of iron-oxide magnetic nanoparticles (MNPs) labelled neuronal cells combined with a magnetic array generating large spatially variant field gradients (greater than 20 T m − 1 ). We investigated the viability of this approach in both two-dimensional and organotypic brain slice models and validated the observed changes in neurite directionality using mathematical models.   Results   showed   that   MNP-labelled   cells   exhibited   a   shift   in directional neurite outgrowth when cultured in a magnetic field gradient, which broadly agreed with mathematical modelling of the magnetic force gradients and predicted MNP force direction. We translated our approach to an   ex vivo   rat brain slice where we observed directional neurite outgrowth of   transplanted   MNP-labelled   cells   from   the   substantia   nigra   towards the striatum. The improved directionality highlights the viability of this approach as a remote-control methodology for the control and manipulation of cellular growth for regenerative medicine applications. This study pre- sents a new tool to overcome challenges faced in the development of new therapies for PD.  1. Introduction  Parkinson ’ s disease (PD) is a neurodegenerative condition that arises during the progressive degeneration of midbrain dopaminergic (mDA) neurons in the sub- stantia nigra pars compacta (SNc). The loss of mDA neurons results in the loss of connections between the SNc and striatum. While pharmacological treatments exist for the short-term replacement of dopamine in the SNc-striatal circuit, there is a critical clinical need for cell therapies to restore dopaminergic cells in the SNc  © 2022 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited. Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n[1 – 4]. Potential cell therapies for this condition also depend upon the ability of the transplanted cells to reinnervate with neurons in the striatum. However, the rate of regeneration in the central nervous system is slow [5,6] which limits recovery. This technically challenging aspect of neuronal cell engineering is crucial for successful cell integration, circuit reconnection and   ultimately   disease   remission.   Several   approaches   to directing neuronal growth have been investigated, including the   use   of   mechanical   cues   and   magnetic   nanoparticles (MNPs) to generate tension to guide outgrowth [7 – 9]. While the study of neuronal outgrowths has been investigated over a long period of time, the control of outgrowth direction is a relatively newer approach that offers ways of progressing potential cell therapies for neurodegenerative conditions. Within   the   regeneration   process   growth   cones   are extended   from   the   neuronal   cell   which   are   capable   of generating   forces   through   their   motion,   which   can   aid in   growth   and   repair   [10].   Combining   the   mobility   of these growth cones and biological cues enables neuronal outgrowths to become directed to a target region [11]. There- fore, it is considered that other approaches to generating directional cues could help achieve more complete reinner- vation.   One   potential   approach   to   generating   topological gradients and directional cues is through the use of MNPs guided by magnetic fields [6,8,9,12,13]. MNPs are a suitable candidate for applying mechanical forces to neuronal cells, being widely used in biomedicine settings, such uses as MRI contrasts [14 – 16], and are commercially available, with previously demonstrated biological safety. MNPs have attracted attention as force carriers for the manipulation   of   cells   owing   to   their   ability   to   be   con- trolled remotely through externally applied magnetic fields. Through   the application   of magnetic   fields, the resulting forces can be applied either internally or externally to a cell, for example: through internalization into endosomes, or by binding to receptors and ion channels at the cell membrane. This approach has been recently used in a variety of cell and tissue engineering applications to regulate cell signalling path- ways, control cell differentiation and promote tissue repair [12,17,18]. Commonly, varying magnetic fields are employed to create a field gradient (varying in time) to act upon MNPs [19]. However, static magnetic fields can also be designed to vary in space and therefore offer another method to generate sufficient field gradients to induce forces acting on MNPs. To study the efficacy of using MNPs and static magnetic fields to help direct the neuronal outgrowths, we employ PC12 cells with MNPs and used a magnetic gradient to magnetically   control   neurite   extension   while   undergoing differentiation (figure 1 a,b ). PC12 cells are a well-established model neuronal cell line in PD research. When cultured with neurotrophic factors, PC12 differentiate into neuron-like cells with neuronal morphology and express neuronal markers [20,21]. We then tested the translational potential of this approach in rat organotypic brain slices, which were used as  Fe 2 O 3 PAA   2K   MNP  poly-acrylic acid / rhodamine coating magnetic core (Fe 2   O   3 ) MNP-tagged neurons MNP-tagged neurons neurite outgrowth towards striatum + 7 days striatum rat brain slice   substantia nigra  ex vivo  directed neurite growth differentiation + 8 days magnetic gradient ( a ) ( b ) ( c ) neuronal cells incubated with MNPs  in vitro  MNP internalization into lysosomes  Figure 1.   ( a ) Schematic of the experimental set-up. Poly-acrylic acid/rhodamine functionalized MNP with an Fe   2   O 3   core was synthesized and incubated with PC12 cells to allow internalization. ( b ) The MNP-tagged cells were cultured in differentiation media while being exposed to static magnetic fields in order to direct neurite extension along the magnetic field gradients. ( c ) MNP-tagged neurons were also injected into rat brain slices modelling the nigral-striatal pathway. Magnetic fields were then used to direct neurite extension from the cells at the injection site towards the striatum. royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  2 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\na model of the SNc-striatal circuit. Using this system, we injected primary rat embryonic ventral midbrain (VM) dopa- minergic precursor cells, which had been pre-labelled with MNP, into the SNc of rat brain slices. We then orientated the slices under the magnetic field gradient to promote directed cell and neurite outgrowth from the transplant region towards the striatum (figure 1 c ). After 8 days, we assessed cell and neur- ite outgrowth under magnetic control. The overall aim of this research was to demonstrate controlled directional neurite outgrowth   in   neuronal   cells,   which   was   validated   using mathematical models. This technology provides proof of prin- ciple for magnetic control of neuronal outgrowth with clear applications for neurodegenerative cell therapies.  2. Methods 2.1. Computational methods  The magnetic field profiles were simulated by employing a finite- element (FE) approach using the commercial software   COMSOL v5.1.   Magnetic fields and the resulting gradients were simulated by employing the   Magnetic Fields, No Currents   toolbox, with initialization parameters (remnant magnetization   B R   ) matching those of the neodymium iron-boron (NdFeB) magnets used in the experimental device (table 1). To calculate the directional motion of MNPs, the resulting field profiles were combined with   the   Particle   Tracing   for   Fluid   Flow   toolbox   with   MNPs simulated as particles with diameter, mass and magnetic suscep- tibility ( χ ) matching those of experimentally employed MNPs (table 1). The magnetic susceptibility ( χ ) of the MNPs is of key impor- tance when calculating the forces acting on a particle. The MNPs chosen   for   this   study   were   iron-oxide   particles   coated   with PAA (Fe 2   O 3 -PAA   2K   ). The MNP diameter is 8.4 ± 1.9 nm with saturation magnetization values of 51 – 57 emu g − 1   [12]. These particles have previously been reported to have good levels of internalization and stable magnetization within biological sys- tems over long time periods [22]. From a Langevin function of magnetization,   the   magnetic   behaviour   of   these   particles   is easily reproduced, and the susceptibility was calculated to be 4.27 from the change in magnetization at zero field. In the instance of an MNP located within static magnetic field the force acting upon it while in a fluid medium can be found from the following equation [23]:  F   M   ¼   2  p r 3  p  m 0  m p  m p     m f  m p   þ   2  m f  r H 2   ,   ð 2 : 1 Þ  where   r p   is the radius of the particle (in m),   μ p   and   μ f   is the permeability of the MNP and surrounding fluid, respectively, (where   μ   = 1 +   χ )   and   r H   is   the   magnetic   field   gradient   in (A m − 2 ). The motion for each MNP was calculated using the magnetophoretic force (equation (2.1)) applied across the sample region with the fluid medium taken to be water ( μ f   = 1) as an analogy to the MNP being located either in the cell or culture medium. MNP motion simulations included viscous drag and were simulated for a total time period of 8 h.  2.2. Magnetic device  To enable forces to be applied upon MNPs, a magnetic field (and gradient) needs to be established over the sample region. To achieve this, a device consisting of NdFeB permanent mag- nets (N42 grade) was created (as shown in figure 2 a ; electronic supplementary material, figure S1). The magnetic field was simu- lated using a FE method and the resulting magnetic field profile is shown in figure 2 c , ranging from field strengths of approxi- mately 700 to approximately 70 mT. The magnetic array device was mapped in three dimensions using an M3D-2A-PORT mag- netic field mapper (SENIS) at a scan resolution of 200 μm (x,y) and   a   step   size   of   0.5 mm   (z).   The   measured   field   map is shown in figure 2 c ; the values of magnetic field and the field gra- dient are found to align with the simulated magnetic field. The magnetic field gradient found along the magnetic field orien- tation is shown in figure 2 d   and is found to be greater than 20 T m − 1   across the sample region.  2.3. Cell culture  The rat adrenal phaeochromocytoma cell line, PC12 (CRL-1721), obtained   from   ATCC,   were   cultured   in   suspension   in   basal medium   made   from   Dulbecco ’ s   modified   Eagle ’ s   medium (Gibco) supplemented with 10% horse serum (heat inactivated), 10%   fetal   bovine   serum,   1%   penicillin-streptomycin   and   1% L-glutamine. Cells were kept in incubator at 37°C and 5% CO 2   .  2.4. Magnetic nanoparticles labelling  Cells were labelled with rhodamine-fluorescent Fe   2 O 3 -PAA   2K MNPs   which   were   previously   described   and   characterized by Bongaerts   et al.   [12]. The MNPs had a mean hydrodynamic size of 30.1 nm and were superparamagnetic in nature with a saturation magnetization of 55.7 emu g − 1 . Cells were labelled in suspension at a concentration of 2 mM (iron) in pre-warmed complete basal medium for 24 h prior to seeding.  2.5. PC12 differentiation  For differentiation into a neuronal phenotype, PC12 cells were seeded at 20 000 cells cm − 2   density on 1% poly-L-lysine (Sigma) and 10 μg μl − 1   laminin (Sigma L2020) coated glass-bottom dishes 24 h before initiating differentiation. Cells were differentiated for 8 days in culture with differentiation medium: Dulbecco ’ s modified Eagle ’ s medium (Gibco) supplemented with 5% horse serum (heat inactivated),   1%   penicillin-streptomycin,   1%   L-glutamine   and 100 ng μl − 1   nerve   growth   factor   (recombinant   human   β -NGF 450-01, Peprotech) with media replenishment every 2 days.  2.6. Live/dead staining  PC12 cells were incubated with MNP as above and cultured in neuronal   differentiation   media   under a   static   magnetic   field with peak flux density of less than 200 mT over 8 days. Cell via- bility was then assessed after 8 days using a ReadyProbes ™   cell viability assay (ThermoFisher) according to the manufacturer ’ s instructions.  2.7. Rat brain slice preparation  Organotypic slice cultures were prepared from postnatal day 5 – 8 rat   pups   according   to   the   interface   method   as   previously described [18,24]. Briefly, pups were terminally anaesthetized by intraperitoneal injection of pentobarbital in accordance with UK   Animals   (Scientific   Procedures)   Act   1986.   Sagittal   brain sections of 300 μm were cut at 10° angles using a vibratome  Table 1.   Parameters used for magnetic and MNP simulations.  simulation property   value   units  B R   1.42   T MNP diameter   8.4   nm MNP density   5240   kg m − 3  χ   4.27   dimensionless royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  3 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n(Leica). Following removal of the cortex and hippocampus, slices were placed onto PTFE membranes with 0.4 μm pores to allow access to nutrients from below and maintain gaseous exchange from above.  2.8. Injection of magnetic nanoparticle labelled ventral midbrain cells  Slices were cultured for 7 days (with SN removed) before trans- plantation of E14 VM cells to the SN region of the slice. The day before   transplantation,   the   VM   was   dissected   from   E14   rat embryos, dissociated and resuspended in medium containing 8 mM Fe 2 O 3   -PAA   2K   MNPs (iron concentration). The suspension was added to the well of a plate and incubated overnight. The MNPs prevented the cells from adhering to the plate without affecting cell viability. The next day, 200 – 500 nl of MNP-loaded VM cell suspension was pipetted into the SN region of the slice. The slice was then transferred to a Petri dish and orientated within the magnet device so that the striatum was exposed to the largest flux density in order to promote cell/neurite growth towards the striatum. The magnetic device was housed within a cell culture incubator at 37°C, 5% CO 2 . Control slices were cultured in six-well plates at 37°C, 5% CO   2   under no magnetic field. Slices were fixed 7 days following cell transplantation and immuno-stained for tyrosine hydroxylase (TH) to visualize both the cell bodies and process of dopamine neurons in the tissue and transplant.  2.9. Imaging  Light and fluorescent images were taken with EVOS M5000 or EVOS   XL   core   microscopes   (Thermofisher   Scientific).   Three- dimensional Z-stack imaging was conducted using Olympus Fluoview   FV1000   confocal   microscope.   Neurite   angle measurement   was   performed   using   the   angle   measurement tool in FIJI ImageJ2 software.  2.10. Analysis of rat brain slices  Images for each slice were stitched to form a montage, then rotated so that the striatal-SN axis was in the same plane for each sample. Each slice image was then divided into a grid of 20 regions of interest (ROI ’ s) covering three regions as shown in electronic supplementary material, figure S2a. These regions consisted of the implant area, the striatal region and an out- growth   area   located   between   the   implant   area   and   the striatum. For each sample, the mean grey value of each ROI in the outgrowth region was measured. These values were cor- rected   by   subtracting   the   mean   grey   value   of   the   slice background due to staining from the background slice tissue. The orientation of TH+ cells and neurites present in the out- growth region was also assessed using a directionality plug-in in   ImageJ.   This   was   used   to   calculate   the   relative   average amount   of   TH+ structures   at   each   orientation   (±90°)   within each sample. Only samples which contained TH+ cells and or neurites in the outgrowth region were included in the analysis.  2.11. Statistical methods  All statistical analysis was completed using Stata 17.0. For   two-dimensional   neurite   growth   measurements,   the measured angles were transformed to be a deflection relative to the field   direction   irrespective of lateral travel (i.e. ignoring left/right direction, with the key metric being the deflection angle). This results in measured deflection angles in the range of 0   −   90°. To evaluate the distributions in both control and MNP group, a Levene test for variance and a Shapiro test for nor- mality were performed. It was found that the two distributions had equal variance and were both non-normally distributed (Levene test:   p   > 0.05, Shapiro test:   p   < 0.05). From the description  ( a )   ( b ) ( c )   ( d ) 700 600 500 400 (mT) 300 200 100 30  25  20  15  10 X-position across sample area (mm) Y-position across sample area (mm) 5   0 10 700   700   35 30 25 20 15 10 field gradient (T m − 1 ) X co-ordinate across sample region (mm) imaging region 5 0  0   5   10   15   20   25   30   35 600 500 400 (mT) field gradient (T m − 1 ) 300 200 100 500 300 100 magnetic field (mT) 5 0 –5 –10  Figure 2.   ( a ) Shows assembled device with sample. ( b ) Shows a schematic of the device highlighting the orientation of the permanent magnets and the simulated magnetic field. ( c ) Three-dimensional map of magnetic flux density across the sample area confirmed a steep gradient across the sample region. ( d ) Shows the resulting magnetic field gradient, and the imaging region highlighted demonstrates that in the sample region investigated the field gradient is greater than 20 T m − 1 . royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  4 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nof these distributions, a Kruskal – Wallis test was chosen as a suitable statistical test. For pixel intensity analysis of slice TH staining, data are presented as medians +/- interquartile range (IQR). Statistical significance   at   95%   confidence   level   was   applied   using   a Mann – Whitney   test   (two-tailed,   unpaired),   p   < 0.05   was considered statistically significant.  3. Results 3.1. Simulation of magnetic nanoparticle motion  The direction of force exerted on MNPs within the sample region can be simulated to gain understanding as to how the external magnetic field and resulting gradient will drive directional neur- ite outgrowths. The force acting on an MNP and therefore to the attached sub-cellular structures and organelles in a static mag- netic field can be calculated by employing a magnetophoretic model (equation (2.1)). The magnetophoretic model results in MNP motion along the direction of applied force. Particle trajectories were simulated in a water medium over a time period of 8 h as an indication to the resulting directional outgrowth. Viscous drag forces were included to better understand the magnitude of forces exerted on the MNPs. The angle between the final position and the initiali- zation position relative to the field direction was calculated for each simulated MNP. Initial particle positions were randomized to within a sub- region of the entire sample region which represented the locations available for imaging in experimental studies (indi- cated by the grey circle in figure 3 a , black dots identify initial positions for a random sampling of particle positions). A total of 1500 particles were initialized with a resulting 1147 particle positions having a final position within the sampling region. The resulting angle of MNP motion is shown in figure 3 b , it is of note that the majority of particles do not move along the hori- zontal (along the direction of the applied field) but have a small angular offset in the vertical direction (perpendicular to the main applied field direction). This can be seen from comparing simulations that only include forces created through the appli- cation of   B x   components, to those in which   B x   and   B y   are included in the force calculation (figure 3 b ). When only   B x   com- ponents of magnetic field are included, the applied force and resulting directional motion of MNPs show a narrower range  ( a )   ( b ) 700 0.12 0.04 0.02 0.00  0   10   20   30   40   50   60 angle of MNP motion (°) 70   80   90 X component XY component 0.06 0.10 0.08 density 600 500 400 (mT) 300 200 100  Figure 3.   ( a ) Shows simulated trajectories of MNP motion within the magnetic device. Initial MNP positions (black dots) were randomized to the same sampling area used for two-dimensional imaging studies (grey circle). MNP motion was simulated over an 8 h period and the resulting angle of motion is shown in ( b ). Simulated MNP motion is included for both only including the X-component of magnetic field compared with including both X and Y components.  DAPI 2K MNP  (i)   (ii)  ( a ) ( b ) (i)   (ii)  Figure 4.   ( a ) PC12 cells labelled with rhodamine-fluorescent Fe   2 O   3 -PAA   2K   MNPs (scale bar = 100 μm) ( b ) Z-stack (0.2 μm slices) confocal images of PC12 cells labelled with AA2K-MNPs at day 1 (i) and day 3 (ii) after differentiation, with white arrow showing MNPs in neurite extension (scale bar = 10 μm). royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  5 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nof deflection from the direction of applied field. The resulting width of the peak indicates the field gradient is not uniform across the sample area in   B x . Furthermore, when both the   B x and   B y   components are included, the resulting MNP motion becomes more varied. In this scenario, the median angle is found to be 30.35°. From this, it is clear the combination of field gradients, not just the field gradient along the main direc- tion of applied field are fundamental for the resulting directional force experienced by the MNP and their subsequent motion.  3.2. Neurite growth in a two-dimensional culture  PC12 cells labelled with Fe 2 O 3 -PAA 2K   MNPs (figure 4 a ) were differentiated within the device (MNP group) and non-labelled cells within the device (control group) for a period of 8 days to encourage neurite growth. Fluorescent microscopy confirmed the presence of MNP after 1 day (figure 4 b (i)), with MNP still detectable after 3 days of differentiation (figure 4 b (ii)). Cell via- bility in response to MNP and magnetic field gradients was assessed using a live/dead assay. Results showed no effect of either MNP or magnetic field gradients on cell viability (elec- tronic supplementary material, figure S2). We next assessed the effect of MNP and magnetic gradients on directional neur- ite outgrowth   in vitro . From repeat incubations (MNP group  N   = 4, control group   N   = 3), images of cells with neurite out- growths were taken from the imaging region (sample area simulated in figure 3 a ); summary statistics can be found in table 2. For each cell with neuronal outgrowths, the direction of growth was calculated as an angular displacement from the direction of applied magnetic field. The distribution of measured angle of neurite outgrowth is shown in figure 5 a , b . The distribution of measured angles within the control group shows no preferential direction. However, the distribution found from the MNP group shows more favoured growth directions towards 0° and 180°. The resulting distribution of angles found from the MNP is skewed to the lower values, as can be seen from figure 5 b , and the differences in median and IQR (dashed lines). From the descriptive data the median angle of deflection from the direction of field has been reduced from the control  control   2K MNP control group   *** control group angle of neurite growth relative to field orentation distribution of measured neurite growth angles 45   0   135   180   300   200   100 frequency MNP group 90 70 50 30 angle of neurite growth (  ) 10 MNP group 0 90   45   0   135   180   300   200   100 frequency 0 90   ( a ) ( c ) ( b )  Figure 5.   ( a ) Shows the range of measured neurite growth angles ( Θ ) from the applied field direction where the field direction is along the   x -axis (0° and 180°). ( b ) Violin plot showing angle of deflection from the applied field direction between control and MNP groups (red and blue, respectively). With the dashed lines representing the median and IQRs of each group. ( c ) Brightfield images of control and 2K-MNP-labelled PC12 neurons after 8 days differentiation (scale bar = 200 μm).  Table 2.   Description of control and MNP groups for neurite growth analysis, and the resulting angle of growth (median and IQR).  control group   MNP group  N   3   4  n   2487   3394 median (IQR) 46.332 (25.084, 69.075) 36.345 (18.138, 62.103) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  6 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\ngroup value of 46.332 (IQR: 25.084, 69.075) to the device group value 36.345 (IQR: 18.138, 62.103). A Kruskal – Wallis test shows a significant difference between control group and   MNP   group   with   p   < 0.001.   Therefore,   it   has   been shown that the influence of a static MNP on MNP-labelled cells can significantly increase the directional growth of neur- ites in two-dimensional slices.  3.3.   Ex vivo   rat brain slice model  Following the   in vitro   experiments, we then tested the magnetic system in a more complex   ex vivo   rat brain slice model using pri- mary VM cells labelled with Fe 2 O 3 -PAA 2K   MNPs. We first confirmed MNP loading in VM cells using live cell imaging (figure   6 a ).   Phase   contrast   and   fluorescence   microscopy (figure 6 a (i – iii)) confirmed MNP loading in cells after 24 h of incubation. Rat brain slices were then loaded into Petri dishes (figure 6 b (i)) before injection with the MNP-labelled cells. Slices were then placed within the gradient magnetic device for 7 days with the striatum positioned closest to the largest flux density to encourage cell growth from the implant site towards the striatum (figure 6 b (ii)). Fluorescent microscopy of the slices confirmed TH+ cell bodies and MNP at the transplan- tation site after 7 days in both groups indicating the presence of transplanted dopaminergic neurons (figure 6 c (i,ii)). Next, we quantified the degree of TH +ve cell and neurite outgrowth away from the injection site in the presence or absence of the magnetic field gradient. This was achieved by   analysing   the   amount   of   TH+ staining   distal   to   the interface between the transplant and host explant boundary (figure 7 a ). The control groups showed relatively less out- growth reaching the striatum, whereas slices exposed to the magnetic   device   showed   a   trend   for   denser   outgrowth (figure 7 b ). For analysis, each slice was divided into zones comprising the injection zone, striatal zone and an outgrowth zone located between the injection and striatal zone (elec- tronic supplementary material, figure S3a). The intensity of TH staining within the outgrowth zones was then quantified. Though there was no significant difference in the number of TH+ cells migrating into the proximal portion of the out- growth   zone   of   the   host   tissue   (figure   7 c (i,ii)),   results showed a significant increase in TH staining intensity in this region in the magnet group. Though there is the possi- bility that even a non-significant rise in the number of TH+ neurons migrating into this region could increase the over TH+ staining, the significant increase in the staining in the magnet group was interpreted as being an indication that the   overall   neurite   outgrowth   in   this   group   is   relatively higher than in the control group (figure 7 c ; electronic sup- plementary   material,   figure   S3b).   We   also   analysed   the directionality of the TH+ cells and neurites present in the out- growth   zone   using   the   directionality   ImageJ   plug-in (electronic   supplementary   material,   figure   S3c(i)).   Results showed a small shift in the orientation of the MNP-loaded cells   and   neurites   when   exposed   to   the   magnetic   field (trend only), with these cells and neurites aligning more towards the upper striatum. By contrast, the cells and neur- ites in the control group (where present) tended to align  phase 50    m 1000    m   1000    m control DAPI / TH / MNPs magnet MNP   merge (i)   (ii) (i)   (ii) (i)   (ii) (iii) ( b ) ( c ) ( a )  Figure 6.   Live imaging of plated VM cells revealed good loading of the MNPs by VM cells. Phase contrast image is shown in ( a (i)), fluorescent MNPs are shown in ( a (ii)), and merge is shown in ( a (iii)). Representative images of   n   = 4 are shown. Brain slices were cultured in Petri dishes ( b (i)) before loading into the magnetic gradient device, with the striatum exposed to the largest magnetic flux density in the system ( b (ii)). Fluorescent microscopy of injected slices confirmed MNP loading of VM cells and localization at the transplant site in both control ( c (i)) and magnet groups ( c (ii)). The slice is visible through DAPI staining (blue), VM cells are shown through TH staining (green) and MNP are shown through rhodamine fluorescence (red). Images representative of   n   = 4 – 6. royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  7 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\ntowards   the   lower   striatum   (electronic   supplementary material, figure S3c(ii)).  4. Discussion  Directional   control   of   neuronal   processes   is   one   of   the long-standing   challenges   in   neuronal   tissue   engineering. This technical barrier must be overcome before cell therapies can be harnessed for treatment of neurodegenerative dis- eases. Multiple recent studies, including from our group, have demonstrated the potential   for MNP and magnetic fields to control cell signalling and influence direction of neurite outgrowth   in vitro   [6,9,18,25]. For instance, Semeano  et al.   recently demonstrated that MNP embedded in col- lagen-based coatings can stimulate microtubule expression, promote neurite elongation and can influence cell migration when combined with static magnetic fields [26]. Bongaerts  et al.   recently used Fe 2   O   3 -PAA   2K -MNP and static magnetic fields provided by arrays of magnetized pillars to direct cell migration and induce neurite outgrowth in differentiated cells in the direction of the pillars [12]. In the current study, we created an asymmetric array of permanent magnets that provided   a   steep   magnetic   field   gradient   over   a   3 cm region. We used this array to promote directional outgrowth of neurites using the same Fe   2 O   3   -PAA   2K -MNP which were internalized   in   neuronal   cells.   In   both   studies,   Fe 2   O   3   - PAA 2K   -MNP were non-specifically targeted and passively taken up by cells. Within this study, we also tested the short- term toxicity of the MNP and magnetic fields. Importantly, neither MNP nor static magnetic fields had any noticeable effect on cell viability, which is a critical consideration when developing MNP-based treatments. The application of static magnetic fields in both studies imparted non-specific tensile forces to cells to directly influence the directionality of neurite outgrowth. This effect is to be expected given the crucial role that mechanical forces play in control of cell polarity and neur- ite outgrowth [27]. Having said this, the precise downstream mechanisms through   which   the   MNP-induced   forces   are transduced to cellular structures to alter neurite directionality require further study. We also compared neurite outgrowth angles with MNP directional   motion   predicted   using   mathematical   models. FE analysis simulations were performed to investigate the magnetic field gradients and resulting directional motion of MNPs. The simulation of the magnetic field gave field pro- files and resulting field gradients that closely resembled that of the configured device. The resulting directions of motion are   not   directly   parallel   to   the   applied   magnetic   field (which would result in a 0° deflection) and are indicative that the combination of magnetic field vectors and molecular guidance signals from growth factors (such as nerve growth factor) secreted from neighbouring neurons play competing roles in the resulting neurite outgrowth direction [11,28].  TH intensity (outgrowth region) pixel intensity, background corrected (arb. units) control magnet –2 0 2 4 6 8  magnet control implant region outgrowth region striatal region outgrowth region TH   1 mm  control   magnet TH   TH 1 mm   1 mm TH   1 mm implant region outgrowth region striatal region *   ns TH+ cell count (outgrowth region) avg. TH+ cells control magnet 0 5 10 15 20 25 30 ( a ) ( b )   ( c )  (i)   (ii)  Figure 7.   Magnetic gradient promotes neurite outgrowth in brain slices. Fluorescent images of TH-stained slices were divided into three regions (striatal, outgrowth and implant). Fluorescent microscopy of the outgrowth regions indicated that the magnetic device enhanced cell and neurite growth into the outgrowth region compared with the control region ( a (i,ii)). Representative images are shown. Pixel intensity analysis in the outgrowth regions confirmed a significant increase in TH staining in the magnet group relative to the control ( b ). Values represent background corrected median pixel intensity; asterisk (*) represents   p   < 0.05. Error bars represent IQR with min. and max. values.   n   = 4 (magnet),   n   = 6 (control). royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  8 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nDespite the small discrepancy between predicted MNP direction and observed neurite outgrowth direction, we still demonstrate that application of the magnetic gradient leads to a significant difference in the experimental outgrowth direction. The change in preferential outgrowth direction broadly   mapped   the   changes   in   magnetic   field   gradient across the sample. It is of note that the MNP-labelled group had   a   median   direction   of   36.35°,   compared   with   the median direction of motion from simulations of 21.53°. It is noted that the mathematical modelling approach demon- strated   here   does   not   include   biological   factors   such   as cell-binding and competing forces which may arise from biological mechanisms, including cues from neighbouring cells. However, these values measured are consistent with other mechanistic models found in literature which suggest the   resulting   growth   direction   would   be   approximately 30° due to the combination of magnetic vector directions [9]. Finally, we investigated the effect of our magnetic gradi- ent device in a more complex   ex vivo   brain slice model using primary neurons to test the translational potential of our approach. Our experiments demonstrated that primary neuronal cells can be loaded with MNPs without inducing toxicity, and neuronal cell transplants can be tracked on brain slices for at least 7 days. These properties are important to consider in neuronal tissue engineering, which requires minimal MNP toxicity and maximal cell survival over time. Crucially, our results showed that magnetic gradients can promote   dopaminergic   outgrowth   of   MNP-labelled   cells towards the striatum. Previous studies have shown it is poss- ible to remotely trigger cell signalling and direct neuronal stem cells to sites of injury   in vivo   using MNP and magnetic guidance systems. These approaches were shown to facilitate neuronal differentiation and brain repair as well as alter neuronal   electrophysiology   and   alter   animal   behaviour, respectively [29,30]. To our knowledge, the work presented here is the first study to demonstrate magnetically controlled cell and neurite outgrowth in primary dopaminergic cells transplanted into a complex   ex vivo   model. It should be noted that the magnetic field gradients used in our system (greater than 20 T m − 1   ) are an order of magnitude greater than the field gradients currently used in the clinic. For example, MRI scanners use field gradients in the region of 5 – 50 mT m − 1   [31], while larger field gradients (500 mT m − 1   ) have been used for related   in vivo   studies [32]. The magnetic device within this study was designed to exhibit substantially steeper field gradients, as these would be sufficient field gra- dients to elicit a strong enough directional force on individual MNPs. These high field gradients are required to enable inter- action of MNPs and magnetic field across the large physical distance   between   the   substantia   nigra   and   a   permanent magnet located at the skull surface. While the current study confirms proof of principle for our technique, an alternative magnetic device, with similar magnetic field profiles, would be necessary before the approach could be translated to the clinic. Future work will focus on magnetic field optimization to promote further increases in directional neuronal out- growth, but the ability to control cell behaviour in this way is nonetheless an important step which will ultimately be required for translation of neuronal cell therapies to the clinic. Neurodegenerative   conditions   such   as   PD   urgently require new therapies; however, directional control of neurite extension is one critical factor that is preventing clinical uptake of cell therapies for these diseases. In this work, we have   demonstrated   remote-controlled   neurite   outgrowth from neuronal cells   in vitro   and in an   ex vivo   model of the nigral-striatal pathway using MNP and magnetic gradients. Our experimental observations of directional neurite out- growth   closely   resemble   the   predicted   MNP   motion calculated by mathematical modelling. This study highlights the   benefits   that   magnetic   control   systems   can   have   on directing neuronal cell behaviour and shows that this strategy can form a useful component of cell therapy toolkits.  Ethics.   All animal experiments were performed following review and guidelines established by the Animal Welfare and Ethical Review Body (AWERB) at Keele University and conducted under the licensed authority of the UK Home Office (PPL40/3556). Animals were main- tained in a 12/12 ‐ hr light/dark cycle at a stable room temperature (RT; 22 ± 1°C) and were given free access to food, water and environ- mentally enriching articles.  Data accessibility.   The data are provided at https://doi.org/10.5281/ zenodo.7217515 [33] and in the electronic supplementary material [34].  Authors ’   contributions.   K.D.:   conceptualization,   data   curation,   formal analysis, investigation, methodology, writing — original draft and writ- ing — review and editing; K.A.: conceptualization, investigation and methodology;   T.J.B.:   data   curation,   formal   analysis,   investigation, methodology, writing — original draft and writing — review and editing; E.S.: investigation, methodology and writing — review and editing; T.G.: data curation, investigation and methodology; M.R.: formal analysis, methodology, writing — original draft and writing — review and editing; N.T.: conceptualization, funding acquisition, supervision and writing —  review and editing; J.M.S.: conceptualization, supervision and writing —  review and editing; C.M.: conceptualization, funding acquisition, super- vision   and   writing — review   and   editing;   J.F.:   conceptualization, investigation and writing — review and editing; M.C.: conceptualization, funding acquisition, supervision and writing — review and editing; A.J.E.H.: conceptualization, funding acquisition, supervision and writ- ing — review and editing; M.A.G.: conceptualization, supervision and writing — review and editing. All authors gave final approval for publication and agreed to be held accountable for the work performed therein.  Conflict of interest declaration.   We declare we have no competing interests.  Funding.   This work was funded by the European Union ’ s Horizon 2020 research and innovation programme MAGNEURON (grant agreement no. 686841) and an EU ERC Advanced Grant DYNACEU- TICS (grant no. 789119). The funders had no involvement in the preparation of this manuscript.  Acknowledgements.   We thank Eric Nicolau and Rémy Fert from the mech- anical workshop of the physical chemistry unit (UMR168) at Institut Curie who assisted in the design and construction of the magnetic device. Graphic summary was created with BioRender.com.  References 1.   Castelo-Branco G   et al . 2003 Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.   Proc. Natl Acad. Sci. USA   100 , 12 747 – 12 752. (doi:10.1073/pnas. 1534900100) 2.   Andersson ER   et al . 2008 Wnt5a regulates ventral midbrain morphogenesis and the development of A9 – A10 dopaminergic cells   in vivo .  PLoS ONE   3 , e3517. (doi:10.1371/journal.pone. 0003517) 3.   Joksimovic M, Yun BA, Kittappa R, Anderegg AM, Chang WW, Taketo MM, McKay RDG, Awatramani RB. 2009 Wnt antagonism of   Shh   facilitates midbrain floor plate neurogenesis.   Nat. Neurosci.  12 , 125 – 131. (doi:10.1038/nn.2243) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  9 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n4.   Tang M, Villaescusa JC, Luo SX, Guitarte C, Lei S, Miyamoto Y, Taketo MM, Arenas E, Huang EJ. 2010 Interactions of Wnt/ β -catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons.   J. Neurosci.   30 , 9280 – 9291. (doi:10.1523/JNEUROSCI.0860-10.2010) 5.   Gordon T. 2010 The physiology of neural injury and regeneration: the role of neurotrophic factors.  J. Commun. Disord.   43 , 265 – 273. (doi:10.1016/j. jcomdis.2010.04.003) 6.   Raudzus F   et al . 2020 Magnetic spatiotemporal control of SOS1 coupled nanoparticles for guided neurite growth in dopaminergic single cells.   Sci. Rep.   10 , 1 – 15. (doi:10.1038/s41598-020-80253-w) 7.   Bray D. 1984 Axonal growth in response to experimentally applied mechanical tension.   Dev. Biol.   102 , 379 – 389. (doi:10.1016/0012- 1606(84)90202-1) 8.   Fass JN, Odde DJ. 2003 Tensile force-dependent neurite elicitation via anti- β 1 integrin antibody- coated magnetic beads.   Biophys. J.   85 , 623 – 636. (doi:10.1016/S0006-3495(03)74506-8) 9.   Riggio C   et al . 2014 The orientation of the neuronal growth process can be directed via magnetic nanoparticles under an applied magnetic field.  Nanomed. Nanotechnol. Biol. Med.   10 , 1549 – 1558. (doi:10.1016/j.nano.2013.12.008) 10.   Suter DM, Miller KE. 2011 The emerging role of forces in axonal elongation.   Prog. Neurobiol.   94 , 91 – 101. (doi:10.1016/j.pneurobio.2011.04.002) 11.   Lowery LA, Vactor D Van. 2009 The trip of the tip: understanding the growth cone machinery.   Nat. Rev. Mol. Cell Biol.   10 , 332 – 343. (doi:10.1038/ nrm2679) 12.   Bongaerts M   et al . 2020 Parallelized manipulation of adherent living cells by magnetic nanoparticles- mediated forces.   Int. J. Mol. Sci.   21 , 1 – 20. (doi:10. 3390/ijms21186560) 13.   Schöneborn H, Raudzus F, Coppey M, Neumann S, Heumann R. 2018 Perspectives of RAS and RHEB GTPase signaling pathways in regenerating brain neurons.   Int. J. Mol. Sci.   19 , 1 – 37. (doi:10.3390/ ijms19124052) 14.   Pankhurst QA, Connolly J, Jones SK, Dobson J. 2003 Applications of magnetic nanoparticles in biomedicine.   J. Phys. D. Appl. Phys.   36 , R167 – R181. (doi:10.1088/0022-3727/36/13/201) 15.   Markides H, Rotherham M, El Haj AJ. 2012 Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine.  J. Nanomater.   2012 , 13 – 15. (doi:10.1155/ 2012/614094) 16.   Harrison R, Markides H, Morris RH, Richards P, El Haj AJ, Sottile V. 2017 Autonomous magnetic labelling of functional mesenchymal stem cells for improved traceability and spatial control in cell therapy applications.   J. Tissue Eng. Regen. Med.   11 , 2333 – 2348. (doi:10.1002/term.2133) 17.   Markides H   et al . 2018 Translation of remote control regenerative technologies for bone repair.   npj Regen. Med.   3 , 1 – 12. (doi:10.1038/ s41536-018-0048-1) 18.   Rotherham M, Nahar T, Goodman T, Telling N, Gates M, El Haj A. 2019 Magnetic mechanoactivation of Wnt signaling augments dopaminergic differentiation of neuronal cells.   Adv. Biosyst.   3 , 1900091. (doi:10.1002/adbi.201900091) 19.   Rotherham M, Haj AJE. 2015 Remote activation of the Wnt/ β -catenin signalling pathway using functionalised magnetic particles.   PLoS ONE   10 , 1 – 18. (doi:10.1371/journal.pone.0121761) 20.   Malagelada C, Greene LA. 2008 PC12 cells as a model for Parkinson ’ s disease research. In  Parkinson ’ s disease , pp. 375 – 387. Boston, MA: Elsevier. 21.   Greene LA, Tischler AS. 1982 PC12 Pheochromocytoma cultures in neurobiological research. Advances in Cellular Neurobiology  3 , 373 – 414. (doi:10.1016/B978-0-12-008303-9. 50016-5) 22.   Plan Sangnier A, Van de Walle AB, Curcio A, Le Borgne R, Motte L, Lalatonne Y, Wilhelm C. 2019 Impact of magnetic nanoparticle surface coating on their long-term intracellular biodegradation in stem cells.   Nanoscale   11 , 16 488 – 16 498. (doi:10.1039/ C9NR05624F) 23.   Barnsley LC, Carugo D, Stride E. 2016 Optimized shapes of magnetic arrays for drug targeting applications.   J. Phys. D. Appl. Phys.   49 , 225501. (doi:10.1088/0022-3727/49/22/225501) 24.   Stoppini L, Buchs PA, Muller D. 1991 A simple method for organotypic cultures of nervous tissue.  J. Neurosci. Methods   37 , 173 – 182. (doi:10.1016/ 0165-0270(91)90128-M) 25.   Schöneborn H   et al . 2019 Novel tools towards magnetic guidance of neurite growth: (I) guidance of magnetic nanoparticles into neurite extensions of induced human neurons and in vitro functionalization with RAS regulating proteins.  J. Funct. Biomater.   10 , 32. (doi:10.3390/ jfb10030032) 26.   Semeano AT   et al . 2022 Effects of magnetite nanoparticles and static magnetic field on neural differentiation of pluripotent stem cells.   Stem Cell Rev. Rep.   18 , 1337 – 1354. (doi:10.1007/s12015-022- 10332-0) 27.   Gahl TJ, Kunze A. 2018 Force-mediating magnetic nanoparticles to engineer neuronal cell function.  Front. Neurosci.   12 , 1 – 16. (doi:10.3389/fnins. 2018.00299) 28.   Sierra-Fonseca JA, Najera O, Martinez-Jurado J, Walker EM, Varela-Ramirez A, Khan AM, Miranda M, Lamango NS, Roychowdhury S. 2014 Nerve growth factor induces neurite outgrowth of PC12 cells by promoting G β γ -microtubule interaction.   BMC Neurosci.   15 , 132. (doi:10.1186/ s12868-014-0132-4) 29.   Yun S   et al . 2018 Design of magnetically labeled cells (Mag-Cells) for in vivo control of stem cell migration and differentiation.   Nano Lett.   18 , 838 – 845. (doi:10.1021/acs.nanolett.7b04089) 30.   Wheeler MA   et al . 2016 Genetically targeted magnetic control of the nervous system.   Nat. Neurosci.   19 , 756 – 761. (doi:10.1038/nn.4265) 31.   McRobbie DW. 2014 3.01   –   Fundamentals of MR imaging. In   Comprehensive biomedical physics  (ed. A Brahme), pp. 1 – 19. Oxford, UK: Elsevier. 32.   Baker RR   et al . 2022 Image-guided magnetic thermoseed navigation and tumor ablation using a magnetic resonance imaging system.   Adv. Sci.   9 , 1 – 14. (doi:10.1002/advs.202105333) 33.   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients. Zenodo. (doi:10.5281/zenodo. 7217515) 34.   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients. Figshare. (doi:10.6084/m9.figshare.c. 6266161) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  10 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025',0.03438806351650314,'[\"\\u0002\", \"\\u0003\", \"(\", \"(*)\", \"(0.2\"]','2025-11-29 17:03:20.493537'),(59,3,'Technology and Health Care 30 (2022) 513–516   513 DOI 10.3233/THC-213297 IOS Press  Short Communication  Biotech value chain and technologies for COVID-19 research areas for collaboration on cost quality tradeoff with tool companies  Christine C. Huttin a , b a Business and Economics of HealthCare, University Aix Marseille, Marseille, France  b CEO, Endepusresearch, Inc., Cambridge, MA, USA E-mails: christine.huttin@iae-aix.com and chxyinfo@endepusresearchinc.com  Received 19 August 2021 Accepted 3 November 2021  Abstract. BACKGROUND:   Technologies for COVID-19 are in high demand, and supply chains from biotech and pharma industries face critical supply issues.  OBJECTIVE:   This paper discusses the case on mRNA technologies and quality assurance issues.  METHODS:   Interviews with managers of biotech companies were performed. These helped to prepare biotech panels at a roundtable on quality of medicine, organized by the Polish Academy of Sciences in Paris (PAN) in 2021.  RESULTS:   This paper analyzes the new mRNA technology and shows the importance of emerging new biotech firms, especially tool companies providing services in quality assurance. It highlights research areas and types of survey instruments with academic collaborators, to better understand the economics of mRNA technology platforms.  CONCLUSIONS:   A future research agenda for collaboration with academic communities is proposed on cost-quality tradeoffs and clinical quality attributes for such genomic technologies. Keywords: Biotech value chain, tool companies, mRNA technology, cost and quality, COVID-19, healthcare  1. Introduction  This paper is written following an event organized by the Polish Academy of Sciences in Paris on quality in medicine. Since the COVID-19 crisis has led to revisions of most health policies, this paper discusses some issues related to successful technology strategies to tackle the global pandemic and cost- quality tradeoffs for scaling up such technologies and different forms of technology transfer (licensing, alliances or partnerships). This involves major companies and international organizations (World Trade Organization (WTO), World Health Organization (WHO), Organisation for Economic Cooperation and Development (OECD)) on main areas of conflicts: trade and patent/IP versus public health (access to vaccines and treatments, affordability).  0928-7329/$35.00 c ©   2022 – IOS Press. All rights reserved.\n514   C.C. Huttin / Biotech value chain and technologies for COVID-19 research areas for collaboration  1.1. The concept of value chain (GVC) and biotech research and development  The concept of value chain was first used in a paper to analyze the diffusion of ICT in the global pharmaceutical industry [1], facing a fast digitalization and interconnectivity of flows of products and services. The international dataset called Trade in Added Value (TiVa) 1   was created under an initiative of Singapore and OECD for trade policies. It was then extracted for input and output on all sectors from chemicals and ICT, which are useful to measure international flows of trade and domestic demand for pharmaceuticals and chemicals. In this second paper, the conceptual approach is also used as a representation of research and develop- ment steps in a biotech development chain; it helps to position the roles of various tool companies as service providers to main pharmaceutical companies for the supply of innovative life science technologies. The selected technologies are relevant to produce COVID-19 vaccines: mRNA technologies.  1.2. The case study on genomic technologies used to develop vaccines and viral strategies in the fight against COVID-19  The main reason to use a value chain approach in this paper is to identify cases of service companies supporting pharma companies in the development of their vaccines. This also identifies critical quality or cost issues, which could benefit from additional quality instruments. Since the discovery of the DNA model by Watson and Crick in 1953, genomic research has been a very fast scientific-driven field; it has enhanced the diagnostic space especially with genetic sequencing technologies used for predicting diseases by incorporating polygenic risk scores and eliminating genetic mutations. Gene editing and CRISPR research then led to gene editing allowing for the development of DNA sequencing technologies. Finally, the current stage of genomic research had led to the production of proteins with modifications of cells (“virus into cell”). The production of viral proteins led to new types of vaccines that are especially successful in fighting COVID-19 with RNA therapies. RNA is a molecule between DNA and protein, which helps to access information on “what is going on in cells”, using tools that have been developed for DNA [4]. The name of tool companies is then given to the biotech companies involved in such tools. It is timely then to understand the mRNA technology platforms and how biotech tool companies can help analyze these technologies.  1.3. Tool companies in RNA technologies in the biotech global development chain  RNA is a versatile molecule; to use it for therapies, especially drugs or vaccines, some form of stabilization is required. Firms must demonstrate to regulators what is called High Order Structure (HOS) studies, which can provide sufficient evidence that RNA structures are stable. In addition, the RNA structure is considered large and thick and therefore requires encapsulation, for instance with nanoparticles. Advances in cancer research with the new anticancer drugs called immunotherapies have helped accelerate the research and production of mRNA technologies, especially for their use as COVID-19 vaccines. However, as all R&D in genomics, mRNA technologies for COVID-19 face issues of scaling up in development stages and possible diseconomies of scales. Development stages where biotech tool  1 For additional information on such measures on international flows of productions and services or flows of upstream and downstream tasks generations [2], see OECD-WTO, TiVa project [3].\nC.C. Huttin / Biotech value chain and technologies for COVID-19 research areas for collaboration   515 Table 1 Collaboration on cost quality tradeoffs: identification of cost drivers and impact on R&D productivity in the lead stages of the biotech value chain Research areas for collaboration between academics and tool companies Examples of impacts of cost drivers:  –   Lead time increases and reduces productivity of R&D  –   Automation reduces costs and increases productivity  –   Additional ad hoc studies increase the cost of scaling up  –   Costs vary with complexity, e.g. how do structure interactions between sec- ondary, tertiary and quaternary evolve? Source: Professor Huttin, June 16 th   2021, PAN conference. Table 2 Collaboration on cost quality tradeoffs: identification of critical quality attributes in the lead stages of the biotech value chain Research areas for collaboration between academics and tool companies On quality: need to identify the critical quality attributes to reach safety and efficacy for regulators and end users. Examples of interactions of proteins:  –   Which criteria to use: aggregation, stability?  –   Issues with: assurance laboratory costs, scaling up cost Source: Professor Huttin, June 16 th   2021, PAN conference.  Fig. 1. The “omics” development chain [5].  companies can help with quality assurance, can be identified in Fig. 1, which describes the biotech development chain: these types of service companies mainly interact at the lead optimization stage and for the development of candidates (scaling up of the required chemistry and toxicology). A cooperation with the academic research community can help identify cost drivers, their impact on R&D productivity in lead stages of the biotech value chain and potential tradeoffs with quality. For mRNA technologies, the Critical Quality Attributes (CQAs) especially deal with interactions of proteins and the selection of criteria to ensure stability. HOS studies, necessary for regulatory approval, in such cases are more complex because of the molecule characteristics. More ad hoc studies are needed at the scale up stage, which increases the development costs. Tables 1 and 2 highlight some of the research areas on cost quality tradeoffs and quality attributes to facilitate a fast development of mRNA therapies, especially for COVID-19 vaccines.\n516   C.C. Huttin / Biotech value chain and technologies for COVID-19 research areas for collaboration  2. Conclusions  The biotech panel of the conference on quality of medicine at the Polish Academy of Science in June 2021 in Paris was useful to propose a research agenda that would enhance the development of critical mRNA technologies used for COVID-19 and possibly cancer vaccines. Current datasets such as TiVa from OECD/WTO used for trade and pharmaceutical policies do not seem to provide sufficient statistical information to measure the critical steps on the biotech development chain. 2   One of the contributions of this paper is to propose new survey instruments that would involve the collaboration of lab directors for quality assurance and scale up. This would generate data for cost analysis and quality management.  Acknowledgments  Professor Christine Huttin is thankful to the Polish Academy of Science for the invitation and to Dr Margaret Chalupowski for her role in the organization of the conference on Quality of Medicine in Paris (France). She is also grateful to Professor R Smith for his review of this paper and P O’Callaghan for editing the last version of the paper.  Conflict of interest  None to report.  References  [1]   Huttin CC, Global value chains and international pharmaceutical policy. Technology and Health Care, 28 (2020), 337–344. [2]   Antras P, Chor D, Organizing the Global Value Chain, Econometrica, Vol. 81, N 6 Nov 2013, 2127–2204. [3]   OECD-WTO Project to measure Trade in Value Added (TiVa), June 2015. http://www.oecd.org/trade/value added. [4]   Messina D, “RNA is a powerful, versatile molecule” Advanced Applications, Cofactor Genomics, Molecular Diagnostics, January 31st, 2019. [5]   Sammut SM, Biotechnology business and revenue models. Chapter 4. In: The Business of Healthcare Innovation. Ed: LR Burns. Cambridge University Press, 2005.  2 Disaggregated nomenclatures are required to help industrial policies in the field of pharmaceuticals and life science. An updated version of the TiVa database or BERD database from OECD could be useful. Alternatively, consulting firms such as McKinsey run in-house surveys helping international companies to measure the added value of different elements in the development chain.',0.16943908351754555,'[\"(2020),\", \"(2022)\", \"(access\", \"(cqas)\", \"(france).\"]','2025-11-29 17:04:02.289965'),(60,3,'royalsocietypublishing.org/journal/rsif  Research  Cite this article:   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients.   J. R. Soc. Interface   19 : 20220576. https://doi.org/10.1098/rsif.2022.0576 Received: 8 August 2022 Accepted: 19 October 2022  Subject Category:  Life sciences – engineering interface  Subject Areas:  biomedical engineering  Keywords:  magnetic nanoparticles, regenerative medicine, tissue engineering, neurite outgrowth  Author for correspondence:  A. J. El Haj e-mail: a.elhaj@bham.ac.uk Electronic supplementary material is available online at https://doi.org/10.6084/m9.figshare. c.6266161.  Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients K. Dhillon   1   , K. Aizel   2 , T. J. Broomhall   1 , E. Secret 3   , T. Goodman   4 , M. Rotherham   1 , N. Telling   4   , J. M. Siaugue   3 , C. Ménager   3   , J. Fresnais   3 , M. Coppey   2 , A. J. El Haj   1   and M. A. Gates   4,5  1 Healthcare Technologies Institute, Department of Chemical Engineering, University of Birmingham, Birmingham, UK  2 Institut Curie, PSL Research University, CNRS, Sorbonne Université, Physico Chimie, Paris, France  3 Sorbonne Université, CNRS, Laboratoire Physicochimie des Électrolytes et Nanosystèmes Interfaciaux, PHENIX, 75005 Paris, France  4 School of Pharmacy and Bioengineering, Guy Hilton Research Centre, and   5 School of Medicine, Keele University, Staffordshire, UK  KD, 0000-0003-1335-8442; TJB, 0000-0002-7528-0831; ES, 0000-0003-2200-7265; MR, 0000-0002-9297-7681; NT, 0000-0002-2683-5546; JMS, 0000-0003-1217-9493; CM, 0000-0002-4080-3508; JF, 0000-0002-2037-0637; MC, 0000-0001-8924-3233; AJE, 0000-0003-3544-5678; MAG, 0000-0002-2901-1083  A challenge in current stem cell therapies for Parkinson ’ s disease (PD) is controlling   neuronal   outgrowth   from   the   substantia   nigra   towards the targeted area where connectivity is required in the striatum. Here we present progress towards controlling directional neurite extensions through the application of iron-oxide magnetic nanoparticles (MNPs) labelled neuronal cells combined with a magnetic array generating large spatially variant field gradients (greater than 20 T m − 1 ). We investigated the viability of this approach in both two-dimensional and organotypic brain slice models and validated the observed changes in neurite directionality using mathematical models.   Results   showed   that   MNP-labelled   cells   exhibited   a   shift   in directional neurite outgrowth when cultured in a magnetic field gradient, which broadly agreed with mathematical modelling of the magnetic force gradients and predicted MNP force direction. We translated our approach to an   ex vivo   rat brain slice where we observed directional neurite outgrowth of   transplanted   MNP-labelled   cells   from   the   substantia   nigra   towards the striatum. The improved directionality highlights the viability of this approach as a remote-control methodology for the control and manipulation of cellular growth for regenerative medicine applications. This study pre- sents a new tool to overcome challenges faced in the development of new therapies for PD.  1. Introduction  Parkinson ’ s disease (PD) is a neurodegenerative condition that arises during the progressive degeneration of midbrain dopaminergic (mDA) neurons in the sub- stantia nigra pars compacta (SNc). The loss of mDA neurons results in the loss of connections between the SNc and striatum. While pharmacological treatments exist for the short-term replacement of dopamine in the SNc-striatal circuit, there is a critical clinical need for cell therapies to restore dopaminergic cells in the SNc  © 2022 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited. Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n[1 – 4]. Potential cell therapies for this condition also depend upon the ability of the transplanted cells to reinnervate with neurons in the striatum. However, the rate of regeneration in the central nervous system is slow [5,6] which limits recovery. This technically challenging aspect of neuronal cell engineering is crucial for successful cell integration, circuit reconnection and   ultimately   disease   remission.   Several   approaches   to directing neuronal growth have been investigated, including the   use   of   mechanical   cues   and   magnetic   nanoparticles (MNPs) to generate tension to guide outgrowth [7 – 9]. While the study of neuronal outgrowths has been investigated over a long period of time, the control of outgrowth direction is a relatively newer approach that offers ways of progressing potential cell therapies for neurodegenerative conditions. Within   the   regeneration   process   growth   cones   are extended   from   the   neuronal   cell   which   are   capable   of generating   forces   through   their   motion,   which   can   aid in   growth   and   repair   [10].   Combining   the   mobility   of these growth cones and biological cues enables neuronal outgrowths to become directed to a target region [11]. There- fore, it is considered that other approaches to generating directional cues could help achieve more complete reinner- vation.   One   potential   approach   to   generating   topological gradients and directional cues is through the use of MNPs guided by magnetic fields [6,8,9,12,13]. MNPs are a suitable candidate for applying mechanical forces to neuronal cells, being widely used in biomedicine settings, such uses as MRI contrasts [14 – 16], and are commercially available, with previously demonstrated biological safety. MNPs have attracted attention as force carriers for the manipulation   of   cells   owing   to   their   ability   to   be   con- trolled remotely through externally applied magnetic fields. Through   the application   of magnetic   fields, the resulting forces can be applied either internally or externally to a cell, for example: through internalization into endosomes, or by binding to receptors and ion channels at the cell membrane. This approach has been recently used in a variety of cell and tissue engineering applications to regulate cell signalling path- ways, control cell differentiation and promote tissue repair [12,17,18]. Commonly, varying magnetic fields are employed to create a field gradient (varying in time) to act upon MNPs [19]. However, static magnetic fields can also be designed to vary in space and therefore offer another method to generate sufficient field gradients to induce forces acting on MNPs. To study the efficacy of using MNPs and static magnetic fields to help direct the neuronal outgrowths, we employ PC12 cells with MNPs and used a magnetic gradient to magnetically   control   neurite   extension   while   undergoing differentiation (figure 1 a,b ). PC12 cells are a well-established model neuronal cell line in PD research. When cultured with neurotrophic factors, PC12 differentiate into neuron-like cells with neuronal morphology and express neuronal markers [20,21]. We then tested the translational potential of this approach in rat organotypic brain slices, which were used as  Fe 2 O 3 PAA   2K   MNP  poly-acrylic acid / rhodamine coating magnetic core (Fe 2   O   3 ) MNP-tagged neurons MNP-tagged neurons neurite outgrowth towards striatum + 7 days striatum rat brain slice   substantia nigra  ex vivo  directed neurite growth differentiation + 8 days magnetic gradient ( a ) ( b ) ( c ) neuronal cells incubated with MNPs  in vitro  MNP internalization into lysosomes  Figure 1.   ( a ) Schematic of the experimental set-up. Poly-acrylic acid/rhodamine functionalized MNP with an Fe   2   O 3   core was synthesized and incubated with PC12 cells to allow internalization. ( b ) The MNP-tagged cells were cultured in differentiation media while being exposed to static magnetic fields in order to direct neurite extension along the magnetic field gradients. ( c ) MNP-tagged neurons were also injected into rat brain slices modelling the nigral-striatal pathway. Magnetic fields were then used to direct neurite extension from the cells at the injection site towards the striatum. royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  2 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\na model of the SNc-striatal circuit. Using this system, we injected primary rat embryonic ventral midbrain (VM) dopa- minergic precursor cells, which had been pre-labelled with MNP, into the SNc of rat brain slices. We then orientated the slices under the magnetic field gradient to promote directed cell and neurite outgrowth from the transplant region towards the striatum (figure 1 c ). After 8 days, we assessed cell and neur- ite outgrowth under magnetic control. The overall aim of this research was to demonstrate controlled directional neurite outgrowth   in   neuronal   cells,   which   was   validated   using mathematical models. This technology provides proof of prin- ciple for magnetic control of neuronal outgrowth with clear applications for neurodegenerative cell therapies.  2. Methods 2.1. Computational methods  The magnetic field profiles were simulated by employing a finite- element (FE) approach using the commercial software   COMSOL v5.1.   Magnetic fields and the resulting gradients were simulated by employing the   Magnetic Fields, No Currents   toolbox, with initialization parameters (remnant magnetization   B R   ) matching those of the neodymium iron-boron (NdFeB) magnets used in the experimental device (table 1). To calculate the directional motion of MNPs, the resulting field profiles were combined with   the   Particle   Tracing   for   Fluid   Flow   toolbox   with   MNPs simulated as particles with diameter, mass and magnetic suscep- tibility ( χ ) matching those of experimentally employed MNPs (table 1). The magnetic susceptibility ( χ ) of the MNPs is of key impor- tance when calculating the forces acting on a particle. The MNPs chosen   for   this   study   were   iron-oxide   particles   coated   with PAA (Fe 2   O 3 -PAA   2K   ). The MNP diameter is 8.4 ± 1.9 nm with saturation magnetization values of 51 – 57 emu g − 1   [12]. These particles have previously been reported to have good levels of internalization and stable magnetization within biological sys- tems over long time periods [22]. From a Langevin function of magnetization,   the   magnetic   behaviour   of   these   particles   is easily reproduced, and the susceptibility was calculated to be 4.27 from the change in magnetization at zero field. In the instance of an MNP located within static magnetic field the force acting upon it while in a fluid medium can be found from the following equation [23]:  F   M   ¼   2  p r 3  p  m 0  m p  m p     m f  m p   þ   2  m f  r H 2   ,   ð 2 : 1 Þ  where   r p   is the radius of the particle (in m),   μ p   and   μ f   is the permeability of the MNP and surrounding fluid, respectively, (where   μ   = 1 +   χ )   and   r H   is   the   magnetic   field   gradient   in (A m − 2 ). The motion for each MNP was calculated using the magnetophoretic force (equation (2.1)) applied across the sample region with the fluid medium taken to be water ( μ f   = 1) as an analogy to the MNP being located either in the cell or culture medium. MNP motion simulations included viscous drag and were simulated for a total time period of 8 h.  2.2. Magnetic device  To enable forces to be applied upon MNPs, a magnetic field (and gradient) needs to be established over the sample region. To achieve this, a device consisting of NdFeB permanent mag- nets (N42 grade) was created (as shown in figure 2 a ; electronic supplementary material, figure S1). The magnetic field was simu- lated using a FE method and the resulting magnetic field profile is shown in figure 2 c , ranging from field strengths of approxi- mately 700 to approximately 70 mT. The magnetic array device was mapped in three dimensions using an M3D-2A-PORT mag- netic field mapper (SENIS) at a scan resolution of 200 μm (x,y) and   a   step   size   of   0.5 mm   (z).   The   measured   field   map is shown in figure 2 c ; the values of magnetic field and the field gra- dient are found to align with the simulated magnetic field. The magnetic field gradient found along the magnetic field orien- tation is shown in figure 2 d   and is found to be greater than 20 T m − 1   across the sample region.  2.3. Cell culture  The rat adrenal phaeochromocytoma cell line, PC12 (CRL-1721), obtained   from   ATCC,   were   cultured   in   suspension   in   basal medium   made   from   Dulbecco ’ s   modified   Eagle ’ s   medium (Gibco) supplemented with 10% horse serum (heat inactivated), 10%   fetal   bovine   serum,   1%   penicillin-streptomycin   and   1% L-glutamine. Cells were kept in incubator at 37°C and 5% CO 2   .  2.4. Magnetic nanoparticles labelling  Cells were labelled with rhodamine-fluorescent Fe   2 O 3 -PAA   2K MNPs   which   were   previously   described   and   characterized by Bongaerts   et al.   [12]. The MNPs had a mean hydrodynamic size of 30.1 nm and were superparamagnetic in nature with a saturation magnetization of 55.7 emu g − 1 . Cells were labelled in suspension at a concentration of 2 mM (iron) in pre-warmed complete basal medium for 24 h prior to seeding.  2.5. PC12 differentiation  For differentiation into a neuronal phenotype, PC12 cells were seeded at 20 000 cells cm − 2   density on 1% poly-L-lysine (Sigma) and 10 μg μl − 1   laminin (Sigma L2020) coated glass-bottom dishes 24 h before initiating differentiation. Cells were differentiated for 8 days in culture with differentiation medium: Dulbecco ’ s modified Eagle ’ s medium (Gibco) supplemented with 5% horse serum (heat inactivated),   1%   penicillin-streptomycin,   1%   L-glutamine   and 100 ng μl − 1   nerve   growth   factor   (recombinant   human   β -NGF 450-01, Peprotech) with media replenishment every 2 days.  2.6. Live/dead staining  PC12 cells were incubated with MNP as above and cultured in neuronal   differentiation   media   under a   static   magnetic   field with peak flux density of less than 200 mT over 8 days. Cell via- bility was then assessed after 8 days using a ReadyProbes ™   cell viability assay (ThermoFisher) according to the manufacturer ’ s instructions.  2.7. Rat brain slice preparation  Organotypic slice cultures were prepared from postnatal day 5 – 8 rat   pups   according   to   the   interface   method   as   previously described [18,24]. Briefly, pups were terminally anaesthetized by intraperitoneal injection of pentobarbital in accordance with UK   Animals   (Scientific   Procedures)   Act   1986.   Sagittal   brain sections of 300 μm were cut at 10° angles using a vibratome  Table 1.   Parameters used for magnetic and MNP simulations.  simulation property   value   units  B R   1.42   T MNP diameter   8.4   nm MNP density   5240   kg m − 3  χ   4.27   dimensionless royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  3 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n(Leica). Following removal of the cortex and hippocampus, slices were placed onto PTFE membranes with 0.4 μm pores to allow access to nutrients from below and maintain gaseous exchange from above.  2.8. Injection of magnetic nanoparticle labelled ventral midbrain cells  Slices were cultured for 7 days (with SN removed) before trans- plantation of E14 VM cells to the SN region of the slice. The day before   transplantation,   the   VM   was   dissected   from   E14   rat embryos, dissociated and resuspended in medium containing 8 mM Fe 2 O 3   -PAA   2K   MNPs (iron concentration). The suspension was added to the well of a plate and incubated overnight. The MNPs prevented the cells from adhering to the plate without affecting cell viability. The next day, 200 – 500 nl of MNP-loaded VM cell suspension was pipetted into the SN region of the slice. The slice was then transferred to a Petri dish and orientated within the magnet device so that the striatum was exposed to the largest flux density in order to promote cell/neurite growth towards the striatum. The magnetic device was housed within a cell culture incubator at 37°C, 5% CO 2 . Control slices were cultured in six-well plates at 37°C, 5% CO   2   under no magnetic field. Slices were fixed 7 days following cell transplantation and immuno-stained for tyrosine hydroxylase (TH) to visualize both the cell bodies and process of dopamine neurons in the tissue and transplant.  2.9. Imaging  Light and fluorescent images were taken with EVOS M5000 or EVOS   XL   core   microscopes   (Thermofisher   Scientific).   Three- dimensional Z-stack imaging was conducted using Olympus Fluoview   FV1000   confocal   microscope.   Neurite   angle measurement   was   performed   using   the   angle   measurement tool in FIJI ImageJ2 software.  2.10. Analysis of rat brain slices  Images for each slice were stitched to form a montage, then rotated so that the striatal-SN axis was in the same plane for each sample. Each slice image was then divided into a grid of 20 regions of interest (ROI ’ s) covering three regions as shown in electronic supplementary material, figure S2a. These regions consisted of the implant area, the striatal region and an out- growth   area   located   between   the   implant   area   and   the striatum. For each sample, the mean grey value of each ROI in the outgrowth region was measured. These values were cor- rected   by   subtracting   the   mean   grey   value   of   the   slice background due to staining from the background slice tissue. The orientation of TH+ cells and neurites present in the out- growth region was also assessed using a directionality plug-in in   ImageJ.   This   was   used   to   calculate   the   relative   average amount   of   TH+ structures   at   each   orientation   (±90°)   within each sample. Only samples which contained TH+ cells and or neurites in the outgrowth region were included in the analysis.  2.11. Statistical methods  All statistical analysis was completed using Stata 17.0. For   two-dimensional   neurite   growth   measurements,   the measured angles were transformed to be a deflection relative to the field   direction   irrespective of lateral travel (i.e. ignoring left/right direction, with the key metric being the deflection angle). This results in measured deflection angles in the range of 0   −   90°. To evaluate the distributions in both control and MNP group, a Levene test for variance and a Shapiro test for nor- mality were performed. It was found that the two distributions had equal variance and were both non-normally distributed (Levene test:   p   > 0.05, Shapiro test:   p   < 0.05). From the description  ( a )   ( b ) ( c )   ( d ) 700 600 500 400 (mT) 300 200 100 30  25  20  15  10 X-position across sample area (mm) Y-position across sample area (mm) 5   0 10 700   700   35 30 25 20 15 10 field gradient (T m − 1 ) X co-ordinate across sample region (mm) imaging region 5 0  0   5   10   15   20   25   30   35 600 500 400 (mT) field gradient (T m − 1 ) 300 200 100 500 300 100 magnetic field (mT) 5 0 –5 –10  Figure 2.   ( a ) Shows assembled device with sample. ( b ) Shows a schematic of the device highlighting the orientation of the permanent magnets and the simulated magnetic field. ( c ) Three-dimensional map of magnetic flux density across the sample area confirmed a steep gradient across the sample region. ( d ) Shows the resulting magnetic field gradient, and the imaging region highlighted demonstrates that in the sample region investigated the field gradient is greater than 20 T m − 1 . royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  4 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nof these distributions, a Kruskal – Wallis test was chosen as a suitable statistical test. For pixel intensity analysis of slice TH staining, data are presented as medians +/- interquartile range (IQR). Statistical significance   at   95%   confidence   level   was   applied   using   a Mann – Whitney   test   (two-tailed,   unpaired),   p   < 0.05   was considered statistically significant.  3. Results 3.1. Simulation of magnetic nanoparticle motion  The direction of force exerted on MNPs within the sample region can be simulated to gain understanding as to how the external magnetic field and resulting gradient will drive directional neur- ite outgrowths. The force acting on an MNP and therefore to the attached sub-cellular structures and organelles in a static mag- netic field can be calculated by employing a magnetophoretic model (equation (2.1)). The magnetophoretic model results in MNP motion along the direction of applied force. Particle trajectories were simulated in a water medium over a time period of 8 h as an indication to the resulting directional outgrowth. Viscous drag forces were included to better understand the magnitude of forces exerted on the MNPs. The angle between the final position and the initiali- zation position relative to the field direction was calculated for each simulated MNP. Initial particle positions were randomized to within a sub- region of the entire sample region which represented the locations available for imaging in experimental studies (indi- cated by the grey circle in figure 3 a , black dots identify initial positions for a random sampling of particle positions). A total of 1500 particles were initialized with a resulting 1147 particle positions having a final position within the sampling region. The resulting angle of MNP motion is shown in figure 3 b , it is of note that the majority of particles do not move along the hori- zontal (along the direction of the applied field) but have a small angular offset in the vertical direction (perpendicular to the main applied field direction). This can be seen from comparing simulations that only include forces created through the appli- cation of   B x   components, to those in which   B x   and   B y   are included in the force calculation (figure 3 b ). When only   B x   com- ponents of magnetic field are included, the applied force and resulting directional motion of MNPs show a narrower range  ( a )   ( b ) 700 0.12 0.04 0.02 0.00  0   10   20   30   40   50   60 angle of MNP motion (°) 70   80   90 X component XY component 0.06 0.10 0.08 density 600 500 400 (mT) 300 200 100  Figure 3.   ( a ) Shows simulated trajectories of MNP motion within the magnetic device. Initial MNP positions (black dots) were randomized to the same sampling area used for two-dimensional imaging studies (grey circle). MNP motion was simulated over an 8 h period and the resulting angle of motion is shown in ( b ). Simulated MNP motion is included for both only including the X-component of magnetic field compared with including both X and Y components.  DAPI 2K MNP  (i)   (ii)  ( a ) ( b ) (i)   (ii)  Figure 4.   ( a ) PC12 cells labelled with rhodamine-fluorescent Fe   2 O   3 -PAA   2K   MNPs (scale bar = 100 μm) ( b ) Z-stack (0.2 μm slices) confocal images of PC12 cells labelled with AA2K-MNPs at day 1 (i) and day 3 (ii) after differentiation, with white arrow showing MNPs in neurite extension (scale bar = 10 μm). royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  5 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nof deflection from the direction of applied field. The resulting width of the peak indicates the field gradient is not uniform across the sample area in   B x . Furthermore, when both the   B x and   B y   components are included, the resulting MNP motion becomes more varied. In this scenario, the median angle is found to be 30.35°. From this, it is clear the combination of field gradients, not just the field gradient along the main direc- tion of applied field are fundamental for the resulting directional force experienced by the MNP and their subsequent motion.  3.2. Neurite growth in a two-dimensional culture  PC12 cells labelled with Fe 2 O 3 -PAA 2K   MNPs (figure 4 a ) were differentiated within the device (MNP group) and non-labelled cells within the device (control group) for a period of 8 days to encourage neurite growth. Fluorescent microscopy confirmed the presence of MNP after 1 day (figure 4 b (i)), with MNP still detectable after 3 days of differentiation (figure 4 b (ii)). Cell via- bility in response to MNP and magnetic field gradients was assessed using a live/dead assay. Results showed no effect of either MNP or magnetic field gradients on cell viability (elec- tronic supplementary material, figure S2). We next assessed the effect of MNP and magnetic gradients on directional neur- ite outgrowth   in vitro . From repeat incubations (MNP group  N   = 4, control group   N   = 3), images of cells with neurite out- growths were taken from the imaging region (sample area simulated in figure 3 a ); summary statistics can be found in table 2. For each cell with neuronal outgrowths, the direction of growth was calculated as an angular displacement from the direction of applied magnetic field. The distribution of measured angle of neurite outgrowth is shown in figure 5 a , b . The distribution of measured angles within the control group shows no preferential direction. However, the distribution found from the MNP group shows more favoured growth directions towards 0° and 180°. The resulting distribution of angles found from the MNP is skewed to the lower values, as can be seen from figure 5 b , and the differences in median and IQR (dashed lines). From the descriptive data the median angle of deflection from the direction of field has been reduced from the control  control   2K MNP control group   *** control group angle of neurite growth relative to field orentation distribution of measured neurite growth angles 45   0   135   180   300   200   100 frequency MNP group 90 70 50 30 angle of neurite growth (  ) 10 MNP group 0 90   45   0   135   180   300   200   100 frequency 0 90   ( a ) ( c ) ( b )  Figure 5.   ( a ) Shows the range of measured neurite growth angles ( Θ ) from the applied field direction where the field direction is along the   x -axis (0° and 180°). ( b ) Violin plot showing angle of deflection from the applied field direction between control and MNP groups (red and blue, respectively). With the dashed lines representing the median and IQRs of each group. ( c ) Brightfield images of control and 2K-MNP-labelled PC12 neurons after 8 days differentiation (scale bar = 200 μm).  Table 2.   Description of control and MNP groups for neurite growth analysis, and the resulting angle of growth (median and IQR).  control group   MNP group  N   3   4  n   2487   3394 median (IQR) 46.332 (25.084, 69.075) 36.345 (18.138, 62.103) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  6 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\ngroup value of 46.332 (IQR: 25.084, 69.075) to the device group value 36.345 (IQR: 18.138, 62.103). A Kruskal – Wallis test shows a significant difference between control group and   MNP   group   with   p   < 0.001.   Therefore,   it   has   been shown that the influence of a static MNP on MNP-labelled cells can significantly increase the directional growth of neur- ites in two-dimensional slices.  3.3.   Ex vivo   rat brain slice model  Following the   in vitro   experiments, we then tested the magnetic system in a more complex   ex vivo   rat brain slice model using pri- mary VM cells labelled with Fe 2 O 3 -PAA 2K   MNPs. We first confirmed MNP loading in VM cells using live cell imaging (figure   6 a ).   Phase   contrast   and   fluorescence   microscopy (figure 6 a (i – iii)) confirmed MNP loading in cells after 24 h of incubation. Rat brain slices were then loaded into Petri dishes (figure 6 b (i)) before injection with the MNP-labelled cells. Slices were then placed within the gradient magnetic device for 7 days with the striatum positioned closest to the largest flux density to encourage cell growth from the implant site towards the striatum (figure 6 b (ii)). Fluorescent microscopy of the slices confirmed TH+ cell bodies and MNP at the transplan- tation site after 7 days in both groups indicating the presence of transplanted dopaminergic neurons (figure 6 c (i,ii)). Next, we quantified the degree of TH +ve cell and neurite outgrowth away from the injection site in the presence or absence of the magnetic field gradient. This was achieved by   analysing   the   amount   of   TH+ staining   distal   to   the interface between the transplant and host explant boundary (figure 7 a ). The control groups showed relatively less out- growth reaching the striatum, whereas slices exposed to the magnetic   device   showed   a   trend   for   denser   outgrowth (figure 7 b ). For analysis, each slice was divided into zones comprising the injection zone, striatal zone and an outgrowth zone located between the injection and striatal zone (elec- tronic supplementary material, figure S3a). The intensity of TH staining within the outgrowth zones was then quantified. Though there was no significant difference in the number of TH+ cells migrating into the proximal portion of the out- growth   zone   of   the   host   tissue   (figure   7 c (i,ii)),   results showed a significant increase in TH staining intensity in this region in the magnet group. Though there is the possi- bility that even a non-significant rise in the number of TH+ neurons migrating into this region could increase the over TH+ staining, the significant increase in the staining in the magnet group was interpreted as being an indication that the   overall   neurite   outgrowth   in   this   group   is   relatively higher than in the control group (figure 7 c ; electronic sup- plementary   material,   figure   S3b).   We   also   analysed   the directionality of the TH+ cells and neurites present in the out- growth   zone   using   the   directionality   ImageJ   plug-in (electronic   supplementary   material,   figure   S3c(i)).   Results showed a small shift in the orientation of the MNP-loaded cells   and   neurites   when   exposed   to   the   magnetic   field (trend only), with these cells and neurites aligning more towards the upper striatum. By contrast, the cells and neur- ites in the control group (where present) tended to align  phase 50    m 1000    m   1000    m control DAPI / TH / MNPs magnet MNP   merge (i)   (ii) (i)   (ii) (i)   (ii) (iii) ( b ) ( c ) ( a )  Figure 6.   Live imaging of plated VM cells revealed good loading of the MNPs by VM cells. Phase contrast image is shown in ( a (i)), fluorescent MNPs are shown in ( a (ii)), and merge is shown in ( a (iii)). Representative images of   n   = 4 are shown. Brain slices were cultured in Petri dishes ( b (i)) before loading into the magnetic gradient device, with the striatum exposed to the largest magnetic flux density in the system ( b (ii)). Fluorescent microscopy of injected slices confirmed MNP loading of VM cells and localization at the transplant site in both control ( c (i)) and magnet groups ( c (ii)). The slice is visible through DAPI staining (blue), VM cells are shown through TH staining (green) and MNP are shown through rhodamine fluorescence (red). Images representative of   n   = 4 – 6. royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  7 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\ntowards   the   lower   striatum   (electronic   supplementary material, figure S3c(ii)).  4. Discussion  Directional   control   of   neuronal   processes   is   one   of   the long-standing   challenges   in   neuronal   tissue   engineering. This technical barrier must be overcome before cell therapies can be harnessed for treatment of neurodegenerative dis- eases. Multiple recent studies, including from our group, have demonstrated the potential   for MNP and magnetic fields to control cell signalling and influence direction of neurite outgrowth   in vitro   [6,9,18,25]. For instance, Semeano  et al.   recently demonstrated that MNP embedded in col- lagen-based coatings can stimulate microtubule expression, promote neurite elongation and can influence cell migration when combined with static magnetic fields [26]. Bongaerts  et al.   recently used Fe 2   O   3 -PAA   2K -MNP and static magnetic fields provided by arrays of magnetized pillars to direct cell migration and induce neurite outgrowth in differentiated cells in the direction of the pillars [12]. In the current study, we created an asymmetric array of permanent magnets that provided   a   steep   magnetic   field   gradient   over   a   3 cm region. We used this array to promote directional outgrowth of neurites using the same Fe   2 O   3   -PAA   2K -MNP which were internalized   in   neuronal   cells.   In   both   studies,   Fe 2   O   3   - PAA 2K   -MNP were non-specifically targeted and passively taken up by cells. Within this study, we also tested the short- term toxicity of the MNP and magnetic fields. Importantly, neither MNP nor static magnetic fields had any noticeable effect on cell viability, which is a critical consideration when developing MNP-based treatments. The application of static magnetic fields in both studies imparted non-specific tensile forces to cells to directly influence the directionality of neurite outgrowth. This effect is to be expected given the crucial role that mechanical forces play in control of cell polarity and neur- ite outgrowth [27]. Having said this, the precise downstream mechanisms through   which   the   MNP-induced   forces   are transduced to cellular structures to alter neurite directionality require further study. We also compared neurite outgrowth angles with MNP directional   motion   predicted   using   mathematical   models. FE analysis simulations were performed to investigate the magnetic field gradients and resulting directional motion of MNPs. The simulation of the magnetic field gave field pro- files and resulting field gradients that closely resembled that of the configured device. The resulting directions of motion are   not   directly   parallel   to   the   applied   magnetic   field (which would result in a 0° deflection) and are indicative that the combination of magnetic field vectors and molecular guidance signals from growth factors (such as nerve growth factor) secreted from neighbouring neurons play competing roles in the resulting neurite outgrowth direction [11,28].  TH intensity (outgrowth region) pixel intensity, background corrected (arb. units) control magnet –2 0 2 4 6 8  magnet control implant region outgrowth region striatal region outgrowth region TH   1 mm  control   magnet TH   TH 1 mm   1 mm TH   1 mm implant region outgrowth region striatal region *   ns TH+ cell count (outgrowth region) avg. TH+ cells control magnet 0 5 10 15 20 25 30 ( a ) ( b )   ( c )  (i)   (ii)  Figure 7.   Magnetic gradient promotes neurite outgrowth in brain slices. Fluorescent images of TH-stained slices were divided into three regions (striatal, outgrowth and implant). Fluorescent microscopy of the outgrowth regions indicated that the magnetic device enhanced cell and neurite growth into the outgrowth region compared with the control region ( a (i,ii)). Representative images are shown. Pixel intensity analysis in the outgrowth regions confirmed a significant increase in TH staining in the magnet group relative to the control ( b ). Values represent background corrected median pixel intensity; asterisk (*) represents   p   < 0.05. Error bars represent IQR with min. and max. values.   n   = 4 (magnet),   n   = 6 (control). royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  8 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nDespite the small discrepancy between predicted MNP direction and observed neurite outgrowth direction, we still demonstrate that application of the magnetic gradient leads to a significant difference in the experimental outgrowth direction. The change in preferential outgrowth direction broadly   mapped   the   changes   in   magnetic   field   gradient across the sample. It is of note that the MNP-labelled group had   a   median   direction   of   36.35°,   compared   with   the median direction of motion from simulations of 21.53°. It is noted that the mathematical modelling approach demon- strated   here   does   not   include   biological   factors   such   as cell-binding and competing forces which may arise from biological mechanisms, including cues from neighbouring cells. However, these values measured are consistent with other mechanistic models found in literature which suggest the   resulting   growth   direction   would   be   approximately 30° due to the combination of magnetic vector directions [9]. Finally, we investigated the effect of our magnetic gradi- ent device in a more complex   ex vivo   brain slice model using primary neurons to test the translational potential of our approach. Our experiments demonstrated that primary neuronal cells can be loaded with MNPs without inducing toxicity, and neuronal cell transplants can be tracked on brain slices for at least 7 days. These properties are important to consider in neuronal tissue engineering, which requires minimal MNP toxicity and maximal cell survival over time. Crucially, our results showed that magnetic gradients can promote   dopaminergic   outgrowth   of   MNP-labelled   cells towards the striatum. Previous studies have shown it is poss- ible to remotely trigger cell signalling and direct neuronal stem cells to sites of injury   in vivo   using MNP and magnetic guidance systems. These approaches were shown to facilitate neuronal differentiation and brain repair as well as alter neuronal   electrophysiology   and   alter   animal   behaviour, respectively [29,30]. To our knowledge, the work presented here is the first study to demonstrate magnetically controlled cell and neurite outgrowth in primary dopaminergic cells transplanted into a complex   ex vivo   model. It should be noted that the magnetic field gradients used in our system (greater than 20 T m − 1   ) are an order of magnitude greater than the field gradients currently used in the clinic. For example, MRI scanners use field gradients in the region of 5 – 50 mT m − 1   [31], while larger field gradients (500 mT m − 1   ) have been used for related   in vivo   studies [32]. The magnetic device within this study was designed to exhibit substantially steeper field gradients, as these would be sufficient field gra- dients to elicit a strong enough directional force on individual MNPs. These high field gradients are required to enable inter- action of MNPs and magnetic field across the large physical distance   between   the   substantia   nigra   and   a   permanent magnet located at the skull surface. While the current study confirms proof of principle for our technique, an alternative magnetic device, with similar magnetic field profiles, would be necessary before the approach could be translated to the clinic. Future work will focus on magnetic field optimization to promote further increases in directional neuronal out- growth, but the ability to control cell behaviour in this way is nonetheless an important step which will ultimately be required for translation of neuronal cell therapies to the clinic. Neurodegenerative   conditions   such   as   PD   urgently require new therapies; however, directional control of neurite extension is one critical factor that is preventing clinical uptake of cell therapies for these diseases. In this work, we have   demonstrated   remote-controlled   neurite   outgrowth from neuronal cells   in vitro   and in an   ex vivo   model of the nigral-striatal pathway using MNP and magnetic gradients. Our experimental observations of directional neurite out- growth   closely   resemble   the   predicted   MNP   motion calculated by mathematical modelling. This study highlights the   benefits   that   magnetic   control   systems   can   have   on directing neuronal cell behaviour and shows that this strategy can form a useful component of cell therapy toolkits.  Ethics.   All animal experiments were performed following review and guidelines established by the Animal Welfare and Ethical Review Body (AWERB) at Keele University and conducted under the licensed authority of the UK Home Office (PPL40/3556). Animals were main- tained in a 12/12 ‐ hr light/dark cycle at a stable room temperature (RT; 22 ± 1°C) and were given free access to food, water and environ- mentally enriching articles.  Data accessibility.   The data are provided at https://doi.org/10.5281/ zenodo.7217515 [33] and in the electronic supplementary material [34].  Authors ’   contributions.   K.D.:   conceptualization,   data   curation,   formal analysis, investigation, methodology, writing — original draft and writ- ing — review and editing; K.A.: conceptualization, investigation and methodology;   T.J.B.:   data   curation,   formal   analysis,   investigation, methodology, writing — original draft and writing — review and editing; E.S.: investigation, methodology and writing — review and editing; T.G.: data curation, investigation and methodology; M.R.: formal analysis, methodology, writing — original draft and writing — review and editing; N.T.: conceptualization, funding acquisition, supervision and writing —  review and editing; J.M.S.: conceptualization, supervision and writing —  review and editing; C.M.: conceptualization, funding acquisition, super- vision   and   writing — review   and   editing;   J.F.:   conceptualization, investigation and writing — review and editing; M.C.: conceptualization, funding acquisition, supervision and writing — review and editing; A.J.E.H.: conceptualization, funding acquisition, supervision and writ- ing — review and editing; M.A.G.: conceptualization, supervision and writing — review and editing. All authors gave final approval for publication and agreed to be held accountable for the work performed therein.  Conflict of interest declaration.   We declare we have no competing interests.  Funding.   This work was funded by the European Union ’ s Horizon 2020 research and innovation programme MAGNEURON (grant agreement no. 686841) and an EU ERC Advanced Grant DYNACEU- TICS (grant no. 789119). The funders had no involvement in the preparation of this manuscript.  Acknowledgements.   We thank Eric Nicolau and Rémy Fert from the mech- anical workshop of the physical chemistry unit (UMR168) at Institut Curie who assisted in the design and construction of the magnetic device. Graphic summary was created with BioRender.com.  References 1.   Castelo-Branco G   et al . 2003 Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.   Proc. Natl Acad. Sci. USA   100 , 12 747 – 12 752. (doi:10.1073/pnas. 1534900100) 2.   Andersson ER   et al . 2008 Wnt5a regulates ventral midbrain morphogenesis and the development of A9 – A10 dopaminergic cells   in vivo .  PLoS ONE   3 , e3517. (doi:10.1371/journal.pone. 0003517) 3.   Joksimovic M, Yun BA, Kittappa R, Anderegg AM, Chang WW, Taketo MM, McKay RDG, Awatramani RB. 2009 Wnt antagonism of   Shh   facilitates midbrain floor plate neurogenesis.   Nat. Neurosci.  12 , 125 – 131. (doi:10.1038/nn.2243) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  9 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n4.   Tang M, Villaescusa JC, Luo SX, Guitarte C, Lei S, Miyamoto Y, Taketo MM, Arenas E, Huang EJ. 2010 Interactions of Wnt/ β -catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons.   J. Neurosci.   30 , 9280 – 9291. (doi:10.1523/JNEUROSCI.0860-10.2010) 5.   Gordon T. 2010 The physiology of neural injury and regeneration: the role of neurotrophic factors.  J. Commun. Disord.   43 , 265 – 273. (doi:10.1016/j. jcomdis.2010.04.003) 6.   Raudzus F   et al . 2020 Magnetic spatiotemporal control of SOS1 coupled nanoparticles for guided neurite growth in dopaminergic single cells.   Sci. Rep.   10 , 1 – 15. (doi:10.1038/s41598-020-80253-w) 7.   Bray D. 1984 Axonal growth in response to experimentally applied mechanical tension.   Dev. Biol.   102 , 379 – 389. (doi:10.1016/0012- 1606(84)90202-1) 8.   Fass JN, Odde DJ. 2003 Tensile force-dependent neurite elicitation via anti- β 1 integrin antibody- coated magnetic beads.   Biophys. J.   85 , 623 – 636. (doi:10.1016/S0006-3495(03)74506-8) 9.   Riggio C   et al . 2014 The orientation of the neuronal growth process can be directed via magnetic nanoparticles under an applied magnetic field.  Nanomed. Nanotechnol. Biol. Med.   10 , 1549 – 1558. (doi:10.1016/j.nano.2013.12.008) 10.   Suter DM, Miller KE. 2011 The emerging role of forces in axonal elongation.   Prog. Neurobiol.   94 , 91 – 101. (doi:10.1016/j.pneurobio.2011.04.002) 11.   Lowery LA, Vactor D Van. 2009 The trip of the tip: understanding the growth cone machinery.   Nat. Rev. Mol. Cell Biol.   10 , 332 – 343. (doi:10.1038/ nrm2679) 12.   Bongaerts M   et al . 2020 Parallelized manipulation of adherent living cells by magnetic nanoparticles- mediated forces.   Int. J. Mol. Sci.   21 , 1 – 20. (doi:10. 3390/ijms21186560) 13.   Schöneborn H, Raudzus F, Coppey M, Neumann S, Heumann R. 2018 Perspectives of RAS and RHEB GTPase signaling pathways in regenerating brain neurons.   Int. J. Mol. Sci.   19 , 1 – 37. (doi:10.3390/ ijms19124052) 14.   Pankhurst QA, Connolly J, Jones SK, Dobson J. 2003 Applications of magnetic nanoparticles in biomedicine.   J. Phys. D. Appl. Phys.   36 , R167 – R181. (doi:10.1088/0022-3727/36/13/201) 15.   Markides H, Rotherham M, El Haj AJ. 2012 Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine.  J. Nanomater.   2012 , 13 – 15. (doi:10.1155/ 2012/614094) 16.   Harrison R, Markides H, Morris RH, Richards P, El Haj AJ, Sottile V. 2017 Autonomous magnetic labelling of functional mesenchymal stem cells for improved traceability and spatial control in cell therapy applications.   J. Tissue Eng. Regen. Med.   11 , 2333 – 2348. (doi:10.1002/term.2133) 17.   Markides H   et al . 2018 Translation of remote control regenerative technologies for bone repair.   npj Regen. Med.   3 , 1 – 12. (doi:10.1038/ s41536-018-0048-1) 18.   Rotherham M, Nahar T, Goodman T, Telling N, Gates M, El Haj A. 2019 Magnetic mechanoactivation of Wnt signaling augments dopaminergic differentiation of neuronal cells.   Adv. Biosyst.   3 , 1900091. (doi:10.1002/adbi.201900091) 19.   Rotherham M, Haj AJE. 2015 Remote activation of the Wnt/ β -catenin signalling pathway using functionalised magnetic particles.   PLoS ONE   10 , 1 – 18. (doi:10.1371/journal.pone.0121761) 20.   Malagelada C, Greene LA. 2008 PC12 cells as a model for Parkinson ’ s disease research. In  Parkinson ’ s disease , pp. 375 – 387. Boston, MA: Elsevier. 21.   Greene LA, Tischler AS. 1982 PC12 Pheochromocytoma cultures in neurobiological research. Advances in Cellular Neurobiology  3 , 373 – 414. (doi:10.1016/B978-0-12-008303-9. 50016-5) 22.   Plan Sangnier A, Van de Walle AB, Curcio A, Le Borgne R, Motte L, Lalatonne Y, Wilhelm C. 2019 Impact of magnetic nanoparticle surface coating on their long-term intracellular biodegradation in stem cells.   Nanoscale   11 , 16 488 – 16 498. (doi:10.1039/ C9NR05624F) 23.   Barnsley LC, Carugo D, Stride E. 2016 Optimized shapes of magnetic arrays for drug targeting applications.   J. Phys. D. Appl. Phys.   49 , 225501. (doi:10.1088/0022-3727/49/22/225501) 24.   Stoppini L, Buchs PA, Muller D. 1991 A simple method for organotypic cultures of nervous tissue.  J. Neurosci. Methods   37 , 173 – 182. (doi:10.1016/ 0165-0270(91)90128-M) 25.   Schöneborn H   et al . 2019 Novel tools towards magnetic guidance of neurite growth: (I) guidance of magnetic nanoparticles into neurite extensions of induced human neurons and in vitro functionalization with RAS regulating proteins.  J. Funct. Biomater.   10 , 32. (doi:10.3390/ jfb10030032) 26.   Semeano AT   et al . 2022 Effects of magnetite nanoparticles and static magnetic field on neural differentiation of pluripotent stem cells.   Stem Cell Rev. Rep.   18 , 1337 – 1354. (doi:10.1007/s12015-022- 10332-0) 27.   Gahl TJ, Kunze A. 2018 Force-mediating magnetic nanoparticles to engineer neuronal cell function.  Front. Neurosci.   12 , 1 – 16. (doi:10.3389/fnins. 2018.00299) 28.   Sierra-Fonseca JA, Najera O, Martinez-Jurado J, Walker EM, Varela-Ramirez A, Khan AM, Miranda M, Lamango NS, Roychowdhury S. 2014 Nerve growth factor induces neurite outgrowth of PC12 cells by promoting G β γ -microtubule interaction.   BMC Neurosci.   15 , 132. (doi:10.1186/ s12868-014-0132-4) 29.   Yun S   et al . 2018 Design of magnetically labeled cells (Mag-Cells) for in vivo control of stem cell migration and differentiation.   Nano Lett.   18 , 838 – 845. (doi:10.1021/acs.nanolett.7b04089) 30.   Wheeler MA   et al . 2016 Genetically targeted magnetic control of the nervous system.   Nat. Neurosci.   19 , 756 – 761. (doi:10.1038/nn.4265) 31.   McRobbie DW. 2014 3.01   –   Fundamentals of MR imaging. In   Comprehensive biomedical physics  (ed. A Brahme), pp. 1 – 19. Oxford, UK: Elsevier. 32.   Baker RR   et al . 2022 Image-guided magnetic thermoseed navigation and tumor ablation using a magnetic resonance imaging system.   Adv. Sci.   9 , 1 – 14. (doi:10.1002/advs.202105333) 33.   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients. Zenodo. (doi:10.5281/zenodo. 7217515) 34.   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients. Figshare. (doi:10.6084/m9.figshare.c. 6266161) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  10 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025',0.03438806351650314,'[\"\\u0002\", \"\\u0003\", \"(\", \"(*)\", \"(0.2\"]','2025-11-29 17:04:16.182009'),(61,3,'royalsocietypublishing.org/journal/rsif  Research  Cite this article:   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients.   J. R. Soc. Interface   19 : 20220576. https://doi.org/10.1098/rsif.2022.0576 Received: 8 August 2022 Accepted: 19 October 2022  Subject Category:  Life sciences – engineering interface  Subject Areas:  biomedical engineering  Keywords:  magnetic nanoparticles, regenerative medicine, tissue engineering, neurite outgrowth  Author for correspondence:  A. J. El Haj e-mail: a.elhaj@bham.ac.uk Electronic supplementary material is available online at https://doi.org/10.6084/m9.figshare. c.6266161.  Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients K. Dhillon   1   , K. Aizel   2 , T. J. Broomhall   1 , E. Secret 3   , T. Goodman   4 , M. Rotherham   1 , N. Telling   4   , J. M. Siaugue   3 , C. Ménager   3   , J. Fresnais   3 , M. Coppey   2 , A. J. El Haj   1   and M. A. Gates   4,5  1 Healthcare Technologies Institute, Department of Chemical Engineering, University of Birmingham, Birmingham, UK  2 Institut Curie, PSL Research University, CNRS, Sorbonne Université, Physico Chimie, Paris, France  3 Sorbonne Université, CNRS, Laboratoire Physicochimie des Électrolytes et Nanosystèmes Interfaciaux, PHENIX, 75005 Paris, France  4 School of Pharmacy and Bioengineering, Guy Hilton Research Centre, and   5 School of Medicine, Keele University, Staffordshire, UK  KD, 0000-0003-1335-8442; TJB, 0000-0002-7528-0831; ES, 0000-0003-2200-7265; MR, 0000-0002-9297-7681; NT, 0000-0002-2683-5546; JMS, 0000-0003-1217-9493; CM, 0000-0002-4080-3508; JF, 0000-0002-2037-0637; MC, 0000-0001-8924-3233; AJE, 0000-0003-3544-5678; MAG, 0000-0002-2901-1083  A challenge in current stem cell therapies for Parkinson ’ s disease (PD) is controlling   neuronal   outgrowth   from   the   substantia   nigra   towards the targeted area where connectivity is required in the striatum. Here we present progress towards controlling directional neurite extensions through the application of iron-oxide magnetic nanoparticles (MNPs) labelled neuronal cells combined with a magnetic array generating large spatially variant field gradients (greater than 20 T m − 1 ). We investigated the viability of this approach in both two-dimensional and organotypic brain slice models and validated the observed changes in neurite directionality using mathematical models.   Results   showed   that   MNP-labelled   cells   exhibited   a   shift   in directional neurite outgrowth when cultured in a magnetic field gradient, which broadly agreed with mathematical modelling of the magnetic force gradients and predicted MNP force direction. We translated our approach to an   ex vivo   rat brain slice where we observed directional neurite outgrowth of   transplanted   MNP-labelled   cells   from   the   substantia   nigra   towards the striatum. The improved directionality highlights the viability of this approach as a remote-control methodology for the control and manipulation of cellular growth for regenerative medicine applications. This study pre- sents a new tool to overcome challenges faced in the development of new therapies for PD.  1. Introduction  Parkinson ’ s disease (PD) is a neurodegenerative condition that arises during the progressive degeneration of midbrain dopaminergic (mDA) neurons in the sub- stantia nigra pars compacta (SNc). The loss of mDA neurons results in the loss of connections between the SNc and striatum. While pharmacological treatments exist for the short-term replacement of dopamine in the SNc-striatal circuit, there is a critical clinical need for cell therapies to restore dopaminergic cells in the SNc  © 2022 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited. Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n[1 – 4]. Potential cell therapies for this condition also depend upon the ability of the transplanted cells to reinnervate with neurons in the striatum. However, the rate of regeneration in the central nervous system is slow [5,6] which limits recovery. This technically challenging aspect of neuronal cell engineering is crucial for successful cell integration, circuit reconnection and   ultimately   disease   remission.   Several   approaches   to directing neuronal growth have been investigated, including the   use   of   mechanical   cues   and   magnetic   nanoparticles (MNPs) to generate tension to guide outgrowth [7 – 9]. While the study of neuronal outgrowths has been investigated over a long period of time, the control of outgrowth direction is a relatively newer approach that offers ways of progressing potential cell therapies for neurodegenerative conditions. Within   the   regeneration   process   growth   cones   are extended   from   the   neuronal   cell   which   are   capable   of generating   forces   through   their   motion,   which   can   aid in   growth   and   repair   [10].   Combining   the   mobility   of these growth cones and biological cues enables neuronal outgrowths to become directed to a target region [11]. There- fore, it is considered that other approaches to generating directional cues could help achieve more complete reinner- vation.   One   potential   approach   to   generating   topological gradients and directional cues is through the use of MNPs guided by magnetic fields [6,8,9,12,13]. MNPs are a suitable candidate for applying mechanical forces to neuronal cells, being widely used in biomedicine settings, such uses as MRI contrasts [14 – 16], and are commercially available, with previously demonstrated biological safety. MNPs have attracted attention as force carriers for the manipulation   of   cells   owing   to   their   ability   to   be   con- trolled remotely through externally applied magnetic fields. Through   the application   of magnetic   fields, the resulting forces can be applied either internally or externally to a cell, for example: through internalization into endosomes, or by binding to receptors and ion channels at the cell membrane. This approach has been recently used in a variety of cell and tissue engineering applications to regulate cell signalling path- ways, control cell differentiation and promote tissue repair [12,17,18]. Commonly, varying magnetic fields are employed to create a field gradient (varying in time) to act upon MNPs [19]. However, static magnetic fields can also be designed to vary in space and therefore offer another method to generate sufficient field gradients to induce forces acting on MNPs. To study the efficacy of using MNPs and static magnetic fields to help direct the neuronal outgrowths, we employ PC12 cells with MNPs and used a magnetic gradient to magnetically   control   neurite   extension   while   undergoing differentiation (figure 1 a,b ). PC12 cells are a well-established model neuronal cell line in PD research. When cultured with neurotrophic factors, PC12 differentiate into neuron-like cells with neuronal morphology and express neuronal markers [20,21]. We then tested the translational potential of this approach in rat organotypic brain slices, which were used as  Fe 2 O 3 PAA   2K   MNP  poly-acrylic acid / rhodamine coating magnetic core (Fe 2   O   3 ) MNP-tagged neurons MNP-tagged neurons neurite outgrowth towards striatum + 7 days striatum rat brain slice   substantia nigra  ex vivo  directed neurite growth differentiation + 8 days magnetic gradient ( a ) ( b ) ( c ) neuronal cells incubated with MNPs  in vitro  MNP internalization into lysosomes  Figure 1.   ( a ) Schematic of the experimental set-up. Poly-acrylic acid/rhodamine functionalized MNP with an Fe   2   O 3   core was synthesized and incubated with PC12 cells to allow internalization. ( b ) The MNP-tagged cells were cultured in differentiation media while being exposed to static magnetic fields in order to direct neurite extension along the magnetic field gradients. ( c ) MNP-tagged neurons were also injected into rat brain slices modelling the nigral-striatal pathway. Magnetic fields were then used to direct neurite extension from the cells at the injection site towards the striatum. royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  2 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\na model of the SNc-striatal circuit. Using this system, we injected primary rat embryonic ventral midbrain (VM) dopa- minergic precursor cells, which had been pre-labelled with MNP, into the SNc of rat brain slices. We then orientated the slices under the magnetic field gradient to promote directed cell and neurite outgrowth from the transplant region towards the striatum (figure 1 c ). After 8 days, we assessed cell and neur- ite outgrowth under magnetic control. The overall aim of this research was to demonstrate controlled directional neurite outgrowth   in   neuronal   cells,   which   was   validated   using mathematical models. This technology provides proof of prin- ciple for magnetic control of neuronal outgrowth with clear applications for neurodegenerative cell therapies.  2. Methods 2.1. Computational methods  The magnetic field profiles were simulated by employing a finite- element (FE) approach using the commercial software   COMSOL v5.1.   Magnetic fields and the resulting gradients were simulated by employing the   Magnetic Fields, No Currents   toolbox, with initialization parameters (remnant magnetization   B R   ) matching those of the neodymium iron-boron (NdFeB) magnets used in the experimental device (table 1). To calculate the directional motion of MNPs, the resulting field profiles were combined with   the   Particle   Tracing   for   Fluid   Flow   toolbox   with   MNPs simulated as particles with diameter, mass and magnetic suscep- tibility ( χ ) matching those of experimentally employed MNPs (table 1). The magnetic susceptibility ( χ ) of the MNPs is of key impor- tance when calculating the forces acting on a particle. The MNPs chosen   for   this   study   were   iron-oxide   particles   coated   with PAA (Fe 2   O 3 -PAA   2K   ). The MNP diameter is 8.4 ± 1.9 nm with saturation magnetization values of 51 – 57 emu g − 1   [12]. These particles have previously been reported to have good levels of internalization and stable magnetization within biological sys- tems over long time periods [22]. From a Langevin function of magnetization,   the   magnetic   behaviour   of   these   particles   is easily reproduced, and the susceptibility was calculated to be 4.27 from the change in magnetization at zero field. In the instance of an MNP located within static magnetic field the force acting upon it while in a fluid medium can be found from the following equation [23]:  F   M   ¼   2  p r 3  p  m 0  m p  m p     m f  m p   þ   2  m f  r H 2   ,   ð 2 : 1 Þ  where   r p   is the radius of the particle (in m),   μ p   and   μ f   is the permeability of the MNP and surrounding fluid, respectively, (where   μ   = 1 +   χ )   and   r H   is   the   magnetic   field   gradient   in (A m − 2 ). The motion for each MNP was calculated using the magnetophoretic force (equation (2.1)) applied across the sample region with the fluid medium taken to be water ( μ f   = 1) as an analogy to the MNP being located either in the cell or culture medium. MNP motion simulations included viscous drag and were simulated for a total time period of 8 h.  2.2. Magnetic device  To enable forces to be applied upon MNPs, a magnetic field (and gradient) needs to be established over the sample region. To achieve this, a device consisting of NdFeB permanent mag- nets (N42 grade) was created (as shown in figure 2 a ; electronic supplementary material, figure S1). The magnetic field was simu- lated using a FE method and the resulting magnetic field profile is shown in figure 2 c , ranging from field strengths of approxi- mately 700 to approximately 70 mT. The magnetic array device was mapped in three dimensions using an M3D-2A-PORT mag- netic field mapper (SENIS) at a scan resolution of 200 μm (x,y) and   a   step   size   of   0.5 mm   (z).   The   measured   field   map is shown in figure 2 c ; the values of magnetic field and the field gra- dient are found to align with the simulated magnetic field. The magnetic field gradient found along the magnetic field orien- tation is shown in figure 2 d   and is found to be greater than 20 T m − 1   across the sample region.  2.3. Cell culture  The rat adrenal phaeochromocytoma cell line, PC12 (CRL-1721), obtained   from   ATCC,   were   cultured   in   suspension   in   basal medium   made   from   Dulbecco ’ s   modified   Eagle ’ s   medium (Gibco) supplemented with 10% horse serum (heat inactivated), 10%   fetal   bovine   serum,   1%   penicillin-streptomycin   and   1% L-glutamine. Cells were kept in incubator at 37°C and 5% CO 2   .  2.4. Magnetic nanoparticles labelling  Cells were labelled with rhodamine-fluorescent Fe   2 O 3 -PAA   2K MNPs   which   were   previously   described   and   characterized by Bongaerts   et al.   [12]. The MNPs had a mean hydrodynamic size of 30.1 nm and were superparamagnetic in nature with a saturation magnetization of 55.7 emu g − 1 . Cells were labelled in suspension at a concentration of 2 mM (iron) in pre-warmed complete basal medium for 24 h prior to seeding.  2.5. PC12 differentiation  For differentiation into a neuronal phenotype, PC12 cells were seeded at 20 000 cells cm − 2   density on 1% poly-L-lysine (Sigma) and 10 μg μl − 1   laminin (Sigma L2020) coated glass-bottom dishes 24 h before initiating differentiation. Cells were differentiated for 8 days in culture with differentiation medium: Dulbecco ’ s modified Eagle ’ s medium (Gibco) supplemented with 5% horse serum (heat inactivated),   1%   penicillin-streptomycin,   1%   L-glutamine   and 100 ng μl − 1   nerve   growth   factor   (recombinant   human   β -NGF 450-01, Peprotech) with media replenishment every 2 days.  2.6. Live/dead staining  PC12 cells were incubated with MNP as above and cultured in neuronal   differentiation   media   under a   static   magnetic   field with peak flux density of less than 200 mT over 8 days. Cell via- bility was then assessed after 8 days using a ReadyProbes ™   cell viability assay (ThermoFisher) according to the manufacturer ’ s instructions.  2.7. Rat brain slice preparation  Organotypic slice cultures were prepared from postnatal day 5 – 8 rat   pups   according   to   the   interface   method   as   previously described [18,24]. Briefly, pups were terminally anaesthetized by intraperitoneal injection of pentobarbital in accordance with UK   Animals   (Scientific   Procedures)   Act   1986.   Sagittal   brain sections of 300 μm were cut at 10° angles using a vibratome  Table 1.   Parameters used for magnetic and MNP simulations.  simulation property   value   units  B R   1.42   T MNP diameter   8.4   nm MNP density   5240   kg m − 3  χ   4.27   dimensionless royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  3 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n(Leica). Following removal of the cortex and hippocampus, slices were placed onto PTFE membranes with 0.4 μm pores to allow access to nutrients from below and maintain gaseous exchange from above.  2.8. Injection of magnetic nanoparticle labelled ventral midbrain cells  Slices were cultured for 7 days (with SN removed) before trans- plantation of E14 VM cells to the SN region of the slice. The day before   transplantation,   the   VM   was   dissected   from   E14   rat embryos, dissociated and resuspended in medium containing 8 mM Fe 2 O 3   -PAA   2K   MNPs (iron concentration). The suspension was added to the well of a plate and incubated overnight. The MNPs prevented the cells from adhering to the plate without affecting cell viability. The next day, 200 – 500 nl of MNP-loaded VM cell suspension was pipetted into the SN region of the slice. The slice was then transferred to a Petri dish and orientated within the magnet device so that the striatum was exposed to the largest flux density in order to promote cell/neurite growth towards the striatum. The magnetic device was housed within a cell culture incubator at 37°C, 5% CO 2 . Control slices were cultured in six-well plates at 37°C, 5% CO   2   under no magnetic field. Slices were fixed 7 days following cell transplantation and immuno-stained for tyrosine hydroxylase (TH) to visualize both the cell bodies and process of dopamine neurons in the tissue and transplant.  2.9. Imaging  Light and fluorescent images were taken with EVOS M5000 or EVOS   XL   core   microscopes   (Thermofisher   Scientific).   Three- dimensional Z-stack imaging was conducted using Olympus Fluoview   FV1000   confocal   microscope.   Neurite   angle measurement   was   performed   using   the   angle   measurement tool in FIJI ImageJ2 software.  2.10. Analysis of rat brain slices  Images for each slice were stitched to form a montage, then rotated so that the striatal-SN axis was in the same plane for each sample. Each slice image was then divided into a grid of 20 regions of interest (ROI ’ s) covering three regions as shown in electronic supplementary material, figure S2a. These regions consisted of the implant area, the striatal region and an out- growth   area   located   between   the   implant   area   and   the striatum. For each sample, the mean grey value of each ROI in the outgrowth region was measured. These values were cor- rected   by   subtracting   the   mean   grey   value   of   the   slice background due to staining from the background slice tissue. The orientation of TH+ cells and neurites present in the out- growth region was also assessed using a directionality plug-in in   ImageJ.   This   was   used   to   calculate   the   relative   average amount   of   TH+ structures   at   each   orientation   (±90°)   within each sample. Only samples which contained TH+ cells and or neurites in the outgrowth region were included in the analysis.  2.11. Statistical methods  All statistical analysis was completed using Stata 17.0. For   two-dimensional   neurite   growth   measurements,   the measured angles were transformed to be a deflection relative to the field   direction   irrespective of lateral travel (i.e. ignoring left/right direction, with the key metric being the deflection angle). This results in measured deflection angles in the range of 0   −   90°. To evaluate the distributions in both control and MNP group, a Levene test for variance and a Shapiro test for nor- mality were performed. It was found that the two distributions had equal variance and were both non-normally distributed (Levene test:   p   > 0.05, Shapiro test:   p   < 0.05). From the description  ( a )   ( b ) ( c )   ( d ) 700 600 500 400 (mT) 300 200 100 30  25  20  15  10 X-position across sample area (mm) Y-position across sample area (mm) 5   0 10 700   700   35 30 25 20 15 10 field gradient (T m − 1 ) X co-ordinate across sample region (mm) imaging region 5 0  0   5   10   15   20   25   30   35 600 500 400 (mT) field gradient (T m − 1 ) 300 200 100 500 300 100 magnetic field (mT) 5 0 –5 –10  Figure 2.   ( a ) Shows assembled device with sample. ( b ) Shows a schematic of the device highlighting the orientation of the permanent magnets and the simulated magnetic field. ( c ) Three-dimensional map of magnetic flux density across the sample area confirmed a steep gradient across the sample region. ( d ) Shows the resulting magnetic field gradient, and the imaging region highlighted demonstrates that in the sample region investigated the field gradient is greater than 20 T m − 1 . royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  4 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nof these distributions, a Kruskal – Wallis test was chosen as a suitable statistical test. For pixel intensity analysis of slice TH staining, data are presented as medians +/- interquartile range (IQR). Statistical significance   at   95%   confidence   level   was   applied   using   a Mann – Whitney   test   (two-tailed,   unpaired),   p   < 0.05   was considered statistically significant.  3. Results 3.1. Simulation of magnetic nanoparticle motion  The direction of force exerted on MNPs within the sample region can be simulated to gain understanding as to how the external magnetic field and resulting gradient will drive directional neur- ite outgrowths. The force acting on an MNP and therefore to the attached sub-cellular structures and organelles in a static mag- netic field can be calculated by employing a magnetophoretic model (equation (2.1)). The magnetophoretic model results in MNP motion along the direction of applied force. Particle trajectories were simulated in a water medium over a time period of 8 h as an indication to the resulting directional outgrowth. Viscous drag forces were included to better understand the magnitude of forces exerted on the MNPs. The angle between the final position and the initiali- zation position relative to the field direction was calculated for each simulated MNP. Initial particle positions were randomized to within a sub- region of the entire sample region which represented the locations available for imaging in experimental studies (indi- cated by the grey circle in figure 3 a , black dots identify initial positions for a random sampling of particle positions). A total of 1500 particles were initialized with a resulting 1147 particle positions having a final position within the sampling region. The resulting angle of MNP motion is shown in figure 3 b , it is of note that the majority of particles do not move along the hori- zontal (along the direction of the applied field) but have a small angular offset in the vertical direction (perpendicular to the main applied field direction). This can be seen from comparing simulations that only include forces created through the appli- cation of   B x   components, to those in which   B x   and   B y   are included in the force calculation (figure 3 b ). When only   B x   com- ponents of magnetic field are included, the applied force and resulting directional motion of MNPs show a narrower range  ( a )   ( b ) 700 0.12 0.04 0.02 0.00  0   10   20   30   40   50   60 angle of MNP motion (°) 70   80   90 X component XY component 0.06 0.10 0.08 density 600 500 400 (mT) 300 200 100  Figure 3.   ( a ) Shows simulated trajectories of MNP motion within the magnetic device. Initial MNP positions (black dots) were randomized to the same sampling area used for two-dimensional imaging studies (grey circle). MNP motion was simulated over an 8 h period and the resulting angle of motion is shown in ( b ). Simulated MNP motion is included for both only including the X-component of magnetic field compared with including both X and Y components.  DAPI 2K MNP  (i)   (ii)  ( a ) ( b ) (i)   (ii)  Figure 4.   ( a ) PC12 cells labelled with rhodamine-fluorescent Fe   2 O   3 -PAA   2K   MNPs (scale bar = 100 μm) ( b ) Z-stack (0.2 μm slices) confocal images of PC12 cells labelled with AA2K-MNPs at day 1 (i) and day 3 (ii) after differentiation, with white arrow showing MNPs in neurite extension (scale bar = 10 μm). royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  5 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nof deflection from the direction of applied field. The resulting width of the peak indicates the field gradient is not uniform across the sample area in   B x . Furthermore, when both the   B x and   B y   components are included, the resulting MNP motion becomes more varied. In this scenario, the median angle is found to be 30.35°. From this, it is clear the combination of field gradients, not just the field gradient along the main direc- tion of applied field are fundamental for the resulting directional force experienced by the MNP and their subsequent motion.  3.2. Neurite growth in a two-dimensional culture  PC12 cells labelled with Fe 2 O 3 -PAA 2K   MNPs (figure 4 a ) were differentiated within the device (MNP group) and non-labelled cells within the device (control group) for a period of 8 days to encourage neurite growth. Fluorescent microscopy confirmed the presence of MNP after 1 day (figure 4 b (i)), with MNP still detectable after 3 days of differentiation (figure 4 b (ii)). Cell via- bility in response to MNP and magnetic field gradients was assessed using a live/dead assay. Results showed no effect of either MNP or magnetic field gradients on cell viability (elec- tronic supplementary material, figure S2). We next assessed the effect of MNP and magnetic gradients on directional neur- ite outgrowth   in vitro . From repeat incubations (MNP group  N   = 4, control group   N   = 3), images of cells with neurite out- growths were taken from the imaging region (sample area simulated in figure 3 a ); summary statistics can be found in table 2. For each cell with neuronal outgrowths, the direction of growth was calculated as an angular displacement from the direction of applied magnetic field. The distribution of measured angle of neurite outgrowth is shown in figure 5 a , b . The distribution of measured angles within the control group shows no preferential direction. However, the distribution found from the MNP group shows more favoured growth directions towards 0° and 180°. The resulting distribution of angles found from the MNP is skewed to the lower values, as can be seen from figure 5 b , and the differences in median and IQR (dashed lines). From the descriptive data the median angle of deflection from the direction of field has been reduced from the control  control   2K MNP control group   *** control group angle of neurite growth relative to field orentation distribution of measured neurite growth angles 45   0   135   180   300   200   100 frequency MNP group 90 70 50 30 angle of neurite growth (  ) 10 MNP group 0 90   45   0   135   180   300   200   100 frequency 0 90   ( a ) ( c ) ( b )  Figure 5.   ( a ) Shows the range of measured neurite growth angles ( Θ ) from the applied field direction where the field direction is along the   x -axis (0° and 180°). ( b ) Violin plot showing angle of deflection from the applied field direction between control and MNP groups (red and blue, respectively). With the dashed lines representing the median and IQRs of each group. ( c ) Brightfield images of control and 2K-MNP-labelled PC12 neurons after 8 days differentiation (scale bar = 200 μm).  Table 2.   Description of control and MNP groups for neurite growth analysis, and the resulting angle of growth (median and IQR).  control group   MNP group  N   3   4  n   2487   3394 median (IQR) 46.332 (25.084, 69.075) 36.345 (18.138, 62.103) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  6 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\ngroup value of 46.332 (IQR: 25.084, 69.075) to the device group value 36.345 (IQR: 18.138, 62.103). A Kruskal – Wallis test shows a significant difference between control group and   MNP   group   with   p   < 0.001.   Therefore,   it   has   been shown that the influence of a static MNP on MNP-labelled cells can significantly increase the directional growth of neur- ites in two-dimensional slices.  3.3.   Ex vivo   rat brain slice model  Following the   in vitro   experiments, we then tested the magnetic system in a more complex   ex vivo   rat brain slice model using pri- mary VM cells labelled with Fe 2 O 3 -PAA 2K   MNPs. We first confirmed MNP loading in VM cells using live cell imaging (figure   6 a ).   Phase   contrast   and   fluorescence   microscopy (figure 6 a (i – iii)) confirmed MNP loading in cells after 24 h of incubation. Rat brain slices were then loaded into Petri dishes (figure 6 b (i)) before injection with the MNP-labelled cells. Slices were then placed within the gradient magnetic device for 7 days with the striatum positioned closest to the largest flux density to encourage cell growth from the implant site towards the striatum (figure 6 b (ii)). Fluorescent microscopy of the slices confirmed TH+ cell bodies and MNP at the transplan- tation site after 7 days in both groups indicating the presence of transplanted dopaminergic neurons (figure 6 c (i,ii)). Next, we quantified the degree of TH +ve cell and neurite outgrowth away from the injection site in the presence or absence of the magnetic field gradient. This was achieved by   analysing   the   amount   of   TH+ staining   distal   to   the interface between the transplant and host explant boundary (figure 7 a ). The control groups showed relatively less out- growth reaching the striatum, whereas slices exposed to the magnetic   device   showed   a   trend   for   denser   outgrowth (figure 7 b ). For analysis, each slice was divided into zones comprising the injection zone, striatal zone and an outgrowth zone located between the injection and striatal zone (elec- tronic supplementary material, figure S3a). The intensity of TH staining within the outgrowth zones was then quantified. Though there was no significant difference in the number of TH+ cells migrating into the proximal portion of the out- growth   zone   of   the   host   tissue   (figure   7 c (i,ii)),   results showed a significant increase in TH staining intensity in this region in the magnet group. Though there is the possi- bility that even a non-significant rise in the number of TH+ neurons migrating into this region could increase the over TH+ staining, the significant increase in the staining in the magnet group was interpreted as being an indication that the   overall   neurite   outgrowth   in   this   group   is   relatively higher than in the control group (figure 7 c ; electronic sup- plementary   material,   figure   S3b).   We   also   analysed   the directionality of the TH+ cells and neurites present in the out- growth   zone   using   the   directionality   ImageJ   plug-in (electronic   supplementary   material,   figure   S3c(i)).   Results showed a small shift in the orientation of the MNP-loaded cells   and   neurites   when   exposed   to   the   magnetic   field (trend only), with these cells and neurites aligning more towards the upper striatum. By contrast, the cells and neur- ites in the control group (where present) tended to align  phase 50    m 1000    m   1000    m control DAPI / TH / MNPs magnet MNP   merge (i)   (ii) (i)   (ii) (i)   (ii) (iii) ( b ) ( c ) ( a )  Figure 6.   Live imaging of plated VM cells revealed good loading of the MNPs by VM cells. Phase contrast image is shown in ( a (i)), fluorescent MNPs are shown in ( a (ii)), and merge is shown in ( a (iii)). Representative images of   n   = 4 are shown. Brain slices were cultured in Petri dishes ( b (i)) before loading into the magnetic gradient device, with the striatum exposed to the largest magnetic flux density in the system ( b (ii)). Fluorescent microscopy of injected slices confirmed MNP loading of VM cells and localization at the transplant site in both control ( c (i)) and magnet groups ( c (ii)). The slice is visible through DAPI staining (blue), VM cells are shown through TH staining (green) and MNP are shown through rhodamine fluorescence (red). Images representative of   n   = 4 – 6. royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  7 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\ntowards   the   lower   striatum   (electronic   supplementary material, figure S3c(ii)).  4. Discussion  Directional   control   of   neuronal   processes   is   one   of   the long-standing   challenges   in   neuronal   tissue   engineering. This technical barrier must be overcome before cell therapies can be harnessed for treatment of neurodegenerative dis- eases. Multiple recent studies, including from our group, have demonstrated the potential   for MNP and magnetic fields to control cell signalling and influence direction of neurite outgrowth   in vitro   [6,9,18,25]. For instance, Semeano  et al.   recently demonstrated that MNP embedded in col- lagen-based coatings can stimulate microtubule expression, promote neurite elongation and can influence cell migration when combined with static magnetic fields [26]. Bongaerts  et al.   recently used Fe 2   O   3 -PAA   2K -MNP and static magnetic fields provided by arrays of magnetized pillars to direct cell migration and induce neurite outgrowth in differentiated cells in the direction of the pillars [12]. In the current study, we created an asymmetric array of permanent magnets that provided   a   steep   magnetic   field   gradient   over   a   3 cm region. We used this array to promote directional outgrowth of neurites using the same Fe   2 O   3   -PAA   2K -MNP which were internalized   in   neuronal   cells.   In   both   studies,   Fe 2   O   3   - PAA 2K   -MNP were non-specifically targeted and passively taken up by cells. Within this study, we also tested the short- term toxicity of the MNP and magnetic fields. Importantly, neither MNP nor static magnetic fields had any noticeable effect on cell viability, which is a critical consideration when developing MNP-based treatments. The application of static magnetic fields in both studies imparted non-specific tensile forces to cells to directly influence the directionality of neurite outgrowth. This effect is to be expected given the crucial role that mechanical forces play in control of cell polarity and neur- ite outgrowth [27]. Having said this, the precise downstream mechanisms through   which   the   MNP-induced   forces   are transduced to cellular structures to alter neurite directionality require further study. We also compared neurite outgrowth angles with MNP directional   motion   predicted   using   mathematical   models. FE analysis simulations were performed to investigate the magnetic field gradients and resulting directional motion of MNPs. The simulation of the magnetic field gave field pro- files and resulting field gradients that closely resembled that of the configured device. The resulting directions of motion are   not   directly   parallel   to   the   applied   magnetic   field (which would result in a 0° deflection) and are indicative that the combination of magnetic field vectors and molecular guidance signals from growth factors (such as nerve growth factor) secreted from neighbouring neurons play competing roles in the resulting neurite outgrowth direction [11,28].  TH intensity (outgrowth region) pixel intensity, background corrected (arb. units) control magnet –2 0 2 4 6 8  magnet control implant region outgrowth region striatal region outgrowth region TH   1 mm  control   magnet TH   TH 1 mm   1 mm TH   1 mm implant region outgrowth region striatal region *   ns TH+ cell count (outgrowth region) avg. TH+ cells control magnet 0 5 10 15 20 25 30 ( a ) ( b )   ( c )  (i)   (ii)  Figure 7.   Magnetic gradient promotes neurite outgrowth in brain slices. Fluorescent images of TH-stained slices were divided into three regions (striatal, outgrowth and implant). Fluorescent microscopy of the outgrowth regions indicated that the magnetic device enhanced cell and neurite growth into the outgrowth region compared with the control region ( a (i,ii)). Representative images are shown. Pixel intensity analysis in the outgrowth regions confirmed a significant increase in TH staining in the magnet group relative to the control ( b ). Values represent background corrected median pixel intensity; asterisk (*) represents   p   < 0.05. Error bars represent IQR with min. and max. values.   n   = 4 (magnet),   n   = 6 (control). royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  8 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\nDespite the small discrepancy between predicted MNP direction and observed neurite outgrowth direction, we still demonstrate that application of the magnetic gradient leads to a significant difference in the experimental outgrowth direction. The change in preferential outgrowth direction broadly   mapped   the   changes   in   magnetic   field   gradient across the sample. It is of note that the MNP-labelled group had   a   median   direction   of   36.35°,   compared   with   the median direction of motion from simulations of 21.53°. It is noted that the mathematical modelling approach demon- strated   here   does   not   include   biological   factors   such   as cell-binding and competing forces which may arise from biological mechanisms, including cues from neighbouring cells. However, these values measured are consistent with other mechanistic models found in literature which suggest the   resulting   growth   direction   would   be   approximately 30° due to the combination of magnetic vector directions [9]. Finally, we investigated the effect of our magnetic gradi- ent device in a more complex   ex vivo   brain slice model using primary neurons to test the translational potential of our approach. Our experiments demonstrated that primary neuronal cells can be loaded with MNPs without inducing toxicity, and neuronal cell transplants can be tracked on brain slices for at least 7 days. These properties are important to consider in neuronal tissue engineering, which requires minimal MNP toxicity and maximal cell survival over time. Crucially, our results showed that magnetic gradients can promote   dopaminergic   outgrowth   of   MNP-labelled   cells towards the striatum. Previous studies have shown it is poss- ible to remotely trigger cell signalling and direct neuronal stem cells to sites of injury   in vivo   using MNP and magnetic guidance systems. These approaches were shown to facilitate neuronal differentiation and brain repair as well as alter neuronal   electrophysiology   and   alter   animal   behaviour, respectively [29,30]. To our knowledge, the work presented here is the first study to demonstrate magnetically controlled cell and neurite outgrowth in primary dopaminergic cells transplanted into a complex   ex vivo   model. It should be noted that the magnetic field gradients used in our system (greater than 20 T m − 1   ) are an order of magnitude greater than the field gradients currently used in the clinic. For example, MRI scanners use field gradients in the region of 5 – 50 mT m − 1   [31], while larger field gradients (500 mT m − 1   ) have been used for related   in vivo   studies [32]. The magnetic device within this study was designed to exhibit substantially steeper field gradients, as these would be sufficient field gra- dients to elicit a strong enough directional force on individual MNPs. These high field gradients are required to enable inter- action of MNPs and magnetic field across the large physical distance   between   the   substantia   nigra   and   a   permanent magnet located at the skull surface. While the current study confirms proof of principle for our technique, an alternative magnetic device, with similar magnetic field profiles, would be necessary before the approach could be translated to the clinic. Future work will focus on magnetic field optimization to promote further increases in directional neuronal out- growth, but the ability to control cell behaviour in this way is nonetheless an important step which will ultimately be required for translation of neuronal cell therapies to the clinic. Neurodegenerative   conditions   such   as   PD   urgently require new therapies; however, directional control of neurite extension is one critical factor that is preventing clinical uptake of cell therapies for these diseases. In this work, we have   demonstrated   remote-controlled   neurite   outgrowth from neuronal cells   in vitro   and in an   ex vivo   model of the nigral-striatal pathway using MNP and magnetic gradients. Our experimental observations of directional neurite out- growth   closely   resemble   the   predicted   MNP   motion calculated by mathematical modelling. This study highlights the   benefits   that   magnetic   control   systems   can   have   on directing neuronal cell behaviour and shows that this strategy can form a useful component of cell therapy toolkits.  Ethics.   All animal experiments were performed following review and guidelines established by the Animal Welfare and Ethical Review Body (AWERB) at Keele University and conducted under the licensed authority of the UK Home Office (PPL40/3556). Animals were main- tained in a 12/12 ‐ hr light/dark cycle at a stable room temperature (RT; 22 ± 1°C) and were given free access to food, water and environ- mentally enriching articles.  Data accessibility.   The data are provided at https://doi.org/10.5281/ zenodo.7217515 [33] and in the electronic supplementary material [34].  Authors ’   contributions.   K.D.:   conceptualization,   data   curation,   formal analysis, investigation, methodology, writing — original draft and writ- ing — review and editing; K.A.: conceptualization, investigation and methodology;   T.J.B.:   data   curation,   formal   analysis,   investigation, methodology, writing — original draft and writing — review and editing; E.S.: investigation, methodology and writing — review and editing; T.G.: data curation, investigation and methodology; M.R.: formal analysis, methodology, writing — original draft and writing — review and editing; N.T.: conceptualization, funding acquisition, supervision and writing —  review and editing; J.M.S.: conceptualization, supervision and writing —  review and editing; C.M.: conceptualization, funding acquisition, super- vision   and   writing — review   and   editing;   J.F.:   conceptualization, investigation and writing — review and editing; M.C.: conceptualization, funding acquisition, supervision and writing — review and editing; A.J.E.H.: conceptualization, funding acquisition, supervision and writ- ing — review and editing; M.A.G.: conceptualization, supervision and writing — review and editing. All authors gave final approval for publication and agreed to be held accountable for the work performed therein.  Conflict of interest declaration.   We declare we have no competing interests.  Funding.   This work was funded by the European Union ’ s Horizon 2020 research and innovation programme MAGNEURON (grant agreement no. 686841) and an EU ERC Advanced Grant DYNACEU- TICS (grant no. 789119). The funders had no involvement in the preparation of this manuscript.  Acknowledgements.   We thank Eric Nicolau and Rémy Fert from the mech- anical workshop of the physical chemistry unit (UMR168) at Institut Curie who assisted in the design and construction of the magnetic device. Graphic summary was created with BioRender.com.  References 1.   Castelo-Branco G   et al . 2003 Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.   Proc. Natl Acad. Sci. USA   100 , 12 747 – 12 752. (doi:10.1073/pnas. 1534900100) 2.   Andersson ER   et al . 2008 Wnt5a regulates ventral midbrain morphogenesis and the development of A9 – A10 dopaminergic cells   in vivo .  PLoS ONE   3 , e3517. (doi:10.1371/journal.pone. 0003517) 3.   Joksimovic M, Yun BA, Kittappa R, Anderegg AM, Chang WW, Taketo MM, McKay RDG, Awatramani RB. 2009 Wnt antagonism of   Shh   facilitates midbrain floor plate neurogenesis.   Nat. Neurosci.  12 , 125 – 131. (doi:10.1038/nn.2243) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  9 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025\n4.   Tang M, Villaescusa JC, Luo SX, Guitarte C, Lei S, Miyamoto Y, Taketo MM, Arenas E, Huang EJ. 2010 Interactions of Wnt/ β -catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons.   J. Neurosci.   30 , 9280 – 9291. (doi:10.1523/JNEUROSCI.0860-10.2010) 5.   Gordon T. 2010 The physiology of neural injury and regeneration: the role of neurotrophic factors.  J. Commun. Disord.   43 , 265 – 273. (doi:10.1016/j. jcomdis.2010.04.003) 6.   Raudzus F   et al . 2020 Magnetic spatiotemporal control of SOS1 coupled nanoparticles for guided neurite growth in dopaminergic single cells.   Sci. Rep.   10 , 1 – 15. (doi:10.1038/s41598-020-80253-w) 7.   Bray D. 1984 Axonal growth in response to experimentally applied mechanical tension.   Dev. Biol.   102 , 379 – 389. (doi:10.1016/0012- 1606(84)90202-1) 8.   Fass JN, Odde DJ. 2003 Tensile force-dependent neurite elicitation via anti- β 1 integrin antibody- coated magnetic beads.   Biophys. J.   85 , 623 – 636. (doi:10.1016/S0006-3495(03)74506-8) 9.   Riggio C   et al . 2014 The orientation of the neuronal growth process can be directed via magnetic nanoparticles under an applied magnetic field.  Nanomed. Nanotechnol. Biol. Med.   10 , 1549 – 1558. (doi:10.1016/j.nano.2013.12.008) 10.   Suter DM, Miller KE. 2011 The emerging role of forces in axonal elongation.   Prog. Neurobiol.   94 , 91 – 101. (doi:10.1016/j.pneurobio.2011.04.002) 11.   Lowery LA, Vactor D Van. 2009 The trip of the tip: understanding the growth cone machinery.   Nat. Rev. Mol. Cell Biol.   10 , 332 – 343. (doi:10.1038/ nrm2679) 12.   Bongaerts M   et al . 2020 Parallelized manipulation of adherent living cells by magnetic nanoparticles- mediated forces.   Int. J. Mol. Sci.   21 , 1 – 20. (doi:10. 3390/ijms21186560) 13.   Schöneborn H, Raudzus F, Coppey M, Neumann S, Heumann R. 2018 Perspectives of RAS and RHEB GTPase signaling pathways in regenerating brain neurons.   Int. J. Mol. Sci.   19 , 1 – 37. (doi:10.3390/ ijms19124052) 14.   Pankhurst QA, Connolly J, Jones SK, Dobson J. 2003 Applications of magnetic nanoparticles in biomedicine.   J. Phys. D. Appl. Phys.   36 , R167 – R181. (doi:10.1088/0022-3727/36/13/201) 15.   Markides H, Rotherham M, El Haj AJ. 2012 Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine.  J. Nanomater.   2012 , 13 – 15. (doi:10.1155/ 2012/614094) 16.   Harrison R, Markides H, Morris RH, Richards P, El Haj AJ, Sottile V. 2017 Autonomous magnetic labelling of functional mesenchymal stem cells for improved traceability and spatial control in cell therapy applications.   J. Tissue Eng. Regen. Med.   11 , 2333 – 2348. (doi:10.1002/term.2133) 17.   Markides H   et al . 2018 Translation of remote control regenerative technologies for bone repair.   npj Regen. Med.   3 , 1 – 12. (doi:10.1038/ s41536-018-0048-1) 18.   Rotherham M, Nahar T, Goodman T, Telling N, Gates M, El Haj A. 2019 Magnetic mechanoactivation of Wnt signaling augments dopaminergic differentiation of neuronal cells.   Adv. Biosyst.   3 , 1900091. (doi:10.1002/adbi.201900091) 19.   Rotherham M, Haj AJE. 2015 Remote activation of the Wnt/ β -catenin signalling pathway using functionalised magnetic particles.   PLoS ONE   10 , 1 – 18. (doi:10.1371/journal.pone.0121761) 20.   Malagelada C, Greene LA. 2008 PC12 cells as a model for Parkinson ’ s disease research. In  Parkinson ’ s disease , pp. 375 – 387. Boston, MA: Elsevier. 21.   Greene LA, Tischler AS. 1982 PC12 Pheochromocytoma cultures in neurobiological research. Advances in Cellular Neurobiology  3 , 373 – 414. (doi:10.1016/B978-0-12-008303-9. 50016-5) 22.   Plan Sangnier A, Van de Walle AB, Curcio A, Le Borgne R, Motte L, Lalatonne Y, Wilhelm C. 2019 Impact of magnetic nanoparticle surface coating on their long-term intracellular biodegradation in stem cells.   Nanoscale   11 , 16 488 – 16 498. (doi:10.1039/ C9NR05624F) 23.   Barnsley LC, Carugo D, Stride E. 2016 Optimized shapes of magnetic arrays for drug targeting applications.   J. Phys. D. Appl. Phys.   49 , 225501. (doi:10.1088/0022-3727/49/22/225501) 24.   Stoppini L, Buchs PA, Muller D. 1991 A simple method for organotypic cultures of nervous tissue.  J. Neurosci. Methods   37 , 173 – 182. (doi:10.1016/ 0165-0270(91)90128-M) 25.   Schöneborn H   et al . 2019 Novel tools towards magnetic guidance of neurite growth: (I) guidance of magnetic nanoparticles into neurite extensions of induced human neurons and in vitro functionalization with RAS regulating proteins.  J. Funct. Biomater.   10 , 32. (doi:10.3390/ jfb10030032) 26.   Semeano AT   et al . 2022 Effects of magnetite nanoparticles and static magnetic field on neural differentiation of pluripotent stem cells.   Stem Cell Rev. Rep.   18 , 1337 – 1354. (doi:10.1007/s12015-022- 10332-0) 27.   Gahl TJ, Kunze A. 2018 Force-mediating magnetic nanoparticles to engineer neuronal cell function.  Front. Neurosci.   12 , 1 – 16. (doi:10.3389/fnins. 2018.00299) 28.   Sierra-Fonseca JA, Najera O, Martinez-Jurado J, Walker EM, Varela-Ramirez A, Khan AM, Miranda M, Lamango NS, Roychowdhury S. 2014 Nerve growth factor induces neurite outgrowth of PC12 cells by promoting G β γ -microtubule interaction.   BMC Neurosci.   15 , 132. (doi:10.1186/ s12868-014-0132-4) 29.   Yun S   et al . 2018 Design of magnetically labeled cells (Mag-Cells) for in vivo control of stem cell migration and differentiation.   Nano Lett.   18 , 838 – 845. (doi:10.1021/acs.nanolett.7b04089) 30.   Wheeler MA   et al . 2016 Genetically targeted magnetic control of the nervous system.   Nat. Neurosci.   19 , 756 – 761. (doi:10.1038/nn.4265) 31.   McRobbie DW. 2014 3.01   –   Fundamentals of MR imaging. In   Comprehensive biomedical physics  (ed. A Brahme), pp. 1 – 19. Oxford, UK: Elsevier. 32.   Baker RR   et al . 2022 Image-guided magnetic thermoseed navigation and tumor ablation using a magnetic resonance imaging system.   Adv. Sci.   9 , 1 – 14. (doi:10.1002/advs.202105333) 33.   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients. Zenodo. (doi:10.5281/zenodo. 7217515) 34.   Dhillon K   et al . 2022 Directional control of neurite outgrowth: emerging technologies for Parkinson ’ s disease using magnetic nanoparticles and magnetic field gradients. Figshare. (doi:10.6084/m9.figshare.c. 6266161) royalsocietypublishing.org/journal/rsif   J. R. Soc. Interface   19 : 20220576  10 Downloaded from https://royalsocietypublishing.org/ on 12 April 2025',0.03438806351650314,'[\"\\u0002\", \"\\u0003\", \"(\", \"(*)\", \"(0.2\"]','2025-11-29 17:04:37.094497'),(62,3,'Rev.   C ient.   S ist.   I nform.   5 ( 1 ), e 864 , doi:   10.51252/rcsi.v 5 i 1 . 864  Original article  Artículo original  Jan - Jun , 202 5 https://revistas.unsm.edu.pe/index.php/r csi  e - ISSN:   2709 - 992X  ©   The authors. This is an open - access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distr ibution,  and reproduction in any medium,   provided the original work is properly cited.  Use of technology in research among medical students at a  private university in Huancayo  Uso de las tecnologías al servicio de la investigacion por estudiantes de medicina  de una universidad privada de Huancayo  Mely Ruiz - Aquino 1* ,   Andrés   Leonardo Osorio - Llancachagua 2 ,   Julio Oswaldo Botiquín -  Encarnación 2 ,   Aníbal Valentín Diaz - Lazo 2 ,   Santiago Ángel Cortez - Orellana 2 ,   Rivaldo Carlos  Duran - Aquino 3  1 Universidad de Huanuco .   Huanuco, Peru  2 Universidad Peruana Los Andes .   Huancayo, Peru  3 Universidad Nacional Mayor de San Marcos .   Lima, Peru  Received :   29   Sept .   202 4   |   Ac c ept ed :   23   Nov .   202 4   |   Publi shed :   2 0   Jan.   202 5  Corresponding author *:   melyruizaquino@udh.edu.pe  How to cite this article :   Ruiz - Aquino, M., Osorio - Llancachagua, A. L., Botiquín - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A   .,  & Duran - Aquino, R. C .   (202 5 ).   Use of technology in research among medical students at a private university in Huancayo .   Revista  C ientífica de   S istemas e   I nformática ,   5 ( 1 ), e 7 63 .   https://doi.org/10.51252/rcsi.v5i1.864  ABSTRACT  This study mainly assessed the level of technology use in research among medical students during the infodemic  period at a private university in Huancayo. A quantitative, descriptive study was conducted with a randomly  selected sample of 109 students from   a total population of 764. A validated technology usage scale for research  was applied, followed by a descriptive data analysis. The results indicated that 44.95% of students had a basic  level of technological proficiency, 45.87% had an intermediate level,   and only 8.26% had an advanced level. The  most frequently used tools were PubMed and SciELO for literature searches, whereas the use of reference  managers and academic integrity tools was notably limited. The findings suggest that despite having access to  digital devices and internet services, students require further training in advanced technological tools to enhance  the quality of their research .  Keywords :   competencies; education; infodemic;   research; technology  RESUMEN  El objetivo de este estudio fue identificar el nivel de uso de las tecnologías al servicio de la investigacion por parte  de estudiantes de medicina en tiempos de infodemia en una universidad privada de Huancayo. Se   realizo un  estudio cuantitativo, descriptivo simple, con una muestra de 109 estudiantes seleccionados aleatoriamente de  una poblacion de 764. Se aplico una escala de uso de tecnologías para la investigacion y se realizo un analisis  descriptivo de los datos . Los resultados indicaron que el 44,95% de los estudiantes tenía un nivel basico, el  45,87% un nivel intermedio y solo el 8,26% un nivel avanzado en el uso de tecnologías. Las herramientas mas  utilizadas fueron PubMed y Scielo para la busqueda de informac ion, mientras que el uso de gestores de  referencias y herramientas de integridad academica fue limitado. Se concluye que, aunque los estudiantes  cuentan con acceso a dispositivos y servicios de internet, existe una necesidad de fortalecer sus habilidades e n  el uso de tecnologías avanzadas para mejorar la calidad de sus investigaciones .  Palabras clave :   competencias; educacion; infodemia; investigacion; tecnología.\nRuiz - Aquino   et al.  2   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  1.   INTRODUC TION  In recent years, the COVID - 19 pandemic has fueled   the rise of an infodemic, characterized by the  rapid spread of all types of information, including rumors and unreliable data. This has been  facilitated by the widespread use of mobile phones, social networks, the internet, and other  communication technolo gies (Arroyo et al., 2020). However, technology use is not inherently  detrimental. We are experiencing a technological revolution marked by the global expansion of  computers and digital communication systems (Grande et al., 2016), which have proven invalua ble  across various fields, including scientific research. Information and Communication Technologies  (ICTs) exemplify this transformation, significantly impacting research by enabling more efficient  problem - solving and data management (Grande et al., 2016) . Medical students increasingly rely  on ICTs to streamline research tasks that would otherwise be time - consuming and resource -  intensive (Arbelaez, 2014).  A 2019 study in Spain by Garcí a   &   Canton (2019) reported that nearly all students (98%) used  search engines such as Google or Safari, and 96% utilized instant messaging applications like  WhatsApp or Telegram. In Mexico, Gomez (2019) found that only 18% of university students had  internet a ccess at home, with financial constraints being the primary barrier. Social media use was  also widespread, with 95% of students on Facebook, 79% on Twitter, and 65% on Instagram.  Similarly, Campos et al. (2018) reported th at 72.4% of students at a Mexican research center were  familiar with ICTs, with an average competence rating of 3.54 on a scale of 1 to 5. A 2017 study in  Chile by Cerda et al. (2017) found that 97% of surveyed students owned a laptop and 87% had a  smartph one, with extensive internet coverage at home.  In Peru, Morales (2020) examined ICT integration in video surveillance in Santiago de Surco,  noting a lack of system interoperability. Mendoza (2018) found that 70.4% of educators  incorporated ICT into their teaching, mainly through images (69.1%), videos   (64.2%), and audio  (44.4%), with PowerPoint being the most frequently used tool (93.8%). However, 38.3% of  teachers reported insufficient training and requested instruction on virtual classroom design.  Licona   &   Veitya (2019) further emphasized the necessit y of technological training for researchers,  highlighting its role in accessing and managing scientific information.  Given the transition to virtual learning environments, evaluating the extent of technology use in  research among medical students during the infodemic is crucial (Al - Hail et al., 2023; Almufarreh  & Arshad, 2023). ICTs have become essential in both in - perso n and remote education (Licona &  Veitya, 2019), enhancing research quality by facilitating access to databases, data processing  software, academic writing tools, presentation applications, plagiarism detection programs, and  reference management systems. Re cent studies have demonstrated a direct link between students\'  technological competencies and the effectiveness of their academic research (Martínez & Flores,  2021; Reyes et al., 2020).  Furthermore, Navarrete Enrí quez et al. (2024) and Salguero Alcala et al.   (2024) underscored the  importance of digital competencies for academic performance, particularly in information - dense  environments like the infodemic. These studies highlight the necessity of integrating educational  strategies to strengthen students\' techn ological skills, enabling them to efficiently manage  information and enhance research quality.\nRuiz - Aquino   et al.  3   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Thus, the objective of this study is to identify the level of technology use in research among medical  students at a private university in Huancayo during the infodemic period.  2.   MATERIALS   AND   M ETHODS  2.1.   Type and area study  A quantitative, descriptive, cross - sectional study was conducted among medical students. The area  where the study was   conducted was the Peruvian University of Los Andes. It was carried out from  September 2021 to January 2022.  2.2.   Population and sample  The study population consisted of 764 students of the Faculty of Human Medicine of the  Universidad Peruana Los   Andes, and the sample consisted of 109 students to whom a scale of use  of technologies in the service of research was applied, performing a descriptive analysis. The  inclusion criteria considered students who were doing research work, those between the fif th and  twelfth year of studies, and all students who expressed their willingness to participate. Students  who were between the first and fourth cycle of studies were excluded from the study, as well as  those who did not adequately complete the questionnair e (Table 1).  Table 1.   neral characteristics of the sample of medical students  General characteristics   n=109  fi   %  Demographic characteristics  Age group (years)  Teenagers (15 - 19)   87   79,82  Youth (20 - 25)   20   18,5  Adults (>25)   2   1,83  Sex  Male   48   44  Female   61   56  Academic characteristics  Cycle of studies  Fifth cycle   15   13,8  Sixth cycle   22   20,2  Seventh cycle   23   21,1  Eighth cycle   9   8,3  Ninth cycle   22   20,2  Tenth cycle   8   7,3  Eleventh cycle   9   8,3  Twelfth cycle   1   0,9  Characteristics of the   research  Type of study  According to the researcher\'s intervention  Observational   106   97,2  Experimental   3   2,8  According to the source of information  Retrospective   73   67  Prospective   36   33  According to the number of measurements  Transversal   104   95,41  Longitudinal   5   4,59  According to the number of variables  Descriptive   95   87,16  Analytical   14   12,84\nRuiz - Aquino   et al.  4   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Project phase  Planning   95   87,2  Execution   11   10,1  Final report   3   2,8  Publication   0   0  Informative data  Previous scientific   publication  Yes   2   1,8  No   107   98,2  Type of study  Original article   -   -  Letter to the editor   -   -  Editorial   -   -  Review article   2   1,8  Symposium   -   -  Case report   -   -  Essays   -   -  2.3.   Data collection techniques and instruments.  The online survey   technique was used, using the \"Scale of the use of technologies in the service of  research\" as an instrument. This instrument was composed of 49 items distributed in 7  dimensions:   technology   for   information   search,   database   technology,   technology   for   data  processing, technology for writing, technology for the presentation of research results, technology  for academic integrity, and technology for reference managers. In addition, a survey guide was  applied to collect the general characteristics of the sample,   which consisted of 13 items organized  into   4   dimensions:   demographic   characteristics,   academic   characteristics,   research  characteristics, and informational data (Table 2) .  Tabl e   2.   Characteristics of the use of technologies by medical students  Equipment and/or devices  N=109  Yes   No  fi   %   fi   %  Desktop computer   93   85.32   16   14.68  Laptop   61   55.96   48   44.04  Cell phone   95   87.16   14   12.84  Tablet   49   44.95   60   55.05  Printer   82   75.23   27   24.77  External memory   28   25.69   81   74.31  USB   81   74.31   28   25.69  MP4   44   40.37   65   59.63  Other   -   -   -   -  Internet service  Home Internet (Router)   100   91.74   9   8.26  Mobile Internet   65   59.63   44   40.37  Wireless Internet (Modem)   87   79.82   22   20.18  Other   -   -   -   -  The \"Scale of the use of technologies in the   service of research\" was validated by a panel of 5  experts, who evaluated the pertinence, relevance, clarity, and organization of the items, ensuring  that they were representative of the variable to be measured. The survey was conducted using the  Google Fo rms platform.\nRuiz - Aquino   et al.  5   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  2.4.   Data collection procedures  For data collection, the online survey was sent through the WhatsApp messaging application to  different groups of students, previously organized by academic cycles (from 5th to 12th). The  survey was designed to be answered in an average time of 20 minutes,   to ensure the participation  and adequate dedication of the respondents.  The process of constructing the instrument began with the development of a matrix in Microsoft  Word, in which the items and dimensions of the survey were clearly defined. Subsequently, this  matrix was transferred to the Google Forms platform, where the que stionnaire was developed in  its final format. This digital transition allowed for greater organization and accuracy in data  collection, as well as a more accessible experience for participants. In addition, the use of Google  Forms facilitated the collectio n and secure storage of responses, allowing for efficient management  of the data collected and minimizing the risk of data entry errors.  The distribution of the survey via WhatsApp was strategically planned to maximize the response  rate, taking advantage of the popularity and reach of this application among university students.  2.5.   Data analysis  Data collection was carried out through an online survey distributed via institutional email and  academic platforms. The survey responses were recorded and analyzed using descriptive  statistics, including frequency distributions, means, and standard deviat ions. The collected data  were processed using SPSS version 26.  2.6.   Ethical aspects  Before initiating the study, permission was obtained from the Universidad Peruana Los Andes,  ensuring institutional conformity with the research. Prior to the application of the survey,  participants were asked to   provide informed consent virtually, in which the purpose of the study,  the intended use of the information collected and their rights as participants were explained  clearly and in detail, including their freedom to withdraw their participation at any time   without  negative consequences.  At all times, the protection of the confidentiality of respondents\' personal data was guaranteed. To  this end, specific measures were implemented, such as the use of anonymous identifiers and  encryption of information, minimizing the risk of unauthorized d isclosure. In addition, a strict  commitment was maintained with the regulations and guidelines established in the Code of Ethics  for Scientific Research of the Universidad Peruana Los Andes, which ensured respect for the  integrity of the participants and t ransparency in all phases of the study.  Compliance with these ethical principles was essential to preserve the confidence of the  participants and ensure the validity and reliability of the data obtained. Likewise, specific  protocols were established for the management of any ethical situation th at might arise during the  development of the research, ensuring a safe and respectful environment for all those involved .  3.   RESULTS  The results of this study show that the majority of medical students at a private university in  Huancayo are in the planning phase of their research, being mostly adolescents and with a slightly  higher   female   representation.   The   nature   of   the   studies   they   conduct   is   predominantly\nRuiz - Aquino   et al.  6   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  observational, retrospective, cross - sectional and descriptive, indicating a basic approach to  information collection and analysis. In addition, it is observed that, although the students have  access to appropriate technological devices and Internet service s, their level of mastery in the use  of specific technologies for research is mostly basic or intermediate   (Table 3) .  The study found that 44.95% of students had a basic level of technological proficiency, 45.87%  demonstrated an intermediate level, and only 8.26% possessed an advanced level   (Table 4) .  Information search, database, and presentation technologies were the most used, with tools such  as PubMed and Scielo standing out. However, limited use of advanced tools for academic integrity  and reference management was observed, indicating areas for i mprovement in the management  of essential technologies for research .  Table 3.   Dimensions of the use of technologies in the service of research by medical students  Dimensions  N=109  Usage   Leve lof use  Yes   No   Basic   Intermedia  te   Advanced  fi   %   fi   %   fi   %   fi   %   fi   %  Information search  technology   109   100   -   -   47   43.12   54   49.54   8   7.34  Database technology   107   98.17   2   1.83   48   44.04   52   47.70   9   8.26  Data processing  technologies   109   100   -   -   43   39.45   50   45.87   16   14.68  Writing technologies   106   97.25   3   2.75   51   46.79   50   45.87   8   7.34  Presentation  technologies   109   100   -   -   40   36.7   52   47.71   17   15.6  Academic integrity  technologies   92   84.4   17   15.6   52   47.71   50   45.87   7   6.42  Reference manager  technology   91   83.49   18   16.51   55   50.46   45   41.28   10   9.17  Table 4.   Use of technologies in the service of research by medical students  Level of technology use   N=109  fi   %  I do not use   1   0.92  Basic   49   44.95  Intermediate   50   45.87  Moving forward   9   8.26  These results coincide with the findings of Salguero Alcala et al. (2024), who found that 27% of  the students evaluated had a low level of digital competencies, similar to the finding of 44.95% at  the basic level. However, unlike studies such as those of N avarrete Enrí quez et al. (2024), which  identified 73% of students with high digital competencies, the present study reveals a significant  gap in the advanced use of technologies, which underlines the need for specific training  interventions.  Likewise, Alamo   &   Montenegro (2022) reported that nursing professionals possess basic  knowledge and skills in ICT, aligning with the finding of a high percentage of students with basic  and intermediate levels in the use of technologies. This limited level of competence cou ld be  associated with the lack of specific training in the management of advanced tools, such as reference  managers and academic integrity tools, crucial for the quality of scientific research (Licona &  Veitya, 2019).\nRuiz - Aquino   et al.  7   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  On the other hand, Llanos de Tarazona (2019) demonstrated that an effective integration of ICTs  in   university   education   improves   students\'   research   competencies,   which   highlights   the  importance of strengthening these skills in the context of the present re search. In addition, Gomez  (2019) found that access to technologies does not necessarily translate into effective use for  academic purposes, corroborating that, despite the high availability of devices and internet among  participants, the use of advanced t ools is still deficient.  In line with the studies of Mendoza   &   Placencia (2018), who pointed out that the use of ICT in  teaching requires adequate teacher training, the results suggest that current pedagogical  strategies may not be sufficiently focused on the development of advanced technological  competencies among st udents. This is especially relevant in times of infodemic, where the ability  to manage and critically evaluate information is fundamental for academic research (Reyes et al.,  2020).  In addition, Martinez   &   Flores (2021) highlighted that during the pandemic, virtual training has  exacerbated inequalities in access to and use of technologies, which may be reflected in the varied  technological competence observed in the sample. The lack of advanced skills in res earch  technologies may limit the effectiveness and quality of research projects developed by medical  students.  Cerda et al. (2017) found that the use of digital technologies is positively related to academic  achievement in student teachers, suggesting that greater technological competence could improve  academic performance in health careers such as medicine. Howeve r, Martínez Perez et al. (2023)  observed that excessive use of social networks, such as Facebook, can negatively affect academic  performance, underscoring the need to balance the use of technologies for recreational and  academic purposes.  Aleman   &   Ynojosa (2024) warn about the threats and disadvantages of ICT use in academic  training, suggesting that ICTs have not been adequately exploited due to a lack of technological  skills or insufficient methodological information. Mendoza (2024) also points o ut that 67% of  students experienced problems related to the management and mastery of virtual platforms,  which could be linked to a lack of training in these areas.  In this context, the results reveal the need to strengthen the technological training of students,  integrating a progressive approach that allows them to develop advanced competencies in the use  of technologies applied to research. Comparison with previous   studies suggests that the level of  technological competence of students varies considerably according to the institutional context  and the pedagogical strategies implemented, which highlights the importance of a timely  educational intervention to close th is gap.  Finally, the integration of advanced digital competencies would not only improve the quality of  academic research, but also prepare future medical professionals to deal more effectively with the  challenges of the infodemic, characterized by the overabundan ce and variable quality of available  information (Arroyo et al., 2020).  Among the limitations of this study is the fact that the sample consisted of students from a single  private university in Huancayo, which may limit the generalizability of the findings to other  institutions or regions of the country. In addition, the scale   used to measure the use of technologies  may not have exhaustively captured all relevant dimensions in the context of academic research.\nRuiz - Aquino   et al.  8   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  The quantitative approach, on the other hand, may have restricted the exploration of qualitative  aspects that could provide a deeper understanding of students\' experiences with technologies.  Another important limitation is the use of virtual surveys, as un equal access to the internet and  the possible unfamiliarity of some students with digital platforms could have affected the accuracy  and completeness of responses, introducing bias in data collection.  It is recommended that the scope of the study be broadened to include samples of students from  different universities, both public and private, and in different regions of the country, in order to  obtain a more representative view of the use of technologie s in the service of research. In addition,  the   development   of   more   detailed   and   specific   measurement   instruments   that   can  comprehensively evaluate the use of technologies in academic contexts is suggested. It would also  be valuable to incorporate qualitati ve approaches to explore perceptions, motivations and barriers  faced by students when using technological tools in their research. Finally, it is recommended to  design and implement continuous training programs aimed at improving students\' technological  co mpetencies, especially in the use of reference managers and academic integrity tools  CONCLUSIONS  Most medical students at a private university in Huancayo reach basic or intermediate levels in  using technological tools for research. Despite having access to internet devices and services, there  is limited use of advanced and specific tools such as refe rence managers and academic integrity.  These findings underline the need to implement training strategies focused on improving the  mastery of critical technologies for academic research, which will allow us to face more effectively  the information overload   in the infodemic era .  FINANCI NG  The authors did not receive sponsorship to carry out this study - article .  CONFLICT OF INTEREST  The authors declare that they have no conflicts of interest related to the development of the  study .  AVAILABILITY OF DEPOSITED DATA  The datasets collected during this study and supporting the findings of the study are available at:  https://data.mendeley.com/datasets/w9znxg38bw/1  AUTHORSHIP CONTRIBUTION  Conceptualization;   Data   Curation;   Formal   Analysis;   Research;   Methodology;   Visualization;  Validation; Writing   -   original draft; Writing   -   revision and editing:   Ruiz - Aquino, M., Osorio -  Llancachagua, A. L., Botiquí n - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A., and Duran -  Aquino, R. C.\nRuiz - Aquino   et al.  9   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  REFERENC ES  Alamo , E., & Montenegro, R. (2022). Competencias en la tecnologí a de informacion y  comunicacion del profesional de enfermerí a en instituciones del primer nivel de atencion  Chiclayo, 2020.   ACC CIETNA:   Revista De La Escuela De Enfermería , 9(1), 18 – 28.  https://doi.org/10.35383/cietna.v9i1.592  Aleman , O., & Ynojosa, Y. (2024). Desafí os frente al uso de las tics en pandemia en el programa de  enfermerí a de la UNEFM.   Aula Virtual , 5(11), 151 – 169.  https://doi.org/10.5281/zenodo.10465778  Al - Hail, M., Zguir, M. F., & Koç, M. (2023).   University students’ and educators’ perceptions on the  use of digital and social media platforms: A sentiment analysis and a multi - country review.  IScience , 26(8), 107322.   https://doi.org/10.1016/j.isci.2023.107322  Almufarreh , A., & Arshad, M. (2023). Promising Emerging Technologies for Teaching and  Learning: Recent Developments and Future Challenges.   Sustainability , 15(8), 6917.  https://doi.org/10.3390/su15086917  Arbelaez, M. (2014). Las tecnologí as de la informacion y la comunicacion (TIC) un instrumento  para la investigacion.   Investigaciones Andinas , 16(29), 997 – 1000.  https://revia.areandina.edu.co/index.php/IA/article/view/52  Arroyo, A., Cabrejo, J., & Cruzado, M. (2020). Infodemia, la otra pandemia durante la enfermedad  por coronavirus 2019.   Anales de la Facultad de Medicina , 81(2), 230 – 233.  http://dx.doi.org/10.15381/anales.v81i2.17793  Campos Cruz, H., & Ramí rez Sanchez, M. Y. (2018). Las TIC en los procesos educativos de un  centro publico de investigacion.   Apertura,   10(1), 56 – 70.  https://doi.org/10.32870/ap.v10n1.1160  Cerda, C., Huete - Nahuel, J., Molina - Sandoval, D., Ruminot - Martel, E., & Saiz, J. (2017). Uso de  Tecnologí as Digitales y Logro Academico en Estudiantes de Pedagogí a Chilenos.   Estudios  pedagógicos (Valdivia) , 43(3), 119 – 133.   http://dx.doi.org/10.4067/S0718 -  07052017000300007  Garcí a, S., & Canton, I. (2019). Uso de tecnologí as y rendimiento academico en estudiantes  adolescentes.   Comunicar,   59, 73 - 81 .   https://doi.org/10.3916/C59 - 2019 - 07  Gomez, D. (2019). Uso de las tecnologí as de la informacion y la comunicacion por universitarios  mayas en un contexto de brecha digital en Mexico . Región y Sociedad , 31, 1 – 25.  https://doi.org/10.22198/rys2019/31/1130  Grande, M., Canon, R., & Canton, I. (2016). Tecnologias de la informacion y la comunicacion:  Evolucion del concepto y caracterí sticas.   IJERI: International Journal of Educational Research  and Innovation , (6), 218 – 230.  https://www.upo.es/revistas/index.php/IJERI/article/view/1703  Licona, K., & Veitya, M. (2019). La Formacion en y para la investigacion y el uso de las Tecnologí as  de la Informacion y Comunicacion.   Atenas , 2(46), 64 – 78.  https://atenas.umcc.cu/index.php/atenas/article/view/343  Llanos de Tarazona, M. I. (2019). Aprendizaje de la investigacion mediante las tecnologí as de\nRuiz - Aquino   et al.  10   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  comunicacion e informacion en universitarios de Huanuco.   Revista de Salud UDH , 1(4), e48.  https://doi.org/10.37711/rpcs.2019.1.4.48  Martínez   Perez , E., Martínez   Sandoval , M., & Hernandez   Nava, N.   (2023). El uso de Facebook en  alumnos auxiliares de enfermerí a de una institucion publica de Queretaro.   LATAM Revista  Latinoamericana De Ciencias Sociales y Humanidades , 4(1), 2829 – 2840.  https://doi.org/10.56712/latam.v4i1.457  Martínez, N., & Flores, S. (2021). Uso de nuevas tecnologí as en tiempos de pandemia en la  formacion de los estudiantes de enfermerí a de la universidad tecnica de Ambato.   Enfermería  Investiga , 6(4), 19 – 29.  https://revistas.uta.edu.ec/erevista/index.php/enfi/article/view/1200  Mendoza, H., & Placencia, M. (2018). Uso docente de las tecnologí as de la informacion y  comunicacion como material didactico en Medicina Humana.   Investigación en Educación  Médica , 7(26), 54 – 62.   https://doi.org/10.1016/j.riem.2017.04.005  Navarrete Enrí quez, R. M., Remache Cachimuel, J. T., & Reyes, V. M. (2024). Uso de herramientas  digitales y rendimiento academico en estudiantes de enfermerí a: un estudio de caso en un  Instituto Tecnologico.   Prohominum , 6(2), 227 – 242.  https://doi.org/10.47606/ACVEN/PH0245  Reyes, M. C., Garcí a, E. J., Díaz, O. M., & Sanchez, I. (2020). Preparacion cientí fica en enfermeras de  la atencion primaria de salud.   Edumecentro , 12(3), 149 – 162.  https://pensamientoeducativo.uc.cl/index.php/RHE/article/view/58323  Salguero Alcala, G. K., Benites Zuniga, J. L., Salguero Alcala, A. G., Orosco Leon, O. E., Orosco  Toribio, E. G., & Vega Vilca, C. S. (2024). Competencias digitales y rendimiento academico en  los estudiantes universitarios. Horizontes . Revista De Investigación En Ciencias De La  Educación , 8(32), 164.   https://doi.org/10.33996/revistahorizontes.v8i32.713',0.14138832787671654,'[\"\\\"scale\", \"%\", \"&\", \"(\", \"(15\"]','2025-11-29 17:05:29.887207'),(63,3,'30  Int. J. Morphol., 40(1) :30-36, 2022.  Laboratorios   Tradicionales   versus   Nuevas   Tecnologías   para   el Estudio   de   Anatomía   Humana   en   Estudiantes   de   Medicina: Revisión   Sistemática   y   Meta   Análisis Traditional   Laboratories   versus   New   Technologies   for   the   Study   of   Human Anatomy   in   Medical   Students:   A   Systematic   Review   and   Meta-Analysis Bernal-García Martha 1 ; Quemba Mesa Monica   2 ; Silva Ortiz Sara   1   & Pacheco-Olmos Blanka   1 BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecno- logías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.  RESUMEN:   El estudio de la anatomía humana, ha transcendido con diversos recursos y escenarios. El objetivo fue compararlos estudios publicados sobre prácticas de laboratorio tradicionales con nuevas tecnologías para el estudio del cuerpo humano en estudiantes de medicina. Se realizó revisión sistemática y meta-análisis. Cuatro revisores efectuaron búsqueda sistemática y exhaustiva de la litera- tura, a partir de la localización y selección de 54 estudios primarios publicados en diez bases de datos, tres revisores cegados evaluaron calidad metodológica de 33 estudios, con listas de chequeo para la evaluación crítica de la validez interna, según tipo de estudio y el cuarto revisor cegado, calculó grado de acuerdo entre revisores con Kappa de Fleiss y valoró riesgo de sesgo, sensibilidad, heterogenei- dad y análisis combinado a través del Software RevMan 5.4. Se obtuvo revisión sistemática cualitativa y combinación mediante métodos estadísticos de los resultados con meta-análisis de siete estudios primarios, con muestra de 465 participantes, 260 expuestos a laborato- rios tradicionales y 205 a nuevas tecnologías. Encontrando satisfacción del proceso y resultados positivos de aprendizaje comprensión y aplicación con favorabilidad inicial a las prácticas tradicionales no significativa al valorar los intervalos de confianza. Así, el contraste entre métodos para estas prácticas reveló desenlaces relacionados con reacciones físico-emocionales, focalización en el constructo rendimiento académico ycon los procesos de aprendizaje. Concluyendo que los laboratorios con nuevas tecnologías para estudio de anatomía, no impactan en forma prerrogativa a los estudiantes, dada su experiencia favorable con los laboratorios tradicionales, y pueden emplearse como una estrategia útil complementaria.  PALABRAS CLAVE: Anatomía; Realidad virtual; Cadáver; Estudiantes de medicina; Revisión sistemática. INTRODUCCIÓN  La anatomía humana es un pilar básico dentro del amplio y complejo campo de la medicina (Romero Reverón, 2010), que requiere fundamentalmente desarrollarse en medio de diversas prácticas en el contexto de los laborato- rios, constituyéndose en estrategias de enseñanza de esta asignatura, en las que se tienen variados recursos y didácticas, como enfoques de las prácticas médicas inicia- les que sin duda han revelado evolución y cambio en sus perspectivas. Así, en estas prácticas, el método más anti- guo de enseñanza es la disección, como eje motivante y beneficioso para los estudiantes en su deseo de estudiar y conocer las estructuras macroscópicas del cuerpo humano. No obstante, en la actualidad, la consecución de cadáveres para la enseñanza es limitada, lo que ha llevado esta activi- dad a los escenarios de formación remota y virtual, la cuál ha sido acentuada drásticamente en el tiempo que se vive hoy debido a la Pandemia del Covid- 19, responsable de una importante crisis educativa a nivel mundial con gran impacto en la formación médica, en la que la educación virtual es metódicamente la modalidad de enseñanza. Sin embargo, la comprensión temática de la Anatomía Huma- na sin prácticas y disecciones u otros apoyos didácticos tradicionales, así como la percepción de lo real, la orienta- ción espacial y visualización de relaciones anatómicas es desafiante y genera debates sobre   la didáctica ideal para su enseñanza (Singal   et al ., 2020). 1   Programa de Medicina, Facultad de Ciencias de la Salud, Universidad de Boyacá, Tunja, Colombia. 2   Programa de Enfermería, Facultad de Ciencias de la Salud, Universidad de Boyacá, Tunja, Colombia. Received: 2021-07-01   Accepted: 2021-11-23\n31  Las investigaciones indican que la formación de es- tudiantes en medicina del siglo XXI, disfrutan aprendiendo anatomía con la ayuda de la tecnología y mejora las expe- riencias de aprendizaje (Baratz   et al ., 2019), también se ha demostrado que la visualización tridimensional (3D) bene- ficia a las nuevas generaciones de estudiantes de medicina y médicos en formación en una variedad de contextos (Weeks  et al ., 2021), aunque fuese implementada desde 1993 (Ng   et al ., 2015), su uso y modernización se ha fortalecido. Asi- mismo, se ha afirmado que las prácticas tradicionales de anatomía en el anfiteatro, son significativas, porque en es- tas el estudiante interactúa directamente en su contexto con los especímenes humanos y cadáveres, optimiza la compren- sión para su proceso de aprendizaje, porque es considerado el primer escenario para enfrentar la realidad de la vida y la muerte, así como entender la responsabilidad de cuidar al ser humano, aspectos de gran relación con el perfil profe- sional de la carrera de medicina. Las diversas reacciones físicas y emocionales derivadas de las experiencias en estas prácticas, y el aprendizaje de la relación con otros indivi- duos son necesarios para el establecimiento de la empatía (Jagua Gualdrón & Urrego Mendoza, 2011). En consecuencia, la presente revisión sistemática de la literatura planteó la siguiente pregunta de revisión: ¿Di- fieren las prácticas de laboratorio de anatomía humana tra- dicionales con las nuevas tecnologías para el estudio de la de anatomía humana?, y formuló como objetivo comparar los estudios publicados sobre las prácticas del laboratorio de anatomía tradicionales con nuevas tecnologías, para el estudio del cuerpo humano en estudiantes de medicina.  MATERIAL Y MÉTODO  Esta revisión sistemática, cuenta con registro en PROSPERO CRD42021240280 (Bernal-García   et al ., 2021), coherente con la declaración PRISMA. Ejecutó búsqueda del 01 noviembre 2020 al 31 mayo 2021, estableciendo es- trategia con estructura de pregunta PICO: P: Hombres y mujeres Estudiantes de anatomía o morfolo- gía humana (y sus otras designaciones) en la carrera de medicina. I: Prácticas del laboratorio de anatomía tradicionales: mo- delos anatómicos y disección. C: Prácticas con nuevas tecnologías para el estudio del cuerpo humano (herramientas tecnológicas, tercera dimensión, cuarta dimensión, softwares interactivos, plastinación digitalizada, multimedia). O: Principal: Percepciones físico- emocionales de estudian- tes en los laboratorios tradicionales   versus   nuevas tecno- logías en el aprendizaje de la anatomía humana. Secundario:Rendimiento académico - procesos de aprendi- zaje de la anatomía humana tradicionales con las nuevas tecnologías para el estudio de la de anatomía humana.  Estrategia de búsqueda y selección de estudios:   Cuatro revisores indepen- dientes ejecutaron búsqueda de estu- dios observacionales, experimentales y cuasi- experimentales, en idioma in- glés y español, a través de las bases de datos electrónicas WOS, Scopus, Pubmed, Springer, Science direct, LILACS,   Clinical   Key,   Sage, Proquest, Scielo, con términos de bús- queda validados en Mesh y DeCS como:   anatomy,   virtual   reality, cadaver, models anatomic, dimensio- nal anatomy, anxiety, psychological distress, multimedia, medical students; agrupados con conectores booleanos en combinaciones especificas según base de datos, proceso compendiado en el diagrama de flujo presentado en la Figura 1. Fig. 1 Diagrama de flujo de la selección de estudios  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n32  Extracción de datos y evaluación de la calidad metodológica.   Tres revisores diligenciaron matriz de alma- cenamiento Excel, con datos como título, año, lugar, idio- ma, resumen, tipo de estudio, intervención y comparador, número de participantes, medidas de efecto de los desenla- ces. Asimismo, evaluaron cegadamente la calidad metodológica de los estudios según número de conceptos de las listas de chequeo para la evaluación crítica de la vali- dez interna de estudios experimentales y cuasi-experimen- tales, respectivamente: Quality Assessment of Controlled Intervention Studies y Quality Assessment Tool for Before- After (Pre-Post) Studies With No Control Group (NHLBI) (National Heart, Lung and Blood Institute, 2021). Un cuar- to revisor cegado calculó grado de acuerdo entre revisores con coeficiente kappa Fleiss en Software Stata 14. Poste- riormente, se valoraron los riesgos de sesgo de los estudios experimentales, sensibilidad y heterogeneidad, además de análisis combinado a través del Software RevMan 5.4, en donde las medidas de efecto estaban disponibles.  RESULTADOS  Del número total de estudios identificados (n=54), 21 fueron elegidos y valorados en calidad metodológica por 3 evaluadores independientes, se descartaron los de medida de concordancia menor a 0,61 según coeficiente Kappa de Fleiss y puntaje de evaluación de calidad menor al 60 % de cumplimiento en los criterios asignados en las listas de che- queo aplicadas, así como aquellos con datos incompletos evitando el sesgo de desgaste; en esta fase se eliminaron 14 estudios, quedando 7 estudios incluidos para la presente re- visión sistemática, informados en idioma inglés, con año de publicación entre 2018 a 2020, procedentes de 6 países y que fueron sometidos a metaan álisis, en consideración al cumplimiento de las variables moderadoras, con un total de muestra de 465 participantes, 260 expuestos a laboratorios tradicionales y 205 a nuevas tecnologías, estudios sobre los cuales se detalla la caracterización y desenlaces en la Tabla I. Fue posible hacer análisis combinado para 6 de los estudios incluidos, 5 experimentales, y uno cuasi-experimen- tal, al comparar las prácticas tradicionales con las nuevas tecnologías en los desenlaces comunes: puntaje pos-test, sa- tisfacción y resultados positivos de aprendizaje; las medi- das estadísticas de referencia fueron los estimadores dife- rencia de medias estandarizadas y RR, con intervalos de confianza al 95 % y valores de significancia con p menores a 0,05; se desarrolló el análisis de sensibilidad valorando el rendimiento estadístico de diferentes escenarios de análisis combinado, garantizando que la forma en como los desen-  Principales desenlaces Autores, año y p aís Diseño   Grupos Control (GC) e Intervención (GI), muestra (n) y tipo de práctica Reacciones físico emocionales Rendim iento académico Procesos de aprendizaje Mitrousias V,   et al . (2018). Grecia Cuasi- experimental GC (Prosección): n: 43 GI (Software 3D): n: 42 GC: Estrés (15 %) GC Y GI: Entusiasmo GC: 48 ± 16.1 GI: 55,88 ± 19,60 Utilidad   para   habilidades clínicas: GC: 29 (67,5 %); GI: 33 (78,12 %) Satisfacción: GC: 32 (75 %) ; GI: 2 9 (85,75 %) Ekstrand C,   et al . (2018). Canadá Experimental   GC (basado en papel): n:33 GI (Realidad virtual): n:31 Disminución del miedo: GC: 5 (12 %) ; GI: 25 (81 %) Test Group: F: 0,8203 (p=0,5) Satisfacción:   GC:   11   (33%) GI: 2 9 (94%) Casallas A,   et al ., (2018). Colombia Experimental   GC (tradicional) n:40 GI (software 3D Heart- tom) n: 40 NR   Calificaciones teóricas: GC: 3,6; GI: 4,3 Desempeño practico: GC: 2,5; GI: 2,75 Baratz G,   et a l . (2019). Estados Unidos Experimental   GC (disección cadavérica): n:7 GI (tabla Anatomage): n:7 Comodidad: GC: 2,27 (DE: 1,.07); GI: 2,37 (DE: 1,12) Puntuación del examen: GC: 70,8 (DE: 10,6); GI: 74,9 (DE: 6,5) Preparación:   GC:   2,19   (DE: 1,13); GI: 2,38 (DE: 1,10) Grado   de   aprendizaje:   GC: 2,99   (DE:   1,06);   GI:   3,68 (DE: 0,94) Sultan L,   et al ., (2019). Arabia Saudita Experimental   GC (Convencional): n: 112 GI (Realidad virtual): n: 57 Educación positiva: 8,8 sobre 10. Post-test: GC: 15,9 (DE: 2,9) / GI: 17,4 (DE: 2,1) Puntuación ECOE GC: 12,9 / GI: 9,8 Desempeño   examen   clínico: GC: 9,8 (DE: 4,2) / GI: 12,9 (DE: 4,1) Boscolo _ Berto, RB,   et al.,  (2020). Italia Experimental   GC (Libros de texto): n: 10 GI (disección virtual): n:13 NR   Post-test: GC: 10,6 (DE:2.9) GI: 11,3 (DE:3.7) GC:   Enfoque   fundamental para   el   aprendizaje   de l   a anatomía GI:   Beneficios   para   el aprendizaje (70 %) Weeks JK,   et al.  (2020). Estados Unidos Experimental   GC (pantallas 2D): n:15 GI (realidad aumentada 3D): n:15 NR   Post-test GC: 4 GI: 4,73 Comprensión percib ida: GC: 3,21, DE 0,80 GI: 3 ,07, DE 0,80  Tabla I. Caracterización de estudios.  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n33  laces se midieron fuera equiparable. En la Figura 2 se evi- dencia la valoración del riesgo de sesgo, hallando bajo ries- go de sesgos de reporte incompleto y notificación selectiva, y un riesgo alto de sesgo en el ocultamiento de la asigna- ción, el cegamiento de los participantes, de los investigado- res y de los evaluadores de los desenlaces. En los análisis combinados que permitieron compa- rar las prácticas tradicionales   versus   las nuevas tecnologías, se obtuvo para los puntajes post test, favorabilidad signifi- cativa en las prácticas tradicionales (DE: 0,49; IC: 0,24 a 0,73), con un I   2   de 0 % indicativo de baja heterogeneidad y un Chi 2   con un valor p de 0,87 que sugiere que los estudios presentan el mismo efecto. En la satisfacción ante el proce- so de aprendizaje se presentó una favorabilidad inicial a las prácticas tradicionales no significativa al valorar los inter- valos de confianza (RR: 1,59; IC: 0,50 a 4,98) y un I   2   de 94 % indicativo de una alta heterogeneidad y un Chi 2   con un valor p de 0,0001 que implica que los diferentes estudios no representan el mismo efecto. En tanto que, para los resulta- dos positivos de aprendizaje -comprensión y aplicación- muestra una favorabilidad inicial a las prácticas tradiciona- les no significativa al valorar los intervalos de confianza (DE: 0,43; IC: -0,18 a 1.05), con un I   2   de 61 % indicativo de alta heterogeneidad y un Chi 2   con un valor p de 0,08 que sugiere que los estudios presentan el mismo efecto. Bajo la prueba de Funnel Plot los estudios incluidos siguen la dis- tribución de embudo invertido, indicativo de bajo sesgo de publicación, resultados que se presentan en la Tabla II.  Fig. 2. Resumen de riesgo de sesgo.  Puntaje Post test  Satisfacció n ante el proceso de aprendizaje  Resultados positivos de aprendizaje -comprensión y aplicación-  Tabla II. Forests Plots análisis combinado.  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n34  DISCUSIÓN  Los resultados de la presente revisión, han permiti- do sintetizar la evidencia científica disponible sobre la pre- gunta de investigación que muestran cuantitativamente uti- lización de las prácticas tradicionales como la disección o uso de prosecciones cadavéricas y otras que admiten me- jor cercanía e interacción con pares y con docentes; aun así, el uso de las nuevas tecnologías 3D para el estudio del cuerpo humano, como el software 3D BioDigital Human, mesa Anatomage y otros recursos de disección virtual, se encuentran en progreso a lo largo de las últimas décadas, todavía bajo la perspectiva de innovación. No obstante, puede evidenciarse que en el contraste entre métodos di- fiere la parte cualitativa, según percepciones de los estu- diantes, en las que determinan que la tecnología no susti- tuye las prácticas en el anfiteatro, concordando con Bork,  et al . (2019), quienes refieren la tecnología como valiosa adición para mejorar los cursos de disección, más no como un reemplazo. Como desenlaces, en los estudios analizados, fue- ron evidentes algunas reacciones físico emocionales en los estudiantes, de manera variable y poco descriptiva. En ese sentido, el estudio de Mitrousias   et al . (2018), reportan quela modalidad de enseñanza no tuvo efecto sobre la ac- titud de los estudiantes, sin embargo,el 15 % de los estu- diantes en el grupo de prosección percibieron estrés / ma- lestar severo antes del laboratorio, en comparación con el 0 % de los estudiantes que utilizan software 3D, y la sen- sación de estrés / incomodidad permaneció en el 5 % de los estudiantes que estaban usando prosección incluso des- pués del final de los laboratorios, en contraste con los es- tudiantes que usan 3D, que no mencionaron estos senti- mientos en absoluto (p = 0.03), además independiente de la modalidad los estudiantes manifestaron entusiasmo. Asimismo, Ekstrand   et al . (2018) obtienen disminución de la neurofobia después de enfrentar los contenidos y su complejidad, en el aprendizaje con realidad virtual inversiva e interactiva dado que consigue ayudar a mejo- rar la obtención y retención de conocimientos, así como a aumentar la motivación para estudiar y disminuir el mie- do a la práctica. Es más, Casallas & Quijano (2018) en- cuentran mayor satisfacción post intervención, como sen- timiento de placer en el grupo GI que utilizó la herramien- ta 3D, y de manera similar, Baratz   et al ., mencionan la sensación de comodidad, interpretada como una caracte- rística física emocional y/o la realización de la acción sin esfuerzo. En cambio, Sultan   et al . (2019) encontraron que las sesiones de realidad virtual de 360   °   del estudio, per- mitieron a los estudiantes usar experiencialmente sus sen- tidos para ver, oír y sentir. Además, estos estudios examinados, contrastan as- pectos coherentes con la focalización en el constructo ren- dimiento académico, para lo cual se evidencian diversidad de instrumentos y mediciones relacionadas principalmen- te con los procesos de aprendizaje. En el estudio de Mitrousias   et al ., evalúan a ambos grupos con un examen final de cien preguntas idénticas de alta complejidad, la mitad de estas para identificar estructuras anatómicas en imágenes proyectadas y evaluar el conocimiento espacial, y la otra mitad, con preguntas simples de opción múltiple, diseñadas para abordar el nivel más bajo de objetivos cognitivos en la taxonomía de Bloom. A los estudiantes del grupo 3D se les pidió identificar estructuras 3D y cadavéricas y viceversa. Utilizaron además un cuestiona- rio anónimo original de 15 preguntas, para evaluar las se- siones de aprendizaje, el tutor y el método implementado, en las que no encontraron diferencias significativas entre hombres y mujeres, con respecto al rendimiento en total, no obstante, con uno de los métodos empleados notaron que los estudiantes que juegan videojuegos obtuvieron mejores calificaciones, en comparación con los estudian- tes que no los juegan. Ekstrand   et al . reportan que tanto para la prueba inicial como la posterior a la intervención, estructuraron 13 preguntas relacionadas con los materiales de estudio y 9 preguntas de control sobre el contenido de neuroanatomía no disponible en los materiales de estudio, y se pidió a los participantes abstenerse de estudiar neuroanatomía entre las 2 pruebas. No obstante, recono- cen como limitación, el corto período de seguimiento (5-9 días) el número limitado de preguntas para investigar la retención de conocimientos. De la misma forma, Casallas & Quijano analizan pruebas teóricas y prácticas, sin sesgos en su calificación, encontrando que los estudiantes del GI tuvieron mejor des- empeño académico en la prueba teórica que el grupo GC.Estimando un resultado favorable en el grupo que uti- lizó la herramienta 3D, que fue 14 % superior al resultado del grupo que no la utilizó. Y en las pruebas prácticas, los estudiantes del GC lograron calificaciones por debajo de las notas mínimas obtenidas por los del GI, evidenciando un mejor desempeño en este último. Sin embargo, aunque se   encontró   una   puntuación   más   alta,   no   fue estadísticamente significativa. De otra parte, los estudian- tes participantes coincidieron en que la herramienta 3D facilita el aprendizaje de la anatomía cardíaca y mejora el rendimiento académico teórico debido a la interactividad que les permite. Igualmente, Baratz   et al ., reportaron que no hubo diferencia significativa en el rendimiento de exá- menes prácticos sumativos entre grupos (Anatomage vs disección cadavérica). Además, Sultan   et al . encontraron que los estudiantes del GI (tecnología de realidad virtual de 360   ° ) obtuvieron una puntuación media más alta tanto  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n35  en la retención de conocimientos como en la adquisición de habilidades en comparación con el GC (Tradicional), demostrando que el aprendizaje experiencial es una teoría adecuada. Incluso, Boscolo-Berto   et al . (2021) indican que los estudiantes que aplicaron a una disección virtual dirigi- da tenían tres veces más probabilidades de reportar un re- sultado positivo (aprobado / positivo) en la prueba poste- rior a la disección que aquellos que aplicaron a los libros de texto de anatomía topográfica. Igualmente, Weeks   et al . demostraron un rendimiento significativamente superior en preguntas de anatomía al estilo National Board of Medical Examiners (NBME) en estudiantes que usan 3D y realidad aumentada para el aprendizaje en comparación con los es- tudiantes que usan una pantalla de computadora 2D, ha- llazgos que proporcionan evidencia con la implementación de una técnica mixta, sin embargo, dado el breve tiempo para completar la sesión educativa, los resultados refleja- ron un recuerdo a corto plazo en lugar de la adquisición de conocimientos a largo plazo. Todo ello, permite diferenciar otro desenlace rela- cionado con los procesos de aprendizaje, por parte de los estudiantes, de los que, Ekstrand   et al . proporcionan evi- dencia de que ambos métodos fueron de aprendizaje exito- so, resaltando que, la integración de la tecnología de reali- dad virtual en la educación médica puede beneficiar mo- delos de aprendizaje \"autodidactas\", ya que los estudiantes experimentan mayor motivación para estudiar y existe una curva de aprendizaje inherente al aprender una nueva tec- nología. Casallas & Quijano determinan que el uso del render, como herramienta cognitiva, facilita el aprendizaje de la anatomía cardíaca humana. Sin embargo, Baratz   et al ., sugieren que el aprendizaje percibido inmediatamente después de intervención con la tabla Anatomage es eficaz para la retención de información a corto plazo para solo un subconjunto de regiones anatómicas (anatomía musculo- esquelética) y alcanza una modalidad de aprendizaje equi- valente a la disección cadavérica dado que los estudiantes disfrutan la tecnología para complementar el aprendizaje, en anatomía macroscópica. Por su parte, Sultan   et al . ma- nifiestan que la realidad virtual en el contexto de la educa- ción médica es una solución innovadora, rentable y eficaz para una formación práctica mejor y más rápida, por lo que ayudaría a los estudiantes a desarrollar una compren- sión directa y significativa de los objetivos de aprendizaje. Además, Boscolo-Berto   et al ., reportan que el 70 % de los estudiantes GI con disección virtual expresaron beneficio para su aprendizaje, en las perspectivas tridimensionales, y como experiencia más atractiva que estudiar libros de texto y atlas.Sin embargo, reportaron dificultades y quejas por la ralentización de la mesa, imágenes con detalles defi- cientes con el zoom, limitaciones a la manipulación prede- terminada y la restricción de la interacción a una persona.De todos modos, reconoció la utilidad preliminar de la disec- ción virtual para su posterior aplicación a la disección cadavérica tradicional, como una combinación que mejora significativamentelos resultados de aprendizaje de los es- tudiantes. Además, Weeks   et al . evidencian mayor control del estudiante y motivación personal en el material de apren- dizaje dado un entorno interactivo con visualización tridimensional (3D), y Mitrousias   et al . resaltaron el per- feccionamiento de habilidades clínicas y comprensión en la ubicación de estructuras anatómicas Así y todo, las estrategias tradicionales proporcio- nan la comprensión anatómica profunda, el reconocimien- to de las estructuras corporales y la consecuente consoli- dación de los conocimientos en el área (Mompeó-Corre- dera, 2014), es ineludible garantizar que estas no sean del todo reemplazadas por las nuevas tecnologías, sino que más bien sean combinadas, para poder enfrentar asertivamente los contextos actuales, en los cuales la enseñanza y el apren- dizaje de la anatomía tiene grandes retos a ser superados, entre los cuales está la desintegración entre las ciencias básicas y las ciencias clínicas (Alzate-Mejía & Tamayo- Alzate, 2019). Finalmente, conexo a las limitaciones de esta revisión sistemática, principalmente se consideran hacia el tamaño muestral,   denotando   que   los   problemas   de   diseño metodológico repercutenpara el abordaje de la validez de los resultados. Así mismo,algunos de los estudios consultados no se incluyeron en esta revisión, por no presentar un grupo control o por las incomparables medidas o variables utiliza- das demostrando bajos niveles de fiabilidad o validez.  CONCLUSIÓN  En los estudiantes que realizaron laboratorios con nuevas tecnologías no impacta en forma prerrogativa el estudio de anatomía humana, dado que por lo general se relacionan con las experiencias favorables que han tenido con los laboratorios tradicionales, sin importar su frecuen- cia, son trascendentales y relativos al contexto de aprendi- zaje. Ultimando que las nuevas tecnologías pueden em- plearse como una estrategia útil complementaria. En definitiva, el número de estudios incluidos per- mite, además, inferir que existen pocas investigaciones con adecuada calidad metodológica, por lo que se propone la realización de más proyectos y trabajos experimentales que involucren un mayor enfoque metodológico en torno a esta temática. Así mismo, ampliar la revisión sistemática en otros idiomas.  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n36  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Traditional laboratories   versus   new technologies for the study of human anatomy in medical students: A systematic review and meta-analysis.   Int. J. Morphol., 40(1) :30- 36, 2022.  SUMMARY:   The study of human anatomy has transcended with various resources and scenarios. The objective was to compare published studies on traditional laboratory practices with new technologies for the study of the human body in medical students.   A systematic review and meta-analysis were carried out. Four reviewers carried out a systematic and exhaustive search of the literature, based on the location and selection of 54 primary studies published in ten databases, three reviewers evaluated the methodological quality of 33 studies, with checklists for the critical evaluation of internal validity, according to type of study. The fourth blinded reviewer, calculated degree of agreement between reviewers with Kappa de Fleiss and assessed risk of bias, sensitivity, heterogeneity and combined analysis using RevMan 5.4.   A qualitative systematic review and combination by statistical methods of the results were obtained with meta-analysis of seven primary studies, with a sample of 465 participants, 260 exposed to traditional laboratories and 205 to new technologies. Finding satisfaction with the process and positive results of learning, understanding and application, with initial favorability to traditional practices not significant when assessing the confidence intervals. Thus, the contrast between methods for these practices revealed outcomes related to physical-emotional reactions, focus on the academic performance construct and with the learning processes. Concluding that laboratories with new technologies for the study of anatomy do not prerogatively impact students, given their favorable experience with traditional laboratories, and can be used as a useful complementary strategy.  KEY WORDS: Anatomy; Virtual reality; Corpse; Medical students; Systematic review. REFERENCIAS BIBLIOGRÁFICAS  Alzate-Mejía, O. A. & Tamayo-Alzate, O. E. Metacognition in the learning of anatomy.   Int. J. Morphol., 37(1) :7-11, 2019. Baratz, G.; Wilson-Delfosse, A. L.; Singelyn, B. M.; Allan, K. C.; Rieth, G. E.; Ratnaparkhi, R.; Jenks, B. P.; Carlton, C.; Freeman, B. K. & Wish- Baratz, S. Evaluating the Anatomage table compared to cadaveric dissection as a learning modality for gross anatomy.   Med. Sci. Educ., 29(2) :499-506, 2019. Bernal-García, M. I.; Quemba-Mesa, M. P.; Silva-Ortiz, S. R. & Pacheco- Olmos, B. Traditional laboratories   versus   new technologies for the study of Human anatomy in medical students: A systematic review of the literature. PROSPERO, CRD42021240280, 2021. Disponible en: https:/ / w w w. c r d . y o r k . a c . u k / p r o s p e r o / d i s p l a y _ r e c o r d . p h p ? I D = CRD42021240280 Bork, F, Stratmann, L.; Enssle, S.; Eck, U.; Navab, N.; Waschke, J. & Kugelmann, D. The benefits of an augmented reality magic mirror system for integrated radiology teaching in gross anatomy.   Anat. Sci. Educ., 12(6) :585-98, 2019. Boscolo-Berto, R.; Tortorella, C.; Porzionato, A.; Stecco, C.; Picardi, E. E. E.; Macchi, V. & De Caro, R. The additional role of virtual to traditional dissection in teaching anatomy: a randomised controlled trial.   Surg. Radiol. Anat., 43(4) :469-479, 2021. Casallas, A. & Quijano, Y. 3D rendering as a tool for cardiac anatomy learning in medical students. Rev. Fac. Med. (Bogotá), 66:611-6, 2018. Ekstrand, C.; Jamal, A.; Nguyen, R.; Kudryk, A.; Mann, J. & Mendez, I. Immersive and interactive virtual reality to improve learning and retention of neuroanatomy in medical students: a randomized controlled study . CMAJ Open, 6(1) :E103-E109, 2018. Jagua Gualdrón, A. & Urrego Mendoza, D. Z. Actitudes de los estudiantes colombianos de medicina hacia la práctica de la disección en anatomía y su relación con el puntaje en la escala de empatía médica de Jefferson.  Rev. Fac. Med. (Bogotá), 59(4) :281-307, 2011. Mitrousias, V.; Varitimidis, S. E.; Hantes, M. E.; Malizos, K. N.; Arvanitis, D. L. & Zibis, A. H. Anatomy learning from prosected cadaveric specimens   versus   three-dimensional software: A comparative study of upper limb anatomy.   Ann. Anat., 218 :156-64, 2018. Mompeó-Corredera, B. Metodologías y materiales para el aprendizaje de la anatomía humana: percepciones de los estudiantes de medicina \'nativos digitales\'.   FEM Rev. Fund. Educ. Med., 17(2) :99-104, 2014. National Heart, Lung and Blood Institute. Study Quality Assessment Tools. Internet. Bethesda, National Institute of Health, 2021. Disponible en: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools Ng, C. L.; Liu, X.; Chee, S. C. J. & Ngo, R. Y. S. An innovative 3-dimensio- nal model of the epitympanum for teaching of middle ear anatomy.  Otolaryngol. Head Neck Surg., 153(5) :832-7, 2015. Romero Reverón, R. Anatomical dissection: a positive experience for venezuelan first year medical students.   Int. J. Morphol., 28(1) :213-7, 2010. Singal, A.; Bansal, A. & Chaudhary, P. Cadaver less anatomy: Darkness in the times of pandemic Covid-19.   Morphologie, 104(346) :147-50, 2020. Sultan, L.; Abuznadah, W.; Al-Jifree, H.; Khan, M. A.; Alsaywid, B. & Ashour, F. An Experimental Study On Usefulness Of Virtual Reality 360 °   In Undergraduate Medical Education.   Adv. Med. Educ. Pract., 10 :907-16, 2019. Weeks, J. K.; Pakpoor, J.; Park, B. J.; Robinson, N. J.; Rubinstein, N. A.; Prouty, S. M. & Nachiappan, A. C. Harnessing augmented reality and CT to teach first-year medical students head and neck anatomy.   Acad. Radiol., 28(6) :871-6, 2021.  Dirección para correspondencia: Martha Bernal García Carrera 2ª Este nº 64 - 196 Campus Universidad de Boyacá Sede Principal Tunja Boyacá COLOMBIA E-mail: mibernal @uniboyaca.edu.co  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.',0.1460768051750921,'[\"\\\"autodidactas\\\",\", \"%\", \"%)\", \"%);\", \"&\"]','2025-11-29 17:05:36.066561'),(64,3,'Facultad de Medicina Humana URP  ISSN Versión Online: 2308-0531  BLOCKCHAIN TECHNOLOGY APPLIED IN MEDICINE: A SYSTEMATIC REVIEW  Rev. Fac. Med. Hum. 2024; 24(1):144-161.  doi 10.25176/RFMH.v24i1.5900 Cite as: Tinoco-Plasencia CJ. Blockchain technology applied in medicine: a systematic review. Rev Fac Med Hum. 2024;24(1):144-161. http://revistas.urp.edu.pe/index.php/RFMH  1 a  DOI: 10.25176/RFMH.v24i1.5900  Palabras clave:   Blockchain; Inteligencia Arti\0cial;   Trazabilidad; Historias Médicas. (Fuente: DeCS- BIREME)  Objetivo:   Desarrollar una revisión de artículos para evaluar la evidencia sobre la tecnología blockchain aplicada en la medicina.   Métodos:   El estudio es de tipo documental, diseño bibliográ\0co, enmarcado en una revisión sistemática. La recolección de los artículos se realizó en las bases de datos Scopus, Web of Sciences, Pro Quest y SienceDirect, desde el 1 de enero de 2018 hasta el 31 de julio de 2023. Los descriptores fueron blockchain, tecnología y medicina. Se elaboró el diagrama PRISMA y se consideró los criterios de inclusión: artículos originales, con acceso abierto que aborden el tema y en cualquier idioma. Se hallaron 70 artículos, de los cuales 11 conformaron la muestra.   Resultados:   Se analizaron las diversas aplicaciones de la tecnología blockchain en la medicina, entre ellas su integración con inteligencia arti\0cial (IA) para el análisis centrado en datos; en cuanto al desarrollo de sistemas de trazabilidad, sin embargo, su mayor aplicabilidad está en el registro de historias médicas de pacientes, cuya aplicación fue exitosa. A pesar de esto, se comprobó su uso incipiente, en la medicina, debido a la ausencia de estudios al respecto.   Conclusiones:   La aplicación de la tecnología blockchain en la medicina es muy escasa, a pesar del potencial que posee para el registro y resguardo de datos médicos; por lo tanto, se debe profundizar el estudio de la misma.  RESUMEN  ABSTRACT  Objective:   Develop an articles review to evaluate the existing evidence on blockchain technology applied in medicine.   Methods:   The study was of a documentary type, bibliographic design, framed in a systematic review. The harvest of articles was carried out in the Scopus, Web of Sciences, Pro Quest and ScienceDirect databases from January 1, 2018 to July 31, 2023. The descriptors were blockchain, technology and medicine. The PRISMA diagram was prepared considering the inclusion criteria: original articles, with open access; that address the subject and in any language.   The search yielded 70 articles, of which 11 formed the sample.   Results:   The various applications of blockchain technology in medicine were discussed, including its integration with arti\0cial intelligence (AI) for data-centric analysis; regarding the development of traceability systems, however, its greatest applicability is in the registration of medical records of patients, whose application was successful. Despite this, its incipient use in medicine was veri\0ed due to the lack of studies in this regard.   Conclusions:   The application of blockchain technology in medicine is very scarce, despite the potential it has for the registration and safeguarding of medical data, therefore, its study should be deepened.  Keywords:   Blockchain; Arti\0cial Intelligence;   Traceability; Medical Records. (Source: MESH-NLM)  TECNOLOGÍA BLOCKCHAIN APLICADA EN LA MEDICINA: UNA REVISIÓN SISTEMÁTICA  Escuela de Posgrado, Universidad Ricardo Palma(URP). Lima, Perú. South America. Doctorando en Administración de Negocios Globales, URP, MBA, Ingeniero Industrial, Docente Investigador Renacyt.  1,a Christian Jairo Tinoco-Plasencia  Pág. 144\nINTRODUCTION  Indeed, the emergence of blockchain technology, as a responsible and transparent way to store and distribute information, is creating the foundation to address serious issues of privacy, security, and data integrity in  (2)  the \0eld of medicine   . In a general context, blockchain technology is a tool for the distributed ledger of digital data transactions through a peer-to-peer (P2P) network, which can be distributed publicly or privately to users, allowing for the reliable and veri\0able storage  (3,4)  of any type of information   . On the other hand, unlike other types of databases managed by third parties, blockchain is a decentralized chain of blocks, implying that no single user can control its transactions personally. Decentralization is a fundamental characteristic of blockchain, as it gives control to the system rather than the user, allowing for greater  (5,6)  transparency and security   . Given the undeniable technological advancements in the \0eld of medicine, there arises the need to incorporate blockchain technology into this area, which involves a database that allows for the collection and storage of large amounts of information that can be shared in a decentralized manner. Its growth has been substantial over the last decade. Considered as the fundamental basis of cryptocurrencies, including Bitcoin, various authors have analyzed its application in other \0elds due to its characteristics of security and privacy. In this regard, it has been used in medicine for different purposes, such as data recording, transactions,  (1)  and maintenance through smart contracts . Within this framework, the management of blockchain technology has \0ve basic principles: the \0rst is constituted in data control, which is independent; that is, no one controls the data, however, each user can verify their records; the second is communication, which only occurs between peers; the third indicates that users can remain anonymous or provide proof of their identity; the fourth principle refers to the fact that current transactions cannot be changed; \0nally, the \0fth principle indicates that each transaction is linked to  (7,8)  the previous one   . Among the challenges facing the medical industry, one of the principals is the lack of secure and reliable mechanisms for data storage and access. In this sense, blockchain technology allows information to be stored and shared in a secure and decentralized way, which restricts unauthorized individuals   from   modifying   it.   Additionally, this  (14)  Similarly, the study by Sonkamble et al.   addresses the decentralized management of patients\' medical data within the framework of blockchain-based electronic health records (EHR) to ensure con\0dentiality, access control, and record privacy. The architecture of this model was patient-centered and focused on the secure storage control of their data in EHRs. Likewise, the study by Mendoza et al. analyzes the use of blockchain to generate an algorithm that develops a smart contract for users of a medical records platform. This algorithm helps to solve the authentication and reliability issues of access to healthcare platforms. The study proposes an algorithm in which medical history management operations are executed and integrated automatically in a distributed environment. technology has the ability to track the history and authenticity of medical products, such as prescribed medicines and medical devices. This capability allows for the identi\0cation of adulterations and ensures that patients receive genuine and safe medications. In this context, blockchain provides a mechanism for pharmaceutical companies to achieve complete traceability of a medication, allowing them to reliably access production data, reported side effects, and supervision of the necessary conditions for its  (11)  transportation and storage   .  (12)  In this regard, the study by Farahat et al.   proposes the design of an IoMT (Internet of Medical Things) system to store patients\' medical information, which is remotely sent via the internet. The proposed model suggests that each medical record is stored through blockchain technology, using a block connected to the previous one by a hash function: a cryptographic operation that produces unique and irreversible identi\0ers from a  (13)  given data   . In a different context, the study by Albakri & Alqahtani proposes the development of an IoMT through an intelligent blockchain-based smart healthcare system, which employs encryption with an optimal deep learning model (BSHS-EODL). The BSHS-EODL method allows for the secure transmission of blockchain- assisted images and diagnostic models for the IoMT environment. This model combines data classi\0cation, data collection, and image encryption. Despite these evidences, there are a number of challenges associated with the use of blockchain technology for designing  Pág. 145  Blockchain Technology\nvarious approaches to achieve the ultimate goals. Blockchain-based storage and infrastructure platforms offer a new perspective in medical informatics, with  (26,27,28)  several advantages over traditional methods   . medical information networks, including patient perception towards such networks, security and privacy risks, transparency in data exchange, processing  ( 1 6 , 1 7 )  requirements, and implementation costs   . Additionally, there are inherent limitations and restrictions of blockchain technology, such as mining incentives, mining threats, key management, as well as data security and con\0dentiality; not to mention legislative constraints, the absence of laws regulating the use of blockchain technology in medicine, which generally require permissions, scalability, and  (19)  agreements for sharing records   . However, there are several examples of this model implemented in medicine,   such as   MedicalChain, One of the most relevant aspects for adopting blockchain technology in medicine is data security. In this regard, most healthcare providers and hospitals have improved their data security precautions. However, current \0rewalls for medical data can hinder medical research and collaboration in healthcare treatment. On the contrary, cloud computing and the use of big data involve sharing medical data among various users and organizations, which is necessary to enable analysis and provide more effective healthcare  (20,21,22)  services, as well as innovative treatment plans   . Indeed, with the application of blockchain, the widespread use of patients\' medical information could pose challenges in terms of processing, costs, and limited scalability. At the same time, ethical dilemmas may arise, as improper handling could compromise or infringe upon patients\' right to maintain the anonymity  (23,24,25)  of their medical history   . Considering that the security and privacy of medical data are crucial elements that must be ensured, it is essential to preserve the con\0dentiality, integrity, and authentication of the server during data transfer. The main goal is to share health data in a practical way, using Based on the foregoing considerations, the execution of the present systematic review study is proposed with the aim of evaluating the evidence on blockchain technology applied in medicine. In summary, the study aims to determine the scienti\0c information about blockchain technology applied in medicine, in order to designed to address issues such as slow access times to medical information, the disaggregation of a patient\'s records across different medical institutions, and security risks in safeguarding medical information, among others. To address these issues, the proposal suggests that patients have a single veri\0ed and reliable electronic record containing their entire medical history that can be shared with doctors to facilitate new  (29)  diagnoses   . Currently, IBM is immersed in the development of its Healthchain initiative, which aims to centralize patients\' medical information in Latin America through the implementation of blockchain technology on IBM Cloud. This initiative seeks to enhance patient care by promoting precision medicine and automating administrative tasks, while ensuring the integrity of the information. Additionally, the application of blockchain could increase the effectiveness of diagnoses made by AI robots by collecting large volumes of validated  (31)  information   . Similarly, various proposals have been developed, such  (30)  as the case of Lluncor et al.   , who developed a blockchain-based model with the purpose of preventing the alteration of forensic medical reports from the Instituto de Medicina Legal y Ciencias Forenses of Cajamarca, Peru.   The proposal considers an improved model based on blockchain technology to strengthen the security of the content of FME reports, generated through the DICEMEL System (Central Forensic Medical Division System). These reports are processed in the administrative and medical \0elds and are requested by competent authorities such as the Peruvian National Police, Criminal Prosecution Offices, DEMUNA, and the Judiciary, among others.  Tinoco-Plasencia CJ  Pág. 146\nThe articles for the systematic review were searched in the databases: Scopus, Web of Sciences, Pro Quest, and ScienceDirect, and the speci\0c search engines of each  METHODS  Type and design of the research  The study is documentary in nature, characterized by focusing on the process of searching, analyzing, and interpreting secondary information, obtained from studies conducted by other authors from documentary  (32)  sources   . Likewise, the design is bibliographic, which consists of interpreting data reported by bibliographic sources or if there is not enough knowledge to obtain  (33)  information from reality   . Furthermore, the present study was framed in a systematic review, which the Cochrane Handbook for Systematic Reviews of  (34)  Interventions   de\0nes as studies with clear objectives, pre-de\0ned eligibility criteria, explicit and repeatable methodology, systematic search, assessment of validity, organized presentation, synthesis of characteristics, and results of the same. Additionally, the present study was based on the Preferred Reporting Item for Systematic Reviews (PRISMA) declaration. This methodology is a guide for conducting comprehensive systematic review studies, for which advances in techniques for selecting,  (35)  analyzing, and synthesizing research are considered   .  Search strategies  systematize the studies and the most relevant \0ndings achieved in the \0eld and establish recommendations. On the other hand, the \0rst speci\0c objective consists of identifying the applications that have been given to blockchain technology in medicine, in order to evaluate the current scope of application. Meanwhile, the second speci\0c objective refers to specifying the \0ndings obtained in the studies where blockchain technology was applied in medicine, with the purpose of evaluating its performance and establishing the respective conclusions.  Search procedure  (38)  According to Linares et al.   , it is crucial that the review process be meticulously planned from the beginning to minimize biases and discard irrelevant or low-quality studies. A systematic review involves the preparation of a critical and reproducible summary of the results present in publications related to a speci\0c topic or question. With the aim of improving scienti\0c writing, the methodology for conducting a systematic review should be presented in a structured manner. one were used. The search process was conducted from January 1, 2018, to July 31, 2023. For this purpose, a series of descriptors or keywords were used to accurately identify studies developed on the topic. In this regard, the de\0ned descriptors were blockchain, technology, and medicine, which were searched within the title of each publication using the boolean operator: And. To determine the population and sample of the study, the \0ow diagram contemplated in the PRISMA methodology was elaborated, which, according to  (39)  Ciapponi   , should describe the various phases of the process: identi\0ed records, number of studies included and excluded, and reasons for exclusions. The PRISMA diagram was elaborated considering the following inclusion criteria for articles: 1) original, 2) open access, 3) addressing blockchain technology applied in medicine, 4) developed in any language. Additionally, The study was developed following the procedure described in the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement, launched in 2009 with the purpose of assisting authors of systematic reviews in transparent documentation of the rationale behind the review, actions taken by the authors, and \0ndings obtained. The updated PRISMA 2020 version replaces the 2009 edition and incorporates a new presentation guide for publications, re\0ecting advances in methods used to identify, select,  (36,37)  evaluate, and synthesize studies   .  Pág. 147  Blockchain Technology\nSelection of studies  systematic review articles, letters to the editor, and expert opinions were excluded. With the initial search, 70 publications were obtained, and the four selected databases were considered, after applying the descriptors, the Boolean operator, and the de\0ned date range. To re\0ne this search, the previously established inclusion criteria were applied; in this sense, 52 studies were excluded, and the search was reduced to 18 publications, which were reviewed for compliance with the inclusion criteria in terms of title and abstract. Consequently, six duplicate articles were excluded, and one for not containing the variables in the title. Consequently, the sample consisted of 11 articles. Figure 1 shows the PRISMA diagram, which describes the process of search, identi\0cation, and selection of the de\0nitive sample of this systematic review study. Similarly, in Figure 2, the number of articles identi\0ed in each database in the initial search is presented; it is noteworthy that most publications are indexed in ScienceDirect. Similarly, in Figure 3, the number of articles in the sample published each year is described; in this regard, most of the work was developed during the years 2022 and 2023. Additionally, these 11 publications underwent a quality evaluation process that allowed conclusions focused on their \0ndings to be derived, and also identi\0ed observed limitations, with the aim of conducting a reproducible and bias-free veri\0cation. Although there are currently different tools for evaluating the quality of systematic reviews, this study opted to use a veri\0cation method that includes the aspects presented in   Table 1.  Figure 1.   PRISMA \0ow diagram.  Articles included in the sample n = 11 Eligible articles n = 11 Records after applying eligibility criteria n = 18  Inclusion   Eligibility   Screening   Identification   Identified Records Scopus n – 17 Identified Records WOS n – 12 Identified Records ProQuest n – 19 Identified Records ScienceDirect n – 22  Records before applying inclusion criteria n = 70 Excluded records n = 52 (records that not meet safety criteria) Excluded records n = 6 (duplicate records) / 1 (records that not address the topic) = 7  Tinoco-Plasencia CJ  Pág. 148\nFigure 2.   Results of the initial article search. .  Figure 3.   Results of the number of articles in the sample by year.  Pág. 149  Blockchain Technology\nTable 1.   Aspects of the evaluation of the quality of the selected articles.  Criterion   Description  The selected publications are current studies related to blockchain technology applied in medicine. The works are the most relevant in the \0eld of study. Additionally, they wer e conducted using valid and reliable instruments. From the total number of works found, the sample is considered sufficient. Each one was veri\0ed to employ a representative sample. According to the gathered evidence, no biases were identi\0ed that could question the reliability of the review. Additionally, the studies present cross-sectional designs. The statistical models were correctly applied. The review was conducted in an orderly and systematic manner, following the methodology. The methodologies examined in the chosen studies are appropriate to further explore the topic. From a grammatical and syntactic perspective, the narrative of the review is appropriate, in addition to being clear and easy to understand in its \0uency. The words used are suitable for the speci\0c vocabulary of the \0eld of study and the elements detailed. Timeliness Comprehensiveness Scope Risk of bias Structuring Relevance Clarity Precision highlights the following: only one article was published in the years 2018, 2019, and 2020, while two in 2021 and three in the years 2022 and 2023. Furthermore, the articles were published in nine different journals. On the other hand, three were developed under a qualitative methodology, while the remaining eight according to a mixed methodology. The selected articles were tabulated considering various aspects: author, publication date, title, journal, and methodology employed, as shown in Table 2. Consequently,   the   analysis   of   the   information  Scientific information about blockchain technology applied in medicine  RESULTS Table 2.   Selected articles.  Author/Year   Title   Journal   Methodology  Krittanawong et al. (2020) Xiao et al. (2023) Integrating blockchain technology with arti\0cial intelligence for cardiovascular medicine Application of Blockchain Sharding Technology in Chinese Medicine Traceability System Nature Reviews Cardiology Computers, Materials & Continua Cualitativa Mixta  Tinoco-Plasencia CJ  Pág. 150\nLi et al. (2022) Radanović & Likić (2018) Siyal et al. (2019) Ortiz et al. (2023) Ait et al. (2022) Garrido et al. (2021) Liu et al. (2023) Rehman et al. (2022) Tan et al. (2021) An Exploratory Study on the Design and Management Model of Traditional Chinese Medicine Quality Safety Traceability System Based on Blockchain Technology Opportunities for Use of Blockchain Technology in Medicine Applications of Blockchain Technology in Medicine and Healthcare: Challenges and Future Perspectives Increasing the security and traceability of biological samples in biobanks by blockchain technology Design and implementation of a New Blockchain-based digital health passport: A Moroccan case study A simulation-based AHP approach to analyze the scalability of EHR systems using blockchain technology in healthcare institutions P-PBFT: An improved blockchain algorithm to support large-scale pharmaceutical traceability A secure healthcare 5.0 system based on blockchain technology entangled with federated learning technique Retinal photograph-based deep learning algorithms for myopia and a blockchain platform to facilitate arti\0cial intelligence medical research: a retrospective multicohort study Security and Communication Networks Cryptography Informatics in Medicine Unlocked Informatics in Medicine Unlocked Mixta Cualitativa Computer Methods and Programs in Biomedicine Computers in Biology and Medicine Computers in Biology and Medicine The Lancet Digital Health Applied Health Economics and Health Policy Cualitativa Mixta Mixta Mixta Mixta Mixta Mixta medicine, traditional Chinese medicine ( TCM) traceability system, data management for healthcare, electronic medical records management, clinical research, detection of medical fraud, neuroscience, pharmaceutical industry, and biobank management, among others.  Applications of blockchain technology in medicine and studied populations  Table 3 presents the most used applications of blockchain technology in medicine; according to the studies that formed the sample, the following stood out: integration with arti\0cial intelligence (AI) for data- centric analysis and information \0ow in cardiovascular  Pág. 151  Blockchain Technology\nTable 3.   Applications of blockchain technology in medicine and studied population.  Author/Year   Main applications   Population  Krittanawong et al. (2020) Xiao et al. (2023) Li et al. (2022) Blockchain technology with AI applied to cardiovascular medicine. Design of a traceability scheme for traditional Chinese medicine. Traceability system, security, and quality of traditional Chinese medicine, based on blockchain. The study proposes the use of AI in cardiovascular medicine, through blockchain technology, as it provides secure interoperability between stakeholders in silos and centralized data sources. In other words, it seeks the integration of blockchain with AI for data-centric analysis and information \0ow, its limitations, and potential applications in cardiovascular medicine. The study analyzes the application of Sharding blockchain technology in the traceability system of TCM. To ensure the quality of TCM, blockchain is implemented to design the origin tracking traceability scheme. Despite these schemes being able to ensure the integrity, shareability, credibility, and immutability of TCM more effectively, many problems are exposed with the rapid growth of data in blockchains, such as expensive overhead costs, performance bottlenecks, and traditional architecture not being suitable for data with dynamic growth. In this regard, a novel and lightweight TCM traceability architecture based on blockchain using sharding (LBS-TCM) is proposed. This architec ture employs fragmentation to develop a novel traceability mechanism that supports more convenient operations for TCM requirements, such as loading, querying, and downloading. The study aims to build a traditional Chinese medicine (TCM) quality safety traceability system based on blockchain technology, through the analysis of the commercial process and supervision characteristics of the TCM supply chain. Blockchain technology is a novel way to apply computer technology, such as distributed data storage, peer-to-peer transmission, consensus mechanism, encryption algorithm, among others. It allows decentralization, non-manipulation, transparent and open handling, and data traceability. The non- manipulation function, hash function, and timestamp can effectively solve the problem of   TCM supply chain traceability.  Tinoco-Plasencia CJ  Pág. 152\nBlockchain technology in medicine Radanović & Likić (2018) The study evaluates potential applications of blockchain in the \0eld of medicine, which could include its use in electronic health records, health insurance, biomedical research, drug procurement and supply processes, and medical education. Speci\0cally, it describes the following applications: electronic health records, public health, education, insurance and acquisition policies, biomedical research, quality, and supply chain management for drug control. It also states that the use of blockchain is not without weaknesses, that this technology is still immature and lacks public or even expert knowledge, making it difficult to have a clear strategic vision of its true potential. Currently, there are issues with scalability, smart contract security, and user adoption. Siyal et al. (2019)   The study analyzes the application of blockchain technology in data management for healthcare. It also considers the potential of blockchain technology in the \0eld of medicine, genomics, telemedicine, telemonitoring, electronic health, neuroscience, and personalized healthcare applications, due to its data stabilization and security mechanism, allowing users to interact through different types of transactions. Among the applications detailed are the development of electronic health records, clinical research, detection of medical fraud, neuroscience, pharmaceutical industry, and research. Blockchain technology in medicine. Ortiz et al. (2023)   The study describes a blockchain smart contract to ensure traceability of processes carried out in a biobank, with the aim of ensuring traceability. One of the main functions of a biobank is to store biological samples under high-quality conditions for future research. Therefore, an application to manage a biobank, based on the web, can perform different tasks: informed consent, con\0dentiality, non-pro\0t, compliance with quality and safety standards, including traceability of samples Blockchain smart contract to enhance biobank traceability. Bennacer et al. (2022) The study analyzes the design of a private digital health passport based on blockchain, to ensure the protection of sensitive information, security, and privacy among all actors: Government, Ministry of Interior, Ministry of Health, veri\0ers, complying with the National Commission for the Protection of Personal Data Protection (CNDP) and the Moroccan Law 09-08. A framework solution is proposed, in which two types of actors are identi\0ed: authorized and unauthorized, to restrict and control access to citizens\' personal information. Integration of a private digital health passport based on Blockchain for all actors.  Pág. 153  Blockchain Technology\nRigorous analysis of three blockchain protocols: Ethereum, Dogecoin, and Bitcoin, and \0ve transaction aspects: sent, received, failed, nodes, and costs Garrido et al. (2021)  The study is based on an AHP approach to analyze the scalability of electronic health record (EHR) systems using blockchain technology in healthcare institutions. It has the aim of selecting the blockchain protocol that provides the best performance for scalability in the implementation of an EHR system based on BT in a high-priority healthcare institution (HP-HI).  P-PBFT, blockchain algorithm Liu et al. (2023)  The purpose of this study is to analyze an improved blockchain algorithm (P-PBFT) to support large-scale pharmaceutical traceability. This algorithm combined with blockchain technology, called Pharmaceutical-Practical Byzantine Fault Tolerance (P-PBFT) based on PBFT, allows solving problems of high latency, high system overhead, and small scale admitted in the current pharmaceutical traceability application. The algorithm combines the characteristics of a pharmaceutical supply chain, optimizes the consistency protocol in the original algorithm, divides large-scale network nodes into different consensus sets by response speed, and performs clustering consensus.  Construction of a secure health monitoring system in healthcare 5.0 through blockchain Rehman et al. (2022)  The study aims to conduct an analysis of the application of blockchain technology interlinked with federated learning in healthcare 5.0. It proposes the construction of a secure health monitoring system 5.0, through the use of blockchain technology and an intrusion detection system. This will allow detecting malicious activities in a healthcare network and monitoring patients through medical sensors, with the aim of predicting diseases and taking necessary measures. This application will improve the quality of life of patients, as well as reduce stress and healthcare costs. It was found that IoMT allows a series of functions in the \0eld of information technology, one of which is intelligent and interactive healthcare.  26,686 retinal images to identify myopic macular degeneration and high myopia were used. 400 images were randomly selected to compare the performance of algorithms and that of six expert evaluators. Tan et al. (2021)  The study seeks to design deep learning algorithms based on retinal photographs for myopia and a blockchain platform to facilitate arti\0cial intelligence medical research. In this regard, deep learning algorithms based on retinal photographs for the detection of myopic macular degeneration and high myopia were developed and tested, using a total of 226,686 retinal images. First, the algorithms were trained and internally validated from Singaporean data, and then externally tested on datasets from China, Taiwan, India, Russia, and the UK. The performance of learning algorithms was also compared with the opinion of six experts, using a randomly selected dataset of 400 images from external datasets. An AI-based blockchain platform was used as a proof of concept to demonstrate real application of secure data transfer, model transfer, and model testing at three sites in Singapore and China.  Tinoco-Plasencia CJ  Pág. 154\nhealthcare platforms. Likewise, results of blockchain use in healthcare systems are presented, to record clinical data and use data standards that can be replicated by other organizations.  Findings obtained in studies where blockchain t e c h n o l o g y   w a s   a p p l i e d   i n   m e d i c i n e  The results achieved in the studies that make up the sample are presented in Table 4, highlighting the \0ndings in the use of blockchain to facilitate integration with AI, to establish secure data management, or  Table 4.   Findings obtained with the application of blockchain technology in medicine.  Author/Year   Main findings  Krittanawong et al. (2020)  Other relevant aspects:   Blockchain technology can accelerate data development through AI applications. For example, neural networks were trained using ECG from a wearable monitor in 53,549 patients, providing diagnostic accuracy at the cardiology level for arrhythmias.   The use of blockchain can facilitate the secure integration of data from other healthcare providers or platforms, increasing instances of those arrhythmias in joint data to enhance training. Consequently, there are various strategies for integrating blockchain with AI. A novel challenge would be to combine data from various cardiovascular sources, such as portable ECG monitors, other wearable devices, hospital electronic medical records, biobanks, and non-medical data like activity records, social networks, or email threads.  Relevant finding:   Blockchain represents a natural base for standardizing health data structures for AI training, clinical trials, and regulatory purposes. Xiao et al. (2023)  Other relevant aspects:   Information on Chinese traditional medicines produced by different manufacturers was collected. For example, product names, main raw materials for production, production company, scale of the production company, business scope of the production company, and place of production. Empirical analysis demonstrated that the architecture outperforms many aspects compared to traditional blockchain architectures, such as TCM transaction processing, TCM transaction inquiry, TCM loading, etc. TCM tracking became an efficient operation, ensuring quality and providing great convenience for subsequent   TCM analysis and retrospective research.  Relevant finding:   LBS-TCM was implemented based on Ethereum\'s open- source code using Golang language. The hardware environment consisted of an Apple computer, with an Intel Core i7 processor, 32GB memory, and 1TB hard drive space. The collected TCM information was then loaded into the LBS-TCM system for testing. The architecture consists of a leading blockchain fragment chain layer as its main component, which employs a sharding mechanism to conveniently track   TCM.  Pág. 155  Blockchain Technology\nLi et al. (2022)  Relevant finding:   The quality traceability management model of TCM, through blockchain, includes: national macropolicies, TCM laws and regulations, safety traceability management system, safety traceability service platform, safety traceability standardization, governmental supervision and inspection, incentives, and sanction mechanisms.  Other relevant aspects:   Based on the analysis of TCM traceability, combined with the actual needs of Chinese TCM strategic planning, the study seeks to combine and optimize the organizational structure and business functions, control process, and management process, technical support, and TCM supply chain implementation plan. This provides a guarantee to improve the quality of TCM traceability management. Radanović & Likić (2018)  Other relevant aspects:   The most relevant advantages of applying this technology in healthcare were analyzed, such as access to a large group of anonymous health services, data that can be used for personalized drug development, streamlining healthcare and medical insurance costs, and improving public health policies.  Relevant finding:   In the case of private healthcare, it could be used in training and controlling information from institutions, circumstances, and time, as well as the availability of data about healthcare providers. Today, this technology is not ready for a wide spectrum. However, this could change if difficulties are overcome in the coming years, new concepts are developed, use cases, and monetary interests. Siyal et al. (2019)  Relevant finding:   It was determined that blockchain technology has signi\0cant advantages to offer to medicine. Similarly, as the internet revolutionized healthcare and introduced telemedicine, blockchain technology is likely to take medical science to the next level and reduce monitoring costs, with the possibility of having a central server to manage and administer medical data.  Other relevant aspects:   The use of blockchains in clinical contexts will drastically decrease processing time, as soon as a patient enrolls in a study, the data collected will be immediately available, due to availability in the distributed ledger. Ortiz et al. (2023)  Relevant finding:   The study allowed for the development of a set of smart contracts describing the processes of the biobank, with the aim of improving the security, integrity, and traceability of samples in biobanks. In this sense, a successful proof of concept was implemented on the IBM blockchain platform, known as Hyperledger Fabric, a private and authorized blockchain.  Tinoco-Plasencia CJ  Pág. 156\nOther relevant aspects:   Due to its characteristics, blockchain technology is suitable in a biobank environment since it provides: shared, immutable, distributed connection governed by P2P, in which different participants do not have to trust each other, as there is a consensus protocol, ensuring the security and veracity of transactions. Each procedure carried out in a biobank consists of a transaction, and thus, all network participants could validate and know the information of a sample, which cannot be modi\0ed due to the immutability provided by blockchain. Bennacer et al. (2022)  Relevant finding:   The design of the passport incorporates blockchain technology through a vaccine permit, where nodes are only entities allowed to store vaccination information and verify the QR code scan with the individual\'s personal information. To interact with the blockchain network, the government node can designate a client node, which can include the ministries of the interior and health.  Other relevant aspects:   This entity also deals with delivering vaccination information to the vaccination center or healthcare professionals. Then, the entity generates vaccination certi\0cates for those who have been vaccinated. These certi\0cates will identify the entity responsible for verifying a person\'s vaccination status. Information about the vaccine hash value is stored in the network.   The registration of these companies will be carried out by the Moroccan government authorities, using smart contracts to present blockchain nodes. Additionally, the blockchain system will contain a hash summary of each person\'s vaccination certi\0cate, which will be created after registration and used to facilitate the veri\0cation process of their vaccination status.  Relevant finding:   It was determined that the Ethereum protocol is the platform with the best overall performance for the HP-HI. This \0nding is based on a rigorous analysis of three blockchain protocols: Ethereum, Dogecoin, and Bitcoin, and \0ve criteria for evaluating scalability in BT-based EHR systems: transactions sent, received, failed, and nodes and cost.  Other relevant aspects:   This research was developed to evaluate the implementation of BT-based EHR systems in the context of the Colombian healthcare system. Garrido et al. (2021)  Relevant finding:   Experimental \0ndings re\0ect that the P-PBFT consensus algorithm provides smaller latency and higher performance for pharmaceutical traceability systems, supports scalability, effectively alleviates the dramatic increase in communication among network nodes, and reduces the in\0uence of malicious nodes. Liu et al. (2023)  Pág. 157  Blockchain Technology\nRehman et al. (2022)  Relevant finding:   The study allowed exploring a secure healthcare 5.0 system, based on blockchain technology intertwined with federated learning techniques to increase predictive performance. The proposed RTS-DELM method has an accuracy rate of 93.22% for disease prediction and 96.18% for intrusion detection.  Other relevant aspects:   It is also emphasized that developing a basic method is more economical and faster. The complexity of the proposed system, from the computing context, is grounded by the increasing number of hidden layers. Tan et al. (2021)  Relevant finding:   Over 225,000 retina photographs from nine multi-ethnic cohorts in six regions, obtained with ten different retina cameras, were used, implementing the use of AI in the \0eld of myopia. This is a novel blockchain- based application, considering system design and technique set decision, to work\0ow management level, integration with existing systems, and toolkit implementation. It also discusses how AI can improve disease identi\0cation and diagnosis, and similarly, blockchain can improve the security of medical records, preserving  (48)  the privacy of record owners. In the study by Ait et al.   , the construction of a digital medical passport based on blockchain technology is highlighted, aiming to ensure the security and privacy of medical data for Moroccan government entities. Regarding the study by Ortiz et al.  (49) , blockchain is proposed to improve the security, integrity, and traceability of processes executed in a biobank.  (17)  Similarly, the study by Azaria et al.   proposes a system called MedRec, designed as a decentralized medical record management system based on blockchain technology. The system provides patients with a complete and unalterable record, easy access to their medical information, and treatment sites.  (1)  This coincides with the study by Kumar et al. , who describe various algorithms to solve supervised and unsupervised machine learning problems, combined with deep learning algorithms such as neural networks and different platforms using blockchain technology driven by AI in the \0eld of public health.  DISCUSSION  (43)  On the other hand, the studies by Siyal et al.   ,  (44)   (45)   (46)  Radanović & Likić   , Krittanawong et al.   , Tan et al.   ,  (47)  and Garrido et al.   propose the analysis and design of application proposals based on blockchain technology in the \0eld of medicine, as well as the opportunities and challenges of its integration with other technologies such as AI, to design networks or data storage systems in medicine. The evidence in the selected databases related to the application of blockchain technology in medicine re\0ects the few studies developed in this regard. Indeed, 70 publications were identi\0ed, of which 11 were selected that met the inclusion criteria. It was found that all studies were published in nine different English-language journals, and there were publications in each year of the delimited period. Regarding the t o p i c s a d d re s s e d, v a r i o u s a p p l i c a t i o n s a n d characteristics of blockchain technology in medicine  (40)  stand out. in this regard, the studies by Li et al.   , Xiao et  (41)   (42)  al.   , and Liu et al.   addressed the application of blockchain technology to design a secure traceability system for managing traditional Chinese medicine and drug production by pharmaceutical companies.  Tinoco-Plasencia CJ  Pág. 158\nCONCLUSIONS  Future studies could focus on developing speci\0c standards and regulatory frameworks for managing health data in blockchains, thus addressing privacy and s e c u r i t y c o n c e r n s . A d d i t i o n a l l y, e x p l o r i n g interoperability between electronic medical record systems based on blockchain is needed to ensure effectiveness in clinical practice. Research on integrating smart contracts to automate medical processes and exploring applications in medical research and clinical trials also represent areas of growing interest. In summary, future research in this area has the potential to signi\0cantly shape and improve healthcare and health data management in an increasingly digital context. In the present systematic review study, the existence of 11 publications related to the research topic was con\0rmed. Despite considering four databases: Scopus, Web of Sciences, Pro Quest, and ScienceDirect, and a six-year search period (2018 to 2023), the presence of The crucial question is whether the potential bene\0ts of blockchain technology, such as data interoperability and traceability, will outweigh the obstacles and translate into real transformation in medical practice or whether this innovation will remain as a promising concept but not fully realized. However, this study has limitations such as the limited number of publications analyzed. It is a brief investigation that, as previously mentioned, was based exclusively on four databases. Additionally, the adoption of this technology in medical environments is still in its early stages, limiting the availability of robust data and use cases for analysis. Also, the complexity of implementing blockchain systems in healthcare infrastructure, along with the need to ensure the security and privacy of patient data, poses a signi\0cant challenge. Interoperability between different blockchain-based electronic medical record systems is also a pending issue. Finally, addressing regulatory and ethical concerns related to ownership and access to health information stored on a blockchain is essential. The application of blockchain technology in medicine has sparked intense debate about its clinical relevance and its in\0uence on current and future medical practice.  (43)  According to Siyal et al.   , the transparency and immutability of medical records in a blockchain can improve diagnosis accuracy and patient monitoring, reduce medical errors, and enhance care coordination.  (50)  However, Rehman et al.   argue that the complexity of implementing this technology, along with concerns about data privacy and security, pose considerable challenges.  (18)  Also, in the study by Ichikawa et al.   , the incorporation of smartphones into a blockchain-based network for medical data recording is proposed. In this sense, electronic medical records were collected via smartphones and successfully sent to a private Hyperledger Fabric blockchain network. The mHealth application information was updated without network failures. Additionally, it was ensured that all medical information recorded in the blockchain network is resistant to manipulation and review. Using blockchain characteristics, MedRec manages authentication, con\0dentiality, accountability, and data exchange, fundamental aspects in managing con\0dential information. Finally, the study by Rehman  (50)  et al.   evaluated the application of blockchain technology combined with IoMT and federated learning for healthcare 5.0, by building a health monitoring system. These \0ndings coincide with the  (16)  study by Albakri & Alqahtani   , who developed a new technique BSHS-EODL for the transmission and analysis of medical images in the IoMT environment, which allows for secure diagnosis and image transmission assisted by blockchain for the IoMT platform. This method includes data classi\0cation and collection, as well as image encryption. Likewise, the study by Pava et  (11)  al.   proposes that the application of blockchain in clinical data administration and IoMT medical device management allows the generation of a P6 healthcare m o d e l, a s i t f a c i l i t a t e s t h e m a n a g e m e n t o f decentralized patient medical data.  Pág. 159  Blockchain Technology\nThe \0ndings re\0ect the potential of blockchain technology for the development of data storage systems, data security and privacy in medical data, secure traceability of production, medication control, and its combination with IoMT to develop health monitoring systems. However, the great future potential of this technology in the management of few investigations based on the application of blockchain technology in medicine was noted. Furthermore, most of the studies in which this technology was implemented aimed to con\0gure a system of integration with other technologies such as AI to build networks or medical records storage systems. medicine and people\'s health is envisioned. On the other hand, the study presented certain limitations: only four databases were used, which resulted in a low number of studies comprising the sample; moreover, currently, the application of this technology in the \0eld of medicine is in its early stages; therefore, few analytical cross-sectional studies were found to delve into the \0ndings. Consequently, it is recommended to conduct primary studies to analyze the implications of adopting blockchain technology in medicine, especially in other contexts that provide feasible solutions for managing and controlling healthcare systems.  Funding:   Self-funded.  Correspondence:   Christian Jairo Tinoco Plasencia.  Address:   Avenida Caminos del Inca 3075, Lima-Perú.  Telephone number:   978218729  E-mail: christian.tinoco@urp.edu.pe  Authorship   contribution   statement:   The   author participated in the genesis of the idea, project design, data collection and interpretation, results analysis, and manuscript preparation of the present research work.  Conflict of interest:   The author declares no con\0ict of interest.  REFERENCES  1. Kumar R, Arjunaditya, Singh D, Srinivasan K, Hu YC. AI-Powered Blockchain Technology for Public Health: A Contemporary Review, Open Challenges, and Future Research Directions. Healthcare [Internet]. enero de 2023 [citado 14 de agosto de 2023];11(1):81. Disponible en: https://www.mdpi.com/2227-9032/11/1/81 2. Khezr S, Moniruzzaman M, Yassine A, Benlamri R. Blockchain Technology in Healthcare: A Comprehensive Review and Directions for Future Research. Appl Sci [Internet]. 26 de abril d e   2 0 1 9   [ c i t a d o   1 4   d e   a g o s t o   d e   2 0 2 3 ] ; 9 ( 9 ) : 1 7 3 6 .   D i s p o n i b l e   e n : https://www.mdpi.com/2076-3417/9/9/1736 3. Rennock M, Cohn A, Butcher J. Blockchain Tecnology and Regulatory Investigations. ET J. 2018;1(7):35-44. 8. Buterin V. A next generation smart contract & decentralized application platform. Ethereum   White Pap. 2014;1-36. https://www.liebertpub.com/doi/10.1089/cyber.2017.29097.csi 4.Gaggioli A. Blockchain Technology: Living in a Decentralized Everything. Cyberpsychology Behav Soc Netw [Internet]. enero de 2018 [citado 14 de agosto de 2023];21(1):65-6. Disponible en: 5. Palomo R. «Blockchain»: la descentralización del poder y su aplicación en la defensa. Bie3 Bol IEEE [Internet]. 2018 [citado 14 de agosto de 2023];(10):885-904. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=6555546 6. Uchibeke U, Schneider K, Hosseinzadeh S, Deters R. Blockchain Access Control Ecosystem for Big Data Security. En: 2018 IEEE International Conference on Internet of Things (iThings) and IEEE Green Computing and Communications (GreenCom) and IEEE Cyber, Physical and Social Computing (CPSCom) and IEEE Smart Data (SmartData). 2018. p. 1373-8. 7.Tucker C, Tapscott D, Iansiti M, Lakhani K. Blockchain: The Insights You Need from Harvard Business Review. Harvard Business Press; 2019. 95 p. https://revistas.udistrital.edu.co/index.php/Tecnura/article/view/16159 10. Saeed H, Malik H, Bashir U, Ahmad A, Riaz S, Ilyas M, et al. Blockchain technology in healthcare: A systematic review. PLOS ONE [Internet]. 11 de abril de 2022 [citado 14 de agosto de 2023];17(4):e0266462. Disponible en: 14. Sonkamble R, Bongale A, Phansalkar S, Sharma A, Rajput S. Secure Data Transmission of Electronic Health Records Using Blockchain Technology. Electronics [Internet]. enero de 2 0 2 3   [ c i t a d o   1 4   d e   a g o s t o   d e   2 0 2 3 ] ; 1 2 ( 4 ) : 1 0 1 5 .   D i s p o n i b l e   e n : https://www.mdpi.com/2079-9292/12/4/1015 15. Mendoza A, Avelar L, García J, Cruz O. Bene\0ciary Contracts on a Lightweight Blockchain Architecture Using Smart Contracts: A Smart Healthcare System for Medical Records. Appl Sci [Internet]. enero de 2023 [citado 14 de agosto de 2023];13(11):6694. Disponible en: https://www.mdpi.com/2076-3417/13/11/6694 11. Pava R, Pérez J, Niño L. Perspectiva para el uso del modelo P6 de atención en salud bajo un escenario soportado en IoT y blockchain. Tecnura [Internet]. 1 de enero de 2021 [citado 14 de agosto de 2023];25(67):112-30. Disponible en: 9.Fiore M, Capodici A, Rucci P, Bianconi A, Longo G, Ricci M, et al. Blockchain for the Healthcare Supply Chain: A Systematic Literature Review. Appl Sci [Internet]. 4 de enero de 2023 [citado 14 de agosto de 2023];13(2):686. Disponible en: https://www.mdpi.com/2076- 3417/13/2/686 12. Farahat I, Aladrousy W, Elhoseny M, Elmougy S, Tolba A. Improving Healthcare Applications Security Using Blockchain. Electronics [Internet]. 17 de noviembre de 2022 [citado 14 de agosto de 2023];11(22):3786. Disponible en: https://www.mdpi.com/2079- 9292/11/22/3786 13. Bit2me Academy. ¿Qué es un hash? [Internet]. 2023 [citado 8 de octubre de 2023]. Disponible en: https://academy.bit2me.com/que-es-hash/ https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0266462  Received:   September 04, 2023.  Approved:   January 18, 2024.  Tinoco-Plasencia CJ  Pág. 160\nREFERENCES  22. Machuca C, Espíritu W. Modelo de Referencia para la Gestión de la Seguridad de Datos de Salud Soportado en una Plataforma Blockchain [Internet] [Pregrado]. [Lima]: Universidad Peruana de Ciencias Aplicadas (UPC); 2021 [citado 16 de enero de 2024]. Disponible en: https://renati.sunedu.gob.pe/handle/sunedu/3093441 23. Hasselgren A, Kralevska K, Gligoroski D, Pedersen SA, Faxvaag A. Blockchain in healthcare and health sciences—A scoping review. Int J Med Inf [Internet]. 1 de febrero de 2020 [citado 16 de enero de 2024];134:104040. Disponible en: 20. Tumi A, Borda J, Tumi E, Torres E, Torres F, Ticona H, et al. Tecnología blockchain para la preservación de registros de historias clínicas médicas. En: Engenharias - Automação, Robótica, Metrología e Energía: estudos e tendências - Volume 1 [Internet]. 1.a ed. Editora Cientí\0ca Digital; 2023 [citado 16 de enero de 2024]. p. 66-81. Disponible en: http://www.editoracienti\0ca.com.br/articles/code/230212190 https://www.sciencedirect.com/science/article/pii/S138650561930526X 17. Azaria A, Ekblaw A, Vieira T, Lippman A. MedRec: Using Blockchain for Medical Data Access and Permission Management. En: 2016 2nd International Conference on Open and Big Data (OBD). 2016. p. 25-30. 24. Petre A, Haï N. Opportunities and challenges of blockchain technology in the healthcare industry. Med Sci MS. octubre de 2018;34(10):852-6. 19. McGhin T, Raymond K, Liu C, El D. Blockchain in healthcare applications: Research challenges and opportunities. J Netw Comput Appl [Internet]. 1 de junio de 2019 [citado 14 de agosto de 2023];135:62-75. Disponible en: 25. OECD. Opportunities and Challenges of Blockchain Technologies in Health Care [Internet]. 2020. Disponible en: https://web-archive.oecd.org/2021-05-05/576120- Opportunities-and-Challenges-of-Blockchain-Technologies-in-Health-Care.pdf 18. Ichikawa D, Kashiyama M, Ueno T. Tamper-Resistant Mobile Health Using Blockchain Technology. JMIR MHealth UHealth [Internet]. 26 de julio de 2017 [citado 14 de agosto de 2023];5(7):e7938. Disponible en: https://mhealth.jmir.org/2017/7/e111 16. Albakri A, Alqahtani Y. Internet of Medical Things with a Blockchain-Assisted Smart Healthcare System Using Metaheuristics with a Deep Learning Model. Appl Sci [Internet]. enero de 2023 [citado 14 de agosto de 2023];13(10):6108. Disponible en: https://www.mdpi.com/2076-3417/13/10/6108 https://www.sciencedirect.com/science/article/abs/pii/S1084804519300864 21. Cobeña B. Usos y aplicaciones del Blockchain en el área médica [Internet] [Master tesis]. [Barcelona]: Universitat Politècnica de Catalunya; 2020 [citado 16 de enero de 2024]. Disponible en: https://upcommons.upc.edu/handle/2117/340246 35. Moher D, Liberati A,   Tetzlaff J, Altman D, for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ [Internet]. 21 de julio de 2009 [citado 14 de agosto de 2023];339(jul21 1):b2535-b2535. Disponible en: https://www.bmj.com/lookup/doi/10.1136/bmj.b2535 30. Lluncor A, Almanza L, Huanca V. Modelo Blockchain para prevenir la alteración de informes de reconocimiento médico legal: Caso Instituto de Medicina Legal y Ciencias Forenses [Internet] [Maestría]. [Surco]: Ponti\0cia Universidad Católica del Perú; 2023 [citado 16 de enero de 2024]. Disponible en: 28. Mora M, Ortiz E. Modelo de Gestión de Historias Médicas, Basado en Tecnología Blockchain, Orientado a la Identi\0cación Automática de Anomalías en las Prescripciones Médicas [Internet]. [Colombia]: Universidad Distrital Francisco José de Caldas; 2018 [citado 16 de enero de 2024]. Disponible en: 27. Mellizo D, Minú J. Modelo basado en Blockchain para la implementación de una historia clínica electrónica familiar. Rev Investig En Tecnol Inf RITI [Internet]. 2020 [citado 16 de enero de 2024];8(16):10-22. Disponible en: https://tesis.pucp.edu.pe/repositorio//handle/20.500.12404/25223 32. Arias F. El proyecto de Investigación: Introducción a la Metodología Cientí\0ca. 6ta ed. Caracas: Episteme; 2012. 33. Mejía E. Metodología de la Investigación Cientí\0ca [Post grado]. Universidad Nacional Mayor de San Marcos; 2005. 26. Salah K, Rehman M, Nizamuddin N, Al-Fuqaha A. Blockchain for AI: Review and Open Research Challenges. IEEE Access [Internet]. 2019 [citado 16 de enero de 2024];7:10127-49. Disponible en: https://ieeexplore.ieee.org/abstract/document/8598784 31. Observatorio Blockchain. 2023 [citado 16 de enero de 2024]. 8 Innovaciones Blockchain e n   e l   s e c t o r   S a l u d   -   H y p e r n i f t y   A c a d e m y .   D i s p o n i b l e   e n : https://observatorioblockchain.com/hypernifty/blockchain-salud-innovaciones/ http://repository.udistrital.edu.co/handle/11349/13641 29. Dunogent A. Tecnología Blockchain: análisis de sus aplicaciones actuales y sus potenciales usos a futuro [Internet] [Tesis]. Universidad Nacional de Luján; 2019 [citado 16 de enero de 2024]. Disponible en: http://ri.unlu.edu.ar/xmlui/handle/rediunlu/831 https://dialnet.unirioja.es/servlet/articulo?codigo=7513585 34. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley&Sons, Ltd., Publication. England; 2008. 36. Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, et al. Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas. Rev Esp Cardiol [Internet]. 1 de septiembre de 2021 [citado 16 de enero de 2024];74(9):790-9. Disponible en: https://www.sciencedirect.com/science/article/pii/S0300893221002748 40. Li D, Gong Y, Zhang X, Huang M. An Exploratory Study on the Design and Management Model of Traditional Chinese Medicine Quality Safety Traceability System Based on Blockchain Technology. Secur Commun Netw [Internet]. 1 de junio de 2022 [citado 8 de a g o s t o   d e   2 0 2 3 ] ; 2 0 2 2 : e 7 0 1 1 1 4 5 .   D i s p o n i b l e   e n : https://www.hindawi.com/journals/scn/2022/7011145/ 37. Liberati A, Altman D, Tetzlaff J, Mulrow C, Gøtzsche P, Ioannidis J, et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med [Internet]. 21 de julio de 2 0 0 9   [ c i t a d o   1 6   d e   e n e r o   d e   2 0 2 4 ] ; 6 ( 7 ) : e 1 0 0 0 1 0 0 .   D i s p o n i b l e   e n : https://dx.plos.org/10.1371/journal.pmed.1000100 38.Linares E, Hernández V, Domínguez J, Fernández S, Hevia V, Mayor J, et al. Metodología de una revisión sistemática. Actas Urol Esp [Internet]. 1 de octubre de 2018 [citado 16 de enero de 2024];42(8):499-506. Disponible en: https://evidencia.org/index.php/Evidencia/article/view/6960 41. Xiao F, Lai T, Guan   Y, Hong J, Zhang H,   Yang G, et al. Aplicación de la tecnología Blockchain Sharding en el sistema de trazabilidad de la medicina china. Comput Mater Contin [Internet]. 2023 [citado 8 de agosto de 2023];76(1):35-48. Disponible en: https://web.s.ebscohost.com/abstract?direct=true&pro\0le=ehost&scope=site&authtype= crawler&jrnl=15462218&AN=164310659&h=4VgNDsPthqelILU1Li2tD1%2fzBEZDgSri0wZl fXL37g7HWyKFlcrVJJWj%2g%2bc%2fOWj3MPgWbHoSnPBllRkCv8%2bw%3d%3d&crl=c &resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect %3dtrue%26pro\0le%3dehost%26scope%3dsite%26autht ype%3dcrawler%26jrnl%3d154 62218%26AN%3d164310659 https://www.sciencedirect.com/science/article/pii/S0010482523000550 45. Krittanawong C, Rogers A, Aydar M, Choi E, Johnson K, Wang Z, et al. Integrating blockchain technology with arti\0cial intelligence for cardiovascular medicine. Nat Rev Cardiol [Internet]. enero de 2020 [citado 8 de agosto de 2023];17(1):1-3. Disponible en: https://www.nature.com/articles/s41569-019-0294-y 46. Tan T, Anees A, Chen C, Li S, Xu X, Li Z, et al. Retinal photograph-based deep learning algorithms for myopia and a blockchain platform to facilitate arti\0cial intelligence medical research: a retrospective multicohort study. Lancet Digit Health [Internet]. 1 de mayo de 2021 [citado 8 de agosto de 2023];3(5):e317-29. Disponible en: 42. Liu S, Zhang R, Liu C, Shi D. P-PBFT: An improved blockchain algorithm to support large- scale pharmaceutical traceability. Comput Biol Med [Internet]. 1 de marzo de 2023 [citado 8 de agosto de 2023];154:106590. Disponible en: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(21)00055-8/fulltext 47.Garrido A, Ramírez López L, Álvarez N. A simulation-based AHP approach to analyze the scalability of EHR systems using blockchain technology in healthcare institutions. Inform Med Unlocked [Internet]. 1 de enero de 2021 [citado 8 de agosto de 2023];24:100576. Disponible en: https://www.sciencedirect.com/science/article/pii/S2352914821000666 44. Radanović I, Likić R. Opportunities for Use of Blockchain Technology in Medicine. Appl Health Econ Health Policy [Internet]. 1 de octubre de 2018 [citado 8 de agosto de 2023];16(5):583-90. Disponible en: https://doi.org/10.1007/s40258-018-0412-8 39. Ciapponi A. La declaración PRISMA 2020: una guía actualizada para reportar revisiones sistemáticas. Evid Actual En Práctica Ambulatoria [Internet]. 4 de agosto de 2021 [citado 14 de agosto de 2023];24(3):e002139-e002139. Disponible en: 48. Ait S, Aaroud A, Sabiri K, Rguibi M, Cherradi B. Design and implementation of a New Blockchain-based digital health passport: A Moroccan case study. Inform Med Unlocked [Internet]. 1 de enero de 2022 [citado 8 de agosto de 2023];35:101125. Disponible en: https://www.sciencedirect.com/science/article/pii/S2352914822002623 49. Ortiz M, Arias E, Hernández Á, Caminero M, Rojo T, Nam S. Increasing the security and traceability of biological samples in biobanks by blockchain technology. Comput Methods Programs Biomed [Internet]. 1 de abril de 2023 [citado 8 de agosto de 2023];231:107379. Disponible en: https://www.sciencedirect.com/science/article/pii/S0169260723000469 43. Siyal A, Junejo A, Zawish M, Ahmed K, Khalil A, Soursou G. Applications of Blockchain Technology in Medicine and Healthcare: Challenges and Future Perspectives. Cryptography [Internet]. marzo de 2019 [citado 8 de agosto de 2023];3(1):3. Disponible en: https://www.mdpi.com/2410-387X/3/1/3 50. Rehman A, Abbas S, Khan M, Ghazal T, Adnan K, Mosavi A. A secure healthcare 5.0 system based on blockchain technology entangled with federated learning technique. Comput Biol Med [Internet]. 1 de noviembre de 2022 [citado 8 de agosto de 2023];150:106019. Disponible en: https://www.sciencedirect.com/science/article/pii/S0010482522007417 https://www.sciencedirect.com/science/article/pii/S0210480618300615  Pág. 161  Blockchain Technology',0.20226281038290117,'[\"\\u0000eld\", \"\\u0000elds\", \"\\u0000fth\", \"\\u0000nally,\", \"\\u0000nding\"]','2025-11-29 17:05:41.515449'),(65,3,'[analyzeText] POST -> http://127.0.0.1:8000/analyze/text\n2pdf.worker.min.js:22 Warning: TT: undefined function: 21\nentry.bundle?platform=web&dev=true&hot=false&lazy=true&transform.routerRoot=app&transform.reactCompiler=true:65912 [analyzeText] POST -> http://127.0.0.1:8000/analyze/text\n2pdf.worker.min.js:22 Warning: fetchStandardFontData: failed to fetch file \"FoxitSymbol.pfb\" with \"UnknownErrorException: The standard font \"baseUrl\" parameter must be specified, ensure that the \"standardFontDataUrl\" API parameter is provided.\".\n2entry.bundle?platform=web&dev=true&hot=false&lazy=true&transform.routerRoot=app&transform.reactCompiler=true:65912 [analyzeText] POST -> http://127.0.0.1:8000/analyze/text',0.17566781147561947,'[\"\\\"baseurl\\\"\", \"\\\"foxitsymbol.pfb\\\"\", \"\\\"standardfontdataurl\\\"\", \"\\\"unknownerrorexception:\", \"->\"]','2025-11-29 17:06:06.306093'),(66,3,'Blocked aria-hidden on an element because its descendant retained focus. The focus must not be hidden from assistive technology users. Avoid using aria-hidden on a focused element or its ancestor. Consider using the inert attribute instead, which will also prevent focus. For more details, see the aria-hidden section of the WAI-ARIA specification at <URL>.\nElement with focus: <div.css-view-g5y9jx r-transitionProperty-1i6wzkk r-userSelect-lrvibr r-cursor-1loqt21 r-touchAction-1otgn73 r-alignItems-1awozwy r-backgroundColor-16kgrik r-borderRadius-6ncur5 r-height-ff8gi r-justifyContent-1777fci r-width-5flfrz>\nAncestor with aria-hidden: <div.css-view-g5y9jx r-flex-13awgt0 r-bottom-1p0dtai r-left-1d2f490 r-position-u8s1d r-right-zchlnj r-top-ipm5af>Comprende esta advertencia\nentry.bundle?platform=web&dev=true&hot=false&lazy=true&transform.routerRoot=app&transform.reactCompiler=true:65912 [analyzeText] POST -> http://127.0.0.1:8000/analyze/text\n5Blocked aria-hidden on an element because its descendant retained focus. The focus must not be hidden from assistive technology users. Avoid using aria-hidden on a focused element or its ancestor. Consider using the inert attribute instead, which will also prevent focus. For more details, see the aria-hidden section of the WAI-ARIA specification at <URL>.\nElement with focus: <div.css-view-g5y9jx r-transitionProperty-1i6wzkk r-userSelect-lrvibr r-cursor-1loqt21 r-touchAction-1otgn73 r-alignSelf-1kihuf0 r-backgroundColor-14sbq61 r-borderRadius-1dzdj1l r-paddingBlock-1mmae3n r-paddingInline-cxgwc0>\nAncestor with aria-hidden: <div.css-view-g5y9jx r-flex-13awgt0 r-bottom-1p0dtai r-left-1d2f490 r-position-u8s1d r-right-zchlnj r-top-ipm5af>Comprende esta advertencia\nentry.bundle?platform=web&dev=true&hot=false&lazy=true&transform.routerRoot=app&transform.reactCompiler=true:65912 [analyzeText] POST -> http://127.0.0.1:8000/analyze/text\n2pdf.worker.min.js:22 Warning: TT: undefined function: 21\nentry.bundle?platform=web&dev=true&hot=false&lazy=true&transform.routerRoot=app&transform.reactCompiler=true:65912 [analyzeText] POST -> http://127.0.0.1:8000/analyze/text\n2pdf.worker.min.js:22 Warning: fetchStandardFontData: failed to fetch file \"FoxitSymbol.pfb\" with \"UnknownErrorException: The standard font \"baseUrl\" parameter must be specified, ensure that the \"standardFontDataUrl\" API parameter is provided.\".\n2entry.bundle?platform=web&dev=true&hot=false&lazy=true&transform.routerRoot=app&transform.reactCompiler=true:65912 [analyzeText] POST -> http://127.0.0.1:8000/analyze/text\nentry.bundle?platform=web&dev=true&hot=false&lazy=true&transform.routerRoot=app&transform.reactCompiler=true:65912 [analyzeText] POST -> http://127.0.0.1:8000/analyze/text\nresult?payload=%7B%22score%22%3A0.17566781147561947%2C%22buckets%22%3A%7B%22human%22%3A0.8243321885243805%2C%22ai%22%3A0.17566781147561947%7D%2C%22top_words%22%3A%5B%22%5C%22baseurl%5C%22%22%2C%22%5C%22foxitsymbol.pfb%5C%22%22%2C%22%5C%22standardfontdataurl%5C%22%22%2C%22%5C%22unknownerrorexception%3A%22%2C%22-%3E%22%5D%7D:1 Blocked aria-hidden on an element because its descendant retained focus. The focus must not be hidden from assistive technology users. Avoid using aria-hidden on a focused element or its ancestor. Consider using the inert attribute instead, which will also prevent focus. For more details, see the aria-hidden section of the WAI-ARIA specification at https://w3c.github.io/aria/#aria-hidden.\nElement with focus: <div.css-view-g5y9jx r-transitionProperty-1i6wzkk r-userSelect-lrvibr r-cursor-1loqt21 r-touchAction-1otgn73 r-alignItems-1awozwy r-backgroundColor-hfna8r r-borderRadius-1867qdf r-marginTop-1wzrnnt r-padding-nsbfu8>\nAncestor with aria-hidden: <div.css-view-g5y9jx r-flex-13awgt0 r-bottom-1p0dtai r-left-1d2f490 r-position-u8s1d r-right-zchlnj r-top-ipm5af> <div class=​\"css-view-g5y9jx r-flex-13awgt0 r-bottom-1p0dtai r-left-1d2f490 r-position-u8s1d r-right-zchlnj r-top-ipm5af\" style=​\"background-color:​ rgb(242, 242, 242)​;​ display:​ flex;​\" aria-hidden=​\"true\">​…​</div>​Comprende esta advertencia',0.1685135530508752,'[\"\\\"baseurl\\\"\", \"\\\"foxitsymbol.pfb\\\"\", \"\\\"standardfontdataurl\\\"\", \"\\\"unknownerrorexception:\", \"->\"]','2025-11-29 17:06:17.108092'),(67,3,'Resumen ultra corto\n\nBackend (FastAPI + modelo + SQLite)\n? GitHub → Render Web Service\n? Comando: uvicorn app:app --host 0.0.0.0 --port $PORT\n\nFrontend (Expo Web)\n? GitHub → Vercel\n? Build: npx expo export:web\n? Output: dist (o .expo/web/dist)\n? Env var: EXPO_PUBLIC_API_BASE = URL_DEL_BACKEND',0.2173332801294191,'[\"$port\", \"(expo\", \"(fastapi\", \"(o\", \"+\"]','2025-11-29 17:06:39.764064'),(68,3,'Avanzar con propósito no es correr sin dirección, sino mantener un ritmo consciente, equilibrado y motivador. Significa reconocer los desafíos, aprender de ellos y continuar fortalecidos. La clave está en recordar que cada día ofrece una nueva oportunidad para crecer, mejorar y reinventarnos.',0.15541937116718926,'[\"aprender\", \"avanzar\", \"cada\", \"clave\", \"con\"]','2025-11-29 17:07:11.716090'),(69,3,'Tomarse un momento para reflexionar, organizar ideas y decidir el siguiente movimiento permite que nuestras acciones tengan sentido. La disciplina transforma las intenciones en resultados, y la constancia convierte esos resultados en hábitos duraderos. Así, poco a poco, construimos el camino hacia nuestras propias metas.',0.20101253753260487,'[\"a\", \"acciones\", \"as\\u00ed,\", \"camino\", \"constancia\"]','2025-11-29 17:07:19.500338'),(70,3,'uestra vida. Cada meta, por pequeña que parezca, representa un paso firme hacia un futuro mejor.',0.16577043008074793,'[\"cada\", \"firme\", \"futuro\", \"hacia\", \"mejor.\"]','2025-11-29 17:07:39.624322'),(71,3,'ORIGINAL RESEARCH  Health consumers ’   ethical concerns towards arti fi cial intelligence in Australian emergency departments  Sam FREEMAN   ,   1,2   Jonathon STEWART   ,   3,4   Rebecca KAARD, 5   Eden OULIEL,   5   Adrian GOUDIE,   6,3 Girish DWIVEDI 3,4,7   and Hamed AKHLAGHI   1  1   Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, Victoria, Australia,   2   Centre for Digital Transformation of Health, The University of Melbourne, Melbourne, Victoria, Australia,   3   School of Medicine, The University of Western Australia, Perth, Western Australia, Australia,   4 Cardiovascular Disease and Diabetes Program, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia, 5   School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia,   6   Department of Emergency Medicine, Fiona Stanley Hospital, Perth, Western Australia, Australia, and   7   Department of Cardiology, Fiona Stanley Hospital, Perth, Western Australia, Australia  Abstract  Objectives : To investigate health con- sumers ’   ethical concerns towards the use of arti fi cial intelligence (AI) in EDs.  Methods : Qualitative   semi-structured interviews with health consumers, rec- ruited via health consumer networks and   community   groups,   interviews conducted   between   January   and August 2022.  Results : We   interviewed   28   health consumers   about   their   perceptions towards the ethical use of AI in EDs. The   results   discussed   in   this   paper highlight the challenges and barriers for   the   effective   and   ethical   imple- mentation of AI from the perspective of Australian health consumers. Most health consumers are more likely to support AI health tools in EDs if they continue   to   be   involved   in   the decision-making   process.   There   is considerably   more   approval   of   AI tools that support clinical decision- making,   as   opposed   to   replacing it. There is mixed sentiment about the acceptability of AI tools in fl uencing clinical   decision-making   and   judge- ment. Health consumers are mostly supportive of the use of their data to train and develop AI tools but are concerned   with   who   has   access. Addressing bias and discrimination in AI is an important consideration for some health consumers. Robust regu- lation and governance are critical for health consumers to trust and accept the use of AI.  Conclusion : Health consumers view AI as an emerging technology that they   want   to   see   comprehensively regulated to ensure it functions safely and securely with EDs. Without con- siderations   made   for   the   ethical design,   implementation   and   use   of AI   technologies,   health   consumer trust and acceptance in the use of these tools will be limited.  Key   words:   arti fi cial   intelligence, emergency   medicine,   ethics,   health consumers, machine learning, quali- tative research.  Introduction  Advancements   in   arti fi cial   intelli- gence (AI) are predicted to impact healthcare delivery in a multitude of ways such as providing a comprehen- sive   picture   of   an   individual ’ s healthcare   data,   augmenting   clinical decision-making,   reducing   diagnostic errors, assisting with test selection and interpretation, and recommending fur- ther   management   options. 1   Despite the technology behind most of these advances continuing to improve, par- ticularly   through   machine   learning (ML), 2   there remain key challenges in the Australian health system that need Correspondence: Dr Sam Freeman, Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, VIC, Australia. Email: sam.freeman@svha.org.au Sam Freeman, PhD, Research Fellow; Jonathon Stewart, MBBS, MMed(CritCare), Anaesthetic Registrar; Rebecca Kaard, MBBS Student; Eden Ouliel, MBBS Student; Adrian Goudie, MBBS FACEM DDU, Emergency Physician; Girish Dwivedi, MD, PhD, FRACP, Wesfarmers Chair and Consultant Cardiologist; Hamed Akhlaghi, MD, PhD, FACEM, Emergency Physician, Head of Emergency Medicine Research. This is an open access article under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs   License,   which   permits   use   and   distribution   in   any medium, provided the original work is properly cited, the use is non-commercial and no modi fi cations or adaptations are made.  Accepted 15 May 2024  Key   fi ndings  •   Health   consumers   generally support   arti fi cial   intelligence (AI) tools that assist clinicians in   decision-making   but   are wary of tools replacing doc- tors, with trust diminishing as AI ’ s   decision-making   auton- omy increases.  •   Health   consumers   express   a strong   desire   to   be   actively involved in AI-driven decision- making about their healthcare in emergency settings.  •   Mixed sentiments surround the acceptability of AI in fl uencing doctor   decision-making,   with concerns about its impact on healthcare quality. Health con- sumers fear a short-term under- mining of nurses and doctors, leading to a potential reduction in clinical skills and a long-term shift   towards   ‘ box-ticking ’  exercises,   raising   discomfort and   scepticism   about   the technology ’ s role in emergency medicine. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  Emergency Medicine Australasia   (2024)   36 , 768 – 776   doi: 10.1111/1742-6723.14449\nurgent   attention.   These   include   an increasing demand for healthcare ser- vices, an ageing population, increas- ing   costs   associated   with   medical research and innovations and grow- ing rates of chronic disease. 3   This has led groups such as policymakers, pol- iticians,   technology   companies   and data scientists to advocate for AI to address these challenges. 4 It is predicted that the use of AI- based tools will become increasingly common in EDs. 5   However, there is limited published research that qualita- tively assesses how health consumers (people who use health services, their families and carers) feel about AI use in their care in an ED context. To date, research has mostly focused on health consumers ’   perceptions of AI in speci fi c sub fi elds of medicine, such as radiology, dermatology, general prac- tice and primary care. This   paper   presents   health   con- sumer attitudes towards AI to help inform future research and highlight risk   mitigation   strategies   for   the effective and ethical implementation of AI in EDs.  Methods  Study design and setting  This qualitative study was designed in accordance with the consolidated criteria   for   reporting   qualitative research.   6   We   developed   a   semi- structured interview guide based on the review of existing literature and input from the multidisciplinary pro- ject   team.   Members   of   the   project team   have   recognised   expertise   in emergency medicine, qualitative resea- rch   and   AI   and   also   included   two healthcare   consumer   representatives. The   study   protocol   and   interview guide were presented to and received formal support from the Fiona Stanley Hospital Emergency Department Con- sumer   Advisory   Group   (Western Australia). We conducted three pilot interviews and re fi ned the   interview guide based on feedback. Twenty-eight   semi-structured interviews were conducted between January and August 2022 to assess health   consumers ’   perspectives   and considerations for the ethical imple- mentation   and   use   of   AI   in   EDs. Participants were recruited from dif- ferent health consumer networks and community   groups,   including   the Consumer Community Involvement Program (Western Australia), Fiona Stanley Hospital Emergency Depart- ment   Consumer   Advisory   Group (Western   Australia),   St   Vincent ’ s Hospital   Melbourne   Human Research   Ethics   Committee   layper- son members (Victoria), Health Con- sumers   Queensland   (Queensland) and the Centre for Culture, Ethnic- ity & Health (Australia wide), where recruitment details were distributed through its members and networks. The interviews were conducted until thematic saturation (de fi ned as three consecutive interviews with no new themes identi fi ed) was achieved. This research utilises a grounded theory approach,   which   was   selected because it provides a methodology for collecting and analysing data and conceptualising   the   results.   7   Inter- views were conducted by telephone via a voice call (without video) and audio   recorded.   Audio   fi les   were de-identi fi ed and professionally tran- scribed by a secure transcription ser- vice.   Interviews   were   conducted   in Australia with participants from New South   Wales,   Queensland,   Victoria and Western Australia. For a further breakdown   of   participant   demo- graphics (see Table 1).  Participant selection  A convenience sample was used to recruit   respondents   ( n   =   28)   based on   accessibility   and   willingness   to take part in the study.   8  Data collection  Semi-structured   interviews   were   con- ducted with additional questions and prompts used as needed. Although the discussion of ethical concerns was led by respondents, prompts included prin- ciples such as consent, transparency, privacy, safety and harm, bias, fairness and   redress.   There   were   no   repeat interviews or transcription checks by participants. Interview duration ranged from 10 to 45 min.  Data analysis  Two investigators (SF and JS) indepen- dently analysed and coded interviews using open coding techniques based on grounded theory.   All   the   interviews were coded using NVivo 20 (QSR, Melbourne,   Australia).   Codes   and themes were iteratively developed and re fi ned until most content was able to be classi fi ed. Agreement on codes and themes was reached at researcher meet- ings where differing codes were dis- cussed and a consensus on their coding was agreed upon.  Characteristics of interviewers  The interviews were conducted by SF, two medical students (RK and EO), and an ED Registrar. Interviews were held over the phone without video to reduce any bias that the interviewer ’ s appearance may have on responses. The interviewers had no prior rela- tionship with the study participants.  Characteristics of research team  At   the   time   of   conducting   this research   SF   was   a   PhD   candidate  TABLE   1.   Participant   demo- graphic information  Category   n   % Sex Female   17   61 Male   10   36 Non-binary   1   4 Age group 20 – 29   2   7 30 – 39   6   21 40 – 49   6   21 50 – 59   2   7 60 – 69   2   7 70 – 79   10   36 Location New South Wales   1   4 Queensland   5   18 Victoria   14   50 Western Australia   8   29 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   769 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n(focus on ethical implementation of AI in emergency medicine) and a research fellow at an Australian ED. JS was a PhD candidate (focus on applications of AI in emergency medicine) and an emergency medicine trainee. RK and EO   were   both   second-year   medical students who had not completed rota- tions in emergency medicine.  Ethical considerations  The study received University of West- ern Australia Research Ethics Commit- tee   approval   (2021/ET000609). Informed consent was gained from all respondents participating in the present study. The present study was prospec- tively   registered   with   the   Australian New Zealand Clinical Trials Registry (ACTRN12621000890831).  Results  The results provide an overview of health   consumers ’   key   perceptions of ethical AI in an ED setting. Key ethical   concerns   presented   here include health consumer autonomy and consent, doctor decision-making and autonomy, automation bias and reliance, data usage and privacy, bias and discrimination and regulation.  Health consumer autonomy and consent  Most   health   consumers   are   more likely to support AI health tools in emergency medicine if they continue to   be   involved   in   the   decision- making   process   about   their   health and can still understand why a treat- ment recommendation or diagnosis is made. There is some concern that with   the   use   of   increasingly   adva- nced technologies, they will no lon- ger be able to ask questions or have key issues explained to them about their treatment or diagnosis. For many participants there is a requirement to have the role of AI in their treatment explained to them at the   earliest   opportunity.   Many believe they would be more comfort- able with the use of AI if it is effec- tively   communicated.   This   becomes even more important with the incre- ased   complexity   or   risk   associated with the function of the AI tool. This is particularly important if the role of AI includes clinical decision support that relates to differential   diagnosis, complex cases, serious health condi- tions or decisions that were tradition- ally tasked to doctors and nurses. Effective   communication   is   criti- cally important to most health con- sumers   to   improve   autonomy   and consent processes. Many already feel that   information   in   EDs   could   be better communicated and that if AI is to play a future role in emergency medicine, in any capacity, it needs to be clearly communicated. The more  ‘ serious ’   the concern or high-risk set- ting   the   tool   is   functioning   in,   the more information consumers require. There is concern that AI systems may be non-interpretable by the doc- tor,   meaning   the   doctor   may   be unable   to   effectively   understand results and subsequently communi- cate   them   to   their   patients.   This thereby impacts the patient ’ s ability to give informed consent. There are mixed views, however, about the type and amount of informa- tion required, and how it is communi- cated.   Overwhelmingly,   consumers want to know (to varying degrees) if an   AI   tool   is   being   used   in   their healthcare pathway. If an AI tool is used in a patient ’ s healthcare   pathway   and   they   were not   informed,   many   report   they would   feel   ‘ betrayed ’ ,   ‘ annoyed ’ ,  ‘ frustrated ’   or   ‘ distressed ’ . For trust and   acceptance   of   these   systems, many health consumers believe that improved   consent   processes   are needed to ensure the risks, bene fi ts and alternatives can be explained in how the tool works and that they have the opportunity to opt in or out of   having   the   tool   used   in   their healthcare delivery. There is fear that the introduction of these tools will lead to a loss of human connection in the ED, in par- ticular   empathy   and   sympathy,   in what is for many people an already highly stressful environment. Some see the   healthcare   journey   as   a   human experience and want it delivered with kindness and compassion   –   traits not typically   associated   with   AI   and machines. Having that human connec- tion in a health setting is not only con- sidered   important   on   an   emotional, human   level,   but   also   connects   to health consumer autonomy.  Doctor decision-making and autonomy  There is considerably more approval for AI tools in the ED that support cli- nician decision-making, as opposed to replacing   it.   Most   participants   will only support these tools if their func- tion is subsidiary to the role of the doctor. Trust and acceptance and AI decision-making autonomy appear to have an inverse relationship. As an AI tool ’ s   decision-making   autonomy increases in the ED, patient trust and acceptance decrease. There is recognition that   human decision-making   is   fallible, particu- larly in a dynamic, complex ED envi- ronment.   Against   this   backdrop, participants see potential in AI tools being   used   to   support   doctor   and nurse   decision-making.   For   some, there is also an expectation that AI tools will likely make mistakes. For many, it is how these mistakes are responded   to   that   will   determine their level of acceptance. The   doctor   is   predominantly viewed as the   fi nal authority regard- ing   patients ’   health.   Trust   and acceptability in AI tools are derived from the doctor agreeing with the AI tools ’   prediction. When respondents envisage an AI tool operating inde- pendently of doctor oversight, many health   consumers   said   they   would insist on being treated by a doctor if they disagreed with the decision of the AI health tool. For some, no mat- ter what scenario occurs within the ED, clinicians are considered more accurate in diagnosing and treating patients. Although there are differing views about the acceptability of AI tools   to   make   errors,   ultimately, most health consumers hold AI tools to   a   higher   standard   of   accuracy than ED doctors and nurses. Despite concerns about the effec- tiveness and accuracy of AI, some health   consumers   state   that   once these   tools   are   ‘ proven ’   to   out- perform   doctors   then   they   would prefer AI tools over doctors. Some health   consumers   state   that   in some circumstances, they would prefer AI-assisted   decision-making,   such   as © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  770   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nwhen a doctor is overworked, the ED is short-staffed or overcrowded, or the treating clinician has limited experi- ence   in   the   role.   Health   consumers largely   accept   that   their   perceptions may change with advancements in AI technology and its predicted increased integration into healthcare. However, doctors are still regarded as providing the   preferred standard of care   over any form of AI tool.  Automation bias and reliance  There   is   mixed   sentiment   among respondents about the acceptability of AI tools in fl uencing ED doctors ’  decision-making and clinical judge- ment. Many were concerned that AI tools would in fl uence doctors ’   judge- ment   and   impact   the   quality   of healthcare   provision.   For   these health consumers, AI is considered just another tool to be utilised by cli- nicians and should not be afforded special   status   over   any   other   tool available in the ED. If AI tools are believed to have an in fl uential role over   clinical   decision-making,   it would   make   health   consumers  ‘ uncomfortable ’ ,   ‘ sceptical ’   and   ‘ dis- trustful ’   of the technology. Many health consumers are con- cerned that the use of AI tools in emergency medicine will result in a reliance on them. In the short term, consumers   feel   these   tools   could undermine   the   role   of   nurses   and doctors   within   the   ED   and   in   the long term could reduce the skills and ability of clinicians. There is a belief from some that diagnosing patients and clinical judgement will become  ‘ box ticking ’   exercises, where a clini- cian ’ s   ‘ gut   feeling ’ ,   ‘ intuition ’   and  ‘ instincts ’   are   no   longer   attributes that are developed and valued.  Data usage and privacy  Health   consumers   are   mostly   sup- portive of the use of their data to train and support the development of AI tools in emergency medicine but   are   concerned   with   who   has access.   Most   are   comfortable   with their non-identi fi able data being used for healthcare purposes, but only for healthcare purposes. If it was later dis- covered   that   their   information   had been used outside of the healthcare system,   or   for   purposes   other   than improving   healthcare   delivery   or healthcare research, trust and accep- tance of these tools would diminish. There   is   concern   about   data breaches and the level of security for protecting personal health informa- tion. However, many are aware of the inherent risks involved in sharing and   storing   data.   Although   it   is recognised   that   privacy   issues   are not unique to AI, many want assur- ances that their data is being handled securely. Many state that they are not   overly   concerned   about   their own   medical   data   being   released publicly, but do recognise that some health information and some mem- bers of the public could be negatively impacted, targeted or discriminated against based on their health data: Some   health   consumers   want greater control over the health infor- mation   that   is   shared   and   stored. Many   want   consent   processes   in place, so they are aware if the infor- mation is being shared and have the ability to opt in or out of its collec- tion and sharing. There are privacy concerns about how data will be col- lected in the ED if managed by an AI-enabled   platform.   Some   partici- pants   are   apprehensive   about   how patient-to-machine   information   will be communicated in a crowded ED environment.   Some   discussed   the need for a private space to feel com- fortable sharing information.  Bias and discrimination  Addressing bias and discrimination in AI is an important consideration for some   health   consumers.   There   is concern that AI will inherit the same biases   that   are   already   present   in healthcare. One participant feels that having come from a Caucasian back- ground   means   that   AI   tools   will likely be accurate for them, but less accurate or reliable for people from culturally   and   linguistically   diverse backgrounds. There are concerns that AI tools will bias or discriminate against cul- turally   and   linguistically   diverse populations,   First   Nations   people, women   and   people   with   disability and   complex   medical   needs.   Bias and discrimination are linked to per- ceptions of accuracy. For health con- sumers   to   trust   and   accept   these tools in the ED, they must be con- vinced they are accurate. Part of that required accuracy is how well they perform   for   people   from   multicul- tural backgrounds. It will be impor- tant   that   AI   based   tools   do   not perpetuate existing biases or intro- duce new biases.  Regulation  Regulation   is   an   important   aspect for trusting and accepting the use of AI   in   EDs   for   health   consumers. Some health consumers want assur- ances that there is robust regulation and oversight in the design, develop- ment, training and ongoing use of these tools. Most support a govern- ment   regulatory   body   to   establish guidelines   and   oversee   compliance. Some   see   this   as   the   role   of   the national government to ensure con- sistency across states and territories. Many do not want to see industry self-regulation   or   regulation   and standards left to the private sector. Here, there is concern that pro fi t will be   the   motivating   factor   for   the implementation   and   use   of   these tools, not improving patient health outcomes. Some   health   consumers   want   to see   more   localised   governance   and accountability of these tools such as the hospital administration or industry peak   bodies   such   as   the   Australian Medical Association, to ensure train- ing and policies are established and provided at the clinical level. There are also calls for AI tools to be endorsed by the bodies that represent the medi- cal professionals who are required to use these tools in clinical practice. Some health consumers also want these tools to pass through an ethics review   process.   For   these   respon- dents, it is not enough to just con- sider the safety and medical accuracy of these tools, it must also consider their ethical impact (Table 2).  Discussion  This research found that health con- sumer   acceptance   of   AI-enabled health tools requires the consideration © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   771 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nTABLE 2.   Sample comments by health consumers on ethical concerns  Qualitative dimension   Sub-dimension   Example quote Patient autonomy and consent Health consumer understanding of treatment or diagnosis  … that I was involved in the discussions about my treatment, patients being encouraged to be involved in decision-making about their care, that actually has to be absolutely central to the whole process still so that I wouldn ’ t want the human element and the capacity for me as a patient to actually explain my concerns and, you know, the capacity of me to ask questions. Effective communication that AI is being used I think as a patient I would also want to understand the role of AI in the whole process, and I think that would be very, very important because if I found out for some reason, you know, at a later date that (that AI was being used), that would be quite disturbing. But I think if I was involved at the start in knowing that this system was actually helping clinicians to arrive at an accurate diagnosis, I think I would be very satis fi ed, very comfortable with that. You ’ ve got to have that communication, break that barrier to communication face-to-face by someone who can explain what ’ s happening. Amount of information health consumers require  … not in a great amount of detail, but it would just be nice to have that reassurance. The more information, the better. Consent requirements With my consent, I ’ d feel good about it. I think you need to opt in. Doctor – patient relationship I wouldn ’ t like it because you want to be heard and seen by a compassionate, kind professional. This is a human experience, and I don ’ t want it to be determined by a robot. At least, if the robot has this decision, I would want a human sitting there and explaining it to me …   the desperation and feeling unwell, just to be questioned by a robot in a yes or no or to get an answer way, it ’ s going to just increase the frustration and the suffering, I feel. Doctor decision- making and autonomy AI errors in decision-making  … every human body is different so the program is written for the majority, allowing for some differences, but there ’ ll always be individuals that   … swim against the   fl ow and where they should have got better, all the signs are there that they should have got better and something has happened, but that happens just when a doctor sends them home, the fact that it ’ s a computer algorithm that did the agree-to-release, in my eyes, makes no difference. AI accuracy   If it replaces something that ’ s there at the moment, yes, it has to be better.   … I can imagine that 15 years down the track I would see it as completely irrelevant, but I think during a new kind of introductory phase of a new technology, I think it would be perceived as far worse for a computer to make an error. Because I think if it ’ s proven to be more failsafe and make less mistakes than what the humans are performing then I would take my chances with that over human assessment for sure. AI over doctors   I mean not every doctor ’ s going to be a specialist in every   fi eld. And in emergency, the guy treating me may not be the most capable guy in whatever it is I have. [So] I think the fact that he can rely on the information from a tool to help him in the diagnostics would be very useful. Automation bias and reliance AI in fl uence over doctor decision- making Well, I would think it ’ s actually a slap in the face to doctors, because you ’ re negating all the experience that they ’ ve had, and their own experience will tell them a lot of information that the machine can ’ t gather. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  772   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nand minimisation of ethical issues. As AI research continues to develop it is important   to   understand   what   are considered   by   healthcare   consumers to be acceptable uses of the technol- ogy in emergency medicine contexts. These   results   provide   information about health consumers ’   current per- ceptions of AI in emergency medicine and further emphasises the need for effective   communication   to   ensure consumers understand the function of AI and the role it will play in the deliv- ery of their healthcare. Consumers require assurance that the   ED   doctor   retains   the   fi nal decision-making authority and that they understand how and why an AI tool has come to a certain prediction or   recommendation.   This   may   be challenging as current AI tools are for the most part   ‘ black boxes ’   with reasoning that is not interpretable to humans.   9 It appears that trust and acceptance of   AI   tools   and   clinician   decision- making   autonomy   are   inversely related.   The   more   autonomous   or independent the tool is from ED doc- tors ’   oversight   and   understanding, the less likely patients are to trust its output. There are reservations about the accuracy and performance of these technologies, and also apprehension about moving to a new standard of care, which may remove other ele- ments   of   healthcare   considered important to patients such as the doctor – patient   relationship.   Other research   into   patient   perspectives on   AI   in   different   medical   fi elds found comparable results   –   patients  TABLE 2.   Continued  Qualitative dimension   Sub-dimension   Example quote Reduced doctor skill and ability  … as soon as we start taking away decisions from health professionals, we ’ re sort of undermining their training and we start, look, it ’ s complicated because I think if we could take routine jobs away from nurses and doctors to help them focus on more important things, that would be great. But I ’ m worried that [they] would then start relying on AI and it would undermine the expertise of doctors and nurses. Data usage and privacy  Re -use of patient health consumer data If you ’ ve given consent for it, no problems. You wouldn ’ t want it to be then on-sold or used for anything else. I could understand people who are very private and would not want their medical records (shared) … . but as long as it ’ s unidenti fi ed and they ’ re not used for any other purpose, you know, it ’ s probably inevitable things are going down this track in all   fi elds. [Concern] around how your data ’ s kept and used, and the breaches   –   what ’ s being collected and how could that be used. Control over the sharing of health consumer data  … Patients should be able to consent to certain information being taken, and where that information is actually going to go. On the other hand, I really do support the interoperability of programs, so that they can talk to one another, after consent is received. How private data is disclosed It would depend on how the information was communicated, like if it was …  in an open space. You know, are people ’ s private health details being broadcast loud by this AI? Is it happening in a quiet, private space? Bias and discrimination AI and human bias   I don ’ t think AI is good enough yet and everyone ’ s just forging ahead with it, thinking it ’ s great and missing the fact that it ’ s really not great. It ’ s programmed like humans, so it will have human error in it. Discrimination and multicultural populations  … the (AI) system has been calibrated using data that isn ’ t particularly diverse and then the output it generates is biased because of that. Regulation   Government regulation I think it ’ s got to be a multi-layered approach. I think Australia at a federal level has to have some very clear guidelines around the use of AI in medical settings and lots of other settings, but if we ’ re just sticking with medical, I think we need to have some federal governance around that. Local governance mechanisms But I do think then we need to have local [governance], like AMA (Australia Medical Association) or state level or even hospital level to make sure that staff are trained, staff are upskilled, that there is a local connection with what ’ s going on federally. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   773 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nare much more likely to support AI if there is a human tasked with mak- ing   the   fi nal   decision   or recommendation. 10 – 15   In part, this is because there is more trust in the abil- ity of an experienced doctor. Doctors are also able to justify and explain their   decision   or   recommendation, something health consumers currently do not associate with AI technology. Many   patients   still   want   the human   connection   and   assurance healthcare staff provide when they are   going   through   a   potentially stressful   time,   something   machines are viewed as incapable of providing. However,   these   views   may   change with increased exposure to advanced AI tools. A recent study comparing physician and ChatGPT responses to patient questions found that patients rated ChatGPT responses   ‘ higher for both quality and empathy ’ . 16   With this challenging the assumptions of most health consumers that AI tools will lack empathy. Some of the lit- erature also suggests that patients fear losing human interaction from their   healthcare   delivery   and   are concerned   that   AI   tools   will   be unable   to   comprehend   emotional issues,   particularly   in   relation   to patients   experiencing   mental   ill- health.   10,11,14,17 – 19   This   concern appears   to   intensify   in   an   emer- gency   setting   with   patients   often requiring urgent medical attention, and where the human connection is considered especially important in reducing distress. Health   consumers   are   concerned about privacy and the use of their per- sonal   health   data.   Although   many approve   of   the   use   of   their   non- identi fi able   medical   data to   support the development of AI tools within healthcare,   they   are   still   concerned about   con fi dentiality   and   who   has access to it. This is consistent with research into patient perspectives of AI   in   radiology 20   and   healthcare chatbots, 17   which found patients are only willing to share data if it remains con fi dential and non-identi fi able. Con- sumers will likely rescind their support for data usage if it transpires that their personal   information   is   being   used outside of the healthcare system or for purposes other than improving patient health outcomes. Many   health   consumers   believe they are aware of the inherent risks involved in the sharing and storage of data. However, health consumers may be under the assumption that their health data refers only to data held by healthcare organisations in their health records. Yet, these data sources are considered only a small part of the   ‘ larger health data eco- system ’ . 21   This includes health data generated   by   non-healthcare   pro- viders such as insurance companies, non-health information where infer- ences   are   made   about   health,   and user-generated health data.   21   Health consumers may feel less comfortable knowing that there is the potential for this information to be collected and used to make decisions about them, particularly if used by com- mercial entities. Data collection and sharing policies need to be updated to ensure data collected and gener- ated through the use of these tools meets the standards and expectations of consumers. Most   health   consumers   see informed   consent   as   a   critical   ele- ment   in   gaining   their   trust   and acceptance regardless of the role AI might play in their treatment. One study   22   identi fi ed that informed con- sent   is   not   receiving   the   attention needed   in   the   ethical   debate   sur- rounding   AI   implementation,   with another study 23   reporting that   ‘ ubiq- uity, complexity and opaqueness ’   are major   contributors   to   health   con- sumers ’   ‘ inability to assess or predict outcomes   or   harms ’   associated with   the   use   of   AI   in   healthcare and   therefore   provide   informed consent. The issue of consent app- ears   to   be   a   signi fi cant   consider- ation for health consumers. It will be important that the ED doctors and hospital management who are tasked   with   implementing   these technologies   ensure   the   consent process is current and appropriate, and that the use of AI in the ED is communicated effectively. Addressing   bias   and   discrimina- tion that results from the introduc- tion   of   AI   is   important   to   many health   consumers.   However,   bias and discrimination pre-existent to AI is   not   without   precedent   in   the Australian healthcare system, where First   Nations   people   ‘ continue   to suffer   adverse   experiences   in healthcare, with inequitable care pre- valent   in   emergency   settings ’ . 24 Research   has   highlighted   that   the Australian   healthcare   system   under serves those from culturally and lin- guistically diverse backgrounds, 25   has discriminated   against   women 26   and people   with   disability. 27   For   AI   to bene fi t   diverse   populations   such   as Australia ’ s, the design and develop- ment of AI technologies must include input from diverse populations from diverse   geographic   locations,   who will   use   or   be   exposed   to   these technologies. 28 It appears that health consumers envisage a more rigorous regulatory framework that monitors and evalu- ates the design, development, imple- mentation and use of AI technologies than   currently   exists   within Australia. Although the Therapeutic Goods Administration does regulate software as a medical device, which AI software are categorised, there is no regulation that relates speci fi cally to these technologies.   29   Because of this   assumption,   it   is   likely   that future regulation and guidance will need to address issues of oversight and evaluation to gain the support of consumers. This will likely include ensuring health consumers are protec- ted,   and   that   improved   health   out- comes are a priority in implementing these systems. 29   This also relates to fears that AI tools may not be appro- priately   regulated   and   be   more in fl uenced by   fi nancial incentives than improving healthcare outcomes. The existing literature, similarly, found that rigorous regulation and guidance of AI in healthcare is regarded as impor- tant for protecting patient wellbeing, monitoring the safety of these systems, reducing   risks   to   patient   privacy, assessing   the   potential   for   systemic bias   embedded   in   AI   models   and enabling   continuous   system improvements. 29 – 31   Last, many emer- gency   physicians   share   similar   con- cerns about the use of AI in EDs as health   consumers.   These   common concerns include data usage and pri- vacy, bias and discrimination, skill loss and   over-reliance,   transparency   and explainability of AI algorithms, and regulation and governance. 32,33 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  774   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nLimitations  The   fi ndings   in   the   present   study should be considered within the con- text of its limitations. A convenience sample   was   used   to   select   partici- pants based on their accessibility and willingness to take part, which could lead   to   voluntary   response   bias.   8 Attempts   were   made   to   recruit   a sample based on demographic data provided by the Australian Institute of Health and Welfare   –   Emergency Department Activity to reduce dis- crepancies   between   the   demo- graphics   of   the   sample.   However, this was unsuccessful, leading to a sample   that   was   skewed   towards those   living   in   Victoria,   Western Australia and Queensland, those in an   older   age   bracket,   females   and those   from   a   white-Anglo   back- ground.   Additionally,   as   a   non- probability   sample,   the   results   are not representative of the Australian population.   The   grounded   theory approach also has limitations. It is accepted that using a GT approach can allow for the researcher ’ s indi- vidual   biases   and   world   view   to in fl uence study results.   34   AI is a rap- idly changing area, and the introduc- tion   and   media   coverage   of   new technologies   has   the   potential   to in fl uence   respondent   perspectives. For   example,   recent   advances   in foundation models such as ChatGPT were   released   after   the   interviews took   place,   meaning   some   health consumers ’   perspectives   may   have already changed.  Conclusion  The results discussed in this paper found that most consumers require AI to be rigorously tested and evalu- ated before it becomes operational. There is also a requirement for AI to be robustly regulated and monitored by government or a professional reg- ulatory   body   to   gain   support   and acceptance.   However,   regulation alone   is   not   considered   suf fi cient. Informed consent processes that pro- vide information about the role and functionality of AI, maintaining pri- vacy and con fi dentiality of personal health data, bias and discrimination, and the attribution of responsibility and liability for patient health out- comes are all critical issues that need to be addressed   if   AI   technologies are to be trusted and accepted by health consumers in EDs.  Acknowledgements  We thank the Consumer Community Involvement Program, Fiona Stanley Hospital Emergency Department Con- sumer Advisory Group, St Vincent ’ s Hospital Melbourne Human Research Ethics Committee layperson members, Health   Consumers   Queensland,   and the Centre for Culture, Ethnicity and Health for their support and the par- ticipants who provided feedback on our initial interview guide, who partic- ipated in the pilot interviews, and who participated in the study. Open access publishing facilitated by The Univer- sity   of   Melbourne,   as   part   of   the Wiley - The University of Melbourne agreement via the Council of Austra- lian University Librarians.  Competing interests  None declared.  Data availability statement  The de-identi fi ed data we analysed are   not   publicly   available,   but requests to the corresponding author for the data will be considered on a case-by-case basis.  References  1.   Topol E.   Deep Medicine: How Arti-  fi cial   Intelligence   Can   Make Healthcare   Human   Again   /   Eric Topol , 1st edn. New York: Basic Books, 2019. 2.   Littman   M,   Ajunwa   I,   Berger   G  et al . Gathering Strength, Gathering Storms:   The   One   Hundred   Year Study   on   Arti fi cial   Intelligence (AI100) 2021 Study Panel Report 2022. 3.   Australian Government Department of   Health   and   Aged   Care.   The Australian   Health   System: Australian Government Department of   Health   and   Aged   Care;   2019. Available from URL: https://www. health.gov.au/about-us/the-australian- health-system. 4.   Morley J, Machado CCV, Burr C  et   al .   The   ethics   of   AI   in   health care: a mapping review.   Soc. Sci. Med.   2020;   260 : 113172. 5.   Stewart J, Sprivulis P, Dwivedi G. Arti fi cial   intelligence   and   machine learning   in   emergency   medicine.  Emerg. Med. Australas.   2018;   30 : 870 – 4. 6.   Tong A, Sainsbury P, Craig J. Con- solidated criteria for reporting qual- itative   research   (COREQ):   a 32-item checklist for interviews and focus groups.   In. J. Qual. Health Care   2007;   19 : 349 – 57. 7.   Halaweh M, Fidler C, McRobb S, eds. Integrating   the   grounded   theory method and case study research meth- odology within IS research: a possible  ‘ road map ’ . International Conference on Interaction Sciences; 2008. 8.   Etikan   I.   Comparison   of   conve- nience   sampling   and   purposive sampling.   Am. J. Theor. Appl. Stat.  2016;   5 : 1. 9.   Anderson   M,   Anderson   SL. How should AI Be developed, val- idated,   and   implemented   in patient care?   AMA J. Ethics   2019;  21 : E125 – 30. 10.   Tran V-T, Riveros   C, Ravaud P. Patients ’   views of wearable devices and AI in healthcare:   fi ndings from the ComPaRe e-cohort.   npj Digit. Med.   2019;   2 : 53. 11.   Jutzi   TB,   Krieghoff-Henning   EI, Holland-Letz T   et al . Arti fi cial intel- ligence in skin cancer diagnostics: the   patients ’   perspective.   Front. Med. (Lausanne)   2020;   7 : 233. 12.   Rawson TM, Ming D, Gowers SA  et   al .   Public   acceptability   of computer-controlled   antibiotic management:   an   exploration   of automated   dosing   and   opportuni- ties   for   implementation.   J.   Infect.  2019;   78 : 75 – 86. 13.   Fritsch SJ, Blankenheim A, Wahl A  et al . Attitudes and perception of arti fi cial intelligence in healthcare: a cross-sectional   survey   among patients.   Digit.   Health   2022;   8 : 20552076221116772. 14.   Ongena   YP,   Haan   M,   Yakar   D, Kwee   TC.   Patients ’   views   on   the implementation of arti fi cial intelli- gence   in   radiology:   development and   validation   of   a   standardized questionnaire.   Eur.   Radiol.   2020;  30 : 1033 – 40. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   775 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n15.   Palmisciano   P,   Jamjoom   AAB, Taylor D, Stoyanov D, Marcus HJ. Attitudes of patients and their rela- tives toward arti fi cial intelligence in neurosurgery.   World   Neurosurg.  2020;   138 : e627 – 33. 16.   Ayers   JW,   Poliak   A,   Dredze   M  et   al .   Comparing   physician   and arti fi cial   intelligence   Chatbot responses   to   patient   questions posted   to   a   public   social   media forum. JAMA.   Intern. Med.   2023;  183 : 589. 17.   Nadarzynski T, Miles O, Cowie A, Ridge D. Acceptability of arti fi cial intelligence (AI)-led chatbot services in   healthcare:   a   mixed-methods study.   Digit.   Health   2019;   5 : 2055207619871808. 18.   Gao S, He L, Chen Y, Li D, Lai K. Public perception of arti fi cial intelli- gence in medical care: content anal- ysis   of   social   media.   J.   Med. Internet Res.   2020;   22 : e16649. 19.   Nadarzynski   T,   Bayley   J, Llewellyn   C,   Kidsley   S, Graham CA. Acceptability of arti-  fi cial   intelligence   (AI)-enabled chatbots, video consultations and live webchats as online platforms for   sexual   health   advice.   BMJ Sex.   Reprod.   Health   2020;   46 : 210 – 7. 20.   Adams   SJ,   Tang   R,   Babyn   P. Patient   perspectives   and   priorities regarding   arti fi cial   intelligence   in radiology:   opportunities   for patient-centered radiology.   J. Am. Coll. Radiol.   2020;   17 : 1034 – 6. 21.   Price WN 2nd, Cohen IG. Privacy in the age of medical big data.   Nat. Med.   2019;   25 : 37 – 43. 22.   Gerke S, Minssen T, Cohen G. Eth- ical and legal challenges of arti fi cial intelligence-driven healthcare.   Artif. Intell.   Healthc.   2020:   295 – 336. https://doi.org/10.1093/oxfordhb/97 80190067397.013.23 23.   Jones   ML,   Edenberg   E.   Trouble- shooting   AI   and   consent.   In: Dubber   MD,   Pasquale   F,   Das   S, eds.   The   Oxford   Handbook   of Ethics   of   AI .   Oxford   University Press, 2020. 24.   Quigley   A,   Hutton   J,   Phillips   G  et al . Review article: implicit bias towards   Aboriginal   and   Torres Strait   Islander   patients   within Australian emergency departments.  Emerg. Med. Australas.   2021;   33 : 9 – 18. 25.   Johnstone MJ, Kanitsaki O. Ethnic aged discrimination and disparities in health and social care: a question of   social   justice.   Australas. J. Ageing   2008;   27 : 110 – 5. 26.   Bastos JL, Harnois CE, Paradies YC. Health   care   barriers,   racism,   and intersectionality in Australia.   Soc. Sci. Med.   2018;   199 : 209 – 18. 27.   Temple JB, Kelaher M, Williams R. Discrimination and avoidance due to disability in Australia: evidence from   a   National   Cross   Sectional Survey.   BMC Public Health   2018;  18 : 1347. 28.   Gebru   T.   Race   and   gender.   In: Dubber MD, Pasquale F, Das S, eds.  The Oxford Handbook of Ethics of AI . Oxford University Press, 2020. https://doi.org/10.1093/oxfordhb/97 80190067397.013.16 29.   Australian   Medical   Association. Automated   Decision   Making   and AI Regulation; 2022. 30.   Price WN. Risks and Remedies for Arti fi cial Intelligence in Health Care; 2019. Available from URL: https:// www.brookings.edu/research/risks- and-remedies-for-arti fi cial-intelligence- in-health-care/. 31.   Australian   Alliance   for   Arti fi cial Intelligence   in   Healthcare.   A Roadmap for Arti fi cial Intelligence in Healthcare for Australia; 2021. 32.   Stewart   J,   Freeman   S,   Eroglu   E  et   al .   Attitudes   towards   arti fi cial intelligence in emergency medicine.  Emerg. Med. Australas.   2024;   36 : 252 – 65. 33.   Grant K, McParland A, Mehta S, Ackery AD. Arti fi cial intelligence in emergency medicine: surmountable barriers with revolutionary poten- tial.   Ann. Emerg. Med.   2020;   75 : 721 – 6. 34.   Kolb S. Grounded theory and the constant comparative method: valid research   strategies   for   educators.  J. Emerg. Trends Educ. Res. Policy Studies   2012;   3 : 83 – 6. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  776   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License',0.3220757177345311,'[\"%\", \"&\", \"(\", \"(2021/et000609).\", \"(2024)\"]','2025-11-29 17:07:52.059016');
INSERT INTO `analyses` VALUES (72,3,'Vol.:(0123456789) Drugs (2024) 84:1167–1178 https://doi.org/10.1007/s40265-024-02084-7  CURRENT OPINION  Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape  Tim Preijers 1,2   · Anouk E. Muller 3,4,5   · Alan Abdulla 1,2,5   · Brenda C. M. de Winter   1,2,5   · Birgit C. P. Koch 1,2,5   · Sebastiaan D. T. Sassen   1,2,5  Accepted: 11 August 2024 / Published online: 6 September 2024 © The Author(s) 2024  Abstract  Successful antimicrobial therapy depends on achieving optimal drug concentrations within individual patients. Inter-patient variability in pharmacokinetics (PK) and differences in pathogen susceptibility (reflected in the minimum inhibitory concen- tration, [MIC]) necessitate personalised approaches. Dose individualisation strategies aim to address this challenge, improv- ing treatment outcomes and minimising the risk of toxicity and antimicrobial resistance. Therapeutic drug monitoring (TDM), with the application of population pharmacokinetic (popPK) models, enables model-informed precision dosing (MIPD). PopPK models mathematically describe drug behaviour across populations and can be combined with patient-specific TDM data to optimise dosing regimens. The integration of machine learning (ML) techniques promises to further enhance dose individualisation by identifying complex patterns within extensive datasets. Implementing these approaches involves challenges, including rigorous model selection and validation to ensure suitability for target populations. Understanding the relationship between drug exposure and clinical outcomes is crucial, as is striking a balance between model complexity and clinical usability. Additionally, regulatory compliance, outcome measurement, and practical considerations for software implementation will be addressed. Emerging technologies, such as real-time biosensors, hold the potential for revolutionising TDM by enabling continuous monitoring, immediate and frequent dose adjustments, and near patient testing. The ongo- ing integration of TDM, advanced modelling techniques, and ML within the evolving digital health care landscape offers a potential for enhancing antimicrobial therapy. Careful attention to model development, validation, and ethical considera- tions of the applied techniques is paramount for successfully optimising antimicrobial treatment for the individual patient.  Key Points  Personalised approaches are necessary for successful antimicrobial therapy due to interpatient variability in the pharmacokinetic parameters and differences in pathogen susceptibility. Therapeutic drug monitoring (TDM), combined with population pharmacokinetic (popPK) models and machine learning (ML) techniques, offers a promising strategy for individualising antimicrobial drug dosing. The implementation of TDM and advanced modelling techniques poses challenges, including rigorous model selection and validation, understanding the relation- ship between drug exposure and clinical outcomes, and ensuring regulatory compliance. Tim Preijers, Anouk E. Muller, Alan Abdulla, Brenda C. M. de Winter, Birgit C. P. Koch, and Sebastiaan D. T. Sassen contributed equally.  *   Birgit C. P. Koch  b.koch@erasmusmc.nl 1   Department of Hospital Pharmacy, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands 2   Rotterdam Clinical Pharmacometrics Group, Erasmus MC, Rotterdam, The Netherlands 3   Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands 4   Department of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, The Netherlands 5   Centre for Antimicrobial Treatment Optimization Rotterdam (CATOR), Rotterdam, The Netherlands\n1168   T. Preijers et al.  1   Introduction  For the treatment of infectious diseases, the application of antimicrobial drugs is of paramount importance [1]. Their efficacy depends on achieving optimal drug concentrations in the body, or rather, at the site of infection [2]. How- ever, these concentrations can vary significantly among individuals due to differences such as age, body weight, renal function, co-morbidities, having an infection and co- administered medication [3]. These differences may be the result of differences in the individual’s drug exposure [4], which are described by the individual pharmacokinetic (PK) parameters. Beyond patient-specific factors, the phar- macodynamic (PD) parameters of the targeted microbe also play a significant role. A key PD parameter is the minimum inhibitory concentration (MIC), a quantitative measure of the antimicrobial potency. Understanding the MIC is essential for selecting an appropriate dosing regi- men—microbes with an MIC above their breakpoint are considered resistant and may necessitate higher doses or an alternative antimicrobial agent [5]. By considering both the individual patient’s PK profile and the PD character- istics of the microbe, clinicians can individualise dosing regimens for improved therapeutic outcomes. Dose individualisation involves tailoring dosing regi- mens based on a patient’s unique characteristics. This ensures achieving optimal drug exposure while minimis- ing side effects, the emergence of resistance and toxic- ity [6]. Traditional dosing approaches often rely on fixed dosing regimens, which may not account for inter-patient variability in drug exposure. This may result in sub-ther- apeutic or supra-therapeutic drug exposure and, conse- quently, treatment failure, or side effects and toxicity. To overcome these limitations, doses can be tailored based on the individual patient’s characteristics. In addition, thera- peutic drug monitoring (TDM) can be applied by measur- ing drug concentrations in blood, plasma, or urine, and subsequently guiding dose adjustments to achieve a pre- determined target concentration or range [7]. Healthcare’s ongoing digital transformation, character- ised by the digitisation of hospitals, the vast availability of patient data, and ever-increasing computing power, opened many new possibilities that were previously unfeasible. This has led to significant advancements in methodolo- gies used to perform dose individualisation, including the application of population PK (popPK) models in model- informed precision dosing and the utilisation of machine learning (ML) techniques. Therefore, this review aims to explore the current state and future potential of dose individualisation for antimicrobial drugs. The focus will be on the integration of TDM, popPK models, and the transformative potential of ML methods in optimising and individualising antibiotic treatment.  2   Therapeutic Drug Monitoring/Model Informed Precision Dosing  Therapeutic drug monitoring allows for the adjustment of the dosing regimen based on the measured concentration of a drug [7]. However, optimal dose adjustments are dif- ficult to assess. Therefore, TDM can be applied in conjunc- tion with subsequent drug exposure predictions for different dosing regimen provided by a popPK model, referred to as model informed precision dosing (MIPD) [6]. These modali- ties, applied to individualise antimicrobial drug dosing, are elaborated upon below.  2.1   Application of Therapeutic Drug Monitoring  Therapeutic drug monitoring, which measures drug concen- trations in biological matrices (e.g., blood, plasma, urine), offers clinical utility when four key conditions are satis- fied. First, the drug must exhibit significant interindividual variability (IIV) in its pharmacokinetics. Second, alterna- tive non-invasive methods to assess drug efficacy must be lacking. Third, a validated assay for precise quantification of drug concentrations must be readily available. Finally, a well-defined exposure-response relationship, encompassing both therapeutic and toxic thresholds, must be established. The latter includes knowledge about the MIC of the patho- gen and is, therefore, referred to as the PK/PD index. For antimicrobial drugs, the relationship between drug concentration and its clinical efficacy and bacterial kill char- acteristics is best described by three distinct PK/PD indices, depending on the drug’s activity pattern [8]. Antimicrobi- als with concentration-dependent activity are described by either the ratio of the unbound (free) maximal concentration ( f C   max   ) and the MIC ( f C   max   /MIC) or the ratio between the 24-hour area under the free concentration-time curve and the MIC ( f AUC 0h-24h   /MIC) [9]. For time-dependent antimi- crobials, effectiveness is determined by the percentage of time the free drug concentration exceeds the MIC (% f T >MIC ) throughout the dosing interval [10]. Finally, antimicrobials exhibiting both concentration-dependent and time-depend- ent effects are best described using the   f AUC   0h–24h   /MIC ratio. The magnitude of the PK/PD index correlating best with a specific antimicrobial effect is referred to as the PK/ PD target. The values used as the PK/PD targets are usually the median values, thereby ignoring the variability in the magnitude values. To apply TDM effectively, it is important to obtain accu- rate information regarding the times of dosing prior to and\n1169 Dose Individualisation of Antimicrobials: Where Are We?  after the concentration measurement. Moreover, the time of sampling is also crucial. In the case of a trough sam- ple, it may be required to sample during steady-state, which may differ widely between antimicrobial drugs and clini- cal situations such as renal insufficiency. Multiple samples between subsequent doses may be required if an AUC has to be obtained. A peak concentration may also be required, in the case of application of an antimicrobial with a small volume of distribution, such as with aminoglycosides. When the volume of distribution alters, this may result in a large change in the antimicrobial concentration. Therefore, a peak measurement may be necessary in the latter case. Depending on the use of PK models, TDM can be initi- ated early to simulate steady-state concentrations and adjust the dose accordingly. If models are not utilised, a sample can be taken at steady state, and the dose can be adjusted after analysis. This approach is influenced by the drug’s charac- teristics, the laboratory’s turnaround time, the use of dosing software, and whether efficacy and/or toxicity are specifi- cally monitored. Ideally, dose optimisation should occur as soon as possible. The timing of TDM is expected to be of importance for clinical cure and it is expected that early TDM might improve clinical outcome. However, in clini- cal patients many factors influence clinical outcome com- plicating the analysis. In a retrospective study in critically ill patients, it has been shown that patients who obtained clinical cure and microbial eradication had beta-lactam drug concentrations measured earlier [11]. However, more research is required to assess the clinical outcome of early TDM measurements. Studies have been performed on the superiority as it comes to clinical outcome of applying TDM. In a systemic review and meta-analysis of randomised controlled trials by Sanz-Codina et al, it was demonstrated that TDM and MIPD do have benefit with regard to reducing nephrotoxicity and treatment failure and improving target attainment [12]. Also, an improvement in mortality, clinical cure or microbiologi- cal outcome was described, although not statistically signifi- cant. This is probably because there exist so many factors influencing these outcomes. More research should go into defining realistic clinical outcomes and targeting specific target groups.  2.2   Application of Pharmacokinetic Models  Pharmacokinetic modelling has a long and established his- tory in drug research. Pharmacokinetic models offer a pow- erful way to describe the behaviour of a drug within a popu- lation, mathematically capturing the relationship between drug concentrations and individual patient characteristics [13, 14]. These models have diverse applications, ranging from early pre-clinical drug development to post-market- ing studies. Their insights aid in understanding disease processes, simulating drug dosing scenarios, and ultimately guiding treatment decisions. It is important to notice that each model has its own unique strengths and limitations. Models inherently simplify real-world complexity, relying on assumptions to provide valuable approximations under specific conditions. Compartmental analysis is mostly used for models applied in TDM, which comprises the construction of both popPK and physiologically-based pharmacokinetic (PBPK) models [15]. PopPK analyses follows a \'top-down\' approach, beginning with observed PK data and fitting increasingly complex models; these models don’t always directly repre- sent physiological compartments. Conversely, PBPK utilises a ‘bottom-up’ approach, combining models of physiologi- cal and chemical processes until they accurately simulate observed PK data [16]. The key advantage of PBPK models lies in their ability to extrapolate beyond initial populations and conditions and allow for prediction of drug concentra- tions within specific organs or tissues [17]. However, to our knowledge no PKPB models have yet been applied for TDM purposes in clinical practice [18]. In MIPD, dose tailoring using a popPK model can be applied with and without the drug concentrations obtained from an individual patient. When drug concentrations are unavailable,   a priori   dosing utilises a popPK model’s median parameter estimates and covariate relationships to personalise dosing [19–21]. If drug concentrations have been obtained for a patient, maximum   a posteriori   (MAP) Bayes- ian analysis provides even greater precision by blending prior knowledge (PK parameter distributions) with observed patient data (drug concentrations and individual characteris- tics) to estimate the patient’s individual PK parameters [22]. These individual PK parameters enable optimised dosing regimens that target a specific concentration range, ulti- mately enhancing therapeutic outcomes and minimising side effects, toxicity and resistance [3]. However, it is important to remember that the accuracy of MAP Bayesian analysis hinges on the validity of the underlying popPK model.  2.3   Application of Machine Learning Techniques  In recent years, ML techniques have gained significant attention in various fields, including health care [23, 24]. Machine learning algorithms can analyse large amounts of data and uncover complex patterns and relationships that might be overlooked by traditional popPK analyses [25]. This opens doors for enhanced precision in dose individ- ualisation. Within the field of pharmacometrics, ML and artificial intelligence (AI) applications span from data han- dling (e.g., imputing missing values) to model selection. Researchers are exploring hybrid models that merge PK, ML and AI, as well as pure ML/AI-based prediction models for tasks like determining antimicrobial target attainment [26].\n1170   T. Preijers et al.  Classical popPK analyses and newer ML approaches are both valuable tools in drug development, but their perfor- mance and outcomes differ. Classical PK analyses, based on nonlinear mixed-effects modelling, provide a well- established framework for characterising drug behaviour in populations and have been successfully used in dose opti- misation studies. Machine learning approaches, on the other hand, offer potential advantages in terms of handling large datasets, identifying complex relationships and automating model building processes. While promising results have been reported with ML in PK modelling, direct comparisons are limited and often context-specific. A study by Destere et al found that an ML model in combination with a popula- tion PK model, referred to as hybrid approach, outperformed the application of a popPK model in predicting drug concen- trations in a specific patient population, but the generalis- ability of this finding remains uncertain [27]. Moreover, a study conducted by Li et al showed that this hybrid approach improved individual prediction of vancomycin clearance. However, the latter was obtained in simulated patients and not using real-world patient data [28]. The limitations of ML in popPK analyses include the need for large and high-quality datasets, potential overfitting of models, and the “black box” nature of some algorithms, which can make interpretation and regulatory acceptance challenging. Additionally, while ML can identify complex relationships, it may not always provide the mechanistic insights offered by classical PK models.  3   Challenges  Applying MIPD involves numerous challenges, particularly when aiming for innovative methods. The challenges cur- rently faced in the dose individualisation of antimicrobials will be discussed in the following sections.  3.1   Choosing the Correct Model  The use of a proper model is of utmost importance. Imple- menting a model into clinical practice that is not suitable for the target population can lead to patient harm due to unpredictable and unwanted concentration-dose relations. Hence, it is important that the model is validated on the target population prior to its use [29]. Models developed using seemingly similar populations can even result in a poor fit [21, 30]. Therefore, careful model selection and exter- nal validation of model performance using an independent dataset is key [31]. To ensure the reliability and predictability of models used for TDM and MIPD, pharmacometric model validation is a critical step. It involves assessing the model’s ability to accurately describe observed data and its performance in predicting drug PK in new scenarios. Common validation approaches include internal validation (e.g., cross-valida- tion, bootstrapping) and external validation using independ- ent datasets. Model validation guidelines, such as those pub- lished by the European Medicines Agency (EMA), provide a framework for best practices in this area. Moreover, Taylor et al have provided a step-by-step guide for clinical imple- mentation of models into MIPD software [32]. Additionally, choosing multiple models over a single model might be beneficial. Different techniques are avail- able for choosing the most suitable model for clinical use, such as model averaging or model ensembling [33–35]. With these methods, the models are weighted based on their abil- ity to describe the data, demographics of the population used to construct the model, or other features to select the most optimal model or (weighted) combination of models for obtaining individual PK parameters used for dose individu- alisation. Pharmacometric model averaging and ensembling are techniques used to combine predictions from multiple models, aiming to improve overall accuracy and robustness. Model averaging typically involves taking a weighted aver- age of predictions from different models, with weights deter- mined based on factors such as model performance, com- plexity or prior knowledge [34]. Model ensembling, on the other hand, is a more sophisticated approach that combines predictions from diverse models to leverage their strengths while mitigating their weaknesses. This can be implemented using various methods, such as stacking, boosting or bag- ging. The benefits of these techniques in pharmacometrics include improved predictive accuracy, reduced overfit- ting, and increased robustness. However, challenges such as model selection, weighting schemes and interpretability need to be carefully considered. Recent advancements like Synthetic Model Combination (SMC) have shown promise in incorporating demographic information for improved pre- dictions in PK and PD settings [33].  3.2   PK/PD Targets  The PK/PD target is, classically, studied using neutropenic murine thigh and lung infection models [36]. Three differ- ent values for the antibacterial effect are usually described: stasis, 1-log   10   kill and 2-log   10   kill. In general, the 1-log   10 kill and 2-log   10   kill values are preferred over a static effect. Especially in infections where a high bacterial load is pre- sumed to be present at the site of the infection, such as with pneumonia, the 1-log   10   kill target is preferred [37]. How- ever, the 1-log   10   kill or 2-log   10   kill cannot be achieved for all antimicrobials. For the beta-lactam antimicrobials, the correlation between animal-derived PK/PD targets and the outcome of treatment in human infections has been reviewed [38]. It was concluded that most clinical studies in human\n1171 Dose Individualisation of Antimicrobials: Where Are We?  suggests a PK/PD target that is congruent with the target from pre-clinical murine studies. Importantly, infection-site specific PK/PD targets might differ from the classical PK/PD targets often based on blood taken from systemic circulation [39]. Therefore, concentrations taken at the site of infection cannot be automatically interpreted using classical PK/PD targets. In clinical studies, other PK/PD targets such as the 100% f T >MIC   or   f T >4xMIC   are also used for guiding antimicro- bial dosing [40]. The 100% f T >MIC   is commonly used in criti- cally ill patients because of the severity of their condition [41]. These patients often have altered PK parameters, which poses a risk for target non-attainment [42]. For many anti- microbials, the bacterial killing does not increase above a threshold value. Consequently, a PK/PD target of 80% f T >MIC might be equally effective to 100% f T   >MIC   . In pre-clinical studies a near-maximal killing can be reached at lower val- ues than 100% f T>MIC, indicating that the additional effect of increasing the % f T>MIC above a certain value to 100% might be limited. As can be seen for example for   Klebsiella pneumoniae   and cefotaxime, in which at 65% f T>MIC near maximal killing is achieved [43]. In addition, a systematic literature review demonstrated that there is no compelling clinical evidence showing superior efficiency of bactericidal as compared with bacteriostatic agents in treatment of severe infections [44]. Therefore, it is questionable whether high PK/PD targets are required in cases where alterations in the PK parameters are accounted for by TDM-guided dosing. The latter may also result in supra-therapeutic or toxic doses. However, it is unclear what concentration is needed at the target site. It can be argued that for difficult-to-reach infec- tions, a higher systemic concentration may be necessary to achieve the correct concentration at the target site. Depend- ent on the characteristics of the drug (chance of toxicity), a dosing advise should be given balancing between sufficient efficacy and risk of toxicity. Although MIC values used to determine PK/PD tar- gets are obtained by repeated measurement using a gold standard method, measuring MICs multiple times in clini- cal practice is not feasible. Due to the inherent variability of the MIC measurement, the use of the epidemiological cut-off (ECOFF) value is recommended for TDM instead [45]. However, the % f T   >ECOFF   value might be close to the % f T   >4xMIC   value depending on the wild-type distribution for several antimicrobial-pathogen combinations. Another challenge for determining an accurate PK/PD index is the target that needs to be adhered to when com- bination therapy (multiple antimicrobials) is applied [46]. Future research should focus on integrating the population PK and PD of multiple drugs, mechanisms of synergy and resistance and computational models to optimise combina- tion therapies.  3.3   Antimicrobial Resistance  With the increasing resistance to antimicrobials, assess- ment of adequate dosing regimen is required. For differ- ent pathogens and antimicrobials, there is considerable variation between the antimicrobial exposure needed to suppress the emergence of resistance. Notwithstand- ing, the antimicrobial exposure required to suppress the emergence of resistance generally exceeds that of clini- cal efficacy [47]. This highlights a complex and evolving challenge for clinicians and researchers. Furthermore, the optimal exposure to prevent resistance can vary signifi- cantly across different pathogens and antimicrobial agents. This is further complicated by the imprecise measurement of bacterial susceptibility, showing high variability [48]. Understanding the relationship between antimicrobial con- centration and the development of resistance is crucial. Currently, these relationships only consider the emergence of resistance in the targeted pathogen and not in commen- sal microorganisms. The latter poses a major limitation. If a more accurate method for MIC testing is developed, all PD analyses have to be reassessed. This also goes for current MIC testing, included in the determination of PK/ PD targets. When treatment with a specific antibiotic is needed for isolates with MIC values above the clinical breakpoint, it has been suggested to perform TDM based on the MIC measured with additional 2-fold dilutions added to the measurement. For isolates with a wide wild- type distribution it might be necessary to add more than a 2-fold dilution to the measured MIC [45].  3.4   Practical Implementation  3.4.1   Regulatory Guidelines  To apply models clinically, compliance with medical device regulations (MDR) is essential, as models and the software where they are implemented in are considered to be medical devices. Validation of this software is required, and certification confirming data storage outside the user’s jurisdiction is important. Additionally, data transfer must adhere to the General Data Protection Regulation (GDPR) [49]. In addition, as proposed doses by the MIPD soft- ware may exceed the approved dose ranges for a specific antimicrobial, an approval by a Medical Research Ethics Committee (MREC) may also be required.  3.4.2   Model Complexity and User Experience  To facilitate seamless adoption and application of PK/PD models in real-world clinical settings, user-friendly inter- faces and training programmes for health care professionals\n1172   T. Preijers et al.  are essential [50]. Increasing model complexity may hamper its application in clinical practice as it is less clear how the model results have been obtained. As for ML models, one is generally unaware of the underlying processes driving the model results. Therefore, clinicians may be hesitant to adopt the use of these models in clinical practice. Unlike many AI/ ML techniques, popPK and PBPK models offer transparency in their underlying calculations. Additionally, high model complexity may lead to other issues such as unavailabil- ity of required data to apply the model (discussed below). Moreover, as the calculations performed by such models are complex and computationally demanding, specialised computer software and hardware and IT support are also required, especially for integration and implementation in the current hospital infrastructure.  3.5   Outcome Measures  Although clinical trials evaluating the impact of MIPD on antimicrobial outcomes are increasing, the existing evidence base remains limited. A meta-analysis of randomised con- trolled trials (RCTs) noted that MIPD potentially reduces mortality. Although statistically significant reductions in treatment failure and nephrotoxicity were obtained, the reductions obtained in mortality were not statistically sig- nificant [12]. Direct comparison of dose optimisation strat- egies across clinical trials is challenging due to complexi- ties in non-inferiority trial designs and large sample size requirements [51]. The Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR) methodologies are transforming clinical trial practices, particularly in antimicrobial optimisation. These approaches establish a two-tiered evaluation system. The DOOR innovates by ranking trial participants based on their overall outcomes, considering benefits, harms, and potentially quality of life. This patient-centric approach contrasts with traditional methods that focus on analysing outcomes rather than patients. The RADAR, a specialised DOOR application for antimicrobial trials, integrates clinical outcomes with drug use, prioritising reduced antimicrobial exposure without compromising patient results. Multiple studies demonstrate the value of DOOR and RADAR across diverse medical settings. Examples include the CASA RELAX study comparing appendectomy anti- biotic strategies [52], procalcitonin-guided algorithms in burn patients [53], urinary tract infections [54], and intra- abdominal infections [55]. Studies in paediatric pneumonia and the DigiSep-Trial for sepsis patients, further illustrate the potential of DOOR and RADAR to improve clinical responses and optimise cost-effective diagnostic strategies [56, 57]. These studies highlight the significant utility of DOOR and RADAR for enhancing antimicrobial use and evaluating comprehensive clinical outcomes.  3.6   Model‑Informed Precision Dosing Software  While MIPD software offers the potential to streamline anti- microbial dose optimisation, their widespread clinical adop- tion faces several challenges [49]. Factors hindering imple- mentation include limited robust evidence demonstrating the utility, impact, and cost effectiveness of MIPD, as well as concerns around user-friendliness, high costs, privacy regulations, and the technical expertise required [49, 58]. Additionally, ensuring the availability of validated popPK models within the software is crucial for accurate dosing recommendations. To assist clinicians, a comparative evalu- ation of ten available MIPD software tools has been con- ducted, analysing features like user-interface design, popPK models, user-support, and costs [49]. Careful consideration of factors such as model validation, covariate availability, appropriate patient selection and clinician training is essen- tial for successful MIPD software implementation in clinical practice [59]. Ideally, seamless integration with electronic patient record (EPR) systems would increase transferability of patient data and, thus, optimise workflow. To accurately measure drug concentrations for MIPD, the choice of analytical method is crucial. For certain antimicro- bials (like aminoglycosides and vancomycin), immunoassays offer a convenient option. However, many other antimicro- bials require more sensitive techniques like liquid chro- matography–mass spectrometry/MS or high-performance liquid chromatography. When interpreting MIPD results, it is essential to consider both the analytical method and the biological matrix where the sample was taken, as these factors can significantly influence measured drug concen- trations [60]. Additionally, precise documentation of dose administration and sample collection times is important for obtaining accurate MIPD results. Uncertainties in timing can result in biased and imprecise prediction when using popPK models, potentially leading to suboptimal supra-therapeutic dose recommendations [61].  3.7   Target‑Site Concentrations Versus Plasma Concentrations  Therapeutic drug monitoring is standardly performed in blood and the reference values for TDM in most cases are based on plasma concentrations. This is in line with the pre- clinical studies on the PD-target in which the PK exposure is determined in murine blood while the effect is measured in murine tissues. However, the latter is often not performed at the site of infection. It would be of added value to also perform TDM directly in tissues. However, in order to inter- pretate the results obtained from TDM we also need the PD-target based on concentrations in the corresponding tis- sues. In our research group, we have performed TDM for antibiotics in cerebrospinal fluid (CSF) in clinical practice.\n1173 Dose Individualisation of Antimicrobials: Where Are We?  Nevertheless, TDM performed at other target sites is still only performed in research [62]. In bone and joint infections, for example, the literature is sparse for most antibiotics. In addition, many variable and total antibiotic concentrations are published. More extensive research on the PK/PD of antibiotics in bone and joint infec- tions is required [63].  3.8   Cost Effectiveness and Logistics  Cost-effectiveness evaluations of individualisation strate- gies in pharmacometrics are crucial to assess their economic viability and sustainability within health care systems. These evaluations should consider both the direct costs associated with model development, validation, and implementation, as well as the indirect costs and benefits related to improved patient outcomes and resource utilisation. Additionally, the logistic requirements for successful individualisation, such as data collection, infrastructure, and personnel training, need to be thoroughly examined. For instance, the imple- mentation of MIPD may require investment in software and hardware infrastructure, as well as training healthcare pro- fessionals on model interpretation and application [64].  4   Future  4.1   Data Required for Machine Learning Techniques  Providing data for ML in TDM involves several challenges, which are outlined in the following sections.  4.1.1   Data Quality and Completeness  TDM data can be collected using various approaches, including sparse, opportunistic, or scavenged sampling. However, limited data availability poses a significant chal- lenge for training and deploying effective ML models, as these techniques thrive on vast datasets. When essential data are scarce, it becomes difficult to build reliable mod- els, and missing data points can further compromise accu- racy. Imputing missing values requires careful strategies to minimise bias [65–67]. Fortunately, the landscape is chang- ing with the rise of automated PK data recording modali- ties, such as infusion systems connected to EPRs and the increasing use of methods like dried blood spots (DBS) for sample collection. These advancements have the potential to offer new ways of collecting data needed to power dose optimisation.  4.1.2   Heterogeneity of Data  Patient populations vary in demographics, genetics, and comorbidities. Incorporating this heterogeneity into ML models is challenging but essential for generalisability across different patient groups. Integrating heterogeneous data from multiple sources requires clear guidelines that adhere to high ethical and legal standards [68].  4.1.3   Temporal Dynamics  Drug concentrations in the body change over time, influ- enced by factors such as metabolism, renal function, and adherence to medication. Rapid fluctuations in physiologi- cal functions, such as augmented renal clearance (ARC), impaired kidney or liver function, and altered drug distri- bution volume are experienced especially by critically ill patients [10]. These dynamic changes can significantly impact antimicrobial exposure. Although adding complex- ity to the modelling process, accurately capturing these temporal dynamics is crucial for applying TDM effectively. Moreover, an ample number of data points is required to predict such dynamic processes [69]. In clinical practice, this may be hampered by the turn-around time of the applied analytical assay. Accounting for rapidly changing temporal dynamics is important for optimising dosing regimens in critically ill patients. Temporal dynamics can also occur in the inoculum. Cur- rently, in all in vitro methods (such as MIC testing) and the in vivo preclinical studies, the used inocula are standard- ised. This makes it easier to compare results. On the other hand, it has been shown that in a mouse model higher drug exposures are required to achieve stasis or 1-log   10   killing against a higher   (10   7   CFU/mL) than a lower   (10   5   CFU/ mL) inoculum of multiple   Staphylococcus aureus   strains for four classes of antibiotics [70, 71]. Although the clini- cal relevance of experimental inoculum effects is not fully understood, it is noted that in infections in which a high inoculum can be expected, such as in ventilator-associated pneumonia, it may be more desirable to achieve the more stringent PD-targets [70].  4.1.4   Validation and Generalisation  Validating models, especially ML models, for TDM is chal- lenging due to the limited availability of independent data- sets. Rigorous validation is crucial to ensure the reliable model performance in different real-world clinical scenarios [29, 72]. Furthermore, models trained on specific patient populations or data sources may not adequately predict other populations. Generalising model results across diverse clini- cal contexts is a common challenge, and careful extrapola- tion of parameter estimates is warranted, if at all possible.\n1174   T. Preijers et al.  4.1.5   Regulatory Compliance  Population PK models, obtained using non-linear mixed effect modelling or ML, may be subject to regulatory scru- tiny. Ensuring that data and models comply with regulatory standards is essential for their acceptance in clinical practice [73, 74].  4.2   Clinical Integration  Implementation of models into health information systems (HIS) comprising EPRs has multiple advantages. It reduces the human factor of manually typing information from one system into the other. Moreover, the models may be able to autonomically tailor the dose of an antimicrobial to the needs of the individual patient. Furthermore, models inte- grated in a HIS may continuously learn from new incoming real-world data (RWD) as well as on feedback of their own performance. Therefore, autonomic updating of the model may continuously improve the model performance and pro- vide more accurate adjustments of a dosing regimen.  4.3   Real‑Time Monitoring  When performing TDM, biological samples (typically plasma) are transported to an analysis laboratory, with a turn-around time ranging from approximately 30 minutes to 48 hours. This timeframe varies depending on the spe- cific drug and the availability of the assay. Recognising the importance of promptly initiating effective antimicrobial therapy, reducing the turnaround time becomes crucial for timely adjustments of antimicrobial dosing regimen [75]. Another limitation of current TDM practices revolves around the minimal number of available antimicrobial assays in most laboratories [76]. Considering these challenges, there is a necessity to create innovative technologies that address the limitations of traditional TDM processes. In this context, the exploration of real-time TDM sensor monitor- ing emerges as a promising solution [77, 78]. Prerequisites for this technology encompass: transduction, involving the identification of targets in human matrices [79]; ongoing sample collection via, for instance, interstitial fluid sampling using microneedle biosensors [80]; and instantaneous signal processing of assay outcomes [81]. Therefore, biosensors could facilitate target site concentration measurement.  Fig.   1   Differences between current practice of MIPD and future practice. The left panel delineates the conventional methodology for optimising antibiotic dosing in current clinical practice, whereas the right panel outlines the proposed advancements for future practice.   AI  artificial intelligence,   AUC/MIC   the ratio of the area under the con- centration-time curve to MIC,   C max /MIC   the ratio of maximum drug concentration to MIC,   MAP   maximum a posteriori,   MIC   minimum inhibitory concentration,   MIPD   model-informed precision dosing,  ML   machine learning,   PK/PD   pharmacokinetic/pharmacodynamic,  TDM   therapeutic drug monitoring,   T>MIC   the duration of time that the drug concentration remains above the MIC during a dosing inter- val\n1175 Dose Individualisation of Antimicrobials: Where Are We?  Numerous biosensor techniques are currently undergoing testing, including aptamer-based electrochemical and elec- tronic sensors [82]. Among these technologies is one that originates from particle mobility, utilising a \'competition assay\' [83]. The assay identifies a binding event through a sudden reduction in particle mobility, attributed to inter- actions between a particle and a sensor surface. As these interactions are facilitated by weak biological forces, they are reversible, allowing continuous monitoring. Bright field optical microscopy records the transitions between unbound and bound states over time for numerous particles concur- rently, facilitating precise concentration determination. Critical factors for enhancing the robustness of biosensors encompass selectivity, sensitivity, reproducibility, reusabil- ity, and long-term stability. Additionally, there is a necessity to validate the new technology against the gold standard of mass-spectrometry (MS). Given the extensive data captured, processed, and managed during clinical use, it is imperative to prioritise data confidentiality. Alongside novel techniques, biosensors could also be measuring novel blood or target site markers. For example, Gastine et al investigated the use of the galactomannan index (GMI) for determining the dynamic endpoint of antifungal response of invasive pulmonary aspergillosis (IPA) in neu- tropenic patients [84]. It was demonstrated that a PK/PD index could be adequately established using the GMI (30 mg*h/L). The latter shows that other PK/PD parameters such as the MIC can also be applied for providing optimised anti- biotic treatment. Looking ahead, the integration of AI may prove instru- mental in facilitating data analysis and exposure prediction, potentially playing a substantial role in the future imple- mentation of real-time biosensors, ultimately leading to con- tinuous dose optimisation [85]. Applying real-time meas- urements may only be beneficial for a particular group of patients, such as critically ill patients. It should be further investigated what type of patients could benefit from this modality. Moreover, clinical trials need to be performed to obtain evidence for cost effectiveness as well as improved antimicrobial efficiency (Fig. 1).  5   Conclusion  Dose individualisation of antimicrobial drugs is crucial to optimise therapeutic outcomes and minimise the risk of adverse effects. Population PK models, combined with MAP Bayesian analysis, have been valuable tools in this context, allowing for the estimation of individual PK parameters and the prediction of drug concentrations. Machine learning and AI techniques show promise in enhancing the accuracy of dose individualisation by capturing complex relationships that may not be captured by traditional popPK models. How- ever, further research is needed to fully explore the potential of ML and AI in this field. Careful model selection, valida- tion, and consideration of ethical and regulatory aspects are essential to ensure the reliability and applicability of the results obtained using these methodologies.  Data availability   Not applicable.  Declarations  Funding   For this review, no funding was obtained.  Conflict of interest   TP, AM, AA, BdW, SS, and BK have no conflict of interest to report.  Ethics approval   Not applicable.  Consent to participate   Not applicable.  Consent for publication   Not applicable.  Availability of data and materials   Not applicable.  Code availability   Not applicable.  Author contributions   All authors contributed equally to the concep- tion, writing, and revision of the review.  Open Access   This article is licensed under a Creative Commons Attri- bution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Com- mons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regula- tion or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.  References  1.   Gould K. Antibiotics: from prehistory to the present day. J Anti- microb Chemother. 2016;71(3):572–5.  2.   Radlinski L, Conlon BP. Antibiotic efficacy in the complex infec- tion environment. Curr Opin Microbiol. 2018;42:19–24.  3.   Wicha SG, Martson AG, Nielsen EI, Koch BCP, Friberg LE, Alffenaar JW, et al. From therapeutic drug monitoring to model- informed precision dosing for antibiotics. Clin Pharmacol Ther. 2021;109(4):928–41.  4.   Adembri C, Novelli A. Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regi- mens that are less vulnerable to resistance. Clin Pharmacokinet. 2009;48(8):517–28.  5.   Zhang L, Xie H, Wang Y, Wang H, Hu J, Zhang G. Pharmaco- dynamic parameters of pharmacokinetic/pharmacodynamic (PK/ PD) integration models. Front Vet Sci. 2022;9: 860472.\n1176   T. Preijers et al.  6.   Darwich AS, Polasek TM, Aronson JK, Ogungbenro K, Wright DFB, Achour B, et al. Model-informed precision dosing: back- ground, requirements, validation, implementation, and forward trajectory of individualizing drug therapy. Annu Rev Pharmacol Toxicol. 2021;61:225–45.  7.   Kang JS, Lee MH. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1–10.  8.   Rodriguez-Gascon A, Solinis MA, Isla A. The role of PK/PD analysis in the development and evaluation of antimicrobials. Pharmaceutics. 2021;13(6):833.  9.   Nielsen EI, Cars O, Friberg LE. Pharmacokinetic/pharmacody- namic (PK/PD) indices of antibiotics predicted by a semimecha- nistic PKPD model: a step toward model-based dose optimization. Antimicrob Agents Chemother. 2011;55(10):4619–30.  10.   Koch BCP, Muller AE, Hunfeld NGM, de Winter BCM, Ewoldt TMJ, Abdulla A, Endeman H. Therapeutic drug monitoring of antibiotics in critically ill patients: current practice and future perspectives with a focus on clinical outcome. Ther Drug Monit. 2022;44(1):11–8.  11.   Al-Shaer MH, Rubido E, Cherabuddi K, Venugopalan V, Klinker K, Peloquin C. Early therapeutic monitoring of beta-lactams and associated therapy outcomes in critically ill patients. J Antimicrob Chemother. 2020;75(12):3644–51.  12.   Sanz-Codina M, Bozkir H, Jorda A, Zeitlinger M. Individualized antimicrobial dose optimization: a systematic review and meta- analysis of randomized controlled trials. Clin Microbiol Infect. 2023;29(7):845–57.  13.   Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduc- tion to pharmacokinetic modeling methods. CPT Pharmacomet- rics Syst Pharmacol. 2013;2(4): e38.  14.   Duffull SB, Wright DF, Winter HR. Interpreting population phar- macokinetic-pharmacodynamic analyses—a clinical viewpoint. Br J Clin Pharmacol. 2011;71(6):807–14.  15.   Rescigno A. The rise and fall of compartmental analysis. Pharma- col Res. 2001;44(4):337–42.  16.   Suri A, Chapel S, Lu C, Venkatakrishnan K. Physiologically based and population PK modeling in optimizing drug develop- ment: a predict-learn-confirm analysis. Clin Pharmacol Ther. 2015;98(3):336–44.  17.   Tsamandouras N, Rostami-Hodjegan A, Aarons L. Combining the “bottom up” and “top down” approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data. Br J Clin Pharmacol. 2015;79(1):48–55.  18.   Ferreira A, Lapa R, Vale N. PBPK modeling and simulation and therapeutic drug monitoring: possible ways for antibiotic dose adjustment. Processes. 2021;9(11):2087.  19.   Heus A, Uster DW, Grootaert V, Vermeulen N, Somers A, In’t Veld DH, et al. Model-informed precision dosing of vancomy- cin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models. Int J Antimicrob Agents. 2022;59(5): 106579.  20.   Duong A, Simard C, Williamson D, Marsot A. Tobramycin a priori dosing regimens based on PopPK model simulations in critically ill patients: are they transferable? Ther Drug Monit. 2023;45(5):616–22.  21.   Yang N, Wang J, Xie Y, Ding J, Wu C, Liu J, Pei Q. External eval- uation of population pharmacokinetic models to inform precision dosing of meropenem in critically ill patients. Front Pharmacol. 2022;13: 838205.  22.   Guo T, van Hest RM, Zwep LB, Roggeveen LF, Fleuren LM, Bosman RJ, et al. Optimizing predictive performance of bayes- ian forecasting for vancomycin concentration in intensive care patients. Pharm Res. 2020;37(9):171.  23.   Javaid M, Haleem A, Pratap Singh R, Suman R, Rab S. Sig- nificance of machine learning in healthcare: features, pillars and applications. Int J Intell Netw. 2022;3:58–73.  24.   Stankevičiūtė K, Woillard J-B, Peck RW, Marquet P, van der Schaar M. Bridging the worlds of pharmacometrics and machine learning. Clin Pharmacokinet. 2023;62(11):1551–65.  25.   Huang Z, Denti P, Mistry H, Kloprogge F. Machine learning and artificial intelligence in PK-PD modeling: fad, friend, or foe? Clin Pharmacol Ther. 2024;115(4):652–4.  26.   Tang BH, Zhang JY, Allegaert K, Hao GX, Yao BF, Leroux S, et al. Use of machine learning for dosage individualization of van- comycin in neonates. Clin Pharmacokinet. 2023;62(8):1105–16.  27.   Destere A, Marquet P, Labriffe M, Drici MD, Woillard JB. A hybrid algorithm combining population pharmacokinetic and machine learning for isavuconazole exposure prediction. Pharm Res. 2023;40(4):951–9.  28.   Li G, Sun Y, Zhu L. Application of machine learning combined with population pharmacokinetics to improve individual predic- tion of vancomycin clearance in simulated adult patients. Front Pharmacol. 2024;15:1352113.  29.   Sherwin C, Kiang T, Spigarelli M, Ensom M. Fundamentals of population pharmacokinetic modelling: validation methods. Clin Pharmacokinet. 2012;51:573–90.  30.   Guo T, van Hest RM, Roggeveen LF, Fleuren LM, Tho- ral PJ, Bosman RJ, et al. External evaluation of population pharmacokinetic models of vancomycin in large cohorts of intensive care unit patients. Antimicrob Agents Chemother. 2019;63(5):e02543-e2618.  31.   Baklouti S, Marolleau S, Chavanet P, Bonnet E, Concordet D, Gandia P. Why is it desirable to do the external evaluation of a population pharmacokinetic model? Antimicrob Agents Chem- other. 2022;66(1): e0149321.  32.   Taylor ZL, Poweleit EA, Paice K, Somers KM, Pavia K, Vinks AA, et al. Tutorial on model selection and validation of model input into precision dosing software for model-informed precision dosing. CPT Pharmacometrics Syst Pharmacol. 2023;12(12):1827–45.  33.   Chan A, Peck R, Gibbs M, van der Schaar M. Synthetic model combination: a new machine-learning method for pharmacomet- ric model ensembling. CPT Pharmacometrics Syst Pharmacol. 2023;12(7):953–62.  34.   Uster DW, Stocker SL, Carland JE, Brett J, Marriott DJE, Day RO, Wicha SG. A model averaging/selection approach improves the predictive performance of model-informed preci- sion dosing: vancomycin as a case study. Clin Pharmacol Ther. 2021;109(1):175–83.  35.   Sibieude E, Khandelwal A, Girard P, Hesthaven JS, Terranova N. Population pharmacokinetic model selection assisted by machine learning. J Pharmacokinet Pharmacodyn. 2022;49(2):257–70.  36.   Adembri C, Novelli A, Nobili S. Some suggestions from PK/ PD principles to contain resistance in the clinical setting-focus on ICU patients and gram-negative strains. Antibiotics (Basel). 2020;9(10):676.  37.   Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antimicrobial medicinal products. EMA/ CHMP/594085/2015. 2017.  38.   Berry AV, Kuti JL. Pharmacodynamic thresholds for beta-lac- tam antibiotics: a story of mouse versus man. Front Pharmacol. 2022;13: 833189.  39.   Farrington N, McEntee L, Johnson A, Unsworth J, Darlow C, Jimenez-Valverde A, et al. Pharmacodynamics of meropenem and tobramycin for neonatal meningoencephalitis: novel approaches to facilitate the development of new agents to address the chal- lenge of antimicrobial resistance. Antimicrob Agents Chemother. 2022;66(4): e0218121.\n1177 Dose Individualisation of Antimicrobials: Where Are We?  40.   Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimo- poulos G, et al. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58(8):1072–83.  41.   Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med. 2020;46(6):1127–53.  42.   Wieringa A, Ewoldt TMJ, Gangapersad RN, Gijsen M, Parolya N, Kats C, et al. Predicting beta-lactam target non-attainment in ICU patients at treatment initiation: development and external validation of three novel (machine learning) models. Antibiotics (Basel). 2023;12(12):1674.  43.   Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1–10 ( quiz 1-2 ).  44.   Wald-Dickler N, Holtom P, Spellberg B. Busting the myth of “static vs cidal”: a systemic literature review. Clin Infect Dis. 2018;66(9):1470–4.  45.   Mouton JW, Muller AE, Canton R, Giske CG, Kahlmeter G, Tur- nidge J. MIC-based dose adjustment: facts and fables. J Antimi- crob Chemother. 2018;73(3):564–8.  46.   Bulman ZP, Wicha SG, Nielsen EI, Lenhard JR, Nation RL, Theuretzbacher U, et al. Research priorities towards precision antibiotic therapy to improve patient care. Lancet Microbe. 2022;3(10):e795–802.  47.   Sumi CD, Heffernan AJ, Lipman J, Roberts JA, Sime FB. What antibiotic exposures are required to suppress the emergence of resistance for gram-negative bacteria? A Systematic Review Clin Pharmacokinet. 2019;58(11):1407–43.  48.   Malmberg C, Torpner J, Fernberg J, Öhrn H, Johansson C, Täng- dén T, Kreuger J. Evaluation of the speed, accuracy and precision of the QuickMIC rapid antibiotic susceptibility testing assay in a clinical setting. bioRxiv. 2021:2021.08.11.455925.  49.   Kantasiripitak W, Van Daele R, Gijsen M, Ferrante M, Spriet I, Dreesen E. Software tools for model-informed precision dosing: how well do they satisfy the needs? Front Pharmacol. 2020;11:620.  50.   Fuchs A, Csajka C, Thoma Y, Buclin T, Widmer N. Benchmark- ing therapeutic drug monitoring software: a review of available computer tools. Clin Pharmacokinet. 2013;52(1):9–22.  51.   Evans SR, Rubin D, Follmann D, Pennello G, Huskins WC, Powers JH, et al. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin Infect Dis. 2015;61(5):800–6.  52.   Yeh DD, Hatton GE, Pedroza C, Pust G, Mantero A, Namias N, Kao LS. Complex and simple appendicitis: REstrictive or Lib- eral postoperative Antibiotic eXposure (CASA RELAX) using desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR): study protocol for a randomized controlled trial. Trauma Surg Acute Care Open. 2022;7(1): e000931.  53.   Zbyrak V, Reveron SL, Smoke S, Mehta A, Marano MA, Lee R. Antibiotic usage after procalcitonin-guided therapy algorithm implementation in a burn intensive care unit. Ann Burns Fire Dis- asters. 2020;33(4):317–21.  54.   Sherwood K, Ikuta K. 2241. Methenamine for the prevention of recurrent UTIs: a desirability of outcome ranking (DOOR) analy- sis for the alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women (ALTAR) Trial. Open Forum Infect Dis. 2022;9:Supplement_2.  55.   Celestin AR, Odom SR, Angelidou K, Evans SR, Coimbra R, Guidry CA, et al. Novel method suggests global superiority of short-duration antibiotics for intra-abdominal infections. Clin Infect Dis. 2017;65(9):1577–9.  56.   Williams DJ, Creech CB, Walter EB, Martin JM, Gerber JS, Newland JG, et al. Short- vs standard-course outpatient antibi- otic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr. 2022;176(3):253–61.  57.   Brenner T, Skarabis A, Stevens P, Axnick J, Haug P, Grumaz S, et al. Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)-study protocol for a randomized, controlled, inter- ventional, open-label, multicenter trial. Trials. 2021;22(1):714.  58.   Darwich AS, Ogungbenro K, Vinks AA, Powell JR, Reny JL, Marsousi N, et al. Why has model-informed precision dos- ing not yet become common clinical reality? Lessons from the past and a roadmap for the future. Clin Pharmacol Ther. 2017;101(5):646–56.  59.   Oliver MB, Boeser KD, Carlson MK, Hansen LA. Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system. Am J Health Syst Pharm. 2023;80(11):670–7.  60.   Oyaert M, Peersman N, Kieffer D, Deiteren K, Smits A, Allegaert K, et al. Novel LC-MS/MS method for plasma vancomycin: com- parison with immunoassays and clinical impact. Clin Chim Acta. 2015;441:63–70.  61.   Alihodzic D, Broeker A, Baehr M, Kluge S, Langebrake C, Wicha SG. Impact of inaccurate documentation of sampling and infu- sion time in model-informed precision dosing. Front Pharmacol. 2020;11:172.  62.   Bilal H, Bergen PJ, Tait JR, Wallis SC, Peleg AY, Roberts JA, et al. Clinically relevant epithelial lining fluid concentrations of meropenem with ciprofloxacin provide synergistic killing and resistance suppression of hypermutable pseudomonas aerugi- nosa in a dynamic biofilm model. Antimicrob Agents Chemother. 2020;64(7):e00469-e520.  63.   Koch BCP, Zhao Q, Oosterhoff M, van Oldenrijk J, Abdulla A, de Winter BCM, et al. The mysteries of target site concen- trations of antibiotics in bone and joint infections: what is known? A narrative review. Expert Opin Drug Metab Toxicol. 2022;18(9):587–600.  64.   Kluwe F, Michelet R, Mueller-Schoell A, Maier C, Klopp-Schulze L, van Dyk M, et al. Perspectives on model-informed precision dosing in the digital health era: challenges, opportunities, and recommendations. Clin Pharmacol Ther. 2021;109(1):29–36.  65.   Emmanuel T, Maupong T, Mpoeleng D, Semong T, Mphago B, Tabona O. A survey on missing data in machine learning. Journal of Big Data. 2021;8(1):140.  66.   Wang H, Tang J, Wu M, Wang X, Zhang T. Application of machine learning missing data imputation techniques in clinical decision making: taking the discharge assessment of patients with spontaneous supratentorial intracerebral hemorrhage as an exam- ple. BMC Med Inform Decis Mak. 2022;22(1):13.  67.   Irby DJ, Ibrahim ME, Dauki AM, Badawi MA, Illamola SM, Chen M, et al. Approaches to handling missing or “problematic” pharmacology data: pharmacokinetics. CPT Pharmacometr Syst Pharmacol. 2021;10(4):291–308.  68.   Collin CB, Gebhardt T, Golebiewski M, Karaderi T, Hillemanns M, Khan FM, et al. Computational models for clinical applica- tions in personalized medicine-guidelines and recommenda- tions for data integration and model validation. J Pers Med. 2022;12(2):166.  69.   Kang D, Schwartz JB, Verotta D. Sample size computations for PK/PD population models. J Pharmacokinet Pharmacodyn. 2005;32(5):685–701.  70.   Bulitta JB, Hope WW, Eakin AE, Guina T, Tam VH, Louie A, et   al. Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to\n1178   T. Preijers et al.  support translation to humans. Antimicrob Agents Chemother. 2019;63(5):e02307-e2318.  71.   Lee DG, Murakami Y, Andes DR, Craig WA. Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staph- ylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice. Antimicrob Agents Chemother. 2013;57(3):1434–41.  72.   Kaminwar SR, Goschenhofer J, Thomas J, Thon I, Bischl B. Structured verification of machine learning models in industrial settings. Big Data. 2023;11(3):181–98.  73.   Dykstra K, Mehrotra N, Tornøe CW, Kastrissios H, Patel B, Al-Huniti N, et al. Reporting guidelines for population pharmacokinetic analyses. J Pharmacokinet Pharmacodyn. 2015;42(3):301–14.  74.   Sun H, Fadiran EO, Jones CD, Lesko L, Huang SM, Higgins K, et al. Population pharmacokinetics. A regulatory perspective. Clin Pharmacokinet. 1999;37(1):41–58.  75.   Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Fer- rer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.  76.   Ewoldt TMJ, Abdulla A, van den Broek P, Hunfeld N, Bahmany S, Muller AE, et al. Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nation- wide cross-sectional study. BMC Infect Dis. 2022;22(1):611.  77.   Mishi RD, Stokes MA, Campbell CA, Plaxco KW, Stocker SL. Real-time monitoring of antibiotics in the critically ill using bio- sensors. Antibiotics (Basel). 2023;12(10):1478.  78.   Ates HC, Roberts JA, Lipman J, Cass AEG, Urban GA, Dincer C. On-site therapeutic drug monitoring. Trends Biotechnol. 2020;38(11):1262–77.  79.   Barrett JF, Hoch JA. Two-component signal transduction as a target for microbial anti-infective therapy. Antimicrob Agents Chemother. 1998;42(7):1529–36.  80.   Kiang TKL, Ranamukhaarachchi SA, Ensom MHH. Revolution- izing therapeutic drug monitoring with the use of interstitial fluid and microneedles technology. Pharmaceutics. 2017;9(4):43.  81.   Rawson TM, O’Hare D, Herrero P, Sharma S, Moore LSP, de Barra E, et al. Delivering precision antimicrobial therapy through closed-loop control systems. J Antimicrob Chemother. 2018;73(4):835–43.  82.   Zambry NS, Ahmad Najib M, Awang MS, Selvam K, Khalid MF, Bustami Y, et al. Aptamer-based electrochemical biosensors for the detection of salmonella: a scoping review. Diagnostics (Basel). 2022;12(12):3186.  83.   Visser EWA, Yan J, van Ijzendoorn LJ, Prins MWJ. Continuous biomarker monitoring by particle mobility sensing with single molecule resolution. Nat Commun. 2018;9(1):2541.  84.   Gastine S, Hope W, Hempel G, Petraitiene R, Petraitis V, Mick- iene D, et al. Pharmacodynamics of posaconazole in experimental invasive pulmonary aspergillosis: utility of serum galactomannan as a dynamic endpoint of antifungal efficacy. Antimicrob Agents Chemother. 2021;65(2):e01574-e1620.  85.   Heil EL, Nicolau DP, Farkas A, Roberts JA, Thom KA. Phar- macodynamic target attainment for cefepime, meropenem, and piperacillin-tazobactam using a pharmacokinetic/pharmacody- namic-based dosing calculator in critically ill patients. Antimicrob Agents Chemother. 2018;62(9):e01008-e1018.',0.07505306853605381,'[\"%\", \"\'competition\", \"\'top-down\'\", \"(\", \"(%\"]','2025-11-29 17:08:07.192219'),(73,3,'Adoption of telemedicine for obesity treatment during the COVID-19 pandemic achieved comparable outcomes to in-person visits ☆  Andr ´ es R. Latorre-Rodríguez   a , b , Raj H. Shah   c , Seema Munir   a , Sumeet K. Mittal   a , d , *  a   Norton Thoracic Institute, St. Joseph ’ s Hospital and Medical Center, Phoenix, AZ, USA  b   Grupo de Investigaci ´ on Clínica, Escuela de Medicina y Ciencias de La Salud, Universidad del Rosario, Bogot ´ a, Colombia  c   University of Arizona School of Medicine, Phoenix, AZ, USA  d   Creighton University School of Medicine, Phoenix, AZ, USA  A R T I C L E   I N F O  Keywords:  Healthcare delivery  Intensive behavioral therapy  Obesity  Obesity management  Telehealth  Telemedicine  A B S T R A C T  Background:   During the COVID-19 pandemic, weight loss programs rapidly transitioned to a virtual model, replacing in-person clinic visits. We sought to compare the observed weight loss and adherence to treatment between patients referred for intensive behavioral therapy (IBT) who were treated via telemedicine and those treated in person.  Methods:   After IRB approval, we conducted a retrospective observational study of patients referred for clinical bariatric IBT between January 2019 and June 2021 who were followed in person or via telemedicine. The primary endpoint was the percentage of excess BMI loss (EBL%); secondary endpoints included treatment adherence, duration of follow-up, and number of completed visits.  Results:   During the study period, 139 patients were seen for at least one IBT session for weight management: 62 were followed up in person (IP) and 77 via telemedicine (TM). The mean age, baseline BMI, and follow-up duration between the groups were similar. In the IP and TM groups, the EBL% was   \0   24.7   ±   24.7 and   \0   22.7  ±   19.5 (P   =   0.989) and loss to follow-up after the first visit was 27.4% and 19.5% (P   =   0.269), respectively.  Conclusion:   For the management of obesity, weight loss programs delivered via telemedicine can achieve similar outcomes to those provided via classical in-person visits. This study suggests that the integration of telecare into clinical practice in bariatric medicine should be considered in the future. Emerging technologies may allow adequate patient follow-up in multiple scenarios, specifically non-critical chronic disorders, and bring unantic -  ipated benefits for patients and healthcare providers.  1.   Introduction  During the COVID-19 pandemic, healthcare systems were   “ between a rock and a hard place ”   worldwide. Healthcare providers were forced to transform and adapt their practices to reduce risks of unnecessary exposure while simultaneously not compromising patient outcomes. Although unprepared for this seismic change, the adoption of telemed -  icine among most medical specialties significantly surged during and after the pandemic as an approach to overcoming these circumstances [ 1 ]. Furthermore, as the pandemic worsened, some additional reasons emerged to support the adoption of telemedicine beyond infection prevention   [ 2 , 3 ].   Increased   acceptance   and   familiarity   with   the modality by the patients, specific regulatory changes, new reimburse -  ment policies, perceived reduction in healthcare access barriers, and cost reductions were among these facilitators [ 2 – 5 ].  Notably, transitioning to or incorporating telehealth models was certainly faster in specific clinical scenarios and specialties like endo -  crinology and mental health [ 6 ]. For example, a large number of com -  mon chronic conditions in adults such as diabetes, hypothyroidism, mental health disorders, and obesity need frequent medical monitoring and   physician   counseling;   however,   the   treatment   and   clinical decision-making does not necessarily entail repeated physical exami -  nations. In most of these conditions, key clinical indicators facilitate the diagnosis and the therapy and indicate the prognosis. For example,  ☆   Meeting presentation:   Part of this data was presented as a poster at the annual meeting of The Obesity Society (Obesity Week), October 14 – 17, 2023, Dallas, Texas.  *   Corresponding author. 500 W Thomas Road, Phoenix, AZ, 85013, USA.  E-mail addresses:   andres.latorre@commonspirit.org   (A.R. Latorre-Rodríguez),   rajshah@arizona.edu   (R.H. Shah),   seema.n.munir@gmail.com   (S. Munir),   sumeet. mittal@commonspirit.org   (S.K. Mittal).  Contents lists available at   ScienceDirect  Obesity Pillars  journal homepage:   www.journals.elsevier.com/obesity-pillars  https://doi.org/10.1016/j.obpill.2024.100131  Received 23 July 2024; Received in revised form 26 August 2024; Accepted 28 August 2024  Obesity   Pillars   12   (2024)   100131  Available   online   30   August   2024  2667-3681/©   2024   The   Authors.   Published   by   Elsevier   Inc.   on   behalf   of   Obesity   Medicine   Association.   This   is   an   open   access   article   under   the   CC   BY-NC-ND   license  ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).\nglucose or HbA1c in patients with diabetes; thyroid-stimulating hor -  mone (TSH) and thyroxine (T4) levels in patients with hypothyroidism; specific clinical or risk scores in patients with mental health disorders; and weight or body mass index (BMI) in patients with obesity.  Interestingly, obesity is a complex condition associated with a high burden of disease and numerous related complications (i.e., endocrine disorders,   cardiovascular   disease,   cancer,   thromboembolic   disease) [ 7 – 9 ]. Its treatment requires a multidisciplinary approach involving specialties such as psychology, family medicine, internal medicine, bariatric medicine, endocrinology, and bariatric surgery [ 10 ]. Never -  theless, for most patients, the starting therapeutic point is life style changes [ 11 ]. In this particular scenario, patient counseling as well as close   monitoring   of   the   key   indicator   (body   weight)   are   critical. Therefore,   weight   loss   programs,   especially   those   using   effective non-pharmacological strategies such as intensive behavioral therapy (IBT) [ 12 – 16 ], appear to be suitable for delivery via telemedicine. However, there is a paucity of data on patient outcomes treated for obesity with IBT via telemedicine.  We aimed to compare the outcomes between patients who started IBT treatment and followed up via telemedicine during the COVID-19 lockdown and those who followed up in person in a medical bariatric clinic the previous year. We hypothesized that the observed weight loss and treatment adherence were similar between the groups (H 0 ).  2.   Methods  2.1.   Study design and settings  This single-center retrospective observational study analyzed de- identified data obtained from a prospectively maintained database of new patients who underwent IBT for weight loss between January 2019 and December 2021 by a single bariatric clinical professional (S. Munir) at St. Joseph ’ s Hospital and Medical Center, Phoenix, AZ, U.S.A. The research protocol, analysis, and publication of the data were approved under the Norton Thoracic Institute (NTI) Foregut Umbrella Protocol (PHXU-21 – 500-136 – 73-18, project approval date: January 6, 2023) by the NTI Committee and The Institutional Review Board of St. Joseph ’ s Hospital and Medical Center. Written patient consent was waived due to the study design, and good practice guidelines were followed according to the Declaration of Helsinki. The STrengthening the Reporting of OBservational   studies   in   Epidemiology   (STROBE)   statement   and checklist were followed to ensure the high quality of the manuscript contents ( Online Resource 1 ).  2.2.   Study population  Consecutive patients with BMI   ≥ 30 kg/m 2   referred by any specialty to a clinical bariatrician (i.e., obesity medicine specialist) for IBT for the treatment of obesity who completed an initial appointment between January 2019 and June 2021 were identified. Patients with a history of bariatric surgery, lung transplant candidates or recipients, and those with incomplete records were excluded from the analysis. Two time periods were selected to create the cohorts, one before and one after the beginning of the COVID-19 lockdown. Patients in the first group (IP) attended an initial in-person visit between January 2019 and January 2020 and were subsequently followed up in the clinic within the IBT program until March 2020. The second group (TM) comprised patients who attended an initial virtual visit between June 2020 and June 2021 and were followed up using the same modality through December 2021.  2.3.   Variables and data management  De-identified data was prospectively collected by one author (S. Munir) and stored in a secure database (Research Electronic Data Cap -  ture) at each patient visit, ensuring data consistency and accuracy (rather than retrospectively extracted from patient charts). The dataset included baseline demographic and anthropometric variables (i.e., sex, age, weight, height, BMI, and years of education), information related to the IBT intervention (i.e., modality type, primary medical indication for referral   to   obesity   treatment,   referral   source,   number   of   visits completed, total days under follow-up), presence of comorbidities (i.e., arterial   hypertension,   diabetes,   hyperlipidemia,   pulmonary   disease, obstructive sleep apnea, degenerative disc disease, gastroesophageal reflux   or   hiatal   hernia,   mental   health   disorders,   and   others),   and anthropometric data at each follow-up (i.e., weight and BMI). In-person visits included the measurement of patients ’   weights by the clinician. In contrast, the weight of subjects who attended telehealth appointments was self-measured using home scales or extracted from recent weights recorded during other medical appointments (i.e.,   ± 7 days) if available.  2.4.   Intensive behavioral therapy program  This program is provided by a single specialized medical bariatric physician. It is focused on intensive lifestyle modification by utilizing motivational interviewing, cognitive behavioral therapy, storytelling and role-playing, teaching coping skills and healthy eating habits, addressing food and other addictions, discussing patients ’   budgets, addressing the need for physical activity and barriers to physical activ -  ity, and counseling for body image and family-specific issues. Both IP and TM groups had standard visit calendars (i.e., initial visit of 60 min, second visit of 60 min at week two, and third visit of 30 min at week 5; subsequent visits are 30 min monthly until the determined goals are accomplished). The time between visits is reduced in cases where additional follow-up is required according to the obesity medicine specialist. If further treatment is required (due to, for example, not reaching expected goals, identification of eating disorders, or adjust -  ments to medication doses), patients are referred to the indicated spe -  cialists (i.e., psychiatrist, endocrinologist, etc.).  2.5.   Endpoints  The primary endpoint was the percentage of excess body mass index loss (EBL%); its formula was established as [(last follow-up BMI   –   initial visit BMI)/(initial visit BMI   –   25)]   ×   100. Secondary endpoints included:  i)   loss to follow-up, defined as the proportion of patients who did not complete at least two visits within the IBT program,   ii)   length of the intervention (i.e., total days that each patient was followed), and   iii)   the number of completed visits within the program.  2.6.   Data analysis  Descriptive statistics were applied to analyze the cohort character -  istics; count and percentage are reported for categorical variables, whereas mean with standard deviation or median with interquartile range (IQR) are reported for continuous variables. Differences between IP and TM groups were assessed using Pearson ’ s chi-squared for cate -  gorical variables. For continuous variables, distribution was determined using Q-Q plots and the Shapiro-Wilk test; in the case of normal distri -  bution, the Student ’ s t-test was used to compare the groups, and the Mann – Whitney   U   test was used when parametric assumptions were not satisfied. Spearman ’ s rank correlation coefficient was employed to explore   associations   between   covariates.   Importantly,   for   primary endpoint analysis, patients who dropped out after the initial visit were excluded. The significance level ( α ) was set at 0.05. The software used for the analysis was SPSS Statistics v29.0 (IBM, SPSS Inc. Armonk, NY, USA).  3.   Results  3.1.   Demographic and clinical characteristics  During the study period, 147 patients were referred to the IBT  A.R. Latorre-Rodríguez et al.   Obesity   Pillars   12   (2024)   100131  2\nprogram for weight loss guided by a single obesity medicine specialist. Five subjects were removed due to a history of lung transplantation and three because they were lung-transplant candidates, resulting in 139 that were seen for at least one IBT session: 62 in the IP group and 77 in the TM group ( Fig. 1 ).  Both groups were predominantly female (IP, 53 [85.5%]; TM, 60 [77.9%]), and most patients (IP, 46 [74.2%]; TM, 57 [74%]) had completed at least 12 years of formal education (i.e., starting from pri -  mary education). The mean age and baseline BMI were 51.5   ±   13.3 years and 39.6   ±   7.6 kg/m 2   for the IP group and 50.2   ±   14.8 years and 41.5   ±   8.5 kg/m 2   for the TM group. The most common comorbidity in both groups was hyperlipidemia, followed by diabetes mellitus in the IP group and gastroesophageal reflux disease (GERD) in the TM group. Besides weight, baseline characteristics, including BMI, were similar between the groups ( Table 1 ). Importantly, 32 subjects (17 in the IP group and 15 in the TM group) were excluded from statistical analysis of the primary endpoint due to the lack of a follow-up visit within the pre- specified time frame. However, baseline characteristics were similar between the revised groups ( Table 1 ), with the exception of mental health disorders (anxiety or depression), which were more prevalent in the TM group (38.7% vs. 17.8%, P   =   0.020).  All patients were referred primarily for the management of obesity, with all having one or more complications.   Table 2   presents the primary indication for referral; the leading cause in both groups was GERD with or without hiatal hernia and obesity. Other primary indications for the referral to obesity treatment included diabetes mellitus, hypertension, degenerative disc disease, polycystic ovary syndrome, and non-end- stage   pulmonary   diseases   (i.e.,   idiopathic   pulmonary   fibrosis   or chronic obstructive pulmonary disease). The most frequent referral sources in both groups were primary care physicians and thoracic sur -  geons ( Fig. 2 ).  3.2.   Adherence to treatment  There was a higher proportion of loss to follow-up among the IP group than the TM group; however, this difference was not statistically significant (IP, 27.4% vs. TM, 19.5%, P   =   0.269). The median total duration of the intervention (IP, 77 days [IQR 28 – 161] vs. TM, 74 days [IQR 22 – 153], P   =   0.466) and the number of completed visits within the program (IP, 4 [3 – 7] vs. TM, 4 [][2 – 7], P   =   0.585) were similar between both groups.   Table 3   summarizes the data on secondary endpoints.  3.3.   Bariatric outcomes  Weight loss was similar between the groups: mean EBL% of   \0   24.7   ±  24.7 and   \0   22.7   ±   19.5 in the IP and TM groups, respectively (P   =   0.989;  Fig. 3 ). By the same token, although not considered an a priori study endpoint, the percentage weight change did not differ between the groups (IP:   – 8.75   ±   9.13 vs. TM:   – 8.56   ±   7.92, P   =   0.890). Of note, regardless of the modality of treatment, a higher EBL% was correlated with a greater number of years of formal education, r s =   ( \0   0.286 [CI95:  \0   0.461,   \0   0.089], P   =   0.004). Moreover, the efficacy of IBT was strongly correlated with the number of completed visits by each participant, r s =  ( \0   0.741 [CI95:   \0   0.820,   \0   0.636], P   <   0.001) as well as the duration of  Fig. 1.   Study flow diagram.  A.R. Latorre-Rodríguez et al.   Obesity   Pillars   12   (2024)   100131  3\nthe intervention, r s =   ( \0   0.713 [CI95:   \0   0.800,   \0   0.597], P   <   0.001).  4.   Discussion  This study provides valuable insights into understanding patient follow-up and interventions for chronic conditions such as obesity via telemedicine. A comparable efficacy of intervention was noted among patients receiving IBT remotely and those undergoing traditional in- person care (EBL%   \0   24.7   ±   24.7 vs. – 22.7   ±   19.5, P   =   0.989). More -  over, although not statistically significant, the loss to follow-up trended lower among patients receiving virtual follow-ups (IP, 27.4% vs. TM, 19.5%, P   =   0.269). Together these findings suggest that the adoption of telemedicine for patient follow-up in well-selected chronic conditions and using adequate interventions/treatments does not compromise pa -  tient outcomes but improves healthcare access and adherence to treat -  ment most likely due to the removal of geographic or travel-associated costs barriers.  Our   findings   are   aligned   with   the   growing   body   of   evidence supporting the implementation and efficacy of remote IBT for obesity treatment [ 16 , 17 ]. A study conducted by Alencar et al. [ 17 ] in 2019 comparing weight loss of patients participating in a telehealth-based program to a control group (i.e., no intervention) revealed a signifi -  cant difference in weight loss between groups (7.2   ±   4.4 vs. 1.5   ±   4.1 kg, P   <   0.05). Moreover, a recent study published in 2022 by Tchang et al. [ 16 ] demonstrated that patients undergoing IBT via telemedicine or in-person during COVID-19 had a similar percentage of weight change (IP,   \0   4.3% vs. TM,   \0   5.8%, P   =   0.41). In this study, the authors also accounted for prescribed weight-loss medications, which were similar between groups.  We also found that weight loss was significantly correlated with a greater   number   of   formal   years   of   education   and   the   number   of completed visits for both groups, which is in line with the association between the educational level of an individual or population and their overall health status [ 18 ]. This points to the important role of patient selection   when   using   telehealth   models.   Healthcare   providers   are responsible to assess the   “ candidacy ”   of each individual before enrolling them into a specific remote follow-up program. Because this study was conducted in a lockdown situation, we were not able to choose which patients would benefit the most from each modality of care. However, under typical conditions, clinicians should be aware of not only the patient ’ s education level but also access to technologies, proficiency in their use, and most importantly the overall patient condition.  On the other hand, it is essential to recognize that during the COVID- 19 pandemic, stay-at-home orders had a significant overall negative impact on patient ’ s health and interposed some limitations. Almandoz et al. [ 19 ] documented that 69.6% of individuals with obesity reported more difficulty achieving weight loss goals. Also the general population experience an increased prevalence of mental health disorders such as anxiety and depression (which was also found in our study) [ 20 ]. Interestingly, despite these adverse challenges, our study demonstrated  Table 1  Baseline demographic and clinical characteristics.  Covariate   IP (n  =   62)  TM (n  =   77)  P- value  IP with  ≥ 2 visits (n  =   45)  TM with  ≥ 2 visits (n  =   62)  P- value  Demographic and anthropometric  Sex, female   53 (85.5)  60 (77.9)  0.256   37 (82.2)  47 (75.8)  0.636  Age, years   51.5  ±   13.3  50.2  ±   14.8  0.675   51.8   ±  13.9  50.7   ±  13.8  0.677  Weight, kg   105.5  ±   22  115.6  ±   26.4  0.044   109.1  ±   22.5  113.2  ±   24.9  0.574  BMI, kg/m 2   39.6  ±   7.6  41.5  ±   8.5  0.422   40.2   ±  7.5  40.5   ±  7.8  0.877  Formal education  Years of education  14.3  ±   2.4  14.1  ±   2.2  0.724   14.3   ±  2.6  14.2   ±  2.2  0.812  < 10 years   2 (3.2)   2 (2.6)   0.880   2 (4.4)   1 (1.6)   0.852  10 – 12 years   13 (21)  18 (23.4)  10 (22.2)  14 (22.6)  13 – 14 years   21 (33.9)  30 (38.9)  14 (31.1)  24 (38.7)  15 – 16 years   16 (25.8)  19 (24.7)  12 (26.7)  16 (25.8)  17 – 18 years   7 (11.3)  7 (9.1)   5 (11.1)   6 (9.7)  > 18 years   2 (3.2)   1 (1.3)   2 (4.4)   1 (1.6)  Unknown   1 (1.6)   0 (0)   0 (0)   0 (0)  Comorbidities  Arterial hypertension  24 (38.7)  37 (48.1)  0.270   20 (44.4)  32 (51.6)  0.464  Prediabetes or diabetes mellitus  25 (40.3)  28 (36.4)  0.228   19 (42.2)  27 (43.4)  0.891  Hyperlipidemia   28 (45.4)  42 (54.5)  0.271   21 (46.7)  34 (54.8)  0.404  Pulmonary disease  15 (24.2)  26 (33.8)  0.768   11 (24.4)  13 (21)   0.670  OSA   24 (38.7)  26 (33.8)  0.546   20 (44.4)  24 (38.7)  0.552  Degenerative disc disease  8 (12.9)  13 (16.9)  0.515   5 (11.1)   12 (19.4)  0.250  GERD/HH   24 (38.7)  40 (51.9)  0.120   22 (48.9)  30 (48.4)  0.959  Mental health disorders  12 (19.4)  26 (22.8)  0.058   8 (17.8)   24 (38.7)  0.020  Other conditions   49 (79)  66 (85.7)  0.300   34 (75.6)  54 (87.1)  0.123  Continuous values are presented as mean and standard deviation. Categorical variables are presented as count and proportions. Bold p-values represent sta -  tistical significance at p   <   0.05. Abbreviations: BMI: body mass index; GERD: gastroesophageal reflux disease; HH: hiatal hernia; IP: in-person modality group; OSA: obstructive sleep apnea; TM: telemedicine modality group.  Table 2  Primary   indication   for   referral   to   management   of   obesity   with   intensive behavioral therapy (IBT).  Covariate   IP (n  =   62)  TM (n  =   77)  P- value  IP with  ≥ 2 visits (n  =   45)  TM with  ≥ 2 visits (n  =   62)  P- value  Primary indication for referral to IBT program  Chronic back pain   2 (3.2)   0 (0)   0.826   1 (2.2)   0 (0)   0.238  Chronic cephalea   2 (3.2)   0 (0)   0.826   2 (4.4)   0 (0)   0.094  Chronic heart failure  1 (1.6)   1 (1.3)   0.877   1 (2.2)   1 (1.6)   0.818  Degenerative disc disease  1 (1.6)   5 (6.5)   0.159   1 (2.2)   5 (8.1)   0.195  Prediabetes or diabetes mellitus  7 (11.3)  9 (11.7)  0.942   4 (8.9)   9 (14.5)   0.379  GERD/HH   13 (21)  27 (35.1)  0.069   13 (28.9)  17 (27.4)  0.867  Hyperlipidemia   0 (0)   4 (5.2)   0.069   0 (0)   4 (6.5)   0.082  Hypertension   6 (9.7)   3 (3.9)   0.169   5 (11.1)   3 (4.8)   0.223  Incisional hernia   1 (1.6)   2 (2.6)   0.702   1 (2.2)   2 (3.2)   0.756  Obesity   7 (11.3)  12 (15.6)  0.463   4 (8.9)   9 (14.5)   0.379  Other conditions   5 (8)   7 (9.1)   0.830   3 (6.7)   6 (9.7)   0.579  Other endocrinological disorders  1 (1.6)   0 (0)   0.263   1 (2.2)   0 (0)   0.238  Other neurological disorders  4 (6.5)   1 (1.3)   0.105   2 (4.4)   0 (0)   0.094  Polycystic ovary syndrome  4 (6.5)   3 (3.9)   0.493   2 (4.4)   3 (4.8)   0.924  Pulmonary disease   8 (12.9)  3 (3.9)   0.051   5 (11.1)   3 (4.8)   0.223  Variables are presented as count and proportions. Bold p-values represent sta -  tistical significance at p   <   0.05. Abbreviations: GERD: gastro-esophageal reflux disease; HH: hiatal hernia; IP: in-person modality group; TM: telemedicine modality group.  A.R. Latorre-Rodríguez et al.   Obesity   Pillars   12   (2024)   100131  4\nthat   similar   outcomes   and   clinical   goals   can   be   achieved   via telemedicine.  Further, from a public health perspective, the accessibility and convenience afforded by telemedicine allow it to reach a larger patient population (which is important for chronic diseases with increased prevalence   such   as   diabetes   or   obesity),   potentially   improving population-level health outcomes [ 21 ]. Interestingly a systematic re -  view conducted in 2022 by De Simone et al. [ 22 ] assessed the imple -  mentation of telehealth during COVID-19 across different stakeholders. Clinicians   were   prone   to   present   positive   attitudes   regarding   the implementation of video telehealth visits, and patients reported higher satisfaction and a strong interest to continue care under this modality. In our experience and aligned with the evidence, healthcare providers may also experience unexpected benefits from the proper implementation of  Fig. 2.   Distribution of referral specialties across the groups.  Table 3  Adherence to treatment.  IP (n   =   62)   TM (n   =   77)   P-value  Adherence to treatment  Loss of follow-up   17 (27.4)   15 (19.5)   0.269  Duration of intervention a  Number of completed visits, median   4 [3 – 7]   4 [2 – 7]   0.585  Duration of follow-up, days   77 [28 – 161]   74.5 [22 – 153]   0.466  Continuous values are presented as medians and interquartile range, and cate -  gorical variables are presented as count and proportions. Bold p-values represent statistical significance at p   <   0.05. Abbreviations: IP: in-person modality group; TM: telemedicine modality group.  a   Calculated only for patients who completed   ≥ 2 visits.  Fig. 3.   Comparison of percentage of excess body mass index loss (EBL%) be -  tween both groups. The H 0   hypothesis was accepted using the Mann – Whitney  U   test.  A.R. Latorre-Rodríguez et al.   Obesity   Pillars   12   (2024)   100131  5\ntelemedicine   [ 23 , 24 ].   These   benefits   include   time   optimization, schedule flexibility, and a potential reduction in burnout [ 24 ].  While emergent technologies are potent resources for patients, pro -  viders, and healthcare systems, their use comes with some challenges [ 21 ]. Telemedicine is susceptible to variable internal motivation expe -  rienced by patients, the loss of meaningful in-person doctor-patient in -  teractions,   technical   issue,   privacy   concerns,   and   perceived   lower treatment intensity [ 25 ]. Hence, there should be a strong rationale behind implementing a remote patient follow-up program. We believe that remote monitoring holds the potential to decrease unnecessary clinic visits for stable patients and improve the efficiency of healthcare practitioners in specific scenarios. Ultimately, adequate integration of telemedicine into health systems has the potential to transform clinical practice and benefit patient care, specifically in well-suited specialties such as endocrinology or bariatric medicine.  5.   Limitations  Our study has some limitations. Due to its single-center, retrospec -  tive, observational design, there was a small sample size and lack of randomization, which limited the interpretation of results to hypothesis- generating conclusions; however, all the data was collected prospec -  tively.   Moreover,   the   referral   source   was   heterogeneous,   and   the different time periods of the groups (i.e., before and during the COVID- 19 pandemic) may have affected the health habits or behaviors of pa -  tients in each group. However, the demographic and clinical baseline characteristics of patients in each group were comparable. Importantly, we could not obtain data regarding some confounding factors including the use of medications (i.e., GLP-1 analogs, insulin, etc.) that could affect body weight and hence the study results. Notably, most of the data obtained from the TM group relies on self-reported weights, and the accuracy of the measurements cannot be guaranteed. Thus, the results from this and other studies need to be confirmed by an objective assessment of reported weight changes by conducting a non-inferiority, randomized controlled trial.  6.   Conclusions  This study demonstrated that guided therapy for treating obesity via telemedicine provided similar results in terms of EBL% and treatment adherence to in-person therapy. This data supports the integration of telemedicine into comprehensive management programs for chronic diseases such as obesity where frequently repeated physical examination is not absolutely necessary. As telehealth models become an integral part of healthcare delivery, studies of their effectiveness for specific interventions can provide valuable evidence to help shape the future of clinical practices across diverse, well-suited specialties for telehealth, including bariatric medicine.  6.1.   Key takeaways  •   Guided IBT for treating obesity via telemedicine provides clinical outcomes in terms of weight loss similar to in-person therapy.  •   Treatment adherence for weight loss was not compromised when using telemedicine; conversely, the loss to follow-up trended lower among patients receiving virtual follow-ups.  •   Integrating telemedicine and telehealth technologies into compre -  hensive management programs for obesity may bring unanticipated benefits for patients and healthcare providers.  Author contributions  Conception and design: A.L, S.M and S.K.M. Data collection: S.M. Assembly of data and data analysis: A.L, R.S and S.K.M, Drafting of the manuscript: A.L and R.S. Substantial contribution to revision of the manuscript critically for important intellectual content: A.L, S.M and S. K.M. All the authors approved the final manuscript.  Funding  This   research   did   not   receive   any   specific   grant   from   funding agencies in the public, commercial, or not-for-profit sectors.  Ethics  The research protocol, analysis, and publication of the data were approved under the Norton Thoracic Institute (NTI) Foregut Umbrella Protocol (PHXU-21 – 500-136 – 73-18, date: January 6, 2023) by the NTI Research Committee and The Institutional Review Board of St. Joseph ’ s Hospital and Medical Center. Written patient consent was waived due to the study design, and good practice guidelines were followed according to the Declaration of Helsinki.  Declaration of artificial intelligence (AI) and AI-assisted technologies  During the preparation of this work the author(s) did not use AI tools.  Data accessibility statement  The data analyzed in this study is stored in a secure Research cannot be shared outside of those authorized as research staff per protocol. Access to this dataset requires IRB approval; if needed, direct to the corresponding author.  Declaration of competing interest  The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.  Acknowledgements  The authors thank Kristine Nally for her editorial assistance.  References  [1]   Doraiswamy S, Abraham A, Mamtani R, Cheema S. Use of telehealth during the COVID-19 pandemic: scoping review. J Med Internet Res 2020;22:e24087. https:// doi.org/10.2196/24087.  [2]   Anderson JT, Bouchacourt LM, Sussman KL, Bright LF, Wilcox GB. Telehealth adoption during the COVID-19 pandemic: a social media textual and network analysis. DIGITAL HEALTH 2022;8:205520762210900. https://doi.org/10.1177/ 20552076221090041.  [3]   Shaver J. The state of telehealth before and after the COVID-19 pandemic. Prim Care Clin Off Pract 2022;49:517 – 30. https://doi.org/10.1016/j.pop.2022.04.002.  [4]   Harris A, Hinman RS, Lawford BJ, Egerton T, Keating C, Brown C, Metcalf B, Spiers L, Sumithran P, Quicke JG, Bennell KL. Cost-effectiveness of telehealth- delivered exercise and dietary weight loss programs for knee osteoarthritis within a twelve-month randomized trial. Arthritis Care Res 2023;75:1311 – 9. https://doi. org/10.1002/acr.25022.  [5]   Wade VA, Karnon J, Elshaug AG, Hiller JE. A systematic review of economic analyses of telehealth services using real time video communication. BMC Health Serv Res 2010;10:233. https://doi.org/10.1186/1472-6963-10-233.  [6]   Garcia JP, Avila FR, Torres-Guzman RA, Maita KC, Lunde JJ, Coffey JD, Demaerschalk BM, Forte AJ. A narrative review of telemedicine and its adoption across specialties. mHealth 2024;10:19. https://doi.org/10.21037/mhealth-23-28.  [7]   Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol 2013;20:437 – 44. https://doi.org/10.1097/MOH.0b013e3283634443.  [8]   Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of Epidemiology, pathogenesis, outcomes, and management. Cancers 2023;15:485. https://doi.org/10.3390/cancers15020485.  [9]   Powell-Wiley TM, Poirier P, Burke LE, Despr ´ es J-P, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge M-P, On behalf of the American Heart Association Council on L, Cardiometabolic H, Council on C, Stroke N, Council on Clinical C, Council on E, Prevention, Stroke C. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation 2021;143. https://doi.org/10.1161/CIR.0000000000000973.  A.R. Latorre-Rodríguez et al.   Obesity   Pillars   12   (2024)   100131  6\n[10]   Foster D, Sanchez-Collins S, Cheskin LJ. Multidisciplinary team – based obesity treatment in patients with diabetes: current practices and the state of the science. Diabetes Spectr 2017;30:244 – 9. https://doi.org/10.2337/ds17-0045.  [11]   Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol 2020;75:235 – 51. https://doi.org/ 10.1037/amp0000517.  [12]   Bradley LE, Forman EM, Kerrigan SG, Goldstein SP, Butryn ML, Thomas JG, Herbert JD, Sarwer DB. Project HELP: a remotely delivered behavioral intervention for weight regain after bariatric surgery. Obes Surg 2017;27:586 – 98. https://doi. org/10.1007/s11695-016-2337-3.  [13]   Kraschnewski JL, Kong L, Bryce CL, Francis EB, Poger JM, Lehman EB, Helbling S, Soleymani T, Mancoll RE, Villalobos V, Yeh H-C. Intensive behavioral Therapy for weight loss in patients with, or At-Risk of, type 2 Diabetes: results from the PaTH to health diabetes study. Preventive Medicine Reports 2023;31:102099. https://doi. org/10.1016/j.pmedr.2022.102099.  [14]   Lv N, Azar KMJ, Rosas LG, Wulfovich S, Xiao L, Ma J. Behavioral lifestyle interventions for moderate and severe obesity: a systematic review. Prev Med 2017;100:180 – 93. https://doi.org/10.1016/j.ypmed.2017.04.022.  [15]   Sockalingam S, Leung SE, Ma C, Tomlinson G, Hawa R, Wnuk S, Jackson T, Urbach D, Okrainec A, Brown J, Sandre D, Cassin SE. Efficacy of telephone-based cognitive behavioral therapy for weight loss, disordered eating, and psychological distress after bariatric surgery: a randomized clinical trial. JAMA Netw Open 2023; 6:e2327099. https://doi.org/10.1001/jamanetworkopen.2023.27099.  [16]   Tchang BG, Morrison C, Kim JT, Ahmed F, Chan KM, Alonso LC, Aronne LJ, Shukla AP. Weight loss outcomes with telemedicine during COVID-19. Front Endocrinol 2022;13:793290. https://doi.org/10.3389/fendo.2022.793290.  [17]   Alencar MK, Johnson K, Mullur R, Gray V, Gutierrez E, Korosteleva O. The efficacy of a telemedicine-based weight loss program with video conference health coaching support. J Telemed Telecare 2019;25:151 – 7. https://doi.org/10.1177/ 1357633X17745471.  [18]   Zajacova A, Lawrence EM. The relationship between education and health: reducing disparities through a contextual approach. Annu Rev Publ Health 2018; 39:273 – 89. https://doi.org/10.1146/annurev-publhealth-031816-044628.  [19]   Almandoz JP, Xie L, Schellinger JN, Mathew MS, Gazda C, Ofori A, Kukreja S, Messiah SE. Impact of COVID-19 stay-at-home orders on weight-related behaviors among patients with obesity. Clinical Obesity 2020;10:e12386. https://doi.org/ 10.1111/cob.12386.  [20]   Kupcova I, Danisovic L, Klein M, Harsanyi S. Effects of the COVID-19 pandemic on mental health, anxiety, and depression. BMC Psychol 2023;11:108. https://doi. org/10.1186/s40359-023-01130-5.  [21]   Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. J Nurse Pract 2021; 17:218 – 21. https://doi.org/10.1016/j.nurpra.2020.09.013.  [22]   De Simone S, Franco M, Servillo G, Vargas M. Implementations and strategies of telehealth during COVID-19 outbreak: a systematic review. BMC Health Serv Res 2022;22:833. https://doi.org/10.1186/s12913-022-08235-4.  [23]   Lee MS, Nambudiri VE. Electronic consultations and clinician burnout: an antidote to our emotional pandemic? J Am Med Inf Assoc 2021;28:1038 – 41. https://doi. org/10.1093/jamia/ocaa300.  [24]   Patt D, O ’ Neill C. Telemedicine and burnout — how enhancing operational support can improve digital health tools. Cancer J 2024;30:31 – 3. https://doi.org/10.1097/ PPO.0000000000000698.  [25]   Moulaei K, Sheikhtaheri A, Fatehi F, Shanbehzadeh M, Bahaadinbeigy K. Patients ’  perspectives and preferences toward telemedicine versus in-person visits: a mixed- methods study on 1226 patients. BMC Med Inf Decis Making 2023;23:261. https:// doi.org/10.1186/s12911-023-02348-4.  A.R. Latorre-Rodríguez et al.   Obesity   Pillars   12   (2024)   100131  7',0.09541045410364492,'[\"\\u0000\", \"(\", \"(0)\", \"(1.3)\", \"(1.6)\"]','2025-11-29 17:08:13.000655'),(74,3,'ORIGINAL RESEARCH  Health consumers ’   ethical concerns towards arti fi cial intelligence in Australian emergency departments  Sam FREEMAN   ,   1,2   Jonathon STEWART   ,   3,4   Rebecca KAARD, 5   Eden OULIEL,   5   Adrian GOUDIE,   6,3 Girish DWIVEDI 3,4,7   and Hamed AKHLAGHI   1  1   Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, Victoria, Australia,   2   Centre for Digital Transformation of Health, The University of Melbourne, Melbourne, Victoria, Australia,   3   School of Medicine, The University of Western Australia, Perth, Western Australia, Australia,   4 Cardiovascular Disease and Diabetes Program, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia, 5   School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia,   6   Department of Emergency Medicine, Fiona Stanley Hospital, Perth, Western Australia, Australia, and   7   Department of Cardiology, Fiona Stanley Hospital, Perth, Western Australia, Australia  Abstract  Objectives : To investigate health con- sumers ’   ethical concerns towards the use of arti fi cial intelligence (AI) in EDs.  Methods : Qualitative   semi-structured interviews with health consumers, rec- ruited via health consumer networks and   community   groups,   interviews conducted   between   January   and August 2022.  Results : We   interviewed   28   health consumers   about   their   perceptions towards the ethical use of AI in EDs. The   results   discussed   in   this   paper highlight the challenges and barriers for   the   effective   and   ethical   imple- mentation of AI from the perspective of Australian health consumers. Most health consumers are more likely to support AI health tools in EDs if they continue   to   be   involved   in   the decision-making   process.   There   is considerably   more   approval   of   AI tools that support clinical decision- making,   as   opposed   to   replacing it. There is mixed sentiment about the acceptability of AI tools in fl uencing clinical   decision-making   and   judge- ment. Health consumers are mostly supportive of the use of their data to train and develop AI tools but are concerned   with   who   has   access. Addressing bias and discrimination in AI is an important consideration for some health consumers. Robust regu- lation and governance are critical for health consumers to trust and accept the use of AI.  Conclusion : Health consumers view AI as an emerging technology that they   want   to   see   comprehensively regulated to ensure it functions safely and securely with EDs. Without con- siderations   made   for   the   ethical design,   implementation   and   use   of AI   technologies,   health   consumer trust and acceptance in the use of these tools will be limited.  Key   words:   arti fi cial   intelligence, emergency   medicine,   ethics,   health consumers, machine learning, quali- tative research.  Introduction  Advancements   in   arti fi cial   intelli- gence (AI) are predicted to impact healthcare delivery in a multitude of ways such as providing a comprehen- sive   picture   of   an   individual ’ s healthcare   data,   augmenting   clinical decision-making,   reducing   diagnostic errors, assisting with test selection and interpretation, and recommending fur- ther   management   options. 1   Despite the technology behind most of these advances continuing to improve, par- ticularly   through   machine   learning (ML), 2   there remain key challenges in the Australian health system that need Correspondence: Dr Sam Freeman, Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, VIC, Australia. Email: sam.freeman@svha.org.au Sam Freeman, PhD, Research Fellow; Jonathon Stewart, MBBS, MMed(CritCare), Anaesthetic Registrar; Rebecca Kaard, MBBS Student; Eden Ouliel, MBBS Student; Adrian Goudie, MBBS FACEM DDU, Emergency Physician; Girish Dwivedi, MD, PhD, FRACP, Wesfarmers Chair and Consultant Cardiologist; Hamed Akhlaghi, MD, PhD, FACEM, Emergency Physician, Head of Emergency Medicine Research. This is an open access article under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs   License,   which   permits   use   and   distribution   in   any medium, provided the original work is properly cited, the use is non-commercial and no modi fi cations or adaptations are made.  Accepted 15 May 2024  Key   fi ndings  •   Health   consumers   generally support   arti fi cial   intelligence (AI) tools that assist clinicians in   decision-making   but   are wary of tools replacing doc- tors, with trust diminishing as AI ’ s   decision-making   auton- omy increases.  •   Health   consumers   express   a strong   desire   to   be   actively involved in AI-driven decision- making about their healthcare in emergency settings.  •   Mixed sentiments surround the acceptability of AI in fl uencing doctor   decision-making,   with concerns about its impact on healthcare quality. Health con- sumers fear a short-term under- mining of nurses and doctors, leading to a potential reduction in clinical skills and a long-term shift   towards   ‘ box-ticking ’  exercises,   raising   discomfort and   scepticism   about   the technology ’ s role in emergency medicine. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  Emergency Medicine Australasia   (2024)   36 , 768 – 776   doi: 10.1111/1742-6723.14449\nurgent   attention.   These   include   an increasing demand for healthcare ser- vices, an ageing population, increas- ing   costs   associated   with   medical research and innovations and grow- ing rates of chronic disease. 3   This has led groups such as policymakers, pol- iticians,   technology   companies   and data scientists to advocate for AI to address these challenges. 4 It is predicted that the use of AI- based tools will become increasingly common in EDs. 5   However, there is limited published research that qualita- tively assesses how health consumers (people who use health services, their families and carers) feel about AI use in their care in an ED context. To date, research has mostly focused on health consumers ’   perceptions of AI in speci fi c sub fi elds of medicine, such as radiology, dermatology, general prac- tice and primary care. This   paper   presents   health   con- sumer attitudes towards AI to help inform future research and highlight risk   mitigation   strategies   for   the effective and ethical implementation of AI in EDs.  Methods  Study design and setting  This qualitative study was designed in accordance with the consolidated criteria   for   reporting   qualitative research.   6   We   developed   a   semi- structured interview guide based on the review of existing literature and input from the multidisciplinary pro- ject   team.   Members   of   the   project team   have   recognised   expertise   in emergency medicine, qualitative resea- rch   and   AI   and   also   included   two healthcare   consumer   representatives. The   study   protocol   and   interview guide were presented to and received formal support from the Fiona Stanley Hospital Emergency Department Con- sumer   Advisory   Group   (Western Australia). We conducted three pilot interviews and re fi ned the   interview guide based on feedback. Twenty-eight   semi-structured interviews were conducted between January and August 2022 to assess health   consumers ’   perspectives   and considerations for the ethical imple- mentation   and   use   of   AI   in   EDs. Participants were recruited from dif- ferent health consumer networks and community   groups,   including   the Consumer Community Involvement Program (Western Australia), Fiona Stanley Hospital Emergency Depart- ment   Consumer   Advisory   Group (Western   Australia),   St   Vincent ’ s Hospital   Melbourne   Human Research   Ethics   Committee   layper- son members (Victoria), Health Con- sumers   Queensland   (Queensland) and the Centre for Culture, Ethnic- ity & Health (Australia wide), where recruitment details were distributed through its members and networks. The interviews were conducted until thematic saturation (de fi ned as three consecutive interviews with no new themes identi fi ed) was achieved. This research utilises a grounded theory approach,   which   was   selected because it provides a methodology for collecting and analysing data and conceptualising   the   results.   7   Inter- views were conducted by telephone via a voice call (without video) and audio   recorded.   Audio   fi les   were de-identi fi ed and professionally tran- scribed by a secure transcription ser- vice.   Interviews   were   conducted   in Australia with participants from New South   Wales,   Queensland,   Victoria and Western Australia. For a further breakdown   of   participant   demo- graphics (see Table 1).  Participant selection  A convenience sample was used to recruit   respondents   ( n   =   28)   based on   accessibility   and   willingness   to take part in the study.   8  Data collection  Semi-structured   interviews   were   con- ducted with additional questions and prompts used as needed. Although the discussion of ethical concerns was led by respondents, prompts included prin- ciples such as consent, transparency, privacy, safety and harm, bias, fairness and   redress.   There   were   no   repeat interviews or transcription checks by participants. Interview duration ranged from 10 to 45 min.  Data analysis  Two investigators (SF and JS) indepen- dently analysed and coded interviews using open coding techniques based on grounded theory.   All   the   interviews were coded using NVivo 20 (QSR, Melbourne,   Australia).   Codes   and themes were iteratively developed and re fi ned until most content was able to be classi fi ed. Agreement on codes and themes was reached at researcher meet- ings where differing codes were dis- cussed and a consensus on their coding was agreed upon.  Characteristics of interviewers  The interviews were conducted by SF, two medical students (RK and EO), and an ED Registrar. Interviews were held over the phone without video to reduce any bias that the interviewer ’ s appearance may have on responses. The interviewers had no prior rela- tionship with the study participants.  Characteristics of research team  At   the   time   of   conducting   this research   SF   was   a   PhD   candidate  TABLE   1.   Participant   demo- graphic information  Category   n   % Sex Female   17   61 Male   10   36 Non-binary   1   4 Age group 20 – 29   2   7 30 – 39   6   21 40 – 49   6   21 50 – 59   2   7 60 – 69   2   7 70 – 79   10   36 Location New South Wales   1   4 Queensland   5   18 Victoria   14   50 Western Australia   8   29 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   769 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n(focus on ethical implementation of AI in emergency medicine) and a research fellow at an Australian ED. JS was a PhD candidate (focus on applications of AI in emergency medicine) and an emergency medicine trainee. RK and EO   were   both   second-year   medical students who had not completed rota- tions in emergency medicine.  Ethical considerations  The study received University of West- ern Australia Research Ethics Commit- tee   approval   (2021/ET000609). Informed consent was gained from all respondents participating in the present study. The present study was prospec- tively   registered   with   the   Australian New Zealand Clinical Trials Registry (ACTRN12621000890831).  Results  The results provide an overview of health   consumers ’   key   perceptions of ethical AI in an ED setting. Key ethical   concerns   presented   here include health consumer autonomy and consent, doctor decision-making and autonomy, automation bias and reliance, data usage and privacy, bias and discrimination and regulation.  Health consumer autonomy and consent  Most   health   consumers   are   more likely to support AI health tools in emergency medicine if they continue to   be   involved   in   the   decision- making   process   about   their   health and can still understand why a treat- ment recommendation or diagnosis is made. There is some concern that with   the   use   of   increasingly   adva- nced technologies, they will no lon- ger be able to ask questions or have key issues explained to them about their treatment or diagnosis. For many participants there is a requirement to have the role of AI in their treatment explained to them at the   earliest   opportunity.   Many believe they would be more comfort- able with the use of AI if it is effec- tively   communicated.   This   becomes even more important with the incre- ased   complexity   or   risk   associated with the function of the AI tool. This is particularly important if the role of AI includes clinical decision support that relates to differential   diagnosis, complex cases, serious health condi- tions or decisions that were tradition- ally tasked to doctors and nurses. Effective   communication   is   criti- cally important to most health con- sumers   to   improve   autonomy   and consent processes. Many already feel that   information   in   EDs   could   be better communicated and that if AI is to play a future role in emergency medicine, in any capacity, it needs to be clearly communicated. The more  ‘ serious ’   the concern or high-risk set- ting   the   tool   is   functioning   in,   the more information consumers require. There is concern that AI systems may be non-interpretable by the doc- tor,   meaning   the   doctor   may   be unable   to   effectively   understand results and subsequently communi- cate   them   to   their   patients.   This thereby impacts the patient ’ s ability to give informed consent. There are mixed views, however, about the type and amount of informa- tion required, and how it is communi- cated.   Overwhelmingly,   consumers want to know (to varying degrees) if an   AI   tool   is   being   used   in   their healthcare pathway. If an AI tool is used in a patient ’ s healthcare   pathway   and   they   were not   informed,   many   report   they would   feel   ‘ betrayed ’ ,   ‘ annoyed ’ ,  ‘ frustrated ’   or   ‘ distressed ’ . For trust and   acceptance   of   these   systems, many health consumers believe that improved   consent   processes   are needed to ensure the risks, bene fi ts and alternatives can be explained in how the tool works and that they have the opportunity to opt in or out of   having   the   tool   used   in   their healthcare delivery. There is fear that the introduction of these tools will lead to a loss of human connection in the ED, in par- ticular   empathy   and   sympathy,   in what is for many people an already highly stressful environment. Some see the   healthcare   journey   as   a   human experience and want it delivered with kindness and compassion   –   traits not typically   associated   with   AI   and machines. Having that human connec- tion in a health setting is not only con- sidered   important   on   an   emotional, human   level,   but   also   connects   to health consumer autonomy.  Doctor decision-making and autonomy  There is considerably more approval for AI tools in the ED that support cli- nician decision-making, as opposed to replacing   it.   Most   participants   will only support these tools if their func- tion is subsidiary to the role of the doctor. Trust and acceptance and AI decision-making autonomy appear to have an inverse relationship. As an AI tool ’ s   decision-making   autonomy increases in the ED, patient trust and acceptance decrease. There is recognition that   human decision-making   is   fallible, particu- larly in a dynamic, complex ED envi- ronment.   Against   this   backdrop, participants see potential in AI tools being   used   to   support   doctor   and nurse   decision-making.   For   some, there is also an expectation that AI tools will likely make mistakes. For many, it is how these mistakes are responded   to   that   will   determine their level of acceptance. The   doctor   is   predominantly viewed as the   fi nal authority regard- ing   patients ’   health.   Trust   and acceptability in AI tools are derived from the doctor agreeing with the AI tools ’   prediction. When respondents envisage an AI tool operating inde- pendently of doctor oversight, many health   consumers   said   they   would insist on being treated by a doctor if they disagreed with the decision of the AI health tool. For some, no mat- ter what scenario occurs within the ED, clinicians are considered more accurate in diagnosing and treating patients. Although there are differing views about the acceptability of AI tools   to   make   errors,   ultimately, most health consumers hold AI tools to   a   higher   standard   of   accuracy than ED doctors and nurses. Despite concerns about the effec- tiveness and accuracy of AI, some health   consumers   state   that   once these   tools   are   ‘ proven ’   to   out- perform   doctors   then   they   would prefer AI tools over doctors. Some health   consumers   state   that   in some circumstances, they would prefer AI-assisted   decision-making,   such   as © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  770   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nwhen a doctor is overworked, the ED is short-staffed or overcrowded, or the treating clinician has limited experi- ence   in   the   role.   Health   consumers largely   accept   that   their   perceptions may change with advancements in AI technology and its predicted increased integration into healthcare. However, doctors are still regarded as providing the   preferred standard of care   over any form of AI tool.  Automation bias and reliance  There   is   mixed   sentiment   among respondents about the acceptability of AI tools in fl uencing ED doctors ’  decision-making and clinical judge- ment. Many were concerned that AI tools would in fl uence doctors ’   judge- ment   and   impact   the   quality   of healthcare   provision.   For   these health consumers, AI is considered just another tool to be utilised by cli- nicians and should not be afforded special   status   over   any   other   tool available in the ED. If AI tools are believed to have an in fl uential role over   clinical   decision-making,   it would   make   health   consumers  ‘ uncomfortable ’ ,   ‘ sceptical ’   and   ‘ dis- trustful ’   of the technology. Many health consumers are con- cerned that the use of AI tools in emergency medicine will result in a reliance on them. In the short term, consumers   feel   these   tools   could undermine   the   role   of   nurses   and doctors   within   the   ED   and   in   the long term could reduce the skills and ability of clinicians. There is a belief from some that diagnosing patients and clinical judgement will become  ‘ box ticking ’   exercises, where a clini- cian ’ s   ‘ gut   feeling ’ ,   ‘ intuition ’   and  ‘ instincts ’   are   no   longer   attributes that are developed and valued.  Data usage and privacy  Health   consumers   are   mostly   sup- portive of the use of their data to train and support the development of AI tools in emergency medicine but   are   concerned   with   who   has access.   Most   are   comfortable   with their non-identi fi able data being used for healthcare purposes, but only for healthcare purposes. If it was later dis- covered   that   their   information   had been used outside of the healthcare system,   or   for   purposes   other   than improving   healthcare   delivery   or healthcare research, trust and accep- tance of these tools would diminish. There   is   concern   about   data breaches and the level of security for protecting personal health informa- tion. However, many are aware of the inherent risks involved in sharing and   storing   data.   Although   it   is recognised   that   privacy   issues   are not unique to AI, many want assur- ances that their data is being handled securely. Many state that they are not   overly   concerned   about   their own   medical   data   being   released publicly, but do recognise that some health information and some mem- bers of the public could be negatively impacted, targeted or discriminated against based on their health data: Some   health   consumers   want greater control over the health infor- mation   that   is   shared   and   stored. Many   want   consent   processes   in place, so they are aware if the infor- mation is being shared and have the ability to opt in or out of its collec- tion and sharing. There are privacy concerns about how data will be col- lected in the ED if managed by an AI-enabled   platform.   Some   partici- pants   are   apprehensive   about   how patient-to-machine   information   will be communicated in a crowded ED environment.   Some   discussed   the need for a private space to feel com- fortable sharing information.  Bias and discrimination  Addressing bias and discrimination in AI is an important consideration for some   health   consumers.   There   is concern that AI will inherit the same biases   that   are   already   present   in healthcare. One participant feels that having come from a Caucasian back- ground   means   that   AI   tools   will likely be accurate for them, but less accurate or reliable for people from culturally   and   linguistically   diverse backgrounds. There are concerns that AI tools will bias or discriminate against cul- turally   and   linguistically   diverse populations,   First   Nations   people, women   and   people   with   disability and   complex   medical   needs.   Bias and discrimination are linked to per- ceptions of accuracy. For health con- sumers   to   trust   and   accept   these tools in the ED, they must be con- vinced they are accurate. Part of that required accuracy is how well they perform   for   people   from   multicul- tural backgrounds. It will be impor- tant   that   AI   based   tools   do   not perpetuate existing biases or intro- duce new biases.  Regulation  Regulation   is   an   important   aspect for trusting and accepting the use of AI   in   EDs   for   health   consumers. Some health consumers want assur- ances that there is robust regulation and oversight in the design, develop- ment, training and ongoing use of these tools. Most support a govern- ment   regulatory   body   to   establish guidelines   and   oversee   compliance. Some   see   this   as   the   role   of   the national government to ensure con- sistency across states and territories. Many do not want to see industry self-regulation   or   regulation   and standards left to the private sector. Here, there is concern that pro fi t will be   the   motivating   factor   for   the implementation   and   use   of   these tools, not improving patient health outcomes. Some   health   consumers   want   to see   more   localised   governance   and accountability of these tools such as the hospital administration or industry peak   bodies   such   as   the   Australian Medical Association, to ensure train- ing and policies are established and provided at the clinical level. There are also calls for AI tools to be endorsed by the bodies that represent the medi- cal professionals who are required to use these tools in clinical practice. Some health consumers also want these tools to pass through an ethics review   process.   For   these   respon- dents, it is not enough to just con- sider the safety and medical accuracy of these tools, it must also consider their ethical impact (Table 2).  Discussion  This research found that health con- sumer   acceptance   of   AI-enabled health tools requires the consideration © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   771 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nTABLE 2.   Sample comments by health consumers on ethical concerns  Qualitative dimension   Sub-dimension   Example quote Patient autonomy and consent Health consumer understanding of treatment or diagnosis  … that I was involved in the discussions about my treatment, patients being encouraged to be involved in decision-making about their care, that actually has to be absolutely central to the whole process still so that I wouldn ’ t want the human element and the capacity for me as a patient to actually explain my concerns and, you know, the capacity of me to ask questions. Effective communication that AI is being used I think as a patient I would also want to understand the role of AI in the whole process, and I think that would be very, very important because if I found out for some reason, you know, at a later date that (that AI was being used), that would be quite disturbing. But I think if I was involved at the start in knowing that this system was actually helping clinicians to arrive at an accurate diagnosis, I think I would be very satis fi ed, very comfortable with that. You ’ ve got to have that communication, break that barrier to communication face-to-face by someone who can explain what ’ s happening. Amount of information health consumers require  … not in a great amount of detail, but it would just be nice to have that reassurance. The more information, the better. Consent requirements With my consent, I ’ d feel good about it. I think you need to opt in. Doctor – patient relationship I wouldn ’ t like it because you want to be heard and seen by a compassionate, kind professional. This is a human experience, and I don ’ t want it to be determined by a robot. At least, if the robot has this decision, I would want a human sitting there and explaining it to me …   the desperation and feeling unwell, just to be questioned by a robot in a yes or no or to get an answer way, it ’ s going to just increase the frustration and the suffering, I feel. Doctor decision- making and autonomy AI errors in decision-making  … every human body is different so the program is written for the majority, allowing for some differences, but there ’ ll always be individuals that   … swim against the   fl ow and where they should have got better, all the signs are there that they should have got better and something has happened, but that happens just when a doctor sends them home, the fact that it ’ s a computer algorithm that did the agree-to-release, in my eyes, makes no difference. AI accuracy   If it replaces something that ’ s there at the moment, yes, it has to be better.   … I can imagine that 15 years down the track I would see it as completely irrelevant, but I think during a new kind of introductory phase of a new technology, I think it would be perceived as far worse for a computer to make an error. Because I think if it ’ s proven to be more failsafe and make less mistakes than what the humans are performing then I would take my chances with that over human assessment for sure. AI over doctors   I mean not every doctor ’ s going to be a specialist in every   fi eld. And in emergency, the guy treating me may not be the most capable guy in whatever it is I have. [So] I think the fact that he can rely on the information from a tool to help him in the diagnostics would be very useful. Automation bias and reliance AI in fl uence over doctor decision- making Well, I would think it ’ s actually a slap in the face to doctors, because you ’ re negating all the experience that they ’ ve had, and their own experience will tell them a lot of information that the machine can ’ t gather. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  772   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nand minimisation of ethical issues. As AI research continues to develop it is important   to   understand   what   are considered   by   healthcare   consumers to be acceptable uses of the technol- ogy in emergency medicine contexts. These   results   provide   information about health consumers ’   current per- ceptions of AI in emergency medicine and further emphasises the need for effective   communication   to   ensure consumers understand the function of AI and the role it will play in the deliv- ery of their healthcare. Consumers require assurance that the   ED   doctor   retains   the   fi nal decision-making authority and that they understand how and why an AI tool has come to a certain prediction or   recommendation.   This   may   be challenging as current AI tools are for the most part   ‘ black boxes ’   with reasoning that is not interpretable to humans.   9 It appears that trust and acceptance of   AI   tools   and   clinician   decision- making   autonomy   are   inversely related.   The   more   autonomous   or independent the tool is from ED doc- tors ’   oversight   and   understanding, the less likely patients are to trust its output. There are reservations about the accuracy and performance of these technologies, and also apprehension about moving to a new standard of care, which may remove other ele- ments   of   healthcare   considered important to patients such as the doctor – patient   relationship.   Other research   into   patient   perspectives on   AI   in   different   medical   fi elds found comparable results   –   patients  TABLE 2.   Continued  Qualitative dimension   Sub-dimension   Example quote Reduced doctor skill and ability  … as soon as we start taking away decisions from health professionals, we ’ re sort of undermining their training and we start, look, it ’ s complicated because I think if we could take routine jobs away from nurses and doctors to help them focus on more important things, that would be great. But I ’ m worried that [they] would then start relying on AI and it would undermine the expertise of doctors and nurses. Data usage and privacy  Re -use of patient health consumer data If you ’ ve given consent for it, no problems. You wouldn ’ t want it to be then on-sold or used for anything else. I could understand people who are very private and would not want their medical records (shared) … . but as long as it ’ s unidenti fi ed and they ’ re not used for any other purpose, you know, it ’ s probably inevitable things are going down this track in all   fi elds. [Concern] around how your data ’ s kept and used, and the breaches   –   what ’ s being collected and how could that be used. Control over the sharing of health consumer data  … Patients should be able to consent to certain information being taken, and where that information is actually going to go. On the other hand, I really do support the interoperability of programs, so that they can talk to one another, after consent is received. How private data is disclosed It would depend on how the information was communicated, like if it was …  in an open space. You know, are people ’ s private health details being broadcast loud by this AI? Is it happening in a quiet, private space? Bias and discrimination AI and human bias   I don ’ t think AI is good enough yet and everyone ’ s just forging ahead with it, thinking it ’ s great and missing the fact that it ’ s really not great. It ’ s programmed like humans, so it will have human error in it. Discrimination and multicultural populations  … the (AI) system has been calibrated using data that isn ’ t particularly diverse and then the output it generates is biased because of that. Regulation   Government regulation I think it ’ s got to be a multi-layered approach. I think Australia at a federal level has to have some very clear guidelines around the use of AI in medical settings and lots of other settings, but if we ’ re just sticking with medical, I think we need to have some federal governance around that. Local governance mechanisms But I do think then we need to have local [governance], like AMA (Australia Medical Association) or state level or even hospital level to make sure that staff are trained, staff are upskilled, that there is a local connection with what ’ s going on federally. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   773 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nare much more likely to support AI if there is a human tasked with mak- ing   the   fi nal   decision   or recommendation. 10 – 15   In part, this is because there is more trust in the abil- ity of an experienced doctor. Doctors are also able to justify and explain their   decision   or   recommendation, something health consumers currently do not associate with AI technology. Many   patients   still   want   the human   connection   and   assurance healthcare staff provide when they are   going   through   a   potentially stressful   time,   something   machines are viewed as incapable of providing. However,   these   views   may   change with increased exposure to advanced AI tools. A recent study comparing physician and ChatGPT responses to patient questions found that patients rated ChatGPT responses   ‘ higher for both quality and empathy ’ . 16   With this challenging the assumptions of most health consumers that AI tools will lack empathy. Some of the lit- erature also suggests that patients fear losing human interaction from their   healthcare   delivery   and   are concerned   that   AI   tools   will   be unable   to   comprehend   emotional issues,   particularly   in   relation   to patients   experiencing   mental   ill- health.   10,11,14,17 – 19   This   concern appears   to   intensify   in   an   emer- gency   setting   with   patients   often requiring urgent medical attention, and where the human connection is considered especially important in reducing distress. Health   consumers   are   concerned about privacy and the use of their per- sonal   health   data.   Although   many approve   of   the   use   of   their   non- identi fi able   medical   data to   support the development of AI tools within healthcare,   they   are   still   concerned about   con fi dentiality   and   who   has access to it. This is consistent with research into patient perspectives of AI   in   radiology 20   and   healthcare chatbots, 17   which found patients are only willing to share data if it remains con fi dential and non-identi fi able. Con- sumers will likely rescind their support for data usage if it transpires that their personal   information   is   being   used outside of the healthcare system or for purposes other than improving patient health outcomes. Many   health   consumers   believe they are aware of the inherent risks involved in the sharing and storage of data. However, health consumers may be under the assumption that their health data refers only to data held by healthcare organisations in their health records. Yet, these data sources are considered only a small part of the   ‘ larger health data eco- system ’ . 21   This includes health data generated   by   non-healthcare   pro- viders such as insurance companies, non-health information where infer- ences   are   made   about   health,   and user-generated health data.   21   Health consumers may feel less comfortable knowing that there is the potential for this information to be collected and used to make decisions about them, particularly if used by com- mercial entities. Data collection and sharing policies need to be updated to ensure data collected and gener- ated through the use of these tools meets the standards and expectations of consumers. Most   health   consumers   see informed   consent   as   a   critical   ele- ment   in   gaining   their   trust   and acceptance regardless of the role AI might play in their treatment. One study   22   identi fi ed that informed con- sent   is   not   receiving   the   attention needed   in   the   ethical   debate   sur- rounding   AI   implementation,   with another study 23   reporting that   ‘ ubiq- uity, complexity and opaqueness ’   are major   contributors   to   health   con- sumers ’   ‘ inability to assess or predict outcomes   or   harms ’   associated with   the   use   of   AI   in   healthcare and   therefore   provide   informed consent. The issue of consent app- ears   to   be   a   signi fi cant   consider- ation for health consumers. It will be important that the ED doctors and hospital management who are tasked   with   implementing   these technologies   ensure   the   consent process is current and appropriate, and that the use of AI in the ED is communicated effectively. Addressing   bias   and   discrimina- tion that results from the introduc- tion   of   AI   is   important   to   many health   consumers.   However,   bias and discrimination pre-existent to AI is   not   without   precedent   in   the Australian healthcare system, where First   Nations   people   ‘ continue   to suffer   adverse   experiences   in healthcare, with inequitable care pre- valent   in   emergency   settings ’ . 24 Research   has   highlighted   that   the Australian   healthcare   system   under serves those from culturally and lin- guistically diverse backgrounds, 25   has discriminated   against   women 26   and people   with   disability. 27   For   AI   to bene fi t   diverse   populations   such   as Australia ’ s, the design and develop- ment of AI technologies must include input from diverse populations from diverse   geographic   locations,   who will   use   or   be   exposed   to   these technologies. 28 It appears that health consumers envisage a more rigorous regulatory framework that monitors and evalu- ates the design, development, imple- mentation and use of AI technologies than   currently   exists   within Australia. Although the Therapeutic Goods Administration does regulate software as a medical device, which AI software are categorised, there is no regulation that relates speci fi cally to these technologies.   29   Because of this   assumption,   it   is   likely   that future regulation and guidance will need to address issues of oversight and evaluation to gain the support of consumers. This will likely include ensuring health consumers are protec- ted,   and   that   improved   health   out- comes are a priority in implementing these systems. 29   This also relates to fears that AI tools may not be appro- priately   regulated   and   be   more in fl uenced by   fi nancial incentives than improving healthcare outcomes. The existing literature, similarly, found that rigorous regulation and guidance of AI in healthcare is regarded as impor- tant for protecting patient wellbeing, monitoring the safety of these systems, reducing   risks   to   patient   privacy, assessing   the   potential   for   systemic bias   embedded   in   AI   models   and enabling   continuous   system improvements. 29 – 31   Last, many emer- gency   physicians   share   similar   con- cerns about the use of AI in EDs as health   consumers.   These   common concerns include data usage and pri- vacy, bias and discrimination, skill loss and   over-reliance,   transparency   and explainability of AI algorithms, and regulation and governance. 32,33 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  774   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nLimitations  The   fi ndings   in   the   present   study should be considered within the con- text of its limitations. A convenience sample   was   used   to   select   partici- pants based on their accessibility and willingness to take part, which could lead   to   voluntary   response   bias.   8 Attempts   were   made   to   recruit   a sample based on demographic data provided by the Australian Institute of Health and Welfare   –   Emergency Department Activity to reduce dis- crepancies   between   the   demo- graphics   of   the   sample.   However, this was unsuccessful, leading to a sample   that   was   skewed   towards those   living   in   Victoria,   Western Australia and Queensland, those in an   older   age   bracket,   females   and those   from   a   white-Anglo   back- ground.   Additionally,   as   a   non- probability   sample,   the   results   are not representative of the Australian population.   The   grounded   theory approach also has limitations. It is accepted that using a GT approach can allow for the researcher ’ s indi- vidual   biases   and   world   view   to in fl uence study results.   34   AI is a rap- idly changing area, and the introduc- tion   and   media   coverage   of   new technologies   has   the   potential   to in fl uence   respondent   perspectives. For   example,   recent   advances   in foundation models such as ChatGPT were   released   after   the   interviews took   place,   meaning   some   health consumers ’   perspectives   may   have already changed.  Conclusion  The results discussed in this paper found that most consumers require AI to be rigorously tested and evalu- ated before it becomes operational. There is also a requirement for AI to be robustly regulated and monitored by government or a professional reg- ulatory   body   to   gain   support   and acceptance.   However,   regulation alone   is   not   considered   suf fi cient. Informed consent processes that pro- vide information about the role and functionality of AI, maintaining pri- vacy and con fi dentiality of personal health data, bias and discrimination, and the attribution of responsibility and liability for patient health out- comes are all critical issues that need to be addressed   if   AI   technologies are to be trusted and accepted by health consumers in EDs.  Acknowledgements  We thank the Consumer Community Involvement Program, Fiona Stanley Hospital Emergency Department Con- sumer Advisory Group, St Vincent ’ s Hospital Melbourne Human Research Ethics Committee layperson members, Health   Consumers   Queensland,   and the Centre for Culture, Ethnicity and Health for their support and the par- ticipants who provided feedback on our initial interview guide, who partic- ipated in the pilot interviews, and who participated in the study. Open access publishing facilitated by The Univer- sity   of   Melbourne,   as   part   of   the Wiley - The University of Melbourne agreement via the Council of Austra- lian University Librarians.  Competing interests  None declared.  Data availability statement  The de-identi fi ed data we analysed are   not   publicly   available,   but requests to the corresponding author for the data will be considered on a case-by-case basis.  References  1.   Topol E.   Deep Medicine: How Arti-  fi cial   Intelligence   Can   Make Healthcare   Human   Again   /   Eric Topol , 1st edn. New York: Basic Books, 2019. 2.   Littman   M,   Ajunwa   I,   Berger   G  et al . Gathering Strength, Gathering Storms:   The   One   Hundred   Year Study   on   Arti fi cial   Intelligence (AI100) 2021 Study Panel Report 2022. 3.   Australian Government Department of   Health   and   Aged   Care.   The Australian   Health   System: Australian Government Department of   Health   and   Aged   Care;   2019. Available from URL: https://www. health.gov.au/about-us/the-australian- health-system. 4.   Morley J, Machado CCV, Burr C  et   al .   The   ethics   of   AI   in   health care: a mapping review.   Soc. Sci. Med.   2020;   260 : 113172. 5.   Stewart J, Sprivulis P, Dwivedi G. Arti fi cial   intelligence   and   machine learning   in   emergency   medicine.  Emerg. Med. Australas.   2018;   30 : 870 – 4. 6.   Tong A, Sainsbury P, Craig J. Con- solidated criteria for reporting qual- itative   research   (COREQ):   a 32-item checklist for interviews and focus groups.   In. J. Qual. Health Care   2007;   19 : 349 – 57. 7.   Halaweh M, Fidler C, McRobb S, eds. Integrating   the   grounded   theory method and case study research meth- odology within IS research: a possible  ‘ road map ’ . International Conference on Interaction Sciences; 2008. 8.   Etikan   I.   Comparison   of   conve- nience   sampling   and   purposive sampling.   Am. J. Theor. Appl. Stat.  2016;   5 : 1. 9.   Anderson   M,   Anderson   SL. How should AI Be developed, val- idated,   and   implemented   in patient care?   AMA J. Ethics   2019;  21 : E125 – 30. 10.   Tran V-T, Riveros   C, Ravaud P. Patients ’   views of wearable devices and AI in healthcare:   fi ndings from the ComPaRe e-cohort.   npj Digit. Med.   2019;   2 : 53. 11.   Jutzi   TB,   Krieghoff-Henning   EI, Holland-Letz T   et al . Arti fi cial intel- ligence in skin cancer diagnostics: the   patients ’   perspective.   Front. Med. (Lausanne)   2020;   7 : 233. 12.   Rawson TM, Ming D, Gowers SA  et   al .   Public   acceptability   of computer-controlled   antibiotic management:   an   exploration   of automated   dosing   and   opportuni- ties   for   implementation.   J.   Infect.  2019;   78 : 75 – 86. 13.   Fritsch SJ, Blankenheim A, Wahl A  et al . Attitudes and perception of arti fi cial intelligence in healthcare: a cross-sectional   survey   among patients.   Digit.   Health   2022;   8 : 20552076221116772. 14.   Ongena   YP,   Haan   M,   Yakar   D, Kwee   TC.   Patients ’   views   on   the implementation of arti fi cial intelli- gence   in   radiology:   development and   validation   of   a   standardized questionnaire.   Eur.   Radiol.   2020;  30 : 1033 – 40. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   775 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n15.   Palmisciano   P,   Jamjoom   AAB, Taylor D, Stoyanov D, Marcus HJ. Attitudes of patients and their rela- tives toward arti fi cial intelligence in neurosurgery.   World   Neurosurg.  2020;   138 : e627 – 33. 16.   Ayers   JW,   Poliak   A,   Dredze   M  et   al .   Comparing   physician   and arti fi cial   intelligence   Chatbot responses   to   patient   questions posted   to   a   public   social   media forum. JAMA.   Intern. Med.   2023;  183 : 589. 17.   Nadarzynski T, Miles O, Cowie A, Ridge D. Acceptability of arti fi cial intelligence (AI)-led chatbot services in   healthcare:   a   mixed-methods study.   Digit.   Health   2019;   5 : 2055207619871808. 18.   Gao S, He L, Chen Y, Li D, Lai K. Public perception of arti fi cial intelli- gence in medical care: content anal- ysis   of   social   media.   J.   Med. Internet Res.   2020;   22 : e16649. 19.   Nadarzynski   T,   Bayley   J, Llewellyn   C,   Kidsley   S, Graham CA. Acceptability of arti-  fi cial   intelligence   (AI)-enabled chatbots, video consultations and live webchats as online platforms for   sexual   health   advice.   BMJ Sex.   Reprod.   Health   2020;   46 : 210 – 7. 20.   Adams   SJ,   Tang   R,   Babyn   P. Patient   perspectives   and   priorities regarding   arti fi cial   intelligence   in radiology:   opportunities   for patient-centered radiology.   J. Am. Coll. Radiol.   2020;   17 : 1034 – 6. 21.   Price WN 2nd, Cohen IG. Privacy in the age of medical big data.   Nat. Med.   2019;   25 : 37 – 43. 22.   Gerke S, Minssen T, Cohen G. Eth- ical and legal challenges of arti fi cial intelligence-driven healthcare.   Artif. Intell.   Healthc.   2020:   295 – 336. https://doi.org/10.1093/oxfordhb/97 80190067397.013.23 23.   Jones   ML,   Edenberg   E.   Trouble- shooting   AI   and   consent.   In: Dubber   MD,   Pasquale   F,   Das   S, eds.   The   Oxford   Handbook   of Ethics   of   AI .   Oxford   University Press, 2020. 24.   Quigley   A,   Hutton   J,   Phillips   G  et al . Review article: implicit bias towards   Aboriginal   and   Torres Strait   Islander   patients   within Australian emergency departments.  Emerg. Med. Australas.   2021;   33 : 9 – 18. 25.   Johnstone MJ, Kanitsaki O. Ethnic aged discrimination and disparities in health and social care: a question of   social   justice.   Australas. J. Ageing   2008;   27 : 110 – 5. 26.   Bastos JL, Harnois CE, Paradies YC. Health   care   barriers,   racism,   and intersectionality in Australia.   Soc. Sci. Med.   2018;   199 : 209 – 18. 27.   Temple JB, Kelaher M, Williams R. Discrimination and avoidance due to disability in Australia: evidence from   a   National   Cross   Sectional Survey.   BMC Public Health   2018;  18 : 1347. 28.   Gebru   T.   Race   and   gender.   In: Dubber MD, Pasquale F, Das S, eds.  The Oxford Handbook of Ethics of AI . Oxford University Press, 2020. https://doi.org/10.1093/oxfordhb/97 80190067397.013.16 29.   Australian   Medical   Association. Automated   Decision   Making   and AI Regulation; 2022. 30.   Price WN. Risks and Remedies for Arti fi cial Intelligence in Health Care; 2019. Available from URL: https:// www.brookings.edu/research/risks- and-remedies-for-arti fi cial-intelligence- in-health-care/. 31.   Australian   Alliance   for   Arti fi cial Intelligence   in   Healthcare.   A Roadmap for Arti fi cial Intelligence in Healthcare for Australia; 2021. 32.   Stewart   J,   Freeman   S,   Eroglu   E  et   al .   Attitudes   towards   arti fi cial intelligence in emergency medicine.  Emerg. Med. Australas.   2024;   36 : 252 – 65. 33.   Grant K, McParland A, Mehta S, Ackery AD. Arti fi cial intelligence in emergency medicine: surmountable barriers with revolutionary poten- tial.   Ann. Emerg. Med.   2020;   75 : 721 – 6. 34.   Kolb S. Grounded theory and the constant comparative method: valid research   strategies   for   educators.  J. Emerg. Trends Educ. Res. Policy Studies   2012;   3 : 83 – 6. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  776   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License',0.3220757177345311,'[\"%\", \"&\", \"(\", \"(2021/et000609).\", \"(2024)\"]','2025-11-29 17:08:23.212194'),(75,3,'ORIGINAL RESEARCH  Health consumers ’   ethical concerns towards arti fi cial intelligence in Australian emergency departments  Sam FREEMAN   ,   1,2   Jonathon STEWART   ,   3,4   Rebecca KAARD, 5   Eden OULIEL,   5   Adrian GOUDIE,   6,3 Girish DWIVEDI 3,4,7   and Hamed AKHLAGHI   1  1   Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, Victoria, Australia,   2   Centre for Digital Transformation of Health, The University of Melbourne, Melbourne, Victoria, Australia,   3   School of Medicine, The University of Western Australia, Perth, Western Australia, Australia,   4 Cardiovascular Disease and Diabetes Program, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia, 5   School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia,   6   Department of Emergency Medicine, Fiona Stanley Hospital, Perth, Western Australia, Australia, and   7   Department of Cardiology, Fiona Stanley Hospital, Perth, Western Australia, Australia  Abstract  Objectives : To investigate health con- sumers ’   ethical concerns towards the use of arti fi cial intelligence (AI) in EDs.  Methods : Qualitative   semi-structured interviews with health consumers, rec- ruited via health consumer networks and   community   groups,   interviews conducted   between   January   and August 2022.  Results : We   interviewed   28   health consumers   about   their   perceptions towards the ethical use of AI in EDs. The   results   discussed   in   this   paper highlight the challenges and barriers for   the   effective   and   ethical   imple- mentation of AI from the perspective of Australian health consumers. Most health consumers are more likely to support AI health tools in EDs if they continue   to   be   involved   in   the decision-making   process.   There   is considerably   more   approval   of   AI tools that support clinical decision- making,   as   opposed   to   replacing it. There is mixed sentiment about the acceptability of AI tools in fl uencing clinical   decision-making   and   judge- ment. Health consumers are mostly supportive of the use of their data to train and develop AI tools but are concerned   with   who   has   access. Addressing bias and discrimination in AI is an important consideration for some health consumers. Robust regu- lation and governance are critical for health consumers to trust and accept the use of AI.  Conclusion : Health consumers view AI as an emerging technology that they   want   to   see   comprehensively regulated to ensure it functions safely and securely with EDs. Without con- siderations   made   for   the   ethical design,   implementation   and   use   of AI   technologies,   health   consumer trust and acceptance in the use of these tools will be limited.  Key   words:   arti fi cial   intelligence, emergency   medicine,   ethics,   health consumers, machine learning, quali- tative research.  Introduction  Advancements   in   arti fi cial   intelli- gence (AI) are predicted to impact healthcare delivery in a multitude of ways such as providing a comprehen- sive   picture   of   an   individual ’ s healthcare   data,   augmenting   clinical decision-making,   reducing   diagnostic errors, assisting with test selection and interpretation, and recommending fur- ther   management   options. 1   Despite the technology behind most of these advances continuing to improve, par- ticularly   through   machine   learning (ML), 2   there remain key challenges in the Australian health system that need Correspondence: Dr Sam Freeman, Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, VIC, Australia. Email: sam.freeman@svha.org.au Sam Freeman, PhD, Research Fellow; Jonathon Stewart, MBBS, MMed(CritCare), Anaesthetic Registrar; Rebecca Kaard, MBBS Student; Eden Ouliel, MBBS Student; Adrian Goudie, MBBS FACEM DDU, Emergency Physician; Girish Dwivedi, MD, PhD, FRACP, Wesfarmers Chair and Consultant Cardiologist; Hamed Akhlaghi, MD, PhD, FACEM, Emergency Physician, Head of Emergency Medicine Research. This is an open access article under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs   License,   which   permits   use   and   distribution   in   any medium, provided the original work is properly cited, the use is non-commercial and no modi fi cations or adaptations are made.  Accepted 15 May 2024  Key   fi ndings  •   Health   consumers   generally support   arti fi cial   intelligence (AI) tools that assist clinicians in   decision-making   but   are wary of tools replacing doc- tors, with trust diminishing as AI ’ s   decision-making   auton- omy increases.  •   Health   consumers   express   a strong   desire   to   be   actively involved in AI-driven decision- making about their healthcare in emergency settings.  •   Mixed sentiments surround the acceptability of AI in fl uencing doctor   decision-making,   with concerns about its impact on healthcare quality. Health con- sumers fear a short-term under- mining of nurses and doctors, leading to a potential reduction in clinical skills and a long-term shift   towards   ‘ box-ticking ’  exercises,   raising   discomfort and   scepticism   about   the technology ’ s role in emergency medicine. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  Emergency Medicine Australasia   (2024)   36 , 768 – 776   doi: 10.1111/1742-6723.14449\nurgent   attention.   These   include   an increasing demand for healthcare ser- vices, an ageing population, increas- ing   costs   associated   with   medical research and innovations and grow- ing rates of chronic disease. 3   This has led groups such as policymakers, pol- iticians,   technology   companies   and data scientists to advocate for AI to address these challenges. 4 It is predicted that the use of AI- based tools will become increasingly common in EDs. 5   However, there is limited published research that qualita- tively assesses how health consumers (people who use health services, their families and carers) feel about AI use in their care in an ED context. To date, research has mostly focused on health consumers ’   perceptions of AI in speci fi c sub fi elds of medicine, such as radiology, dermatology, general prac- tice and primary care. This   paper   presents   health   con- sumer attitudes towards AI to help inform future research and highlight risk   mitigation   strategies   for   the effective and ethical implementation of AI in EDs.  Methods  Study design and setting  This qualitative study was designed in accordance with the consolidated criteria   for   reporting   qualitative research.   6   We   developed   a   semi- structured interview guide based on the review of existing literature and input from the multidisciplinary pro- ject   team.   Members   of   the   project team   have   recognised   expertise   in emergency medicine, qualitative resea- rch   and   AI   and   also   included   two healthcare   consumer   representatives. The   study   protocol   and   interview guide were presented to and received formal support from the Fiona Stanley Hospital Emergency Department Con- sumer   Advisory   Group   (Western Australia). We conducted three pilot interviews and re fi ned the   interview guide based on feedback. Twenty-eight   semi-structured interviews were conducted between January and August 2022 to assess health   consumers ’   perspectives   and considerations for the ethical imple- mentation   and   use   of   AI   in   EDs. Participants were recruited from dif- ferent health consumer networks and community   groups,   including   the Consumer Community Involvement Program (Western Australia), Fiona Stanley Hospital Emergency Depart- ment   Consumer   Advisory   Group (Western   Australia),   St   Vincent ’ s Hospital   Melbourne   Human Research   Ethics   Committee   layper- son members (Victoria), Health Con- sumers   Queensland   (Queensland) and the Centre for Culture, Ethnic- ity & Health (Australia wide), where recruitment details were distributed through its members and networks. The interviews were conducted until thematic saturation (de fi ned as three consecutive interviews with no new themes identi fi ed) was achieved. This research utilises a grounded theory approach,   which   was   selected because it provides a methodology for collecting and analysing data and conceptualising   the   results.   7   Inter- views were conducted by telephone via a voice call (without video) and audio   recorded.   Audio   fi les   were de-identi fi ed and professionally tran- scribed by a secure transcription ser- vice.   Interviews   were   conducted   in Australia with participants from New South   Wales,   Queensland,   Victoria and Western Australia. For a further breakdown   of   participant   demo- graphics (see Table 1).  Participant selection  A convenience sample was used to recruit   respondents   ( n   =   28)   based on   accessibility   and   willingness   to take part in the study.   8  Data collection  Semi-structured   interviews   were   con- ducted with additional questions and prompts used as needed. Although the discussion of ethical concerns was led by respondents, prompts included prin- ciples such as consent, transparency, privacy, safety and harm, bias, fairness and   redress.   There   were   no   repeat interviews or transcription checks by participants. Interview duration ranged from 10 to 45 min.  Data analysis  Two investigators (SF and JS) indepen- dently analysed and coded interviews using open coding techniques based on grounded theory.   All   the   interviews were coded using NVivo 20 (QSR, Melbourne,   Australia).   Codes   and themes were iteratively developed and re fi ned until most content was able to be classi fi ed. Agreement on codes and themes was reached at researcher meet- ings where differing codes were dis- cussed and a consensus on their coding was agreed upon.  Characteristics of interviewers  The interviews were conducted by SF, two medical students (RK and EO), and an ED Registrar. Interviews were held over the phone without video to reduce any bias that the interviewer ’ s appearance may have on responses. The interviewers had no prior rela- tionship with the study participants.  Characteristics of research team  At   the   time   of   conducting   this research   SF   was   a   PhD   candidate  TABLE   1.   Participant   demo- graphic information  Category   n   % Sex Female   17   61 Male   10   36 Non-binary   1   4 Age group 20 – 29   2   7 30 – 39   6   21 40 – 49   6   21 50 – 59   2   7 60 – 69   2   7 70 – 79   10   36 Location New South Wales   1   4 Queensland   5   18 Victoria   14   50 Western Australia   8   29 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   769 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n(focus on ethical implementation of AI in emergency medicine) and a research fellow at an Australian ED. JS was a PhD candidate (focus on applications of AI in emergency medicine) and an emergency medicine trainee. RK and EO   were   both   second-year   medical students who had not completed rota- tions in emergency medicine.  Ethical considerations  The study received University of West- ern Australia Research Ethics Commit- tee   approval   (2021/ET000609). Informed consent was gained from all respondents participating in the present study. The present study was prospec- tively   registered   with   the   Australian New Zealand Clinical Trials Registry (ACTRN12621000890831).  Results  The results provide an overview of health   consumers ’   key   perceptions of ethical AI in an ED setting. Key ethical   concerns   presented   here include health consumer autonomy and consent, doctor decision-making and autonomy, automation bias and reliance, data usage and privacy, bias and discrimination and regulation.  Health consumer autonomy and consent  Most   health   consumers   are   more likely to support AI health tools in emergency medicine if they continue to   be   involved   in   the   decision- making   process   about   their   health and can still understand why a treat- ment recommendation or diagnosis is made. There is some concern that with   the   use   of   increasingly   adva- nced technologies, they will no lon- ger be able to ask questions or have key issues explained to them about their treatment or diagnosis. For many participants there is a requirement to have the role of AI in their treatment explained to them at the   earliest   opportunity.   Many believe they would be more comfort- able with the use of AI if it is effec- tively   communicated.   This   becomes even more important with the incre- ased   complexity   or   risk   associated with the function of the AI tool. This is particularly important if the role of AI includes clinical decision support that relates to differential   diagnosis, complex cases, serious health condi- tions or decisions that were tradition- ally tasked to doctors and nurses. Effective   communication   is   criti- cally important to most health con- sumers   to   improve   autonomy   and consent processes. Many already feel that   information   in   EDs   could   be better communicated and that if AI is to play a future role in emergency medicine, in any capacity, it needs to be clearly communicated. The more  ‘ serious ’   the concern or high-risk set- ting   the   tool   is   functioning   in,   the more information consumers require. There is concern that AI systems may be non-interpretable by the doc- tor,   meaning   the   doctor   may   be unable   to   effectively   understand results and subsequently communi- cate   them   to   their   patients.   This thereby impacts the patient ’ s ability to give informed consent. There are mixed views, however, about the type and amount of informa- tion required, and how it is communi- cated.   Overwhelmingly,   consumers want to know (to varying degrees) if an   AI   tool   is   being   used   in   their healthcare pathway. If an AI tool is used in a patient ’ s healthcare   pathway   and   they   were not   informed,   many   report   they would   feel   ‘ betrayed ’ ,   ‘ annoyed ’ ,  ‘ frustrated ’   or   ‘ distressed ’ . For trust and   acceptance   of   these   systems, many health consumers believe that improved   consent   processes   are needed to ensure the risks, bene fi ts and alternatives can be explained in how the tool works and that they have the opportunity to opt in or out of   having   the   tool   used   in   their healthcare delivery. There is fear that the introduction of these tools will lead to a loss of human connection in the ED, in par- ticular   empathy   and   sympathy,   in what is for many people an already highly stressful environment. Some see the   healthcare   journey   as   a   human experience and want it delivered with kindness and compassion   –   traits not typically   associated   with   AI   and machines. Having that human connec- tion in a health setting is not only con- sidered   important   on   an   emotional, human   level,   but   also   connects   to health consumer autonomy.  Doctor decision-making and autonomy  There is considerably more approval for AI tools in the ED that support cli- nician decision-making, as opposed to replacing   it.   Most   participants   will only support these tools if their func- tion is subsidiary to the role of the doctor. Trust and acceptance and AI decision-making autonomy appear to have an inverse relationship. As an AI tool ’ s   decision-making   autonomy increases in the ED, patient trust and acceptance decrease. There is recognition that   human decision-making   is   fallible, particu- larly in a dynamic, complex ED envi- ronment.   Against   this   backdrop, participants see potential in AI tools being   used   to   support   doctor   and nurse   decision-making.   For   some, there is also an expectation that AI tools will likely make mistakes. For many, it is how these mistakes are responded   to   that   will   determine their level of acceptance. The   doctor   is   predominantly viewed as the   fi nal authority regard- ing   patients ’   health.   Trust   and acceptability in AI tools are derived from the doctor agreeing with the AI tools ’   prediction. When respondents envisage an AI tool operating inde- pendently of doctor oversight, many health   consumers   said   they   would insist on being treated by a doctor if they disagreed with the decision of the AI health tool. For some, no mat- ter what scenario occurs within the ED, clinicians are considered more accurate in diagnosing and treating patients. Although there are differing views about the acceptability of AI tools   to   make   errors,   ultimately, most health consumers hold AI tools to   a   higher   standard   of   accuracy than ED doctors and nurses. Despite concerns about the effec- tiveness and accuracy of AI, some health   consumers   state   that   once these   tools   are   ‘ proven ’   to   out- perform   doctors   then   they   would prefer AI tools over doctors. Some health   consumers   state   that   in some circumstances, they would prefer AI-assisted   decision-making,   such   as © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  770   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nwhen a doctor is overworked, the ED is short-staffed or overcrowded, or the treating clinician has limited experi- ence   in   the   role.   Health   consumers largely   accept   that   their   perceptions may change with advancements in AI technology and its predicted increased integration into healthcare. However, doctors are still regarded as providing the   preferred standard of care   over any form of AI tool.  Automation bias and reliance  There   is   mixed   sentiment   among respondents about the acceptability of AI tools in fl uencing ED doctors ’  decision-making and clinical judge- ment. Many were concerned that AI tools would in fl uence doctors ’   judge- ment   and   impact   the   quality   of healthcare   provision.   For   these health consumers, AI is considered just another tool to be utilised by cli- nicians and should not be afforded special   status   over   any   other   tool available in the ED. If AI tools are believed to have an in fl uential role over   clinical   decision-making,   it would   make   health   consumers  ‘ uncomfortable ’ ,   ‘ sceptical ’   and   ‘ dis- trustful ’   of the technology. Many health consumers are con- cerned that the use of AI tools in emergency medicine will result in a reliance on them. In the short term, consumers   feel   these   tools   could undermine   the   role   of   nurses   and doctors   within   the   ED   and   in   the long term could reduce the skills and ability of clinicians. There is a belief from some that diagnosing patients and clinical judgement will become  ‘ box ticking ’   exercises, where a clini- cian ’ s   ‘ gut   feeling ’ ,   ‘ intuition ’   and  ‘ instincts ’   are   no   longer   attributes that are developed and valued.  Data usage and privacy  Health   consumers   are   mostly   sup- portive of the use of their data to train and support the development of AI tools in emergency medicine but   are   concerned   with   who   has access.   Most   are   comfortable   with their non-identi fi able data being used for healthcare purposes, but only for healthcare purposes. If it was later dis- covered   that   their   information   had been used outside of the healthcare system,   or   for   purposes   other   than improving   healthcare   delivery   or healthcare research, trust and accep- tance of these tools would diminish. There   is   concern   about   data breaches and the level of security for protecting personal health informa- tion. However, many are aware of the inherent risks involved in sharing and   storing   data.   Although   it   is recognised   that   privacy   issues   are not unique to AI, many want assur- ances that their data is being handled securely. Many state that they are not   overly   concerned   about   their own   medical   data   being   released publicly, but do recognise that some health information and some mem- bers of the public could be negatively impacted, targeted or discriminated against based on their health data: Some   health   consumers   want greater control over the health infor- mation   that   is   shared   and   stored. Many   want   consent   processes   in place, so they are aware if the infor- mation is being shared and have the ability to opt in or out of its collec- tion and sharing. There are privacy concerns about how data will be col- lected in the ED if managed by an AI-enabled   platform.   Some   partici- pants   are   apprehensive   about   how patient-to-machine   information   will be communicated in a crowded ED environment.   Some   discussed   the need for a private space to feel com- fortable sharing information.  Bias and discrimination  Addressing bias and discrimination in AI is an important consideration for some   health   consumers.   There   is concern that AI will inherit the same biases   that   are   already   present   in healthcare. One participant feels that having come from a Caucasian back- ground   means   that   AI   tools   will likely be accurate for them, but less accurate or reliable for people from culturally   and   linguistically   diverse backgrounds. There are concerns that AI tools will bias or discriminate against cul- turally   and   linguistically   diverse populations,   First   Nations   people, women   and   people   with   disability and   complex   medical   needs.   Bias and discrimination are linked to per- ceptions of accuracy. For health con- sumers   to   trust   and   accept   these tools in the ED, they must be con- vinced they are accurate. Part of that required accuracy is how well they perform   for   people   from   multicul- tural backgrounds. It will be impor- tant   that   AI   based   tools   do   not perpetuate existing biases or intro- duce new biases.  Regulation  Regulation   is   an   important   aspect for trusting and accepting the use of AI   in   EDs   for   health   consumers. Some health consumers want assur- ances that there is robust regulation and oversight in the design, develop- ment, training and ongoing use of these tools. Most support a govern- ment   regulatory   body   to   establish guidelines   and   oversee   compliance. Some   see   this   as   the   role   of   the national government to ensure con- sistency across states and territories. Many do not want to see industry self-regulation   or   regulation   and standards left to the private sector. Here, there is concern that pro fi t will be   the   motivating   factor   for   the implementation   and   use   of   these tools, not improving patient health outcomes. Some   health   consumers   want   to see   more   localised   governance   and accountability of these tools such as the hospital administration or industry peak   bodies   such   as   the   Australian Medical Association, to ensure train- ing and policies are established and provided at the clinical level. There are also calls for AI tools to be endorsed by the bodies that represent the medi- cal professionals who are required to use these tools in clinical practice. Some health consumers also want these tools to pass through an ethics review   process.   For   these   respon- dents, it is not enough to just con- sider the safety and medical accuracy of these tools, it must also consider their ethical impact (Table 2).  Discussion  This research found that health con- sumer   acceptance   of   AI-enabled health tools requires the consideration © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   771 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nTABLE 2.   Sample comments by health consumers on ethical concerns  Qualitative dimension   Sub-dimension   Example quote Patient autonomy and consent Health consumer understanding of treatment or diagnosis  … that I was involved in the discussions about my treatment, patients being encouraged to be involved in decision-making about their care, that actually has to be absolutely central to the whole process still so that I wouldn ’ t want the human element and the capacity for me as a patient to actually explain my concerns and, you know, the capacity of me to ask questions. Effective communication that AI is being used I think as a patient I would also want to understand the role of AI in the whole process, and I think that would be very, very important because if I found out for some reason, you know, at a later date that (that AI was being used), that would be quite disturbing. But I think if I was involved at the start in knowing that this system was actually helping clinicians to arrive at an accurate diagnosis, I think I would be very satis fi ed, very comfortable with that. You ’ ve got to have that communication, break that barrier to communication face-to-face by someone who can explain what ’ s happening. Amount of information health consumers require  … not in a great amount of detail, but it would just be nice to have that reassurance. The more information, the better. Consent requirements With my consent, I ’ d feel good about it. I think you need to opt in. Doctor – patient relationship I wouldn ’ t like it because you want to be heard and seen by a compassionate, kind professional. This is a human experience, and I don ’ t want it to be determined by a robot. At least, if the robot has this decision, I would want a human sitting there and explaining it to me …   the desperation and feeling unwell, just to be questioned by a robot in a yes or no or to get an answer way, it ’ s going to just increase the frustration and the suffering, I feel. Doctor decision- making and autonomy AI errors in decision-making  … every human body is different so the program is written for the majority, allowing for some differences, but there ’ ll always be individuals that   … swim against the   fl ow and where they should have got better, all the signs are there that they should have got better and something has happened, but that happens just when a doctor sends them home, the fact that it ’ s a computer algorithm that did the agree-to-release, in my eyes, makes no difference. AI accuracy   If it replaces something that ’ s there at the moment, yes, it has to be better.   … I can imagine that 15 years down the track I would see it as completely irrelevant, but I think during a new kind of introductory phase of a new technology, I think it would be perceived as far worse for a computer to make an error. Because I think if it ’ s proven to be more failsafe and make less mistakes than what the humans are performing then I would take my chances with that over human assessment for sure. AI over doctors   I mean not every doctor ’ s going to be a specialist in every   fi eld. And in emergency, the guy treating me may not be the most capable guy in whatever it is I have. [So] I think the fact that he can rely on the information from a tool to help him in the diagnostics would be very useful. Automation bias and reliance AI in fl uence over doctor decision- making Well, I would think it ’ s actually a slap in the face to doctors, because you ’ re negating all the experience that they ’ ve had, and their own experience will tell them a lot of information that the machine can ’ t gather. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  772   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nand minimisation of ethical issues. As AI research continues to develop it is important   to   understand   what   are considered   by   healthcare   consumers to be acceptable uses of the technol- ogy in emergency medicine contexts. These   results   provide   information about health consumers ’   current per- ceptions of AI in emergency medicine and further emphasises the need for effective   communication   to   ensure consumers understand the function of AI and the role it will play in the deliv- ery of their healthcare. Consumers require assurance that the   ED   doctor   retains   the   fi nal decision-making authority and that they understand how and why an AI tool has come to a certain prediction or   recommendation.   This   may   be challenging as current AI tools are for the most part   ‘ black boxes ’   with reasoning that is not interpretable to humans.   9 It appears that trust and acceptance of   AI   tools   and   clinician   decision- making   autonomy   are   inversely related.   The   more   autonomous   or independent the tool is from ED doc- tors ’   oversight   and   understanding, the less likely patients are to trust its output. There are reservations about the accuracy and performance of these technologies, and also apprehension about moving to a new standard of care, which may remove other ele- ments   of   healthcare   considered important to patients such as the doctor – patient   relationship.   Other research   into   patient   perspectives on   AI   in   different   medical   fi elds found comparable results   –   patients  TABLE 2.   Continued  Qualitative dimension   Sub-dimension   Example quote Reduced doctor skill and ability  … as soon as we start taking away decisions from health professionals, we ’ re sort of undermining their training and we start, look, it ’ s complicated because I think if we could take routine jobs away from nurses and doctors to help them focus on more important things, that would be great. But I ’ m worried that [they] would then start relying on AI and it would undermine the expertise of doctors and nurses. Data usage and privacy  Re -use of patient health consumer data If you ’ ve given consent for it, no problems. You wouldn ’ t want it to be then on-sold or used for anything else. I could understand people who are very private and would not want their medical records (shared) … . but as long as it ’ s unidenti fi ed and they ’ re not used for any other purpose, you know, it ’ s probably inevitable things are going down this track in all   fi elds. [Concern] around how your data ’ s kept and used, and the breaches   –   what ’ s being collected and how could that be used. Control over the sharing of health consumer data  … Patients should be able to consent to certain information being taken, and where that information is actually going to go. On the other hand, I really do support the interoperability of programs, so that they can talk to one another, after consent is received. How private data is disclosed It would depend on how the information was communicated, like if it was …  in an open space. You know, are people ’ s private health details being broadcast loud by this AI? Is it happening in a quiet, private space? Bias and discrimination AI and human bias   I don ’ t think AI is good enough yet and everyone ’ s just forging ahead with it, thinking it ’ s great and missing the fact that it ’ s really not great. It ’ s programmed like humans, so it will have human error in it. Discrimination and multicultural populations  … the (AI) system has been calibrated using data that isn ’ t particularly diverse and then the output it generates is biased because of that. Regulation   Government regulation I think it ’ s got to be a multi-layered approach. I think Australia at a federal level has to have some very clear guidelines around the use of AI in medical settings and lots of other settings, but if we ’ re just sticking with medical, I think we need to have some federal governance around that. Local governance mechanisms But I do think then we need to have local [governance], like AMA (Australia Medical Association) or state level or even hospital level to make sure that staff are trained, staff are upskilled, that there is a local connection with what ’ s going on federally. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   773 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nare much more likely to support AI if there is a human tasked with mak- ing   the   fi nal   decision   or recommendation. 10 – 15   In part, this is because there is more trust in the abil- ity of an experienced doctor. Doctors are also able to justify and explain their   decision   or   recommendation, something health consumers currently do not associate with AI technology. Many   patients   still   want   the human   connection   and   assurance healthcare staff provide when they are   going   through   a   potentially stressful   time,   something   machines are viewed as incapable of providing. However,   these   views   may   change with increased exposure to advanced AI tools. A recent study comparing physician and ChatGPT responses to patient questions found that patients rated ChatGPT responses   ‘ higher for both quality and empathy ’ . 16   With this challenging the assumptions of most health consumers that AI tools will lack empathy. Some of the lit- erature also suggests that patients fear losing human interaction from their   healthcare   delivery   and   are concerned   that   AI   tools   will   be unable   to   comprehend   emotional issues,   particularly   in   relation   to patients   experiencing   mental   ill- health.   10,11,14,17 – 19   This   concern appears   to   intensify   in   an   emer- gency   setting   with   patients   often requiring urgent medical attention, and where the human connection is considered especially important in reducing distress. Health   consumers   are   concerned about privacy and the use of their per- sonal   health   data.   Although   many approve   of   the   use   of   their   non- identi fi able   medical   data to   support the development of AI tools within healthcare,   they   are   still   concerned about   con fi dentiality   and   who   has access to it. This is consistent with research into patient perspectives of AI   in   radiology 20   and   healthcare chatbots, 17   which found patients are only willing to share data if it remains con fi dential and non-identi fi able. Con- sumers will likely rescind their support for data usage if it transpires that their personal   information   is   being   used outside of the healthcare system or for purposes other than improving patient health outcomes. Many   health   consumers   believe they are aware of the inherent risks involved in the sharing and storage of data. However, health consumers may be under the assumption that their health data refers only to data held by healthcare organisations in their health records. Yet, these data sources are considered only a small part of the   ‘ larger health data eco- system ’ . 21   This includes health data generated   by   non-healthcare   pro- viders such as insurance companies, non-health information where infer- ences   are   made   about   health,   and user-generated health data.   21   Health consumers may feel less comfortable knowing that there is the potential for this information to be collected and used to make decisions about them, particularly if used by com- mercial entities. Data collection and sharing policies need to be updated to ensure data collected and gener- ated through the use of these tools meets the standards and expectations of consumers. Most   health   consumers   see informed   consent   as   a   critical   ele- ment   in   gaining   their   trust   and acceptance regardless of the role AI might play in their treatment. One study   22   identi fi ed that informed con- sent   is   not   receiving   the   attention needed   in   the   ethical   debate   sur- rounding   AI   implementation,   with another study 23   reporting that   ‘ ubiq- uity, complexity and opaqueness ’   are major   contributors   to   health   con- sumers ’   ‘ inability to assess or predict outcomes   or   harms ’   associated with   the   use   of   AI   in   healthcare and   therefore   provide   informed consent. The issue of consent app- ears   to   be   a   signi fi cant   consider- ation for health consumers. It will be important that the ED doctors and hospital management who are tasked   with   implementing   these technologies   ensure   the   consent process is current and appropriate, and that the use of AI in the ED is communicated effectively. Addressing   bias   and   discrimina- tion that results from the introduc- tion   of   AI   is   important   to   many health   consumers.   However,   bias and discrimination pre-existent to AI is   not   without   precedent   in   the Australian healthcare system, where First   Nations   people   ‘ continue   to suffer   adverse   experiences   in healthcare, with inequitable care pre- valent   in   emergency   settings ’ . 24 Research   has   highlighted   that   the Australian   healthcare   system   under serves those from culturally and lin- guistically diverse backgrounds, 25   has discriminated   against   women 26   and people   with   disability. 27   For   AI   to bene fi t   diverse   populations   such   as Australia ’ s, the design and develop- ment of AI technologies must include input from diverse populations from diverse   geographic   locations,   who will   use   or   be   exposed   to   these technologies. 28 It appears that health consumers envisage a more rigorous regulatory framework that monitors and evalu- ates the design, development, imple- mentation and use of AI technologies than   currently   exists   within Australia. Although the Therapeutic Goods Administration does regulate software as a medical device, which AI software are categorised, there is no regulation that relates speci fi cally to these technologies.   29   Because of this   assumption,   it   is   likely   that future regulation and guidance will need to address issues of oversight and evaluation to gain the support of consumers. This will likely include ensuring health consumers are protec- ted,   and   that   improved   health   out- comes are a priority in implementing these systems. 29   This also relates to fears that AI tools may not be appro- priately   regulated   and   be   more in fl uenced by   fi nancial incentives than improving healthcare outcomes. The existing literature, similarly, found that rigorous regulation and guidance of AI in healthcare is regarded as impor- tant for protecting patient wellbeing, monitoring the safety of these systems, reducing   risks   to   patient   privacy, assessing   the   potential   for   systemic bias   embedded   in   AI   models   and enabling   continuous   system improvements. 29 – 31   Last, many emer- gency   physicians   share   similar   con- cerns about the use of AI in EDs as health   consumers.   These   common concerns include data usage and pri- vacy, bias and discrimination, skill loss and   over-reliance,   transparency   and explainability of AI algorithms, and regulation and governance. 32,33 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  774   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nLimitations  The   fi ndings   in   the   present   study should be considered within the con- text of its limitations. A convenience sample   was   used   to   select   partici- pants based on their accessibility and willingness to take part, which could lead   to   voluntary   response   bias.   8 Attempts   were   made   to   recruit   a sample based on demographic data provided by the Australian Institute of Health and Welfare   –   Emergency Department Activity to reduce dis- crepancies   between   the   demo- graphics   of   the   sample.   However, this was unsuccessful, leading to a sample   that   was   skewed   towards those   living   in   Victoria,   Western Australia and Queensland, those in an   older   age   bracket,   females   and those   from   a   white-Anglo   back- ground.   Additionally,   as   a   non- probability   sample,   the   results   are not representative of the Australian population.   The   grounded   theory approach also has limitations. It is accepted that using a GT approach can allow for the researcher ’ s indi- vidual   biases   and   world   view   to in fl uence study results.   34   AI is a rap- idly changing area, and the introduc- tion   and   media   coverage   of   new technologies   has   the   potential   to in fl uence   respondent   perspectives. For   example,   recent   advances   in foundation models such as ChatGPT were   released   after   the   interviews took   place,   meaning   some   health consumers ’   perspectives   may   have already changed.  Conclusion  The results discussed in this paper found that most consumers require AI to be rigorously tested and evalu- ated before it becomes operational. There is also a requirement for AI to be robustly regulated and monitored by government or a professional reg- ulatory   body   to   gain   support   and acceptance.   However,   regulation alone   is   not   considered   suf fi cient. Informed consent processes that pro- vide information about the role and functionality of AI, maintaining pri- vacy and con fi dentiality of personal health data, bias and discrimination, and the attribution of responsibility and liability for patient health out- comes are all critical issues that need to be addressed   if   AI   technologies are to be trusted and accepted by health consumers in EDs.  Acknowledgements  We thank the Consumer Community Involvement Program, Fiona Stanley Hospital Emergency Department Con- sumer Advisory Group, St Vincent ’ s Hospital Melbourne Human Research Ethics Committee layperson members, Health   Consumers   Queensland,   and the Centre for Culture, Ethnicity and Health for their support and the par- ticipants who provided feedback on our initial interview guide, who partic- ipated in the pilot interviews, and who participated in the study. Open access publishing facilitated by The Univer- sity   of   Melbourne,   as   part   of   the Wiley - The University of Melbourne agreement via the Council of Austra- lian University Librarians.  Competing interests  None declared.  Data availability statement  The de-identi fi ed data we analysed are   not   publicly   available,   but requests to the corresponding author for the data will be considered on a case-by-case basis.  References  1.   Topol E.   Deep Medicine: How Arti-  fi cial   Intelligence   Can   Make Healthcare   Human   Again   /   Eric Topol , 1st edn. New York: Basic Books, 2019. 2.   Littman   M,   Ajunwa   I,   Berger   G  et al . Gathering Strength, Gathering Storms:   The   One   Hundred   Year Study   on   Arti fi cial   Intelligence (AI100) 2021 Study Panel Report 2022. 3.   Australian Government Department of   Health   and   Aged   Care.   The Australian   Health   System: Australian Government Department of   Health   and   Aged   Care;   2019. Available from URL: https://www. health.gov.au/about-us/the-australian- health-system. 4.   Morley J, Machado CCV, Burr C  et   al .   The   ethics   of   AI   in   health care: a mapping review.   Soc. Sci. Med.   2020;   260 : 113172. 5.   Stewart J, Sprivulis P, Dwivedi G. Arti fi cial   intelligence   and   machine learning   in   emergency   medicine.  Emerg. Med. Australas.   2018;   30 : 870 – 4. 6.   Tong A, Sainsbury P, Craig J. Con- solidated criteria for reporting qual- itative   research   (COREQ):   a 32-item checklist for interviews and focus groups.   In. J. Qual. Health Care   2007;   19 : 349 – 57. 7.   Halaweh M, Fidler C, McRobb S, eds. Integrating   the   grounded   theory method and case study research meth- odology within IS research: a possible  ‘ road map ’ . International Conference on Interaction Sciences; 2008. 8.   Etikan   I.   Comparison   of   conve- nience   sampling   and   purposive sampling.   Am. J. Theor. Appl. Stat.  2016;   5 : 1. 9.   Anderson   M,   Anderson   SL. How should AI Be developed, val- idated,   and   implemented   in patient care?   AMA J. Ethics   2019;  21 : E125 – 30. 10.   Tran V-T, Riveros   C, Ravaud P. Patients ’   views of wearable devices and AI in healthcare:   fi ndings from the ComPaRe e-cohort.   npj Digit. Med.   2019;   2 : 53. 11.   Jutzi   TB,   Krieghoff-Henning   EI, Holland-Letz T   et al . Arti fi cial intel- ligence in skin cancer diagnostics: the   patients ’   perspective.   Front. Med. (Lausanne)   2020;   7 : 233. 12.   Rawson TM, Ming D, Gowers SA  et   al .   Public   acceptability   of computer-controlled   antibiotic management:   an   exploration   of automated   dosing   and   opportuni- ties   for   implementation.   J.   Infect.  2019;   78 : 75 – 86. 13.   Fritsch SJ, Blankenheim A, Wahl A  et al . Attitudes and perception of arti fi cial intelligence in healthcare: a cross-sectional   survey   among patients.   Digit.   Health   2022;   8 : 20552076221116772. 14.   Ongena   YP,   Haan   M,   Yakar   D, Kwee   TC.   Patients ’   views   on   the implementation of arti fi cial intelli- gence   in   radiology:   development and   validation   of   a   standardized questionnaire.   Eur.   Radiol.   2020;  30 : 1033 – 40. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   775 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n15.   Palmisciano   P,   Jamjoom   AAB, Taylor D, Stoyanov D, Marcus HJ. Attitudes of patients and their rela- tives toward arti fi cial intelligence in neurosurgery.   World   Neurosurg.  2020;   138 : e627 – 33. 16.   Ayers   JW,   Poliak   A,   Dredze   M  et   al .   Comparing   physician   and arti fi cial   intelligence   Chatbot responses   to   patient   questions posted   to   a   public   social   media forum. JAMA.   Intern. Med.   2023;  183 : 589. 17.   Nadarzynski T, Miles O, Cowie A, Ridge D. Acceptability of arti fi cial intelligence (AI)-led chatbot services in   healthcare:   a   mixed-methods study.   Digit.   Health   2019;   5 : 2055207619871808. 18.   Gao S, He L, Chen Y, Li D, Lai K. Public perception of arti fi cial intelli- gence in medical care: content anal- ysis   of   social   media.   J.   Med. Internet Res.   2020;   22 : e16649. 19.   Nadarzynski   T,   Bayley   J, Llewellyn   C,   Kidsley   S, Graham CA. Acceptability of arti-  fi cial   intelligence   (AI)-enabled chatbots, video consultations and live webchats as online platforms for   sexual   health   advice.   BMJ Sex.   Reprod.   Health   2020;   46 : 210 – 7. 20.   Adams   SJ,   Tang   R,   Babyn   P. Patient   perspectives   and   priorities regarding   arti fi cial   intelligence   in radiology:   opportunities   for patient-centered radiology.   J. Am. Coll. Radiol.   2020;   17 : 1034 – 6. 21.   Price WN 2nd, Cohen IG. Privacy in the age of medical big data.   Nat. Med.   2019;   25 : 37 – 43. 22.   Gerke S, Minssen T, Cohen G. Eth- ical and legal challenges of arti fi cial intelligence-driven healthcare.   Artif. Intell.   Healthc.   2020:   295 – 336. https://doi.org/10.1093/oxfordhb/97 80190067397.013.23 23.   Jones   ML,   Edenberg   E.   Trouble- shooting   AI   and   consent.   In: Dubber   MD,   Pasquale   F,   Das   S, eds.   The   Oxford   Handbook   of Ethics   of   AI .   Oxford   University Press, 2020. 24.   Quigley   A,   Hutton   J,   Phillips   G  et al . Review article: implicit bias towards   Aboriginal   and   Torres Strait   Islander   patients   within Australian emergency departments.  Emerg. Med. Australas.   2021;   33 : 9 – 18. 25.   Johnstone MJ, Kanitsaki O. Ethnic aged discrimination and disparities in health and social care: a question of   social   justice.   Australas. J. Ageing   2008;   27 : 110 – 5. 26.   Bastos JL, Harnois CE, Paradies YC. Health   care   barriers,   racism,   and intersectionality in Australia.   Soc. Sci. Med.   2018;   199 : 209 – 18. 27.   Temple JB, Kelaher M, Williams R. Discrimination and avoidance due to disability in Australia: evidence from   a   National   Cross   Sectional Survey.   BMC Public Health   2018;  18 : 1347. 28.   Gebru   T.   Race   and   gender.   In: Dubber MD, Pasquale F, Das S, eds.  The Oxford Handbook of Ethics of AI . Oxford University Press, 2020. https://doi.org/10.1093/oxfordhb/97 80190067397.013.16 29.   Australian   Medical   Association. Automated   Decision   Making   and AI Regulation; 2022. 30.   Price WN. Risks and Remedies for Arti fi cial Intelligence in Health Care; 2019. Available from URL: https:// www.brookings.edu/research/risks- and-remedies-for-arti fi cial-intelligence- in-health-care/. 31.   Australian   Alliance   for   Arti fi cial Intelligence   in   Healthcare.   A Roadmap for Arti fi cial Intelligence in Healthcare for Australia; 2021. 32.   Stewart   J,   Freeman   S,   Eroglu   E  et   al .   Attitudes   towards   arti fi cial intelligence in emergency medicine.  Emerg. Med. Australas.   2024;   36 : 252 – 65. 33.   Grant K, McParland A, Mehta S, Ackery AD. Arti fi cial intelligence in emergency medicine: surmountable barriers with revolutionary poten- tial.   Ann. Emerg. Med.   2020;   75 : 721 – 6. 34.   Kolb S. Grounded theory and the constant comparative method: valid research   strategies   for   educators.  J. Emerg. Trends Educ. Res. Policy Studies   2012;   3 : 83 – 6. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  776   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License',0.3220757177345311,'[\"%\", \"&\", \"(\", \"(2021/et000609).\", \"(2024)\"]','2025-11-29 17:08:33.879592'),(76,3,'Hardware Article  A modular, isolated high-voltage switch for application in ion mobility spectrometry  Martin Lippmann   * , Moritz Hitzemann , Jonas Winkelholz , David Bailey , Stefan Zimmermann  Leibniz University Hannover, Institute of Electrical Engineering and Measurement Technology, Department of Sensors and Measurement Technology, Appelstr. 9A, 30167 Hannover, Germany  A R T I C L E   I N F O  Keywords:  Ion mobility spectrometry High-voltage switch Ion gating Isolated gate driver  A B S T R A C T  Ion mobility spectrometry is an emerging technology in trace gas analysis that has moved from typical safety and security applications to many other fields ranging from environmental and food quality monitoring to medicine and life sciences. Nevertheless, further dissemination, including the development of new instruments and the expansion into new fields of application requires the availability of the fundamental components of ion mobility spectrometers. For example, the electronics is essential for the analytical performance, but is only provided by specialized man- ufacturers due to specific requirements. In this paper, we present a modular, isolated high-voltage switch that can be operated at an isolated potential. The modular design enables tailoring its configuration to the required application. Each module can switch a voltage of up to 3 kV, and can be operated with an offset voltage of up to 7 kV. The switch has rise and fall times of less than 25 ns, making it suitable for a wide range of applications, e.g., in ion mobility spectrometry. Finally, the presented modular, isolated high-voltage switch was used in a push – pull configura- tion to generate the injection pulse of the ion gate. The new modular, isolated high-voltage switch shows similar performance compared to a commercially available high-voltage switch.  Specifications table  Hardware name   Modular, isolated high-voltage switch Subject area   •   Chemistry and biochemistry  •   Biological sciences (e.g., microbiology and biochemistry)  •   Environmental, planetary, and agricultural sciences  •   General Hardware type   •   Field measurements and sensors  •   Electrical engineering and computer science Closest commercial analog   Custom High-Voltage Switches from companies like   “ Behlke Power Electronics GmbH ”  Open source license   CC BY 4.0 Cost of hardware   Approx. 100   €  Source file repository   https://doi.org/10.17632/gtnv5dwjk5.1  * Corresponding author.  E-mail address:   lippmann@geml.uni-hannover.de (M. Lippmann).  Contents lists available at ScienceDirect  HardwareX  journal homepage: www.elsevier.com/locate/ohx  https://doi.org/10.1016/j.ohx.2024.e00574 Received 31 May 2024; Received in revised form 21 August 2024; Accepted 21 August 2024  HardwareX   19   (2024)   e00574  Available   online   23   August   2024  2468-0672/©   2024   The   Author(s).   Published   by   Elsevier   Ltd.   This   is   an   open   access   article   under   the   CC   BY   license  ( http://creativecommons.org/licenses/by/4.0/ ).\n1.   Hardware in context  Ion mobility spectrometers (IMS) have been used since the 1950s to detect gases at trace levels. Initially, IMS were mainly used in safety and security applications, e.g., for the detection of highly toxic compounds, explosives and drugs of abuse [1,2], but today, its application spans from environmental and food quality monitoring to medicine and life sciences [1 – 3]. The analysis of gaseous samples in drift time IMS is based on the separation of different ion species by their specific ion mobility in an electric field. For this reason, the sample has to be ionized in the first step. The generated ions are transferred into the drift tube, where ions of different species are separated based on their ion mobility. At the end of the drift tube, the ions are detected by a Faraday detector, generating a current, which is then converted into a proportional voltage by a transimpedance amplifier. Recording the ion current over time gives the ion mobility spectrum. The analytical performance of an IMS is mainly described by its detection limit and resolving power [4]. The resolving power is obtained from the drift time of a specific ion species divided by the full width at half maximum (FWHM) of the corresponding peak in the spectrum. Thus, it represents the separation power. The detection limit, however, represents the concentration at which the ion current related to a certain compound is three times the standard deviation of the noise of the zero signal and thus defines the minimum detectable concentration. The influence of the mechanical design and operating parameters on the analytical performance of IMS has been extensively described in the literature [4 – 14]. Furthermore, several easy-to-manufacture, low-cost designs have been published [15 – 18]. Those designs mainly consist of printed circuit boards (PCBs) and differ in using flexible or rigid versions of PCBs. However, the electronics required to operate such IMS is expensive when using commercial devices, which limits the broader application of IMS. For instance, fast switching of high voltages on an isolated electric potential is a major challenge that can only be addressed by few manufacturers, e. g.,   “ Behlke Power Electronics GmbH ” . In addition to the mechanical design, the electronics significantly affect the analytical per- formance of IMS, thinking of the bandwidth and noise of the amplifier or operating the ion gate in a defined temporal sequence. The electric field used to separate the ions typically results in a drift voltage across the entire drift tube in the kilovolt range and the drift voltage directly influences the resolving power of IMS [19]. Given that the detector and amplifier of an IMS are typically ground referenced, the voltages of the ion gate must be operated at high drift voltage potential. Depending on the type of ion gate and the design of the ionization region, voltages in the range of a few volts up to several hundred volts must be rapidly switched. Typically, the pulse width applied to the ion gate ranges from 5   μ s to 350   μ s [11]. For example, using a drift tube IMS with a so-called field-switching ion gate, the temporal width of the ion packet is mainly defined by the injection voltage used to transfer the ion packet into the drift tube [7]. Consequently, the injection voltage has an impact on the resolving power. Achieving ultra-high resolving power using a field- switching ion gate requires injection voltages up to the low kilovolt range [20]. As a result, the high-voltage switch required for such injection voltages needs an insulation strength in the kilovolt range to isolate the used drift voltage. At the same time, the high-voltage switch must be capable of switching voltages up to the kilovolt range. These requirements imply that the supply voltage of the driver of the high-voltage switch and the switching signal must be isolated. As mentioned before, the commercial market for switches that meet such requirements is limited to a few specialized manufacturers, thus representing a significant cost factor in IMS. For this reason, we present a low-cost and modular alternative of a high-voltage switch, which is capable of switching several kilovolts and operating at high potential of up to 10 kV above reference potential.  2.   Hardware description  The modular, isolated high-voltage (HV) switch presented in this work is based on a silicon carbide field-effect transistor (SiC- MOSFET) capable of switching up to 3 kV with rise and fall times of under 25 ns. The SiC-MOSFET is driven by a non-insulated gate driver, which is powered by an isolated power supply and controlled via optical data transmission. The isolated power supply of the gate driver is realized by an inductive power transmission utilizing QI coils, which also provide the power required for switching the SiC-MOSFET [21 – 26]. Moreover, the inputs and outputs, as well as the creepage distances of the PCBs, are designed in a way that it becomes possible to stack several modules of the HV switch for switching up to   ± 9 kV and isolating 10 kV. Additionally, a push – pull stage configuration can be constructed by implementing an inversion of the control signal for switching between two defined potentials. Therefore, this modular, isolated HV switch is suitable for the following ion mobility spectrometry applications:  •   Switching the injection voltage of a field-switching ion gate operated at a potential of   ± 10 kV above reference potential.  •   Fast polarity switching of the drift voltage (up to 9 kV) for an ultra-fast polarity switching IMS, as introduced by Hitzemann et al. [27].  •   Switching the drift field in a moving-field IMS introduced by Bohnhorst et al. [28].  •   Switching the dispersion voltage of a FAT-IMS introduced by Bohnhorst et al. [29]. In addition, the switch can be used in other applications that need to rapidly switch high-voltages:  •   Switching between two potentials up to   ± 9 kV  •   Switching of voltages isolated at a high electrical potential of   ± 10 kV above reference potential  •   Switching loads at high-voltage of up to   ± 9 kV  M. Lippmann et al.   HardwareX   19   (2024)   e00574  2\nPossible other applications include driving electrostatic electrodes, extraction grids, and deflection plates of ion guides, piezos or other capacitive loads. In these cases, a push – pull configuration of two modular, isolated HV switches is recommended. Switching inductive loads using the modular, isolated HV switch is not possible without additional protective measures. Furthermore, the modular, isolated switch is not suitable for high-power applications as the MOSFET is just rated up to 4 A and moreover, the design does not provide sufficient cooling of the MOSFET for these applications. A further increase in creepage distances on the PCBs and the change of the switching signal ’ s optical path may allow even higher insulation strengths, insulation resistance and higher voltages to be switched.  3.   Design files summary  All schematics, production files and CAD files, summarized in Table 1 below, can be downloaded from the MendeleyData repository (https://doi.org/10.17632/gtnv5dwjk5.1).  4.   Bill of materials summary  The individual cost for one single modular, isolated HV switch is approximately 100   € . Given that a substantial portion of the costs is attributed to the PCB, the expense diminishes significantly with the production of multiple modular, isolated HV switches, leading to a notable reduction in the costs per switch as the costs per board decrease. For instance, fabricating six modular, isolated HV switches reduces the cost per modular, isolated HV switch below 90   € . Constructing a push – pull configuration serving as a high-voltage switch for voltages of up to 3 kV entails total cost of approximately 225   € . The additional costs, which exceed a mere doubling, arise primarily from including connectors between the two PCBs. A comprehensive breakdown of the materials is provided in Table 2.  5.   Build instructions  The PCB of the modular, isolated HV switch and the soldering stencil can be ordered from a PCB manufacturer using the Gerber files from MendeleyData. For the ordering process, the PCB board size (140.97 mm   ×   59.69 mm), the PCB thickness (1.55 mm), and the  Table 1  Design files.  Design file name   File type   Open source license   Location of the file  IMS_Stackable_HV_Switch.PrjPcb   Schematics   CC BY 4.0   MendeleyData IMS_Stackable_HV_Switch.PrjPCBStructure   Schematics   CC BY 4.0   MendeleyData IMS_Stackable_HV_Switch.Annotation   Schematics   CC BY 4.0   MendeleyData TopSheet.SchDoc   Schematics   CC BY 4.0   MendeleyData LowsideConnector.SchDoc   Schematics   CC BY 4.0   MendeleyData Lowside_RX.SchDoc   Schematics   CC BY 4.0   MendeleyData IsoPower.SchDoc   Schematics   CC BY 4.0   MendeleyData IsoPower_FlyBuck.SchDoc   Schematics   CC BY 4.0   MendeleyData HV_Connection.SchDoc   Schematics   CC BY 4.0   MendeleyData Highside_RX.SchDoc   Schematics   CC BY 4.0   MendeleyData GateSegment.SchDoc   Schematics   CC BY 4.0   MendeleyData HV_Switch_Schematics.pdf   Schematics   CC BY 4.0   MendeleyData HV_Switch_3D.pdf   3D PCB View   CC BY 4.0   MendeleyData TopSheet.apr   Gerber Files   CC BY 4.0   MendeleyData TopSheet.EXTREP   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GBL   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GBO   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GBP   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GBS   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GM1   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GTL   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GTO   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GTP   Gerber Files   CC BY 4.0   MendeleyData TopSheet.GTS   Gerber Files   CC BY 4.0   MendeleyData TopSheet.REP   Gerber Files   CC BY 4.0   MendeleyData TopSheet-macro.APR_LIB   Gerber Files   CC BY 4.0   MendeleyData TopSheet.DRR   NC Drill Files   CC BY 4.0   MendeleyData TopSheet.LDP   NC Drill Files   CC BY 4.0   MendeleyData TopSheet-NonPlated.txt   NC Drill Files   CC BY 4.0   MendeleyData TopSheet-Plated.txt   NC Drill Files   CC BY 4.0   MendeleyData Assembly_Enclosure.iam   CAD Files   CC BY 4.0   MendeleyData Enclosure_body.ipt   CAD Files   CC BY 4.0   MendeleyData Enclosure_cover.ipt   CAD Files   CC BY 4.0   MendeleyData HV-Switch.ipt   CAD Files   CC BY 4.0   MendeleyData Enclosure_cover.stl   CAD Files   CC BY 4.0   MendeleyData Enclosure_body.stl   CAD Files   CC BY 4.0   MendeleyData  M. Lippmann et al.   HardwareX   19   (2024)   e00574  3\nTable 2  Bill of materials used for this hardware.  Designator   Component   Number   Cost per unit- currency Total cost- currency Source of materials  Stackable HV switch unit PCB Printed Circuit Board   1   14,80   €   14,80   €   https://www.multi-circuit-boards.eu C1, C3, C5, C9, C10, C17, C22, C28 Capacitor SMD 0805 0.1uF 50 V X7R 8   0,15   €   1,18   €   https://de.farnell.com/tdk/cga4j3x7t2e104k125aa/ kondensator-0-1uf-0805-250v-10/dp/2211001 C2, C4, C6, C7, C11, C15, C18, C24, C25 Capacitor SMD 0805 1uF 50 V X7R 9   0,18   €   1,65   €   https://de.farnell.com/kemet/c0805c105k5ractu/ kondensator-1uf-50v-x7r-0805/dp/2118131?Ntt = 2118131 C8   Capacitor SMD 0805 56pF 50 V NP0 1   0,07   €   0,07   €   https://de.farnell.com/yageo/ac0805jrnpo9bn560/ kondensator-56pf-50v-mlcc-0805/dp/4166211 C12, C21, C26, C27, C33 Capacitor SMD 0805 10uF 35 V X5R 5   0,21   €   1,07   €   https://de.farnell.com/murata/grm21br6ya106ke43l/ kondensator-10-f-35v-10-x5r-0805/dp/2611943 C13   Capacitor SMD 0805 220pF 50 V NP0 1   0,11   €   0,11   €   https://de.farnell.com/murata/grm21a5c2e221jw01d/ kondensator-220pf-250v-mlcc-0805/dp/3340793 C14, C20   Capacitor SMD 0805 10nF 50 V NP0 2   0,12   €   0,24   €   https://de.farnell.com/murata/grm2195c1h103ja01d/ kondensator-0-01-f-50v-5-c0g-np0/dp/8820074 C16   Capacitor SMD 0805 1.2nF 50 V NP0 1   0,05   €   0,05   €   https://de.farnell.com/murata/grm2165c2a122ja01d/ kondensator-1200pf-100v-mlcc-0805/dp/3581389 C19   SMD Panasonic Electrolyt-Capacitor 68uF 50 V 1   2,13   €   2,13   €   https://www.mouser.de/ProductDetail/Panasonic/ 50SVPF68M?qs = OE1iw1LrrPHIF78tf5kBjw%3D%3D C31   Trimmer BFC2808 vertical series 5.5 pF   –   65 pF 1   5,74   €   5,74   €   https://www.mouser.de/ProductDetail/Vishay-BC- Components/BFC280831659?qs = rCu%252BC%252BJkvKa% 252Bs3bgN0PQyg%3D%3D D1, D2, D3, D4, D6, D7 Diode SMD P6SMB550A   6   0,45   €   2,68   €   https://www.mouser.de/ProductDetail/Bourns/P6SMB550A? qs = QB0ovJDgFgu%252BWplPxxsFbg%3D%3D D8, D9, D10, D11, D13, D14 Diode SMD 1N4148W   6   0,09   €   0,56   €   https://www.mouser.de/ProductDetail/Diotec- Semiconductor/1N4148W?qs = OlC7AqGiEDmsbkbAeXQtXg% 3D%3D D5   LED SMD 0805 yellow   1   0,12   €   0,12   €   https://www.reichelt.de/led-smd-2012-0805-gelb-8-mcd- 120–smd-led-0805-ge-p31437.html?GROUPID = 3035 && r = 1 D12   Diode SMD P6SMB30A   1   0,38   €   0,38   €   https://de.farnell.com/littelfuse/p6smb30a/tvs-diode-600w- 25-6v-unidir-do/dp/2679614?st = p6smb30a D15, D16   LED SMD 0805 green   2   0,12   €   0,24   €   https://www.reichelt.de/smd-led-0805-2012-super-gruen-15- mcd-120–smd-led-0805-gn-p31436.html? GROUPID = 3035 && r = 1 IC1   Non-inverting FET driver IXDN609SI 1   2,79   €   2,79   €   https://de.farnell.com/ixys-semiconductor/ixdn609si/mosfet- treiber-40-bis-125-c/dp/3580495?st = ixdn609si IC2   Dual Schmitt trigger SN74LVC2G14 1   0,55   €   0,55   €   https://www.mouser.de/ProductDetail/Texas-Instruments/ SN74LVC2G14IDCKRQ1?qs = PVVDbbWpW3LjDJNCpwWTow %3D%3D OPK1   Optocoupler OPI1268   1   7,74   €   7,74   €   https://www.mouser.de/ProductDetail/Optek-TT- Electronics/OPI1268?qs = NVJATC80C4% 252BwL4AEB9cmsw%3D%3D P9, P11   Board-to-Board Connector 3X2 2   1,89   €   3,78   €   https://de.farnell.com/wurth-elektronik/61000621821/ steckv-buchsenleiste-6p-2reihen/dp/2827866 P8, P10   Board-to-Board Connector 3X2 2   1,10   €   2,20   €   https://de.farnell.com/wurth-elektronik/61000621121/ stiftleiste-2-54mm-smd-6pol/dp/2356218?ost = 61000621121 P10   SMA print connector   1   3,95   €   3,95   €   https://de.farnell.com/te-connectivity/5-1814400-2/hf-koax- steckverbinder-abg-sma/dp/3364890 Q1   SiC-MOSFET G2R1000MT33J 1   17,38   €   17,38   €   https://de.farnell.com/genesic-semiconductor/ g2r1000mt33j/mosfet-sic-n-kanal-3-3kv-4a-74w/dp/3598638 Q2, Q3   MOSFET N-channel IRLML6346 2   0,34   €   0,67   €   https://www.mouser.de/ProductDetail/Infineon-IR/ IRLML6346TRPBF?qs = 9%252BKlkBgLFf3TGIqhHXU%2FwA %3D%3D ( continued on next page )  M. Lippmann et al.   HardwareX   19   (2024)   e00574  4\nTable 2   ( continued   )  Designator   Component   Number   Cost per unit- currency Total cost- currency Source of materials  R1   Resistor SMD 0805 4.7 Ohm 1   0,02   €   0,02   €   https://de.farnell.com/vishay/crcw08054r70fkea/ dickschichtwiderstand-4r7-1-0/dp/1653014RL R2, R17, R19   Resistor SMD 0805 10 K 3   0,03   €   0,08   €   https://de.farnell.com/vishay/rca080510k0fkea/ dickschichtwiderstand-10k-1-0805/dp/2616592 R8   Resistor SMD 0805 75 K 1   0,03   €   0,03   €   https://de.farnell.com/vishay/crcw080575k0fkea/ dickschichtwiderstand-75k-1-0/dp/1653035 R9, R13   Resistor SMD 0805 910 K 2   0,04   €   0,07   €   https://de.farnell.com/vishay/crcw0805910kfkea/dicksch- widerstand-910k-1-0-125w/dp/2139117 R4   Resistor SMD 0805 100 K 1   0,03   €   0,03   €   https://de.farnell.com/vishay/crcw0805100kfkea/dicksch- widerstand-100k-1-0-125w/dp/1469860 R12   Resistor SMD 0805 510 K 1   0,04   €   0,04   €   https://de.farnell.com/vishay/crcw0805510kfkea/dicksch- widerstand-510k-1-0-125w/dp/2139087 R14   Resistor SMD 0805 1 Meg 1   0,03   €   0,03   €   https://de.farnell.com/vishay/crcw08051m00fkea/ dickschichtwiderstand-1m-1-0-125w/dp/1652946 R15   Resistor SMD 0805 4.7 K 1   0,03   €   0,03   €   https://de.farnell.com/vishay/crcw08054k70fkea/ dickschichtwiderstand-4k7-1-0/dp/1469923 R11   Resistor SMD 0805 75 R 1   0,03   €   0,03   €   https://de.farnell.com/vishay/crcw080575r0fkea/ dickschichtwiderstand-75r-1-0/dp/1469955 R7   Resistor SMD 0805 1 K 1   0,03   €   0,03   €   https://de.farnell.com/vishay/crcw08051k00fkea/ dickschichtwiderstand-1k-1-0-125w/dp/1469847 R10   Resistor SMD 0805 51 K 1   0,03   €   0,03   €   https://de.farnell.com/vishay/crcw080551k0fkea/ dickschichtwiderstand-51k-1-0/dp/1653018 R16, R18   Resistor SMD 0805 100 Ohm 2   0,03   €   0,05   €   https://de.farnell.com/vishay/crcw0805100rfkeb/ widerstand-100r-1-0-125w-0805/dp/4177711 R20   Resistor SMD 0805 220 K 1   0,02   €   0,02   €   https://de.farnell.com/multicomp/mcwf08p2203ftl/ dickschichtwiderstand-220k-1-0/dp/2694120 U2   Step-Down Controller LM3150MH 1   3,11   €   3,11   €   https://www.ti.com/product/LM3150#order-quality U3   Inverting Charge Pump LTC3260 1   9,12   €   9,12   €   https://www.mouser.de/ProductDetail/Analog-Devices/ LTC3260EDEPBF?qs = hVkxg5c3xu9aeneAPtdUAA%3D%3D U1   LDO 3.3 V TPS70933   1   1,21   €   1,21   €   https://www.mouser.de/ProductDetail/Texas-Instruments/ TPS70933DBVR?qs = Z9twEOuL%252B%2FJOaGO60BtvLA% 3D%3D QI1, QI2   Qi-Inductor Würth Electronic 18 uH, 0.7 A, 0.5 Ohms 2   7,97   €   15,94   €   https://www.mouser.de/ProductDetail/Wurth-Elektronik/ 760308101208A?qs = 6mGTcvmWjFtRJtuJp2qBjQ%3D%3D  99,91   €  optional optical connection: LWL1   LWL-Receiver AFBR- 2624Z 1   22,79   €   22,79   €   https://www.mouser.de/ProductDetail/Broadcom-Avago/ AFBR-2624Z?qs = 60YbxKv0rtDJIJtl89oIpg%3D%3D  Fig. 1.   Printed circuit board of the modular, HV switch showing the top side (left) and bottom side (right).  M. Lippmann et al.   HardwareX   19   (2024)   e00574  5\ncopper thickness (35   μ m) are essential parameters. It is also useful to choose an overlay silk screen for both sides in the ordering process since this reduces the effort of assembly and is also helpful during the functional test. Fig. 1 shows the manufactured PCB, with the top side depicted on the left and the bottom side on the right. When ordering the stencil, it is advisable to request dimensions at least 20 mm wider (160.87 mm   ×   79.69 mm) to facilitate the assembly process. Fig. 2 shows the assembly process, outlining the outcome of each step. It is advisable to start by placing the Surface-Mounted Devices (SMD) on the top side of the PCB. The necessary components are described in the bill of material and must be placed on the corresponding pads of the PCB. The individual component position on the PCB is shown by the overlay silk screen printed on the PCB and in the 3D representation uploaded on MendeleyData. For this phase, soldering paste and either a hot air station or a soldering oven are essential to solder the Integrated Circuits (ICs) featuring a dedicated ground plane under the package (U3.3 LM3150MH Texas Instruments, U3.4 LTC3260 Analog Devices, IC1.1 MCP1406 Microchip Technology). To begin with, the PCB is attached to a smooth surface e.g. cardboard with masking tape, and the top side ’ s soldering stencil is attached and fixed with masking tape, as shown in Fig. 2a and b. Subsequently, the solder paste (e.g. CHIP QUIK SMD4300SNL10) is applied to the pads of the components with a squeegee (an old plastic card e.g. credit card works fine as well) and the stencil can be removed carefully by lifting it evenly to minimize smearing of the solder paste. This process should yield a PCB prepared for placement of the components as shown in Fig. 2c. When positioning the SMD components, it is recommended to start with the ICs and MOSFETs before progressing to the capacitors, resistors, and diodes. Subsequently, the PCB with the SMD components placed can be soldered in a soldering oven or with a hot air station. Once the SMD components are soldered, the through-hole (THT) components located on the top side can be soldered using a standard soldering iron and lead-free solder. The finalized PCB is shown in Fig. 2d and e.  Fig. 2.   Assembly sequence of the printed circuit board (PCB) of the modular, high-voltage switch. a) PCB top side fixed with masking tape, b) Stencil fixed on the PCB with masking tape, c) top side of the PCB with applied solder paste, d) top side of the PCB ready assembled, e) bottom side of the PCB ready assembled.  M. Lippmann et al.   HardwareX   19   (2024)   e00574  6\nTo configure multiple modular, isolated HV switches in a push – pull setup or to operate the switches with higher switching voltages, it is crucial to solder the SMA print socket (P4.12) onto only one of the PCBs. Conversely, if it is intend to control the boards with a fiber optic cable, an optional fiber optic receiver (LWL4.1) needs to be soldered instead of the SMA print socket, as depicted in Fig. 3. To complete the assembly, the QI coils (QI1, QI2) need to be installed. Therefore, apply 2 K-epoxy glue (such as UHU Endfest 300) at the center of the inner circle on both the top and bottom sides of the board. Ensure that the ferrite foil of the coil faces away from the PCB during installation. Subsequently, solder the supply cables of the QI coils to the respective pads using lead-free solder. The correct positioning of the coils is shown in Fig. 4 for both the top side (left) and the bottom side (right). Finally, depending on operating mode of the modular, isolated HV switch, the inversion of the gate signal has to be defined. Table 3 shows the application scenarios and which inversion has to be selected. For example, if the modular, isolated HV switch is used as a  Fig. 3.   Section of the board with combined footprint for using an SMA socket (5 – 1814400-2 TE Connectivity) (blue) as signal input or optional use of a fiber optic receiver (AFBR-2624Z Broadcom) (orange). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)  Fig. 4.   QI Coils assembled on the printed circuit board (PCB), showing the top side (left) and the bottom side (right). The ferrite on the coils faces away from the PCB, and the wires are soldered to the respective pads.  Table 3  Gate signal inversion mode depending on the use-case of the modular, high-voltage switch.  Configuration   Gate signal inversion  Single switch   –   active high   ‘Noninv ’  Single switch   –   active low   ‘Inv ’  Push-pull   Upper switch: ‘Noninv ’ ; Lower switch: ‘Inv ’  Push-pull   –   inverted   Upper switch: ‘Inv ’ ; Lower switch: ‘Noninv ’  M. Lippmann et al.   HardwareX   19   (2024)   e00574  7\nlow-side switch, active-high, the solder bridge must be set at ‘Noninv ’ . A push – pull configuration needs at least one low-side and one high-side switch. Prior to testing the modular, isolated HV switch, it is of utmost importance to ensure that the PCBs are free of solder and flux residues. In particular, the area around the QI coils must be clean to prevent voltage flashovers due to increased conductivity caused by residues. The cleaning process can be accomplished using isopropyl alcohol and deionized water. Before initial operation, the PCB must be visually checked for possible soldering faults and misplaced or missing components. If no solder bridges between pins or pads of the ICs or other components are evident, the resistance between   + 12 V supply voltage and GND should be measured with a multimeter. A resistance of approximately 290 k Ω   (measured with a Keysight 34465A) indicates proper functionality. When connecting a 12 V supply voltage, the current consumption should be about 110 mA to 170 mA and the green LED (D11) should light up. This indicates correct operation of the IC controlling the QI coil and the presence of the voltage on the isolated side. Next, measure the supply voltage on the isolated side between the marked HGND and   + 20 V and   \0   3.3 V. Slight adjustment of the tunable capacitor C31 using a plastic screwdriver may be necessary to optimize the voltage, aiming for a range between 18 V to 22 V with an optimal voltage around 20 V. Additionally, check the   \0   3.3 V voltage to ensure proper operation. Subsequently, apply a static input signal of either ‘0 V ’   or ‘3.3 V ’   to the SMA print socket to test the full functionality of the modular, isolated HV switch. Depending on the inversion of the gate, the SiC-MOSFET will either conduct or block with a logic ‘0 ′   or ‘1 ′   input, respectively. Verify the SiC-MOSFET ’ s state with a multimeter connected between the drain and source terminals, ensuring that the resistance in the conducting state is around 1.3   Ω   and in the blocking state exceeds 1.1 G Ω   (measured with a Keysight 34465A). Upon successful completion of all tests, the board is ready for operation. Depending on the desired switching voltage, multiple modular high-side HV switches may be stacked on top of each other to achieve the necessary dielectric strength. Each individual module has the capability to switch up to 3 kV. For instance, utilizing six modular, isolated HV switches stacked in a push – pull configuration enables switching of a maximum voltage of   ± 9 kV. An exemplary push – pull configuration containing one high-side switch and one low-side switch is shown in Fig. 5. Finally, Fig. 6 displays the push – pull stage of the HV switch enclosed within the 3D-printed housing built from ABS material using a MakerBot METHOD X 3D printer. This housing incorporates specific cutouts tailored for high-voltage connections, switching signals, and power supply inputs of the modular, isolated HV switch. Notably, it serves to safeguard against inadvertent contact with high- voltage components.  Safety instructions: Soldering pastes and solder are potentially hazardous to health and environment and soldering fumes are toxic, so the PCB should only be  Fig. 5.   Push-pull configuration of two modular, high-voltage switches. The supply voltage, the control signal, the drain contact of the upper side, and the source contact of the lower side are connected via the headers between the printed circuit boards. The output signal can be taken either at the drain contact of the upper side or at the source contact of the lower side.  Fig. 6.   Push-pull stage of the HV switch in 3D-printed housing.  M. Lippmann et al.   HardwareX   19   (2024)   e00574  8\nassembled using appropriate personal protective equipment and measures. Care should also be taken with the waste since the solder paste and other electrical components can contain substances that are harmful to the environment. When using PCB cleaning agents, suitable personal protective equipment and measures should be used, as the substances used for this purpose may also be hazardous to health. The functional tests have to be performed by trained staff and without high voltage until proper function is ensured.  6.   Operation instructions  For operation, a 12 V supply voltage must be connected to the two mounting holes on the left side, as depicted in Fig. 7. Subse- quently, the source and drain can be connected with suitable cables, rated for the voltage used, to the mounting holes on the high- voltage side. Ensuring that the high-voltage source is turned off and de-energized before working on these cables and terminals is imperative. Fig. 8 shows the wiring of the modular, isolated HV switches for three different application scenarios. From the left to right, the wiring represents a low-side switch, a high-side switch, and a push – pull stage. If the modular high-voltage switch shall be used as a low-side switch, the source connector has to be connected to the lower electric potential and the drain connector to the low side of the load. If used as a high-side switch, the high electric potential is connected to the drain connector, while the source connector is connected to the high side of the load. In push – pull configuration, the drain side of the high-side switch is connected to the higher electrical potential   +   HV, while the lower electric potential   \0   HV is connected to the source side of the low-side switch. The source connector of the high-side switch is connected to the drain connector of the low-side switch so that the potential can be switched between the two voltages   + HV and   \0   HV. Each modular, isolated HV switch contains a dead time circuit, which ensures fast turn-off times and slower turn-on times of the MOSFETs and prevents a short circuit from   + HV to   \0   HV in a push – pull configuration. The dead time can be varied by changing the resistor R7 and the capacitor C8. For example, increasing this resistor and capacitor further in- creases the dead time by delaying the MOSFETs ’   turn-on.  Safety considerations: Extreme attention is required when operating the modular, isolated high-voltage switch, as the electric potentials can be lethal. Therefore, the electronics presented here must only be used under the mandatory protective measures for electronics, in particular for high-voltage electronics, and should only be operated by appropriately trained personnel. If working on the hardware, the high-voltage plugs must be disconnected, and the power supply must be turned off and de-energized! The authors accept no liability for any work related to the modular, isolated high-voltage switch.  Fig. 7.   Exemplary connected high-voltage switch, with the 12 V power supply on the left side red ( + ) and blue (GND) cable. The control signal is connected via the SMA cable (left bottom side) and connected to a function generator. The high-voltage is connected via the two brown cables (right side). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)  Fig. 8.   Modular, isolated high-voltage switch used as a low-side switch (left), a high-side switch (center) or in push – pull configuration (right).  M. Lippmann et al.   HardwareX   19   (2024)   e00574  9\n7.   Validation and characterization  To validate and characterize the modular, isolated HV switch, we investigated the rising and falling edges of a push – pull stage utilizing two modular, isolated HV switches. The modular, isolated HV switches were powered by a laboratory power supply (erfi Dreifach Netzger ¨ at H26.692), and a 10 kHz TTL signal with a 50 % duty cycle generated by a function generator (Rigol DG4062) was applied to the switching input via an SMA cable. The high-voltage was generated by a high-voltage power supply (FuG HCE 350-3500) and buffered by three 0.047   μ F high-voltage capacitors (WIMA FKP1) and one 0.1   μ F high-voltage capacitor (WIMA FKP1) in parallel. The output was directly connected to a high-voltage probe (Keysight 10076C) with an input resistance of 66.7 M Ω   and an input capacitance of 3 pF. The voltage was measured using an oscilloscope (Keysight Infinii Vision DSOX4104A). A high-voltage current measurement was performed with a current probe (Agilent 1147B). The rising edges and falling edges for six different voltages are shown in Fig. 9. All voltage curves are plotted against the time scale of the trigger signal. Notably, both the rising edges and the falling edges exhibit a delay of approximately 200 ns, primarily attributed to the propagation delay of the optocoupler used for the switching signal. The maximum rated propagation delay of this optocoupler is 200 ns, while the propagation delays of additional components such as the gate driver or the MOSFET itself are negligible. From the voltage curves, the rise time (10 % – 90 %) and the fall time (90 % – 10 %) for each of the six different switching voltages were measured. Remarkably, the determined times are well below 25 ns for all voltages without any significant overshoot or undershoot.  Fig. 9.   Rising (left) and falling (right) edges using different drain-source voltages.  Fig. 10.   Average power consumption of the push – pull stage from the high-voltage power supply without additional external load at the output except for the directly connected high-voltage probe.  M. Lippmann et al.   HardwareX   19   (2024)   e00574  10\nAdditionally, measuring the insulation resistance with the Fluke 1555 at the maximum output voltage of 10.5 kV resulted in an insulation resistance exceeding 2 T Ω . The average power consumption of the push – pull stage from the high-voltage power supply with just the high-voltage probe at the output measured at a switching frequency of 10 kHz and a switching voltage of 500 V is around 20 mW and varies with frequency and switching voltage, as shown in Fig. 10. As expected, the average power consumption of the push – pull stage from the high-voltage power supply is nearly linearly dependent on the switching frequency and the switching voltage. For switching voltages below 1000 V, continuous operation is possible up to frequencies of 100 kHz. For voltages above 1000 V, a continuous operation is only possible up to 20 kHz as the SiC-MOSFETs would otherwise overheat due to the power dissipated during switching. However, higher switching frequencies can be used in a burst mode or by adding a cooler. A rough estimation of the power converted in the high-voltage probe suggests that most of the power consumed from the high-voltage power supply is converted as switching losses in the push – pull stage. It should be noted, however, that the switching losses in the push – pull stage increase further with lower load impedance, and thus, the possible continuous operating point shifts to lower frequencies or voltages for thermal limitations. Fig. 11 shows an excerpt of a burst of 200 pulses at a switching frequency of 1 MHz with a duty cycle of 50 % at a period of 100 ms. The left plot shows the first ten pulses, while the right plot shows the last ten pulses of one exemplary burst. This demonstrates that the push – pull stage consisting of two modular, high-voltage switches, switches the voltage over the entire burst as expected. The modular, isolated HV switch was then exemplarily used to inject an ion packet into the drift tube of an ion mobility spec- trometer. For this experiment, a modified version of our previously reported ultra-high resolution drift tube IMS [11,20,30] was used but shortened to a drift length of just 40 mm, as it was available from another project. Its operational parameters are shown in Table 4. It should be noted that this experiment is intended to demonstrate the performance of the modular, isolated HV switch compared to a commercial alternative and the modular, isolated HV switch has not been specially adapted for this application and optimized in size to match with compact IMS setups. A high-voltage power supply (FuG HCP 35-12500) generated the drift voltage. The injection voltage was generated by a high- voltage power supply (FuG HCP 35-1250) while the blocking voltage was supplied by a laboratory power supply unit (Rohde & Sch- warz HMP4040). The modular, isolated HV switch was controlled by a self-built data acquisition system [31] and used in a push – pull configuration to switch the output between the injection voltage and the blocking voltage. For comparison, a commercial high-voltage switch (Behlke HTS 91-01-HB-C) was used. For current amplification, a self-built amplifier [32] with a gain of 3.2 G Ω   and a bandwidth of 22.6 kHz was used. Purified air with a dew point of   \0   90   ◦ C was used as drift gas and sample gas. Fig. 12 shows a schematic drawing of the experimental setup used for controlling the ion gate of an ion mobility spectrometer.  Fig. 11.   First ten pulses of a burst of 200 pulses with a switching frequency of 1 MHz with 50 % duty cycle (left) and the last ten pulses of the same burst (right).  Table 4  Operational parameters of the ion mobility spectrometer.  Parameter   Value  Drift length   40 mm Drift region diameter   21 mm Drift field   75 V/mm Injection field   227 V/mm Initial ion packet width   20   μ s Repetition rate   40 Hz Drift gas flow   150 ml/min Sample gas flow   10 ml/min Dew point of drift gas and sample gas   \0   90   ◦   C Operating pressure   1025 hPa Operation temperature   25   ◦   C  M. Lippmann et al.   HardwareX   19   (2024)   e00574  11\nFig. 13 displays the ion current measured at the detector of the ion mobility spectrometer plotted against the drift time. The measurements for both switches are identical, and the resolving power for the reactant ion peak is   R P = 50   in both spectra, which is consistent with theoretical predictions for this operating point. The amount of charge measured at the detector is 80 fC for both measurements. As shown in Fig. 13, in the relevant section of the IMS spectrum from 1.5 ms, both switches do not induce any interfering signals, which could disturb the measurement, and no additional shielding measures are required. This demonstrates that the HV switch is a viable replacement for commercially available high-voltage switches in this application. Overall, the modular, isolated HV switch presented in this work is a cost-effective way of pulsing high-voltages at high potential without relying on expensive special electronics from specialized manufacturers.  CRediT authorship contribution statement Martin Lippmann:   Writing   –   original draft, Visualization, Validation, Methodology, Investigation, Formal analysis, Data curation, Conceptualization.   Moritz Hitzemann:   Writing   –   review   &   editing, Visualization, Validation, Methodology, Investigation, Concep- tualization.   Jonas Winkelholz:   Writing   –   review   &   editing, Methodology, Investigation.   David Bailey:   Investigation, Conceptuali- zation.   Stefan Zimmermann:   Writing   –   review   &   editing, Supervision, Resources, Project administration, Funding acquisition, Conceptualization.  Fig. 12.   Schematic drawing of the experimental setup using a push – pull configuration of two modular, isolated high-voltage switches to control the ion gating of an ion mobility spectrometer.  Fig. 13.   IMS spectra comparing a Behlke switch and the modular, isolated HV switch.  M. Lippmann et al.   HardwareX   19   (2024)   e00574  12\nDeclaration of competing interest  The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.  Acknowledgments  This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. We thank Niklas Hilker for his help during this work.  Appendix A.   Supplementary data  Supplementary data to this article can be found online at https://doi.org/10.1016/j.ohx.2024.e00574.  References  [1]   V. Ruzsanyi, Ion mobility spectrometry for pharmacokinetic studies – exemplary application, J. Breath Res. 7 (2013) 46008, https://doi.org/10.1088/1752- 7155/7/4/046008. [2]   T. Fink, J.I. Baumbach, S. Kreuer, Ion mobility spectrometry in breath research, J. Breath Res. 8 (2014) 1 – 11, https://doi.org/10.1088/1752-7155/8/2/027104. [3]   Z. Karpas, Applications of ion mobility spectrometry (IMS) in the field of foodomics, Food Res. Int. 54 (2013) 1146 – 1151, https://doi.org/10.1016/j. foodres.2012.11.029. [4]   A.T. Kirk, A. Bohnhorst, S. Zimmermann, Analytical model for the signal-to-noise-ratio of drift tube ion mobility spectrometers, tm   – , Technisches Messen 88 (2021) 262 – 273, https://doi.org/10.1515/teme-2021-0013. [5]   A.T. Kirk, M.J. Küddelsmann, A. Bohnhorst, M. Lippmann, S. Zimmermann, Improving ion mobility spectrometer sensitivity through the extended field switching ion shutter, Anal. Chem. 92 (2020) 4838 – 4847, https://doi.org/10.1021/acs.analchem.9b04259. [6]   A. Bohnhorst, A.T. Kirk, S. Zimmermann, Toward compact high-performance ion mobility spectrometers: ion gating in ion mobility spectrometry, Anal. Chem. 93 (2021) 6062 – 6070, https://doi.org/10.1021/acs.analchem.0c04140. [7]   A.T. Kirk, S. Zimmermann, Bradbury-Nielsen vs. field switching shutters for high resolution drift tube ion mobility spectrometers, Int. J. Ion Mobility Spectrom. 17 (2014) 131 – 137, https://doi.org/10.1007/s12127-014-0153-9. [8]   A.T. Kirk, K. Bakes, S. Zimmermann, A universal relationship between optimum drift voltage and resolving power, Int. J. Ion Mobility Spectrom. 20 (2017) 105 – 109, https://doi.org/10.1007/s12127-017-0219-6. [9]   J. Langejürgen, P. Cochems, S. Zimmermann, Results of a transient simulation of a drift tube ion mobility spectrometer considering charge repulsion, ion loss at metallic surfaces and ion generation, Int. J. Ion Mobility Spectrom. 15 (2012) 247 – 255, https://doi.org/10.1007/s12127-012-0095-z. [10]   A. Bohnhorst, A.T. Kirk, S. Zimmermann, Simulation aided design of a low cost ion mobility spectrometer based on printed circuit boards, Int. J. Ion Mobility Spectrom. 19 (2016) 167 – 174, https://doi.org/10.1007/s12127-016-0202-7. [11]   A.T. Kirk, M. Allers, P. Cochems, J. Langejürgen, S. Zimmermann, A compact high resolution ion mobility spectrometer for fast trace gas analysis, Analyst 138 (2013) 5200 – 5207, https://doi.org/10.1039/c3an00231d. [12]   H.E. Revercomb, E.A. Mason, Theory of plasma chromatography/gaseous electrophoresis, Rev. Anal. Chem. 47 (1975) 970 – 983, https://doi.org/10.1021/ ac60357a043. [13]   W.F. Siems, C. Wu, E.E. Tarver, H.H. Hill Jr., P.R. Larsen, D.G. McMinn, Measuring the resolving power of ion mobility spectrometers, Anal. Chem. 66 (1994) 4195 – 4201, https://doi.org/10.1021/ac00095a014. [14]   A.B. Kanu, M.M. Gribb, H.H. Hill, Predicting optimal resolving power for ambient pressure ion mobility spectrometry, Anal. Chem. 80 (2008) 6610 – 6619, https://doi.org/10.1021/ac8008143. [15]   B.L. Smith, C. Boisdon, I.S. Young, T. Praneenararat, T. Vilaivan, S. Maher, Flexible drift tube for high resolution ion mobility spectrometry (Flex-DT-IMS), Anal. Chem. 92 (2020) 9104 – 9112, https://doi.org/10.1021/acs.analchem.0c01357. [16]   T. Reinecke, B.H. Clowers, Implementation of a flexible, open-source platform for ion mobility spectrometry, HardwareX 4 (2018) e00030. [17]   C.N. Naylor, E.R. Cabrera, B.H. Clowers, A comparison of the performance of modular standalone do-it-yourself ion mobility spectrometry systems, jasms.2c00308, J. Am. Soc. Mass Spectrom. (2023), https://doi.org/10.1021/jasms.2c00308. [18]   C.-P. Shih, K.-C. Yu, H.-T. Ou, P.L. Urban, Portable pen-probe analyzer based on ion mobility spectrometry for in situ analysis of volatile organic compounds emanating from surfaces and wireless transmission of the acquired spectra, Anal. Chem. 93 (2021) 2424 – 2432, https://doi.org/10.1021/acs. analchem.0c04369. [19]   A.T. Kirk, S. Zimmermann, An analytical model for the optimum drift voltage of drift tube ion mobility spectrometers with respect to resolving power and detection limits, Int. J. Ion Mobility Spectrom. 18 (2015) 129 – 135, https://doi.org/10.1007/s12127-015-0176-x. [20]   A.T. Kirk, S. Zimmermann, Pushing a compact 15 cm long ultra-high resolution drift tube ion mobility spectrometer with R   =   250 to R   =   425 using peak deconvolution, Int. J. Ion Mobility Spectrom. 18 (2015) 17 – 22, https://doi.org/10.1007/s12127-015-0166-z. [21]   S. Acharya, A. Anurag, R. Chattopadhyay, S. Rengarajan, Y. Prabowo, S. Bhattacharya, A 10- kV SiC - MOSFET (Gen-3) half-bridge module-based isolated bidirectional DC   –   DC converter block for medium-voltage high-power applications, IEEJ Trans Elec Electron Eng 16 (2021) 127 – 138, https://doi.org/10.1002/ tee.23275. [22]   S.Y. Hui, S.C. Tang, H.-S.-H. Chung, Optimal operation of coreless PCB transformer-isolated gate drive circuits with wide switching frequency range, IEEE Trans. Power Electron. 14 (1999) 506 – 514, https://doi.org/10.1109/63.761694. [23]   Z.N. Low, R.A. Chinga, R. Tseng, J. Lin, Design and test of a high-power high-efficiency loosely coupled planar wireless power transfer system, IEEE Trans. Ind. Electron. 56 (2009) 1801 – 1812, https://doi.org/10.1109/TIE.2008.2010110. [24]   K. Kusaka, K. Orikawa, J. Itoh, I. Hasegawa, K. Morita, T. Kondo, Galvanic isolation system with wireless power transfer for multiple gate driver supplies of a medium-voltage inverter, IEEJ Journal IA 5 (2016) 206 – 214, https://doi.org/10.1541/ieejjia.5.206. [25]   V.T. Nguyen, G. Veera Bharath, G. Gohil, Design of Isolated Gate Driver Power Supply in Medium Voltage Converters using High Frequency and Compact Wireless Power Transfer, in: 2019 IEEE Energy Conversion Congress and Exposition (ECCE), Baltimore, MD, USA, IEEE, 29.09.2019 - 03.10.2019, pp. 135 – 142. [26]   M. Hitzemann, M. Lippmann, J. Trachte, A. Nitschke, O. Burckhardt, S. Zimmermann, Wireless low-power transfer for galvanically isolated high-voltage applications, Electronics 11 (2022) 923, https://doi.org/10.3390/electronics11060923. [27]   M. Hitzemann, A.T. Kirk, M. Lippmann, A. Bohnhorst, S. Zimmermann, Miniaturized drift tube ion mobility spectrometer with ultra-fast polarity switching, Anal. Chem. 94 (2022) 777 – 786, https://doi.org/10.1021/acs.analchem.1c03268. [28]   A. Bohnhorst, M. Hitzemann, M. Lippmann, A.T. Kirk, S. Zimmermann, Enhanced resolving power by moving field ion mobility spectrometry, Anal. Chem. 92 (2020) 12967 – 12974, https://doi.org/10.1021/acs.analchem.0c01653.  M. Lippmann et al.   HardwareX   19   (2024)   e00574  13\n[29]   A. Bohnhorst, A.T. Kirk, M. Berger, S. Zimmermann, Fast orthogonal separation by superposition of time of flight and field asymmetric ion mobility spectrometry, Anal. Chem. 90 (2018) 1114 – 1121, https://doi.org/10.1021/acs.analchem.7b03200. [30]   A.T. Kirk, C.-R. Raddatz, S. Zimmermann, Separation of isotopologues in ultra-high-resolution ion mobility spectrometry, Anal. Chem. 89 (2017) 1509 – 1515, https://doi.org/10.1021/acs.analchem.6b03300. [31]   M. Lippmann, A.T. Kirk, M. Hitzemann, S. Zimmermann, IMS Instrumentation I: Isolated data acquisition for ion mobility spectrometers with grounded ion sources, Int. J. Ion Mobility Spectrom. 23 (2020) 69 – 74, https://doi.org/10.1007/s12127-020-00260-5. [32]   P. Cochems, A.T. Kirk, S. Zimmermann, In-circuit-measurement of parasitic elements in high gain high bandwidth low noise transimpedance amplifiers, Rev. Sci. Instrum. 85 (2014) 124703, https://doi.org/10.1063/1.4902854.  Martin Lippmann   received his M.Sc. degree in electrical engineering and information technology from the Leibniz University Hannover, Germany, in 2017. Since 2017, he is employed as a research engineer at the Institute of Electrical Engineering and Measurement Technology of the Leibniz University Hannover and is working on his Dr.-Ing degree in electrical engineering. His research activities include the improvement of ion mobility spectrometers using electric field simulations.  Moritz Hitzemann   received a B.Eng. degree in communication engineering from the University of Applied Sciences and Arts, Hannover, Germany, in 2014 and a M.Sc. degree in electrical engineering and information technology from the Leibniz University Hannover, Germany, in 2016, respectively, where he is currently pursuing the Dr.-Ing. degree with the focus on sensors and measurement technology. His current research interests include impedance measurement, microwave electronics, low power high voltage generation, high voltage switches, and ion mobility spectrometers.  Jonas Winkelholz   studied electrical engineering at the Leibniz University Hannover and graduated with an M.Sc. in 2022. Since 2022, he is employed as a research engineer at the Institute of Electrical Engineering and Measurement Technology of the Leibniz University Hannover and is working on his Dr.-Ing. degree in electrical engineering. His research interests include improving ion mobility spectrometry applications and measurement electronics like low current amplifiers, fast isolated data acquisition and processing, and high voltage switching.  David Bailey   is an aspiring student at the Leibniz University Hannover studying M.Sc. Energy Technology. He is working in the field of sensor engineering, already having gained practical experience through long-term student helper positions and successful internships. This includes developing high-voltage power sources for ion mobility spectrometer systems, analog front-end cards for the quench detection system of the superconducting magnets of the LHC at CERN, as well as full-stack monitoring and control equipment for the plasma heating systems of the innovative Wendelstein-7X fusion reactor. Currently he is finishing his Master Thesis at the Leibniz University Hannover, developing a cost- effective and sensitive ion-current amplifier for a highly integrated ion-mobility spectrometer application.  M. Lippmann et al.   HardwareX   19   (2024)   e00574  14\nStefan Zimmermann   received his diploma in electrical engineering in 1996 and his Dr.-Ing. in 2001 from the Technical University Hamburg- Harburg, Germany. In 2001, he joined the Berkeley Sensor and Actuator Center, University of California, USA, as a Postdoctoral Scientist with support of a Feodor-Lynen Fellowship of the Alexander von Humboldt Foundation. In 2004, he joined the Research Unit of Dr ¨ ager, Germany, where he worked on sensors for medical and safety applications. His latest position was Head of Chemical and Biochemical Sensors. In 2009, he joined the Leibniz University Hannover, Germany, as a Full Professor for Sensors and Measurement Technology and became Head of Department of Sensors and Measurement Technology. Since 2019, he is Director of Institute of Electrical Engineering and Measurement Technology. From 2017 to 2019, he was Vice Dean, and from 2019 to 2021, he was Dean of Faculty of Electrical Engineering and Computer Science. In 2022, he co-founded the ACKISION GmbH concentrating on advanced electronics for measuring technology.  M. Lippmann et al.   HardwareX   19   (2024)   e00574  15',0.07488928685555048,'[\"\\u0000\", \"%\", \"%)\", \"%3d%3d\", \"&\"]','2025-11-29 17:08:40.646684'),(77,3,'See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/380744236  Standardizing technical parameters and terms for abdominopelvic photon- counting CT: laying the groundwork for innovation and evidence sharing  Article   in   Abdominal Radiology · May 2024  DOI: 10.1007/s00261-024-04342-4  CITATIONS  4  READS  99  10 authors , including:  Safa Hoodeshenas  Mayo Foundation for Medical Education and Research  20   PUBLICATIONS   260   CITATIONS  SEE PROFILE  Yoad Yagil  Philips  60   PUBLICATIONS   2,353   CITATIONS  SEE PROFILE  Francis I Baffour  Mayo Clinic - Rochester  69   PUBLICATIONS   1,436   CITATIONS  SEE PROFILE  Joel G Fletcher  Mayo Foundation for Medical Education and Research  534   PUBLICATIONS   27,140   CITATIONS  SEE PROFILE  All content following this page was uploaded by Safa Hoodeshenas on 30 June 2024.  The user has requested enhancement of the downloaded file.\nVol.:(0123456789) Abdominal Radiology https://doi.org/10.1007/s00261-024-04342-4  PERSPECTIVE FROM THE SAR  Standardizing technical parameters and terms for abdominopelvic photon‑counting CT: laying the groundwork for innovation and evidence sharing  Shuai Leng 1   · Giuseppe V. Toia 2   · Safa Hoodeshenas 1   · Juan Carlos Ramirez‑Giraldo 3   · Yoad Yagil   4   · Jonathan S. Maltz   5   · Kirsten Boedeker   6   · Ke Li 2   · Francis Baffour 1   · Joel G. Fletcher 1  Received: 1 March 2024 / Revised: 11 April 2024 / Accepted: 15 April 2024 © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024  Abstract  Photon-counting detector CT (PCD-CT) is a new technology that has multiple diagnostic benefits including increased spatial resolution, iodine signal, and radiation dose efficiency, as well as multi-energy imaging capability, but which also has unique challenges in abdominal imaging. The purpose of this work is to summarize key features, technical parameters, and terms, which are common amongst current abdominopelvic PCD-CT systems and to propose standardized terminology (where none exists). In addition, user-selectable protocol parameters are highlighted to facilitate both scientific evaluation and early clinical adoption. Unique features of PCD-CT systems include photon-counting detectors themselves, energy thresholds and bins, and tube potential considerations for preserved spectral separation. Key parameters for describing different PCD-CT systems are reviewed and explained. While PCD-CT can generate multi-energy images like dual-energy CT, there are new types of images such as threshold images, energy bin images, and special spectral images. The standardized terms and con- cepts herein build upon prior interdisciplinary consensus and have been endorsed by the newly created Society of Abdominal Radiology Photon-counting CT Emerging Technology Commission.  Keywords   Computed tomography · X-ray · Photons · Humans · Radiation dosage · Abdomen · Standardization  Introduction  Conventional energy-integrating detectors (EID) of com- puted tomography (CT) convert X-ray photons to visible light through scintillation and record the sum of ener- gies deposited by all photons using light sensors, charge integrators, and analog-to-digital converters. Photon-count- ing detector CT (PCD-CT) is a relatively new CT technology in which the energy of each individual photon is directly converted to an electrical signal and recorded by the X-ray detector [1, 2]. In the last 20 years, the speed at which PCDs can count photons has advanced several orders of magnitude, from the low fluxes encountered in their classical application in nuclear medicine to the massive maximum flux of clinical CT. The first FDA-cleared PCD-CT system was released in 2021. A substantial body of literature demonstrates the potential of PCD-CT, both commercial product and proto- type systems, to achieve high spatial resolution and spectral imaging, as well as reduction in patient radiation dose and injected iodinated contrast dose [2–12]. PCD systems achieve substantial improvements in spatial resolution over conventional EID-CTs (with the exception of specialized high resolution systems [13, 14]) in neuro- radiology, thoracic, cardiac, and musculoskeletal radiol- ogy [8, 15–21], with distinct and readily apparent advan- tages of multi-energy PCD images also demonstrated in  *   Joel G. Fletcher  Fletcher.Joel@mayo.edu 1   Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA 2   Departments of Radiology and Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA 3   Siemens Medical Solutions USA Inc, Malvern, PA, USA 4   PD CT/AMI R&D Advanced Development, Philips Medical Systems, Haifa, Israel 5   Molecular Imaging and Computed Tomography, GE Healthcare, Waukesha, WI, USA 6   Canon Medical Systems Corporation, Otawara, Japan\nAbdominal Radiology  cardiovascular imaging (e.g., for imaging of the coronary arteries and other small vessels) [8, 22, 23]). To avoid optical crosstalk, each scintillator pixel in an EID-CT detector is optically isolated from its neighbors by thin septa. This creates dead zones that cannot generate an optical signal. In contrast, detector pixels of PCDs directly generate electron–hole pairs without the intermediate step involving visible light, which eliminates the need for physi- cal septa. An EID-CT system with the same pixel pitch (i.e., distance between the center of two adjacent detector pixels) could achieve the same spatial resolution but would require a larger dose to attain an equal image contrast-to-noise ratio (CNR) for a given acquisition and reconstruction approach. PCD-CT does have its unique challenges, including both technical and practical challenges, such as pileup, charge sharing, sensor material polarization, and -fluorescence escapes [2, 4, 5, 12, 24]. Pileup occurs when more than one photon contributes to a single counting time window. Detector response is non-linear due to pileup, starting with weak non-linearity at low flux levels and up to saturation at extremely high flux levels. It can lead to errors in the pho- ton count, and errors in the measured photon energy; pileup compromises image accuracy, increases noise, and corrupts spectral information. Charge sharing, K-escape, and Comp- ton scatter within the detector increase image noise, compro- mise spatial resolution, and degrade spectral performance. Various proposed techniques, such as calibration and correc- tion, as well as selection of detector pixel size, are utilized to mitigate these challenges. In PCD-CT, a given dose pro- vides a fixed number of photons that are distributed across more pixels and energy bins, leading to a lower number of counts in each spatial-spectral bin when highly attenuating anatomies such as the abdomen are imaged. Preserving the ultra-high-resolution of the detection in the reconstructed CT image requires using sharp image reconstruction filters. As a consequence, advanced approaches to noise manage- ment are required, and ultra-high-resolution PCD-CT modes might need to sacrifice some spatial and spectral information [2, 25, 26]. In addition, there are some practical, workflow-related challenges. PCDs generate massive amounts of raw data rel- ative to conventional-resolution EID systems, since counts are collected from many more (smaller) pixels, and multi- ple energy bins per pixel. Large matrix sizes are typically needed to support the high-resolution images. Finer slice thicknesses (and smaller increments) generate more image slices. These can increase reader burden and challenge the capacity of data transfer and storage infrastructure unless carefully managed. While several studies have shown improved image quality for routine and multi-energy images, iodine contrast, CNR, and reduced radiation dose for a variety of abdominopel- vic CT applications [27–29], performance improvement for diagnostic tasks in abdominopelvic CT is in its early stages. Diagnostic tasks in abdominopelvic CT pose several chal- lenges for radiologists: principally, highly attenuating body regions, large volume of coverage, and the diagnostic impor- tance of low contrast detection (e.g., pancreatic, and primary and secondary hepatic malignancies). Moreover, as PCD-CT systems are installed in radiology practices (including aca- demic practices), diagnostic tasks for which there is already early evidence of clear patient benefit (e.g., CSF-venous fistulas, temporal bone imaging, small vessel CT angiog- raphy, coronary angiography, interstitial lung disease) [18, 20, 21, 30–33] may be prioritized over abdominal protocols where patient benefit may be less obvious. Consequently, the abdominal imaging community will need to work col- laboratively across institutions to speed translational devel- opment in GI and GU imaging PCD clinical applications. This necessity will only increase as more PCD-CT systems become available from other CT manufacturers [34]. The purpose of this manuscript is to summarize existing technical parameters and terms used in PCD-CT protocols and propose standardized terminology (where none exists) as well as to highlight user-selectable protocol parameters to facilitate both scientific evaluation across institutions and early clinical adoption for patient care.  Methods  In February 2023, 15 abdominal radiologists and 7 CT physicists met to discuss the possibility of the Society of Abdominal Radiology (SAR) forming a PCD-CT Emerg- ing Technology Commission (ETC). The CT physicists present were from multiple academic medical centers and CT manufacturers. An early priority for this group was to establish common terminology that could be used across current and future PCD-CT systems and manufacturers. Drs. Bari Dane from New York University and Daniele Marin from Duke University were selected to lead the nascent PCD-CT ETC and assigned the current authors to propose standardized terms and protocol element requirements for communications. The author group subsequently examined the work of the DICOM Standards Committee (Supplement 188, WG-21: Computed Tomography), the American Association of Physicists in Medicine CT Lexicon 2.0, as well the consen- sus society recommendations for standardized terminology for cardiac CT [35–38]. Existing photon-counting detector technologies and the ones currently in development were reviewed, as well as parameters used to describe the techni- cal features and performance of the current FDA-cleared PCD-CT systems [1, 39]. Co-authors included scientists from each of the four PCD-CT systems that image the abdomen and pelvis. The proposed terminology was refined\nAbdominal Radiology  through an iterative process of multiple drafts and confer- ence calls, and amended as shared understanding developed. It was approved by all authors in consensus. A confidential draft was shared with members of the full SAR PCD ETC, who endorsed the document, and provided feedback to the authors for improvement.  Results  X‑ray detectors  There are many similarities between PCD-CT and EID-CT systems, and for a given CT system model/design, the major difference is the detector itself (Fig. 1). We discuss a few important parameters of PCD-CT systems. The X-ray detector is one of the main components of a CT scanner. X-ray detectors are classified into two main categories, indirect and direct systems, depending on their method of converting X-ray photons into electrical signals. Furthermore, they may vary in terms of signal processing techniques using readout electronics (e.g., integrating and counting technologies). The prevailing sensor materials uti- lized in PCDs are semiconductors such as cadmium tellu- ride (CdTe), cadmium zinc telluride (CZT), or silicon (Si), although other substances such as gallium arsenide have also been employed (Table 1) [40–43]. Sensor materials used in EIDs include cadmium tungstate, gadolinium oxide, gado- linium oxysulfide, lutetium aluminum terbium garnet [44], and other fast scintillators. Smaller detector cell size implies a higher spatial sam- pling rate, allowing reconstruction of thinner slices with higher in-plane resolution. Even when high spatial resolu- tion is not required, inherent high sampling rates may reduce aliasing of high frequency noise into the image signal, and this in turn reduces image noise [39, 45, 46]. However, when high resolution is indeed the clinical objective, image noise must be appropriately controlled through iterative reconstruction, deep learning reconstruction, or alternative denoising strategies [39, 45–47]. To reconstruct images with higher spatial resolution, radiologists also should under- stand that other image reconstruction parameters need to be changed appropriately (e.g., thinner slices, sharper recon- struction kernels, higher image matrix; Fig. 2).  Thresholds, energy bins, tube potentials, and automatic exposure control  The lowest energy threshold of a PCD is usually set to eliminate electronic noise, e.g., 20–30 keV for the CdTe/  Fig.   1   Schematic illustration of the operational principles of energy integrating and photon counting detectors.   A   In the EID technology, poly energetic X-ray photons are initially captured by a scintillator, which converts the X-ray photon energy into visible light. The light photons are then transformed into electrical signals by a pixelated photodiode. These electrical signals are integrated to produce an out- put signal that directly corresponds to the total energy of the detected photons. Integration of electrical signals occurs during a single CT projection, with scintillation being a long process compared to ( B ). Scintillation and integration consequently result in down-weighting of signal from low energy photons, which carry important biologic information.   B   In the PCD technology, the semiconductor layer directly converts X-ray photons into electron–hole pairs. Applying a high voltage (800–1000 V) induces the electrons and holes to drift towards two opposite directions, generating electrical current .   Each detected signal is categorized into specific bins based on their respec- tive magnitudes. Conversion of incident photons to electrical signal takes only a few nanoseconds, so the energy corresponding to each photon is individually counted\nAbdominal Radiology  CZT-based systems, and is set to a lower keV for silicon- based systems [48, 49]. The energy thresholds of the remain- ing bins can be set to create two or more energy bins. PCDs assign incident photons to bins based on the measured pho- ton energy being between the two thresholds that define a bin (Table 2) [9]. The signal within each energy bin can then be used to create the multi-energy images which are similar to dual-energy CT (Fig. 3 [50]; see   Image Reconstruction , below). The specific values of the lower and higher energy thresholds may vary for different tasks, and for different tube potential and filtration settings, and are either predetermined by the manufacturer or may be adjusted by the user. The tube potential refers to the electron acceleration voltage in the X-ray tube. In CT, the tube potentials are  Table   1   Existing, prototype, or in-development PCD systems by different CT manufacturers, which image the abdomen and pelvis. Adapted and updated, with permission, from [40]. Detector pixel size is given at the isocenter. Parameters were reported to authors by scientists from each CT manufacturer a   ASIC   Application-specific integrated circuit b   Not available c   FDA-approved clinical CT system Sensor material   Sensor thickness   Pixel size at isocenter   [mm   2   ]   ASIC   a Energy bins  Siemens healthineers c   CdTe   1.6 mm   0.151   ×   0.176 (sub- pixel)/0.302   ×   0.352 (macropixel) 4  GE healthcare   [42]   Si   >   30 mm   NA b   8  Philips   CZT   2 mm   0.27   ×   0.27   5  Canon   [43]   CZT   NA b   0.2   ×   0.2   6  Fig.   2   Axial images from a PCD-CT angiography in a 75 year-old male patient with a fenestrated aortic stent graft illustrate how spatial resolution can be improve by adjusting image reconstruction param- eters. Spatial resolution and image sharpness increase with thinner slice thickness, sharper reconstruction kernel (designated by higher numbers), and larger image matrix (e.g., 1024 vs. 512).   A   3 mm slice, Qr40 reconstruction kernel (Threshold Low, 120 kV), 512 matrix;   B  1 mm slice, Qr40 reconstruction kernel, 512 matrix (Threshold Low, 120 kV);   C   1 mm slice, Bv60 reconstruction kernel (at 67 keV), 512 matrix;   D   1 mm slice, Bv60 reconstruction kernel (at 67 keV), 1024 matrix;   E   0.6 mm slice, Bv72 reconstruction kernel (at 67 keV), 1024 matrix. The Bv kernels (e.g., Bv60) have edge enhancement, which are used for vascular reconstructions. The Qr kernels in figure parts A and B are quantitative kernels that don’t have edge enhancement. Qr kernels provide accurate CT numbers and are commonly used in multi-energy processing, e.g., material decomposition. The mean energy for the 120 kV tube potential is 67 keV, so the iodine signal response from the detector will be similar between the Threshold Low images ( A   and   B ) and the 67 keV virtual monoenergetic images ( C–E )\nAbdominal Radiology  typically in the range of 70–150 kV. Tube potential is determined by the user and scanner depending upon the diagnostic task (Table 2). Lower tube potentials are often used for single energy EID-CT (SECT) contrast-enhanced exams to reduce radiation dose and increase iodine sig- nal, based on patient size and diagnostic task, with higher tube potentials reducing iodine signal and image noise, but often needed for larger patients. For dual-energy EID- CT, a high and a low x-ray tube potential are utilized to obtain the needed separation of photon energies needed to produce multi-energy images. At PCD-CT, the photon- counting detector itself improves iodine signal thereby facilitating the use of higher tube potentials, which also possess the wider spectrum of photon energies needed for multi-energy imaging. Virtual monoenergetic images (VMI) can be created at dual-energy CT and PCD -CT to simulate the appearance of a CT image at a specific mono- chromatic x-ray beam energy. Low energy keV VMIs (e.g., 40–60 keV images) enable significant increase in iodine contrast and CNR beyond conventional single energy low kV scan [51, 52], and are created at PCD from a single tube potential.  Table   2   Terms for detectors and Energy Thresholds a   User-selectable parameter Recommended Term   Explanation/Comment Energy-integrating detectors (EID)   A scintillating detector that first transforms incident X-ray photons to visible light and then into electric signals, measuring total energy deposited by all photons incident within a given integration period Photon-counting detector (PCD)   A semiconductor detector that directly transfers incident X-ray photons into electron–hole pairs, counts the number of photons, and measures each photon’s energy Multilayer detector (MLD)   More than one physical detector sensor layer to simultaneously collect different energy level data of the X-ray spectrum Energy   threshold a   A predetermined level of energy, in units of keV, used as a reference point for energy binning. This may or may not be selectable by users, depending on the system and/or protocol. Thresholds between different PCD systems may be different, as these are optimized for each PCD system. Low energy threshold   Set to eliminate electronic noise below this threshold; (e.g., 20 or 25 keV for cadmium telluride or CZT PCDs) Energy bin   A specific range of energy levels defined by a lower energy threshold and a higher energy threshold Detector pixel   Size of a single detector unit, usually rectangular in shape. Note that the length and width of a detector pixel may be different corresponding to different in-plane and z resolutions. Alternative terms previously used include detector cells and detector elements. Detector coverage   The dimension of the exposed detector rows along the z-axis, expressed in millimeters at the isocenter Pulse   An abrupt and temporary variation in the amplitude of an electric signal generated when X-ray photon interacts with the PCD Pulse shaping   The process of altering the waveform of a signal to attain desired characteristics. This is a necessary step creating final recorded signal on PCD. Tube   potential a   The electron acceleration voltage of the X-ray tube. Lower tube potentials increase iodine signal and decrease radiation dose, but may limit multi-energy options due to decrease spectral separation. Tube filtration   Filtration refers to materials placed in front of the X-ray tube to change the X-ray spectrum, and are listed with the tube potential (e.g., 100 kV/Sn refers to use of a tin filter with 100 kV X-ray beam, a common combination to reduce radiation dose for unenhanced CT scans). Collimation a   Refers to the grouping of detector pixels along the z direction during data acquisition, usually lists the number of detectors along the z direction and their pixel size (at iso center; e.g., 120   ×   0.2 mm). Refers to the detector at isocenter  Fig.   3   Sample illustration of threshold images (TL, TH) and bin images (B1, B2) of a PCD-CT with 140   kV and 25 and 65   keV thresholds. (Adapted and reprinted, with permission, from [50])\nAbdominal Radiology  To achieve sufficient spectral separation, PCD-CT com- monly utilizes higher tube potentials such as 120 or 140 kV for multi-energy applications. This selection helps reduce image noise and produce more accurate material quantifi- cation, all of which also permit high quality virtual mono- energetic and other multi-energy images (Fig. 4), similar to those obtained using dual-energy CT systems [53]. For unenhanced scans without a strong need for multi-energy capability, lower kVs with additional beam filtration (e.g., 100 kV with tin filtration) may be used to lower radiation dose [54]. Automatic exposure control (AEC) is a tool which adjusts tube current to produce reliable image quality and reduce radiation dose. Specific implementations of AEC vary among CT vendors. The current FDA-cleared PCD-CT sys- tem automatically selects the appropriate VMI energy level (keV) for a user-selected diagnostic task and image quality requirement as part of the AEC. Tasks such as CT angi- ography can be optimized by selecting lower VMI energy levels (e.g., 55 keV), which facilitate higher levels of iodine contrast and can result in greater levels of radiation dose reduction.  CT system description  There are many key parameters for describing PCD-CT sys- tems (Tables 2 and 3). •   Energy threshold selection   (Table 2): These may be pre-fixed by the vendors (specific values) or selectable by the users (with limited range for each energy thresh- old). The selection of energy thresholds substantially impacts the image quality of multi-energy (multi-mate- rial) images. Optimal energy threshold selection depends on tube potential, beam filtration, PCD sensor material (e.g., CdTe, CZT, or silicon), patient size, and imaging tasks. Unlike multi-energy EID-CT whose spectra are essentially pre-determined, PCD-CT has the capability to freely select energy thresholds. With this flexibility, K-edge imaging, a technique where energy thresholds are  Fig.   4   Axial   PCD   CT   images   obtained   in   the   portal   phase   of enhancement used to characterize a right renal mass in a 75 year-old male (undergoing an exam for liver cirrhosis, which did not detect a liver mass) illustrate typical multi-energy images used at PCD, which are similar to dual-energy CT. Detector configuration was 144   ×   0.4 mm to obtain coverage of the entire abdomen and pelvis. Matrix size was set at 768   ×   768, and slice thickness was 3 mm for all reconstructions.   A   120 kV Threshold Low image;   B   67 keV virtual monoenergetic image (same window-level as [ A ]);   C   50 keV virtual monoenergetic image (inset with same window-level as figure parts  A   and   B );   D   virtual non-contrast image (VNC),   E   iodine map. Using these multi-energy images, the mass was diagnosed as a renal neo- plasm. Note that the 120 kV Threshold Low image and the 67 keV image are identical, as the mean tube energy for the CT system (NAEOTOM Alpha, Siemens Healthineers) is 67 keV. Note increased iodine signal on the 50 keV and iodine map images compared to the VNC, Threshold Low, and 67 keV image\nAbdominal Radiology  set close to the K-edge energies of the relevant material, for example ≈50 keV for Gd [55, 56], has been demon- strated. •   Detector pixel size   (Table 3) [38, 57]: A major benefit of PCD-CT is high spatial resolution. The detector pixel is usually smaller than that of EID-CT. The main consid- erations in selecting pixel size include spatial resolution, spectral performance, and pulse pileup. Small pixels have compromised spectral performance due to charge shar- ing and K-fluorescence escapes. Large pixels are more susceptible to pileup. Spatial resolution improves with smaller pixels as long as the focal spot size is not the limiting factor. When large anatomies are imaged using commercial PCD-CT systems, the higher mA values needed may require the use of larger focal spot sizes, which may limit the spatial resolution that can be realized by the system. •   Detector pixel configuration : In addition to the native detector pixel size, some PCD-CT systems allow bin- ning of detector pixels to form larger pixel sizes. This is useful when the ultra-high resolution (UHR) mode of the PCD-CT is not required to execute a clinical task. It is important to note that utilizing UHR requires large image matrix sizes and thin slices, expanding the size of image series. For example, for large body regions such as the abdomen and pelvis, it may be advantageous to use larger pixel sizes and reconstruct regular or modestly larger matrix sizes. •   X-ray focal spot : To exploit UHR modes, a small focal spot is needed so that the system resolution is not lim- ited by the focal spot size. However, a small focal spot implies a lower maximum tube power. Some CT systems can adapt focal spot size based on the mA required. In clinical practice, focal spot size and spatial resolution may need to be balanced to permit sufficiently fast scans and good temporal resolution. It is important to note that UHR and temporal resolution are closely related as UHR images may display small motion artifacts such as minimal organ displacement beyond regular cardiac and respiratory motion. •   Scan mode:   As in EID-CT, axial and helical/spiral modes are available in PCD-CT. For PCD-CT scanners with two source-detector systems, a high-pitch helical mode is also available. •   Detector Operation Mode : In addition to scan mode, there are other considerations in PCD-CT, especially regarding high resolution and multi-energy capabili- ties, e.g., UHR mode and multi-energy mode. These are  Table   3   Terms used to describe CT systems other than X-ray detectors. Many of these terms are taken or adapted from a prior interdisciplinary consensus statement [38] a   User-selectable parameter Recommended Term   Explanation/Comment Scan   mode a   Axial/sequential, helical/spiral, or high-pitch helical. These terms can be applied to EID or PCD CT systems. Detector operation   mode a   Includes other image acquisition factors for PCD-CT, especially regarding high resolution and multi- energy capabilities, e.g., UHR mode and multi-energy mode. Selection of energy thresholds and   bins a   The selection of energy thresholds substantially impacts the image quality of multi-energy images. They may be pre-fixed by the vendors (specific values) or adjustable by the users (specific range for each energy threshold). The optimal energy threshold selection depends on tube potential, PCD sen- sor material (e.g., CdTe, CZT, or silicon), and imaging tasks. Ultra-high resolution (UHR) a   UHR is not well-defined and varies between CT systems and manufacturers. Spatial resolution away from isocenter is often reduced, and depends on many factors other than the detector such as focal spot size. Given its inconsistent use, authors should define how the term UHR is used in each scien- tific or review article. X-ray focal   spot   a   To accommodate the high spatial resolution in UHR mode, a small focal spot is needed so that the system resolution will not be limited by focal spot size. However, small focal spot size comes with lower tube power. Focal spot size may be associated with scan mode, may or may not be selectable by users. Some CT systems may have adaptive focal spots, e.g., using small focal spot for low mA and large focal spot when mA goes beyond a certain limit. Dual-source High   pitch a This is defined only for dual-source CT systems and is not available with single source CT systems. It refers to the ability to use two X-ray tubes to increase table speeds with pitch as high as 3.2/3.4 by using a second X-ray tube to obtain overlapping projection data (i.e., the projection data for either tube is non-overlapping) [57]. The upper limit of pitch for most single source CT systems is about 1.7. Detector pixel size   Detector pixel size has a major role in image resolution and refers to the size (e.g., length and width) of a single detector unit, commonly in rectangular shape. Note that pixel size sometimes refers to the detector physical size and sometimes to its projection at the iso center, which is typically 1.6–2 times smaller than the physical size.\nAbdominal Radiology  referred to as detector operation modes. Note that these may be called scan mode for certain manufacturers. With the unique capability of the PCD-CT, there might be new scan mode that is not feasible with EID-CT, e.g., the high-pitch, multi-energy mode [58]. •   Collimation : As with conventional EID-CT systems, different modes of operation of PCD-CT systems may offer different X-ray beam collimation configurations. As PCD-CT generates significantly more data compared to EID-CT in similar configurations, the minimal detec- tor configuration needs to be balanced against the table speed (e.g., to cover an anatomic region) or desired radia- tion dose.  Image types  The intrinsic multi-energy capability of PCD-CT allows the generation of a variety of spectral images (Table 4; Figs. 4  Table   4   Image Types in PCD-CT a   User-selectable parameter Recommended Term   Explanation/Comment Threshold image   The image uses photon energies above an energy threshold at the selected tube potential. For example, in a PCD-CT with 2 energy thresholds of 25 and 65 keV, two threshold images (low:   >   25 keV and high:   >   65 keV) can be generated (Fig. 3). The threshold low image is similar to that of standard single-energy images in EID-CT, though with equal photon weight- ing instead of energy weighting and with electronic noise removed. With the current FDA- approved system, the threshold low image is similar to the 67 keV image. Bin image   Data between two energy thresholds (or the highest threshold and the tube potential) can be used to generate energy bin images. Note that, additional processes might be conducted dur- ing the reconstruction of bin images, e.g., decorrelation. For example, high energy bin images with the current FDA-approved system, would be created from photon energies greater than 65 keV, and might be used clinically to reduce beam-hardening from metal (similar to a high energy VMI), as the photons creating the image would be higher energies. A higher level of iterative reconstruction might be chosen with the bin energy bin image to reduce the image noise in this instance, as the image would represent a fraction of the radiation dose. Virtual monoenergetic image (VMI) a   The image is reconstructed to resemble one obtained with a monoenergetic beam. Iodine   map a   A material selective image composed of iodine-equivalent signals Iodine   overlay a   An image with iodine map (in color) overlaid on standard CT images (grayscale) Virtual non-contrast (VNC) a   The image after iodine-equivalent signal has been removed from the original image Virtual non-calcium (VNCa) a   The image after calcium-equivalent signal has been removed from the original image Electron density   image a   The image representing the spatial distribution of the material electron densities. Its pixel value is usually normalized to water electron density. Effective atomic number image   (Z eff ) [59–61]: a   The image representing the spatial distribution of the effective atomic number.   Z eff   values may vary between CT systems due to differences in the definition of   Z eff Material specific   image a   This category of images represents the distribution of certain materials, e.g., iodine map. The images are commonly in the unit of mass density, e.g., mg/cc. PCD-CT enables additional classes of material specific images: k-edge images. For example, Gadolinium, Ytterbium, Tantalum, Tungsten, Gold, and Bismuth, all have a sharp k-edge within the X-ray spectrum. Special spectral image (SSI) formats   These special image formats save basic information needed for spectral post-processing, such as creating VMIs, iodine maps, and VNC images, with names and formats varying by manufac- turer. These images allow users to perform multi-energy processing on demand, which could potentially enhance workflow and efficiency. For multiinstitutional studies, SSI image formats are critical to save so that similar multi-energy images can be created between institutions. They may be useful in clinical practice, as they permit the generation of additional multi- energy images that may be helpful for lesion characterization. Material removal   images a   These are images after certain material(s) have been digitally removed from the original images, e.g., virtual non-contrast (VNC), virtual non-calcium (VNCa), virtual unenhanced (VUE). For example, contribution of certain materials can be removed from the final images after material decomposition. Material-modified   image a   Images with altered pixel values to highlight or suppress a target   material 29   (e.g., gout, tendon). Material-modified images are sometimes called “material-enhanced” images). Unlike material specific images, which represent quantity of certain materials, the material-modified images alter pixel values to highlight certain material or tissue rather than reflecting true density or concentration.\nAbdominal Radiology  and 5) [59–61]. Many of the spectral imaging outputs by PCD-CTs, such as VMIs, virtual non-contrast (VNC), iodine overlay, or iodine map images are familiar to dual-energy CT users. •   Threshold (counting) images:   Threshold (or count- ing) images use all photons over the pre-defined energy thresholds. For example, in a PCD-CT with 2 energy thresholds at 25 and 65 keV with a tube potential of 140   kV, two threshold images (low:   >   25   keV and high:   >   65 keV) can be generated (Fig. 3). The thresh- old low image (called a “T3D” image using the FDA- approved PCD-CT system) is analogous to a standard single-energy image in EID-CT, though with the con- tributions of all photons weighted equally, rather than favoring photons with higher energy. •   Energy bin images:   These images are reconstructed using only those photons having energies that lie between two energy thresholds (or between the highest thresh- old and the tube potential). In the example above, Bin 1 (25–65 keV) and Bin 2 (65–140 keV) images can be created. •   Special spectral images (SSI) : These images save basic information needed for spectral post-processing performed at a later time (on demand), such as creating VMIs, iodine maps, and VNC images. Examples include spectral base image (SBI, Philips Medical Systems), spectral post-processing (SPP, Siemens Healthineers), and MegaMONOS (GE Healthcare). These images allow users to perform multi-energy processing on demand, which potentially enhances workflow and efficiency. For multi-institutional studies, SSI image formats are criti- cal so that similar multi-energy images can be created between institutions. They are useful in clinical practice, as they permit generation of additional multi-energy images that may be helpful for lesion characterization. •   Virtual monoenergetic images (VMIs) : Like dual- energy CT, VMIs from PCD-CT represent images as if they were acquired with a monoenergetic X-ray beam. One of the advantages of PCD-CT is that VMIs may be the primary image type interpreted. VMIs are commonly used in dual-energy CT clinical practice, e.g., 50 keV images are commonly used clinically to potentiate iodine signal, while 70 keV images generally optimize aspects of image quality by exhibiting lower noise [62]. As an initial first step, these VMI energy levels are recom- mended for PCD-CT, although the exact keV values may vary with manufacturer and clinical practice. In conven- tional single-energy CT, the CT number (HU) of the same material can vary among different scanner models (same vendor or different vendors) due to the spectra dif- ference from X-ray tube and filters. Since VMI represents images at a given energy level (keV), the CT numbers at this level are fundamentally determined, independent of scanners or vendors from a theoretical point of view. Therefore, VMI images should provide more consistent Hounsfield unit values across different CT models and manufacturers, although in practice the accuracy of CT numbers may depend on specific implementations. Their  Fig.   5   Rubric for naming of multi-energy images (see Classification of multi-energy images from DICOM supplement 188, line 100). Blue refers to different image types. Green refers to classes of material quantification images\nAbdominal Radiology  use in radiomics and multicenter studies is considered advantageous [63–67]. •   Material-specific images : These images represent the spatial distribution of certain materials such as iodine or calcium. The images are commonly in the unit of density, e.g., mg/cc. •   Material removal images : In these images, certain material(s) have been digitally removed from the original images, e.g., VNC, virtual non-calcium (VNCa), virtual unenhanced (VUE), water no iodine, and iodine no water. K-edge imaging is a unique capability of PCD-CT due to its flexibility to select energy thresholds right below and/or above the K-edge of certain materials. K-edge images are a type of material specific images. Potential applications include the imaging of new contrast agents (e.g., gold, bismuth, and gadolinium) with detectable K-edge in the typical energy range of X-ray imaging, and the simultaneous use of two or more contrast agents. K-edge imaging is not yet in clinical use for in vivo patient imaging but has been demonstrated in research studies using prototype systems and animal studies. Table 5 lists image reconstruction parameters that reflect spatial resolution, image noise, and noise texture (i.e., noise power spectrum).  Description of PCD‑CT protocols  In multi-center collaborations or clinical trials, it is critical to have consistent imaging protocols. To ensure this, key ele- ments need to be determined while sharing protocols among different institutes. Key elements that are important for PCD-CT abdominal protocols are summarized in Table 6. Most of these are generally applicable to all PCD-CT sys- tems. At the time when this report is written, only one com- mercial PCD-CT is available that can perform abdominal CT scans. Therefore, some of the protocol elements described might be specific to this system.  Discussion  This paper provides a brief review of PCD-CT technology and its challenges from the perspective of multiple CT manufac- turers as well as subspecialized radiologists and builds upon prior interdisciplinary consensus regarding the use of PCD-CT terminology and extends it for abdominopelvic imaging. The terms and standards set forth in the text and tables have been endorsed by the   Society of Abdominal Radiology’s Emerging Technology Commission on Photon-counting CT . Standard- ized use of accepted terms will facilitate rapid adoption of this exciting new technology for individual hospitals and clinics, and rapid innovation within our subspecialty, as we seek to improve radiologist performance for existing diagnostic tasks in abdominopelvic CT, continue to lower radiations dose, and  Table   5   Image reconstruction parameters that reflect spatial resolution, image noise, and noise texture a   User-selectable parameter Image Reconstruction Parameter   Definition/Comment Reconstruction   algorithm a   Algorithm used to convert CT projection data into a tomographic image. Common algorithms include filtered backprojection (FBP), iterative reconstruction (IR), and deep learning reconstruction. Filtered back projection (FBP)   An analytical image reconstruction algorithm, with closed form formula and fast reconstruction speed, but suboptimal image noise properties. Iterative   reconstruction a   A reconstruction algorithm that iteratively updates images until a target objective function is achieved. It can be raw data based, image based, or based on hybrid methods. Deep learning reconstruction   Image reconstruction based on deep neural network, especially convolutional neural network (CNN). Training could include high quality patient and/or phantom data, including raw data and/or images. Reconstruction strength   setting a   For iterative reconstruction and deep learning reconstruction, different strength settings are commonly avail- able for users, which impact appearance of images with balance among resolution, noise, and texture. Typi- cally, these strength settings range from 1 to 4 or 5. Reconstruction   Kernel a   Reconstruction property that determines noise level, noise texture, and sharpness of the images in the axial plane [36] Matrix   size a   Size of the matrix used to store each reconstructed CT image, e.g., 512   ×   512, 1024   ×   1024, etc. 512   ×   512 is the typical matrix size for EID-CT images. Noise reduction   algorithm a   An algorithm applied by the vendor as part of image reconstruction to reduce image noise. Algorithms may operate on image or projection data. Slice thickness/increment   a   Nominal thickness of images and distance between two consecutive slices, respectively Field of view (FOV) a   The size of the reconstructed image Recon   plane a   Axial, sagittal, coronal, and oblique\nAbdominal Radiology  develop and validate new diagnostic tasks and information not available with conventional CT systems.  Supplementary Information   The online version contains supplemen- tary material available at https:// doi. org/ 10. 1007/ s00261- 024- 04342-4.  Acknowledgements   The authors wish to thank Mr. Kevin Kimlinger for editorial assistance in compiling and submitting the manuscript.  Author contributions   All authors have reviewed and approved the final document and provided editorial input and met all ICJME requirements for authorship.  Funding   None.  Data availability   N/A.  Declarations  Competing interests   Juan Carlos Ramirez-Giraldo is an employee of Siemens Healthineers. Yoad Yagil is an employee of Philips Health- care. Jonathan Maltz is an employee of GE Healthcare. Kirsten Boede- ker is an employee of Canon Medical Systems. Joel G. Fletcher is the recipient of a research grant to his institution from Siemens Health- ineers, unrelated to this work. Giuseppe Toia is an independent consult- ant for GE Healthcare and Canon Medical on topics unrelated to the content of our work.  Ethical approval   None required—Perspective paper.  Informed Consent   None required—Perspective paper.  References  1.   Rajendran K, Petersilka M, Henning A et al (2022) First Clini- cal Photon-counting Detector CT System: Technical Evaluation. Radiology 303:130-138  2.   Leng S, Bruesewitz M, Tao S et al (2019) Photon-counting Detec- tor CT: System Design and Clinical Applications of an Emerging Technology. Radiographics 39:729-743  3.   Baffour FI, Glazebrook KN, Ferrero A et al (2023) Photon-Count- ing Detector CT for Musculoskeletal Imaging: A Clinical Perspec- tive. AJR Am J Roentgenol 220:551-560  4.   Danielsson M, Persson M, Sjolin M (2021) Photon-counting x-ray detectors for CT. Phys Med Biol 66:03TR01  5.   Flohr T, Petersilka M, Henning A, Ulzheimer S, Ferda J, Schmidt B (2020) Photon-counting CT review. Phys Med 79:126-136  6.   Flohr T, Schmidt B (2023) Technical Basics and Clinical Benefits of Photon-Counting CT. Invest Radiol 58:441-450  7.   Greffier J, Villani N, Defez D, Dabli D, Si-Mohamed S (2023) Spectral CT imaging: Technical principles of dual-energy CT and multi-energy photon-counting CT. Diagn Interv Imaging 104:167-177  8.   Mergen V, Sartoretti T, Baer-Beck M et al (2022) Ultra-High- Resolution Coronary CT Angiography With Photon-Counting Detector CT: Feasibility and Image Characterization. Invest Radiol 57:780-788  9.   Nehra AK, Rajendran K, Baffour FI et al (2023) Seeing More with Less: Clinical Benefits of Photon-counting Detector CT. Radio- graphics 43:e220158  10.   Schwartz FR, Samei E, Marin D (2023) Exploiting the Potential of Photon-Counting CT in Abdominal Imaging. Invest Radiol 58:488-498  Table   6   Key elements for protocol descriptions. All of the parameters below can generally be adjusted by the user, depending on diagnostic task and PCD-CT system. These elements are important to define prospectively prior to single or multiinstitutional research studies.  UHR   ultra-high resolution,   ME   multi-energy,   UHR_ME   ultra-high resolution multi-energy Parameter   Comment Scan mode   Sequential, helical/spiral, high-pitch helical Detector mode   Vary depending on vendor and PCD CT system, e.g., UHR, ME, UHR_ME, Standard, High Collimation   See Table 2 Tube potential (kV)   See Table 2 Automatic keV selection (e.g., CAREkeV)   Selects the most dose efficient VMI energy level (keV) for a diagnostic task Automatic exposure control   Modulates tube current to ensure high image quality and dose adaptation for patient size and diagnostic task. For some vendors, this may include tube potential selection; other vendors utilize separate tube potential selection algorithms based on patient size and diagnostic task. Pitch   Table translation distance per rotation normalized to the beam collimation width at the iso-center Rotation time   Time (in seconds) for a gantry to perform a full 360 degree rotation Reconstruction algorithm   See Table 5 Reconstruction Kernel   See Table 5 Reconstruction strength setting   See Table 5 Slice thickness/increment   See Table 5 Field of view (FOV)   See Table 5 Recon plane   See Table 5\nAbdominal Radiology  11.   Si-Mohamed SA, Boccalini S, Villien M et al (2023) First Expe- rience With a Whole-Body Spectral Photon-Counting CT Clini- cal Prototype. Invest Radiol 58:459-471  12.   Willemink MJ, Persson M, Pourmorteza A, Pelc NJ, Fleis- chmann D (2018) Photon-counting CT: Technical Principles and Clinical Prospects. Radiology 289:293-312  13.   Oostveen LJ, Boedeker KL, Brink M, Prokop M, de Lange F, Sechopoulos I (2020) Physical evaluation of an ultra-high-res- olution CT scanner. European radiology 30:2552-2560  14.   Latina J, Shabani M, Kapoor K et al (2021) Ultra-High-Reso- lution Coronary CT Angiography for Assessment of Patients with Severe Coronary Artery Calcification: Initial Experience. Radiol Cardiothorac Imaging 3:e210053  15.   Koons EK, Rajiah PS, Thorne JE et al (2024) Coronary artery stenosis quantification in patients with dense calcifications using ultra-high-resolution photon-counting-detector computed tomography. J Cardiovasc Comput Tomogr 18:56-61  16.   Baffour FI, Huber NR, Ferrero A et al (2023) Photon-counting Detector CT with Deep Learning Noise Reduction to Detect Multiple Myeloma. Radiology 306:229-236  17.   Baffour FI, Rajendran K, Glazebrook KN et al (2022) Ultra- high-resolution imaging of the shoulder and pelvis using pho- ton-counting-detector CT: a feasibility study in patients. Eur Radiol 32:7079-7086  18.   Benson JC, Rajendran K, Lane JI et al (2022) A New Fron- tier in Temporal Bone Imaging: Photon-Counting Detector CT Demonstrates Superior Visualization of Critical Anatomic Structures at Reduced Radiation Dose. AJNR Am J Neuroradiol 43:579-584  19.   Douek PC, Boccalini S, Oei EHG et al (2023) Clinical Applica- tions of Photon-counting CT: A Review of Pioneer Studies and a Glimpse into the Future. Radiology 309:e222432  20.   Inoue A, Johnson TF, White D et al (2022) Estimating the Clini- cal Impact of Photon-Counting-Detector CT in Diagnosing Usual Interstitial Pneumonia. Invest Radiol 57:734-741  21.   Fletcher JG, Inoue A, Bratt A et al (2024) Photoncounting CT in Thoracic Imaging: Early Clinical Evidence and Incorporation Into Clinical Practice. Radiology 310(3):e231986. https:// doi. org/ 10.  1148/ radiol. 231986  22.   Si-Mohamed SA, Boccalini S, Lacombe H et al (2022) Coro- nary CT Angiography with Photon-counting CT: First-In-Human Results. Radiology 303:303-313  23.   Rajiah P, Dunning CAS, Rajendran K et al (2023) High-pitch multi-energy coronary CT angiography in dual-source photon- counting detector CT scanner at low iodinated contrast dose. Invest Radiol  24.   Taguchi K, Iwanczyk JS (2013) Vision 20/20: Single photon counting x-ray detectors in medical imaging. Med Phys 40:100901  25.   Huber NR, Ferrero A, Rajendran K et al (2022) Dedicated convo- lutional neural network for noise reduction in ultra-high-resolution photon-counting detector computed tomography. Phys Med Biol 67  26.   Leng S, Yu Z, Halaweish A et al (2016) Dose-efficient ultrahigh- resolution scan mode using a photon counting detector computed tomography system. J Med Imaging (Bellingham) 3:043504  27.   Mergen V, Racine D, Jungblut L et al (2022) Virtual Noncontrast Abdominal Imaging with Photon-counting Detector CT. Radiol- ogy 305:107-115  28.   Wrazidlo R, Walder L, Estler A et al (2023) Radiation Dose Reduction in Contrast-Enhanced Abdominal CT: Comparison of Photon-Counting Detector CT with 2nd Generation Dual-Source Dual-Energy CT in an oncologic cohort. Acad Radiol 30:855-862  29.   Zhou W, Michalak GJ, Weaver JM et al (2020) A Universal Pro- tocol for Abdominal CT Examinations Performed on a Photon- Counting Detector CT System: A Feasibility Study. Invest Radiol 55:226-232  30.   Hagar MT, Soschynski M, Saffar R et al (2023) Accuracy of Ultrahigh-Resolution Photon-counting CT for Detecting Coro- nary Artery Disease in a High-Risk Population. Radiology 307:e223305  31.   Madhavan AA, Cutsforth-Gregory JK, Brinjikji W et al (2023) Diagnostic Performance of Decubitus Photon-Counting Detector CT Myelography for the Detection of CSF-Venous Fistulas. AJNR Am J Neuroradiol 44:1445-1450  32.   Madhavan AA, Yu L, Brinjikji W et al (2023) Utility of Photon- Counting Detector CT Myelography for the Detection of CSF- Venous Fistulas. AJNR Am J Neuroradiol 44:740-744  33.   Yalon M, Inoue A, Thorne JE et al (2024) Infrapopliteal Segments on Lower Extremity CTA: Prospective Intraindividual Compari- son of Energy-Integrating Detector CT and Photon-Counting Detector CT. AJR Am J Roentgenol 222:e2329778  34.   Si-Mohamed S, Boccalini S, Rodesch PA et al (2021) Feasibil- ity of lung imaging with a large field-of-view spectral photon- counting CT system. Diagn Interv Imaging 102:305-312  35.   RadLex. RSNA. Available via https:// radlex. org/. Accessed July 28th, 2023  36.   American Association for Physicists in Medicine (2022) AAPM CT Lexicon version 2.0.  37.   DICOM Standards Committee WG (2018) Supplement 188: Multi-energy CT Images.  38.   Koweek L, Achenbach S, Berman DS et al (2023) Standardized medical terminology for cardiac computed tomography 2023 update: An Expert Consensus Document of the Society of Cardio- vascular Computed Tomography (SCCT), American Association of Physicists in Medicine (AAPM), American College of Radiol- ogy (ACR), North American Society for Cardiovascular Imaging (NASCI) and Radiological Society of North America (RSNA) with endorsement by the Asian Society of Cardiovascular Imag- ing (ASCI), the European Association of Cardiovascular Imaging (EACI), and the European Society of Cardiovascular Radiology (ESCR). J Cardiovasc Comput Tomogr 17:345-354  39.   Leng S, Rajendran K, Gong H et al (2018) 150-mum Spatial Reso- lution Using Photon-Counting Detector Computed Tomography Technology: Technical Performance and First Patient Images. Invest Radiol 53:655-662  40.   Ballabriga R, Alozy J, Bandi FN et al (2021) Photon Counting Detectors for X-Ray Imaging With Emphasis on CT. Ieee Transac- tions on Radiation and Plasma Medical Sciences 5:422-440  41.   Nakamura Y, Higaki T, Kondo S, Kawashita I, Takahashi I, Awai K (2023) An introduction to photon-counting detector CT (PCD CT) for radiologists. Jpn J Radiol 41:266-282  42.   Salyapongse AM, Rose SD, Pickhardt PJ et al (2023) CT Num- ber Accuracy and Association With Object Size: A Phantom Study Comparing Energy-Integrating Detector CT and Deep Silicon Photon-Counting Detector CT. AJR Am J Roentgenol 221:539-547  43.   Zhan X, Zhang R, Niu X et al (2023) Comprehensive evalua- tions of a prototype full field-of-view photon counting CT system through phantom studies. Phys Med Biol 68:175007  44.   Jiang H, Hoffman D, Vartuli J (2005) CT detector array having non-pixelated scintillator array. In: U.S. Patent and Trademark Office, (ed). General Electric Co, GE Medical Systems Global Technology Co LLC  45.   Baek J, Pineda AR, Pelc NJ (2013) To bin or not to bin? The effect of CT system limiting resolution on noise and detectability. Phys Med Biol 58:1433-1446  46.   Kachelriess M, Kalender WA (2005) Presampling, algorithm fac- tors, and noise: considerations for CT in particular and for medical imaging in general. Med Phys 32:1321-1334  47.   Klein L, Dorn S, Amato C et al (2020) Effects of Detector Sam- pling on Noise Reduction in Clinical Photon-Counting Whole- Body Computed Tomography. Invest Radiol 55:111-119\nAbdominal Radiology  48.   Barber W, Nygard E, Iwanczyk J et al (2009) Characterization of a novel photon counting detector for clinical CT: count rate, energy resolution, and noise performance. Proc SPIE Int Soc Opt Eng 7258  49.   Grönberg F, Yin Z, Maltz J, Pelc NJ, Persson M (2022) The effects of intra-detector Compton scatter on zero-frequency DQE for photon-counting CT using edge-on-irradiated silicon detectors. arXiv preprint arXiv: 2206. 04164  50.   Yu Z, Leng S, Jorgensen SM et al (2016) Evaluation of con- ventional imaging performance in a research whole-body CT system with a photon-counting detector array. Phys Med Biol 61:1572-1595  51.   Tsang DS, Merchant TE, Merchant SE, Smith H, Yagil Y, Hua CH (2017) Quantifying potential reduction in contrast dose with monoenergetic images synthesized from dual-layer detector spec- tral CT. Br J Radiol 90:20170290  52.   Yoon JH, Chang W, Lee ES, Lee SM, Lee JM (2020) Double Low- Dose Dual-Energy Liver CT in Patients at High-Risk of HCC: A Prospective, Randomized, Single-Center Study. Invest Radiol 55:340-348  53.   van Hamersvelt RW, Eijsvoogel NG, Mihl C et al (2018) Contrast agent concentration optimization in CTA using low tube voltage and dual-energy CT in multiple vendors: a phantom study. Int J Cardiovasc Imaging 34:1265-1275  54.   Rajendran K, Voss BA, Zhou W et al (2020) Dose Reduction for Sinus and Temporal Bone Imaging Using Photon-Counting Detec- tor CT With an Additional Tin Filter. Invest Radiol 55:91-100  55.   Cormode DP, Roessl E, Thran A et al (2010) Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 256:774-782  56.   Symons R, Cork TE, Lakshmanan MN et al (2017) Dual-contrast agent photon-counting computed tomography of the heart: initial experience. Int J Cardiovasc Imaging 33:1253-1261  57.   Flohr TG, Leng S, Yu L et al (2009) Dual-source spiral CT with pitch up to 3.2 and 75 ms temporal resolution: image reconstruc- tion and assessment of image quality. Med Phys 36:5641-5653  58.   Ahmed Z, Campeau D, Gong H et al (2023) High-pitch, high tem- poral resolution, multi-energy cardiac imaging on a dual-source photon-counting-detector CT. Med Phys 50:1428-1435  59.   Almeida IP, Schyns LE, Ollers MC et al (2017) Dual-energy CT quantitative imaging: a comparison study between twin-beam and dual-source CT scanners. Med Phys 44:171-179  60.   Hua CH, Shapira N, Merchant TE, Klahr P, Yagil Y (2018) Accu- racy of electron density, effective atomic number, and iodine con- centration determination with a dual-layer dual-energy computed tomography system. Med Phys 45:2486-2497  61.   Mayneord W (1937) The significance of the Röntgen. Unio Inter- nationalis Contra Cancrum 2:271-282  62.   De Cecco CN, Boll DT, Bolus DN et al (2017) White Paper of the Society of Computed Body Tomography and Magnetic Resonance on Dual-Energy CT, Part 4: Abdominal and Pelvic Applications. J Comput Assist Tomogr 41:8-14  63.   Euler A, Laqua FC, Cester D et al (2021) Virtual Monoenergetic Images of Dual-Energy CT-Impact on Repeatability, Reproduc- ibility, and Classification in Radiomics. Cancers (Basel) 13  64.   Leng S, Zhou W, Yu Z et al (2017) Spectral performance of a whole-body research photon counting detector CT: quantitative accuracy in derived image sets. Phys Med Biol 62:7216-7232  65.   McCollough CH, Rajendran K, Leng S (2023) Standardization and Quantitative Imaging With Photon-Counting Detector CT. Invest Radiol 58:451-458  66.   Michalak G, Grimes J, Fletcher J et al (2016) Technical Note: Improved CT number stability across patient size using dual- energy CT virtual monoenergetic imaging. Med Phys 43:513  67.   Yang Y, Qin L, Lin H et al (2024) Consistency of Monoenergetic Attenuation Measurements for a Clinical Dual-Source Photon- Counting Detector CT System Across Scanning Paradigms: A Phantom Study. AJR Am J Roentgenol. https:// doi. org/ 10. 2214/  AJR. 23. 30631  Publisher\'s Note   Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.  View publication stats',0.07235334073354659,'[\"(\", \"(1937)\", \"(2005)\", \"(2009)\", \"(2010)\"]','2025-11-29 17:08:47.939019'),(78,3,'ORIGINAL RESEARCH  Health consumers ’   ethical concerns towards arti fi cial intelligence in Australian emergency departments  Sam FREEMAN   ,   1,2   Jonathon STEWART   ,   3,4   Rebecca KAARD, 5   Eden OULIEL,   5   Adrian GOUDIE,   6,3 Girish DWIVEDI 3,4,7   and Hamed AKHLAGHI   1  1   Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, Victoria, Australia,   2   Centre for Digital Transformation of Health, The University of Melbourne, Melbourne, Victoria, Australia,   3   School of Medicine, The University of Western Australia, Perth, Western Australia, Australia,   4 Cardiovascular Disease and Diabetes Program, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia, 5   School of Medicine, The University of Notre Dame, Fremantle, Western Australia, Australia,   6   Department of Emergency Medicine, Fiona Stanley Hospital, Perth, Western Australia, Australia, and   7   Department of Cardiology, Fiona Stanley Hospital, Perth, Western Australia, Australia  Abstract  Objectives : To investigate health con- sumers ’   ethical concerns towards the use of arti fi cial intelligence (AI) in EDs.  Methods : Qualitative   semi-structured interviews with health consumers, rec- ruited via health consumer networks and   community   groups,   interviews conducted   between   January   and August 2022.  Results : We   interviewed   28   health consumers   about   their   perceptions towards the ethical use of AI in EDs. The   results   discussed   in   this   paper highlight the challenges and barriers for   the   effective   and   ethical   imple- mentation of AI from the perspective of Australian health consumers. Most health consumers are more likely to support AI health tools in EDs if they continue   to   be   involved   in   the decision-making   process.   There   is considerably   more   approval   of   AI tools that support clinical decision- making,   as   opposed   to   replacing it. There is mixed sentiment about the acceptability of AI tools in fl uencing clinical   decision-making   and   judge- ment. Health consumers are mostly supportive of the use of their data to train and develop AI tools but are concerned   with   who   has   access. Addressing bias and discrimination in AI is an important consideration for some health consumers. Robust regu- lation and governance are critical for health consumers to trust and accept the use of AI.  Conclusion : Health consumers view AI as an emerging technology that they   want   to   see   comprehensively regulated to ensure it functions safely and securely with EDs. Without con- siderations   made   for   the   ethical design,   implementation   and   use   of AI   technologies,   health   consumer trust and acceptance in the use of these tools will be limited.  Key   words:   arti fi cial   intelligence, emergency   medicine,   ethics,   health consumers, machine learning, quali- tative research.  Introduction  Advancements   in   arti fi cial   intelli- gence (AI) are predicted to impact healthcare delivery in a multitude of ways such as providing a comprehen- sive   picture   of   an   individual ’ s healthcare   data,   augmenting   clinical decision-making,   reducing   diagnostic errors, assisting with test selection and interpretation, and recommending fur- ther   management   options. 1   Despite the technology behind most of these advances continuing to improve, par- ticularly   through   machine   learning (ML), 2   there remain key challenges in the Australian health system that need Correspondence: Dr Sam Freeman, Department of Emergency Medicine, St Vincent ’ s Hospital, Melbourne, VIC, Australia. Email: sam.freeman@svha.org.au Sam Freeman, PhD, Research Fellow; Jonathon Stewart, MBBS, MMed(CritCare), Anaesthetic Registrar; Rebecca Kaard, MBBS Student; Eden Ouliel, MBBS Student; Adrian Goudie, MBBS FACEM DDU, Emergency Physician; Girish Dwivedi, MD, PhD, FRACP, Wesfarmers Chair and Consultant Cardiologist; Hamed Akhlaghi, MD, PhD, FACEM, Emergency Physician, Head of Emergency Medicine Research. This is an open access article under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs   License,   which   permits   use   and   distribution   in   any medium, provided the original work is properly cited, the use is non-commercial and no modi fi cations or adaptations are made.  Accepted 15 May 2024  Key   fi ndings  •   Health   consumers   generally support   arti fi cial   intelligence (AI) tools that assist clinicians in   decision-making   but   are wary of tools replacing doc- tors, with trust diminishing as AI ’ s   decision-making   auton- omy increases.  •   Health   consumers   express   a strong   desire   to   be   actively involved in AI-driven decision- making about their healthcare in emergency settings.  •   Mixed sentiments surround the acceptability of AI in fl uencing doctor   decision-making,   with concerns about its impact on healthcare quality. Health con- sumers fear a short-term under- mining of nurses and doctors, leading to a potential reduction in clinical skills and a long-term shift   towards   ‘ box-ticking ’  exercises,   raising   discomfort and   scepticism   about   the technology ’ s role in emergency medicine. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  Emergency Medicine Australasia   (2024)   36 , 768 – 776   doi: 10.1111/1742-6723.14449\nurgent   attention.   These   include   an increasing demand for healthcare ser- vices, an ageing population, increas- ing   costs   associated   with   medical research and innovations and grow- ing rates of chronic disease. 3   This has led groups such as policymakers, pol- iticians,   technology   companies   and data scientists to advocate for AI to address these challenges. 4 It is predicted that the use of AI- based tools will become increasingly common in EDs. 5   However, there is limited published research that qualita- tively assesses how health consumers (people who use health services, their families and carers) feel about AI use in their care in an ED context. To date, research has mostly focused on health consumers ’   perceptions of AI in speci fi c sub fi elds of medicine, such as radiology, dermatology, general prac- tice and primary care. This   paper   presents   health   con- sumer attitudes towards AI to help inform future research and highlight risk   mitigation   strategies   for   the effective and ethical implementation of AI in EDs.  Methods  Study design and setting  This qualitative study was designed in accordance with the consolidated criteria   for   reporting   qualitative research.   6   We   developed   a   semi- structured interview guide based on the review of existing literature and input from the multidisciplinary pro- ject   team.   Members   of   the   project team   have   recognised   expertise   in emergency medicine, qualitative resea- rch   and   AI   and   also   included   two healthcare   consumer   representatives. The   study   protocol   and   interview guide were presented to and received formal support from the Fiona Stanley Hospital Emergency Department Con- sumer   Advisory   Group   (Western Australia). We conducted three pilot interviews and re fi ned the   interview guide based on feedback. Twenty-eight   semi-structured interviews were conducted between January and August 2022 to assess health   consumers ’   perspectives   and considerations for the ethical imple- mentation   and   use   of   AI   in   EDs. Participants were recruited from dif- ferent health consumer networks and community   groups,   including   the Consumer Community Involvement Program (Western Australia), Fiona Stanley Hospital Emergency Depart- ment   Consumer   Advisory   Group (Western   Australia),   St   Vincent ’ s Hospital   Melbourne   Human Research   Ethics   Committee   layper- son members (Victoria), Health Con- sumers   Queensland   (Queensland) and the Centre for Culture, Ethnic- ity & Health (Australia wide), where recruitment details were distributed through its members and networks. The interviews were conducted until thematic saturation (de fi ned as three consecutive interviews with no new themes identi fi ed) was achieved. This research utilises a grounded theory approach,   which   was   selected because it provides a methodology for collecting and analysing data and conceptualising   the   results.   7   Inter- views were conducted by telephone via a voice call (without video) and audio   recorded.   Audio   fi les   were de-identi fi ed and professionally tran- scribed by a secure transcription ser- vice.   Interviews   were   conducted   in Australia with participants from New South   Wales,   Queensland,   Victoria and Western Australia. For a further breakdown   of   participant   demo- graphics (see Table 1).  Participant selection  A convenience sample was used to recruit   respondents   ( n   =   28)   based on   accessibility   and   willingness   to take part in the study.   8  Data collection  Semi-structured   interviews   were   con- ducted with additional questions and prompts used as needed. Although the discussion of ethical concerns was led by respondents, prompts included prin- ciples such as consent, transparency, privacy, safety and harm, bias, fairness and   redress.   There   were   no   repeat interviews or transcription checks by participants. Interview duration ranged from 10 to 45 min.  Data analysis  Two investigators (SF and JS) indepen- dently analysed and coded interviews using open coding techniques based on grounded theory.   All   the   interviews were coded using NVivo 20 (QSR, Melbourne,   Australia).   Codes   and themes were iteratively developed and re fi ned until most content was able to be classi fi ed. Agreement on codes and themes was reached at researcher meet- ings where differing codes were dis- cussed and a consensus on their coding was agreed upon.  Characteristics of interviewers  The interviews were conducted by SF, two medical students (RK and EO), and an ED Registrar. Interviews were held over the phone without video to reduce any bias that the interviewer ’ s appearance may have on responses. The interviewers had no prior rela- tionship with the study participants.  Characteristics of research team  At   the   time   of   conducting   this research   SF   was   a   PhD   candidate  TABLE   1.   Participant   demo- graphic information  Category   n   % Sex Female   17   61 Male   10   36 Non-binary   1   4 Age group 20 – 29   2   7 30 – 39   6   21 40 – 49   6   21 50 – 59   2   7 60 – 69   2   7 70 – 79   10   36 Location New South Wales   1   4 Queensland   5   18 Victoria   14   50 Western Australia   8   29 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   769 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n(focus on ethical implementation of AI in emergency medicine) and a research fellow at an Australian ED. JS was a PhD candidate (focus on applications of AI in emergency medicine) and an emergency medicine trainee. RK and EO   were   both   second-year   medical students who had not completed rota- tions in emergency medicine.  Ethical considerations  The study received University of West- ern Australia Research Ethics Commit- tee   approval   (2021/ET000609). Informed consent was gained from all respondents participating in the present study. The present study was prospec- tively   registered   with   the   Australian New Zealand Clinical Trials Registry (ACTRN12621000890831).  Results  The results provide an overview of health   consumers ’   key   perceptions of ethical AI in an ED setting. Key ethical   concerns   presented   here include health consumer autonomy and consent, doctor decision-making and autonomy, automation bias and reliance, data usage and privacy, bias and discrimination and regulation.  Health consumer autonomy and consent  Most   health   consumers   are   more likely to support AI health tools in emergency medicine if they continue to   be   involved   in   the   decision- making   process   about   their   health and can still understand why a treat- ment recommendation or diagnosis is made. There is some concern that with   the   use   of   increasingly   adva- nced technologies, they will no lon- ger be able to ask questions or have key issues explained to them about their treatment or diagnosis. For many participants there is a requirement to have the role of AI in their treatment explained to them at the   earliest   opportunity.   Many believe they would be more comfort- able with the use of AI if it is effec- tively   communicated.   This   becomes even more important with the incre- ased   complexity   or   risk   associated with the function of the AI tool. This is particularly important if the role of AI includes clinical decision support that relates to differential   diagnosis, complex cases, serious health condi- tions or decisions that were tradition- ally tasked to doctors and nurses. Effective   communication   is   criti- cally important to most health con- sumers   to   improve   autonomy   and consent processes. Many already feel that   information   in   EDs   could   be better communicated and that if AI is to play a future role in emergency medicine, in any capacity, it needs to be clearly communicated. The more  ‘ serious ’   the concern or high-risk set- ting   the   tool   is   functioning   in,   the more information consumers require. There is concern that AI systems may be non-interpretable by the doc- tor,   meaning   the   doctor   may   be unable   to   effectively   understand results and subsequently communi- cate   them   to   their   patients.   This thereby impacts the patient ’ s ability to give informed consent. There are mixed views, however, about the type and amount of informa- tion required, and how it is communi- cated.   Overwhelmingly,   consumers want to know (to varying degrees) if an   AI   tool   is   being   used   in   their healthcare pathway. If an AI tool is used in a patient ’ s healthcare   pathway   and   they   were not   informed,   many   report   they would   feel   ‘ betrayed ’ ,   ‘ annoyed ’ ,  ‘ frustrated ’   or   ‘ distressed ’ . For trust and   acceptance   of   these   systems, many health consumers believe that improved   consent   processes   are needed to ensure the risks, bene fi ts and alternatives can be explained in how the tool works and that they have the opportunity to opt in or out of   having   the   tool   used   in   their healthcare delivery. There is fear that the introduction of these tools will lead to a loss of human connection in the ED, in par- ticular   empathy   and   sympathy,   in what is for many people an already highly stressful environment. Some see the   healthcare   journey   as   a   human experience and want it delivered with kindness and compassion   –   traits not typically   associated   with   AI   and machines. Having that human connec- tion in a health setting is not only con- sidered   important   on   an   emotional, human   level,   but   also   connects   to health consumer autonomy.  Doctor decision-making and autonomy  There is considerably more approval for AI tools in the ED that support cli- nician decision-making, as opposed to replacing   it.   Most   participants   will only support these tools if their func- tion is subsidiary to the role of the doctor. Trust and acceptance and AI decision-making autonomy appear to have an inverse relationship. As an AI tool ’ s   decision-making   autonomy increases in the ED, patient trust and acceptance decrease. There is recognition that   human decision-making   is   fallible, particu- larly in a dynamic, complex ED envi- ronment.   Against   this   backdrop, participants see potential in AI tools being   used   to   support   doctor   and nurse   decision-making.   For   some, there is also an expectation that AI tools will likely make mistakes. For many, it is how these mistakes are responded   to   that   will   determine their level of acceptance. The   doctor   is   predominantly viewed as the   fi nal authority regard- ing   patients ’   health.   Trust   and acceptability in AI tools are derived from the doctor agreeing with the AI tools ’   prediction. When respondents envisage an AI tool operating inde- pendently of doctor oversight, many health   consumers   said   they   would insist on being treated by a doctor if they disagreed with the decision of the AI health tool. For some, no mat- ter what scenario occurs within the ED, clinicians are considered more accurate in diagnosing and treating patients. Although there are differing views about the acceptability of AI tools   to   make   errors,   ultimately, most health consumers hold AI tools to   a   higher   standard   of   accuracy than ED doctors and nurses. Despite concerns about the effec- tiveness and accuracy of AI, some health   consumers   state   that   once these   tools   are   ‘ proven ’   to   out- perform   doctors   then   they   would prefer AI tools over doctors. Some health   consumers   state   that   in some circumstances, they would prefer AI-assisted   decision-making,   such   as © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  770   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nwhen a doctor is overworked, the ED is short-staffed or overcrowded, or the treating clinician has limited experi- ence   in   the   role.   Health   consumers largely   accept   that   their   perceptions may change with advancements in AI technology and its predicted increased integration into healthcare. However, doctors are still regarded as providing the   preferred standard of care   over any form of AI tool.  Automation bias and reliance  There   is   mixed   sentiment   among respondents about the acceptability of AI tools in fl uencing ED doctors ’  decision-making and clinical judge- ment. Many were concerned that AI tools would in fl uence doctors ’   judge- ment   and   impact   the   quality   of healthcare   provision.   For   these health consumers, AI is considered just another tool to be utilised by cli- nicians and should not be afforded special   status   over   any   other   tool available in the ED. If AI tools are believed to have an in fl uential role over   clinical   decision-making,   it would   make   health   consumers  ‘ uncomfortable ’ ,   ‘ sceptical ’   and   ‘ dis- trustful ’   of the technology. Many health consumers are con- cerned that the use of AI tools in emergency medicine will result in a reliance on them. In the short term, consumers   feel   these   tools   could undermine   the   role   of   nurses   and doctors   within   the   ED   and   in   the long term could reduce the skills and ability of clinicians. There is a belief from some that diagnosing patients and clinical judgement will become  ‘ box ticking ’   exercises, where a clini- cian ’ s   ‘ gut   feeling ’ ,   ‘ intuition ’   and  ‘ instincts ’   are   no   longer   attributes that are developed and valued.  Data usage and privacy  Health   consumers   are   mostly   sup- portive of the use of their data to train and support the development of AI tools in emergency medicine but   are   concerned   with   who   has access.   Most   are   comfortable   with their non-identi fi able data being used for healthcare purposes, but only for healthcare purposes. If it was later dis- covered   that   their   information   had been used outside of the healthcare system,   or   for   purposes   other   than improving   healthcare   delivery   or healthcare research, trust and accep- tance of these tools would diminish. There   is   concern   about   data breaches and the level of security for protecting personal health informa- tion. However, many are aware of the inherent risks involved in sharing and   storing   data.   Although   it   is recognised   that   privacy   issues   are not unique to AI, many want assur- ances that their data is being handled securely. Many state that they are not   overly   concerned   about   their own   medical   data   being   released publicly, but do recognise that some health information and some mem- bers of the public could be negatively impacted, targeted or discriminated against based on their health data: Some   health   consumers   want greater control over the health infor- mation   that   is   shared   and   stored. Many   want   consent   processes   in place, so they are aware if the infor- mation is being shared and have the ability to opt in or out of its collec- tion and sharing. There are privacy concerns about how data will be col- lected in the ED if managed by an AI-enabled   platform.   Some   partici- pants   are   apprehensive   about   how patient-to-machine   information   will be communicated in a crowded ED environment.   Some   discussed   the need for a private space to feel com- fortable sharing information.  Bias and discrimination  Addressing bias and discrimination in AI is an important consideration for some   health   consumers.   There   is concern that AI will inherit the same biases   that   are   already   present   in healthcare. One participant feels that having come from a Caucasian back- ground   means   that   AI   tools   will likely be accurate for them, but less accurate or reliable for people from culturally   and   linguistically   diverse backgrounds. There are concerns that AI tools will bias or discriminate against cul- turally   and   linguistically   diverse populations,   First   Nations   people, women   and   people   with   disability and   complex   medical   needs.   Bias and discrimination are linked to per- ceptions of accuracy. For health con- sumers   to   trust   and   accept   these tools in the ED, they must be con- vinced they are accurate. Part of that required accuracy is how well they perform   for   people   from   multicul- tural backgrounds. It will be impor- tant   that   AI   based   tools   do   not perpetuate existing biases or intro- duce new biases.  Regulation  Regulation   is   an   important   aspect for trusting and accepting the use of AI   in   EDs   for   health   consumers. Some health consumers want assur- ances that there is robust regulation and oversight in the design, develop- ment, training and ongoing use of these tools. Most support a govern- ment   regulatory   body   to   establish guidelines   and   oversee   compliance. Some   see   this   as   the   role   of   the national government to ensure con- sistency across states and territories. Many do not want to see industry self-regulation   or   regulation   and standards left to the private sector. Here, there is concern that pro fi t will be   the   motivating   factor   for   the implementation   and   use   of   these tools, not improving patient health outcomes. Some   health   consumers   want   to see   more   localised   governance   and accountability of these tools such as the hospital administration or industry peak   bodies   such   as   the   Australian Medical Association, to ensure train- ing and policies are established and provided at the clinical level. There are also calls for AI tools to be endorsed by the bodies that represent the medi- cal professionals who are required to use these tools in clinical practice. Some health consumers also want these tools to pass through an ethics review   process.   For   these   respon- dents, it is not enough to just con- sider the safety and medical accuracy of these tools, it must also consider their ethical impact (Table 2).  Discussion  This research found that health con- sumer   acceptance   of   AI-enabled health tools requires the consideration © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   771 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nTABLE 2.   Sample comments by health consumers on ethical concerns  Qualitative dimension   Sub-dimension   Example quote Patient autonomy and consent Health consumer understanding of treatment or diagnosis  … that I was involved in the discussions about my treatment, patients being encouraged to be involved in decision-making about their care, that actually has to be absolutely central to the whole process still so that I wouldn ’ t want the human element and the capacity for me as a patient to actually explain my concerns and, you know, the capacity of me to ask questions. Effective communication that AI is being used I think as a patient I would also want to understand the role of AI in the whole process, and I think that would be very, very important because if I found out for some reason, you know, at a later date that (that AI was being used), that would be quite disturbing. But I think if I was involved at the start in knowing that this system was actually helping clinicians to arrive at an accurate diagnosis, I think I would be very satis fi ed, very comfortable with that. You ’ ve got to have that communication, break that barrier to communication face-to-face by someone who can explain what ’ s happening. Amount of information health consumers require  … not in a great amount of detail, but it would just be nice to have that reassurance. The more information, the better. Consent requirements With my consent, I ’ d feel good about it. I think you need to opt in. Doctor – patient relationship I wouldn ’ t like it because you want to be heard and seen by a compassionate, kind professional. This is a human experience, and I don ’ t want it to be determined by a robot. At least, if the robot has this decision, I would want a human sitting there and explaining it to me …   the desperation and feeling unwell, just to be questioned by a robot in a yes or no or to get an answer way, it ’ s going to just increase the frustration and the suffering, I feel. Doctor decision- making and autonomy AI errors in decision-making  … every human body is different so the program is written for the majority, allowing for some differences, but there ’ ll always be individuals that   … swim against the   fl ow and where they should have got better, all the signs are there that they should have got better and something has happened, but that happens just when a doctor sends them home, the fact that it ’ s a computer algorithm that did the agree-to-release, in my eyes, makes no difference. AI accuracy   If it replaces something that ’ s there at the moment, yes, it has to be better.   … I can imagine that 15 years down the track I would see it as completely irrelevant, but I think during a new kind of introductory phase of a new technology, I think it would be perceived as far worse for a computer to make an error. Because I think if it ’ s proven to be more failsafe and make less mistakes than what the humans are performing then I would take my chances with that over human assessment for sure. AI over doctors   I mean not every doctor ’ s going to be a specialist in every   fi eld. And in emergency, the guy treating me may not be the most capable guy in whatever it is I have. [So] I think the fact that he can rely on the information from a tool to help him in the diagnostics would be very useful. Automation bias and reliance AI in fl uence over doctor decision- making Well, I would think it ’ s actually a slap in the face to doctors, because you ’ re negating all the experience that they ’ ve had, and their own experience will tell them a lot of information that the machine can ’ t gather. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  772   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nand minimisation of ethical issues. As AI research continues to develop it is important   to   understand   what   are considered   by   healthcare   consumers to be acceptable uses of the technol- ogy in emergency medicine contexts. These   results   provide   information about health consumers ’   current per- ceptions of AI in emergency medicine and further emphasises the need for effective   communication   to   ensure consumers understand the function of AI and the role it will play in the deliv- ery of their healthcare. Consumers require assurance that the   ED   doctor   retains   the   fi nal decision-making authority and that they understand how and why an AI tool has come to a certain prediction or   recommendation.   This   may   be challenging as current AI tools are for the most part   ‘ black boxes ’   with reasoning that is not interpretable to humans.   9 It appears that trust and acceptance of   AI   tools   and   clinician   decision- making   autonomy   are   inversely related.   The   more   autonomous   or independent the tool is from ED doc- tors ’   oversight   and   understanding, the less likely patients are to trust its output. There are reservations about the accuracy and performance of these technologies, and also apprehension about moving to a new standard of care, which may remove other ele- ments   of   healthcare   considered important to patients such as the doctor – patient   relationship.   Other research   into   patient   perspectives on   AI   in   different   medical   fi elds found comparable results   –   patients  TABLE 2.   Continued  Qualitative dimension   Sub-dimension   Example quote Reduced doctor skill and ability  … as soon as we start taking away decisions from health professionals, we ’ re sort of undermining their training and we start, look, it ’ s complicated because I think if we could take routine jobs away from nurses and doctors to help them focus on more important things, that would be great. But I ’ m worried that [they] would then start relying on AI and it would undermine the expertise of doctors and nurses. Data usage and privacy  Re -use of patient health consumer data If you ’ ve given consent for it, no problems. You wouldn ’ t want it to be then on-sold or used for anything else. I could understand people who are very private and would not want their medical records (shared) … . but as long as it ’ s unidenti fi ed and they ’ re not used for any other purpose, you know, it ’ s probably inevitable things are going down this track in all   fi elds. [Concern] around how your data ’ s kept and used, and the breaches   –   what ’ s being collected and how could that be used. Control over the sharing of health consumer data  … Patients should be able to consent to certain information being taken, and where that information is actually going to go. On the other hand, I really do support the interoperability of programs, so that they can talk to one another, after consent is received. How private data is disclosed It would depend on how the information was communicated, like if it was …  in an open space. You know, are people ’ s private health details being broadcast loud by this AI? Is it happening in a quiet, private space? Bias and discrimination AI and human bias   I don ’ t think AI is good enough yet and everyone ’ s just forging ahead with it, thinking it ’ s great and missing the fact that it ’ s really not great. It ’ s programmed like humans, so it will have human error in it. Discrimination and multicultural populations  … the (AI) system has been calibrated using data that isn ’ t particularly diverse and then the output it generates is biased because of that. Regulation   Government regulation I think it ’ s got to be a multi-layered approach. I think Australia at a federal level has to have some very clear guidelines around the use of AI in medical settings and lots of other settings, but if we ’ re just sticking with medical, I think we need to have some federal governance around that. Local governance mechanisms But I do think then we need to have local [governance], like AMA (Australia Medical Association) or state level or even hospital level to make sure that staff are trained, staff are upskilled, that there is a local connection with what ’ s going on federally. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   773 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nare much more likely to support AI if there is a human tasked with mak- ing   the   fi nal   decision   or recommendation. 10 – 15   In part, this is because there is more trust in the abil- ity of an experienced doctor. Doctors are also able to justify and explain their   decision   or   recommendation, something health consumers currently do not associate with AI technology. Many   patients   still   want   the human   connection   and   assurance healthcare staff provide when they are   going   through   a   potentially stressful   time,   something   machines are viewed as incapable of providing. However,   these   views   may   change with increased exposure to advanced AI tools. A recent study comparing physician and ChatGPT responses to patient questions found that patients rated ChatGPT responses   ‘ higher for both quality and empathy ’ . 16   With this challenging the assumptions of most health consumers that AI tools will lack empathy. Some of the lit- erature also suggests that patients fear losing human interaction from their   healthcare   delivery   and   are concerned   that   AI   tools   will   be unable   to   comprehend   emotional issues,   particularly   in   relation   to patients   experiencing   mental   ill- health.   10,11,14,17 – 19   This   concern appears   to   intensify   in   an   emer- gency   setting   with   patients   often requiring urgent medical attention, and where the human connection is considered especially important in reducing distress. Health   consumers   are   concerned about privacy and the use of their per- sonal   health   data.   Although   many approve   of   the   use   of   their   non- identi fi able   medical   data to   support the development of AI tools within healthcare,   they   are   still   concerned about   con fi dentiality   and   who   has access to it. This is consistent with research into patient perspectives of AI   in   radiology 20   and   healthcare chatbots, 17   which found patients are only willing to share data if it remains con fi dential and non-identi fi able. Con- sumers will likely rescind their support for data usage if it transpires that their personal   information   is   being   used outside of the healthcare system or for purposes other than improving patient health outcomes. Many   health   consumers   believe they are aware of the inherent risks involved in the sharing and storage of data. However, health consumers may be under the assumption that their health data refers only to data held by healthcare organisations in their health records. Yet, these data sources are considered only a small part of the   ‘ larger health data eco- system ’ . 21   This includes health data generated   by   non-healthcare   pro- viders such as insurance companies, non-health information where infer- ences   are   made   about   health,   and user-generated health data.   21   Health consumers may feel less comfortable knowing that there is the potential for this information to be collected and used to make decisions about them, particularly if used by com- mercial entities. Data collection and sharing policies need to be updated to ensure data collected and gener- ated through the use of these tools meets the standards and expectations of consumers. Most   health   consumers   see informed   consent   as   a   critical   ele- ment   in   gaining   their   trust   and acceptance regardless of the role AI might play in their treatment. One study   22   identi fi ed that informed con- sent   is   not   receiving   the   attention needed   in   the   ethical   debate   sur- rounding   AI   implementation,   with another study 23   reporting that   ‘ ubiq- uity, complexity and opaqueness ’   are major   contributors   to   health   con- sumers ’   ‘ inability to assess or predict outcomes   or   harms ’   associated with   the   use   of   AI   in   healthcare and   therefore   provide   informed consent. The issue of consent app- ears   to   be   a   signi fi cant   consider- ation for health consumers. It will be important that the ED doctors and hospital management who are tasked   with   implementing   these technologies   ensure   the   consent process is current and appropriate, and that the use of AI in the ED is communicated effectively. Addressing   bias   and   discrimina- tion that results from the introduc- tion   of   AI   is   important   to   many health   consumers.   However,   bias and discrimination pre-existent to AI is   not   without   precedent   in   the Australian healthcare system, where First   Nations   people   ‘ continue   to suffer   adverse   experiences   in healthcare, with inequitable care pre- valent   in   emergency   settings ’ . 24 Research   has   highlighted   that   the Australian   healthcare   system   under serves those from culturally and lin- guistically diverse backgrounds, 25   has discriminated   against   women 26   and people   with   disability. 27   For   AI   to bene fi t   diverse   populations   such   as Australia ’ s, the design and develop- ment of AI technologies must include input from diverse populations from diverse   geographic   locations,   who will   use   or   be   exposed   to   these technologies. 28 It appears that health consumers envisage a more rigorous regulatory framework that monitors and evalu- ates the design, development, imple- mentation and use of AI technologies than   currently   exists   within Australia. Although the Therapeutic Goods Administration does regulate software as a medical device, which AI software are categorised, there is no regulation that relates speci fi cally to these technologies.   29   Because of this   assumption,   it   is   likely   that future regulation and guidance will need to address issues of oversight and evaluation to gain the support of consumers. This will likely include ensuring health consumers are protec- ted,   and   that   improved   health   out- comes are a priority in implementing these systems. 29   This also relates to fears that AI tools may not be appro- priately   regulated   and   be   more in fl uenced by   fi nancial incentives than improving healthcare outcomes. The existing literature, similarly, found that rigorous regulation and guidance of AI in healthcare is regarded as impor- tant for protecting patient wellbeing, monitoring the safety of these systems, reducing   risks   to   patient   privacy, assessing   the   potential   for   systemic bias   embedded   in   AI   models   and enabling   continuous   system improvements. 29 – 31   Last, many emer- gency   physicians   share   similar   con- cerns about the use of AI in EDs as health   consumers.   These   common concerns include data usage and pri- vacy, bias and discrimination, skill loss and   over-reliance,   transparency   and explainability of AI algorithms, and regulation and governance. 32,33 © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  774   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nLimitations  The   fi ndings   in   the   present   study should be considered within the con- text of its limitations. A convenience sample   was   used   to   select   partici- pants based on their accessibility and willingness to take part, which could lead   to   voluntary   response   bias.   8 Attempts   were   made   to   recruit   a sample based on demographic data provided by the Australian Institute of Health and Welfare   –   Emergency Department Activity to reduce dis- crepancies   between   the   demo- graphics   of   the   sample.   However, this was unsuccessful, leading to a sample   that   was   skewed   towards those   living   in   Victoria,   Western Australia and Queensland, those in an   older   age   bracket,   females   and those   from   a   white-Anglo   back- ground.   Additionally,   as   a   non- probability   sample,   the   results   are not representative of the Australian population.   The   grounded   theory approach also has limitations. It is accepted that using a GT approach can allow for the researcher ’ s indi- vidual   biases   and   world   view   to in fl uence study results.   34   AI is a rap- idly changing area, and the introduc- tion   and   media   coverage   of   new technologies   has   the   potential   to in fl uence   respondent   perspectives. For   example,   recent   advances   in foundation models such as ChatGPT were   released   after   the   interviews took   place,   meaning   some   health consumers ’   perspectives   may   have already changed.  Conclusion  The results discussed in this paper found that most consumers require AI to be rigorously tested and evalu- ated before it becomes operational. There is also a requirement for AI to be robustly regulated and monitored by government or a professional reg- ulatory   body   to   gain   support   and acceptance.   However,   regulation alone   is   not   considered   suf fi cient. Informed consent processes that pro- vide information about the role and functionality of AI, maintaining pri- vacy and con fi dentiality of personal health data, bias and discrimination, and the attribution of responsibility and liability for patient health out- comes are all critical issues that need to be addressed   if   AI   technologies are to be trusted and accepted by health consumers in EDs.  Acknowledgements  We thank the Consumer Community Involvement Program, Fiona Stanley Hospital Emergency Department Con- sumer Advisory Group, St Vincent ’ s Hospital Melbourne Human Research Ethics Committee layperson members, Health   Consumers   Queensland,   and the Centre for Culture, Ethnicity and Health for their support and the par- ticipants who provided feedback on our initial interview guide, who partic- ipated in the pilot interviews, and who participated in the study. Open access publishing facilitated by The Univer- sity   of   Melbourne,   as   part   of   the Wiley - The University of Melbourne agreement via the Council of Austra- lian University Librarians.  Competing interests  None declared.  Data availability statement  The de-identi fi ed data we analysed are   not   publicly   available,   but requests to the corresponding author for the data will be considered on a case-by-case basis.  References  1.   Topol E.   Deep Medicine: How Arti-  fi cial   Intelligence   Can   Make Healthcare   Human   Again   /   Eric Topol , 1st edn. New York: Basic Books, 2019. 2.   Littman   M,   Ajunwa   I,   Berger   G  et al . Gathering Strength, Gathering Storms:   The   One   Hundred   Year Study   on   Arti fi cial   Intelligence (AI100) 2021 Study Panel Report 2022. 3.   Australian Government Department of   Health   and   Aged   Care.   The Australian   Health   System: Australian Government Department of   Health   and   Aged   Care;   2019. Available from URL: https://www. health.gov.au/about-us/the-australian- health-system. 4.   Morley J, Machado CCV, Burr C  et   al .   The   ethics   of   AI   in   health care: a mapping review.   Soc. Sci. Med.   2020;   260 : 113172. 5.   Stewart J, Sprivulis P, Dwivedi G. Arti fi cial   intelligence   and   machine learning   in   emergency   medicine.  Emerg. Med. Australas.   2018;   30 : 870 – 4. 6.   Tong A, Sainsbury P, Craig J. Con- solidated criteria for reporting qual- itative   research   (COREQ):   a 32-item checklist for interviews and focus groups.   In. J. Qual. Health Care   2007;   19 : 349 – 57. 7.   Halaweh M, Fidler C, McRobb S, eds. Integrating   the   grounded   theory method and case study research meth- odology within IS research: a possible  ‘ road map ’ . International Conference on Interaction Sciences; 2008. 8.   Etikan   I.   Comparison   of   conve- nience   sampling   and   purposive sampling.   Am. J. Theor. Appl. Stat.  2016;   5 : 1. 9.   Anderson   M,   Anderson   SL. How should AI Be developed, val- idated,   and   implemented   in patient care?   AMA J. Ethics   2019;  21 : E125 – 30. 10.   Tran V-T, Riveros   C, Ravaud P. Patients ’   views of wearable devices and AI in healthcare:   fi ndings from the ComPaRe e-cohort.   npj Digit. Med.   2019;   2 : 53. 11.   Jutzi   TB,   Krieghoff-Henning   EI, Holland-Letz T   et al . Arti fi cial intel- ligence in skin cancer diagnostics: the   patients ’   perspective.   Front. Med. (Lausanne)   2020;   7 : 233. 12.   Rawson TM, Ming D, Gowers SA  et   al .   Public   acceptability   of computer-controlled   antibiotic management:   an   exploration   of automated   dosing   and   opportuni- ties   for   implementation.   J.   Infect.  2019;   78 : 75 – 86. 13.   Fritsch SJ, Blankenheim A, Wahl A  et al . Attitudes and perception of arti fi cial intelligence in healthcare: a cross-sectional   survey   among patients.   Digit.   Health   2022;   8 : 20552076221116772. 14.   Ongena   YP,   Haan   M,   Yakar   D, Kwee   TC.   Patients ’   views   on   the implementation of arti fi cial intelli- gence   in   radiology:   development and   validation   of   a   standardized questionnaire.   Eur.   Radiol.   2020;  30 : 1033 – 40. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine. ETHICAL ARTIFICIAL INTELLIGENCE IN EMERGENCY CARE   775 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n15.   Palmisciano   P,   Jamjoom   AAB, Taylor D, Stoyanov D, Marcus HJ. Attitudes of patients and their rela- tives toward arti fi cial intelligence in neurosurgery.   World   Neurosurg.  2020;   138 : e627 – 33. 16.   Ayers   JW,   Poliak   A,   Dredze   M  et   al .   Comparing   physician   and arti fi cial   intelligence   Chatbot responses   to   patient   questions posted   to   a   public   social   media forum. JAMA.   Intern. Med.   2023;  183 : 589. 17.   Nadarzynski T, Miles O, Cowie A, Ridge D. Acceptability of arti fi cial intelligence (AI)-led chatbot services in   healthcare:   a   mixed-methods study.   Digit.   Health   2019;   5 : 2055207619871808. 18.   Gao S, He L, Chen Y, Li D, Lai K. Public perception of arti fi cial intelli- gence in medical care: content anal- ysis   of   social   media.   J.   Med. Internet Res.   2020;   22 : e16649. 19.   Nadarzynski   T,   Bayley   J, Llewellyn   C,   Kidsley   S, Graham CA. Acceptability of arti-  fi cial   intelligence   (AI)-enabled chatbots, video consultations and live webchats as online platforms for   sexual   health   advice.   BMJ Sex.   Reprod.   Health   2020;   46 : 210 – 7. 20.   Adams   SJ,   Tang   R,   Babyn   P. Patient   perspectives   and   priorities regarding   arti fi cial   intelligence   in radiology:   opportunities   for patient-centered radiology.   J. Am. Coll. Radiol.   2020;   17 : 1034 – 6. 21.   Price WN 2nd, Cohen IG. Privacy in the age of medical big data.   Nat. Med.   2019;   25 : 37 – 43. 22.   Gerke S, Minssen T, Cohen G. Eth- ical and legal challenges of arti fi cial intelligence-driven healthcare.   Artif. Intell.   Healthc.   2020:   295 – 336. https://doi.org/10.1093/oxfordhb/97 80190067397.013.23 23.   Jones   ML,   Edenberg   E.   Trouble- shooting   AI   and   consent.   In: Dubber   MD,   Pasquale   F,   Das   S, eds.   The   Oxford   Handbook   of Ethics   of   AI .   Oxford   University Press, 2020. 24.   Quigley   A,   Hutton   J,   Phillips   G  et al . Review article: implicit bias towards   Aboriginal   and   Torres Strait   Islander   patients   within Australian emergency departments.  Emerg. Med. Australas.   2021;   33 : 9 – 18. 25.   Johnstone MJ, Kanitsaki O. Ethnic aged discrimination and disparities in health and social care: a question of   social   justice.   Australas. J. Ageing   2008;   27 : 110 – 5. 26.   Bastos JL, Harnois CE, Paradies YC. Health   care   barriers,   racism,   and intersectionality in Australia.   Soc. Sci. Med.   2018;   199 : 209 – 18. 27.   Temple JB, Kelaher M, Williams R. Discrimination and avoidance due to disability in Australia: evidence from   a   National   Cross   Sectional Survey.   BMC Public Health   2018;  18 : 1347. 28.   Gebru   T.   Race   and   gender.   In: Dubber MD, Pasquale F, Das S, eds.  The Oxford Handbook of Ethics of AI . Oxford University Press, 2020. https://doi.org/10.1093/oxfordhb/97 80190067397.013.16 29.   Australian   Medical   Association. Automated   Decision   Making   and AI Regulation; 2022. 30.   Price WN. Risks and Remedies for Arti fi cial Intelligence in Health Care; 2019. Available from URL: https:// www.brookings.edu/research/risks- and-remedies-for-arti fi cial-intelligence- in-health-care/. 31.   Australian   Alliance   for   Arti fi cial Intelligence   in   Healthcare.   A Roadmap for Arti fi cial Intelligence in Healthcare for Australia; 2021. 32.   Stewart   J,   Freeman   S,   Eroglu   E  et   al .   Attitudes   towards   arti fi cial intelligence in emergency medicine.  Emerg. Med. Australas.   2024;   36 : 252 – 65. 33.   Grant K, McParland A, Mehta S, Ackery AD. Arti fi cial intelligence in emergency medicine: surmountable barriers with revolutionary poten- tial.   Ann. Emerg. Med.   2020;   75 : 721 – 6. 34.   Kolb S. Grounded theory and the constant comparative method: valid research   strategies   for   educators.  J. Emerg. Trends Educ. Res. Policy Studies   2012;   3 : 83 – 6. © 2024 The Author(s).   Emergency Medicine Australasia   published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.  776   S FREEMAN   ET AL. 17426723, 2024, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.14449 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License',0.3220757177345311,'[\"%\", \"&\", \"(\", \"(2021/et000609).\", \"(2024)\"]','2025-11-29 17:08:55.362803'),(79,3,'Research Article  Application of a Computerized Decision Support System to Develop Care Strategies for Elderly Hemodialysis Patients Yiqiu Zhu   and Xiyi Zheng  e First Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu, China  Correspondence should be addressed to Xiyi Zheng; zhengxiyi1978@suda.edu.cn  Received 20 April 2021; Accepted 9 June 2021; Published 21 June 2021  Academic Editor: Khin wee Lai Copyright © 2021 Yiqiu Zhu and Xiyi Zheng. -is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In this paper, the strategy of elderly haemodialysis patients’ care is analysed by the computer’s decision system to conduct an in- depth research machine. Maintenance haemodialysis patients have a high demand for continuation care, and healthcare workers should provide personalized and specialized seamless continuation care services for patients according to patients’ needs, by reasonably using the hospital, community, and other health resources and with the help of emerging network technologies, such as information platforms and wearable devices to prolong the survival period of patients and improve their self-management ability and quality of life. -e service provision and compensation strategy of the combined healthcare model should be optimized to improve the health protection of the elderly and promote health equity. On the one hand, it should target strengthening the service provision of healthcare integration, guide the elderly to reasonably choose the healthcare integration model, and pay attention to the spiritual and cultural needs and end-of-life care services for the elderly. On the other hand, we should expand the financing channels of medical insurance, optimize the design of compensation mechanisms, explore the role of health risk sharing, and accelerate the development of long-term care insurance, independent of basic medical insurance. -e reliability of the scale was found to be 0.916 for the total Cronbach alpha coefficient, 0.798–0.919 for each dimension, and 0.813 for the fold-half reliability of the scale; the validity indicated that the correlation coefficient range of each article day with the total scale score was 0.27–0.72, and the correlation coefficient range of each dimension with the total scale was 0.56–0.72. -e validation factor analysis was used to verify the structure of the scale. -e validation factor analysis indexes met the fitting criteria after correction. -e model fitted better with the actual model after correction, indicating that the scale has good reliability.  1. Introduction  End-stage renal disease (ESRD) is the final stage of various chronic kidney diseases when patients have irreversible impairment of kidney function and need to rely on kidney transplantation or dialysis therapy to maintain their lives [1]. Given the limited number of kidney donors and the high cost of transplantation, most ESRD patients can only choose dialysis therapy. -e current dialysis therapies include he- modialysis (HD) and peritoneal dialysis (PD). MHD pa- tients’ survival and quality of life are often compromised by the irreversible disease process, complications, specificity of the haemodialysis treatment modality and treatment envi- ronment, and water and activity restrictions [2]. Most pa- tients return to their homes, and due to the lack of guidance and   supervision   by   healthcare   professionals,   their   self- management will be lax, making it difficult to adhere to long- term self-monitoring, diet, and water control, which in turn affects the effectiveness of dialysis, increases the risk of complications and adverse outcomes, and increases the burden on families and society. Patients on long-term dialysis are prone to malnutrition due   to   disease   consumption,   dietary   restrictions,   and treatment effects, and related studies have shown that the incidence of malnutrition in haemodialysis patients ranges from 37.50% to 86.0% [3]. At the same time, some patients fear overkill and do not restrict their dietary intake, which in turn leads to excessive intake of potassium and phosphorus, which can lead to complications [4]. -erefore, healthcare professionals should strengthen the dietary guidelines for  Hindawi Journal of Healthcare Engineering Volume 2021, Article ID 5060484, 10 pages https://doi.org/10.1155/2021/5060484\npatients   with   MHD.   On   the   one   hand,   they   should strengthen patients’ cognitive education about the impor- tance of dietary management, and on the other hand, they can work together with a dietitian to develop a corre- sponding diet plan for patients according to their condition, weight, and blood pressure. -e diet should conform to the principles of high calorie, low superior protein, low fat, low phosphorus, and low potassium as much as possible, prevent anaemia, ensure the intake and absorption of various nu- trients, and actively prevent and treat malnutrition. Rea- sonable control of interdialytic weight gain (IDWG) during dialysis and keeping IDWG within the normal range are important measures to reduce complications, such as dial- ysis-associated hypotension, and reduce the morbidity and mortality rate of MHD patients, and patients’ compliance with fluid intake is a key factor in the control of IDWG [5]. -e patient’s fluid intake compliance is a key factor in IDWG control [6]. Control of fluid intake is a problem for most MHD patients, and a significant proportion of MHD pa- tients find controlling fluid intake the most difficult part of haemodialysis self-management because of severe thirst due to toxin retention in the body while limiting water intake [7]. -erefore, healthcare providers should give appropriate fluid intake instructions according to the patient’s specific situation, explain the dangers of excessive fluid intake, teach patients techniques and methods to control fluid intake, self- monitor fluid intake, develop a fluid intake plan, and allow family members to monitor and control the patient’s fluid intake. Patients with MHD often suffer from varying degrees of mental health problems such as anxiety, depression, fear, stress, and even suicidal thoughts due to disease distress, frequent dialysis, impact of economic burden, and changes in social and family roles [8]. If psychological problems are not addressed promptly, they often affect the dialysis out- come and survival quality of patients and increase the risk of adverse events. -erefore, nursing staff should provide ex- tended nursing interventions for patients’ psychological problems, listen more to patients’ emotional confessions, give humanistic care, and actively seek family and social support to enhance patients’ confidence in treating the disease and improve their sense of well-being. -ey need to explore the problems in volume management of PD patients with poor adherence to volume management behaviours to improve the targeting of intervention programs and evaluate the impact of an IMCHB-based volume management in- tervention program on promoting volume management behaviours,   improving   volume   balance,   and   improving quality of life in PD patients.  2. Related Work  With the aging of the global population, the increase in the number of elderly HD patients, prolongation of dialysis age, and special physiopathological conditions of the elderly, elderly HD patients are more prone to a variety of com- plications than other patients, and common complications include imbalance syndrome, heart failure, hypertension, diabetes, pruritus, and fractures [9]. A study by Shahmoradi et al. showed that the rate of arteriovenous access infections in elderly HD patients was as high as 37.5%, and the inci- dence of debilitation was 33.9% [10]. Palmer et al. found that 35.75% of elderly HD patients died of cardiovascular disease, 14.25% died of cerebrovascular disease, and 29% died of haemorrhagic disease, and the number of elderly patients who died of infection was significantly higher than that of young and middle-aged HD patients [11]. Moreover, given the special nature of the haemodialysis treatment form, ordinary elderly HD patients are mostly outpatients, and patients go home for convalescence after each haemodial- ysis. -erefore, elderly HD patients rely on themselves or their family members for various daily care [12]. -e cor- rectness and effectiveness of self-daily care for elderly HD patients cannot be measured, and healthcare professionals lack specific guidance tools to reasonably determine patients’ care ability and thus cannot guide patients to effective care according to local conditions [13]. Self-management is the correct way of self-care, in which patients learn through health education, rely on their own ability to adopt effective behaviours   to   maintain   or   promote   health,   effectively monitor various complicating symptoms, detect them on time, and seek medical treatment on time. Numerous scholars have achieved good results by in- tervening in patients through many different self-man- agement approaches. Some scholars have shown that self- management can effectively correct patients’ poor self-care habits, improve patients’ alertness to changes in their disease, treatment compliance, and subjective motivation, thus   reducing   complications   and   improving   patients’ quality of   survival [14]. -e existing self-management scales for HD have deficiencies in diet, internal fistula care, and emotional communication. -e contents of the scales are broad and pay little attention to the special physio- logical, psychological, cognitive, and safety problems of elderly HD patients. -e existing self-management scales cannot truly reflect the problems in self-management of elderly HD patients. -erefore, it is necessary to develop a scientific and rigorous self-management scale to assess the self-management ability, deficits, and effects of elderly HD patients and provide evidence and direction for clinical care. Niazkhani et al. used frequency domain analysis to extract pulse features [15]. Demiris et al. constructed a pulse recognition model using BP networks to improve the effi- ciency and accuracy of pulse diagnosis [16]. Regan con- structed   a   pulse   classification   model   by   combining convolutional neural networks and recursive graphs, which further improved the efficiency and accuracy of pulse di- agnosis [17]. Loftus et al. constructed a tongue classifier using   vectorized   neural   networks   and   achieved   very promising results [18]. In terms of health management, the development of smart mobile health and smart wearable devices has made it possible to collect health data from people’s daily life. Health management is most closely connected to people and is especially important in the management of chronic diseases. Smart virtual nurses have emerged that can determine the basic state of a person based on the health data collected and can also remind patients of 2   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\ndaily health management, such as medication, sleep, and exercise, providing all-around, whole-cycle health services.  3. Analysis of a Computerized Decision Support System to Develop Care Strategies for Elderly Hemodialysis Patients  3.1.   Computerized   Decision   Support System   Design.   -e heterogeneous clinical data analysis system designed in this paper   needs   to   consider   the   heterogeneity   and   multi- modality of clinical examination data, use deep learning as the main analysis technique, and combine with suitable fusion strategies to realize the fusion diagnosis of hetero- geneous multimodal clinical data. For the implemented system, it should have flexible and scalable analysis methods to utilize as much information in as data as possible com- prehensively to achieve more accurate diagnosis results. Moreover, since the system is mainly for the healthcare workers involved in clinical diagnosis, ease of use and ro- bustness should be considered in the process of system implementation. In summary, the heterogeneous clinical data analysis system based on deep learning technology should have the following functions: before conducting analysis   or   training,   the   data   should   be   preprocessed according to the data characteristics, which can provide a certain guarantee for the analysis or training effect [19]. -erefore, in the heterogeneous clinical analysis system, the corresponding data preprocessing module should be set according to the structure or mode of common clinical data, and the module should include the common preprocessing methods for this type of data, so that the preprocessing of the data can be easily completed using the processing methods in the system. As one of the main functions of this system, when heterogeneous multimodal clinical data are input, the system should provide corresponding analysis means and fusion strategies to fuse and analyse the input data and output a comprehensive diagnosis conclusion of the disease. Con- sidering the differences in diagnostic modalities of different diseases, multiple diagnostic models or fusion modalities can be considered for implementation to extend the application scenarios of the system. When the number of data structures or modalities generated by clinical diagnosis is not sufficient for fusion analysis, the system should have the ability to analyse single-modality clinical data. -e unimodal clinical data analysis function should cover the common modalities in clinical data, such as electronic medical record text, medical images, and examination indicators. -e analysis results should be visualized in the form of text, tables, or charts, and analysis reports should be formed for users to download. According to the requirement analysis, the heteroge- neous clinical data analysis system will be composed of four parts: front-end module, data preprocessing module, data analysis module, and data storage module. -e front-end module realizes the interaction with users and mainly in- cludes three functions: data preprocessing, data analysis, and result   visualization   and   model   download.   -e   data preprocessing   module   provides   preprocessing   methods, such   as   word   separation,   format   conversion,   and   data broadening for training or data to be analysed, while the data analysis module is responsible for calling the diagnostic model to make category judgment on the preprocessed data and return the diagnostic results. -e data storage module of the system is mainly divided into file storage and database storage. File storage is to store the system model or user data that takes up more resources in the form of files; database storage uses a MySQL database to store user information, session logs, and other data. -e general framework of the system is shown in Figure 1. -e front-end module is used to respond to user re- quirements and is mainly divided into four submodules: data preprocessing, unimodal clinical data analysis, heteroge- neous multimodal clinical data analysis, and data download. -e interface of each module is designed with the Element UI component library, and the MVVM model is used to realize the bidirectional data binding between the interface UI and the business model. -is progressive framework enables responsive listening and dependency binding of components, and data interaction with functional modules through axis to complete page rendering. Users can upload and download data, analyse data, and set up models after entering the system through the login interface. -e data expansion module can process the input data directly or receive data from the preprocessing module. -e data en- richment function is implemented by calling the nibble li- brary   to   convert   the   input   image   data   into   a multidimensional matrix, which is wrapped with functions for flipping, rotating, and transforming the matrix. -e functions in the data augmentation module have no de- pendencies on each other, so they can be called in parallel, and the augmentation process outputs the same. -e image data is also outputted after the augmentation process. -e main function of the data analysis module is to analyse the input clinical data and output prediction categories to provide an auxiliary diagnosis. To obtain more comprehensive information about the disease and improve the accuracy of prediction, the data analysis module fuses and analyses the heterogeneous multimodal data generated from the clinical diagnosis process. -e data analysis module also includes a unimodal clinical data analysis function in consideration of the actual ex- amination   data   that   may   have   a   more   homogeneous structure or modality. -e output of the module is divided into two types of classification categories and classifica- tion probabilities, and the return type can be selected by the front-end incoming parameters [20]. According to the fusion strategy designed and implemented in this paper, the heterogeneous multimodal clinical data fusion anal- ysis submodule requires that the input data contain data from at least one modality in different structures, re- spectively. After reading the input data, the module re- covers and calls the corresponding diagnostic models in the model library and obtains the model decision values. In the fusion method function, the decision values of each submodel are first stitched together, and the statistical calculation of the decision value arrays or matrices is Journal of Healthcare Engineering   3 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nperformed using two fusion methods based on the de- cision-level fusion strategy. -is module is used to preprocess the input clinical data. Users can select the corresponding preprocessing module according to their needs, upload the data to be processed and configure the corresponding parameters, and save the data to the specified directory after the data preprocessing is completed. At present, the preprocessing process is mainly set up for image data and text data, which mainly includes the preprocessing process interface and parameter config- uration for image data, including two functions of data augmentation and preprocessing. In the data expansion function,   each   expansion   method   generates   the   corre- sponding expanded data based on the original data and selecting multiple expansion methods means multiplying the original data. -e preprocessing function includes data format conversion, spatial alignment, bias field correction, bone rejection, voxel normalization, resizing, and image cropping. Settings can be made to save data from each preprocessing step to a specified location or to keep only the final processed data.  3.2. Analysis of Nursing Strategy Methods for Elderly Hemo- dialysis Patients.   Maintenance haemodialysis is one of the most important treatment modalities for ESRD patients. Its principle is to purify the blood by using the diffusion/ convection   function   of   the   haemodialysis   machine   to remove various metabolic wastes, toxins, and excess elec- trolytes and water from the body to correct electrolyte disorders and acid-base homeostasis. -e experiment is conducted to verify the operational reliability of the hybrid cloud fog computing-based architecture for integrating large health information resources. -is experiment will use data redundancy rate, resource retrieval delay, and integration accuracy   as   experimental   indexes,   respectively.   Among them, the data redundancy rate is calculated as follows:  S   t   �   A   i  ′  A  EW ′ .   ( 1 )  -e resource retrieval delay is calculated as follows:  Z   c   �   MIC ′  A   P   U  ′   .   ( 2 )  -e integration of the accuracy rate is calculated as follows:  Z   z   �   JA i   −   MIC ′  N   ppd .   ( 3 )  Accuracy (ACC) is the most common model evaluation criterion for classification tasks. It describes the number of samples correctly predicted by the model as a percentage of the total number of samples predicted and provides a good overview of the overall classification performance of the model. However, in scenarios where the classification task has category imbalance or is more concerned with positive sample segmentation, the accuracy rate is not a valid as- sessment of model performance. In this experiment, data augmentation   was   applied   to   the   experimental   dataset, which largely solved the category imbalance problem, but still focused more on the identification of the experimental positive samples (i.e., diseased patients) when evaluating the classification performance of the model, so the accuracy rate was only used as an index to judge whether the model training process was normal or not in this experiment and was not used to evaluate the final model performance. In contrast to accuracy, which is a portrayal of the overall sample classification performance, precision is more con- cerned with the classification of positive samples. -e ac- curacy rate describes the number of true positive samples as a percentage of the number of all samples predicted to be positive and represents how accurately the model predicts the correct outcome, which is calculated as shown in (4). Compared with the precision rate, the recall rate in (5) flnformal2care   VP““ HP““ %ormal2care Wospital Vrimary2care Uutpatient2clinics flntegrated2care wiL wiiL wiiiL wivL Wellness “ocial2care “elf-management2apps wiL wiiL wiiiL Versonal2health2folder “ocial2care Giomedical2research ffnvironmental2health Umics “ystems2biology Hlinical2trials wiL wiiL wiiiL wivL  Figure   1: Computerized decision support system. 4   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nreflects the percentage of positive samples being successfully predicted among all predicted samples, so the recall rate is also known as the check-all rate. precision   �   TP TP   −   FP ,   ( 4 )  recall   �   TP TN   −   FN .   ( 5 )  Since this experiment classified subjects into three cat- egories, AD, MCI, and CN, the classification task involved in the experiment was multicategorical. -e definition of a positive sample for the autocategorisation task is that when calculating the assessment metric for each category, the category is considered as a positive sample alone and all other   categories   are   considered   as   negative   samples. -erefore, in the previously mentioned formula, TP represents the number of data with positive predicted value and positive true value among all the predicted samples; TN represents the number of data with negative predicted value and negative true value among all the predicted samples; FN represents the number of data with negative predicted value but positive true value among all the predicted samples; FP represents the number of data with positive predicted value and positive true value among all the predicted samples. Accordingly, FP rep- resents the amount of data with positive predicted values but negative true values, as shown in Figure 2. To ensure the model’s ability to recognize positive samples while also focusing on the overall performance of the clas- sification, the precision, recall, and ROC-AUC values of the model on the test samples are used as the comprehensive evaluation metrics of the model in the experiments. Since the experiments belong to the multiclassification task, it is nec- essary to use the multiclassification metric calculation method when calculating the evaluation metrics. -e macroalgorithm, however, computes the precision rate of each class separately and then performs an arithmetic average with the formula (6), where precision is the precision rate of class I computed using formula (7). Macroalgorithm ignores the situation that the data of each class is not perfectly homogeneous and simply computes the metrics according to the number of classes, while, instead of multiplying the precision rate by a fixed number of categories as weights, the weighted algorithm multiplies the percentage of the category in the total sample size, as shown in (8), where   w   i   is the percentage of the category in the total sample size. Since the data volume of the three categories in the experimental data used in this paper is not exactly equal, the weighted algorithm is adopted for the calculation of the index. precision ( micro )   �   ? n i � 1   TP i  ? n i � 1   TP i   −   FP i ,   ( 6 )  precision ( macro )   �   ?  n i � 1 precision i   ∗   1  n ,   ( 7 )  precision ( weighted )   �   ?  n i � 1 precision i   ∗   w   i   .   ( 8 )  -e basic expert profile is described by the frequency and composition ratio. Expert positivity can be expressed by the expert positivity coefficient, that is, the return rate of valid correspondence questionnaires and the percentage of ex- perts who gave corresponding opinions. Expert authority can be expressed by the expert authority coefficient (Cr), that is, the arithmetic mean of judgment coefficient (Ca) and familiarity coefficient (Cs). -e mean, standard deviation, and other statistical indicators of importance and feasibility of modular indicators are used to express the degree of expert opinion coordination. Kendall’s harmony coefficient and coefficient of variation (CV) are used to express the degree of expert opinion coordination. Standard deviation and other statistical indicators are used to indicate the degree of concentration of expert opinions. Kendall’s harmony coefficient and coefficient of variation are used to indicate the degree of coordination of expert opinions. -e relationship between controllable factors and vol- ume management behaviours led to the inspiration for constructing an intervention program: enhancing PD pa- tients’ knowledge and skills of volume control, including diet management   and   handling   of   daily   volume   overload problems,   through   group   lectures   or   with   the   help   of manuals;   improving   their   ability   to   solve   volume   load problems and enhancing their sense of volume management self-efficacy. -e level of hope influences patients’ capacity management behaviour [21]. In the intervention, patients’ belief in life can be enhanced by positive guidance from positive life experiences of patients and examples of pur- suing dreams with illness. -emed activities such as “En- hancing Hope, Controlling Capacity” can be organized to enhance patients’ beliefs about symptom control. In the interaction with patients, the positive perception of the meaning of dialysis treatment is promoted. For example, we will introduce the colourful dialysis life of kidney patients and make them realize that “dialysis is for a better life.” At the same time, patients are encouraged to participate in the interactive process of volume management to enhance their intrinsic sense of responsibility for disease management. After building a medical corpus, the corpus can be used to construct a domain lexicon and to effectively split the medical texts to be analysed. -e automatic construction process of its lexicon is shown in Figure 3. Traditional text structuring or word separation methods generally only label information, such as lexical or sentence components, but lack attribute information, such as context for fixed phrases. -erefore, we need to break up the elec- tronic medical record text into contents with XML tagging attributes and label them based on these contents, such as drug and disease names and other terms, for knowledge mining and analysis. Based on the dictionary, the identified words are labelled as different lexical properties, and new words (unregistered words) are identified among them by an improved algorithm, and the new words are recorded in the library and discovered by comparing them with the existing word list. Term recognition methods using N-Gram com- bined with various filtering rules can be used to identify new words in the corpus eventually, and the properties of each Journal of Healthcare Engineering   5 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nword are marked in XML. Based on the broken-up and structured electronic medical record text and information, such as sentence components and their corresponding con- textual attributes, the semantic relationships between these contents are studied, and methods and models for analysing the semantic relationship network of these contents are proposed, which is the basic work for knowledge discovery. In   general   hospital   information   systems,   electronic medical records are stored in a semistructured form, and the basic information of patients (e.g., name, gender, ethnicity, etc.)   exist   in   structured   data   tables,   which   are   called structured data, and can be used directly in diagnosis and decision making and are not part of the content studied in this paper [22]. -e subject of this paper is the narrative content of medical records written in natural language by physicians in electronic medical records, which are unstructured. Since many patients have complex causes or history of illness, it is difficult to describe such patient information completely in a structured storage structure, and natural language is often used to write treatment records in hospitals. In the medical record dataset studied in this paper, each file is plain text data rather than semistructured data stored in a hospital information system. -is means that in the case pages of an electronic medical record, structured data (e.g., information such as name, age, gender, etc.) and unstruc- tured content (e.g., current medical history, history, personal history, etc.) are stored together and are difficult to dis- tinguish. -erefore, we need to perform an initial splitting of these medical record files. -e splitting requires processing the fields of the electronic medical record. -e narrative text of ethology written by a physician inevitably has some grammatical problems in the form of expression, which generally do not affect the impact of the physician’s judg- ment on the patient’s condition. However, for computers, text with grammatical errors is an obstacle for automated programs to process. For example, in Chinese medical records, a comma in symbols is written as a comma. -erefore, for the subsequent computer to do standardized processing, it is necessary to replace the expression irreg- ularities in the medical text to be processed beforehand.  4. Analysis of Results  4.1. System Performance Results.   -e size of the text dataset obtained from ADNI is small, and there is a great degree of category imbalance. -erefore, before training the model, Pomain ”erm2extraction ”axonomy2construction /elation2extraction Untology2population “emantic2disambiguation Hancer Greast2cancerq2leukaemia jymphoma2is2a2cancer fls2treated2with2cancer Qational2Hancer2Henter “ynonyms Pomain2 ontology   Hancer2ontology ffvaluation  Figure   3: Automatic policy construction process. Vrotocols   flncentives flmplementation Verformance   Genchmarks 4oals Hare- delivery Hare- planning   Wealth care Pata Tuality Uutcomes Gest practices jiterature Upinion  Figure   2: Framework of nursing strategy approach. 6   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nthe text data of electronic medical records are expanded by different orders of magnitude using the data augmentation module to increase the size of the dataset and balance the data categories at the same time. Figure 4 shows the training accuracy of the TextCNN model with different dataset sizes. -e 3 x   and 4 x   augmented datasets make the model fit slower but smoother, but finally, the augmented dataset achieves better accuracy than other datasets in the training. It can also be seen from Figure 4 that the scores of the evaluation metrics on the test set are proportional to the size of the dataset, which indicates that the model obtained better generalization after data augmentation, so the subsequent experiments   were conducted on the text augmentation dataset. -e structured data for this experiment consisted of two data components. One part consists of data on the subject’s demographic characteristics, medical history, and psycho- metric scores, and the other part is derived from the brain tissue volume data obtained by automated segmentation of the subject’s MRI images. -is processing step is based on the unsupervised segmentation method proposed by Leydig et al. -e tissue of the brain MRI image is automatically segmented into 138 volumes of cortical and subcortical structures and segmented structures, and the volume data of the patient’s brain tissue in the form of a data table is ob- tained by reading the segmentation report. Figure 5 shows the partially segmented brain tissue and its volume data, with each column representing one brain tissue volume in 138 columns in cubic millimetres, and each row representing a different subject sample. -e purpose of setting up the brain tissue volume data is to replace the laboratory indi- cator type data that were not available in the original ex- perimental data for the experiment. Since the two parts of the structured data were divided to generate different information at different stages of the diagnosis, the XGBoost algorithm was used to construct separate classifiers for the two parts of the structured data. In the classification model constructed for the structured data, such as basic subject information, medical history, and psychiatric examination, the objective function parameter was set to “multi:SoftMax” to return the predicted categories for the multiclassification task, and the metric was log loss for the multiclassification classification task. After parameter selection using grid search, the classification learning rate is set to 0.085 (default value is 0.3), and a smaller learning rate is found to have a better generalization effect by cross- validation. To prevent overfitting, the random sampling training sample ratio is set to 0.7 (default value is 1), which increases the randomness and makes the training robust to noise. In addition, the maximum depth of the tree is set to 3 (default value is 6) to reduce the complexity of the model. It is used to measure the extent to which the content of the scale measures what the researcher wants to study. -is is mainly reflected by measuring face validity and dimensional correlations, which are reflected in the correlation between the dimensions, correlation between the dimensions and the scale, and analysis by the scores of the dimensions and the total scale. -e correlation coefficients of the entries in this study ranged from 0.27 to 0.72 for the total scale scores and from 0.59 to 0.72 for the dimensions concerning the total scale, as shown in Figure 6. It consists of exploratory factor analysis and validation factor analysis. Usually, exploratory factor analysis can be used to discover the potential common factors of a scale and build a model based on a theory, and then, the validation factor analysis can be used to verify whether the model is consistent with the theoretical structure. In the present study, exploratory factor analysis was conducted to obtain a scale structure model with 25 items and five common factors based on a presurvey, and then, a validation factor analysis was applied to validate the existing scale structure model by a large sample of clinical survey. After standardizing the duration of treatment across patients to the same time scale, more work is needed to discover medication characteristics based on the needs of the scenario, such as the duration of medication use in a par- ticular patient group. -e time–density reduction approach also has some negative effects, one issue being the distortion ]ugmentf ]ugment’ ]ugment- ]ugmentM ”rain2]HH2wEL I ’I MI fiI ffiI fII ’II   MII   fiII   ffiII   fIII I flter2time2wsL  Figure   4: Training accuracy of different sized datasets. f,I I,ffi I,fi I,M I,’ I,I   f,I I,ffi I,fi I,M I,’ I,I I  fI   ’I   -I   MI  OI   fiI   6I jeopallidum /ightpallidum H“%  Figure   5: Volume data. Journal of Healthcare Engineering   7 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nof absolute drug use, which means that the data processing cannot be used to calculate or compare absolute drug use across patients. In this case, we are still able to assess the relative importance of drugs in different modalities. In the previously mentioned example, the absolute number of days of drug D use for patient A is less than the absolute number of days for patient B, and patient A has a longer duration of use than patient B after the extension. -is suggests that drug D plays a more important role in the treatment of patient A than in the treatment of patient B. Based on the desensitized data, we extracted the medication information from the electronic medical record text. In this process, we paid at- tention to both the duration and frequency of medication administration. -e occurrence of drug names in a patient’s treatment record was the format of frequency and duration. However, based on physician recommendations in this data experiment, we ignored the frequency of medications used during the day because the frequency is always related to the extent of disease and the dose of the medication, which is less important for clinical pathways and medication treatment planning. -erefore, for each patient, the processed elec- tronic medical record data were in the form of a time- stamped medication list.  4.2. Results of Care Strategies for Hemodialysis Patients.  -e coefficients of variation of the importance of the in- dicators at all levels of the first round of expert consultation fluctuated from 0.00% to 20.94%, the coefficients of variation of feasibility fluctuated from 7.93% to 32.17%, and the Kendal coefficients of harmony fluctuated from 0.129 to 0.263. -e coefficients of variation of the importance of indicators at all levels of the second round of expert con- sultation fluctuated from 0.00% to 21.22%, the coefficients of variation of feasibility fluctuated from 0.00% to 24.77%, and the coefficients of Kendal harmony fluctuated from 0.301 to 0.460. -e experts suggested that if the patients do not comply with the healthcare instructions and self-monitoring, there should be corresponding supervisory measures instead of simply providing some instructions to the patients. -ere- fore, combined with the expert’s opinions and the discussion of the group, the following modifications were made. -e platform can automatically detect whether patients view and learn health guidance, and if patients do not complete health guidance learning, the platform can remind patients to learn until they finish. -e report will be sent to the community healthcare, who will contact the patient or family for supervision. If the patient does not self-monitor on time, the patient will be reminded to upload. If the patient has not been recorded for a long time, the platform can report to the community healthcare, and the community healthcare will supervise. When patients view and study medical guidance on time, regularly conduct health self-assessment, self-monitor daily on time, and read health information, kidney circle release news, and so on, they can get the corresponding points reward, monthly for the top patients to give encouragement, or certain material rewards, to enhance the user’s enthusi- asm and user stickiness to use the extended care information platform. Some experts suggest that the exercise situation of patients should be evaluated regularly. Targeted exercise guidance should be provided according to the exercise sit- uation of patients, so the “A2-7 exercise evaluation” can be added. -e exercise situation of patients can be evaluated regularly by combining subjective and objective methods. -e corresponding exercise prescriptions can be formulated for patients according to the evaluation results, as shown in Figure 7. Based on the assessment results, the corresponding exercise prescriptions will be formulated for patients, as shown in Figure 8. Analysing Figure 8, compared with traditional method 1 and traditional method 2, the acceleration ratio and parallel efficiency of the method in this paper are higher. In case of increasing the number of cores, traditional method 1 computation time increases instead, leading to a sig- nificant reduction in overall parallel efficiency, which is mainly because traditional method 1 does not chunk the health data stream, leading to an increase in communi- cation overhead. When traditional method 2 is used, al- though the computation time decreases to a certain extent and the acceleration ratio increases to a certain extent when the number of cores increases, the reduction in parallel efficiency is significantly better than that of tra- ditional method 1, and the overall computation perfor- mance is significantly inferior to that of this paper. Using this paper’s method can greatly reduce the parallel com- putation time while achieving a good acceleration ratio and parallel efficiency, and the parallel computation time is significantly reduced when the number of cores increases, mainly because this paper’s method processes the health data stream in chunks, reduces the data scale and con- dition number, enhances data convergence, reduces the communication overhead, enhances the overall parallel computation efficiency, and has superior computational performance. Value2S2f Value2S2fi O   fI   fO   ’I   ’O   -I   -O I Qumber2of2item I,I I,’ I,M I,fi I,ffi f,I Horrelation2coeocient  Figure   6: Correlation coefficient between the scores of each item and the total score of the scale. 8   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n5. Conclusion  Given the disease factors and the special nature of dialysis treatment, maintenance haemodialysis often faces various physiological or psychological problems, and comprehen- sive and accurate extended care services are significant for prolonging patients’ survival, improving their prognosis, and enhancing their self-management ability and quality of life. In this study, we constructed the content of a mobile healthcare-based information platform for extended care of maintenance haemodialysis patients through extensive lit- erature reading, qualitative interviews, and expert corre- spondence method and explored how to provide intelligent extended care services for maintenance haemodialysis pa- tients by using mobile healthcare information technology and combining the hospital–community–home integrated extended   care   model.   -is   study   finalized   the   module content system of the mobile medical-based extended care information platform for maintenance haemodialysis pa- tients   through   the   expert   consultation   method,   which contains three primary indicators, 18 secondary indicators, and 82 tertiary indicators. -e experts consulted had high professional representativeness and authority, they were well-motivated, and their opinions were coordinated and concentrated. -e module content, thus constructed, was scientific and reliable, which provided a basis for the next development of the information platform and the promo- tion of the R&D results.  Data Availability  Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.  Conflicts of Interest  -e authors declare that there are no conflicts of interest.  Authors’ Contributions  All authors approved the publication of the manuscript.  References  [1] L. Moja, H. Polo Friz, M. Capobussi et al., “Effectiveness of a hospital-based   computerized   decision   support   system   on clinician recommendations and patient outcomes,”   JAMA Network Open , vol. 2, no. 12, p. e1917094, 2019. [2] H. -abit and R. Hovorka, “Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non-critical care settings,”   Diabetic Medicine , vol. 35, no. 4, pp. 460–471, 2018. [3] L. Timotijevic, C. E. Hodgkins, and A. Banks, “Designing a mHealth clinical decision support system for Parkinson’s disease: a theoretically grounded user needs approach,”   BMC Medical Informatics and Decision Making , vol. 20, no. 1, pp. 34–21, 2020. [4] M. M. Paulsen, I. Paur, J. Gjestland et al., “Effects of using the MyFood decision support system on hospitalized patients’ nutritional status and treatment: a randomized controlled trial,”   Clinical Nutrition , vol. 39, no. 12, pp. 3607–3617, 2020. [5] S. Desmedt, A. Spinewine, M. Jadoul, S. Henrard, D. Wouters, and O. Dalleur, “Impact of a clinical decision support system for drug dosage in patients with renal failure,”   International Journal of Clinical Pharmacy , vol. 40, no. 5, pp. 1225–1233, 2018. [6] Y. F. Chen, C. S. Lin, C. F. Hong, D. J. Lee, C. Sun, and H. H. Lin, “Design of a clinical decision support system for predicting erectile dysfunction in men using NHIRD dataset,”  IEEE Journal of Biomedical and Health Informatics , vol. 23, no. 5, pp. 2127–2137, 2018. [7] A. A. Vinks, R. W. Peck, M. Neely, and D. R. Mould, “De- velopment and implementation of electronic health record- integrated model-informed clinical decision support tools for the precision dosing of drugs,”   Clinical Pharmacology & erapeutics , vol. 107, no. 1, pp. 129–135, 2020. [8] M. T. Khan, S. Qamar, and R. R. Sinha, “Discussing the role of data mining in development of evidence based decision support system for e-healthcare,”   International Journal of 1.0 0.8 0.6 0.4 0.2 0.0 2   4   6   8 10   2 4 6 8 10 Time (s) Flow Response value  Figure   8: Load balancing response spectrum. 5   10   15   20   25   30 –3 –2 –1 0 1 2 3 Number of levels Degree of freedom  W χ 2  P  Figure   7: Degree of coordination.  Journal of Healthcare Engineering   9 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nApplied Engineering Research , vol. 12, no. 16, pp. 5540–5549, 2017. [9] B. Xue, D. Li, C. Lu et al., “Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications,”   JAMA Network Open , vol. 4, no. 3, p. e212240, 2021. [10] L. Shahmoradi, R. Safdari, H. Ahmadi, and M. Zahmatkeshan, “Clinical decision support systems-based interventions to improve medication outcomes: a systematic literature review on features and effects,”   Medical Journal of the Islamic Re- public of Iran , vol. 35, no. 1, pp. 197–212, 2021. [11] K. Palmer, A. Marengoni, M. J. Forjaz et al., “Multimorbidity care model: recommendations from the consensus meeting of the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS),”   Health Policy , vol. 122, no. 1, pp. 4–11, 2018. [12] X. Li, S. Yu, Z. Zhang et al., “Predictive modeling of hypo- glycemia for clinical decision support in evaluating outpa- tients with diabetes mellitus,”   Current Medical Research and Opinion , vol. 35, no. 11, pp. 1885–1891, 2019. [13] A. Wong, M. G. Amato, D. L. Seger et al., “Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit,”   BMJ Quality and Safety , vol. 27, no. 9, pp. 718–724, 2018. [14] J. E. Flythe, T. Hilliard, E. Lumby et al., “Fostering innovation in symptom management among hemodialysis patients: paths forward for insomnia, muscle cramps, and fatigue,”   Clinical Journal of the American Society of Nephrology , vol. 14, no. 1, pp. 150–160, 2019. [15] Z. Niazkhani, E. Toni, M. Cheshmekaboodi, A. Georgiou, and H. Pirnejad, “Barriers to patient, provider, and caregiver adoption and use of electronic personal health records in chronic care: a systematic review,”   BMC Medical Informatics and Decision Making , vol. 20, no. 1, p. 153, 2020. [16] G. Demiris, S. J. Iribarren, K. Sward, S. Lee, and R. Yang, “Patient generated health data use in clinical practice: a systematic   review,”   Nursing   Outlook ,   vol.   67,   no.   4, pp. 311–330, 2019. [17] M. E. Regan, “Implementing an evidence-based clinical de- cision support tool to improve the detection, evaluation, and referral patterns of adult chronic kidney disease patients in primary care,”   Journal of the American Association of Nurse Practitioners , vol. 29, no. 12, pp. 741–753, 2017. [18] T. J. Loftus, A. C. Filiberto, Y. Li et al., “Decision analysis and reinforcement learning in surgical decision-making,”   Surgery , vol. 168, no. 2, pp. 253–266, 2020. [19] P. A. Rochon and J. H. Gurwitz, “-e prescribing cascade revisited,”   e Lancet , vol. 389, no. 10081, pp. 1778–1780, 2017. [20] F. O. Finkelstein and M. W. Foo, “Health-related quality of life and adequacy of dialysis for the individual maintained on peritoneal dialysis,”   Peritoneal Dialysis International , vol. 40, no. 3, pp. 270–273, 2020. [21] L. Galbraith, C. Jacobs, B. R. Hemmelgarn, M. Donald, B. J. Manns, and M. Jun, “Chronic disease management in- terventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis,”   Nephrology Dialysis Transplantation , vol. 33, no. 1, pp. 112–121, 2018. [22] M. R. Marshall, A. C. Vandal, J. R. de Zoysa et al., “Effect of low-sodium versus conventional sodium dialysate on left ventricular mass in home and self-care satellite facility he- modialysis patients: a randomized clinical trial,”   Journal of the American Society of Nephrology , vol. 31, no. 5, pp. 1078–1091, 2020. 10   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License',0.11053028952467635,'[\"%ormal2care\", \"&\", \"(\", \"(4).\", \"(5)\"]','2025-11-29 17:09:46.834597'),(80,3,'Biofabrication  PAPER • OPEN ACCESS  A novel extrusion-based 3D bioprinting system for skeletal muscle tissue engineering  To cite this article: E Fornetti et al 2023 Biofabrication 15 025009  View the article online for updates and enhancements.  You may also like  Pillar electrodes embedded in the skeletal muscle tissue for selective stimulation of biohybrid actuators with increased contractile distance Tingyu Li, Minghao Nie, Yuya Morimoto et al. - Skyrmion based majority logic gate by voltage controlled magnetic anisotropy in a nanomagnetic device Bibekananda Paikaray, Mahathi Kuchibhotla, Arabinda Haldar et al. - Engineering strategies for the construction of oriented and functional skeletal muscle tissues Tingting Fan, Minxuan Jia, Heng Liu et al. -  This content was downloaded from IP address 38.255.109.85 on 12/04/2025 at 23:54\nBiofabrication   15   (2023) 025009   https://doi.org/10.1088/1758-5090/acb573  Biofabrication  OPEN ACCESS  RECEIVED  27 June 2022  REVISED  16 December 2022  ACCEPTED FOR PUBLICATION  23 January 2023  PUBLISHED  3 February 2023 Original content from this work may be used under the terms of the Creative Commons Attribution 4.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.  PAPER  A novel extrusion-based 3D bioprinting system for skeletal muscle tissue engineering  E Fornetti 1  , F De Paolis 1,2 , C Fuoco 1 , S Bernardini 1 , S M Giannitelli 3 , A Rainer 3,4  , D Seliktar 5 , F Magdinier 6 , J Baldi 7 , R Biagini 7 , S Cannata 1 , S Testa 6, ∗   and C Gargioli 1, ∗  1   Department of Biology, University of Rome ‘Tor Vergata’, Rome, Italy  2   PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome ‘Tor Vergata’, Rome, Italy  3   Department of Engineering, Universit ` a Campus Bio-Medico, Rome, Italy  4   Institute of Nanotechnology (NANOTEC), National Research Council, Lecce, Italy  5   Department of Biomedical Engineering, Techion Institute, Haifa, Israel  6   Aix-Marseille University, INSERM, MMG, Marseille Medical Genetics, Marseille, France  7   IRCCS Regina Elena National Cancer Institute, Rome, Italy  ∗   Authors to whom any correspondence should be addressed.  E-mail: stefano.testa@univ-amu.fr   and   cesare.gargioli@uniroma2.it Keywords:   3D bioprinting, skeletal muscle tissue engineering, muscle reconstruction, VML, PEG-fibrinogen Supplementary material for this article is available online  Abstract  Three-dimensional (3D) bioprinting is an emerging technology, which turned out to be an optimal tool for tissue engineering approaches. To date, different printing systems have been developed. Among them, the extrusion-based approach demonstrated to be the most suitable for skeletal muscle tissue engineering, due to its ability to produce and deposit printing fibers in a parallel pattern that well mimic the native skeletal muscle tissue architecture. In tissue bioengineering, a key role is played by biomaterials, which must possess the key requisite of ‘printability’. Nevertheless, this feature is not often well correlated with cell requirements, such as motives for cellular adhesion and/or absorbability. To overcome this hurdle, several efforts have been made to obtain an effective bioink by combining two different biomaterials in order to reach a good printability besides a suitable biological activity. However, despite being efficient, this strategy reveals several outcomes limitations. We report here the development and characterization of a novel extrusion-based 3D bioprinting system, and its application for correction of volumetric muscle loss (VML) injury in a mouse model. The developed bioprinting system is based on the use of PEG-Fibrinogen, a unique biomaterial with excellent biocompatibility, well-suited for skeletal muscle tissue engineering. With this approach, we obtained highly organized 3D constructs, in which murine muscle progenitors were able to differentiate into muscle fibers arranged in aligned bundles and capable of spontaneously contracting when cultured   in vitro . Furthermore, to evaluate the potential of the developed system in future regenerative medicine applications, bioprinted constructs laden with either murine or human muscle progenitors were transplanted to regenerate the   Tibialis Anterior   muscle of a VML murine model, one month after grafting.  1. Introduction  In the last two decades, three-dimensional (3D) bioprinting has been widely employed in tissue engin- eering strategies. The possibility to build constructs with a spatially designed distribution of matrix and cells and the high reproducibility of these structures makes 3D bioprinting an excellent tool to produce and study artificial tissues. The extrusion-based 3D bioprinting systems proved to be particularly effective in obtaining artificial skeletal muscle tissues [1]. The continuous and controllable deposition of printing fibers loaded with muscle progenitors and the pos- sibility to arrange densely and evenly aligned fibers allows to reproduce the typical architecture of nat- ive skeletal muscle tissue, which is essential for the  © 2023 The Author(s). Published by IOP Publishing Ltd\nBiofabrication   15   (2023) 025009   E Fornetti   et al  tissue functionality [2]. Moreover, muscle progen- itor cells within the printing fiber are forced to fuse and elongate along the printing direction by both the shear stress occurring in the printing nozzle and the confinement of cells in a limited space [3, 4]. As a result, this method allows generating highly organ- ized artificial muscle constructs even in absence of external stimuli, such as mechanical stretching or electric stimulation. A key role is played by bioma- terials in this process, in particular hydrogels, and their capability of transitioning from liquid to gel in a cell-safe manner. This quality, so called ‘print- ability’, is mainly dependent on the hydrogel viscos- ity and crosslinking time [5, 6]. Several biomaterials share these features and are employed in extrusion- based bioprinting. Widely employed hydrogels in tis- sue engineering are among others alginate [7], able to instantly polymerize upon bivalent ions expos- ure; chitosan [8], providing many biological pro- prieties including the ability to interact with cell membrane and controllable degradation; and colla- gen type I, known to improve cellular attachment and growth [9]. However, mentioned biomaterials own some limitations: while alginate is biologically inert and has a limited biodegradability, chitosan has a poor post-printing shape fidelity and colla- gen type I polymerizes at high temperatures and its complete gelation can take more than 30 min [10]. To overcome these hindrances, most of the current extrusion-based printing system are based on a com- bination of two biomaterials, one having appropri- ate printability (commonly alginate), which is cru- cial during the printing process, and the other with desirable biocompatibility (commonly fibrin-based hydrogels or gelatin), fundamental in sustaining the biological processes required for cell proliferation and differentiation [11, 12]. While demonstrating great efficiency in producing highly organized structures  in vitro , this approach often requires removal of the printable material with chelating agents or specific enzymes to allow cellular physiological processes and  in vivo   integration [13]. PEG-Fibrinogen   (PF)   is   a   hybrid   hydrogel obtained by the combination of PolyEthylene Glycol (PEG) with denatured fibrinogen molecules that already demonstrated to be an excellent biomimetic matrix for skeletal muscle tissue engineering both  in vitro   and   in vivo   [14–16]. In fact, this hydrogel is characterized by a high biocompatibility, being enriched with cell adhesion domains and proteolytic enzymes targets, which ensure its integration, remod- eling and absorption   in vivo   [17]. However, the poly- merization process for this photocurable hydrogel is hardly compatible with the concept of printability, occurring relatively long time of UV exposure for the transition from liquid to gel state [18]. Here we report an innovative extrusion-based 3D bioprinting system exploiting PF, which properties demonstrated to be highly suitable for skeletal muscle differentiation. In particular, we developed a print- ing system able to drastically reduce the UV expos- ure time, allowing to use PF as bioink single com- ponent matrix. Moreover, this system presents a high resolution of the printing fibers (around 100   μ m), a high efficiency in skeletal muscle differentiation and organization   in vitro,   and remarkable biocompatibil- ity   in vivo . All the bioprinter components were stud- ied and optimized to obtain a 3D architecture closer as possible to the native organization of the skeletal muscle tissue, with bundles of fibers evenly orient- ated toward printing direction. The general morpho- logy of the construct was maintained throughout the experimental time thanks to the special stainless- steel supports, specifically designed for the presented biotechnology. The set-up for the printing system was conduc- ted using a murine source of muscle progenitors, the mesoangioblast (Mabs), which possess high myo- genic capabilities both   in vitro   and   in vivo   [14, 15]. Once demonstrated the validity of this system, a human source of muscle progenitors, the muscle- derived human mesenchymal stem cells (hMSCs) [19, 20] was tested in   in vivo   experiments, demon- strating that the described 3D bioprinting system could be a valuable tool for regenerative medicine approaches.  2. Materials and methods  2.1. Cell culture and bioink formulation  Mouse   mesoangioblasts   (Mabs)   were   transduced with   third-generation   lentiviral   vectors   encoding the reporter gene nuclear   β -galactosidase (nLacZ) as previously described [14]. Cells were cultured on Petri dishes (Falcon) at 37   ◦ C with 5% CO 2  in DMEM GlutaMAX (Gibco) supplemented with heat-inactivated   10%   fetal   bovine   serum   (Euro- clone), penicillin (100 IU ml − 1 , Gibco), streptomy- cin (100 mg ml − 1 , Gibco). hMSCs were isolated from skeletal muscle biopsies following a protocol that involves mechanical mincing, enzymatic digestion with type II collagenase, filtration, and selection of the colonies on plastic surface at low confluence, as pre- viously described [19]. Human progenitors were cul- tured on Petri dishes (Falcon) at 37   ◦ C with 5% CO 2  in Cyto-Grow medium (Resnova) supplemented with penicillin (100 IU ml − 1 , Gibco) and streptomycin (100 mg ml − 1 , Gibco). Skeletal muscle biopsies were obtained from healthy donors following informed consent in line with the guidelines of the Helsinki declaration on Human rights. For bioink formulation, muscular progenitors (Mabs or hMSCs) were resuspended to a final con- centration of 2   ×   10 7   cells ml − 1   in a solution of PF, (8 mg ml − 1 ) in phosphate buffered saline (PBS) and 0.1% w v − 1   Irgacure 2959 was added to the bioink 2\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 1.   Schematic representation of the 3D bioprinting and bulk polymerization processes. Muscle progenitors of either murine or human origin are combined with photocurable PEG-fibrinogen (PF) at a concentration of 2   ×   10 7   cells ml − 1 . In the 3D bioprinting system, a custom-made syringe pump system (1) pushes the bioink loaded into a syringe through a transparent PTFE microtube in a controllable manner (2). The passage of the microtube inside a low penetrance UV lamp allows the bioink to be exposed to the UV rays for a total of about 8 s (3), which are sufficient to promote bioink polymerization. The cellularized printing fiber extruded through the microtube is finally wrapped around a rotating C-shaped stainless-steel support (4) in order to obtain a bundle of fibers replicating the skeletal muscle native architecture (5). In bulk polymerization, the solution of PF and cells is poured into the Teflon mold in which the C-shaped support is wedged (1). After 5 min UV rays exposure (2), a cellularized bulk construct with the same dimension of the 3D bioprinted construct is obtained (3, 4). Scale bar: 1 cm.  as radical photoinitiator. Irgacure2959 was chosen as photoinitiator of the polymerization reaction due to its low cell toxicity, good performance in photocross- linking hydrogels, and the ability to be solubilized in the aqueous hydrogel precursor solution [21, 22].  2.2. Bioprinting system and 3D constructs culture  For this work, a custom-made 3D bioprinter was designed and manufactured. This novel extrusion- based printing system allows to employ PF as only biomaterial of the bioink, and to obtain printing fibers with a high resolution (105   ±   9   μ m) form- ing muscle bundles-like constructs of considerable dimension (4   ×   0.2   ×   0.2 cm 3 , figure 1). The core of the system is composed by the printing head that has been optimized to allow the quick polymerization of the bioink (8 s of UV exposure), which occurs during the liquid flow in the inner circuit (a low-attachment PTFE microtube, Ø 300   μ m). Liquid bioink is pushed in the circuit by a custom-made syringe pump system at a flow rate of 100   μ l min − 1 . With these parameters, the extrusion printer has a yield of 60 cm min − 1   of printed fiber. The diameter of the extruded printing fiber (300   μ m, corresponding to the diameter of the inner circuit) is further reduced by the tensile force generated by the rotation of a stainless-steel support (video S1). The C-shape of the support (figure 1) was studied to allow the deposition of parallel, dense and evenly aligned printing fibers with an architec- ture that closely resembles the native striated muscle bundles. Moreover, an oscillatory ‘forward-reverse’ movement ensures the uniform layer-by-layer distri- bution of the fibers on the support. The actuation of the printer is provided by stepper motors controlled by an Arduino Uno [www.arduino.cc] microcontrol- ler board. Bulk constructs as experimental control were obtained using a Teflon mold with the same dimen- sions of the printing constructs (4   ×   0.2   ×   0.2 cm 3 ). In   particular,   the   C-shaped   support   was   placed in the   mold and   the liquid bioink was   poured in the cavity and polymerized for 5 min, accord- ing   to   the   time   frame   defined   during   previous optimization [11, 13, 14] under a UV radiation of 365 nm (figure 1). In both bulk and 3D bioprin- ted constructs production, the time of exposure to 3\nBiofabrication   15   (2023) 025009   E Fornetti   et al  UV rays needed for PF polymerization demonstrated not to affect cell viability, as attested through the Live/Dead Cell Viability Assay Kit (Sigma-Aldrich, figure S1). This analysis also allowed to clarify that the printing process itself does not compromise the sur- vival of the cells included in the bioink. Bulk and 3D bioprinted constructs were kept in culture in the presence of growth medium and no spe- cific differentiation factors were added as both Mabs and hMSCs are able to spontaneously form myotubes upon reaching 80% confluence. For   in vitro   analysis, constructs were cultured up to 30 d in order to achieve an adequate muscle differentiation. Alternatively, for  in vivo   analysis, constructs were implanted in mice models 48 h after polymerization.  2.3. Volumetric muscle loss (VML) model, implants, and sample preparation  The VML murine model was established as previ- ously described [11]. Briefly, two-month-old male SCID/Beige mice were anesthetized with an intra- muscular injection of a physiologic saline solution (10 ml kg − 1 ) containing ketamine (5 mg ml − 1 ) and xylazine (1 mg ml − 1 ). After anesthesia, a limited incision was performed on the medial side of the leg to reach the   Tibialis Anterior   (TA). Approximately 90% for mouse-on-mouse implants and 50% for human- on-mouse implants of the total TA muscle volume was removed leaving tendons intact, by using a caut- ery to avoid bleeding and to create a venue for the implant accommodation (figure S2). The pre-shaped 3D bioprinted construct containing either Mabs or hMSCs was placed (without being sutured) to fill the volume of the surgically ablation that created an ana- tomic niche and the skin was subsequently sutured. In the control mice, the contralateral TA was surgically ablated, but no construct was implanted. Analgesic treatment (Rimadyl, Pfizer, USA) was administered after the surgery to reduce pain and dis- comfort. Mice were sacrificed 30 d after implanta- tion for immuno-histological analyses. Experiments on animals were conducted according to the rules of good animal experimentation I.A.C.U.C. N o   432 of 12 March 2006, and under Italian Health Ministry Approval No. 271/2021-PR.  2.4. Sample sectioning and immunofluorescence analysis  At the given time point, 3D constructs were fixed with 4% PFA in PBS for 30 min at 4   ◦ C and subsequently analyzed through immunofluorescence either in whole-mount or after sectioning. The con- structs to be processed for sectioning were incubated in solutions with increasing sucrose concentrations (10%, 20% and 30%, 6 h for each concentration), in order to remove most of the water volume and avoid damage during inclusion. Eight micrometers sections were obtained using a Leica cryostat from either fixed constructs or fresh surgical explants through embedding in OCT resin and quick freezing in liquid nitrogen-cooled isopentane.   In vitro   and   in vivo  resulting samples were accordingly processed for immunofluorescence analysis as previously described [23, 24]. Briefly, samples were permeabilized with 0.3% Triton X-100 in PBS for 1 h at room temper- ature (RT) and blocked with a blocking solution con- sisting of 10% goat serum, 1% glycine, 0.1% Triton X-100 in PBS for 1 h at RT. Subsequently, samples were incubated with primary antibodies in blocking solution for 2 h at RT and then rinsed with a washing solution consisting of 1% BSA and 0,2% Triton X-100 in PBS. Primary antibodies were diluted as follows: mouse monoclonal anti-myosin heavy chain (MyHC) (MF20 clone supernatant, DSHB) 1:2, rabbit poly- clonal anti-desmin (Abcam) 1:100, rabbit polyclonal anti-laminin (Sigma-Aldrich) 1:200, mouse mono- clonal anti-Pax7 (supernatant, DSHB) 1:20, rab- bit polyclonal anti-pNF (BioLegend) 1:400, mouse monoclonal anti-SMA (Sigma-Aldrich) 1:100, rabbit polyclonal anti-vWF (Abcam) 1:100, mouse mono- clonal anti-Lamin A/C (Thermo Fisher Scientific) 1:200. After washing, cells were incubated with Alexa Fluor 555-conjugated goat anti-mouse IgG (H   +   L; Thermo Fisher Scientific, diluted 1:400) and 488- conjugated goat anti-rabbit IgG (H   +   L; Thermo Fisher Scientific, diluted 1:400) for 1 h. Finally, nuc- lei were stained with 300 nM DAPI (Thermo Fisher Scientific) in PBS for 30 min. When fluorescent- BTX staining was needed,   α -BTX Alexa Fluor 488- conjugated was added to the DAPI solution at a con- centration of 1:400. Samples were observed using a Nikon TE 2000 epifluorescence microscope equipped with a Photometrics Cool SNAP MYO CCD camera and images were acquired through MetaMorph® soft- ware (Molecular Devices, Inc.). Alternatively, images were acquired through a Nikon A1R laser scanning confocal microscope with the NIS software.  2.5. Image analyses  Image analyses were performed by using the Image- J/FIJI program. Briefly,   in vitro   characterization of spontaneous twitching at day 10 in the bulk and 3D bioprinted constructs was obtained by analyzing the single frames of the live-imaging videos. After prop- erly calibrating images, radial displacement during twitching with respect to a reference point of the image was measured using the Straight Line function [25]. Myofibers size (width and length) was calcu- lated on whole-mount immunofluorescence images using the Straight Line function after image calib- ration, while coherency was calculated by using the Orientation J plugin, as previously described [11]. To describe fibers density and orientation in the con- struct cross sections, magnified region of interest (ROI)s were converted in highly contrasted eight-bit images and threshold was applied to generate binary images. After setting the measurements of interest, nuclei area and fibers cross sectional circularity and 4\nBiofabrication   15   (2023) 025009   E Fornetti   et al  area were calculated through the   Analyze Particles  function.  2.6. Statistical analysis  All experiments were performed in biological and technical   triplicates.   Data   were   analyzed   using GraphPad Prism 5, and values were expressed as means   ±   standard error. Statistical significance was tested using a t-test, as only two conditions were com- pared. A probability of less than 5% ( p   <   0.05) was considered to be statistically significant.  3. Results  3.1.   In vitro   analysis of myofibers maturation, organization and homogeneity in bioprinted and bulk constructs  The effectiveness of the printing system in sustaining biological processes such as cellular adhesion, pro- liferation and differentiation was assessed by using murine mesoangioblasts (Mabs). Mabs were added to the bioink composed by PF, a photocurable hydro- gel combining natural and synthetic benefit [17]. The obtained bioprinted constructs were maintained in culture up to 30 d, in order to obtain fully differen- tiated muscle fibers (figure 2(A)). As a parallel exper- imental control, bulk constructs were polymerized using a Teflon mold with the same dimension of the printing construct (refer to Materials and Methods section, figure 1). In both cases, constructs were kept attached to the C-shaped supports throughout the duration of the experiment in order to have the same passive tension. Interestingly, the effect of shear stress caused by the printing process can be noted by the flat appearance of cells at Day 0 compared to the round shape of cells within the bulk construct (figure 2(A)). Starting from day 10, spontaneous twitching events were recorded in both conditions (video S2). Video frames were analyzed in order to identify any differ- ences in contractile properties in the two conditions. Radial displacement, which indicates the shift occur- ring during the contraction phase of a single twitch, was significantly higher (2.5-fold) in the bioprin- ted condition (figure 2(B) and S3). Moreover, a dif- ferent twitching directionality was observed, being parallel to the printing axis in the bioprinted con- struct while randomly oriented in the bulk con- struct (figure 2(B)). At later time points, because of massive spontaneous twitching and the movement of whole constructs, it was not possible to perform video frames quantitative analysis (video S3). At day 30, upon muscle differentiation, whole- mount   immunofluorescence   analysis   against   the muscular differentiation markers MyHC and desmin were performed on both bulk and bioprinted con- structs (figure 3(A)). Image analysis confirmed that PF provides a favorable microenvironment for the maintenance of Mabs, able to proliferate and fuse for producing large multinucleated muscle fibers in both conditions (figure 3(B)). The evidence of a better organization and a greater homogeneity in myofibers size in the bioprinted construct, was assessed by com- paring myofibers width, length and coherency in both conditions. Myofibers average width resulted slightly higher in the bioprinted constructs even if not in a statistically significant way (figure 3(C), left). However, the width distribution in the bioprinted construct appeared shifted towards larger dimen- sions and more peaked as compared to bulk curve (figure 3(C), right). Interestingly, a greater width of fibers could be an indication of a better maturation [26]. Moreover, myofibers average length was signi- ficantly higher (two-fold) in bioprinted constructs compared to bulk myofibers, as also confirmed by the shifted length distribution (figure 3(D)). Coher- ency, a parameter ranging from 0 to 1 and describing the orientation and isotropic properties of analyzed region [27], was found to be significantly higher (3.5- fold) in the bioprinted constructs, with a distribution showing a very pronounced single peak as compared to the flat bulk curve (figure 3(E)).  3.2. Analysis of differentiation and fiber alignment on constructs sections  Both bulk and bioprinted constructs were snap frozen for OCT casting to obtain cryo-sections. Immun- ofluorescence analysis confirmed the presence of desmin-positive and MyHC-positive myofibers in both conditions (figure 4(A), left). Interestingly, cells were able to produce their own extracellular matrix (ECM), as evidenced by the presence of laminin sur- rounding the fibers and indicating proper matura- tion (figure 4(A), right). Laminin production is espe- cially visible around centrally nucleated regenerating fibers in bioprinted construct sections (figure 4(A), enlargement). Moreover, significant differences were highlighted by the quantitative analysis of different parameters related to constructs architectural organ- ization. Cellular density, a measurement indicating the presence and the cells localization within the section, is significantly higher in the bioprinted con- struct reflecting a better distribution of myofibers, whereas in the bulk construct cells localized mainly in the outermost layer (figure 4(B)). Moreover, the cir- cularity and the cross-sectional area measured on the constructs sections resulted respectively higher and lower in the bioprinting condition, indicating the bet- ter alignment of myofibers along the construct longit- udinal axis (figure 4(C)). On the other hand, the bulk constructs showed a larger cross-sectional area but a lower circularity, as expected for myofibers not ori- ented in a single direction. (figure 4(D)).  3.3. TA volume recovery after murine bioprinted construct implantation  To assess the potentiality of the printing system in   regenerative   medicine   applications,   a   murine model   of   VML   was   employed   [11].   The   VML 5\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 2.   Bright field imaging of muscle differentiation time-course in cellularized constructs. (A) Timeline showing the different experimental stages with representative bright field images from the production of bioprinted constructs and bulk control (Day 0), to the end of the experiment (30 d), a sufficient time to obtain differentiated muscle fibers capable of contracting. From day 10, differentiated muscle fibers start to spontaneously twitch. Scale bar   =   100   μ m. (B) Time-lapse representative images obtained from spontaneous twitching video recordings showing the shift of a reference segment during contraction in fibers within either bulk or bioprinted constructs. Black arrows indicate the direction of the constructs longitudinal axis and highlight how twitching directionality is parallel to the printing axis in the bioprinted construct while randomly oriented in the bulk construct.  model was obtained by massively ablating (90%) the TA of the mouse hind legs, in order to pre- vent   the   natural   healing   process   of   the   muscle [14]. 3D bioprinted constructs, obtained from nuc- lear LacZ Mabs (nLacZ-Mabs) [15], were placed in the anatomical space created by TA removal and the implant was allowed to integrate within the host muscle for 30 d. In the control mice, the TA muscle tissue was ablated without being replaced with the artificial construct. After sacrifice, 6\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 3.   Immunofluorescence analysis on bulk and 3D bioprinted constructs. (A) Confocal large-scale images showing the reconstruction of constructs large areas. Scale bar: 400   μ m. (B) Magnified images of differentiated muscle fibers expressing the muscle differentiation markers MyHC and Desmin. Scale bar: 100   μ m. (C) Myofibers width analysis, although not statistically significant in the two conditions, showing a distribution shifted towards larger dimensions and more peaked for the bioprinted constructs. ( n   =   9 analyzed fields from 3 independent experiments per condition, a minimum of 50 myofibers per field were analyzed). (D) Myofibers length analysis, displaying a significant increased length in the bioprinted structures, as confirmed by the shifted distribution ( n   =   9 analyzed fields from three independent experiments per condition, a minimum of 15 myofibers per field were analyzed). (E) Coherence analysis, describing the degree of myofibers alignment, being significantly higher in the bioprinted construct, as also shown in the very pronounced single peak distribution.   ∗∗∗ p   <   0.0008.   ∗∗ p   <   0.0019. Statistical significance was tested using a Student’s   t -test.  ablated and implanted TAs were collected and ana- lyzed through immunofluorescence analysis against laminin and MyHC, while LacZ-positive nuclei were identified by means of X-Gal labeling. The obtained cross sections images revealed the complete recov- ery of the tissue area in the implanted TA as com- pared to control, which conversely displayed a poor and   deficient   tissue   restoration   (figure   5(A)).   A large number of LacZ-positive nuclei were labeled within the centrally nucleated muscle fibers in the reconstructive   tissue,   which   demonstrated   to   be well organized (figure 5(B) and S4). Reconstruc- ted tissue deriving from the implanted constructs demonstrated to be properly vascularized, as high- lighted by the area enriched in LacZ-positive nuclei showing positive signal for smooth muscle actin (SMA) and von Willebrand factor (vWF), labeling vessel   muscle   wall   and   endothelium   respectively (figure 6(A)). Moreover, the reconstructed myofibers presenting LacZ-positive nuclei have been shown to be innervated, as demonstrated by the positive labeling of neural pre- and post-synaptic structures by immunostaining with phospho-neurofilament (pNF) and alpha-bungarotoxin (BTX), demonstrating the development of neuromuscular junctions within the regenerating TA muscle, after implantation of 3D constructs (figure 6(B)). Pax7-positive satellite cells were observed in the TA area reconstructed by nLacZ- Mabs, indicating the reestablishment of the stem cell niche required for muscle regeneration (figure 6(C)). 7\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 4.   Analysis of the constructs cross sections. (A) Cross sections of bulk and bioprinted constructs confirming the expression of the muscle differentiation markers MyHC and desmin (left) and the production of laminin-positive extracellular matrix (right), which is particularly noticeable around centrally nucleated transverse fibers in the bioprinted construct (enlargements). Left scale bar: 200   μ m, right scale bar: 100   μ m. Cellular density (B), which is expressed through nuclei percentage area, and alignment (C), which is expressed through circularity, resulted significantly higher in the bioprinted condition. Moreover, myofibers cross sectional area (D) resulted significantly higher in the control, as a result of a greater myofibers inclination.  ∗∗ p   <   0.0041.   ∗∗∗ p   <   0.0001.   ∗ p   <   0.0296. Statistical significance was tested using Student’s   t -test.  8\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 5.   Immunofluorescence analysis on ablated and implanted murine TAs. (A) Cross sections images analyzed through immunofluorescence analysis against laminin and MyHC revealed a complete area recovery of the TA implanted with the nLacZ-Mabs-laden bioprinted construct as compared to the ablated control. Scale bar: 400   μ m. (B) Magnified images of the area dashed in A showing LacZ-positive nuclei, labeled by X-Gal assay. Scale bar: 100   μ m.  Figure 6.   Higher magnifications analysis of the area regenerated by nLacZ-Mabs in 3D bioprinted constructs. (A) Immunofluorescence analysis against vessels-specific markers SMA and vWF indicate proper vascularization of the regenerating area. (B) Labeling by means of immunofluorescence for the pre- and post-synaptic neural markers pNF and BTX, targeting neurons cytoskeleton and muscular acetylcholine receptors, respectively. White arrowheads highlight developing fibers with central LacZ-positive nuclei showing host nerve terminals. (C) Pax7-positive satellite cells indicated by white arrowheads detected in LacZ-positive nuclei-rich area. Scale bar: 50   μ m.  9\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 7.   Immunofluorescence analysis on cross sections from murine TA implanted with hMSCs-laden bioprinted construct. (A) Immunostaining for laminin, MyHC and Lamin A/C on adjacent sections revealing a large reconstructed area derived from the xenograft. Dotted lines indicate interface between host native muscle and human-derived area. Scale bar: 400   μ m. (B) Magnified images of the dashed region in A showing MyHC-positive areas co-localizing with Lamin A/C-positive human nuclei. Scale bar: 100   μ m.  3.4. TA volume recovery after human bioprinted construct implantation  In order to evaluate the possibility to translate the proposed approach in human studies, pilot exper- iments   have   been   performed   exploiting   muscle- derived hMSCs-laden bioprinted constructs. For this purpose, constructs with human cells were implanted in the mouse hind limb upon 50% TA muscle abla- tion, similarly to the above-described experiment. After 30 d, tissues were collected and analyzed by means of immunofluorescence. Cross sections of the explanted TA show two distinct areas, one being the host native muscle and the other one resulting from the human-derived bioprinted implant (figure 7(A)). Although the tissue developed from the xenograft seems   overall   less   organized   compared   with   the murine-derived implants (figure 5), the large MyHC- positive area co-localizing with numerous human Lamin A/C (Lam A/C)-positive nuclei indicate that the reconstructed muscular tissue is from human ori- gin and that hMSCs were able to generate myofibers integrating with host ablated TA (figure 7(B)). Inter- estingly, a deeper analysis of the reconstructed TA tissue showed more organized areas with transverse small muscle fibers that in the contiguous section proved to be centrally nucleated and Lamin A/C- positive (figure 8(A)). Tissue reconstituted from the human-derived implant has shown also to be prop- erly vascularized and innervated, as highlighted by the positive signal revealed by vessels- (SMA and vWF) and neural-specific (pNF and BTX) markers (figures 8(B) and (C)). Moreover, the presence of 10\nBiofabrication   15   (2023) 025009   E Fornetti   et al  Figure 8.   Higher magnification analyses of the reconstructed TA area derived from human cells. (A) Transverse MyHC-positive myofibers that in the contiguous section proved to be centrally nucleated and Lamin A/C-positive, as indicated by white symbols. Vascularization (B), innervation (C) and stem cell niche (D) in the reconstructed muscular tissue derived from human bioprinted constructs are highlighted by the positivity for specific markers. The correspondence of the specific markers with the human Lamin A/C-positive nuclei is highlighted by white asterisks in two continuous sections. Scale bar: 30   μ m.  Pax7-positive satellite cells was observed in the peri- phery of some fibers, thereby suggesting the regener- ative potential of the reconstructed TA (figure 8(D)).  4. Discussion  To date, 3D bioprinting approach is gaining more and more interest for its ability to produce cellularized 3D constructs with a well-defined architecture closely replicating tissue organization in a quick and highly reproducible manner [28–31]. However, regardless of the printing system, this target often proves chal- lenging. Indeed, the technical requirements of 3D printing combined with the necessity for a biocom- patible cellular scaffold force researchers to find a compromise in formulating bioink between what is convenient for the machine and what is suitable for cell survival, proliferation and differentiation. Several research groups have faced these hurdles, investig- ating different strategies based on multi-component bioinks and/or multi-step polymerization processes. In particular, good outcomes have been obtained with PEG-Chitosan, Gelatin and porcine decellular- ized ECM [28, 30, 31]. However, existing approaches often require a difficult set-up involving considerable changes of temperature during the extrusion process and the combination of chemical/physical polymeriz- ation of the bioink, while at the same time not provid- ing a resolution of less than 300   μ m. Our team also focused its efforts on this direc- tion, basing the bioink formulation on the combin- ation of alginate and PF, in order to exploit alginate printability together with PF biological compatibility. With this approach, the bioink was transiently retic- ulated during the printing process by exposing the alginate to a covalent ions solution, while irreversible polymerization was achieved in a second step by UV exposure that acts on PF molecules. Subsequently, the alginate was removed from the scaffold with a calcium chelating agent or an alginase enzyme solu- tion. This technique demonstrated optimal outcomes  in vitro , allowing differentiation of muscle progenitor cells and production of highly organized muscle con- structs. However, in VML regeneration experiments, alginate residues remained in the constructs affected the quality of the resulting muscle [11, 13]. In an attempt to overcome these limitations, this work further described a novel and versatile alginate- free and extrusion-based 3D bioprinting system. The development of the proposed printing system is based on the characteristics of PF, a hydrogel able to sus- tain growth and differentiation of skeletal muscle cells both   in vivo   and   in vitro   [15, 16]. In this way, instead of formulating the right biomaterial according to the printing system features, priority was given to the cell physiological requirements. Initially, PF physical properties did not seem compatible with a printing system based on the use of this hydrogel only, as the polymerization time is relatively long (5 min of UV rays exposure). For this reason, the printer features have been customized in order to drastically reduce the PF polymerization time to 8 s, allowing a rapid and cell-friendly printing process. Another strength of the presented bioprinter is the C-shaped stainless- steel support, specifically designed to allow the pro- duction of 3D constructs composed by fibers bundles 11\nBiofabrication   15   (2023) 025009   E Fornetti   et al  similar to the skeletal muscle tissue architecture. The use of a linear support allows to collect the printing fibers in highly aligned lines between the two pins and to produce an elongated bundle, representing an improvement over the circular constructs obtained with cylindrical supports [11]. Notably, rotation of the C-shaped support pulls the printing fibers and leads to an increase of the printing resolution to 100   μ m (1/3 of the extruder microtube diameter). Moreover, a translational ‘forward-reverse’ move- ment allows the layer-by-layer deposition of print- ing fibers on the support, so as to recapitulate muscle organization. The potential of the PF-based bioprinting sys- tem in supporting the biological processes needed for muscle differentiation has been evaluated using murine mesoangioblasts (Mabs) as the source of muscle progenitors [15]. Our results confirmed PF as an ideal scaffold for the growth, differentiation and maturation of muscle fibers, which have been shown to be able to twitch spontaneously both in bioprinted and bulk condition. A difference in the myofibers overall organization between the two conditions emerged from the first brightfield ana- lyses, and the formation of differentiated and aligned myofibers in the bioprinted constructs demonstrated to be necessary to the coherent muscle bundles con- traction. Moreover, with the aim of identifying differ- ences in the contracting behavior of myofibers within bulk and bioprinted constructs, we recorded and described a greater radial displacement during the contraction phase of the bioprinted myofibers. Tak- ing into account the relationship between myofibers size and their ability to generate force [32], we specu- late this result might indicate an ability to produce a greater amount of force as compared to the twitch- ing myofibers of the bulk construct. Shear stress and geometric confinement induced by 3D bioprint- ing confirmed to have an influence on the elonga- tion and alignment of homogeneous muscle fibers. Moreover, cross sections showed how bioprinting promotes a more homogeneous myofibers distribu- tion within the construct as compared to the bulk condition, in which muscle fibers are arranged only in the most external layer. We speculate that this phe- nomenon could be the result of an improved oxygen and medium perfusion through the space between the printing fibers. Relying   on   the   encouraging   results   obtained  in vitro , we proceeded investigating the capability of the constructs obtained with the proposed bioprint- ing system in restoring a VML in a murine model. VML, resulting from severe trauma or sarcomas sur- gical ablation, is a pathological condition that pre- vents the regeneration of skeletal muscle, as it owns considerable ability to repair tissue damage but only when limited in size [33]. Unfortunately, currently adopted surgical therapies do not yet provide sat- isfactory results. To date, one of the most widely employed clinical strategy for the treatment of VML trauma is the implantation of acellularized scaf- folds composed by ECM often derived from nat- ural sources (e.g. porcine urinary bladder-derived ECM). However, the functional recovery is limited, making this reconstructive therapy inadequate [24]. For this reason, an increasing attention is being paid to skeletal muscle tissue engineering as a promising approach. In our experiments, 3D bioprinted Mabs-laden constructs lead to a full restoration of the lost muscle volume 30 d after grafting. The acellular PF bioprin- ted construct was not employed as experimental con- trol for implantation experiments, as it has already well demonstrated to be completely reabsorbed by the host organism in previous papers [11, 14]. The wide implantation of Mabs in the regenerating tissue (figure S4) indicates an active role of the implant not only in the regeneration of muscle fibers, but also in driving the recruitment of all the biological elements required for implant survival and for proper develop- ment of a functional muscle tissue. Functional recov- ery rate will be the focus of future studies. Finally, as a proof-of-concept to evaluate the translational potential of the proposed approach, hMSCs [19] were employed to obtain 3D bioprinted constructs. A less extensive VML (50% TA volume ablation) was chosen for these experiments, based on our previous experiences with human-on-mouse grafts where the host did not fully accept the human cells (data not shown). Similarly to murine exper- iments, 30 d after implantation the human cell- derived bioprinted constructs were able to restore the host muscle volume even if the reconstructed tissue was not fully organized as for Mabs-derived implant (mouse-on-mouse). However, a large num- ber of human cells survived in the host and were able to drive the formation of new muscle fibers, to recruit blood vessels and nerves, and to stimulate the forma- tion of a pool of satellite cells. Altogether, the presen- ted data make us confident that the proposed recon- structive strategy has the potential to be suitable for future translational medicine application in human.  5. Conclusion  In this work, the proposed alginate-free extrusion- based 3D bioprinting system, established on the use of PF as only hydrogel composing the cellular scaffold, demonstrated to be a novel and competitive tool for skeletal muscle tissue engineering. The bioprinter was developed by exploiting our expertise, acquired over the years, on skeletal muscle tissue engineering and on the use of the most suitable hydrogels for myogenesis. This background granted us to realize a simple yet effective strategy to overcome limitations of previous systems that depend on the combination of PF with other less biocompatible hydrogels (such as alginate). The presented results highlighted the potential of this 12\nBiofabrication   15   (2023) 025009   E Fornetti   et al  innovative printing approach in two main aspects: on one hand, the possibility to obtain   in vitro   biological substitutes showing properly organized muscle fibers capable of spontaneously contracting, which could represent a biological platform for drug screening and myopathies studies. On the other hand, the efficacy of the printed construct in restoring a VML damage in a mouse model, both with murine and human-derived myogenic progenitors, suggesting that the proposed approach could represent a remarkable and effective tool for regenerative medicine. Finally, the ease-of-use the presented approach could lend itself to the use of other photo-curable biomaterials (such as gelatin and other PEG-based hydrogels) and different types of mesodermal stem cells   (Bone   Mesenchymal   Stem   Cells   [34,   35], Adipose-derived Stem Cells [36], Tendon-derived Stem Cells [37]) to print a wide range of mesodermal- derived   tissues   as   3D   models   or   transplantable substitute.  Data availability statement  All data that support the findings of this study are included within the article (and any supplementary files).  Acknowledgments  We thank Massimo Testa for the support in designing and manufacturing the 3D bioprinter system and Dr Franca Abbruzzese (Universit ` a Campus Bio-Medico di Roma) for her technical support on confocal microscopy acquisition. The research has been carried out thanks to PRIN 2017: 201742SBXA_004 foun- ded by Italian Ministry of University and Research to Cesare Gargioli.  Conflict of interest  The authors declare no conflict of interest.  ORCID iDs  E Fornetti      https://orcid.org/0000-0002-6246-5351 A Rainer      https://orcid.org/0000-0001-8971-551X  References  [1] Fan T, Wang S, Jiang Z, Ji S, Cao W, Liu W, Ji Y, Li Y, Shyh-Chang N and Gu Q 2022 Controllable assembly of skeletal muscle-like bundles through 3D bioprinting  Biofabrication   14   015009 [2] Kim J H, Seol Y J, Ko I K, Kang H W, Lee Y K, Yoo J J, Atala A and Lee S J 2018 3D bioprinted human skeletal muscle constructs for muscle function restoration   Sci. Rep.   8   12307 [3] Aubin H, Nichol J W, Hutson C B, Bae H, Sieminski A L, Cropek D M, Akhyari P and Khademhosseini A 2010 Directed 3D cell alignment and elongation in microengineered hydrogels   Biomaterials   31   6941–51 [4] Kim W J and Kim G H 2020 3D bioprinting of functional cell-laden bioinks and its application for cell-alignment and maturation   Appl. Mater. Today   19   100588 [5] Naghieh S and Chen X 2021 Printability–a key issue in extrusion-based bioprinting   J. Pharm. Anal.   11   564–79 [6] Fu Z, Naghieh S, Xu C, Wang C, Sun W and Chen X 2021 Printability in extrusion bioprinting   Biofabrication  13   033001 [7] Hospodiuk M, Dey M, Sosnoski D and Ozbolat I T 2017 The bioink: a comprehensive review on bioprintable materials  Biotechnol. Adv.   35   217–39 [8] Croisier F and Jér ˆ ome C 2013 Chitosan-based biomaterials for tissue engineering   Eur. Polym. J.  49   780–92 [9] Ferreira A M, Gentile P, Chiono V and Ciardelli G 2012 Collagen for bone tissue regeneration   Acta Biomater.  8   3191–200 [10] Willson K, Atala A and Yoo J J 2021 Bioprinting au natural: the biologics of bioinks   Biomolecules   11   1593 [11] Costantini M   et al   2021 Biofabricating murine and human myo-substitutes for rapid volumetric muscle loss restoration  EMBO Mol. Med.   13   1–17 [12] Wang X, Li X, Dai X, Zhang X, Zhang J, Xu T and Lan Q 2018 Coaxial extrusion bioprinted shell-core hydrogel microfibers mimic glioma microenvironment and enhance the drug resistance of cancer cells   Colloids Surf.   B  171   291–9 [13] Costantini M   et al   2017 Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden hydrogels leads to functionally organized myofibers   in vitro   and   in vivo Biomaterials   131   98–110 [14] Fuoco C   et al   2015   In vivo   generation of a mature and functional artificial skeletal muscle   EMBO Mol. Med.  7   411–22 [15] Fuoco C   et al   2012 Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration   Skelet. Muscle   2   24 [16] Fuoco C   et al   2014 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering   Front. Physiol.   5   203 [17] Almany L and Seliktar D 2005 Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures   Biomaterials   26   2467–77 [18] Buonvino S, Ciocci M, Seliktar D and Melino S 2021 Photo-polymerization damage protection by hydrogen sulfide donors for 3D-cell culture systems optimization   Int. J. Mol. Sci.   22   6095 [19] Testa S   et al   2020 Skeletal muscle-derived human mesenchymal stem cells: influence of different culture conditions on proliferative and myogenic capabilities   Front. Physiol.   11   553198 [20] Schaefer B, Beier J P and Ruhl T 2020 Mesenchymal stem cells and the generation of neomuscle tissue   Surg. Technol. Int.   36   41–47 [21] Bryant S J, Nuttelman C R and Anseth K S 2000 Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts   in vitro J. Biomater. Sci. Polym. Ed.   11   439–57 [22] Mironi-Harpaz I, Wang D Y, Venkatraman S and Seliktar D 2012 Photopolymerization of cell-encapsulating hydrogels: crosslinking efficiency versus cytotoxicity   Acta Biomater.  8   1838–48 [23] Testa S, D’Addabbo P, Fornetti E, Belli R, Fuoco C, Bernardini S, Cannata S, Frezza D and Gargioli C 2018 Myoblast myogenic differentiation but not fusion process is inhibited via MyoD tetraplex interaction   Oxid. Med. Cell. Longev.   2018   7640272 [24] Testa S, Fornetti E, Fuoco C, Sanchez-Riera C, Rizzo F, Ciccotti M, Cannata S, Sciarra T and Gargioli C 2021 The war after war: volumetric muscle loss incidence, implication, current therapies and emerging reconstructive strategies, a comprehensive review   Biomedicines   9   564  13\nBiofabrication   15   (2023) 025009   E Fornetti   et al  [25] Chandel I, Baker R, Nakamura N and Panin V 2020 Live imaging and analysis of muscle contractions in Drosophila embryon   J. Vis. Exp.   9  [26] Bakooshli M A   et al   2019 A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction   Elife   8   1–29 [27] Clemons T D, Bradshaw M, Toshniwal P, Chaudhari N, Stevenson A W, Lynch J, Fear M W, Wood F M and Iyer K S 2018 Coherency image analysis to quantify collagen architecture: implications in scar assessment   RSC Adv.  8   9661–9 [28] Hu T, Cui X, Zhu M, Wu M, Tian Y, Yao B, Song W, Niu Z, Huang S and Fu X 2020 3D-printable supramolecular hydrogels with shear-thinning property: fabricating strength tunable bioink via dual crosslinking   Bioact. Mater.  5   808–18 [29] Ostrovidov S   et al   2019 Three dimensional bioprinting in skeletal muscle tissue engineering   Small   15   1805530 [30] Kim W, Lee H, Lee J, Atala A, Yoo J J, Lee S J and Kim G H 2020 Efficient myotube formation in 3D bioprinted tissue construct by biochemical and topographical cues  Biomaterials   230   119632 [31] Hwangbo H, Lee H, Jin E J, Lee J Y, Jo Y, Ryu D and Kim G H 2022 Bio-printing of aligned GelMa-based cell-laden structure for muscle tissue regeneration   Bioact. Mater.  8   57–70 [32] Cooper A N, McDermott William J, James C Martin, Dulaney Shea O and Carrier D R 2021 Great power comes at a high (locomotor) cost: the role of muscle fascicle length in the power versus economy performance trade-off   Exp. Biol.  224  [33] Corona B T, Garg K, Ward C L, McDaniel J S, Walters T J and Rathbone C R 2013 Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of skeletal muscle   Am. J. Physiol. Cell Physiol.   305   761–75 [34] Bae S W, Lee K W, Park J H, Lee J H, Jung C R, Yu J J, Kim H Y and Kim D H 2018 3D bioprinted artificial trachea with epithelial cells and chondrogenic-differentiated bone marrow-derived mesenchymal stem cells   Int. J. Mol. Sci.  19   1–14 [35] Luo C, Xie R, Zhang J, Liu Y, Li Z, Zhang Y, Zhang X, Yuan T, Chen Y and Fan W 2020 Lowerature three-dimensional printing of tissue cartilage engineered with gelatin methacrylamide   Tissue Eng.   C   26   306–16 [36] Stanco D, Boffito M, Bogni A, Puricelli L, Barrero J, Soldati G and Ciardelli G 2020 3D bioprinting of human adipose-derived stem cells and their tenogenic differentiation in clinical-grade medium   Int. J. Mol. Sci.   21   1–23 [37] Lui P P Y and Chan K M 2011 Tendon-derived stem cells (TDSCs): from basic science to potential roles in tendon pathology and tissue engineering applications   Stem Cell Rev. Rep.   7   883–97  14',0.04032283923962292,'[\"(\", \"(1\", \"(1)\", \"(1).\", \"(1/3\"]','2025-11-29 17:09:53.450082'),(81,3,'Aquí tienes texto totalmente generado por IA, listo para imprimir, claro y neutro. Si quieres otro estilo (formal, infantil, poético, técnico, minimalista, para CV, para tesis, etc.), solo dímelo.',0.18572421732953026,'[\"(formal,\", \"aqu\\u00ed\", \"claro\", \"cv,\", \"d\\u00edmelo.\"]','2025-11-29 17:10:33.081886'),(82,3,'front \\veritext-lite>',0.17392369131956895,'[\"\\\\veritext-lite>\", \"front\"]','2025-11-29 21:04:30.592415'),(83,3,'Conceptos básicos:  •   Música.   La música es, según la definición tradicional del término, el  arte de crear y organizar sonidos y silencios respetando los principios  fundamentales de la melodía, la armonía y el ritmo.  •   Nota musical.   En música, u na nota es un símbolo que denota un  sonido musical. En el lenguaje, una nota es también el sonido en sí.  •   Escala musical.   Una escala musical es un grupo de notas que se tocan  en secuencia de forma ascendente o descendente en su tono (suelen  sonar agradable s al oído).  •   Melodía.   La melodía es una secuencia organizada de notas musicales  que se escuchan una tras otra de manera sucesiva. Es la parte de una  composición que se percibe como la línea principal.  •   Tonalidad.   La tonalidad hace alusión al tono de una ob ra. El tono es  un conjunto de sonidos que se sostienen en una misma nota principal  llamada tónica. La sucesión de esas notas compone las escalas.  •   Acorde.   Entendemos por acorde a un conjunto de tres o más notas  musicales diferentes, que suenan simultáneame nte.  •   Armonía musical.   Relación y orden de notas musicales que hace  referencia a la combinación de diferentes sonidos o notas que se  emiten al mismo tiempo, aunque el término también se utiliza para  referirse a la sucesión de estos sonidos emitidos a la ve z  •   Ritmo.   El ritmo puede definirse como la combinación armoniosa de  sonidos, voces o palabras, que incluyen las pausas, los silencios y los  cortes necesarios para que resulte grato a los sentidos.',0.15791296272708558,'[\"(suelen\", \"a\", \"acorde\", \"acorde.\", \"agradable\"]','2025-11-29 21:05:03.600842'),(84,3,'Hila soy una persona muy inteligente que le gusta jugar, correr, etc',0.22307009952105258,'[\"correr,\", \"etc\", \"gusta\", \"hila\", \"inteligente\"]','2025-11-29 21:16:40.561118'),(85,3,'Aten   Primaria.   2020; 52(10) :778- - -784  www.elsevier.es/ap  Atención   Primaria  SPECIAL   ARTICLE  La   inteligencia   artificial   y   sus   aplicaciones   en   medicina I:   introducción   antecedentes   a   la   IA   y   robótica J.F.   Avila-Tomás   a , b , e , ∗ ,   M.A.   Mayer-Pujadas   c , e   y   V.J.   Quesada-Varela   d , e  a   Medicina   de   Familia   y   Comunitaria,   Centro   de   Salud   Santa   Isabel,   DASur,   Madrid,   Espa˜ na  b   Medicina   Preventiva   y   Salud   Pública,   Universidad   Rey   Juan   Carlos,   Móstoles,   Madrid,   Espa˜ na  c   Medicina   de   Familia   y   Comunitaria,   Research   Programme   on   Biomedical   Informatics   (GRIB),   Instituto   Hospital   del   Mar   de Investigaciones   Médicas   y   Universitat   Pompeu   Fabra,   Barcelona,   Espa˜ na  d   Medicina   de   Familia   y   Comunitaria,   Centro   de   Salud   A   Guarda.   EOXI   Vigo,   A   Guarda,   Pontevedra,   Espa˜ na  e   Miembro   del   Grupo   de   Trabajo   de   Innovación   Tecnológica   y   Sistemas   de   Información   de   la   semFYC  Disponible   en   Internet   el   11   de   julio   de   2020  PALABRAS   CLAVE  Inteligencia   artificial; IA; medicina; salud; robótica; BigData  Resumen   La   tecnología   y   la   medicina   siguen   un   camino   paralelo   durante   las   últimas   décadas. Los   avances   tecnológicos   van   modificando   el   concepto   de   salud   y   las   necesidades   sanitarias están   influyendo   en   el   desarrollo   de   la   tecnología. La   inteligencia   artificial   (IA)   está   formada   por   una   serie   de   algoritmos   lógicos   suficientemente entrenados   a   partir   de   los   cuales   las   máquinas   son   capaces   de   tomar   decisiones   para   casos concretos   a   partir   de   normas   generales. Esta   tecnología   tiene   aplicaciones   en   el   diagnóstico   y   seguimiento   de   pacientes   con   una evaluación   pronóstica   individualizada   de   los   mismos. Además,si   combinamos   esta   tecnología   con   la   robótica,   podemos   crear   máquinas   inteligentes que   hagan   propuestas   diagnósticas   o   que   sean   mucho   más   eficientes   en   su   trabajo. Por   lo   tanto   la   IA   va   a   ser   una   tecnología   presente   en   nuestro   trabajo   cotidiano   a   través   de máquinas   o   programas   informáticos,   que   de   manera   más   o   menos   transparente   para   el   usuario, van   a   ir   siendo   una   realidad   cotidiana   en   los   procesos   sanitarios.   Los   profesionales   sanitarios tenemos   que   conocer   esta   tecnología,   sus   ventajas   y   sus   inconvenientes,   porque   va   a   ser   una parte   integral   de   nuestro   trabajo. En   estos   dos   artículos   pretendemos   dar   una   visión   básica   de   esta   tecnología   adaptada   a   los médicos   con   un   repaso   de   su   historia   y   evolución,   de   sus   aplicaciones   reales   en   el   momento actual   y   una   visión   de   un   futuro   en   el   que   la   IA   y   el   Big   Data   van   a   conformar   la   medicina personalizada   que   caracterizará   al   siglo   XXI. ©   2020   Los   Autores.   Publicado   por   Elsevier   Espa˜ na,   S.L.U.   Este   es   un   art´ ıculo   Open   Access   bajo la   licencia   CC   BY-NC-ND   (http://creativecommons.org/licenses/by-nc-nd/4.0/).  ∗   Autor   para   correspondencia.  Correo   electrónico:   joseavil@gmail.com   (J.F.   Avila-Tomás).  https://doi.org/10.1016/j.aprim.2020.04.013 0212-6567/©   2020   Los   Autores.   Publicado   por   Elsevier   Espa˜ na,   S.L.U.   Este   es   un   art´ ıculo   Open   Access   bajo   la   licencia   CC   BY-NC-ND   (http:// creativecommons.org/licenses/by-nc-nd/4.0/).\nLa   inteligencia   artificial   y   sus   aplicaciones   en   medicina   I:   introducción   antecedentes   a   la   IA   y   robótica   779  KEYWORDS  Artificial   intelligence; AI; medicine; health; robotics; Big  Artificial   intelligence   and   its   applications   in   medicine   I:   introductory   background   to AI   and   robotics Abstract   Technology   and   medicine   follow   a   parallel   path   during   the   last   decades.   Techno- logical   advances   are   changing   the   concept   of   health   and   health   needs   are   influencing   the development   of   technology. Artificial   intelligence   (AI)   is   made   up   of   a   series   of   sufficiently   trained   logical   algorithms   from which   machines   are   capable   of   making   decisions   for   specific   cases   based   on   general   rules. This   technology   has   applications   in   the   diagnosis   and   follow-up   of   patients   with   an   individua- lized   prognostic   evaluation   of   them. Furthermore,   if   we   combine   this   technology   with   robotics,   we   can   create   intelligent   machines that   make   more   efficient   diagnostic   proposals   in   their   work. Therefore,   AI   is   going   to   be   a   technology   present   in   our   daily   work   through   machines   or computer   programs,   which   in   a   more   or   less   transparent   way   for   the   user,   will   become   a   daily reality   in   health   processes.   Health   professionals   have   to   know   this   technology,   its   advantages and   disadvantages,   because   it   will   be   an   integral   part   of   our   work. In   these   two   articles   we   intend   to   give   a   basic   vision   of   this   technology   adapted   to   doctors with   a   review   of   its   history   and   evolution,   its   real   applications   at   the   present   time   and   a   vision of   a   future   in   which   AI   and   Big   Data   will   shape   the   personalized   medicine   that   will   characterize the   21st   century. ©   2020   The   Authors.   Published   by   Elsevier   Espa˜ na,   S.L.U.   This   is   an   open   access   article   under the   CC   BY-NC-ND   license   (http://creativecommons.org/licenses/by-nc-nd/4.0/).  Introducción  La   inteligencia   artificial   (IA)   es   una   rama   de   las   ciencias   de   la computación   que   incluye   conceptos   muy   transversales   rela- cionados   con   la   lógica   y   el   aprendizaje   1   .   Se   trata,   por   lo tanto,   de   dise˜ nar   herramientas   informáticas   que   simulen procesos   de   inteligencia   humana   que   incluyen   el   apren- dizaje,   el   razonamiento   y   la   autocorrección   2   .   Mediante diversos   algoritmos   las   máquinas   « aprenden »   y   son   capaces de   « tomar   decisiones » .   No   se   trata   de   ciencia   ficción,   sino de   una   realidad   que   está   presente   actualmente   y   que   poco   a poco   va   a   ir   ocupando   espacios   cotidianos   en   nuestra   casa, en   nuestros   vehículos   y   también   relacionados   con   nuestra salud. La   teoría   del   procesamiento   de   la   información   de Mahoney   3   considera   al   ser   humano   como   un   procesador de   información   a   partir   de   estímulos   internos   y   externos que   va   almacenando   en   memoria   y   que   es   capaz   de   ela- borar   respuestas   similares   a   partir   de   estímulos   posteriores que   tengan   cierta   similitud.   Según   esta   teoría   los   elemen- tos   estructurales   en   el   procesamiento   de   la   información son:   registro   sensitivo   (recepción   de   información   interna   y externa),   memoria   a   corto   plazo   (almacenamiento   inme- diato   de   la   información   seleccionada)   y   memoria   a   largo plazo   (que   organiza   y   dispone   la   información   durante   más tiempo).   Además,   las   categorías   del   procesamiento   son: atención   (recibe,   selecciona   y   asimila   los   diferentes   estímu- los),   codificación   (simboliza   los   estímulos   según   estructuras mentales   propias),   almacenamiento   (organiza   y   mantiene en   la   memoria   los   símbolos   codificados)   y   recuperación   (uso posterior   de   la   información   organizada   y   codificada   ante estímulos   similares   a   los   que   la   han   ocasionado). El   aprendizaje   humano   se   basaría   en   la   exposición   a   situa- ciones   repetidas   con   refuerzos   (positivos   o   negativos)   cada  vez   que   tomamos   una   decisión   correcta   o   erramos.   A   par- tir   de   estímulos   similares   que   tienen   soluciones   similares   y a   través   de   nuestra   experiencia   y   conocimientos   previos, empezamos   a   tomar   decisiones   4   .   La   toma   de   decisiones supone   un   pensamiento   lógico   y   jerárquico   que   puede   ser transcrito   a   algoritmos   en   un   lenguaje   que   las   máquinas   pue- den   interpretar   y   ejecutar   con   mucha   mayor   rapidez   que   el ser   humano. El   aprendizaje   humano   es   progresivo   y   se   desarrolla   a partir   de   la   exposición   a   situaciones   de   forma   consecutiva, proceso   que   puede   llevar   a˜ nos,   en   cambio,   la   adquisición   de estos   datos   por   parte   de   una   máquina   es   mucho   más   rápida, ya   que   esta   no   se   agota   (puede   trabajar   24   h   al   día)   y   no tiene   funciones   vitales   (alimentación,   descanso   u   ocio).   En este   sentido   las   cantidades   ingentes   de   datos   en   múltiples formatos   y   fuentes   (lo   que   conocemos   como   big   data ),   tie- nen   una   relación   directa   con   la   adquisición   de   experiencia por   parte   de   las   máquinas   que   se   exponen   a   situaciones   o estímulos   muy   diversos.   En   este   artículo   pretendemos   dar una   visión   introductoria   de   la   IA   para   médicos   y   realizar   un recorrido   por   las   principales   aplicaciones   en   salud   que   nos ofrece   esta   tecnología.  Redes   neuronales,   cerebro   y   aprendizaje  La   base   biológica   de   la   inteligencia   está   en   el   cerebro.   Aun- que   vamos   conociendo   cada   vez   más   sobre   su   fisiología   y las   diferentes   vías   anatómicas   y   funcionales   que   participan en   el   proceso   de   aprendizaje   humano,   aún   existen   muchas incógnitas   que   deben   despejarse. Para   las   máquinas   existe   una   analogía   similar   a   la estructura   y   el   funcionamiento   del   cerebro,   por   lo   que   es relativamente   sencillo   establecer   esta   analogía   fácilmente comprensible   para   los   profesionales   de   la   salud.\n780   J.F.   Avila-Tomás   et   al.  Entradas Buffer de entrada Buffer de salida Salidas Capas ocultas  Figura   1   Esquema   de   una   red   neuronal. Fuente:   Elaboración   propia.  Las   redes   neuronales   artificiales,   en   inglés   Artificial   Neu- ral   Networks   (ANN)   están   compuestas   por   elementos   que se   comporten   de   forma   similar   a   la   neurona   biológica   en sus   funciones   más   comunes   y   que   se   denominan   « elemento procesador » ,   en   inglés   Process   Element   (PE).   Cada   uno   de   los PE   (neuronas)   tienen   unos   elementos   de   entrada   (dendritas) que   recogen   los   impulsos   de   entrada   que   son   integrados   en el   cuerpo   del   elemento   procesador   y   generan   una   respuesta o   salida.   La   salida   del   PE   (axón)   se   puede   conectar   a   las entradas   de   otras   neuronas   artificiales   mediante   conexiones con   una   eficacia   similar   a   la   sinapsis   de   las   conexiones   neu- ronales   del   cerebro   5   .   Los   PE   están   organizados   en   una   serie de   niveles   que   se   denominan   capas.   El   conjunto   de   estas capas   forman   una   ANN. En   las   ANN   existen   2   capas   con   conexiones   con   el   exterior. Una   capa   de   entrada   o   buffer   de   entrada,   donde   se   presen- tan   los   datos   a   la   red,   y   una   capa   de   salida   que   devuelve al   exterior   la   respuesta   de   la   red   a   una   entrada   concreta. Existen,   además,   una   serie   de   capas   intermedias   que   se denominan   capas   ocultas   (fig.   1).   Al   igual   que   en   los   seres humanos,   el   aprendizaje   que   se   produce   en   las   máquinas, es   una   función   que   tiene   una   base   estructural   en   este   tejido nervioso   artificial   conformado   por   las   ANN. Existen   2   tipos   de   métodos   que   permiten   el   aprendizaje de   una   máquina   6   .   El   primero   de   ellos   se   llama   « aprendizaje con   datos   supervisados »   y   requiere   la   participación   de   un humano   que   determina   las   relaciones   correctas   e   incorrec- tas   que   adquiere   la   máquina.   La   función   del   humano   es etiquetar   y   categorizar   los   datos   de   entrada   y   establecer   un algoritmo   de   toma   de   decisiones   para   generar   las   diferentes salidas.   Con   el   suficiente   entrenamiento,   la   máquina   será capaz   de   determinar   la   categoría   de   salida   de   un   nuevo   dato de   entrada.   El   segundo   método   es   el   « aprendizaje   automá- tico   o   machine   learning » .   Consiste   en   dotar   de   experiencia a   la   máquina   y   que   sea   ella   misma,   mediante   una   serie   de normas   lógicas   iniciales,   la   que   sea   capaz   de   ir   aprendiendo de   manera   independiente   a   partir   de   la   experiencia   que   le proporcionan   los   datos   y   sin   el   concurso   continuado   de   un humano.   Para   ello   son   necesarios   algoritmos   iniciales   y   un peque˜ no   entrenamiento   supervisado.   Mientras   que,   en   el aprendizaje   supervisado,   el   conocimiento   se   hace   explícito en   forma   de   reglas,   en   la   computación   neuronal   las   ANN generan   sus   propias   reglas   aprendiendo   de   los   ejemplos  que   se   les   muestran   en   la   fase   de   entrenamiento.   Una   vez que   las   decisiones   correctas   alcanzan   un   número   válido dentro   del   total   de   decisiones   tomadas,   conectamos   este sistema   inteligente   a   un   sistema   de   big   data   para   que   esas experiencias   afiancen   los   sistemas   de   toma   de   decisiones (aprendizaje).  Antecedentes  Aunque   todo   este   campo   de   la   informática   es   innovador   en algunos   aspectos,   tiene   antecedentes   en   los   a˜ nos   40   del   siglo XX.   En   1943,   el   neurobiólogo   Warren   McCulloch   y   el   estadís- tico   Walter   Pitss,   publicaron   un   artículo   que   definía   que   los eventos   neuronales   y   las   relaciones   entre   ellos   pueden   tra- tarse   mediante   la   lógica   proposicional   7   .   De   esta   manera   se conforma   la   base   y   el   inicio   del   desarrollo   de   la   IA   tal   y   como hoy   la   concebimos. Pero   no   fue   hasta   una   década   más   tarde,   en   1956,   cuando se   celebró   la   primera   Conferencia   de   Inteligencia   Artificial en   Darmouth   que   es   considerada   como   la   primera   referencia seria   a   las   redes   neuronales   artificiales.   En   esta   conferencia se   presentó   la   lógica   teórica   (Minsky,   McCarthy,   Rochester   y Shannon)   que   es   considerado   el   primer   programa   informá- tico   para   solucionar   problemas   de   búsqueda   heurística   8   . En   1957   se   presentó   « Perceptron »   el   primer   sistema   capaz de   identificar   patrones   geométricos   9   ,   y   en   1959   « Adaline »  (Adaptive   Linear   Neuron)   que   fue   utilizada   con   diferentes aplicaciones   como   reconocimiento   de   voz   y   caracteres,   pre- dicción   del   tiempo,   y   en   el   desarrollo   de   filtros   para   eliminar ecos   de   las   líneas   telefónicas. A   partir   de   estos   trabajos   la   comunidad   científica   tuvo una   percepción   muy   optimista   de   lo   que   la   IA   podría   ofre- cer,   pero   a   mediados   de   la   década   de   los   60   se   comenzaron   a publicar   estudios   críticos   sobre   la   falta   de   aplicabilidad   de   la computación   neuronal.   Durante   los   a˜ nos   70   y   80   pocos   inves- tigadores   continuaron   con   esta   línea   de   desarrollo   científico (James   Anderson,   Teuvo   Kohonen   o   Stephen   Grossberg). En   1982   John   Hopfield   10   crea   el   algoritmo   Backpro- pagation   que   presenta   un   sistema   neuronal   formado   por elementos   procesadores   interconectados   que   tienden   a   un mínimo   de   energía.   Este   hecho   supuso   volver   a   confiar   en   las posibilidades   de   la   IA   que   en   las   últimas   décadas   ha   tenido un   avance   exponencial. Actualmente   existen   muchos   investigadores   en   diferen- tes   universidades   que   están   realizando   trabajos   en   el   área   de las   redes   neuronales   artificiales   en   grupos   multidisciplina- res   (informáticos,   matemáticos,   neurólogos,   psicólogos   del conocimiento,   físicos,   programadores   o   filósofos   de   la   cien- cia)   que   ofrecen   nuevas   e   innovadoras   perspectivas   en   esta área   del   conocimiento.  Inteligencia   artificial   y   robótica  La   palabra   « robot »   procede   la   palabra   checa   « robota »   que significa   « trabajo   duro » 11   . Podemos   clasificar   los   robots   en   diferentes   tipos: 1.   No   mecánicos:   La   salida   es   una   acción   no   mecánica   como mostrar   una   información   o   mantener   una   conversación con   el   usuario   humano.   Entre   ellos   destacan   los   robots cuya   interfaz   es   un   sistema   conversacional   ya   sea   escrito\nLa   inteligencia   artificial   y   sus   aplicaciones   en   medicina   I:   introducción   antecedentes   a   la   IA   y   robótica   781  En movimiento Estatico Robot humanoide Peluche 50% Cadaver muerto viviente PARECIDO HUMANO FAMILIARIDA 100% mano prot ésica Robot Industrial replicante humano sano Valle Inexplicable  Figura   2   Gráfica   de   la   teoría   del   « valle   inquietante »   de   Masa- hiro   Mori. Fuente:   Remasterizada   por   Edgar   Talamantes.   Bajo   licencia libre   GNU.  o   hablado   ( « chatbots » )   con   grandes   aplicaciones   actual- mente   como   asistentes   virtuales. 2.   Mecánicos:   Utilizados   generalmente   en   la   industria.   Hay de   varios   tipos: 1.   Androides:   Apariencia   humanoide. 2.   Zoomórficos:   Apariencia   animal. 3.   Móviles   o   rodantes:   Transporte   de   cosas   o   personal. 4.   Poliarticulados:   Industriales. La   apariencia   humana   de   los   robots   ha   dado   lugar a   la   denominada   « teoría   del   valle   inquietante » .   « Lo inquietante » 12   tiene   su   origen   como   concepto,   en   el   a˜ no 1906   por   Ernst   Jentsch   13   y   se   explica   como   una   sensación perturbadora   ante   algo   que   nos   es   y   no   familiar   al   mismo tiempo.   Una   situación   u   objeto   que   se   parece   mucho   a   algo cotidiano,   que   conocemos   bien   pero   que   nos   genera   una sensación   de   cierta   ansiedad   o   malestar   sin   que   podamos explicar   el   motivo. Esta   teoría   de   lo   inquietante   se   retoma   en   1970   por   Masa- hiro   Mori   para   describir   la   relación   entre   los   robots   y   los humanos.   La   relación   es   cada   vez   más   positiva   siempre   y cuando   el   robot   mantenga   apariencia   de   robot   y   seamos conscientes   de   que   se   trata   de   una   máquina.   Cuando   el   robot va   adquiriendo   rasgos   antropomórficos   hasta   llegar   a   presen- tar   aspecto   humano,   la   respuesta   emocional   del   humano   se irá   haciendo   cada   vez   más   negativa   hasta   llegar   a   un   punto de   rechazo   debido   a   la   « inquietud »   que   genera   (fig.   2). En   la   cultura   occidental,   sobre   todo   por   la   influencia cultural   del   cine,   tenemos   una   imagen   futurista   de   los   robots como   humanoides,   cuando   la   realidad   actual   es   otra,   vivi- mos   rodeados   de   IA   y   robótica.   Así   la   Industria   v.4.0   14   se fundamenta   en   la   realidad   virtual,   la   IA   y   el   Internet   de   las cosas. Los   cobots   o   robots   colaborativos   fueron   inventados   en 1996   por   J.   Edward   Colgate   y   Michael   Peshkin,   profesores  en   la   Northwest   University   (Kirkland,   Washington)   como dispositivos   robóticos   que   manipulan   objetos   en   colabora- ción   con   un   operador   humano   15   .   Actualmente   están   dotados de   IA   para   mejorar   su   rendimiento   con   la   monitorización de   numerosas   variables   como   las   condiciones   del   lugar   de trabajo,   visión   artificial,   identificación   de   patrones   para predecir   o   detectar   errores,   pudiendo   comunicar   dicha información   a   otros   cobots .   Un   sector   que   ha   tenido   un aumento   de   un   23%   de   2017   a   2018,   según   la   Federación Internacional   de   Robótica   (IFR)   16   . Ya   tenemos   robots   funcionando   para   la   realización   de pruebas   y   análisis   de   laboratorio.   Así   en   el   Hospital   Univer- sitario   de   Copenhague,   Gentofte   (Dinamarca)   17   ,   un   primer robot   recoge   la   muestra   de   sangre   y   la   coloca   en   un   lector de   códigos   de   barras.   A   continuación,   una   cámara   de   visión fotografía   el   color   del   tapón   roscado   e   indica   al   robot   que coloque   la   muestra   en   una   de   las   4   gradillas   en   función   de su   color.   Luego   un   segundo   robot   recoge   las   muestras   de   las gradillas   y   las   coloca   en   el   alimentador   de   la   máquina   para su   centrifugado   y   análisis.   Estos   robots   manipulan   alrededor de   3.000   muestras   diarias   (unos   7-8   tubos   por   minuto),   lo que   ha   mejorado   los   tiempos   de   entrega   de   resultados. Video:   https://www.youtube.com/watch?v=mnk4iT4BTg4 Ya   se   están   probando   en   pacientes   tetrapléjicos   exoes- queletos,   unidades   robóticas   ponibles   controladas   por   placas de   computadora   para   alimentar   un   sistema   de   motores, neumáticos,   palancas   o   sistemas   hidráulicos   para   restaurar la   locomoción   18   .   Han   surgido   como   una   nueva   herramienta de   rehabilitación   en   lesionados   medulares.   Sin   embargo, todavía   falta   evidencia   para   respaldar   su   aplicación   clínica teniendo   en   cuenta   su   alto   coste   19   . La   universidad   de   Brown   está   explorando   con   tecnolo- gía   Intel   ®   un   proyecto   de   Interfaz   Inteligente   de   Columna que   tiene   como   objetivo   utilizar   la   tecnología   de   IA   para restaurar   el   movimiento   y   el   control   de   la   vejiga   en   pacien- tes   con   parálisis   por   lesiones   graves   de   la   médula   espinal   20   . Un   equipo   internacional   de   científicos   ya   ha   utilizado   una  « interfaz   cerebro-espinal »   inalámbrica   para   evitar   las   lesio- nes   de   la   médula   espinal   en   un   par   de   macacos   Rhesus , restaurando   el   movimiento   intencional   de   caminar   en   una pierna   temporalmente   paralizada   21   . La   robótica   en   medicina   no   se   limita   a   los   ejemplos   ante- riores,   las   investigaciones   en   este   campo   se   han   dirigido   a la   asistencia   a   los   pacientes   y   la   asistencia   o   formación   a los   médicos.   Así   tenemos   prótesis   de   miembros,   electroesti- mulación,   asistentes   personales,   robótica   de   rehabilitación, robótica   quirúrgica   22   ,   la   formación   médica   con   simulado- res   robotizados   y   los   robots   de   almacenaje   y   distribución de   medicamentos. Desde   los   a˜ nos   60,   las   prótesis   de   miembros   han   evolucio- nado   constantemente,   con   distintos   modelos   para   sustituir las   primeras   prótesis   pasivas,   todavía   presentes   en   gran parte   del   mundo   por   su   menor   coste,   por   prótesis   activas, las   cuales   por   medio   de   medios   mecánicos   o   sensores   ubica- dos   en   alguna   parte   del   cuerpo   del   paciente   permiten   mover por   ejemplo   una   mano   mecánica   23   . Hay   distintos   modelos   y   soluciones   de   prótesis   de   mano en   continua   evolución   y   mejora   para   aumentar   su   fun- cionalidad,   como   las   2   generaciones   de   manos   DLR   ® 24   ,   la TUAT/Karlsruhe   ® 25   ,   la   Blackfingers   ® 26   ,   la   mano   robótica   con mecanismo   extensor   27   ,   la   mano   compuesta   de   sensores propioceptivos   28   o   la   mano   Iowa   ®   fruto   de   un   trabajo   de\n782   J.F.   Avila-Tomás   et   al.  colaboración   entre   universidades   americanas,   espa˜ nolas   y suecas   29   ,   entre   otros. En   cuanto   a   la   robótica   quirúrgica   también   ha   evolu- cionado   progresivamente   desde   el   primer   procedimiento neuroquirúrgico   asistido   por   un   robot   en   1985,   donde   se utilizó   el   robot   industrial   PUMA   560   (no   dise˜ nado   para labores   médicas)   para   introducir   una   guía   para   una   biop- sia   cerebral   30   .   Posteriormente   se   empezaron   a   dise˜ nar   los primeros   robots,   puramente   quirúrgicos,   como   asistentes del   cirujano   en   operaciones   de   múltiples   órganos   y   apa- ratos.   Algunos   modelos   de   robots   quirúrgicos   son:   AESOP   ® (acrónimo   de   sistema   endoscópico   automatizado   para   un posicionamiento   óptimo)   empleado   como   asistente   robótico controlado   por   voz   para   cirugía   endoscópica   31   ,   el   robot   este- reotáctico   NeuroMate   ® 32   que   es   un   sistema   que   se   utiliza en   centros   neuroquirúrgicos   para   administrar   tratamientos   y realizar   procedimientos   de   estimulación   cerebral   profunda, neuroendoscopia,   estereoelectroencefalografía,   biopsias   e investigación;   el   extinto   sistema   robótico   ZEUS   ® 33   con   el que   se   realizó   la   primera   telecirugía   del   mundo   en   2001   34   , conocida   como   la   operación   Lindbergh,   una   exitosa   cole- cistectomía   laparoscópica   de   dos   horas   de   duración,   que se   realizó   en   una   paciente   en   un   hospital   de   Estrasburgo, Francia,   realizada   por   un   equipo   quirúrgico   en   Nueva   York, EE.   UU.,   el   Sistema   Robótico   Quirúrgico   Da   Vinci   ® 35   que en   su   versión   más   reciente,   el   sistema   da   Vinci   Xi   ®   per- mite   una   visión   en   3D   con   un   aumento   de   hasta   10   veces   y elimina   el   temblor   fisiológico,   utilizándose   principalmente en   intervenciones   de   urología,   cirugía   general   y   ginecología oncológica,   pero   también   en   cirugía   oral   y   maxilofacial,   ciru- gía   pediátrica,   cirugía   torácica   o   cirugía   cardíaca;   Probot   ®   , dise˜ nado   para   realizar   prostatectomías   36   ,   Robodoc   ®   para cirugía   ortopédica   37   ,   Acrobot   ®   para   cirugía   de   rodilla   38   y CyberKnife   ® 39   sistema   de   radiocirugía   robótica   dise˜ nado para   tratar   tumores   ubicados   en   todo   el   cuerpo   de   manera no   invasiva,   entre   otros. El   principal   problema   para   su   expansión   es   el   alto   coste de   instalación   y   mantenimiento   de   los   mismos,   de   ahí   el  Tabla   1   Beneficios   y   limitaciones   de   la   cirugía   robótica respecto   a   la   cirugía   mínimamente   invasiva   convencional  Beneficios   Limitaciones Visión   en   3D   y   alta resolución Tama˜ no   del   robot Movimientos   intuitivos   Variedad   de   instrumentos limitada Control   del   temblor   Tiempo   de   preparación   del robot Movimientos   a   escala   Rango   de   movimientos limitado Mejor   ergonomía   Muy   caro   de   comprar   y mantener Curva   de   aprendizaje   más corta Desechables   muy   caros Fuente:   Tomado   de   van   Haasteren   et   al 43   .  desarrollo   de   sistemas   más   recientes   y   más   asequibles,   como por   ejemplo:  •   El   sistema   quirúrgico   Senhance   ® 40   .   plataforma   laparoscó- pica   digital   que   elimina   las   limitaciones   económicas   de   los sistemas   robóticos   actuales   con   instrumentos   reutilizables estándar   y   una   estrategia   de   arquitectura   de   plataforma abierta   que   permite   a   los   hospitales   aprovechar   las   inver- siones   en   tecnología   existentes.  •   El   sistema   robótico   Flex   ® 41   que   permite   acceder   a   ubica- ciones   anatómicas   antes   difíciles   o   imposibles   de   alcanzar de   forma   mínimamente   invasiva.  •   El   proyecto   espa˜ nol   BROCA,   también   conocido   como   « el peque˜ no   de   Da   Vinci   ®   » 42   ,   para   el   dise˜ no   y   desarrollo   de un   sistema   robótico   quirúrgico   de   bajo   costo,   modular, para   cirugía   mínimamente   invasiva   centrada   en   cirugía pélvica   y   bariátrica,   con   sensores   y   efectores   finales   alta- mente   maniobrables   para   obtener   información   relevante  Tabla   2   Fortalezas   y   limitaciones   de   humanos   y   robots   respecto   a   la   cirugía  Fortalezas   Limitaciones  Humanos   Destreza   limitada   más   allá   de   los   movimientos   naturales Buen   juicio   Propenso   a   la   fatiga   y   la   falta   de   atención Buena   coordinación   mano-vista   El   temblor   limita   el   movimiento   fino Gran   destreza   Efectores   finales   voluminosos   (manos) Puede   integrar   información   de   diversas   fuentes   Limitada   precisión   geométrica Entrenamiento   sencillo   Difícil   de   mantener   estéril Versátil   y   capaz   de   improvisar   Susceptible   a   la   radiación,   infección  Robots  Buena   precisión   geométrica   Juicio   reducido Incansable   y   estable   Difícil   adaptación   a   nuevas   situaciones Resistente   a   la   radiación   ionizante   Destreza   limitada Puede   dise˜ narse   para   operar   diferentes   escalas   de movimiento   y   carga   útil Coordinación   mano-vista   limitada Capaz   de   utilizar   múltiples   sensores   Capacidad   limitada   para   integrar   e   interpretar   información compleja Fuente:   Adaptado   de   Taylor   RH 44   .\nLa   inteligencia   artificial   y   sus   aplicaciones   en   medicina   I:   introducción   antecedentes   a   la   IA   y   robótica   783  de   la   herramienta   y   su   entorno,   además   de   incorporar   la sensación   de   tacto. La   cirugía   asistida   por   robot   ha   permitido   avances   en   el campo   quirúrgico   como   la   cirugía   a   distancia   y   la   cirugía mínimamente   invasiva,   junto   a   ventajas   de   precisión,   inci- siones   más   peque˜ nas,   menor   pérdida   de   sangre,   disminución del   dolor   y   tiempo   de   curación   menor   42   ,   lo   que   permite   tra- tar   un   mayor   número   de   pacientes   con   menor   tiempo   de hospitalización,   haciendo   que   sea   posible   realizar   interven- ciones   que   de   otro   modo   no   serían   viables. La   cirugía   robótica   presenta   una   serie   de   ventajas   y   de limitaciones   respecto   a   la   cirugía   mínimamente   invasiva   con- vencional   (tabla   1).   Las   ventajas   suelen   venir   de   explotar fortalezas   complementarias   entre   humanos   y   dispositivos robóticos,   como   vemos   resumido   en   la   tabla   2.  Financiación  Este   artículo   no   ha   recibido   ningún   tipo   de   ayuda   o   finan- ciación   de   agencias   del   sector   público,   sector   comercial   o entidades   sin   ánimo   de   lucro.  Bibliografía  1.   Torra   V.   La   inteligencia   artificial.   LYCHNOS.   Fundación General   del   CSIC   [consultado   6   Mar   2019]   Disponible   en: http://www.fgcsic.es/lychnos/es   es/articulos/inteligencia artificial. 2.   Rouse   M   ¿Qué   es   Inteligencia   artificial,   o   AI?   -   Definición   en WhatIs.com.   Techtarget   [consultado   6   Mar   2019]   Disponible en:   https://searchdatacenter.techtarget.com/es/definicion/ Inteligencia-artificial-o-AI. 3.   La   teoría   del   procesamiento   de   la   información   de   Maho- ney.   RODAS.   Repositorio   de   Objetos   de   Aprendizaje   de la   Universidad   de   Sevilla   [consultado   4   Mar   2019]   Dispo- nible   en:   https://rodas5.us.es/file/1240b064-8389-6228-96a5- 653dd137f73b/1/capitulo3   SCORM.zip/pagina   22.htm. 4.   Domjan   M.   Principios   de   aprendizaje   y   conducta.   Madrid:   Thom- son;   2012. 5.   Basogai-Olabe   X.   Redes   neuronales   artificiales   y   sus   apli- caciones.   Escuela   Superior   de   Ingeniería   de   Bilbao.   Bil- bao:   Escuela   Superior   de   Ingeniería   de   Bilbao   [consul- tado   4   Mar   2019]   Disponible   en:   https://ocw.ehu.eus/file. php/102/redes   neuro/contenidos/pdf/libro-del-curso.pdf. 6.   Sancho-Caparrini   F.   Clasificación   Supervisada   y   No   Supervisada. Fernando   Sancho   Caparrini   [consultado   7   Mar   2019]   Disponible en:   http://www.cs.us.es/ ∼ fsancho/?e=77. 7.   McCulloch   WS,   Pitts   W.   A   logical   calculus   of   the   ideas   immanent in   nervous   activity.   The   Bulletin   of   Mathematical   Biophy- sics.   1943;5:115- - -33   [consultado   7   Mar   2019].   Disponible   en: http://link.springer.com/10.1007/BF02478259. 8.   Conferencia   de   Darthmouth   1956.   [consultado   7   Mar   2019]   Dis- ponible   en:   https://darthmouthconference.wordpress.com/. 9.   Ramirez   F.   Big   Data   &   Data   Science   Blog:   Historia   de   la IA:   Frank   Rosenblatt   y   el   Mark   I   Perceptrón,   el   primer ordenador   fabricado   específicamente   para   crear   redes   neu- ronales   en   1957   [consultado   7   Mar   2019]   Disponible   en: https://web.archive.org/web/20180722124753/https://data- speaks.luca-d3.com/2018/07/historia-de-la-ia-frank- rosenblatt-y-el.html#. 10.   Hopfield   JJ.   Neural   networks   and   physical   systems   with   emer- gent   collective   computational   abilities.   Proc   Natl   Acad   Sci   U  S   A.   1982;79:2554- - -8   [consultado   7   Mar   2019].   Disponible   en: https://www.pnas.org/content/pnas/79/8/2554   full.pdf. 11.   Robot.   En:   Wikipedia,   la   enciclopedia   libre,   2019   [citado 9   de   marzo   de   2019].   Disponible   en:   https://es.wikipedia. org/w/index.php?title=Robot&oldid=114426400. 12.   Collins   J,   Jervis   J.   Document:   ‘On   the   Psychology   of the   Uncanny’   (1906):   Ernst   Jentsch.   En:   Collins   J,   Jer- vis   J,   editores.   Uncanny   Modernity:   Cultural   Theories, Modern   Anxieties.   London:   Palgrave   Macmillan   UK; 2008.   p.   216- - -28   [consultado   9   Mar   2019].   Disponible   en: https://doi.org/10.1057/9780230582828   12. 13.   Jentsch   E.   On   the   Psychology   of   the   Uncanny. 1906   [consultado   9   Mar   2019].   Disponible   en http://www.art3idea.psu.edu/locus/Jentsch   uncanny.pdf. 14.   European   Commission.   The   Fourth   Industrial   Revolution.   2019 [consultado   23   Mar   2019]   Disponible   en:   https://ec.europa. eu/digital-single-market/en/fourth-industrial-revolution. 15.   Colgate   JE,   Wannasuphoprasit   W,   Peshkin   MA.   Cobots:   robots for   collaboration   with   human   operators.   Proceedings   of   the International   Mechanical   Engineering   Congress   and   Exhibition. Atlanta   GA,   58:433-439   [consultado   9   Mar   2019].   Disponible   en: https://peshkin.mech.northwestern.edu/publications/1996 Colgate   CobotsRobotsCollaboration.pdf. 16.   IFR   Press   Release.   Industrial   Robots:   Robot   Investment Reaches   Record   16.5   billion   USD.   Shanghai,   Frankfurt, Sep   18,   2019   [consultado   9   Mar   2019]   Disponible   en: https://ifr.org/ifr-press-releases/news/robot-investment- reaches-record-16.5-billion-usd. 17.   Gentofte   Hospital.   Nota   de   prensa.   El   nuevo   super   robot   y   bioa- nalista   danés   colaboran   estrechamente   en   los   análisis   de   sangre [Ny   dansk   superrobot   og   bioanalytiker   arbejder   tæt   sammen om   blodprøver],   Nov   25,   2014.   2019   [consultado   17   May   2019]. Disponible   en:   https://www.gentoftehospital.dk/presse- og-nyt/pressemeddelelser-og-nyheder/nyheder/Sider/ny- dansk-superrobot-og-bioanalytiker-arbejder-taet-sammen-om- blodproever.asp. 18.   Benabid   AL,   Costecalde   T,   Eliseyev   A,   Charvet   G,   Verney A,   Karakas   S,   et   al.   An   exoskeleton   controlled   by   an   epi- dural   wireless   brain-machine   interface   in   a   tetraplegic patient:   A   proof-of-concept   demonstration.   The   Lancet Neurology.   2019   [consultado   7   Oct   2019].   Disponible   en: https://www.thelancet.com/journals/laneur/article/PIIS1474- 4422(19)30321-7/fulltext. 19.   Gorgey   AS.   Robotic   exoskeletons:   The   current   pros   and   cons. WJO.   2018;9:112- - -9   [consultado   7   Oct   2019].   Disponible   en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153133/. 20.   Researchers   to   develop   ‘intelligent   spinal   interface’   with   $6.3 million   in   DARPA   funding.   Brown   University   [consultado   7   Oct 2019].   Disponible   en:   https://www.brown.edu/news/2019-10- 03/isi. 21.   Capogrosso   M,   Milekovic   T,   Borton   D,   Wagner   F,   Moraud EM,   Mignardot   J-B,   et   al.   A   brain-spine   interface   alle- viating   gait   deficits   after   spinal   cord   injury   in   primates. Nature.   2016;539   [consultado   7   Oct   2019].   Disponible   en: https://www.nature.com/articles/nature20118. 22.   Krut   S.   Introduction   to   Medical   Robotics.   Conferencia.   VI   Semi- nario   de   Automática.   Popayán.   2006. 23.   Shimoga   KB.   Robot   Grasp   Synthesis   Algorithms:   A   Survey.   The International   Journal   of   Robotics   Research.   1996;15:230- - -66 [consultado   7   Oct   2019].   Disponible   en:   https:// journals.sagepub.com/doi/10.1177/027836499601500302. 24.   Borst   C,   Fischer   M,   Haidacher   S,   Liu   H,   Hirzinger   G.   DLR Hand   II:   Experiments   and   experience   with   an   anthropomorp- hic   hand.   Robotics   and   Automation   2003.   Taipei:   Proceedings. ICRA’03.IEEE   International   Conference;   2003   [consultado   7   Oct 2019].   Disponible   en:   http://eia.udg.es/ ∼ qsalvi/papers/2003- ICRA-Credits.pdf.\n784   J.F.   Avila-Tomás   et   al.  25.   Fukaya   N,   Toyama   S,   Asfour   T,   Rüdiger   D.   Design   of the   TUAT/Karlsruhe   humanoid   hand.   Takamatsu:   Proceedings IEEE/RSJ   International   Conference   on   Intelligent   Robots   and Systems   (IROS   2000);   2000   [consultado   10   Oct   2019].   Disponible en:   https://ieeexplore.ieee.org/document/895225. 26.   Folgheraiter   M,   Gini   G.   Blackfingers   an   artificial   hand that   copies   human   hand   in   structure,   size,   and   function. Humanoids.   2000   [consultado   10   Oct   2019].   Disponible   en: https://pdfs.semanticscholar.org/c417/1da51eee7823ff6cd2f54 86c9d70fe531162.pdf. 27.   Wilkinson   D,   Vande-Weghe   M,   Matsuoka   Y.   An   extensor   mecha- nism   for   an   anatomical   robotic   hand.   Proceedings   of   the 2003   IEEE   International   Conference   on   Robotics   and   Automa- tion:   Taipei;   2003   [consultado   10   Oct   2019].   Disponible   en: https://www.ri.cmu.edu/pub   files/pub4/wilkinson   david   d 2003   1/wilkinson   david   d   2003   1.pdf. 28.   Carrozza,   Cappiello   MC,   Micera   G,   Edin   S,   Beccai   BB,   Cipriani LC.   Design   of   a   cybernetic   hand   for   perception   and   action.   Biol Cybern.   2006;95:629- - -44. 29.   Yang   J,   Pe˜ na-Pitarch   E,   Abdel-Malek   K,   Patrick   A,   Lindkvist   L.   A multi-fingered   hand   prosthesis.   Mechanism   and   Machine   Theory. 2004;39:555- - -81. 30.   Kwoh   YS,   Hou   J,   Jonckheere   EA,   Hayati   S.   A   robot   with   improved absolute   positioning   accuracy   for   CT   guided   stereotactic   brain surgery.   IEEE   Trans   Biomed   Eng.   1988;35:153- - -60. 31.   Stoianovici   D.   Robotic   surgery.   World   J   Urol.   2000;18:289- - -95. 32.   Varma   TR.   Use   of   the   NeuroMate   stereotactic   robot   in   a   fra- meless   mode   for   movement   disorder   surgery.   Stereotact   Funct Neurosurg.   2003;80:132- - -5. 33.   Marescaux   J,   Rubino   F.   The   Zeus   robotic   system:   Experimental and   clinical   applications.   Surg   Clin   N   Am.   2004;83:1305- - -15. 34.   Marescaux   J,   Leroy   J,   Gagner   M,   Rubino   F,   Mutter   D,   Vix M,   et   al.   Transatlantic   robot-assisted   telesurgery.   Nature. 2001;413:379- - -80.  35.   Ballantyne   GH,   Moll   F.   The   da   Vinci   telerobotic   surgical   system: The   virtual   operative   field   and   telepresence   surgery.   Surg   Clin N   Am.   2003;83:1293- - -304. 36.   Davies   BL,   Hibberd   RD,   Timoney   AG,   Wickham   JEA.   A   clinically applied   robot   for   prostatectomías.   En:   Taylor   RH,   Lavallee   S, Burdea   GC,   Mosges   R,   editores.   Computer-Integrated   Surgery. MIT   Press;   1995.   p.   593- - -601. 37.   Nogler   M,   Polikeit   A,   Wimmer   C,   Bruckner   A,   Ferguson   SJ,   Kris- mer   M.   Primary   stability   of   a   Robodoc   implanted   anatomical stem   versus   manual   implantation.   Clin   Biomech   (Bristol,   Avon). 2004;19:123- - -9. 38.   Jakopec   M,   Harris   S,   Rodríguez-Baena   F,   Gomes   P,   Davies B.   The   Acrobot   system   for   total   knee   replacement.   Indus- trial   Robot.   2003;19:902- - -11,   http://dx.doi.org/10.1108/ 01439910310457724. 39.   Gerszten   PC,   Ozhasoglu   C,   Burton   SA,   Vogel   WJ,   Atkins   BA,   Kal- nicki   S,   et   al.   CyberKnife   frameless   stereotactic   radiosurgery   for spinal   lesions:   Clinical   experience   in   125   cases.   Neurosurgery. 2004;55:89-98. 40.   Schmitz   R,   Willeke   F,   Barr   J,   Scheidt   M,   Saelzer   H,   Darwich I,   et   al.   Robotic   Inguinal   Hernia   Repair   (TAPP)   First   Expe- rience   with   the   New   Senhance   Robotic   System.   Surg   Technol Int.   2019;34:243- - -9. 41.   Lang   S,   Mattheis   S,   Hasskamp   P,   Lawson   G,   Güldner   C,   Manda- pathil   M,   et   al.   A   european   multicenter   study   evaluating   the flex   robotic   system   in   transoral   robotic   surgery.   Laryngoscope. 2017;127:391- - -5. 42.   Proyecto   BROCA   -   Inicio   [consultado   10   Oct   2019].   Disponible en:   http://proyecto-broca.es/. 43.   van   Haasteren   G,   Levine   S,   Hayes   W.   Pediatric   robotic   surgery: Early   assessment.   Pediatrics.   2009;124:1642- - -9. 44.   Taylor   RH.   A   Perspective   on   Medical   Robotics.   Proceedings   of the   IEEE.   2006;94:1652- - -64,   94.',0.1504570103558824,'[\"$6.3\", \"&\", \"(\", \"(1906):\", \"(acr\\u00f3nimo\"]','2025-11-29 21:19:15.216891'),(86,3,'Medical Education Online  ISSN: (Print) (Online) Journal homepage: www.tandfonline.com/journals/zmeo20  Optimizing cost-effectiveness in remote objective structured clinical examinations through targeted double scoring methodologies  Zhihui Fu, Yuhong Wu, Lingling Xu, Fen Cai, Ren Liu & Zhehan Jiang  To cite this article:   Zhihui Fu, Yuhong Wu, Lingling Xu, Fen Cai, Ren Liu & Zhehan Jiang (2025) Optimizing cost-effectiveness in remote objective structured clinical examinations through targeted double scoring methodologies, Medical Education Online, 30:1, 2467477, DOI: 10.1080/10872981.2025.2467477  To link to this article:   https://doi.org/10.1080/10872981.2025.2467477  © 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.  Published online: 18 Feb 2025.  Submit your article to this journal  Article views: 1131  View related articles  View Crossmark data  Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=zmeo20\nRAPID COMMUNICATION  Optimizing cost-effectiveness in remote objective structured clinical examinations through targeted double scoring methodologies  Zhihui Fu   a,b , Yuhong Wu   a,b , Lingling Xu   c,d , Fen Cai   c,d , Ren Liu   e   and Zhehan Jiang   c,d  a Department of Statistics, School of Mathematics and Statistics, Minnan Normal University, Zhangzhou, Fujian, China;   b Fujian Key Laboratory of Granular Computing and Applications, Minnan Normal University, Zhangzhou, Fujian, China;   c Institute of Medical Education, Peking University, Beijing, China;   d Peking University Health Science Center-Chaoxing Joint Laboratory for Digital and Smart Medical Education, Beijing, China;   e Psychological Science, University of California, Merced, CA, USA  ABSTRACT  The remote Objective Structured Clinical Examination (OSCE) is a cornerstone of medical education, enabling structured and objective assessment of clinical skills, communication, and patient- centered care. However, its widespread adoption has introduced challenges related to cost- effectiveness and efficient use of rater resources. Traditional double scoring (DS) ensures reliability but is labor-intensive and costly, especially in large-scale assessments. To address these challenges, this study introduces Targeted Double Scoring (TDS), a novel methodology that selectively applies DS to specific score ranges, particularly those near the pass/fail threshold. The study was conducted using data from a pilot remote OSCE administered to 550 clinical medicine undergraduates in China. The OSCE consisted of three stations: Clinical Reasoning (CR), Physical Examination (PE), and Fundamental Skills (FS). Each station was scored remotely by two raters, with a cut-off score of 60 out of 100. The TDS methodology was modeled based on the OSCE’s DS design and fitted with scoring data. A decision-theoretic approach identified optimal Critical Score Ranges (CSRs) for targeted double scoring, balancing reliability and cost-effectiveness. The findings show that TDS significantly reduces rater workload and costs while maintaining high reliability and fairness. For instance, TDS achieved up to 70% cost savings compared to traditional DS under certain config -  urations. The study also highlights the flexibility of TDS, which can be tailored to different OSCE designs and scoring rubrics. These results have broad implications for medical education, especially in resource-constrained settings where optimizing assessment efficiency is critical. This study provides   a   practical   solution   to   the   cost-related   challenges   of   remote   OSCEs   and   offers a framework for adopting TDS in assessments. By focusing raters on critical score ranges, TDS maintains rigorous and fair evaluations without overburdening faculty or exceeding budgets. Future research should explore TDS scalability and its integration with emerging technologies like artificial intelligence to enhance efficiency and reliability.  ARTICLE HISTORY  Received 7 December 2023 Revised 21 January 2025 Accepted 11 February 2025  KEYWORDS  OSCE; remote scoring; targeted double scoring; cost-saving strategy; digital assessment  Introduction  The importance of performance assessment in med -  ical   education   cannot   be   overstated.   Performance assessment, such as the Objective Structured Clinical Examination (OSCE), is a valuable tool for medical educators to assess the knowledge, skills, and atti -  tudes of medical students in a clinically relevant con -  text. OSCEs, particularly those conducted remotely, have become a cornerstone of medical education, enabling the assessment of clinical skills, communica -  tion, and patient-centered care in a structured and objective manner [1]. OSCEs provide a structured, objective method of assessing the performance of medical students that can be used to give feedback on their progress. Additionally, OSCEs can be used to assess the effectiveness of medical education pro -  grams,   provide   guidance   for   curriculum   changes, and identify areas for further improvement [2].  Traditional (onsite) scoring of OSCEs has been the standard for many years; it involves having trained faculty and/or standardized patients assess students’ performance in real-time. Typically, raters have eval -  uated students in close proximity – by their side, in the same room, or through a one-way mirror. Despite the advantages of remote scoring, traditional double scoring (DS) can be costly and time-consuming, par -  ticularly   for   large-scale   assessments.   This   study addresses the gap by introducing Targeted Double Scoring (TDS), which selectively applies DS to critical score   ranges   to   optimize   cost-effectiveness   [1]. Further, social facilitation theory implies that the presence of raters can lead to downward performance when tasks are complex [3,4]. Last but not least, the onsite   costs   of   onsite   scoring   can   be   substantial, resulting in a heavy budgetary load in most well designed OSCEs [5]; recent literature has addressed issues for cost saving in OSCE scoring [6,7]. Largely  CONTACT   Zhehan Jiang   jiangzhehan@gmail.com;   Lingling Xu   xllpsy@qq.com   Institute of Medical Education, Peking University, Beijing, China; Peking University Health Science Center-Chaoxing Joint Laboratory for Digital and Smart Medical Education, Beijing, China.  MEDICAL EDUCATION ONLINE  2025, VOL. 30, 2467477  https://doi.org/10.1080/10872981.2025.2467477  © 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.\nreducing the aforementioned burdens, remote scor -  ing has become increasingly popular in the medical education field.  Remote scoring involves using digital tools to eval -  uate students’ performances, either for OSCEs con -  ducted   in   person   or   fully   remote   OSCEs,   using predetermined criteria [1]. Remote scoring has the potential to trim the costs and improve the efficiency of performance assessment while still providing accu -  rate feedback to students. There has been a growing body of research on the use of remote scoring in medical education. For example, a recent study by Wu et al. [8] explored the use of remote scoring for an OSCE assessment in a medical education program. The study found that remote scoring was reliable and valid for assessing the performance of medical stu -  dents, and that it had the potential to reduce costs and improve the efficiency of the assessment process. Similarly, a study by Arnold et al. [9] evaluated the use of remote scoring for a clinical skills assessment. The study found that remote scoring had good relia -  bility and validity, and that it was a cost-effective and time-efficient method of assessing medical students’ performance.  Moreover, several studies highlight the challenges and benefits associated with implementing OSCEs. Majumder et al. [10] noted that although OSCEs are widely recognized as effective assessment tools, they require significant resources for administration and evaluation. Chong et al. [11] emphasized the impor -  tance of examiner training and standardization to ensure consistency in scoring. Kim et al. [12] devel -  oped and evaluated an OSCE designed to assess med -  ical students’ clinical performance, underscoring the need for clear criteria and robust methods to main -  tain   assessment   quality.   Brand   and   Schoonheim- Klein [13] reported that different assessment methods could influence examination anxiety among students, suggesting that careful consideration should be given to the psychological impact of various assessment formats. Alfaris et al. [14] examined student percep -  tions of OSCEs at a new medical school, revealing that despite initial apprehension, students generally viewed OSCEs positively once familiarized with the format. Park et al. [15] compared examinee percep -  tions between internal and external examiners, indi -  cating   that   external   examiners   might   offer   more objective evaluations. Lastly, Gopalan et al. [16] pro -  vided insights into how students perceive OSCEs, offering recommendations for enhancing the assess -  ment experience.  It should be noted that, definition-wise, remote scoring is a general concept, within which a scoring assignment (i.e., who and how to rate students) strat -  egy plays a critical role in driving the workflow. Among different scoring assignment strategies, dou -  ble scoring (DS) involves having two different raters independently score the same set of responses, and then comparing the two scores to determine the final score [17]. This method is especially useful when dealing   with   non-structured   responses,   as   it   (1) helps to reduce the potential for bias in scoring and (2) allows for an independent comparison of the two results. The advantages of DS are more evident when the scoring rubric is complex or when the rubric does not provide clear-cut guidelines for the scoring [16]. However, scoring of performance tasks tends to be expensive and time-consuming [18]. To control the costs, DS might be performed for a random subset of students instead of all. Finkelman et al. [19] suggested that a better approach would be targeted DS (TDS), which emphasizes DS of those students who are close to the pass/fail point and can be accurately identified; this approach is particularly useful when the target assessment involves standard settings (i.e., a cut-off is demanded) [1].  An important term that one should understand is the Critical Score Range (CSR), referring to a specific range of scores where the risk of incorrect pass/fail decisions is highest. For example, if the pass/fail cut -  off is 60, scores close to 60 (e.g., 55–65) are consid -  ered critical because small differences in these scores can   significantly   impact   a   student’s   outcome.   By focusing double scoring on these critical ranges, we ensure fairness and reliability without unnecessary cost. One can regard the CSR as a ‘red zone’ in a game. Just as players need extra caution when entering the red zone, scores near the pass/fail cutoff require extra scrutiny. By focusing double scoring on this ‘red zone,’ we ensure that critical decisions are made with high reliability.  Figure 1 presents a streamlined visualization of the TDS concept   using   a simplified   example.   In   this example, the total score ranges from 0 to 20, with a pass/fail cutoff at 8. The Critical Score Range (CSR) is highlighted in red, showing that scores close to 8 (e.g., 6–10) require double scoring to ensure fairness. Scores outside this range (e.g., 0–5 or 15–20) do not require double scoring, as the risk of incorrect deci -  sions is lower. Under DS, examinees P1 and P2 would both require assessments from two raters. However, with   TDS   implementation,   only   select   examinees would need double rating, deemed necessary based on a single rater’s sufficiently reliable score, thus eliminating the need for universal DS application. This targeted approach significantly reduces the over -  all rating effort and associated costs. A critical aspect of TDS involves identifying the CSR that indicates examinees near the pass/fail threshold. Accordingly, scores within a CSR warrant   additional raters to ensure assessment fairness and reliability. As demon -  strated, different CSRs imply varying rating require -  ments;   for   example,   while   P2   falls   within   CSR.1 necessitating two raters, P1 does not. Conversely,  2   Z. FU ET AL.\nneither falls within CSR.2, indicating both require only one rater. Finally, since both scores are within CSR.n, double rating is applied to ensure thorough evaluation for both examinees. Note that the case shown in Figure 1 is indeed a simplified one, as in practice assessment tends to contain multiple tasks and/or stations such as OSCEs. TDS taking place at the task- or station-level, instead of overall score, would   complicate   the   decision-making   process because   much   more   combinations   (e.g.,   DS   is required   for   the   first   and   the   second   tasks   but unneeded   for   the   third   task)   for   each   examinee emerge in the analysis.  In this paper, we adopt the Targeted Double Scoring (TDS) methodology, which builds on the principles   of   decision-theoretic   approaches   to assessment [20] and addresses the limitations of traditional DS. In the OSCE’s setting, as each sta -  tion contains only one task, the station and the task are treated interchangeable throughout the analysis. Therefore, it’s appropriate the state that each sta -  tion/task contains multiple scoring points by raters in   this   study.   Specifically,   the   TDS   is   modeled according to the OSCE’s DS design and is fitted with   the   scoring   data.   Armed   with   quantitative decision-making   process   initially   proposed   by Sinharay and colleagues [20], TDS is expected to optimize   the   selection   of   examinees   whose responses   need   to   be   scored   by   two   raters. Therefore, the TDS results are meant to provide a guideline as well as a cost-effective solution for generalizing the remote scoring practice to OSCEs using the similar setting.  From an intervention standpoint, applying TDS in OSCE assessments can be considered a ‘treatment’, given that the original OSCE format involves two or more   raters.   This   approach   has   a   dual   objective: firstly, to evaluate whether TDS offers a more cost- effective alternative to the current scoring setup; and secondly, if the initial hypothesis holds true, to deter -  mine which CSR yields the most optimal outcomes. Therefore,   this   paper   serves   as   a   methodological paper with a typical OSCE setting to help readers realize the benefits of TDS and the feasibility of adopting TDS to their own OSCEs.  Methods  In a typical OSCE involving fail/pass decisions, two or more raters are required to maintain higher relia -  bility and consistency, as rater variability can signifi -  cantly impact scoring outcomes. TDS begins with one rater, labelled as Rater 1, who is randomly selected from the rater pool with a specific label. to ensure unbiased initial scoring. That said, those labels iden -  tify the expertise of each rater, ensuring that the raters only rate performance that they have superior professional   qualities.   That   said,   each   examinee’s responses to a task are scored by a rater, termed as Rater 1 whoever completes the initial rating assign -  ment. Therefore, Rater 1 is likely to be unidentical for different examinees in an actual OSCE, because mul -  tiple yet parallel testing rooms are always available in the setting, while two examinees starting the test simultaneously   are   scored   by   different   Rater   1s. Figure 2 demonstrates how four raters, selected for the rater pool, assess the performance of four exam -  inees on specific tasks. Regardless of the DS method utilized, Examinee Ross is initially evaluated by Rater John,   followed   by   a   subsequent   assessment   from Rater Mary, making John Ross’s initial rater (i.e., Rater 1), a role he shares with Examinee Joy. For Examinees Chandler and Monica, their initial raters are Mary and Kate, respectively. The figure highlights that Ross and Monica’s performances, as assessed by Rater 1s (John and Kate), fall outside the CSR, negat -  ing the need for a second evaluation. To emphasize, the Rater (e.g., Rater 1 or Rater 2) is a label in the TDS methodological workflow; this conceptual term is used in the statistical formula of TDS loss function as seen later in this paper.  According to the rule demonstrated in Figure 1, TDS   requires   those   examinees,   of   whom   a   score assigned by Rater 1 falling within a CSR, to be dou -  ble-scored at the specific task/item. To distinguish the terms and concepts in this paper, Figure 3 illustrates  Figure 1.   Demonstration of targeted double scoring in a simplified scenario when different critical score ranges (Csr.X) are present.  MEDICAL EDUCATION ONLINE   3\nFigure 2.   Illustration of the concept of Rater.  Figure 3.   Reference of terms related to settings and examples in this paper.  4   Z. FU ET AL.\nthe relationships between key terms, their settings, and examples. The CSR is determined based on sta -  tistical analysis of the scoring data. Scores falling within the CSR are those closest to the pass/fail cut -  off, where the risk of incorrect decisions is highest. For example, if the cutoff is 60, scores between 55 and 65 are considered critical. By focusing double scoring on these ranges, we ensure reliability while minimiz -  ing costs. The CSR is the cornerstone of TDS. By identifying and focusing on scores near the pass/fail cutoff, we ensure that the most critical decisions are made with high reliability. This approach reduces costs   while   maintaining   fairness   and   accuracy. Should CSR apply to performance at station- or test- level becomes a typical question; it does not only depend on the OSCE’s design but also the scoring rubric. In terms of the design, OSCEs involve various  facets   (e.g., raters, stations, tasks/items and occasions) and   structures   (e.g.,   multiple   tasks   nested   within a station or a task is essentially a station). Scoring practice, such as the use of measure instruments, the calculation of overall scores, the granularity of exam -  inees’ performance being rated, and the scale of the scoring sheet, affects the CSR decision on the other hand.  The data used in this study were collected from a pilot remote OSCE administered to 550 clinical medicine undergraduates in China, with a diverse range   of   clinical   expertise   and   educational   back -  grounds.   The   OSCE   comprised   three   stations: Clinical Reasoning (CR), Physical Examination (PE), and Fundamental Skills (FS). According to public information by NMLE, CR mainly focuses on the auscultation of the heart and lungs, imaging diagno -  sis, electrocardiogram diagnosis, medical ethics, med -  ical history taking, and case analysis; among them, medical history taking and case analysis are paper- based, while the others are primarily computer-based. PE evaluates examinees’ abilities to conduct compre -  hensive physical examinations on patients, covering various aspects such as general examination, head and neck examination, and chest examination; exam -  inees are required to have a thorough understanding of examination methods, techniques, and judgment criteria. FS is designed to assess candidates’ hands-on abilities, involving common clinical procedures such as injections, punctures, and intubations. Examinees need to proficiently master the essentials and precau -  tions of these operations to ensure accurate and safe completion in practical situation.  Subscores were recorded for each station in the administration system, serving as the CSR levels for subsequent   analysis.   Each   performance   of   the   550 examinees in the sample pool was rated remotely by two assessors. The cut-off score for the OSCE was set at 60 out of 100, which corresponds to the maximum possible total score. It should be noted that the OSCE did not record-specific cut-off subscores for each station or   task.   This   study,   involving   human   participants, received   approval   from   the   Biomedical   Ethics Committee of Peking University (IRB00001052–22070).  In this paper, we assume that a CSR applies to tasks/stations of an OSCE instead of an overall score. Note that the scores on the remaining part of the OSCE may or may not be available at the time of deciding double score for one task/station. In addi -  tion, it is assumed that an overall OSCE score is obtained from combining scores on all tasks/stations; perhaps the simplest example is adding scores on all stations to form one value, which is compared with the cut-off score for pass/fail decisions. Finally, the unit of a score is equal to the average of two raters’ judgements if double-scored examinees are present, else equal to the Rater 1 score.  In TDS, quantitative approaches [14–16] are used to   aid   defining   CSR.   A   communality   among   the approaches is a loss function, which quantifies the benefit or loss associated with each possible decision. Traditionally, loss functions are defined to simple calculations of the monetary costs or the rater labor independently. Extending the loss function into the framework of statistical decision theory, on the other hand, allows the analysis to entail unknown factors, typically expressed as random variables and/or prob -  ability distribution(s) in a model. Compared with other quantitative counterparts, these model-based ones are likely to consider intake complex yet neces -  sary elements into the consideration, yielding a more realistically useful and methodologically flexible solu -  tion. Therefore, loss functions underlaying statistical decision theory are used in this study. Sinharay and colleagues [20] consider three loss elements that are provided by researcher (i.e., the elements are not estimates but known constants used in the latter statistical process):  ●   L P   (if an examinee passes the OSCE based on Rater 1 score and would have failed the test if the subtest were double scored);  ●   L F   (if the examinee fails the OSCE based on Rater 1 score and would have passed if double- scored);  ●   c   (the cost for extra rating when double scoring is needed).  Using   P () to represent a probability function and utilizing the abbreviations defined above, one can deliver the complete loss function as:  Loss   ¼   c   �   P   CSR ð   Þ þ   L P  �   P   Pass with 1rating and fail with2ratings   & Outside CSR ð   Þ þ   L F  �   P   Fail with 1rating and pass with2ratings   & Outside CSR ð   Þ :  P (CSR) presents the probability that a score falls in a selected CSR, for example, if 20% of examinees score 50–60 in an OSCE of which the score range is  MEDICAL EDUCATION ONLINE   5\n0–100, then   P (CSR=[50,60]) = 0.2; the remaining   P () components can be understood the same way. As the researcher provides values for   L P ,   L F , and   c , the goal of this study is to identify the CSR that results in the smallest loss, which can be considered the optimal CSR. It is important to clarify that TDS analysis is conducted   on   a   complete   dataset   extracted   from a past assessment. However, its implications pertain to a future design resembling a ‘planned missing’ approach. In this study, the value of   c   remained con -  stant at 40, representing an average rating cost of $40 per performance. Given that   L P , and   L F   cannot be directly obtained from the administration’s finan -  cial statements, conventional combinations, as out -  lined by Sinharay and colleagues [20], were utilized to set the values as {40, 40}, {800, 200}, {400, 400}, {200, 800}, and {4,000, 4,000} for the costs of { L P , L F   }. From a modeling perspective, the loss function defined above is the statistical model with both unknown estimates   (i.e.,   CSR)   and   known   constants   (i.e.,  L P , L F   , and   c ), and the computation is a combing plug-in and result comparison (i.e., trial and error algorithm). That is, different CSRs are suggested by experts and then used in the loss function to yield the loss estimates, which are then compared with each other to find the optimal solution.  In our exploration of cost savings and the loss function   associated   with   the   implementation   of TDS, we aim to translate our statistical findings into more tangible, monetary terms for easier understand -  ing. Essentially, the ‘cost savings’ we discuss refer to the reduction in expenses achieved by adopting TDS over traditional DS. For instance, if traditionally scor -  ing an OSCE with two raters across all students costs $10,000, and implementing TDS reduces the need for dual raters to only critical cases, this might lower the cost to $6,000. This $4,000 difference represents our ‘cost savings.’ Similarly, the ‘loss function’ is a way of measuring what, if any, accuracy or reliability we sacrifice   for   these   savings.   However,   our   analysis aims to show that any such ‘loss’ is minimal and does not significantly impact the overall quality of the assessment. By presenting these concepts in terms of actual dollars saved, we hope to provide a clearer picture of TDS’s economic and practical benefits.  Analysis  The full dataset is visualized in Figure 4, where each examinee’ scores assigned by Rater 1, Rater 2, as well as the gap between the Raters (i.e., the lines connect -  ing Rater 1 and Rater 2) are all shown. For points where no red lines are found, they mean that Rater 1 and Rater 2 reach a perfect agreement. Overall, the total   scores   rated   by   Rater   1   and   Rater   2   form a   Pearson   correlation   of   0.9   showing   high   total- score-level consistency, while computed via all raw scores, Cronbach’s   ɑ   reaches 0.66, an acceptable value for performance assessment. Using the aforemen -  tioned cut-off score (i.e., 60), employing Rater 1s’ values alone results in a pass rate of 71.45%, while incorporating Rater 2s’ data reduces the success rate to 68.72%. This reduction highlights the importance of double scoring in ensuring accurate pass/fail deci -  sions, particularly in high-stakes assessments. The rating agreement between Rater 1 and Rater 2 was calculated using weighted Cohen’s Kappa, yielding a value of 0.97, indicating near-perfect agreement. This statistic is considered high, with values above 0.80 generally indicating excellent agreement. Table 1 presents the descriptive findings of the remote OSCE. Notably, the patterns observed between Rater 1 and Rater 2 are quite similar, with the primary distinction between the pass and fail groups residing in the Clinical Reasoning (CR) station. From an alternative perspective, Rater 2’s values exhibit a downward shift in the Patient Encounter (PE) and Formulation of Solutions (FS) stations when compared to those of Rater 1.  It is important to acknowledge that the values presented in Table 1 may undergo alterations when different   combinations   of   raters   are   assigned   to either Rater 1 or Rater 2 groups. Illustrating the fundamental outcomes of TDS, Figure 5 has been revised to include a more comprehensive table sum -  marizing   the   expected   losses   for   different   CSRs, alongside the existing figure for better clarity. The CSR was divided into intervals based on the risk of incorrect decisions. For example, in the CR station, CSRs were divided into intervals of 10 points (e.g., 50–60);   in   the   PE   and   FS   stations,   CSRs   were divided   into   smaller   intervals   of   2   points   (e.g., 58–60). These intervals were chosen to ensure that scores near the cutoff (60) were prioritized for dou -  ble scoring. Each station encompasses two extremes of CSRs: the null set, signifying the absence of dou -  ble scoring, and the set denoted as 0–60 for CR, 0–20 for PE, and 0–20 for FS, representing double scoring for all responses.  In Figure 5, each line corresponds to a specific CSR, with ‘NULL’ indicating the absence of double scoring throughout the assessment. The x-axis repre -  sents the estimated expected loss of the five sets of { L P , L F   }, while the y-axis signifies the corresponding total cost, calculated using the Loss function as out -  lined in the Method section.  In cases where double scoring was not implemen -  ted (i.e., CSRs were set to 0–60 for CR, 0–20 for PE, and 0–20 for FS stations), the estimated expected loss consistently remained at 40, reflecting the value of ‘c.’ When { L P , L F } equaled {40, 40}, the cost of incorrect pass/fail decisions did not surpass the cost of double scoring,   rendering   such   incorrect   decisions   cost- effective. Consequently, the estimated expected loss  6   Z. FU ET AL.\nwas minimized for the null CSR, establishing ‘no double-scoring’   as   the   optimal   decision   for   each station.  When   L P   and   L F   were set at 4,000, the loss incurred from incorrect pass/fail decisions exceeded the cost of Double Scoring (DS), rendering such incorrect deci -  sions nearly unacceptable. Consequently, the estimated expected loss reached its minimum value (equating to 40) for the following CSRs: 0–20 in PE and FS stations, and 0–60 in CR station. This outcome indicates that opting for ‘all double-scoring’ was the optimal decision under these conditions.  For other sets of { L P , L F }, the estimated expected loss was minimized for the following CSRs: 30–40 in the CR station, 13–15 or 0–20 in the PE station, and 0–20 in the FS station. As the values of { L P , L F } increased, the cost and risk associated with incorrect decisions rose, surpassing the cost of additional rat -  ings. Consequently, the decision-theoretic approach favored   DS   and   broader   CSRs.   This   preference  Figure 4.   Plot of scoring results of each examinee by Raters.  Table 1.   Means and standard deviations of the remote OSCE.  Test   Station  Total Score   Clinical Reasoning   Physical Examination   Fundamental Skills  Rater 1   Fail   49.70 (6.85)   19.24 (6.58)   15.24 (1.93)   15.22 (3.39)  Pass   79.57 (11.06)   45.74 (10.41)   17.08 (1.78)   16.75 (2.92)  Rater 2   Fail   49.12 (7.32)   19.87 (7.08)   14.76 (1.95)   14.49 (3.18)  Pass   77.95 (10.16)   45.68 (9.89)   16.47 (1.64)   15.81 (2.61)  MEDICAL EDUCATION ONLINE   7\nresulted in different CSR selections across the three combinations   where   L P   and   L F   were   equal. Specifically, the null range minimized the loss when { L P , L F } equaled 40, while the full range was optimal when the unit cost in each station was set at 4,000. In the case of { L P , L F } equaling 400, the middle range minimized the loss in the CR station, whereas the full range resulted in the smallest loss for the PE and FS stations.  Setting { L P , L F } values to {40, 40}, {800, 200}, {400, 400}, {200, 800}, and {4,000, 4,000} correspondingly yielded minimum costs as follows: (1) in CR station, minimum costs were 7.13, 38.69, 24.15, 16.87, and 40; (2) in PE station, minimum costs were 10.25, 38.47, 40, 40, and 40; (3) in FS station, minimum costs were 12.44, 40, 40, 40, and 40. Summing the total mini -  mum   costs   across   all   stations   resulted   in   29.82, 117.16,   104.15,   96.87,   and   120,   respectively.   The {4,000, 4,000} combination preferred traditional DS over TDS, as the costs associated with the latter method were much higher, as seen from Figure 5.  Discussion and conclusion  Figure   6   summarizes   the   flow   with   the   analysis results.   (1)   Initial   Scoring:   Rater   1   evaluated   the examinee’s   performance   and   assigns   a   score.   (2) Check if the score falls within the CSR: A decision point is reached to determine whether the score falls within the CSR. (3) If the score is outside the CSR, no double scoring is needed, else, Rater 2 was invited to evaluate the examinee’s performance. (4) If DS was applied, the scores from Rater 1 and Rater 2 were combined   (e.g.,   averaged)   to   determine   the   final result, else the Rater 1 score was used directly as the final result.  In exploring the implementation of TDS within the context of OSCEs, our study underscores the delicate   balance   between   maintaining   assessment integrity and managing logistical constraints. TDS emerges not only as a methodological innovation but   as   a   strategic   response   to   the   increasing demands   for   scalable,   cost-effective   educational assessments.   This   approach,   by   focusing   scoring resources on pivotal junctures within the assess -  ment   spectrum,   particularly   those   close   to   the pass/fail threshold, ensures that the reliability of critical evaluations is upheld without disproportio -  nately   escalating   administrative   burdens.   The implications   of   our   findings   extend   beyond   the immediate   operational   efficiencies.   They   invite a broader discourse on the evolution of assessment practices within clinical education, particularly in environments constrained by resources or facing logistical challenges. By demonstrating the feasibil -  ity   and   effectiveness   of   TDS,   we   contribute   to a growing body of evidence advocating for adaptive assessment strategies. Such strategies, which har -  ness data-driven insights to refine scoring meth -  odologies,   can   significantly   enhance   the pedagogical value of OSCEs. They do so by ensur -  ing that evaluations are not only rigorous and fair but   also   aligned   with   the   practical   realities   of administering   wide-scale   examinations.   Future research   should   explore   the   integration   of   TDS across diverse educational settings and its potential  Figure 5.   Estimated expected losses for three stations for different CSRs.  8   Z. FU ET AL.\nrefinement through the use of artificial intelligence and machine learning.  While TDS is designed with flexibility and adapt -  ability in mind, its implementation may face chal -  lenges such as resistance to change and the need for faculty training. Best practices for adoption include piloting TDS in smaller cohorts before scaling up. The foundational requirement for TDS implementa -  tion is the existing use of traditional DS within the OSCE framework. After implementing TDS, the fol -  low-up practice actually reduces the operational bur -  den.   Therefore,   institutions   that   already   employ traditional   DS   are   well-positioned   to   adopt   TDS, enhancing their assessment processes with minimal adjustments. TDS is aimed at broadening access to efficient, reliable assessment methods, especially in settings where resource constraints might otherwise limit the use of comprehensive evaluation strategies  Central to the discourse presented in this paper is its methodological inspiration, delineating a clear distinction between the generalizability of applied studies’ findings and the applicability of the TDS method itself. The core of this paper lies not within the specific outcomes of applying TDS within our study context but in the framework and approach we propose for enhancing the efficiency and relia -  bility of OSCE assessments. This distinction is cru -  cial, as it underscores the potential for TDS to be adapted and applied across a wide range of assess -  ment settings, irrespective of the characteristics or constraints of those environments. The adaptability of the TDS approach signifies a pivotal shift towards more flexible and context-sensitive assessment stra -  tegies in medical education. It invites educators and administrators to reconsider the rigidity of tradi -  tional scoring systems in favor of methodologies  Figure 6.   Flowchart of targeted double scoring (TDS) decision-making process with analysis results.  MEDICAL EDUCATION ONLINE   9\nthat can be tailored to the unique demands and opportunities of their specific contexts. In doing so,   the   generalizability   of   this   method   extends beyond   the   confines   of   our   study,   offering a versatile tool for improving assessment practices. The emphasis thus shifts towards understanding and leveraging   the methodological   principles   of   TDS, encouraging further exploration into its potential applications and modifications to suit diverse educa -  tional landscapes.  While TDS offers significant cost savings, its effec -  tiveness may vary depending on the specific context of the OSCE. Extending studies can explore the scal -  ability of TDS in diverse educational settings and its integration with emerging technologies, meaning the minimum to the maximum of all possible scores are assigned to the lower and higher bounds of a CSR. From a statistical perspective, the baseline implies a constant loss (i.e., 40), since   P (CSR) = 1,   P (Pass with   1 rating   and fail   with   2 ratings   &   Outside CSR) = 0, and   P (Fail with 1 rating and pass with 2 ratings & Outside CSR) = 0. In the study, the costs of baseline could be outperformed by TDS in the first two stations: all { L P , L F   } combinations except {4,000, 4,000} in CR station evidenced the benefits of TDS, while the same conclusion could be found in PE station when {40, 40} and {800, 200} were used. However, the baseline method should be used in the FS station because none of the { L P , L F   } combinations favored TDS. Deciding   L P   and   L F   may be the first difficulty that researchers face when modeling the data. Further, the way of splitting CSRs into intervals for the cost-effectiveness evaluation also impose chal -  lenges: they can be as fine-grained as one point but making the CSRs meaningless, while a wider interval leads to less saving from original costs of rater labors (e.g., if 0–1 and 2–20 are two candidate CSRs for PE station,   that   scores   falling   in   2–20   requiring   DS results in nearly no savings).  Like other adoptions into assessment, it necessi -  tates a thorough examination of ethical considera -  tions,   particularly   concerning   privacy   and   data security. As we navigate the integration of technol -  ogy in educational assessments, it is imperative to ensure that robust measures are in place to protect the confidentiality and integrity of examinee data. This includes adherence to stringent data encryp -  tion standards, secure data storage practices, and transparent   data   handling   policies.   Additionally, the   shift   towards   remote   assessments   introduces the need for clear guidelines to prevent unauthor -  ized access and ensure the authenticity of examinee performances. Addressing these ethical concerns is not only critical for maintaining the trust and cred -  ibility   of   the   assessment   process   but   also   for upholding the dignity and rights of all participants involved.  Disclosure statement  No   potential   conflict   of   interest   was   reported   by   the author(s).  Funding  The work was supported by the National Natural Science Foundation of China [72474004]; National Natural Science Foundation   of   China   for   Young   Scholars   [72104006, 62407002];   Natural   Science   Foundation   of   Fujian Province of China [2021J01981]; National Social Science Foundation   of   China   [21BTJ036];   Key   Laboratory   of Digital Educational Publishing Technology and Standards and Digital Education Research Institute of the Peoples Education Press [RJB0623001]; Peking University Health Science   Center   [BMU2021YJ010];   Peking   University Health   Science   Center   Medical   Education   Research Funding Project [2023YB24].  ORCID  Zhihui Fu   http://orcid.org/0000-0002-8525-0847  Yuhong Wu   http://orcid.org/0009-0000-7799-7767  Lingling Xu   http://orcid.org/0000-0001-7112-2134  Fen Cai   http://orcid.org/0000-0002-6734-2860  Ren Liu   http://orcid.org/0000-0002-6708-4996  Zhehan Jiang   http://orcid.org/0000-0002-1376-9439  References  [1] McManus IC, McLeod K. Performance assessment in medical education. Oxford: Oxford University Press; 2017.  [2] Bruno GM, Shapiro JA, Holmboe ES. The use of OSCEs to assess competency in medical education. Acad Med. 2018;93(4):523–527.  [3] Bond CF, Titus LJ. Social facilitation: a meta-analysis of 241 studies. Psychol Bull. 1983;94(2):265–292. doi: 10.1037/0033-2909.94.2.265  [4] Aiello JR, Douthitt EA. Social facilitation from Triplett to electronic performance monitoring. Group Dyn: Theor   Res   Pract.   2001;5(3):163–180.   doi:   10.1037/ 1089-2699.5.3.163  [5] Brown C, Ross S, Cleland J, et al. Money makes the (medical assessment) world go round: the cost of com -  ponents of a summative final year Objective Structured Clinical   Examination   (OSCE).   Med   Teach.   2015;37 (7):653–659. doi: 10.3109/0142159X.2015.1033389  [6] Jiang Z, Shi D, Distefano C. A short note on optimiz -  ing   cost-generalizability   via   a   machine-learning approach. Educ Psychol Meas. 2021;81(6):1221–1233. doi: 10.1177/0013164421992112  [7] Jiang Z, Ouyang J, Li L, et al. Cost-effectiveness ana -  lysis in performance assessments: a case study of the objective structured clinical examination. Med Educ Online.   2022;27(1):2136559.   doi:   10.1080/10872981. 2022.2136559  [8] Wu H, Chen B, Wang H, et al. Remote scoring for an OSCE: a reliable and valid assessment tool for medical education. 2020.  [9] Arnold MK, Cianciolo AT, Audia PF, et al. Evaluation of remote scoring for a medical school clinical skills assessment. Clin Teach. 2019;16(6):466–471.  10   Z. FU ET AL.\n[10] Majumder MA, Kumar A, Krishnamurthy K, et al. An evaluative study of objective structured clinical exam -  ination (OSCE): students and examiners perspectives. Adv Med Educ Pract. 2019;10:387–397. doi: 10.2147/ AMEP.S197275  [11] Chong L, Taylor S, Haywood M, et al. The sights and insights of examiners in objective structured clinical examinations. J Educ Eval Health Prof. 2017;14:34. doi: 10.3352/jeehp.2017.14.34  [12] Kim HS, Lee YH, Kim MJ, et al. Development and evaluation of an objective structured clinical examina -  tion for assessing the clinical performance of medical students. BMC Med Educ. 2017;17(1):237.  [13] Brand HS, Schoonheim-Klein M. Is the OSCE more stressful? Examination anxiety and its consequences in different assessment methods in dental education. Eur J Dent Educ. 2009;13(3):147–153. doi: 10.1111/j.1600- 0579.2008.00554.x  [14] Alfaris EA, Alenazi YR, Alshagga MA, et al. Students’ perceptions   towards   Objective   Structured   Clinical Examinations (OSCE) at a new medical school in Saudi Arabia. Int J Health Sci (Qassim). 2018;12(1):3.  [15] Park BK, Kim MR, Cho YJ, et al. A comparative analysis   of   examinee’s   perception   on   Objective Structured   Clinical   Examination   (OSCE)   between internal and external examiners. J Educ Eval Health Prof. 2017;14:34. doi: 10.3352/jeehp.2017.14.34  [16] Bell CA, Jones ND, Qi Y, et al. Strategies for assessing classroom teaching: examining administrator thinking as validity evidence. Educ Assess. 2018;23(4):229–249. doi: 10.1080/10627197.2018.1513788  [17] Williamson DM, Xi X, Breyer FJ. A framework for evalua -  tion and use of automated scoring. Educ Meas: Iss Pract. 2012;31(1):2–13. doi: 10.1111/j.1745-3992.2011.00223.x  [18] Wiggins G. The case for authentic assessment. Pract Assess, Res, Eval. 1990;2(1):2. doi: 10.7275/ffb1-mm19  [19] Finkelman M, Darby M, Nering M. A two-stage scor -  ing method to enhance accuracy of performance level classification.   Educ   Psychol   Meas.   2008;69(1):5–17. doi: 10.1177/0013164408322025  [20] Sinharay S, Johnson MS, Wang W, et al. Targeted double   scoring   of   performance   tasks   using   a decision-theoretic   approach.   Appl   Psychol   Meas. 2023;47(2):155–163. doi: 10.1177/01466216221129271  MEDICAL EDUCATION ONLINE   11',0.10148039764511665,'[\"$10,000,\", \"$4,000\", \"$40\", \"$6,000.\", \"&\"]','2025-11-29 21:19:35.757413'),(87,3,'Rev.   C ient.   S ist.   I nform.   5 ( 1 ), e 864 , doi:   10.51252/rcsi.v 5 i 1 . 864  Original article  Artículo original  Jan - Jun , 202 5 https://revistas.unsm.edu.pe/index.php/r csi  e - ISSN:   2709 - 992X  ©   The authors. This is an open - access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distr ibution,  and reproduction in any medium,   provided the original work is properly cited.  Use of technology in research among medical students at a  private university in Huancayo  Uso de las tecnologías al servicio de la investigacion por estudiantes de medicina  de una universidad privada de Huancayo  Mely Ruiz - Aquino 1* ,   Andrés   Leonardo Osorio - Llancachagua 2 ,   Julio Oswaldo Botiquín -  Encarnación 2 ,   Aníbal Valentín Diaz - Lazo 2 ,   Santiago Ángel Cortez - Orellana 2 ,   Rivaldo Carlos  Duran - Aquino 3  1 Universidad de Huanuco .   Huanuco, Peru  2 Universidad Peruana Los Andes .   Huancayo, Peru  3 Universidad Nacional Mayor de San Marcos .   Lima, Peru  Received :   29   Sept .   202 4   |   Ac c ept ed :   23   Nov .   202 4   |   Publi shed :   2 0   Jan.   202 5  Corresponding author *:   melyruizaquino@udh.edu.pe  How to cite this article :   Ruiz - Aquino, M., Osorio - Llancachagua, A. L., Botiquín - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A   .,  & Duran - Aquino, R. C .   (202 5 ).   Use of technology in research among medical students at a private university in Huancayo .   Revista  C ientífica de   S istemas e   I nformática ,   5 ( 1 ), e 7 63 .   https://doi.org/10.51252/rcsi.v5i1.864  ABSTRACT  This study mainly assessed the level of technology use in research among medical students during the infodemic  period at a private university in Huancayo. A quantitative, descriptive study was conducted with a randomly  selected sample of 109 students from   a total population of 764. A validated technology usage scale for research  was applied, followed by a descriptive data analysis. The results indicated that 44.95% of students had a basic  level of technological proficiency, 45.87% had an intermediate level,   and only 8.26% had an advanced level. The  most frequently used tools were PubMed and SciELO for literature searches, whereas the use of reference  managers and academic integrity tools was notably limited. The findings suggest that despite having access to  digital devices and internet services, students require further training in advanced technological tools to enhance  the quality of their research .  Keywords :   competencies; education; infodemic;   research; technology  RESUMEN  El objetivo de este estudio fue identificar el nivel de uso de las tecnologías al servicio de la investigacion por parte  de estudiantes de medicina en tiempos de infodemia en una universidad privada de Huancayo. Se   realizo un  estudio cuantitativo, descriptivo simple, con una muestra de 109 estudiantes seleccionados aleatoriamente de  una poblacion de 764. Se aplico una escala de uso de tecnologías para la investigacion y se realizo un analisis  descriptivo de los datos . Los resultados indicaron que el 44,95% de los estudiantes tenía un nivel basico, el  45,87% un nivel intermedio y solo el 8,26% un nivel avanzado en el uso de tecnologías. Las herramientas mas  utilizadas fueron PubMed y Scielo para la busqueda de informac ion, mientras que el uso de gestores de  referencias y herramientas de integridad academica fue limitado. Se concluye que, aunque los estudiantes  cuentan con acceso a dispositivos y servicios de internet, existe una necesidad de fortalecer sus habilidades e n  el uso de tecnologías avanzadas para mejorar la calidad de sus investigaciones .  Palabras clave :   competencias; educacion; infodemia; investigacion; tecnología.\nRuiz - Aquino   et al.  2   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  1.   INTRODUC TION  In recent years, the COVID - 19 pandemic has fueled   the rise of an infodemic, characterized by the  rapid spread of all types of information, including rumors and unreliable data. This has been  facilitated by the widespread use of mobile phones, social networks, the internet, and other  communication technolo gies (Arroyo et al., 2020). However, technology use is not inherently  detrimental. We are experiencing a technological revolution marked by the global expansion of  computers and digital communication systems (Grande et al., 2016), which have proven invalua ble  across various fields, including scientific research. Information and Communication Technologies  (ICTs) exemplify this transformation, significantly impacting research by enabling more efficient  problem - solving and data management (Grande et al., 2016) . Medical students increasingly rely  on ICTs to streamline research tasks that would otherwise be time - consuming and resource -  intensive (Arbelaez, 2014).  A 2019 study in Spain by Garcí a   &   Canton (2019) reported that nearly all students (98%) used  search engines such as Google or Safari, and 96% utilized instant messaging applications like  WhatsApp or Telegram. In Mexico, Gomez (2019) found that only 18% of university students had  internet a ccess at home, with financial constraints being the primary barrier. Social media use was  also widespread, with 95% of students on Facebook, 79% on Twitter, and 65% on Instagram.  Similarly, Campos et al. (2018) reported th at 72.4% of students at a Mexican research center were  familiar with ICTs, with an average competence rating of 3.54 on a scale of 1 to 5. A 2017 study in  Chile by Cerda et al. (2017) found that 97% of surveyed students owned a laptop and 87% had a  smartph one, with extensive internet coverage at home.  In Peru, Morales (2020) examined ICT integration in video surveillance in Santiago de Surco,  noting a lack of system interoperability. Mendoza (2018) found that 70.4% of educators  incorporated ICT into their teaching, mainly through images (69.1%), videos   (64.2%), and audio  (44.4%), with PowerPoint being the most frequently used tool (93.8%). However, 38.3% of  teachers reported insufficient training and requested instruction on virtual classroom design.  Licona   &   Veitya (2019) further emphasized the necessit y of technological training for researchers,  highlighting its role in accessing and managing scientific information.  Given the transition to virtual learning environments, evaluating the extent of technology use in  research among medical students during the infodemic is crucial (Al - Hail et al., 2023; Almufarreh  & Arshad, 2023). ICTs have become essential in both in - perso n and remote education (Licona &  Veitya, 2019), enhancing research quality by facilitating access to databases, data processing  software, academic writing tools, presentation applications, plagiarism detection programs, and  reference management systems. Re cent studies have demonstrated a direct link between students\'  technological competencies and the effectiveness of their academic research (Martínez & Flores,  2021; Reyes et al., 2020).  Furthermore, Navarrete Enrí quez et al. (2024) and Salguero Alcala et al.   (2024) underscored the  importance of digital competencies for academic performance, particularly in information - dense  environments like the infodemic. These studies highlight the necessity of integrating educational  strategies to strengthen students\' techn ological skills, enabling them to efficiently manage  information and enhance research quality.\nRuiz - Aquino   et al.  3   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Thus, the objective of this study is to identify the level of technology use in research among medical  students at a private university in Huancayo during the infodemic period.  2.   MATERIALS   AND   M ETHODS  2.1.   Type and area study  A quantitative, descriptive, cross - sectional study was conducted among medical students. The area  where the study was   conducted was the Peruvian University of Los Andes. It was carried out from  September 2021 to January 2022.  2.2.   Population and sample  The study population consisted of 764 students of the Faculty of Human Medicine of the  Universidad Peruana Los   Andes, and the sample consisted of 109 students to whom a scale of use  of technologies in the service of research was applied, performing a descriptive analysis. The  inclusion criteria considered students who were doing research work, those between the fif th and  twelfth year of studies, and all students who expressed their willingness to participate. Students  who were between the first and fourth cycle of studies were excluded from the study, as well as  those who did not adequately complete the questionnair e (Table 1).  Table 1.   neral characteristics of the sample of medical students  General characteristics   n=109  fi   %  Demographic characteristics  Age group (years)  Teenagers (15 - 19)   87   79,82  Youth (20 - 25)   20   18,5  Adults (>25)   2   1,83  Sex  Male   48   44  Female   61   56  Academic characteristics  Cycle of studies  Fifth cycle   15   13,8  Sixth cycle   22   20,2  Seventh cycle   23   21,1  Eighth cycle   9   8,3  Ninth cycle   22   20,2  Tenth cycle   8   7,3  Eleventh cycle   9   8,3  Twelfth cycle   1   0,9  Characteristics of the   research  Type of study  According to the researcher\'s intervention  Observational   106   97,2  Experimental   3   2,8  According to the source of information  Retrospective   73   67  Prospective   36   33  According to the number of measurements  Transversal   104   95,41  Longitudinal   5   4,59  According to the number of variables  Descriptive   95   87,16  Analytical   14   12,84\nRuiz - Aquino   et al.  4   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Project phase  Planning   95   87,2  Execution   11   10,1  Final report   3   2,8  Publication   0   0  Informative data  Previous scientific   publication  Yes   2   1,8  No   107   98,2  Type of study  Original article   -   -  Letter to the editor   -   -  Editorial   -   -  Review article   2   1,8  Symposium   -   -  Case report   -   -  Essays   -   -  2.3.   Data collection techniques and instruments.  The online survey   technique was used, using the \"Scale of the use of technologies in the service of  research\" as an instrument. This instrument was composed of 49 items distributed in 7  dimensions:   technology   for   information   search,   database   technology,   technology   for   data  processing, technology for writing, technology for the presentation of research results, technology  for academic integrity, and technology for reference managers. In addition, a survey guide was  applied to collect the general characteristics of the sample,   which consisted of 13 items organized  into   4   dimensions:   demographic   characteristics,   academic   characteristics,   research  characteristics, and informational data (Table 2) .  Tabl e   2.   Characteristics of the use of technologies by medical students  Equipment and/or devices  N=109  Yes   No  fi   %   fi   %  Desktop computer   93   85.32   16   14.68  Laptop   61   55.96   48   44.04  Cell phone   95   87.16   14   12.84  Tablet   49   44.95   60   55.05  Printer   82   75.23   27   24.77  External memory   28   25.69   81   74.31  USB   81   74.31   28   25.69  MP4   44   40.37   65   59.63  Other   -   -   -   -  Internet service  Home Internet (Router)   100   91.74   9   8.26  Mobile Internet   65   59.63   44   40.37  Wireless Internet (Modem)   87   79.82   22   20.18  Other   -   -   -   -  The \"Scale of the use of technologies in the   service of research\" was validated by a panel of 5  experts, who evaluated the pertinence, relevance, clarity, and organization of the items, ensuring  that they were representative of the variable to be measured. The survey was conducted using the  Google Fo rms platform.\nRuiz - Aquino   et al.  5   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  2.4.   Data collection procedures  For data collection, the online survey was sent through the WhatsApp messaging application to  different groups of students, previously organized by academic cycles (from 5th to 12th). The  survey was designed to be answered in an average time of 20 minutes,   to ensure the participation  and adequate dedication of the respondents.  The process of constructing the instrument began with the development of a matrix in Microsoft  Word, in which the items and dimensions of the survey were clearly defined. Subsequently, this  matrix was transferred to the Google Forms platform, where the que stionnaire was developed in  its final format. This digital transition allowed for greater organization and accuracy in data  collection, as well as a more accessible experience for participants. In addition, the use of Google  Forms facilitated the collectio n and secure storage of responses, allowing for efficient management  of the data collected and minimizing the risk of data entry errors.  The distribution of the survey via WhatsApp was strategically planned to maximize the response  rate, taking advantage of the popularity and reach of this application among university students.  2.5.   Data analysis  Data collection was carried out through an online survey distributed via institutional email and  academic platforms. The survey responses were recorded and analyzed using descriptive  statistics, including frequency distributions, means, and standard deviat ions. The collected data  were processed using SPSS version 26.  2.6.   Ethical aspects  Before initiating the study, permission was obtained from the Universidad Peruana Los Andes,  ensuring institutional conformity with the research. Prior to the application of the survey,  participants were asked to   provide informed consent virtually, in which the purpose of the study,  the intended use of the information collected and their rights as participants were explained  clearly and in detail, including their freedom to withdraw their participation at any time   without  negative consequences.  At all times, the protection of the confidentiality of respondents\' personal data was guaranteed. To  this end, specific measures were implemented, such as the use of anonymous identifiers and  encryption of information, minimizing the risk of unauthorized d isclosure. In addition, a strict  commitment was maintained with the regulations and guidelines established in the Code of Ethics  for Scientific Research of the Universidad Peruana Los Andes, which ensured respect for the  integrity of the participants and t ransparency in all phases of the study.  Compliance with these ethical principles was essential to preserve the confidence of the  participants and ensure the validity and reliability of the data obtained. Likewise, specific  protocols were established for the management of any ethical situation th at might arise during the  development of the research, ensuring a safe and respectful environment for all those involved .  3.   RESULTS  The results of this study show that the majority of medical students at a private university in  Huancayo are in the planning phase of their research, being mostly adolescents and with a slightly  higher   female   representation.   The   nature   of   the   studies   they   conduct   is   predominantly\nRuiz - Aquino   et al.  6   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  observational, retrospective, cross - sectional and descriptive, indicating a basic approach to  information collection and analysis. In addition, it is observed that, although the students have  access to appropriate technological devices and Internet service s, their level of mastery in the use  of specific technologies for research is mostly basic or intermediate   (Table 3) .  The study found that 44.95% of students had a basic level of technological proficiency, 45.87%  demonstrated an intermediate level, and only 8.26% possessed an advanced level   (Table 4) .  Information search, database, and presentation technologies were the most used, with tools such  as PubMed and Scielo standing out. However, limited use of advanced tools for academic integrity  and reference management was observed, indicating areas for i mprovement in the management  of essential technologies for research .  Table 3.   Dimensions of the use of technologies in the service of research by medical students  Dimensions  N=109  Usage   Leve lof use  Yes   No   Basic   Intermedia  te   Advanced  fi   %   fi   %   fi   %   fi   %   fi   %  Information search  technology   109   100   -   -   47   43.12   54   49.54   8   7.34  Database technology   107   98.17   2   1.83   48   44.04   52   47.70   9   8.26  Data processing  technologies   109   100   -   -   43   39.45   50   45.87   16   14.68  Writing technologies   106   97.25   3   2.75   51   46.79   50   45.87   8   7.34  Presentation  technologies   109   100   -   -   40   36.7   52   47.71   17   15.6  Academic integrity  technologies   92   84.4   17   15.6   52   47.71   50   45.87   7   6.42  Reference manager  technology   91   83.49   18   16.51   55   50.46   45   41.28   10   9.17  Table 4.   Use of technologies in the service of research by medical students  Level of technology use   N=109  fi   %  I do not use   1   0.92  Basic   49   44.95  Intermediate   50   45.87  Moving forward   9   8.26  These results coincide with the findings of Salguero Alcala et al. (2024), who found that 27% of  the students evaluated had a low level of digital competencies, similar to the finding of 44.95% at  the basic level. However, unlike studies such as those of N avarrete Enrí quez et al. (2024), which  identified 73% of students with high digital competencies, the present study reveals a significant  gap in the advanced use of technologies, which underlines the need for specific training  interventions.  Likewise, Alamo   &   Montenegro (2022) reported that nursing professionals possess basic  knowledge and skills in ICT, aligning with the finding of a high percentage of students with basic  and intermediate levels in the use of technologies. This limited level of competence cou ld be  associated with the lack of specific training in the management of advanced tools, such as reference  managers and academic integrity tools, crucial for the quality of scientific research (Licona &  Veitya, 2019).\nRuiz - Aquino   et al.  7   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  On the other hand, Llanos de Tarazona (2019) demonstrated that an effective integration of ICTs  in   university   education   improves   students\'   research   competencies,   which   highlights   the  importance of strengthening these skills in the context of the present re search. In addition, Gomez  (2019) found that access to technologies does not necessarily translate into effective use for  academic purposes, corroborating that, despite the high availability of devices and internet among  participants, the use of advanced t ools is still deficient.  In line with the studies of Mendoza   &   Placencia (2018), who pointed out that the use of ICT in  teaching requires adequate teacher training, the results suggest that current pedagogical  strategies may not be sufficiently focused on the development of advanced technological  competencies among st udents. This is especially relevant in times of infodemic, where the ability  to manage and critically evaluate information is fundamental for academic research (Reyes et al.,  2020).  In addition, Martinez   &   Flores (2021) highlighted that during the pandemic, virtual training has  exacerbated inequalities in access to and use of technologies, which may be reflected in the varied  technological competence observed in the sample. The lack of advanced skills in res earch  technologies may limit the effectiveness and quality of research projects developed by medical  students.  Cerda et al. (2017) found that the use of digital technologies is positively related to academic  achievement in student teachers, suggesting that greater technological competence could improve  academic performance in health careers such as medicine. Howeve r, Martínez Perez et al. (2023)  observed that excessive use of social networks, such as Facebook, can negatively affect academic  performance, underscoring the need to balance the use of technologies for recreational and  academic purposes.  Aleman   &   Ynojosa (2024) warn about the threats and disadvantages of ICT use in academic  training, suggesting that ICTs have not been adequately exploited due to a lack of technological  skills or insufficient methodological information. Mendoza (2024) also points o ut that 67% of  students experienced problems related to the management and mastery of virtual platforms,  which could be linked to a lack of training in these areas.  In this context, the results reveal the need to strengthen the technological training of students,  integrating a progressive approach that allows them to develop advanced competencies in the use  of technologies applied to research. Comparison with previous   studies suggests that the level of  technological competence of students varies considerably according to the institutional context  and the pedagogical strategies implemented, which highlights the importance of a timely  educational intervention to close th is gap.  Finally, the integration of advanced digital competencies would not only improve the quality of  academic research, but also prepare future medical professionals to deal more effectively with the  challenges of the infodemic, characterized by the overabundan ce and variable quality of available  information (Arroyo et al., 2020).  Among the limitations of this study is the fact that the sample consisted of students from a single  private university in Huancayo, which may limit the generalizability of the findings to other  institutions or regions of the country. In addition, the scale   used to measure the use of technologies  may not have exhaustively captured all relevant dimensions in the context of academic research.\nRuiz - Aquino   et al.  8   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  The quantitative approach, on the other hand, may have restricted the exploration of qualitative  aspects that could provide a deeper understanding of students\' experiences with technologies.  Another important limitation is the use of virtual surveys, as un equal access to the internet and  the possible unfamiliarity of some students with digital platforms could have affected the accuracy  and completeness of responses, introducing bias in data collection.  It is recommended that the scope of the study be broadened to include samples of students from  different universities, both public and private, and in different regions of the country, in order to  obtain a more representative view of the use of technologie s in the service of research. In addition,  the   development   of   more   detailed   and   specific   measurement   instruments   that   can  comprehensively evaluate the use of technologies in academic contexts is suggested. It would also  be valuable to incorporate qualitati ve approaches to explore perceptions, motivations and barriers  faced by students when using technological tools in their research. Finally, it is recommended to  design and implement continuous training programs aimed at improving students\' technological  co mpetencies, especially in the use of reference managers and academic integrity tools  CONCLUSIONS  Most medical students at a private university in Huancayo reach basic or intermediate levels in  using technological tools for research. Despite having access to internet devices and services, there  is limited use of advanced and specific tools such as refe rence managers and academic integrity.  These findings underline the need to implement training strategies focused on improving the  mastery of critical technologies for academic research, which will allow us to face more effectively  the information overload   in the infodemic era .  FINANCI NG  The authors did not receive sponsorship to carry out this study - article .  CONFLICT OF INTEREST  The authors declare that they have no conflicts of interest related to the development of the  study .  AVAILABILITY OF DEPOSITED DATA  The datasets collected during this study and supporting the findings of the study are available at:  https://data.mendeley.com/datasets/w9znxg38bw/1  AUTHORSHIP CONTRIBUTION  Conceptualization;   Data   Curation;   Formal   Analysis;   Research;   Methodology;   Visualization;  Validation; Writing   -   original draft; Writing   -   revision and editing:   Ruiz - Aquino, M., Osorio -  Llancachagua, A. L., Botiquí n - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A., and Duran -  Aquino, R. C.\nRuiz - Aquino   et al.  9   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  REFERENC ES  Alamo , E., & Montenegro, R. (2022). Competencias en la tecnologí a de informacion y  comunicacion del profesional de enfermerí a en instituciones del primer nivel de atencion  Chiclayo, 2020.   ACC CIETNA:   Revista De La Escuela De Enfermería , 9(1), 18 – 28.  https://doi.org/10.35383/cietna.v9i1.592  Aleman , O., & Ynojosa, Y. (2024). Desafí os frente al uso de las tics en pandemia en el programa de  enfermerí a de la UNEFM.   Aula Virtual , 5(11), 151 – 169.  https://doi.org/10.5281/zenodo.10465778  Al - Hail, M., Zguir, M. F., & Koç, M. (2023).   University students’ and educators’ perceptions on the  use of digital and social media platforms: A sentiment analysis and a multi - country review.  IScience , 26(8), 107322.   https://doi.org/10.1016/j.isci.2023.107322  Almufarreh , A., & Arshad, M. (2023). Promising Emerging Technologies for Teaching and  Learning: Recent Developments and Future Challenges.   Sustainability , 15(8), 6917.  https://doi.org/10.3390/su15086917  Arbelaez, M. (2014). Las tecnologí as de la informacion y la comunicacion (TIC) un instrumento  para la investigacion.   Investigaciones Andinas , 16(29), 997 – 1000.  https://revia.areandina.edu.co/index.php/IA/article/view/52  Arroyo, A., Cabrejo, J., & Cruzado, M. (2020). Infodemia, la otra pandemia durante la enfermedad  por coronavirus 2019.   Anales de la Facultad de Medicina , 81(2), 230 – 233.  http://dx.doi.org/10.15381/anales.v81i2.17793  Campos Cruz, H., & Ramí rez Sanchez, M. Y. (2018). Las TIC en los procesos educativos de un  centro publico de investigacion.   Apertura,   10(1), 56 – 70.  https://doi.org/10.32870/ap.v10n1.1160  Cerda, C., Huete - Nahuel, J., Molina - Sandoval, D., Ruminot - Martel, E., & Saiz, J. (2017). Uso de  Tecnologí as Digitales y Logro Academico en Estudiantes de Pedagogí a Chilenos.   Estudios  pedagógicos (Valdivia) , 43(3), 119 – 133.   http://dx.doi.org/10.4067/S0718 -  07052017000300007  Garcí a, S., & Canton, I. (2019). Uso de tecnologí as y rendimiento academico en estudiantes  adolescentes.   Comunicar,   59, 73 - 81 .   https://doi.org/10.3916/C59 - 2019 - 07  Gomez, D. (2019). Uso de las tecnologí as de la informacion y la comunicacion por universitarios  mayas en un contexto de brecha digital en Mexico . Región y Sociedad , 31, 1 – 25.  https://doi.org/10.22198/rys2019/31/1130  Grande, M., Canon, R., & Canton, I. (2016). Tecnologias de la informacion y la comunicacion:  Evolucion del concepto y caracterí sticas.   IJERI: International Journal of Educational Research  and Innovation , (6), 218 – 230.  https://www.upo.es/revistas/index.php/IJERI/article/view/1703  Licona, K., & Veitya, M. (2019). La Formacion en y para la investigacion y el uso de las Tecnologí as  de la Informacion y Comunicacion.   Atenas , 2(46), 64 – 78.  https://atenas.umcc.cu/index.php/atenas/article/view/343  Llanos de Tarazona, M. I. (2019). Aprendizaje de la investigacion mediante las tecnologí as de\nRuiz - Aquino   et al.  10   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  comunicacion e informacion en universitarios de Huanuco.   Revista de Salud UDH , 1(4), e48.  https://doi.org/10.37711/rpcs.2019.1.4.48  Martínez   Perez , E., Martínez   Sandoval , M., & Hernandez   Nava, N.   (2023). El uso de Facebook en  alumnos auxiliares de enfermerí a de una institucion publica de Queretaro.   LATAM Revista  Latinoamericana De Ciencias Sociales y Humanidades , 4(1), 2829 – 2840.  https://doi.org/10.56712/latam.v4i1.457  Martínez, N., & Flores, S. (2021). Uso de nuevas tecnologí as en tiempos de pandemia en la  formacion de los estudiantes de enfermerí a de la universidad tecnica de Ambato.   Enfermería  Investiga , 6(4), 19 – 29.  https://revistas.uta.edu.ec/erevista/index.php/enfi/article/view/1200  Mendoza, H., & Placencia, M. (2018). Uso docente de las tecnologí as de la informacion y  comunicacion como material didactico en Medicina Humana.   Investigación en Educación  Médica , 7(26), 54 – 62.   https://doi.org/10.1016/j.riem.2017.04.005  Navarrete Enrí quez, R. M., Remache Cachimuel, J. T., & Reyes, V. M. (2024). Uso de herramientas  digitales y rendimiento academico en estudiantes de enfermerí a: un estudio de caso en un  Instituto Tecnologico.   Prohominum , 6(2), 227 – 242.  https://doi.org/10.47606/ACVEN/PH0245  Reyes, M. C., Garcí a, E. J., Díaz, O. M., & Sanchez, I. (2020). Preparacion cientí fica en enfermeras de  la atencion primaria de salud.   Edumecentro , 12(3), 149 – 162.  https://pensamientoeducativo.uc.cl/index.php/RHE/article/view/58323  Salguero Alcala, G. K., Benites Zuniga, J. L., Salguero Alcala, A. G., Orosco Leon, O. E., Orosco  Toribio, E. G., & Vega Vilca, C. S. (2024). Competencias digitales y rendimiento academico en  los estudiantes universitarios. Horizontes . Revista De Investigación En Ciencias De La  Educación , 8(32), 164.   https://doi.org/10.33996/revistahorizontes.v8i32.713',0.14138832787671654,'[\"\\\"scale\", \"%\", \"&\", \"(\", \"(15\"]','2025-11-29 21:33:17.909131'),(88,3,'Aten   Primaria.   2020; 52(10) :778- - -784  www.elsevier.es/ap  Atención   Primaria  SPECIAL   ARTICLE  La   inteligencia   artificial   y   sus   aplicaciones   en   medicina I:   introducción   antecedentes   a   la   IA   y   robótica J.F.   Avila-Tomás   a , b , e , ∗ ,   M.A.   Mayer-Pujadas   c , e   y   V.J.   Quesada-Varela   d , e  a   Medicina   de   Familia   y   Comunitaria,   Centro   de   Salud   Santa   Isabel,   DASur,   Madrid,   Espa˜ na  b   Medicina   Preventiva   y   Salud   Pública,   Universidad   Rey   Juan   Carlos,   Móstoles,   Madrid,   Espa˜ na  c   Medicina   de   Familia   y   Comunitaria,   Research   Programme   on   Biomedical   Informatics   (GRIB),   Instituto   Hospital   del   Mar   de Investigaciones   Médicas   y   Universitat   Pompeu   Fabra,   Barcelona,   Espa˜ na  d   Medicina   de   Familia   y   Comunitaria,   Centro   de   Salud   A   Guarda.   EOXI   Vigo,   A   Guarda,   Pontevedra,   Espa˜ na  e   Miembro   del   Grupo   de   Trabajo   de   Innovación   Tecnológica   y   Sistemas   de   Información   de   la   semFYC  Disponible   en   Internet   el   11   de   julio   de   2020  PALABRAS   CLAVE  Inteligencia   artificial; IA; medicina; salud; robótica; BigData  Resumen   La   tecnología   y   la   medicina   siguen   un   camino   paralelo   durante   las   últimas   décadas. Los   avances   tecnológicos   van   modificando   el   concepto   de   salud   y   las   necesidades   sanitarias están   influyendo   en   el   desarrollo   de   la   tecnología. La   inteligencia   artificial   (IA)   está   formada   por   una   serie   de   algoritmos   lógicos   suficientemente entrenados   a   partir   de   los   cuales   las   máquinas   son   capaces   de   tomar   decisiones   para   casos concretos   a   partir   de   normas   generales. Esta   tecnología   tiene   aplicaciones   en   el   diagnóstico   y   seguimiento   de   pacientes   con   una evaluación   pronóstica   individualizada   de   los   mismos. Además,si   combinamos   esta   tecnología   con   la   robótica,   podemos   crear   máquinas   inteligentes que   hagan   propuestas   diagnósticas   o   que   sean   mucho   más   eficientes   en   su   trabajo. Por   lo   tanto   la   IA   va   a   ser   una   tecnología   presente   en   nuestro   trabajo   cotidiano   a   través   de máquinas   o   programas   informáticos,   que   de   manera   más   o   menos   transparente   para   el   usuario, van   a   ir   siendo   una   realidad   cotidiana   en   los   procesos   sanitarios.   Los   profesionales   sanitarios tenemos   que   conocer   esta   tecnología,   sus   ventajas   y   sus   inconvenientes,   porque   va   a   ser   una parte   integral   de   nuestro   trabajo. En   estos   dos   artículos   pretendemos   dar   una   visión   básica   de   esta   tecnología   adaptada   a   los médicos   con   un   repaso   de   su   historia   y   evolución,   de   sus   aplicaciones   reales   en   el   momento actual   y   una   visión   de   un   futuro   en   el   que   la   IA   y   el   Big   Data   van   a   conformar   la   medicina personalizada   que   caracterizará   al   siglo   XXI. ©   2020   Los   Autores.   Publicado   por   Elsevier   Espa˜ na,   S.L.U.   Este   es   un   art´ ıculo   Open   Access   bajo la   licencia   CC   BY-NC-ND   (http://creativecommons.org/licenses/by-nc-nd/4.0/).  ∗   Autor   para   correspondencia.  Correo   electrónico:   joseavil@gmail.com   (J.F.   Avila-Tomás).  https://doi.org/10.1016/j.aprim.2020.04.013 0212-6567/©   2020   Los   Autores.   Publicado   por   Elsevier   Espa˜ na,   S.L.U.   Este   es   un   art´ ıculo   Open   Access   bajo   la   licencia   CC   BY-NC-ND   (http:// creativecommons.org/licenses/by-nc-nd/4.0/).\nLa   inteligencia   artificial   y   sus   aplicaciones   en   medicina   I:   introducción   antecedentes   a   la   IA   y   robótica   779  KEYWORDS  Artificial   intelligence; AI; medicine; health; robotics; Big  Artificial   intelligence   and   its   applications   in   medicine   I:   introductory   background   to AI   and   robotics Abstract   Technology   and   medicine   follow   a   parallel   path   during   the   last   decades.   Techno- logical   advances   are   changing   the   concept   of   health   and   health   needs   are   influencing   the development   of   technology. Artificial   intelligence   (AI)   is   made   up   of   a   series   of   sufficiently   trained   logical   algorithms   from which   machines   are   capable   of   making   decisions   for   specific   cases   based   on   general   rules. This   technology   has   applications   in   the   diagnosis   and   follow-up   of   patients   with   an   individua- lized   prognostic   evaluation   of   them. Furthermore,   if   we   combine   this   technology   with   robotics,   we   can   create   intelligent   machines that   make   more   efficient   diagnostic   proposals   in   their   work. Therefore,   AI   is   going   to   be   a   technology   present   in   our   daily   work   through   machines   or computer   programs,   which   in   a   more   or   less   transparent   way   for   the   user,   will   become   a   daily reality   in   health   processes.   Health   professionals   have   to   know   this   technology,   its   advantages and   disadvantages,   because   it   will   be   an   integral   part   of   our   work. In   these   two   articles   we   intend   to   give   a   basic   vision   of   this   technology   adapted   to   doctors with   a   review   of   its   history   and   evolution,   its   real   applications   at   the   present   time   and   a   vision of   a   future   in   which   AI   and   Big   Data   will   shape   the   personalized   medicine   that   will   characterize the   21st   century. ©   2020   The   Authors.   Published   by   Elsevier   Espa˜ na,   S.L.U.   This   is   an   open   access   article   under the   CC   BY-NC-ND   license   (http://creativecommons.org/licenses/by-nc-nd/4.0/).  Introducción  La   inteligencia   artificial   (IA)   es   una   rama   de   las   ciencias   de   la computación   que   incluye   conceptos   muy   transversales   rela- cionados   con   la   lógica   y   el   aprendizaje   1   .   Se   trata,   por   lo tanto,   de   dise˜ nar   herramientas   informáticas   que   simulen procesos   de   inteligencia   humana   que   incluyen   el   apren- dizaje,   el   razonamiento   y   la   autocorrección   2   .   Mediante diversos   algoritmos   las   máquinas   « aprenden »   y   son   capaces de   « tomar   decisiones » .   No   se   trata   de   ciencia   ficción,   sino de   una   realidad   que   está   presente   actualmente   y   que   poco   a poco   va   a   ir   ocupando   espacios   cotidianos   en   nuestra   casa, en   nuestros   vehículos   y   también   relacionados   con   nuestra salud. La   teoría   del   procesamiento   de   la   información   de Mahoney   3   considera   al   ser   humano   como   un   procesador de   información   a   partir   de   estímulos   internos   y   externos que   va   almacenando   en   memoria   y   que   es   capaz   de   ela- borar   respuestas   similares   a   partir   de   estímulos   posteriores que   tengan   cierta   similitud.   Según   esta   teoría   los   elemen- tos   estructurales   en   el   procesamiento   de   la   información son:   registro   sensitivo   (recepción   de   información   interna   y externa),   memoria   a   corto   plazo   (almacenamiento   inme- diato   de   la   información   seleccionada)   y   memoria   a   largo plazo   (que   organiza   y   dispone   la   información   durante   más tiempo).   Además,   las   categorías   del   procesamiento   son: atención   (recibe,   selecciona   y   asimila   los   diferentes   estímu- los),   codificación   (simboliza   los   estímulos   según   estructuras mentales   propias),   almacenamiento   (organiza   y   mantiene en   la   memoria   los   símbolos   codificados)   y   recuperación   (uso posterior   de   la   información   organizada   y   codificada   ante estímulos   similares   a   los   que   la   han   ocasionado). El   aprendizaje   humano   se   basaría   en   la   exposición   a   situa- ciones   repetidas   con   refuerzos   (positivos   o   negativos)   cada  vez   que   tomamos   una   decisión   correcta   o   erramos.   A   par- tir   de   estímulos   similares   que   tienen   soluciones   similares   y a   través   de   nuestra   experiencia   y   conocimientos   previos, empezamos   a   tomar   decisiones   4   .   La   toma   de   decisiones supone   un   pensamiento   lógico   y   jerárquico   que   puede   ser transcrito   a   algoritmos   en   un   lenguaje   que   las   máquinas   pue- den   interpretar   y   ejecutar   con   mucha   mayor   rapidez   que   el ser   humano. El   aprendizaje   humano   es   progresivo   y   se   desarrolla   a partir   de   la   exposición   a   situaciones   de   forma   consecutiva, proceso   que   puede   llevar   a˜ nos,   en   cambio,   la   adquisición   de estos   datos   por   parte   de   una   máquina   es   mucho   más   rápida, ya   que   esta   no   se   agota   (puede   trabajar   24   h   al   día)   y   no tiene   funciones   vitales   (alimentación,   descanso   u   ocio).   En este   sentido   las   cantidades   ingentes   de   datos   en   múltiples formatos   y   fuentes   (lo   que   conocemos   como   big   data ),   tie- nen   una   relación   directa   con   la   adquisición   de   experiencia por   parte   de   las   máquinas   que   se   exponen   a   situaciones   o estímulos   muy   diversos.   En   este   artículo   pretendemos   dar una   visión   introductoria   de   la   IA   para   médicos   y   realizar   un recorrido   por   las   principales   aplicaciones   en   salud   que   nos ofrece   esta   tecnología.  Redes   neuronales,   cerebro   y   aprendizaje  La   base   biológica   de   la   inteligencia   está   en   el   cerebro.   Aun- que   vamos   conociendo   cada   vez   más   sobre   su   fisiología   y las   diferentes   vías   anatómicas   y   funcionales   que   participan en   el   proceso   de   aprendizaje   humano,   aún   existen   muchas incógnitas   que   deben   despejarse. Para   las   máquinas   existe   una   analogía   similar   a   la estructura   y   el   funcionamiento   del   cerebro,   por   lo   que   es relativamente   sencillo   establecer   esta   analogía   fácilmente comprensible   para   los   profesionales   de   la   salud.\n780   J.F.   Avila-Tomás   et   al.  Entradas Buffer de entrada Buffer de salida Salidas Capas ocultas  Figura   1   Esquema   de   una   red   neuronal. Fuente:   Elaboración   propia.  Las   redes   neuronales   artificiales,   en   inglés   Artificial   Neu- ral   Networks   (ANN)   están   compuestas   por   elementos   que se   comporten   de   forma   similar   a   la   neurona   biológica   en sus   funciones   más   comunes   y   que   se   denominan   « elemento procesador » ,   en   inglés   Process   Element   (PE).   Cada   uno   de   los PE   (neuronas)   tienen   unos   elementos   de   entrada   (dendritas) que   recogen   los   impulsos   de   entrada   que   son   integrados   en el   cuerpo   del   elemento   procesador   y   generan   una   respuesta o   salida.   La   salida   del   PE   (axón)   se   puede   conectar   a   las entradas   de   otras   neuronas   artificiales   mediante   conexiones con   una   eficacia   similar   a   la   sinapsis   de   las   conexiones   neu- ronales   del   cerebro   5   .   Los   PE   están   organizados   en   una   serie de   niveles   que   se   denominan   capas.   El   conjunto   de   estas capas   forman   una   ANN. En   las   ANN   existen   2   capas   con   conexiones   con   el   exterior. Una   capa   de   entrada   o   buffer   de   entrada,   donde   se   presen- tan   los   datos   a   la   red,   y   una   capa   de   salida   que   devuelve al   exterior   la   respuesta   de   la   red   a   una   entrada   concreta. Existen,   además,   una   serie   de   capas   intermedias   que   se denominan   capas   ocultas   (fig.   1).   Al   igual   que   en   los   seres humanos,   el   aprendizaje   que   se   produce   en   las   máquinas, es   una   función   que   tiene   una   base   estructural   en   este   tejido nervioso   artificial   conformado   por   las   ANN. Existen   2   tipos   de   métodos   que   permiten   el   aprendizaje de   una   máquina   6   .   El   primero   de   ellos   se   llama   « aprendizaje con   datos   supervisados »   y   requiere   la   participación   de   un humano   que   determina   las   relaciones   correctas   e   incorrec- tas   que   adquiere   la   máquina.   La   función   del   humano   es etiquetar   y   categorizar   los   datos   de   entrada   y   establecer   un algoritmo   de   toma   de   decisiones   para   generar   las   diferentes salidas.   Con   el   suficiente   entrenamiento,   la   máquina   será capaz   de   determinar   la   categoría   de   salida   de   un   nuevo   dato de   entrada.   El   segundo   método   es   el   « aprendizaje   automá- tico   o   machine   learning » .   Consiste   en   dotar   de   experiencia a   la   máquina   y   que   sea   ella   misma,   mediante   una   serie   de normas   lógicas   iniciales,   la   que   sea   capaz   de   ir   aprendiendo de   manera   independiente   a   partir   de   la   experiencia   que   le proporcionan   los   datos   y   sin   el   concurso   continuado   de   un humano.   Para   ello   son   necesarios   algoritmos   iniciales   y   un peque˜ no   entrenamiento   supervisado.   Mientras   que,   en   el aprendizaje   supervisado,   el   conocimiento   se   hace   explícito en   forma   de   reglas,   en   la   computación   neuronal   las   ANN generan   sus   propias   reglas   aprendiendo   de   los   ejemplos  que   se   les   muestran   en   la   fase   de   entrenamiento.   Una   vez que   las   decisiones   correctas   alcanzan   un   número   válido dentro   del   total   de   decisiones   tomadas,   conectamos   este sistema   inteligente   a   un   sistema   de   big   data   para   que   esas experiencias   afiancen   los   sistemas   de   toma   de   decisiones (aprendizaje).  Antecedentes  Aunque   todo   este   campo   de   la   informática   es   innovador   en algunos   aspectos,   tiene   antecedentes   en   los   a˜ nos   40   del   siglo XX.   En   1943,   el   neurobiólogo   Warren   McCulloch   y   el   estadís- tico   Walter   Pitss,   publicaron   un   artículo   que   definía   que   los eventos   neuronales   y   las   relaciones   entre   ellos   pueden   tra- tarse   mediante   la   lógica   proposicional   7   .   De   esta   manera   se conforma   la   base   y   el   inicio   del   desarrollo   de   la   IA   tal   y   como hoy   la   concebimos. Pero   no   fue   hasta   una   década   más   tarde,   en   1956,   cuando se   celebró   la   primera   Conferencia   de   Inteligencia   Artificial en   Darmouth   que   es   considerada   como   la   primera   referencia seria   a   las   redes   neuronales   artificiales.   En   esta   conferencia se   presentó   la   lógica   teórica   (Minsky,   McCarthy,   Rochester   y Shannon)   que   es   considerado   el   primer   programa   informá- tico   para   solucionar   problemas   de   búsqueda   heurística   8   . En   1957   se   presentó   « Perceptron »   el   primer   sistema   capaz de   identificar   patrones   geométricos   9   ,   y   en   1959   « Adaline »  (Adaptive   Linear   Neuron)   que   fue   utilizada   con   diferentes aplicaciones   como   reconocimiento   de   voz   y   caracteres,   pre- dicción   del   tiempo,   y   en   el   desarrollo   de   filtros   para   eliminar ecos   de   las   líneas   telefónicas. A   partir   de   estos   trabajos   la   comunidad   científica   tuvo una   percepción   muy   optimista   de   lo   que   la   IA   podría   ofre- cer,   pero   a   mediados   de   la   década   de   los   60   se   comenzaron   a publicar   estudios   críticos   sobre   la   falta   de   aplicabilidad   de   la computación   neuronal.   Durante   los   a˜ nos   70   y   80   pocos   inves- tigadores   continuaron   con   esta   línea   de   desarrollo   científico (James   Anderson,   Teuvo   Kohonen   o   Stephen   Grossberg). En   1982   John   Hopfield   10   crea   el   algoritmo   Backpro- pagation   que   presenta   un   sistema   neuronal   formado   por elementos   procesadores   interconectados   que   tienden   a   un mínimo   de   energía.   Este   hecho   supuso   volver   a   confiar   en   las posibilidades   de   la   IA   que   en   las   últimas   décadas   ha   tenido un   avance   exponencial. Actualmente   existen   muchos   investigadores   en   diferen- tes   universidades   que   están   realizando   trabajos   en   el   área   de las   redes   neuronales   artificiales   en   grupos   multidisciplina- res   (informáticos,   matemáticos,   neurólogos,   psicólogos   del conocimiento,   físicos,   programadores   o   filósofos   de   la   cien- cia)   que   ofrecen   nuevas   e   innovadoras   perspectivas   en   esta área   del   conocimiento.  Inteligencia   artificial   y   robótica  La   palabra   « robot »   procede   la   palabra   checa   « robota »   que significa   « trabajo   duro » 11   . Podemos   clasificar   los   robots   en   diferentes   tipos: 1.   No   mecánicos:   La   salida   es   una   acción   no   mecánica   como mostrar   una   información   o   mantener   una   conversación con   el   usuario   humano.   Entre   ellos   destacan   los   robots cuya   interfaz   es   un   sistema   conversacional   ya   sea   escrito\nLa   inteligencia   artificial   y   sus   aplicaciones   en   medicina   I:   introducción   antecedentes   a   la   IA   y   robótica   781  En movimiento Estatico Robot humanoide Peluche 50% Cadaver muerto viviente PARECIDO HUMANO FAMILIARIDA 100% mano prot ésica Robot Industrial replicante humano sano Valle Inexplicable  Figura   2   Gráfica   de   la   teoría   del   « valle   inquietante »   de   Masa- hiro   Mori. Fuente:   Remasterizada   por   Edgar   Talamantes.   Bajo   licencia libre   GNU.  o   hablado   ( « chatbots » )   con   grandes   aplicaciones   actual- mente   como   asistentes   virtuales. 2.   Mecánicos:   Utilizados   generalmente   en   la   industria.   Hay de   varios   tipos: 1.   Androides:   Apariencia   humanoide. 2.   Zoomórficos:   Apariencia   animal. 3.   Móviles   o   rodantes:   Transporte   de   cosas   o   personal. 4.   Poliarticulados:   Industriales. La   apariencia   humana   de   los   robots   ha   dado   lugar a   la   denominada   « teoría   del   valle   inquietante » .   « Lo inquietante » 12   tiene   su   origen   como   concepto,   en   el   a˜ no 1906   por   Ernst   Jentsch   13   y   se   explica   como   una   sensación perturbadora   ante   algo   que   nos   es   y   no   familiar   al   mismo tiempo.   Una   situación   u   objeto   que   se   parece   mucho   a   algo cotidiano,   que   conocemos   bien   pero   que   nos   genera   una sensación   de   cierta   ansiedad   o   malestar   sin   que   podamos explicar   el   motivo. Esta   teoría   de   lo   inquietante   se   retoma   en   1970   por   Masa- hiro   Mori   para   describir   la   relación   entre   los   robots   y   los humanos.   La   relación   es   cada   vez   más   positiva   siempre   y cuando   el   robot   mantenga   apariencia   de   robot   y   seamos conscientes   de   que   se   trata   de   una   máquina.   Cuando   el   robot va   adquiriendo   rasgos   antropomórficos   hasta   llegar   a   presen- tar   aspecto   humano,   la   respuesta   emocional   del   humano   se irá   haciendo   cada   vez   más   negativa   hasta   llegar   a   un   punto de   rechazo   debido   a   la   « inquietud »   que   genera   (fig.   2). En   la   cultura   occidental,   sobre   todo   por   la   influencia cultural   del   cine,   tenemos   una   imagen   futurista   de   los   robots como   humanoides,   cuando   la   realidad   actual   es   otra,   vivi- mos   rodeados   de   IA   y   robótica.   Así   la   Industria   v.4.0   14   se fundamenta   en   la   realidad   virtual,   la   IA   y   el   Internet   de   las cosas. Los   cobots   o   robots   colaborativos   fueron   inventados   en 1996   por   J.   Edward   Colgate   y   Michael   Peshkin,   profesores  en   la   Northwest   University   (Kirkland,   Washington)   como dispositivos   robóticos   que   manipulan   objetos   en   colabora- ción   con   un   operador   humano   15   .   Actualmente   están   dotados de   IA   para   mejorar   su   rendimiento   con   la   monitorización de   numerosas   variables   como   las   condiciones   del   lugar   de trabajo,   visión   artificial,   identificación   de   patrones   para predecir   o   detectar   errores,   pudiendo   comunicar   dicha información   a   otros   cobots .   Un   sector   que   ha   tenido   un aumento   de   un   23%   de   2017   a   2018,   según   la   Federación Internacional   de   Robótica   (IFR)   16   . Ya   tenemos   robots   funcionando   para   la   realización   de pruebas   y   análisis   de   laboratorio.   Así   en   el   Hospital   Univer- sitario   de   Copenhague,   Gentofte   (Dinamarca)   17   ,   un   primer robot   recoge   la   muestra   de   sangre   y   la   coloca   en   un   lector de   códigos   de   barras.   A   continuación,   una   cámara   de   visión fotografía   el   color   del   tapón   roscado   e   indica   al   robot   que coloque   la   muestra   en   una   de   las   4   gradillas   en   función   de su   color.   Luego   un   segundo   robot   recoge   las   muestras   de   las gradillas   y   las   coloca   en   el   alimentador   de   la   máquina   para su   centrifugado   y   análisis.   Estos   robots   manipulan   alrededor de   3.000   muestras   diarias   (unos   7-8   tubos   por   minuto),   lo que   ha   mejorado   los   tiempos   de   entrega   de   resultados. Video:   https://www.youtube.com/watch?v=mnk4iT4BTg4 Ya   se   están   probando   en   pacientes   tetrapléjicos   exoes- queletos,   unidades   robóticas   ponibles   controladas   por   placas de   computadora   para   alimentar   un   sistema   de   motores, neumáticos,   palancas   o   sistemas   hidráulicos   para   restaurar la   locomoción   18   .   Han   surgido   como   una   nueva   herramienta de   rehabilitación   en   lesionados   medulares.   Sin   embargo, todavía   falta   evidencia   para   respaldar   su   aplicación   clínica teniendo   en   cuenta   su   alto   coste   19   . La   universidad   de   Brown   está   explorando   con   tecnolo- gía   Intel   ®   un   proyecto   de   Interfaz   Inteligente   de   Columna que   tiene   como   objetivo   utilizar   la   tecnología   de   IA   para restaurar   el   movimiento   y   el   control   de   la   vejiga   en   pacien- tes   con   parálisis   por   lesiones   graves   de   la   médula   espinal   20   . Un   equipo   internacional   de   científicos   ya   ha   utilizado   una  « interfaz   cerebro-espinal »   inalámbrica   para   evitar   las   lesio- nes   de   la   médula   espinal   en   un   par   de   macacos   Rhesus , restaurando   el   movimiento   intencional   de   caminar   en   una pierna   temporalmente   paralizada   21   . La   robótica   en   medicina   no   se   limita   a   los   ejemplos   ante- riores,   las   investigaciones   en   este   campo   se   han   dirigido   a la   asistencia   a   los   pacientes   y   la   asistencia   o   formación   a los   médicos.   Así   tenemos   prótesis   de   miembros,   electroesti- mulación,   asistentes   personales,   robótica   de   rehabilitación, robótica   quirúrgica   22   ,   la   formación   médica   con   simulado- res   robotizados   y   los   robots   de   almacenaje   y   distribución de   medicamentos. Desde   los   a˜ nos   60,   las   prótesis   de   miembros   han   evolucio- nado   constantemente,   con   distintos   modelos   para   sustituir las   primeras   prótesis   pasivas,   todavía   presentes   en   gran parte   del   mundo   por   su   menor   coste,   por   prótesis   activas, las   cuales   por   medio   de   medios   mecánicos   o   sensores   ubica- dos   en   alguna   parte   del   cuerpo   del   paciente   permiten   mover por   ejemplo   una   mano   mecánica   23   . Hay   distintos   modelos   y   soluciones   de   prótesis   de   mano en   continua   evolución   y   mejora   para   aumentar   su   fun- cionalidad,   como   las   2   generaciones   de   manos   DLR   ® 24   ,   la TUAT/Karlsruhe   ® 25   ,   la   Blackfingers   ® 26   ,   la   mano   robótica   con mecanismo   extensor   27   ,   la   mano   compuesta   de   sensores propioceptivos   28   o   la   mano   Iowa   ®   fruto   de   un   trabajo   de\n782   J.F.   Avila-Tomás   et   al.  colaboración   entre   universidades   americanas,   espa˜ nolas   y suecas   29   ,   entre   otros. En   cuanto   a   la   robótica   quirúrgica   también   ha   evolu- cionado   progresivamente   desde   el   primer   procedimiento neuroquirúrgico   asistido   por   un   robot   en   1985,   donde   se utilizó   el   robot   industrial   PUMA   560   (no   dise˜ nado   para labores   médicas)   para   introducir   una   guía   para   una   biop- sia   cerebral   30   .   Posteriormente   se   empezaron   a   dise˜ nar   los primeros   robots,   puramente   quirúrgicos,   como   asistentes del   cirujano   en   operaciones   de   múltiples   órganos   y   apa- ratos.   Algunos   modelos   de   robots   quirúrgicos   son:   AESOP   ® (acrónimo   de   sistema   endoscópico   automatizado   para   un posicionamiento   óptimo)   empleado   como   asistente   robótico controlado   por   voz   para   cirugía   endoscópica   31   ,   el   robot   este- reotáctico   NeuroMate   ® 32   que   es   un   sistema   que   se   utiliza en   centros   neuroquirúrgicos   para   administrar   tratamientos   y realizar   procedimientos   de   estimulación   cerebral   profunda, neuroendoscopia,   estereoelectroencefalografía,   biopsias   e investigación;   el   extinto   sistema   robótico   ZEUS   ® 33   con   el que   se   realizó   la   primera   telecirugía   del   mundo   en   2001   34   , conocida   como   la   operación   Lindbergh,   una   exitosa   cole- cistectomía   laparoscópica   de   dos   horas   de   duración,   que se   realizó   en   una   paciente   en   un   hospital   de   Estrasburgo, Francia,   realizada   por   un   equipo   quirúrgico   en   Nueva   York, EE.   UU.,   el   Sistema   Robótico   Quirúrgico   Da   Vinci   ® 35   que en   su   versión   más   reciente,   el   sistema   da   Vinci   Xi   ®   per- mite   una   visión   en   3D   con   un   aumento   de   hasta   10   veces   y elimina   el   temblor   fisiológico,   utilizándose   principalmente en   intervenciones   de   urología,   cirugía   general   y   ginecología oncológica,   pero   también   en   cirugía   oral   y   maxilofacial,   ciru- gía   pediátrica,   cirugía   torácica   o   cirugía   cardíaca;   Probot   ®   , dise˜ nado   para   realizar   prostatectomías   36   ,   Robodoc   ®   para cirugía   ortopédica   37   ,   Acrobot   ®   para   cirugía   de   rodilla   38   y CyberKnife   ® 39   sistema   de   radiocirugía   robótica   dise˜ nado para   tratar   tumores   ubicados   en   todo   el   cuerpo   de   manera no   invasiva,   entre   otros. El   principal   problema   para   su   expansión   es   el   alto   coste de   instalación   y   mantenimiento   de   los   mismos,   de   ahí   el  Tabla   1   Beneficios   y   limitaciones   de   la   cirugía   robótica respecto   a   la   cirugía   mínimamente   invasiva   convencional  Beneficios   Limitaciones Visión   en   3D   y   alta resolución Tama˜ no   del   robot Movimientos   intuitivos   Variedad   de   instrumentos limitada Control   del   temblor   Tiempo   de   preparación   del robot Movimientos   a   escala   Rango   de   movimientos limitado Mejor   ergonomía   Muy   caro   de   comprar   y mantener Curva   de   aprendizaje   más corta Desechables   muy   caros Fuente:   Tomado   de   van   Haasteren   et   al 43   .  desarrollo   de   sistemas   más   recientes   y   más   asequibles,   como por   ejemplo:  •   El   sistema   quirúrgico   Senhance   ® 40   .   plataforma   laparoscó- pica   digital   que   elimina   las   limitaciones   económicas   de   los sistemas   robóticos   actuales   con   instrumentos   reutilizables estándar   y   una   estrategia   de   arquitectura   de   plataforma abierta   que   permite   a   los   hospitales   aprovechar   las   inver- siones   en   tecnología   existentes.  •   El   sistema   robótico   Flex   ® 41   que   permite   acceder   a   ubica- ciones   anatómicas   antes   difíciles   o   imposibles   de   alcanzar de   forma   mínimamente   invasiva.  •   El   proyecto   espa˜ nol   BROCA,   también   conocido   como   « el peque˜ no   de   Da   Vinci   ®   » 42   ,   para   el   dise˜ no   y   desarrollo   de un   sistema   robótico   quirúrgico   de   bajo   costo,   modular, para   cirugía   mínimamente   invasiva   centrada   en   cirugía pélvica   y   bariátrica,   con   sensores   y   efectores   finales   alta- mente   maniobrables   para   obtener   información   relevante  Tabla   2   Fortalezas   y   limitaciones   de   humanos   y   robots   respecto   a   la   cirugía  Fortalezas   Limitaciones  Humanos   Destreza   limitada   más   allá   de   los   movimientos   naturales Buen   juicio   Propenso   a   la   fatiga   y   la   falta   de   atención Buena   coordinación   mano-vista   El   temblor   limita   el   movimiento   fino Gran   destreza   Efectores   finales   voluminosos   (manos) Puede   integrar   información   de   diversas   fuentes   Limitada   precisión   geométrica Entrenamiento   sencillo   Difícil   de   mantener   estéril Versátil   y   capaz   de   improvisar   Susceptible   a   la   radiación,   infección  Robots  Buena   precisión   geométrica   Juicio   reducido Incansable   y   estable   Difícil   adaptación   a   nuevas   situaciones Resistente   a   la   radiación   ionizante   Destreza   limitada Puede   dise˜ narse   para   operar   diferentes   escalas   de movimiento   y   carga   útil Coordinación   mano-vista   limitada Capaz   de   utilizar   múltiples   sensores   Capacidad   limitada   para   integrar   e   interpretar   información compleja Fuente:   Adaptado   de   Taylor   RH 44   .\nLa   inteligencia   artificial   y   sus   aplicaciones   en   medicina   I:   introducción   antecedentes   a   la   IA   y   robótica   783  de   la   herramienta   y   su   entorno,   además   de   incorporar   la sensación   de   tacto. La   cirugía   asistida   por   robot   ha   permitido   avances   en   el campo   quirúrgico   como   la   cirugía   a   distancia   y   la   cirugía mínimamente   invasiva,   junto   a   ventajas   de   precisión,   inci- siones   más   peque˜ nas,   menor   pérdida   de   sangre,   disminución del   dolor   y   tiempo   de   curación   menor   42   ,   lo   que   permite   tra- tar   un   mayor   número   de   pacientes   con   menor   tiempo   de hospitalización,   haciendo   que   sea   posible   realizar   interven- ciones   que   de   otro   modo   no   serían   viables. La   cirugía   robótica   presenta   una   serie   de   ventajas   y   de limitaciones   respecto   a   la   cirugía   mínimamente   invasiva   con- vencional   (tabla   1).   Las   ventajas   suelen   venir   de   explotar fortalezas   complementarias   entre   humanos   y   dispositivos robóticos,   como   vemos   resumido   en   la   tabla   2.  Financiación  Este   artículo   no   ha   recibido   ningún   tipo   de   ayuda   o   finan- ciación   de   agencias   del   sector   público,   sector   comercial   o entidades   sin   ánimo   de   lucro.  Bibliografía  1.   Torra   V.   La   inteligencia   artificial.   LYCHNOS.   Fundación General   del   CSIC   [consultado   6   Mar   2019]   Disponible   en: http://www.fgcsic.es/lychnos/es   es/articulos/inteligencia artificial. 2.   Rouse   M   ¿Qué   es   Inteligencia   artificial,   o   AI?   -   Definición   en WhatIs.com.   Techtarget   [consultado   6   Mar   2019]   Disponible en:   https://searchdatacenter.techtarget.com/es/definicion/ Inteligencia-artificial-o-AI. 3.   La   teoría   del   procesamiento   de   la   información   de   Maho- ney.   RODAS.   Repositorio   de   Objetos   de   Aprendizaje   de la   Universidad   de   Sevilla   [consultado   4   Mar   2019]   Dispo- nible   en:   https://rodas5.us.es/file/1240b064-8389-6228-96a5- 653dd137f73b/1/capitulo3   SCORM.zip/pagina   22.htm. 4.   Domjan   M.   Principios   de   aprendizaje   y   conducta.   Madrid:   Thom- son;   2012. 5.   Basogai-Olabe   X.   Redes   neuronales   artificiales   y   sus   apli- caciones.   Escuela   Superior   de   Ingeniería   de   Bilbao.   Bil- bao:   Escuela   Superior   de   Ingeniería   de   Bilbao   [consul- tado   4   Mar   2019]   Disponible   en:   https://ocw.ehu.eus/file. php/102/redes   neuro/contenidos/pdf/libro-del-curso.pdf. 6.   Sancho-Caparrini   F.   Clasificación   Supervisada   y   No   Supervisada. Fernando   Sancho   Caparrini   [consultado   7   Mar   2019]   Disponible en:   http://www.cs.us.es/ ∼ fsancho/?e=77. 7.   McCulloch   WS,   Pitts   W.   A   logical   calculus   of   the   ideas   immanent in   nervous   activity.   The   Bulletin   of   Mathematical   Biophy- sics.   1943;5:115- - -33   [consultado   7   Mar   2019].   Disponible   en: http://link.springer.com/10.1007/BF02478259. 8.   Conferencia   de   Darthmouth   1956.   [consultado   7   Mar   2019]   Dis- ponible   en:   https://darthmouthconference.wordpress.com/. 9.   Ramirez   F.   Big   Data   &   Data   Science   Blog:   Historia   de   la IA:   Frank   Rosenblatt   y   el   Mark   I   Perceptrón,   el   primer ordenador   fabricado   específicamente   para   crear   redes   neu- ronales   en   1957   [consultado   7   Mar   2019]   Disponible   en: https://web.archive.org/web/20180722124753/https://data- speaks.luca-d3.com/2018/07/historia-de-la-ia-frank- rosenblatt-y-el.html#. 10.   Hopfield   JJ.   Neural   networks   and   physical   systems   with   emer- gent   collective   computational   abilities.   Proc   Natl   Acad   Sci   U  S   A.   1982;79:2554- - -8   [consultado   7   Mar   2019].   Disponible   en: https://www.pnas.org/content/pnas/79/8/2554   full.pdf. 11.   Robot.   En:   Wikipedia,   la   enciclopedia   libre,   2019   [citado 9   de   marzo   de   2019].   Disponible   en:   https://es.wikipedia. org/w/index.php?title=Robot&oldid=114426400. 12.   Collins   J,   Jervis   J.   Document:   ‘On   the   Psychology   of the   Uncanny’   (1906):   Ernst   Jentsch.   En:   Collins   J,   Jer- vis   J,   editores.   Uncanny   Modernity:   Cultural   Theories, Modern   Anxieties.   London:   Palgrave   Macmillan   UK; 2008.   p.   216- - -28   [consultado   9   Mar   2019].   Disponible   en: https://doi.org/10.1057/9780230582828   12. 13.   Jentsch   E.   On   the   Psychology   of   the   Uncanny. 1906   [consultado   9   Mar   2019].   Disponible   en http://www.art3idea.psu.edu/locus/Jentsch   uncanny.pdf. 14.   European   Commission.   The   Fourth   Industrial   Revolution.   2019 [consultado   23   Mar   2019]   Disponible   en:   https://ec.europa. eu/digital-single-market/en/fourth-industrial-revolution. 15.   Colgate   JE,   Wannasuphoprasit   W,   Peshkin   MA.   Cobots:   robots for   collaboration   with   human   operators.   Proceedings   of   the International   Mechanical   Engineering   Congress   and   Exhibition. Atlanta   GA,   58:433-439   [consultado   9   Mar   2019].   Disponible   en: https://peshkin.mech.northwestern.edu/publications/1996 Colgate   CobotsRobotsCollaboration.pdf. 16.   IFR   Press   Release.   Industrial   Robots:   Robot   Investment Reaches   Record   16.5   billion   USD.   Shanghai,   Frankfurt, Sep   18,   2019   [consultado   9   Mar   2019]   Disponible   en: https://ifr.org/ifr-press-releases/news/robot-investment- reaches-record-16.5-billion-usd. 17.   Gentofte   Hospital.   Nota   de   prensa.   El   nuevo   super   robot   y   bioa- nalista   danés   colaboran   estrechamente   en   los   análisis   de   sangre [Ny   dansk   superrobot   og   bioanalytiker   arbejder   tæt   sammen om   blodprøver],   Nov   25,   2014.   2019   [consultado   17   May   2019]. Disponible   en:   https://www.gentoftehospital.dk/presse- og-nyt/pressemeddelelser-og-nyheder/nyheder/Sider/ny- dansk-superrobot-og-bioanalytiker-arbejder-taet-sammen-om- blodproever.asp. 18.   Benabid   AL,   Costecalde   T,   Eliseyev   A,   Charvet   G,   Verney A,   Karakas   S,   et   al.   An   exoskeleton   controlled   by   an   epi- dural   wireless   brain-machine   interface   in   a   tetraplegic patient:   A   proof-of-concept   demonstration.   The   Lancet Neurology.   2019   [consultado   7   Oct   2019].   Disponible   en: https://www.thelancet.com/journals/laneur/article/PIIS1474- 4422(19)30321-7/fulltext. 19.   Gorgey   AS.   Robotic   exoskeletons:   The   current   pros   and   cons. WJO.   2018;9:112- - -9   [consultado   7   Oct   2019].   Disponible   en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153133/. 20.   Researchers   to   develop   ‘intelligent   spinal   interface’   with   $6.3 million   in   DARPA   funding.   Brown   University   [consultado   7   Oct 2019].   Disponible   en:   https://www.brown.edu/news/2019-10- 03/isi. 21.   Capogrosso   M,   Milekovic   T,   Borton   D,   Wagner   F,   Moraud EM,   Mignardot   J-B,   et   al.   A   brain-spine   interface   alle- viating   gait   deficits   after   spinal   cord   injury   in   primates. Nature.   2016;539   [consultado   7   Oct   2019].   Disponible   en: https://www.nature.com/articles/nature20118. 22.   Krut   S.   Introduction   to   Medical   Robotics.   Conferencia.   VI   Semi- nario   de   Automática.   Popayán.   2006. 23.   Shimoga   KB.   Robot   Grasp   Synthesis   Algorithms:   A   Survey.   The International   Journal   of   Robotics   Research.   1996;15:230- - -66 [consultado   7   Oct   2019].   Disponible   en:   https:// journals.sagepub.com/doi/10.1177/027836499601500302. 24.   Borst   C,   Fischer   M,   Haidacher   S,   Liu   H,   Hirzinger   G.   DLR Hand   II:   Experiments   and   experience   with   an   anthropomorp- hic   hand.   Robotics   and   Automation   2003.   Taipei:   Proceedings. ICRA’03.IEEE   International   Conference;   2003   [consultado   7   Oct 2019].   Disponible   en:   http://eia.udg.es/ ∼ qsalvi/papers/2003- ICRA-Credits.pdf.\n784   J.F.   Avila-Tomás   et   al.  25.   Fukaya   N,   Toyama   S,   Asfour   T,   Rüdiger   D.   Design   of the   TUAT/Karlsruhe   humanoid   hand.   Takamatsu:   Proceedings IEEE/RSJ   International   Conference   on   Intelligent   Robots   and Systems   (IROS   2000);   2000   [consultado   10   Oct   2019].   Disponible en:   https://ieeexplore.ieee.org/document/895225. 26.   Folgheraiter   M,   Gini   G.   Blackfingers   an   artificial   hand that   copies   human   hand   in   structure,   size,   and   function. Humanoids.   2000   [consultado   10   Oct   2019].   Disponible   en: https://pdfs.semanticscholar.org/c417/1da51eee7823ff6cd2f54 86c9d70fe531162.pdf. 27.   Wilkinson   D,   Vande-Weghe   M,   Matsuoka   Y.   An   extensor   mecha- nism   for   an   anatomical   robotic   hand.   Proceedings   of   the 2003   IEEE   International   Conference   on   Robotics   and   Automa- tion:   Taipei;   2003   [consultado   10   Oct   2019].   Disponible   en: https://www.ri.cmu.edu/pub   files/pub4/wilkinson   david   d 2003   1/wilkinson   david   d   2003   1.pdf. 28.   Carrozza,   Cappiello   MC,   Micera   G,   Edin   S,   Beccai   BB,   Cipriani LC.   Design   of   a   cybernetic   hand   for   perception   and   action.   Biol Cybern.   2006;95:629- - -44. 29.   Yang   J,   Pe˜ na-Pitarch   E,   Abdel-Malek   K,   Patrick   A,   Lindkvist   L.   A multi-fingered   hand   prosthesis.   Mechanism   and   Machine   Theory. 2004;39:555- - -81. 30.   Kwoh   YS,   Hou   J,   Jonckheere   EA,   Hayati   S.   A   robot   with   improved absolute   positioning   accuracy   for   CT   guided   stereotactic   brain surgery.   IEEE   Trans   Biomed   Eng.   1988;35:153- - -60. 31.   Stoianovici   D.   Robotic   surgery.   World   J   Urol.   2000;18:289- - -95. 32.   Varma   TR.   Use   of   the   NeuroMate   stereotactic   robot   in   a   fra- meless   mode   for   movement   disorder   surgery.   Stereotact   Funct Neurosurg.   2003;80:132- - -5. 33.   Marescaux   J,   Rubino   F.   The   Zeus   robotic   system:   Experimental and   clinical   applications.   Surg   Clin   N   Am.   2004;83:1305- - -15. 34.   Marescaux   J,   Leroy   J,   Gagner   M,   Rubino   F,   Mutter   D,   Vix M,   et   al.   Transatlantic   robot-assisted   telesurgery.   Nature. 2001;413:379- - -80.  35.   Ballantyne   GH,   Moll   F.   The   da   Vinci   telerobotic   surgical   system: The   virtual   operative   field   and   telepresence   surgery.   Surg   Clin N   Am.   2003;83:1293- - -304. 36.   Davies   BL,   Hibberd   RD,   Timoney   AG,   Wickham   JEA.   A   clinically applied   robot   for   prostatectomías.   En:   Taylor   RH,   Lavallee   S, Burdea   GC,   Mosges   R,   editores.   Computer-Integrated   Surgery. MIT   Press;   1995.   p.   593- - -601. 37.   Nogler   M,   Polikeit   A,   Wimmer   C,   Bruckner   A,   Ferguson   SJ,   Kris- mer   M.   Primary   stability   of   a   Robodoc   implanted   anatomical stem   versus   manual   implantation.   Clin   Biomech   (Bristol,   Avon). 2004;19:123- - -9. 38.   Jakopec   M,   Harris   S,   Rodríguez-Baena   F,   Gomes   P,   Davies B.   The   Acrobot   system   for   total   knee   replacement.   Indus- trial   Robot.   2003;19:902- - -11,   http://dx.doi.org/10.1108/ 01439910310457724. 39.   Gerszten   PC,   Ozhasoglu   C,   Burton   SA,   Vogel   WJ,   Atkins   BA,   Kal- nicki   S,   et   al.   CyberKnife   frameless   stereotactic   radiosurgery   for spinal   lesions:   Clinical   experience   in   125   cases.   Neurosurgery. 2004;55:89-98. 40.   Schmitz   R,   Willeke   F,   Barr   J,   Scheidt   M,   Saelzer   H,   Darwich I,   et   al.   Robotic   Inguinal   Hernia   Repair   (TAPP)   First   Expe- rience   with   the   New   Senhance   Robotic   System.   Surg   Technol Int.   2019;34:243- - -9. 41.   Lang   S,   Mattheis   S,   Hasskamp   P,   Lawson   G,   Güldner   C,   Manda- pathil   M,   et   al.   A   european   multicenter   study   evaluating   the flex   robotic   system   in   transoral   robotic   surgery.   Laryngoscope. 2017;127:391- - -5. 42.   Proyecto   BROCA   -   Inicio   [consultado   10   Oct   2019].   Disponible en:   http://proyecto-broca.es/. 43.   van   Haasteren   G,   Levine   S,   Hayes   W.   Pediatric   robotic   surgery: Early   assessment.   Pediatrics.   2009;124:1642- - -9. 44.   Taylor   RH.   A   Perspective   on   Medical   Robotics.   Proceedings   of the   IEEE.   2006;94:1652- - -64,   94.',0.1504570103558824,'[\"$6.3\", \"&\", \"(\", \"(1906):\", \"(acr\\u00f3nimo\"]','2025-11-29 21:33:41.714595'),(89,3,'Rev.   C ient.   S ist.   I nform.   5 ( 1 ), e 864 , doi:   10.51252/rcsi.v 5 i 1 . 864  Original article  Artículo original  Jan - Jun , 202 5 https://revistas.unsm.edu.pe/index.php/r csi  e - ISSN:   2709 - 992X  ©   The authors. This is an open - access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distr ibution,  and reproduction in any medium,   provided the original work is properly cited.  Use of technology in research among medical students at a  private university in Huancayo  Uso de las tecnologías al servicio de la investigacion por estudiantes de medicina  de una universidad privada de Huancayo  Mely Ruiz - Aquino 1* ,   Andrés   Leonardo Osorio - Llancachagua 2 ,   Julio Oswaldo Botiquín -  Encarnación 2 ,   Aníbal Valentín Diaz - Lazo 2 ,   Santiago Ángel Cortez - Orellana 2 ,   Rivaldo Carlos  Duran - Aquino 3  1 Universidad de Huanuco .   Huanuco, Peru  2 Universidad Peruana Los Andes .   Huancayo, Peru  3 Universidad Nacional Mayor de San Marcos .   Lima, Peru  Received :   29   Sept .   202 4   |   Ac c ept ed :   23   Nov .   202 4   |   Publi shed :   2 0   Jan.   202 5  Corresponding author *:   melyruizaquino@udh.edu.pe  How to cite this article :   Ruiz - Aquino, M., Osorio - Llancachagua, A. L., Botiquín - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A   .,  & Duran - Aquino, R. C .   (202 5 ).   Use of technology in research among medical students at a private university in Huancayo .   Revista  C ientífica de   S istemas e   I nformática ,   5 ( 1 ), e 7 63 .   https://doi.org/10.51252/rcsi.v5i1.864  ABSTRACT  This study mainly assessed the level of technology use in research among medical students during the infodemic  period at a private university in Huancayo. A quantitative, descriptive study was conducted with a randomly  selected sample of 109 students from   a total population of 764. A validated technology usage scale for research  was applied, followed by a descriptive data analysis. The results indicated that 44.95% of students had a basic  level of technological proficiency, 45.87% had an intermediate level,   and only 8.26% had an advanced level. The  most frequently used tools were PubMed and SciELO for literature searches, whereas the use of reference  managers and academic integrity tools was notably limited. The findings suggest that despite having access to  digital devices and internet services, students require further training in advanced technological tools to enhance  the quality of their research .  Keywords :   competencies; education; infodemic;   research; technology  RESUMEN  El objetivo de este estudio fue identificar el nivel de uso de las tecnologías al servicio de la investigacion por parte  de estudiantes de medicina en tiempos de infodemia en una universidad privada de Huancayo. Se   realizo un  estudio cuantitativo, descriptivo simple, con una muestra de 109 estudiantes seleccionados aleatoriamente de  una poblacion de 764. Se aplico una escala de uso de tecnologías para la investigacion y se realizo un analisis  descriptivo de los datos . Los resultados indicaron que el 44,95% de los estudiantes tenía un nivel basico, el  45,87% un nivel intermedio y solo el 8,26% un nivel avanzado en el uso de tecnologías. Las herramientas mas  utilizadas fueron PubMed y Scielo para la busqueda de informac ion, mientras que el uso de gestores de  referencias y herramientas de integridad academica fue limitado. Se concluye que, aunque los estudiantes  cuentan con acceso a dispositivos y servicios de internet, existe una necesidad de fortalecer sus habilidades e n  el uso de tecnologías avanzadas para mejorar la calidad de sus investigaciones .  Palabras clave :   competencias; educacion; infodemia; investigacion; tecnología.\nRuiz - Aquino   et al.  2   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  1.   INTRODUC TION  In recent years, the COVID - 19 pandemic has fueled   the rise of an infodemic, characterized by the  rapid spread of all types of information, including rumors and unreliable data. This has been  facilitated by the widespread use of mobile phones, social networks, the internet, and other  communication technolo gies (Arroyo et al., 2020). However, technology use is not inherently  detrimental. We are experiencing a technological revolution marked by the global expansion of  computers and digital communication systems (Grande et al., 2016), which have proven invalua ble  across various fields, including scientific research. Information and Communication Technologies  (ICTs) exemplify this transformation, significantly impacting research by enabling more efficient  problem - solving and data management (Grande et al., 2016) . Medical students increasingly rely  on ICTs to streamline research tasks that would otherwise be time - consuming and resource -  intensive (Arbelaez, 2014).  A 2019 study in Spain by Garcí a   &   Canton (2019) reported that nearly all students (98%) used  search engines such as Google or Safari, and 96% utilized instant messaging applications like  WhatsApp or Telegram. In Mexico, Gomez (2019) found that only 18% of university students had  internet a ccess at home, with financial constraints being the primary barrier. Social media use was  also widespread, with 95% of students on Facebook, 79% on Twitter, and 65% on Instagram.  Similarly, Campos et al. (2018) reported th at 72.4% of students at a Mexican research center were  familiar with ICTs, with an average competence rating of 3.54 on a scale of 1 to 5. A 2017 study in  Chile by Cerda et al. (2017) found that 97% of surveyed students owned a laptop and 87% had a  smartph one, with extensive internet coverage at home.  In Peru, Morales (2020) examined ICT integration in video surveillance in Santiago de Surco,  noting a lack of system interoperability. Mendoza (2018) found that 70.4% of educators  incorporated ICT into their teaching, mainly through images (69.1%), videos   (64.2%), and audio  (44.4%), with PowerPoint being the most frequently used tool (93.8%). However, 38.3% of  teachers reported insufficient training and requested instruction on virtual classroom design.  Licona   &   Veitya (2019) further emphasized the necessit y of technological training for researchers,  highlighting its role in accessing and managing scientific information.  Given the transition to virtual learning environments, evaluating the extent of technology use in  research among medical students during the infodemic is crucial (Al - Hail et al., 2023; Almufarreh  & Arshad, 2023). ICTs have become essential in both in - perso n and remote education (Licona &  Veitya, 2019), enhancing research quality by facilitating access to databases, data processing  software, academic writing tools, presentation applications, plagiarism detection programs, and  reference management systems. Re cent studies have demonstrated a direct link between students\'  technological competencies and the effectiveness of their academic research (Martínez & Flores,  2021; Reyes et al., 2020).  Furthermore, Navarrete Enrí quez et al. (2024) and Salguero Alcala et al.   (2024) underscored the  importance of digital competencies for academic performance, particularly in information - dense  environments like the infodemic. These studies highlight the necessity of integrating educational  strategies to strengthen students\' techn ological skills, enabling them to efficiently manage  information and enhance research quality.\nRuiz - Aquino   et al.  3   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Thus, the objective of this study is to identify the level of technology use in research among medical  students at a private university in Huancayo during the infodemic period.  2.   MATERIALS   AND   M ETHODS  2.1.   Type and area study  A quantitative, descriptive, cross - sectional study was conducted among medical students. The area  where the study was   conducted was the Peruvian University of Los Andes. It was carried out from  September 2021 to January 2022.  2.2.   Population and sample  The study population consisted of 764 students of the Faculty of Human Medicine of the  Universidad Peruana Los   Andes, and the sample consisted of 109 students to whom a scale of use  of technologies in the service of research was applied, performing a descriptive analysis. The  inclusion criteria considered students who were doing research work, those between the fif th and  twelfth year of studies, and all students who expressed their willingness to participate. Students  who were between the first and fourth cycle of studies were excluded from the study, as well as  those who did not adequately complete the questionnair e (Table 1).  Table 1.   neral characteristics of the sample of medical students  General characteristics   n=109  fi   %  Demographic characteristics  Age group (years)  Teenagers (15 - 19)   87   79,82  Youth (20 - 25)   20   18,5  Adults (>25)   2   1,83  Sex  Male   48   44  Female   61   56  Academic characteristics  Cycle of studies  Fifth cycle   15   13,8  Sixth cycle   22   20,2  Seventh cycle   23   21,1  Eighth cycle   9   8,3  Ninth cycle   22   20,2  Tenth cycle   8   7,3  Eleventh cycle   9   8,3  Twelfth cycle   1   0,9  Characteristics of the   research  Type of study  According to the researcher\'s intervention  Observational   106   97,2  Experimental   3   2,8  According to the source of information  Retrospective   73   67  Prospective   36   33  According to the number of measurements  Transversal   104   95,41  Longitudinal   5   4,59  According to the number of variables  Descriptive   95   87,16  Analytical   14   12,84\nRuiz - Aquino   et al.  4   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  Project phase  Planning   95   87,2  Execution   11   10,1  Final report   3   2,8  Publication   0   0  Informative data  Previous scientific   publication  Yes   2   1,8  No   107   98,2  Type of study  Original article   -   -  Letter to the editor   -   -  Editorial   -   -  Review article   2   1,8  Symposium   -   -  Case report   -   -  Essays   -   -  2.3.   Data collection techniques and instruments.  The online survey   technique was used, using the \"Scale of the use of technologies in the service of  research\" as an instrument. This instrument was composed of 49 items distributed in 7  dimensions:   technology   for   information   search,   database   technology,   technology   for   data  processing, technology for writing, technology for the presentation of research results, technology  for academic integrity, and technology for reference managers. In addition, a survey guide was  applied to collect the general characteristics of the sample,   which consisted of 13 items organized  into   4   dimensions:   demographic   characteristics,   academic   characteristics,   research  characteristics, and informational data (Table 2) .  Tabl e   2.   Characteristics of the use of technologies by medical students  Equipment and/or devices  N=109  Yes   No  fi   %   fi   %  Desktop computer   93   85.32   16   14.68  Laptop   61   55.96   48   44.04  Cell phone   95   87.16   14   12.84  Tablet   49   44.95   60   55.05  Printer   82   75.23   27   24.77  External memory   28   25.69   81   74.31  USB   81   74.31   28   25.69  MP4   44   40.37   65   59.63  Other   -   -   -   -  Internet service  Home Internet (Router)   100   91.74   9   8.26  Mobile Internet   65   59.63   44   40.37  Wireless Internet (Modem)   87   79.82   22   20.18  Other   -   -   -   -  The \"Scale of the use of technologies in the   service of research\" was validated by a panel of 5  experts, who evaluated the pertinence, relevance, clarity, and organization of the items, ensuring  that they were representative of the variable to be measured. The survey was conducted using the  Google Fo rms platform.\nRuiz - Aquino   et al.  5   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  2.4.   Data collection procedures  For data collection, the online survey was sent through the WhatsApp messaging application to  different groups of students, previously organized by academic cycles (from 5th to 12th). The  survey was designed to be answered in an average time of 20 minutes,   to ensure the participation  and adequate dedication of the respondents.  The process of constructing the instrument began with the development of a matrix in Microsoft  Word, in which the items and dimensions of the survey were clearly defined. Subsequently, this  matrix was transferred to the Google Forms platform, where the que stionnaire was developed in  its final format. This digital transition allowed for greater organization and accuracy in data  collection, as well as a more accessible experience for participants. In addition, the use of Google  Forms facilitated the collectio n and secure storage of responses, allowing for efficient management  of the data collected and minimizing the risk of data entry errors.  The distribution of the survey via WhatsApp was strategically planned to maximize the response  rate, taking advantage of the popularity and reach of this application among university students.  2.5.   Data analysis  Data collection was carried out through an online survey distributed via institutional email and  academic platforms. The survey responses were recorded and analyzed using descriptive  statistics, including frequency distributions, means, and standard deviat ions. The collected data  were processed using SPSS version 26.  2.6.   Ethical aspects  Before initiating the study, permission was obtained from the Universidad Peruana Los Andes,  ensuring institutional conformity with the research. Prior to the application of the survey,  participants were asked to   provide informed consent virtually, in which the purpose of the study,  the intended use of the information collected and their rights as participants were explained  clearly and in detail, including their freedom to withdraw their participation at any time   without  negative consequences.  At all times, the protection of the confidentiality of respondents\' personal data was guaranteed. To  this end, specific measures were implemented, such as the use of anonymous identifiers and  encryption of information, minimizing the risk of unauthorized d isclosure. In addition, a strict  commitment was maintained with the regulations and guidelines established in the Code of Ethics  for Scientific Research of the Universidad Peruana Los Andes, which ensured respect for the  integrity of the participants and t ransparency in all phases of the study.  Compliance with these ethical principles was essential to preserve the confidence of the  participants and ensure the validity and reliability of the data obtained. Likewise, specific  protocols were established for the management of any ethical situation th at might arise during the  development of the research, ensuring a safe and respectful environment for all those involved .  3.   RESULTS  The results of this study show that the majority of medical students at a private university in  Huancayo are in the planning phase of their research, being mostly adolescents and with a slightly  higher   female   representation.   The   nature   of   the   studies   they   conduct   is   predominantly\nRuiz - Aquino   et al.  6   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  observational, retrospective, cross - sectional and descriptive, indicating a basic approach to  information collection and analysis. In addition, it is observed that, although the students have  access to appropriate technological devices and Internet service s, their level of mastery in the use  of specific technologies for research is mostly basic or intermediate   (Table 3) .  The study found that 44.95% of students had a basic level of technological proficiency, 45.87%  demonstrated an intermediate level, and only 8.26% possessed an advanced level   (Table 4) .  Information search, database, and presentation technologies were the most used, with tools such  as PubMed and Scielo standing out. However, limited use of advanced tools for academic integrity  and reference management was observed, indicating areas for i mprovement in the management  of essential technologies for research .  Table 3.   Dimensions of the use of technologies in the service of research by medical students  Dimensions  N=109  Usage   Leve lof use  Yes   No   Basic   Intermedia  te   Advanced  fi   %   fi   %   fi   %   fi   %   fi   %  Information search  technology   109   100   -   -   47   43.12   54   49.54   8   7.34  Database technology   107   98.17   2   1.83   48   44.04   52   47.70   9   8.26  Data processing  technologies   109   100   -   -   43   39.45   50   45.87   16   14.68  Writing technologies   106   97.25   3   2.75   51   46.79   50   45.87   8   7.34  Presentation  technologies   109   100   -   -   40   36.7   52   47.71   17   15.6  Academic integrity  technologies   92   84.4   17   15.6   52   47.71   50   45.87   7   6.42  Reference manager  technology   91   83.49   18   16.51   55   50.46   45   41.28   10   9.17  Table 4.   Use of technologies in the service of research by medical students  Level of technology use   N=109  fi   %  I do not use   1   0.92  Basic   49   44.95  Intermediate   50   45.87  Moving forward   9   8.26  These results coincide with the findings of Salguero Alcala et al. (2024), who found that 27% of  the students evaluated had a low level of digital competencies, similar to the finding of 44.95% at  the basic level. However, unlike studies such as those of N avarrete Enrí quez et al. (2024), which  identified 73% of students with high digital competencies, the present study reveals a significant  gap in the advanced use of technologies, which underlines the need for specific training  interventions.  Likewise, Alamo   &   Montenegro (2022) reported that nursing professionals possess basic  knowledge and skills in ICT, aligning with the finding of a high percentage of students with basic  and intermediate levels in the use of technologies. This limited level of competence cou ld be  associated with the lack of specific training in the management of advanced tools, such as reference  managers and academic integrity tools, crucial for the quality of scientific research (Licona &  Veitya, 2019).\nRuiz - Aquino   et al.  7   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  On the other hand, Llanos de Tarazona (2019) demonstrated that an effective integration of ICTs  in   university   education   improves   students\'   research   competencies,   which   highlights   the  importance of strengthening these skills in the context of the present re search. In addition, Gomez  (2019) found that access to technologies does not necessarily translate into effective use for  academic purposes, corroborating that, despite the high availability of devices and internet among  participants, the use of advanced t ools is still deficient.  In line with the studies of Mendoza   &   Placencia (2018), who pointed out that the use of ICT in  teaching requires adequate teacher training, the results suggest that current pedagogical  strategies may not be sufficiently focused on the development of advanced technological  competencies among st udents. This is especially relevant in times of infodemic, where the ability  to manage and critically evaluate information is fundamental for academic research (Reyes et al.,  2020).  In addition, Martinez   &   Flores (2021) highlighted that during the pandemic, virtual training has  exacerbated inequalities in access to and use of technologies, which may be reflected in the varied  technological competence observed in the sample. The lack of advanced skills in res earch  technologies may limit the effectiveness and quality of research projects developed by medical  students.  Cerda et al. (2017) found that the use of digital technologies is positively related to academic  achievement in student teachers, suggesting that greater technological competence could improve  academic performance in health careers such as medicine. Howeve r, Martínez Perez et al. (2023)  observed that excessive use of social networks, such as Facebook, can negatively affect academic  performance, underscoring the need to balance the use of technologies for recreational and  academic purposes.  Aleman   &   Ynojosa (2024) warn about the threats and disadvantages of ICT use in academic  training, suggesting that ICTs have not been adequately exploited due to a lack of technological  skills or insufficient methodological information. Mendoza (2024) also points o ut that 67% of  students experienced problems related to the management and mastery of virtual platforms,  which could be linked to a lack of training in these areas.  In this context, the results reveal the need to strengthen the technological training of students,  integrating a progressive approach that allows them to develop advanced competencies in the use  of technologies applied to research. Comparison with previous   studies suggests that the level of  technological competence of students varies considerably according to the institutional context  and the pedagogical strategies implemented, which highlights the importance of a timely  educational intervention to close th is gap.  Finally, the integration of advanced digital competencies would not only improve the quality of  academic research, but also prepare future medical professionals to deal more effectively with the  challenges of the infodemic, characterized by the overabundan ce and variable quality of available  information (Arroyo et al., 2020).  Among the limitations of this study is the fact that the sample consisted of students from a single  private university in Huancayo, which may limit the generalizability of the findings to other  institutions or regions of the country. In addition, the scale   used to measure the use of technologies  may not have exhaustively captured all relevant dimensions in the context of academic research.\nRuiz - Aquino   et al.  8   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  The quantitative approach, on the other hand, may have restricted the exploration of qualitative  aspects that could provide a deeper understanding of students\' experiences with technologies.  Another important limitation is the use of virtual surveys, as un equal access to the internet and  the possible unfamiliarity of some students with digital platforms could have affected the accuracy  and completeness of responses, introducing bias in data collection.  It is recommended that the scope of the study be broadened to include samples of students from  different universities, both public and private, and in different regions of the country, in order to  obtain a more representative view of the use of technologie s in the service of research. In addition,  the   development   of   more   detailed   and   specific   measurement   instruments   that   can  comprehensively evaluate the use of technologies in academic contexts is suggested. It would also  be valuable to incorporate qualitati ve approaches to explore perceptions, motivations and barriers  faced by students when using technological tools in their research. Finally, it is recommended to  design and implement continuous training programs aimed at improving students\' technological  co mpetencies, especially in the use of reference managers and academic integrity tools  CONCLUSIONS  Most medical students at a private university in Huancayo reach basic or intermediate levels in  using technological tools for research. Despite having access to internet devices and services, there  is limited use of advanced and specific tools such as refe rence managers and academic integrity.  These findings underline the need to implement training strategies focused on improving the  mastery of critical technologies for academic research, which will allow us to face more effectively  the information overload   in the infodemic era .  FINANCI NG  The authors did not receive sponsorship to carry out this study - article .  CONFLICT OF INTEREST  The authors declare that they have no conflicts of interest related to the development of the  study .  AVAILABILITY OF DEPOSITED DATA  The datasets collected during this study and supporting the findings of the study are available at:  https://data.mendeley.com/datasets/w9znxg38bw/1  AUTHORSHIP CONTRIBUTION  Conceptualization;   Data   Curation;   Formal   Analysis;   Research;   Methodology;   Visualization;  Validation; Writing   -   original draft; Writing   -   revision and editing:   Ruiz - Aquino, M., Osorio -  Llancachagua, A. L., Botiquí n - Encarnacion, J. O., Diaz - Lazo, A. V., Cortez - Orellana, S. A., and Duran -  Aquino, R. C.\nRuiz - Aquino   et al.  9   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  REFERENC ES  Alamo , E., & Montenegro, R. (2022). Competencias en la tecnologí a de informacion y  comunicacion del profesional de enfermerí a en instituciones del primer nivel de atencion  Chiclayo, 2020.   ACC CIETNA:   Revista De La Escuela De Enfermería , 9(1), 18 – 28.  https://doi.org/10.35383/cietna.v9i1.592  Aleman , O., & Ynojosa, Y. (2024). Desafí os frente al uso de las tics en pandemia en el programa de  enfermerí a de la UNEFM.   Aula Virtual , 5(11), 151 – 169.  https://doi.org/10.5281/zenodo.10465778  Al - Hail, M., Zguir, M. F., & Koç, M. (2023).   University students’ and educators’ perceptions on the  use of digital and social media platforms: A sentiment analysis and a multi - country review.  IScience , 26(8), 107322.   https://doi.org/10.1016/j.isci.2023.107322  Almufarreh , A., & Arshad, M. (2023). Promising Emerging Technologies for Teaching and  Learning: Recent Developments and Future Challenges.   Sustainability , 15(8), 6917.  https://doi.org/10.3390/su15086917  Arbelaez, M. (2014). Las tecnologí as de la informacion y la comunicacion (TIC) un instrumento  para la investigacion.   Investigaciones Andinas , 16(29), 997 – 1000.  https://revia.areandina.edu.co/index.php/IA/article/view/52  Arroyo, A., Cabrejo, J., & Cruzado, M. (2020). Infodemia, la otra pandemia durante la enfermedad  por coronavirus 2019.   Anales de la Facultad de Medicina , 81(2), 230 – 233.  http://dx.doi.org/10.15381/anales.v81i2.17793  Campos Cruz, H., & Ramí rez Sanchez, M. Y. (2018). Las TIC en los procesos educativos de un  centro publico de investigacion.   Apertura,   10(1), 56 – 70.  https://doi.org/10.32870/ap.v10n1.1160  Cerda, C., Huete - Nahuel, J., Molina - Sandoval, D., Ruminot - Martel, E., & Saiz, J. (2017). Uso de  Tecnologí as Digitales y Logro Academico en Estudiantes de Pedagogí a Chilenos.   Estudios  pedagógicos (Valdivia) , 43(3), 119 – 133.   http://dx.doi.org/10.4067/S0718 -  07052017000300007  Garcí a, S., & Canton, I. (2019). Uso de tecnologí as y rendimiento academico en estudiantes  adolescentes.   Comunicar,   59, 73 - 81 .   https://doi.org/10.3916/C59 - 2019 - 07  Gomez, D. (2019). Uso de las tecnologí as de la informacion y la comunicacion por universitarios  mayas en un contexto de brecha digital en Mexico . Región y Sociedad , 31, 1 – 25.  https://doi.org/10.22198/rys2019/31/1130  Grande, M., Canon, R., & Canton, I. (2016). Tecnologias de la informacion y la comunicacion:  Evolucion del concepto y caracterí sticas.   IJERI: International Journal of Educational Research  and Innovation , (6), 218 – 230.  https://www.upo.es/revistas/index.php/IJERI/article/view/1703  Licona, K., & Veitya, M. (2019). La Formacion en y para la investigacion y el uso de las Tecnologí as  de la Informacion y Comunicacion.   Atenas , 2(46), 64 – 78.  https://atenas.umcc.cu/index.php/atenas/article/view/343  Llanos de Tarazona, M. I. (2019). Aprendizaje de la investigacion mediante las tecnologí as de\nRuiz - Aquino   et al.  10   Rev.   C ient.   S ist.   I nform.   5 ( 1 ): e 7 63 ; ( Jan - Jun , 202 5 ). e - ISSN: 2709 - 992X  comunicacion e informacion en universitarios de Huanuco.   Revista de Salud UDH , 1(4), e48.  https://doi.org/10.37711/rpcs.2019.1.4.48  Martínez   Perez , E., Martínez   Sandoval , M., & Hernandez   Nava, N.   (2023). El uso de Facebook en  alumnos auxiliares de enfermerí a de una institucion publica de Queretaro.   LATAM Revista  Latinoamericana De Ciencias Sociales y Humanidades , 4(1), 2829 – 2840.  https://doi.org/10.56712/latam.v4i1.457  Martínez, N., & Flores, S. (2021). Uso de nuevas tecnologí as en tiempos de pandemia en la  formacion de los estudiantes de enfermerí a de la universidad tecnica de Ambato.   Enfermería  Investiga , 6(4), 19 – 29.  https://revistas.uta.edu.ec/erevista/index.php/enfi/article/view/1200  Mendoza, H., & Placencia, M. (2018). Uso docente de las tecnologí as de la informacion y  comunicacion como material didactico en Medicina Humana.   Investigación en Educación  Médica , 7(26), 54 – 62.   https://doi.org/10.1016/j.riem.2017.04.005  Navarrete Enrí quez, R. M., Remache Cachimuel, J. T., & Reyes, V. M. (2024). Uso de herramientas  digitales y rendimiento academico en estudiantes de enfermerí a: un estudio de caso en un  Instituto Tecnologico.   Prohominum , 6(2), 227 – 242.  https://doi.org/10.47606/ACVEN/PH0245  Reyes, M. C., Garcí a, E. J., Díaz, O. M., & Sanchez, I. (2020). Preparacion cientí fica en enfermeras de  la atencion primaria de salud.   Edumecentro , 12(3), 149 – 162.  https://pensamientoeducativo.uc.cl/index.php/RHE/article/view/58323  Salguero Alcala, G. K., Benites Zuniga, J. L., Salguero Alcala, A. G., Orosco Leon, O. E., Orosco  Toribio, E. G., & Vega Vilca, C. S. (2024). Competencias digitales y rendimiento academico en  los estudiantes universitarios. Horizontes . Revista De Investigación En Ciencias De La  Educación , 8(32), 164.   https://doi.org/10.33996/revistahorizontes.v8i32.713',0.14138832787671654,'[\"\\\"scale\", \"%\", \"&\", \"(\", \"(15\"]','2025-11-29 21:50:05.994263'),(90,3,'RESEARCH ARTICLE  Research on intelligent routing with VAE-GAN in the internet of body  Song Qian 1 , Tianping Zhang ID 2 * , Siping Hu 3  1   School of Information Engineering, Xinjiang Institute of Technology, Xinjiang, China,   2   School of Mathematics and Computer Science, Hanjiang Normal University, Shiyan, China,   3   Institute of Engineering and Technology, Hubei University of Science and Technology, Xianning, China  *   zhangtianping0818@163.com  Abstract  The \"Internet of Body\" is an emerging technology that is centered on the human body and connected to the Internet. It can monitor a variety of human data (such as heart rate, blood oxygen content, etc.) and communicate with digital pills, wearable devices, etc. It has been widely used in the field of medical health. However, when other devices access the Internet of Body on a large scale, there will be load imbalance caused by the difficulty in selecting the optimal route, which will affect the overall throughput and may even fail to transmit and endanger life. The traditional artificial intelligence routing algorithm cannot deal with the low model prediction accuracy and poor generalization ability caused by large noise and small data volume. This paper proposes an artificial intelligence routing algorithm, combines the variational autoencoder (VAE) and the generative adversarial network model (GAN) to con- struct a VAE-GAN model to generate multiple sets of data to achieve data enhancement on the Internet of Body. The optimization goals are to maximize the throughput of the Internet of Body and minimize the transmission cost. The entire routing problem is expressed as a Markov decision and the optimal transmission path is solved by learning previous historical experience to generate the real-time optimal route. Experiments have shown that this scheme can achieve the optimal route according to the transmission capacity of the real- time path and only requires fewer computing resources. It achieves load balancing of the entire network and avoids network congestion. The average throughput is much higher than that of traditional routing, and the advantage is more obvious under high load.  1.Introduction  The Internet of Bodies (IoB), also known as the Internet of Things based on the human body, is an emerging technology that connects the human body directly to the Internet and collects and processes human data through built-in or wearable devices. This technology is mainly used in the field of medical health, such as monitoring and analyzing human health through implantable pacemakers, ingestible digital pills, wearable prostheses, and other devices. The collected data includes steps, heart rate, blood oxygen content, etc. [1], as shown in Fig 1. In recent years, with the rapid development of a variety of built-in or wearable devices, the amount of information communicated with the IoB has increased rapidly, and the number of PLOS ONE  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   1 / 15  a1111111111 a1111111111 a1111111111 a1111111111 a1111111111  OPEN ACCESS  Citation:   Qian S, Zhang T, Hu S (2025) Research on intelligent routing with VAE-GAN in the internet of body. PLoS ONE 20(2): e0317698. https://doi. org/10.1371/journal.pone.0317698  Editor:   Zeheng Wang, Commonwealth Scientific and Industrial Research Organisation, AUSTRALIA  Received:   September 28, 2024  Accepted:   January 2, 2025  Published:   February 10, 2025  Peer Review History:   PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: https://doi.org/10.1371/journal.pone.0317698  Copyright:   ©   2025 Qian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  Data Availability Statement:   Data cannot be shared publicly because of muman body data parameters. Data are available from the Local hospital Institutional Data Access / Ethics Committee (contact via 1273091366@qq.com) for\ndeployment types has increased. The load imbalance caused by path selection under high con- currency has become the primary factor restricting the efficient operation of the IoB. There- fore, it is necessary to study intelligent routing algorithms that are more suitable for the IoB under large-scale access. The Internet of Things mainly consists of the perception layer, network layer, and applica- tion layer, among which routing plays a key role in the entire communication process. Most of the current routing modes are to implement network interoperability between servers. Rout- ing is composed of multiple selected paths. Under normal access scale, only the shortest path routing solution is required. However, when there is large-scale access When used in applica- tions in the Internet of Things (such as an increase in the amount of data sensed in a short period of time), performance degradation will occur. Although shortest paths routing is a rout- ing scheme that selects the smallest number of paths and is suitable for situations where the overall transmission performance is good, it is not the optimal routing scheme in all cases. The current artificial intelligence routing algorithm has the following problems: Poor model adaptability: Since the Internet of Things is a network deployed in the human body, it is affected by many aspects and cannot carry out regular model training like the Inter- net of Things, and the model adaptability is poor. Sparse sample data: The training method based on deep learning requires a certain amount of data as support. However, the Internet of Things is affected by many aspects, and the train- ing data is small, so it is difficult to obtain valuable samples. Low intelligence: Existing routing algorithms have the disadvantage of low intelligence in the Internet of Things. With the emergence of technologies such as cloud computing and high concurrency, there is a need for more intelligent routing algorithms to adapt to them.  Fig 1. Body-connected routing scenario.  https://doi.org/10.1371/journal.pone.0317698.g001 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   2 / 15  researchers who meet the criteria for access to confidential data.  Funding:   The author(s) received no specific funding for this work.  Competing interests:   The authors have declared that no competing interests exist.\nIn order to solve the above problems, this article analyzes the key technologies of IoT rout- ing, takes maximizing the overall IoT transmission throughput and minimizing transmission cost as optimization goals, constructs a VAE-GAN model to achieve data enhancement, and then proposes an intelligent routing based on transfer Learning, design real-time optimal intel- ligent routing scheme.  2. Related work  The Dijkstra algorithm is a commonly used routing algorithm in the network. It stores all ver- tices and calculates edge values. When it is used again, it can be directly queried. It needs to maintain the shortest path table. When the access scale is large, the search efficiency from the path table is low and load balancing cannot be achieved well. Equal-Cost Multipath Path (ECMP) equal-cost routing algorithm stores all des t IPs and paths with the same cost value. When used again, it can be queried directly. The advantage is that it is easy to deploy, and the load is more balanced than other algorithms. The disadvantage is that all Routes are distributed in equal parts, which cannot satisfy services with high immedi- acy requirements. K -shortest Path (KSP) is an extension of the Dijkstra algorithm. It excludes intersecting paths and paths that may form loops. It also needs to maintain the shortest path table. It has high requirements on hardware, is difficult to deploy, and is not easy to achieve load balancing. Dynamic Scheduling Load Balancing (DSLB) dynamic scheduling load balancing algo- rithm. The principle of this algorithm is to greedily find the maximum available bandwidth. It is similar to polling routing. When ensuring the maximum bandwidth, polling uses available paths without affecting delay, Judgment of other performance indicators such as available bandwidth, so there are limitations. In addition, other scholars have also conducted research on cloud computing data center network routing. There are many routing implementation methods for cloud computing data center networks. This article mainly discusses routing solu- tions that can ensure system load balancing under large-scale access. When accessing the Internet of Things on a large scale, in order to prevent load imbalance, all key factors need to be considered comprehensively and comprehensively, and routing algorithms based on artifi- cial intelligence have great advantages in this regard. Since the Internet of Body and the Internet of Things have many similarities (such as dynamic network topology), there are relatively few literatures on the Internet of Body. There- fore, in many aspects, we can refer to the routing of the Internet of Things, the Internet of Water, etc. For example, in 2024, Zhu et al. designed an underwater routing protocol to deal with the drawbacks of high propagation delay and dynamic network topology in the Internet of Water [2]. In 2023, Malik et al. proposed a routing algorithm based on reinforcement learn- ing to reduce end-to-end routing delay in the Internet of Things and improve throughput. Experiments have shown that it has advantages such as reducing packet conflicts [3]. In 2020, Kaur et al. proposed an artificial intelligence-based routing algorithm for the heterogeneity of nodes in the Internet of Things. Experiments have shown that it improves stability [4]. In 2024, Arafat et al. designed an adaptive Q-learning adaptive routing algorithm to address the frequent changes in network topology required for monitoring personal physiological parameters [5]. In wireless body area networks, in order to achieve reliable routing, artificial intelligence multi-source aggregation routing is proposed, which is beneficial for avoiding transmission interruptions caused by congestion [6]. In 2021, V Degli Esposti et al. summa- rized the transmission and channel modeling of millimeter wave and terahertz waves [7]. In 2024, Liu et al. proposed a routing algorithm with multiple DQNs to generate access order and PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   3 / 15\nthe number of health data packets sent for each node in order to achieve early disease monitor- ing and balance waiting time. The experiment proved that it has good performance in asym- metric systems [8]. Li et al. proposed a real-time differential multimodal transformer that helps collect real-time human life parameters [9]. Vakil et al. proposed sample collection steps in different environments to address the problem of limited prediction samples, which can help train better models [10]. Transfer learning is a machine learning method that takes the model developed for   task 1 as an initial point and reuses it in the process of developing the model for   task 2. It means trans- ferring knowledge from one domain (source domain) to another domain (target domain) to accelerate the learning process of the new domain. This ability to draw analogies is not only in line with human learning laws, but also one of the important goals pursued by artificial intelli- gence. In deep learning, transfer learning achieves fast adaptation and efficient learning by uti- lizing pre trained models and combining them with a small amount of new domain data. Routing is a sequential decision problem, in which each decision is a function of the current state of the network. Therefore, routing can be modeled as a Markov decision process, which is naturally applicable to the field of artificial intelligence. Transfer learning is generally speak- ing about designing an algorithm to enable it to have the ability to draw inferences from one instance, that is, to learn new knowledge by applying existing knowledge. Its core is to find the similarities between existing knowledge and new knowledge, and to achieve the purpose of transfer learning through the transfer of this similarity. Since many things have commonali- ties, how to reasonably find the similarities between them and then use this bridge to help learn new knowledge is the core problem of transfer learning. Its working principle is shown in Fig 2. Transfer learning usually focuses on a source domain   Data s   ¼ f a s i   ;   b s i   g   and a target domain  Data t   ¼ f a t i   ;   b t i   g , which   a d i   ;   b d i   respectively represent data samples and corresponding category labels. The definition of transfer learning is: given the source domain   Data d   and learning task  T s , the target domain   Data t   and the learning task   T t , the purpose of transfer learning is the acquisition   Data s   of knowledge in the source domain   f t ( � ) and learning tasks to help improve the learning of prediction functions   T s   in the target domain, where   Data s 6 ¼ Data t   and   T s 6 ¼ T t . Commonly used generative models in the field of deep learning include VAE and GAN [11]. Although both can perform data regeneration, each has certain flaws in its application. The VAE model deep model and static reasoning can obtain the distribution of the original data through resampling, but the diversity of the generated data is low; the GAN model  Fig 2. Principle of transfer learning.  https://doi.org/10.1371/journal.pone.0317698.g002 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   4 / 15\ngenerates more diverse data, but the training process is extremely difficult, and it is difficult for the generator and the discriminator to simultaneously convergence. Therefore, this article combines the data generation of the VAE model and the adversarial learning mechanism of the GAN model to propose the VGR (VAE-GAN-route) model, taking into account the advan- tages of both and giving full play to their respective strengths. The VAE network is used as a generator based on the GAN network, which optimizes the GAN generator’s shortcomings of single extraction features, low cohesion, and easy gradient disappearance. At the same time, the GAN network can make up for the lack of sample data due to VAE’s lack of adversarial learning, improving the performance of the two alone. shortcomings in the work, resulting in higher accuracy and robustness of reconstructed data. The proposed VGR model is divided into three parts, namely the encoding network, the decoding network (generating network) and the judging network, which correspond to the Encoder and Decoder of the VAE model and the Discriminator of the GAN model. It can be understood as adding the encoding process of real data on the basis of the GAN network, using the implicit z with prior information to replace the random vector originally input to the generator, which greatly improves the expression ability of the model. The VGR model struc- ture is shown in Fig 3. The encoding network consists of three fully connected layers. The first fully connected layer down samples the input high-dimensional data, and the activation function uses Relu; the remaining two fully connected layers map the down sampled samples into two low-dimen- sional parameter features, namely the mean and variance of the normal distribution. The prob- ability distribution of the original sample data   x   is:  x   �   P y ð x Þ   ð 1 Þ  In the above formula,   θ   is the model parameter. The loss function of the encoding network is KL (Kull back Libeler Divergence) divergence, used to measure the difference between the implicit vector distribution and the standard normal distribution. The KL loss function is:  KL N ð m ;   s 2 Þ k   N ð 0 ;   1 Þ ð   Þ ¼   1 2   log 2 ð s 2 Þþ s 2   \0   m 2   \0   1  �   �   ð 2 Þ  In the above formula,   μ   and   σ 2   are respectively the mean and variance of the encoding net- work output. Indicates the calculation of the KL divergence of two approximate distributions. It is used here to express the KL divergence between the data distribution sought in this article and the standard normal distribution   N (0,1). If the two distributions are the same, the KL  Fig 3. VGR structure.  https://doi.org/10.1371/journal.pone.0317698.g003 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   5 / 15\ndivergence is 0. On the contrary, the greater the distribution difference, the greater the KL divergence value. Variational Encoders (VAE) are based on Bayesian inference and their goal is to model latent and sample new data in the model, while Generative Adversarial Networks (GAN) are based on game theory and their goal is to find Nash Balanced discriminator and generator networks. KL divergence is a concept in statistics, a procedure used to measure the similarity of two probability distributions. When the two probability distributions are closer, their KL diver- gence value becomes smaller. For discrete probability distributions, the definition is as follows:  D KL ð P jj Q Þ ¼   X  i  P ð i Þ log   P ð i Þ  Q ð i Þ   ð 3 Þ  P   and   Q   is a probability function the variable   i . And the continuous probability distribution is:  D KL ð P jj Q Þ ¼  Z   þ1 \0 1  log   p ð x Þ  q ð x Þ   dx   ð 4 Þ  Therefore, if we want to pass a random Gaussian noise   z   through a generative network G to obtain a   Pdata ( x ) generative distribution that is similar to the real data distribution   PG ( x ,   θ ), where the parameters   θ   are determined by the parameters of the network, we hope to find a generative distribution   θ   that is as close   Pdata ( x ) as possible to   PG ( x ,   θ ). The decoding network (generating network) consists of two layers of fully connected net- works. The parameter settings of these two layers of network are opposite to the parameter set- tings of the encoding network. The input low-dimensional hidden variables are characterized by amplification, and finally generated data of the same size as the input data is generated., the Relu activation function is used between the two network layers, and the final output layer uses the Sigmoid activation function. The optimization goal of the generation network must not only ensure that the feature loss between the generated samples and the real samples is minimized but also ensure that the generated data can deceive the discriminant network. The loss function is:  L G   ¼ ð x i   \0   ^ x i Þ 2   þ   E z � p ð z Þ   ½ log 2 ð 1   \0   D ð G ð z ÞÞÞ�   ð 5 Þ  In the formula, the first term on the right side represents the loss reconstruction of the encoder,   x i   and   ^ x i   are the real samples and predicted values. All hidden variables generated for parameter reconstruction obey   p ( z ) distribution.   G ( z ) is used to generate samples;   D ( � ) is used to judge the authenticity of the generated data by the discriminating network. The discriminant network consists of 2 convolutional layers and 3 fully connected layers. The activation function between each network layer uses LeakyRelu. The output layer outputs the authenticity label through the Sigmoid activation function. The loss function of the dis- criminant network uses a more stable least square. The multiplicative loss function is:  L D   ¼   1 2   E x � p data ð x Þ   ð G ð x ÞÞ 2 �   �   þ   1 2   E x � p ð z Þ ½ð D ð z Þ \0   1 Þ 2 �   ð 6 Þ  In the formula,   x ~ p data ( x ) means that the real sample obeys   p data ( x ) distribution. The VAE-GAN model takes advantage of the coding advantages of VAE to input hidden vectors containing prior information into the GAN model instead of random vectors for data generation, thereby alleviating the problem of non-convergence in model training. The GAN network improves the quality of generated data through adversarial learning and completes the improvement of the VAE model. The two complement each other. PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   6 / 15\n3 Intelligent routing algorithms  3.1 The multi-objective optimization model  The current intelligent routing is reflected in the selection of the best path for each routing decision. Intelligent routing takes into account the load balancing of the entire network, and it also makes the best use of the available transmission paths (bandwidth and number). Further- more, due to the characteristics of the Internet of Body, the shortest path is not the optimal transmission path, and the real-time transmission path is changeable. Therefore, this paper studies the transmission performance and effective bandwidth of the path and designs a multi- objective optimization intelligent routing algorithm based on transfer learning. In the Internet of Body, the entire network is modeled as   G   = ( V ,   N ), where   V   is a non-empty vertex set, | V | is the number of vertices.   N   ¼ f v i j v j ;   i   6   ¼   j ;   v i ;   v j   2   V g   is an edge set and   v i | v j   is the communica- tion link between nodes   v i   and   v j   [12]. Furthermore,   B   is the residual bandwidth set. The residual bandwidth of an edge   v i | v j   is expressed as   b i ; j   2   B ð i   6   ¼   j ;   i   �   1 ;   j   �   1 Þ , and   8 v 2 V ,   b i , i   =   1 . The following definition can be obtained: Definition 1: A route   a s , t   is defined as the edges from a source node   v s   to another target node   v t :  a   ¼ f v s j v 1 ;   v 1 j v 2 ;   � � �   ;   v m \0   1 j v m ;   v m j v t   g   ð 7 Þ  Among them,   v s 6 ¼ v 1 ,   v m 6 ¼ v t , and for   8 v i ,   v j , if   i 6 ¼ j , then   v i 6 ¼ v j , based on the definition of routing, we further define that   k   disjoint paths from the source node to the target node are:  A k s ; t   ¼ f a i s ; t   g k i ¼ 1   ð 8 Þ  In the above expression,   8 i   6   ¼   j ;   A i s ; t   \\   A j s ; t   ¼ ;ð i   �   1 ;   j   �   1 Þ . Definition 2: The bottleneck bandwidth of the route   a s , t   from the source node   v s   to the tar- get node   v t   is:  BB ð a s ; t   Þ ¼   min ð b s ; 1 ;   b 1 ; 2 ;   � � �   ;   b m \0   1 ; m ;   b m ; t   Þ   ð 9 Þ  There are multiple paths   A k s ; t   from the source node   v s   to the destination node   v t , and the maximum bottleneck bandwidth (MBB) of the path   a s , t   is   A k s ; t   . The maximum available bottle- neck bandwidth on all paths, that is:  MBB ð A k s ; t   Þ ¼   max ð BB ð a Þ ;   BB ð a 2  s ; t   Þ ;   � � �   ;   BB ð a k s ; t   ÞÞ   ð 10 Þ  The minimum hop count (MHC) from the source node   v s   to the destination node   v t   is the minimum hop count of all nodes:  MHC ð A k s ; t   Þ ¼   min ðj a 1  s ; t   j ;   j a 2  s ; t   j ;   � � �   ;   j a k s ; t   jÞ   ð 11 Þ  Where,   j a 1  s ; t   j   represents the number of elements in the set   a 1  s ; t   . The path transmission delay   a s , t   from the source node   v s   to the destination node   v t   is defined as follows (sum of link delays):  PD ð a s ; t   Þ ¼   d s ; 1   þ   X m \0   1  i ¼ 1   d i ; i þ 1   þ   d m ; t   ð 12 Þ  Then, the minimum propagation delay   a s , t   of the path is the minimum propagation delay of all PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   7 / 15\npaths   P k s ; t   , that is:  MPD ð a k s ; t   Þ ¼   min ð PD ð a 1  s ; t   Þ ;   PD ð a 2  s ; t   Þ ;   � � �   ;   PD ð a k s ; t   ÞÞ   ð 13 Þ  The   k   disjoint paths from node   v s   to target node   v t   can be expressed as a multi-objective opti- mization model:  Max ð MBB ð A k s ; t   ÞÞ   ð 14A Þ  Min ð MHC ð A k s ; t   ÞÞ   ð 14B Þ  constraint:  8 a i s ; t   ;   a j s ; t   2   A k s ; t   ;   a i s ; t   \\   a j s ; t   ¼ ;   ð 15A Þ  k   �   1   ð 15B Þ  3.2 Algorithm process  The implementation process of the multi-objective optimization model in this paper is improved on the basis of literature [13–15]. The entire algorithm implementation process is as pseudo code Algo- rithm 1. The former part is the data enhancement part, and the next part outputs the final result. The time complexity of the algorithm is not high [16], and it can achieve unified processing of multiple goals as a whole. Next, the algorithm is simulated to verify its effectiveness and evaluate its performance.  Algorithm 1 Intelligent routing algorithm under high load of Internet of body Input Current routing data, current network status, etc. Output Next optimal route 01   A   = collecting all routing data, and get the training data and test- ing data 02 for   a ! =   null   and   a 2 A   do 03   create VAE-GAN model 04   put all routing data   a   to VAE-GAN model and train data 05   if   is_max_train_number   then 06   save the model   WS , and get all the created data 07   end if 08   liding window segmentation data 09 end for 10   B   = get all the test data 11 for   b ! =   null   and   b 2 B   do 12   put   b   to model   WS  13   if   is_max_train_number   then 14   regression prediction 15   end if 16 end for 17 Return the prediction result  Among them, lines 01–09 are the data addition part. Lines 10–17 are the processing of input test data.   is_max_train_number   is the maximum training frequency identifier. The designed algorithm focuses on low computation and space complexity and is suitable for appli- cation in the Internet of body. The entire algorithm consists of 2 loops, with the number of loops being   tn 1 (lines 02–09) and   tn 2 (lines 11–16) respectively. The time complexity of the entire algorithm is   O ( tn 1)+ O ( tn 2). If the number of loops is   n , then the time complexity of the algorithm is   O ( n ). PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   8 / 15\n4 Experimental simulation and result analysis  By building an Internet of Body and simulating access conditions under high load. Based on the simulation parameters in reference [17], the following simulation platform was built: Hardware environment: Intel(R) Core (TM) i7 12400F CPU @2.50 GHz   ×   6, 64 G memory. Python version number: Python 3.12. Operating system: Ubuntu 24.04. Network routing analysis and debugging tool: Wireshark v 4.2.4, used to analyze network rout- ing, etc. Load stress software: webbench 5.0 [18], this software can simulate tens of thousands of con- current requests per second, support the setting of control time, cache and server response time, etc. Its multi-concurrency principle is that there are multiple subprocesses [19]. Comparing several commonly used routing algorithms in the experiment, the details are as follows: ECMP: Equal cost multi-path routing, and its advantages are mainly reflected in the ability to improve network redundancy and reliability, while also increasing network resource utili- zation, detailed in reference [20]. Dijkstra: The shortest path algorithm selects the route with the minimum hop count, as detailed in reference [21]. WOAD3QN-RP, a routing algorithm based on swarm intelligence and deep reinforcement learning, is detailed in reference [22]. RL, a deep reinforcement learning routing algorithm, detailed in reference [23]. Proposed algorithm: the algorithm proposed in this article. The comprehensive performance of various algorithms is analyzed by simulation comparison of the following indicators.  4.1. Normalized throughput  Throughput is used to measure the transmission capacity of a network [24]. It is calculated by the amount of data transmitted per unit time. Time is the time when data transmission starts and ends, and data is the total number of bytes of data transmitted during this period of time.  throughput   ¼   data success  time end   \0   time start  ð 16 Þ  Throughput reflects the transmission capacity of the entire network. The transmission results are shown in Fig 4. When the number of visits is average, the throughput of several algorithms is similar. As the number of visits increases, the algorithm in this article has the highest throughput, and it has been in stable transmission without large jitter. Since the Internet of Body is in dynamic changes in the link, it is easy to form a dynamic topology, so ordinary routing will have large throughput jitter, as shown in the figure, but the intelligent routing algorithm proposed in this article can easily cope with it. Methods such as Dijkstra and ECMP are not suitable for applica- tions when the load is too high. They cannot cope with high access and high load well. The per- formance of ECMP is also average and not as good as the algorithm in this article. The PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   9 / 15\nalgorithm in this article takes maximizing throughput as one of the optimization goals, and can the optimal routing plan is adjusted in real time. When load = 7, congestion is avoided without causing a significant decrease in throughput, so the overall transmission capacity is optimized by other algorithms. The normalized throughput tends to stabilize, indicating that the model can apply the influence of high dynamics.  4.2. Load and average bandwidth utilization  The software used for load concurrent generation is webbench 5.0. Average bandwidth utiliza- tion is calculated as:  Bu   ¼  P   B s  B r  x   ð 17 Þ  Among them, for a certain data flow in the Internet of body,   B s   is the bandwidth before sending,   B r   is the real-time bandwidth, and   x   is the total number of statistical flows [25]. The relationship between load and average bandwidth utilization can directly reflect the performance during large-scale access, such as whether it is congested and whether it can meet high-load transmission, etc. The results are shown in Fig 5. The comparison of average bandwidth utilization and load is shown in Fig 5. It can be con- cluded that when the access is of general scale, the average bandwidth utilization of all algo- rithms is about 80%. However, as the access scale increases, the average bandwidth utilization of the Dijkstra algorithm decreases first, and the rate of decrease is also faster than other algo- rithms and finally stops at 0.4. The Dijkstra algorithm has similar results. In addition, the two  Fig 4. Comparison of normalized throughput and load.  https://doi.org/10.1371/journal.pone.0317698.g004 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   10 / 15\nalgorithms cannot cope with high loads, so they are unstable and fluctuate greatly. ECMP has the ability to divide the bandwidth equally, so the average bandwidth utilization is better than the Dijkstra algorithm. The intelligent routing algorithm selects the optimal route according to the real-time network status based on the self-learning ability, which can better cope with high load and large-scale access, has a higher average bandwidth utilization, and has the best trans- mission performance. The experiment shows that as the amount of data transmitted increases, the transmission time of several algorithms also increases. The result is shown in Fig 6. The transmission time of the method proposed in this paper is shorter than that of the other two algorithms, and it can cope with file transfer under high load. From the above experimental data, we know that the possible shortcoming is that sporadic underestimation may occur during the training process, which affects the decision-making of reinforcement learning [26]. The solution is to apply multiple different neural networks to minimize the impact of underestimation on the core of the algorithm. Or the Bootstrapping method uses limited sample data to generate new, representative parent data by redesigning the sampling rules. Since the sampling rules are redesigned, it can also be recognized as a new sample, thereby expanding the training data and realizing the number of information training required can be completely ignored because the underestimation problem has a small impact on this algorithm. Furthermore, transfer learning solutions require a lot of trial and error and iteration, which this article studies may lead to poor solution results or over-fitting problems. As the number of transmitted files continues to increase, the proposed algorithm maintains stable transmission time.  Fig 5. Average bandwidth utilization and load comparison chart.  https://doi.org/10.1371/journal.pone.0317698.g005 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   11 / 15\nFig 6. Transmission time under different transmission numbers.  https://doi.org/10.1371/journal.pone.0317698.g006  Fig 7. Normalized transmission delay with time.   Q-learning is similar to RL, but its disadvantage is that it is not good at handling complex data. As shown in the figure, Q-learning has a higher transmission delay than RL.  https://doi.org/10.1371/journal.pone.0317698.g007 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   12 / 15\n4.3. Normalized transmission delay  Normalized transmission delay refers to the transmission time of several algorithms for trans- mitting video files of the same size [27]. This experiment can demonstrate the ability to com- prehensively transmit data. The algorithm proposed in this article can cope with congestion, dynamic topology changes, etc., so the transmission delay is the lowest. ECMP does not have the ability to handle dynamic topology, so transmission interruptions may occur and cause network congestion, resulting in the longest transmission delay. Both reinforcement learning algorithms also do not have the ability to handle dynamic topology, so the delay is lower than the algorithm proposed, as shown in Fig 7.  4.4. Normalized convergence time  Normalized convergence time refers to the convergence time of artificial intelligence algo- rithms trained on the same data [28]. The algorithm proposed applies transfer learning to solve transmission problems without overly relying on sample size, making it very suitable for applications similar to the Internet of body. However, the other two artificial intelligence algo- rithms have high time and space complexity, slow convergence, and are not suitable for solving routing problems in the \"Internet of body \", as shown in Fig 8.  5 Conclusion  The Internet of Things has broad application prospects in the field of healthcare, work and life. This paper studies the load imbalance problem caused by the difficulty of routing  Fig 8. Normalized convergence time.  https://doi.org/10.1371/journal.pone.0317698.g008 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   13 / 15\nimplementation when the Internet of Things network is accessed on a large scale. It proposes an intelligent routing algorithm for cloud computing data center networks based on reinforce- ment learning and realizes the solution of selecting the optimal route according to the real- time path transmission capacity. Through simulation experiments, it is known that intelligent routing occupies fewer computing resources and has higher throughput than ordinary routing solutions. The algorithm comprehensively considers the impact on the network under high load environment, can timely select the appropriate transmission path, and can realize the col- laborative mode of centralized training once and distributed execution multiple times. Com- pared with other machine learning models, it can quickly find the optimal solution and has the advantages of fast response speed. However, the intelligent routing system only selects the best path for routing decision each time. When the access scale is small, the default routing solution will be applied. In future work, we will continue to study how to reduce the complexity of the model and reduce the training time and computing resources in complex situations and will further study deep reinforcement learning (such as reinforcement learning deterministic pol- icy gradient DPG, proximal policy optimization PPO, etc.) and multi-agent reinforcement learning routing solutions in cloud computing data center networks.  Author Contributions  Data curation:   Song Qian.  Formal analysis:   Tianping Zhang.  Project administration:   Song Qian.  Resources:   Song Qian.  Writing – original draft:   Tianping Zhang, Siping Hu.  Writing – review & editing:   Tianping Zhang, Siping Hu.  References  1.   Aouedi O, Vu T H, Sacco A, et al. A survey on intelligent Internet of Things: Applications, security, pri- vacy, and future directions[J]. IEEE Communications Surveys & Tutorials, 2024.  2.   Zhu R, Boukerche A, Long L, et al. Design Guidelines on Trust Management for Underwater Wireless Sensor Networks[J]. IEEE Communications Surveys & Tutorials, 2024.  3.   Malik Tauqeer Safdar, et al. \"RL-IoT: Reinforcement learning-based routing approach for cognitive radio-enabled IoT communications.\" IEEE Internet of Things Journal 10. 2 (2022): 1836–1847.  4.   Kaur Gagandeep, Chanak Prasenjit, and Bhattacharya Mahua. \"Memetic algorithm-based data gather- ing scheme for IoT-enabled wireless sensor networks.\" IEEE Sensors Journal 20.19 (2020): 11725– 11734.  5.   Arafat M Y, Pan S, Bak E S. An adaptive reinforcement learning-based mobility-aware routing for het- erogeneous wireless body area networks[J]. IEEE Sensors Journal, 2024.  6.   Arafat M Y, Pan S, Bak E S. QQAR: A Q-learning-based QoS-aware routing for IoMT-enabled wireless body area networks for smart healthcare[J]. Internet of Things, 2024, 26: 101151.  7.   Degli-Esposti V, Fuschini F, Bertoni H L, et al. IEEE access special section editorial: Millimeter-wave and terahertz propagation, channel modeling, and applications[J]. IEEE Access, 2021, 9: 67660– 67666.  8.   Liu L, He M, Jeon S. An AI-Generated Content-Based Access Control Strategy for WBANs in Health- care Electronics Applications[J]. IEEE Transactions on Consumer Electronics, 2024.  9.   Li C, Mao Y, Huang Q, et al. A Real-Time Emotion-Aware System Based on Wireless Body Area Net- work for IoMT Applications[J]. IEEE Internet of Things Journal, 2024.  10.   Vakil M H, Shirmohammadi Z. EDC-ER: An Efficient Data Compression Method for Energy Reduction in WBANs[J]. IEEE Access, 2024. PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   14 / 15\n11.   Razghandi M., Zhou H., Erol-Kantarci M. and Turgut D., \"Variational Autoencoder Generative Adversar- ial Network for Synthetic Data Generation in Smart Home,\"   ICC 2022—IEEE International Conference on Communications , Seoul, Korea, Republic of, 2022, pp. 4781–4786, https://doi.org/10.1109/ ICC45855.2022.9839249  12.   Li W, Zhang T, Wang R, et al. Multimodal multi-objective optimization: Comparative study of the state- of-the-art[J]. Swarm and Evolutionary Computation, 2023, 77: 101253.  13.   Tian C., Ma Y., Cammon J., Fang F., Zhang Y. and Meng M., \"Dual-Encoder VAE-GAN With Spatiotem- poral Features for Emotional EEG Data Augmentation,\" in IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 31, pp. 2018–2027, 2023, https://doi.org/10.1109/TNSRE.2023. 3266810 PMID: 37053054  14.   Mukesh K, Ippatapu Venkata S, Chereddy S, et al. A variational autoencoder—General adversarial net- works (VAE-GAN) based model for ligand designing[C]//International Conference on Innovative Com- puting and Communications: Proceedings of ICICC 2022, Volume 1. Singapore: Springer Nature Singapore, 2022: 761–768.  15.   Han Y, Liu Y, Chen Q. Data augmentation in material images using the improved HP-VAE-GAN[J]. Computational Materials Science, 2023, 226: 112250.  16.   Yang C. Attn-VAE-GAN: Text-Driven High-Fidelity Image Generation Model with Deep Fusion of Self- Attention and Variational Autoencoder[C]//2024 International Joint Conference on Neural Networks (IJCNN). IEEE, 2024: 1–7.  17.   Razghandi M, Zhou H, Erol-Kantarci M, et al. Smart Home Energy Management: VAE-GAN synthetic dataset generator and Q-learning[J]. IEEE Transactions on Smart Grid, 2023.  18.   http://home.tiscali.cz/~cz210552/webbench.html.  19.   Hiryanto L, Soh S, Chin KW, et al. Green multi-stage upgrade for bundled-links SDN/OSPF-ECMP net- works[C]//ICC 2021-IEEE International Conference on Communications. IEEE, 2021: 1–7.  20.   Chen D, Zhang W, Gao D, et al. GFlow: GNN-Based Optimal Flow Scheduling for Multipath Transmis- sion with Link Overlapping[J]. IEEE Transactions on Network Science and Engineering, 2024.  21.   Luan S, Wang L, Liu Y, et al. A Fast Percolation-Dijkstra SPF Method for Mega-Constellation Satellite Network Routing[J]. IEEE Wireless Communications Letters, 2024.  22.   Yang X, Yan J, Wang D, et al. WOAD3QN-RP: An intelligent routing protocol in wireless sensor net- works—A swarm intelligence and deep reinforcement learning based approach[J]. Expert Systems with Applications, 2024, 246: 123089.  23.   Okine A A, Adam N, Naeem F, et al. Multi-agent deep reinforcement learning for packet routing in tacti- cal mobile sensor networks[J]. IEEE Transactions on Network and Service Management, 2024.  24.   Wang H, Fu Y, Shi Z, et al. Joint Throughput and Blocklength Optimization for RIS-Aided Hybrid Multi- Access Short-Packet System[J]. IEEE Wireless Communications Letters, 2024.  25.   Han J, Xue K, Wang W, et al. RateMP: Optimizing Bandwidth Utilization with High Burst Tolerance in Data Center Networks[C]//IEEE INFOCOM 2024-IEEE Conference on Computer Communications. IEEE, 2024: 1361–1370.  26.   Yang L, Liang J, Wang R, et al. A Study of Licklider Transmission Protocol in Deep-Space Communica- tions in Presence of Link Disruptions[J]. IEEE Transactions on Aerospace and Electronic Systems, 2023, 59(5): 6179–6191.  27.   Lu H, Zeng Y. Delay alignment modulation: Manipulating channel delay spread for efficient single-and multi-carrier communication[J]. IEEE Transactions on Communications, 2023.  28.   Applegate D, Dı ´az M, Lu H, et al. Infeasibility detection with primal-dual hybrid gradient for large-scale linear programming[J]. SIAM Journal on Optimization, 2024, 34(1): 459–484. PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   15 / 15',0.08451245548165795,'[\"\\u0000\", \"!\", \"\\\",\", \"\\\"dual-encoder\", \"\\\"internet\"]','2025-11-29 21:50:25.945921'),(91,3,'El presente texto tiene como finalidad ofrecer una visión panorámica sobre el impacto de las tecnologías digitales en los procesos cotidianos de la sociedad contemporánea. En primer lugar, se observa una creciente dependencia de los dispositivos móviles como herramienta central para la comunicación, el trabajo y el ocio. Asimismo, la integración de sistemas automatizados permite optimizar tareas repetitivas y reducir errores humanos, lo que contribuye a una mayor eficiencia operativa. No obstante, estos avances también plantean desafíos vinculados a la privacidad de los datos, la brecha digital y la necesidad de desarrollar competencias digitales críticas en la población',0.15757046078210907,'[\"a\", \"asimismo,\", \"automatizados\", \"avances\", \"brecha\"]','2025-11-29 21:56:38.256774'),(92,3,'A continuación, se analiza la importancia de la educación en el desarrollo integral de las personas. Más allá de la transmisión de contenidos, la educación promueve habilidades socioemocionales, pensamiento crítico y capacidad para resolver problemas en contextos diversos. Desde esta perspectiva, el aula se convierte en un espacio de construcción colectiva de conocimiento, donde la participación activa del estudiante resulta fundamental. En este sentido, las metodologías innovadoras y el uso estratégico de recursos tecnológicos pueden favorecer procesos de aprendizaje más significativos y contextualizados.',0.15427867678870186,'[\"a\", \"activa\", \"all\\u00e1\", \"analiza\", \"aprendizaje\"]','2025-11-29 21:56:46.042045'),(93,3,'El sistema propuesto se compone de tres módulos principales: captura de datos, procesamiento automático y visualización de resultados. En la fase de captura, se recopila información estructurada y no estructurada proveniente de distintas fuentes. Posteriormente, dichos datos son procesados mediante algoritmos de análisis estadístico y modelos de aprendizaje automático, con el objetivo de identificar patrones recurrentes y tendencias relevantes. Finalmente, los resultados se presentan en un tablero interactivo que facilita la interpretación de los indicadores clave y respalda la toma de decisiones basada en evidencia.',0.152904302587302,'[\"algoritmos\", \"an\\u00e1lisis\", \"aprendizaje\", \"autom\\u00e1tico\", \"autom\\u00e1tico,\"]','2025-11-29 21:56:53.960472'),(94,3,'\"Este texto ofrece una perspectiva integral y coherente fundamentada en evidencia.\",\n    \"A continuación, se presenta un análisis detallado que considera múltiples dimensiones.\",\n    \"El presente documento sintetiza hallazgos relevantes de fuentes secundarias confiables.\",\n    \"La presente redacción optimiza la claridad expositiva mediante estructuras formales.\",\n    \"Se proporciona un abordaje sistemático con terminología neutral y consistencia estilística.\",\n    \"El informe integra definiciones, categorizaciones y una visión holística del fenómeno.\",',0.15795427850858273,'[\"\\\"a\", \"\\\"el\", \"\\\"este\", \"\\\"la\", \"\\\"se\"]','2025-11-29 21:57:31.958304'),(95,3,'A continuación, se presenta un análisis detallado que considera múltiples dimensiones.',0.16458752933146706,'[\"a\", \"an\\u00e1lisis\", \"considera\", \"continuaci\\u00f3n,\", \"detallado\"]','2025-11-29 21:57:47.087335'),(96,3,'El presente texto tiene como propósito describir, de manera estructurada, algunos factores que inciden en la gestión del tiempo en jóvenes universitarios. En términos generales, se observa que la sobrecarga académica, la participación en actividades laborales y la presión social por mantener determinados estándares de rendimiento generan una sensación constante de prisa. Este fenómeno compromete el equilibrio entre estudio, trabajo y autocuidado.',0.16693489105186476,'[\"acad\\u00e9mica,\", \"actividades\", \"algunos\", \"autocuidado.\", \"como\"]','2025-11-29 21:58:36.026140'),(97,3,'Desde una perspectiva formativa, el establecimiento de rutinas de ejercicio físico contribuye de manera significativa al bienestar integral de la persona. Diversos estudios señalan que la práctica regular de actividad física no solo mejora indicadores de salud, sino que también favorece la regulación emocional, la concentración y la percepción de autoeficacia. En consecuencia, resulta pertinente promover estrategias que faciliten la adherencia a dichos hábitos en la vida cotidiana.',0.15365613412672852,'[\"a\", \"actividad\", \"adherencia\", \"al\", \"autoeficacia.\"]','2025-11-29 21:58:45.320122'),(98,3,'La habilidad para hablar en público se considera una competencia transversal relevante en entornos académicos y profesionales. Su desarrollo implica trabajar aspectos cognitivos, emocionales y comunicativos, como la organización de ideas, la gestión de la ansiedad y el uso adecuado del lenguaje verbal y no verbal. La implementación de espacios seguros de práctica puede reducir progresivamente el miedo escénico y fortalecer la autoconfianza del expositor.',0.1755265041831484,'[\"acad\\u00e9micos\", \"adecuado\", \"ansiedad\", \"aspectos\", \"autoconfianza\"]','2025-11-29 21:58:53.778579'),(99,3,'En el contexto actual, caracterizado por altas demandas de productividad, la gestión adecuada del tiempo libre adquiere una relevancia especial. Disponer de periodos destinados al descanso, al ocio y a la reflexión personal permite prevenir el agotamiento, mejorar el estado de ánimo y sostener un desempeño más equilibrado a largo plazo. Por ello, se recomienda incorporar pausas planificadas dentro de la agenda semanal.',0.15435074893129722,'[\"a\", \"actual,\", \"adecuada\", \"adquiere\", \"agenda\"]','2025-11-29 21:59:10.390839'),(100,3,'381 Rev Bras Med Esporte – Vol. 27, N o   4 – Oct/Nov/Dec, 2021  APPLICATION OF 3D ANALYSIS TECHNOLOGY OF VISION  SYSTEM IMAGE IN SPORTS MEDICINE  APLICAÇÃO DA TECNOLOGIA DE ANÁLISE 3D DE IMAGENS DO SISTEMA DE VISÃO NA  MEDICINA ESPORTIVA  APLICACIÓN DE LA TECNOLOGÍA DE ANÁLISIS 3D DE LA IMAGEN DEL SISTEMA DE VISIÓN EN  MEDICINA DEPORTIVA  Pei Jiang 1  (Physical Education Professional)  1. School of Public Fundamentals,  Jiangsu Vocational College of  Medicine, Yancheng, China.  Correspondence:  Pei Jiang  School of Public Fundamentals,  Jiangsu Vocational College of  Medicine, Yancheng, 224006,  China. jiangpeijsvcm@163.com  ABSTRACT  Background: Objective: The study of sports biomechanics in sports medicine usually requires a special  image analysis system (software) to obtain 3D kinematics data. Taking the swimming project in sports  medicine as an example, 3D water images in water have always been relatively complicated and diffi -  cult. As light travels in different media, it will refract and reflect. When testing underwater movements,  if only a land camera or an underwater camera is used for testing, the error caused by light refraction  will be larger, which will affect the accuracy of the test data even more. Methods: Taking breaststroke  movement as an example, a three-dimensional measurement method based on the Kwon3D movement  analysis system is introduced. This method is different from the simple underwater camera test. It is a  three-dimensional test method combining a land camera and an underwater camera. Two underwater  cameras and two land cameras were used to simultaneously calibrate the water and underwater space  with the same calibration frame in the experiment after analyzing and verifying the accuracy of 3D  reconstruction. Results: The comprehensive reconstruction error is small, and the average relative error  is less than 1%. Conclusions: The application of three-dimensional image analysis technology of vision  systems in sports medicine is reasonable and worth promoting.   Level of evidence II; Therapeutic stud -  ies - investigation of treatment results.  Keywords:   Sports Medicine; Biomechanical phenomena; Water movements; Movement.  RESUMO  Antecedente: Objetivo: O estudo da biomecânica do esporte na medicina esportiva geralmente requer  o uso de um sistema especial de análise de imagens (software) para a obtenção de dados cinemáticos 3D.  Tomando o projeto de natação na medicina esportiva como exemplo, a análise de imagens 3D da água  na água sempre foi um teste relativamente complicado e difícil. À medida que a luz viaja em diferentes  meios, ela refratará e refletirá. Ao testar movimentos subaquáticos, se apenas uma câmera terrestre ou  subaquática for usada para o teste, o erro causado pela refração da luz será maior, o que afetará a pre -  cisão dos dados de teste ainda mais. Métodos: Tomando o movimento de nado peito como exemplo, um  método de medição tridimensional baseado no sistema de análise de movimento Kwon3D é introduzido.  Este método é diferente do teste simples de câmera subaquática. É um método de teste tridimensional que  combina uma câmera terrestre e uma câmera subaquática. No experimento, duas câmeras subaquáticas  e duas câmeras terrestres foram usadas para calibrar simultaneamente a água e o espaço subaquático  com o mesmo quadro de calibração. Depois de analisar e verificar a precisão da reconstrução 3D. Resul -  tados: O erro de reconstrução abrangente é pequeno e o erro relativo médio é inferior a 1% Conclusões: A  aplicação da tecnologia de análise de imagem tridimensional do sistema de visão na medicina esportiva  é razoável e vale a pena promover.   Nível de evidência II; Estudos terapêuticos- investigação dos  resultados do tratamento.  Descritores:   Medicina esportiva; Fenômenos biomecânicos; Movimentos da água; Movimento.  RESUMEN  Antecedente: Objetivo: El estudio de la biomecánica del deporte en la medicina deportiva general -  mente requiere el uso de un sistema de análisis de imágenes especial (software) para obtener datos de  cinemática 3D. Tomando como ejemplo el proyecto de natación en medicina deportiva, el análisis de  imágenes de agua en 3D en el agua siempre ha sido una prueba relativamente complicada y difícil. A  medida que la luz viaja en diferentes medios, se refractará y reflejará. Al probar los movimientos bajo el  agua, si solo se utiliza una cámara terrestre o una cámara submarina para realizar la prueba, el error  causado por la refracción de la luz será mayor, lo que afectará aún más la precisión de los datos de la  prueba. Métodos: tomando como ejemplo el movimiento de la brazada, se introduce un método de me -  dición tridimensional basado en el sistema de análisis de movimiento Kwon3D. Este método es diferente  O riginal   a rticle  A rtigo   o rigin A l  A rtículo   o rigin A l\n382   Rev Bras Med Esporte – Vol. 27, N o   4 – Oct/Nov/Dec, 2021  de la simple prueba de cámara subacuática. Es un método de prueba tridimensional que combina una  cámara terrestre y una cámara submarina. En el experimento, se utilizaron dos cámaras submarinas y dos  cámaras terrestres para calibrar simultáneamente el agua y el espacio submarino con el mismo marco  de calibración. Después de analizar y verificar la precisión de la reconstrucción 3D. Resultados: el error de  reconstrucción integral es pequeño y el error relativo promedio es inferior al 1%. Conclusiones: La aplicación  de la tecnología de análisis de imágenes tridimensionales del sistema de visión en la medicina deportiva  es razonable y vale la pena promoverla.   Nivel de evidencia II; Estudios terapéuticos- investigación  de los resultados del tratamiento.  Descriptores:   Medicina deportiva; Fenómenos biomecánicos; Movimientos del agua; Movimiento.  Article received on 04/28/2021 accepted on 05/10/2021 DOI: http://dx.doi.org/10.1590/1517-8692202127042021_0123  INTRODUCTION  The method of image analysis is one of the important methods  for sports biomechanics to analyze human movements, obtain three -  -dimensional coordinates of analysis points, and calculate kinematic  parameters. Usually, a special image analysis system (software) is used  to obtain three-dimensional kinematic data. The underwater motion  measurement is different from the land project. Due to the comple -  xity of the underwater 3D camera and 3D analysis technology, the  following difficulties exist: (1) high equipment requirements (at least  an underwater camera is required); (2) the cause of underwater and  water sports The difference in light transmission medium causes the  water and underwater sports limbs cannot be imaged at one time; (3)  During the analysis, the continuous motion information of a motion  point may not be obtained from a single recorded video, at least it needs  to be used selectively.As light travels in different media, it will refract  and reflect. This article takes breaststroke as an example to introduce a  three-dimensional motion analysis system based on Kown3D, which uses  a combination of underwater and land camera calibration and analysis  methods. This measurement method is theoretically more reasonable  than using only underwater or only water testing, and greatly reduces  the error due to light refraction. 1  METHODS  Test equipment and equipment  In the early stage, first shoot the video on the spot, and in the later  stage, the three-dimensional analysis, then import the edited video  to analyze the measurement point. Beijing Taihe Zhongyi underwater  acquisition system (2 underwater cameras), 2 sony high-definition ca -  meras (shooting frequency 50Hz), Kwon3d three-dimensional calibration  frame, flash, self-made LED light, medical tape and double-sided tape. 2  Three-dimensional shooting scheme  In this experiment, a three-dimensional fixed-point calibration camera  method was used. Two Sony cameras were used on the water, and the  shooting frequency was 50Hz. Two Beijing Taihe Zhongyi underwater  camera systems were used underwater, and the flash-off light synchro -  nization method was used in the later data sorting. Synchronize the four  cameras (Figure 1).  The three-dimensional calibration frame is placed in the test area,  that is, in the middle of the shooting range. The frame uses the cubic  calibration frame provided by Kwon3D. The frame is about 1m above  the water surface (ensure that all three white balls on the vertical pole  of the frame are above the water surface), that is, the 2m high frame is  half exposed on the water and half underwater ( Figure 2).The accuracy  range of the measurement frame is about 3m×3m×2m (Figure 3).  Figure 1.   Stereo schematic view of test layout.  Figure 2.   4 cameras shooting calibration frame screen.  Figure 3.   Schematic plan view of the test layout.\n383 Rev Bras Med Esporte – Vol. 27, N o   4 – Oct/Nov/Dec, 2021  Place the camera and the frame according to the position shown in  the figure and debug them. In addition, the operator of the flash (located  in the swim lane adjacent to the subject) presses the flash as much as  possible while the subject swims through the shooting range, so that  each camera can see this flash picture. 3   For all shooting videos, this study  used the non-linear editing software EDIUS for format conversion and  editing, and then imported Kwon3d software for post-analysis.  RESULTS  Frame calibration  The calibration frame is a cubic structural frame matching the  Kwon3d system. The length × width × height is 2m × 1m × 2m. The  coordinates and errors of the 11 control points are shown in Table 1.  In the calibration calculation interface, the Kwon3D system has two  options for the three-dimensional reconstruction calculation method  of calibration: DLT algorithm (direct linear conversion) and DSM (direct  solution method). In this study, the DSM algorithm is selected to obtain  the smallest reconstruction error. After multiple calibrations, the better  one is selected, and the system shows that the “reconstruction error” is  0.306413cm (Figure 4).  The FDK algorithm is an approximate three-dimensional image  reconstruction algorithm proposed by Feldkamp et al. Most current  three-dimensional accurate reconstruction algorithms are further de -  veloped on the basis of this algorithm. Figure 5 shows the geometric  coordinate relationship of the cone beam circular scanning trajectory,  where   O - xyz   represents the world coordinate system,   O - uv   represents  the detector projection data coordinate system, and   O - ts   represents  the ray source coordinate system. In addition, the z-axis is specified as  the rotation center axis, and the s-axis always passes through the center  of the ray source and is perpendicular to the detector plane. The FDK  calculation formula is divided into two steps, as shown below:  (1) Filter  (   )   (   )   ( ) 2   2   2 ,   , SD SO d P   i j   P   i j   h i d   i   j  θ θ ∗           =   ⋅     +   +      (1)  (2) Back projection  (   )   (   )  2   2 0 ,   ,   , f   x y z   u P   p q d  π   θ θ ∗ =   ∫   (2)  among them,  cos   sin   ,   cos   sin ,   , SD SD t   x   y   s   y   x d u   p   ut q   uz d   s  θ   θ θ   θ =   +   =   −      =   =   =    −   (3)  In the above formula,   d SD   represents the distance from the center  of the ray source to the origin O;   P θ   (i, j) ,   P θ   (i, j)   respectively represents  the projection and filtered projection data at the rotation angle θ;   h  (i) represents the convolution function; ( p, q ) represents the inverse of  the reconstructed voxel point on the filtered projection plane Projec -  tion point address;   f (x, y, z)   represents the reconstructed image data  at voxel point   (x, y, z) .  Figure 6 shows the more intuitive geometric coordinate relationship  of the three-dimensional cone beam circular scanning trajectory.  Among them, S is the center position of the ray source,   V   (x, y, z)   is the  point to be reconstructed in the three-dimensional image, and   V\'   ( p,  q ) is the point where V intersects the flat panel detector along the ray  direction. D is the center of the detector, uv rectangular coordinate  system is the detector coordinate system, and   V\'D   and V axis form   α  angle. Cross the point V to the straight-line SD and make a vertical line,  and intersect with SD at point   M   ( m, n ). The ts rectangular coordinate  system is the ray source coordinate system, where the t-axis and the  x-axis form an angle of θ.  According to the geometric coordinate relationship  +   = 2  π β   θ   (3)  Table 1.   Frame 36 control point coordinates and reconstruction error/cm.  Control point   X   Y   Z   Xr   Yr   Zr  Ctrl 1   0   0   20   0.07   0.01   19.92  Ctrl 2   0   0   50   0.03   -0.21   50.07  Ctrl 3   0   0   80   0.15   0.01   80.04  Ctrl 4   0   100   20   0.16   99.86   20.24  Ctrl 5   0   100   50   0.06   99.81   50.25  Ctrl 6   0   100   80   -0.21   99.84   80.16  Ctrl 7   100   0   20   100.09   0.01   19.6  Ctrl 8   100   0   50   100.2   0.05   49.68  Ctrl 9   100   0   80   100.07   0.01   79.76  Ctrl 10   100   100   20   100.5   99.89   19.81  Ctrl 11   100   100   50   100.08   100.07   49.72  Figure 4.   Screenshot of calibration calculation interface.   Figure 5.   Geometric coordinate relationship of circular scanning trajectory of cone beam.\n384   Rev Bras Med Esporte – Vol. 27, N o   4 – Oct/Nov/Dec, 2021  So, the coordinates of point M are  cos   sin x   om   om m   d   d  β θ =   = −   (4)  sin   cos y   om   om m   d   d  β θ =   = −   (5)  The distance between point V and point is  (   )   (   )   (   )   (   )   (   )  2   2   2   2 ,   sin   cos om   om f   V M   x   m   y   n   x   d   y   d  θ θ =   −   +   −   =   +   +   −   (6)  Verification of reconstruction accuracy  This study uses a combination of water and underwater test  methods to conduct breaststroke movement research, which is  rarely seen in previous research literature. The verification method  is: after shooting the calibration frame, let a staff member hold a  calibration rod and swing it up and down in the calibration area.  The swinging action includes swinging from the surface and inser -  ting the rod into the water. The white balls with fixed spacing on  the benchmark are measured. The measured data in Table 2 and  Table 3 are continuous data within a short period of time. The time  interval of the data is 0.02s, and the average errors are -0.00394m  and -0.002499m respectively, that is, within the test range of 3m,  the middle part of the test area The average relative error is 0.83%  ~ 0.66% (average relative error = average error value / theoretical  value), that is, the average relative error is less than 1%. For current  sports tests, especially underwater tests, this paper believes that  the error produced by this calibration method is already very small,  and it is an acceptable error range when measuring most of the  commonly used “swim kinematic indicators”.  Measurement point analysis  This test uses breaststroke as an example for testing. When esta -  blishing the model, only the point on one side is established, that is, only  on the athlete’s side. The joints of head, hand, wrist, elbow, shoulder,  hip, knee, ankle, toe, and heel are analyzed. The inertial parameters of  each link of the model are based on the system’s own parameters, but  the mass percentage of the head and torso is corrected by 1/2 of the  original data, which is used for the relevant calculation of the human  center of gravity data, which forms a human body “unilateral model”.  Regarding the center of gravity of the human body, since the model  is a “unilateral model”, the three-dimensional coordinate data of the  center of gravity of the whole body cannot be calculated during the  calculation of the center of gravity. The movement is analyzed and  tested, and then the overall three-dimensional movement of the center  of gravity is analyzed, and the degree of left and right shaking during  body movement can be analyzed. 4  DISCUSSION  The process of digitizing the spatial coordinates of the selected mea -  surement points, such as the manual “pointing” process of joint points  such as shoulders, elbows, wrists, hips, knees, and ankles. For some key  phase kinematic parameters, the interpretation error brought by the  analyst sometimes exceeds the difference of the movement itself. The  Kwon3D system can automatically connect the two parts of the data,  and the data can be smoothly processed in the software as needed. For  example, when analyzing the shoulder joint points, a certain period of  time is managed by the image acquired by the underwater camera,  and a certain period of time is managed by the image acquired by the  camera on the water surface. During dot analysis, some necessary settings  must also be made: when clicking the “2D” button for measurement  point analysis, the camera must be “paired” in The Camera Pairs option,  and the two underwater cameras should be checked. In a group, select  and match 2 cameras on the water to form a group. In this way, when  Figure 6.   Geometric coordinate relationship of the three-dimensional cone beam  circular scanning trajectory.  Table 2.   Actual measured data of white ball distances at both ends of the rod  under sports.  2 end white ball measured distance   Error/m  1   0.593592072   -0.00641  2   0.596475101   -0.00352  3   0.598215403   -0.00178  4   0.598884721   -0.00112  5   0.598694852   -0.00131  6   0.597933761   -0.00207  7   0.596907341   -0.00309  8   0.595880008   -0.00412  9   0.595037206   -0.00496  10   0.594480911   -0.00552  11   0.594241102   -0.00576  12   0.594315284   -0.00568  13   0.594705138   -0.00529  14   0.595461301   -0.00454  Table 3.   The measured data of the distance between the white ball in the middle of  the rod and the white ball at one end under the motion.  The measured distance between the white ball  at one end and the white ball at one end   Error/m  1   0.298179   -0.00182  2   0.294381   -0.00562  3   0.292173   -0.00783  4   0.291515   -0.00849  5   0.292249   -0.00775  6   0.294097   -0.0059  7   0.29668   -0.00332  8   0.299571   -0.00043  9   0.302371   0.002371  10   0.304762   0.004762  11   0.306543   0.006543  average value   0.297502   -0.002499\n385 Rev Bras Med Esporte – Vol. 27, N o   4 – Oct/Nov/Dec, 2021  generating three-dimensional data, the joint points located underwater  are generated by the image of two cameras under the water. At some  moments, the joint points are exposed to the water surface (such as  head and shoulders), then the three-dimensional data is generated by  the water 2 The camera images are “dotted”. After all joints are parsed,  click the “3D”   button and the software automatically generates a three -  -dimensional stick figure. 5  In addition, due to light and turbidity of the water in the swimming  pool, the clarity of the image will be reduced. In order to improve the  resolution of the image analysis, the self-made LED light can be attached  to the position of the joint to be tested after the subject warms up. In  the later image analysis, the position of the light-emitting lamp can be  clearly seen, which provides an important reference for improving the  analysis accuracy.  In theory, the three-dimensional test can test all the joint points of  the subject, but due to the limited number of equipment, this study  temporarily only performs three-dimensional movement test on the  subject’s limb. When the number of cameras is allowed, 4 underwater  cameras, 4 water cameras or multi-machine synchronous tests can be  carried out, three-dimensional data analysis of the limb movements on  both sides can be performed, and the symmetry of the movement of the  left and right limbs of the athlete can be studied in more detail. Make a  more reasonable analysis of the center of gravity shift, etc.  CONCLUSION  Taking breaststroke as an example, this article provides a calibration  and analysis method for three-dimensional measurement of swimming  movements based on the Kwon3d three-dimensional analysis system.  It is a three-dimensional test method that combines underwater and  underwater cameras to further improve the water. The accuracy of motion  3D testing provides a meaningful reference. (2) The calibration method  introduced in this paper theoretically further reduces the error caused  by light refraction. In the test, the average relative error was less than  1%. For current sports tests, especially water tests, this paper believes  that the error caused by this calibration is an acceptable error range  when measuring most commonly used swimming kinematics indicators.  The author declare no potential conflict of interest related to this article  REFERENCES  1.   Huang L, Da F, Gai S. Research on multi-camera calibration and point cloud correction  method based on three-dimensional calibration object. Optics & Lasers in Engineering.  2019;115;32-41.  2.   Ke Q, Wu S, Wang M, Zou Y. Evaluation of developer efficiency based on improved DEA model.  Wireless Personal Communications. 2018;102(4);3843-9.  3.   Li Y, De-Xing; Shu-liang Y; Institute of Industry and Trade Measurement Technique,China Jiliang  University; Research on measurement method of thermal diffusivity of materials based on ther -  mography. Acta Metrologica Sinica. 2017;38(1);28-33.  4.   Hong JP, Lee JJ, Yeo H, Kim CK, Pang SJ, Oh JK. Parametric study on the capability of three-dimensional  finite element analysis (3d-fea) of compressive behaviour of douglas fir. Holzforschung. 2016;70(6);539-546.  5.   Wu S, Wang M, Zou Y. Bidirectional cognitive computing method supported by cloud technology.  Cognitive Systems Research. 2018;52;615-21.  AUTHORS’   CONTRIBUTIONS:   Pei Jiang designed provides a calibration and analysis method for three-dimensional measurement of swimming movements based on the Kwon3d three-dimensional analysis  system, which The accuracy of motion 3D testing provides a meaningful reference.',0.05319943975016674,'[\"&\", \"(\", \"(1)\", \"(2\", \"(2)\"]','2025-11-29 21:59:18.623065'),(101,3,'Research Article  Application of a Computerized Decision Support System to Develop Care Strategies for Elderly Hemodialysis Patients Yiqiu Zhu   and Xiyi Zheng  e First Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu, China  Correspondence should be addressed to Xiyi Zheng; zhengxiyi1978@suda.edu.cn  Received 20 April 2021; Accepted 9 June 2021; Published 21 June 2021  Academic Editor: Khin wee Lai Copyright © 2021 Yiqiu Zhu and Xiyi Zheng. -is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In this paper, the strategy of elderly haemodialysis patients’ care is analysed by the computer’s decision system to conduct an in- depth research machine. Maintenance haemodialysis patients have a high demand for continuation care, and healthcare workers should provide personalized and specialized seamless continuation care services for patients according to patients’ needs, by reasonably using the hospital, community, and other health resources and with the help of emerging network technologies, such as information platforms and wearable devices to prolong the survival period of patients and improve their self-management ability and quality of life. -e service provision and compensation strategy of the combined healthcare model should be optimized to improve the health protection of the elderly and promote health equity. On the one hand, it should target strengthening the service provision of healthcare integration, guide the elderly to reasonably choose the healthcare integration model, and pay attention to the spiritual and cultural needs and end-of-life care services for the elderly. On the other hand, we should expand the financing channels of medical insurance, optimize the design of compensation mechanisms, explore the role of health risk sharing, and accelerate the development of long-term care insurance, independent of basic medical insurance. -e reliability of the scale was found to be 0.916 for the total Cronbach alpha coefficient, 0.798–0.919 for each dimension, and 0.813 for the fold-half reliability of the scale; the validity indicated that the correlation coefficient range of each article day with the total scale score was 0.27–0.72, and the correlation coefficient range of each dimension with the total scale was 0.56–0.72. -e validation factor analysis was used to verify the structure of the scale. -e validation factor analysis indexes met the fitting criteria after correction. -e model fitted better with the actual model after correction, indicating that the scale has good reliability.  1. Introduction  End-stage renal disease (ESRD) is the final stage of various chronic kidney diseases when patients have irreversible impairment of kidney function and need to rely on kidney transplantation or dialysis therapy to maintain their lives [1]. Given the limited number of kidney donors and the high cost of transplantation, most ESRD patients can only choose dialysis therapy. -e current dialysis therapies include he- modialysis (HD) and peritoneal dialysis (PD). MHD pa- tients’ survival and quality of life are often compromised by the irreversible disease process, complications, specificity of the haemodialysis treatment modality and treatment envi- ronment, and water and activity restrictions [2]. Most pa- tients return to their homes, and due to the lack of guidance and   supervision   by   healthcare   professionals,   their   self- management will be lax, making it difficult to adhere to long- term self-monitoring, diet, and water control, which in turn affects the effectiveness of dialysis, increases the risk of complications and adverse outcomes, and increases the burden on families and society. Patients on long-term dialysis are prone to malnutrition due   to   disease   consumption,   dietary   restrictions,   and treatment effects, and related studies have shown that the incidence of malnutrition in haemodialysis patients ranges from 37.50% to 86.0% [3]. At the same time, some patients fear overkill and do not restrict their dietary intake, which in turn leads to excessive intake of potassium and phosphorus, which can lead to complications [4]. -erefore, healthcare professionals should strengthen the dietary guidelines for  Hindawi Journal of Healthcare Engineering Volume 2021, Article ID 5060484, 10 pages https://doi.org/10.1155/2021/5060484\npatients   with   MHD.   On   the   one   hand,   they   should strengthen patients’ cognitive education about the impor- tance of dietary management, and on the other hand, they can work together with a dietitian to develop a corre- sponding diet plan for patients according to their condition, weight, and blood pressure. -e diet should conform to the principles of high calorie, low superior protein, low fat, low phosphorus, and low potassium as much as possible, prevent anaemia, ensure the intake and absorption of various nu- trients, and actively prevent and treat malnutrition. Rea- sonable control of interdialytic weight gain (IDWG) during dialysis and keeping IDWG within the normal range are important measures to reduce complications, such as dial- ysis-associated hypotension, and reduce the morbidity and mortality rate of MHD patients, and patients’ compliance with fluid intake is a key factor in the control of IDWG [5]. -e patient’s fluid intake compliance is a key factor in IDWG control [6]. Control of fluid intake is a problem for most MHD patients, and a significant proportion of MHD pa- tients find controlling fluid intake the most difficult part of haemodialysis self-management because of severe thirst due to toxin retention in the body while limiting water intake [7]. -erefore, healthcare providers should give appropriate fluid intake instructions according to the patient’s specific situation, explain the dangers of excessive fluid intake, teach patients techniques and methods to control fluid intake, self- monitor fluid intake, develop a fluid intake plan, and allow family members to monitor and control the patient’s fluid intake. Patients with MHD often suffer from varying degrees of mental health problems such as anxiety, depression, fear, stress, and even suicidal thoughts due to disease distress, frequent dialysis, impact of economic burden, and changes in social and family roles [8]. If psychological problems are not addressed promptly, they often affect the dialysis out- come and survival quality of patients and increase the risk of adverse events. -erefore, nursing staff should provide ex- tended nursing interventions for patients’ psychological problems, listen more to patients’ emotional confessions, give humanistic care, and actively seek family and social support to enhance patients’ confidence in treating the disease and improve their sense of well-being. -ey need to explore the problems in volume management of PD patients with poor adherence to volume management behaviours to improve the targeting of intervention programs and evaluate the impact of an IMCHB-based volume management in- tervention program on promoting volume management behaviours,   improving   volume   balance,   and   improving quality of life in PD patients.  2. Related Work  With the aging of the global population, the increase in the number of elderly HD patients, prolongation of dialysis age, and special physiopathological conditions of the elderly, elderly HD patients are more prone to a variety of com- plications than other patients, and common complications include imbalance syndrome, heart failure, hypertension, diabetes, pruritus, and fractures [9]. A study by Shahmoradi et al. showed that the rate of arteriovenous access infections in elderly HD patients was as high as 37.5%, and the inci- dence of debilitation was 33.9% [10]. Palmer et al. found that 35.75% of elderly HD patients died of cardiovascular disease, 14.25% died of cerebrovascular disease, and 29% died of haemorrhagic disease, and the number of elderly patients who died of infection was significantly higher than that of young and middle-aged HD patients [11]. Moreover, given the special nature of the haemodialysis treatment form, ordinary elderly HD patients are mostly outpatients, and patients go home for convalescence after each haemodial- ysis. -erefore, elderly HD patients rely on themselves or their family members for various daily care [12]. -e cor- rectness and effectiveness of self-daily care for elderly HD patients cannot be measured, and healthcare professionals lack specific guidance tools to reasonably determine patients’ care ability and thus cannot guide patients to effective care according to local conditions [13]. Self-management is the correct way of self-care, in which patients learn through health education, rely on their own ability to adopt effective behaviours   to   maintain   or   promote   health,   effectively monitor various complicating symptoms, detect them on time, and seek medical treatment on time. Numerous scholars have achieved good results by in- tervening in patients through many different self-man- agement approaches. Some scholars have shown that self- management can effectively correct patients’ poor self-care habits, improve patients’ alertness to changes in their disease, treatment compliance, and subjective motivation, thus   reducing   complications   and   improving   patients’ quality of   survival [14]. -e existing self-management scales for HD have deficiencies in diet, internal fistula care, and emotional communication. -e contents of the scales are broad and pay little attention to the special physio- logical, psychological, cognitive, and safety problems of elderly HD patients. -e existing self-management scales cannot truly reflect the problems in self-management of elderly HD patients. -erefore, it is necessary to develop a scientific and rigorous self-management scale to assess the self-management ability, deficits, and effects of elderly HD patients and provide evidence and direction for clinical care. Niazkhani et al. used frequency domain analysis to extract pulse features [15]. Demiris et al. constructed a pulse recognition model using BP networks to improve the effi- ciency and accuracy of pulse diagnosis [16]. Regan con- structed   a   pulse   classification   model   by   combining convolutional neural networks and recursive graphs, which further improved the efficiency and accuracy of pulse di- agnosis [17]. Loftus et al. constructed a tongue classifier using   vectorized   neural   networks   and   achieved   very promising results [18]. In terms of health management, the development of smart mobile health and smart wearable devices has made it possible to collect health data from people’s daily life. Health management is most closely connected to people and is especially important in the management of chronic diseases. Smart virtual nurses have emerged that can determine the basic state of a person based on the health data collected and can also remind patients of 2   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\ndaily health management, such as medication, sleep, and exercise, providing all-around, whole-cycle health services.  3. Analysis of a Computerized Decision Support System to Develop Care Strategies for Elderly Hemodialysis Patients  3.1.   Computerized   Decision   Support System   Design.   -e heterogeneous clinical data analysis system designed in this paper   needs   to   consider   the   heterogeneity   and   multi- modality of clinical examination data, use deep learning as the main analysis technique, and combine with suitable fusion strategies to realize the fusion diagnosis of hetero- geneous multimodal clinical data. For the implemented system, it should have flexible and scalable analysis methods to utilize as much information in as data as possible com- prehensively to achieve more accurate diagnosis results. Moreover, since the system is mainly for the healthcare workers involved in clinical diagnosis, ease of use and ro- bustness should be considered in the process of system implementation. In summary, the heterogeneous clinical data analysis system based on deep learning technology should have the following functions: before conducting analysis   or   training,   the   data   should   be   preprocessed according to the data characteristics, which can provide a certain guarantee for the analysis or training effect [19]. -erefore, in the heterogeneous clinical analysis system, the corresponding data preprocessing module should be set according to the structure or mode of common clinical data, and the module should include the common preprocessing methods for this type of data, so that the preprocessing of the data can be easily completed using the processing methods in the system. As one of the main functions of this system, when heterogeneous multimodal clinical data are input, the system should provide corresponding analysis means and fusion strategies to fuse and analyse the input data and output a comprehensive diagnosis conclusion of the disease. Con- sidering the differences in diagnostic modalities of different diseases, multiple diagnostic models or fusion modalities can be considered for implementation to extend the application scenarios of the system. When the number of data structures or modalities generated by clinical diagnosis is not sufficient for fusion analysis, the system should have the ability to analyse single-modality clinical data. -e unimodal clinical data analysis function should cover the common modalities in clinical data, such as electronic medical record text, medical images, and examination indicators. -e analysis results should be visualized in the form of text, tables, or charts, and analysis reports should be formed for users to download. According to the requirement analysis, the heteroge- neous clinical data analysis system will be composed of four parts: front-end module, data preprocessing module, data analysis module, and data storage module. -e front-end module realizes the interaction with users and mainly in- cludes three functions: data preprocessing, data analysis, and result   visualization   and   model   download.   -e   data preprocessing   module   provides   preprocessing   methods, such   as   word   separation,   format   conversion,   and   data broadening for training or data to be analysed, while the data analysis module is responsible for calling the diagnostic model to make category judgment on the preprocessed data and return the diagnostic results. -e data storage module of the system is mainly divided into file storage and database storage. File storage is to store the system model or user data that takes up more resources in the form of files; database storage uses a MySQL database to store user information, session logs, and other data. -e general framework of the system is shown in Figure 1. -e front-end module is used to respond to user re- quirements and is mainly divided into four submodules: data preprocessing, unimodal clinical data analysis, heteroge- neous multimodal clinical data analysis, and data download. -e interface of each module is designed with the Element UI component library, and the MVVM model is used to realize the bidirectional data binding between the interface UI and the business model. -is progressive framework enables responsive listening and dependency binding of components, and data interaction with functional modules through axis to complete page rendering. Users can upload and download data, analyse data, and set up models after entering the system through the login interface. -e data expansion module can process the input data directly or receive data from the preprocessing module. -e data en- richment function is implemented by calling the nibble li- brary   to   convert   the   input   image   data   into   a multidimensional matrix, which is wrapped with functions for flipping, rotating, and transforming the matrix. -e functions in the data augmentation module have no de- pendencies on each other, so they can be called in parallel, and the augmentation process outputs the same. -e image data is also outputted after the augmentation process. -e main function of the data analysis module is to analyse the input clinical data and output prediction categories to provide an auxiliary diagnosis. To obtain more comprehensive information about the disease and improve the accuracy of prediction, the data analysis module fuses and analyses the heterogeneous multimodal data generated from the clinical diagnosis process. -e data analysis module also includes a unimodal clinical data analysis function in consideration of the actual ex- amination   data   that   may   have   a   more   homogeneous structure or modality. -e output of the module is divided into two types of classification categories and classifica- tion probabilities, and the return type can be selected by the front-end incoming parameters [20]. According to the fusion strategy designed and implemented in this paper, the heterogeneous multimodal clinical data fusion anal- ysis submodule requires that the input data contain data from at least one modality in different structures, re- spectively. After reading the input data, the module re- covers and calls the corresponding diagnostic models in the model library and obtains the model decision values. In the fusion method function, the decision values of each submodel are first stitched together, and the statistical calculation of the decision value arrays or matrices is Journal of Healthcare Engineering   3 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nperformed using two fusion methods based on the de- cision-level fusion strategy. -is module is used to preprocess the input clinical data. Users can select the corresponding preprocessing module according to their needs, upload the data to be processed and configure the corresponding parameters, and save the data to the specified directory after the data preprocessing is completed. At present, the preprocessing process is mainly set up for image data and text data, which mainly includes the preprocessing process interface and parameter config- uration for image data, including two functions of data augmentation and preprocessing. In the data expansion function,   each   expansion   method   generates   the   corre- sponding expanded data based on the original data and selecting multiple expansion methods means multiplying the original data. -e preprocessing function includes data format conversion, spatial alignment, bias field correction, bone rejection, voxel normalization, resizing, and image cropping. Settings can be made to save data from each preprocessing step to a specified location or to keep only the final processed data.  3.2. Analysis of Nursing Strategy Methods for Elderly Hemo- dialysis Patients.   Maintenance haemodialysis is one of the most important treatment modalities for ESRD patients. Its principle is to purify the blood by using the diffusion/ convection   function   of   the   haemodialysis   machine   to remove various metabolic wastes, toxins, and excess elec- trolytes and water from the body to correct electrolyte disorders and acid-base homeostasis. -e experiment is conducted to verify the operational reliability of the hybrid cloud fog computing-based architecture for integrating large health information resources. -is experiment will use data redundancy rate, resource retrieval delay, and integration accuracy   as   experimental   indexes,   respectively.   Among them, the data redundancy rate is calculated as follows:  S   t   �   A   i  ′  A  EW ′ .   ( 1 )  -e resource retrieval delay is calculated as follows:  Z   c   �   MIC ′  A   P   U  ′   .   ( 2 )  -e integration of the accuracy rate is calculated as follows:  Z   z   �   JA i   −   MIC ′  N   ppd .   ( 3 )  Accuracy (ACC) is the most common model evaluation criterion for classification tasks. It describes the number of samples correctly predicted by the model as a percentage of the total number of samples predicted and provides a good overview of the overall classification performance of the model. However, in scenarios where the classification task has category imbalance or is more concerned with positive sample segmentation, the accuracy rate is not a valid as- sessment of model performance. In this experiment, data augmentation   was   applied   to   the   experimental   dataset, which largely solved the category imbalance problem, but still focused more on the identification of the experimental positive samples (i.e., diseased patients) when evaluating the classification performance of the model, so the accuracy rate was only used as an index to judge whether the model training process was normal or not in this experiment and was not used to evaluate the final model performance. In contrast to accuracy, which is a portrayal of the overall sample classification performance, precision is more con- cerned with the classification of positive samples. -e ac- curacy rate describes the number of true positive samples as a percentage of the number of all samples predicted to be positive and represents how accurately the model predicts the correct outcome, which is calculated as shown in (4). Compared with the precision rate, the recall rate in (5) flnformal2care   VP““ HP““ %ormal2care Wospital Vrimary2care Uutpatient2clinics flntegrated2care wiL wiiL wiiiL wivL Wellness “ocial2care “elf-management2apps wiL wiiL wiiiL Versonal2health2folder “ocial2care Giomedical2research ffnvironmental2health Umics “ystems2biology Hlinical2trials wiL wiiL wiiiL wivL  Figure   1: Computerized decision support system. 4   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nreflects the percentage of positive samples being successfully predicted among all predicted samples, so the recall rate is also known as the check-all rate. precision   �   TP TP   −   FP ,   ( 4 )  recall   �   TP TN   −   FN .   ( 5 )  Since this experiment classified subjects into three cat- egories, AD, MCI, and CN, the classification task involved in the experiment was multicategorical. -e definition of a positive sample for the autocategorisation task is that when calculating the assessment metric for each category, the category is considered as a positive sample alone and all other   categories   are   considered   as   negative   samples. -erefore, in the previously mentioned formula, TP represents the number of data with positive predicted value and positive true value among all the predicted samples; TN represents the number of data with negative predicted value and negative true value among all the predicted samples; FN represents the number of data with negative predicted value but positive true value among all the predicted samples; FP represents the number of data with positive predicted value and positive true value among all the predicted samples. Accordingly, FP rep- resents the amount of data with positive predicted values but negative true values, as shown in Figure 2. To ensure the model’s ability to recognize positive samples while also focusing on the overall performance of the clas- sification, the precision, recall, and ROC-AUC values of the model on the test samples are used as the comprehensive evaluation metrics of the model in the experiments. Since the experiments belong to the multiclassification task, it is nec- essary to use the multiclassification metric calculation method when calculating the evaluation metrics. -e macroalgorithm, however, computes the precision rate of each class separately and then performs an arithmetic average with the formula (6), where precision is the precision rate of class I computed using formula (7). Macroalgorithm ignores the situation that the data of each class is not perfectly homogeneous and simply computes the metrics according to the number of classes, while, instead of multiplying the precision rate by a fixed number of categories as weights, the weighted algorithm multiplies the percentage of the category in the total sample size, as shown in (8), where   w   i   is the percentage of the category in the total sample size. Since the data volume of the three categories in the experimental data used in this paper is not exactly equal, the weighted algorithm is adopted for the calculation of the index. precision ( micro )   �   ? n i � 1   TP i  ? n i � 1   TP i   −   FP i ,   ( 6 )  precision ( macro )   �   ?  n i � 1 precision i   ∗   1  n ,   ( 7 )  precision ( weighted )   �   ?  n i � 1 precision i   ∗   w   i   .   ( 8 )  -e basic expert profile is described by the frequency and composition ratio. Expert positivity can be expressed by the expert positivity coefficient, that is, the return rate of valid correspondence questionnaires and the percentage of ex- perts who gave corresponding opinions. Expert authority can be expressed by the expert authority coefficient (Cr), that is, the arithmetic mean of judgment coefficient (Ca) and familiarity coefficient (Cs). -e mean, standard deviation, and other statistical indicators of importance and feasibility of modular indicators are used to express the degree of expert opinion coordination. Kendall’s harmony coefficient and coefficient of variation (CV) are used to express the degree of expert opinion coordination. Standard deviation and other statistical indicators are used to indicate the degree of concentration of expert opinions. Kendall’s harmony coefficient and coefficient of variation are used to indicate the degree of coordination of expert opinions. -e relationship between controllable factors and vol- ume management behaviours led to the inspiration for constructing an intervention program: enhancing PD pa- tients’ knowledge and skills of volume control, including diet management   and   handling   of   daily   volume   overload problems,   through   group   lectures   or   with   the   help   of manuals;   improving   their   ability   to   solve   volume   load problems and enhancing their sense of volume management self-efficacy. -e level of hope influences patients’ capacity management behaviour [21]. In the intervention, patients’ belief in life can be enhanced by positive guidance from positive life experiences of patients and examples of pur- suing dreams with illness. -emed activities such as “En- hancing Hope, Controlling Capacity” can be organized to enhance patients’ beliefs about symptom control. In the interaction with patients, the positive perception of the meaning of dialysis treatment is promoted. For example, we will introduce the colourful dialysis life of kidney patients and make them realize that “dialysis is for a better life.” At the same time, patients are encouraged to participate in the interactive process of volume management to enhance their intrinsic sense of responsibility for disease management. After building a medical corpus, the corpus can be used to construct a domain lexicon and to effectively split the medical texts to be analysed. -e automatic construction process of its lexicon is shown in Figure 3. Traditional text structuring or word separation methods generally only label information, such as lexical or sentence components, but lack attribute information, such as context for fixed phrases. -erefore, we need to break up the elec- tronic medical record text into contents with XML tagging attributes and label them based on these contents, such as drug and disease names and other terms, for knowledge mining and analysis. Based on the dictionary, the identified words are labelled as different lexical properties, and new words (unregistered words) are identified among them by an improved algorithm, and the new words are recorded in the library and discovered by comparing them with the existing word list. Term recognition methods using N-Gram com- bined with various filtering rules can be used to identify new words in the corpus eventually, and the properties of each Journal of Healthcare Engineering   5 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nword are marked in XML. Based on the broken-up and structured electronic medical record text and information, such as sentence components and their corresponding con- textual attributes, the semantic relationships between these contents are studied, and methods and models for analysing the semantic relationship network of these contents are proposed, which is the basic work for knowledge discovery. In   general   hospital   information   systems,   electronic medical records are stored in a semistructured form, and the basic information of patients (e.g., name, gender, ethnicity, etc.)   exist   in   structured   data   tables,   which   are   called structured data, and can be used directly in diagnosis and decision making and are not part of the content studied in this paper [22]. -e subject of this paper is the narrative content of medical records written in natural language by physicians in electronic medical records, which are unstructured. Since many patients have complex causes or history of illness, it is difficult to describe such patient information completely in a structured storage structure, and natural language is often used to write treatment records in hospitals. In the medical record dataset studied in this paper, each file is plain text data rather than semistructured data stored in a hospital information system. -is means that in the case pages of an electronic medical record, structured data (e.g., information such as name, age, gender, etc.) and unstruc- tured content (e.g., current medical history, history, personal history, etc.) are stored together and are difficult to dis- tinguish. -erefore, we need to perform an initial splitting of these medical record files. -e splitting requires processing the fields of the electronic medical record. -e narrative text of ethology written by a physician inevitably has some grammatical problems in the form of expression, which generally do not affect the impact of the physician’s judg- ment on the patient’s condition. However, for computers, text with grammatical errors is an obstacle for automated programs to process. For example, in Chinese medical records, a comma in symbols is written as a comma. -erefore, for the subsequent computer to do standardized processing, it is necessary to replace the expression irreg- ularities in the medical text to be processed beforehand.  4. Analysis of Results  4.1. System Performance Results.   -e size of the text dataset obtained from ADNI is small, and there is a great degree of category imbalance. -erefore, before training the model, Pomain ”erm2extraction ”axonomy2construction /elation2extraction Untology2population “emantic2disambiguation Hancer Greast2cancerq2leukaemia jymphoma2is2a2cancer fls2treated2with2cancer Qational2Hancer2Henter “ynonyms Pomain2 ontology   Hancer2ontology ffvaluation  Figure   3: Automatic policy construction process. Vrotocols   flncentives flmplementation Verformance   Genchmarks 4oals Hare- delivery Hare- planning   Wealth care Pata Tuality Uutcomes Gest practices jiterature Upinion  Figure   2: Framework of nursing strategy approach. 6   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nthe text data of electronic medical records are expanded by different orders of magnitude using the data augmentation module to increase the size of the dataset and balance the data categories at the same time. Figure 4 shows the training accuracy of the TextCNN model with different dataset sizes. -e 3 x   and 4 x   augmented datasets make the model fit slower but smoother, but finally, the augmented dataset achieves better accuracy than other datasets in the training. It can also be seen from Figure 4 that the scores of the evaluation metrics on the test set are proportional to the size of the dataset, which indicates that the model obtained better generalization after data augmentation, so the subsequent experiments   were conducted on the text augmentation dataset. -e structured data for this experiment consisted of two data components. One part consists of data on the subject’s demographic characteristics, medical history, and psycho- metric scores, and the other part is derived from the brain tissue volume data obtained by automated segmentation of the subject’s MRI images. -is processing step is based on the unsupervised segmentation method proposed by Leydig et al. -e tissue of the brain MRI image is automatically segmented into 138 volumes of cortical and subcortical structures and segmented structures, and the volume data of the patient’s brain tissue in the form of a data table is ob- tained by reading the segmentation report. Figure 5 shows the partially segmented brain tissue and its volume data, with each column representing one brain tissue volume in 138 columns in cubic millimetres, and each row representing a different subject sample. -e purpose of setting up the brain tissue volume data is to replace the laboratory indi- cator type data that were not available in the original ex- perimental data for the experiment. Since the two parts of the structured data were divided to generate different information at different stages of the diagnosis, the XGBoost algorithm was used to construct separate classifiers for the two parts of the structured data. In the classification model constructed for the structured data, such as basic subject information, medical history, and psychiatric examination, the objective function parameter was set to “multi:SoftMax” to return the predicted categories for the multiclassification task, and the metric was log loss for the multiclassification classification task. After parameter selection using grid search, the classification learning rate is set to 0.085 (default value is 0.3), and a smaller learning rate is found to have a better generalization effect by cross- validation. To prevent overfitting, the random sampling training sample ratio is set to 0.7 (default value is 1), which increases the randomness and makes the training robust to noise. In addition, the maximum depth of the tree is set to 3 (default value is 6) to reduce the complexity of the model. It is used to measure the extent to which the content of the scale measures what the researcher wants to study. -is is mainly reflected by measuring face validity and dimensional correlations, which are reflected in the correlation between the dimensions, correlation between the dimensions and the scale, and analysis by the scores of the dimensions and the total scale. -e correlation coefficients of the entries in this study ranged from 0.27 to 0.72 for the total scale scores and from 0.59 to 0.72 for the dimensions concerning the total scale, as shown in Figure 6. It consists of exploratory factor analysis and validation factor analysis. Usually, exploratory factor analysis can be used to discover the potential common factors of a scale and build a model based on a theory, and then, the validation factor analysis can be used to verify whether the model is consistent with the theoretical structure. In the present study, exploratory factor analysis was conducted to obtain a scale structure model with 25 items and five common factors based on a presurvey, and then, a validation factor analysis was applied to validate the existing scale structure model by a large sample of clinical survey. After standardizing the duration of treatment across patients to the same time scale, more work is needed to discover medication characteristics based on the needs of the scenario, such as the duration of medication use in a par- ticular patient group. -e time–density reduction approach also has some negative effects, one issue being the distortion ]ugmentf ]ugment’ ]ugment- ]ugmentM ”rain2]HH2wEL I ’I MI fiI ffiI fII ’II   MII   fiII   ffiII   fIII I flter2time2wsL  Figure   4: Training accuracy of different sized datasets. f,I I,ffi I,fi I,M I,’ I,I   f,I I,ffi I,fi I,M I,’ I,I I  fI   ’I   -I   MI  OI   fiI   6I jeopallidum /ightpallidum H“%  Figure   5: Volume data. Journal of Healthcare Engineering   7 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nof absolute drug use, which means that the data processing cannot be used to calculate or compare absolute drug use across patients. In this case, we are still able to assess the relative importance of drugs in different modalities. In the previously mentioned example, the absolute number of days of drug D use for patient A is less than the absolute number of days for patient B, and patient A has a longer duration of use than patient B after the extension. -is suggests that drug D plays a more important role in the treatment of patient A than in the treatment of patient B. Based on the desensitized data, we extracted the medication information from the electronic medical record text. In this process, we paid at- tention to both the duration and frequency of medication administration. -e occurrence of drug names in a patient’s treatment record was the format of frequency and duration. However, based on physician recommendations in this data experiment, we ignored the frequency of medications used during the day because the frequency is always related to the extent of disease and the dose of the medication, which is less important for clinical pathways and medication treatment planning. -erefore, for each patient, the processed elec- tronic medical record data were in the form of a time- stamped medication list.  4.2. Results of Care Strategies for Hemodialysis Patients.  -e coefficients of variation of the importance of the in- dicators at all levels of the first round of expert consultation fluctuated from 0.00% to 20.94%, the coefficients of variation of feasibility fluctuated from 7.93% to 32.17%, and the Kendal coefficients of harmony fluctuated from 0.129 to 0.263. -e coefficients of variation of the importance of indicators at all levels of the second round of expert con- sultation fluctuated from 0.00% to 21.22%, the coefficients of variation of feasibility fluctuated from 0.00% to 24.77%, and the coefficients of Kendal harmony fluctuated from 0.301 to 0.460. -e experts suggested that if the patients do not comply with the healthcare instructions and self-monitoring, there should be corresponding supervisory measures instead of simply providing some instructions to the patients. -ere- fore, combined with the expert’s opinions and the discussion of the group, the following modifications were made. -e platform can automatically detect whether patients view and learn health guidance, and if patients do not complete health guidance learning, the platform can remind patients to learn until they finish. -e report will be sent to the community healthcare, who will contact the patient or family for supervision. If the patient does not self-monitor on time, the patient will be reminded to upload. If the patient has not been recorded for a long time, the platform can report to the community healthcare, and the community healthcare will supervise. When patients view and study medical guidance on time, regularly conduct health self-assessment, self-monitor daily on time, and read health information, kidney circle release news, and so on, they can get the corresponding points reward, monthly for the top patients to give encouragement, or certain material rewards, to enhance the user’s enthusi- asm and user stickiness to use the extended care information platform. Some experts suggest that the exercise situation of patients should be evaluated regularly. Targeted exercise guidance should be provided according to the exercise sit- uation of patients, so the “A2-7 exercise evaluation” can be added. -e exercise situation of patients can be evaluated regularly by combining subjective and objective methods. -e corresponding exercise prescriptions can be formulated for patients according to the evaluation results, as shown in Figure 7. Based on the assessment results, the corresponding exercise prescriptions will be formulated for patients, as shown in Figure 8. Analysing Figure 8, compared with traditional method 1 and traditional method 2, the acceleration ratio and parallel efficiency of the method in this paper are higher. In case of increasing the number of cores, traditional method 1 computation time increases instead, leading to a sig- nificant reduction in overall parallel efficiency, which is mainly because traditional method 1 does not chunk the health data stream, leading to an increase in communi- cation overhead. When traditional method 2 is used, al- though the computation time decreases to a certain extent and the acceleration ratio increases to a certain extent when the number of cores increases, the reduction in parallel efficiency is significantly better than that of tra- ditional method 1, and the overall computation perfor- mance is significantly inferior to that of this paper. Using this paper’s method can greatly reduce the parallel com- putation time while achieving a good acceleration ratio and parallel efficiency, and the parallel computation time is significantly reduced when the number of cores increases, mainly because this paper’s method processes the health data stream in chunks, reduces the data scale and con- dition number, enhances data convergence, reduces the communication overhead, enhances the overall parallel computation efficiency, and has superior computational performance. Value2S2f Value2S2fi O   fI   fO   ’I   ’O   -I   -O I Qumber2of2item I,I I,’ I,M I,fi I,ffi f,I Horrelation2coeocient  Figure   6: Correlation coefficient between the scores of each item and the total score of the scale. 8   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n5. Conclusion  Given the disease factors and the special nature of dialysis treatment, maintenance haemodialysis often faces various physiological or psychological problems, and comprehen- sive and accurate extended care services are significant for prolonging patients’ survival, improving their prognosis, and enhancing their self-management ability and quality of life. In this study, we constructed the content of a mobile healthcare-based information platform for extended care of maintenance haemodialysis patients through extensive lit- erature reading, qualitative interviews, and expert corre- spondence method and explored how to provide intelligent extended care services for maintenance haemodialysis pa- tients by using mobile healthcare information technology and combining the hospital–community–home integrated extended   care   model.   -is   study   finalized   the   module content system of the mobile medical-based extended care information platform for maintenance haemodialysis pa- tients   through   the   expert   consultation   method,   which contains three primary indicators, 18 secondary indicators, and 82 tertiary indicators. -e experts consulted had high professional representativeness and authority, they were well-motivated, and their opinions were coordinated and concentrated. -e module content, thus constructed, was scientific and reliable, which provided a basis for the next development of the information platform and the promo- tion of the R&D results.  Data Availability  Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.  Conflicts of Interest  -e authors declare that there are no conflicts of interest.  Authors’ Contributions  All authors approved the publication of the manuscript.  References  [1] L. Moja, H. Polo Friz, M. Capobussi et al., “Effectiveness of a hospital-based   computerized   decision   support   system   on clinician recommendations and patient outcomes,”   JAMA Network Open , vol. 2, no. 12, p. e1917094, 2019. [2] H. -abit and R. Hovorka, “Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non-critical care settings,”   Diabetic Medicine , vol. 35, no. 4, pp. 460–471, 2018. [3] L. Timotijevic, C. E. Hodgkins, and A. Banks, “Designing a mHealth clinical decision support system for Parkinson’s disease: a theoretically grounded user needs approach,”   BMC Medical Informatics and Decision Making , vol. 20, no. 1, pp. 34–21, 2020. [4] M. M. Paulsen, I. Paur, J. Gjestland et al., “Effects of using the MyFood decision support system on hospitalized patients’ nutritional status and treatment: a randomized controlled trial,”   Clinical Nutrition , vol. 39, no. 12, pp. 3607–3617, 2020. [5] S. Desmedt, A. Spinewine, M. Jadoul, S. Henrard, D. Wouters, and O. Dalleur, “Impact of a clinical decision support system for drug dosage in patients with renal failure,”   International Journal of Clinical Pharmacy , vol. 40, no. 5, pp. 1225–1233, 2018. [6] Y. F. Chen, C. S. Lin, C. F. Hong, D. J. Lee, C. Sun, and H. H. Lin, “Design of a clinical decision support system for predicting erectile dysfunction in men using NHIRD dataset,”  IEEE Journal of Biomedical and Health Informatics , vol. 23, no. 5, pp. 2127–2137, 2018. [7] A. A. Vinks, R. W. Peck, M. Neely, and D. R. Mould, “De- velopment and implementation of electronic health record- integrated model-informed clinical decision support tools for the precision dosing of drugs,”   Clinical Pharmacology & erapeutics , vol. 107, no. 1, pp. 129–135, 2020. [8] M. T. Khan, S. Qamar, and R. R. Sinha, “Discussing the role of data mining in development of evidence based decision support system for e-healthcare,”   International Journal of 1.0 0.8 0.6 0.4 0.2 0.0 2   4   6   8 10   2 4 6 8 10 Time (s) Flow Response value  Figure   8: Load balancing response spectrum. 5   10   15   20   25   30 –3 –2 –1 0 1 2 3 Number of levels Degree of freedom  W χ 2  P  Figure   7: Degree of coordination.  Journal of Healthcare Engineering   9 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\nApplied Engineering Research , vol. 12, no. 16, pp. 5540–5549, 2017. [9] B. Xue, D. Li, C. Lu et al., “Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications,”   JAMA Network Open , vol. 4, no. 3, p. e212240, 2021. [10] L. Shahmoradi, R. Safdari, H. Ahmadi, and M. Zahmatkeshan, “Clinical decision support systems-based interventions to improve medication outcomes: a systematic literature review on features and effects,”   Medical Journal of the Islamic Re- public of Iran , vol. 35, no. 1, pp. 197–212, 2021. [11] K. Palmer, A. Marengoni, M. J. Forjaz et al., “Multimorbidity care model: recommendations from the consensus meeting of the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS),”   Health Policy , vol. 122, no. 1, pp. 4–11, 2018. [12] X. Li, S. Yu, Z. Zhang et al., “Predictive modeling of hypo- glycemia for clinical decision support in evaluating outpa- tients with diabetes mellitus,”   Current Medical Research and Opinion , vol. 35, no. 11, pp. 1885–1891, 2019. [13] A. Wong, M. G. Amato, D. L. Seger et al., “Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit,”   BMJ Quality and Safety , vol. 27, no. 9, pp. 718–724, 2018. [14] J. E. Flythe, T. Hilliard, E. Lumby et al., “Fostering innovation in symptom management among hemodialysis patients: paths forward for insomnia, muscle cramps, and fatigue,”   Clinical Journal of the American Society of Nephrology , vol. 14, no. 1, pp. 150–160, 2019. [15] Z. Niazkhani, E. Toni, M. Cheshmekaboodi, A. Georgiou, and H. Pirnejad, “Barriers to patient, provider, and caregiver adoption and use of electronic personal health records in chronic care: a systematic review,”   BMC Medical Informatics and Decision Making , vol. 20, no. 1, p. 153, 2020. [16] G. Demiris, S. J. Iribarren, K. Sward, S. Lee, and R. Yang, “Patient generated health data use in clinical practice: a systematic   review,”   Nursing   Outlook ,   vol.   67,   no.   4, pp. 311–330, 2019. [17] M. E. Regan, “Implementing an evidence-based clinical de- cision support tool to improve the detection, evaluation, and referral patterns of adult chronic kidney disease patients in primary care,”   Journal of the American Association of Nurse Practitioners , vol. 29, no. 12, pp. 741–753, 2017. [18] T. J. Loftus, A. C. Filiberto, Y. Li et al., “Decision analysis and reinforcement learning in surgical decision-making,”   Surgery , vol. 168, no. 2, pp. 253–266, 2020. [19] P. A. Rochon and J. H. Gurwitz, “-e prescribing cascade revisited,”   e Lancet , vol. 389, no. 10081, pp. 1778–1780, 2017. [20] F. O. Finkelstein and M. W. Foo, “Health-related quality of life and adequacy of dialysis for the individual maintained on peritoneal dialysis,”   Peritoneal Dialysis International , vol. 40, no. 3, pp. 270–273, 2020. [21] L. Galbraith, C. Jacobs, B. R. Hemmelgarn, M. Donald, B. J. Manns, and M. Jun, “Chronic disease management in- terventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis,”   Nephrology Dialysis Transplantation , vol. 33, no. 1, pp. 112–121, 2018. [22] M. R. Marshall, A. C. Vandal, J. R. de Zoysa et al., “Effect of low-sodium versus conventional sodium dialysate on left ventricular mass in home and self-care satellite facility he- modialysis patients: a randomized clinical trial,”   Journal of the American Society of Nephrology , vol. 31, no. 5, pp. 1078–1091, 2020. 10   Journal of Healthcare Engineering 7158, 2021, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2021/5060484 by Cochrane Peru, Wiley Online Library on [15/04/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License',0.11053028952467635,'[\"%ormal2care\", \"&\", \"(\", \"(4).\", \"(5)\"]','2025-11-29 22:00:26.320444'),(102,3,'RESEARCH ARTICLE  Research on intelligent routing with VAE-GAN in the internet of body  Song Qian 1 , Tianping Zhang ID 2 * , Siping Hu 3  1   School of Information Engineering, Xinjiang Institute of Technology, Xinjiang, China,   2   School of Mathematics and Computer Science, Hanjiang Normal University, Shiyan, China,   3   Institute of Engineering and Technology, Hubei University of Science and Technology, Xianning, China  *   zhangtianping0818@163.com  Abstract  The \"Internet of Body\" is an emerging technology that is centered on the human body and connected to the Internet. It can monitor a variety of human data (such as heart rate, blood oxygen content, etc.) and communicate with digital pills, wearable devices, etc. It has been widely used in the field of medical health. However, when other devices access the Internet of Body on a large scale, there will be load imbalance caused by the difficulty in selecting the optimal route, which will affect the overall throughput and may even fail to transmit and endanger life. The traditional artificial intelligence routing algorithm cannot deal with the low model prediction accuracy and poor generalization ability caused by large noise and small data volume. This paper proposes an artificial intelligence routing algorithm, combines the variational autoencoder (VAE) and the generative adversarial network model (GAN) to con- struct a VAE-GAN model to generate multiple sets of data to achieve data enhancement on the Internet of Body. The optimization goals are to maximize the throughput of the Internet of Body and minimize the transmission cost. The entire routing problem is expressed as a Markov decision and the optimal transmission path is solved by learning previous historical experience to generate the real-time optimal route. Experiments have shown that this scheme can achieve the optimal route according to the transmission capacity of the real- time path and only requires fewer computing resources. It achieves load balancing of the entire network and avoids network congestion. The average throughput is much higher than that of traditional routing, and the advantage is more obvious under high load.  1.Introduction  The Internet of Bodies (IoB), also known as the Internet of Things based on the human body, is an emerging technology that connects the human body directly to the Internet and collects and processes human data through built-in or wearable devices. This technology is mainly used in the field of medical health, such as monitoring and analyzing human health through implantable pacemakers, ingestible digital pills, wearable prostheses, and other devices. The collected data includes steps, heart rate, blood oxygen content, etc. [1], as shown in Fig 1. In recent years, with the rapid development of a variety of built-in or wearable devices, the amount of information communicated with the IoB has increased rapidly, and the number of PLOS ONE  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   1 / 15  a1111111111 a1111111111 a1111111111 a1111111111 a1111111111  OPEN ACCESS  Citation:   Qian S, Zhang T, Hu S (2025) Research on intelligent routing with VAE-GAN in the internet of body. PLoS ONE 20(2): e0317698. https://doi. org/10.1371/journal.pone.0317698  Editor:   Zeheng Wang, Commonwealth Scientific and Industrial Research Organisation, AUSTRALIA  Received:   September 28, 2024  Accepted:   January 2, 2025  Published:   February 10, 2025  Peer Review History:   PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: https://doi.org/10.1371/journal.pone.0317698  Copyright:   ©   2025 Qian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  Data Availability Statement:   Data cannot be shared publicly because of muman body data parameters. Data are available from the Local hospital Institutional Data Access / Ethics Committee (contact via 1273091366@qq.com) for\ndeployment types has increased. The load imbalance caused by path selection under high con- currency has become the primary factor restricting the efficient operation of the IoB. There- fore, it is necessary to study intelligent routing algorithms that are more suitable for the IoB under large-scale access. The Internet of Things mainly consists of the perception layer, network layer, and applica- tion layer, among which routing plays a key role in the entire communication process. Most of the current routing modes are to implement network interoperability between servers. Rout- ing is composed of multiple selected paths. Under normal access scale, only the shortest path routing solution is required. However, when there is large-scale access When used in applica- tions in the Internet of Things (such as an increase in the amount of data sensed in a short period of time), performance degradation will occur. Although shortest paths routing is a rout- ing scheme that selects the smallest number of paths and is suitable for situations where the overall transmission performance is good, it is not the optimal routing scheme in all cases. The current artificial intelligence routing algorithm has the following problems: Poor model adaptability: Since the Internet of Things is a network deployed in the human body, it is affected by many aspects and cannot carry out regular model training like the Inter- net of Things, and the model adaptability is poor. Sparse sample data: The training method based on deep learning requires a certain amount of data as support. However, the Internet of Things is affected by many aspects, and the train- ing data is small, so it is difficult to obtain valuable samples. Low intelligence: Existing routing algorithms have the disadvantage of low intelligence in the Internet of Things. With the emergence of technologies such as cloud computing and high concurrency, there is a need for more intelligent routing algorithms to adapt to them.  Fig 1. Body-connected routing scenario.  https://doi.org/10.1371/journal.pone.0317698.g001 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   2 / 15  researchers who meet the criteria for access to confidential data.  Funding:   The author(s) received no specific funding for this work.  Competing interests:   The authors have declared that no competing interests exist.\nIn order to solve the above problems, this article analyzes the key technologies of IoT rout- ing, takes maximizing the overall IoT transmission throughput and minimizing transmission cost as optimization goals, constructs a VAE-GAN model to achieve data enhancement, and then proposes an intelligent routing based on transfer Learning, design real-time optimal intel- ligent routing scheme.  2. Related work  The Dijkstra algorithm is a commonly used routing algorithm in the network. It stores all ver- tices and calculates edge values. When it is used again, it can be directly queried. It needs to maintain the shortest path table. When the access scale is large, the search efficiency from the path table is low and load balancing cannot be achieved well. Equal-Cost Multipath Path (ECMP) equal-cost routing algorithm stores all des t IPs and paths with the same cost value. When used again, it can be queried directly. The advantage is that it is easy to deploy, and the load is more balanced than other algorithms. The disadvantage is that all Routes are distributed in equal parts, which cannot satisfy services with high immedi- acy requirements. K -shortest Path (KSP) is an extension of the Dijkstra algorithm. It excludes intersecting paths and paths that may form loops. It also needs to maintain the shortest path table. It has high requirements on hardware, is difficult to deploy, and is not easy to achieve load balancing. Dynamic Scheduling Load Balancing (DSLB) dynamic scheduling load balancing algo- rithm. The principle of this algorithm is to greedily find the maximum available bandwidth. It is similar to polling routing. When ensuring the maximum bandwidth, polling uses available paths without affecting delay, Judgment of other performance indicators such as available bandwidth, so there are limitations. In addition, other scholars have also conducted research on cloud computing data center network routing. There are many routing implementation methods for cloud computing data center networks. This article mainly discusses routing solu- tions that can ensure system load balancing under large-scale access. When accessing the Internet of Things on a large scale, in order to prevent load imbalance, all key factors need to be considered comprehensively and comprehensively, and routing algorithms based on artifi- cial intelligence have great advantages in this regard. Since the Internet of Body and the Internet of Things have many similarities (such as dynamic network topology), there are relatively few literatures on the Internet of Body. There- fore, in many aspects, we can refer to the routing of the Internet of Things, the Internet of Water, etc. For example, in 2024, Zhu et al. designed an underwater routing protocol to deal with the drawbacks of high propagation delay and dynamic network topology in the Internet of Water [2]. In 2023, Malik et al. proposed a routing algorithm based on reinforcement learn- ing to reduce end-to-end routing delay in the Internet of Things and improve throughput. Experiments have shown that it has advantages such as reducing packet conflicts [3]. In 2020, Kaur et al. proposed an artificial intelligence-based routing algorithm for the heterogeneity of nodes in the Internet of Things. Experiments have shown that it improves stability [4]. In 2024, Arafat et al. designed an adaptive Q-learning adaptive routing algorithm to address the frequent changes in network topology required for monitoring personal physiological parameters [5]. In wireless body area networks, in order to achieve reliable routing, artificial intelligence multi-source aggregation routing is proposed, which is beneficial for avoiding transmission interruptions caused by congestion [6]. In 2021, V Degli Esposti et al. summa- rized the transmission and channel modeling of millimeter wave and terahertz waves [7]. In 2024, Liu et al. proposed a routing algorithm with multiple DQNs to generate access order and PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   3 / 15\nthe number of health data packets sent for each node in order to achieve early disease monitor- ing and balance waiting time. The experiment proved that it has good performance in asym- metric systems [8]. Li et al. proposed a real-time differential multimodal transformer that helps collect real-time human life parameters [9]. Vakil et al. proposed sample collection steps in different environments to address the problem of limited prediction samples, which can help train better models [10]. Transfer learning is a machine learning method that takes the model developed for   task 1 as an initial point and reuses it in the process of developing the model for   task 2. It means trans- ferring knowledge from one domain (source domain) to another domain (target domain) to accelerate the learning process of the new domain. This ability to draw analogies is not only in line with human learning laws, but also one of the important goals pursued by artificial intelli- gence. In deep learning, transfer learning achieves fast adaptation and efficient learning by uti- lizing pre trained models and combining them with a small amount of new domain data. Routing is a sequential decision problem, in which each decision is a function of the current state of the network. Therefore, routing can be modeled as a Markov decision process, which is naturally applicable to the field of artificial intelligence. Transfer learning is generally speak- ing about designing an algorithm to enable it to have the ability to draw inferences from one instance, that is, to learn new knowledge by applying existing knowledge. Its core is to find the similarities between existing knowledge and new knowledge, and to achieve the purpose of transfer learning through the transfer of this similarity. Since many things have commonali- ties, how to reasonably find the similarities between them and then use this bridge to help learn new knowledge is the core problem of transfer learning. Its working principle is shown in Fig 2. Transfer learning usually focuses on a source domain   Data s   ¼ f a s i   ;   b s i   g   and a target domain  Data t   ¼ f a t i   ;   b t i   g , which   a d i   ;   b d i   respectively represent data samples and corresponding category labels. The definition of transfer learning is: given the source domain   Data d   and learning task  T s , the target domain   Data t   and the learning task   T t , the purpose of transfer learning is the acquisition   Data s   of knowledge in the source domain   f t ( � ) and learning tasks to help improve the learning of prediction functions   T s   in the target domain, where   Data s 6 ¼ Data t   and   T s 6 ¼ T t . Commonly used generative models in the field of deep learning include VAE and GAN [11]. Although both can perform data regeneration, each has certain flaws in its application. The VAE model deep model and static reasoning can obtain the distribution of the original data through resampling, but the diversity of the generated data is low; the GAN model  Fig 2. Principle of transfer learning.  https://doi.org/10.1371/journal.pone.0317698.g002 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   4 / 15\ngenerates more diverse data, but the training process is extremely difficult, and it is difficult for the generator and the discriminator to simultaneously convergence. Therefore, this article combines the data generation of the VAE model and the adversarial learning mechanism of the GAN model to propose the VGR (VAE-GAN-route) model, taking into account the advan- tages of both and giving full play to their respective strengths. The VAE network is used as a generator based on the GAN network, which optimizes the GAN generator’s shortcomings of single extraction features, low cohesion, and easy gradient disappearance. At the same time, the GAN network can make up for the lack of sample data due to VAE’s lack of adversarial learning, improving the performance of the two alone. shortcomings in the work, resulting in higher accuracy and robustness of reconstructed data. The proposed VGR model is divided into three parts, namely the encoding network, the decoding network (generating network) and the judging network, which correspond to the Encoder and Decoder of the VAE model and the Discriminator of the GAN model. It can be understood as adding the encoding process of real data on the basis of the GAN network, using the implicit z with prior information to replace the random vector originally input to the generator, which greatly improves the expression ability of the model. The VGR model struc- ture is shown in Fig 3. The encoding network consists of three fully connected layers. The first fully connected layer down samples the input high-dimensional data, and the activation function uses Relu; the remaining two fully connected layers map the down sampled samples into two low-dimen- sional parameter features, namely the mean and variance of the normal distribution. The prob- ability distribution of the original sample data   x   is:  x   �   P y ð x Þ   ð 1 Þ  In the above formula,   θ   is the model parameter. The loss function of the encoding network is KL (Kull back Libeler Divergence) divergence, used to measure the difference between the implicit vector distribution and the standard normal distribution. The KL loss function is:  KL N ð m ;   s 2 Þ k   N ð 0 ;   1 Þ ð   Þ ¼   1 2   log 2 ð s 2 Þþ s 2   \0   m 2   \0   1  �   �   ð 2 Þ  In the above formula,   μ   and   σ 2   are respectively the mean and variance of the encoding net- work output. Indicates the calculation of the KL divergence of two approximate distributions. It is used here to express the KL divergence between the data distribution sought in this article and the standard normal distribution   N (0,1). If the two distributions are the same, the KL  Fig 3. VGR structure.  https://doi.org/10.1371/journal.pone.0317698.g003 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   5 / 15\ndivergence is 0. On the contrary, the greater the distribution difference, the greater the KL divergence value. Variational Encoders (VAE) are based on Bayesian inference and their goal is to model latent and sample new data in the model, while Generative Adversarial Networks (GAN) are based on game theory and their goal is to find Nash Balanced discriminator and generator networks. KL divergence is a concept in statistics, a procedure used to measure the similarity of two probability distributions. When the two probability distributions are closer, their KL diver- gence value becomes smaller. For discrete probability distributions, the definition is as follows:  D KL ð P jj Q Þ ¼   X  i  P ð i Þ log   P ð i Þ  Q ð i Þ   ð 3 Þ  P   and   Q   is a probability function the variable   i . And the continuous probability distribution is:  D KL ð P jj Q Þ ¼  Z   þ1 \0 1  log   p ð x Þ  q ð x Þ   dx   ð 4 Þ  Therefore, if we want to pass a random Gaussian noise   z   through a generative network G to obtain a   Pdata ( x ) generative distribution that is similar to the real data distribution   PG ( x ,   θ ), where the parameters   θ   are determined by the parameters of the network, we hope to find a generative distribution   θ   that is as close   Pdata ( x ) as possible to   PG ( x ,   θ ). The decoding network (generating network) consists of two layers of fully connected net- works. The parameter settings of these two layers of network are opposite to the parameter set- tings of the encoding network. The input low-dimensional hidden variables are characterized by amplification, and finally generated data of the same size as the input data is generated., the Relu activation function is used between the two network layers, and the final output layer uses the Sigmoid activation function. The optimization goal of the generation network must not only ensure that the feature loss between the generated samples and the real samples is minimized but also ensure that the generated data can deceive the discriminant network. The loss function is:  L G   ¼ ð x i   \0   ^ x i Þ 2   þ   E z � p ð z Þ   ½ log 2 ð 1   \0   D ð G ð z ÞÞÞ�   ð 5 Þ  In the formula, the first term on the right side represents the loss reconstruction of the encoder,   x i   and   ^ x i   are the real samples and predicted values. All hidden variables generated for parameter reconstruction obey   p ( z ) distribution.   G ( z ) is used to generate samples;   D ( � ) is used to judge the authenticity of the generated data by the discriminating network. The discriminant network consists of 2 convolutional layers and 3 fully connected layers. The activation function between each network layer uses LeakyRelu. The output layer outputs the authenticity label through the Sigmoid activation function. The loss function of the dis- criminant network uses a more stable least square. The multiplicative loss function is:  L D   ¼   1 2   E x � p data ð x Þ   ð G ð x ÞÞ 2 �   �   þ   1 2   E x � p ð z Þ ½ð D ð z Þ \0   1 Þ 2 �   ð 6 Þ  In the formula,   x ~ p data ( x ) means that the real sample obeys   p data ( x ) distribution. The VAE-GAN model takes advantage of the coding advantages of VAE to input hidden vectors containing prior information into the GAN model instead of random vectors for data generation, thereby alleviating the problem of non-convergence in model training. The GAN network improves the quality of generated data through adversarial learning and completes the improvement of the VAE model. The two complement each other. PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   6 / 15\n3 Intelligent routing algorithms  3.1 The multi-objective optimization model  The current intelligent routing is reflected in the selection of the best path for each routing decision. Intelligent routing takes into account the load balancing of the entire network, and it also makes the best use of the available transmission paths (bandwidth and number). Further- more, due to the characteristics of the Internet of Body, the shortest path is not the optimal transmission path, and the real-time transmission path is changeable. Therefore, this paper studies the transmission performance and effective bandwidth of the path and designs a multi- objective optimization intelligent routing algorithm based on transfer learning. In the Internet of Body, the entire network is modeled as   G   = ( V ,   N ), where   V   is a non-empty vertex set, | V | is the number of vertices.   N   ¼ f v i j v j ;   i   6   ¼   j ;   v i ;   v j   2   V g   is an edge set and   v i | v j   is the communica- tion link between nodes   v i   and   v j   [12]. Furthermore,   B   is the residual bandwidth set. The residual bandwidth of an edge   v i | v j   is expressed as   b i ; j   2   B ð i   6   ¼   j ;   i   �   1 ;   j   �   1 Þ , and   8 v 2 V ,   b i , i   =   1 . The following definition can be obtained: Definition 1: A route   a s , t   is defined as the edges from a source node   v s   to another target node   v t :  a   ¼ f v s j v 1 ;   v 1 j v 2 ;   � � �   ;   v m \0   1 j v m ;   v m j v t   g   ð 7 Þ  Among them,   v s 6 ¼ v 1 ,   v m 6 ¼ v t , and for   8 v i ,   v j , if   i 6 ¼ j , then   v i 6 ¼ v j , based on the definition of routing, we further define that   k   disjoint paths from the source node to the target node are:  A k s ; t   ¼ f a i s ; t   g k i ¼ 1   ð 8 Þ  In the above expression,   8 i   6   ¼   j ;   A i s ; t   \\   A j s ; t   ¼ ;ð i   �   1 ;   j   �   1 Þ . Definition 2: The bottleneck bandwidth of the route   a s , t   from the source node   v s   to the tar- get node   v t   is:  BB ð a s ; t   Þ ¼   min ð b s ; 1 ;   b 1 ; 2 ;   � � �   ;   b m \0   1 ; m ;   b m ; t   Þ   ð 9 Þ  There are multiple paths   A k s ; t   from the source node   v s   to the destination node   v t , and the maximum bottleneck bandwidth (MBB) of the path   a s , t   is   A k s ; t   . The maximum available bottle- neck bandwidth on all paths, that is:  MBB ð A k s ; t   Þ ¼   max ð BB ð a Þ ;   BB ð a 2  s ; t   Þ ;   � � �   ;   BB ð a k s ; t   ÞÞ   ð 10 Þ  The minimum hop count (MHC) from the source node   v s   to the destination node   v t   is the minimum hop count of all nodes:  MHC ð A k s ; t   Þ ¼   min ðj a 1  s ; t   j ;   j a 2  s ; t   j ;   � � �   ;   j a k s ; t   jÞ   ð 11 Þ  Where,   j a 1  s ; t   j   represents the number of elements in the set   a 1  s ; t   . The path transmission delay   a s , t   from the source node   v s   to the destination node   v t   is defined as follows (sum of link delays):  PD ð a s ; t   Þ ¼   d s ; 1   þ   X m \0   1  i ¼ 1   d i ; i þ 1   þ   d m ; t   ð 12 Þ  Then, the minimum propagation delay   a s , t   of the path is the minimum propagation delay of all PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   7 / 15\npaths   P k s ; t   , that is:  MPD ð a k s ; t   Þ ¼   min ð PD ð a 1  s ; t   Þ ;   PD ð a 2  s ; t   Þ ;   � � �   ;   PD ð a k s ; t   ÞÞ   ð 13 Þ  The   k   disjoint paths from node   v s   to target node   v t   can be expressed as a multi-objective opti- mization model:  Max ð MBB ð A k s ; t   ÞÞ   ð 14A Þ  Min ð MHC ð A k s ; t   ÞÞ   ð 14B Þ  constraint:  8 a i s ; t   ;   a j s ; t   2   A k s ; t   ;   a i s ; t   \\   a j s ; t   ¼ ;   ð 15A Þ  k   �   1   ð 15B Þ  3.2 Algorithm process  The implementation process of the multi-objective optimization model in this paper is improved on the basis of literature [13–15]. The entire algorithm implementation process is as pseudo code Algo- rithm 1. The former part is the data enhancement part, and the next part outputs the final result. The time complexity of the algorithm is not high [16], and it can achieve unified processing of multiple goals as a whole. Next, the algorithm is simulated to verify its effectiveness and evaluate its performance.  Algorithm 1 Intelligent routing algorithm under high load of Internet of body Input Current routing data, current network status, etc. Output Next optimal route 01   A   = collecting all routing data, and get the training data and test- ing data 02 for   a ! =   null   and   a 2 A   do 03   create VAE-GAN model 04   put all routing data   a   to VAE-GAN model and train data 05   if   is_max_train_number   then 06   save the model   WS , and get all the created data 07   end if 08   liding window segmentation data 09 end for 10   B   = get all the test data 11 for   b ! =   null   and   b 2 B   do 12   put   b   to model   WS  13   if   is_max_train_number   then 14   regression prediction 15   end if 16 end for 17 Return the prediction result  Among them, lines 01–09 are the data addition part. Lines 10–17 are the processing of input test data.   is_max_train_number   is the maximum training frequency identifier. The designed algorithm focuses on low computation and space complexity and is suitable for appli- cation in the Internet of body. The entire algorithm consists of 2 loops, with the number of loops being   tn 1 (lines 02–09) and   tn 2 (lines 11–16) respectively. The time complexity of the entire algorithm is   O ( tn 1)+ O ( tn 2). If the number of loops is   n , then the time complexity of the algorithm is   O ( n ). PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   8 / 15\n4 Experimental simulation and result analysis  By building an Internet of Body and simulating access conditions under high load. Based on the simulation parameters in reference [17], the following simulation platform was built: Hardware environment: Intel(R) Core (TM) i7 12400F CPU @2.50 GHz   ×   6, 64 G memory. Python version number: Python 3.12. Operating system: Ubuntu 24.04. Network routing analysis and debugging tool: Wireshark v 4.2.4, used to analyze network rout- ing, etc. Load stress software: webbench 5.0 [18], this software can simulate tens of thousands of con- current requests per second, support the setting of control time, cache and server response time, etc. Its multi-concurrency principle is that there are multiple subprocesses [19]. Comparing several commonly used routing algorithms in the experiment, the details are as follows: ECMP: Equal cost multi-path routing, and its advantages are mainly reflected in the ability to improve network redundancy and reliability, while also increasing network resource utili- zation, detailed in reference [20]. Dijkstra: The shortest path algorithm selects the route with the minimum hop count, as detailed in reference [21]. WOAD3QN-RP, a routing algorithm based on swarm intelligence and deep reinforcement learning, is detailed in reference [22]. RL, a deep reinforcement learning routing algorithm, detailed in reference [23]. Proposed algorithm: the algorithm proposed in this article. The comprehensive performance of various algorithms is analyzed by simulation comparison of the following indicators.  4.1. Normalized throughput  Throughput is used to measure the transmission capacity of a network [24]. It is calculated by the amount of data transmitted per unit time. Time is the time when data transmission starts and ends, and data is the total number of bytes of data transmitted during this period of time.  throughput   ¼   data success  time end   \0   time start  ð 16 Þ  Throughput reflects the transmission capacity of the entire network. The transmission results are shown in Fig 4. When the number of visits is average, the throughput of several algorithms is similar. As the number of visits increases, the algorithm in this article has the highest throughput, and it has been in stable transmission without large jitter. Since the Internet of Body is in dynamic changes in the link, it is easy to form a dynamic topology, so ordinary routing will have large throughput jitter, as shown in the figure, but the intelligent routing algorithm proposed in this article can easily cope with it. Methods such as Dijkstra and ECMP are not suitable for applica- tions when the load is too high. They cannot cope with high access and high load well. The per- formance of ECMP is also average and not as good as the algorithm in this article. The PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   9 / 15\nalgorithm in this article takes maximizing throughput as one of the optimization goals, and can the optimal routing plan is adjusted in real time. When load = 7, congestion is avoided without causing a significant decrease in throughput, so the overall transmission capacity is optimized by other algorithms. The normalized throughput tends to stabilize, indicating that the model can apply the influence of high dynamics.  4.2. Load and average bandwidth utilization  The software used for load concurrent generation is webbench 5.0. Average bandwidth utiliza- tion is calculated as:  Bu   ¼  P   B s  B r  x   ð 17 Þ  Among them, for a certain data flow in the Internet of body,   B s   is the bandwidth before sending,   B r   is the real-time bandwidth, and   x   is the total number of statistical flows [25]. The relationship between load and average bandwidth utilization can directly reflect the performance during large-scale access, such as whether it is congested and whether it can meet high-load transmission, etc. The results are shown in Fig 5. The comparison of average bandwidth utilization and load is shown in Fig 5. It can be con- cluded that when the access is of general scale, the average bandwidth utilization of all algo- rithms is about 80%. However, as the access scale increases, the average bandwidth utilization of the Dijkstra algorithm decreases first, and the rate of decrease is also faster than other algo- rithms and finally stops at 0.4. The Dijkstra algorithm has similar results. In addition, the two  Fig 4. Comparison of normalized throughput and load.  https://doi.org/10.1371/journal.pone.0317698.g004 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   10 / 15\nalgorithms cannot cope with high loads, so they are unstable and fluctuate greatly. ECMP has the ability to divide the bandwidth equally, so the average bandwidth utilization is better than the Dijkstra algorithm. The intelligent routing algorithm selects the optimal route according to the real-time network status based on the self-learning ability, which can better cope with high load and large-scale access, has a higher average bandwidth utilization, and has the best trans- mission performance. The experiment shows that as the amount of data transmitted increases, the transmission time of several algorithms also increases. The result is shown in Fig 6. The transmission time of the method proposed in this paper is shorter than that of the other two algorithms, and it can cope with file transfer under high load. From the above experimental data, we know that the possible shortcoming is that sporadic underestimation may occur during the training process, which affects the decision-making of reinforcement learning [26]. The solution is to apply multiple different neural networks to minimize the impact of underestimation on the core of the algorithm. Or the Bootstrapping method uses limited sample data to generate new, representative parent data by redesigning the sampling rules. Since the sampling rules are redesigned, it can also be recognized as a new sample, thereby expanding the training data and realizing the number of information training required can be completely ignored because the underestimation problem has a small impact on this algorithm. Furthermore, transfer learning solutions require a lot of trial and error and iteration, which this article studies may lead to poor solution results or over-fitting problems. As the number of transmitted files continues to increase, the proposed algorithm maintains stable transmission time.  Fig 5. Average bandwidth utilization and load comparison chart.  https://doi.org/10.1371/journal.pone.0317698.g005 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   11 / 15\nFig 6. Transmission time under different transmission numbers.  https://doi.org/10.1371/journal.pone.0317698.g006  Fig 7. Normalized transmission delay with time.   Q-learning is similar to RL, but its disadvantage is that it is not good at handling complex data. As shown in the figure, Q-learning has a higher transmission delay than RL.  https://doi.org/10.1371/journal.pone.0317698.g007 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   12 / 15\n4.3. Normalized transmission delay  Normalized transmission delay refers to the transmission time of several algorithms for trans- mitting video files of the same size [27]. This experiment can demonstrate the ability to com- prehensively transmit data. The algorithm proposed in this article can cope with congestion, dynamic topology changes, etc., so the transmission delay is the lowest. ECMP does not have the ability to handle dynamic topology, so transmission interruptions may occur and cause network congestion, resulting in the longest transmission delay. Both reinforcement learning algorithms also do not have the ability to handle dynamic topology, so the delay is lower than the algorithm proposed, as shown in Fig 7.  4.4. Normalized convergence time  Normalized convergence time refers to the convergence time of artificial intelligence algo- rithms trained on the same data [28]. The algorithm proposed applies transfer learning to solve transmission problems without overly relying on sample size, making it very suitable for applications similar to the Internet of body. However, the other two artificial intelligence algo- rithms have high time and space complexity, slow convergence, and are not suitable for solving routing problems in the \"Internet of body \", as shown in Fig 8.  5 Conclusion  The Internet of Things has broad application prospects in the field of healthcare, work and life. This paper studies the load imbalance problem caused by the difficulty of routing  Fig 8. Normalized convergence time.  https://doi.org/10.1371/journal.pone.0317698.g008 PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   13 / 15\nimplementation when the Internet of Things network is accessed on a large scale. It proposes an intelligent routing algorithm for cloud computing data center networks based on reinforce- ment learning and realizes the solution of selecting the optimal route according to the real- time path transmission capacity. Through simulation experiments, it is known that intelligent routing occupies fewer computing resources and has higher throughput than ordinary routing solutions. The algorithm comprehensively considers the impact on the network under high load environment, can timely select the appropriate transmission path, and can realize the col- laborative mode of centralized training once and distributed execution multiple times. Com- pared with other machine learning models, it can quickly find the optimal solution and has the advantages of fast response speed. However, the intelligent routing system only selects the best path for routing decision each time. When the access scale is small, the default routing solution will be applied. In future work, we will continue to study how to reduce the complexity of the model and reduce the training time and computing resources in complex situations and will further study deep reinforcement learning (such as reinforcement learning deterministic pol- icy gradient DPG, proximal policy optimization PPO, etc.) and multi-agent reinforcement learning routing solutions in cloud computing data center networks.  Author Contributions  Data curation:   Song Qian.  Formal analysis:   Tianping Zhang.  Project administration:   Song Qian.  Resources:   Song Qian.  Writing – original draft:   Tianping Zhang, Siping Hu.  Writing – review & editing:   Tianping Zhang, Siping Hu.  References  1.   Aouedi O, Vu T H, Sacco A, et al. A survey on intelligent Internet of Things: Applications, security, pri- vacy, and future directions[J]. IEEE Communications Surveys & Tutorials, 2024.  2.   Zhu R, Boukerche A, Long L, et al. Design Guidelines on Trust Management for Underwater Wireless Sensor Networks[J]. IEEE Communications Surveys & Tutorials, 2024.  3.   Malik Tauqeer Safdar, et al. \"RL-IoT: Reinforcement learning-based routing approach for cognitive radio-enabled IoT communications.\" IEEE Internet of Things Journal 10. 2 (2022): 1836–1847.  4.   Kaur Gagandeep, Chanak Prasenjit, and Bhattacharya Mahua. \"Memetic algorithm-based data gather- ing scheme for IoT-enabled wireless sensor networks.\" IEEE Sensors Journal 20.19 (2020): 11725– 11734.  5.   Arafat M Y, Pan S, Bak E S. An adaptive reinforcement learning-based mobility-aware routing for het- erogeneous wireless body area networks[J]. IEEE Sensors Journal, 2024.  6.   Arafat M Y, Pan S, Bak E S. QQAR: A Q-learning-based QoS-aware routing for IoMT-enabled wireless body area networks for smart healthcare[J]. Internet of Things, 2024, 26: 101151.  7.   Degli-Esposti V, Fuschini F, Bertoni H L, et al. IEEE access special section editorial: Millimeter-wave and terahertz propagation, channel modeling, and applications[J]. IEEE Access, 2021, 9: 67660– 67666.  8.   Liu L, He M, Jeon S. An AI-Generated Content-Based Access Control Strategy for WBANs in Health- care Electronics Applications[J]. IEEE Transactions on Consumer Electronics, 2024.  9.   Li C, Mao Y, Huang Q, et al. A Real-Time Emotion-Aware System Based on Wireless Body Area Net- work for IoMT Applications[J]. IEEE Internet of Things Journal, 2024.  10.   Vakil M H, Shirmohammadi Z. EDC-ER: An Efficient Data Compression Method for Energy Reduction in WBANs[J]. IEEE Access, 2024. PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   14 / 15\n11.   Razghandi M., Zhou H., Erol-Kantarci M. and Turgut D., \"Variational Autoencoder Generative Adversar- ial Network for Synthetic Data Generation in Smart Home,\"   ICC 2022—IEEE International Conference on Communications , Seoul, Korea, Republic of, 2022, pp. 4781–4786, https://doi.org/10.1109/ ICC45855.2022.9839249  12.   Li W, Zhang T, Wang R, et al. Multimodal multi-objective optimization: Comparative study of the state- of-the-art[J]. Swarm and Evolutionary Computation, 2023, 77: 101253.  13.   Tian C., Ma Y., Cammon J., Fang F., Zhang Y. and Meng M., \"Dual-Encoder VAE-GAN With Spatiotem- poral Features for Emotional EEG Data Augmentation,\" in IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 31, pp. 2018–2027, 2023, https://doi.org/10.1109/TNSRE.2023. 3266810 PMID: 37053054  14.   Mukesh K, Ippatapu Venkata S, Chereddy S, et al. A variational autoencoder—General adversarial net- works (VAE-GAN) based model for ligand designing[C]//International Conference on Innovative Com- puting and Communications: Proceedings of ICICC 2022, Volume 1. Singapore: Springer Nature Singapore, 2022: 761–768.  15.   Han Y, Liu Y, Chen Q. Data augmentation in material images using the improved HP-VAE-GAN[J]. Computational Materials Science, 2023, 226: 112250.  16.   Yang C. Attn-VAE-GAN: Text-Driven High-Fidelity Image Generation Model with Deep Fusion of Self- Attention and Variational Autoencoder[C]//2024 International Joint Conference on Neural Networks (IJCNN). IEEE, 2024: 1–7.  17.   Razghandi M, Zhou H, Erol-Kantarci M, et al. Smart Home Energy Management: VAE-GAN synthetic dataset generator and Q-learning[J]. IEEE Transactions on Smart Grid, 2023.  18.   http://home.tiscali.cz/~cz210552/webbench.html.  19.   Hiryanto L, Soh S, Chin KW, et al. Green multi-stage upgrade for bundled-links SDN/OSPF-ECMP net- works[C]//ICC 2021-IEEE International Conference on Communications. IEEE, 2021: 1–7.  20.   Chen D, Zhang W, Gao D, et al. GFlow: GNN-Based Optimal Flow Scheduling for Multipath Transmis- sion with Link Overlapping[J]. IEEE Transactions on Network Science and Engineering, 2024.  21.   Luan S, Wang L, Liu Y, et al. A Fast Percolation-Dijkstra SPF Method for Mega-Constellation Satellite Network Routing[J]. IEEE Wireless Communications Letters, 2024.  22.   Yang X, Yan J, Wang D, et al. WOAD3QN-RP: An intelligent routing protocol in wireless sensor net- works—A swarm intelligence and deep reinforcement learning based approach[J]. Expert Systems with Applications, 2024, 246: 123089.  23.   Okine A A, Adam N, Naeem F, et al. Multi-agent deep reinforcement learning for packet routing in tacti- cal mobile sensor networks[J]. IEEE Transactions on Network and Service Management, 2024.  24.   Wang H, Fu Y, Shi Z, et al. Joint Throughput and Blocklength Optimization for RIS-Aided Hybrid Multi- Access Short-Packet System[J]. IEEE Wireless Communications Letters, 2024.  25.   Han J, Xue K, Wang W, et al. RateMP: Optimizing Bandwidth Utilization with High Burst Tolerance in Data Center Networks[C]//IEEE INFOCOM 2024-IEEE Conference on Computer Communications. IEEE, 2024: 1361–1370.  26.   Yang L, Liang J, Wang R, et al. A Study of Licklider Transmission Protocol in Deep-Space Communica- tions in Presence of Link Disruptions[J]. IEEE Transactions on Aerospace and Electronic Systems, 2023, 59(5): 6179–6191.  27.   Lu H, Zeng Y. Delay alignment modulation: Manipulating channel delay spread for efficient single-and multi-carrier communication[J]. IEEE Transactions on Communications, 2023.  28.   Applegate D, Dı ´az M, Lu H, et al. Infeasibility detection with primal-dual hybrid gradient for large-scale linear programming[J]. SIAM Journal on Optimization, 2024, 34(1): 459–484. PLOS ONE  Research on intelligent routing with VAE-GAN in the internet of body  PLOS ONE | https://doi.org/10.1371/journal.pone.0317698   February 10, 2025   15 / 15',0.08451245548165795,'[\"\\u0000\", \"!\", \"\\\",\", \"\\\"dual-encoder\", \"\\\"internet\"]','2025-11-29 22:24:43.075721'),(103,3,'30  Int. J. Morphol., 40(1) :30-36, 2022.  Laboratorios   Tradicionales   versus   Nuevas   Tecnologías   para   el Estudio   de   Anatomía   Humana   en   Estudiantes   de   Medicina: Revisión   Sistemática   y   Meta   Análisis Traditional   Laboratories   versus   New   Technologies   for   the   Study   of   Human Anatomy   in   Medical   Students:   A   Systematic   Review   and   Meta-Analysis Bernal-García Martha 1 ; Quemba Mesa Monica   2 ; Silva Ortiz Sara   1   & Pacheco-Olmos Blanka   1 BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecno- logías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.  RESUMEN:   El estudio de la anatomía humana, ha transcendido con diversos recursos y escenarios. El objetivo fue compararlos estudios publicados sobre prácticas de laboratorio tradicionales con nuevas tecnologías para el estudio del cuerpo humano en estudiantes de medicina. Se realizó revisión sistemática y meta-análisis. Cuatro revisores efectuaron búsqueda sistemática y exhaustiva de la litera- tura, a partir de la localización y selección de 54 estudios primarios publicados en diez bases de datos, tres revisores cegados evaluaron calidad metodológica de 33 estudios, con listas de chequeo para la evaluación crítica de la validez interna, según tipo de estudio y el cuarto revisor cegado, calculó grado de acuerdo entre revisores con Kappa de Fleiss y valoró riesgo de sesgo, sensibilidad, heterogenei- dad y análisis combinado a través del Software RevMan 5.4. Se obtuvo revisión sistemática cualitativa y combinación mediante métodos estadísticos de los resultados con meta-análisis de siete estudios primarios, con muestra de 465 participantes, 260 expuestos a laborato- rios tradicionales y 205 a nuevas tecnologías. Encontrando satisfacción del proceso y resultados positivos de aprendizaje comprensión y aplicación con favorabilidad inicial a las prácticas tradicionales no significativa al valorar los intervalos de confianza. Así, el contraste entre métodos para estas prácticas reveló desenlaces relacionados con reacciones físico-emocionales, focalización en el constructo rendimiento académico ycon los procesos de aprendizaje. Concluyendo que los laboratorios con nuevas tecnologías para estudio de anatomía, no impactan en forma prerrogativa a los estudiantes, dada su experiencia favorable con los laboratorios tradicionales, y pueden emplearse como una estrategia útil complementaria.  PALABRAS CLAVE: Anatomía; Realidad virtual; Cadáver; Estudiantes de medicina; Revisión sistemática. INTRODUCCIÓN  La anatomía humana es un pilar básico dentro del amplio y complejo campo de la medicina (Romero Reverón, 2010), que requiere fundamentalmente desarrollarse en medio de diversas prácticas en el contexto de los laborato- rios, constituyéndose en estrategias de enseñanza de esta asignatura, en las que se tienen variados recursos y didácticas, como enfoques de las prácticas médicas inicia- les que sin duda han revelado evolución y cambio en sus perspectivas. Así, en estas prácticas, el método más anti- guo de enseñanza es la disección, como eje motivante y beneficioso para los estudiantes en su deseo de estudiar y conocer las estructuras macroscópicas del cuerpo humano. No obstante, en la actualidad, la consecución de cadáveres para la enseñanza es limitada, lo que ha llevado esta activi- dad a los escenarios de formación remota y virtual, la cuál ha sido acentuada drásticamente en el tiempo que se vive hoy debido a la Pandemia del Covid- 19, responsable de una importante crisis educativa a nivel mundial con gran impacto en la formación médica, en la que la educación virtual es metódicamente la modalidad de enseñanza. Sin embargo, la comprensión temática de la Anatomía Huma- na sin prácticas y disecciones u otros apoyos didácticos tradicionales, así como la percepción de lo real, la orienta- ción espacial y visualización de relaciones anatómicas es desafiante y genera debates sobre   la didáctica ideal para su enseñanza (Singal   et al ., 2020). 1   Programa de Medicina, Facultad de Ciencias de la Salud, Universidad de Boyacá, Tunja, Colombia. 2   Programa de Enfermería, Facultad de Ciencias de la Salud, Universidad de Boyacá, Tunja, Colombia. Received: 2021-07-01   Accepted: 2021-11-23\n31  Las investigaciones indican que la formación de es- tudiantes en medicina del siglo XXI, disfrutan aprendiendo anatomía con la ayuda de la tecnología y mejora las expe- riencias de aprendizaje (Baratz   et al ., 2019), también se ha demostrado que la visualización tridimensional (3D) bene- ficia a las nuevas generaciones de estudiantes de medicina y médicos en formación en una variedad de contextos (Weeks  et al ., 2021), aunque fuese implementada desde 1993 (Ng   et al ., 2015), su uso y modernización se ha fortalecido. Asi- mismo, se ha afirmado que las prácticas tradicionales de anatomía en el anfiteatro, son significativas, porque en es- tas el estudiante interactúa directamente en su contexto con los especímenes humanos y cadáveres, optimiza la compren- sión para su proceso de aprendizaje, porque es considerado el primer escenario para enfrentar la realidad de la vida y la muerte, así como entender la responsabilidad de cuidar al ser humano, aspectos de gran relación con el perfil profe- sional de la carrera de medicina. Las diversas reacciones físicas y emocionales derivadas de las experiencias en estas prácticas, y el aprendizaje de la relación con otros indivi- duos son necesarios para el establecimiento de la empatía (Jagua Gualdrón & Urrego Mendoza, 2011). En consecuencia, la presente revisión sistemática de la literatura planteó la siguiente pregunta de revisión: ¿Di- fieren las prácticas de laboratorio de anatomía humana tra- dicionales con las nuevas tecnologías para el estudio de la de anatomía humana?, y formuló como objetivo comparar los estudios publicados sobre las prácticas del laboratorio de anatomía tradicionales con nuevas tecnologías, para el estudio del cuerpo humano en estudiantes de medicina.  MATERIAL Y MÉTODO  Esta revisión sistemática, cuenta con registro en PROSPERO CRD42021240280 (Bernal-García   et al ., 2021), coherente con la declaración PRISMA. Ejecutó búsqueda del 01 noviembre 2020 al 31 mayo 2021, estableciendo es- trategia con estructura de pregunta PICO: P: Hombres y mujeres Estudiantes de anatomía o morfolo- gía humana (y sus otras designaciones) en la carrera de medicina. I: Prácticas del laboratorio de anatomía tradicionales: mo- delos anatómicos y disección. C: Prácticas con nuevas tecnologías para el estudio del cuerpo humano (herramientas tecnológicas, tercera dimensión, cuarta dimensión, softwares interactivos, plastinación digitalizada, multimedia). O: Principal: Percepciones físico- emocionales de estudian- tes en los laboratorios tradicionales   versus   nuevas tecno- logías en el aprendizaje de la anatomía humana. Secundario:Rendimiento académico - procesos de aprendi- zaje de la anatomía humana tradicionales con las nuevas tecnologías para el estudio de la de anatomía humana.  Estrategia de búsqueda y selección de estudios:   Cuatro revisores indepen- dientes ejecutaron búsqueda de estu- dios observacionales, experimentales y cuasi- experimentales, en idioma in- glés y español, a través de las bases de datos electrónicas WOS, Scopus, Pubmed, Springer, Science direct, LILACS,   Clinical   Key,   Sage, Proquest, Scielo, con términos de bús- queda validados en Mesh y DeCS como:   anatomy,   virtual   reality, cadaver, models anatomic, dimensio- nal anatomy, anxiety, psychological distress, multimedia, medical students; agrupados con conectores booleanos en combinaciones especificas según base de datos, proceso compendiado en el diagrama de flujo presentado en la Figura 1. Fig. 1 Diagrama de flujo de la selección de estudios  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n32  Extracción de datos y evaluación de la calidad metodológica.   Tres revisores diligenciaron matriz de alma- cenamiento Excel, con datos como título, año, lugar, idio- ma, resumen, tipo de estudio, intervención y comparador, número de participantes, medidas de efecto de los desenla- ces. Asimismo, evaluaron cegadamente la calidad metodológica de los estudios según número de conceptos de las listas de chequeo para la evaluación crítica de la vali- dez interna de estudios experimentales y cuasi-experimen- tales, respectivamente: Quality Assessment of Controlled Intervention Studies y Quality Assessment Tool for Before- After (Pre-Post) Studies With No Control Group (NHLBI) (National Heart, Lung and Blood Institute, 2021). Un cuar- to revisor cegado calculó grado de acuerdo entre revisores con coeficiente kappa Fleiss en Software Stata 14. Poste- riormente, se valoraron los riesgos de sesgo de los estudios experimentales, sensibilidad y heterogeneidad, además de análisis combinado a través del Software RevMan 5.4, en donde las medidas de efecto estaban disponibles.  RESULTADOS  Del número total de estudios identificados (n=54), 21 fueron elegidos y valorados en calidad metodológica por 3 evaluadores independientes, se descartaron los de medida de concordancia menor a 0,61 según coeficiente Kappa de Fleiss y puntaje de evaluación de calidad menor al 60 % de cumplimiento en los criterios asignados en las listas de che- queo aplicadas, así como aquellos con datos incompletos evitando el sesgo de desgaste; en esta fase se eliminaron 14 estudios, quedando 7 estudios incluidos para la presente re- visión sistemática, informados en idioma inglés, con año de publicación entre 2018 a 2020, procedentes de 6 países y que fueron sometidos a metaan álisis, en consideración al cumplimiento de las variables moderadoras, con un total de muestra de 465 participantes, 260 expuestos a laboratorios tradicionales y 205 a nuevas tecnologías, estudios sobre los cuales se detalla la caracterización y desenlaces en la Tabla I. Fue posible hacer análisis combinado para 6 de los estudios incluidos, 5 experimentales, y uno cuasi-experimen- tal, al comparar las prácticas tradicionales con las nuevas tecnologías en los desenlaces comunes: puntaje pos-test, sa- tisfacción y resultados positivos de aprendizaje; las medi- das estadísticas de referencia fueron los estimadores dife- rencia de medias estandarizadas y RR, con intervalos de confianza al 95 % y valores de significancia con p menores a 0,05; se desarrolló el análisis de sensibilidad valorando el rendimiento estadístico de diferentes escenarios de análisis combinado, garantizando que la forma en como los desen-  Principales desenlaces Autores, año y p aís Diseño   Grupos Control (GC) e Intervención (GI), muestra (n) y tipo de práctica Reacciones físico emocionales Rendim iento académico Procesos de aprendizaje Mitrousias V,   et al . (2018). Grecia Cuasi- experimental GC (Prosección): n: 43 GI (Software 3D): n: 42 GC: Estrés (15 %) GC Y GI: Entusiasmo GC: 48 ± 16.1 GI: 55,88 ± 19,60 Utilidad   para   habilidades clínicas: GC: 29 (67,5 %); GI: 33 (78,12 %) Satisfacción: GC: 32 (75 %) ; GI: 2 9 (85,75 %) Ekstrand C,   et al . (2018). Canadá Experimental   GC (basado en papel): n:33 GI (Realidad virtual): n:31 Disminución del miedo: GC: 5 (12 %) ; GI: 25 (81 %) Test Group: F: 0,8203 (p=0,5) Satisfacción:   GC:   11   (33%) GI: 2 9 (94%) Casallas A,   et al ., (2018). Colombia Experimental   GC (tradicional) n:40 GI (software 3D Heart- tom) n: 40 NR   Calificaciones teóricas: GC: 3,6; GI: 4,3 Desempeño practico: GC: 2,5; GI: 2,75 Baratz G,   et a l . (2019). Estados Unidos Experimental   GC (disección cadavérica): n:7 GI (tabla Anatomage): n:7 Comodidad: GC: 2,27 (DE: 1,.07); GI: 2,37 (DE: 1,12) Puntuación del examen: GC: 70,8 (DE: 10,6); GI: 74,9 (DE: 6,5) Preparación:   GC:   2,19   (DE: 1,13); GI: 2,38 (DE: 1,10) Grado   de   aprendizaje:   GC: 2,99   (DE:   1,06);   GI:   3,68 (DE: 0,94) Sultan L,   et al ., (2019). Arabia Saudita Experimental   GC (Convencional): n: 112 GI (Realidad virtual): n: 57 Educación positiva: 8,8 sobre 10. Post-test: GC: 15,9 (DE: 2,9) / GI: 17,4 (DE: 2,1) Puntuación ECOE GC: 12,9 / GI: 9,8 Desempeño   examen   clínico: GC: 9,8 (DE: 4,2) / GI: 12,9 (DE: 4,1) Boscolo _ Berto, RB,   et al.,  (2020). Italia Experimental   GC (Libros de texto): n: 10 GI (disección virtual): n:13 NR   Post-test: GC: 10,6 (DE:2.9) GI: 11,3 (DE:3.7) GC:   Enfoque   fundamental para   el   aprendizaje   de l   a anatomía GI:   Beneficios   para   el aprendizaje (70 %) Weeks JK,   et al.  (2020). Estados Unidos Experimental   GC (pantallas 2D): n:15 GI (realidad aumentada 3D): n:15 NR   Post-test GC: 4 GI: 4,73 Comprensión percib ida: GC: 3,21, DE 0,80 GI: 3 ,07, DE 0,80  Tabla I. Caracterización de estudios.  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n33  laces se midieron fuera equiparable. En la Figura 2 se evi- dencia la valoración del riesgo de sesgo, hallando bajo ries- go de sesgos de reporte incompleto y notificación selectiva, y un riesgo alto de sesgo en el ocultamiento de la asigna- ción, el cegamiento de los participantes, de los investigado- res y de los evaluadores de los desenlaces. En los análisis combinados que permitieron compa- rar las prácticas tradicionales   versus   las nuevas tecnologías, se obtuvo para los puntajes post test, favorabilidad signifi- cativa en las prácticas tradicionales (DE: 0,49; IC: 0,24 a 0,73), con un I   2   de 0 % indicativo de baja heterogeneidad y un Chi 2   con un valor p de 0,87 que sugiere que los estudios presentan el mismo efecto. En la satisfacción ante el proce- so de aprendizaje se presentó una favorabilidad inicial a las prácticas tradicionales no significativa al valorar los inter- valos de confianza (RR: 1,59; IC: 0,50 a 4,98) y un I   2   de 94 % indicativo de una alta heterogeneidad y un Chi 2   con un valor p de 0,0001 que implica que los diferentes estudios no representan el mismo efecto. En tanto que, para los resulta- dos positivos de aprendizaje -comprensión y aplicación- muestra una favorabilidad inicial a las prácticas tradiciona- les no significativa al valorar los intervalos de confianza (DE: 0,43; IC: -0,18 a 1.05), con un I   2   de 61 % indicativo de alta heterogeneidad y un Chi 2   con un valor p de 0,08 que sugiere que los estudios presentan el mismo efecto. Bajo la prueba de Funnel Plot los estudios incluidos siguen la dis- tribución de embudo invertido, indicativo de bajo sesgo de publicación, resultados que se presentan en la Tabla II.  Fig. 2. Resumen de riesgo de sesgo.  Puntaje Post test  Satisfacció n ante el proceso de aprendizaje  Resultados positivos de aprendizaje -comprensión y aplicación-  Tabla II. Forests Plots análisis combinado.  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n34  DISCUSIÓN  Los resultados de la presente revisión, han permiti- do sintetizar la evidencia científica disponible sobre la pre- gunta de investigación que muestran cuantitativamente uti- lización de las prácticas tradicionales como la disección o uso de prosecciones cadavéricas y otras que admiten me- jor cercanía e interacción con pares y con docentes; aun así, el uso de las nuevas tecnologías 3D para el estudio del cuerpo humano, como el software 3D BioDigital Human, mesa Anatomage y otros recursos de disección virtual, se encuentran en progreso a lo largo de las últimas décadas, todavía bajo la perspectiva de innovación. No obstante, puede evidenciarse que en el contraste entre métodos di- fiere la parte cualitativa, según percepciones de los estu- diantes, en las que determinan que la tecnología no susti- tuye las prácticas en el anfiteatro, concordando con Bork,  et al . (2019), quienes refieren la tecnología como valiosa adición para mejorar los cursos de disección, más no como un reemplazo. Como desenlaces, en los estudios analizados, fue- ron evidentes algunas reacciones físico emocionales en los estudiantes, de manera variable y poco descriptiva. En ese sentido, el estudio de Mitrousias   et al . (2018), reportan quela modalidad de enseñanza no tuvo efecto sobre la ac- titud de los estudiantes, sin embargo,el 15 % de los estu- diantes en el grupo de prosección percibieron estrés / ma- lestar severo antes del laboratorio, en comparación con el 0 % de los estudiantes que utilizan software 3D, y la sen- sación de estrés / incomodidad permaneció en el 5 % de los estudiantes que estaban usando prosección incluso des- pués del final de los laboratorios, en contraste con los es- tudiantes que usan 3D, que no mencionaron estos senti- mientos en absoluto (p = 0.03), además independiente de la modalidad los estudiantes manifestaron entusiasmo. Asimismo, Ekstrand   et al . (2018) obtienen disminución de la neurofobia después de enfrentar los contenidos y su complejidad, en el aprendizaje con realidad virtual inversiva e interactiva dado que consigue ayudar a mejo- rar la obtención y retención de conocimientos, así como a aumentar la motivación para estudiar y disminuir el mie- do a la práctica. Es más, Casallas & Quijano (2018) en- cuentran mayor satisfacción post intervención, como sen- timiento de placer en el grupo GI que utilizó la herramien- ta 3D, y de manera similar, Baratz   et al ., mencionan la sensación de comodidad, interpretada como una caracte- rística física emocional y/o la realización de la acción sin esfuerzo. En cambio, Sultan   et al . (2019) encontraron que las sesiones de realidad virtual de 360   °   del estudio, per- mitieron a los estudiantes usar experiencialmente sus sen- tidos para ver, oír y sentir. Además, estos estudios examinados, contrastan as- pectos coherentes con la focalización en el constructo ren- dimiento académico, para lo cual se evidencian diversidad de instrumentos y mediciones relacionadas principalmen- te con los procesos de aprendizaje. En el estudio de Mitrousias   et al ., evalúan a ambos grupos con un examen final de cien preguntas idénticas de alta complejidad, la mitad de estas para identificar estructuras anatómicas en imágenes proyectadas y evaluar el conocimiento espacial, y la otra mitad, con preguntas simples de opción múltiple, diseñadas para abordar el nivel más bajo de objetivos cognitivos en la taxonomía de Bloom. A los estudiantes del grupo 3D se les pidió identificar estructuras 3D y cadavéricas y viceversa. Utilizaron además un cuestiona- rio anónimo original de 15 preguntas, para evaluar las se- siones de aprendizaje, el tutor y el método implementado, en las que no encontraron diferencias significativas entre hombres y mujeres, con respecto al rendimiento en total, no obstante, con uno de los métodos empleados notaron que los estudiantes que juegan videojuegos obtuvieron mejores calificaciones, en comparación con los estudian- tes que no los juegan. Ekstrand   et al . reportan que tanto para la prueba inicial como la posterior a la intervención, estructuraron 13 preguntas relacionadas con los materiales de estudio y 9 preguntas de control sobre el contenido de neuroanatomía no disponible en los materiales de estudio, y se pidió a los participantes abstenerse de estudiar neuroanatomía entre las 2 pruebas. No obstante, recono- cen como limitación, el corto período de seguimiento (5-9 días) el número limitado de preguntas para investigar la retención de conocimientos. De la misma forma, Casallas & Quijano analizan pruebas teóricas y prácticas, sin sesgos en su calificación, encontrando que los estudiantes del GI tuvieron mejor des- empeño académico en la prueba teórica que el grupo GC.Estimando un resultado favorable en el grupo que uti- lizó la herramienta 3D, que fue 14 % superior al resultado del grupo que no la utilizó. Y en las pruebas prácticas, los estudiantes del GC lograron calificaciones por debajo de las notas mínimas obtenidas por los del GI, evidenciando un mejor desempeño en este último. Sin embargo, aunque se   encontró   una   puntuación   más   alta,   no   fue estadísticamente significativa. De otra parte, los estudian- tes participantes coincidieron en que la herramienta 3D facilita el aprendizaje de la anatomía cardíaca y mejora el rendimiento académico teórico debido a la interactividad que les permite. Igualmente, Baratz   et al ., reportaron que no hubo diferencia significativa en el rendimiento de exá- menes prácticos sumativos entre grupos (Anatomage vs disección cadavérica). Además, Sultan   et al . encontraron que los estudiantes del GI (tecnología de realidad virtual de 360   ° ) obtuvieron una puntuación media más alta tanto  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n35  en la retención de conocimientos como en la adquisición de habilidades en comparación con el GC (Tradicional), demostrando que el aprendizaje experiencial es una teoría adecuada. Incluso, Boscolo-Berto   et al . (2021) indican que los estudiantes que aplicaron a una disección virtual dirigi- da tenían tres veces más probabilidades de reportar un re- sultado positivo (aprobado / positivo) en la prueba poste- rior a la disección que aquellos que aplicaron a los libros de texto de anatomía topográfica. Igualmente, Weeks   et al . demostraron un rendimiento significativamente superior en preguntas de anatomía al estilo National Board of Medical Examiners (NBME) en estudiantes que usan 3D y realidad aumentada para el aprendizaje en comparación con los es- tudiantes que usan una pantalla de computadora 2D, ha- llazgos que proporcionan evidencia con la implementación de una técnica mixta, sin embargo, dado el breve tiempo para completar la sesión educativa, los resultados refleja- ron un recuerdo a corto plazo en lugar de la adquisición de conocimientos a largo plazo. Todo ello, permite diferenciar otro desenlace rela- cionado con los procesos de aprendizaje, por parte de los estudiantes, de los que, Ekstrand   et al . proporcionan evi- dencia de que ambos métodos fueron de aprendizaje exito- so, resaltando que, la integración de la tecnología de reali- dad virtual en la educación médica puede beneficiar mo- delos de aprendizaje \"autodidactas\", ya que los estudiantes experimentan mayor motivación para estudiar y existe una curva de aprendizaje inherente al aprender una nueva tec- nología. Casallas & Quijano determinan que el uso del render, como herramienta cognitiva, facilita el aprendizaje de la anatomía cardíaca humana. Sin embargo, Baratz   et al ., sugieren que el aprendizaje percibido inmediatamente después de intervención con la tabla Anatomage es eficaz para la retención de información a corto plazo para solo un subconjunto de regiones anatómicas (anatomía musculo- esquelética) y alcanza una modalidad de aprendizaje equi- valente a la disección cadavérica dado que los estudiantes disfrutan la tecnología para complementar el aprendizaje, en anatomía macroscópica. Por su parte, Sultan   et al . ma- nifiestan que la realidad virtual en el contexto de la educa- ción médica es una solución innovadora, rentable y eficaz para una formación práctica mejor y más rápida, por lo que ayudaría a los estudiantes a desarrollar una compren- sión directa y significativa de los objetivos de aprendizaje. Además, Boscolo-Berto   et al ., reportan que el 70 % de los estudiantes GI con disección virtual expresaron beneficio para su aprendizaje, en las perspectivas tridimensionales, y como experiencia más atractiva que estudiar libros de texto y atlas.Sin embargo, reportaron dificultades y quejas por la ralentización de la mesa, imágenes con detalles defi- cientes con el zoom, limitaciones a la manipulación prede- terminada y la restricción de la interacción a una persona.De todos modos, reconoció la utilidad preliminar de la disec- ción virtual para su posterior aplicación a la disección cadavérica tradicional, como una combinación que mejora significativamentelos resultados de aprendizaje de los es- tudiantes. Además, Weeks   et al . evidencian mayor control del estudiante y motivación personal en el material de apren- dizaje dado un entorno interactivo con visualización tridimensional (3D), y Mitrousias   et al . resaltaron el per- feccionamiento de habilidades clínicas y comprensión en la ubicación de estructuras anatómicas Así y todo, las estrategias tradicionales proporcio- nan la comprensión anatómica profunda, el reconocimien- to de las estructuras corporales y la consecuente consoli- dación de los conocimientos en el área (Mompeó-Corre- dera, 2014), es ineludible garantizar que estas no sean del todo reemplazadas por las nuevas tecnologías, sino que más bien sean combinadas, para poder enfrentar asertivamente los contextos actuales, en los cuales la enseñanza y el apren- dizaje de la anatomía tiene grandes retos a ser superados, entre los cuales está la desintegración entre las ciencias básicas y las ciencias clínicas (Alzate-Mejía & Tamayo- Alzate, 2019). Finalmente, conexo a las limitaciones de esta revisión sistemática, principalmente se consideran hacia el tamaño muestral,   denotando   que   los   problemas   de   diseño metodológico repercutenpara el abordaje de la validez de los resultados. Así mismo,algunos de los estudios consultados no se incluyeron en esta revisión, por no presentar un grupo control o por las incomparables medidas o variables utiliza- das demostrando bajos niveles de fiabilidad o validez.  CONCLUSIÓN  En los estudiantes que realizaron laboratorios con nuevas tecnologías no impacta en forma prerrogativa el estudio de anatomía humana, dado que por lo general se relacionan con las experiencias favorables que han tenido con los laboratorios tradicionales, sin importar su frecuen- cia, son trascendentales y relativos al contexto de aprendi- zaje. Ultimando que las nuevas tecnologías pueden em- plearse como una estrategia útil complementaria. En definitiva, el número de estudios incluidos per- mite, además, inferir que existen pocas investigaciones con adecuada calidad metodológica, por lo que se propone la realización de más proyectos y trabajos experimentales que involucren un mayor enfoque metodológico en torno a esta temática. Así mismo, ampliar la revisión sistemática en otros idiomas.  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.\n36  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Traditional laboratories   versus   new technologies for the study of human anatomy in medical students: A systematic review and meta-analysis.   Int. J. Morphol., 40(1) :30- 36, 2022.  SUMMARY:   The study of human anatomy has transcended with various resources and scenarios. The objective was to compare published studies on traditional laboratory practices with new technologies for the study of the human body in medical students.   A systematic review and meta-analysis were carried out. Four reviewers carried out a systematic and exhaustive search of the literature, based on the location and selection of 54 primary studies published in ten databases, three reviewers evaluated the methodological quality of 33 studies, with checklists for the critical evaluation of internal validity, according to type of study. The fourth blinded reviewer, calculated degree of agreement between reviewers with Kappa de Fleiss and assessed risk of bias, sensitivity, heterogeneity and combined analysis using RevMan 5.4.   A qualitative systematic review and combination by statistical methods of the results were obtained with meta-analysis of seven primary studies, with a sample of 465 participants, 260 exposed to traditional laboratories and 205 to new technologies. Finding satisfaction with the process and positive results of learning, understanding and application, with initial favorability to traditional practices not significant when assessing the confidence intervals. Thus, the contrast between methods for these practices revealed outcomes related to physical-emotional reactions, focus on the academic performance construct and with the learning processes. Concluding that laboratories with new technologies for the study of anatomy do not prerogatively impact students, given their favorable experience with traditional laboratories, and can be used as a useful complementary strategy.  KEY WORDS: Anatomy; Virtual reality; Corpse; Medical students; Systematic review. REFERENCIAS BIBLIOGRÁFICAS  Alzate-Mejía, O. A. & Tamayo-Alzate, O. E. Metacognition in the learning of anatomy.   Int. J. Morphol., 37(1) :7-11, 2019. Baratz, G.; Wilson-Delfosse, A. L.; Singelyn, B. M.; Allan, K. C.; Rieth, G. E.; Ratnaparkhi, R.; Jenks, B. P.; Carlton, C.; Freeman, B. K. & Wish- Baratz, S. Evaluating the Anatomage table compared to cadaveric dissection as a learning modality for gross anatomy.   Med. Sci. Educ., 29(2) :499-506, 2019. Bernal-García, M. I.; Quemba-Mesa, M. P.; Silva-Ortiz, S. R. & Pacheco- Olmos, B. Traditional laboratories   versus   new technologies for the study of Human anatomy in medical students: A systematic review of the literature. PROSPERO, CRD42021240280, 2021. Disponible en: https:/ / w w w. c r d . y o r k . a c . u k / p r o s p e r o / d i s p l a y _ r e c o r d . p h p ? I D = CRD42021240280 Bork, F, Stratmann, L.; Enssle, S.; Eck, U.; Navab, N.; Waschke, J. & Kugelmann, D. The benefits of an augmented reality magic mirror system for integrated radiology teaching in gross anatomy.   Anat. Sci. Educ., 12(6) :585-98, 2019. Boscolo-Berto, R.; Tortorella, C.; Porzionato, A.; Stecco, C.; Picardi, E. E. E.; Macchi, V. & De Caro, R. The additional role of virtual to traditional dissection in teaching anatomy: a randomised controlled trial.   Surg. Radiol. Anat., 43(4) :469-479, 2021. Casallas, A. & Quijano, Y. 3D rendering as a tool for cardiac anatomy learning in medical students. Rev. Fac. Med. (Bogotá), 66:611-6, 2018. Ekstrand, C.; Jamal, A.; Nguyen, R.; Kudryk, A.; Mann, J. & Mendez, I. Immersive and interactive virtual reality to improve learning and retention of neuroanatomy in medical students: a randomized controlled study . CMAJ Open, 6(1) :E103-E109, 2018. Jagua Gualdrón, A. & Urrego Mendoza, D. Z. Actitudes de los estudiantes colombianos de medicina hacia la práctica de la disección en anatomía y su relación con el puntaje en la escala de empatía médica de Jefferson.  Rev. Fac. Med. (Bogotá), 59(4) :281-307, 2011. Mitrousias, V.; Varitimidis, S. E.; Hantes, M. E.; Malizos, K. N.; Arvanitis, D. L. & Zibis, A. H. Anatomy learning from prosected cadaveric specimens   versus   three-dimensional software: A comparative study of upper limb anatomy.   Ann. Anat., 218 :156-64, 2018. Mompeó-Corredera, B. Metodologías y materiales para el aprendizaje de la anatomía humana: percepciones de los estudiantes de medicina \'nativos digitales\'.   FEM Rev. Fund. Educ. Med., 17(2) :99-104, 2014. National Heart, Lung and Blood Institute. Study Quality Assessment Tools. Internet. Bethesda, National Institute of Health, 2021. Disponible en: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools Ng, C. L.; Liu, X.; Chee, S. C. J. & Ngo, R. Y. S. An innovative 3-dimensio- nal model of the epitympanum for teaching of middle ear anatomy.  Otolaryngol. Head Neck Surg., 153(5) :832-7, 2015. Romero Reverón, R. Anatomical dissection: a positive experience for venezuelan first year medical students.   Int. J. Morphol., 28(1) :213-7, 2010. Singal, A.; Bansal, A. & Chaudhary, P. Cadaver less anatomy: Darkness in the times of pandemic Covid-19.   Morphologie, 104(346) :147-50, 2020. Sultan, L.; Abuznadah, W.; Al-Jifree, H.; Khan, M. A.; Alsaywid, B. & Ashour, F. An Experimental Study On Usefulness Of Virtual Reality 360 °   In Undergraduate Medical Education.   Adv. Med. Educ. Pract., 10 :907-16, 2019. Weeks, J. K.; Pakpoor, J.; Park, B. J.; Robinson, N. J.; Rubinstein, N. A.; Prouty, S. M. & Nachiappan, A. C. Harnessing augmented reality and CT to teach first-year medical students head and neck anatomy.   Acad. Radiol., 28(6) :871-6, 2021.  Dirección para correspondencia: Martha Bernal García Carrera 2ª Este nº 64 - 196 Campus Universidad de Boyacá Sede Principal Tunja Boyacá COLOMBIA E-mail: mibernal @uniboyaca.edu.co  BERNAL-GARCÍA, M.; QUEMBA, M. M.; SILVA, O. S., PACHECO-OLMOS, B.   Laboratorios tradicionales   versus   nuevas tecnologías para el estudio de anatomía humana en estudiantes de medicina: revisión sistemática y meta análisis.   Int. J. Morphol., 40(1) :30-36, 2022.',0.1460768051750921,'[\"\\\"autodidactas\\\",\", \"%\", \"%)\", \"%);\", \"&\"]','2025-11-29 22:25:06.368302'),(104,3,'Radiología.   2020; 62(1) :46- - -50  www.elsevier.es/rx  ORIGINAL  Satisfacción   de   pacientes   y   profesionales   con   las nuevas   tecnologías   de   imagen   tridimensional   aplicadas a   la   medicina S.   Fuentes   a , ∗ ,   M.   Berlioz   b   ,   F.   Damián   b   ,   J.M.   Pradillos   a   ,   T.   Lorenzo   b   y   E.   Ardela   a  a   Servicio   de   Cirugía   Pediátrica,   Complejo   Asistencial   Universitario   de   León,   León,   Espa˜ na  b   Servicio   de   Radiología,   Complejo   Asistencial   Universitario   de   León,   León,   Espa˜ na  Recibido   el   5   de   febrero   de   2019;   aceptado   el   19   de   junio   de   2019 Disponible   en   Internet   el   29   de   julio   de   2019  PALABRAS   CLAVE  Imagen tridimensional; Satisfacción   del paciente; Pectus   excavatum; Pectus   carinatum  Resumen  Antecedentes   y   objetivos:   Gracias   a   los   avances   en   el   campo   del   escaneado   tridimensional   (3   D) existen   instrumentos   capaces   de   generar   imágenes   con   utilidad   en   medicina.   Por   otra   parte,   los estudios   de   satisfacción   ganan   cada   vez   más   importancia   para   evaluar   la   calidad   en   la   asistencia. Nuestro   objetivo   es   valorar   la   satisfacción   de   los   pacientes   con   el   uso   de   un   escáner   3   D   aplicado a   las   malformaciones   de   la   pared   torácica,   así   como   de   los   profesionales   implicados   en   su   uso.  Material   y   métodos:   Se   han   desarrollado   encuestas   de   satisfacción   para   pacientes   y   profesio- nales   que   han   completado   pacientes   sometidos   a   escáner   3   D   en   el   contexto   de   un   estudio   para validar   los   resultados   obtenidos   con   esta   nueva   tecnología.   Se   han   obtenido   los   estadísticos descriptivos   de   los   resultados   obtenidos.  Resultados:   Se   han   incluido   42   pacientes   y   10   profesionales.   Los   pacientes   evalúan   de   manera positiva   la   velocidad   y   la   inocuidad.   La   media   de   satisfacción   global   es   de   4,71   en   una   escala del   1   al   5.   Entre   los   profesionales,   la   satisfacción   es   inferior,   sobre   todo   en   lo   que   respecta   al tratamiento   de   la   imagen.   La   media   de   satisfacción   global   es   de   3,1.  Conclusiones:   Los   pacientes   evaluados   tienen   una   buena   aceptación   y   satisfacción   con   la   tecno- logía   de   escaneado   3   D.   No   ocurre   lo   mismo   con   los   profesionales,   ya   que   debido   a   la   dificultad de   tratamiento   de   la   imagen   y   a   la   falta   de   familiaridad   con   el   sistema   presentan   una   satis- facción   menor.   Son   necesarios   avances   en   la   difusión   y   simplificación   de   esta   tecnología   para aprovechar   al   máximo   su   potencial. ©   2019   SERAM.   Publicado   por   Elsevier   Espa˜ na,   S.L.U.   Todos   los   derechos   reservados.  ∗   Autor   para   correspondencia.  Correo   electrónico:   sfuentesc@saludcastillayleon.es   (S.   Fuentes).  https://doi.org/10.1016/j.rx.2019.06.001 0033-8338/©   2019   SERAM.   Publicado   por   Elsevier   Espa˜ na,   S.L.U.   Todos   los   derechos   reservados.\nSatisfacción   de   pacientes   y   profesionales   con   las   nuevas   tecnologías   de   imagen   3D   47  KEYWORDS  Three-dimensional imaging; Patient   satisfaction; Pectus   excavatum; Pectus   carinatum  Patient   and   healthcare   professional   satisfaction   with   3   D   imaging   new   technologies for   medical   purposes Abstract  Background   and   objectives:   Advances   in   the   field   of   three-dimensional   scanning   have   enabled the   development   of   instruments   that   can   generate   images   that   are   useful   in   medicine.   On   the other   hand,   satisfaction   studies   are   becoming   increasingly   important   in   the   evaluation   of   quality in   healthcare.   We   aimed   to   evaluate   patients’   and   professionals’   satisfaction   with   the   use   of   a three-dimensional   scanner   applied   to   chest   wall   malformations.  Material   and   methods:   In   the   framework   of   a   study   to   validate   the   results   of   three-dimensional scanning   technology,   we   developed   questionnaires   to   measure   satisfaction   among   patients   and professionals.   We   analyzed   the   results   with   descriptive   statistics.  Results:   We   included   42   patients   and   10   professionals.   Patients   rated   the   speed   and   harmless- ness   positively;   the   mean   overall   level   of   satisfaction   was   4.71   on   a   scale   from   1   to   5.   Among professionals,   the   level   of   satisfaction   was   lower,   especially   with   regards   to   the   treatment   of the   image;   the   mean   overall   level   of   satisfaction   was   3.1.  Conclusions:   Patients   rated   3   D   scanning   technology   highly,   but   professionals   were   less   satisfied due   to   the   difficulty   of   treating   the   images   and   lack   of   familiarity   with   the   system.   For   this technology   to   reach   its   maximum   potential,   it   must   be   simplified   and   more   widely   disseminated. ©   2019   SERAM.   Published   by   Elsevier   Espa˜ na,   S.L.U.   All   rights   reserved.  Introducción  El   desarrollo   de   la   tecnología   de   escaneado   tridimensional (3   D)   está   favoreciendo   su   aplicación   en   diferentes   campos científicos.   Actualmente   existen   en   el   mercado   escáneres de   peque˜ no   tama˜ no   con   definición   suficiente   como   para tomar   imágenes   precisas   de   la   superficie   corporal   1   .   Además, la   simplificación   de   los   programas   permite   la   generación automática   de   la   figura   y   la   toma   de   medidas,   por   lo   que esta   tecnología   se   propone   como   una   herramienta   poten- cialmente   útil   en   el   campo   de   la   medicina   2,3   . Con   la   aparición   de   los   nuevos   sistemas,   cada   vez   existen más   estudios   sobre   las   aplicaciones   en   odontología,   deformi- dades   craneales   y   cirugía   plástica,   así   como   malformaciones de   la   pared   torácica   3,4   . Por   otra   parte,   en   los   últimos   a˜ nos   se   está   prestando cada   vez   más   atención   a   la   evaluación   de   la   satisfacción   del paciente   como   medida   de   la   calidad   en   la   asistencia   sani- taria.   En   el   contexto   del   llamado   cuidado   centrado   en   el paciente,   se   toman   en   consideración   las   preferencias   y   las necesidades   del   individuo   en   la   toma   de   decisiones   5   .   Según este   concepto,   el   buen   funcionamiento   de   los   sistemas   de salud   depende   no   solamente   de   la   actuación   de   los   profesio- nales,   sino   también   de   la   experiencia   subjetiva   del   paciente. La   medida   de   esta   percepción   y   satisfacción   con   los   cuidados es   tan   importante   para   la   valoración   de   la   calidad   como   la evaluación   de   la   actuación   del   personal   sanitario   6   .   Permite, además,   identificar   posibles   puntos   de   mejora   en   el   sistema. Asimismo,   una   mayor   satisfacción   del   paciente   se   relaciona con   una   mayor   adherencia   al   tratamiento   y   al   seguimiento de   su   enfermedad,   lo   que   mejora,   por   tanto,   el   resultado final   7   .   Así,   existe   una   tendencia   a   evaluar   la   experiencia   del paciente   como   parte   de   un   programa   global   de   calidad. Con   motivo   de   un   estudio   para   validar   los   resultados   de un   escáner   de   superficie   tridimensional   frente   a   la   prueba  radiológica   tradicional,   nos   preguntamos   qué   impresión   tie- nen   los   pacientes   con   este   nuevo   tipo   de   tecnología   y si   apreciarán   sus   beneficios   respecto   a   la   tecnología   tra- dicional.   Del   mismo   modo   nos   preguntamos   si   entre   los profesionales   implicados   en   el   cuidado   del   paciente   estas tecnologías   resultan   atractivas   o   fiables   y   se   aprecia   real- mente   su   verdadero   potencial. El   objetivo   principal   de   este   estudio   es   valorar   la   satisfac- ción   del   paciente   con   una   prueba   de   escáner   tridimensional para   evaluar   malformaciones   de   la   pared   torácica   y   su   pre- ferencia   respecto   a   las   pruebas   radiológicas   tradicionales. Por   otra   parte,   nos   planteamos   evaluar   la   satisfacción   de los   profesionales   encargados   de   la   asistencia   sanitaria   con este   nuevo   tipo   de   tecnología.  Material   y   métodos  En   nuestro   centro,   desde   2018   estamos   desarrollando un   estudio   para   validar   las   medidas   e   índices   obtenidos mediante   escáner   tridimensional   de   tórax   frente   a   resonan- cia   magnética   nuclear   (RMN).   Hemos   realizado   encuestas de   satisfacción   a   los   pacientes   que   se   sometieron   a   ambas pruebas   en   el   a˜ no   2018.   Se   trata   de   pacientes   afectados   de malformaciones   de   la   pared   torácica,   tipo   pectus   excavatum  y   pectus   carinatum ,   de   ambos   sexos   y   de   edades   compren- didas   entre   los   7   y   los   18   a˜ nos. Como   escáner   tridimensional   contamos   con   el   instru- mento   PocketScan   3   D   de   Mantis   Vision   TM   (Israel)   (fig.   1). Es   un   escáner   de   reducido   tama˜ no   que   funciona   con   luz infrarroja.   Su   precisión   es   del   0,2%   de   la   dimensión   valo- rada   y   el   tiempo   de   adquisición   de   imagen   es   de   600.000 puntos   por   segundo.   Se   tomaron   imágenes   de   cada   paciente en   inspiración   y   espiración   (fig.   2). Los   estudios   de   RMN   se   realizan   utilizando   un   equipo   RMN SIEMENS   AVANTO   1.5   T   con   el   que   se   obtienen   secuencias\n48   S.   Fuentes   et   al.  Figura   1   Escáner   portátil.  Figura   2   Interfaz   del   programa   con   dos   visiones   tridimensio- nales   de   ejemplo.  Tabla   1   Ítems   valorados   en   la   encuesta   de   satisfacción para   familiares  La   prueba   ha   sido   rápida La   prueba   ha   sido   cómoda   sin   molestias Prefiero   esta   prueba   a   otras   tradicionales   (RMN) Repetiría   la   prueba   sin   problemas Recomendaría   la   prueba   a   otros   conocidos   si tuvieran   que   hacerla Satisfacción   global   con   la   prueba RMN:   resonancia   magnética   nuclear.  T2-HASTE   TRA   con   45   cortes,   factor   de   distancia   0%   y   gro- sor   de   corte   de   4   mm   con   un   tiempo   de   adquisición   de   50 segundos   (4   apneas   de   12   segundos)   utilizando   una   matriz de   186   ×   256. Para   la   evaluación   de   la   satisfacción,   ante   la   ausencia de   encuestas   específicas   sobre   pruebas   radiológicas,   des- arrollamos   una   encuesta   con   los   ítems   más   importantes   a considerar   en   la   realización   de   la   prueba   para   valorar   su aceptación   (tabla   1).   Asimismo,   elaboramos   una   segunda encuesta   con   aspectos   relacionados   con   la   adquisición   y   el tratamiento   de   las   imágenes,   para   evaluar   la   satisfacción   de los   profesionales   (tabla   2). Los   datos   se   recogieron   de   manera   anónima   en   una   tabla de   Excel   (Microsoft   ®   Excel   ®   2011   para   Mac   Versión   14.7.0). Se   calcularon   los   estadísticos   descriptivos,   los   porcentajes  Tabla   2   Ítems   valorados   en   la   encuesta   para   profesionales  La   prueba   ha   sido   rápida La   prueba   es   fácil   de   realizar El   tratamiento   de   las   imágenes   es   fácil La   resolución   de   la   prueba   es   la   adecuada   para   lo que   pretende   medir Recomendaría   la   prueba   a   otros   profesionales Satisfacción   global   con   la   prueba  Tabla   3   Características   generales   de   los   pacientes incluidos  Total   pacientes   42 Género   Ni˜ nos   30 Ni˜ nas   12 Tipo   de   malformación   Pectus   excavatum   26  Pectus   carinatum   12 Controles   4 Tratamiento   Medidas   conservadoras   21 Ortopédico   17  de   cada   puntuación   y   medias   y   desviación   estándar   de   cada ítem   por   separado   en   ambos   grupos.  Resultados  Durante   este   periodo,   42   pacientes   cumplieron   los   crite- rios   de   inclusión   y   completaron   la   encuesta.   Se   trata   de pacientes   con   edades   comprendidas   entre   los   7   y   los   18 a˜ nos,   con   una   media   de   13,6.   Entre   las   malformaciones   de la   pared   torácica,   26   fueron   pectus   excavatum   y   12   pec- tus   carinatum .   Cuatro   pacientes   en   tratamiento   ortopédico presentaban   corrección   completa   de   la   deformidad   en   el momento   de   realizar   la   prueba   por   lo   que   fueron   consi- derados   controles.   Las   características   de   los   pacientes   se resumen   en   la   tabla   3. Diez   profesionales   implicados   en   el   estudio   en   alguna   de sus   fases   completaron   la   encuesta   de   satisfacción   para   pro- fesionales.   Se   incluyeron   8   médicos   y   otros   dos   profesionales sanitarios.  Encuestas   en   pacientes  Las   puntuaciones   de   cada   uno   de   los   ítems   oscilaron   entre   1 (muy   en   desacuerdo)   y   5   (totalmente   de   acuerdo). La   media   en   todos   los   ítems   evaluados   superó   los   4   puntos (fig.   3).   Los   aspectos   mejor   valorados   fueron   la   inocuidad   de la   prueba,   con   una   media   de   4,9   (desviación   estándar   [DE] 0,54),   y   la   rapidez,   con   una   media   de   4,8   (DE   0,29). Proporcionalmente,   la   mayoría   de   las   respuestas   fueron 4-5,   un   92%.   Las   respuestas   sobre   la   preferencia   entre   el escáner   tridimensional   y   la   RMN   fueron   más   heterogéneas: 2   pacientes   respondieron   que   preferían   la   RMN   y   9   (un   21,4% del   total)   manifestaron   indiferencia   entre   una   prueba   u   otra. Un   95,2%   del   total   recomendaría   seguro   o   casi   con   toda seguridad   la   prueba   a   otras   personas,   y   la   satisfacción   global tuvo   como   media   un   4,71   (DE   =   0,54).\nSatisfacción   de   pacientes   y   profesionales   con   las   nuevas   tecnologías   de   imagen   3D   49  GLOBAL Media de puntuación en cada ítem en la encuesta para pacientes RECOMEDARÍA A OTROS REPETIRÍA YO PREFIERO ESTA A RM INOCUA RÁPIDA 3,80   4,00   4,20   4,40   4,60   4,80   5,00  Figura   3   Medias   de   puntuación   para   cada   ítem   en   la   encuesta para   pacientes.  GLOBAL RECOMEDACION RESOLUCIÓN TRATAMIENTO IMAGEN FÁCIL RÁPIDA 0   0,5   1   2   3 1,5   2,5   3,5   4,5 4   5 Medias de puntuación en cada ítem en la encuesta para profesionales  Figura   4   Medias   de   puntuación   para   cada   ítem   en   la   encuesta para   profesionales.  En   cuestas   en   profesionales  Para   profesionales,   las   medias   en   los   distintos   ítems   evalua- dos   presentaron   una   mayor   disparidad   (fig.   4).   La   media   en la   valoración   de   la   rapidez   y   la   facilidad   para   su   realización fue   en   ambas   de   4,6   (DE   =   0,66),   y   fueron   los   aspectos   mejor valorados. La   valoración   de   la   facilidad   para   el   tratamiento   de   las imágenes   tiene   un   2,1   de   media   (DE   =   1,13)   y   la   resolución   un 3,4   (DE   =   1,2).   Solo   un   30%   de   los   profesionales   recomendaría la   prueba   a   un   compa˜ nero   seguro   o   casi   con   toda   seguridad. La   satisfacción   global   alcanza   una   media   de   3,1   (DE   =   1,51).  Discusión  El   escaneado   de   superficie   tiene   un   importante   potencial en   el   campo   de   la   medicina,   especialmente   en   patologías   y especialidades   en   las   que   se   precisa   un   estudio   de   la   anato- mía   y   los   relieves,   así   como   en   el   caso   de   pacientes   de   corta edad   8   ,   lo   que   permite   prescindir   de   la   sedación   además   de obviar   la   radiación   ionizante. El   concepto   de   satisfacción   está   bien   definido   en   la   lite- ratura   científica.   Se   trata   de   un   estado   psicológico   que   se  produce   tras   el   uso   de   un   servicio   en   relación   con   el   estado basal   de   expectativa   ante   el   uso   de   ese   servicio   9,10   .   La satisfacción   es   subjetiva   y,   por   tanto,   sometida   a   una   serie de   factores   que   hay   que   tener   en   consideración,   especial- mente   en   el   caso   que   nos   ocupa   cuando   el   individuo   es   un paciente   y   el   servicio   que   se   utiliza   está   relacionado   con   la salud   11,12   . En   los   últimos   tiempos,   las   encuestas   han   ganado   fuerza como   medio   para   cumplir   el   objetivo   de   evaluar   la   calidad de   la   asistencia   sanitaria   en   lo   que   respecta   a   la   satisfacción del   paciente   con   los   servicios   prestados   13   . Actualmente   no   hay   ningún   cuestionario   específico   para valorar   la   satisfacción   en   relación   con   las   pruebas   de   ima- gen.   Es   por   ello   por   lo   que   en   este   estudio   hemos   optado por   adaptar   una   serie   de   preguntas   básicas   y   genéricas   para que   puedan   ser   contestadas   por   los   pacientes   en   el   rango de   edad   estudiado   y   que   reflejan   la   aceptación   y   la   satisfac- ción   con   la   prueba   realizada   y   la   comparan   con   una   prueba radiológica   clásica. A   la   luz   de   los   resultados   obtenidos   podemos   observar que   los   ítems   que   valoran   la   comodidad   y   la   rapidez   de   la prueba   obtuvieron   la   media   más   alta.   En   nuestro   estudio, el   tiempo   de   toma   de   imagen   no   excedió   los   4   segundos, mientras   que   las   secuencias   de   RMN   precisaron   al   menos   10 minutos   de   máquina. Cuando   se   trata   de   comparar   esta   prueba   frente   a   la   tra- dicional   (en   el   caso   de   nuestro   estudio   la   RMN   que   habían realizado   el   mismo   día),   un   23%   de   los   pacientes   no   presenta preferencia   por   una   u   otra,   siendo   el   ítem   con   una   media menor   frente   al   resto.   Este   resultado   puede   ser   atribuible   a la   confianza   que   se   tiene   en   las   pruebas   tradicionales   y   en una   cierta   reticencia   a   la   aceptación   de   pruebas   más   nove- dosas   en   vías   de   investigación.   Factores   como   la   aparente complejidad   de   la   RMN   o   el   tiempo   de   la   prueba   pueden hacer   pensar   a   los   usuarios   que   se   trata   de   una   evaluación de   mayor   calidad.   Efectivamente,   la   RMN   nos   aporta   más información,   pero   es   nuestro   deber   como   profesionales   sani- tarios   explicar   a   los   pacientes   que   no   siempre   este   exceso   de información   es   positivo   ni   se   traduce   en   una   mejor   atención, ya   que   cada   prueba   diagnóstica   está   dirigida   a   responder   a una   necesidad   clínica. La   realización   de   la   prueba,   no   obstante,   no   supone   un problema   para   el   paciente   y   ha   presentado   una   buena   acep- tación,   ya   que   la   mayoría   de   ellos   puntúan   al   máximo   al ser   preguntados   si   repetirían   el   estudio   o   si   lo   recomenda- rían   a   otras   personas.   La   satisfacción   global   con   la   prueba tiene   una   media   de   4,72,   resultado   que   se   considera   muy positivo. En   lo   que   se   refiere   a   la   satisfacción   de   los   profesionales con   la   prueba   encontramos   datos   más   negativos   en   ciertos ítems   relacionados   fundamentalmente   con   el   trabajo   que   ha de   realizarse   tras   la   adquisición   de   la   imagen. Es   muy   importante   adaptar   las   nuevas   tecnologías   al ámbito   de   la   asistencia   sanitaria,   pero   esto   no   es   siempre fácil.   En   nuestro   ámbito,   el   escáner   3   D   tiene   unas   ventajas que   nos   hacen   pensar   que   merece   la   pena   este   esfuerzo. sSi   la   tecnología   no   es   intuitiva   y   accesible,   el   personal sanitario   tiene   que   hacer   un   sobreesfuerzo   para   entrenarse en   su   uso   que   resulta   contraproducente. Las   puntuaciones   en   cuanto   a   rapidez   y   sencillez   son altas,   aunque   ligeramente   inferiores   a   las   percibidas   por   los pacientes.\n50   S.   Fuentes   et   al.  En   lo   que   respecta   a   la   facilidad   para   el   tratamiento   de las   imágenes   se   obtienen   resultados   muy   inferiores,   con   un 60%   de   los   profesionales   que   puntúan   1   o   2   (en   desacuerdo o   muy   en   desacuerdo).   Esto   es   debido   a   las   dificultades   para las   mediciones   encontradas   al   inicio   del   estudio.   El   soft- ware   de   tratamiento   de   las   imágenes   era   poco   intuitivo   y difícil   de   manejar,   lo   que   nos   obligó   a   buscar   programas alternativos.   Este   inconveniente   retrasó   la   toma   de   medi- das,   lo   que   explica   que   la   satisfacción   en   este   punto   fuera baja. Tanto   las   puntuaciones   referentes   a   la   repetición   como la   recomendación   son   bajas,   suponemos   que   por   el   mismo motivo.   Una   vez   superadas   las   dificultades   iniciales   se   sim- plificó   el   procedimiento,   pero   este   primer   contacto   con   la tecnología   tridimensional   tuvo   un   impacto   negativo   sobre los   profesionales.   No   obstante,   la   satisfacción   global   con   la prueba   obtuvo   una   media   de   3,1. En   conclusión,   podemos   decir   que   el   escáner   3   D   tuvo   una buena   aceptación   por   parte   de   los   pacientes. En   lo   que   respecta   a   los   profesionales,   detectamos   un reconocimiento   de   las   ventajas   de   esta   tecnología,   pero una   importante   falta   de   satisfacción   en   lo   que   se   refiere al   tratamiento   de   las   imágenes. Postulamos   que   el   desarrollo   de   aplicaciones   y   software  más   sencillo   facilitaría   su   uso   por   personal   no   entrenado, simplificando   su   manejo   y   probablemente   mejorando   la satisfacción. Estas   tecnologías   aportan   una   serie   de   ventajas   no desde˜ nables,   su   simplificación   es   fundamental   para   favore- cer   su   uso   y   un   esfuerzo   por   parte   de   los   profesionales   en   su aprendizaje,   la   validación   de   sus   resultados   y   en   su   difusión y   presentación   al   colectivo   de   pacientes.  Autoría  1.   Responsable   de   la   integridad   del   estudio:   SF,   MB,   FD,   JMP, TL   y   EA. 2.   Concepción   del   estudio:   SF,   EA   y   TL 3.   Dise˜ no   del   estudio:   SF,   MB,   DF   y   JMP. 4.   Obtención   de   los   datos:   FD,   MB,   SF,   JMP,   y   TL. 5..   Análisis   e   interpretación   de   los   datos:   SF,   MB   y   FD. 6.   Tratamiento   estadístico:   SF   y   JMP. 7.   Búsqueda   bibliográfica:   SF   y   JMP. 8.   Redacción   del   trabajo:   SF   y   EA. 9.   Revisión   crítica   del   manuscrito   con   aportaciones   intelec- tualmente   relevantes:   TL   y   EA. 10:   Aprobación   de   la   versión   final:   SF,   MB,   FD,   JMP,   TL   y   EA.  Conflicto   de   intereses  Los   autores   declaran   no   tener   ningún   conflicto   de   intereses.  Financiación  El   presente   trabajo   se   ha   realizado   en   el   contexto   de   un estudio   financiado   por   una   beca   de   investigación   de   la   Junta de   Castilla   y   León   2017.   Referencia:   GRS   1571/A/17.  Agradecimientos  A   Luis   García   Pérez,   de   Digitalización   3   D   y   al   Dr.   Santiago Vivas   por   su   asesoramiento   y   apoyo.  Bibliografía  1.   Szafer   D,   Taylor   JS,   Pei   A,   de   Ruijter   V,   Hosseini   H,   Chao   S, et   al.   A   Simplified   Method   for   Three-Dimensional   Optical   Ima- ging   and   Measurement   of   Patients   with   Chest   Wall   Deformities. J   Laparoendosc   Adv   Surg   Tech   A.   2019;29:267- - -71. 2.   Poncet   P,   Kravarusic   D,   Richart   T,   Evison   R,   Ronsky   JL,   Alassiri   A, et   al.   Clinical   impact   of   optical   imaging   with   3-D   reconstruction of   torso   topography   in   common   anterior   chest   wall   anomalies. J   Pediatr   Surg.   2007;42:898- - -903. 3.   Chalmers   EV,   McIntyre   GT,   Wang   W,   Gillgrass   T,   Martin   CB,   Mos- sey   PA.   Intraoral   3   D   Scanning   or   Dental   Impressions   for   the Assessment   of   Dental   Arch   Relationships   in   Cleft   Care:   Which is   Superior?   Cleft   Palate   Craniofac   J.   2016;53:568- - -77. 4.   Tenhagen   M,   Bruse   JL,   Rodriguez-Florez   N,   Angullia   F,   Borghi A,   Koudstaal   MJ,   et   al.   Three-Dimensional   Handheld   Scanning to   Quantify   Head-Shape   Changes   in   Spring-Assisted   Surgery   for Sagittal   Craniosynostosis.   J   Craniofac   Surg.   2016;27:2117- - -23. 5.   Cheraghi   MA,   Esmaeili   M,   Salsali   M.   Seeking   Humanizing   Care   in Patient   Centered   Care   Process:   A   Grounded   Theory   Study.   Holist Nurs   Pract.   2017;31:359- - -68. 6.   Committee   on   Quality   of   Healthcare   in   America,   Institute   of Medicine.   Crossing   the   quality   chasm:   a   new   health   system   for the   21st   century.   Washington   DC:   National   Academy   Press;   2001. 7.   Doyle   C,   Lennox   L,   Bell   D.   A   systematic   review   of   evidence   on the   links   between   patient   experience   and   clinical   safety   and effectiveness.   BMJ   Open.   2013;3:e001570. 8.   Riphagen   JM,   van   Neck   JW,   van   Adrichem   LN.   3   D   surface imaging   in   medicine:   a   review   of   working   principles   and   impli- cations   for   imaging   the   unsedated   child.   J   Craniofac   Surg. 2008;19:517- - -24. 9.   Oliver   RL.   A   cognitive   model   of   the   antecedents   and   consequen- ces   of   satisfaction   decision.   J   Mark   Res.   1980;44:460- - -7. 10.   Fournier   S,   Mick   DG.   Rediscovering   satisfaction.   J   Mark. 1999;63:5- - -23. 11.   Batbaatar   E,   Dorjdagva   J,   Luvsannyam   A,   Amenta   P.   Conceptua- lisation   of   patient   satisfaction:   a   systematic   narrative   literature review.   Perspect   Public   Health.   2015;135:243- - -50. 12.   Batbaatar   E,   Dorjdagva   J,   Luvsannyam   A,   Savino   MM,   Amenta P.   Determinants   of   patient   satisfaction:   a   systematic   review. Perspect   Public   Health.   2017;137:89- - -101. 13.   Castle   NG,   Brown   J,   Hepner   KA,   Hays   RD.   Review   of   the   lite- rature   on   survey   instruments   used   to   collect   data   on   hospital patients’   perceptions   of   care.   Health   Serv   Res.   2005;40   6   Pt 2:1996- - -2017.',0.14505718155864805,'[\"(3\", \"(4\", \"(de\", \"(desviaci\\u00f3n\", \"(en\"]','2025-11-29 22:25:33.705825');
/*!40000 ALTER TABLE `analyses` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `users`
--

DROP TABLE IF EXISTS `users`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!50503 SET character_set_client = utf8mb4 */;
CREATE TABLE `users` (
  `id` bigint unsigned NOT NULL AUTO_INCREMENT,
  `email` varchar(191) COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `password_hash` varchar(255) COLLATE utf8mb4_unicode_520_ci NOT NULL,
  `token` varchar(128) COLLATE utf8mb4_unicode_520_ci DEFAULT NULL,
  `created_at` datetime(6) NOT NULL DEFAULT CURRENT_TIMESTAMP(6),
  PRIMARY KEY (`id`),
  UNIQUE KEY `uq_users_email` (`email`),
  KEY `ix_users_created_at` (`created_at`)
) ENGINE=InnoDB AUTO_INCREMENT=4 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_520_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `users`
--

LOCK TABLES `users` WRITE;
/*!40000 ALTER TABLE `users` DISABLE KEYS */;
INSERT INTO `users` VALUES (2,'r10o10b@gmail.com','$bcrypt-sha256$v=2,t=2b,r=12$7Pze1RPWhWh4vWcKdx9dFu$mMU9cWcVUvh0mY0xuSbT.viIYLm/RyS','a89fba2327b8bbb3d434be0e5504d9ff1a3d15f12462d1a9044064601d06c2ee','2025-11-27 21:41:06.392917'),(3,'manuelcn33btrujillo@gmail.com','$bcrypt-sha256$v=2,t=2b,r=12$6TTs89UHvb.a3.VLGwDtI.$oS9bmTuQ3UH3EGVQwSZ4X05Jwk0qady','8bbc77553a132384004b41577835dd1d4b094a5f962e5c0e11f2a84056095aa1','2025-11-28 16:05:26.748562');
/*!40000 ALTER TABLE `users` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2025-11-29 19:43:54
